Start XTANDI at disease progression to metastatic CRPC for your patients on GnRH therapy* 1

Transcription

1 AUA2015 Sharing Knowledge/Setting Standards new orleans Meeting Program

2 XTANDI (enzalutamide) capsules is indicated for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC). Start XTANDI at disease progression to metastatic CRPC for your patients on GnRH therapy* 1 *Or after bilateral orchiectomy. 1 Important Safety Information Contraindications XTANDI (enzalutamide) capsules can cause fetal harm when administered to a pregnant woman based on its mechanism of action and findings in animals. XTANDI is not indicated for use in women. XTANDI is contraindicated in women who are or may become pregnant. Warnings and Precautions In Study 1, conducted in patients with metastatic castration-resistant prostate cancer (CRPC) who previously received docetaxel, seizure occurred in 0.9% of patients who were treated with XTANDI and 0% treated with placebo. In Study 2, conducted in patients with chemotherapy-naïve metastatic CRPC, seizure occurred in 0.1% of patients who were treated with XTANDI and 0.1% treated with placebo. Patients experiencing a seizure were permanently discontinued from therapy and all seizure events resolved. There is no clinical trial experience re-administering XTANDI to patients who experienced a seizure, and limited clinical trial experience in patients with predisposing factors for seizure. Study 1 excluded the use of concomitant medications that may lower threshold, whereas Study 2 permitted the use of these medications. Because of the risk of seizure associated with XTANDI use, patients should be advised of the risk of engaging in any activity during which sudden loss of consciousness could cause serious harm to themselves or others. Permanently discontinue XTANDI in patients who develop a seizure during treatment. Adverse Reactions The most common adverse reactions ( 10%) reported from the two combined clinical trials that occurred more commonly ( 2% over placebo) in the XTANDI-treated patients were asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, and dizziness/vertigo. Other Adverse Reactions include: Laboratory Abnormalities: In the two studies, Grade 1-4 neutropenia occurred in 15% of patients treated with XTANDI (1% Grade 3-4) and in 6% of patients treated with placebo (0.5% Grade 3-4). The incidence of Grade 1-4 thrombocytopenia was 6% of patients treated with XTANDI (0.3% Grade 3-4) and 5% of patients on placebo (0.5% Grade 3-4). Grade 1-4 elevations in ALT occurred in 10% of patients treated with XTANDI (0.2% Grade 3-4) and 16% of patients treated with placebo (0.2% Grade 3-4). Grade 1-4 elevations in bilirubin occurred in 3% of patients treated with XTANDI (0.1% Grade 3-4) and 2% of patients treated with placebo (no Grade 3-4). Infections: In Study 1, 1% of XTANDI versus 0.3% of placebo patients and in Study 2, 1 patient in each treatment group (0.1%) had an infection resulting in death.

3 Significantly extended radiographic progression-free survival 1 83% reduction in risk of radiographic disease progression or death with XTANDI + GnRH therapy* vs placebo + GnRH therapy* (co-primary endpoint: HR = 0.17 [95% CI, ]; P < ) Estimated median radiographic progression-free survival was not reached (95% CI, 13.8-not reached) for XTANDI + GnRH therapy* and was 3.7 months (95% CI, ) for placebo + GnRH therapy* 1 Significantly delayed time to chemotherapy initiation 1 Delayed time to chemotherapy initiation by a median of 28.0 months with XTANDI + GnRH therapy* vs 10.8 months with placebo + GnRH therapy* (HR = 0.35 [95% CI, ]; P < ) Significantly improved overall survival 1 29% reduction in risk of death with XTANDI + GnRH therapy* vs placebo + GnRH therapy* (co-primary endpoint: HR = 0.71 [95% CI, ]; P < ) Estimated median overall survival was 32.4 months (95% CI, 30.1-not reached) for XTANDI + GnRH therapy* and 30.2 months (95% CI, 28.0-not reached) for placebo + GnRH therapy* 1 Oral, once-daily dosing with no required steroid coadministration 1 Dosage: XTANDI 160 mg (four 40 mg capsules) is administered orally, once daily Steroids were allowed but not required 94% of insured patient lives are covered for XTANDI 3 As of February A product s placement on a plan formulary involves a variety of factors known only to the plan and is subject to eligibility. To learn more, please visit XtandiHCP.com Falls: In the two studies, falls including fall-related injuries occurred in 9% of XTANDI patients vs 4% treated with placebo. Falls were not associated with loss of consciousness or seizure. Fall-related injuries were more severe in XTANDI patients and included non-pathologic fractures, joint injuries, and hematomas. Hypertension: In the two studies, hypertension was reported in 11% of patients receiving XTANDI and 4% of patients receiving placebo. No patients experienced hypertensive crisis. Medical history of hypertension was balanced between arms. Hypertension led to study discontinuation in < 1% of XTANDI or placebo treated patients. Drug Interactions Effect of Other Drugs on XTANDI - Administration of strong CYP2C8 inhibitors can increase the plasma exposure to XTANDI. Co-administration of XTANDI with strong CYP2C8 inhibitors should be avoided if possible. If co-administration of XTANDI cannot be avoided, reduce the dose of XTANDI. Co-administration of XTANDI with strong or moderate CYP3A4 and CYP2C8 inducers may alter the plasma exposure of XTANDI and should be avoided if possible. Effect of XTANDI on Other Drugs - XTANDI is a strong CYP3A4 inducer and a moderate CYP2C9 and CYP2C19 inducer in humans. Avoid CYP3A4, CYP2C9 and CYP2C19 substrates with a narrow therapeutic index, as XTANDI may decrease the plasma exposures of these drugs. If XTANDI is co-administered with warfarin (CYP2C9 substrate), conduct additional INR monitoring. Please see adjacent pages for Brief Summary of Full Prescribing Information. As seen in the PREVAIL trial (Study 2): a multinational, double-blind, randomized, phase 3 trial that enrolled 1717 patients with metastatic CRPC that progressed on GnRH therapy or after bilateral orchiectomy, and who had not received prior cytotoxic chemotherapy. All patients continued on GnRH therapy. 1,2 In the PREVAIL trial, 27% of patients in the XTANDI arm and 30% of patients in the placebo arm received glucocorticoids for varying reasons. In the AFFIRM trial (Study 1), 48% of patients in the XTANDI arm and 46% of patients in the placebo arm received glucocorticoids. AFFIRM was a phase 3, multicenter, placebo controlled, randomized trial that enrolled 1199 patients with metastatic CRPC who had previously received docetaxel. 1 References: 1. XTANDI [package insert]. Northbrook, IL: Astellas Pharma US, Inc. 2. Beer TM, Armstrong AJ, Rathkopf DE, et al. Enzalutamide in metastatic prostate cancer before chemotherapy. N Engl J Med. 2014;371: Data on file, Medivation, Inc Astellas Pharma US, Inc. All rights reserved. Printed in USA PM 3/15 XTANDI, Astellas, and the flying star logo are trademarks of Astellas Pharma Inc.

4 XTANDI (enzalutamide) capsules for oral use Initial U.S. Approval: 2012 BRIEF SUMMARY OF PRESCRIBING INFORMATION The following is a brief summary. Please see the package insert for full prescribing information. INDICATIONS AND USAGE XTANDI is indicated for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC). CONTRAINDICATIONS Pregnancy XTANDI can cause fetal harm when administered to a pregnant woman based on its mechanism of action and findings in animals. XTANDI is not indicated for use in women. XTANDI is contraindicated in women who are or may become pregnant. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, apprise the patient of the potential hazard to the fetus and the potential risk for pregnancy loss [see Use in Specific Populations (8.1)]. WARNINGS AND PRECAUTIONS Seizure In Study 1, which enrolled patients who previously received docetaxel, 7 of 800 (0.9%) patients treated with XTANDI experienced a seizure and no patients treated with placebo experienced a seizure. Seizure occurred from 31 to 603 days after initiation of XTANDI. In Study 2, 1 of 871 (0.1%) chemotherapy-naive patients treated with XTANDI and 1 of 844 (0.1%) patients treated with placebo experienced a seizure. Patients experiencing seizure were permanently discontinued from therapy and all seizure events resolved. There is no clinical trial experience readministering XTANDI to patients who experienced seizure. Limited safety data are available in patients with predisposing factors for seizure because these patients were generally excluded from the trials. These exclusion criteria included a history of seizure, underlying brain injury with loss of consciousness, transient ischemic attack within the past 12 months, cerebral vascular accident, brain metastases, and brain arteriovenous malformation. Study 1 excluded the use of concomitant medications that may lower the seizure threshold, whereas Study 2 permitted the use of these medications. Because of the risk of seizure associated with XTANDI use, patients should be advised of the risk of engaging in any activity where sudden loss of consciousness could cause serious harm to themselves or others. Permanently discontinue XTANDI in patients who develop a seizure during treatment. ADVERSE REACTIONS Clinical Trial Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. Two randomized clinical trials enrolled patients with metastatic prostate cancer that has progressed on androgen deprivation therapy (GnRH therapy or bilateral orchiectomy), a disease setting that is also defined as metastatic CRPC. In both studies, patients received XTANDI 160 mg orally once daily in the active treatment arm or placebo in the control arm. All patients continued androgen deprivation therapy. Patients were allowed, but not required, to take glucocorticoids. The most common adverse reactions ( 10%) that occurred more commonly ( 2% over placebo) in the XTANDI-treated patients from the two randomized clinical trials were asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, and dizziness/vertigo. Study 1: Metastatic Castration-Resistant Prostate Cancer Following Chemotherapy Study 1 enrolled 1199 patients with metastatic CRPC who had previously received docetaxel. The median duration of treatment was 8.3 months with XTANDI and 3.0 months with placebo. During the trial, 48% of patients on the XTANDI arm and 46% of patients on the placebo arm received glucocorticoids. Grade 3 and higher adverse reactions were reported among 47% of XTANDI-treated patients and 53% of placebo-treated patients. Discontinuations due to adverse events were reported for 16% of XTANDI-treated patients and 18% of placebo-treated patients. The most common adverse reaction leading to treatment discontinuation was seizure, which occurred in 0.9% of the XTANDI-treated patients compared to none (0%) of the placebo-treated patients. Table 1 shows adverse reactions reported in Study 1 that occurred at a 2% higher frequency in the XTANDI arm compared to the placebo arm. Table 1. Adverse Reactions in Study 1 XTANDI N = 800 Grade 1-4 a (%) Grade 3-4 (%) Placebo N = 399 Grade 1-4 (%) Grade 3-4 (%) General Disorders Asthenic Conditions b Peripheral Edema Musculoskeletal And Connective Tissue Disorders Back Pain Arthralgia Musculoskeletal Pain Muscular Weakness Musculoskeletal Stiffness Gastrointestinal Disorders Diarrhea Vascular Disorders Hot Flush Hypertension Nervous System Disorders Headache Dizziness c Spinal Cord Compression and Cauda Equina Syndrome Paresthesia Mental Impairment Disorders d Hypoesthesia Infections And Infestations Upper Respiratory Tract 10.9 Infection e Lower Respiratory Tract And Lung Infection f Psychiatric Disorders Insomnia Anxiety Renal And Urinary Disorders Hematuria Pollakiuria Injury, Poisoning And Procedural Complications Fall Non-pathologic Fractures Skin And Subcutaneous Tissue Disorders Pruritus Dry Skin Table 1. Adverse Reactions in Study 1 (cont.) Respiratory Disorders Epistaxis a CTCAE v4 b Includes asthenia and fatigue. c Includes dizziness and vertigo. d Includes amnesia, memory impairment, cognitive disorder, and disturbance in attention. e Includes nasopharyngitis, upper respiratory tract infection, sinusitis, rhinitis, pharyngitis, and laryngitis. f Includes pneumonia, lower respiratory tract infection, bronchitis, and lung infection. Study 2: Chemotherapy-naive Metastatic Castration- Resistant Prostate Cancer Study 2 enrolled 1717 patients with metastatic CRPC who had not received prior cytotoxic chemotherapy, of whom 1715 received at least one dose of study drug. The median duration of treatment was 17.5 months with XTANDI and 4.6 months with placebo. Grade 3-4 adverse reactions were reported in 44% of XTANDItreated patients and 37% of placebo-treated patients. Discontinuations due to adverse events were reported for 6% of XTANDI-treated patients and 6% of placebo-treated patients. The most common adverse reaction leading to treatment discontinuation was fatigue/asthenia, which occurred in 1% of patients on each treatment arm. Table 2 includes adverse reactions reported in Study 2 that occurred at a 2% higher frequency in the XTANDI arm compared to the placebo arm. Table 2. Adverse Reactions in Study 2 XTANDI N = 871 Grade 1-4 a (%) General Disorders Grade 3-4 (%) Grade 1-4 (%) Placebo N = 844 Grade 3-4 (%) Asthenic Conditions b Peripheral Edema Musculoskeletal And Connective Tissue Disorders Back Pain Arthralgia Gastrointestinal Disorders Constipation Diarrhea Vascular Disorders Hot Flush Hypertension Nervous System Disorders Dizziness c Headache Dysgeusia Mental Impairment Disorders d Restless Legs Syndrome Respiratory Disorders Dyspnea e Infections And Infestations Upper Respiratory 16.4 Tract Infection f Lower Respiratory Tract And Lung Infection g Psychiatric Disorders Insomnia

5 Table 2. Adverse Reactions in Study 2 (cont.) Renal And Urinary Disorders Hematuria Injury, Poisoning And Procedural Complications Fall Non- Pathological Fracture Metabolism and Nutrition Disorders Decreased Appetite Investigations Weight Decreased Reproductive System and Breast Disorders Gynecomastia a CTCAE v4 b Includes asthenia and fatigue. c Includes dizziness and vertigo. d Includes amnesia, memory impairment, cognitive disorder, and disturbance in attention. e Includes dyspnea, exertional dyspnea, and dyspnea at rest. f Includes nasopharyngitis, upper respiratory tract infection, sinusitis, rhinitis, pharyngitis, and laryngitis. g Includes pneumonia, lower respiratory tract infection, bronchitis, and lung infection. Laboratory Abnormalities In the two randomized clinical trials, Grade 1-4 neutropenia occurred in 15% of patients treated with XTANDI (1% Grade 3-4) and in 6% of patients treated with placebo (0.5% Grade 3-4). The incidence of Grade 1-4 thrombocytopenia was 6% of patients treated with XTANDI (0.3% Grade 3-4) and 5% of patients treated with placebo (0.5% Grade 3-4). Grade 1-4 elevations in ALT occurred in 10% of patients treated with XTANDI (0.2% Grade 3-4) and 16% of patients treated with placebo (0.2% Grade 3-4). Grade 1-4 elevations in bilirubin occurred in 3% of patients treated with XTANDI (0.1% Grade 3-4) and 2% of patients treated with placebo (no Grade 3-4). Infections In Study 1, 1% of patients treated with XTANDI compared to 0.3% of patients treated with placebo died from infections or sepsis. In Study 2, 1 patient in each treatment group (0.1%) had an infection resulting in death. Falls and Fall-related Injuries In the two randomized clinical trials, falls including fall-related injuries, occurred in 9% of patients treated with XTANDI compared to 4% of patients treated with placebo. Falls were not associated with loss of consciousness or seizure. Fall-related injuries were more severe in patients treated with XTANDI and included non-pathologic fractures, joint injuries, and hematomas. Hypertension In the two randomized trials, hypertension was reported in 11% of patients receiving XTANDI and 4% of patients receiving placebo. No patients experienced hypertensive crisis. Medical history of hypertension was balanced between arms. Hypertension led to study discontinuation in < 1% of patients in each arm. DRUG INTERACTIONS Drugs that Inhibit or Induce CYP2C8 Co-administration of a strong CYP2C8 inhibitor (gemfibrozil) increased the composite area under the plasma concentration-time curve (AUC) of enzalutamide plus N-desmethyl enzalutamide by 2.2-fold in healthy volunteers. Co-administration of XTANDI with strong CYP2C8 inhibitors should be avoided if possible. If co-administration of XTANDI with a strong CYP2C8 inhibitor cannot be avoided, reduce the dose of XTANDI [see Dosage and Administration (2.2) and Clinical Pharmacology (12.3)]. The effects of CYP2C8 inducers on the pharmacokinetics of enzalutamide have not been evaluated in vivo. Co-administration of XTANDI with strong or moderate CYP2C8 inducers (e.g., rifampin) may alter the plasma exposure of XTANDI and should be avoided if possible. Selection of a concomitant medication with no or minimal CYP2C8 induction potential is recommended [see Clinical Pharmacology (12.3)]. Drugs that Inhibit or Induce CYP3A4 Co-administration of a strong CYP3A4 inhibitor (itraconazole) increased the composite AUC of enzalutamide plus N-desmethyl enzalutamide by 1.3-fold in healthy volunteers [see Clinical Pharmacology (12.3)]. The effects of CYP3A4 inducers on the pharmacokinetics of enzalutamide have not been evaluated in vivo. Co-administration of XTANDI with strong CYP3A4 inducers (e.g., carbamazepine, phenobarbital, phenytoin, rifabutin, rifampin, rifapentine) may decrease the plasma exposure of XTANDI and should be avoided if possible. Selection of a concomitant medication with no or minimal CYP3A4 induction potential is recommended. Moderate CYP3A4 inducers (e.g., bosentan, efavirenz, etravirine, modafinil, nafcillin) and St. John s Wort may also reduce the plasma exposure of XTANDI and should be avoided if possible [see Clinical Pharmacology (12.3)]. Effect of XTANDI on Drug Metabolizing Enzymes Enzalutamide is a strong CYP3A4 inducer and a moderate CYP2C9 and CYP2C19 inducer in humans. At steady state, XTANDI reduced the plasma exposure to midazolam (CYP3A4 substrate), warfarin (CYP2C9 substrate), and omeprazole (CYP2C19 substrate). Concomitant use of XTANDI with narrow therapeutic index drugs that are metabolized by CYP3A4 (e.g., alfentanil, cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus and tacrolimus), CYP2C9 (e.g., phenytoin, warfarin) and CYP2C19 (e.g., S-mephenytoin) should be avoided, as enzalutamide may decrease their exposure. If co-administration with warfarin cannot be avoided, conduct additional INR monitoring [see Clinical Pharmacology (12.3)]. USE IN SPECIFIC POPULATIONS Pregnancy - Pregnancy Category X [see Contraindications (4)]. Risk Summary XTANDI can cause fetal harm when administered to a pregnant woman based on its mechanism of action and findings in animals. While there are no human data on the use of XTANDI in pregnancy and XTANDI is not indicated for use in women, it is important to know that maternal use of an androgen receptor inhibitor could affect development of the fetus. Enzalutamide caused embryofetal toxicity in mice at exposures that were lower than in patients receiving the recommended dose. XTANDI is contraindicated in women who are or may become pregnant while receiving the drug. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, apprise the patient of the potential hazard to the fetus and the potential risk for pregnancy loss. Advise females of reproductive potential to avoid becoming pregnant during treatment with XTANDI. Animal Data In an embryo-fetal developmental toxicity study in mice, enzalutamide caused developmental toxicity when administered at oral doses of 10 or 30 mg/kg/day throughout the period of organogenesis (gestational days 6-15). Findings included embryo-fetal lethality (increased post-implantation loss and resorptions) and decreased anogenital distance at 10 mg/kg/day, and cleft palate and absent palatine bone at 30 mg/kg/day. Doses of 30 mg/kg/day caused maternal toxicity. The doses tested in mice (1, 10 and 30 mg/kg/day) resulted in systemic exposures (AUC) approximately 0.04, 0.4 and 1.1 times, respectively, the exposures in patients. Enzalutamide did not cause developmental toxicity in rabbits when administered throughout the period of organogenesis (gestational days 6-18) at dose levels up to 10 mg/kg/day (approximately 0.4 times the exposures in patients based on AUC). Nursing Mothers XTANDI is not indicated for use in women. It is not known if enzalutamide is excreted in human milk. Because many drugs are excreted in human milk, and because of the potential for serious adverse reactions in nursing infants from XTANDI, a decision should be made to either discontinue nursing, or discontinue the drug taking into account the importance of the drug to the mother. Pediatric Use Safety and effectiveness of XTANDI in pediatric patients have not been established. Geriatric Use Of 1671 patients who received XTANDI in the two randomized clinical trials, 75% were 65 and over, while 31% were 75 and over. No overall differences in safety or effectiveness were observed between these patients and younger patients. Other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Patients with Renal Impairment A dedicated renal impairment trial for XTANDI has not been conducted. Based on the population pharmacokinetic analysis using data from clinical trials in patients with metastatic CRPC and healthy volunteers, no significant difference in enzalutamide clearance was observed in patients with pre-existing mild to moderate renal impairment (30 ml/min creatinine clearance [CrCL] 89 ml/min) compared to patients and volunteers with baseline normal renal function (CrCL 90 ml/min). No initial dosage adjustment is necessary for patients with mild to moderate renal impairment. Severe renal impairment (CrCL < 30 ml/min) and end-stage renal disease have not been assessed [see Clinical Pharmacology (12.3)]. Patients with Hepatic Impairment A dedicated hepatic impairment trial compared the composite systemic exposure of enzalutamide plus N-desmethyl enzalutamide in volunteers with baseline mild or moderate hepatic impairment (Child-Pugh Class A and B, respectively) versus healthy controls with normal hepatic function. The composite AUC of enzalutamide plus N-desmethyl enzalutamide was similar in volunteers with mild or moderate baseline hepatic impairment compared to volunteers with normal hepatic function. No initial dosage adjustment is necessary for patients with baseline mild or moderate hepatic impairment. Baseline severe hepatic impairment (Child-Pugh Class C) has not been assessed [see Clinical Pharmacology (12.3)]. OVERDOSAGE In the event of an overdose, stop treatment with XTANDI and initiate general supportive measures taking into consideration the half-life of 5.8 days. In a dose escalation study, no seizures were reported at < 240 mg daily, whereas 3 seizures were reported, 1 each at 360 mg, 480 mg, and 600 mg daily. Patients may be at increased risk of seizure following an overdose. NONCLINICAL TOXICOLOGY Carcinogenesis, Mutagenesis, Impairment of Fertility Long-term animal studies have not been conducted to evaluate the carcinogenic potential of enzalutamide. Enzalutamide did not induce mutations in the bacterial reverse mutation (Ames) assay and was not genotoxic in either the in vitro mouse lymphoma thymidine kinase (Tk) gene mutation assay or the in vivo mouse micronucleus assay. Based on nonclinical findings in repeat-dose toxicology studies, which were consistent with the pharmacological activity of enzalutamide, male fertility may be impaired by treatment with XTANDI. In a 26-week study in rats, atrophy of the prostate and seminal vesicles was observed at 30 mg/kg/day (equal to the human exposure based on AUC). In 4-, 13-, and 39-week studies in dogs, hypospermatogenesis and atrophy of the prostate and epididymides were observed at 4 mg/kg/day (0.3 times the human exposure based on AUC). Manufactured by: Catalent Pharma Solutions, LLC, St. Petersburg, FL Manufactured for and Distributed by: Astellas Pharma US, Inc., Northbrook, IL Marketed by: Astellas Pharma US, Inc., Northbrook, IL Medivation, Inc., San Francisco, CA Revised: September B006-XTA-BRFS Rx Only 2014 Astellas Pharma US, Inc. XTANDI is a registered trademark of Astellas Pharma Inc PM

6 For your patients with overactive bladder (OAB) Rethin OAB Treatment Myrbetriq is a ß 3 -adrenergic agonist treatment indicated for patients with OAB symptoms of urge urinary incontinence, urgency, and urinary frequency. It may be time to take another look at OAB treatment with Myrbetriq. INDICATIONS AND USAGE Myrbetriq (mirabegron) is a beta-3 adrenergic agonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. IMPORTANT SAFETY INFORMATION Myrbetriq can increase blood pressure. Periodic blood pressure determinations are recommended, especially in hypertensive patients. Myrbetriq is not recommended for use in severe uncontrolled hypertensive patients (defined as systolic blood pressure 180 mm Hg and/or diastolic blood pressure 110 mm Hg). Urinary retention in patients with bladder outlet obstruction (BOO) and in patients taking antimuscarinic medications for the treatment of OAB has been reported in postmarketing experience in patients taking mirabegron. A controlled clinical safety study in patients with BOO did not demonstrate increased urinary retention in Myrbetriq patients; however, Myrbetriq should be administered with caution to patients with clinically significant BOO. Myrbetriq should also be administered with caution to patients taking antimuscarinic medications for the treatment of OAB.

7 IMPORTANT SAFETY INFORMATION (cont d) Since Myrbetriq is a moderate CYP2D6 inhibitor, the systemic exposure to CYP2D6 substrates such as metoprolol and desipramine is increased when co-administered with Myrbetriq. Therefore, appropriate monitoring and dose adjustment may be necessary, especially with narrow therapeutic index drugs metabolized by CYP2D6, such as thioridazine, flecainide, and propafenone. Most commonly reported adverse reactions (>2% and >placebo) for Myrbetriq 25 mg and 50 mg vs placebo, respectively, were hypertension (11.3%, 7.5% vs 7.6%), nasopharyngitis (3.5%, 3.9% vs 2.5%), urinary tract infection (4.2%, 2.9% vs 1.8%), and headache (2.1%, 3.2% vs 3.0%). Please see Brief Summary of Prescribing Information for Myrbetriq (mirabegron) on following page. Visit Booth #1017 to learn more Myrbetriq is a registered trademark of Astellas Pharma Inc Astellas Pharma US, Inc. All rights reserved. Printed in USA PM May 2015

8 BRIEF SUMMARY OF PRESCRIBING INFORMATION The following information is a brief summary only. See full prescribing information for MYRBETRIQ. MYRBETRIQ (mirabegron) extended-release tablets INDICATIONS AND USAGE Myrbetriq is a beta-3 adrenergic agonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency CONTRAINDICATIONS None WARNINGS AND PRECAUTIONS Increases in Blood Pressure Myrbetriq can increase blood pressure. Periodic blood pressure determinations are recommended, especially in hypertensive patients. Myrbetriq is not recommended for use in patients with severe uncontrolled hypertension (defined as systolic blood pressure greater than or equal to 180 mmhg and/or diastolic blood pressure greater than or equal to 110 mmhg) [see Clinical Pharmacology (12.2)]. In two, randomized, placebo-controlled, healthy volunteer studies, Myrbetriq was associated with dose-related increases in supine blood pressure. In these studies, at the maximum recommended dose of 50 mg, the mean maximum increase in systolic/diastolic blood pressure was approximately 3.5/1.5 mmhg greater than placebo. In contrast, in OAB patients in clinical trials, the mean increase in systolic and diastolic blood pressure at the maximum recommended dose of 50 mg was approximately mmhg greater than placebo. Worsening of pre-existing hypertension was reported infrequently in Myrbetriq patients. Urinary Retention in Patients with Bladder Outlet Obstruction and in Patients Taking Antimuscarinic Medications for OAB Urinary retention in patients with bladder outlet obstruction (BOO) and in patients taking antimuscarinic medications for the treatment of OAB has been reported in postmarketing experience in patients taking mirabegron. A controlled clinical safety study in patients with BOO did not demonstrate increased urinary retention in Myrbetriq patients; however, Myrbetriq should be administered with caution to patients with clinically significant BOO. Myrbetriq should also be administered with caution to patients taking antimuscarinic medications for the treatment of OAB [see Clinical Pharmacology (12.2)]. Patients Taking Drugs Metabolized by CYP2D6 Since mirabegron is a moderate CYP2D6 inhibitor, the systemic exposure to CYP2D6 substrates such as metoprolol and desipramine is increased when co-administered with mirabegron. Therefore, appropriate monitoring and dose adjustment may be necessary, especially with narrow therapeutic index drugs metabolized by CYP2D6, such as thioridazine, flecainide, and propafenone [see Drug Interactions (7.1) and Clinical Pharmacology (12.3)] ADVERSE REACTIONS Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice. In three, 12 week, double-blind, placebo-controlled, safety and efficacy studies in patients with overactive bladder (Studies 1, 2, and 3), Myrbetriq was evaluated for safety in 2736 patients, [see Clinical Studies (14)]. Study 1 also included an active control. For the combined Studies 1, 2, and 3, 432 patients received Myrbetriq 25 mg, 1375 received Myrbetriq 50 mg, and 929 received Myrbetriq 100 mg once daily. In these studies, the majority of the patients were Caucasian (94%), and female (72%) with a mean age of 59 years (range 18 to 95 years). Myrbetriq was also evaluated for safety in 1632 patients who received Myrbetriq 50 mg once daily (n=812 patients) or Myrbetriq 100 mg (n=820 patients) in a 1 year, randomized, fixed dose, double-blind, active controlled, safety study in patients with overactive bladder (Study 4). Of these patients, 731 received Myrbetriq in a previous 12 week study. In Study 4, 1385 patients received Myrbetriq continuously for at least 6 months, 1311 patients received Myrbetriq for at least 9 months, and 564 patients received Myrbetriq for at least 1 year. The most frequent adverse events (0.2%) leading to discontinuation in Studies 1, 2 and 3 for the 25 mg or 50 mg dose were nausea, headache, hypertension, diarrhea, constipation, dizziness and tachycardia. Atrial fibrillation (0.2%) and prostate cancer (0.1%) were reported as serious adverse events by more than 1 patient and at a rate greater than placebo. Table 1 lists adverse reactions, derived from all adverse events, that were reported in Studies 1, 2 and 3 at an incidence greater than placebo and in 1% or more of patients treated with Myrbetriq 25 mg or 50 mg once daily for up to 12 weeks. The most commonly reported adverse reactions (greater than 2% of Myrbetriq patients and greater than placebo) were hypertension, nasopharyngitis, urinary tract infection and headache. Table 1: Percentages of Patients with Adverse Reactions, Derived from All Adverse Events, Exceeding Placebo Rate and Reported by 1% or More Patients Treated With Myrbetriq 25 mg or 50 mg Once Daily in Studies 1, 2, and 3 Placebo (%) Myrbetriq 25 mg (%) Myrbetriq 50 mg (%) Number of Patients Hypertension* Nasopharyngitis Urinary Tract Infection Headache Placebo (%) Myrbetriq 25 mg (%) Myrbetriq 50 mg (%) Number of Patients Constipation Upper Respiratory Tract Infection Arthralgia Diarrhea Tachycardia Abdominal Pain Fatigue *Includes reports of blood pressure above the normal range, and BP increased from baseline, occurring predominantly in subjects with baseline hypertension. Other adverse reactions reported by less than 1% of patients treated with Myrbetriq in Studies 1, 2, or 3 included: Cardiac disorders: palpitations, blood pressure increased [see Clinical Pharmacology (12.2)] Eye disorders: glaucoma [see Clinical Pharmacology (12.2)] Gastrointestinal disorders: dyspepsia, gastritis, abdominal distension Infections and Infestations: sinusitis, rhinitis Investigations: GGT increased, AST increased, ALT increased, LDH increased Renal and urinary disorders: nephrolithiasis, bladder pain Reproductive system and breast disorders: vulvovaginal pruritus, vaginal infection Skin and subcutaneous tissue disorders: urticaria, leukocytoclastic vasculitis, rash, pruritus, purpura, lip edema Table 2 lists the rates of the most commonly reported adverse reactions, derived from all adverse events in patients treated with Myrbetriq 50 mg for up to 52 weeks in Study 4. The most commonly reported adverse reactions (>3% of Myrbetriq patients) were hypertension, urinary tract infection, headache, and nasopharyngitis. Table 2: Percentages of Patients with Adverse Reactions, Derived from all Adverse Events, Reported by Greater Than 2% of Patients Treated With Myrbetriq 50 mg Once Daily in Study 4 Myrbetriq 50 mg (%) Active Control (%) Number of Patients Hypertension Urinary Tract Infection Headache Nasopharyngitis Back Pain Constipation Dry Mouth Dizziness Sinusitis Influenza Arthralgia Cystitis In Study 4, in patients treated with Myrbetriq 50 mg once daily, adverse reactions leading to discontinuation reported by more than 2 patients and at a rate greater than active control included: constipation (0.9%), headache (0.6%), dizziness (0.5%), hypertension (0.5%), dry eyes (0.4%), nausea (0.4%), vision blurred (0.4%), and urinary tract infection (0.4%). Serious adverse events reported by at least 2 patients and exceeding active control included cerebrovascular accident (0.4%) and osteoarthritis (0.2%). Serum ALT/AST increased from baseline by greater than 10-fold in 2 patients (0.3%) taking Myrbetriq 50 mg, and these markers subsequently returned to baseline while both patients continued Myrbetriq. In Study 4, serious adverse events of neoplasm were reported by 0.1%, 1.3%, and 0.5% of patients treated with Myrbetriq 50 mg, Myrbetriq 100 mg and active control once daily, respectively. Neoplasms reported by 2 patients treated with Myrbetriq 100 mg included breast cancer, lung neoplasm malignant and prostate cancer. In a separate clinical study in Japan, a single case was reported as Stevens-Johnson syndrome with increased serum ALT, AST and bilirubin in a patient taking Myrbetriq 100 mg as well as an herbal medication (Kyufu Gold). Postmarketing Experience Because these spontaneously reported events are from the worldwide postmarketing experience, from a population of uncertain size, the frequency of events and the role of mirabegron in their causation cannot be reliably determined. The following events have been reported in association with mirabegron use in worldwide postmarketing experience: Urologic: urinary retention [see Warnings and Precautions (5.2)] DRUG INTERACTIONS Drug interaction studies were conducted to investigate the effect of co-administered drugs on the pharmacokinetics of mirabegron and the effect of mirabegron on the pharmacokinetics of co-administered drugs (e.g., ketoconazole, rifampin, solifenacin, tamsulosin, and oral contraceptives) [see Clinical Pharmacology (12.3)]. No dose adjustment is recommended when these drugs are co-administered with mirabegron. Although no dose adjustment is recommended with solifenacin or tamsulosin based on the lack of pharmacokinetic interaction, Myrbetriq should be administered with caution to patients taking antimuscarinic medications for the treatment of OAB and in patients with clinically significant BOO because of the risk of urinary retention [see Warnings and Precautions (5.2)].

9 The following are drug interactions for which monitoring is recommended: Drugs Metabolized by CYP2D6 Since mirabegron is a moderate CYP2D6 inhibitor, the systemic exposure of drugs metabolized by CYP2D6 enzyme such as metoprolol and desipramine is increased when co-administered with mirabegron. Therefore, appropriate monitoring and dose adjustment may be necessary when Myrbetriq is co-administered with these drugs, especially with narrow therapeutic index CYP2D6 substrates, such as thioridazine, flecainide, and propafenone [see Warnings and Precautions (5.3) and Clinical Pharmacology (12.3)]. Digoxin When given in combination, mirabegron increased mean digoxin C max from 1.01 to 1.3 ng/ml (29%) and AUC from 16.7 to 19.3 ng.h/ml (27%). Therefore, for patients who are initiating a combination of mirabegron and digoxin, the lowest dose for digoxin should initially be considered. Serum digoxin concentrations should be monitored and used for titration of the digoxin dose to obtain the desired clinical effect [see Clinical Pharmacology (12.3)]. Warfarin The mean C max of S- and R-warfarin was increased by approximately 4% and AUC by approximately 9% when administered as a single dose of 25 mg after multiple doses of 100 mg mirabegron. Following a single dose administration of 25 mg warfarin, mirabegron had no effect on the warfarin pharmacodynamic endpoints such as International Normalized Ratio (INR) and prothrombin time. However, the effect of mirabegron on multiple doses of warfarin and on warfarin pharmacodynamic end points such as INR and prothrombin time has not been fully investigated [see Clinical Pharmacology (12.3)] USE IN SPECIFIC POPULATIONS Pregnancy Pregnancy Category C There are no adequate and well-controlled studies using Myrbetriq in pregnant women. Myrbetriq should be used during pregnancy only if the potential benefit to the patient outweighs the risk to the patient and fetus. Women who become pregnant during Myrbetriq treatment are encouraged to contact their physician. Risk Summary Based on animal data, mirabegron is predicted to have a low probability of increasing the risk of adverse developmental outcomes above background risk. Reversible adverse developmental findings consisting of delayed ossification and wavy ribs in rats and decreased fetal body weights in rabbits occurred at exposures greater than or equal to 22 and 14 times, respectively, the maximal recommended human dose (MRHD). At maternally toxic exposures decreased fetal weights were observed in rats and rabbits, and fetal death, dilated aorta, and cardiomegaly were reported in rabbits. Nursing Mothers It is not known whether Myrbetriq is excreted in human milk. Mirabegron was found in the milk of rats at concentrations twice the maternal plasma level. Mirabegron was found in the lungs, liver, and kidneys of nursing pups. No studies have been conducted to assess the impact of Myrbetriq on milk production in humans, its presence in human breast milk, or its effects on the breast-fed child. Because Myrbetriq is predicted to be excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Pediatric Use The safety and effectiveness of Myrbetriq in pediatric patients have not been established. Geriatric Use No dose adjustment is necessary for the elderly. The pharmacokinetics of Myrbetriq is not significantly influenced by age [see Clinical Pharmacology (12.3)]. Of 5648 patients who received Myrbetriq in the phase 2 and 3 studies, 2029 (35.9%) were 65 years of age or older, and 557 (9.9%) were 75 years of age or older. No overall differences in safety or effectiveness were observed between patients younger than 65 years of age and those 65 years of age or older in these studies. Renal Impairment Myrbetriq has not been studied in patients with end stage renal disease (CL cr <15 ml/min or egfr <15 ml/min/1.73 m 2 or patients requiring hemodialysis), and, therefore is not recommended for use in these patient populations. In patients with severe renal impairment (CL cr 15 to 29 ml/min or egfr 15 to 29 ml/min/1.73 m 2 ), the daily dose of Myrbetriq should not exceed 25 mg. No dose adjustment is necessary in patients with mild or moderate renal impairment (CL cr 30 to 89 ml/min or egfr 30 to 89 ml/min/1.73 m 2 ) [see Clinical Pharmacology (12.3)]. Hepatic Impairment Myrbetriq has not been studied in patients with severe hepatic impairment (Child-Pugh Class C), and therefore is not recommended for use in this patient population. In patients with moderate hepatic impairment (Child-Pugh Class B), the daily dose of Myrbetriq should not exceed 25 mg. No dose adjustment is necessary in patients with mild hepatic impairment (Child-Pugh Class A) [see Clinical Pharmacology (12.3)]. Gender No dose adjustment is necessary based on gender. When corrected for differences in body weight, the Myrbetriq systemic exposure is 20% to 30% higher in females compared to males OVERDOSAGE Mirabegron has been administered to healthy volunteers at single doses up to 400 mg. At this dose, adverse events reported included palpitations (1 of 6 subjects) and increased pulse rate exceeding 100 bpm (3 of 6 subjects). Multiple doses of mirabegron up to 300 mg daily for 10 days showed increases in pulse rate and systolic blood pressure when administered to healthy volunteers. Treatment for overdosage should be symptomatic and supportive. In the event of overdosage, pulse rate, blood pressure and ECG monitoring is recommended CLINICAL PHARMACOLOGY Pharmacodynamics Urodynamics The effects of Myrbetriq on maximum urinary flow rate and detrusor pressure at maximum flow rate were assessed in a urodynamic study consisting of 200 male patients with lower urinary tract symptoms (LUTS) and BOO. Administration of Myrbetriq once daily for 12 weeks did not adversely affect the mean maximum flow rate or mean detrusor pressure at maximum flow rate in this study. Nonetheless, Myrbetriq should be administered with caution to patients with clinically significant BOO [see Warnings and Precautions (5.2)]. Cardiac Electrophysiology The effect of multiple doses of Myrbetriq 50 mg, 100 mg and 200 mg once daily on QTc interval was evaluated in a randomized, placebo- and active- controlled (moxifloxacin 400 mg) four-treatment-arm parallel crossover study in 352 healthy subjects. In a study with demonstrated ability to detect small effects, the upper bound of the one-sided 95% confidence interval for the largest placebo adjusted, baseline-corrected QTc based on individual correction method (QTcI) was below 10 msec. For the 50 mg Myrbetriq dose group (the maximum approved dosage), the mean difference from placebo on QTcI interval at 4-5 hours post-dose was 3.7 msec (upper bound of the 95% CI 5.1 msec). For the Myrbetriq 100 mg and 200 mg doses groups (dosages greater than the maximum approved dose and resulting in substantial multiples of the anticipated maximum blood levels at 50 mg), the mean differences from placebo in QTcI interval at 4-5 hours post-dose were 6.1 msec (upper bound of the 95% CI 7.6 msec) and 8.1 msec (upper bound of the 95% CI 9.8 msec), respectively. At the Myrbetriq 200 mg dose, in females, the mean effect was 10.4 msec (upper bound of the 95% CI 13.4 msec). In this thorough QT study, Myrbetriq increased heart rate on ECG in a dose dependent manner. Maximum mean increases from baseline in heart rate for the 50 mg, 100 mg, and 200 mg dose groups compared to placebo were 6.7 beats per minutes (bpm), 11 bpm, and 17 bpm, respectively. In the clinical efficacy and safety studies, the change from baseline in mean pulse rate for Myrbetriq 50 mg was approximately 1 bpm. In this thorough QT study, Myrbetriq also increased blood pressure in a dose dependent manner (see Effects on Blood Pressure). Effects on Blood Pressure In a study of 352 healthy subjects assessing the effect of multiple daily doses of 50 mg, 100 mg, and 200 mg of Myrbetriq for 10 days on the QTc interval, the maximum mean increase in supine SBP/DBP at the maximum recommended dose of 50 mg was approximately 4.0/1.6 mmhg greater than placebo. The 24-hour average increases in SBP compared to placebo were 3.0, 5.5, and 9.7 mmhg at Myrbetriq doses of 50 mg, 100 mg and 200 mg, respectively. Increases in DBP were also dose-dependent, but were smaller than SBP. In another study in 96 healthy subjects to assess the impact of age on pharmacokinetics of multiple daily doses of 50 mg, 100 mg, 200 mg, and 300 mg of Myrbetriq for 10 days, SBP also increased in a dose-dependent manner. The mean maximum increases in SBP were approximately 2.5, 4.5, 5.5 and 6.5 mmhg for Myrbetriq exposures associated with doses of 50 mg, 100 mg, 200 mg and 300 mg, respectively. In three, 12-week, double-blind, placebo-controlled, safety and efficacy studies (Studies 1, 2 and 3) in OAB patients receiving Myrbetriq 25 mg, 50 mg, or 100 mg once daily, mean increases in SBP/DBP compared to placebo of approximately mmhg were observed. Morning SBP increased by at least 15 mmhg from baseline in 5.3%, 5.1%, and 6.7% of placebo, Myrbetriq 25 mg and Myrbetriq 50 mg patients, respectively. Morning DBP increased by at least 10 mmhg in 4.6%, 4.1% and 6.6% of placebo, Myrbetriq 25 mg, and Myrbetriq 50 mg patients, respectively. Both SBP and DBP increases were reversible upon discontinuation of treatment NONCLINICAL TOXICOLOGY Carcinogenesis, Mutagenesis, Impairment of Fertility Carcinogenicity Long-term carcinogenicity studies were conducted in rats and mice dosed orally with mirabegron for two years. Male rats were dosed at 0, 12.5, 25, or 50 mg/kg/day and female rats and both sexes of mice were dosed at 0, 25, 50, or 100 mg/kg/day. Mirabegron showed no carcinogenic potential at systemic exposures (AUC) 38 to 45-fold higher in rats and 21 to 38-fold higher in mice than the human systemic exposure at the 50 mg dose. Mutagenesis Mirabegron was not mutagenic in the Ames bacterial reverse mutation assay, did not induce chromosomal aberrations in human peripheral blood lymphocytes at concentrations that were not cytotoxic, and was not clastogenic in the rat micronucleus assay. Impairment of Fertility Fertility studies in rats showed that mirabegron had no effect on either male or female fertility at non-lethal doses up to 100 mg/kg/day. Systemic exposures (AUC) at 100 mg/kg in female rats was estimated to be 22 times the MRHD in women and 93 times the MRHD in men. PATIENT COUNSELING INFORMATION Inform patients that Myrbetriq may increase blood pressure. Periodic blood pressure determinations are recommended, especially in patients with hypertension. Myrbetriq has also been associated with infrequent urinary tract infections, rapid heartbeat, rash, and pruritus. Inform patients that urinary retention has been reported when taking mirabegron in combination with antimuscarinic drugs used in the treatment of overactive bladder. Instruct patients to contact their physician if they experience these effects while taking Myrbetriq. Patients should read the patient leaflet entitled Patient Information before starting therapy with Myrbetriq. Rx Only PRODUCT OF JAPAN OR IRELAND See bottle label or blister package for origin Manufactured by: Astellas Pharma Technologies, Inc. Norman, Oklahoma Marketed and Distributed by: Astellas Pharma US, Inc. Northbrook, Illinois *Myrbetriq is a registered trademark of Astellas Pharma Inc. All other trademarks or registered trademarks are the property of their respective owners Astellas Pharma US, Inc. Revised: February C011-MIR-BRFS PM

10 NOTES

11 Table of Contents Board of Directors... 3 Committees... 4 CME Information... 6 Specialty Programs... 8 Office of Education Courses... 9 Friday Society for Pediatric Urology Basic Sciences Symposium Society of University Urologists/Society of Urology Chairpersons and Program Directors Urologic Oncology Research Symposium Society of Genitourinary Reconstructive Surgeons/Society of Urologic Prosthetic Surgeons A Decade of Pharmacotherapy for OAB Poster, Podium and Video Sessions Society for Fetal Urology Poster, Podium and Video Sessions Crossfire - Controversies in Urology Poster, Podium and Video Sessions Saturday Sexual Medicine Society of North America Engineering and Urology Society Residents Forum Live Surgery I Arab Association of Urology Society for Pediatric Urology Poster and Podium Sessions Society for Basic Urologic Research/Society of Urologic Oncology Joint Session World Chinese Urological Society Indian American Urological Association AUA/Confederación Americana de Urología AUA/American College of Osteopathic Surgeons Urology Program Science of Female Pelvic Health Poster and Podium Sessions Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction Society of Urologic Oncology Bangladesh Association of Urological Surgeons Poster, Podium and Video Sessions Society for Basic Urologic Research Second Opinion Cases Urology Care by the APN/PA Innovations in Urology: AUA and the Endourological Society AUA-Eurasian Urology Platform Joint Program of the Hungarian and Polish Urological Associations Poster, Podium and Video Sessions Sunday Plenary Sessions I and II Society of Women in Urology (SWIU) Annual Breakfast Meeting Poster, Podium and Video Sessions Urologic Care for the Allied Health Professional INDEXES EXHIBITORS TUESDAY MONDAY SUNDAY SATURDAY FRIDAY COURSES 1

12 Urologic Oncology Forum International Prostate Forum Poster, Podium and Video Sessions Society for the Study of Male Reproduction Society of Urologic Robotic Surgery AUA/AACU Health Policy Forum Poster, Podium and Video Sessions Research Forum Sessions I and II Society for Infection and Inflammation in Urology Live Surgery II History Forums I and II Korean World Urologic Congress Geriatric Urological Society British Association of Urological Surgeons/Urological Society of Australia and New Zealand Japanese Urological Association AUA/FDA/SUO Workshop Urological Congenitalism Forum R. Frank Jones Urological Society Sociedad Argentina de Urología Association Française d Urologie Poster, Podium and Video Sessions Monday Plenary Sessions I and II Poster, Podium and Video Sessions Young Urologists Forum Research on Calculus Kinetics (ROCK) Society AUA/Brazilian/Portuguese Urology Program Russian Urology Program AUA Town Hall: Testosterone: Too Much or Not Enough? Poster, Podium and Video Sessions Egyptian Urological Society Urologic Society for Transplantation and Renal Surgery American Society for Men s Health Pan African Urological Surgeons Association/Caribbean Urological Association Società Italiana di Urologia/AUA Joint Meeting Endocrine Forum Large Urology Group Practice Association Poster, Podium and Video Sessions SWIU Women Leaders in Urology Forum AQUA Registry Forum Tuesday Plenary Sessions I and II Poster and Podium Sessions Exhibitor Listing Author Index Subject Index

13 Board of Directors Officers of the Board of Directors President...William W. Bohnert President-Elect...William F. Gee Immediate Past President...Pramod C. Sogani Secretary...Gopal H. Badlani Treasurer...Steven M. Schlossberg Section Representatives to the Board of Directors Mid-Atlantic...Craig A. Peters New England...Kevin R. Loughlin New York...Muhammad S. Choudhury North Central...Stephen Y. Nakada Northeastern...John D. Denstedt South Central...Randall B. Meacham Southeastern...Thomas F. Stringer Western...Jeffrey E. Kaufman AUA Headquarters American Urological Association, Inc Corporate Boulevard Linthicum, Maryland Telephone: FAX: Website: Annual Business Meeting New Orleans Morial Convention Center Room 214 Tuesday, May 19, 12:30 pm 3

14 Committees Gopal H. Badlani, Chair Jeff Albaugh Dean G. Assimos Gregory T. Bales John M. Barry Carolyn Best Arthur L. Burnett, II Jeffrey B. Campbell Douglas A. Canning Culley C. Carson, III Patrick C. Cartwright Erik P. Castle Gaetano Ciancio Peter E. Clark J. Quentin Clemens Rodney D. Cotten Ashleigh Decker Ross M. Decter Ananias C. Diokno Sean P. Elliott Christopher P. Evans Gina Fries Pat F. Fulgham David A. Ginsberg David S. Goldfarb Leonard G. Gomella Tomas L. Griebling Frederick A. Gulmi Lawrence S. Hakim Jeffrey M. Holzbeierlein David F. Jarrard Program Planning Committee Keith A. Jarvi Mark J. Jordan Anil Kapoor Edward D. Kim David J. Klumpp Kathleen C. Kobashi Barry A. Kogan Peter N. Kolettis Badrinath R. Konety John C. Lieske Armando J. Lorenzo Jill A. Macoska Andrew E. MacNeily Thomas P. McBride Elspeth McDougall Kurt A. McCammon Stephen Y. Nakada R. Corey O Connor Lane S. Palmer Michel A. Pontari Christopher R. Porter Gail S. Prins Daniel I. Rosenstein Hossein Sadeghi-Nejad Jennifer S. Singer Eila D. Skinner J. Brantley Thrasher Dean A. Tripp Johannes W. G. Vieweg Elaine Worcester Elizabeth Yerkes Jay T. Bishoff Toby C. Chai Joseph J. Del Pizzo Matthew T. Gettman Mohan Gundeti Misop Han Program Video Review Committee Altan K. Ilkay Richard K. Lee Jay D. Raman Jaspreet S. Sandhu Alexis E. Te Program Abstract Review Committee Tamer Abou Youssif Rolf Ackermann Rosalyn M. Adam Kourosh Afshar Madhusudan Agarwal Thomas E. Ahlering Karl-Erik Andersson Gerald L. Andriole Kenneth W. Angermeier Noel A. Armenakas William J. Aronson Dean G. Assimos Anthony Atala J. Chris Austin Paul F. Austin Riccardo Autorino Gopal H. Badlani K.C. Balaji Chris Bangma Daniel A. Barocas Arie S. Belldegrun Enrique G. Bellver Nelson Bennett Ryan K. Berglund Trinity Bivalacqua Jerry G. Blaivas Stephane Bolduc Stephen A. Boorjian James F. Borin Robert Brannigan Peter N. Bretan Benjamin Breyer Arthur L. Burnett, II Ralph Buttyan Jeffrey A. Cadeddu Daniel J. Canter Culley C. Carson, III H. Ballantine Carter William J. Catalona Toby Chai David Chan Michael Chancellor Sam S. Chang Ben Chew Joseph Chin George J. Christ Peter E. Clark J. Quentin Clemens Michael Coburn Craig V. Comiter Michael Cookson Christopher S. Cooper Hillary L. Copp Nicholas G. Cost Anthony D Amico Rajvir Dahiya Douglas Dahl Philipp Dahm Guido Dalbagni Firouz Daneshgari Sakti Das John W. Davis Donna Deng Louis J. Denis John D. Denstedt Mahesh Desai Mihir M. Desai Serkan Deveci Jordan Dimitrakov Colin P.N. Dinney Michael E. DiSanto S. Machele Donat Marcus Drake James A. Eastham Scott E. Eggener Mostafa M. Elhilali Sean P. Elliott Rainer M.E. Engel Erdal Erturk Gregg R. Eure Christopher P. Evans Amr F. Fergany Fernando Ferrer Robert C. Flanigan 4

15 Neil E. Fleshner Richard S. Foster Matthew O. Fraser Patricio Gargollo Mark Garzotto Jason R. Gee Matthew Gettman Robert H. Getzenberg Reza Ghavamian Inderbir Gill Peter J. Gilling Jeffrey R. Gingrich Jordan Gitlin Martin E. Gleave David A. Goldfarb Marc Goldstein Leonard G. Gomella Alex Gomelsky Ricardo R. Gonzalez Mark L. Gonzalgo E. Ann Gormley Michael Grasso Tomas L. Griebling Andreas Gross Mohan S. Gundeti Khurshid A. Guru Jorge Gutierrez Aceves Thomas J. Guzzo Gabriel Haas Oliver W. Hakenberg Lawrence S. Hakim Joanna Hannan Kazunori Hattori Richard E. Hautmann Wayne J. G. Hellstrom Ashok K. Hemal Gerard D. Henry Adonis K. Hijaz Nicholas M. Holmes Jeffrey M. Holzbeierlein Michael H. Hsieh William C. Huang Robert E. Hurst David F. Jarrard Keith Jarvi Rama Jayanthi Ted Johnson J. Stephen Jones Steven Joniau Mark L. Jordan Jean Joseph Dov Kadmon Martin Kaefer Ashish M. Kamat Jihad H. Kaouk Steven A. Kaplan Ronald Kaufman Louis R. Kavoussi Francis X. Keeley Saeed R. Khan Makarand K. Khochikar Antoine E. Khoury Adam S. Kibel Kathleen Kobashi Michael Koch Thomas F. Kolon Badrinath R. Konety John N. Krieger John Kryger Sanjay B. Kulkarni Natasha Kyprianou M. Pilar Laguna Dolores Lamb Jaime Landman Paul H. Lange Jerilyn M. Latini Cheryl T. Lee Chung Lee Bradley C. Leibovich Gary E. Lemack Michael P. Leonard Herb Lepor Lori Lerner Seth Lerner John A. Libertino Deborah J. Lightner Hans Lilja Daniel W. Lin W. Marston Linehan James E. Lingeman Larry I. Lipshultz Mark S. Litwin Vinata Lokeshwar Armando Lorenzo Yair Lotan Kevin Loughlin Franklin C. Lowe William T. Lowrance Tom F. Lue Dawn L. MacLellan Danil V. Makarov Stanley B. Malkowicz Jodi K. Maranchie Viraj Master Brian R. Matlaga Tadashi Matsuda Christopher McClung Patrick McKenna Kevin T. McVary Mani M. Menon Edward Messing Peter D. Metcalfe David C. Miller Martin Miner Rosalia Misseri James L. Mohler Robert Moldwin Manoj Monga Drogo K. Montague Michael Moran Allen F. Morey Elizabeth R. Mueller John P. Mulhall Ravi Munver Stephen Y. Nakada Ajay Nangia Durwood E. Neal Ajay Nehra Caleb P. Nelson Joel B. Nelson Casey Ng J. Curtis Nickel Alan M. Nieder Craig S. Niederberger Victor W. Nitti Robert Oates Takehiko Ogawa Zhamshid H. Okhunov Kenneth Pace Lane S. Palmer Allan J. Pantuck Dipen Parekh Alan W. Partin Anup Patel Sutchin Patel John G. Pattaras Margaret Pearle David F. Penson Drew Peterson Daniel P. Petrylak Michael Phelan John L. Phillips Peter A. Pinto Louis Pisters Carol Podlasek Michel Pontari Christopher R. Porter Michael P. Porter Glenn M. Preminger Joseph C. Presti Raj S. Pruthi Marcus L. Quek Ranjith Ramasamy Abhay M. Rane Ardeshir Rastinehad Ashish V. Rawandale Leonardo O. Reis Jerome P. Richie Claus G. Roehrborn Nirit Rosenblum Eric S. Rovner Michael Ruggieri Daniel B. Rukstalis Paul Russo Fred Saad Hossein Sadeghi-Nejad Arthur Sagalowsky Martin G. Sanda Jaspreet Singh Sandhu Jay Sandlow Richard Santucci Michael Sarosdy Harriette M. Scarpero Anthony J. Schaeffer Douglas S. Scherr Peter N. Schlegel Mark P. Schoenberg Bradley F. Schwartz Allen D. Seftel John Seigne Jay Shah Ojas Shah Arieh Shalhav Joel Sheinfeld Patrick J. Shenot Alan W. Shindel Neal Shore Daniel A. Shoskes Mark Sigman Robert A. Sikes Matthew N. Simmons Ajay Singla Joseph A. Smith Mark S. Soloway Rene Sotelo Philippe E. Spiess John P. Spirnak Gary Steinberg Arnulf Stenzl M. Lynn Stothers Seth A. Strope Urs E. Studer Chandru P. Sundaram Douglas Sutherland Robert M. Sweet Scott Tagawa Samir S. Taneja Simon Tanguay Alexis E. Te Serdar Tekgul Ryan P. Terlecki John C. Thomas Edouard J. Trabulsi Quoc-Dien Trinh Thomas Turk Robert Uzzo Sandip P. Vasavada Vijaya Vemulakonda Run Wang Wolfgang Weidner Alan J. Wein Robert M. Weiss Howard N. Winfield J. Stuart Wolf, Jr. Christopher G. Wood Guan Wu Armand Zini Kevin Zorn 5

16 CME Information Statement of Need Urologists need a thorough knowledge of the most recent developments and techniques in urology to ensure the highest standards of patient care and safety. Learning Objectives At the conclusion of the 2015 Annual Meeting, participants should be able to: describe recent developments in the medical and surgical management of urology patients identify new technologies for the treatment of urologic problems outline the role of simulators in urologic training analyze the potential threats to urologic practice and specify possible solutions Accreditation Statement The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Designation The American Urological Association designates this live activity for a maximum of 65.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Non-physician Health Professionals The AUA is not accredited to offer credit for nonphysician health professionals. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit. Evidence-Based Content It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias. AUA Disclosure Policy All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners with information so they can make their own judgments. Resolution of Conflict of Interest All disclosures will be reviewed by the program/ course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest: Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director and/or Education Content Review Committee or its subgroup Limit content to evidence with no recommendations Introduction of a debate format with an unbiased moderator (point-counterpoint) Inclusion of moderated panel discussion Publication of a parallel or rebuttal article for an article that is felt to be biased Limit equipment representatives to providing logistics and operation support only in procedural demonstrations Divestiture of the relationship by faculty Off-label or Unapproved Use of Drugs or Devices It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses. Disclaimer The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA. Consent to Use of Photographic Images: Attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA s use and distribution (both now and in the future) of the attendee s image or voice in photographs and electronic reproductions of such meetings and activities. 6

17 CME Information Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms. Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association. Special Assistance/Dietary Needs: The American Urological Association complies with the Americans with Disabilities Act 12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk. Getting Your CME Credits or Certificate of Attendance You can claim your CME/Certificate of Attendance several ways: Onsite: Hall B2, CME Booth in Registration Saturday, Noon 6 p.m. Sunday & Monday, 6:30 a.m. 4 p.m. Tuesday, 6:30 a.m. 5 p.m. Online: Mobile App (iphone, ipad, Android phones and tablets) Note: All 2015 Annual Meeting CME credits/participation must be claimed by December 31, Credits/ participation for the 2015 Annual Meeting cannot be claimed after this date. You must scan your badge upon entrance into courses and sessions (except for Plenary) offered for credit to have your credits automatically entered onto your transcript. All Plenary Session credits must be self-claimed with a valid badge log-in at the CME Booth, online, or via the Annual Meeting Mobile App. Credits will be awarded only to the person whose name is associated with the badge. Questions about CME? CME@AUAnet.org. 7

18 Specialty Programs Page American Society for Men s Health Arab Association of Urology Association Française d Urologie AUA/American College of Osteopathic Surgeons AUA/Brazilian/Portuguese Urology Program AUA/Confederación Americana de Urología AUA-Eurasian Urology Platform Bangladesh Association of Urological Surgeons British Association of Urological Surgeons/Urological Society of Australia and New Zealand Egyptian Urological Society Engineering and Urology Society Geriatric Urological Society Indian American Urological Association Innovations in Urology: AUA and the Endourological Society Japanese Urological Association Joint Program of the Hungarian and Polish Urological Associations Korean World Urologic Congress Large Urology Group Practice Association Pan African Urological Surgeons Association/Caribbean Urological Association R. Frank Jones Urological Society Research on Calculus Kinetics (ROCK) Society Russian Urology Program Sexual Medicine Society of North America Sociedad Argentina de Urología Società Italiana di Urologia Society for Basic Urologic Research Society for Basic Urologic Research/Society of Urologic Oncology Society for Fetal Urology Society for Infection and Inflammation in Urology Society for Pediatric Urology... 17, 59 Society for the Study of Male Reproduction Society of Genitourinary Reconstructive Surgeons/Society of Urologic Prosthetic Surgeons Society of University Urologists/Society of Urology Chairpersons and Program Directors Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction Society of Urologic Oncology Society of Urologic Robotic Surgery Society of Women in Urology Urologic Society for Transplantation and Renal Surgery World Chinese Urological Society

19 Friday, May 15, 2015 OFFICE OF EDUCATION COURSES ALL COURSES ARE 8:30 am - 6:30 pm COURSES 8:30 am - 11:30 am 01 PG DISORDERS OF THE PENIS: PEYRONIE S DISEASE, PRIAPISM, CONGENITAL CURVATURE, ADULT ACQUIRED BURIED PENIS AND CORPORAL FRACTURE Laurence Levine, Director David Ralph, Gregory Broderick Room: RO PG REOPERATIVE PELVIC FLOOR MEDICINE: FOR THE UROLOGIST AND GYNECOLOGIST Howard Goldman, Director Mickey Karram, Kamran Sajadi Room: RO-5 03 PG ROBOT-ASSISTED RADICAL PROSTATECTOMY: BEYOND THE LEARNING CURVE John Davis, Director Koon Rha, Fatih Atug, Declan Murphy, Kevin Zorn Room: RO PG MANAGEMENT OF URETERAL STRICTURE DISEASE Louis Kavoussi, Director Richard Link, Thomas Jarrett, Sammy Elsamra Room: RO-8 05 PG MANAGEMENT OF PROSTATE CANCER: A CASE BASED APPROACH WITH EMPHASIS ON INTEGRATING NEW MOLECULAR DIAGNOSTICS INTO CLINICAL PRACTICE Eric Klein, Director Andrew Stephenson Room: RO-9 1:00 pm - 3:00 pm 06 IC PRACTICAL CONSIDERATIONS IN GENITOURINARY PROSTHETIC SURGERY Drogo Montague, Director Room: RO-1 07 IC ESTABLISHING AN ADVANCED PROSTATE CANCER CLINIC: A GUIDE FOR THE COMMUNITY UROLOGIST Basir Tareen, Director Raoul Concepcion, Gregory Hanson Room: RO IC EVALUATION AND MANAGEMENT OF UROGENITAL PAIN Michael Sabia, Director Hossein Sadeghi-Nejad, Allen Seftel Room: RO-4 09 IC PROSTATE CANCER DIAGNOSTICS: PSA, PROSTATE BIOPSY AND BEYOND J. Stephen Jones, Director Daniel Barocas Room: RO-5 10 IC TESTOSTERONE THERAPY: NEW CONCEPTS FOR A RAPIDLY CHANGING FIELD Abraham Morgentaler, Director Abdul Traish Room: RO IC GUIDELINES BASED EVALUATION AND TREATMENT OF MLUTS AND BPH Steven Kaplan, Director Claus Roehrborn, Alexis Te Room: RO-8 12 IC NOCTURIA: ADVANCES IN DIAGNOSIS AND MANAGEMENT Jeffrey Weiss, Director Room: RO-9 3:30 pm - 6:30 pm 51 PG ENDOUROLOGÍA AVANZADA - MANEJO DE CIRUGIA RENAL PERCUTEA Y CIRUGIA INTRARRENAL RETROGRADA COMPLEJA (ESTE CURSO SE PRESENTA SÓLO EN ESPAÑOL) Jorge Gutierrez-Aceves, Director Jose Amon-Sesmero, Francisco Daels Room: RO-4 Saturday, May 16, :30 am - 11:30 am 13 PG NERVE SPARING RADICAL CYSTECTOMY AND ORTHOTOPIC BLADDER SUBSTITUTION: KEYS TO SUCCESS AND UPDATES Urs Studer, Director Room: RO PG SURGEONS AS EDUCATORS: A PRIMER FOR ACADEMIC DEVELOPMENT AND TEACHING EXCELLENCE Tobias Kohler, Director Bradley Schwartz, Kurt McCammon, Patrick McKenna Room: RO-4 15 PG VASECTOMY REVERSAL AND MALE INFERTILITY TREATMENT IN THE ICSI ERA Peter Schlegel, Director Robert Oates, Sheldon Marks Room: RO-5 8:30 am - 6:30 pm 16 PG COMPLICATIONS OF ROBOTIC UROLOGICAL SURGERY: PREVENTION, RECOGNITION AND MANAGEMENT Rene Sotelo, Director Reza Ghavamian, Joseph Smith, Monish Aron Room: RO-8 1:00 pm - 3:00 pm 18 IC NUTRITION COUNSELING FOR THE PREVENTION OF UROLITHIASIS Patrick Lowry, Director Kristina Penniston, Sutchin Patel Room: RO IC LAPAROSCOPIC DONOR NEPHRECTOMY: STEP-BY-STEP APPROACH Mahesh Desai, Director Arvind Ganpule Room: RO-4 9

20 OFFICE OF EDUCATION COURSES ALL COURSES ARE 20 IC SUCCESSFUL INTEGRATION OF ADVANCED PRACTICE NURSES AND PHYSICIAN ASSISTANTS INTO UROLOGY PRACTICES Claus Roehrborn, Director Brad Hornberger Room: RO-5 21 IC BOTULINUM TOXIN: WHY USE IT, HOW TO DO IT, WHAT ARE THE RESULTS? Michael Chancellor, Director Room: RO IC UROLOGY 911: HANDLING INTRAOPERATIVE CONSULTS Michael Schwartz, Director Brian Duty, Jessica Kreshover Room: RO-8 23 IC PHYSICIAN CONTRACT NEGOTIATION: EMPLOYMENT AND OWNERSHIP IN THE CURRENT ECONOMIC CLIMATE Thomas Stringer, Director Thomas Crawford, Michael Igel Room: RO-9 3:30 pm - 6:30 pm 24 PG REAL MEN GET REAL PELVIC PAIN Jeannette Potts, Director Stanley Antolak, Dean Tripp, Christopher Payne, Rhonda Kotarinos Room: RO PG MALE HEALTH: STRATEGIES FOR MANAGING LIFELONG WELLNESS Richard Pelman, Director Mark Moyad, Kevin Loughlin, S. Larry Goldenberg, Stacy Loeb, Martin Miner Room: RO-4 26 PG RESIDENT PERFORMED ULTRASOUND: THE ESSENTIALS Bruce Gilbert, Director R. Ernest Sosa, Frederick Gulmi, Pat F. Fulgham Room: RO-5 27 PG UROLOGICAL TRAUMA AND RECONSTRUCTION Allen Morey, Director Michael Coburn, Noel Armenakas Room: RO PG VASECTOMY: A VERY PRACTICAL COURSE ON PREOPERATIVE, INTRAOPERATIVE AND POSTOPERATIVE MANAGEMENT Ira Sharlip, Director Joel Marmar, Stanton Honig, Jay Sandlow Room: RO-9 Sunday, May 17, :00 am - 8:00 am 29 IC MANAGEMENT OF LOCALLY ADVANCED AND METASTATIC RENAL CELL CARCINOMA: A CASE BASED APPROACH Christopher Wood, Director E. Jason Abel, Vitaly Margulis Room: RO IC NEW TECHNIQUES IN BPH SURGERY: ENDOSCOPIC ENUCLEATION Peter Gilling, Director Andreas Gross, Lori Lerner Room: RO-4 31 IC CONTEMPORARY TREATMENT STRATEGIES IN THE MANAGEMENT OF PENILE CANCER Philippe Spiess, Director Sukhbinder Minhas, Chris Protzel Room: RO-5 32 IC AUA GUIDELINE: CASTRATION-RESISTANT PROSTATE CANCER UPDATE Michael Cookson, Director William Lowrance, Adam Kibel Room: RO IC CONTEMPORARY RECONSTRUCTIVE STRATEGIES IN PROSTHETIC UROLOGY Jay Simhan, Co-Director Allen Morey, Co-Director Room: RO-8 6:00 am - 6:30 pm 34 IC ROBOTIC RADICAL CYSTECTOMY: GETTING STARTED AND TIPS AND TRICKS FROM THE EXPERTS Michael Woods, Director Erik Castle, Angela Smith Room: RO-9 8:30 am - 11:30 am 35 PG URINARY DIVERSION AFTER ROBOT- ASSISTED RADICAL CYSTECTOMY Hani Rashid, Director Ahmed Ghazi, Khurshid Guru, Guan Wu Room: RO-1 36 PG UROLITHIASIS: METABOLIC EVALUATION AND MEDICAL TREATMENT Margaret Pearle, Director Glenn Preminger, Michael Lipkin, Sara Best Room: RO PG PRACTICAL URORADIOLOGY: THE OFFICE BASED INTERPRETATION OF UROLOGIC RADIOGRAPHIC STUDIES Jay Bishoff, Director Srinivas Vourganti, Sero Andonian, Shane Anderson Room: RO-4 38 PG MEDICAL MALPRACTICE IN UROLOGY: HOW TO PREVENT AND DEFEND Christopher Coogan, Director David Sobel, Elizabeth Kavaler, James Saxton Room: RO-5 10

21 39 PG MANAGEMENT OF COMMON PSA DILEMMAS Gerald Andriole, Director Adam Kibel, Anthony D Amico, A. Oliver Sartor Room: RO PG URODYNAMIC EVALUATION AND ADVANCES IN MANAGEMENT OF ADULT NEUROGENIC BLADDER: A CASE BASED APPROACH Hari Tunuguntla, Director Stephen Kraus, Angelo Gousse Room: RO-8 41 PG HOW GENERAL UROLOGISTS CAN EVALUATE AND TREAT MALE INFERTILITY Marc Goldstein, Director Mark Sigman, Peter Chan Room: RO-9 1:00 pm - 3:00 pm OFFICE OF EDUCATION COURSES ALL COURSES ARE 42 IC RENAL BIOPSY UPDATE: INDICATIONS, TECHNIQUES, PITFALLS AND RECENT PATHOLOGICAL MODIFICATIONS TO OPTIMIZE RESULTS Raymond Leveillee, Director J. Stuart Wolf, Merce Jorda Room: RO-1 43 IC TESTICULAR CANCER: CURRENT CONCEPTS AND CONTROVERSIES Joel Sheinfeld, Director Brett Carver, George Bosl Room: RO IC THE USE OF ROBOTIC TECHNOLOGY IN FEMALE PELVIC FLOOR RECONSTRUCTION Jennifer Anger, Director Kimberly Kenton, Karyn Eilber Room: RO-4 45 IC MANEJO MÉDICO DEL PACIENTE MASCULINO CON SÍNTOMAS DE VÍAS URINARIAS BAJAS (ESTE CURSO SE PRESENTA SOLO EN ESPANOL) Enrique Lenero-Llaca, Director Arturo Garcia-Mora, Mariano Sotomayor Room: RO-5 46 IC UROLITHIASIS: SURGICAL MANAGEMENT, PERCUTANEOUS, SHOCK WAVE LITHOTRIPSY AND URETEROSCOPY - HOW WE DO IT Stephen Nakada, Director Manoj Monga, Bodo Knudsen Room: RO IC CONTEMPORARY CONCEPTS AND CONTROVERSIES IN THE DIAGNOSIS AND MANAGEMENT OF UPPER TRACT UROTHELIAL CARCINOMA (UTUC) Shahrokh Shariat, Director Surena Matin, Wes Kassouf, Douglas Scherr Room: RO-8 48 IC COMMON PROBLEMS IN PEDIATRIC UROLOGY: WHAT EVERY UROLOGIST SHOULD KNOW Richard Rink, Director Mark Cain Room: RO-9 3:30 pm - 6:30 pm 49 PG HOW TO IMPLEMENT THE AUA MEN S HEALTH CHECKLIST IN PRACTICE Ridwan Shabsigh, Director Steve Kopecky, Allen Seftel, Bruce Campbell Room: RO-1 50 PG MANAGEMENT OF NONMUSCLE INVASIVE BLADDER CANCER: PRACTICAL SOLUTIONS FOR COMMON PROBLEMS Cheryl Lee, Director J. Alfred Witjes, Theresa Koppie, Ashish Kamat Room: RO PG OPTIMIZATION OF SEXUAL FUNCTION OUTCOMES IN THE PATIENT WITH PROSTATE CANCER John Mulhall, Director Francesco Montorsi, Andrew McCullough Room: RO-5 53 PG PROSTATE CANCER UPDATE 2015 William Catalona, Director Stacy Loeb, Stanley Liauw, Douglas Dahl, Robert Nadler, Russell Szmulewitz Room: RO PG ADVANCED PERCUTANEOUS NEPHROLITHOTOMY Evangelos Liatsikos, Director John Denstedt, Thomas Knoll Room: RO-8 55 PG GLOBAL PERSPECTIVES IN URETHRAL RECONSTRUCTION Hunter Wessells, Director Sanjay Kulkarni, Guido Barbagli Room: RO-9 COURSES Monday, May 18, :00 am - 8:00 am 56 IC THE OPTIMIZED SURGICAL JOURNEY: USING ENHANCED RECOVERY TECHNIQUES AND FAST TRACK PROTOCOLS TO IMPROVE SURVIVORSHIP AFTER MAJOR UROLOGIC SURGERY Jay Shah, Director Janet Baack Kukreja Room: RO-1 57 IC UPDATE ON AUA CANCER RELATED GUIDELINES: PREPARATION FOR CERTIFICATION Sam Chang, Director Peter Clark, Daniel Lin Room: RO-2-3 6:00 am - 6:30 pm 58 IC THE ROLE OF SACRAL NEUROMODULATION IN UROLOGICAL PRACTICE Steven Siegel, Director Norbert Kaula Room: RO-4 11

22 OFFICE OF EDUCATION COURSES ALL COURSES ARE 59 IC OPTIMIZING PROSTATE CANCER DIAGNOSTICS: TRANSPERINEAL, TRANSRECTAL AND MRI-ULTRASOUND FUSION TARGETED BIOPSIES Richard Popert, Director Janette Kinsella, John Ward, Ben Challacombe, Haesun Choi Room: RO-5 60 IC ACTIVE SURVEILLANCE FOR PROSTATE CANCER Laurence Klotz, Co-Director Ian Thompson, Co-Director Mark Emberton Room: RO IC CONTROVERSIES AND CONSENSUS IN FEMALE UROLOGY: A CASE BASED APPROACH Eric Rovner, Director David Ginsberg, J. Quentin Clemens, David Sussman Room: RO-8 62 IC FULL SPECTRUM OF UPPER TRACT TCC TREATMENT Majid Eshghi, Director John Phillips, Muhammad Choudhury Room: RO-9 8:30 am - 11:30 am 63 PG PRIMARY AND REOPERATIVE HYPOSPADIAS REPAIR: EVIDENCE-BASED DECISION MAKING Warren Snodgrass, Director Nicol Bush Room: RO-1 64 PG CONTEMPORARY UROLOGICAL MANAGEMENT OF WOMEN WITH SEXUAL DYSFUNCTION Irwin Goldstein, Director Kenneth Peters, Noel Kim, Andrew Goldstein Room: RO PG INFERTILITY UPDATE 2015: A COMPREHENSIVE APPROACH TO THE CLINICAL DIAGNOSIS AND TREATMENT OF THE INFERTILE MALE Larry Lipshultz, Director Edmund Sabanegh, Craig Niederberger, Robert Brannigan Room: RO-4 66 PG CHALLENGES IN THE EVALUATION AND MANAGEMENT OF POST-PROSTATECTOMY INCONTINENCE Craig Comiter, Co-Director Ajay Singla, Co-Director Zaki Almallah Room: RO-5 67 PG UTI CLINICAL STRATEGIES FOR UROLOGICAL PRACTICE John Krieger, Director Richard Grady, Kurt Naber, Wolfgang Weidner Room: RO PG IMPROVING THE OUTCOMES OF ROBOTIC UROLOGIC SURGERY: A STATE-OF-THE-ART VIDEO-BASED COURSE Vipul Patel, Director Sam Bhayani, David Albala, Alexandre Mottrie, Rafael Coelho, Bernardo Rocco Room: RO-8 69 PG COMPREHENSIVE MANAGEMENT OF T1A RENAL CELL CARCINOMA: A PRACTICAL REVIEW TO OPTIMIZE PATIENT TREATMENT AND OUTCOMES Jaime Landman, Director James McKiernan, Anthony Chang, Laura Findeiss Room: RO-9 1:00 pm - 3:00 pm 70 IC TRATAMIENTO CONTEMPORÂNEO DEL PROLAPSO DE ÓRGANOS PÉLVICOS SIN MALLAS (ESTE CURSO SE PRESENTA SÓLO EN ESPAÑOL) Paulo Palma, Director Cassio Riccetto, Larissa Rodriguez Room: RO-1 71 IC MANAGEMENT OF SMALL RENAL MASSES, TECHNICAL ADVANCES IN NEPHRON SPARING SURGERY, AND MANAGEMENT OF LOCALLY ADVANCED RCC: A CASE BASED APPROACH Steven Campbell, Director Robert Uzzo, Brian Lane Room: RO IC GERIATRIC UROLOGY: BASIC PRINCIPLES FOR UROLOGIC PRACTICE Tomas Griebling, Director E. Camille Vaughan, Theodore Johnson Room: RO-4 73 IC EVALUATION AND MANAGEMENT OF URINARY TRACT BLEEDING: FROM ASYMPTOMATIC MICROHEMATURIA TO INTRACTABLE HEMORRHAGIC CYSTITIS Stephen Boorjian, Director Jay Raman, Daniel Barocas Room: RO-5 74 IC SURGICAL AND MINIMALLY INVASIVE MANAGEMENT OF FEMALE STRESS URINARY INCONTINENCE Victor Nitti, Director Harriette Scarpero Room: RO IC DIFFICULT CASES IN HIGH RISK BLADDER CANCER: AN EVIDENCE-BASED APPROACH Michael Cookson, Director Timothy Masterson, Jeffrey Holzbeierlein Room: RO-8 76 IC AUA GUIDELINE: PEYRONIE S DISEASE Ajay Nehra, Director Arthur Burnett, Alan Shindel Room: RO-9 12

23 3:30 pm - 6:30 pm OFFICE OF EDUCATION COURSES ALL COURSES ARE 77 PG EVALUATION AND MANAGEMENT OF PEDIATRIC VOIDING DYSFUNCTION Lane Palmer, Director Christopher Cooper, Paul Austin Room: RO-1 17 PG HARNESSING THE TELEMEDICINE AND MHEALTH REVOLUTIONS TO IMPROVE YOUR CLINICAL PRACTICE Matthew Gettman, Co-Director Todd Morgan, Co-Director Ted Skolarus, Alexander Kutikov, Benjamin Lee, Jeremy Shelton Room: RO PG TREATMENT OF COMPLEX UROLITHIASIS AND ENDOUROLOGIC COMPLICATIONS Amy Krambeck, Director Nicole Miller, Vernon Pais, John Lieske Room: RO-4 80 PG SURVEILLANCE OR TREATMENT: THE 3 MS - MARKERS, MAPPING AND MRI FOR LOCALIZED PROSTATE CANCER E. David Crawford, Director Matthew Cooperberg, M. Scott Lucia, Nelson Stone Room: RO PG CODING AND REIMBURSEMENT UPDATE 2015 Ronald Kaufman, Co-Director Stephanie Stinchcomb, Jonathan Rubenstein Room: RO-8 82 PG INTEGRATION OF MULTIPARAMETRIC MRI INTO THE UROLOGIC MANAGEMENT OF PROSTATE CANCER Samir Taneja, Co-Director Peter Pinto, Co-Director Peter Choyke, Ardeshir Rastinehad, Sadhna Verma Room: RO-9 COURSES 79 PG FOUNDATIONS OF FEMALE UROLOGY J. Christian Winters, Director Nirit Rosenblum, Stephen Kraus Room: RO-5 Tuesday, May 19, :00 am - 8:00 am 83 IC URINARY DIVERSION: CURRENT INDICATIONS, TECHNIQUES AND MANAGEMENT OF COMPLICATIONS Siamak Daneshmand, Director Eila Skinner Room: RO-4 84 IC NATIVE TISSUE REPAIRS FOR INCONTINENCE AND PROLAPSE Philippe Zimmern, Director Elise Billings De Room: RO-5 85 IC TESTOSTERONE: DIAGNOSIS AND MANAGEMENT OF THE HYPOGONADAL MALE Wayne Hellstrom, Director Mohit Khera, Martin Miner Room: RO IC PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE (PVP) AND GREEN LASER ENUCLEATION OF THE PROSTATE (GREENLEP) USING THE 532NM LITHIUM TRIBORATE LASER Henry Woo, Director Fernando Sancha, Oliver Reich Room: RO-8 8:30 am - 11:30 am 88 PG THE MANAGEMENT OF UROLITHIASIS: A CASE AND EVIDENCE-BASED APPROACH Brian Matlaga, Director James Lingeman, Dean Assimos, Ojas Shah Room: RO-1 6:00 am - 11:30 am 89 PG CATASTROPHES, COMPLICATIONS AND CORRECTIONS Arthur Smith, Director Jean de la Rosette, Ralph Clayman, David Hoenig Room: RO PG URETHRAL RECONSTRUCTION Kenneth Angermeier, Director Daniel Rosenstein, Kennon Miller, Kenneth Carney Room: RO-4 91 PG BUILDING A STATEWIDE QUALITY COLLABORATIVE: LESSONS FROM THE MUSIC EXPERIENCE Frank Burks, Director Brian Lane, Susan Linsell, David Miller Room: RO-5 92 PG ADVANCED URETEROSCOPY: OVERCOMING CHALLENGING PROBLEMS Michael Grasso, Director Scott Hubosky, Olivier Traxer, Demetrius Bagley Room: RO PG SEQUENCING NOVEL AGENTS AND UNDERSTANDING NOVEL CONCEPTS IN HORMONE NAÏVE AND CASTRATION RESISTANT PROSTATE CANCER 2015 Judd Moul, Director Christopher Sweeney, Lawrence Karsh Room: RO-8 94 PG INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME: A PRIMER AND A WORLD VIEW Philip Hanno, Director Mauro Cervigni, Arndt Van Ophoven, Jorgen Nordling, David Burks Room: RO-9 13

24 NOTES

25 NOTES

26 NOTES

27 EVERYONE HAS A STORY. SEE THE NEXT CHAPTER TODAY. Program by Day Visit Janssen Booth #1617 to learn more. Janssen Biotech, Inc. Janssen Biotech, Inc /

28 Program by Day 3 THINGS YOU CAN T MISS AT OUR BOOTH - REGISTRATION AREA - CELEBRATE 40 YEARS OF RESEARCH Cake Cutting Sunday, May 17 2:30 pm NETWORK with the leading patient advocacy groups Patient Advocacy Meet and Greet Monday, May 18 4 to 6 pm Pick up your FREE T-SHIRT and learn about our new website* Hurry as t-shirts are limited! *Must attend a short website demo in order to receive the t-shirt.

29 MP Moderated Poster Session, PD Podium Session Friday, May 15, 2015 SOCIETY FOR PEDIATRIC UROLOGY - FRIDAY Grand Ballroom Hilton New Orleans Riverside 7:30 am - 5:30 pm FRIDAY 7:30 SESSION 1: PRIZE S Moderators: Stephane Bolduc, Earl Cheng 8:45 PANEL DISCUSSION: HYPOSPADIAS PANEL Moderator: Michael Leonard Panelists: Mark Zaontz, Rafael Gosalbez, Keith Rourke 9:45 BREAK 10:15 SESSION 2: COMPLEX INCONTINENCE Moderators: Peter Metcalfe, Katie Willihnganz- Lawson 11:15 MEREDITH CAMPBELL LECTURE: TINY TOTS PROJECT John Heaton 1:30 SESSION 3: SFU PERINATAL UROLOGY Moderators: Travis Groth, Miguel Castellan 2:30 SFU PANEL: BLADDER EXSTROPHY Panelists: Michael Mitchell, Barry Duel, Bradley Kropp, John Kryger 4:00 BREAK 4:30 SESSION 4: PENIS/HYPOSPADIAS Moderators: Gianpaolo Capolicchio, Dawn McLellan 5:30 ADJOURN 12:00 LUNCH (ON OWN) Friday, May 15, 2015 BASIC SCIENCES SYMPOSIUM - AGING AND UROLOGIC MANIFESTATIONS Room New Orleans Morial Convention Center 8:00 am - 5:00 pm 8:00 OPENING REMARKS Carolyn Best, George Christ 8:15 REVERSING DYSFUNCTION IN AGING TISSUE BY TARGETING SYSTEMIC SIGNALS Amy Wagers 8:55 Q&A 9:10 AGING, HYPOGONADISM, AND UROLOGIC MANIFESTATIONS IN MEN Moderator: Barry Zirkin AGING AND DECLINING TESTOSTERONE: PAST, PRESENT AND FUTURE Barry Zirkin 9:30 ANDROGENS AND PROSTATE DISEASE RISK Stephanie Page 9:50 ESTROGEN REGULATION IN BPH AND THE LOWER URINARY TRACT William Ricke 10:10 ACTIONS OF TESTOSTERONE ON THE AGING MALE GH AXIS Johannes Veldhuis 10:30 Q&A 10:45 GENITOURINARY COMPLICATIONS OF AGING MEN Moderator: Kevin McVary AGING AND LUTS IN MEN Kevin McVary 11:05 AGING AND THE INTERPLAY BETWEEN THE PROSTATE AND CHANGES IN THE BLADDER Claus Roehrborn 11:25 LIFE COURSE FACTORS & LOWER URINARY TRACT DYSFUNCTION: THE GUCARDIA STUDY Stephen Van Den Eeden 11:45 Q&A 12:00 LUNCH 1:15 ADVANCES IN UNDERSTANDING AGING- RELATED INCONTINENCE IN WOMEN Moderator: Tomas Griebling GENETIC PREDICTORS OF THE RESPONSE TO URGE INCONTINENCE THERAPY Jennifer Wu 1:35 UROTHELIAL PHYSIOLOGY IN URINARY CONTINENCE AND INCONTINENCE Lori Birder 1:55 URINARY INCONTINENCE, BODY MASS, AND BODY COMPOSITION IN OLDER WOMEN Alison Huang 2:15 URGENCY INCONTINENCE IN OLDER ADULTS Tomas L. Griebling 2:35 Q&A 2:50 BRAIN ACTIVITY IN OVERACTIVE BLADDER Neil Resnick 3:10 ADVANCED THERAPEUTIC DIRECTIONS TO TREAT THE UNDERACTIVE BLADDER Michael Chancellor 3:30 FEMALE PELVIC FLOOR CHANGES WITH AGING Margot Damaser 3:50 Q&A *Presenting author 17

30 4:05 CENTRAL NERVOUS SYSTEM MANIFESTATIONS OF AGING AND UROLOGIC CONSEQUENCES Moderator: Sylvia Suadicani VOIDING DYSFUNCTION AND PARKINSON S DISEASE Lysanne Campeau 4:25 MULTIPLE SCLEROSIS MODELS Sylvia Suadicani 4:45 Q&A 5:00 CLOSING REMARKS AND ADJOURN Carolyn Best Friday, May 15, :00 am - 5:00 pm SOCIETY OF UNIVERSITY UROLOGISTS / SOCIETY OF UROLOGY CHAIRPERSONS AND PROGRAM DIRECTORS (SUU/SUCPD) La Nouvelle New Orleans Morial Convention Center 8:00 SUU PROGRAM WELCOME Program Chair: Douglas Canning 8:05 THE UROLOGY MATCH: WHERE WE WERE, WHERE WE ARE, AND WHERE WE SHOULD GO HISTORY OF THE MATCH Steven Weissbart 8:10 HOW COMPETITIVE IS THE MATCH? Fatima Husain 8:15 WOULD APPLICATION LIMITS IMPROVE THE MATCH? Steven Weissbart 8:25 WAYS TO IMPROVE THE MATCH Moderators: Jeffrey Stock, Steven Weissbart Panelists: Steven Campbell, Kirtishri Mishra, Eila Skinner, Alan Wein 8:45 MANAGING RESIDENTS IN THE 21ST CENTURY Moderators: Steven Weissbart, Jeffrey Stock Panelists: Carl Olsson, Byron Joyner, J. Christopher Austin 9:15 LEGAL PITFALLS OF THE ELECTRONIC MEDICAL RECORD: A PLAINTIFF S ATTORNEY S PERSPECTIVE Ben Rubinowitz 9:45 MEDICAL MALPRACTICE DISCUSSION Moderator: Mitchell Benson 10:00 AUA UPDATE: ELECTRONIC EDUCATION AND DATA REGISTRY Gopal Badlani 10:10 BREAK 10:25 VALUE BASED HEALTH CARE AND ACADEMIC UROLOGY: HOW DO WE PREPARE? David Penson 11:00 VALUE BASED CARE AS APPLIED TO UROLOGY Moderator: Steve Kim Panelists: David Miller, Mark Litwin, Gregory Tasian 11:25 ACADEMIC/INDUSTRY PUBLICATION PRACTICE: DOS AND DON TS Grannum Sant 11:45 DOS AND DON TS DISCUSSION Moderator: Barry Kogan 12:00 ANNUAL SUU BUSINESS MEETING 12:30 ANNUAL SUCPD BUSINESS MEETING 1:00 SUCPD PROGRAM WELCOME Program Chair: Eila Skinner 1:05 THE EXPERIENCE OF STUDENTS GOING THROUGH THE MATCH Eila Skinner 1:20 UROLOGY FELLOWSHIP PROGRAMS PEDIATRICS Richard Grady 1:30 ONCOLOGY Peter Clark 1:40 FPMRS Craig Comiter 1:50 LAP/ENDO Stephen Nakada 2:00 INFERTILITY Robert Brannigan 2:10 TRAUMA/RECONSTRUCTION Jill Buckley 2:20 PANEL DISCUSSION WITH QUESTIONS Moderator: Eila Skinner 2:45 CLOUD SOURCING FOR VIDEO EVALUATION Thomas Lendvay 3:00 TRAINING FELLOWS TO BE EFFECTIVE TEACHERS Sapan Ambani, Cheryl Lee 3:15 BREAK 3:30 RRC REPORT Randall Meacham 3:40 ACGME REPORT Mary Turner 3:50 ABU UPDATE J. Brantley Thrasher 4:00 AUA OFFICE OF EDUCATION REPORT Elspeth McDougall 4:10 AUA MEDICAL STUDENT CURRICULUM William Hulbert 4:20 AUA CORE CURRICULUM UPDATE John Mulhall 18

31 4:30 GRANT RECIPIENT REPORTS UROLOGY ULTRASOUND TRAINING PROTOCOL AND ASSESSMENT PROGRAM (2011) Geoffrey Box 4:35 FUNDAMENTALS IN RESEARCH TEACHING IN UROLOGY RESIDENCY PROGRAMS: NEEDS ASSESSMENT AND DEVELOPMENT OF A FORMAL RESEARCH DIDACTIC CURRICULUM (2012) Dennis Liu 4:40 DEVELOPMENT AND VALIDATION OF AN IPAD LAPAROSCOPY TRAINER (2012) Jaime Landman 4:45 DEVELOPMENT OF AN IPAD SURGICAL ATLAS APPLICATION FOR UROLOGY TRAINEES (2013) Jaime Landman 4:50 FEASIBILITY OF A DESKTOP SIMULATION USING DIGITAL AVATARS TO TEACH UROLOGY RESIDENTS DIFFICULT COMMUNICATION SKILLS (2013) Bruce Kava 4:55 SERIOUS GAMES: COMPETITION VS. INCENTIVES TO ENGAGE RESIDENT IN QUALITY-IMPROVEMENT EDUCATION (2014) Charles Scales 5:00 ADJOURN FRIDAY Friday, May 15, :00 am - 5:00 pm UROLOGIC ONCOLOGY RESEARCH SYMPOSIUM: HIGH IMPACT SCIENCE IN UROLOGIC ONCOLOGY AND PROGRESS IN BIOMEDICAL IMAGING Room New Orleans Morial Convention Center 8:00 WELCOME 8:05 SESSION I: BEST OF SCIENCE IN UROLOGIC ONCOLOGY, PART I Moderator: William Isaacs THE ROLE OF IMMUNE CHECKPOINT MODULATION IN THE TREATMENT OF ADVANCED BLADDER CANCER Daniel Petrylak 8:25 INTRINSIC SUBTYPES OF BLADDER CANCER: IMPLICATIONS FOR PROGNOSTICATION AND THERAPY David McConkey 8:45 EXPLOITING VULNERABILITIES CAUSED BY GENES THAT REPROGRAM CANCER METABOLISM Dan Theodorescu 9:05 Q&A 9:15 SESSION II: BEST OF SCIENCE IN UROLOGIC ONCOLOGY, PART 2 Moderator: Marston Linehan LESSONS LEARNED FROM PREVENTION TRIALS IN GU ONCOLOGY Ian Thompson 9:35 DISCOVERING THE GENES FOR INHERITED PROSTATE CANCER William Isaacs 9:55 THE GENETIC AND METABOLIC BASIS OF KIDNEY CANCER Marston Linehan 10:15 MOLECULAR CHARACTERIZATION OF CHROMOPHOBIC RCC Chad Creighton 10:35 NEW HORIZONS: CHROMATIN MODIFIERS IN KIDNEY CANCER Kim Rathmell 10:55 Q&A 11:05 SESSION III: BEST SCIENCE FROM THE UROLOGIC RESEARCH SOCIETY Moderator: Ganesh Palapattu INTRODUCTION TO THE UROLOGIC RESEARCH SOCIETY (URS) Samir Taneja 11:15 RESISTANCE TO AR PATHWAY INHIBITORS Martin Gleave 11:35 ROLE FOR THE HEXOSAMINE BIOSYNTHETIC PATHWAY IN ANDROGEN DEPENDENT PROSTATE CANCER Ganesh Palapattu 11:55 THE MECHANISMS AND THE BIOLOGY OF MICRO- AND BONE- METASTASES IN PROSTATE CANCER George Thalmann 12:15 Q&A 12:25 LUNCH 1:15 SESSION IV: BASIC CONCEPTS AND TECHNOLOGIES FOR BIOMEDICAL IMAGING Moderator: Martin Pomper IMAGING PROBES FOR TARGETED THERAPY Peter Choyke 1:35 PSMA-TARGETED IMAGING OF PROSTATE CANCER Martin Pomper 1:55 IMAGE-GUIDED ROBOTS Dan Stoianovici *Presenting author 19

32 2:15 TISSUE-LEVEL IMAGING IN 3-D George Christ 2:35 Q&A 2:45 SESSION V: TRANSLATIONAL RESEARCH AND APPLICATION Moderator: Inderbir Gill EMERGING USE OF MRI FOR DETERMINING TUMOR TYPE AND FOR ASSESSING RENAL FUNCTION William Huang 3:05 INTRAOPERATIVE IMAGING FOR PARTIAL NEPHRECTOMY Inderbir Gill 3:25 STATUS OF GENOMIC STUDIES IN PROSTATE CANCER Ashutosh Tewari 3:45 THE ROLE OF IMAGING IN PROSTATE CANCER FOCAL THERAPY Samir Taneja 4:05 LYMPH NODE IMAGING FOR PROSTATE AND BLADDER CANCER Urs Studer 4:25 FIBEROPTIC CONFOCAL LASER ENDOMICROSCOPY: TOWARDS OPTICAL BIOPSY FOR TISSUE CHARACTERIZATION DURING UROLOGIC SURGERY Li-Ming Su 4:45 Q&A 5:00 ADJOURN Friday, May 15, :30 am - 4:00 pm SOCIETY OF GENITOURINARY RECONSTRUCTIVE SURGEONS (GURS) / SOCIETY OF UROLOGIC PROSTHETIC SURGEONS (SUPS) La Nouvelle New Orleans Morial Convention Center 9:30 OPENING REMARKS Society Chairs: Sean Elliott, Allen Morey, Ajay Nehra OPENING SESSION 9:40 DEVINE LECTURE: CHALLENGES IN MALE GENITAL TRAUMA Moderator: Daniel Dugi Michael Coburn 10:00 SCOTT LECTURE: DEVELOPMENT OF THE MALE TRANSOBTURATOR SLING Moderator: Raul Ordorica Peter Rehder 10:20 DISCUSSION 10:30 URETHRA SESSION Moderators: Hadley Wood, Keith Rourke ROLE OF STAGED URETHROPLASTY IN ADULTS Paul Anderson 10:40 ROLE OF STAGED URETHROPLASTY IN CHILDREN Nicol Bush 10:50 ROLE OF PENILE INVERSION IN URETHROPLASTY Justin Chee 11:00 ROLE OF PROSTATIC URETHRAL LIFT IN BPH Peter Chin 11:10 DISCUSSION AND AUDIENCE RESPONSE QUESTIONS 11:30 URETER SESSION Moderators: Jeremy Myers, Lee Zhao ROLE OF BUCCAL MUCOSA GRAFT IN URETERAL RECONSTRUCTION Michael Stifelman 12:00 INDUSTRY SPONSORED LUNCH SYMPOSIUM (NON-CME PORTION OF PROGRAM) 1:00 MALE INCONTINENCE SESSION Moderators: Jack Walter, Anna Lawrence ROLE OF 3.5 CM AUS CUFF Jay Simhan 1:10 ROLE OF TRANSCORPORAL AND TANDEM AUS CUFF Kurt McCammon 1:20 ROLE OF URETHRAL LIGATION Kenneth Angermeier 1:30 ROLE OF URETHROPLASTY (AND NON- TRANSECTING TECHNIQUES) IN AUS PATIENT Daniela Andrich 1:40 DISCUSSION AND AUDIENCE RESPONSE QUESTIONS 2:00 BREAK WITH EXHIBITS 2:30 PENIS SESSION Moderators: Michael Metro, Andrew Kramer ROLE OF YACHIA CORPOROPLASTY IN PEYRONIE S DISEASE Ronald Lewis 2:40 THE ROLE OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM (CCH) IN PEYRONIE S DISEASE Wayne Hellstrom 2:50 ROLE OF ULTRASOUND IN PENILE FRACTURE Andre Cavalcanti 3:00 ROLE OF GLANS RESURFACING IN BXO AND PENILE CANCER David Sofield 11:40 DISCUSSION 20

33 3:10 ROLE OF KETOCONAZOLE IN MANAGING RECURRENT ISCHEMIC PRIAPISM Laurence Levine 3:20 DISCUSSION AND AUDIENCE RESPONSE QUESTIONS 4:00 ADJOURN FRIDAY Friday, May 15, 2015 A DECADE OF PHARMACOTHERAPY FOR OAB: WHAT HAVE WE LEARNED? Room New Orleans Morial Convention Center 10:00 am - 12:05 pm 10:00 INTRODUCTION: GOALS & OBJECTIVES Alan Wein 10:05 ORIGIN OF THE TERM OAB Paul Abrams 10:25 CRITICAL LOOK AT THE TERM Jerry Blaivas 10:45 ANTICHOLINERGICS: HAVE THEY STOOD THE TEST OF TIME Marcus Drake 11:25 BETA 3 AGONISTS: WILL IT FILL THE VOID? Victor Nitti 11:45 WHAT IS NEW IN THE PIPELINE? Karl-Erik Andersson 12:05 CONCLUDING REMARKS Alan Wein 11:05 CLINICAL TRIALS VS. REAL WORLD EXPERIENCE OF ANTICHOLINERGICS Sender Herschorn Friday, May 15, 2015 Moderated Poster Session 1 PROSTATE CANCER: MARKERS I Room New Orleans Morial Convention Center Moderators: Daniel Lin and Mark Frydenberg 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP1-01 THE 17-GENE GENOMIC PROSTATE SCORE (GPS) ASSAY: INITIAL CLINICAL EXPERIENCE OF 4,000 PATIENTS Aaron Katz*, Andrew Ho, Garden City, NY, Emily Burke, Bela Denes, Ruixiao Lu, Megan Rothney, Michael Bonham, Athanasios Tsiatis, Jeffrey Lawrence, Phillip Febbo, Redwood City, CA MP1-04 MP1-02 MP1-03 ASSOCIATION OF GENETIC VARIANTS IN TELOMERE-RELATED GENES WITH PROSTATE CANCER RISK AND RECURRENCE Chengyuan Gu*, Yao Zhu, Dingwei Ye, Shanghai, China, People s Republic of VALIDATED URINE-BASED MULTIGENE SIGNATURE FOR DETECTION OF AGGRESSIVE PROSTATE CANCER Jean-François Haince, Guillaume Beaudry, Eric Paquet, Quebec City, Canada, Lorne Aaron, Greenfield Park, Canada, Robert Sabbagh, Sherbrooke, Canada, Vincent Fradet*, Quebec City, Canada, Neil Fleshner, Toronto, Canada, Yves Fradet, Quebec City, Canada EVALUATION OF GENOMIC SIGNATURES IN INTERMEDIATE TO HIGH RISK MEN TREATED WITH RADICAL PROSTATECTOMY BUT WITHOUT ADDITIONAL THERAPY UPON PSA RISE Michael Johnson*, Baltimore, MD, Kasra Yousefi, Nicholas Erho, Voleak Choeurng, Lucia Lam, Vancouver, Canada, Helen L. Fedor, Baltimore, MD, Elai Davicioni, Vancouver, Canada, Edward Schaeffer, Ashley Ross, Baltimore, MD MP1-05 A MULTI-CENTER COMPARISON OF A 17- GENE GENOMIC PROSTATE SCORE (GPS) AS A PREDICTOR OF OUTCOMES IN AFRICAN-AMERICAN (AA) AND CAUCASIAN (CA) MEN WITH CLINICALLY LOCALIZED PROSTATE CANCER (PCA) Jennifer Cullen*, Rockville, MD, Isabell Sesterhenn, Silver Spring, MD, Eric Klein, Cleveland, OH, James Mohler, Buffalo, NY, Peter Carroll, Matthew Cooperberg, San Francisco, CA, Nan Zhang, Tara Maddala, Dejan Knezevic, Athanasios Tsiatis, H. Jeffrey Lawrence, Phillip Febbo, Redwood City, CA *Presenting author 21

34 MP1-06 MP1-07 MP1-08 MP1-09 MP1-10 MP1-11 CLINICAL BENEFITS AND COSTS OF A 17-GENE ASSAY DESIGNED TO ASSESS DISEASE-PROGRESSION RISK AFTER POSITIVE PROSTATE CANCER BIOPSY Marc Dall Era*, Davis, CA, Steven N. Michalopoulos, Menlo Park, CA, Béla S. Denes, Redwood City, CA, Jennifer Tighe, Menlo Park, CA, John Hornberger, Stanford, CA ENRICHMENT OF CIRCULATING TUMOR CELLS IN PATIENTS WITH LOCALIZED PROSTATE CANCER USING A MICROFLUIDIC DEVICE Tilman Todenhöfer*, Emily Park, Hamid Abdi, Alex Li, Richard Ross, Xiaoyan Deng, Chao Jin, Simon Duffy, Martin Gleave, Hongshen Ma, Peter Black, Vancouver, Canada PATIENT AUA RISK CLASSIFICATION BASED ON COMBINED CLINICAL CELL CYCLE RISK (CCR) SCORE Jack Cuzick*, London, United Kingdom, Steven Stone, Julia Reid, Salt Lake City, UT, Gabrielle Fisher, Henrik Møller, London, United Kingdom, Michael Brawer, Salt Lake City, UT, Peter Scardino, New York, NY, Neal Shore, Myrtle Beach, SC PROSPECTIVE CORRELATION BETWEEN PROBABILITY OF FAVORABLE PATHOLOGY ON THE 17-GENE GENOMIC PROSTATE SCORE AND ACTUAL PATHOLOGIC OUTCOMES AT RADICAL PROSTATECTOMY Michael Whalen*, James McKiernan, Mitchell Benson, Ketan Badani, New York, NY VALIDATION OF AN ACTIVE SURVEILLANCE THRESHOLD FOR THE CCP SCORE IN CONSERVATIVELY MANAGED MEN WITH LOCALIZED PROSTATE CANCER Jack Cuzick*, London, United Kingdom, Steven Stone, Salt Lake City, UT, Gabrielle Fisher, Zi Hua Yang, Bernard North, Daniel Berney, Luis Beltran, London, United Kingdom, David Greenberg, Cambridge, United Kingdom, Henrik Møller, London, United Kingdom, Julia Reid, Alexander Gutin, Jerry Lanchbury, Michael Brawer, Salt Lake City, UT, Peter Scardino, New York, NY VALIDATION OF THE DECIPHER PROSTATE CANCER CLASSIFIER IN INTERMEDIATE TO HIGH RISK MEN TREATED WITH RADICAL PROSTATECTOMY BUT WITHOUT ADDITIONAL THERAPY UPON PSA RISE Ashley Ross*, Michael Johnson, Baltimore, MD, Kasra Yousefi, Vancouver, Canada, Bruce Trock, Baltimore, MD, Voleak Choeurng, Lucia Lam, Vancouver, Canada, Helen L. Fedor, Baltimore, MD, Mercedeh Ghadessi, Christine Buerki, Vancouver, Canada, Stephanie Glavaris, Debasish Sundi, Jeffrey Tosoian, Misop Han, Elizabeth Humphreys, Alan Partin, George Netto, Baltimore, MD, Elai Davicioni, Vancouver, Canada, Edward Schaeffer, Baltimore, MD MP1-12 MP1-13 MP1-14 MP1-15 MP1-16 MP1-17 COMPARATIVE ANALYSIS OF AFRICAN AMERICAN AND EUROPEAN AMERICAN MEN USING A PROSTATE CANCER GENOMIC CLASSIFIER Michael Johnson*, Baltimore, MD, Voleak Choeurng, Kasra Yousefi, Vancouver, Canada, Elai Davicioni, San Diego, CA, Eric Klein, Cleveland, OH, Robert Den, Adam Dicker, Philadelphia, PA, Ashley Ross, Edward Schaeffer, Baltimore, MD EXTENSION AND SEVERITY OF PROSTATE INFLAMMATION AND ATROPHY ARE INDEPENDENTLY ASSOCIATED WITH LOWER PSA LEVELS IN MEN UNDERGOING PROSTATE BIOPSY Daniel Moreira*, Rochester, MN, Gerald Andriole, St Louis, MO, Ramiro Castro- Santamaria, King of Prussia, PA, Stephen Freedland, Durham, NC DEFINING ADVERSE PATHOLOGY FOR LOWER RISK MEN UNDERGOING RADICAL PROSTATECTOMY Michael A. Kozminski*, Scott Tomlins, Udit Singhal, Louis Lu, Ted A. Skolarus, Ganesh S. Palapattu, Jeffrey S. Montgomery, Alon Z. Weizer, Rohit Mehra, Brent K. Hollenbeck, David C. Miller, Felix Y. Feng, Todd M. Morgan, Ann Arbor, MI QUANTITATIVE HISTOMORPHOMETRIC ANALYSIS OF PROSTATE BIOPSY IMAGES PREDICT FAVORABLE OUTCOME IN ACTIVE SURVEILLANCE PATIENTS George Lee*, Cleveland, OH, Robert Veltri, Guangjing Zhu, H. Ballentine Carter, Patricia Landis, Jonathan Epstein, Baltimore, MD, Anant Madabhushi, Cleveland, OH DETECTION OF APOPTOTIC AND NON- APOPTOTIC DISSEMINATED TUMOR CELLS IN THE BONE MARROW AT THE TIME OF RADICAL PROSTATECTOMY Tilman Todenhöfer*, Vancouver, Canada, Jörg Hennenlotter, Frank Faber, Ursula Kühs, Tuebingen, Germany, Tanja Fehm, Duesseldorf, Germany, Diethelm Wallwiener, Tuebingen, Germany, David Schilling, Frankfurt, Germany, Georgios Gakis, Simone Bier, Johannes Mischinger, Stefan Aufderklamm, Arnulf Stenzl, Christian Schwentner, Tuebingen, Germany PTEN STATUS DETERMINATION IN PROSTATE CANCER: COMPARISON OF IHC AND FISH IN A LARGE MULTI- CENTER COHORT Tamara L. Lotan*, Carlos L. Morais, Baltimore, MD, Wei Wei, Houston, TX, Tamara Jamaspishvili, Kingston, Canada, Ziding Feng, Houston, TX, Jesse McKenney, Cleveland, OH, Jeff Simko, San Francisco, CA, Dean Troyer, Fairfax, VA, Lawrence True, Seattle, WA, James D. Brooks, Palo Alto, CA, Jeremy Squire, Sao Paulo, Brazil, CAnary Pathology Team Investigating Tissue Biomarkers (CAPIT), Palo Alto, CA 22

35 MP1-18 MP1-19 PROGNOSTIC IMPACT OF SECOND PRIMARY MALIGNANCIES ON THE OVERALL SURVIVAL OF PATIENTS WITH METASTATIC PROSTATE CANCER Kyo Chul Koo*, Ki Hong Kim, Sang Un Park, Koon Ho Rha, Sung Joon Hong, Byung Ha Chung, Seoul, Korea, Republic of A NOVEL LIVE CELL MICROFLUIDIC DIAGNOSTIC USING PHENOTYPIC BIOMARKERS WITH OBJECTIVE ALGORITHMIC ANALYSIS FOR PROSTATE CANCER RISK STRATIFICATION Kimberly Rieger-Christ*, Travis Sullivan, Burlington, MA, Naveen Kella, Ray Hernandez, San Antonio, TX, Vladimir Mouraviev, Syracuse, NY, Kevin Knopf, San Francisco, CA, Hani Rashid, Rochester, NY, Michael Manak, Wendell Su, Brad Hogan, Andrew Min, Delaney Berger, Matthew Whitfield, Jonathan Varsanik, Mani Foroohar, Ashok Chander, Beverly, MA, David Albala, Syracuse, NY, Grannum Sant, Boston, MA MP1-20 DISTINGUISHING INDOLENT FROM AGGRESSIVE PROSTATE CANCER IN ACTIVE SURVEILLANCE USING PARTIALWAVE SPECTROSCOPY TO MEASURE NANOCYTOLOGICAL FIELD CARCINOGENESIS James Kearns*, Chicago, IL, Brian Helfand, Charles Brendler, Evanston, IL, Hemant Roy, Boston, MA, Chi-Hsiung Wang, Kristian Novakovic, Evanston, IL, Hariharan Subramanian, Di Zhang, Charles Maneval, Vadim Backman, Chicago, IL FRIDAY Friday, May 15, 2015 Moderated Poster Session 2 BLADDER CANCER: UPPER TRACT TCC I Room New Orleans Morial Convention Center Moderators: Michael Droller and Maurizio Brausi 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP2-01 CONTRALATERAL UPPER TRACT UROTHELIAL CARCINOMA AFTER NEPHROURETERECTOMY: THE PREDICTIVE ROLE OF METHYLATION STATUS Lei Zhang*, Gengyan Xiong, Dong Fang, Xuesong Li, Jin Liu, Weimin Ci, Wei Zhao, Beijing, China, People s Republic of, Nirmish Singla, Dallas, TX, Zhisong He, Li Zhou, Beijing, China, People s Republic of MP2-04 MP2-02 MP2-03 HIGH EXPRESSION OF KARYOPHERIN 2 DEFINES POOR PROGNOSIS IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH RADICAL NEPHROURETERECTOMY Boxing Su*, Beijing, China, People s Republic of, Bentao Shi, Shenzhen, China, People s Republic of, Yuan Tang, Dong Fang, Genyan Xiong, Zhongqiang Guo, Xuesong Li, Liqun Zhou, Beijing, China, People s Republic of PROGNOSTIC AND PREDICTIVE VALUE OF EPIGENETIC BIOMARKERS IN UPPER TRACT UROTHELIAL CARCINOMA Gengyan Xiong, Jin Liu, Dong Fang, Xuesong Li, Liqun Zhou*, Beijing, China, People s Republic of MP2-05 MP2-06 PROGNOSTIC VALUE OF SERUM CYFRA 21-1 IN PATIENTS WITH G3 OR MUSCLE INVASIVE UPPER URINARY TRACT CANCER Akihiro Yano*, Hironori Sugiyama, Eiken Cho, Hideki Takeshita, Yohei Okada, Hideki Nagamatsu, Makoto Morozumi, Satoru Kawakami, Takumi Yamada, Kawagoe, Japan IDENTIFICATION OF CIRCULATING MICRORNA SIGNATURES FOR UPPER TRACT UROTHELIAL CARCINOMA DETECTION Jun Tao*, Pengchao Li, Chao Qin, Qiang Lu, Nanjing, China, People s Republic of MULTI-INSTITUTIONAL VALIDATION OF THE PREDICTIVE VALUE OF KI-67 IN PATIENTS WITH HIGH-GRADE UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT Laura-Maria Krabbe*, Muenster, Germany, Aditya Bagrodia, Ahmed Haddad, Payal Kapur, Dina Khalil, Linda Hynan, Dallas, TX, Christopher Wood, Jose Karam, Houston, TX, Alon Weizer, Ann Arbor, MI, Jay Raman, Hershey, PA, Mesut Remzi, Vienna, Austria, Nathalie Rioux-Leclerq, Rennes, France, Andrea Haitel, Vienna, Austria, Marco Roscigno, Bergamo, Italy, Christian Bolenz, Mannheim, Germany, Karim Bensalah, Rennes, France, Arthur Sagalowsky, Dallas, TX, Shahrokh Shariat, Vienna, Austria, Yair Lotan, Vitaly Margulis, Dallas, TX *Presenting author 23

36 MP2-07 MP2-08 MP2-09 MP2-10 MP2-11 A SYSTEMATIC REVIEW AND META- ANALYSIS OF CLINICOPATHOLOGIC FACTORS LINKED WITH INTRAVESICAL RECURRENCE AFTER RADICAL NEPHROURETERECTOMY TO TREAT UPPER TRACT UROTHELIAL CARCINOMA Thomas Seisen*, Benjamin Granger, Paris, France, Pierre Colin, Lille, France, Priscilla Léon, Guillemette Utard, Raphaële Renard- Penna, Eva Compérat, Pierre Mozer, Olivier Cussenot, Paris, France, Shahrokh Shariat, Vienna, Austria, Morgan Rouprêt, Paris, France URINARY PH IS HIGHLY ASSOCIATED WITH BLADDER RECURRENCE AFTER NEPHROURETERECTOMY FOR UPPER URINARY TRACT UROTHELIAL CARCINOMA PATIENTS WITH POSITIVE SMOKING HISTORY Hiroki Ide*, Eiji Kikuchi, Nobuyuki Tanaka, Akira Miyajima, Mototsugu Oya, Tokyo, Japan NOMOGRAM FOR PREDICTION OF RECURRENCE-FREE SURVIVAL IN PATIENTS WITH HIGH-GRADE UPPER TRACT UROTHELIAL CARCINOMA AFTER EXTIRPATIVE THERAPY Laura-Maria Krabbe*, Muenster, Germany, Okyaz Eminaga, Cologne, Germany, Shahrokh Shariat, Vienna, Austria, Yair Lotan, Arthur Sagalowsky, Dallas, TX, Jay Raman, Hershey, PA, Christopher Wood, Houston, TX, Alon Weizer, Ann Arbor, MI, Marco Roscigno, Bergamo, Italy, Francesco Montorsi, Milan, Italy, Christian Bolenz, Mannheim, Germany, Mesut Remzi, Vienna, Austria, Karim Bensalah, Rennes, France, Wassim Kassouf, Montreal, Canada, Vitaly Margulis, Dallas, TX THE IMPACT OF PERIOPERATIVE BLOOD TRANSFUSION AND NUMBER OF TRANSFUSED UNITS ON SURVIVAL FOLLOWING RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA Michael Rink*, Armin Soave, Atiqullah Aziz, Hamburg, Germany, Fahmy Al-Sayed, Tübingen, Germany, Oliver Engel, Sven Peine, Luis A. Kluth, Felix K. Chun, Roland Dahlem, Hamburg, Germany, Arnulf Stenzl, Tübingen, Germany, Maximilian Burger, Regensburg, Germany, Margit Fisch, Hamburg, Germany, Hans-Martin Fritsche, Regensburg, Germany, Georgios Gakis, Tübingen, Germany STAGE-SPECIFIC IMPACT OF TUMOR LOCATION ON ONCOLOGIC OUTCOMES IN PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA Yi-Sheng Tai*, Yunlin, Taiwan, Chung-Hsin Chen, Chao-Yuan Huang, Huai-Chin Tai, Sho-Mon Wang, Yeong-Shiau Pu, Taipei, Taiwan MP2-12 MP2-13 MP2-14 MP2-15 MP2-16 PROGNOSTIC IMPACT OF TUMOR STAGE ON POSITIVE LYMPH NODE STATUS IN UPPER TRACT UROTHELIAL CARCINOMA FOLLOWING RADICAL NEPHROURETERECTOMY Atiqullah Aziz*, Hamburg, Germany, Shahrokh F. Shariat, Vienna, Austria, Luis Alex Kluth, Hamburg, Germany, Georgios Gakis, Tübingen, Germany, Hans-Martin Fritsche, Regensburg, Germany, Morgan Roupret, Paris, France, Harun Fajkovic, Vienna, Austria, Armin Soave, Hamburg, Germany, Giacomo Novara, Padua, Italy, Armin Pycha, Bolzano, Italy, Mesut Remzi, Korneuburg, Austria, Richard Zigeuner, Graz, Austria, Jay D. Raman, Hershey, PA, Alberto Briganti, Milan, Italy, Karim Bensalah, Rennes, France, Vitaly Margulis, Dallas, TX, Evanguelos Xylinas, Paris, France, Margit Fisch, Michael Rink, Hamburg, Germany RADIOGRAPHIC FINDINGS ON CT SCAN ASSOCIATED WITH LYMPH NODE METASTASES IN UPPER TRACT UROTHELIAL CARCINOMA Eugene Cha*, Alyssa Yee, Melissa Assel, Maura Micco, John Sfakianos, Philip Kim, Fara Friedman, Itay Sternberg, Daniel Sjoberg, H. Alberto Vargas, Jonathan Coleman, New York, NY SIMULTANEOUS PRESENCE OF BLADDER CANCER AND PREVIOUS HISTORY OF BLADDER CANCER HAVE DIFFERENT IMPACTS ON CLINICAL OUTCOME OF UPPER TRACT UROTHELIAL CARCINOMA FOLLOWING RADICAL NEPHROURETERECTOMY masayuki hagiwara*, Ichikawa, Japan, Eiji Kikuchi, Tokyo, Japan, jyun Hagiuda, Hidaka Kouno, Ken Nakagawa, Ichikawa, Japan, Mototsugu Oya, Tokyo, Japan PATTERNS OF LYMPHATIC METASTASES IN UPPER TRACT UROTHELIAL CARCINOMA Patrick Espiritu, Tampa, FL, Jonathan Coleman, John Sfakianos, New York, NY, Philippe Spiess, Tampa, FL, Surena Matin*, Houston, TX NATIONAL VARIATION IN PERFORMANCE OF LYMPHADENECTOMY DURING NEPHROURETERECTOMY FOR UROTHELIAL CARCINOMA: THE IMPACT OF SURGICAL APPROACH AND HOSPITAL CHARACTERISTICS Shane Pearce*, Joseph Pariser, Sanjay Patel, Gary Steinberg, Arieh Shalhav, Norm Smith, Chicago, IL 24

37 MP2-17 MP2-18 TEMPLATE-BASED LYMPHADENECTOMY REDUCES THE RISK OF REGIONAL LYMPH NODE RECURRENCE IN PATIENTS WITH UPPER/MIDDLE URETERAL CANCER Tsunenori Kondo*, Tokyo, Japan, Isao Hara, Wakayama, Japan, Toshio Takagi, Tokyo, Japan, Yoshiki Kodama, Wakayama, Japan, Yasunobu Hashimoto, Hirohito Kobayashi, Junpei Iizuka, Kenji Omae, Kazuhiko Yoshida, Kazunari Tanabe, Tokyo, Japan PREOPERATIVE SELECTION ALGORITHM FOR ELIGIBLE NEOADJUVANT CHEMOTHERAPY PATIENTS IN UPPER TRACT UROTHELIAL CARCINOMAS Shingo Moriyama*, Kazutaka Saito, Junichiro Ishioka, Masaya Ito, Manabu Tatokoro, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Noboru Numao, Yasuhisa Fujii, Kazunori Kihara, Tokyo, Japan MP2-19 MP2-20 HIGH RISK UPPER URINARY TRACT UROTHELIAL CARCINOMA PATIENTS WITH LYMPHOVASCULAR INVASION HAVE THE ADVANTAGE OF ADJUVANT CHEMOTHERAPY Shinichi Yamashita*, Akihiro Ito, Sendai, Japan, Ichiro Shintaku, Higashimatsushima, Japan, Tatsuo Tochigi, Natori, Japan, Fumihiko Soma, Hachinohe, Japan, Takashige Namima, Sendai, Japan, Shinnosuke Katoh, Yuzawa, Japan, Shozo Ota, Sendai, Japan, Atsushi Kyan, Shirakawa, Japan, Kazuhiko Orikasa, Kesennuma, Japan, Kenji Numahata, Yamagata, Japan, Atsushi Takeda, Ichinoseki, Japan, Masataka Aizawa, Naomasa Ioritani, Yasuhiro Kaiho, Haruo Nakagawa, Yoichi Arai, Sendai, Japan FEASIBILITY STUDY OF PERSONALIZED PEPTIDE VACCINATION FOR PLATINUM- BASED CHEMOTHERAPY RESISTANT METASTATIC UPPER TRACT UROTHELIAL CARCINOMA PATIENTS Shigetaka Suekane*, Masanori Noguchi, Kousuke Ueda, Tsukasa Igawa, Tetsuro Sasada, Kyogo Itoh, Kurume, Japan FRIDAY Friday, May 15, 2015 Moderated Poster Session 3 BENIGN PROSTATIC HYPERPLASIA: SURGICAL THERAPY & NEW TECHNOLOGY I Room New Orleans Morial Convention Center Moderators: Peter Gilling and Bilal Chughtai 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP3-01 BPH6 RANDOMIZED STUDY OF PROSTATIC URETHRAL LIFT (PUL) VS TRANSURETHRAL RESECTION OF THE PROSTATE (TURP): OUTCOMES AND PATIENT SATISFACTION Neil Barber*, Frimley, United Kingdom, Jens Sønsken, Herlev, Denmark, Christian Gratze, Munich, Germany, Mark Speakman, Taunton, United Kingdom, Richard Berges, Cologne, Germany, Ulrich Wetterauer, Freiburg, Germany, Damien Greene, Sunderland, United Kingdom, Karl-Dietrich Sievert, Tuebingen, Germany, Christopher Chapple, Sheffield, United Kingdom, Francesco Montorsi, Milan, Italy MP3-03 MP3-04 MP3-05 MP3-02 CROSSOVER STUDY OF THE PROSTATIC URETHRAL LIFT FOR LUTS SECONDARY TO BPH: 2 YEAR RESULTS Henry Woo*, Sydney, Australia, Anthony Cantwell, Daytona Beach, FL, William Bogache, Myrtle Beach, SC, Stephen Richardson, Salt Lake City, UT, Ronald Tutrone, Towson, MD, Prem Rashid, Port Macquarie, Australia, Jack Barkin, Toronto, Canada, James Fagelson, Denver, CO, Peter Chin, Figtree, Australia IMAGE GUIDED ROBOTIC WATERJET ABLATION (AQUABLATION) OF THE PROSTATE: CLINICAL EXPERIENCE OF A NOVEL TECHNOLOGY FOR BPH Mihir Desai*, Los Angeles, CA, Abhishek Laddha, Nadiad, India, Raed A Azhar, Los Angeles, CA, Shashikant Mishra, Mahesh Desai, Ravindra Ravindra Sabnis, Nadiad, India WITHDRAWN MULTI-INSTITUTIONAL RETROSPECTIVE REVIEW OF ROBOT-ASSISTED LAPAROSCOPIC SIMPLE PROSTATECTOMY Andrew Harbin*, Philadelphia, PA, Jeff Villanueva, Washington, DC, Benjamin Katz, Philadelphia, PA, Vineet Agrawal, Guan Wu, Hani Rashid, Jean Joseph, Rochester, NY, Jonathan Hwang, Washington, DC, David Lee, Daniel Eun, Philadelphia, PA *Presenting author 25

38 MP3-06 MP3-07 MP3-08 MP3-09 MP3-10 MP3-11 MP3-12 MATCHED COMPARISON OF OUTCOMES FOLLOWING OPEN AND ROBOTIC- ASSISTED SIMPLE PROSTATECTOMY AT A SINGLE INSTITUTION Philip Zhao*, Nikhil Gupta, David Leavitt, New Hyde Park, NY, Sammy Elsamra, New Brunswick, NJ, Louis Kavoussi, Zeph Okeke, Richard Ashley, Lee Richstone, New Hyde Park, NY REPORT OF TRANSURETHRAL RESECTION OF PROSTATE IN THE PAST TWENTY YEARS:THE EXPERIENCE OF 3112 CASES FROM ONE CENTER Li Zuo*, JianGang Zou, ZhongXing Zhou, ShuYan Lu, Yangzhi Chen, Changzhou, China, People s Republic of BIPOLAR VAPORIZATION CAUSES HIGHER COMPLICATION RATES COMPARED TO BIPOLAR LOOP RESECTION: A RANDOMIZED PROSPECTIVE TRIAL Osama Abdelwahab*, Tarek Soliman, Hammoda Sherif, Benha, Egypt, Mohamad Habous, Jedda, Saudi Arabia, Osama Laban, Tabouk, Saudi Arabia, Richard Santucci, Detroit, MI COMPARISON OF SURGICAL OUTCOMES IN BENIGN PROSTATIC HYPERTROPHY MANAGEMENT USING THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM Devin Haddad*, Louis Krane, Gopal Badlani, Majid Mirzazadeh, Winston-Salem, NC REDUCTION OF ENLARGED PROSTATE DECREASES THE INCIDENCE OF INGUINAL HERNIA Yu-Hua Fan*, Hsiao-Jen Chung, Eric Huang, Alex Lin, Kuang-Kuo Chen, Taipei, Taiwan RESULTS OF TRANS URETHRAL ENUCLEATION AND RESECTION OF PROSTATE (TUERP) USING UNIPOLAR RESECTOSCOPE: A COST EFFECTIVE NEW TECHNIQUE! Muhammad Salam*, Jahangir Kabir, Ehetesham Haque, Faisal Islam, Ghazi Shahinul Islam, Ibrahim Kaisar, Dhaka, Bangladesh LONG-TERM EVALUATION OF TRANSURETHRAL INCISION OF THE PROSTATE FOR TREATMENT OF BENIGN PROSTATE HYPERPLASIA: ANALYSIS OF 75 CASES WITH A MEAN 8-YEAR FOLLOW-UP PERIOD Paulo Cordeiro*, Hugo Barone, Eduardo Muracca Yoshinaga, Élcio Nakano, William C Nahas, Miguel Srougi, Alberto A Antunes, Sao Paulo, Brazil MP3-13 MP3-14 MP3-15 MP3-16 MP3-17 MP3-18 EFFICACY OF THERMO-EXPANDABLE INTRA-PROSTATIC STENT (MEMOKATH TM 028) AS AN ALTERNATIVE APPROACH FOR BENIGN PROSTATIC HYPERPLASIA PATIENTS WITH SIGNIFICANT COMORBIDITIES: COMPARISON WITH TRANSURETHRAL RESECTION OF THE PROSTATE Phil Hyun Song*, Yeong Uk Kim, Jae Young Choi, Young Hwii Ko, Ki Hak Moon, Hee Chang Jung, Daegu, Korea, Republic of CHANGES OF THE URINARY NERVE GROWTH FACTOR (NGF) LEVELS AFTER RELIEF OF OBSTRUCTION IN THE PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC OBSTRUCTION (BPO) USING HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) Jeongyun Jeong*, Tae Heon Kim, Hyun Hwan Sung, Myung-Soo Choo, Kyu-Sung Lee, Seoul, Korea, Republic of PREDICTORS OF ENUCLEATION AND MORCELLATION TIME DURING HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) Marawan El Tayeb*, M. Francesca Monn, Naeem Bhojani, Matthew J. Mellon, James C. Sloan, Ronald S. Boris, James E. Lingeman, Indianapolis, IN DETAILED ASSESSMENT OF LOWER URINARY TRACT SYMPTOMS AND ERECTILE FUNCTION AFTER HOLEP: A PROSPECTIVE STUDY Sascha Ahyai*, Irina Marik, Armin Soave, Andreas Becker, Marianne Schmid, Derya Tilki, Luis Kluth, Felix Chun, Margit Fisch, Hamburg, Germany ENUCLEATION TIME-ENERGY-EFFICACY (ETEE, ENUCLEATED WEIGHT/ENUCLEATION TIME/CONSUMED ENERGY): A MORE APPROPRIATE PARAMETER FOR ESTIMATING THE OPERATIVE LEARNING CURVE FOR HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) Tae Beom Kim*, Jin Hyu Oh, Han Jung, Kyung Jin Chung, Incheon, Korea, Republic of, Sung Tae Cho,, Korea, Republic of, Khae Hawn Kim, Kwang Taek Kim, Sang Jin Yoon, Incheon, Korea, Republic of URINARY INCONTINENCE AFTER LASER PROSTATECTOMY FOR BPH CONTEMPORARY EXPERIENCE Abdulrahman Alruwaily*, Rabia Siddiqui, Maggie Bierlein, Sara Lenherr, John Wei, Ann Arbor, MI 26

39 MP3-19 DEEPGREEN: PROSPECTIVE MRI EVALUATION OF TISSULAR EFFECTS AFTER PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE WITH GREENLIGHT AMS XPS-180W Romain Huet*, Romain Mathieu, Tanguy Rohou, Gregory Verhoest, Karim Bensalah, Sébastien Vincendeau, Rennes, France MP3-20 PREDICTORS OF PERIOPERATIVE COMPLICATIONS AND REOPERATION IN PATIENTS TREATED WITH PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE Malte Rieken*, Sanwei Guo, Georg Müller, Gernot Bonkat, Jan Ebbing, Thomas Gasser, Alexander Bachmann, Basel, Switzerland FRIDAY Friday, May 15, 2015 Moderated Poster Session 4 PROSTATE CANCER: EPIDEMIOLOGY & NATURAL HISTORY I Room New Orleans Morial Convention Center Moderators: Neil Fleshner and Stacy Loeb 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP4-01 DEVELOPMENT OF INTERMEDIATE AND HIGH-RISK PROSTATE CANCER AFTER TESTICULAR CANCER Andrew Riggin*, M. Minhaj Siddiqui, Baltimore, MD MP4-06 METASTATIC PROSTATE CANCER IN MEN ON ACTIVE SURVEILLANCE Toshihiro Yamamoto*, Danny Vespirini, Andrew Loblaw, Alezandre Mamedov, Liying Zhang, Laurence Klotz, Toronto, Canada MP4-02 MP4-03 MP4-04 MP4-05 INFLAMMATION IN BENIGN PROSTATE TISSUE AND PROSTATE CANCER IN THE FINASTERIDE ARM OF THE PROSTATE CANCER PREVENTION TRIAL Teemu Murtola*, Tampere, Finland, Bora Gurel, Kocaeli, Turkey, Martin Umbehr, Zurich, Switzerland, Scott Lucia, Denver, CO, Ian Thompson, San Antonio, TX, Phyllis Goodman, Alan Kristal, Seattle, WA, Howard Parnes, Bethesda, MD, Scott Lippman, La Jolla, CA, Siobhan Sutcliffe, St Louis, MO, Sarah Peskoe, Charles Drake, William Nelson, Angelo De Marzo, Elizabeth Platz, Baltimore, MD CONTEMPORARY ACTIVE SURVEILLANCE RATES FOR NEWLY DIAGNOSED PROSTATE CANCER PATIENTS IN COMMUNITY UROLOGY PRACTICES Jeremy Shelton*, Los Angeles, CA, Phillip Buffington, Cincinnati, OH, Alec Koo, Torrance, CA, Neal Shore, Myrtle Beach, SC CLINICAL OUTCOMES OF CONSERVATIVELY MANAGED PROSTATE CANCER AMONG AFRICAN AMERICAN MEN Amar Patel*, Martin Sanda, Dattatraya Patil, Muta Issa, John Petros, Atlanta, GA USE OF INITIAL ACTIVE SURVEILLANCE AMONG MEN WITH LOW-RISK PROSTATE CANCER FOLLOW UP AND FALL OUT Maria Komisarenko*, Narhari Timilshina, Shabbir Alibhai, Alexandre Zlotta, Robert Hamilton, Girish Kulkarni, Neil Fleshner, Antonio Finelli, Toronto, Canada MP4-07 MP4-08 MP4-09 MP4-10 IS A THRESHOLD VOLUME OF DISEASE NECESSARY FOR GG3 4 7 PROSTATE CANCER TO METASTASIZE? Christine Murekeyisoni*, Kristopher Attwood, Shervin Badkhshan, Kurshid Guru, James Mohler, Eric Kauffman, Buffalo, NY ASSOCIATION OF GENETIC POLYMORPHISMS ACROSS THE TERT GENE Jian Kang*, Shanghai, China, People s Republic of ENDOGENOUS AND EXOGENOUS TESTOSTERONE AND THE RISK OF PROSTATE CANCER AND PROSTATE SPECIFIC ANTIGEN Peter Boyle*, Alice Koechlin, Maria Bota, Ecully, France, Alberto d Onofrio, Lyon, France, David G Zaridze, Moscow, Russian Federation, Paul Perrin, Lyon, France, John Fitzpatrick, Dublin, Ireland, Arthur L Burnett, Baltimore, MD, Mathieu Boniol, Ecully, France ONE OUT OF THREE INFERTILE MEN YOUNGER THAN 40 YEARS HAVE A TOTAL SERUM PSA VALUE GREATER THAN 1 NG/ML - FINDINGS OF A CROSS- SECTIONAL SURVEY IN WHITE- EUROPEAN MEN PRESENTING FOR COUPLE S INFERTILITY Alessandro Serino*, Paolo Capogrosso, Luca Boeri, Eugenio Ventimiglia, Giovanni La Croce, Giulia Castagna, Angela Pecoraro, Marco Paciotti, Silvia Ippolito, Roberta Scano, Milan, Italy, Rocco Damiano, Catanzaro, Italy, Francesco Montorsi, Andrea Salonia, Milan, Italy *Presenting author 27

40 MP4-11 MP4-12 MP4-13 MP4-14 MP4-15 RADICAL PROSTATECTOMY TRENDS IN THE UNITED STATES: Mark Tyson*, Scottsdale, AZ, Paul Andrews, Erik Castle, Phoenix, AZ, Alexander Parker, Jacksonville, FL POPULATION-BASED ANALYSIS OF ADJUVANT RADIATION THERAPY FOLLOWING RADICAL PROSTATECTOMY Charles Nottingham*, Sanjay Patel, Scott Eggener, Stanley Liauw, chicago, IL CONDITIONAL CANCER SPECIFIC SURVIVAL FOLLOWING RADICAL PROSTATECTOMY DEPENDS ON PREOPERATIVE RISK CLASSIFICATION Sung-Woo Park, Yangsan-si, Gyeongnam, Korea, Republic of, Debasish Sundi*, Zhaoyong Feng, Bruce Trock, Elizabeth Humphreys, Alan Partin, Misop Han, Baltimore, MD LONG-TERM CANCER CONTROL OUTCOMES IN PROSTATE CANCER (PCA) PATIENTS TREATED WITH ROBOTIC- ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP): A MULTI- INSTITUTIONAL DATABASE ANALYSIS Firas Abdollah*, Dane Klett, Akshay Sood, Jesse Sammon, Daniel Pucheril, Detroit, MI, Burkhard Beyer, Hamburg, Germany, Nicola Fossati, Giorgio Gandaglia, Milan, Italy, Craig Rogers, Hans Stricker, Wooju Jeong, James Peabody, Detroit, MI, Alexander Haese, Hamburg, Germany, Francesco Montorsi, Milan, Italy, Markus Graefen, Hamburg, Germany, Alberto Briganti, Milan, Italy, Mani Menon, Detroit, MI IMPACT OF POSITIVE SURGICAL MARGINS ON MORTALITY AFTER RADICAL PROSTATECTOMY BY DISEASE RISK GROUP Alexa Meyer*, Danny Lascano, Jamie S Pak, LaMont Barlow, Jared C Levinson, Rajat E Lamington, James M McKiernan, Mitchell C Benson, Manhattan, NY MP4-16 MP4-17 MP4-18 MP4-19 MP4-20 PATTERNS OF CLINICAL RECURRENCE AND IMPACT OF SITE OF METASTASIS ON MORTALITY OF PATIENTS WITH NODE POSITIVE PROSTATE CANCER AFTER RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION Alessandro Nini*, Giorgio Gandaglia, Nicola Fossati, Marco Bianchi, Nazareno Suardi, Milan, Italy, Firas Abdollah, Detroit, MI, Shahrokh F. Shariat, Vienna, Austria, Walter Cazzaniga, Stefano Luzzago, Vito Cucchiara, Roberto Bertini, Francesco Montorsi, Alberto Briganti, Milan, Italy PATHOLOGIC GLEASON 8-10: DO ALL MEN DO POORLY? RESULTS FROM THE SEARCH DATABASE Sean Fischer*, Ross Simon, Lauren Howard, Durham, NC, William Aronson, Los Angeles, CA, Martha Terris, August, GA, Christopher Kane, San Diego, CA, Christopher Amling, Portland, OR, Matt Cooperberg, San Francisco, CA, Stephen Freedland, Adriana Vidal, Durham, NC REGIONAL VARIATION IN PROSTATE CANCER DIAGNOSIS IN THE UNITED STATES: A STUDY OF CONTEMPORARY MEDICARE BENEFICIARIES Rachel Moses*, Nino Dsebisashvili, Philip Goodney, Elias Hyams, Lebanon, NH NINETY-DAY PERIOPERATIVE MORTALITY IN RADICAL PROSTATECTOMY AMONG SWEDISH MEN 1998 TO 2012 Alexander P Cole*, Boston, MA, Johan Björklund, Solna, Sweden, Yasin Folkvaljon, Uppsala, Sweden, Stefan Carlsson, Stockholm, Sweden, David Robinson, Jönköping, Sweden, Stacy Loeb, New York, NY, Pär Stattin, Umeå, Sweden, Olof Akre, Stockholm, Sweden CONTEMPORARY INCIDENCE AND MORTALITY RATES OF NEUROENDOCRINE PROSTATE CANCER Aaron Moore*, Shaheen Alanee, Max Nutt, Danuta Dynda, Ahmed El-Zawahry, Kevin McVary, Springfield, IL 28

41 Friday, May 15, 2015 Podium Session 1 URODYNAMICS/INCONTINENCE/FEMALE UROLOGY: NEUROGENIC VOIDING DYSFUNCTION I Room New Orleans Morial Convention Center Moderator: Eric Rovner 10:30 am - 12:30 pm FRIDAY TIME NUMBER TITLE TIME NUMBER TITLE 10:30 PD1-01 LONG-TERM EFFICACY AND SAFETY OF ONABOTULINUMTOXINA IN PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY: ANALYSIS AMONG PATIENTS WHO COMPLETED 4 YEARS OF TREATMENT Eric Rovner*, Charleston, SC, Alfred Kohan, Bethpage, NY, Emmanuel Chartier-Kastler, Paris, France, Klaus-Peter Jünemann, Kiel, Germany, Giulio Del Popolo, Florence, Italy, Sender Herschorn, Toronto, Canada, Manher Joshi, Brenda Jenkins, Irvine, CA, Quanhong Ni, Bridgewater, NJ, Victor Nitti, New York, NY 10:40 PD1-02 EFFECT OF DETRUSOR BOTULINUM TOXIN AINJECTION ON THE UROTHELIAL DYSFUNCTION IN CHRONIC SPINAL CORD INJUREDBLADDERS V COMPARISON AMONG BASELINE, 3 MONTHS AND 6 MONTHS AFTER INJECTION Sheng-Fu Chen*, Cheng-Ling Lee, Jia-Hui Chang, Hann-Chorng Kuo, Hualien, Taiwan 10:50 PD1-03 DOES REDUCTION OF NUMBER OF INTRADETRUSOR INJECTION SITES OF ABOBOTULINUMTOXINA IMPACT EFFICACY AND SAFETY IN A RAT MODEL OF NEUROGENIC DETRUSOR OVERACTIVITY? Amélie Huynh Le Maux, Montigny-Le- Bretonneux, France, Bernadette Pignol, Les Ulis, France, Delphine Behr-Roussel*, Montigny-Le-Bretonneux, France, Jean-Luc Blachon, Pierre-Etienne Chabrier, Philippe Picaut, Les Ulis, France, Jacques Bernabé, Montigny-Le-Bretonneux, France, Francois Giuliano, Pierre Denys, Garches, France 11:00 PD1-04 DETRUSOR INJECTIONS OF ONABOTULINUM TOXIN A (BOTOX ) VERSUS ABOBOTULINUM TOXIN A (DYSPORT ) IN THE MANAGEMENT OF NEUROGENIC DETRUSOR OVERACTIVITY: A CASE CONTROL STUDY benoit peyronnet*, Rennes, France, castellacanal evelyne, roumiguie mathieu, marque philippe, rischmann pascal, game xavier, Toulouse, France 11:10 PD1-05 HIGHER NEURAL CORRELATES FOLLOWING INTRAVESICAL BOTULINUM TOXIN- A IN MULTIPLE SCLEROSIS (MS) PATIENTS VIA CONCURRENT FUNCTIONAL MAGNETIC RESONANCE IMAGING (FMRI) AND URODYNAMIC STUDIES (UDS) Michael Shy*, Christof Karmonik, Jeff Anderson, Abdulaziz Alkattan, Timothy Boone, Steve Fung, Houston, TX, Sophie Fletcher, Santa Rosa, CA, Rose Khavari, Houston, TX 11:20 PD1-06 EFFECT OF ONABOTULINUMTOXINA TREATMENT FOR NEUROGENIC DETRUSOR OVER ACTIVITY ON THE PREVENTION OF AUTONOMIC DYSREFLEXIA FOLLOWING SPINAL CORD INJURY Renee Fougere, Katharine Currie, Lynn Stothers*, Mark Nigro, Daniel Rapaport, Andrei Krassioukov, Vancouver, Canada 11:30 PD1-07 INTRADETRUSOR BOTULINUM TOXIN INJECTIONS FOR THE MANAGEMENT OF IMPAIRED BLADDER COMPLIANCE REFRACTORY TO ANTI-CHOLINERGIC DRUGS Dane Johnson*, Robert O Connor, Michael Guralnick, Milwaukee, WI 11:40 PD1-08 DOES ASYMPTOMATIC BACTERIURIA INCREASES THE RISK OF UROSEPSIS OR MODIFIES INTRA-DETRUSOR BOTULINUM TOXIN A (BONTA) EFFICACY? Shachar Aharony*, Ornella Lam Van-Ba, Jaques Corcos, Montreal, Canada 11:50 PD1-09 UROLOGICAL SURVEILLANCE AND MEDICAL COMPLICATIONS AFTER SPINAL CORD INJURY IN THE UNITED STATES Anne P Cameron*, Ann Arbor, MI, Julie Lai, Santa Monica, CA, Christopher S Saigal, Los Angeles, CA, J Quentin Clemens, Ann Arbor, MI, NIDDK Urological Diseases in America Project, Santa Monica, CA 12:00 PD1-10 SUPRASPINAL CONTROL OF LOWER URINARY TRACT FUNCTION IN PATIENTS WITH SPINAL CORD INJURY: AN FMRI STUDY Lorenz Leitner*, Matthias Walter, Patrick Freund, Ulrich Mehnert, Zürich, Switzerland, Martina D. Liechti, London, United Kingdom, Lars Michels, Spyros Kollias, Thomas M. Kessler, Zürich, Switzerland *Presenting author 29

42 12:10 PD1-11 SPINAL CORD INJURY INDUCED TEMPORAL CHANGES IN BLADDER EXPRESSION OF CYTOKINES INDICATE ROLE OF INFLAMMATION IN VOIDING DYSFUNCTION Subrata Pore*, Mahendra Kashyap, Katsumi Kadekawa, Naoki Yoshimura, Pradeep Tyagi, Pittsburgh, PA 12:20 PD1-12 HEATING OF THE INTERSTIM SACRAL NEUROMODULATION DEVICE IN A SIMULATED PHANTOM MODEL DURING LUMBAR AND PELVIC MAGNETIC RESONANCE IMAGING (MRI) Adrienne Quirouet*, Stephen Jones, Pallab Bhattacharyya, Howard Goldman, Cleveland, OH Friday, May 15, 2015 Podium Session 2 SEXUAL FUNCTION/DYSFUNCTION/ANDROLOGY: PENIS/TESTIS/URETHRA: BENIGN DISEASE Room New Orleans Morial Convention Center Moderator: Culley Carson, III 10:30 am - 12:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 10:30 PD2-01 BURIED PENIS IN ADULTS PRESENTATION, SURGICAL TECHNIQUES AND OUTCOME Tet Yap*, Matus Chocolaty, Raheem Amr, Giulio Garaffa, Nim Christopher, Suks Minhas, Ralph David, London, United Kingdom 11:20 PD2-06 THE ASSESSMENT OF THE ROLE OF ANDROGEN RECEPTORS AT THE DEVELOPMENT OF CONGENITAL PENILE CURVATURE DISEASE Emre Salabas*, Canan Kucukgergin, Harun Ozkan, Murat Dincer, Sule Seckin, Ates Kadioglu, Istanbul, Turkey 10:40 PD2-02 TRENDS IN THE UTILIZATION OF PENILE PROSTHESES IN THE TREATMENT OF ERECTILE DYSFUNCTION Daniel Lee*, Bobby Najari, Wesley Davison, Bashir Al Hussein Al Awamlh, Fujun Zhao, John Mulhall, Darius Paduch, Bilal Chughtai, Richard Lee, New York, NY 10:50 PD2-03 NONINFECTED PENILE PROSTHESES CULTURE DURING REVISION SURGERIES; COMPARISON BETWEEN ANTIBIOTIC COATED AND UNCOATED DEVICES Seyfettin Ciftci, Kocaeli, Turkey, Tijen Nemut, Sakarya, Turkey, Melih Culha*, Hasan Yilmaz, Murat Ustuner, Ufuk Yavuz, Levend Ozkan, Kocaeli, Turkey 11:00 PD2-04 TESTOSTERONE REPLACEMENT THERAPY (TRT) INFREQUENTLY USED IN HYPOGONADAL MEN Wendy Poage*, Aurora, CO, Nelson Stone, New York, NY, E. David Crawford, aurora, CO 11:10 PD2-05 IDIOPATHIC PARTIAL THROMBOSIS IS ASSOCIATED WITH CYCLING AND THE PRESENCE OF A FIBROUS WEB ON MRI Emmanuel Weyne*, Charlotte Schillebeeckx, Caroline Jamaer, Pieter D hulst, Leuven, Belgium, Giorgio Bozzini, Milan, Italy, Richard Grunert, Burlinghton, VT, Piet Hoebeke, Gent, Belgium, Steven Joniau, Maarten Albersen, Leuven, Belgium 11:30 PD2-07 FUNCTIONAL OUTCOMES AND FOLLOW- UP CARE AFTER PRIAPISM TREATMENT: A CONTEMPORARY EXPERIENCE AT A SINGLE INSTITUTION Stephen Kappa*, Elizabeth Green, Shreyas Joshi, Melissa Kaufman, Doug Milam, Nashville, TN 11:40 PD2-08 HIGH RISK OF PRIAPISM IN RECREATIONAL INTRACAVERNOSAL DRUG ABUSERS Gustavo Diaz*, Rafael Yanes, Akshay Bhandari, Alan Nieder, Miami Beach, FL 11:50 PD2-09 PATIENT SATISFACTION WITH TESTICULAR PROSTHESIS AFTER ORCHIECTOMY FOR TESTICULAR CANCER Brian Hu*, Hooman Djaladat, Sepehr Shojaei, Siamak Daneshmand, Los Angeles, CA 12:00 PD2-10 INFLATABLE PENILE PROSTHESIS FAILURE AND COMPLICATIONS: REVIEW OF A NATIONAL DATABASE Judith C Hagedorn, Nathan Osburn*, Scott Lundy, Seattle, WA, Tanner Miest, Rochester, MN, Bryan B Voelzke, Seattle, WA 12:10 PD2-11 DOES TUMOR SIZE, ULTRASONOGRAPHIC FINDINGS, SERUM HUMAN CHORIONIC GONADOTROPIN(HCG) LEVEL CAN PREDICT THE LIKELIHOOD OF BENIGN TESTICULAR HISTOLOGY? Gang Song*, Beijing, China, People s Republic of 30

43 12:20 PD2-12 TREATMENT OF PRIAPISM IN THE EMERGENCY DEPARTMENT PRIOR TO UROLOGIC SURGERY CONSULTATION: A CONTEMPORARY EXPERIENCE AT A SINGLE INSTITUTION Elizabeth Green*, Stephen Kappa, Shreyas Joshi, Melissa Kaufman, Doug Milam, Nashville, TN FRIDAY Friday, May 15, 2015 Video Session 1 10:30 am - 12:00 pm AWARD WINNING VIDEO SESSION The videos in this session as well as the video libraries from the Annual Meetings may be viewed in the Surgical Video Library and purchased in the Products Store during the Annual Meeting. Both are located in Registration Hall B2. All years of the Surgical Video Library may also be purchased online at Room New Orleans Morial Convention Center Moderators: Misop Han and Jay Raman TIME NUMBER TITLE TIME NUMBER TITLE 1st Place Honorable Mention V9-10 SIMULATED INANIMATE MODEL FOR PHYSICAL LEARNING EXPERIENCE (SIMPLE) FOR ROBOTIC PARTIAL NEPHRECTOMY USING A 3-D PRINTED KIDNEY MODEL Ahmed Ghazi*, Jonathan Stone, Braden Candela, Michael Richards, Jean Joseph, Rochester, NY 2nd Place V6-01 ROBOT ASSISTED FLEXIBLE URETEROSCOPIC LASER LITHOTRIPSY, WITH AVICENNA ROBOFLEX Jens Rassweiler*, Heillbronn, Germany, Remzi Saglam, Ankara, Turkey, Olivier Traxer, Paris, France, A. Sinan Kabakci, Zafer Tokatli, Abdurrahim Imamoglu, Ankara, Turkey, Glenn Preminger, Durham, NC 3rd Place V5-04 RESECTABLE PHYSICAL 3-D MODELS UTILIZING 3-D PRINTER TECHNOLOGY FOR ROBOTIC PARTIAL NEPHRECTOMY Michael Maddox*, Allison Feibus, Benjamin Lee, Julie Wang, Raju Thomas, Jonathan Silberstein, New Orleans, LA Honorable Mention V8-02 MANAGEMENT OF CHALLENGING URETHRO-ILEAL ANASTOMOSIS DURING ROBOTIC INTRACORPOREAL NEOBLADDER FORMATION Nima Almassi*, Homayoun Zargar, Vishnu Ganesan, Amr Fergany, Georges Pascal Haber, Cleveland, OH V11-01 NOTES-ASSISTED LAPAROSCOPIC TRANSVESICAL BLADDER DIVERTICULECTOMY Ahmed Magdy*, Michael Mitterberger, Günter Janetschek, Salzburg, Austria Honorable Mention V4-01 PERINEAL ROBOT ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (P-RALP) Oktay Akca*, Peter Caputo, Humberto Laydner, Homayoun Zargar, Daniel Ramirez, Juan Jimenez, Hiury Andrade, Robert J Stein, Cleveland, OH, Selami Albayrak, Istanbul, Turkey, Kenneth Angermeier, Jihad H Kaouk, Cleveland, OH Friday, May 15, 2015 SOCIETY FOR FETAL UROLOGY (SFU) Grand Hilton New Orleans Riverside 12:00 pm - 4:00 pm 12:00 SFU BUSINESS MEETING (SFU MEMBERS ONLY) 1:30 SESSION 3: SFU PERINATAL UROLOGY Moderators: Travis Groth, Miguel Castellan 2:30 SFU PANEL: BLADDER EXSTROPHY Panelists: Michael Mitchell, Barry Duel, Bradley Kropp, John Kryger *Presenting author 31

44 Friday, May 15, 2015 Moderated Poster Session 5 GENERAL & EPIDEMIOLOGICAL TRENDS & SOCIOECONOMICS: EVIDENCE-BASED MEDICINE & OUTCOMES I Room New Orleans Morial Convention Center Moderators: Michael Porter and John Hollingsworth 1:00 pm - 3:00 pm NUMBER TITLE NUMBER TITLE MP5-01 GEOGRAPHIC AND TEMPORAL TRENDS IN GLOBAL BLADDER CANCER MORBIDITY AND MORTALITY Catherine Harris*, Jonathan Brajtbord, Maxwell Meng, Anobel Odisho, San Francisco, CA MP5-08 METFORMIN USE IS ASSOCIATED WITH DECREASED RISK OF RENAL CELL CANCER Abdo Kabarriti*, Ben Boursi, Ronac Mamtani, Thomas Guzzo, Kevin Haynes, Yu-Xiao Yang, S. Bruce Malkowicz, Philadelphia, PA MP5-02 MP5-03 MP5-04 MP5-05 MP5-06 MP5-07 PARTIAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER: PRACTICE PATTERNS AND OUTCOMES IN THE GENERAL POPULATION Michael Leveridge*, D Robert Siemens, Jason Izard, Xuejiao Wei, William Mackillop, David Berman, Christopher Booth, Kingston, Canada ADHERENCE AND ADEQUACY OF THE BLADDER CANCER GUIDELINES FOR POST-TUR FOLLOW-UP INTERVAL Takuro Sunada, Takashi Kobayashi*, Yoshiyuki Matsui, Takahiro Inoue, Tomomi Kamba, Osamu Ogawa, Kyoto, Japan PERIOPERATIVE OUTCOMES OF TRANSURETHRAL RESECTION OF BLADDER TUMORS USING THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM (NSQIP) DATABASE David C Brooks*, Devin A. Haddad, Robert C Kovell, Ryan P Terlecki, Winston Salem, NC UNDERSTANDING THE RELATIONSHIP BETWEEN 30- AND 90- DAY EMERGENCY ROOM VISITS AND READMISSIONS FOLLOWING RADICAL CYSTECTOMY E. Sophie Spencer*, Peter Greene, Matthew Lyons, Anne Marie Meyer, Ke Meng, Raj Pruthi, Eric Wallen, Michael Woods, Matthew Nielsen, Angela Smith, Chapel Hill, NC 90-DAY COMPLICATIONS IN PATIENTS UNDERGOING RADICAL CYSTECTOMY ON ENHANCED RECOVERY PROTOCOL Behrod Katebian*, Soroush Bazargani, Los Angeles, CA, Hamed Ahmadi, Portland, OR, Gus Miranda, Jie Cai, Anne Schuckman, Siamak Daneshmand, Hooman Djaladat, Los Angeles, CA AN EMPIRICAL EVALUATION OF VARIATION IN INTENSITY OF SURVIVORSHIP CARE AND ITS EFFECT ON KIDNEY CANCER-SPECIFIC SURVIVAL William Sohn*, Amy Graves, Sam Chang, Daniel Barocas, David Penson, Matthew Resnick, Nashville, TN MP5-09 MP5-10 MP5-11 MP5-12 MP5-13 MP5-14 CLEAR CELL RENAL CELL CARCINOMA: SOCIOECONOMIC PREDICTORS OF METASTATIC DISEASE AT DIAGNOSIS Zachary Klaassen*, Augusta, GA, John M. DiBianco, Roseau, Dominica, Rita P. Jen, Lael Reinstatler, Austin J. Evans, Qiang Li, Rabii Madi, Martha K. Terris, Augusta, GA PROPHYLACTIC PELVIC LYMPH NODE DISSECTION IN PENILE CANCER PATIENTS Rosa Djajadiningrat*, Erik van Werkhoven, Simon Horenblas, Amsterdam, Netherlands PRIMARY GENITO-URINARY MELANOMA AMONG MEN AND WOMEN Alejandro Sanchez*, Dayron Rodriguez, Christopher B. Allard, Seth K. Bechis, Mark A. Preston, Jed-Sian Cheng, Glen W. Barrisford, Adam S. Feldman, Boston, MA UNDERSTANDING THE LIMITATIONS OF PROSTATE-SPECIFIC ANTIGEN TESTING DOES NOT DETER MEN FROM UNDERGOING PROSTATE CANCER SCREENING Michael Fenstermaker*, Stacy Loeb, Heather T. Gold, Joseph Ravenell, Danil Makarov, New York, NY DOES DIGITAL RECTAL EXAMINATION PROVIDE ADDITIONAL VALUE IN THE ERA OF PSA SCREENING?: LESSONS FROM THE PLCO STUDY Tao Cui*, Robert C Kovell, David C Brooks, Ryan P Terlecki, Winston Salem, NC RANDOMIZED, SINGLE CENTER TRIAL OF THE EFFECT OF EXTENDING TIME FROM PERI-PROSTATIC LIDOCAINE INJECTION TO ONSET OF TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY ON PATIENT-REPORTED PAIN SCORES Ram Pathak*, Alexander Parker, Andrea Tavlarides, Julia Crook, Nancy Diehl, Scott Alford, Michael Heckman, Todd Igel, Jacksonville, FL 32

45 MP5-15 MP5-16 MP5-17 EMERGING DISPARITY IN TREATMENT FOR PROSTATE CANCER AMONG HISPANIC MEN- DATA FROM SEER Kelvin Moses*, Nashville, TN, Heather Orom, Alicia Brasel, Buffalo, NY, Jacquelyne Gaddy, Chicago, IL, Willie Underwood, III, Buffalo, NY EXTERNAL VALIDATION OF 10-YEAR OTHER CAUSE MORTALITY RISK ESTIMATION TOOLS FOR MEN NEWLY DIAGNOSED WITH PROSTATE CANCER Daniel Frendl*, Gordon FitzGerald, Mara Epstein, Jennifer Yates, Robert Blute, Jr, Mitchell Sokoloff, John Ware, Jr, Worcester, MA RELATIONSHIP BETWEEN PATIENT EXPECTATIONS, FUNCTIONAL OUTCOMES, AND PATIENT SATISFACTION FOLLOWING RADICAL PROSTATECTOMY Michael Fenstermaker*, Herbert Lepor, New York, NY MP5-19 MP5-20 THE IMPACT OF CARE COORDINATION ON RADICAL PROSTATECTOMY OUTCOMES John M. Hollingsworth*, Ann Arbor, MI, Russell J. Funk, Minneapolis, MN, Spencer A. Garrison, Jason Owen-Smith, Samuel R. Kaufman, Ann Arbor, MI, Bruce E. Landon, Boston, MA, James E. Montie, Brahmajee K. Nallamothu, Ann Arbor, MI NOTABLE OUTCOMES AND TRACKABLE EVENTS AFTER SURGERY (NOTES): A COMPOSITE MEASURE TO ASSESS UNCOMPLICATED RECOVERY AFTER RADICAL PROSTATECTOMY Stacie Myers*, Khurshid Ghani, Rodney Dunn, Ann Arbor, MI, Brian Lane, Grand Rapids, MI, Yuqing Gao, Susan Linsell, David Miller, James Montie, Ann Arbor, MI FRIDAY MP5-18 A MULTI-INSTITUTIONAL ANALYSIS OF THE IMPACT OF OBESITY ON COMPLICATIONS AFTER ROBOTIC VS. OPEN RADICAL PROSTATECTOMY Elodi Dielubanza, Apas Aggarwal*, Nicholas Hackett, Oluwarotimi Nettey, John Kim, Shilajit Kundu, Chicago, IL Friday, May 15, 2015 Moderated Poster Session 6 PROSTATE CANCER: MARKERS II Room New Orleans Morial Convention Center Moderator: Alexander Kutikov 1:00 pm - 3:00 pm NUMBER TITLE NUMBER TITLE MP6-01 URINARY BIOMARKERS FOR THE DETECTION OF PROSTATE CANCER IN PATIENTS WITH HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA (HGPIN) Juan M Bastarós*, Tamara Sequeiros, José Placer, Jacques Planas, Lucas Regis, Milagros Sánchez, Marina Rigau, Melania Montes, Inés de Torres, Jaume Reventós, Andreas Doll, Juan Morote, Barcelona, Spain MP6-03 MP6-02 LOCATION OF DISEASE DOES NOT IMPACT PCA3 S ABILITY TO PREDICT CANCER ON BIOPSY Padraic O Malley*, Bashir Al Hussein Al Awamlh, Daniel P Nguyen, New York, NY, Martin G Sanda, Atlanta, GA, Ian M Thompson, San Antonio, TX, John T Wei, Ann Arbor, MI, Richard Lee, Mark A Rubin, Christopher E Barbieri, Michael P Hermann, Douglas S Scherr, New York, NY MP6-04 A NOVEL BIOMARKER SIGNATURE WHICH MAY PREDICT AGGRESSIVE DISEASE IN AFRICAN-AMERICAN MEN WITH PROSTATE CANCER Kosj Yamoah*, Philadelphia, PA, Michael Johnson, Baltimore, MD, Voleak Choeurng, Kasra Yousefi, Zaid Haddad, Vancouver, Canada, Robert Den, Priti Lal, Michael Feldman, Adam Dicker, Philadelphia, PA, Eric Klein, Cleveland, OH, Elai Davicioni, San Diego, CA, Timothy Rebbeck, Philadelphia, PA, Edward Schaeffer, Baltimore, MD THE 4KSCORE TEST PREDICTS HIGH- GRADE PROSTATE CANCER ON BIOPSY WITH PSA LESS THAN 4 NG PER MILLILITER Vinita Mathur, Vincent Linder, Yan Dong, Miami, FL, Dan Sjoberg*, New York, NY, Richard Roberts, Michael Reeve, David Okrongly, Jay Newmark, Grannum Sant, Mitchell Steiner, Miami, FL *Presenting author 33

46 MP6-05 MP6-06 MP6-07 MP6-08 MP6-09 THE ASSOCIATION OF PREOPERATIVE NEUTROPHIL TO LYMPHOCYTE RATIO WITH ONCOLOGIC OUTCOMES FOLLOWING RADICAL PROSTATECTOMY FOR PROSTATE CANCER Vidit Sharma*, Patrick A Cockerill, Boyd R Viers, Laureano J Rangel, Rachel E Carlson, R. Jeffrey Karnes, Matthew K Tollefson, Rochester, MN PROSTATE HEALTH INDEX PREDICTS UPGRADING OF MEN ON 5-ALPHA REDUCTASE INHIBITORS E. David Crawford*, Paul Arangua, Clifford Jones, Wendy Poage, Aurora, CO, Nelson Stone, New York, NY, Francisco G. La Rosa, Aurora, CO, Stacy Loeb, New York, NY, Priya N. Werahera, Aurora, CO SENSITIVITY OF [-2]PROPSA AS AN ULTRASENSITIVE PSA SURROGATE FOR THE PREDICTION OF EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: AN OBSERVATIONAL COHORT STUDY Massimo Lazzeri*, Giovanni Lughezzani, Alberto Abrate, Andrea Losa, Alessandro Mistretta, Nicolò Maria Buffi, Giuliana Lista, Giulio Maria Gadda, Alessandro Larcher, Nicola Fossati, Paolo Dell Oglio, Milan, Italy, Vittorio Bini, Perugia, Italy, Ferruccio Ceriotti, Giorgio Guazzoni, Milan, Italy A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFECTS OF POMEGRANATE EXTRACT ON RISING PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN MEN FOLLOWING PRIMARY THERAPY FOR PROSTATE CANCER Allan Pantuck*, Los Angeles, CA, Curtis Pettaway, Houston, TX, Robert Dreicer, Cleveland, OH, John Corman, Seattle, WA, Andrew Ho, Aaron Katz, Garden City, NY, William Aronson, Sylmar, CA, William Clark, Anchorage, AK, Garrick Simmons, Missoula, MT, David Heber, Los Angeles, CA MOLECULAR AND CLINICAL CHARACTERIZATION OF 1,577 PRIMARY PROSTATE CANCER TUMORS REVEALS NOVEL CLINICAL AND BIOLOGICAL INSIGHTS INTO ITS SUBTYPES Scott Tomlins*, Ann Arbor, MI, Mohammed Alshalalfa, Nicholas Erho, kasra yousefi, Vancouver, Canada, shuang zhao, Ann Arbor, MI, robert den, adam dicker, philadelphia, PA, bruce trock, Angelo Demarzo, Ashley Ross, Edward Schaeffer, Baltimore, MD, Erick Klein, Cristina Magi- Galluzzi, cleveland, OH, jeffery karnes, Rober Jenkins, Rochester, MN, elai davicioni, vancouver, Canada, Felix Feng, Ann Arbor, MI MP6-10 MP6-11 MP6-12 MP6-13 MP6-14 MP6-15 TISSUE SPECIFIC EXPRESSION OF ANDROGEN RECEPTOR VARIANT 7 IN PROSTATE CANCER PROGRESSION: A POTENTIAL ROLE OF ARV7 IN CARCINOGENESIS Tyler M. Bauman*, Emily A. Ricke, Wei Huang, William A. Ricke, Madison, WI A NOVEL BLOOD-BASED ASSAY FOR DETECTING ANDROGEN RECEPTOR SPLICE VARIANTS IN PATIENTS WITH ADVANCED PROSTATE CANCER Xichun Liu, Elisa Ledet, Yanfeng Qi, Yan Dong, Oliver Sartor, Haitao Zhang*, New Orleans, LA EPIGENETIC ASSAY STRATIFIES PROSTATE CANCER PATIENTS RISK FOR AGGRESSIVENESS Leander Van Neste, Maastricht, Netherlands, Wim Van Criekinge*, Ghent, Belgium, Joseph Bigley, Irvine, CA, William E Grizzle, George W Adams, Birmingham, AL, Gary P Kearney, Sandra M Gaston, Boston, MA PTEN LOSS BY IMMUNOHISTOCHEMISTRY IS ASSOCIATED WITH BIOCHEMICAL RECURRENCE IN ERG-NEGATIVE PROSTATE TUMORS: A STUDY OF THE CANARY COHORT Tamara L. Lotan*, Baltimore, MD, Wei Wei, Houston, TX, Carlos L. Morais, Baltimore, MD, Ziding Feng, Houston, TX, Sarah Hawley, Baltimore, MD, Ladan Fazli, Antonio Hurtado-Coll, Vancouver, Canada, Dean Troyer, Fairfax, VA, Jesse McKenney, Cleveland, OH, Jeff Simko, San Francisco, CA, Lawrence True, Seattle, WA, James D. Brooks, CAnary Pathology Team Investigating Tissue Biomarkers (CAPIT), Palo Alto, CA DNA METHYLATION ABERRATIONS IN GLEASON PATTERN 4 PROSTATIC CARCINOMA WITH CRIBRIFORM ARCHITECTURE OR INTRADUCTAL CARCINOMA: A RADICAL PROSTATECTOMY STUDY Ekaterina Olkhov-Mitsel*, Farshid Siadat, Toronto, Canada, Dominique Trudel, Montreal, Canada, Ken Kron, liyang Liu, Neil E. Fleshner, Theodorus Van der Kwast, Bharati Bapat, Toronto, Canada PTEN LOSS AND ERG EXPRESSION IN PROSTATE CANCER SURVIVAL Thomas Ahearn*, Andreas Pettersson, Ericka Ebot, Travis Gerke, Boston, MA, Carlos De Morais, Jessica Hicks, Baltimore, MD, Kathryn Wilson, Jennifer Rider, Boston, MA, Michelangelo Fiorentino, Bologna, Israel, Stephen Finn, Dublin, Ireland, Edward Giovannucci, Massimo Loda, Meir Stampfer, Boston, MA, Angelo De Marzo, Baltimore, MD, Lorelei Mucci, Boston, MA, Tamara Lotan, Baltimore, MD 34

47 MP6-16 MP6-17 GERMLINE VARIANTS WITHIN THE PTEN/ PI3K AXIS AND ASSOCIATION WITH CASTRATE RESISTANT PROSTATE CANCER AND PROSTATE CANCER SPECIFIC MORTALITY Ryan Kopp*, New York, NY, John Sullivan, Dublin, Ireland, James Hayes, James Eastham, Kenneth Offit, Joseph Vijai, Robert Klein, New York, NY PREDICTIVE VALUE OF PLASMA SOLUBLE MET PROTEIN CONCENTRATION IN PATIENTS WITH PROSTATE CANCER Deborah R. Kaye, Baltimore, MD, Peter A. Pinto, Fabiola Cecchi, Joseph Reilly, Bethesda, MD, Alice Semerjian*, Washington, DC, Alessio Giubellino, Bethesda, MD, Gopal Gupta, Chicago, IL, Peter L. Choyke, W. Marston Linehan, Donald P. Bottaro, Bethesda, MD MP6-19 MP6-20 PREOPERATIVE SERUM TRIGLYCERIDE LEVEL IS A POTENTIAL PREDICTOR OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY Minyong Kang*, Chang Wook Jeong, Ja Hyeon Ku, Cheol Kwak, Hyeon Hoe Kim, Seoul, Korea, Republic of THE ROLE OF THE INSULIN LIKE GROWTH FACTOR (IGF) AXIS IN PREDICTING BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY Kieran J Breen*, Noel M Fitzgerald, Yue Fan, Susie Boyce, Amanda O Neill, John M Fitzpatrick, R William Watson, Dublin, Ireland FRIDAY MP6-18 PROSTATE CANCER RECURRENCE CAN BE PREDICTED BY MEASURING NUCLEAR ORGANIZATION AND SHAPE PARAMETERS IN ADJACENT BENIGN REGIONS ON RADICAL PROSTATECTOMY SPECIMENS George Lee*, Cleveland, OH, Robert Veltri, Baltimore, MD, Sahirzeeshan Ali, Cleveland, OH, Jonathan Epstein, Christhunesa Christudass, Baltimore, MD, Anant Madabhushi, Cleveland, OH Friday, May 15, 2015 Moderated Poster Session 7 BLADDER CANCER: UPPER TRACT TCC II Room New Orleans Morial Convention Center Moderators: Thomas Jarrett and Michael Grasso 1:00 pm - 3:00 pm NUMBER TITLE NUMBER TITLE MP7-01 PREOPERATIVE NOMOGRAM TO PREDICT PERIOPERATIVE COMPLICATIONS AFTER RADICAL NEPHROURETERECTOMY Yu-Kuan Lin*, Hershey, PA, Tobias Klatte, Shahrokh Shariat, Vienna, Austria, Laura- Maria Krabbe, Vitaly Margulis, Dallas, TX, Alex Arnouk, Costas Lallas, Edouard Trabulsi, Philadelphia, PA, Gregory Bozzini, Pierre Colin, CHRU Lille, France, Sarah Drouin, Morgan Rouprêt, Paris, France, Benoit Peyronnet, Karim Bensalah, Rennes, France, Kari Bailey, David Canes, Burlington, MA, Jay Raman, Hershey, PA MP7-02 MP7-03 THE SYSTEMIC INFLAMMATION-BASED GLASGOW PROGNOSTIC SCORE AS A POWERFUL PROGNOSTIC FACTOR IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA Teruo Inamoto*, Takatsuki, Japan, Shigeru Sakano, Kitakyushu, Japan, Tomoaki Takai, Kazumasa Komura, Taizo Uchimoto, Kenkichi Saito, Naoki Tanda, Koichiro Minami, Takatsuki, Japan, Kazuhiro Nagao, Ryo Inoue, Ube, Japan, Kiyoshi Takahara, Takatsuki, Japan, Hideyasu Matsuyama, Ube, Japan, Haruhito Azuma, Takatsuki, Japan IS THERE A CORRELATION OF HISTOPATHOLOGIC FEATURES WHICH PREDICT UPPER TRACT UROTHELIAL RECURRENCE FOLLOWING RADICAL CYSTECTOMY? Anvi Raina, Louis Krane*, Ahmed Aboumohamed, Ashok K Hemal, Winston Salem, NC *Presenting author 35

48 MP7-04 MP7-05 MP7-06 MP7-07 MP7-08 PREOPERATIVE PREDICTIVE FACTORS OF ENDOSCOPIC MANAGEMENT IN PATIENTS WITH UPPER TRACT UROTHELIAL CANCER Jae yong Jeong, Young hyo Choi, Joon hyung Park*, Sang eun Lee, Sin woo Lee, Hyun hwan Sung, seoul, Korea, Republic of, Jeong hee Hong, Cheonan, Korea, Republic of, Hwang gyun Jeon, Byong chang Jeong, Seong il Seo, Hyun moo Lee, Han yong Choi, Seong soo Jeon, seoul, Korea, Republic of PROGNOSTIC VALUE OF THE PT3 SUBCLASSIFICATION FOR UPPER TRACT UROTHELIAL CARCINOMAS OF THE RENAL PELVICALYCEAL SYSTEM Thomas Seisen*, Eva Compérat, Paris, France, Pierre Colin, Lille, France, Priscilla Léon, Laurent Nison, Paris, France, Gregory Bozzini, Lille, France, Christian Pfister, Rouen, France, Laurent Guy, Clermont Ferrand, France, Alain Ruffion, Lyon, France, Jean Luc Descotes, Paris, France, Jacques Irani, Poitiers, France, Alexandre De La Taille, Créteil, France, Thierry Lebret, Suresnes, France, Olivier Cussenot, Paris, France, Shahrokh Shariat, Vienna, Austria, Morgan Rouprêt, Paris, France MULTICENTER EXTERNAL VALIDATION OF A POST-OPERATIVE NOMOGRAM FOR PREDICTING THE RISK OF INTRAVESICAL RECURRENCE AFTER RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA Thomas Seisen*, Vincent Hupertan, Paris, France, Pierre Colin, Lille, France, Priscilla Léon, Gregory Bozzini, Paris, France, Laurent Nison, Lille, France, Véronique Phé, François Rozet, Pierre Mozer, Olivier Cussenot, Paris, France, Shahrokh Shariat, Vienna, Austria, Morgan Rouprêt, Paris, France ENDOSCOPIC MANAGEMENT FOR UPPER TRACT UROTHELIAL CANCER (UTUC) COMPARED TO IMMEDIATE NEPHROURETERECTOMY: SURVIVAL OUTCOMES IN SEER DATABASE AND CANCER CENTER COHORT Katie Murray*, Andrew Winer, Aditya Bagrodia, Samuel Kaffenberger, Michael Vacchio, Alexander Sankin, Eugene Cha, Nicole Benfante, Guido Dalbagni, New York, NY, Joel Vetter, St. Louis, MO, Jonathan Coleman, New York, NY, Seth Strope, St. Louis, MO THE COMPREHENSIVE COMPLICATION INDEX (CCI) IS MORE ACCURATE THAN THE CLAVIEN-DINDO GRADING SYSTEM IN PREDICTING LENGTH OF STAY FOLLOWING RADICAL NEPHROURETERECTOMY Rosa Park*, Chris Rjepaj, Jay D. Raman, Hershey, PA MP7-09 MP7-10 MP7-11 MP7-12 MP7-13 INCREASED EZH2 EXPRESSION IS ASSOCIATED WITH ADVERSE ONCOLOGIC OUTCOMES FOLLOWING RADICAL NEPHROURETERECTOMY Jay D. Raman*, Carla Caruso, Zhaohai Yang, David DeGraff, Hershey, PA, Shahrokh Shariat, Vienna, Austria, Jose Karam, Christopher Wood, Houston, TX, Alon Weizer, Ann Arbor, MI, Mesut Remzi, Andrea Haitel, Vienna, Austria, Karim Bensalah, Nathalie Rioux-Leclerq, Rennes, France, Christian Bolenz, Mannheim, Germany, Marco Roscigno, Bergamo, Italy, Laura-Maria Krabbe, Payal Kapur, Yair Lotan, Vitaly Margulis, Dallas, TX THE PROGNOSTIC IMPACT OF HISTONE H3K27 TRIMETHYLATION REGULATED BY EZH2 IN PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA Yasumasa Miyazaki*, Takeo Kosaka, Shuji Mikami, Eiji Kikuchi, Nobuyuki Tanaka, Yota Yasumizu, Akira Miyajima, Yasunori Okada, Mototsugu Oya, Tokyo, Japan PROGNOSTIC IMPACT OF NUCLEOPHOSMIN/B23 EXPRESSION IN UPPER TRACT UROTHELIAL CARCINOMA (UTUC) IN PATIENTS UNDERGOING RADICAL NEPHROURETERECTOMY (RNU) Harutake Sawazaki*, Keiichi Ito, Takako Asano, Kenji Kuroda, Akinori Sato, Junichi Asakuma, Akio Horiguchi, Kenji Seguchi, Tomohiko Asano, Tokorozawa, Japan DETECTION OF FGFR3 MUTATIONS FROM URINE SEDIMENT DNA TO PREDICT THE RISK OF INTRAVESICAL RECURRENCE AFTER RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA Thomas Seisen*, Morgan Rouprêt, Géraldine Cancel-Tassin, Priscilla Léon, Eva Compérat, Sarah Drouin, Véronique Phé, Raphaële Renard-Penna, Pierre Mozer, Olivier Cussenot, Paris, France GENETIC SIGNATURES ARE ASSOCIATED WITH ADVERSE PATHOLOGIC AND CLINICAL OUTCOMES IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA (UTUC) Aditya Bagrodia*, Eugene Cha, New York, NY, John Sfakianos, New, NY, Gopa Iyer, Byron Lee, Sasinya Scott, Emily Zabor, Ronak Shah, Qinghu Ren, Philip Kim, Ari Hakimi, Irina Ostrovnaya, Jonathan Rosenberg, Guido Dalbagni, Dean Bajorin, Victor Reuter, Michael Berger, Bernard Bochner, Hikmat Al-Ahmadie, David Solit, Jonathan Coleman, New York, NY 36

49 MP7-14 MP7-15 MP7-16 EXPRESSION OF STEROID HORMONE RECEPTORS AND ITS PROGNOSTIC SIGNIFICANCE IN UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT (UCUUT) Eiji Kashiwagi*, Baltimore, MD, Kazutoshi Fujita, Suita, Japan, Seiji Yamaguchi, Hiroaki Fushimi, Osaka, Japan, Leonardo Reis, George Netto, Baltimore, MD, Norio Nonomura, Suita, Japan, Hiroshi Miyamoto, Baltimore, MD SIMPLE PREDICTION OF POSTOPERATIVE RENAL FUNCTION WITH DYNAMIC CT BEFORE NEPHROURETERECTOMY: THE RATIO OF RENAL CORTEX ENHANCEMENT BETWEEN DISEASED AND CONTRALATERAL KIDNEY Yuma Waseda*, Yudai Ishikawa, Keizou Kawano, Ibaraki, Japan, Kazunori Kihara, Tokyo, Japan, Shinji Morimoto, Ibaraki, Japan MOLECULAR DIAGNOSIS OF LYMPH NODE METASTASIS IN PATIENT WITH UPPER URINARY TRACT CANCER WHO HAD EXTENDED LYMPHADENECTOMY Yoshiki Kodama*, Nagahide Matsumura, Yasuo Kohjimoto, Isao Hara, Wakayama, Japan, Tsunenori Kondo, Tokyo, Japan MP7-18 MP7-19 MP7-20 EXTERNAL VALIDATION OF TALL SCORE FOR PREDICTION OF ONCOLOGICAL OUTCOMES OF HIGH GRADE UPPER TRACT UROTHELIAL CARCINOMA AFTER RADICAL NEPHROURETERECTOMY Kyle Spradling*, Zhamshid Okhunov, Orange, CA, Yair Lotan, Arthur Sagalowsky, Dallas, TX, Shahrokh Shariat, Vienna, Austria, Jaime Landman, Ramy Youssef, Orange, CA EARLY REPEATED URETEROSCOPY WITHIN 6-8 WEEKS AFTER A PRIMARY ENDOSCOPIC TREATMENT IN PATIENTS WITH UPPER TRACT UROTHELIAL CELL CARCINOMA - PRELIMINARY FINDINGS Luca Villa*, Jonathan Cloutier, Julien Letendre, Achilles Ploumidis, Paris, France, Andrea Salonia, Milan, Italy, Jean-Nicolas Cornu, Paris, France, Francesco Montorsi, Milan, Italy, Olivier Traxer, Paris, France THE ASSOCIATION BETWEEN RESECTION OF BLADDER CANCERS AROUND URETERAL ORIFICES AND UPPER TRACT UROTHELIAL CANCERS Muammer Altok, Isparta, Turkey, Ali Feyzullah şahin*, SItkI Ün, Osman Koca, Rauf Taner Divrik, Izmir, Turkey FRIDAY MP7-17 HISTOLOGICAL VARIANTS OF UPPER URINARY TRACT UROTHELIAL CARCINOMA: THE 18-YEAR MSKCC EXPERIENCE Andrew Winer*, Michael Vacchio, Katie Murray, Samuel Kaffenberger, Aditya Bagrodia, Eugene Cha, Alexander Sankin, John Sfakianos, Guido Dalbagni, Jonathan Coleman, New York, NY Friday, May 15, 2015 Moderated Poster Session 8 URODYNAMICS/INCONTINENCE/FEMALE UROLOGY: BASIC RESEARCH I Room New Orleans Morial Convention Center Moderators: Matthew Fraser and Karl-Dietrich Sievert 1:00 pm - 3:00 pm NUMBER TITLE NUMBER TITLE MP8-01 THE ESTABLISHMENT OF AN UNDERACTIVE BLADDER MODEL FOLLOWING A HYSTERECTOMY IN MONKEY Daisuke Wakamatsu*, Jun Kida, Takeya Otsuki, Hiroki Okada, Hidekazu Matsuya, Osaka, Japan, Noritoshi Sekido, Tokyo, Japan MP8-03 MP8-02 CHARACTERIZATION OF THE MURINE BLADDER RESPONSE TO SUBTOTAL CYSTECTOMY: A MODEL OF MAMMALIAN ORGAN REGENERATION Grace Delos Santos*, Maywood, IL, Andrew Flum, Natalie Kukulka, Robert Dettman, Edward Gong, Chicago, IL MP8-04 SKELETAL MYOGENIC DIFFERENTIATION OF URINE-DERIVED STEM CELLS, ANGIOGENESIS AND INNERVATION USING HYDROGEL LOADED WITH GROWTH FACTORS FOR POTENTIAL IN TREATMENT OF URINARY INCONTINENCE Guihua Liu, Rajesh Pareta, Rongpei Wu, Yingai Shi, Chunhua Deng, Xiaobo Zhou, Anthony Atala, Emmanuel Opara, Yuanyuan Zhang*, Winston Salem, NC UNDERACTIVE BLADDER IN OBESE- PRONE RATS FED A HIGH FAT DIET Nazema Siddiqui*, Alexis Dieter, Cindy Amundsen, Jillene Brooks, Danielle Degoski, Matthew Fraser, Durham, NC *Presenting author 37

50 MP8-05 MP8-06 MP8-07 MP8-08 MP8-09 MP8-10 MP8-11 OBESITY-INDUCED METABOLIC SYNDROME PROMOTE LOWER URINARY TRACT SYMPTOMS (LUTS) IN A MOUSE MODEL Qiqi He, Sanjeev Shukla, Cleveland, OH, Zhiping Wang, Lanzhou, China, People s Republic of, Guiming Liu, Bernadette Erokwu, Chris Flask, Lan Lu, Melissa Babcook, Firouz Daneshgari, Sanjay Gupta*, Cleveland, OH PREVENTIVE EFFECTS OF CALORIC RESTRICTION ON AGING-ASSOCIATED BIOLOGICAL AND MOLECULAR CHANGES IN THE RAT BLADDER AND DORSAL ROOT GANGLIA Hiroki Ito*, Naoki Aizawa, Rino Sugiyama, Jun Kamei, Yoshiyuki Akiyama, Koji Ichihara, Yasunori Fujita, Tokyo, Japan, Toshio Kojima, Aichi, Japan, Yukio Homma, Tokyo, Japan, Yoshinobu Kubota, Yokohama, Japan, Masafumi Ito, Tokyo, Japan, Karl-Erik Andersson, Aarhus, Denmark, Yasuhiko Igawa, Tokyo, Japan HIGH FAT DIET IS RELATED TO BLADDER DYSFUNCTION: AN URODYNAMIC- CONTROLLED EXPERIMENTAL STUDY UM RATS Andre Matos Oliveira*, Fernando F Fonseca, Sabrina T Reis, Luiz O Leiria, Katia R Leite, William C Nahas, Miguel Srougi, Alberto A Antunes, Sao Paulo, Brazil PROLONGED ISCHEMIA MEDIATES OVERACTIVE BLADDER TRANSITION TO UNDERACTIV BLADDER Zuohui Zhao, Jing-Hua Yang, Portia Thurmond, Kazem Azadzoi*, Boston, MA A NEW MATERIAL TO BE USED AS A URETHRAL COVERAGE LAYER DURING THE IMPLANTATION OF ARTIFICIAL DEVICES Salvador Vilar Correia Lima*, Marcílio Romero Machado, Flávia Cristina Pinto, Mariana Montenegro de Melo Lira, Olávio Campos Jr, Danielly Karla Leal de Lima, José Lamartine de Andrade Andrade, Recife, Brazil REDUCTION IN PELVIC ORGAN PROLAPSE IN LYSYL OXIDASE LIKE-1 (LOXL1) KNOCKOUT (KO) MICE USING A CELL BASED THERAPY Bruna M. Couri*, Brittaney Wilson-Harris, Javier Pizarro-Berdichevsky, Ali Borazjani, Samantha D. Gonzalez-Ramos, Geerke Dijkema, Mei Kuang, Brian M. Balog, Margot S. Damaser, Cleveland, OH QUALITY, ACCESSIBILITY AND READABILITY OF ONLINE HEALTH INFORMATION ON URINARY INCONTINENCE Hendrik Borgmann*, Jan-Henning Wölm, Michael Reiter, Kilian Gust, Stefan Vallo, Georg Bartsch Jr, Roman Blaheta, Igor Tsaur, Axel Haferkamp, Frankfurt, Germany MP8-12 A NEUROTROPHIC AGENT, N- HEXACOSANOL, PREVENTS THE DEVELOPMENT OF BLADDER HYPERACTIVITY IN A RAT MODEL OF CHRONIC BLADDER ISCHEMIA Masanori Nomiya*, Mozomu Miyazaki, Kentaro Ikegami, Koriyama, Japan, Takahisa Noma, Yukio Hayashi, Tsukuba, Japan, Osamu Yamaguchi, Koriyama, Japan MP8-13 MP8-14 MP8-15 MP8-16 MP8-17 MP8-18 PLASMID-BASED CELL-SPECIFIC GENE TRANSFER TO TREAT OVERACTIVE BLADDER SYNDROME Aryeh Keehn*, Moses Tar, Kelvin Davies, Sylvia Suadicani, Arnold Melman, Bronx, NY THE BENEFICIAL EFFECT OF RESVERATROL ON BLADDER FUNCTION IN A RAT MODEL OF CHRONIC BLADDER ISCHEMIA Norifumi Sawada*, Satoru Kira, Tatsuya Ihara, Yuki Imai, Nobuhiro Takahashi, Hidenori Zakohji, Chuo, Japan, Masanori Nomiya, Koriyama, Japan, Masayuki Takeda, Chuo, Japan ELECTRICAL STIMULATION OF THE SPINAL DORSAL ROOT INHIBITS REFLEX BLADDER CONTRACTION AND EXTERNAL URETHRA SPHINCTER ACTIVITY: IS THIS HOW SACRAL NEUROMODULATION WORKS? Jian Ren*, Beijing, China, People s Republic of, Daniel Chew, Nikesh Thiruchelvam, Cambridge, United Kingdom CHRONIC BILATERAL PUDENDAL NERVE ELECTRICAL STIMULATION IMPROVES RECOVERY FROM SIMULATED CHILDBIRTH INJURY IN A STRESS URINARY INCONTINENCE MODEL Kangli Deng*, Danli Lin, Brett Hanzlicek, Qi-Xiang Song, Hui Zhu, Margot Damaser, Cleveland, OH HIPPOCAMPAL MICROSTIMULATION OR MICROINJECTION OF NMDA IONOTROPIC GLUTAMATE RECEPTOR ANTAGONIST INHIBITS MICTURITION REFLEX IN URETHANE-ANESTHETIZED RATS Yosuke Matsuta*, Satoshi Yokoi, Fukui, Japan, Bing Shen, James R. Roppolo, William C. de Groat, Changfeng Tai, Pittsburgh, PA, Osamu Yokoyama, Fukui, Japan THE ROLE OF THE BRAINSTEM IN TIBIAL INHIBITION OF THE MICTURITION REFLEX IN CATS Matthew Ferroni*, Richard Slater, Bing Shen, Zhiying Xiao, Jicheng Wang, Andy Lee, James Roppolo, William de Groat, Changfeng Tai, Pittsburgh, PA 38

51 MP8-19 A NEW MECHANISM OF INFECTION- INDUCED BLADDER HYPERACTIVITY: LIPOPOLYSACCHARIDE CAUSES RAPID ATP RELEASE FROM UROTHELIUM AND STIMULATES THE MECHANOSENSORY AFFERENT PATHWAY Kentaro Takezawa*, Makoto Kondo, Hiroshi Kiuchi, Tetsuji Soda, Shinichiro Fukuhara, Suita, Japan, Tetsuya Takao, Osaka, Japan, Yasushi Miyagawa, Suita, Japan, Akira Tsujimura, Tokyo, Japan, Kazumasa Matsumoto-Miyai, Awaji, Japan, Shoichi Shimada, Norio Nonomura, Suita, Japan MP8-20 ONABOTULINUMTOXINA VERSUS ABOBOTULINUMTOXINA: POTENCY AND DIFFUSION CAPACITY ON THE BLADDER WALL Raquel Oliveira, Ana Coelho, Antonio Avelino, Francisco Cruz*, Porto, Portugal FRIDAY Friday, May 15, 2015 Podium Session 3 ADRENAL Room New Orleans Morial Convention Center Moderators: Rajeev Kumar and Howard Winfield 1:00 pm - 3:00 pm TIME NUMBER TITLE TIME NUMBER TITLE 1:00 PD3-01 OPEN VERSUS ROBOTIC ADRENALECTOMY A MATCHED PAIR ANALYSIS Kai Probst*, Carsten Ohlmann, Stefan Siemer, Michael Stöckle, Martin Janssen, Homburg, Germany 1:10 PD3-02 IN PRIMARY ALDOSTERONISM WITH BILATERAL ADRENAL ADNOMAS, LAPAROSCOPIC BILATERAL ADRENAL SURGERY COULD BE AN OPTIONAL TREATMENT UNDER SELECTIVE ADRENAL VENOUS SAMPLING Yoshihide Kawasaki*, Shigeto Ishidoya, Akihiro Ito, Yasuhiro Kaiho, Ryo Morimoto, Kei Takase, Yoichi Arai, Sendai, Japan 1:20 PD3-03 RATIONALE FOR PARTIAL ADRENALECTOMY: REVIEW OF DANGERS TO ADRENAL GLAND Alosh Madala*, Michael Daugherty, Gennady Bratslavsky, Syracuse, NY 1:30 PD3-04 LESS POSTERIOR RETROPERITONEOSCOPIC ADRENALECTOMY: STEP-BY-STEP TECHNIQUE DESCRIPTION AND COMPARISON WITH 3-PORTS LATERAL RETROPERITONEAL APPROACH Marcos Tobias-Machado, Igor Nunes-Silva*, Marcel A. Silveira, Oseas Castro Neves, Alexandre Kyoshi Hidaka, Antonio Carlos Lima Pompeo, São Paulo, Brazil 1:40 PD3-05 RECURRENT SOMATIC MUTATIONS UNDERLIE CORTICOTROPIN- INDEPENDENT CUSHING S SYNDROME Shigekatsu Maekawa*, Tokyo, Japan, Yusuke Sato, Kyoto, Japan, Toru Nakagawa, Haruki Kume, Tokyo, Japan, Seishi Ogawa, Kyoto, Japan, Yukio Homma, Tokyo, Japan 1:50 PD3-06 IMPACT OF PRIMARY HISTOLOGY ON DISEASE FREE SURVIVAL AFTER MINIMALLY INVASIVE ADRENALECTOMY FOR METASTATIC CANCER Mariaconsiglia Ferriero*, Rome, Italy, Giuseppe Simone, Turin, Italy, Rocco Papalia, Riccardo Mastroianni, Salvatore Guaglianone, Michele Gallucci, Rome, Italy 2:00 PD3-07 CONDITIONAL SURVIVAL ANALYSIS FOR PATIENTS WITH ADRENAL CORTICAL CARCINOMAS: RESULTS FROM POPULATION-BASED DATA Yuanyuan Qu*, Yao Zhu, Dingwei Ye, Shanghai, China, People s Republic of 2:10 PD3-08 IMPACT OF IMPAIRED GLUCOSE TOLERANCE ON THE DEVELOPMENT OF HYPOGLYCEMIA FOLLOWING REMOVAL OF PHEOCHROMOCYTOMA Manabu Tatokoro*, Yasukazu Nakanishi, Yoshinobu Komai, Yoh Matsuoka, Junichiro Ishioka, Noboru Numao, Takanobu Yoshimoto, Kazutaka Saito, Yasuhisa Fujii, Yoshihiro Ogawa, Kazunori Kihara, Tokyo, Japan 2:20 PD3-09 PHEOCHROMOCYTOMA: A COMPARISON OF PERIOPERATIVE MANAGEMENT WITH CALCIUM CHANNEL BLOCKERS AND SELECTIVE AND NON-SELECTIVE ALPHA RECEPTOR BLOCKERS Ryan W Zipper*, Clinton D Bahler, M Francesca Monn, David Y Yang, Matthew J Mellon, Chandru P Sundaram, Indianapolis, IN 2:30 PD3-10 PREOPERATIVE BODY MASS INDEX PREDICTS THE NEED OF POSTOPERATIVE CATECHOLAMINE SUPPORT IN PHEOCHROMOCYTOMA PATIENTS Takeshi Namekawa*, Nobushige Takeshita, Ken Wakai, Miki Fuse, Shinichi Sakamoto, Koji Kawamura, Takashi Imamoto, Tomohiko Ichikawa, Chiba, Japan *Presenting author 39

52 2:40 PD3-11 MARKER-NEGATIVE PHEOCHROMOCYTOMA Shira Winters, Louis Krane, Majid Mirzazadeh*, Winston-Salem, NC 2:50 PD3-12 HEALTH RELATED QUALITY OF LIFE IN PATIENTS UNDERGOING LAPAROSCOPIC ADRENALECTOMY Ostap Dovirak*, Jialin Mao, Catrina Crociani, Kimberly Taylor, Peter Chang, Andrew Wagner, Boston, MA Friday, May 15, 2015 Podium Session 4 IMAGING/RADIOLOGY: URORADIOLOGY I Room New Orleans Morial Convention Center Moderator: Edouard Trabulsi 1:00 pm - 3:00 pm TIME NUMBER TITLE TIME NUMBER TITLE 1:00 PD4-01 FOLLOW UP OF LOWER URETERAL STONES: A PROSPECTIVE COMPARATIVE STUDY BETWEEN NON-CONTRAST COMPUTED TOMOGRAPHY AND COLOR DOPPLER ULTRASOUND Emad Elsobky*, Abu Dhabi, United Arab Emirates, Ravi Kadasne, Chandrashekar Anjikar, Mahmoud Abdel-Gawad, Al ain, United Arab Emirates 1:10 PD4-02 SHOULD BONE MINERAL DENSITY (BMD) BE INCLUDED IN THE METABOLIC EVALUATION OF YOUNG ADULTS WITH CALCIUM KIDNEY STONE DISEASE?: A PROSPECTIVE STUDY Uttam Mete*, Prashant Raj Garg, Mahesh Prakash, Pinaki Dutta, Chandigarh, India 1:20 PD4-03 A COMPARISON OF CALCULATED ABSORBED RADIATION ORGAN DOSES AND IMAGE QUALITY FOR ITERATIVE VERSUS FILTERED BACK PROJECTION CT IN KIDNEY STONE PATIENTS Rishi Modh*, Akira Yamamoto, James Mason, Elizabeth Vorhis, Lori Deitte, Cyrus Monroe, Anna Mench, Rebecca H. Lamoureux, Izabella Lipnharski, Jacob Batson, Derek Lee, Carl Henriksen, Manuel Arreola, Benjamin Canales, Gainesville, FL 1:30 PD4-04 USE OF FLUOROSCOPY AND POTENTIAL LONG-TERM RADIATION EFFECTS ON CATARACT FORMATION Rutveej Patel*, Justin Dubin, Sammy Elsamra, Ephrem Olweny, Robert Weiss, New Brunswick, NJ 1:40 PD4-05 INCIDENCE OF CONTRAST REACTION DURING NON-INTRAVENOUS URINARY TRACT IMAGING Robert Blackwell, Eric Kirshenbaum*, Matthew Zapf, Anai Kothari, Paul Kuo, Robert Flanigan, Gopal Gupta, Maywood, IL 1:50 PD4-06 A RANDOMIZED CONTROL TRIAL DEMONSTRATES THAT ULTRASOUND- GUIDED PERCUTANEOUS RENAL ACCESS IS A TEACHABLE SKILL Pauline Filippou*, Anobel Odisho, Krishna Ramaswamy, San Francisco, CA, Weiguo Hu, Jianxing Li, Beijing, China, People s Republic of, Thomas Chi, San Francisco, CA 2:00 PD4-07 PREOPERATIVE FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY ON THE DIAGNOSIS IN UPPER URINARY TRACT CANCER Seiji Asai*, Toshio Kakuda, Kouji Hara, Terutaka Noda, Kenichi Nishimura, Tetsuya Fukumoto, Noriyoshi Miura, Yutaka Yanagihara, Akitomi Shirato, Yuki Miyauchi, Tadahiko Kikugawa, Masao Miyagawa, Nozomu Tanji, Masayoshi Yokoyama, Toon, Japan 2:10 PD4-08 PRE-TREATMENT CT TEXTURAL ANALYSIS OF LARGE PRIMARY RENAL CELL CARCINOMAS; TUMOR HETEROGENEITY CORRELATES WITH HISTOLOGY AND CLINICAL OUTCOMES E. Jason Abel*, Meghan Lubner, Alejandro Munoz Del Rio, Nicholas Stabo, Perry Pickhardt, Madison, WI 2:20 PD4-09 VASOACTIVE INTESTINAL PEPTIDE AND PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE RECEPTOR 1 (VPAC1) TARGETED IMAGING OF PROSTATE CANCER: A PILOT STUDY Edouard Trabulsi*, Sushil Tripathi, Peter McCue, Ruth Birbe, Eric Wickstrom, Leonard Gomella, Sung Kim, Charles Intenzo, Madhukar Thakur, Philadelphia, PA 40

53 2:30 PD4-10 REPRODUCIBILITY OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING AND FUSION- GUIDED PROSTATE BIOPSY: MULTI- INSTITUTIONAL EXTERNAL VALIDATION BY A PROPENSITY SCORE MATCHED COHORT Steven F. Abboud*, Arvin K. George, Thomas Frye, Bethesda, MD, Ardeshir R. Rastinehad, New Hyde Park, NY, Richard Ho, Michele Fascelli, Raju chelluri, Nabeel Shakir, Annerleim Walton- Diaz, Sandeep Sankineni, Baris Turkbey, Peter L. Choyke, Bradford J. Wood, Maria J. Merino, Peter A. Pinto, Bethesda, MD 2:40 PD4-11 THE RELATIONSHIP OF INCREASING MRI SUSPICION SCORE AND THE IDENTIFICATION OF HIGH GRADE PROSTATE CANCER ON MRI FUSION TARGETED BIOPSY Xiaosong Meng*, Andrew B. Rosenkrantz, Michael Fenstermaker, Neil Mendhiratta, Richard Huang, Fang-Ming Deng, Ming Zhou, William C. Huang, Herbert Lepor, Samir S. Taneja, New York, NY 2:50 PD4-12 3D ACOUSTIC RADIATION FORCE IMPULSE (ARFI) ELASTICITY IMAGING OF PROSTATE CANCER: CORRELATION BETWEEN IN VIVO IMAGING AND WHOLE MOUNT HISTOLOGY Melissa Mendez*, Mark Palmeri, Zachary Miller, Tyler Glass, Stephen Rosenzweig, Andrew Buck, John Madden, Thomas Polascik, Kathryn Nightingale, Durham, NC FRIDAY Friday, May 15, 2015 Podium Session 5 BENIGN PROSTATIC HYPERPLASIA: SURGICAL THERAPY & NEW TECHNOLOGY II Room New Orleans Morial Convention Center Moderator: Ricardo Gonzalez 1:00 pm - 3:00 pm TIME NUMBER TITLE TIME NUMBER TITLE 1:00 PD5-01 THREE YEAR DURABILITY OF THE PROSTATIC URETHRAL LIFT FOR BPH: RESULTS OF A PROSPECTIVE, MULTI- CENTER, RANDOMIZED STUDY Claus Roehrborn*, Dallas, TX, Steven Gange, Salt Lake City, UT, Neal Shore, Myrtle Beach, SC, Jonathan Giddens, Woodbridge, Canada, Damien Bolton, Melbourne, Australia, Barrett Cowan, Denver, CO, Thomas Brown, Daytona Beach, FL, Kevin McVary, Springfield, IL, Peter Chin, Figtree, Australia, Alexis Te, New York, NY, Shahram Gholami, San Jose, CA, Prem Rashid, Port Macquarie, Australia, William Moseley, San Diego, CA, Ronald Tutrone, Towson, MD, Sheldon Freedman, Las Vegas, NV, Peter Incze, Oakville,, Canada, K. Scott Coffield, Temple,, TX, Fernando Borges, St. Petersburg, FL, Daniel Rukstalis, Winston- Salem, NC 1:10 PD5-02 MULTICENTER EXPERIENCE OF A NOVEL TREATMENT FOR BPH: AQUABLATION IMAGE GUIDED ROBOT-ASSISTED WATER JET ABLATION OF THE PROSTATE Peter Gilling*, Tauranga, New Zealand, Andrew Tan, Perth, Australia, Paul Anderson, Melbourne, Australia 1:20 PD5-03 CLINICALLY AND STATISTICALLY SIGNIFICANT CHANGES SEEN IN SHAM SURGERY ARMS OF BENIGN PROSTATIC HYPERPLASIA SURGERY TRIALS Charles Welliver*, Albany, NY, Michael Kottwitz, Kevin McVary, Springfield, IL 1:30 PD5-04 CAN WE PREDICT WHICH PATIENTS WILL PRESENT RESOLUTION OF DETRUSOROVERACTIVITY (DO) AFTER TRANSURETHRAL RESECTION OF THE PROSTATE (TURP)? Alexandre Iscaife*, Sabrina T Reis, Aline Albertini, Marco A Nunes, Antonio M Lucon, Willian C Nahas, Miguel Srougi, Alberto A Antunes, Sao Paulo, Brazil 1:40 PD5-05 USE OF ADDITIONAL THERAPY FOR BENIGN PROSTATIC HYPERPLASIA AFTER TURP AND LASER VAPORIZATION Niraj Badhiwala*, Adrienne Kuxhausen, Joel Vetter, Seth Strope, St. Louis, MO 1:50 PD5-06 EVALUATION OF LASER ENUCLEATION TECHNIQUES IN THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA: A SYSTEMATIC REVIEW AND META- ANALYSIS Sam Chopra*, Cindy Garcia, Venu Chalasani, Henry Woo, Sydney, Australia *Presenting author 41

54 2:00 PD5-07 COST-BENEFIT COMPARISON OF ROBOTIC-ASSISTED SIMPLE PROSTATECTOMY (RASP), TRANSURETHRAL RESECTION (TURP), AND PHOTOVAPORIZATION (PVP) FOR BENIGN PROSTATIC HYPERPLASIA (BPH) Andrew Eschenroeder*, Devin Haddad, Sij Hemal, Gopal Badlani, Winston Salem, NC 2:10 PD MONTH RESULTS FOR A PROSPECTIVE RANDOMIZED CONTROLLED STUDY COMPARING GREENLIGHT XPS TO TURP DEMONSTRATE DURABILITY OF RESPONSE AT 24-MONTHS James Andrew Thomas*, Bridgend, Wales, United Kingdom, Andrea Tubaro, Rome, Italy, Neil Barber, Frimley, Camberley Surrey, United Kingdom, Frank d Ancona, Nijmegen, Netherlands, Gordon Muir, London, United Kingdom, Ulrich Witzsch, Frankfurt, Germany, Marc-Oliver Grimm, Jena, Germany, Joan Benejam, Manacor, Spain, Jens-Uwe Stolzenburg, Leipzig, Germany, Antony Riddick, Edinburgh, Scotland, United Kingdom, Sascha Pahernik, Heidelberg, Germany, Johannes Roelink, Almelo/Hengelo, Netherlands, Filip Ameye, Gent, Belgium, Christian Saussine, Strasbourg, France, Frank Bruyere, Tours, France, Wolfgang Loidl, Linz, Austria, Tim Larner, Brighton, United Kingdom, Nirjan Gogoi, Wakefield, United Kingdom, Richard Hindley, Hampshire, United Kingdom, Rolf Muschter, Rotenburg, Germany, Andrew Thorpe, Newcastle upon Tyne, United Kingdom, Nitin Shrotri, Kent, United Kingdom, Stuart Graham, London, United Kingdom, Moritz Hamann, Kiel, Germany, Kurt Miller, Berlin, Germany, Martin Schostak, Magdeburg, Germany, Carlos Capitan, Madrid, Spain, Helmut Knispel, Berlin, Germany, Alexander Bachmann, Basel, Switzerland 2:20 PD5-09 IMPACT OF PHOTOSELECTIVE VAPORIZATION OF PROSTATE IN MANAGEMENT OF PROSTATE CANCER Pradère Benjamin*, Tours, France, Peyronnet Benoit, Rennes, France, Brichart Nicolas, Bruyère Franck, Tours, France 2:30 PD5-10 TRANSURETHRAL RESECTION OF THE PROSTATE (GL-XPS OR TURP) DOES NOT RESULT IN SIGNIFICANT IMPAIRMENT OF ERECTILE FUNCTION James Andrew Thomas*, Bridgend, Wales, United Kingdom, Andrea Tubaro, Rome, Italy, Neil Barber, Frimley, Camberley Surrey, United Kingdom, Frank d Ancona, Nijmegen, Netherlands, Gordon Muir, London, United Kingdom, Ulrich Witzsch, Frankfurt, Germany, Marc-Oliver Grimm, Jena, Germany, Joan Benejam, Manacor, Spain, Jens-Uwe Stolzenburg, Leipzig, Germany, Antony Riddick, Edinburgh, Scotland, United Kingdom, Sascha Pahernik, Heidelberg, Germany, Johannes Roelink, Almelo/Hengelo, Netherlands, Filip Ameye, Gent, Belgium, Christian Saussine, Strasbourg, France, Frank Bruyere, Tours, France, Wolfgang Loidl, Linz, Austria, Tim Larner, Brighton, United Kingdom, Nirjan Gogoi, Wakefield, United Kingdom, Richard Hindley, Hampshire, United Kingdom, Rolf Muschter, Rotenburg, Germany, Andrew Thorpe, Newcastle upon Tyne, United Kingdom, Nitin Shrotri, Kent, United Kingdom, Stuart Graham, London, United Kingdom, Moritz Hamann, Kiel, Germany, Kurt Miller, Berlin, Germany, Martin Schostak, Magdeburg, Germany, Carlos Capitan, Madrid, Spain, Helmut Knispel, Berlin, Germany, Alexander Bachmann, Basel, Switzerland 2:40 PD5-11 THE IMPACT OF TRAINING ON THE PERIOPERATIVE AND INTERMEDIATE FUNCTIONAL OUTCOMES AFTER HOLMIUM LASER ENUCLEATION OF THE PROSTATE Haidar Abdul-Muhsin*, Mark Tyson, Karen Stern, Rafael Nuñez, Mitchell Humphreys, Phoenix, AZ 2:50 PD5-12 SEXUAL FUNCTION CHANGES FOLLOWING DIFFERENT TRANSURETHRAL PROSTATE SURGERIES: PROSPECTIVE SHAM CONTROLLED STUDY Ahmed Elshal*, Ramy Mekkawy, Ahmed EL- Assmy, Diaa-Eldin Taha, Ahmed EL-Nahas, Ahmed Mosbah, Hamdy El-Kappany, El- Housseiny Ibrahiem, Mansoura, Egypt 42

55 Friday, May 15, 2015 Video Session 2 1:00 pm - 3:00 pm FEMALE VOIDING DYSFUNCTION The videos in this session as well as the video libraries from the Annual Meetings may be viewed in the Surgical Video Library and purchased in the Products Store during the Annual Meeting. Both are located in Registration Hall B2. All years of the Surgical Video Library may also be purchased online at Room New Orleans Morial Convention Center Moderators: Toby Chai and Courtenay Moore FRIDAY NUMBER TITLE NUMBER TITLE V2-01 TRANSABDOMINAL SACROCOLPOPEXY WITH RECTUS FASCIA GRAFT Adrienne Quirouet*, Cleveland, OH, Nitya Abraham, New York, NY, Howard Goldman, Cleveland, OH V2-09 ROBOTIC-ASSISTED MESH EXPLANTATION AND BLADDER RECONSTRUCTION James Bienvenu*, Robert Elder, Wesley White, Knoxville, TN V2-02 AUTOLOGOUS FASCIAL PUBOVAGINAL SLING: CONTEMPORARY INDICATIONS, TECHNIQUES, AND CHALLENGES Lindsey Cox*, Anne Cameron, J. Quentin Clemens, Ann Arbor, MI V2-03 PUBOVAGINAL SLING WITH TENSOR FASCIA LATA Judy M. Choi*, Patkawat Ramart, Diana Kang, Seth Cohen, Lenny Ackerman, Shlomo Raz, Los Angeles, CA V2-04 RECTUS FASCIA SPIRAL SLING (RFSS) TECHNIQUE FOR WOMEN WITH MULTIPLE FAILED STRESS INCONTINENCE SURGERY DUE TO SEVERE INTRINSIC SPHINCTERIC DEFICIENCY Fikret Fatih Onol*, Sinasi Yavuz Onol, Mehmet Cenk Gürbüz, Ahmet Tahra, Eyüp Veli Küçük, Istanbul, Turkey V2-05 SURGICAL TECHNIQUE, SURGICAL BENCHMARKS AND IMPACT OF TEAM CONSTANCY ON SURGICAL DURATION IN ROBOT-ASSISTED ISOLATED SACROCOLPOPEXY AND SACROCOLPOPEXY COMBINED WITH MODIFIED BURCH COLPOSUSPENSION PROCEDURE. EXPERIENCE IN ONE INSTITUTION IN 120 CASES Assen Alexandrov, Carolin Hach, Stephan Buse*, Essen, Germany V2-06 SKENE S GLAND CYST EXCISION Philippe Zimmern*, Gary Lemack, Dallas, TX V2-07 ROBOTIC-ASSISTED VESICOVAGINAL FISTULA REPAIR AND RIGHT URETERAL REIMPLANT Christopher Hartman*, Paras Shah, Akinwunmi Carons, Michael Schwartz, Farzeen Firoozi, New Hyde Park, NY V2-08 ROBOTIC-ASSISTED LAPAROSCOPIC REMOVAL OF EXTRUDED SACROCOLPOPEXY MESH Kai-wen Chuang*, Christopher Hartman, Akin Carons, Manaf Alom, Paras Shah, Lee Richstone, Farzeen Firoozi, New Hyde Park, NY V2-10 IDENTIFICATION OF THE S3 FORAMEN DURING TRANSFORAMINAL SACRAL NEUROMODULATION LEAD PLACEMENT A NOVEL ROLLING PEN TECHNIQUE Amanda Saltzman*, Kristi Hebert, Howard Woo, Ryan Krlin, New Orleans, LA V2-11 EXCISION OF URERTHRAL DIVERTICULUM WITH RECTUS FASCIA SLING Mahmoud Mohamed*, Ayman Mahdy, Cincinnati, OH V2-12 TRANSVAGINAL APPROACH TO URETHRAL RECONSTRUCTION AFTER MIDURETHRAL SLING COMPLICATION Tony Nimeh*, Chicago, IL, Elisabetta Constantini, Perugia, Italy, Whitney Halgrimson, Chicago, IL, Manuel Di Biase, Perugia, Italy, Ervin Kocjancic, Chicago, IL V2-13 LAPAROSCOPIC EXTRAVESICAL REPAIR OF VESICOVAGINAL FISTULA Xiao Han*, Ho Yee Tiong, David Consigliere, Singapore, Singapore V2-14 VAGINAL EXCISION OF PERIVESICAL MASS Mahmoud Mohamed*, Ayman Mahdy, Cincinnati, OH *Presenting author 43

56 Friday, May 15, 2015 CROSSFIRE: CONTROVERSIES IN UROLOGY Hall New Orleans Morial Convention Center 1:00 pm - 5:00 pm 12:58 WELCOME AND ANNOUNCEMENTS 1:00 REVERSAL OF VASECTOMY IN THE ERA OF INTRACYTOPLASMIC SPERM INJECTION (ICSI) IS NOT WORTH THE EFFORT Moderator: Harris Nagler Debater - Pro: Gianpiero Palermo Debater - Pro: Peter Schlegel Debater - Con: Edmund Sabanegh Debater - Con: Larry Lipshultz 1:30 SACROCOLPOPEXY FOR APICAL PROLAPSE IS NOT THE GOLD STANDARD Moderator: J. Christian Winters Debater - Pro: Philippe Zimmern Debater - Pro: Saad Juma Debater - Con: Michael Albo Debater - Con: Nirit Rosenblum 2:00 FOCAL THERAPY FOR PROSTATE CANCER: HOPE OR HYPE Moderator: Peter Scardino Debater - Hope: Aaron Katz Debater - Hope: Mark Emberton Debater - Hype: Eric Klein Debater - Hype: Mark Gonzalgo 2:30 BLADDER SPARING FOR INVASIVE BLADDER CANCER IS NOT CANCER SPARING Moderator: Urs Studer Debater - Pro: Ashish Kamat Debater - Pro: James Catto Debater - Con: William Shipley Debater - Con: Bernard Bochner 3:00 OTC ALPHA BLOCKER IS NOT IN THE BEST INTEREST OF PATIENTS Moderator: Claus Roehrborn Debater - Pro: Kevin McVary Debater - Pro: Christian Gratzke Debater - Con: Marc Gittelman Debater - Con: Franklin Lowe 3:30 SHOCK WAVE LITHOTRIPSY SHOULD BE RETIRED Moderator: Ralph Clayman Debater - Pro: Olivier Traxer Debater - Pro: Glenn Preminger Debater - Con: Geert Tailly Debater - Con: James Lingeman 4:00 NEUROMODULATION SHOULD BE THE FIRST CHOICE OVER BOTULINUM TOXIN FOR IDO Moderator: Dirk De Ridder Debater - Pro: Steven Siegel Debater - Pro: Anurag Das Debater - Con: Christopher Smith Debater - Con: Michael Chancellor 4:30 NO DEFLUX FOR REFLUX Moderator: Anthony Atala Debater - Pro: Jonathan Routh Debater - Pro: Alan Retik Debater - Con: Jack Elder Debater - Con: Stephane Bolduc 44

57 Friday, May 15, 2015 Moderated Poster Session 9 GENERAL & EPIDEMIOLOGICAL TRENDS & SOCIOECONOMICS: EVIDENCE-BASED MEDICINE & OUTCOMES II Room New Orleans Morial Convention Center Moderators: Gabriel Haas and Scott Delacroix 3:30 pm - 5:30 pm FRIDAY NUMBER TITLE NUMBER TITLE MP9-01 COMPARATIVE EFFECTIVENESS OF AGGRESSIVE VS NON-AGGRESSIVE TREATMENT FOR HIGH-GRADE PROSTATE CANCER ACROSS DIFFERENT COMORBIDITY LEVELS Timothy Daskivich*, Los Angeles, CA, Julie Lai, Andrew Dick, Claude Setodji, Janet Hanley, Santa Monica, CA, Mark Litwin, Christopher Saigal, Los Angeles, CA MP9-07 MP9-08 MP9-02 MP9-03 MP9-04 MP9-05 MP9-06 OLDER AGE PREDICTS GLEASON SCORE UPGRADING DURING LONG-TERM MONITORING ON ACTIVE SURVEILLANCE Jeffrey Tosoian*, Amar Srivastava, Max Kates, Patricia Landis, Jonathan Epstein, Mufaddal Mamawala, H. Ballentine Carter, Bruce Trock, Baltimore, MD THE EFFECT OF HEALTHCARE SYSTEM ON APPROPRIATENESS OF PROSTATE CANCER IMAGING: DO PATIENTS GET BETTER CARE IN VA OR FEE-FOR- SERVICE MEDICARE? Danil Makarov*, Heather Gold, Dawn Walter, New York, NY, Evercita Eugenio, Seattle, WA, Scott Sherman, New York, NY, Cary Gross, New Haven, CT, Steven Zeliadt, Seattle, WA A NOVEL COMPREHENSIVE COMPLICATION INDEX BY CLAVIEN IN PATIENTS WITH RADICAL PROSTATECTOMY Burkhard Beyer*, Markus Graefen, Hartwig Huland, Thomas Steuber, Hamburg, Germany INCIDENCE AND CHARACTERISTICS OF UNCOMPLICATED RECURRENT URINARY TRACT INFECTIONS IN A NATIONAL SAMPLE OF COMMUNITY DWELLING WOMEN Anne M Suskind*, San Francisco, CA, Christopher S Saigal, Los Angeles, CA, Janet M Hanley, Julie Lai, Claude M Setodji, Santa Monica, CA, J. Quentin Clemens, Ann Arbor, MI, Urologic Diseases of America Project UDA, Los Angeles, CA IMPACT OF COUNTY RURALITY AND UROLOGIST DENSITY ON UROLOGIC CANCER MORTALITY IN ILLINOIS Daniel Sadowski*, Springfield, IL, Thomas Frye, Bethesda, MD, Shaheen Alanee, Whitney Zahnd, Wiley Jenkins, Danuta Dynda, Georgia Mueller, Kevin McVary, Springfield, IL MP9-09 MP9-10 MP9-11 MP9-12 MP9-13 THE METHODOLOGICAL QUALITY AND PUBLICATION OF INDUSTRY VERSUS NON-INDUSTRY TRIALS FOR TESTOSTERONE TREATMENT Sean Skeldon*, Toronto, Canada, Larry Goldenberg, Michael Law, Vancouver, Canada IMPACT OF SMOKING ON PERIOPERATIVE OUTCOMES AFTER MAJOR UROLOGIC SURGERY Akshay Sood*, Detroit, MI, Marianne Schmid, Boston, MA, Logan Campbell, Victor Kapoor, Firas Abdollah, Dane Klett, Deepansh Dalela, Detroit, MI, Steven Chang, Boston, MA, Felix Chun, Hamburg, Germany, Adam Kibel, Boston, MA, Jesse Sammon, James Peabody, Mani Menon, Detroit, MI, Margit Fisch, Hamburg, Germany, Quoc-Dien Trinh, Boston, MA PREDICTORS OF CONTINUED SMOKING AFTER THE DIAGNOSIS OF A GENITOURINARY MALIGNANCY Stephen Hurley*, Saumya Easaw, Andrew Drago, Christina Palmer, Tayna Uddin, Thomas O Grady, Mark Wille, Courtney Hollowell, Chicago, IL FACTORS ASSOCIATED WITH SUICIDE IN PATIENTS WITH GENITOURINARY MALIGNANCIES Zachary Klaassen*, Rita P. Jen, Augusta, GA, John M. DiBianco, Roseau, Dominica, Lael Reinstatler, Qiang Li, Rabii Madi, Ronald W. Lewis, Arthur M. Smith, Durwood E. Neal, Jr., Augusta, GA, Kelvin A. Moses, Nashville, TN, Martha K. Terris, Augusta, GA LONG-TERM RISK OF UROLOGIC COMPLICATIONS FOLLOWING CERVICAL CANCER TREATMENT Robert Goldfarb*, Yunhua Fan, Stephanie Jarosek, Haitao Chu, Beth Virnig, Sean Elliott, Minneapolis, MN PATIENT-CENTERED TREATMENT DECISIONS: USING CONJOINT ANALYSIS AS AN AID FOR SHARED DECISION- MAKING FOR URETHRAL STRICTURE TREATMENT Lindsay Hampson*, Thomas Gaither, Leslie Wilson, Jie Ting, Isabel Allen, Benjamin Breyer, San Francisco, CA IN PATIENTS WITH POST-OPERATIVE VENOUS THROMBOEMBOLIC EVENTS, PHARMACOLOGIC PROPHYLAXIS IS FREQUENTLY UNDERDOSED Raman Unnikrishnan*, Benjamin Cohen, Michelle Ponziano, Venkatesh Krishnamurthi, Cleveland, OH *Presenting author 45

58 MP9-14 MP9-15 MP9-16 POSTOPERATIVE SEPSIS PREDICTION IN PATIENTS UNDERGOING MAJOR CANCER SURGERY Akshay Sood*, Firas Abdollah, Jesse Sammon, Dane Klett, Daniel Pucheril, Detroit, MI, Kaustav Majumder, Marianne Schmid, Adam Kibel, Boston, MA, Mani Menon, Detroit, MI, Quoc-Dien Trinh, Boston, MA IDENTIFYING RISK FACTORS FOR READMISSION TO THE SURGICAL INTENSIVE CARE UNIT FOLLOWING MAJOR UROLOGICAL SURGERY: A 24- MONTH EXPERIENCE Mark Hockenberry*, Zachary Smith, Philadelphia, PA, Kavita Gupta, District of Columbia, DC, Matthew Robertson, Charlottesville, VA, Niels Martin, Thomas Guzzo, Philadelphia, PA NATIONAL MULTI-INSTITUTIONAL CAUSES AND PREDICTORS OF 30-DAY UNPLANNED READMISSION AFTER MAJOR UROLOGIC SURGERY USING THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM Raffaella DeRosa*, Alexander Ernest, Michael Lustik, Joseph Sterbis, Leah McMann, Honolulu, HI MP9-18 MP9-19 MP9-20 ANTICIPATING THE IMPACT OF ACCOUNTABLE CARE ORGANIZATIONS ON THE COST AND QUALITY OF UROLOGIC CANCER CARE Lindsey Herrel*, Scott Hawken, Chandy Ellimoottil, Zachary Montgomery, Zaojun Ye, David Miller, Ann Arbor, MI DO HOSPITAL RANKINGS CORRELATE WITH ACTUAL OUTCOMES? Joel Durinka*, Philadelphia, PA, Afshin Parsikia, Ryan Flynn, Jorge Ortiz, Toledo, OH BASELINE CLINICAL CARACHTERISTICS AND PATHOLOGICAL OUTCOMES FOLLOWING ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP): A POPULATION BASED PROSPECTIVE SERIES Lorenzo Tosco*, Leuven, Belgium, Filip Ameye, Ghent, Belgium, Simone Albisinni, Brussels, Belgium, Peter Dekuyper, Ghent, Belgium, David Jegou, Thierry Quackels, Thierry Roumeguere, Brussels, Belgium, Ben Van Cleynenbreugel, Leuven, Belgium, Nancy Van Damme, Liesbet Van Eycken, Brussels, Belgium, Steven Joniau, Leuven, Belgium MP9-17 UTILIZATION AND OUTCOMES OF INPATIENT SURGERY AT SAFETY-NET HOSPITALS Lindsey Herrel*, Zaojun Ye, David Miller, Ann Arbor, MI Friday, May 15, 2015 Moderated Poster Session 10 SEXUAL FUNCTION/DYSFUNCTION/ANDROLOGY: PENIS/TESTIS/URETHRA: MALIGNANT DISEASE Room New Orleans Morial Convention Center Moderator: Jeffrey Holzbeierlein NUMBER TITLE NUMBER TITLE MP10-01 SURGICAL MANAGEMENT OF PATIENTS WITH ADVANCED GERM CELL TUMORS FOLLOWING SALVAGE CHEMOTHERAPY WITH PACLITAXEL, IFOSFAMIDE AND CISPLATIN (TIP) OR PACLITAXEL PLUS IFOSFAMIDE FOLLOWED BY HIGH DOSE CARBOPLATIN AND ETOPOSIDE WITH STEM CELL SUPPORT (TICE): MEM Mariam Imnadze*, Darren Feldman, Brett Carver, George Bosl, Robert Motzer, Dean Bajorin, Joel Sheinfeld, New York, NY MP10-02 RETROPERITONEAL LYMPH NODE DISSECTION AS FIRST-LINE TREATMENT FOR NODE POSITIVE SEMINOMA Brian Hu*, Swar Shah, Sepehr Shojaei, Siamak Daneshmand, Los Angeles, CA 3:30 pm - 5:30 pm MP10-03 MODIFICATION OF N STAGING SYSTEMS FOR PENILE CANCER A A BE MORE PRECISELY PREDICATIVE OF PROGNOSIS Kai Yao, Zaishang Li, guangzhou, China, People s Republic of, Peng Chen, Urumchi, China, People s Republic of, Fangjian Zhou, Zike Qin, Zhuowei Liu, Yonghong Li, Pei Dong, Hui Han*, guangzhou, China, People s Republic of MP10-04 LONG-TERM INCIDENCE OF METACHRONOUS CONTRALATERAL TESTIS CANCER: IMPACT OF HISTOLOGY Farhang Rabbani*, Susan MacDonald, Bronx, NY MP10-05 CLINICAL OUTCOME OF PATIENTS WITH FIBROSIS/NECROSIS AT POST- CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION FOR ADVANCED GERM CELL TUMORS Roy Mano*, Brett Carver, George Bosl, Robert Motzer, Dean Bajorin, Darren Feldman, Joel Sheinfeld, New York, NY 46

59 MP10-06 SURGICAL TREATMENT OF PRIMARY DISEASE FOR PENILE SQUAMOUS CELL CARCINOMA: A SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) DATABASE ANALYSIS Gu Weijie*, Zhu Yao, Ye Dingwei, Shanghai, China, People s Republic of MP10-07 CURRENT TRENDS IN IMAGING PENILE CANCER FOR DIAGNOSIS AND SURVEILLANCE Aaron Benham*, Jonathan Heinlein, Nabil Bissada, Daniel Culkin, Oklahoma City, OK, Sean Elliott, Oluwakayode Adejoro, Minneapolis, MN, Joel Slaton, Oklahoma City, OK MP10-08 MODIFIED TEMPLATE RETROPERITONEAL LYMPH NODE DISSECTION FOR POSTCHEMOTHERAPY RESIDUAL TUMOR: A LONG TERM UPDATE Jane S. Cho*, Hristos Kaimakliotis, Timothy A. Masterson, K. Clint Cary, Richard Bihrle, Richard S. Foster, Indianapolis, IN MP10-09 CONTEMPORARY USE OF RETROPERITONEAL LYMPH NODE DISSECTION FOR STAGE II NON- SEMINOMATOUS GERM CELL TUMOR: A POPULATION-BASED STUDY USING SURVEILLANCE EPIDEMIOLOGY AND END RESULTS Eugene Pietzak, III*, Jeremy Bonzo, S. Bruce Malkowicz, Alan Wein, Thomas Guzzo, Philadelphia, PA MP10-10 OUTCOMES OF PROGRESSION ON SURVEILLANCE FOR CLINICAL STAGE I NONSEMINOMATOUS GERM CELL TUMOURS Madhur Nayan*, Michael AS Jewett, Lynn Anson-Cartwright, Philippe Bedard, Malcolm Moore, Peter Chung, Padraig Warde, Joan Sweet, Martin O Malley, Robert J Hamilton, Toronto, Canada MP10-11 PELVIC EXTRANODAL EXTENSION LEADS TO WORSE OUTCOMES IN PENILE CANCER PATIENTS WITH POSITIVE PELVIC LYMPH NODES AND IS ASSOCIATED WITH A SURVIVAL BENEFIT AFTER ADJUVANT CHEMOTHERAPY: A MULTI-INSTITUTIONAL STUDY Pranav Sharma*, Tampa, FL, Rosa Djajadiningrat, Amsterdam, Netherlands, Kamran Zargar-Shoshtari, Tampa, FL, Mario Catanzaro, Milan, Italy, Yao Zhu, Shanghai, China, People s Republic of, Nicola Nicolai, Milan, Italy, Simon Horenblas, Amsterdam, Netherlands, Philippe Spiess, Tampa, FL MP10-12 BILATERAL TESTICULAR GERM CELL TUMORS IN THE ERA OF MULTIMODAL THERAPY Ryan Kopp*, Michael Chevinsky, Melanie Bernstein, George Bosl, Robert Motzer, Dean Bajorin, Darren Feldman, Brett Carver, Joel Sheinfeld, New York, NY MP10-13 CLINICAL OUTCOME OF RETROPERITONEAL LYMPH NODE DISSECTION AFTER CHEMOTHERAPY IN PATIENTS WITH PURE EMBRYONAL CARCINOMA IN THE ORCHIECTOMY SPECIMEN Catherine Dowling*, Melissa Assel, John Musser, Joshua Meeks, Dan Sjoberg, George Bosl, Robert Motzer, Dean Bajorin, Darren Feldman, Brett Carver, Joel Sheinfeld, New York, NY MP10-14 EFFICACY AND TOLERABILITY OF TIP (PACLITAXEL, IFOSFAMIDE AND CISPLATIN) INCORPORATED INTO INDUCTION CHEMOTHERAPY FOR PATIENTS WITH INTERMEDIATE- OR POOR-RISK METASTATIC GERM CELL TUMORS Masatomo Nishikawa*, Hideaki Miyake, Masato Fujisawa, Kobe, Japan MP10-15 PATTERNS OF CARE AND SURVIVAL OUTCOMES FOR MALIGNANT SEX CORD STROMAL TESTICULAR CANCER: RESULTS FROM THE NATIONAL CANCER DATA BASE John S. Banerji*, Katherine Odem-Davis, Erika M. Wolff, Khanh N. Pham, Craig R. Nichols, Christopher R. Porter, Seattle, WA MP10-16 SUBSTITUTION URETHROPLASTY FOR TREATMENT OF DISTAL URETHRAL CARCINOMA AND CARCINOMA IN SITU Meghana Kulkarni*, Mahua Sahu, Alberto Coscione, Davendra Sharma, Benjamin Ayres, Nicholas Watkin, London, United Kingdom MP10-17 MANAGEMENT OF CHYLOUS LEAK AFTER RETROPERITONEAL LYMPH NODE DISSECTION FOR ADVANCED TESTICULAR CANCER Jane S. Cho*, Hristos Kaimakliotis, K. Clint Cary, Timothy A. Masterson, Richard Bihrle, Richard S. Foster, Indianapolis, IN MP10-18 PITUITARY-LEYDIG AXIS DYSFUNCTION PRIOR TO ORCHIECTOMY IN TESTICULAR GERM CELL CANCER Claire Sadler, Daniel Shin, Kenneth Faber, Hooman Djaladat, Siamak Daneshmand*, Los Angeles, CA MP10-19 OUTCOMES IN PATIENTS WITH VIABLE CANCER AT POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION John Musser*, Catherine Dowling, New York, NY, Shilajit Kundu, Chicago, IL, Brett Carver, George Bosl, Dean Bajorin, Darren Feldman, Robert Motzer, Joel Sheinfeld, New York, NY FRIDAY *Presenting author 47

60 Friday, May 15, 2015 Moderated Poster Session 11 IMAGING/RADIOLOGY: URORADIOLOGY II Room New Orleans Morial Convention Center Moderators: Christopher Porter and Art Rastinehad 3:30 pm - 5:30 pm NUMBER TITLE NUMBER TITLE MP11-01 VALUE OF ULTRASOUND IN THE DIAGNOSIS OF URETERIC STONE A SINGLE INSTITUTION STUDY arun panackal*, santhosh kumar, muscat, Oman MP11-02 STONE DIMENSIONS, SKIN-TO-STONE DISTANCE, HOUNSFIELD UNIT DENSITY, AND VISCERAL FAT AREA ARE PRESERVED EVEN WITH ULTRA-LOW DOSE COMPUTERIZED TOMOGRAPHY IN STONE PATIENTS Jennifer E. Heckman*, Meghan G. Lubner, Richard Bruce, Madison, WI, Ronald M. Summers, Jiamin Liu, Bethesda, MD, Perry J. Pickhardt, Stephen Y. Nakada, Madison, WI MP11-03 CONTEMPORARY IMAGING PRACTICE PATTERNS AFTER URETEROSCOPY FOR STONE DISEASE Mohamed Omar, Hemant Chaparala, Manoj Monga, Sri Sivalingam*, Cleveland, OH MP11-04 NEW INSIGHTS INTO THE GENESIS AND ADHERENCE OF URINARY CALCULI USING HIGH RESOLUTION MICROSCOPY Sunita Ho*, San Francisco, CA, Frances Allen, Andrew Minor, Berkeley, CA, Sabra Djomehri, Ling Chen, Thomas Chi, Krishna Ramaswamy, Marshall Stoller, San Francisco, CA MP11-05 MR-US FUSION BIOPSY: IMPORTANCE OF BOTH SYSTEMATIC AND TARGETED SAMPLING TO DIAGNOSE PROSTATE CANCER Christopher Filson*, Daniel Margolis, Jiaoti Huang, Shyam Natarajan, Patricia Lieu, Frederick Dorey, Leonard Marks, Los Angeles, CA MP11-06 RESULTS OF TARGETED BIOPSY WITH REAL-TIME BALLOON INFLATION ELASTOGRAPHY OF PROSTATE Masahiro Sumura*, Kouhei Ogawa, Taichi Nagami, Haruki Anjiki, Chiaki Koike, Naoko Arichi, Yozo Mitsui, Shigenobu Nakamura, Takeo Hiraoka, Hiroaki Yasumoto, Shinji Hara, Takeshi Yoshizako, Hiroaki Shiina, Izumo, Shimane, Japan MP11-07 T2-WEIGHTED/DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING AS A NOVEL SCORING MODE FOR THE EARLY DETECTION OF PROSTATE CANCER Xuan Wang*, Ming Liu, Jianye Wang, Min Chen, Ben Wan, Chunmei Li, Gang Wan, Wei Zhang, Yong Zhang, Beijing, China, People s Republic of, Yuanyuan Zhang, Winston-Salem, NC MP11-08 MANUALLY CONTROLLED TARGETED BIOPSY WITH REAL-TIME FUSION IMAGE OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGE AND TRANSRECTAL ULTRASOUND IMAGE FOR THE DIAGNOSIS OF PROSTATE CANCER BASED ON PROSTATE IMAGE- REPORTING AND DATA SYSTEM Sunao Shoji*, Shinichiro Hiraiwa, Akio Hashimoto, Kazunobu Hashida, Jun Endo, Tetsuro Tomonaga, Mayura Nakano, Takuma Tajiri, Hachioji, Japan, Toshiro Terachi, Shimokasuya, Japan, Toyoaki Uchida, Hachioji, Japan MP11-09 TRANSPERINEAL TEMPLATE-GUIDED PROSTATE BIOPSY IN PATIENTS INITIATING ACTIVE SURVEILLANCE: A MULTI-INSTITUTIONAL COMPARISON Khanh Pham*, Katherine Odem-Davis, Claudio Jeldres, Christopher Porter, Seattle, WA, John Wei, Todd Morgan, Ann Arbor, MI MP11-10 UTILITY OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING (MPMRI) IN THE EVALUATION OF MEN FOR ACTIVE SURVEILLANCE OF PROSTATE CANCER Simpa Salami*, Anna Marie Sonstegard, Oksana Yaskiv, New Hyde Park, NY, Baris Turkbey, Bethesda, MD, Robert Villani, Eran Ben-Levi, Ardeshir Rastinehad, New Hyde Park, NY MP11-11 SARCOPENIA AS A PROGNOSTIC BIOMARKER OF METASTATIC RENAL CELL CARCINOMA: ITS EFFECT ON SURVIVAL BENEFIT FROM CYTOREDUCTIVE NEPHRECTOMY Hiroshi Fukushima*, Fumitaka Koga, Yasukazu Nakanishi, Kenichi Tobisu, Tokyo, Japan MP11-12 DEVELOPMENT AND VALIDATION OF A NOVEL PREDICTION MODEL FOR FAT- POOR ANGIOMYOLIPOMA IN SMALL RENAL MASSES BASED ON RADIOLOGICAL AND CLINICAL FEATURES Hajime Tanaka*, Yasuhisa Fujii, Masaya Ito, Manabu Tatokoro, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Junji Yonese, Kazunori Kihara, Tokyo, Japan MP11-13 PREDICTORS OF VOLUME LOSS AFTER ROBOTIC PARTIAL NEPHRECTOMY: INFLUENCE OF TUMOR LOCATION BASED ON VASCULAR ANATOMY Clinton D Bahler*, Kevin J Flynn, David Y Yang, Hitesh Dube, Chandru P Sundaram, Indianapolis, IN 48

61 MP11-14 QUANTITATIVE PERFUSION MEASUREMENTS IN RENAL MASSES WITH ASL AND DCE MRI AT 3T CORRELATE WITH MICROVASCULAR DENSITY AT HISTOPATHOLOGY Yue Zhang, Payal Kapur, Qing Yuan, Ananth Madhuranthakam, Dallas, TX, Ingrid Carvo, Sabina Signoretti, Boston, MA, Ivan Dimitrov, Yin Xi, Katherine Wicks, Vitaly Margulis, Jeffrey Cadeddu, Aaron Lay, James Brugarolas, Ivan Pedrosa*, Dallas, TX MP11-15 DEVELOPMENT OF A TARGETED GADOLINIUM CONTRAST FOR NONINVASIVE OF MAGNETIC RESONANCE (MR) IMAGING OF NON- MUSCLE INVASIVE BLADDER CANCER Joel Slaton*, Carole Davis, Nataliya Smith, Debbie Saunders, Paul Hauser, Robert Hurst, Rheal Towner, Oklahoma City, OK MP11-16 USE OF 18 F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (FDG PET/CT) TO PREDICT VIABLE LYMPH NODE METASTASES FOLLOWING PREOPERATIVE CHEMOTHERAPY FOR MUSCLE INVASIVE AND ADVANCED-STAGE BLADDER CANCER Byron Lee*, Aditya Bagrodia, Timothy Donahue, Guido Dalbagni, Jonathan Rosenberg, Dean Bajorin, Hebert Alberto Vargas, Bernard Bochner, New York, NY MP11-17 USING TRANSLABIAL ULTRASOUND AS AN EFFECTIVE TOOL TO VISUALIZE MESH EROSION INTO THE URETHRA AND BLADDER Seth A. Cohen*, Karoly A. Viragh, Leah Y. Nakamura, Anne L. Ackerman, Patkawat Ramart, Diana C. Kang, Judy M. Choi, Ja- Hong Kim, Steven S. Raman, Shlomo Raz, Los Angeles, CA MP D-ULTRASOUND ORIENTED ADJUSTMENT FOR SPHINCTERIC URETHRA PRIOR TO VELOCITY-FLOW EVALUATION USING DOPPLER ULTRASONOGRPAHY Hideo Ozawa*, Okayama, Japan, Michael Chancellor, Royal Oak, MI, Atsushi Nagai, Kurashiki, Japan, Hiromi Kumon, Okayama, Japan MP11-19 MAGNETIC RESONANCE VISIBILITY OF IRON LABELED MESENCHYMAL STEM CELLS FOR ENDOSCOPIC INJECTION INTO THE PORCINE URETHRAL SPHINCTER Susanne Will, Tübingen, Germany, Karl- Dietrich Sievert*, Lübeck, Germany, Martin Vaegler, Petros Martirosian, Frank Eibofner, Fritz Schick, Jörg Schmehl, Gerd Grözinger, Rüdiger Bantleon, Konstantin Nikolaou, Ulrich Kramer, Tübingen, Germany MP11-20 DIFFUSION TENSOR IMAGING OF THE NEURONAL NETWORK INNERVATING THE LOWER URINARY TRACT Jens Wöllner*, Peter Zweers, Jörg Krebs, Juergen Pannek, Nottwil, Switzerland FRIDAY Friday, May 15, 2015 Moderated Poster Session 12 URODYNAMICS/INCONTINENCE/FEMALE UROLOGY: BASIC RESEARCH II Room New Orleans Morial Convention Center Moderators: Larissa Rodriguez and Henry Lai 3:30 pm - 5:30 pm NUMBER TITLE NUMBER TITLE MP12-01 SPINAL METABOTROPIC GLUTAMATE RECEPTOR 5 INVOLVEMENT IN PUDENDAL INHIBITION OF NOCICEPTIVE BLADDER REFLEX IN CATS Jeremy Reese*, Marc Rogers, Zhiying Xiao, Bing Shen, Jicheng Wang, Zayed Schwen, James Roppolo, William DeGroat, Tai Changfeng, Pittsburgh, PA MP12-02 TRANSCRIPTIONAL REGULATION OF CORTICOTROPIN RELEASING FACTOR GENE EXPRESSION Lizath Aguiniga*, Anthony Schaeffer, David Klumpp, Chicago, IL MP12-03 FUNCTIONAL CHANGES OF THE BLADDER IN VIVO IN MICE LACKING TRANSIENT RECEPTOR POTENTIAL MELASTAIN 2 (TRPM2) CHANNELS Jun Kamei*, Naoki Aizawa, Tokyo, Japan, Takayuki Nakagawa, Kyoto, Japan, Hiroki Ito, Rino Sugiyama, Yoshiyuki Akiyama, Koji Ichihara, Tokyo, Japan, Shuji Kaneko, Kyoto, Japan, Yukio Homma, Yasuhiko Igawa, Tokyo, Japan *Presenting author 49

62 MP12-04 DETRUSOR OVERACTIVITY INDUCED BY CEREBRAL INFARCTION MAY BE ASSOCIATED WITH ENHANCED ACTIVITY OF RHO-KINASE IN THE BLADDER Hironobu Akino*, Keiko Nagase, Xinmin Zha, Yoshitaka Aoki, Hideaki Ito, Nobuyuki Oyama, Osamu Yokoyama, Fukui, Japan MP12-05 LUMBAR TO SACRAL NERVE REROUTING TO RESTORE VOIDING FUNCTION IN A FELINE SPINAL CORD INJURY MODEL Jacques Corcos*, Ornella Lam Van Ba, Romain Caremel, Shachar Aharony, Oleg Loutochin, Montreal, Canada, Mary Barbe, Philadelphia, PA, Line Jacques, Montreal, Canada, Gerald F. Tuite, Saint Petersburg, FL, Michael R. Ruggieri, Sr, Philadelphia, PA MP12-06 SUPRASPINAL ACTIVITY TO AUTOMATED, REPETITIVE BLADDER FILLING - AN FMRI STUDY Matthias Walter*, Lorenz Leitner, Lars Michels, Spyros Kollias, Thomas M. Kessler, Ulrich Mehnert, Zürich, Switzerland MP12-07 THE ROLE OF GLYCINE IN PUDENDAL NERVE STIMULATION AND BLADDER OVERACTIVITY Marc J. Rogers*, Jeremy N. Reese, Zhiying Xiao, Bing Shen, Jicheng Wang, Zeyad Schwen, James R. Roppolo, William C. de Groat, Changfeng Tai, Pittsburgh, PA MP12-08 NOXIOUS ELECTRICAL STIMULATION OF PELVIC FLOOR INDUCES TRANSIENT DYSFUNCTIONAL VOIDING IN RABBITS Amy D. Dobberfuhl*, Sara Spettel, Catherine Schuler, Robert M. Levin, Andrew H. Dubin, Elise J.B. De, Albany, NY MP12-09 A NOVEL INTRACEREBRAL HEMORRHAGE-INDUCED RAT MODEL OF NEUROGENIC VOIDING DYSFUNCTION: ANALYSIS OF LOWER URINARY TRACT FUNCTION Young Sam Cho*, Kwan Joong Joo, Heung Jae Park, Chil Hun Kwon, Seoul, Korea, Republic of MP12-10 WHITE AND GRAY MATTER DAMAGE ARE RELATED TO URGE INCONTINENCE Becky Clarkson*, Stasa Tadic, Neil Resnick, Derek Griffiths, Pittsburgh, PA MP12-11 URODYNAMIC INVESTIGATION: A SENSIBLE TOOL TO DEFINE NORMAL LOWER URINARY TRACT FUNCTION? Lorenz Leitner*, Matthias Walter, Ulrich Mehnert, Thomas M. Kessler, Zürich, Switzerland MP12-12 ENHANCED SPINAL GLYCINERGIC SYSTEM BY GLYCINE TRANSPORTER TYPE 2 (GLYT2) INHIBITION REDUCES NEUROGENIC DETRUSOR OVERACTIVITY IN RATS WITH SPINAL CORD INJURY Tsuyoshi Yoshizawa*, Satoru Yoshikawa, Hiroki Okada, Pittsburgh, PA, Satoru Takahashi, Tokyo, Japan, Naoki Yoshimura, Pittsburgh, PA MP12-13 COITAL URINARY INCONTINENCE IN RATS José Luis Palacios*, Margarita Juárez, Raúl Juárez, Alfonso Medel, Yolanda Cruz, Tlaxcala, Mexico MP12-14 INVESTIGATIONS INTO THE MECHANISTIC LINK BETWEEN ELEVATED URINE BDNF LEVELS AND EXPRESSION OF CONNEXIN 43 IN BLADDER BIOPSY OF OVERACTIVE BLADDER PATIENTS Mahendra Kashyap*, Subrata Pore, Willam C Degroat, Christopher J Chermansky, Naoki Yoshimura, Pradeep Tyagi, Pittsburgh, PA MP12-15 ACUTE LENGTH ADAPTATION AND ADJUSTABLE PRELOAD TENSION IN THE HUMAN DETRUSOR: THE CONCEPT OF A DETRUSOR TENSION SENSOR Andrew Colhoun*, John Speich, MaryEllen Dolat, Joseph Habibi, R. Wayne Barbee, Paul Ratz, Adam Klausner, Richmond, VA MP12-16 DYNAMIC COMPLIANCE: A NOVEL METRIC FOR THE URODYNAMIC FILLING PHASE Andrew Colhoun*, John Speich, Jay Sulek, Paul Ratz, R. Wayne Barbee, J. Tyler Roseman, Adam Klausner, Richmond, VA MP12-17 PROTECTIVE EFFECT OF A RHO-KINASE INHIBITOR ON CHRONIC ISCHEMIA- RELATED BLADDER DYSFUNCTION Hidenori Akaihata*, Fukushima, Japan, Masanori Nomiya, Koriyama, Japan, Nobuhiro Haga, Nobuhiro Kushida, Kei Ishibashi, Ken Aikawa, Fukushima, Japan, Osamu Yamaguchi, Koriyama, Japan, Yoshiyuki Kojima, Fukushima, Japan MP12-18 EFFECTS OF LIPOSOME-BASED LOCAL SUPPRESSION OF NERVE GROWTH FACTOR IN THE BLADDER ON AUTONOMIC DYSREFLEXIA DURING URINARY BLADDER DISTENTION IN RATS WITH SPINAL CORD INJURY Katsumi Kadekawa*, Tsuyoshi Yoshizawa, Pradeep Yyagi, Pittsburgh, PA, Kimio Sugaya, Okinawa, Japan, Naoki Yoshimura, Pittsburgh, PA MP12-19 SPONTANEOUS MICTURITION BEHAVIOR AND CYSTOMETRIC EVALUATION OF BLADDER FUNCTION IN P2X7 RECEPTOR DEFICIENT MICE Hiromitsu Negoro*, Kyoto, Japan, Nuan Cui, Bronx, NY, Osamu Ogawa, Kyoto, Japan, Sylvia Suadicani, Bronx, NY MP12-20 SUPRASPINAL ACTIVITY TO BLADDER COLD SENSATION IN HEALTHY SUBJECTS - AN FMRI STUDY Matthias Walter*, Lorenz Leitner, Lars Michels, Spyros Kollias, Thomas M. Kessler, Ulrich Mehnert, Zürich, Switzerland 50

63 Friday, May 15, 2015 Moderated Poster Session 13 BENIGN PROSTATIC HYPERPLASIA: SURGICAL THERAPY & NEW TECHNOLOGY III Room New Orleans Morial Convention Center Moderators: Andreas Gross and Giuseppe Carrieri 3:30 pm - 5:30 pm FRIDAY NUMBER TITLE NUMBER TITLE MP13-01 PATIENT S PERCEPTIONS ABOUT EJACULATORY VOLUME CHANGES AFTER HOLMIUM LASER ENUCLEATION OF THE PROSTATE Jae-Seung Paick, Hyung Suk Kim*, Seoul, Korea, Republic of, Min Chul Cho, Young Ju Lee, Myong Kim, Min Yong Kang, Jeong Kwon Kim, Ju Hyun Park, Seung Beom Ha, Seoul, Korea, Republic of MP13-02 IMPACT OF PROSTATE VOLUME ON SURGICAL EFFECTIVENESS AND SAFETY WITH XPS GREENLIGHT LASER. OUTCOMES OF A MULTICENTER RETROSPECTIVE STUDY Mahmood A. Hai*, Westland, MI, Ricardo R. Gonzalez, Houston, TX, Gregg R. Eure, Virginia Beach, VA, Lewis S. Kriteman, Roswell, GA, Kevin C. Zorn, Montreal, Canada MP13-03 TOWARDS OPTIMIZING PROSTATE TISSUE RETRIEVAL AFTER HOLMIUM LASER ENUCLEATION OF THE PROSTATE: PROSPECTIVE ASSESSMENT OF DIFFERENT APPROACHES Ahmed Elshal*, Ramy Mekkawy, Ahmed EL- Assmy, Ahmed EL-Nahas, Mansoura, Egypt MP13-04 IS POWER EVERYTHING IN HOLMIUM LASER ENUCLEATION OF THE PROSTATE SURGERY? THE FIRST REPORTED 50 WATT HOLMIUM LASER ENUCLEATION OF THE PROSTATE SERIES Farooq Khan*, Mohamed Asad Saleemi, Sanjeev Taneja, Asher Alam, Luton, United Kingdom, Ian Nunney, Norwich, United Kingdom, Michal Sut, Tevita Futo Aho, Cambridge, United Kingdom MP13-05 PREDICTORS OF REOPERATION AFTER HOLMIUM LASER ENUCLEATION OF THE PROSTATE FOR MANAGEMENT OF SYMPTOMATIC BENIGN PROSTATE HYPERPLASIA Mohamed Elkoushy*, Ahmed Elshal, Mostafa Elhilali, Montreal, Canada MP13-06 IS THE CAPSULAR PERFORATION A COMPLICATION OF HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP)? José Placer*, Carlos Salvador, David Lorente, Ana Celma, Jacques Planas, Enrique Trilla, Miguel Ángel López Pacios, Christian Isalt, Lucas Regis, Pol Servián, Juan Morote, Barcelona, Spain MP13-07 CAN MEN WITH BOTH BENIGN PROSTATIC OBSTRUCTION AND BLADDER UNDERACTIVITY BENEFIT FROM HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) MORE THAN FROM PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE (PVP)? Min Chul Cho*, Goyang-si, Korea, Republic of, Seung Beom Ha, Ju Hyun Park, Sung Yong Cho, Seoul, Korea, Republic of, Seung Baik, Gwangju, Korea, Republic of, Kwang Ho You, Gwangmyeong, Korea, Republic of, Ja Hyeon Ku, Seung-June Oh, Soo Woong Kim, Seoul, Korea, Republic of, Kwang Soo Lee, Goyang-si, Korea, Republic of, Jae- Seung Paick, Seoul, Korea, Republic of MP13-08 PROSPECTIVE EVALUATION OF LASER PROSTATECTOMY USING A NEW 1.9 M THULIUM LASER: 1 YEAR FOLLOW-UP David Zimmermann*, Patrick Honeck, Thomas Knoll, Gunnar Wendt-Nordahl, Sindelfingen, Germany MP13-09 DOES 5 -REDUCTASE INHIBITIOR AFFECT THE EFFICIENCY OF THULIUM: YAG (REVOLIX ) VAPOENUCLEATION OF THE PROSTATE FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA? Jae Il Chung*, Jae Seung Chung, Won IK Seo, Pil Moon Kang, Jang Ho Yoon, Wan Seok Kim, Dong Il Kang, Kweon Sik Min, Seong Cheol Kim, Cheol Kyu Oh, Sang Hyun Park, Seok San Park, Busan, Korea, Republic of MP13-10 THULIUM VAPOENUCLEATION OF THE PROSTATE (THUVEP): LONG-TERM RESULTS DURING 6-YEAR FOLLOW-UP OF 500 PROCEDURES Christopher Netsch*, Daniela Jakobler, Thorsten Bach, Andreas J. Gross, Hamburg, Germany MP13-11 THULIUM VAPOENUCLEATION OF THE PROSTATE (THUVEP) FOR PROSTATES LARGER THAN 80ML: LONG-TERM DURABILITY OF THE PROCEDURE Christopher Netsch*, Daniela Jakobler, Thorsten Bach, Andreas J. Gross, Hamburg, Germany MP13-12 AGE-STRATIFIED OUTCOMES OF THULIUM VAPOENUCLEATION OF THE PROSTATE (THUVEP) Christopher Netsch*, Daniela Jakobler, Thorsten Bach, Andreas J. Gross, Hamburg, Germany *Presenting author 51

64 MP13-13 FUNCTIONAL RESULTS AFTER PHOTOVAPORISATION OF THE PROSTATE (PVP) WITH GREENLIGHT XPS LASER: A PROSPECTIVE MULTI- INSTITUTIONAL STUDY Maxime Thoulouzan*, Romain Huet, Romain Mathieu, Karim Bensalah, Rennes, France, Jehanne Calves, Brest, France, Pierre Coeurdacier, Cesson-Sévigné, France, Luc Corbel, Emmanuel Della Negra, Saint-Brieuc, France, Alexandre Fourcade, Brest, France, Benoit Gires, Vivien Grafeille, Rennes, France, Marie-Aimée Perrouin-Verbe, Sophie Serey-Eiffel, Antoine Valeri, Brest, France, Grégory Verhoest, Sébastien Vincendeau, Rennes, France, Georges Fournier, Brest, France MP W LBO LASER VAPORIZATION OF THE PROSTATE FOR BENIGN PROSTATIC HYPERPLASIA IN HIGH-RISK PATIENTS Pierre-Alain Hueber*, Marc Nicolas Bienz, Roger Valdivieso, Hugo Lavigueur-Blouin, Montreal, Canada, Vincent Misrai, Toulouse, France, Matthew Rutman, Alexis Te, Bilal Chughtai, New York, NY, Neil Barber, Amr Emara, Frimley, Surrey, United Kingdom, Ravi Munver, Hackensack, NJ, Naeem Bhojani, Kevin Zorn, Montreal, Canada MP13-15 DO ANTIPLATELET AND ANTICOAGULANT INCREASE RISK OF HAEMORRHAGIC COMPLICATIONS IN PHOTOVAPORIZATION OF PROSTATE BY GREENLIGHT LASER Pradère Benjamin*, Tours, France, Peyronnet Benoit, Rennes, France, Brichart Nicolas, Bruyère Franck, Tours, France MP13-16 EVALUATION OF SAFETY, EFFICIENCY AND SURGICAL OUTCOMES BETWEEN GREENLIGHT 180W-XPS TECHNIQUES: COMPARISON OF PURE PHOTO- VAPORIZATION AND VAPOR-INCISION TECHNIQUES Kevin C. Zorn*, Montreal, Canada, Ricardo R. Gonzalez, Houston, TX, Greg R Eure, Virginia Beach, VA, Lewis S. Kriteman, Roswell, GA, Pierre-Alain Hueber, Abdullah Alenizi, Marc Bienz, Khaled ElHosni, Malek Meskawi, Montreal, Canada, Mahmood A. Hai, Westland, MI MP13-17 EN BLOC ENUCLEATION OF THE PROSTATE USING A SURGICAL 532-NM LASER (GREENLEP) TECHNIQUE: INITIAL RESULTS Vincent Misrai, Julien Guillotreau*, Benoit Bordier, Toulouse, France, Henry Woo, Sydney, Australia, Fernando Gomez-Sancha, Madrid, Spain MP13-18 GREENLIGHT XPS PHOTOVAPORIZATION FOR LARGE PROSTATIC ADENOMAS (>80 ML): A PROSPECTIVE MULTI- INSTITUTIONAL STUDY Maxime Thoulouzan*, Romain Huet, Romain Mathieu, Karim Bensalah, Rennes, France, Jehanne Calves, Brest, France, Pierre Coeurdacier, Cesson-Sévigné, France, Luc Corbel, Emmanuel Della Negra, Saint-Brieuc, France, Alexandre Fourcade, Brest, France, Benoit Gires, Vivien Grafeille, Rennes, France, Marie-Aimée Perrouin-Verbe, Sophie Serey-Eiffel, Antoine Valeri, Brest, France, Grégory Verhoest, Sébastien Vincendeau, Rennes, France, Georges Fournier, Brest, France MP13-19 THE LEARNING CURVE OF MULTIPLE OPERATORS FOR LASER ENUCLEATION OF PROSTATE IN TREATMENT OF BENIGN PROSTATE OBSTRUCTION Jonathan Lopater*, Pierre Etienne Theveniaud, Nauman Zafar, Walid Massoud, Frederic Girard, Mohammed Fennouri, Laurent Lamy, Hervé Baumert, Paris, France MP MONTH EVALUATION BY VALIDATED QUESTIONNAIRES OF VOIDING AND STORAGE SYMPTOMS AFTER SURGERY FOR BLADDER OUTLET OBSTRUCTION (PVP XPS 180W, HOLEP, TURP) Borja Lopez*, Carlos Capitán, Isabel M. Jiménez-Valladolid, Virginia Hernández, Enrique De la Peña, Elia Pérez-Fernández, Carlos Llorente, Madrid, Spain 52

65 Friday, May 15, 2015 Podium Session 6 PROSTATE CANCER: EPIDEMIOLOGY & NATURAL HISTORY II Room New Orleans Morial Convention Center Moderators: Steven Joniau and Christopher Kane 3:30 pm - 5:30 pm FRIDAY TIME NUMBER TITLE TIME NUMBER TITLE 3:30 PD6-01 ASPIRIN, NSAID AND RISK OF HIGH- GRADE PROSTATE CANCER: RESULTS FROM THE REDUCE STUDY Adriana C. Vidal*, Lauren E. Howard, Durham, NC, Daniel M. Moreira, Rochester, MN, Ramiro Castro-Santamaria, King of Prussia, PA, Gerald L. Andriole, St. Louis, MO, Stephen J. Freedland, Durham, NC 3:40 PD ALPHA REDUCTASE INHIBITOR USE AND PROSTATE CANCER SURVIVAL IN THE FINNISH PROSTATE CANCER SCREENING TRIAL Teemu Murtola*, Elina Karppa, Tampere, Finland, Kimmo Taari, Helsinki, Finland, Teuvo Tammela, Anssi Auvinen, Tampere, Finland 3:50 PD6-03 METFORMIN USE PREDICTS AN OVERALL SURVIVAL ADVANTAGE IN DIABETIC VETERANS WITH PROSTATE CANCER Daniel Reznicek*, Elena Klyushnenkova, Richard Alexander, Baltimore, MD 4:00 PD6-04 A PROSPECTIVE, LONGITUDINAL ACTIVE SURVEILLANCE PROGRAM FOR FAVORABLE-RISK PROSTATE CANCER: LONG TERM OUTCOMES Jeffrey Tosoian*, Mufaddal Mamawala, Jonathan Epstein, Patricia Landis, Sacha Wolf, Bruce Trock, H. Ballentine Carter, Baltimore, MD 4:10 PD6-05 CHANGE IN PREDICTED PROGNOSIS AFTER RADICAL PROSTATECTOMY DURING FOLLOW-UP IN AN ACTIVE SURVEILLANCE COHORT John B. Eifler, Jr.*, Daren Diiorio, Chaochen You, Nashville, TN, Vidhush Yarlagadda, Birmingham, AL, David F. Penson, Joseph A. Smith, Jr., Sam Chang, Nashville, TN, Michael S. Cookson, Oklahoma City, OK, Daniel A. Barocas, Nashville, TN 4:20 PD6-06 NATIONAL PROSTATE CANCER PRACTICE TRENDS: EVOLVING TOWARD EVIDENCE-BASED PRACTICE ACROSS RISK STRATA Matthew Cooperberg*, Peter Carroll, San Francisco, CA 4:40 PD6-08 HOSPITAL READMISSIONS AFTER TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY IN THE VA MEDICAL SYSTEM Mark Garzotto*, James Edwards, Michael Conlin, Portland, OR 4:50 PD6-09 POLYMORPHISMS IN GENES OF THE GLUCOSE- AND ENERGY-METABOLISM PATHWAYS AND PROSTATE CANCER: INTERPLAY WITH METFORMIN Teemu Murtola*, Tiina Wahlfors, Antti Haring, Tampere, Finland, Kimmo Taari, Ulf-Håkan Stenman, Helsinki, Finland, Teuvo Tammela, Tampere, Finland, Johanna Schleutker, Turku, Finland, Anssi Auvinen, Tampere, Finland 5:00 PD6-10 ADVERSE EVENTS AFTER RADICAL PROSTATECTOMY AND CURATIVE RADIOTHERAPY. POPULATION-BASED NATION-WIDE REGISTER STUDY Jón Ö. Friðriksson, Umeå, Sweden, Yasin Folkvaljon, Uppsala, Sweden, Per Nilsson, Lund, Sweden, David Robinson, Jönköping, Sweden, Ingela F. Frank Lissbrant, Gothenburg, Sweden, Behfar Ehdaie*, James A. Eastham, New York, NY, Anders Widmark, Camilla Thellenberg, Pär Stattin, Umeå, Sweden 5:10 PD6-11 OUTCOMES AND COSTS FOLLOWING TREATMENT FOR LOCALLY ADVANCED PROSTATE CANCER: RESULTS FROM SEER-MEDICARE Rachael Sussman*, Washington, DC, Andrew Harbin, Philidelphia, PA, John Lynch, Washington, DC, Jim Hu, Los Angeles, CA, Keith Kowalczyk, Washington, DC 5:20 PD6-12 DIMINISHING RETURNS OF ROBOTIC DIFFUSION: COMPLICATIONS FOLLOWING ROBOT-ASSISTED RADICAL PROSTATECTOMY Jesse Sammon*, Firas Abdollah, Dane Klett, Daniel Pucheril, Akshay Sood, Detroit, MI, Quoc-Dien Trinh, Boston, MA, Mani Menon, Detroit, MI 4:30 PD6-07 EJACULATION FREQUENCY AND RISK OF PROSTATE CANCER: UPDATED RESULTS FROM THE HEALTH PROFESSIONALS FOLLOW-UP STUDY Jennifer Rider*, Kathryn Wilson, Rachel Kelly, Erika Ebot, Edward Giovannucci, Lorelei Mucci, Boston, MA *Presenting author 53

66 NOTES

67 MP Moderated Poster Session, PD Podium Session Saturday, May 16, 2015 SEXUAL MEDICINE SOCIETY OF NORTH AMERICA (SMSNA) Room New Orleans Morial Convention Center 7:00 am - 6:15 pm 7:00 BREAKFAST SYMPOSIUM (BREAKFAST INCLUDED, ROOM , NON-CME) 8:00 (CME PORTION OF PROGRAM BEGINS) PRESIDENTIAL WELCOME Lawrence Hakim 8:05 CME ACTIVITY ANNOUNCEMENTS Run Wang 8:10 SESSION 1 - PEYRONIE S DISEASE MEDICAL THERAPY Moderators: Lawrence Hakim, Brian Christine ISSM LECTURE: COLLAGENASE CLOSTRIDUIM HISTOLYTICUM INJECTION: UPDATE 2015 Wayne Hellstrom 8:25 POINT/COUNTERPOINT: VERAPAMIL INJECTION - STILL A VIABLE OPTION Nelson Bennett, Chad Ritenour 8:45 POINT/COUNTERPOINT: INTERFERON 2B INJECTION - STILL A VIABLE OPTION Andrew McCullough, Mustafa Usta 9:05 Q&A 9:15 SESSION 2 - PEYRONIE S DISEASE SURGICAL THERAPY Moderators: Serge Carrier, LeRoy Jones PLICATION IS THE BEST OPTION Anthony Bella 9:25 EXCISION AND GRAFTING: WHO SHOULD GET IT? Doron Stember 9:35 PENILE IMPLANT SHOULD BE OFFERED EARLY Landon Trost 9:45 LENGTH AND GIRTH RESTORATION WITHOUT GRAFT 9:55 Q&A 10:05 BREAK 10:20 SESSION 3 - JSM, ICSM AND SMSNA Moderators: Run Wang, Luca Incrocci JSM LECTURE: 2015 AND BEYOND- EDITOR- IN-CHIEF S NOTE John Mulhall 10:35 ICSM UPDATE Gerald Brock 10:45 TESTOSTERONE REPLACEMENT PATTERN AMONG SMSNA MEMBERS Hossein Sadeghi-Nejad 10:55 Q&A 11:05 SESSION 4 - PRIAPISM Moderators: Gregory Broderick, Trinity Bivalacqua FROM BENCH RESEARCH TO MEANINGFUL CLINICAL PREVENTION Arthur Burnett 11:15 MEDICAL INTERVENTION Laurence Levine 11:25 SURGICAL THERAPY - THE PREFERRED SHUNT PROCEDURE Justin Parker 11:35 POINT/COUNTERPOINT: EARLY VS LATE IMPLANTS Allen Morey, David Ralph 11:55 Q&A 12:05 LUNCH SYMPOSIUM (LUNCH INCLUDED, ROOM , NON-CME) (CME PORTION OF PROGRAM RESUMES IN ROOM ) 1:05 SESSION 5 - FEMALE SEXUAL DYSFUNCTION Moderators: Susan Goldstein, Noel Kim STATE OF ART IN FEMALE SEXUAL DYSFUNCTION Annamaria Giraldi 1:15 FEMALE SEXUAL DYSFUNCTION: WHAT UROLOGISTS SHOULD KNOW Seth Cohen 1:25 FEMALE SEXUAL DYSFUNCTION: WHAT GYNECOLOGISTS SHOULD KNOW Andrew Goldstein 1:35 Q&A 1:45 SESSION 6-2ND ANNUAL IRA D. SHARLIP LECTURE AND AWARD Moderators: Ira Sharlip, Ronald Lewis 2:00 Q&A THE ROAD FROM UROLOGIST TO SEXUAL MEDICINE SPECIALIST Irwin Goldstein 2:05 SESSION 7 - PENILE IMPLANT Moderators: John Mulcahy, Andrew Kramer POINT/COUNTERPOINT: TWO-PIECE INFLATABLE IMPLANT HAS NO ROLE IN MODERN ERA Steven Wilson, Ashley Tapscott 2:25 SST: PREVENTION, IDENTIFICATION, INTRA- OPERATIVE CORRECTION Rafael Carrion 2:35 POST PENILE IMPLANT REHABILITATION: WHAT AND WHEN Gerard Henry 2:45 CODING FOR REIMBURSEMENT IN PROSTHETIC UROLOGY Edward Karpman 2:55 Q&A SATURDAY *Presenting author 55

68 3:05 BREAK 3:20 SESSION 8 - MALE ORGASM AND EJACULATORY DISORDERS Moderators: Stanley Althof, Christian Nelson PSYCHOTHERAPY FOR DECREASED ORGASM WITH NORMAL HORMONAL PROFILE Michael Perelman 3:30 MEDICAL THERAPY FOR DECREASED ORGASM WITH NORMAL HORMONAL PROFILE Tobias Kohler 3:40 TREATMENT OF PREMATURE EJACULATION: UPDATE 2015 Ricardo Munarriz 3:50 Q&A 4:00 SESSION 9 - TRANSLATIONAL SEXUAL MEDICINE Moderators: Kelvin Davies, Michael DiSanto LOW ENERGY SHOCK WAVE FOR ERECTILE DYSFUNCTION: SCIENCE OR FICTION Tom Lue 4:10 NANOTECHNOLOGY FOR ERECTION DYSFUNCTION: ARE WE READY FOR CLINICAL TRIAL Carol Podlasek 4:20 Q&A 4:25 SESSION 10 - SEXUAL DYSFUNCTION - EXPANDED FIELD Moderators: Chris McMahon, Kwangsung Park ASSOCIATION OF FERTILITY AND SEXUAL DYSFUNCTION Alexander Pastuszak 4:35 SEXUAL DYSFUNCTION ASSOCIATED WITH COLORECTAL CANCER TREATMENT: AN IGNORED CONDITION O. Lenaine Westney 4:45 SEXUAL BEHAVIOR AND PROSTATE CANCER RISK Marie-Elise Parent 4:55 Q&A 5:05 SESSION 11 - SEXUAL MEDICINE FOR LGBT PERSONS Moderators: Alan Shindel, Hui Jiang ADDRESSING SEXUALITY AND SEXUAL DYSFUNCTION IN LGBT PERSONS Mohit Khera 5:15 PROSTATE CANCER AND SEXUALITY IN GAY MEN David Latini 5:25 SEXUAL BEHAVIOR AND DYSFUNCTIONS IN WOMEN WHO HAVE SEX WITH WOMEN Vanessa Schick 5:35 Q&A 5:45 (NON-CME PORTION) SESSION 12 -THE PIPELINE: DRUG DEVELOPMENT IN SEXUAL HEALTH Moderators: Gregory Broderick, Run Wang Presenter: Andrew McCullough 6:00 SMSNA BUSINESS MEETING Saturday, May 16, :15 am - 4:30 pm ENGINEERING AND UROLOGY SOCIETY (EUS) - SECTION OF THE ENDOUROLOGICAL SOCIETY Napoleon Hilton New Orleans Riverside 7:25 WELCOME Program Chair: Peter Schulam, Jean Zheng 7:30 SESSION 1: ADVANCES IN URETERAL STENT DEVELOPMENT Moderator: Ravindra Kulkarni BIODEGRADABLE MATERIALS IN UROLOGY Ben Chew 7:40 ANTIMICROBIAL APPROACHES TO RENDERING URINARY BIOMATERIAL SURFACES STERILE Dirk Lange 7:50 A NEW STENT Ravindra Kulkarni 8:00 COMMERCIALIZING NEW STENT TECHNLOGY: CHALLENGES & OPPORTUNITIES Tim Harrah 8:10 QUESTIONS 8:20 SESSION 2: REGENERATIVE MEDICINE Moderator: Peter Schulam UPDATE ON REGENERATIVE MEDICINE Anthony Atala 8:50 ENGINEERING AN ILEAL CONDUIT Deepak Jain 9:10 QUESTIONS 9:15 AWARDS PRESENTATION Dan Stoianovici 9:30 SESSION 3: ESUT SESSION Chairman: Alberto Breda Moderators: Jens Rassweiler, Pilar Laguna Pes DYNA-CT-NAVIGATED ROBOTIC SURGERY Dogu Teber 9:45 NEW DEVELOPMENTS IN ROBOTIC FLEXIBLE URETEROSCOPY Jens Rassweiler 56

69 10:00 NOVEL USE OF ULTRASOUND FOR KIDNEY STONE MANAGEMENT - FIRST CLINICAL STUDY Jonathan Harper 10:15 LATEST NEWS FROM THE IRCAD - NOTES, LESS & MORE Roland van Velthoven 10:30 SESSION 4: INTERVENTIONAL UROLOGIC ONCOLOGY THE NEW FRONTIER OF PROSTATE CANCER IMAGING, BEYOND MULTI-PARAMETRIC MRI Peter Choyke 10:45 LATEST ADVANCES IN PROSTATE FUSION BIOPSY Srinivas Vourganti 11:00 THE CURRENT AND EMERGING ROLE OF RENAL BIOPSY FOR THE RENAL MASS Jaime Landman 11:15 RENAL TUMOR ABLATION: WHAT S NEW ON THE HORIZON Brian Shuch 11:30 CURRENT AND EMERGING INDICATIONS FOR PROSTATE EMBOLIZATION Ardeshir Rastinehad 11:45 CURRENT STATUS OF FOCAL THERAPY MODALITIES FOR PROSTATE CANCER Peter Pinto 12:00 LUNCH 1:00 SESSION 5: LESS AND NOTES Moderator: Abhay Rane 1:10 LESS AND NOTES PUBLICATIONS UPDATE Brian Irwin 1:20 NEW ROBOTIC LESS IS THE WAY FORWARD Jihad Kaouk 1:30 LESS IN THE DEVELOPING WORLD P. P. Rao 1:40 LESS DONOR NEPHRECTOMY Ricardo Autorino 1:50 IS LESS HERE TO STAY Lee Ponsky 2:00 INNOVATIONS IN UROLOGY (SCIENCE & TECHNOLOGY HALL) SESSION 6: IMAGED GUIDED WORKING GROUP Moderator: James Borin MRI/US FUSION FOR DIAGNOSIS AND TREATMENT OF PROSTATE CANCER IN THE OFFICE SETTING Samir Taneja 2:10 TECHNICAL SOLUTIONS TO IMPROVE THE MANAGEMENT OF NON-MUSCLE INVASIVE TRANSITIONAL CELL CARCINOMA Evangelos Liatsikos 2:20 FIBEROPTIC CONFOCAL LASER ENDOMICROSCOPY: OPTICAL TISSUE CHARACTERIZATION OF RENAL TUMORS Li-Ming Su 2:30 3D PRINTING OF UROLOGICAL MALIGNANCIES Jonathan Silberstein 2:40 LAPAROSCOPIC HIFU FOR THE TREATMENT OF SMALL RENAL MASSES Chandru Sundaram 2:50 NEW HORIZONS FOR IMAGING OF KIDNEY STONES TO GUIDE THERAPY Ojas Shah SATURDAY Saturday, May 16, 2015 RESIDENTS FORUM Room New Orleans Morial Convention Center 7:30-11:45 am 7:30 REGISTRATION 7:45 WELCOME AND INTRODUCTORY REMARKS Residents Committee Chair: John Lacy 7:50 PEARLS FOR CONTRACTS, INCOME CENTERS AND ESTABLISHING A PROSTHETIC UROLOGY PRACTICE Gerard Henry AN EXPERT S VIEW TO FINDING THE IDEAL JOB Moderator: Ben Ristau, Residents Committee Vice Chair 8:10 CLINICAL ASPECT WITH PANEL OF EXPERTS ACADEMICS Gennady Bratslavsky 8:18 HOSPITAL-EMPLOYED Richard Santucci 8:26 RESEARCH-ORIENTED Doug Clayton 8:34 PRIVATE PRACTICE Chris Schrepferman 8:45 ROUND TABLE Q&A 9:10 BUSINESS ASPECT WITH PANEL OF EXPERTS PRACTICE BUY-INS, HOW TO FIND BEST UROLOGY POSITION FOR YOUR UROLOGY CAREER AND PEACE OF MIND Roger Bonds 9:20 CONTRACT PITFALLS, HOW TO NEGOTIATE IDEAL CONTRACT Thomas Crawford 9:30 DEBT MANAGEMENT/INVESTMENTS Marshall Gifford *Presenting author 57

70 9:40 ROUND TABLE Q&A 10:10 BREAK 10:20 CORE CURRICULUM SERIES John Mulhall 10:30 TEACHING AWARD PRESENTATION 10:40 RAFFLE DRAWING/CLOSING REMARKS 11:00 LUNCH WITH A FELLOW SESSION A: QUESTION AND ANSWER SESSION: IS PROSTHETIC UROLOGY FELLOWSHIP A GOOD FIT FOR ME? Gerard Henry, Michael Pryor, Martin Gross SESSION B: QUESTION AND ANSWER SESSION: CHOOSE YOUR FELLOWSHIP 10:45 FELLOWS INTRODUCTION Saturday, May 16, 2015 Live Surgery Program LIVE SURGERY I Hall New Orleans Morial Convention Center Moderators: Ashok Hemal and James Porter 7:30 am - 12:00 pm 7:30 MICRO, ULTRA-MINI, AND SUPER PERCUTANEOUS NEPHROLITHOTOMY Surgeons: R.B. Sabnis, Janak Desai, Madhu Agrawal, Kaushik Shah Panelists: Mahesh Desai, Arthur Smith 8:45 SHOCK AND AWE-NEW PHYSICIAN CONTROLLED PCNL LITHOTRIPSY WITH SUPERIOR SPEED AND EFFICIENCY Surgeon: Raju Thomas Operating Room Monitor: Ben Chew Panelists: Mahesh Desai, Arthur Smith 9:45 ROBOTIC ASSISTED PARTIAL NEPHRECTOMY Surgeon: Sam Bhayani Panelists: Mahesh Desai, Arthur D. Smith 11:00 MALE STRESS URINARY INCONTINENCE SLING SURGERY Surgeon: Andrew Peterson Panelist: Jaspreet Sandhu Saturday, May 16, 2015 ARAB ASSOCIATION OF UROLOGY (AAU) Room New Orleans Morial Convention Center 7:30 am - 12:10 pm 7:30 BREAKFAST & REGISTRATION 7:50 WELCOME AND INTRODUCTIONS Michael Blute, Hassan Abol-Enein, Gopal Badlani, Raja Khauli 8:00 SESSION I: PROSTATE CANCER UPDATE Chairmen: Abdou Khair Chamssuddin, Khalid Sayyid CURRENT STATUS & INDICATIONS FOR ACTIVE SURVEILLANCE IN PROSTATE CANCER Laurence Klotz 8:15 PRECISION MEDICINE IN PROSTATE CANCER - THE DAWN OF THE GENOMIC ERA Eric Klein 8:30 CLINICAL T3 DISEASE: IS THERE A ROLE OF ROBOTIC RADICAL PROSTATECTOMY? Stephen Boorjian 8:45 CONTROL OF THE PRIMARY TUMOR IN THE SETTING OF ADVANCED PROSTATE CANCER Brian Chapin 9:00 PANEL DISCUSSION/DEBATE: DILEMMAS IN PROSTATE CANCER SCREENING, DIAGNOSIS & MANAGEMENT Moderator: Raja Khauli Panelists: Peter Albertsen, Stephen Boorjian, Laurence Klotz, Brian Chapin 9:25 COFFEE BREAK 9:45 SESSION II: ADVANCED KIDNEY CANCER Chairmen: Yasser Farahat, Abdul Naser Shunaigat STRATEGIES & TECHNICAL CONSIDERATIONS IN SURGICAL TREATMENT FOR ADVANCED RCC Bradley Leibovich 10:00 ROLE OF METASTECTOMY IN THE MANAGEMENT OF RCC & INDICATIONS FOR ADJUVANT THERAPY Christopher Wood 10:15 CASE PRESENTATIONS & PANEL DISCUSSION: RCC Moderator: Michael Blute Panelists: Christopher Wood, Bradley Leibovich 10:45 SESSION III: SUPERFICIAL BLADDER CANCER/BPH/MEN S HEALTH Chairmen: Georges Nassar, Ahmed Shokeir BCG ALTERNATIVE FOR NMIBC IN LIGHT OF SHORTAGES Badrinath Konety 11:00 BPH: NEW TECHNOLOGY PVP RESULTS; IS TURP STILL THE STANDARD? Shahin Tabatabaei 58

71 11:15 MEDICAL STRATEGIES FOR BPH Kevin McVary 11:30 MEN S HEALTH UPDATE Ajay Nehra 12:10 ADJOURN 11:45 PANEL DISCUSSION/DEBATE: Moderator: Hassan Abol-Enein Panelists: Kevin McVary, Badrinath Konety, Shahin Tabatabaei, Ates Kadioglu SATURDAY Saturday, May 16, 2015 SOCIETY FOR PEDIATRIC UROLOGY - SATURDAY Grand Ballroom Hilton New Orleans Riverside 7:30 am - 5:30 pm 7:30 SESSION 5: VOIDING DYSFUNCTION Moderators: Paul Austin, C. K. Yeung 8:40 PANEL DISCUSSION: SOCIOECONOMICS PANEL (SPU QUALITY INITIATIVE; AFFORDABLE CARE ACT; FELLOWSHIP TRAINING IN PEDIATRIC UROLOGY) Moderator: Lane Palmer Panelists: Barry Kogan, Douglas Husmann, Bradley Kropp 9:45 BREAK 10:15 SPU LECTURE 11:00 SPU PRESIDENTIAL ADDRESS Society President: Barry Kogan 11:15 SPU PRIZE AWARDS AND GRADUATING FELLOWS 11:30 SPU ANNUAL BUSINESS MEETING (SPU MEMBERS ONLY) 12:00 LUNCH (ON OWN) 1:30 SESSION 6: NEUROPATHIC BLADDER Moderators: John Wiener, Kourosh Afshar 2:30 PANEL DISCUSSION: THE THREE WISE MEN Moderator: David Bloom Panelists: Alan Retik, Stephen Koff, Edmond Gonzalez 3:30 SESSION 7: TUMOR, TRAUMA AND TRANSPLANTATION Moderators: Israel Franco, Armando Lorenzo 4:00 BREAK 4:30 SESSION 8: DSD Moderators: Joao Luiz Pippi Salle, David Diamond 5:30 ADJOURN Saturday, May 16, 2015 Moderated Poster Session 14 PROSTATE CANCER: EPIDEMIOLOGY & NATURAL HISTORY III Room New Orleans Morial Convention Center Moderators: Francesco Montorsi and Scott Eggener 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP14-01 USING THE EPIC 26 QOL QUESTIONNAIRE TO DETECT AND ASSESS DEPRESSION IN PATIENTS WITH PROSTATE CANCER Patrick Kilday*, Peter Elliott, George Abdelsayed, Jeff Slezak, Edward Rodriguez, Teresa Harrison, Steven J Jacobsen, Gary W Chien, LOS ANGELES, CA MP14-02 PROSPECTIVE QUALITY OF LIFE IMPACT ANALYSIS FOLLOWING LOCALIZED PROSTATE CANCER TREATMENTS: BRACHYTHERAPY, CRYOTHERAPY, AND RADICAL PROSTATECTOMY LONG-TERM FOLLOW-UP Matthew Ingham*, Arjun Poddar, Mark Shaves, Michael Fabrizio, Raymond Lance, Robert Given, Kurt McCammon, Paul Schellhammer, Michael Williams, Norfolk, VA MP14-03 SIMPLIFIED FRAILTY INDEX PREDICTS ADVERSE SURGICAL OUTCOMES AND INCREASED LENGTH OF STAY IN RADICAL PROSTATECTOMY PATIENTS: AN ANALYSIS OF THE ACS-NSQIP DATABASE Danny Lascano*, Jamie S Pak, Alexander C Small, Mark V Silva, James M McKiernan, G. Joel DeCastro, Sven Wenske, Mitchell C Benson, New York, NY MP14-04 DISSATISFACTION WITH INFORMATION PROVISION AND PATIENT REPORTED OUTCOMES IN PROSTATE CANCER SURVIVORS Paul Kil*, Romy Lamers, Maarten Cuypers, Marieke De Vries, Tilburg, Netherlands, Ruud Bosch, Utrecht, Netherlands, Lonneke vd Poll-Franse, Tilburg, Netherlands *Presenting author 59

72 MP14-05 A PROSPECTIVE COHORT STUDY OF TREATMENT DECISION-MAKING FOR PROSTATE CANCER FOLLOWING PARTICIPATION IN A MULTI- DISCIPLINARY CLINIC Lauren Hurwitz*, Jennifer Cullen, Sally Elsamanoudi, Rockville, MD, Daniel Kim, Jane Hudak, Maryellen Colston, Judith Travis, Bethesda, MD, Huai-Ching Kuo, Rockville, MD, Inger Rosner, Bethesda, MD MP14-06 SELF-REPORTED SEXUAL FUNCTION IS ASSOCIATED WITH PROSTATE CANCER RISK Daniel Zapata*, Lauren E Howard, Jennifer Frank, Simon Ross, Catherine Hoyo, Dolores Grant, Stephen J Freedland, Adriana C Vidal, Durham, NC MP14-07 WHAT ARE WE MISSING? THE PERSISTENCE OF VITALITY SYMPTOM BURDEN IN LONG-TERM PROSTATE CANCER SURVIVORS WITHOUT RECURRENT DISEASE Alexander M. Helfand*, Naveen Krishnan, Daniela A. Wittmann, Sarah T. Hawley, Chang He, Ann Arbor, MI, May Darwish- Yassine, Okemos, MI, Ted A. Skolarus, Ann Arbor, MI MP14-08 THE INCIDENCE OF TREATMENT- RELATED COMPLICATIONS WITH CONTEMPORARY TREATMENT FOR CLINICALLY-LOCALIZED PROSTATE CANCER Christopher Wallis*, Alyson Mahar, Patrick Cheung, Sender Herschorn, Laurence Klotz, Ashraf Al-Matar, Girish Kulkarni, Yuna Lee, Ronald Kodama, Steven Narod, Robert Nam, Toronto, Canada MP14-09 UNEXPECTED LONG-TERM IMPROVEMENTS IN URINARY AND ERECTILE FUNCTION IN A LARGE COHORT OF MEN WITH SELF-REPORTED OUTCOMES FOLLOWING RADICAL PROSTATECTOMY Justin K. Lee*, Daniel D. Sjoberg, Alan Thong, John P. Mulhall, Jaspreet Sandhu, Andrew J. Vickers, Behfar Ehdaie, New York, NY MP14-10 THE ROLE OF PATIENT AND PROVIDER CHARACTERISTICS IN RADICAL PROSTATECTOMY UTILIZATION AND QUALITY OF CARE RESULTS FROM THE CDC PROSTATE CANCER DATA QUALITY AND PATTERNS OF CARE STUDY (CDC POC-BP) Raj Satkunasivam*, Mary Lo, Mariana Stern, Inderbir Gill, Los Angeles, CA, Steven Fleming, Lexington, KY, Xiao-Cheng Wu, New Orleans, LA, Dian Wang, Milwaukee, WI, Michael Goodman, Atlanta, GA, Roger Anderson, Philadelphia, PA, Trevor Thompson, Atlanta, GA, Ann Hamilton, Los Angeles, CA MP14-11 IS BMI THE BEST ADIPOSITY MEASURE FOR PROSTATE CANCER RISK? Lourdes Guerrios*, San Juan, PR, Lauren Howard, Katherine Sourbeer, Evangeline Arulraja, Devon Beverly, Delores J. Grant, Catherine Hoyo, Steve Freedland, Durham, NC MP14-12 OBESE CASTRATION-RESISTANT PROSTATE CANCER PATIENTS MAY BE AT A LOWER RISK OF METASTASIS AND ALL-CAUSE MORTALITY: RESULTS FROM THE SEARCH DATABASE Adriana C. Vidal*, Lauren E. Howard, Durham, NC, Christopher J. Kane, San Diego, CA, Martha K. Terris, Augusta, GA, William J. Aronson, Los Angeles, CA, Matthew R. Cooperberg, San Francisco, CA, Christopher L. Amling, Portland, OR, Stephen J. Freedland, Durham, NC MP14-13 WEIGHING IN ON ACTIVE SURVEILLANCE: IMPACT OF OBESITY ON PATIENT COUNSELING Melissa Mendez*, Mitchell Bassett, Durham, NC, Michael Abern, Chicago, IL, Lionel Banez, Michael Ferrandino, Cary Robertson, Stephen Freedland, Brant Inman, Philip Walther, Judd Moul, Thomas Polascik, Durham, NC MP14-14 EFFECT OF METFORMIN USE ON PROSTATE CANCER Abdo Kabarriti*, Ben Boursi, Ronac Mamatani, Thomas Guzzo, Kevin Haynes, Yu-Xiao Yang, S. Bruce Malkowicz, Philadelphia, PA MP14-15 METABOLIC SYNDROME AND AGGRESSIVE PROSTATE CANCER AND BIOCHEMICAL RECURRENCE AFTER DEFINITIVE TREATMENT Jennifer Beebe-Dimmer*, Lance Heilbrun, Cathryn Bock, Daryn Smith, Izabela Podgorski, Sue Bolton, Isaac Powell, Detroit, MI MP14-16 THE NATURAL HISTORY OF TARGETED BIOPSY NEGATIVE LESIONS IDENTIFIED ON MULTIPARAMETRIC PROSTATE MAGNETIC RESONANCE IMAGING Raju Chelluri*, Thomas Frye, Arvin K. George, Michele Fascelli, Richard Ho, Steven Abboud, Annerleim Walton-Diaz, Baris Turkbey, Bradford J. Wood, Peter A. Pinto, Peter L. Choyke, Bethesda, MD 60

73 MP14-17 IMMEDIATE REPEAT BIOPSY IS NOT NECESSARY IN PATIENTS WITH ATYPICAL SMALL ACINAR PROLIFERATION (ASAP): A MULTI- INSTITUTIONAL REVIEW Andrew Leone*, Providence, RI, Boris Gershman, Rochester, MN, Katherine Rotker, Christi Butler, Providence, RI, Jennifer Fantasia, Achankeng Afiadata, Worcester, MA, Jianhong Li, Providence, RI, Thomas Sebo, Rochester, MN, Amy Zhou, Zhong Jiang, Worcester, MA, Ali Amin, Anthony Mega, Stephen Schiff, Gyan Pareek, Dragan Golijanin, Providence, RI, Jennifer Yates, Worcester, MA, R. Jeffrey Karnes, Rochester, MN, Joseph Renzulli, Providence, RI MP14-18 VERY LOW RISK VS. LOW RISK PROSTATE CANCER DESIGNATIONS IN AN ACTIVE SURVEILLANCE COHORT Andrew J. Cohen*, Joseph J. Pariser, Chicago, IL, Brittany Lapin, Chi-Hsiung Wang, Brian T. Helfand, Michael McGuire, Evanston, IL MP14-19 LYMPH NODE METASTASES IN GLEASON 6 PROSTATE CANCER: DATA FROM A GERMAN MULTICENTER DATABASE Daniel Schindele*, Daniel Baumunk, Simon Blaschke, Magdeburg, Germany, Annette Reinicke, Tom Fischer, Stefan Hinz, Berlin, Germany, Alexander Winter, Oldenburg, Germany, Mario Zacharias, Berlin, Germany, Sebastian Schäfers, Lüdenscheid, Germany, Ulrich Witzsch, Frankfurt, Germany, Robert Kössler, Berlin, Germany, Jan Fichtner, Oberhausen-Sterkrade, Germany, Steffen Weikert, Kurt Miller, Berlin, Germany, Martin Schostak, Magdeburg, Germany MP14-20 SHORT PEAK EXPOSURE TO AMBIENT FINE PARTICULATE MATTER PROBABLY CONTRIBUTED TO INCREASED PROSTATE CANCER MORTALITY Xiaojian Qin*, Fangning Wan, Hailiang Zhang, Bo Dai, Guohai Shi, Yao Zhu, Dingwei Ye, Shanghai, China, People s Republic of SATURDAY Saturday, May 16, 2015 Moderated Poster Session 15 TRAUMA/RECONSTRUCTION: URETHRAL RECONSTRUCTION (INCLUDING STRICTURE) I Room New Orleans Morial Convention Center Moderator: Allen Morey 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP15-01 CHANGING PRACTICE PATTERNS IN THE TREATMENT OF URETHRAL STRICTURE AMONGST AMERICAN UROLOGISTS Joceline S. Liu*, Matthias D. Hofer, Daniel T. Oberlin, Jaclyn Milose, Sarah C. Flury, Chicago, IL, Allen F. Morey, Dallas, TX, Chris M. Gonzalez, Chicago, IL MP15-02 NATIONAL TRENDS IN THE MANAGEMENT OF URETHRAL STRICTURE DISEASE: A 14-YEAR SURVEY OF THE NATIONWIDE INPATIENT SAMPLE Nishant Patel*, San Diego, CA, Michael Liss, San Antonio, TX, Song Wang, La Jolla, CA, Jill Buckley, San Diego, CA MP15-03 NATIONAL VARIATION IN URETHROPLASTY COST AND PREDICTORS OF EXTREME COST: A COST ANALYSIS WITH POLICY IMPLICATIONS Catherine Harris*, Amjad Alwaal, Jack McAninch, Charles McCulloch, Benjamin Breyer, San Francisco, CA MP15-04 ENDOSCOPIC TREATMENT OF VESICOURETHRAL STENOSIS AFTER RADICAL PROSTATECTOMY: OUTCOMES AND PREDICTORS OF SUCCESS Joseph LaBossiere*, Douglas Cheung, Keith Rourke, Edmonton, Canada MP15-05 EFFECTS OF PRIOR RADIATION ON OUTCOMES FROM VESICAL NECK INCISION WITH INTRALESIONAL MITOMYCIN C FOR RECALCITRANT BLADDER NECK CONTRACTURE Ronak Gor*, Phillip Ginsberg, Michael Metro, Philadelphia, PA MP15-06 BIPOLAR INCISION OF BLADDER NECK CONTRACTURE WITH INTRALESIONAL INJECTION OF MITOMYCIN C: A SINGLE INSTITUTION EXPERIENCE Timothy Lyon*, Matthew Ferroni, Kevin Rycyna, Mang Chen, Pittsburgh, PA MP15-07 URETHROTOMY AND HIGH DOSE TRIAMCINOLONE INJECTIONS IN THE TREATMENT OF POST-URETHROPLASTY RECURRENT STRICTURES Jennifer A. Robles*, St Louis, MO, Jairam R. Eswara, Boston, MA, Joel Vetter, Kerry Madison, Steven B. Brandes, St Louis, MO *Presenting author 61

74 MP15-08 AN EX-VIVO ANALYSIS OF VARIOUS SUTURE MATERIALS AND TECHNIQUES, AND TYPES OF URINARY CATHETERS IN VESICOURETHRAL ANASTOMOTIC TENSILE STRENGTH AND CATHETER DISLODGMENT: A PORCINE MODEL Marlon Perera*, Pranav Divakaran, Matthew Roberts, Mackay, Australia, Eric Chung, Brisbane, Australia MP15-09 CRITICAL ANALYSIS OF UROFLOWMETRY FOR URETHRAL STRICTURE DISEASE SURVEILLANCE Christopher A. Tam*, Iowa City, IA, Sean P. Elliott, Minneapolis, MN, Jeremy B. Myers, Salt Lake City, UT, Alex J. Vanni, Burlington, MA, Bryan B. Voelzke, Seattle, WA, Bradley A. Erickson, Iowa City, IA MP15-10 VALSALVA VOIDING DISTINGUISHES SLOW URINARY FLOW CAUSED BY ANTERIOR URETHRAL STRICTURES FROM PROSTATIC OBSTRUCTION Rajveer Purohit*, Matthew Benedon, Gabriel Mekel, New York, NY, James Weinberger, Los Angeles, CA, Johnson Tsui, Jerry Blaivas, New York, NY MP15-11 OUTPATIENT ULTRASOUND URETHROGRAM FOR ASSESSMENT OF ANTERIOR URETHRAL STRICTURE RENDERS RADIATION EXPOSURE UNNECESSARY Darren J Bryk*, Yuka Yamaguchi, Shpetim Telegrafi, Mariana Kozirovsky, Lee C Zhao, New York, NY MP15-12 URETHRAL STRICTURE (US) AND ARTIFICIAL URINARY SPHINCTER (AUS) REINSERTION RATES AFTER URETHRAL REPAIR AT THE TIME OF AUS EXPLANTATION FOR EROSION Stephen Mock*, Elizabeth T. Brown, W. Stuart Reynolds, Melissa R. Kaufman, Douglas F. Milam, Roger R. Dmochowski, Nashville, TN MP15-13 ASSOCIATION BETWEEN TYPE OF PERINEAL INCISION AND WOUND COMPLICATIONS AFTER BULBAR URETHROPLASTY Alexandra Bascom*, Sunita Ghosh, Adrian Fairey, Keith Rourke, Edmonton, Canada MP15-14 DOUBLE TRANSECTION WITH INJURY AT MEMBRANOBULBAR AND PROSTATE BLADDER NECK AFTER PELVIC FRACTURE URETHRAL INJURY Craig Hunter*, Walid Shahrour, Pankaj Joshi, Sandesh Surana, Vikram shah Batra, Sanjay Kulkarni, Pune, India, India MP15-15 REDO - BUCCAL MUCOSA GRAFT URETHROPLASTY: SUCCES RATE AND ORAL MORBIDITY Clemens Rosenbaum*, Marianne Schmid, Tim Ludwig, Luis Kluth, Philip Reiss, Armin Soave, Roland Dahlem, Oliver Engel, Silke Riechardt, Margit Fisch, Sascha Ahyai, Hamburg, Germany MP15-16 REVISION URETHROPLASTY VS PRIMARY URETHROPLASTY: ARE THEY REALLY DIFFERENT? Fabio Castiglione*, Pieter D Hulst, Kathy Vander Eeckt, Frank Van der Aa, Steven Joniau, Leuven, Belgium MP15-17 ASSESSMENT OF THE LEARNING CURVE FOR MALE URETHRAL RECONSTRUCTION: DOES EXPERIENCE MATTER? Sarah Faris*, Christopher Tam, Iowa City, IA, Bryan Voelzke, Seattle, WA, Jeremy Myers, Salt Lake City, UT, Sean Elliott, Minneapolis, MN, Alex Vanni, Burlington, MA, Thomas Smith, III, Houston, TX, Benjamin Breyer, Thomas Gaither, San Francisco, CA, Deep Bhatt, Bradley Erickson, Iowa City, IA MP15-18 PREDICTIVE VALUE OF POST- URETHROPLASTY VOIDING CYSTOURETHROGRAM Daniel Stein*, Ibraheem Malkawi, Richard Santucci, Detroit, MI MP15-19 COLLAGENASE CLOSTRIDIUM HISTOLYTICUM FOR TREATMENT OF URETHRAL STRICTURE DISEASE IN A RAT MODEL OF URETHRAL FIBROSIS Premsant Sangkum*, Hogyoung Kim, New Orleans, LA, Mostafa Bouljihad, Covington, LA, Manish Ranjan, Amrita Datta, Sree Mandava, Faysal Yafi, Suresh Sikka, Asim Abdel-Mageed, Wayne Hellstrom, New Orleans, LA MP15-20 ROBOTIC UROLOGICAL SURGERY FOR BENIGN INDICATIONS: THE USC EXPERIENCE Sameer Chopra*, Shalini Nagaraj, Carlee Beckler, Andre Luis de Castro de Abreu, Raj Satkunasivam, Raed A. Azhar, Charles Metcalfe, Inderbir Gill, Monish Aron, Mihir Desai, Andre K. Berger, Los Angeles, CA 62

75 Saturday, May 16, 2015 Moderated Poster Session 16 8:00 am - 10:00 am GENERAL & EPIDEMIOLOGICAL TRENDS & SOCIOECONOMICS: PRACTICE PATTERNS, COST EFFECTIVENESS I Room New Orleans Morial Convention Center Moderators: Matthew Resnick and Bradley Erickson NUMBER TITLE NUMBER TITLE MP16-01 TEAM STRATEGIES AND TOOLS TO ENHANCE PERFORMANCE AND PATIENT SAFETY (TEAMSTEPPS) IMPROVES OPERATING ROOM EFFICIENCY Matthew Stringer*, Lancaster Weld, James Ebertowski, Timothy Baumgartner, Matthew Kasprenski, Jeremy Kelley, Doug Cho, Erwin Tieva, Kyle Weld, San Antonio, TX MP16-02 INFLUENCE OF INTERDEPARTMENTAL COLLABORATION ON UTILIZATION OF NEOADJUVANT CHEMOTHERAPY PRIOR TO CYSTECTOMY; A 14-YEAR EXPERIENCE Ashley Winter*, Bashir Awamleh, Sameer Mittal, Shiyi Jin, Daniel Nguyen, Scott Tagawa, Douglas Scherr, New York, NY MP16-03 STRATEGIC IMPROVEMENT IN PROSTATE BIOPSY FIXATION; ROLE OF INTERDISCIPLINARY QUALITY COLLABORATION IN UROLOGIC PRACTICE Ashley Winter*, Paul DiMaggio, Brian Robinson, New York, NY MP16-04 USING LEAN / SIX-SIGMA METHODOLOGY TO ACHIEVE IMPROVED ACCESS IN A UROLOGY CLINIC Bradford Stevenson*, Thomas Tieu, Teri Baldini, Springfield, IL, Chris Gonzalez, Chicago, IL, Tobias Kohler, Kevin McVary, Springfield, IL MP16-05 TELEUROLOGY TO ENHANCE ACCESS AND EXPEDITE CARE OF PATIENTS REFERRED WITH HEMATURIA Salil Gabale*, Ilan Safir, Catrina White, I. Jane Kimberl, Debra Fabian, Muta M. Issa, Atlanta, GA MP16-06 WHATSAPP DOC? EVALUATING A NOVEL MODALITY OF COMMUNICATION AMONGST UROLOGY TEAM MEMBERS TO PROMOTE PATIENT SAFETY Clarissa Martyn-Hemphill, Somita Sarkar, John Withington, Ashoke Roy, Rosaline Chisholm, Toby Newton, Diego Ottaviani, Connie Pidgeon, Sonia Szamocki, Daniel Cohen, James Green*, London, United Kingdom MP16-07 IMPLICATIONS OF REGIONALIZING FUSION MRI TECHNOLOGY Karen Wheeler*, Jennifer Lobo, Drew Jensen, Jules Manger, Shawnna Blanchard, Afshan Ornan, Sebastian Feuerlain, Tracey Krupski, Charlottesville, VA MP16-08 ANTICIPATING THE IMPACT OF THE AFFORDABLE CARE ACT ON UROLOGIC CARE AT SAFETY-NET HOSPITALS Lindsey Herrel*, Zaojun Ye, David Miller, Ann Arbor, MI MP16-09 LOW SELF-EFFICACY IS ASSOCIATED WITH DECREASED EMERGENCY DEPARTMENT USE IN UNDERSERVED MEN WITH PROSTATE CANCER Avi S. Baskin*, Lorna Kwan, Sarah E. Connor, Sally L. Maliski, Mark S. Litwin, Los Angeles, CA MP16-10 EQUITABLE COMMUNITY UTILIZATION OF PARTIAL NEPHRECTOMY NATIONALLY FOR MANAGEMENT OF T1A RENAL TUMORS Dhruti Patel*, Robert Abouassaly, Cleveland, OH MP16-11 ASSOCIATION BETWEEN THE SELF- PERCEPTION PERIOD OF LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA AND THE INTERNATIONAL PROSTATE SYMPTOM SCORE Sungryul Shim*, Jaeheon Kim, Young-Ho Kim, Wonjin Lee, Seoul, Korea, Republic of, Sangjin Yoon, Incheon, Korea, Republic of, Jaehyun Bae, , Korea, Republic of MP16-12 CORRELATION BETWEEN SURGEONS AND PATIENTS SUBJECTIVE AND OBJECTIVE PERCEPTIONS OF FRAILTY Daniel Canter*, Wynnewood, PA, Louis Revenig, Yuan Liu, Sungjin Kim, Kenneth Ogan, Viraj A Master, Atlanta, GA MP16-13 SLOW GAIT SPEED PREDICT OF POST- OPERATIVE DELIRIUM IN ELDERLY PATIENTS Masaaki Oikawa*, Teppei Okamoto, Shingo Hatakeyama, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Hirosaki, Japan MP16-14 THE INFLUENCE OF THE USE MEDICAL CLOWNS TO THE REDUCTION OF PREOPERATIVE ANXIETY, POSTOPERATIVE PAIN AND MEDICAL COSTS IN CHILDREN UNDERGOING OUTPATIENT PENILE SURGERY: A RANDOMIZED CONTROLLED TRIAL Stanislav Kocherov*, Yaniv Hen, Sol Jaworowski, Israel Ostrovsky, Judith Gabay, Genady Lev, Avraham Cohen, Ya acov Shvili, Arthur I. Edelman, Boris Chertin, Jerusalem, Israel SATURDAY *Presenting author 63

76 MP16-15 CURRENT UROLOGY RESIDENT VIEWS ON DESIRABLE CHARACTERISTICS FOR FIRST TIME EMPLOYMENT Jyoti Chouhan*, Katherine Fischer, Jeffrey Weiss, Brooklyn, NY MP16-16 THE FEMINIZATION OF THE WORKFORCE IN UROLOGY: SOCIOECONOMIC, WORKFORCE, AND QUALITY OF LIFE ISSUES Nicholas Pruthi, Sophie Spencer*, Matthew Lyons, Peter Greene, Max McKibben, Chapel Hill, NC, Christopher Gonzalez, Chicago, IL, Patrick McKenna, Madison, WI, Matthew Nielsen, Mathew Raynor, Angela Smith, Eric Wallen, Michael Woods, Raj Pruthi, Chapel Hill, NC MP16-17 THE VALUE OF PATHOLOGIC EXAMINATION OF THE FORESKIN FOLLOWING CIRCUMCISION Ilan Safir*, Amar Patel, Brad Moore, Dattatraya Patil, Gabriel Bellott-McGrath, Adeboye Osunkoya, Muta Issa, Atlanta, GA MP16-19 ADHERENCE RATES FOR SELECTIVE MEDICAL THERAPY AMONG PATIENTS WITH KIDNEY STONES Yooni Yi*, Casey Dauw, Maggie Bierlein, Abdul Alruwaily, Khurshid Ghani, Stuart Wolf, John Hollingsworth, Ann Arbor, MI MP16-20 CHANGES IN PRIMARY CARE PROVIDER PRACTICE PATTERNS SINCE 2012: IMPACT OF THE USPSTF GUIDELINE STATEMENT Jennifer Yates*, Mitchell Sokoloff, Achankeng Afiadata, Jennifer Fantasia, David Frendl, Mara Epstein, Roger Luckmann, Worcester, MA MP16-18 PREDISPOSING FACTORS AND OUTCOMES OF MALPRACTICE LITIGATION FOR CASES OF TESTICULAR TORSION: A LEGAL DATABASE REVIEW Marc A Colaco*, Matthew G Heavner, Winston-Salem, NC, Peter L Sunyaro, Newark, NJ, Ryan P Terlecki, Winston- Salem, NC Saturday, May 16, 2015 Moderated Poster Session 17 IMAGING/RADIOLOGY: URORADIOLOGY III Room New Orleans Morial Convention Center Moderators: Daniel Rukstalis and Pat Fulgham 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP17-01 THE POSTERIOR ACOUSTIC SHADOW: EVALUATING STONE SIZE IN PEDIATRIC STONE FORMERS Franklin Lee*, Jonathan Harper, Thomas Lendvay, Seattle, WA, Ziyue Liu, Indianapolis, IN, Barbrina Dunmire, Jonathan Swanson, Manjiri Dighe, Michael Bailey, Mathew Sorensen, Seattle, WA MP17-02 DEVELOPING A PROTOTYPE FOR AN AUTOMATED, LOW-COST 3D ULTRASOUND SCANNER FOR DEDICATED UROLOGICAL APPLICATIONS Ryan Gessner*, Lyle Baumgarten, Paul Dayton, Robert Coward, Chapel Hill, NC MP17-03 A MINIATURE FORWARD-VIEWING ENDOSCOPIC OPTICAL COHERENCE TOMOGRAPHY PROBE FOR RENAL PELVIC IMAGING Xiaoyong Fu, Dhruti Patel*, Hui Zhu, Gregory Maclennan, Yves Wang, Michael Jenkins, Andrew Rollins, Cleveland, OH MP17-04 UROLOGIC IMAGING QUALITY USING A PORTABLE ULTRASOUND WITH REGARD TO THE OPERATOR AND THE DEVICE Arnon Lavi*, Sharon Tzemach, Alon Masiach, Genady Zelichenko, Michael Gross, Leonid Cherbinsky, David Giser, Rafi Shoshana, Ziv Neeman, Michael Cohen, Afula, Israel MP17-05 PROSPECTIVE CLINICAL TRIAL EVALUATING ANTEGRADE NEPHROSTOGRAPHY TO ASSESS URINE FLOW AFTER PERCUTANEOUS NEPHROLITHOTOMY Matthew Truesdale*, Molly Elmer-Dewitt, Bogdana Schmidt, Ian Metzler, David Bayne, Marco Sandri, Marshall Stoller, Thomas Chi, San Francisco, CA MP17-06 RADIATION DOSES IN PRONE VERSUS SUPINE POSITION DURING PERCUTANEOUS NEPHROLITHOTOMY, RESULTS WITH AN ANTHROPOMORPHIC MODEL Jonathan Cloutier*, Jean-Baptiste Terrasa, Luca Villa, Olivier Traxer, Paris, France 64

77 MP17-07 RAPID PRE-PROSTATE BIOPSY MRI, RESULTS OF A CONTROLLED PROSPECTIVE REGISTERED IMPROD- TRIAL Peter J. Bostrom*, Pekka Taimen, Kari Syvänen, Esa Kähkönen, Markku Kallajoki, Hannu Aronen, Ivan Jambor, Turku, Finland MP17-08 MRI-FUSION PROSTATE BIOPSY IN FIRST-TIME BIOPSY COHORT YIELDS INCREASED DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER USING A SIMPLIFIED MRI GRADING SCALE Steven V. Kardos*, Shu Pan, Cayce B. Nawaf, New Haven, CT, Richard Fan, Palo Alto, CA, Daniel Cornfeld, Jeffrey Weinreb, Peter G. Schulam, Preston C. Sprenkle, New Haven, CT MP17-09 TRENDS IN CANCER DETECTION RATE AND COMPLICATIONS AFTER MAGNETIC RESONANCE IMAGING-ULTRASOUND (MRI/US) FUSION-GUIDED PROSTATE BIOPSIES Simpa Salami*, Oksana Yaskiv, New Hyde Park, NY, Baris Turkbey, Bethesda, MD, Robert Villani, Eran Ben-Levi, Ardeshir Rastinehad, New Hyde Park, NY MP17-10 EVALUATION OF PI-RADS CLASSIFICATION IN PREDICTION OF TUMOUR AGGRESSIVENESS COMPARISON TO RADICAL PROSTATECTOMY SPECIMEN Angelika Borkowetz*, Ivan Platzek, Marieta Toma, Stefan Zastrow, Michael Froehner, Rainer Koch, Manfred Wirth, Dresden, Germany MP17-11 COST EFFECTIVENESS OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING FOR DETECTION OF PROSTATE CANCER Ahmed Q Haddad*, Daniel Costa, Ivan Pedrosa, Neil Rofsky, Claus Roehrborn, Yair Lotan, Dallas, TX MP17-12 MOLECULAR ALTERATIONS IN PROSTATE CANCER AND ASSOCIATION WITH MRI FEATURES Daniel Lee*, Jacqueline Fontugne, Naveen Gumpeni, Kyung Park, Theresa MacDonald, Brian Robinson, Andrea Sboner, Juan Miguel Mosquera, Mark Rubin, Christopher Barbieri, New York, NY MP17-13 MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING AND MRI/ULTRASOUND FUSION-GUIDED BIOPSY PREDICTS TOTAL TUMOR BURDEN CONFIRMED BY WHOLE MOUNT PROSTATECTOMY Richard Ho*, Arvin K. George, Thomas Frye, Steven Abboud, Raju Chelluri, Michele Fascelli, Chinonyerem Okoro, Nabeel Shakir, Bethesda, MD, M. Minhaj Siddiqui, Baltimore, MD, Vanessa Moreno, Annerleim Walton- Diaz, Sandeep Sankineni, Maria Merino, Baris Turkbey, Peter Choyke, Bradford J. Wood, Peter Pinto, Bethesda, MD MP17-14 UTILITY OF PREOPERATIVE 3 TESLA MULTIPARAMETRIC PELVIC PHASED- ARRAY MAGNETIC RESONANCE IMAGING IN PREDICTION OF EXTRACAPSULAR EXTENSION OF PROSTATE CANCER AND ITS IMPACT ON SURGICAL MARGIN STATUS: EXPERIENCE AT A CANADIAN TERTIARY ACADEMIC HEALTH CENTER Jen Hoogenes*, Ian Wright, Colm Boylan, Bobby Shayegan, Hamilton, Canada MP17-15 EVALUATION OF TRANSRECTAL ULTRASOUND IN PREOPERATIVE STAGING OF PROSTATE CANCER: CORRELATION WITH THE EXPERIENCE OF THE UROLOGIST Andreas Bannowsky*, Osnabrück, Germany, Daniar Osmonov, Klaus-Peter Jünemann, Kiel, Germany, Hermann van Ahlen, Osnabrück, Germany MP17-16 URETHRA-SPARING TREATMENT WITH HIGH-INTENSITY FOCUSED ULTRASOUND FOR LOCALIZED PROSTATE CANCER Sunao Shoji*, Mayura Nakano, Tetsuro Tomonaga, Hiroshi Fujikawa, Kazuyuki Endo, Akio Hashimoto, Toshiro Terachi, Toyoaki Uchida, Hachioji, Japan MP17-17 SIGNIFICANCE OF URETHRAL FIBROSIS EVALUATED BY PREOPERATIVE MAGNETIC RESONANCE IMAGING AS A PREDICTOR OF CONTINENCE STATUS AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY Hiroyuki Momozono*, Hideaki Miyake, Akira Miyazaki, Masato Fujisawa, Kobe, Japan MP17-18 SUPERB MICROVASCULAR IMAGING FOR THE EVALUATION OF PARENCHYMAL PERFUSION IN THE UNDESCENDED TESTES IN YOUNG CHILDREN Yong Seung Lee*, Sang Won Han, Myung- Joon Kim, Young Jae Im, Mi-Jung Lee, Seoul, Korea, Republic of MP17-19 QUANTITY ASSESSMENT OF VESICOURETERAL REFLUX BY DIRECT RADIONUCLIDE CYSTOGRAPHY Zukhra Sabirzyanova*, Andrey Pavlov, Dmitry Fomin, Gevorg Simonyan, Moscow, Russian Federation MP17-20 MAGNETIC RESONANCE IMAGING IN PATIENTS WITH STRESS URINARY INCONTINENCE - NEW EVALUATION TOOL George Kasyan*, Mariya Barinova, Nataliya Tupikina, Mikhail Gvozdev, Boris Godunov, Dmitry Pushkar, Moscow, Russian Federation SATURDAY *Presenting author 65

78 Saturday, May 16, 2015 Podium Session 7 BLADDER AND URETHRA: ANATOMY, PHYSIOLOGY AND PHARMACOLOGY I Room New Orleans Morial Convention Center Moderators: Christopher Chapple and Arthur Mourtzinos 8:00 am - 10:00 am TIME NUMBER TITLE TIME NUMBER TITLE 8:00 PD7-01 ONO-8055, A NOVEL AND POTENT PROSTANOID EP2 AND EP3 RECEPTOR DUAL AGONIST, IMPROVES VOIDING DYSFUNCTION IN A MONKEY UNDERACTIVE BLADDER MODEL Hidekazu Matsuya*, Takeya Otsuki, Jun Kida, Daisuke Wakamatsu, Hiroki Okada, Osaka, Japan, Noritoshi Sekido, Tokyo, Japan 9:00 PD7-07 A NOVEL TARGET FOR UNDERACTIVE BLADDER DISEASE: TRPV4 CATION CHANNEL ACTIVATION IMPROVES BLADDER FUNCTION IN A RAT MODEL FOR DETRUSOR UNDERACTIVITY Yves Deruyver*, Emmanuel Weyne, Karel Dewulf, Wouter Everaerts, Thomas Voets, Dirk De Ridder, Leuven, Belgium 8:10 PD7-02 DELETION OF THE TRPV4 CATION CHANNEL LEADS TO DECREASED SENSORY INPUT INTO THE CENTRAL NERVOUS SYSTEM DURING THE MICTURITION CYCLE: A PET IMAGING STUDY IN RATS Yves Deruyver*, Roma Rietjens, Jan Franken, Ann Van Santvoort, Cindy Casteels, Thomas Voets, Dirk De Ridder, Leuven, Belgium 8:20 PD7-03 IMPAIRED EXPRESSION AND FUNCTION OF TREK-1, A STRETCH-ACTIVATED TWO-PORE DOMAIN POTASSIUM CHANNEL, UNDERLIES DETRUSOR OVERACTIVITY IN HUMANS Joseph Hypolite, Aurora, CO, Xiao-Qing Pan, Philadelphia, PA, Shandra Wilson, Randall Meacham, Anna Malykhina*, Aurora, CO 8:30 PD7-04 PRECISE CHARACTERIZATION OF BLADDER NECK INNERVATION WITH THREE-DIMENSIONAL IMAGE RECONSTRUCTION Kyle Spradling*, Cyrus Khoyilar, Garen Abedi, Zhamshid Okhunov, Michael del Junco, Renai Yoon, Nicholas Nguyen, Jamie Wikenheiser, Orange, CA, Jiaoti Huang, Los Angeles, CA, Ramy Youssef, Gamal Ghoniem, Jaime Landman, Orange, CA 8:40 PD7-05 VIRAL CYSTITIS INDUCED BY CROSS- INFECTION FROM THE COLON POTENTIAL MECHANISM FOR INTERSTITIAL CYSTITIS Youko Ikeda*, Irina Zabbarova, Sandra Gomez-Amaya, Sunita Shinde, Lori Birder, Anthony Kanai, Pittsburgh, PA 8:50 PD7-06 PUDENDAL NERVE STIMULATION INHIBITS THE VISCEROMOTOR RESPONSES TO URINARY BLADDER DISTENSION IN A NON-OPIOID DEPENDENT MANNER Timothy Ness, Alan Randich, Julie Hill, Jamie McNaught, Birmingham, AL, Dwight Nelson, Xin Su*, Minneapolis, MN 9:10 PD7-08 A THREE DIMENSIONAL MAP OF HUMAN BLADDER INNERVATION J. Purves*, Mount Pleasant, SC, Laura Spruill, Eric Rovner, Elyse Borisko, Alden McCants, Elizabeth Mugo, Ashley Wingard, Thierry Bacro, Thomas Trusk, Monty Hughes, Charleston, SC 9:20 PD7-09 VOLTAGE-GATED KCNQ CHANNELS IN HUMAN DETRUSOR SMOOTH MUSCLE CONTRACTILITY: A NOVEL TARGET FOR THE PHARMACOLOGICAL TREATMENT OF OVERACTIVE BLADDER Aaron Provence*, Kiril L. Hristov, Shankar P. Parajuli, Columbia, SC, Eric S. Rovner, Charleston, SC, Georgi V. Petkov, Columbia, SC 9:30 PD7-10 TURBT OF THE INTRAMURAL PORTION OF THE DISTAL URETER: PREDICTIVE FACTORS FOR SECONDARY STENOSIS AND DEVELOPMENT OF UPPER URINARY TRACT TUMOURS Oscar Rodríguez Faba*, Pablo Juárez del Dago, Josep Maria Gaya, Joan Palou, Ferran Algaba, Humberto Villavicencio, Barcelona, Spain 9:40 PD7-11 SPONTANEOUS VOIDING IS SURPRISINGLY RECOVERABLE VIA OUTLET PROCEDURE AFTER DOCUMENTED UNDERACTIVE BLADDER ON URODYNAMICS Ahmed Alkaram, Elise J.B. De, Amy D. Dobberfuhl*, Albany, NY 9:50 PD7-12 HIGHLY COORDINATED DELIVERY OF UROPLAKIN PROTEINS TO THE APICAL UROTHELIAL CELL SURFACE Jiangyong Ouyang, Xuemei Guo, Krassimira Hadjiolova, Jeremy Miller, Iwona Gumper, Jean-Pierre Simon, New York, NY, Tanya Tolmachova, Miguel Seabra, London, United Kingdom, Mitsunori Fukuda, Sendai, Miyagi, Japan, Xue-Ru Wu, Michael Rindler*, Sun Tung-Tien, Gert Kreibich, New York, NY 66

79 Saturday, May 16, 2015 Podium Session 8 INFECTIONS/INFLAMMATION OF THE GENITOURINARY TRACT: KIDNEY & BLADDER I Room New Orleans Morial Convention Center Moderators: Robert Moldwin and Durwood Neal, Jr. 8:00 am - 10:00 am TIME NUMBER TITLE TIME NUMBER TITLE 8:00 PD8-01 URINARY TRACT INFECTIONS, RESISTANCE PATTERNS AND EFFECTIVENESS OF ANTIMICROBIAL PERIOPERATIVE PROPHYLAXIS AFTER TRANSURETHRAL PROCEDURES Ashkan Mortezavi*, Maryna Fröhlich, Jan Fehr, Tullio Sulser, Daniel Eberli, Zurich, Switzerland 8:10 PD8-02 UPPER TRACT IMAGING ABNORMALITIES RELATED TO RECURRENT URINARY TRACT INFECTIONS RARELY FOUND IN WOMEN Lauren Rego*, Alana Christie, Philippe Zimmern, Dallas, TX 8:20 PD8-03 PREDICTORS OF READMISSION FOR INFECTIOUS COMPLICATIONS FOLLOWING RADICAL CYSTECTOMY RESULTS FROM A MULTI INSTITUTIONAL NATIONAL DATASET Sij Hemal*, Louis Krane, Winston-Salem, NC, Kyle A Richards, Madison, WI, Michael Liss, San Antonio, TX, A Karim Kader, San Diego, CA, Ronald Davis, Winston Salem, NC 8:30 PD8-04 TRANSMOGRIFYING INFECTION STONES: ARE CALCIUM STONES NOW THE COMMONER INFECTION STONES IN PCNL? Ivo Dukic*, Ayo Kalejaiye, Kim Jacobson, Francis Keeley, Anthony Timoney, Joe Philip, Bristol, United Kingdom 8:40 PD8-05 DOES STONE REMOVAL HELP PATIENTS WITH RECURRENT URINARY TRACT INFECTIONS? Mohamed Omar*, Hemant Chaparala, Abdullahi Ahmed, Manoj Monga, Cleveland, OH 8:50 PD8-06 PERIOPERATIVE BLOOD TRANSFUSIONS AS A RISK FACTOR FOR INFECTIOUS COMPLICATIONS AFTER UROLOGIC SURGERY Richard Matulewicz*, Daniel Oberlin, Irene Helenowski, Borko Jovanovic, Shilajit Kundu, Chicago, IL 9:10 PD8-08 RISK FACTORS FOR FEBRILE UTI IN SPINAL CORD INJURY PATIENTS WITH ROUTINE CONCOMITANT INTERMITTENT CATHETERIZATION (CIC) Fukashi Yamamichi, Amagasaki, Hyogo, Japan, Katsumi Shigemura*, Shigeto Mukai, Masashi Nomi, Akihiro Yanagiuchi, Atsushi Sengoku, Kazushi Tanaka, Soichi Arakawa, Masato Fujisawa, Kobe, Japan 9:20 PD8-09 PAINFUL BLADDER FILLING AND PAINFUL URGENCY ARE DISTINCT CHARACTERISTICS IN MEN AND WOMEN WITH UROLOGIC CHRONIC PELVIC PAIN SYNDROMES (UCPPS) A MAPP RESEARCH NETWORK STUDY H. Henry Lai*, St Louis, MO, John Krieger, Seattle, WA, Michel Pontari, Philadelphia, PA, Dedra Buchwald, Seattle, WA, Xiaoling Hou, J. Richard Landis, Philadelphia, PA 9:30 PD8-10 ARE OUR DAILY CLINICS FOLLOWING GUIDELINES FOR PREVENTION OF SURGICAL SITE INFECTION? Katsumi Shigemura*, Soichi Arakawa, Fukashi Yamamichi, Hideaki Miyake, Kazushi Tanaka, Masato Fujisawa, Kobe, Japan 9:40 PD8-11 THE CHARACTERISTICS OF WOMEN TESTING POSITIVE FOR MYCOPLASMA HOMINIS AND UREAPLASMA UREALYTICUM IN THE URINARY TRACT Jessie Liang*, Sarah Rentrop, Andrea Balthazar, Clifton F. Frilot II, Alex Gomelsky, Shreveport, LA 9:50 PD8-12 CHANGING TRENDS IN CAUSATION, PRESENTATION AND MANAGEMENT OF PSOAS ABSCESS Tanvi Sood, Manasa T, Rajeev Sood*, Raman Tanwar, New Delhi, India SATURDAY 9:00 PD8-07 A PROSPECTIVE RANDOMIZED DOUBLE- BLINDED PLACEBO CONTROL TRIAL ON THE EFFECTS OF CRANBERRY SUPPLEMENTATION ON BACTERIAL COLONIZATION AND SYMPTOMATIC URINARY TRACT INFECTIONS IN FEMALES WITH NEUROGENIC BLADDER DYSFUNCTION DEPENDENT ON SELF CATHETERIZATION Jason Scovell*, Houston, TX, Sophie Fletcher, Santa Rosa, CA, Julie Stewart, Rose Khavari, Houston, TX *Presenting author 67

80 Saturday, May 16, 2015 Podium Session 9 URINARY DIVERSION: BLADDER RECONSTRUCTION, AUGMENTATION, SUBSTITUTION, DIVERSION I Room New Orleans Morial Convention Center Moderator: Arnulf Stenzl TIME NUMBER TITLE TIME NUMBER TITLE 8:00 PD9-01 CONTINENCE OUTCOMES FOLLOWING RADICAL CYSTECTOMY AND ORTHOTOPIC NEOBLADDER Swar Shah*, Soroush Bazaragani, Gus Miranda, Kevin Wayne, Hooman Djaladat, Anne Schuckman, Siamak Daneshmand, Los Angeles, CA 8:10 PD9-02 HEALTH RELATED QUALITY OF LIFE AFTER RADICAL CYSTECTOMY IN WOMEN: ORTHOTOPIC NEOBLADDER VERSUS ILEAL LOOP CONDUIT AND IMPACT OF INCONTINENCE Mohamed Zahran, Diaa-eddin Taha, Mohamed Tharwat, Essam M Zidan, Mona A El-Bilsha, Ahmed Harraz, Bedeir Ali-El-Dein*, Mansoura, Egypt 8:20 PD9-03 QUALITY OF LIFE IN 112 MEN AND 33 WOMEN WITH BLADDER CANCER UNDERGOING ILEAL CONDUIT: A MULTICENTRE STUDY AMONG LONG- TERM SURVIVORS Salvatore Siracusano*, Stefano Ciciliato, Renato Talamini, Laura Toffoli, Francesco Visalli, Tommaso Silvestri, Emanuele Belgrano, Trieste, Italy, Mauro Niero, Cristina Lonardi, Maria Angela Cerruto, Verona, Italy, Ciro Imbimbo, Naples, Italy, Marco Racioppi, Rome, Italy, Massimo Iafrate, Padua, Italy, Carolina D Elia, Giovanni Cacciamani, Davide De Marchi, Verona, Italy, Paolo Verze, Naples, Italy, Pierfrancesco Bassi, Rome, Italy, Walter Artibani, Verona, Italy 8:30 PD9-04 QUALITY OF LIFE AFTER URINARY DIVERSION WITH ORTHOTOPIC NEOBLADDER Alexander Kretschmer*, Tobias Grimm, Alexander Buchner, Birte-Swantje Schneevoigt, Maria Apfelbeck, Markus Grabbert, Christian G. Stief, Alexander Karl, Munich, Germany 8:40 PD9-05 ATTITUDES TOWARD THE USE OF CONTINENT URINARY DIVERSIONS IN PATIENTS UNDERGOING CYSTECTOMY: A SURVEY OF THE SOCIETY OF UROLOGIC ONCOLOGY Adam Mellis*, Michael Cookson, Joel Slaton, Oklahoma City, OK 8:50 PD9-06 LONG-TERM FUNCTIONAL OUTCOME AND COMPLICATIONS AFTER RADICAL CYSTECTOMY AND ORTHOTOPIC NEOBLADDER DIVERSION Michael Maidaa, Burbank, CA, Gus Miranda, Inderbir Gill, Siamak Daneshmand, Hooman Djaladat*, Los Angeles, CA 8:00 am - 10:00 am 9:00 PD9-07 EARLY AND LATE COMPLICATIONS OF ROBOTIC RADICAL CYSTECTOMY AND INTRA-CORPOREAL URINARY DIVERSION Raed A Azhar, Andre Luis de Castro Abreu*, Evren Suer, Jie Cai, Gus Miranda, Raj Satkunasivam, Charles Metcalfe, Kelvin Wong, Andre Berger, Monish Aron, Inderbir S Gill, Mihir Desai, Los Angeles, CA 9:10 PD9-08 RISK ASSESSMENT OF LATE COMPLICATIONS AFTER ROBOTIC RADICAL CYSTECTOMY WITH TOTAL INTRACORPOREAL URINARY DIVERSION Mariaconsiglia Ferriero*, Rome, Italy, Giuseppe Simone, Turin, Italy, Rocco Papalia, Salvatore Guaglianone, Michele Gallucci, Rome, Italy 9:20 PD9-09 ANALYSIS OF PERIOPERATIVE OUTCOMES FOR PROCEDURES INVOLVING URINARY DIVERSION USING THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM (NSQIP) DATABASE Robert C Kovell*, David C Brooks, Devin A. Haddad, Ahmed A Aboumohamed, Ryan P Terlecki, Winston Salem, NC 9:30 PD9-10 TIMING OF URETERAL STENT REMOVAL AND POSTOPERATIVE COMPLICATIONS FOLLOWING RADICAL CYSTECTOMY WITH URINARY DIVERSION Justin Matulay, Christopher Sayegh, Julia Finkelstein, Mark Silva*, G. Joel DeCastro, New York, NY 9:40 PD9-11 PREDICTORS OF SYMPTOMATIC URETERO-ENTERIC ANASTOMOTIC STRICTURES AFTER RADICAL CYSTECTOMY AND URINARY DIVERSION Katherine Brewer*, Gillian Stearns, S. Machele Donat, Harry Herr, Bernard Bochner, Guido Dalbagni, Jaspreet Sandhu, New York, NY 9:50 PD9-12 VIDEOURODYNAMIC EVALUATION OF INTRACORPOREALLY RECONSTRUCTED ORTHOTOPIC U-SHAPED ILEAL NEOBLADDERS Antonio Luigi Pastore, Giovanni Palleschi*, Luigi Silvestri, Andrea Ripoli, Antonio Carbone, Latina, Italy 68

81 Saturday, May 16, 2015 Podium Session 10 URODYNAMICS/INCONTINENCE/FEMALE UROLOGY: NEUROGENIC VOIDING DYSFUNCTION II Room New Orleans Morial Convention Center Moderators: Patrick Shenot and Alex Gomelsky 8:00 am - 10:00 am TIME NUMBER TITLE TIME NUMBER TITLE 8:00 PD10-01 THE IMPACT OF PONTINE DISEASE ON LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH MULTIPLE SCLEROSIS Steven Weissbart*, Philadelphia, PA, Anna Malykhina, Denver, CO, Tom Bavaria, Alan Wein, Ariana Smith, Philadelphia, PA 9:00 PD10-07 THE SEVERITY OF BOWEL DYSFUNCTION IN PATIENTS WITH NEUROGENIC BLADDER Anne P Cameron*, Gianna M Rodriguez, Amy Gursky, Chang He, J Quentin Clemens, John T Stoffel, Ann Arbor, MI 8:10 PD10-02 HIGHER NEURAL CORRELATES AT INITIATION OF VOIDING IN PATIENTS WITH MULTIPLE SCLEROSIS WITH NEUROGENIC BLADDER DYSFUNCTION VIA CONCURRENT FUNCTIONAL MAGNETIC RESONANCE IMAGING (FMRI) AND URODYNAMIC STUDIES Michael Shy*, Christof Karmonik, Jeff Anderson, Abdulaziz Alkattan, Timothy Boone, Steve Fung, Houston, TX, Sophie Fletcher, Santa Rosa, CA, Rose Khavari, Houston, TX 8:20 PD10-03 EXTERNAL VALIDATION OF THE NEUROGENIC BLADDER SYMPTOM SCORE IN MULTIPLE SCLEROSIS PATIENTS WITH LOWER URINARY TRACT DYSFUNCTION Giorgio Ivan Russo*, Tommaso Castelli, Eugenia Fragalà, Alessandro Di Rosa, Raimondo Giardina, Vincenzo Favilla, Salvatore Privitera, Sebastiano Cimino, Catania, Italy, Blayne Welk, London, Canada, Giuseppe Morgia, Catania, Italy 8:30 PD10-04 CHANGES IN THE HOFFMANN REFLEX DURING BLADDER FILLING PROVIDE CLUES TO THE PATHOPHYSIOLOGY OF BLADDER DYSFUNCTION IN PATIENTS WITH MULTIPLE SCLEROSIS Antonella Giannantoni, Perugia, Italy, Silvia Proietti, Guido Giusti, Rozzano (MI), Italy, Marilena Gubbiotti, Jacopo Adolfo Rossi de Vermandois, Andrea Boni, Perugia, Italy, Antonella Conte*, Rome, Italy 8:40 PD10-05 UTILIZING MORE RESTRICTIVE CRITERIA FOR OBTAINING URODYNAMICS IN WOMEN WITH MULTIPLE SCLEROSIS DOES NOT RESULT IN MORE WORRISOME FINDINGS Himanshu AGGARWAL*, Rebecca Lavelle, Louise Gliga, Alana Christie, Gary Lemack, Dallas, TX 8:50 PD10-06 THE TENSION FREE VAGINAL TAPE VERSUS THE PUBOVAGINAL SLINGS FOR WOMEN WITH NEUROGENIC STRESS URINARY INCONTINENCE Ahmed El-Azab*, Asyut, Egypt, Sherif El-Nashar, Rochester, MN 9:10 PD10-08 THE NATURAL HISTORY OF NEUROGENIC BLADDER IN ADULTS WITH SEVERE CEREBRAL PALSY Robert Goldfarb*, Daniel Liberman, Yunhua Fan, Andrew Pisansky, Sean Elliott, Minneapolis, MN 9:20 PD10-09 GENTAMICIN INTRAVESICAL INSTILLATIONS DECREASE SYMPTOMATIC URINARY TRACT INFECTIONS AND ORAL ANTIBIOTIC USE IN PATIENTS WITH NEUROGENIC BLADDER ON INTERMITTENT CATHETERIZATION Lindsey Cox*, J. Quentin Clemens, Anne Cameron, Ann Arbor, MI 9:30 PD10-10 FOXP3 EXPRESSION SERVES AS A MARKER OF SQUAMOUS CELL DIFFERENTIATION AND AGGRESSIVE PATHOLOGY OF UROTHELIAL CARCINOMAS IN NEUROGENIC PATIENTS Véronique Phé*, Morgan Rouprêt, Olivier Cussenot, Emmanuel Chartier-Kastler, Paris, France, Xavier Gamé, Toulouse, France, Eva Compérat, Paris, France 9:40 PD10-11 LONG-TERM FUNCTIONAL OUTCOMES AFTER ARTIFICIAL URINARY SPHINCTER (AMS 800 ) IMPLANTATION IN FEMALE NEUROGENIC PATIENTS WITH STRESS URINARY INCONTINENCE Véronique Phé*, Priscilla Léon, Benjamin Granger, Morgan Rouprêt, Paris, France, Pierre Denys, Garches, France, Marc-Olivier Bitker, Emmanuel Charttier-Kastler, Paris, France 9:50 PD10-12 MEDICAL COMPLICATIONS AND UROLOGICAL SURVEILLANCE IN THE UNITED STATES ADULT SPINA BIFIDA POPULATION Yahir Santiago-Lastra*, Anne P Cameron, Ann Arbor, MI, Julie Lai, Santa Monica, CA, Christopher Saigal, Los Angeles, CA, J. Quentin Clemens, Ann Arbor, MI, The NIDDK Urologic Diseases in America Project, Los Angeles, CA SATURDAY *Presenting author 69

82 Saturday, May 16, :00 am - 11:30 am SOCIETY FOR BASIC UROLOGIC RESEARCH/THE SOCIETY OF UROLOGIC ONCOLOGY (SBUR/SUO) JOINT SESSION La Nouvelle New Orleans Morial Convention Center 8:00 WELCOME 8:05 CHALLENGES FACED WITH RE-EMERGING CANCERS Michael Cher 8:15 TUMOR DORMANCY: THE HEMATOPOIETIC STEM CELL NICHE REGULATES DORMANCY Russell Taichman 8:40 MTOR INHIBITORS IN METASTATIC RENAL CANCER - DO THEY WORK AND WHEN DO THEY WORK? Robert Figlin 9:00 EPITHELIAL-MESENCHYMAL-TRANSITION: THE THERAPEUTIC POTENTIAL OF TARGETING THE EPITHELIAL-MESENCHYMAL TRANSITION IN CANCER Fazlul Sarkar 9:20 BREAK 9:40 CIRCULATING TUMOR CELLS: TELLING THE TRUTH ABOUT METASTASIS Massimo Cristofanilli 10:00 PRE-METASTATIC NICHE: BREAST FIBROBLASTS MODULATE EARLY DISSEMINATION, TUMORIGENESIS, AND METASTASIS THROUGH ALTERATION OF EXTRACELLULAR MATRIX CHARACTERISTICS Thea Tlsty 10:25 DEBATE: THE CLONALITY OF PROSTATE CANCER METASTASES - MULTIPLE OR SINGLE ORIGINS? Moderator: Natasha Kyprianou Debaters: Francesca Demichelis, Srinivasan Yegnasubramanian 10:55 DONALD S. COFFEY LECTURE: STEM CELLS AND SIGNALING PATHWAYS IN UROLOGIC REGENERATION AND MALIGNANCY Philip Beachy 11:30 ADJOURN Saturday, May 16, 2015 WORLD CHINESE UROLOGICAL SOCIETY (WCUS) Room New Orleans Morial Convention Center 8:00 am - 2:00 pm 8:00 WELCOME Society Chair: Tom Lue 8:05 SCIENTIFIC PROGRAM Richard Lo 8:10 SESSION 1: LO PING-WAN MEMORIAL LECTURE Moderators: Henry Lai, Richard Lo A 35 YEAR JOURNEY IN FEMALE PELVIS REPAIR Shlomo Raz 8:30 DISCUSSION 8:35 SESSION 2: PROSTATE CANCER Moderators: Yinghao Sun, Teng Lung Lin ADJUVANT THERAPY FOR PATHOLOGICAL T3 PROSTATE CANCER Tony Wu 8:45 PROSTATE CANCER DETECTION PHI C. F. Ng 8:55 UPDATE ON ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY Yiu Ming Kwong 9:05 RADIAL PROSTATECTOMY WITH THE TRANS- BLADDER NECK SLING TECHNIQUE Tiejun Pan 9:15 DISCUSSION 9:20 SESSION 3: BASIC SCIENCE IN ONCOLOGY Moderators: Liyan Zhuang, Chi-Rei Yang TARGETING NOVEL ANDROGEN AXIS RESISTANCE MECHANISMS FOR DEVELOPMENT OF NEXT GENERATION TREATMENT STRATEGIES Allen Gao 9:30 TARGETING PI3K-AR PATHWAYS FOR PROSTATE CANCER MANAGEMENT Benyi Li 9:40 DISCUSSION 9:45 WCUS AWARDS 9:55 SESSION 4: ADVANCE IN LAPAROSCOPY Moderators: Yeh Tan, Peggy Chu, Ming-Tsun Chen RETROPERITONEAL LAPAROSCOPIC SURGERY IN UROLOGY: THE IUPU TECHNIQUES Liqun Zhou 10:05 THE DEVELOPMENT AND APPLICATION OF DR. SUN URETEROSCOPE Xiaofeng Gao 10:15 THE CURRENT PRACTICE OF LAPAROSCOPIC UROLOGY IN TAIWAN Chia-Hsiang Lin 10:25 ROBOTIC PARTIAL NEPHRECTOMY Fan Chi Wai 70

83 10:35 DISCUSSION 10:40 SESSION 5: AJA LECTURE Moderators: Philip Li, Vitalino Carvalho THULIUM LASER IN TREATMENT OF BENIGN PROSTATE HYPERPLASIA Shujie Xia 10:55 HOW TO GET PERMISSIONS TO RE-USE PUBLISHED TABLES/FIGURES IN YOUR NEW MANUSCRIPT Danqing Ren 11:05 SESSION 6: ADVANCE IN INFERTILITY Moderators: Ronny Tan, Xuejun Shang MALE INFERTILITY MICROSURGERIES Peter Chan 11:15 THE APPLICATION OF DIAGNOSTIC MICRODISSECTION TESTICULAR SPERM EXTRACTION FOR INFERTILE MALE WITH NON-OBSTRUCTIVE AZOOSPERMIA William Huang 11:25 TREATMENT OF VARICOCELE Xiangming Mao 11:35 DISCUSSION 11:40 SESSION 7: ED AND OTHERS Moderators: George Chow, Lap Hong Ian, Lee Zhao A NEW THERAPEUTIC APPROACH FOR ERECTILE DYSFUNCTION: ENDOGENOUS STEM CELL Zhongcheng Xin 11:50 ED BASIC RESEARCH UPDATE IN CHINA Yutian Dai 12:00 NOVEL THERAPEUTIC APPROACH FOR URETHRAL CALCULI Lili Liang 12:10 THE TREATMENT OF URINARY STONE BY SOFT URETEROSCOPE Wei Xue 12:20 DISCUSSION 12:25 SESSION 8: BPH AND VOIDING DYSFUNCTION Moderators: Shaw Zhou, Dominic Lee, Yiu Ming Kwong ENDOSCOPIC OPTIONS FOR BPH Liping Xie 12:35 GREEN LIGHT LASER FOR BPH Qiang Dong 12:45 SHOULD WE ARRANGE URODYNAMIC TESTING BEFORE SURGERY FOR STRESS INCONTINENCE? Chieh-Lung Chou 12:55 DISCUSSION 1:00 SESSION 9: POSTER SESSION AND AWARDS 2:00 ADJOURN SATURDAY Saturday, May 16, 2015 INDIAN AMERICAN UROLOGICAL ASSOCIATION (IAUA) Room New Orleans Morial Convention Center 8:00 am - 2:30 pm 8:00 INTRODUCTIONS Program Chair: Anurag Das 8:10 SHOULD USE OF POLYPROPYLENE MESH IN THE VAGINA BE ABANDONED? POINT / COUNTERPOINT Moderator: Gopal Badlani Debaters: E. Ann Gormley, Eric Rovner 8:30 QUESTIONS AND ARS 8:40 OAB GUIDELINES UPDATE E. Ann Gormley 9:00 BULBAR URETHRAL STRICTURES- ENDOSCOPIC MANAGEMENT VS. URETHROPLASTY - A DEBATE Moderator: Edward Wright Debaters: Sanjay Kulkarni, Kennon Miller 9:20 QUESTIONS AND ARS 9:30 ARE ROUTINE MRI FUSION BIOPSIES USEFUL OR WASTEFUL? A DEBATE Moderator: Mani Menon Debaters: Badrinath Konety, Ashutosh Tewari 9:50 QUESTIONS AND ARS 10:00 COFFEE BREAK AND VISIT POSTERS & EXHIBITS 10:20 MANAGEMENT OF RENAL MASSES: EXPERT CASE DISCUSSIONS Moderator: Chandru Sundaram Panelists: Ravi Munver, Ashok Hemal, Mihir Desai 10:50 QUESTIONS AND ARS 11:00 MANAGEMENT OF BPH RELATED LUTS - ROLE OF MINIMALLY INVASIVE PROCEDURES Moderator: Raju Thomas Discussants: Jaspreet Sandhu, Harcharan Gill, Puneet Sindhwani 11:30 USI SESSION MANAGEMENT OF DIFFICULT STONES: EXPERT CASES Moderator: Mantu Gupta Discussants: Ojas Shah, Percy Chibber, Mahesh Desai 12:00 QUESTIONS AND ARS 12:10 ACADEMIA AND INDUSTRY SYNERGY - THE NEW DRUG DEVELOPMENT ECOSYSTEM Moderator: Anurag Das Speakers: Grannum Sant, Deepak Kirpekar *Presenting author 71

84 12:30 SPONSORED LUNCH PROGRAM AND BUSINESS MEETING (NON-CME PORTION OF PROGRAM) 1:30 IAUA BUSINESS MEETING-MEMBERS ONLY (CME RESUMES) 2:30 ADJOURN 2:00 POSTER PRESENTATIONS AND DISCUSSION Moderators: D Ramesh, Ajay Singla, Ramasamy Chettiar Meyyappan, Kim Mammen Saturday, May 16, 2015 AUA/CONFEDERACION AMERICANA DE UROLOGIA (CAU) Great New Orleans Morial Convention Center 8:00 am - 5:00 pm 8:00 MORNING SESSION Moderator: Shlomo Raz TREATMENT OF INFERTILITY Jacob Rajfer 8:30 TREATMENT OF BPH Claus Roehrborn 9:00 TREATMENT OF TESTICULAR CANCER Joel Sheinfeld 9:30 TREATMENT OF KIDNEY STONES Jorge Gutierrez-Aceves 10:00 WELCOMING REMARKS Secretary General, CAU: Hugo Davila 10:05 BREAK 10:30 TARGET BIOPSY IN CANCER OF PROSTATE Leonard Marks 11:00 CARCINOMA OF BLADDER Juan Palou 11:30 CARCINOMA OF PROSTATE William Catalona 12:00 DEBATE: SURGERY FOR STRESS INCONTINENCE WITH VS WITHOUT MESH Debaters: Shlomo Raz, Paulo Palma 12:30 LUNCH 1:30 KIDNEY AFTERNOON SESSION: SEMINAR ON LAPAROSCOPIC AND ROBOTIC SURGERY IN UROLOGY Moderator: Rene Sotelo 2:00 COMPLICATIONS IN ROBOTIC KIDNEY SURGERY Michael Stifelman 2:15 BLADDER ROBOTIC RADICAL CYSTECTOMY, HOW I DO IT? Erik Castle 2:30 DEBATE: RADICAL CYSTECTOMY - OPEN VS ROBOTIC Debaters: Harry Herr, Mihir Desai 3:00 VAGINAL PROLAPSE 3:30 PROSTATE DEBATE PELVIC ORGAN PROLAPSE REPAIR: OPEN VS ROBOTIC Debaters: Mauricio Plata, Ariel Kaufman SURGICAL ANATOMY AND TECHNIQUE OF NERVE PRESERVATION IN ROBOTIC RADICAL PROSTATECTOMY Mani Menon 3:45 RADICAL PROSTATECTOMY IN HIGH RISK AND OLIGO METASTATIC DISEASE Monish Aron 4:00 DEBATE: RADICAL PROSTATECTOMY - OPEN VS ROBOTIC, WHAT S THE EVIDENCE Debaters: William Catalona, Rafael Coelho 4:30 COMPLICATIONS OF ROBOTIC RADICAL PROSTATECTOMY Rene Sotelo 5:00 ADJOURN LAPAROSCOPIC RADICAL NEPHRECTOMY Camilo Giedelman 1:45 NEW FRONTIERS IN ROBOTIC KIDNEY SURGERY Inderbir Gill Saturday, May 16, 2015 AUA/AMERICAN COLLEGE OF OSTEOPATHIC SURGEONS (ACOS) UROLOGY PROGRAM Room New Orleans Morial Convention Center 8:00 am - 6:00 pm Program Chairs: Carolyn Langford, Marta Johnson- Mitchell 8:00 CASTRATE RESISTANT PROSTATE CANCER Gordon Brown 72

85 8:45 DEFINING THE OVERACTIVE BLADDER (OAB) PATHWAY AND IMPROVING TECHNIQUES FOR SNM THERAPY Steven Siegel 9:30 MEN S HEALTH: THINKING OUTSIDE THE BOX Tarek Pacha 10:15 THE DO S AND DON TS OF ANDROLOGY 2015: INFERTILITY, SEXUAL MEDICINE, TESTOSTERONE, AND NEW TECHNOLOGIES Michael Butcher 11:00 SUPERFICIAL BLADDER CANCER AND THE BCG SHORTAGE Edouard Trabulsi 11:45 UROLOGIC ONCOLOGY Thomas Mueller 12:30 LUNCH 1:30 MATRISTEM - SITE SPECIFIC TISSUE REGENERATION GRAFT Carolyn Langford 2:15 URETHROPLASTY: WHAT TO DO AND HOW TO DO IT Richard Santucci 2:45 QUALITY OF LIFE OUTCOMES RESEARCH IN UROLOGY Daniel Stein 3:30 EVALUATION AND MANAGEMENT OF POST- PROSTATECTOMY INCONTINENCE Frank Burks 4:15 ONCOLOGIC/ ROBOTIC CASE STUDIES Ranko Miocinovic, Michael White, Gregory Weigler 5:00 OSTEOPATHIC RESIDENT PRESENTATIONS 6:00 ADJOURN SATURDAY Saturday, May 16, 2015 THE SCIENCE OF FEMALE PELVIC HEALTH La Nouvelle New Orleans Morial Convention Center 8:05 am - 12:05 pm Program Chairs: Lori Birder, Toby Chai 8:05 PANEL 1: BIOMECHANICS AND BIOLOGY OF PELVIC ORGAN SUPPORT MESH AND BIOMECHANICS Pam Moalli 8:35 THE FIBULIN 5 STORY Hiromi Yanagisawa 9:05 Q&A WITH THE PANEL 9:15 PANEL 2: PELVIC ULTRASOUND IMAGING OF PELVIC FLOOR IMAGING OF THE LEVATOR MUSCLE Lieschen Quiroz 9:45 IMAGING OF IMPLANTED MESH Larissa Rodriguez 10:25 PANEL 3: STEM CELLS OF PELVIC FLOOR MEDICINE USE OF MESENCHYMAL STEM CELL TO TREAT PELVIC FLOOR INJURY Margot Damaser 10:50 HOPE AND REALITY OF TISSUE ENGINEERING IN LOWER URINARY TRACT J. Koudy Williams 11:25 DEVELOPING TISSUE ENGINEERING SOLUTIONS FOR PELVIC ORGAN PROLAPSE Sheila MacNeil 11:50 Q&A WITH THE PANEL 10:15 Q&A WITH THE PANEL Saturday, May 16, 2015 Moderated Poster Session 18 TRAUMA/RECONSTRUCTION: URETER, BLADDER, EXTERNAL GENITALIA AND UROTRAUMA I Room New Orleans Morial Convention Center Moderators: Ryan Terlecki and Joel Gelman 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP18-01 THE IMPACT OF MASSIVE TRANSFUSION PROTOCOL ON SIGNIFICANT HEMORRHAGE DURING UROLOGIC SURGERIES Mathew Fakhoury*, Manaf Alom, Michael MP18-03 PENILE FRACTURE: NATIONAL TRENDS IN URETHRAL EVALUATION AND RISK FACTORS FOR URETHRAL INJURY Joseph J. Pariser*, Shane M. Pearce, Sanjay G. Patel, Gregory T. Bales, Chicago, IL Siev, Kai-Wen Chuang, Philip Zhao, Lee Richstone, New Hyde Park, NY MP18-02 WITHDRAWN *Presenting author 73

86 MP18-04 HIGH-GRADE RENAL TRAUMA: DOES MANAGEMENT PREDICT LENGTH OF HOSPITAL STAY? Lindsay Hampson*, Anobel Odisho, Benjamin Breyer, Jack McAninch, San Francisco, CA MP18-05 EPIDEMIOLOGY OF GENITOURINARY TRAUMA IN SERVICE MEMBERS WITH COLORECTAL INJURY WOUNDED DURING OPERATION IRAQI FREEDOM AND OPERATION ENDURING FREEDOM Matthew Kasprenski*, San Antonio, TX, Sean Glasgow, St. Louis, MO, Steven Hudak, San Antonio, TX MP18-06 PREDICTING FACTORS FOR CONSERVATIVE TREATMENT FAILURE IN GRADE IV PEDIATRIC BLUNT RENAL TRAUMA Jun Nyung Lee, Bum Soo Kim, Yun-Sok Ha, Se Yun Kwon, Jae Young Choi, Seock Hwan Choi, Daegu, Korea, Republic of, Deok-Hyun Cho, Gumi-si, Korea, Republic of, Hyun Tae Kim*, Tae-Hwan Kim, Eun Sang Yoo, Tae Gyun Kwon, Sung Kwang Chung, Bup Wan Kim, Daegu, Korea, Republic of MP18-07 CHANGING PATTERNS OF IATROGENIC URETERIC AND BLADDER INJURIES IN THE ERA OF LAPAROSCOPIC AND ROBOTIC SURGERY: A REVIEW OF 114 CONSECUTIVE INJURIES Sunu Philip*, Patrick Hurley, Southfield, MI MP18-08 ADRENAL INJURIES: A NATIONAL TRAUMA DATA BANK ANALYSIS Jairam R. Eswara*, Boston, MA, Valary T. Raup, Julio Geminiani, Joel Vetter, Steven B. Brandes, St Louis, MO MP18-09 IATROGENIC GENITOURINARY INJURIES DURING COLORECTAL SURGERY: CHARACTERIZATION AND LONG-TERM OUTCOMES Valary T. Raup*, St Louis, MO, Jairam R. Eswara, Boston, MA, Steven B. Brandes, St Louis, MO MP18-10 LACTATE LEVELS AT ADMISSION CAN PREDICT NEPHRECTOMY AND MORTALITY IN PATIENTS WITH HIGH GRADE RENAL TRAUMA (AAST III-V) Rodrigo Donalsio da Silva*, Paulo Jaworski, Diedra Gustafson, Leticia Nogueira, Denver, CO, Nathalia Martins Lopes, Curitiba, Brazil, Wilson R. Molina, Fernando J. Kim, Denver, CO MP18-11 CYSTOSCOPY AT THE TIME OF HYSTERECTOMY IMPROVES DETECTION OF URETERAL INJURY: A POPULATION BASED ANALYSIS Robert Blackwell*, Elizabeth Dray, Matthew Zapf, Anai Kothari, Paul Kuo, Robert Flanigan, Gopal Gupta, Maywood, IL MP18-12 BLUNT SCROTAL TRAUMA - IS SURGICAL EXPLORATION NECESSARY? Elaine Redmond*, Fergal MacNamara, Hugh Flood, Limerick, Ireland MP18-13 READMISSION AFTER TREATMENT OF GRADE 3 AND 4 RENAL INJURIES AT A LEVEL 1 TRAUMA CENTER: STATEWIDE ASSESSMENT USING THE COMPREHENSIVE HOSPITAL REPORTING SYSTEM Brian Winters*, Hunter Wessells, Brian Winters, Seattle, WA MP18-14 UROLOGY CONSULTATION CAN IMPROVE SURVIVAL RATES IN RENAL TRAUMA PATIENTS Rodrigo Donalisio da Silva*, Diedra Gustafson, Leticia Nogueira, Wilson R. Molina, Fernando J. Kim, Denver, CO MP18-15 PENETRATING RENAL INJURIES: FEASIBILITY OF NON-OPERATIVE MANAGEMENT Oussama Darwish*, Brian Dang, Prajakta Adsul, Sameer Siddiqui, St. Louis, MO MP18-16 COMPARISON OF NONOPERATIVE AND SURGIAL MANAGEMENT OF RENAL TRAUMA; CAN WE PREDICT WHEN NONOPERATIVE MANAGEMENT FAILS? Marc Bjurlin*, New York, NY, Richard Jacob Fantus, Richard Joseph Fantus, Dana Villines, Chicago, IL MP18-17 ARE ALL PEDIATRIC GRADE 4 RENAL TRAUMAS THE SAME? Christopher Long*, Sasha Tharakan, Dana Weiss, David Chu, Aseem Shukla, Michael Nance, Arun Srinivasan, Philadelphia, PA MP18-18 COMPARISON OF POLYPROPYLENE MESH AND PRIMARY REPAIR IN THE TREATMENT OF BLUNT TESTICULAR RUPTURE Ibrahim Nüvit Tahtali*, Malatya, Turkey, Turan Yildiz, zekeriya Ilce, sakarya, Turkey, Mevlana Derya Balbay, istanbul, Turkey MP18-19 DELAY OF SURGICAL TREATMENT OF PENILE FRACTURE RESULTS IN POOR FUNCTIONAL OUTCOME: RESULTS FROM A LARGE RETROSPECTIVE MULTICENTER EUROPEAN STUDY Giorgio Bozzini*, Milan, Italy, Maarten Albersen, Leuven, Belgium, Javier Romero Otero, Juan Ignacio Martinez-Salamanca, Madrid, Spain, Markus Margreiter, Wien, Austria, Christian Gratzke, Munich, Germany, Eduardo Garcia Cruz, Barcelona, Spain, Alex Mueller, Zurich, Switzerland, Ege Can Serefoglu, Istanbul, Turkey, Paolo Verze, Naples, Italy MP18-20 ENDOSCOPIC RENDEZVOUS PROCEDURE FOR URETERAL IATROGENIC DETACHMENT: REPORT OF A CASE SERIES WITH LONG-TERM OUTCOMES Antonio Luigi Pastore*, Giovanni Palleschi, Luigi Silvestri, Andrea Ripoli, Domenico Autieri, Yazan Al Salhi, Antonio Carbone, Latina, Italy 74

87 Saturday, May 16, 2015 Moderated Poster Session 19 STEM CELL RESEARCH Room New Orleans Morial Convention Center Moderators: Adonis Hijaz and Kazunori Hattori 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP19-01 FUNCTIONAL ANALYSIS OF CANCER STEM-LIKE CELLS BY A NOVEL HSP40 FAMILY MEMBER PROTEIN Hiroki Kusumoto*, Wakayama, Japan, Satoshi Nishizawa, Izumisano, Japan, Yoshihiko Hirohashi, Toshihiko Torigoe, Sapporo, Japan, Nagahide Matsumura, Yasuo Kohjimoto, Wakayama, Japan, Noriyuki Sato, Sapporo, Japan, Isao Hara, Wakayama, Japan MP19-02 HUMAN RENAL PROXIMAL TUBULE CELLS EXPRESSING FUNCTIONAL CHARACTERISTICS WITH MEMBRANOUS AND 3D TUBULAR CHITOSAN SCAFFOLD INI CHIANG*, Taipei, Taiwan MP19-03 THE ANGIOGENIC SIGNALING MOLECULE CYR61 INDUCES INCREASED NEO- VASCULARIZATION IN REGENERATED BLADDER TISSUE Devon Snow-Lisy*, Edward Diaz, Chicago, IL, Jessica Hannick, Maywood, IL, Matthew Bury, Natalie Fuller, Chicago, IL, Nida Ahmad, Maywood, IL, Arun Sharma, Chicago, IL MP19-04 IN-VIVO REGENERATION OF BLADDER MUSCULAR WALL WITH DECELLULARIZED COLON MATRIX: AN EXPERIMENTAL STUDY Abdol-Mohammad Kajbafzadeh, Reza Khorramirouz, Shabnam Sabetkish, Nastaran Sabetkish, Ahmad Masoumi, Sorena Keihani*, Tehran, Islamic Republic of Iran MP19-05 THE HIPPO/MST PATHWAY IS A CRUCIAL PART OF THE BLADDER SMC RESPONSE TO INJURY KJ Aitken, Martin Sidler, Alaleh Samiei, Paul Delgado-Olguin, Darius Bagli*, Toronto, Canada MP19-06 MESENCHYMAL STEM-CELL THERAPY ALLEVIATES INTERSTITIAL CYSTITIS BY ACTIVATING WNT SIGNALING PATHWAY miho song*, Junsoo Park, Myung-Soo Choo, Seoul, Korea, Republic of MP19-07 CAN WE USE HUMAN ADIPOSE-DERIVED STEM CELLS (ADSCS) FROM UROLOGIC CANCER PATIENTS FOR AUTOLOGOUS CELL THERAPY?: A PILOT STUDY Marta Garcia-Contreras, Valencia, Spain, Cesar Vera-Donoso*, Paterna, Spain, José Hernández-Andreu, Valencia, Spain, José García-Verdugo, Paterna, Spain, Elisa Oltra, Valencia, Spain MP19-08 THE MURINE BLADDER SUPPORTS A POPULATION OF STROMAL SCA-1 SMOOTH MUSCLE PROGENITOR CELLS Robert Dettman*, Meredith Lilly, Natalie Kulkulna, Andrew Flum, Grace Delos Santos, Edward Gong, Chicago, IL MP19-09 NOVEL AND COST-EFFECTIVE BIOREACTOR FOR MANUFACTURING HUMAN MULTI-LAYERED UROTHELIAL SHEETS IN TISSUE ENGINEERING Leon Gustaffson, Martin Vaegler, Tubingen, Germany, Karl-Dietrich Sievert*, Tubingen- Lubeck, Germany MP19-10 SYNERGISTIC EFFECTS OF COMBINING UNDIFFERENTIATED ADULT STEM CELLS AND DIFFEREN-TIATED CELLS FOR THE ENGINEERING OF FUNCTIONAL BLADDER SMOOTH MUSCLE TISSUE Souzan Salemi, Daniel Keller, Markus Rottmar, Tullio Sulser, Daniel Eberli*, Zürich, Switzerland MP19-11 WNT-5A OVEREXPRESSING MESENCHYMAL STEM CELLS ENHANCE BLADDER MUSCLE, VESSEL, NERVE, AND UROTHELIUM REGENERATION IN A MURINE MODEL OF BLADDER AUGMENTATION Jessica Hannick*, Maywood, IL, Edward Diaz, Devon Snow-Lisy, Matt Bury, Natalie Fuller, Nida Ahmad, Arun Sharma, Chicago, IL MP19-12 INJECTION OF MESENCHYMAL STEMS CELLS IN RATS WITH CHRONIC CYSTITIS IMPROVES DETRUSOR CONTRACTILITY Jessica Hammett*, Orange, CA, Cody Thorson, Irvine, CA, Felicia Lane, Gamal Ghoniem, Orange, CA, Os Steward, Huiyi Chang, Irvine, CA MP19-13 DEVELOPMENT OF A LARGE XENOGRAFT ANIMAL MODEL TO INVSTIGATE EFFICACY OF CELL-BASED THERAPIES TO TREAT STRESS URINARY INCONTINENCE Bastian Amend, Alexandra Kelp, Martin Vaegler, Arnulf Stenzl, Tubingen, Germany, Karl-Dietrich Sievert*, Tubingen-Lubeck, Germany MP19-14 MAGNETIZATION TRANSFER (MT)-MRI CHARACTERIZES IN VIVO MYOFIBER FORMATION OF MUSCLE PRECURSOR CELLS Markus Rottmar, Andreas Boss, Daniel Eberli*, Zurich, Switzerland SATURDAY *Presenting author 75

88 MP19-15 COMPARATIVE ASSESSMENT OF ORAL AND URETHRAL MUCOSA CELL CULTURES AND IN VITRO ANALYSIS OF THEIR REGENERATIVE AND PROLIFERATIVE PROPERTIES FOR TISSUE ENGINEERING URETHRAL RECONSTRUCTION Graziella Pellegrini*, Francesca Corradini, Modena, Italy, Guido Barbagli, Arezzo, Italy, Michela Zattoni, Michael Giovanardi, Vincenzo Genna, Gianpaolo Bianchi, Modena, Italy, Massimo Lazzeri, Arezzo, Italy MP19-16 HUMAN ADIPOSE TISSUE DERIVED STEM CELLS (HADSCS) PREVENTS FIBROSIS AND BLADDER DYSFUNCTION IN A RAT MODEL OF URETHRAL STRICTURE Fabio Castiglione*, Maarten Albersen, Leuven, Belgium, Andrea Russo, Milan, Italy, Trinity J. Bivalacqua, Baltimore, MD, Francesco Montorsi, Milan, Italy, Steven Joniau, Dirk De Ridder, Leuven, Belgium, Petter Hedlund, Milan, Italy MP19-17 HUMAN URETHRA-ENGINEERED WITH HUMAN MESENCHYMAL STEM CELL WITH MATURATION BY REARRANGEMENT OF CELLS FOR SELF- ORGANIZATION - NEWLY DEVELOPED SCAFFOLD-FREE THREE-DIMENSIONAL BIO-PRINTER - Tokunori Yamamoto*, Yasuto Funahashi, Yoshihisa Mastukawa, Yoshikazu Tsuji, Hideki Mizuno, Nagoya, Japan, Koichi Nakayama, Saga, Japan, Momokazu Gotoh, Nagoya, Japan MP19-18 INTRATUNICAL INJECTION OF ADIPOSE STROMAL VASCULAR FRACTION (SVF) PREVENTS FIBROSIS EXPRESSION IN A RAT MODEL OF PEYRONIE S DISEASE Fabio Castiglione*, Maarten Albersen, Leuven, Belgium, Ettore Di Trapani, Francesco Montorsi, Milan, Italy, Trinity J. Bivalacqua, Baltimore, MD, Steven Joniau, Dirk De Ridder, Leuven, Belgium, Petter Hedlund, Milan, Italy MP19-19 COMPARATIVE STUDY OF AUTOLOGOUS STROMAL VASCULAR FRACTION AND ADIPOSE-DERIVED STEM CELLS FOR ERECTILE FUNCTION RECOVERY IN A RAT MODEL OF CAVERNOUS NERVE INJURY Dalsan You*, Myoung Jin Jang, Bo Hyun Kim, Geehyun Song, Chunwoo Lee, Nayoung Suh, In Gab Jeong, Sang Hoon Song, Kun Suk Kim, Tai Young Ahn, Choung-Soo Kim, Seoul, Korea, Republic of MP19-20 SURVIVIN MEDIATES INFLAMMATION- DRIVEN EXPANSION OF PROGENITOR CELLS IN THE PROSTATE Liang Wang, Edward Srour, Jian-Ting Zhang, Hal Broxmeyer, Travis Jerde*, Indianapolis, IN Saturday, May 16, 2015 Moderated Poster Session 20 INFECTIONS/INFLAMMATION OF THE GENITOURINARY TRACT: KIDNEY & BLADDER II Room New Orleans Morial Convention Center Moderators: Anthony Schaeffer and Claire Yang NUMBER TITLE NUMBER TITLE MP20-01 CYTOTOXIC NECROTIZING FACTOR-1 (CNF-1) TOXIN IN UROPATHOGENIC E. COLI: IS THERE A ROLE FOR VIRULENCE IN URINARY TRACT INFECTION? Jason Michaud*, William Harty, Kwang Sik Kim, Ming-Hsien Wang, Baltimore, MD MP20-02 CONDITIONED MEDIA FROM INFECTED UROTHELIAL CELLS CONTAIN EXOSOMES WITH EPIGENETIC POTENTIAL Kenneth Ting, Alaleh Samiei, Karen J. Aitken, Bryce Weber, Fadi Ibrahim, Akshita Kapila, Frank J. Penna*, Cornelia Tolg, Darius Bagli, Toronto, Canada MP20-03 NLRP3 INFLAMMASOME PLAYS A KEY ROLE IN UROTHELIAL DEFENSE AGAINST UROPATHOGENIC E. COLI Feng He, Yan Liu, Ellen Shapiro, Herbert Lepor, Xue-Ru Wu*, New York, NY 10:30 am - 12:30 pm MP20-04 DNA DAMAGE REPAIR GENES REGULATE BLADDER INFLAMMATION Christopher Dru*, Subhash Haldar, Neil Bhowmick, Los Angeles, CA MP20-05 BLADDER INSTILLATION THEARPY OF MESENCYMAL STEM CELL AND THE ADDITION OF MANNOSE IN A RAT CYSTITIS MODEL- MULTIPLE SUPPRESSIVE EFFECTS FOR EXCESS CYTOKINES Tokunori Yamamoto*, Yasuto Funahashi, Majima Tsuyoshi, Takai Syun, Yoshihisa Matsukawa, Hideki Mizuno, Momokazu Gotoh, Nagoya, Japan 76

89 MP20-06 OPTICAL MONITORING OF DETRUSOR TISSUE OXYGEN SATURATION IN ACUTE LOWER URINARY TRACT INFECTION: A CASE CONTROL COMPARISON Babak Shadgan, Vancouer, Canada, Lynn Stothers, Andrew Macnab*, Mark Nigro, Vancouver, Canada, A Kajbafzadeh, Tehran, Islamic Republic of Iran MP20-07 ALL ASYMPTOMATIC BACTERIURIA, ALL THE TIME Suzanne Groah, Marcos Perez-Losada, Ljubica Caldovic, Inger Ljungberg, Bruce Sprague, Eduardo Castro-Nallar, Neel Shah, Michael Hsieh, Hans Pohl*, Washington, DC MP20-08 PYURIA AND ASYMPTOMATIC BACTERIURIA IS ASSOCIATED WITH NOVEL AND SPECIFIC URINE MICROBIOMES Suzanne Groah, Marcos Perez-Losada, Ljubica Caldovic, Inger Ljungberg, Bruce Sprague, Eduardo Castro-Nallar, Neel Shah, Michael Hsieh, Hans Pohl*, Washington, DC MP20-09 PREDICTIVE VALUE OF ROUTINE URINALYSIS AND URINE MICROSCOPY FOR THE DETECTION OF BACTERIURIA: RESULTS FROM A VETERANS ADMINISTRATION QUALITY ASSURANCE INITIATIVE Kyle Richards*, Stacy Cesario, Sara Best, Susan Deeren, Granville Lloyd, Timothy Moon, Madison, WI MP20-10 A BIOSENSOR FOR RAPID AND SIMULTANEOUS UROPATHOGEN IDENTIFICATION AND CIPROFLOXACIN MINIMUM INHIBITORY CONCENTRATION DETERMINATION Emanuela Altobelli*, Ruchika Mohan, Kathleen Mach, Mandy La Yi Sin, Victoria Anikst, Stanford, CA, Maurizio Buscarini, Rome, Italy, Pak Kin Wong, Tucson, AZ, Vincent Gau, Irwindale, CA, Niaz Banaei, Joseph C. Liao, Stanford, CA MP20-11 ANTIMICROBIAL SUSCEPTIBILITIES OF URINARY EXTENDED SPECTRUM BETA- LACTAMASE-PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE TO FOSFOMYCIN IN HEALTH CARE ASSOCIATED URINARY TRACT INFECTION Ho Seok Chung*, Je-Guk Ryu, Bosung Shin, Deok Hyun Nam, Ho Song Yu, Eu Chang Hwang, Sun-Ouck Kim, Seung Il Jung, Taek Won Kang, Dongdeuk Kwon, Kwangsung Park, Gwangju, Korea, Republic of MP20-12 RECENT ANTIBIOTIC TREATMENT AND THE RISK OF POST-OUTPATIENT CYSTOSCOPY URINARY TRACT INFECTION Justin R. Gregg*, Caroline M. Lai, Thomas R. Talbot, Daniel A. Barocas, Nashville, TN MP20-13 STENT COLONIZATION: DISCORDANCE WITH URINE CULTURE Jennifer Davila-Aponte*, Naveen Nandanan, Sean Corbett, Noah Schenkman, Tracey Krupski, Charlottesville, VA MP20-14 ANTIMICROBIAL UTILIZATION PRIOR TO ENDOUROLOGICAL SURGERY FOR UROLITHIASIS: ENDOUROLOGICAL SOCIETY SURVEY RESULTS Adam Kaplan*, Durham, NC, Ramy Yacoub, Orange, CA, Richard Shin, Fernando Cabrera, Durham, NC, Andreas Neisius, Mainz, Germany, Charles Scales, Durham, NC, Roger Sur, San Diego, CA, Anicka Ackerman, Michael Ferrandino, Durham, NC, Brian Eisner, Boston, MA, Glenn Preminger, Michael Lipkin, Durham, NC MP20-15 FIBRINOGEN RELEASE AND DEPOSITION ON URINARY CATHETERS PLACED DURING UROLOGIC PROCEDURES Jeffrey Larson*, Aaron Potretzke, Jennifer Walker, Ana Lidia Flores-Mireles, Scott Hultgren, Alana Desai, St. Louis, MO MP20-16 REDUCED BLADDER CAPACITY AND INCREASED BLADDER SENSATION IS ASSOCIATED WITH UROTHELIAL DYSFUNCTION AND CHRONIC INFLAMMATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND END- STAGE RENAL DISEASE Jia-Fong Jhang*, Jing-Liang Chen, Jia-Hui Chang, Hann-Chorng Kuo, Hualien, Taiwan MP20-17 INTRAVESICAL LIPOSOMAL TACROLIMUS PROTECTS AGAINST RADIATION CYSTITIS INDUCED BY 3- BEAM TARGETED BLADDER RADIATION Bharathi Raja Rajaganapathy*, Royal Oak, MI, Joseph Janicki, Pittsburgh, PA, Peter Levanovich, Royal Oak, MI, Pradeep Tyagi, Pittsburgh, PA, Jason Hafron, Michael Chancellor, Sarah Krueger, Brian Marples, Royal Oak, MI MP20-18 GRADE 4 HEMORRHAGE RADIATION CYSTITIS TREATED BY EARLY TRANSURETHRAL FULGURATION VERSUS CONSERVATIVE OBSERVATION STRATEGY: OUTCOME COMPARISON FROM 283 CASES Toru Sugiahra*, Hideo Yasunaga, Jun Kamei, Hiroki Matsui, Tohru Nakagawa, Tetsuya Fujimura, Hiroshi Fukuhara, Haruki Kume, Kiyohide Fushimi, Masaaki Tachibana, Yukio Homma, Tokyo, Japan MP20-19 SAFETY AND EFFICACY OF INTRAVESICAL ALUM FOR INTRACTABLE HEMORRHAGIC CYSTITIS: A CONTEMPORARY EVALUATION Mary E. Westerman*, Stephen A. Boorjian, Brian J. Linder, Rochester, MN MP20-20 CYSTECTOMY FOR REFRACTORY HEMORRHAGIC CYSTITIS: CONTEMPORARY ETIOLOGY, PRESENTATION AND OUTCOMES Brian Linder*, Robert Tarrell, Stephen Boorjian, Rochester, MN SATURDAY *Presenting author 77

90 Saturday, May 16, 2015 Moderated Poster Session 21 BLADDER AND URETHRA: ANATOMY, PHYSIOLOGY AND PHARMACOLOGY II Room New Orleans Morial Convention Center Moderators: Karl-Erik Andersson and Michael Ruggieri 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP21-01 HYDROGEN SULFIDE IS A POTENT RELAXING FACTOR IN THE RAT BLADDER AND PROSTATE Takahiro Shimizu*, Shogo Shimizu, Kumiko Nakamura, Nankoku, Japan, Masashi Honda, Yonago, Japan, Keiji Inoue, Motoaki Saito, Nankoku, Japan MP21-02 TRANSLOCATION OF NUCLEAR FACTOR KAPPA B AND EXPRESSION OF CYCLOOXYGENASE-2 IS ENHANCED BY KETAMINE-INDUCED ULCERATIVE CYSTITIS IN RAT BLADDER Yung-Shun Juan*, Yi-Lun Lee, Mei-Yu Jang, Wen-Jeng Wu, Su-E Chen, Kaohsiung, Taiwan, Wei-Chiao Chang, Taipei, Taiwan, Shu-Mien Chuang, Kaohsiung, Taiwan MP21-03 CLINICAL PREDICTORS OF NOCTURIA IN THE SLEEP APNEA POPULATION Omer Raheem*, Ryan Orosco, Terence Davidson, Charles Lakin, San Diego, CA MP21-04 UROTHELIAL EPAC: NOVEL MEDIATOR IN THE REGULATION OF BLADDER CAPACITY Hiroshi Nakagomi*, F.Aura Kullmann, Wily G.Ruiz, Amanda Wolf-Johnston, Gerard Apodaca, Lori A. Birder, Pittsburgh, PA MP21-05 THE ASSOCIATION BETWEEN IMPAIRED URINARY CONTINENCE MECHANISMS AND AGE-RELATED INFLAMMATION IN FEMALE RATS Yasuhiro Sumino*, Oita, Japan, Satoru Yoshikawa, Pittsburgh, PA, Mayuka Shinohara, Ken-ichi Mori, Fuminori Satoh, Hiromitsu Mimata, Oita, Japan, Naoki Yoshimura, Pittsburgh, PA MP21-06 BLADDER SMOOTH MUSCLE CELLS UNDERGO A SYNTHETIC PHENOTYPE SWITCH IN A RAT MODEL OF NEUROGENIC UNDERACTIVE BLADDER DISEASE Emmanuel Weyne*, Yves Deruyver, Karel Dewulf, Roma Rietjens, Leuven, Belgium, Trinity J Bivalacqua, Baltimore, MD, Dirk De Ridder, Frank Van der Aa, Maarten Albersen, Leuven, Belgium MP21-07 SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE AND MULTIPLE ASCENDING DOSES OF THE EP2/EP3 RECEPTOR AGONIST ONO-8055, A POTENTIAL NEW THERAPY FOR UNDERACTIVE BLADDER, IN HEALTHY SUBJECTS Christopher Chapple*, Sheffield, United Kingdom, Mark Bruce, Tomoya Ohno, Tomohiro Kuwayama, Stephen Deacon, London, United Kingdom MP21-08 SKELETAL MYOGENIC DIFFERENTIATION OF HUMAN URINE-DERIVED CELLS AS A POTENTIAL SOURCE OF CELL THERAPY FOR URETHRAL SPHINCTER MUSCLE DYSFUNCTION Wei Chen, Chongqing, China, People s Republic of, M Xie, Bin Yang, S Bharadwaj, Song Li, Guihua Liu, Anthony Atala, Yuanyuan Zhang*, Winston Salem, NC MP21-09 CYSTOMETRIC EFFECTS OF ANDROGEN DEPRIVATION AND DAILY TADALAFIL ADMINISTRATION IN MICE WITH DETRUSOR OVERACTIVITY INDUCED BY NITRIC OXIDE CHRONIC DEFICIENCY Raphael Farias Carvalho*, Ricardo Reges, Patrícia Gaspar, Lucas Marinho, João Batista Cerqueira, Lúcio Flávio Gonzaga-Silva, Fortaleza, Brazil MP21-10 PHYSICAL ACTIVITY MAY PREVENT BLADDER DYSFUNCTION IN OBESE RATS THROUGH OVER-EXPRESSION OF INSULIN SIGNALING RELATED GENES Andre Matos Oliveira*, Fernando F Fonseca, Sabrina T Reis, Vanessa Guimaraes, Katia R Leite, William C Nahas, Miguel Srougi, Alberto A Antunes, Sao Paulo, Brazil MP21-11 CLARITY ILLUMINATES THE STRUCTURAL AND MOLECULAR CHARACTERISTICS OF MOUSE GENITOURINARY TISSUES OVER AND OVER AGAIN Yan Liu, Herbert Lepor, Xue-Ru Wu, Ellen Shapiro*, New York, NY MP21-12 TREATMENT OF RADIATION CYSTITIS VIA P75 RECEPTOR BLOCKADE Youko Ikeda*, Irina Zabbarova, Kathryn Lemon, Neil Lamarre, Michael Epperly, Anthony Kanai, Pittsburgh, PA MP21-13 FUNCTIONAL ROLES OF METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 1A IN CONTROL OF LOWER URINARY TRACT ACTIVITY IN MICE Mitsuharu Yoshiyama*, Tsutomu Mochizuki, Masayuki Takeda, Chuo, Japan MP21-14 UROTHELIAL DYSFUNCTION IN DIABETIC PATIENTS WITH OVERACTIVE BLADDER Chung-Cheng Wang*, New Taipei City, Taiwan, Jing-Hui Lin, Hann-Chorng Kuo, Hualien, Taiwan MP21-15 IMPORTANCE OF DNA-METHYLATION IN PARTIAL BLADDER OUTLET OBSTRUCTION Martin Sidler*, Karen Aitken, Rosanna Weksberg, Darius Bägli, Toronto, Canada 78

91 MP21-16 ROLE OF TRPM4 ON MORPHOLOGICAL AND FUNCTIONAL CHANGES IN THE NEUROGENIC BLADDER F. Aura Kullmann*, Jonathan Beckel, Hiroshi Nakagomi, Amanda Wolf-Johnston, Christian Gauthier, Anthony Kanai, Lori Birder, Pittsburgh, PA MP21-17 MACROPHAGE MIGRATION INHIBITORY FACTOR MEDIATES PROTEASE ACTIVATED RECEPTOR-INDUCED BLADDER PAIN Dimitrios E. Kouzoukas*, Lexington, KY, Katherine L. Meyer-Siegler, St. Petersburg, FL, Fei Ma, Karin N. Westlund, David E. Hunt, Pedro L. Vera, Lexington, KY MP21-18 CONDITIONAL DELETION OF MANGANESE SUPEROXIDE DISMUTASE IN DETRUSOR SMOOTH MUSCLE IS ASSOCIATED WITH BLADDER OVERACTIVITY IN MICE Rania Elrashidy*, Guiming Liu, Nan Xiao, Michael Kavran, Yexiang Huang, Mingfang Tao, Cleveland, OH, Hoda Mohammad, Zagazig, Egypt, C Thomas Powell, Firouz Daneshgari, Cleveland, OH MP21-19 THE IMPACT OF AUTHOPHAGY IN NEUROPATHIC BLADDER REMODELING Souzan Salemi, Ashkan Mortezavi, Maya Horst, Rita Gobet, Tullio Sulser, Daniel Eberli*, Zürich, Switzerland MP21-20 INTRAVESICAL INHIBITION OF P2X3 RECEPTORS IMPROVES BLADDER DYSFUNCTION DEPENDING ON UROTHELIAL EXPRESSION LEVELS FOR THE RECEPTOR IN SCI RATS Jorge Tovar-Perez, Broderick Sutton, Timothy Boone, Alvaro Munoz*, Houston, TX SATURDAY Saturday, May 16, 2015 Moderated Poster Session 22 TECHNOLOGY & INSTRUMENTS: SURGICAL EDUCATION & SKILLS ASSESSMENT I Room New Orleans Morial Convention Center Moderators: James Borin and Mahesh Desai 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP22-01 JOURNAL CLUBS VIA MICROBLOGGING ARE GLOBALIZING CONTINUING MEDICAL EDUCATION: A SYSTEMATIC REVIEW Matthew Roberts*, Brisbane, Australia, Marlon Perera, Mackay, Australia, Nathan Lawrentschuk, Diana Romanic, Nathan Papa, Damien Bolton, Melbourne, Australia MP22-02 APPLICATION OF SIMULATED PATIENT- SPECIFIC 3D PRINTED KIDNEY MODEL FABRICATED BY COLOR MULTI- MATERIAL 3D PRINTER FROM VOLUMETRIC CT TO AID PARTIAL NEPHRECTOMY Yoon Soo Kyung*, Namkug Kim, Dalsan You, Jeong In Gab, Jun Hyuk Hong, Choung-Soo Kim, Myungchan Park, Chanwoo Lee, Sangjun Yoo, Seoul, Korea, Republic of MP22-03 MALLEABLE PHYSICAL MODELS OF RENAL MALIGNANCIES CONSTRUCTED FROM 3-D PRINTERS TO ALLOW SURGICAL RESECTION FOR INDIVIDUALIZED PRE-SURGICAL SIMULATION Michael Maddox*, Allison Feibus, Benjamin Lee, Julie Wang, Raju Thomas, Jonathan Silberstein, New Orleans, LA MP22-04 EVOLUTION OF 3-D PHYSICAL MODELS OF RENAL MALIGNANCIES USING MULTI- MATERIAL 3-D PRINTERS Michael Maddox*, Allison Feibus, Benjamin Lee, Julie Wang, Raju Thomas, Jonathan Silberstein, New Orleans, LA MP22-05 EVALUATION OF TECHNICAL LEARNING- CURVES FOR ROBOT ASSISTED RADICAL PROSTATECTOMY - A MULTI- INSTITUTIONAL STUDY Catherine Lovegrove*, London, United Kingdom, Giacomo Novara, Padua, Italy, Khurshid Guru, Buffalo, NY, Alex Mottrie, Aalst, Italy, Ben Challacombe, London, United Kingdom, Johar Raza, Buffalo, NY, Henk Van der Poel, Amsterdam, Netherlands, James Peabody, Detroit, MI, Rick Popert, Prokar Dasgupta, Kamran Ahmed, London, United Kingdom MP22-06 PRELIMINARY EVALUATION OF THE SIMPORTAL MAJOR VESSEL INJURY (MVI) REPAIR MODEL Domenico Veneziano*, Lauren Poniatowski, Troy Reihsen, Robert Sweet, Minneapolis, MN *Presenting author 79

92 MP22-07 LAPAROSCOPIC IVC INJURY MANAGEMENT TRAINING PREDICTING TECHNICAL & NON-TECHNICAL SKILLS Jason Lee*, Udi Blankstein, Richard Hoang, Michael Ordon, Kenneth Pace, Toronto, Canada MP22-08 INTRAOPERATIVE MRI-GUIDED NAVIGATION OF THE PELVIC FLOOR DURING CLASSIC BLADDER EXSTROPHY AND CLOACAL EXSTROPHY CLOSURE - CUTTING EDGE TECHNOLOGY FOR SURGICAL SKILL EDUCATION Heather Di Carlo*, Baltimore, MD, Eric Massanyi, Akron, OH, Bhavik Shah, Tampa, FL, Aylin Tekes, John Gearhart, Baltimore, MD MP22-09 DEVELOPMENT AND VALIDATION OF AN INTEGRATED SKILLS CURRICULUM WITHIN URETEROSCOPY A RANDOMISED CONTROLLED TRIAL Oliver Brunckhorst*, Shahab Shahid, Abdullatif Aydin, London, United Kingdom, Craig McIlhenny, Larbet, United Kingdom, Shahid Khan, Redhill, United Kingdom, Syed Raza, Buffalo, NY, Arun Sahai, James Brewin, Fernando Bello, Roger Kneebone, Muhammad Khan, Prokar Dasgupta, Kamran Ahmed, London, United Kingdom MP22-10 IMPACT OF MATCHING EDUCATIONAL MATERIALS TO LEARNING STYLE ON ROBOTIC SURGICAL SKILLS TRAINING Daniel Ballow, Justin Fang*, Christopher Kosarek, Travis Green, William Tarry, Susan Tarry, Galveston, TX MP22-11 UNDERSTANDING SURGICAL PERFORMANCE DURING ROBOT- ASSISTED SURGERY: PIERCING THE HORNET S NEST Khurshid Guru*, Somayeh Shafiei, Atif Khan, Mohamed Sharif, Syed Johar Raza, Thomas Fiorica, Mohammad M Durrani, Ehsan Esfahani, Buffalo, NY MP22-12 UROLOGY CORE QUESTION CURRICULUM: UNIVERSITY OF WASHINGTON RESIDENCY EDUCATIONAL TOOL Ryan Hsi*, Byron Joyner, Jonathan Harper, Seattle, WA MP22-13 TRENDS IN MESH USAGE AND RESIDENT INVOLVEMENT FOR VAGINAL SURGERY FROM THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM Devin Haddad*, Louis Krane, Majid Mirzazadeh, Gopal Badlani, Winston-Salem, NC MP22-14 EVALUATION OF IGNITION AND BURN RISK ASSOCIATED WITH CONTEMPORARY FIBEROPTIC AND DISTAL SENSOR ENDOSCOPIC TECHNOLOGY Kyle Spradling*, Brittany Uribe, Zhamshid Okhunov, Martin Hofmann, Michael del Junco, Christina Hwang, Caden Gruber, Ramy Youssef, Jaime Landman, Orange, CA MP22-15 PRELIMINARY EVALUATION OF A NOVEL PCNL TRAINER Ashish Rawandale*, lokesh patni, yaser ahmad, pramod patil, Dhule, India MP22-16 DELIVERY OF A UROLOGY ONLINE COURSE USING MOODLE VERSUS DIDACTIC LECTURES Leonardo O. Reis*, Osamu Ikari, Khaled Ahmed Taha-Neto, Bruno D.B. Carneiro, Gustavo Mendonça, Antonio Gugliotta, Fernandes Denardi, Campinas, Brazil MP22-17 IMPACT OF SPATIAL COGNITIVE ABILITY ON THE PROFICIENCY OF UROLOGICAL SURGEONS IN ROBOT-ASSISTED SURGERY USING MIMIC DV-TRAINER Jun Teishima*, Minoru Hattori, Shogo Inoue, Keisuke Hieda, Shunsuke Shinmei, Hiroyuki Egi, Hideki Ohdan, Akio Matsubara, Hiroshima, Japan MP22-18 EFFECTS OF RESIDENCY TRAINING ON PROSTATE BIOPSY EFFICACY: A REVIEW OF PROSTATE BIOPSIES IN A RESIDENT- RUN CLINIC AT AN INNER-CITY HOSPITAL Allison Polland*, John Griffith, Kathleen Kan, New York, NY, Egor Parkhomenko, True Blue, Grenada, John Sfakianos, New York, NY, Alfred Winkler, Queens, NY MP22-19 INNOVATION, CONSTRUCTION AND ASSESSMENT OF A NOVEL SEAMLESS LAPAROSOPIC PORT PLACEMENT SYSTEM Ashish Rawandale*, lokesh patni, yaser ahmad, Dhule, India MP22-20 PARENTAL STATUS AMONG SUCCESSFUL APPLICANTS TO UROLOGY RESIDENCY Ariella A. Friedman*, Lane S. Palmer, New Hyde Park, NY 80

93 Saturday, May 16, 2015 Podium Session 11 URINARY DIVERSION: BLADDER RECONSTRUCTION, AUGMENTATION, SUBSTITUTION, DIVERSION II Room New Orleans Morial Convention Center Moderator: Richard Hautmann 10:30 am - 12:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 10:30 PD11-01 PELVIC RADIATION IS ASSOCIATED WITH URINARY FISTULAE REPAIR FAILURE AND NEED FOR PERMANENT URINARY DIVERSION Valary T. Raup*, St Louis, MO, Jairam R. Eswara, Boston, MA, Avory M. Heningburg, Steven B. Brandes, St Louis, MO 10:40 PD11-02 URINARY DIVERSION FOR COMPLICATIONS OF PROSTATE CANCER RADIATION TREATMENT Mitchell Bassett*, Darshan Patel, Salt Lake City, UT, Benjamin Breyer, San Francisco, CA, Jonathan Tward, Cameron Thorpe, Salt Lake City, UT, Thomas Gaither, San Francisco, CA, James Hotaling, William Brant, Jeremy Myers, Salt Lake City, UT 10:50 PD11-03 FOLLOW-UP SURGICAL INTERVENTIONS IN PATIENTS WITH URINARY DIVERSION: A COMPARISON BETWEEN ORTHOTOPIC NEOBLADDERS AND ILEAL CONDUITS David Flores*, Katie Murray, William Parker, Daniel Zainfeld, Moben Mirza, Jeffrey Holzbeierlein, Kansas City, KS 11:00 PD11-04 TEMPORAL TRENDS IN CONCOMITANT CYSTECTOMY WITH URINARY DIVERSION FOR BENIGN INDICATIONS IN THE NATIONWIDE INPATIENT SAMPLE Elizabeth T. Brown*, David Osborn, Stephen Mock, Amy Graves, Laurel Milam, Douglas Milam, Melissa Kaufman, Roger Dmochowski, W. Stuart Reynolds, Nashville, TN 11:10 PD11-05 UNDIVERSION OF THE URINARY TRACT: RESULTS FROM A LARGE CYSTECTOMY SERIES (N 1616) Richard Hautmann*, Robert de Petriconi, Ulm, Germany, Juliane Schwarz, Bjoern Volkmer, Kassel, Germany 11:20 PD11-06 DURABILITY OF REVISION SURGERY FOR STENOSIS OF CATHETERIZABLE CHANNELS IN ADULTS Travis Pagliara*, Daniel Liberman, Minneapolis, MN, Jeremy Myers, Salt Lake City, UT, John Stoffel, Ann Arbor, MI, Sean Elliott, Minneapolis, MN 11:30 PD11-07 SLOW WAVE CONDUCTION DISTURBANCES PROXIMAL AND DISTAL TO ILEAL END-TO-END ANASTOMOSIS FOLLOWING ILEOCYSTOPLASTY Fayez Hammad*, Wim Lammers, Al Ain, United Arab Emirates, John Rietbergen, Rotterdam, Netherlands, Betty Stephen, Loay Lubbad, Al Ain, United Arab Emirates 11:40 PD11-08 CONTEMPORARY INDICATIONS FOR ENTEROCYSTOPLASTY IN ADULTS Darshan Patel*, James Hotaling, William Brant, Jeremy Myers, Salt Lake City, UT 11:50 PD11-09 LONG-TERM FUNCTIONAL OUTCOMES OF AUGMENTATION CYSTOPLASTY IN ADULT SPINA BIFIDA PATIENTS: A SINGLE-CENTER EXPERIENCE IN A MULTIDISCIPLINARY TEAM Priscilla Léon*, Emmanuel Chartier-Kastler, Morgan Rouprêt, Paris, France, Pierre Denys, Garches, France, Gilberte Robain, Pierre Montgiat-Artus, Véronique Phé, Paris, France 12:00 PD11-10 AUGMENTATION ENTEROCYSTOPLASTY WITH CONTINENT ILEAL CONDUIT. SURGICAL TECHNIQUE AND OUTCOMES Matias I Gonzalez, Gabriel A Favre, Maria E Zubieta*, Lucas Britez, Oscar H Damia, Juan C Tejerizo, Buenos Aires, Argentina 12:10 PD11-11 PSYCHOLOGICAL AND SEXUOLOGICAL ASPECTS IN YOUNG ADULTS WITH EXSTROPHY-EPISPADIAS COMPLEX: SIMILARITIES AND DIFFERENCES BETWEEN MALE AND FEMALE Massimo Di Grazia*, Sandra Pellizzoni, Michele Rizzo, Paolo Umari, Giovanni Chiriacò, Carlo Trombetta, Waifro Rigamonti, Trieste, Italy 12:20 PD11-12 URINARY TRACT INFECTION AFTER URINARY DIVERSION DIFFERENT PATTERNS OF OCCURRENCE IN PATIENTS WITH ILEAL CONDUIT AND ORTHOTOPIC NEOBLADDER Roy Mano*, Hanan Goldberg, Yariv Stabholz, Danny Hazan, Daniel Kedar, Jack Baniel, Ofer Yossepowitch, Petach Tikva, Israel SATURDAY *Presenting author 81

94 Saturday, May 16, 2015 Podium Session 12 10:30 am - 12:30 pm GENERAL & EPIDEMIOLOGICAL TRENDS & SOCIOECONOMICS: PRACTICE PATTERNS, COST EFFECTIVENESS II Room New Orleans Morial Convention Center Moderators: Christopher Saigal and Ted Skolarus TIME NUMBER TITLE TIME NUMBER TITLE 10:30 PD12-01 COST-EFFECTIVENESS OF MRI TARGETED BIOPSY OF THE PROSTATE yannick Cerantola, Alice Dragomir*, Simon Tanguay, Franck Bladou, Armen Aprikian, Wassim Kassouf, Montreal, Canada 10:40 PD12-02 UTILIZATION AND OUTCOMES OF REPEAT PROSTATE BIOPSY IN A STATEWIDE QUALITY IMPROVEMENT COLLABORATIVE Dinesh Telang*, Roseville, MI, Alice Liu, Yuqing Gao, Susan Linsell, Ann Arbor, MI, Frank Burks, Royal Oak, MI, James Montie, David Miller, Khurshid Ghani, Ann Arbor, MI 10:50 PD12-03 IMPACT OF ADHERENCE TO QUALITY MEASURES FOR LOCALIZED PROSTATE CANCER ON HEALTH-RELATED QUALITY OF LIFE OUTCOMES William Sohn*, Sharon Phillips, Brock O neil, Matthew Resnick, Tatsuki Koyama, David Penson, Daniel Barocas, CEASAR Investigators, Nashville, TN 11:00 PD12-04 TRENDS IN UTILIZATION OF PRIMARY ANDROGEN DEPRIVATION THERAPY FOR LOCALIZED PROSTATE CANCER Mohammed Haseebuddin*, Elizabeth Handorf, Yu-Ning Wong, Philadelphia, PA, Simon Kim, Cleveland, OH, Nikhil Wainganker, Alexander Kutikov, Justin Bekelman, Robert Uzzo, Marc Smaldone, Philadelphia, PA 11:10 PD12-05 DEFINING THE EXTENT AND NATURE OF OVERTREATMENT OF PROSTATE CANCER IN OLDER MEN Daniel Frendl*, Jennifer Yates, Mara Epstein, Robert Blute, Jr, Mitchell Sokoloff, John Ware, Jr, Worcester, MA 11:20 PD12-06 INCREASED PAYMENT FOR OFFICE- BASED MANAGEMENT OF BLADDER CANCER: UNINTENDED CONSEQUENCES IN A FEE-FOR-SERVICE ENVIRONMENT Brock O Neil*, Amy Graves, Daniel Barocas, William Sohn, Sam Chang, David Penson, Matthew Resnick, Nashville, TN 11:30 PD12-07 DECLINE IN THE USE OF RADIATION FOR STAGE I SEMINOMA: ANALYSIS OF THE NATIONAL CANCER DATABASE Nikhil Waingankar*, Elizabeth Handorf, Marc Smaldone, Elizabeth Plimack, Yu-Ning Wong, Mohammed Haseebuddin, Eric Horwitz, Robert Uzzo, Alexander Kutikov, Philadelphia, PA 11:40 PD12-08 LIFE EXPECTANCY AND VARIATION IN TREATMENT FOR EARLY-STAGE KIDNEY CANCER Timothy Daskivich*, Hung-Jui Tan, Mark Litwin, Jim Hu, Los Angeles, CA 11:50 PD12-09 EFFICIENCY AND SATISFACTION OF VIDEO-VISITS IS EQUIVALENT TO AN OFFICE VISIT: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY IN UROLOGY Boyd Viers*, Marcelino Rivera, Igor Frank, Matthew Tollefson, R. Houston Thompson, R. Jeffrey Karnes, Stephen Boorjian, Daniel O Neil, Matthew Gardner, Sarah Jenkins, Deborah Lightner, Matthew Gettman, Rochester, MN 12:00 PD12-10 RACIAL DISPARITIES IN PAIN MEDICATION FOR STONES: RESULTS OF A NATIONWIDE HOSPITAL DATABASE ANALYSIS Courtney K. Rowe*, Deborah S. Hess, James S. Hwong, Francisco J. Gelpi- Hammerschmidt, Boston, MA, Benjamin I. Chung, Palo Alto, CA, Steven L. Chang, Boston, MA 12:10 PD12-11 SURGEON VARIATION IN SURGICAL CASE COSTS Lindsay Hampson*, Anobel Odisho, Peter Carroll, Maxwell Meng, San Francisco, CA 12:20 PD YEAR NEW YORK STATE INPATIENT UROLOGY PRACTICE TRENDS Mark Finkelstein*, Khawaja H Bilal, Rajiv Jayadevan, New York City, NY, Kristian Stensland, Burlington, MA, Michael Palese, New York City, NY 82

95 Saturday, May 16, 2015 Podium Session 13 STONE DISEASE: SURGICAL THERAPY I Room New Orleans Morial Convention Center Moderators: David Duchene and Ali Riza Kural 10:30 am - 12:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 10:30 PD13-01 DUSTING VS BASKETING DURING URETEROSCOPIC LITHOTRIPSY WHAT IS MORE EFFICACIOUS? INTERIM ANALYSIS FROM A MULTI-CENTRE PROSPECTIVE TRIAL FROM THE EDGE RESEARCH CONSORTIUM Ben H. Chew, Vancouver, Canada, Ojas Shah, New York City, NY, Roger L. Sur, San Diego, CA, Bodo E. Knudsen, Columbus, OH, Brian R. Matlaga, Baltimore, MD, Amy E. Krambeck, Rochester, MN, Nicole L. Miller, Nashville, TN, Manoj Monga, Cleveland, OH, Mitchell R. Humphreys*, Phoenix, AZ 10:40 PD13-02 CAN LOW-DOSAGE, DIGITAL X-RAY SCANNING (LODOX) REPLACE COMPUTED TOMOGRAPHY (CT) AND CONVENTIONAL RADIOGRAPHY (CR) IN THE DIAGNOSTICS OF URETERAL STONES? Beat Roth*, Stefanie Hnilicka, Susan D. Meierhans Ruf, Andreas Christe, George N. Thalmann, Bern, Switzerland 10:50 PD13-03 ROBOTIC ANATROPHIC NEPHROLITHOTOMY: IDEA, DEVELOPMENT, EXPLORATION, ASSESSMENT AND LONG-TERM MONITORING (IDEAL) PHASE 0 STUDY Akshay Sood*, Detroit, MI, Jay Rohde, Michael Van Winkle, Atlanta, GA, Dean Assimos, Birmingham, AL, Ashok Hemal, Salem, NC, James Peabody, Mani Menon, Detroit, MI, Khurshid Ghani, Ann Arbor, MI 11:00 PD13-04 COMPARISON OF FLOW CHARACTERISTICS OF NOVEL THREE- DIMENSIONALLY PRINTED URETERAL STENTS VS. STANDARD URETERAL STENTS IN A PORCINE MODEL Zhamshid Okhunov*, Michael Del Junco, Renai Yoon, Garen Abedi, Christopher Pulford, Christina Hwang, Jaime Landman, Orange, CA 11:10 PD13-05 PRESTENTING IN URETERORENOSCOPY: MULTICENTER EVALUATION BY THE INTERNATIONAL COLLABORATION IN ENDOUROLOGY (UROICE) Jan Jessen*, Sindelfingen, Germany, Alberto Breda, Barcelona, Spain, Marianne Brehmer, Aarhus, Denmark, Evangelos Liatsikos, Patras, Greece, Felix Millan Rodriguez, Barcelona, Spain, Palle Osther, Fredericia, Denmark, Cesare Scoffone, Torino, Italy, Thomas Knoll, Sindelfingen, Germany 11:20 PD13-06 RETROPERITONEAL LAPAROSCOPIC TECHNIQUE IN TREATMENT OF COMPLEX RENAL STONES: 104 CASES Qiang Lu*, Pengchao Li, Jun Tao, Chao Qin, Changjun Yin, Nanjing, China, People s Republic of 11:30 PD13-07 NATURAL HISTORY, COMPLICATIONS, AND RE-INTERVENTION RATES OF ASYMPTOMATIC RESIDUAL STONE FRAGMENTS POST-URETEROSCOPY: A REPORT FROM THE EDGE RESEARCH CONSORTIUM Ben H. Chew*, Hilary Brotherhood, Vancouver, Canada, Roger L. Sur, San Diego, CA, Bodo E. Knudsen, Columbus, OH, Nicole L. Miller, Nashville, TN, Courtney Yong, Columbus, OH, Tracy Marien, Nashville, TN, An-Qi Wang, San Diego, CA, Cameron Charchenko, Rochester, MN, Mitchell R. Humphreys, Phoenix, AZ, Amy E. Krambeck, Rochester, MN 11:40 PD13-08 CHANGING PATIENT POSITION CAN ELIMINATE ARRHYTHMIAS DEVELOPING DURING SHOCK WAVE LITHOTRIPSY (SWL) Tarek Alzahrani*, Daniela Ghiculete, Kenneth Pace, R.J. D A. Honey, Toronto, Canada 11:50 PD13-09 MICRO VERSUS MINI PERCUTANEOUS NEPHROLITHOTOMY FOR THE TREATMENT OF PEDIATRIC KIDNEY STONE DISEASE Tuna Karatag, Konya, Turkey, Abdulkadir Tepeler, Mesrur Selcuk Silay, Istanbul, Turkey, Mehmet Nuri Bodakci, Diyarbakir, Turkey, Ibrahim Buldu, Mansur Daggulli, Namik Kemal Hatipoglu, Mustafa Okan Istanbulluoglu*, Abdullah Armagan, Konya, Turkey 12:00 PD13-10 UPPER CALYX APPROACHABILITY USING RIGID NEPHROSCOPES THROUGH A LOWER CALYX ACCESS: COMPARISON BETWEEN PRONE AND SUPINE PCNL AND ASSESSMENT OF ANATOMICAL FACTORS THAT MAY INFLUENCE THIS APPROACH AS MEASURED BY MULTIDETECTOR CT WITH 3D RECONSTRUCTIONS Mario Sofer*, Tel Aviv, Israel, Silvia Proietti, Rozano (MI), Italy, Maharan Kabha, Tel Aviv, Israel, Guido Giusti, Rozano (MI), Italy, Haim Matzkin, Galit Aviram, Tel Aviv, Israel SATURDAY *Presenting author 83

96 12:10 PD13-11 A MULTICENTER EVALUATION OF ZERO- FRAGMENT NEPHROLITHOTOMY: ROBOTIC PYELOLITHOTOMY AND NEPHROLITHOTOMY FOR TREATING RENAL STONES Ryan Swearingen*, Ann Arbor, MI, Rabii Madi, Zachary Klaassen, Augusta, GA, Ketan Badani, New York, NY, Akshay Sood, Jack Elder, Detroit, MI, Kyle Wood, Ashok Hemal, Winston-Salem, NC, Khurshid Ghani, Ann Arbor, MI 12:20 PD13-12 USING AN ELECTRONIC MEDICAL RECORD TO ASSESS PATIENT- REPORTED MORBIDITY AFTER URETEROSCOPY Monica S.C. Morgan*, Jodi A. Antonelli, Nicholas Kavoussi, Niccolo M. Passoni, Adam Cohen, Margaret S. Pearle, Dallas, TX Saturday, May 16, :30 pm - 4:30 pm THE SOCIETY OF URODYNAMICS, FEMALE PELVIC MEDICINE AND UROGENITAL RECONSTRUCTION (SUFU) La Nouvelle New Orleans Morial Convention Center 12:30 WELCOME AND INTRODUCTION Program Chair: Alexander Gomelsky 12:40 PREOP WORK-UP OF POP Moderator: Tracey Wilson Panelists: Anne Pelletier Cameron, Priya Padmanabhan, Christopher Wolter 1:05 Q&A 1:15 NON-SURGICAL TREATMENT OF POP (OBSERVATION, PESSARY, BIOFEEDBACK) Harriette Scarpero, Ariana Smith, Joanna Togami 1:45 Q&A 1:55 SURGERY OF THE APEX (TRANSVAGINAL REPAIR, OPEN/ROBOTIC SACRAL COLPOPEXY, COLPOCLEISIS) Sandip Vasavada, Jennifer Anger, J. Christian Winters 2:35 Q&A 2:45 BREAK 3:00 BIOLOGICS IN POP SURGERY Una Lee 3:15 ROLE OF UTERUS SPARING SURGERY Nirit Rosenblum 3:30 Q&A 3:40 INCONTINENCE PROCEDURE DURING POP REPAIR Moderator: Donna Deng Panelists: Jason Gilleran, Elizabeth Mueller 4:05 Q&A 4:10 STATUS OF MESH IN 2015 Victor Nitti 4:25 Q&A 4:30 ADJOURN Saturday, May 16, 2015 SOCIETY OF UROLOGIC ONCOLOGY (SUO) La Nouvelle New Orleans Morial Convention Center 12:30 pm - 5:00 pm 12:30 WELCOME AND INTRODUCTIONS David Jarrard 12:40 WHITMORE LECTURE THE EMPEROR S NEW CLOTHES: BIAS IN UROLOGIC SCIENCE Introduction: J. Brantley Thrasher Speaker: Ian Thompson 1:00 EVALUATING THE RISK OF LOCALLY ADVANCED AND MICROMETASTATIC BLADDER CANCER PRIOR TO CYSTECTOMY Moderator: Tracy Downs ROLE CONTEMPORARY PRE-CYSTECTOMY NOMOGRAMS AT PREDICTING LOCALLY ADVANCED AND METASTATIC UROTHELIAL BLADDER CANCER Wes Kassouf 1:10 PATHOLOGIC ASSESSMENT AT THE TIME OF TURBT: CAN YOUR INITIAL PATHOLOGY REPORT BE TRUSTED WHEN MAKING TREATMENT DECISIONS Donna Hansel 1:20 OPPORTUNITIES IN PET AND PET/MRI FOR BLADDER CANCER Steven Cho 1:30 LIQUID BIOPSY: CIRCULATING TUMOR CELLS AS BIOMAKERS FOR ADVANCED UROTHELIAL CARCINOMA Trinity Bivalacqua 1:40 CASE DISCUSSION: ASSESSING THE HIGH RISK PATIENT Moderator: Tracy Downs Speakers: Wes Kassouf, Urs Studer, Trinity Bivalacqua, Donna Hansel 84

97 1:50 PERSONALIZED MEDICINE APPROACH TO THE TREATMENT OF ADVANCED PROSTATE CANCER Moderator: Jeffrey Holzbeierlein APPLICATION OF PERSONALIZED MEDICINE TO PROSTATE CANCER Ganesh Palapattu 2:00 WHAT GENOMIC RESEARCH TELLS US ABOUT TREATING PROSTATE CANCER James Brooks 2:10 AR SPLICE VARIANTS AS PREDICTION TOOLS IN ADVANCED PROSTATE CANCER Emmanuel Antonarakis 2:20 PROSTATE CANCER BIOMARKERS FOR TAILORED THERAPY: VALUE ADDED OR ONLY COST David Jarrard 2:30 THE CHANGING FACE OF PROSTATE CANCER TREATMENT: ADT AND EARLY CHEMOTHERAPY Christopher Sweeney 2:40 PANEL DISCUSSION: ARE WE READY FOR MOLECULAR CLASSIFICATION OF ALL TUMORS PRIOR TO TREATMENT? Moderator: Jeffrey Holzbeierlein Panelists: Christopher Sweeney, David Jarrard, James Brooks, Emmanuel Antonarakis 2:55 BREAK 3:10 PENILE CANCER: NEW APPROACHES AND GUIDELINES Moderator: Philippe Spiess UPDATED NCCN GUIDELINES ON PENILE CANCER AND TRIALS Moderator: Philippe Spiess 3:20 PRIMARY PENILE SPARING TREATMENT APPROACHES Adam Feldman 3:30 MANAGEMENT OF INGUINAL LYMPH NODES IN PATIENTS WITH HIGH-RISK PRIMARY PENILE TUMORS AND NO PALPABLE ADENOPATHY OR NON-BULKY LYMPH NODES Viraj Master 3:40 DEBATE: NEOADJUVANT VS. ADJUVANT SYSTEMIC CHEMOTHERAPY FOR PENILE CANCER PATIENTS WITH BULKY INGUINAL ADENOPATHY (CN2/3) IN THE ABSENCE OF OCCULT SITES OF METASTASES) Debaters: Lance Pagliaro, Mayer Fishman 3:55 QUESTIONS AND DISCUSSION 4:00 ENHANCING POST-OPERATIVE RECOVERY AFTER CYSTECTOMY FOR BLADDER CANCER Moderator: Badrinath Konety QUITTING THE RIGHT WAY: EVIDENCE BASED TOBACCO USE PREVENTION Dorothy Hatsukami 4:10 PATTERNS OF TOBACCO USE AND OUTCOMES FROM BLADDER CANCER - POLICY IMPLICATIONS John Gore 4:20 GUIDELINES FOR PERIOPERATIVE CARE AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER: ENHANCED RECOVERY AFTER SURGERY (ERAS) SOCIETY RECOMMENDATIONS Jay Shah 4:30 INTRA-OPERATIVE TECHNIQUES TO ENHANCE POST-OPERATIVE OUTCOMES George Thalmann 4:40 PREVENTING READMISSIONS FOLLOWING CYSTECTOMY Ted Skolarus 4:50 QUESTIONS 5:00 ADJOURN SATURDAY Saturday, May 16, 2015 BANGLADESH ASSOCIATION OF UROLOGICAL SURGEONS (BAUS) Room New Orleans Morial Convention Center 1:00 pm - 3:00 pm 1:00 WELCOME ADDRESS Society President: M A Salam 1:03 SESSION 1: URINARY STONE DISEASE & RENAL TRANSPLANT FLEXIBLE URETEROSCOPY: TECHNIQUE AND TRICKS OF THE TRADE John Denstedt 1:28 OPTIMIZING THE OUTCOME OF RENAL TRANSPLANT IN BANGLADESH AKM Anwarul Islam 1:35 MINI PERC OUR EXPERIENCE / OUR EXPERIENCE IN BANGLADESH Tohid Mohammad Saiful Hossain 1:42 SESSION 2: UROONCOLOGY 1:42 SURGERY FOR MUSCLE INVASIVE BLADDER CANCER Mohammad Hooda 1:49 LAPAROSCOPIC NEPHRECTOMY EXPERIENCE IN BANGLADESH S A Khan *Presenting author 85

98 1:56 SESSION 3: PEDIATRIC & RECONSTRUCTIVE UROLOGY MANAGEMENT OF POSTERIOR URETHRAL VALVE Lane Palmer 2:16 MANAGEMENT OF GENITOURINARY FISTULA M W Islam 2:48 MANAGEMENT OF COMPLEX URETHRAL STRICTURE F Islam 2:55 DISCUSSION & CLOSING REMARKS 3:00 ADJOURN 2:23 LONG-TERM RESULT OF SUBSTITUTION URETHROPLASTY C Dixon Saturday, May 16, 2015 Moderated Poster Session 23 TECHNOLOGY & INSTRUMENTS: SURGICAL EDUCATION & SKILLS ASSESSMENT II Room New Orleans Morial Convention Center Moderators: Robert Sweet and Tadashi Matsuda 1:00 pm - 3:00 pm NUMBER TITLE NUMBER TITLE MP23-01 USING ANDROID SMARTPHONES TO TAKE CYSTOSCOPIC AND URETEROSOPIC IMAGES FOR EXCLUSIVE ONLINE INTERNET REFERRALS Ernesto III Arada*, Luis Florencio, Michael Macalalag, Frederick Mendiola, Jun Dy, Ceasar Ballesteros, Jeremiah Mangahas, Quezon City, Philippines MP23-02 DEVELOPMENT AND CONTENT VALIDATION OF A SAFETY CHECKLIST FOR ROBOT-ASSISTED RADICAL PROSTATECTOMY Catherine Lovegrove*, London, United Kingdom, Giacomo Novara, Padua, Italy, Khurshid Guru, Buffalo, NY, Alex Mottrie, Aalst, Italy, Ben Challacombe, London, United Kingdom, Johar Raza, Buffalo, NY, Henk Van der Poel, Amsterdam, Netherlands, James Peabody, Detroit, MI, Rick Popert, Prokar Dasgupta, Kamran Ahmed, London, United Kingdom MP23-03 NEW INSIGHTS INTO THE PERFORMANCE OF JUNIOR AND SENIOR RESIDENTS ON BASIC UROLOGICAL PROCEDURES Anna Helena de Vries*, Eindhoven, Netherlands, Maaike Boute, Hoorn, Netherlands, Malou Kuppen, Eindhoven, Netherlands, Jeroen van Merriënboer, Maastricht, Netherlands, Evert Koldewijn, Eindhoven, Netherlands, Rob Pelger, Leiden, Netherlands, Barbara Schout, Alkmaar, Netherlands, Cordula Wagner, Amsterdam, Netherlands MP23-04 VALIDATION OF A NOVEL ROBOTIC SKILLS LAB URETHROVESICAL ANASTOMOSIS SIMULATOR Daniel Parisi*, Gregory Murphy, Joseph Wagner, Steven Shichman, Ryan Dorin, Hartford, CT MP23-05 IS THERE A CORRELATION BETWEEN TECHNICAL SKILLS AND NON- TECHNICAL SKILLS PERFORMANCE WITHIN URETEROSCOPY? Oliver Brunckhorst*, Shahab Shahid, Abdullatif Aydin, London, United Kingdom, Craig McIlhenny, Larbet, United Kingdom, Shahid Khan, Redhill, United Kingdom, Arun Sahai, James Brewin, Fernando Bello, Roger Kneebone, Muhammad Khan, Prokar Dasgupta, Kamran Ahmed, London, United Kingdom MP23-06 BATTLE OF THE BOTS: A COMPARISON OF THE STANDARD DA VINCI AND THE DA VINCI SURGICAL SKILLS SIMULATOR IN SURGICAL SKILLS ACQUISITION Kevin Brown, Natalie Mosley*, Elise Drake, Asmita Modak, Marian Campbell, James Tierney, Charleston, WV MP23-07 VASECTOMY SIMULATION MODULE: DIDACTIC, AUDIO-VISUAL, AND LIVE- SIMULATION EXPERIENCE Ram Pathak*, Scott Alford, Todd Igel, Jacksonville, FL MP23-08 INITIAL VALIDATION DURING DEVELOPMENT OF LOW COST ALTERNATIVE TO THE DV-TRAINER USING THE HYDRA SYSTEM Swar Shah*, Eric Hwang, Inderbir Gill, Andrew Hung, Los Angeles, CA MP23-09 A NOVEL TECHNIQUE FOR SIMULATED SURGICAL PROCEDURES USING 3D PRINTING TECHNOLOGY Jonathan Stone*, Braden Candela, Vincent Alleluia, Anees Fazili, Michael Richards, Changyong Feng, Sarah Peyre, Jean Joseph, Ahmed Ghazi, Rochester, NY 86

99 MP23-10 CURRENT OPINIONS OF PROGRAM DIRECTORS ON THE ROLE OF SIMULATION IN UROLOGICAL RESIDENCY TRAINING Ehab Eltahawy, Renee Powell*, Carol Thrush, Katherine Berry, Evan Lacefield, Mohamed Kamel, Little Rock, AR MP23-11 AUGMENTED REALITY ASSISTED UROLOGIC SURGERY (ARAUS): A SURGICAL TRAINING TOOL Tariq Hakky*, Houston, TX, Daniel, R. Martinez, Tampa, FL, Larry, I. Lipshultz, Houston, TX, Philippe, E. Spiess, Rafael, E. Carrion, Tampa, FL MP23-12 ACCELERATED SKILLS ACQUISITION PROTOCOL (ASAP): AN EFFECTIVE TIME- EFFICIENT APPROACH TO VIRTUAL REALITY BASIC TASK SIMULATION TRAINING Ahmed Ghazi*, Aisha Siebert, Changyong feng, Sarah Peyre, Rochester, NY MP23-13 MEDICAL STUDENT DELIBERATE PRACTICE ON A VIRTUAL-REALITY CURRICULUM CAN ACHIEVE EQUIVALENCY TO SENIOR UROLOGY RESIDENT REAL-TIME TRAINING Ahmed Ghazi*, Aisha Siebert, Anees Fazili, Vineet Agrawal, Changyong feng, Sarah Peyre, Rochester, NY MP23-14 WORKPLACE DANGERS AND SAFETY FOR THE UROLOGIST Kelly A. Healy*, Demetrius H. Bagley, Philadelphia, PA MP23-15 COMPARATIVE EVALUATION OF 2D AND NOVEL 3D ROBOTIC SURGERY MENTORING TOOLS Swar Shah*, Los Angeles, CA, Anthony Jarc, Sunnyvale, CA, Eric Hwang, Los Angeles, CA, Joey Chau, Sunnyvale, CA, Jean- Christophe Bernhard, Inderbir Gill, Monish Aron, Andrew Hung, Los Angeles, CA MP23-16 THE ROLE OF HUMAN CADAVERIC PROCEDURAL SIMULATION IN UROLOGY TRAINING Abdullatif Aydin*, Kamran Ahmed, Muhammad Shamim Khan, Prokar Dasgupta, London, United Kingdom, John McCabe, Merseyside, United Kingdom MP23-17 LACK OF AN EXPERIENCED BEDSIDE ASSISTANT MAY ADVERSELY AFFECT OUTCOMES DURING ROBOTIC PROSTATECTOMY Ilana Jacobs*, Aaron Lay, Jeffrey Gahan, Dallas, TX MP23-18 FACE AND CONTENT VALIDATION OF A VASECTOMY SIMULATOR Sangtae Park*, Natalie Fahey, Alex Wind, Omar Farhat, Evanston, IL MP23-19 THE SIMPORTAL FLUORO-LESS C-ARM TRAINER (CAT): PRELIMINARY TRAINING RESULTS Domenico Veneziano*, Minneapolis, MN, Arthur Smith, New York, NY, David Hananel, Troy Reihsen, Jack Stubbs, Jason Speich, Robert Sweet, Minneapolis, MN MP23-20 LIVE SURGICAL DEMONSTRATIONS IN UROLOGY: A SYSTEMATIC REVIEW Oliver Brunckhorst*, Ben Challacombe, Hamid Abboudi, Muhammad Khan, Prokar Dasgupta, Kamran Ahmed, London, United Kingdom SATURDAY Saturday, May 16, 2015 Moderated Poster Session 24 1:00 pm - 3:00 pm GENERAL & EPIDEMIOLOGICAL TRENDS & SOCIOECONOMICS: PRACTICE PATTERNS, COST EFFECTIVENESS III Room New Orleans Morial Convention Center Moderators: Mark Litwin and Bruce Jacobs NUMBER TITLE NUMBER TITLE MP24-01 SECOND PRIMARY MALIGNANCIES: AN ANALYSIS OF SEER DATA Christopher Filson*, Alex Castillo, Lorna Kwan, Mark Litwin, Karim Chamie, Los Angeles, CA MP24-02 GEOGRAPHIC VARIATION OF PROSTATE CANCER INCIDENCE RATE: AN ECOLOGICAL STUDY Matthew Lyons*, Tzy-Mey Kuo, Anne-Marie Meyer, E.Sophie Spencer, Peter Greene, Angela Smith, Michael Woods, Eric Wallen, Raj Pruthi, Matthew Nielsen, Chapel Hill, NC MP24-03 RECEIPT OF INGUINAL LYMPH NODE DISSECTION IN PATIENTS WITH T2 PENILE CANCER: RESULTS FROM THE NATIONAL CANCER DATABASE Mohammed Haseebuddin*, Elizabeth Handorf, Nikhil Wainganker, Rosalia Viterbo, Richard Greenberg, Robert Uzzo, Alexander Kutikov, Marc Smaldone, David Chen, Philadelphia, PA *Presenting author 87

100 MP24-04 USE OF RPLND IN TESTICULAR CANCER IN THE UNITED STATES: RESULTS FROM THE NATIONAL CANCER DATA BASE ( ) Brian Hu*, Los Angeles, CA, Claudio Jeldres, Katherine Odem-Davis, Seattle, WA, Claire Sadler, Los Angeles, CA, Craig Nichols, Christopher Porter, Seattle, WA, Siamak Daneshmand, Los Angeles, CA MP24-05 TREATMENT DELAYS IN THE MANAGEMENT OF MUSCLE INVASIVE BLADDER CANCER: ANALYSIS OF THE NATIONAL CANCER DATABASE Nikhil Waingankar*, Thomas Churilla, Elizabeth Handorf, Mohammed Haseebuddin, Philadelphia, PA, Jeffrey Tomaszewski, Camden, NJ, Daniel Canter, Alexander Kutikov, Eric Horwitz, Richard Greenberg, David Chen, Rosalia Viterbo, Robert Uzzo, Marc Smaldone, Philadelphia, PA MP24-06 THE IMPACT OF INSURANCE STATUS ON TUMOR CHARACTERISTICS AND TREATMENT SELECTION IN CONTEMPORARY PROSTATE CANCER PATIENTS Nicola Fossati, New York, NY, Daniel P. Nguyen*, New York, Italy, Quoc-Dien Trinh, Boston, MA, Jesse Sammon, Akshay Sood, Detroit, MI, Alessandro Larcher, Giorgio Guazzoni, Milan, Italy, Pierre I Karakiewicz, Montreal, Canada, Shahrokh F. Shariat, Vienna, Austria, Francesco Montorsi, Alberto Briganti, Milan, Italy, Mani Menon, Firas Abdollah, Detroit, MI MP24-07 TIME TRENDS IN THE USE OF SECONDARY TREATMENTS FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY Daniel Moreira*, Boris Gershman, Stephen Boorjian, R. Houston Thompson, Igor Frank, Matthew Tollefson, Matthew Gettman, Eric Bergstralh, R. Jeffrey Karnes, Rochester, MN MP24-08 SURGEON VARIATION IN THE COST OF LAPAROSCOPIC NEPHRECTOMY Lindsay Hampson*, Anobel Odisho, Peter Carroll, Maxwell Meng, San Francisco, CA MP24-09 INSURANCE COVERAGE AND DISPARITIES IN KIDNEY CANCER CARE: IMPLICATIONS FOR THE AFFORDABLE CARE ACT Hung-Jui Tan*, Ryan J. Chuang, Aaron A. Laviana, Jim C. Hu, Los Angeles, CA MP24-10 DECLINING USE OF URINARY HERBAL AND VITAMIN SUPPLEMENTS AMONG U.S. MEN IN LONGITUDINAL NATIONAL PROSTATE CANCER SCREENING COHORTS Michael Leapman*, San Francisco, CA, David Crawford, Wendy Poage, Aurora, CO, Nelson Stone, New York, NY MP24-11 TESTOSTERONE REPLACEMENT THERAPY USE AMONG YOUNG PRIVATELY INSURED U.S. MEN, Pravin Rao*, Baltimore, MD, Sheree Boulet, Akanksha Mehta, Atlanta, GA, James Hotaling, Salt Lake City, UT, Michael Eisenberg, Palo Alto, CA, Stanton Honig, New Haven, CT, Lee Warner, Dmitry Kissin, Atlanta, GA, Ajay Nangia, Kansas City, KS, Lawrence Ross, Chicago, IL MP24-12 MULTILEVEL PREDICTORS OF BPH MEDICATION INITIATION IN PRIMARY CARE AND UROLOGY Seth A. Strope*, Saint Louis, MO, Adriennne Kuxhausen, Joel Vetter, Jeff Gill, St. Louis, MO MP24-13 PATTERNS OF NON-SURGICAL MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH) IN THE UNITED STATES Jennifer T. Anger*, Beverly Hills, CA, Howard B. Goldman, Cleveland, OH, Kelly H. Zou, Xuemei Luo, David J. Russell, Doug Chapman, Canan Esinduy, New York, NY, J Quentin Clemens, Ann Arbor, MI MP24-14 DIFFERENCES IN TREATMENT OF BENIGN PROSTATIC HYPERPLASIA BY THE UROLOGIST AND PRIMARY-CARE PHYSICIAN Adam Rensing*, Adrienne Kuxhausen, Joel Vetter, Seth Strope, Saint Louis, MO MP24-15 PREOPERATIVE TESTING FOR STRESS URINARY INCONTINENCE AND PROLAPSE SURGERY: OVERUSE, UNDERUSE, AND COST IMPLICATIONS Tom Feng*, Colby Perkins, Lauren Wood, Jerome Wang, Jenna Borok, Alex Hannemann, Catherine Bresee, Los Angeles, CA, Karyn Eilber, Los Angeles, MS, Jennifer Anger, Los Angeles, CA MP24-16 VARIABILITY IN MEDICARE UTILIZATION AND PAYMENT AMONG UROLOGISTS Joan Ko*, Heather Chalfin, Bruce Trock, Zhaoyong Feng, Elizabeth Humphreys, Sung- Woo Park, H. Ballentine Carter, Kevin Frick, Misop Han, Baltimore, MD MP24-17 PHYSICIAN-OWNED AMBULATORY SURGERY CENTERS AND UTILIZATION OF DISCRETIONARY UROLOGICAL PROCEDURES Chandy Ellimoottil*, Rodney Dunn, Brent Hollenbeck, Ann Arbor, MI MP24-18 THE IMPACT OF READMISSIONS TO SECONDARY HOSPITALS ON FAILURE- TO-RESCUE RATES FOLLOWING MAJOR UROLOGIC CANCER SURGERY Jasmir Nayak*, Sarah Holt, Jonathan Wright, Atreya Dash, John Gore, Seattle, WA 88

101 MP24-19 PATTERNS OF CARE FOR READMISSION FOLLOWING RADICAL CYSTECTOMY IN NEW YORK STATE: DOES THE HOSPITAL MATTER? Jamie S Pak*, Danny Lascano, Daniel Kabat, Julia B Finkelstein, Mark V Silva, G Joel DeCastro, William Gold, James M McKiernan, New York, NY MP24-20 CAUSES OF HOSPITAL READMISSIONS AFTER UROLOGIC CANCER SURGERY Marianne Schmid*, Hamburg, Germany, Abraham Chiang, Boston, MA, Akshay Sood, Logan Campbell, Detroit, MI, Felix Chun, Hamburg, Germany, Deepansh Dalela, Detroit, MI, James Okwara, Boston, MA, Jesse Sammon, Detroit, MI, Adam Kibel, Boston, MA, Mani Menon, Detroit, MI, Margit Fisch, Hamburg, Germany, Quoc-Dien Trinh, Boston, MA SATURDAY Saturday, May 16, 2015 Moderated Poster Session 25 INFECTIONS/INFLAMMATION OF THE GENITOURINARY TRACT: PROSTATE & GENITALIA Room New Orleans Morial Convention Center Moderators: Michel Pontari and Jordan Dimitrakoff 1:00 pm - 3:00 pm NUMBER TITLE NUMBER TITLE MP25-01 RELATIONSHIP BETWEEN TESTOSTERONE AND PROSTATITIS-LIKE SYMPTOMS ASSESSED BY THE NATIONAL INSTITUTES OF HEALTH CHRONIC PROSTATITIS SYMPTOM INDEX Gyeong Eun Min*, Jun Ho Lee, Koo Han Yoo, Dong-Gi Lee, Hyung-Lae Lee, Seoul, Korea, Republic of MP25-02 TESTOSTERONE REPLACEMENT THERAPY FOR HYPOGONADAL PATIENTS WITH CHRONIC PROSTATITIS / CHRONIC PELVIC PAIN SYNDROME Ran Pang*, Jianxin Lu, Xinyao Zhou, Xiaosong Gao, Yaqiang Zhang, Beijing, China, People s Republic of MP25-03 FOSFOMYCIN FOR ANTIBIOTIC PROPHYLAXIS PRIOR TO TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY Andrew Colhoun*, Jay Sulek, Zachary McDowell, Michael Climo, B. Mayer Grob, Richmond, VA MP25-04 TRANSUTRICULAR SEMINAL- VESICULOSCOPY IN THE MANAGEMENT OF SYMPTOMATIC MIDLINE CYSTS OF THE PROSTATE Pil Moon Kang*, Won Ik Seo, Wan Suk Kim, Jang Ho Yoon, Dong Il Kang, Kweon Sik Min, Jae Il Chung, Busan, Korea, Republic of MP25-05 ENHANCED BLADDER PAIN SENSITIVITY DUE TO THE PROSTATE-TO-BLADDER AFFERENT CROSS SENSITIZATION IN A RAT MODEL OF PROSTATITIS Tsuyoshi Majima*, Pittsburgh, PA, Yasuhito Funahashi, Nagoya, Japan, Katsumi Kadekawa, Pittsburgh, PA, Momokazu Gotoh, Nagoya, Japan, Naoki Yoshimura, Pittsburgh, PA MP25-06 MODELS OF LOWER URINARY TRACT SYMPTOMS IN THE PRESENCE AND ABSENCE OF PAIN Daniel J. Mazur*, Anthony J. Schaeffer, Praveen Thumbikat, Chicago, IL MP25-07 PROSTATIC INFLAMMATION EVOKES UPREGULATION OF NEUROTROPHINS IN SENSORY GANGLIA: POSSIBLE CONTRIBUTION TO DYSFUNCTIONAL VOIDING Pradeep Tyagi*, Mahendra Kashyap, Subrata Pore, Zhou Wang, Naoki Yoshimura, Pittsburgh, PA MP25-08 EVALUATION OF THE UTILITY OF DIFFERENT SCORING SYSTEMS (FGSI, LRINEC AND NLR) IN THE MANAGEMENT OF FOURNIER S GANGRENE Ozan Bozkurt, Volkan Sen, Omer Demir, Adil Esen*, Izmir, Turkey MP25-09 RISK FACTORS FOR SELECTIVE SCREENING OF MALE GENITAL CHLAMYDIAL INFECTION Gilho Lee*, Cheonan, Korea, Republic of, Duk Kim, Gyeongsan-Si, Korea, Republic of MP25-10 ETIOLOGY OF SYMPTOMATIC URETHRITIS IN MEN ACCORDING TO SEXUAL BEHAVIORS Hari T. Vigneswaran*, Kathleen Hwang, Joseph F. II Renzulli, Philip A. Chan, Providence, RI MP25-11 NEED FOR URETHROPLASTY IS RARE IN PATIENTS WITH BIOPSY PROVEN LICHEN SCLEROSUS WHO ARE TREATED WITH MULTIMODAL THERAPY Bradley Potts, Michael Belsante*, Ramiro Madden-Fuentes, John Patrick Selph, Andrew Peterson, Durham, NC *Presenting author 89

102 MP25-12 EVALUATION OF PROGNOSTIC FACTORS AND DEFINITION OF NEW PROGNOSTIC PARAMETER IN FOURNIER S GANGRENE Bulent Erol*, Istanbul, Turkey, Altug Tuncel, Ankara, Turkey, Adem Tok, Zonguldak, Turkey, Utku Sari, Istanbul, Turkey, Volkan Hanci, izmir, Turkey, Furkan Sendogan, Turhan Caskurlu, Istanbul, Turkey MP25-13 MICROSURGICAL DENERVATION OF THE SPERMATIC CORD FOR ORCHIALGIA: RESULTS AND PHENOTYPIC ANALYSIS OF TREATMENT FAILURES Daniel Shoskes*, Scott Polackwich, Cleveland, OH MP25-14 THE TREATMENT OF CHRONIC ORCHALGIA WITH TMR TM : SUBSTANTIAL PAIN REDUCTION WITH DURABLE RESULTS Daniel H. Shin*, Los Angeles, CA, Aaron Spitz, Laguna Hills, CA MP25-15 IMPACT OF ROUTINE SCREENING FOR FLUOROQUINOLINE RESISTANT ENTERIC BACTERIA ON INCIDENCE OF POST TRANSRECTAL PROSTATE BIOPSY SEPSIS John Farrell, Jennifer Hicks*, Stephanie Wallace, Peoria, IL, Allen Seftel, Camden, NJ, Thomas Rashid, Peoria, IL MP25-16 IMPACT OF RECTAL SWABS ON INFECTIOUS COMPLICATIONS AFTER TRANSRECTAL PROSTATE BIOPSY Carlos Gustavo Trujillo*, Mauricio Plata, Juan Ignacio Caicedo, Juan Guillermo Cataño, Diana Castelblanco, Angela Marcela Mariño, Bogotá, Colombia MP25-17 RAPID QPCR TO IDENTIFY MULTI-DRUG RESISTANT E. COLI PRIOR TO PROSTATE BIOPSY Michael Liss*, San Antonio, TX, Linda Otelly, San Diego, CA, Veronika Tchesnokova, Seattle, WA, Kyoko Sakamoto, Joshua Fierer, San Diego, CA, Evgeni Sokurenko, Seattle, WA MP25-18 UTILITY OF ENEMAS BEFORE TRANSRECTAL PROSTATE BIOPSIES: PRELIMINARY REPORT Jaime O. Herrera-Caceres*, Sergio Del Moral, Christian Villeda-Sandoval, Benjamin Montaño, Ricardo A. Castillejos-Molina, Carlos E. Mendez-Probst, Mexico City, Mexico MP25-19 EFFICACY OF RECTAL POVIDONE-IODINE SWABS IN DECREASING INFECTIOUS COMPLICATIONS AFTER TRANSRECTAL PROSTATE BIOPSY Jennifer J Ahn*, Jason P Van Batavia, Mitchell C Benson, New York, NY MP25-20 A PERI-PROCEDURAL POVIDONE IODINE RECTAL PREPARATION DECREASES BACTERIURIA AND BACTEREMIA FOLLOWING PROSTATE NEEDLE BIOPSY Jay D. Raman*, Kathleen Lehman, Chris Rjepaj, Hershey, PA, Kalyan Dewan, Girish Kirimanjeswara, University Park, PA Saturday, May 16, 2015 Moderated Poster Session 26 BLADDER CANCER: NON-INVASIVE I Room New Orleans Morial Convention Center Moderators: Stanley Malkowicz and Matthew Tollefson 1:00 pm - 3:00 pm NUMBER TITLE NUMBER TITLE MP26-01 A PHASE II RANDOMIZED, PRESURGICAL PLACEBO-CONTROLLED TRIAL OF POLYPHENON E IN BLADDER CANCER PATIENTS TO EVALUATE BLADDER TISSUE LEVELS OF EGCG AND BIOMARKERS OF GROWTH AND APOPTOSIS Jason Gee*, Burlington, MA, Daniel MP26-03 SINGLE INSTILLATION OF MITOMYCIN C (MMC) PLUS BACILLUS CALMETTE- GUÉRIN (BCG) VERSUS BCG ALONE IN HIGH GRADE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) Brian Weiss*, New York, NY, Alan Wein, S. Bruce Malkowicz, Thomas Guzzo, Philadelphia, PA Saltzstein, KyungMann Kim, Jill Kolesar, Wei Huang, Tom Havighurst, Barbara Wollmer, Jeanne Stublaski, Tracy Downs, Hasan Mukhtar, Madison, WI, Margaret House, Howard Parnes, Bethesda, MD, Howard Bailey, Madison, WI MP26-02 A MANAGEMENT ALGORITHM FOR MITOMYCIN-C (MMC) Amy Luckenbaugh*, David Miller, Alon Weizer, John Stoffel, Jeffrey Montgomery, Ann Arbor, MI 90

103 MP26-04 SAFETY, EFFICACY AND 12-MONTHS RECURRENCE RATE OF LASER VS. ELECTRICAL EN BLOC RESECTION OF UROTHELIUM CARCINOMA OF THE BLADDER: RESULTS OF THE EBRUC TRIAL Mario W. Kramer*, Hannover, Germany, Jens J. Rassweiler, Jan Klein, Heilbronn, Germany, Alexey Martov, Nikolay Baykov, Moscow, Russian Federation, Rodolfo Hurle, Milan, Italy, Guenter Janetschek, Lukas Lusuardi, Salzburg, Austria, Mathias Wolters, Mahmoud Abbas, Hannover, Germany, Armin Leitenberger, Markus Riedl, Wolfsburg, Germany, Udo Nagele, Hall, Austria, Axel S. Merseburger, Markus A. Kuczyk, Hannover, Germany, Marko Babjuk, Prague, Czech Republic, Thomas R.W. Herrmann, Hannover, Germany MP26-05 ACTIVE SURVEILLANCE PROGRAM IN RECURRENT NMIBC Rodolfo Fausto Hurle, Luigi Castaldo, Taverna Gianluigi, Matteo Ferro, Ottavio DeCobelli, Danilo Bottero, Milan, Italy, Daniela Terraciano, Naples, Italy, Luisa Pasini*, Milan, Italy MP26-06 NEUTROPHIL TO LYMPHOCYTE RATIO PREDICTS RECURRENCE OF NON- MUSCLE INVASIVE BLADDER CANCER Emrah Yuruk, Istanbul, Turkey, Theodore R. Saitz*, Portland, OR, Serkan Gonultas, Ege Can Serefoglu, Ahmet Yaser Muslumanoglu, Istanbul, Turkey MP26-07 THE EFFICACY AND LIMITATIONS OF EORTC RISK STRATIFICATION FOR THE PREDICTION OF RECURRENCE AND PROGRESSION OF 1,024 JAPANESE NON- MUSCLE INVASIVE BLADDER CANCERS Takeshi Ieda*, Satoru Muto, Yoshiro Sakamoto, Sohei Takahata, Toshiyuki China, Shinji Shiozawa, Kazutaka Terai, Fumitaka Shimizu, Shin-ichi Hisasue, Yoshiaki Wakumoto, Shigeo Horie, Tokyo, Japan MP26-08 RENIN-ANGIOTENSIN INHIBITORS DECREASE RECURRENCE AFTER TURBT IN NON-MUSCLE INVASIVE BLADDER CANCER Michael L. Blute, Jr.*, Timothy J. Rushmer, Fangfang Shi, Benjamin Fuller, E. Jason Abel, David F. Jarrard, Tracy M. Downs, Madison, WI MP26-09 MODERATE CHRONIC KIDNEY DISEASE (EGFR < 60 ML/MIN) PREDICTS RECURRENCE AND PROGRESSION IN BLADDER CANCER PATIENTS TREATED WITH TRANSURETHRAL RESECTION Michael L. Blute, Jr.*, Timothy J. Rushmer, Fangfang Shi, Benjamin Fuller, E. Jason Abel, David F. Jarrard, Tracy M. Downs, Madison, WI MP26-10 A PROSPECTIVE RANDOMIZED TRIAL OF INTRAVESICAL BACILLUS CALMETTE- GUERIN THERAPY WITH THE TOKYO172 VERSUS CONNAUGHT STRAIN FOR NON- MUSCLE INVASIVE BLADDER CANCER Tatsuro Hayashi*, Takeshi Yuasa, Masayuki Sano, Sho Uehara, Mutsushi Yamasaki, Kiichi Hagiwara, Mizuaki Sakura, Hitoshi Masuda, Shinya Yamamoto, Shinji Urakami, Iwao Fukui, Jyunji Yonese, Tokyo, Japan MP26-11 THE TIMING OF RADICAL CYSTECTOMY FOR BCG FAILURE: COMPARISON OF OUTCOMES AND RISK FACTORS FOR PROGNOSIS Christopher Haas*, LaMont Barlow, G Joel DeCastro, James McKiernan, New York, NY MP26-12 INCIDENCE AND MANAGEMENT OF NON- MUSCLE INVASIVE BLADDER CANCER RECURRENCES AFTER COMPLETE RESPONSE TO COMBINED-MODALITY ORGAN-PRESERVING THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER Alejandro Sanchez*, Matthew F. Wszolek, Rebecca H. Clayman, Dayron Rodriguez, Andrzej Niemierko, Francis J. McGovern, Anthony L. Zietman, Niall M. Heney, W. Scott McDougal, William U. Shipley, Jason A. Efstathiou, Boston, MA MP26-13 PREDICTING PATHOLOGIC AND SURVIVAL OUTCOMES AFTER MULTIPLE SALVAGE INTRAVESICAL THERAPIES FOLLOWED BY RADICAL CYSTECTOMY FOR PERSISTENT NON-MUSCLE- INVASIVE BLADDER CANCER Christopher Haas*, LaMont Barlow, G Joel DeCastro, James McKiernan, New York, NY MP26-14 MEASURING SUCCESS AFTER RADICAL CYSTECTOMY: FEASIBILITY OF A NOVEL COMPOSITE ENDPOINT ( POOR RECOVERY ) TO QUANTIFY OUTCOMES AFTER SURGERY Erika L. Wood*, Houston, TX, Janet E. Baack Krukreja, Rochester, NY, Sima Porten, San Francisco, CA, Wei Qiao, Raphael Ezeagu, Neema Navai, Ashish M. Kamat, Colin P. Dinney, Jay B. Shah, Houston, TX MP26-15 TREND IN TA STAGE UROTHELIAL CARCINOMA OF THE BLADDER: SHIFT TO HIGHER GRADING? Shane Barney*, George Wayne, Elizabeth Nagoda, Mark Soloway, Juan Acuna, Miami, FL MP26-16 NEUTROPHIL TO LYMPHOCYTE RATIO, A NEW PROGNOSTIC FACTOR IN NON MUSCLE INVASIVE BLADDER CANCER Vincenzo Favilla, Tommaso Castelli, Daniele Urzì, Sebastiano Cimino, Salvatore Privitera, Eugenia Fragalà, Giorgio Ivan Russo*, Giuseppe Morgia, Catania, Italy SATURDAY *Presenting author 91

104 MP26-17 T1 HIGH-GRADE (G3) TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER: DELAYED RADICAL CYSTECTOMY IS CORRELATED TO A WORSENED OUTCOME Birte-Swantje Schneevoigt*, Tobias Grimm, Alexander Buchner, Alexander Kretschmer, Maria Apfelbeck, Markus Grabbert, Christian Stief, Alexander Karl, Munich, Germany MP26-18 MULTI-ISTITUTIONAL CONTROLLED STUDIES DO NO REFLECT THE PATIENT S COMPLIANCE TO BCG ENCOUNTERED IN CLINICAL PRACTICE. RESULTS ON 411 PATIENTS Vincenzo Serretta*, Cristina Scalici Gesolfo, Vincenza Alonge, Fabrizio Di Maida, Palermo, Italy, Lorenzo Rocchini, Marco Moschini, Andrea Gallina, Renzo Colombo, Milan, Italy MP26-19 A PROSPECTIVE STUDY ON THE INFLUENCE ON RECURRENCE OF QUITTING CIGARETTE SMOKING AT DIAGNOSIS OF PRIMARY NON MUSCLE INVASIVE BLADDER CANCER Cristina Scalici Gesolfo*, Francesco D Amato, Dario Fontana, Francesco Sommatino, Palermo, Italy, Lorenzo Rocchini, Marco Moschini, Renzo Colombo, Andrea Gallina, Milan, Italy, Vincenzo Serretta, Palermo, Italy MP26-20 SEQUENTIAL INTRAVESICAL GEMCITABINE AND DOCETAXEL FOR THE SALVAGE TREATMENT OF NON- MUSCLE INVASIVE BLADDER CANCER Ryan Steinberg*, Lewis Thomas, Michael O Donnell, Kenneth Nepple, Iowa City, IA Saturday, May 16, 2015 Moderated Poster Session 27 GENERAL & EPIDEMIOLOGICAL TRENDS & SOCIOECONOMICS: QUALITY OF LIFE Room New Orleans Morial Convention Center Moderators: Quoc-Dien Trinh and Timothy Daskivich 1:00 pm - 3:00 pm NUMBER TITLE NUMBER TITLE MP27-01 A RANDOMIZED CONTROLLED TRIAL COMPARING ALPHA BLOCKER (TAMSULOSIN) AND ANTICHOLINERGIC (SOLIFENACIN) IN TREATMENT OF URETERAL STENT RELATED SYMPTOMS Ahmed EL-Nahas*, Mohamed Tharwat, Mohamed Elsaadany, Ahmed Mosbah, Mohamed Gaballah, Mansoura, Egypt MP27-02 THE ASSOCIATION BETWEEN VASCULAR RISK FACTORS AND OVER ACTIVE BLADDER Teruhiko Tsuru*, Isao Araki, Sayaka Kadowaki, Takashi Hisamatsu, Akira Fujiyoshi, Akihiro Kawauchi, Katsuyuki Miura, Hirotsugu Ueshima, Otsu, Japan MP27-03 EFFECTS OF CONTINUOUS LONG-TERM TESTOSTERONE REPLACEMENT THERAPY (TRT) UP TO 11 YEARS IN 115 HYPOGONADAL ELDERLY MEN ON ANTHROPOMETRIC, ENDOCRINE AND METABOLIC PARAMETERS: REAL-LIFE EXPERIENCE FROM AN OBSERVATIONAL REGISTRY STUDY Aksam Yassin*, Yousef Al Mehmadi, Norderstedt-Hamburg, Germany, Dany-Jan Yassin, Braunschweig, Germany, Gheorghe Doros, Abdul Traish, Boston, MA MP27-04 A PSYCHOMETRIC ANALYSIS OF PAIN AND URINARY SYMPTOMS IN PATIENTS WITH INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME AND CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME: FINDINGS FROM MAPP RESEARCH NETWORK James Griffith*, Chicago, IL, Todd Edwards, Seattle, WA, Barry Hong, Siobhan Sutcliffe, St Louis, MO, Michel Pontari, Philadelphia, PA, Niloofar Afari, San Diego, CA, John Krieger, Seattle, WA, Robert Lloyd, Chicago, IL, Frank Tu, Evanston, IL, David Williams, Ann Arbor, MI, Donald Patrick, Seattle, WA, Jayoung Kim, Bruce Naliboff, Los Angeles, CA, Henry Lai, St Louis, MO, Catherine Bradley, Iowa City, IA, Chris Mullins, Bethesda, MD, Richard Landis, Philadelphia, PA MP27-05 SEVERE WAR-RELATED GENITOURINARY INJURIES AMONG MALE SERVICE MEMBERS IN OPERATIONS ENDURING FREEDOM AND IRAQI FREEDOM Jud Janak*, Steven Hudak, Douglas Soderdahl, Jean Orman, JBSA Fort Sam Houston, TX, Kristy Pottol, Wendy Dean, Fort Detrick, MD MP27-06 RESIDENT IMPACT ON PATIENT & SURGEON SATISFACTION AND OUTCOMES: EVIDENCE FOR HEALTH SYSTEM SUPPORT FOR UROLOGY EDUCATION Bradford Stevenson*, Jessica Healey, William Severino, Thomas Baron, David Roszhart, David Lieber, Kevin McVary, Tobias Kohler, Springfield, IL 92

105 MP27-07 THE WISCONSIN STONE QUALITY OF LIFE QUESTIONNAIRE: BASELINE RESULTS FROM A PROSPECTIVE, LONGITUDINAL, MULTI-CENTER VALIDATION STUDY Kristina L Penniston*, Madison, WI, Jodi A Antonelli, Dallas, TX, Timothy D Averch, Pittsburgh, PA, Davis P Viprakasit, Chapel Hill, NC, Roger L Sur, San Diego, CA, Vincent G Bird, Gainesville, FL, Stephen Y Nakada, Madison, WI MP27-08 THE IMPORTANCE OF GRAPHIC LITERACY IN PATIENT-CENTERED COMMUNICATION Jasmir Nayak*, Andrea Hartzler, Seattle, WA, Jason Izard, Kingston, Canada, Bruce Dalkin, John Gore, Seattle, WA MP27-09 I SAW IT ON TV, DOC! DIRECT-TO- CONSUMER TELEVISION ADVERTISING FOR UROLOGICAL PHARMACEUTICAL PRODUCTS, Kevin Koo*, Lebanon, NH, Ronald Yap, Concord, NH MP27-10 POST-OPERATIVE PAIN MANAGEMENT AFTER RADICAL CYSTECTOMY: COMPARING TRADITIONAL AND ENHANCED RECOVERY AFTER SURGERY PROTOCOL AT USC Weichen Xu*, Hamed Ahmadi, Jie Cai, Gus Miranda, Anne Shuckman, Siamak Daneshmand, Hooman Djaladat, Los Angeles, CA MP27-11 DISTINCT SIDE EFFECT PROFILES AFTER CONTEMPORARY TREATMENT OF LOCALIZED PROSTATE CANCER Karen Hoffman*, Houston, TX, JoAnn Alvarez, Daniel Barocas, Tatsuki Koyama, Alicia Morgans, Sharon Phillips, Matthew Resnick, David Penson, CEASAR Investigators, Nashville, TN MP27-12 DETERMINANTS OF INFORMATION NEEDS IN LONG-TERM PROSTATE CANCER SURVIVORS Jennifer Bernat*, Indianapolis, IN, Daniela Wittmann, Sarah Hawley, Ann Arbor, MI, David Haggstrom, Indianapolis, IN, May Darwish-Yassine, Boston, MA, Ted Skolarus, Ann Arbor, MI MP27-13 AGREEMENT BETWEEN PATIENT AND PHYSICIAN REPORTED OUTCOMES AFTER RADICAL PROSTATECTOMY Alan Thong*, Bing Ying Poon, Justin Lee, Daniel Sjoberg, Andrew Vickers, Behfar Ehdaie, New York, NY MP27-14 A CROSS-SECTIONAL COMPARISON STUDY OF SELF-HELP FOR PROSTATE CANCER: HOW DO ONLINE AND FACE-TO- FACE SUPPORT GROUPS DIFFER? Johannes Huber*, Tanja Muck, Philipp Maatz, Dresden, Germany, Anette Brechtel, Andreas Ihrig, Heidelberg, Germany MP27-15 INTOLERANCE OF UNCERTAINTY AND URINARY SYMPTOMS PREDICT ANXIETY FOR MEN ON ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER Hung-Jui Tan*, Leonard S. Marks, Los Angeles, CA, Michael Hoyt, New York, NY, Lorna Kwan, Christopher P. Filson, Malu Macairan, Patricia Lieu, Mark S. Litwin, Annette L. Stanton, Los Angeles, CA MP27-16 EFFECT OF EXERCISE ON QUALITY OF LIFE AND PSYCHOLOGICAL FUNCTION IN MEN WITH PROSTATE CANCER: META- ANALYSES OF >600 MEN FROM 7 RANDOMIZED CLINICAL TRIALS Dharam Kaushik*, San Antonio, TX, Balwinder Singh, Fargo, ND MP27-17 DOMAIN-SPECIFIC SYMPTOM BURDEN AND INFORMATION NEEDS IN PROSTATE CANCER SURVIVORS: A CASE FOR TAILORED LONG-TERM SURVIVORSHIP CARE Jennifer Bernat*, Indianapolis, IN, Daniela Wittmann, Sarah Hawley, Ann Arbor, MI, David Haggstrom, Indianapolis, IN, May Darwish-Yassine, Boston, MA, Ted Skolarus, Ann Arbor, MI MP27-18 BLADDER OUTLET OBSTRUCTION AFTER PROSTATE CANCER TREATMENT: A POPULATION-BASED ANALYSIS Daniel Liberman*, Stephanie Jarosek, Beth Virnig, Sean Elliott, Minneapolis, MN MP27-19 QUALITY OF LIFE AND FUNCTIONAL RESULTS AFTER ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP): A PROSPECTIVE POPULATION-BASED SERIES Lorenzo Tosco*, Leuven, Belgium, Filip Ameye, Ghent, Belgium, Simone Albisinni, Brussels, Belgium, Peter Dekuyper, Ghent, Belgium, David Jegou, Thierry Quackels, Thierry Roumeguere, Brussels, Belgium, Ben Van Cleynenbreugel, Leuven, Belgium, Nancy Van Damme, Liesbet Van Eycken, Brussels, Belgium, Steven Joniau, Leuven, Belgium MP27-20 IMPACT ON HEALTH RELATED QUALITY OF LIFE FOLLOWING TREATMENT OF UROLOGIC CANCERS: RESULTS OF A PROSPECTIVE STUDY John Oliver DeLancey*, Gregory Auffenberg, David Victorson, Shilajit Kundu, Chicago, IL SATURDAY *Presenting author 93

106 Saturday, May 16, 2015 Moderated Poster Session 28 STONE DISEASE: SURGICAL THERAPY II Room New Orleans Morial Convention Center Moderators: Ashish Rawandale and Brian Auge 1:00 pm - 3:00 pm NUMBER TITLE NUMBER TITLE MP28-01 EXTERANAL VALIDATION OF S-RESC-R TO PREDICT STONE-FREE RATE AFTER RIRS Juhyun Park*, Minyong Kang, Songzhe Piao, Jeong Woo Lee, Chang Wook Jeong, Seung Bae Lee, Hwancheol Son, Hyeon Jeong, Sung Yong Cho, Seoul, Korea, Republic of MP28-02 FLEXIBLE URETEROSCOPE REPAIRS USING ORIGINAL MANUFACTURER VERSUS THIRD-PARTY COMPANY Kyle Wood*, Marc Colaco, Ilya Gorbachinsky, Amanda Hughes, Jorge Gutierrez-Aceves, Winston-Salem, NC MP28-03 WILL THE RISKS OF POSTOPERATIVE INFECTION BE INCREASED AFTER URETEROSCOPIC LITHOTRIPSY FOR PATIENTS WITH MILD PYURIA BEFORE THE OPERATION? Hung Keng Li*, New Taipei City, Taiwan, Eric Y. Huang, Alex T.L. Lin, Taipei, Taiwan MP28-04 FLEXIBLE URS HOLMIUM LASER STONE DUSTING VS FRAGMENTAION FOR 2 CM SINGLE RENAL STONE Wael Gamal*, Soahg, Egypt, Ahmed Mmdouh, Sohag, Egypt MP28-05 URETEROSCOPIC REMOVAL OF CALCULUS IN POORLY FUNCTIONING (<10%) KIDNEYS DUE TO URETERIC STONE: A PROSPECTIVE OUTCOME ANALYSIS Prem Nath Dogra*, Rajan Gupta, Prabhjot Singh, Ashish Kumar Saini, Rajeev Kumar, Amlesh Seth, New Delhi, India MP28-06 COST ANALYSIS OF FLEXIBILE URETEROSOPE REPAIRS: EVALUATION OF 655 PROCEDURES IN A COMMUNITY- BASED PRACTICE EXPERIENCE Eugene Kramolowsky*, Zachary McDowell, Blake Moore, David Rapp, Nada Wood, Richmond, VA MP28-07 FLEXIBLE URETEROSCOPY TRAINING. NEW TOOL OF TWO-PART SILICONE MOLD (CAVITIES) BASED ON REAL HUMAN KIDNEYS ENDOCASTS Bruno Marroig*, Marco Pereira Sampaio, Luciano Favorito, Francisco Sampaio, Rio de Janeiro, Brazil MP28-08 THE OUTCOME OF USING A PRE- OPERATIVE J STENT IN URETEROSCOPY: RESULTS FROM THE CLINICAL RESEARCH OFFICE OF ENDOUROLOGICAL SOCIETY URS GLOBAL STUDY Dean Assimos*, Birmingham, AL, Alfonso Crisci, Florence, Italy, Daniel Culkin, Oklahoma City, OK, Wei Xue, Shanghai, China, People s Republic of, Anita Roelofs, Arnhem, Netherlands, Mordechai Duvdevani, Jerusalem, Israel, Mahesh Desai, Nadiad, India, Jean de la Rosette, Amsterdam, Netherlands MP28-09 BALLOON DILATION OF THE URETER: A CONTEMPORARY REVIEW OF OUTCOMES AND COMPLICATIONS Nicholas Kuntz*, Durham, NC, Andreas Neisius, Mainz, Germany, Matvey Tsivian Tsivian, Momin Ghaffar, Fernando Cabrera, Ramy Youssef, Michael Ferrandino, Durham, NC, Nishant Patel, Roger Sur, San Diego, CA, Glenn Preminger, Michael Lipkin, Durham, NC MP28-10 EVIDENCE FOR FLEXIBLE URETERORENOSCOPY (FURS) FOR LARGE RENAL STONES IN THE MODERN ERA: A SYSTEMATIC REVIEW Robert Geraghty, Southampton, United Kingdom, Omar Aboumarzouk, Cardiff, United Kingdom, Bhavan Rai, Dundee, United Kingdom, Chandra shekhar Biyani, Yorkshire, United Kingdom, Nick Rukin, Wolverhampton, United Kingdom, Bhaskar Somani*, Southampton, United Kingdom MP28-11 FEASIBILITY AND OUTCOME OF EMERGENCY URETEROSCOPIC REMOVAL OF LOWER URETERAL STONE UNDER INTRAVENOUS SEDATION: A PROSPECTIVE STUDY Waleed Shabana, Mohamed Teleb, Tamer Dawod*, Zagazig, Egypt MP28-12 EMERGENCY VERSUS ELECTIVE URETEROSCOPIC TREATMENT : WHAT ROLE OF THE EMERGENCY URETEROSCOPY APPROCH IN THE DEFINITIVE TREATMENT OF URETERIC STONES? BENRABAH Rabah*, azli mohcine, nechiche farid, boumelit samir, souid M Bachir, lounici mustapha, algiers, Algeria MP28-13 LEAVE NO STONE UNTURNED? - NEGATIVE URETEROSCOPY RATES Remy Lamberts*, Simon Conti, Stanford, CA, Rajesh Shinghal, San Jose, CA, John Leppert, Stanford, CA, Christopher Elliott, San Jose, CA 94

107 MP28-14 THE RESULTS OF RETROGRADE INTRARENAL SURGERY (RIRS) IN THE TREATMENT OF RENAL STONES LARGER THAN 15 MM. A COMPARATIVE STUDY Hanan Goldberg*, Dor Golomb, Shlomi Tapiero, Yariv Shtabholtz, Avi Shariv, Ronen Holland, Jack Baniel, David Lifshitz, Petach Tiqva, Israel MP28-15 THE EFFECT OF LASER FIBER TIP CLEAVING TECHNIQUE UPON RISK FOR URETEROSCOPE DAMAGE OR URETERAL INJURY Daniel Faaborg*, Edna Miao, Herbert Hodgson, Brandon Peplinski, Kristene Myklak, Muhannad Alsyouf, D. Duane Baldwin, Loma Linda, CA MP28-16 THE EFFECT OF FLEXIBLE URETERORENOSCOPY ON RENAL HEMODYNAMICS Vahit Guzelburc*, Rukiye Kilicarslan, Istanbul, Turkey, Caner Baran, Adana, Turkey, Murat Can Kiremit, Mustafa Yucel Boz, Mustafa Soytas, Rahim Horuz, Selami Albayrak, Istanbul, Turkey MP28-17 LUBRIGLIDE SEQUENTIAL URETERAL DILATORS : A SAFE AND EFFECTIVE METHOD OF URETERAL DILATION TO FACILITATE PRIMARY URETEROSCOPIC INTERVENTION Christopher Mitchell*, Benjamin McCormick, Tracy Marien, Nicole Miller, Nashville, TN MP28-18 PREDICTING RADIATION EXPOSURE IN URETERORENOSCOPY AND LASER LITHOTRIPSY: AN ANALYSIS OF PATIENT AND STONE CHARACTERISTICS Marios Hadjipavlou*, Portsmouth, United Kingdom, Vincent Lam, Jai Seth, Faqar Anjum, Sri Sriprasad, Dartford, Kent, United Kingdom MP28-19 RELATIVE COST COMPARISON OF STANDARD SURGICAL TREATMENTS FOR MEDIUM-SIZED RENAL STONES Blake Hamilton*, Joel Hancock, Salt Lake City, UT MP28-20 COMPARISON OF FLEXIBLE URETERORENOSCOPY AND MINI PERCUTANEOUS NEPHROLITHOTOMY IN TREATMENT OF LOWER CALYCEAL STONES SMALLER THAN 2 CM Mehmet Fatih Akbulut*, Onur Kucuktopcu, Emre Kandemir, Erkan Sonmezay, Abdulmuttalip Simsek, Faruk Ozgor, Murat Binbay, Ahmet Yaser Muslumanoglu, Zafer Gokhan Gurbuz, Istanbul, Turkey SATURDAY Saturday, May 16, 2015 Podium Session 14 TRAUMA/RECONSTRUCTION: URETHRAL RECONSTRUCTION (INCLUDING STRICTURE) II Room New Orleans Morial Convention Center Moderators: Jill Buckley and Ramón Virasoro 1:00 pm - 3:00 pm TIME NUMBER TITLE TIME NUMBER TITLE 1:00 PD14-01 PATIENT AGE RATHER THAN URETHRAL TRANSECTION INFLUENCES ERECTILE FUNCTION AFTER URETHROPLASTY: A PROSPECTIVE ANALYSIS Keith Rourke, Trevor Haines*, Edmonton, Canada 1:10 PD14-02 RECTOURETHRAL FISTULA REPAIR: EXPERIENCE OF VARIOUS APPROACHES OVER 30 YEARS Christopher Zappavigna*, Sender Herschorn, Toronto, Canada 1:20 PD14-03 OPEN SURGICAL RECONSTRUCTION FOR RECALCITRANT BLADDER NECK CONTRACTURES FUNCTIONAL OUTCOME AFTER IMPLANTATION OF AN ARTIFICIAL URINARY SPHINCTER Simon Bugeja*, Anastasia Frost, Enrique Fes, Stella Ivaz, Daniela E Andrich, Anthony R Mundy, London, United Kingdom 1:30 PD14-04 REPEAT ENDOSCOPIC MANIPULATION FOR BULBAR URETHRAL STRICTURES INCREASES STRICTURE LENGTH AND URETHROPLASTY COMPLEXITY BUT DOES NOT AFFECT URETHROPLASTY OUTCOMES David W Chapman*, Abhaya Prasad, Adam Kinnaird, Keith Rourke, Edmonton, Canada 1:40 PD14-05 OUTCOME OF DIRECT VISUAL INTERNAL URETHROTOMY (DVIU) FOR POST- URETHROPLASTY STRICTURES Stephen Mock*, Elizabeth T. Brown, W. Stuart Reynolds, Melissa R. Kaufman, Douglas F. Milam, Roger R. Dmochowski, Nashville, TN 1:50 PD14-06 VALIDATION OF A NON-INVASIVE URETHRAL MONITORING PROTOCOL AFTER URETHRAL RECONSTRUCTION Bradley A. Erickson*, Christopher A. Tam, Iowa City, IA, Sean P. Elliott, Minneapolis, MN, Jeremy B. Myers, Salt Lake City, UT, Alex J. Vanni, Burlington, MA, Bryan B. Voelzke, Seattle, WA *Presenting author 95

108 2:00 PD14-07 PHASE I DEVELOPMENT OF A PATIENT REPORTED OUTCOME MEASURE FOR MALE URETHRAL STRICTURE DISEASE Benjamin Breyer*, San Francisco, CA, Todd Edwards, Donald Patrick, Bryan Voelzke, Seattle, WA 2:10 PD14-08 SEXUAL FUNCTIONAL OUTCOMES WITH DORSAL VS. VENTRAL SUBSTITUTION BULBAR URETHROPLASTY Daniel Liberman*, Minneapolis, MN, Joshua Broghammer, Kansas City, KS, Thomas Smith III, Houston, TX, Bryan Voelzke, Seattle, WA, Bradley Erickson, Iowa City, IA, Christopher McClung, Columbus, OH, Nejd Alsikafi, Gurney, IL, Alex Vanni, Burlington, MA, Jeremy Myers, Salt Lake City, UT, Sean Elliott, Minneapolis, MN 2:20 PD14-09 MOST EFFECTIVE METHOD OF USING BUCCAL GRAFT IN STAGED URETHROPLASTY FOR HYPOSPADIAS CRIPPLE Pankaj Joshi*, Craig Hunter, Walid Shahrour, Sandesh Surana, Vikram shah Batra, Sanjay Kulkarni, Pune, India 2:30 PD14-10 A MULITINSTITUTIONAL EVALUATION OF THE MANAGEMENT AND OUTCOMES OF LONG SEGMENT AND PANURETHRAL STRICTURES Jonathan Warner*, Ann Arbor, MI, Ibraheem Malkawi, Detroit, MI, Panjak Joshi, Sanjay Kulkarni, Pune, India, Guido Barbagli, Arezzo, Italy, Massimo Lazzeri, Milan, Italy, Ryan Mori, Kenneth Angermeier, Cleveland, OH, Justin Han, Christopher Gonzalez, Chicago, IL, Fransisco Martins, Lisbon, Portugal, Reynaldo Gomez, Santiago, Chile, Richard Santucci, Detroit, MI 2:40 PD14-11 SINGLE STAGE VERSUS CLASSICAL STAGED APPROACH FOR PENILE URETHRAL STRICTURES Felix Campos*, Simon Bugeja, Anastasia Frost, Enrique Fes, Stella Ivaz, Daniela E Andrich, Anthony R Mundy, London, United Kingdom 2:50 PD14-12 HETEROGENOUS DISEASE CHARACTERISTICS IN PATIENTS WITH THE CLINICAL DIAGNOSIS OF LICHEN SCLEROSUS Peter Kirk, Heather Crossley, Miriam Hadj- Moussa, Bahaa Malaeb*, Ann Arbor, MI Saturday, May 16, 2015 Podium Session 15 TECHNOLOGY & INSTRUMENTS: LAPAROSCOPY AND ROBOTICS: MALIGNANT DISEASE I Room New Orleans Morial Convention Center Moderators: Dipen Parekh and Jeffrey Cadeddu 1:00 pm - 3:00 pm TIME NUMBER TITLE TIME NUMBER TITLE 1:00 PD15-01 VIDEO-RATE STRUCTURED ILLUMINATION MICROSCOPY FOR RAPID ASSESSMENT OF SURGICAL MARGINS DURING RADICAL PROSTATECTOMY J. Quincy Brown, Michael Maddox*, Mei Wang, Hillary Kimbrell, David Tulman, Tyler Schlichenmeyer, Sree Mandava, Benjamin Lee, New Orleans, LA 1:10 PD15-02 DEVELOPMENT OF NEW THREE- DIMENSIONAL IMAGE SYSTEM FOR TRANSURETHRAL SURGERY Soichiro Yoshida*, Tsuneo Fukuyo, Masaya Ito, Manabu Tatokoro, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara, Bunkyo-ku, Tokyo, Japan 1:20 PD15-03 RANDOMIZED CLINICAL TRIAL EXAMINING THE RETURN OF URINARY CONTINENCE AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY WITH OR WITHOUT A BLADDER NECK SLING Chandru P Sundaram*, Clinton D Bahler, Indianapolis, IN, Steven M Lucas, Detroit, MI, Naveen Kella, San Antonio, TX, Thomas A Gardner, Michael O Koch, Indianapolis, IN 1:30 PD15-04 COMPARISON OF EARLY ONCOLOGIC OUTCOMES IN OPEN VERSUS ROBOTIC- ASSISTED LAPAROSCOPIC PROSTATECTOMY IN A LARGE POPULATION-BASED US COHORT Shane Pearce*, Joseph Pariser, Theodore Karrison, Sanjay Patel, Scott Eggener, Chicago, IL 1:40 PD15-05 COMPARISON OF PERIOPERATIVE COMPLICATIONS FOLLOWING OPEN VERSUS MINIMALLY INVASIVE NEPHROURETERECTOMY Eric DeRoo*, Francesca Monn, Clint Bahler, Chandru Sundaram, Indianapolis, IN 96

109 1:50 PD15-06 NOVEL IMAGE MONITORING SYSTEM USING A HEAD-MOUNTED DISPLAY FOR ASSISTANTS IN DA VINCI SURGERY Soichiro Yoshida*, Bunkyo-ku, Tokyo, Japan, Shohei Fukuda, Toshihiro Kanda, Naotaka Fukui, Kita-Adachi-gun, Saitama, Japan, Kazutaka Saito, Yasuhisa Fujii, Bunkyo-ku, Tokyo, Japan, Yukio Kageyama, Kita-Adachigun, Saitama, Japan, Kazunori Kihara, Bunkyo-ku, Tokyo, Japan 2:00 PD15-07 OPTICAL BIOPSY OF SUSPECTED PENILE CANCER USING CONFOCAL LASER ENDOMICROSCOPY: INITIAL FEASIBILITY STUDY Dimitar V. Zlatev*, Aristeo Lopez, Kathleen E. Mach, Robert V. Rouse, John T. Leppert, Joseph C. Liao, Stanford, CA 2:10 PD15-08 OPEN VERSUS ROBOTIC-ASSISTED LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION FOR TESTICULAR CANCER Kimberly Fischer*, Michael Santomauro, Eric Biewenga, Justin Nork, Patrick Scarborough, Ithaar Derweesh, Sean Stroup, San Diego, CA, Erik Castle, Phoenix, AZ, James Porter, Seattle, WA, James L Esperance, San Diego, CA 2:20 PD15-09 EFFECT OF RENAL VASCULAR CLAMP TYPE AND POSITION UPON LEAK POINT PRESSURE IN HUMAN RENAL ARTERIES David Tryon, Kristene Myklak*, Muhannad Alsyouf, Brandon Peplinski, Javier L. Arenas, Daniel Faaborg, Carol Conceicao, Herbert C. Ruckle, D. Duane Baldwin, Loma Linda, CA 2:30 PD15-10 FEASIBILITY OF HIFU-TRIGGERED SORAFENIB-LOADED LIPOSOME NANOPARTICLES FOR TARGETED DRUG THERAPY IN RENAL CELL CARCINOMA Caleb Abshire*, James Liu, Jaspreet Arora, Hakm Murad, Sree Harsha Mandava, Michael Maddox, Cameron Callaghan, Damir Khismatullin, Vijay John, Benjamin Lee, New Orleans, LA 2:40 PD15-11 INSTRUMENT LIFE FOR ROBOT ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY: ARE TEN LIVES FOR MOST INSTRUMENTS JUSTIFIED? Wesley Ludwig, Michael Gorin, Mark Ball, Edward Schaeffer, Misop Han, Mohamad Allaf*, Baltimore, MD 2:50 PD15-12 DESIGN AND EARLY CLINICAL EXPERIENCE WITH A TACTILE FEEDBACK DRIVEN PELVIC FLOOR MUSCLE TRAINING SMARTPHONE APP Maurice Garcia*, Michael Leapman, Jonathan Brajtbord, Peter Carroll, San Francisco, CA SATURDAY Saturday, May 16, 2015 Podium Session 16 BENIGN PROSTATIC HYPERPLASIA: MEDICAL & NON-SURGICAL THERAPY Room New Orleans Morial Convention Center Moderators: Li-Ping Xie and Steve Kaplan 1:00 pm - 3:00 pm TIME NUMBER TITLE TIME NUMBER TITLE 1:00 PD16-01 NEW INSIGHT OF PSA REDUCTION DURING FINASTERIDE THERAPY Ding Xu*, Jie Ding, Jun Qi, Shanghai, China, People s Republic of 1:10 PD16-02 INVESTIGATION OF PATIENTS DIAGNOSED WITH PROSTATE CANCER DURING DUTASTERIDE TREATMENT Shoichiro Sugiura*, Hisamitsu Ide, Kosuke Kitamura, Satoru Muto, Raizo Yamaguchi, Shigeo Horie, Tokyo, Japan 1:20 PD16-03 A PROSPECTIVE STUDY OF SILODOSIN IN COMPARISION WITH TAMSULOSIN IN THE MANAGEMENT OF PATIENTS IN ACUTE URINARY RETENTION DUE TO BENIGN HYPERPLASIA OF PROSTATE bhavani ginka*, Tirupati, India 1:30 PD16-04 ALTERATIONS OF HEMATOGENESIS AND BONE MINERAL DENSITY AFTER DUTASTERIDE TREATMENT IN AGED PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA Kenichi Mori*, Shinsuke Mizoguchi, Yasuhiro Sumino, Fuminori Sato, Yufu, Japan, Naoki Yoshimura, Pittsburgh, PA, Hiromitsu Mimata, Yufu, Japan 1:40 PD16-05 EFFICACY AND SAFETY OF SILODOSIN AND DUTASTERIDE COMBINATION THERAPY IN ACUTE URINARY RETENTION DUE TO BENIGN PROSTATIC HYPERPLASIA: A SINGLE-ARM PROSPECTIVE STUDY Atsushi Imai*, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Noritaka Kamimura, Kazuaki Yoshikawa, Atsushi Kyan, Toshiaki Kawaguchi, Yasuo Kusumi, Yuji Yagihashi, Chikara Ohyama, Hirosaki, Japan *Presenting author 97

110 1:50 PD16-06 A PROSPECTIVE RANDOMIZED STUDY TO EVALUATE THE OUTCOME OF ALPHABLOCKERS AND THE COMPINATION WITH TADALAFILE IN TREATING LUTS/BPH AND ERECTILE DYSFUNCTION Waleed Shabana, Mohamed Teleb, Tamer Dawod*, Zagazig, Egypt 2:00 PD16-07 ANALYSIS OF CAUSES OF FAILURE OF MEDICAL TREATMENT IN PATIENTS UNDERGOING SURGERY FOR BENIGN ENLARGEMENT OF PROSTATE Ajay Anand*, Jammu, India, Narmada P Gupta, P N Dogra, Amlesh Seth, New Delhi, India 2:10 PD16-08 EVOLUTION: A EUROPEAN REGISTRY EVALUATING MANAGEMENT PRACTICES OF PHARMACOLOGICALLY TREATED PATIENTS WITH LUTS ASSOCIATED WITH BPH. SYMPTOMATIC IMPROVEMENT, PROGRESSION AND TREATMENT DISCONTINUATION RESULTS. A COMPARISON BETWEEN EUROPEAN COUNTRIES Andrea Tubaro*, Rome, Italy, Richard Berges, Cologne, Germany, Mark Speakman, Taunton, United Kingdom, Alexandre de la Taille, Creteil, France, Luis Martínez-Piñeiro, Madrid, Spain, Anup Patel, London, United Kingdom, Christien Caris, Wim Witjes, Arnhem, Netherlands 2:20 PD16-09 HEALTHCARE COSTS FOR OFFICE BASED BENIGN PROSTATIC HYPERPLASIA THERAPIES Craig Smith*, Naperville, IL, Robert Pugach, Los Alamitos, CA 2:30 PD16-10 THE EFFECT OF COMBINED SYSTEMATIZED BEHAVIORAL MODIFICATION EDUCATION PROGRAM (SBMP) WITH DDAVP IN PATIENTS WITH NOCTURIA: A PROSPECTIVE, MULTICENTER, RANDOMIZED, AND PARALLEL STUDY Sung Yong Cho*, Juhyun Park, Songzhe Piao, Seung Bae Lee, Hyeon Jeong, Hwancheol Son, Jang Hwan Kim, JJi-Youn Chun, Miho Song, Myung-Soo Choo, Kyu- Sung Lee, Joon Chul Kim, Seoul, Korea, Republic of, Jong Bo Choi, Suwon, Korea, Republic of, Ju Tae Seo, Seung-June Oh, Seoul, Korea, Republic of 2:40 PD16-11 DUTASTERIDE IMPROVES BONE MINERAL DENSITY IN AGING MALE: A PRELIMINARY STUDY Naoki Wada*, Kazumi Hashizume, Seiji Matsumoto, Hidehiro Kakizaki, Asahikawa, Japan 2:50 PD16-12 SWITCH OF MEDICAL TREATMENT IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS SUGGESTIVE OF BENIGN PROSTATIC HYPERPLASIA OVER 10- YEAR FOLLOW-UP Wonho Jung*, Ji Yong Ha, Byung Hoon Kim, Choal Hee Park, Chun Il Kim, Daegu, Korea, Republic of Saturday, May 16, 2015 Video Session 3 1:00 pm - 3:00 pm MALE VOIDING/SEXUAL DYSFUNCTION/BPH/ INCONTINENCE/INFECTION/INFERTILITY The videos in this session as well as the video libraries from the Annual Meetings may be viewed in the Surgical Video Library and purchased in the Products Store during the Annual Meeting. Both are located in Registration Hall B2. All years of the Surgical Video Library may also be purchased online at Room New Orleans Morial Convention Center Moderators: Jaspreet Sandhu and Tobias Kohler NUMBER TITLE NUMBER TITLE V3-01 USE OF THE OHMMETER TO IDENTIFY THE SITE OF FLUID LEAK DURING ARTIFICIAL URINARY SPHINCTER REVISION SURGERY Michael Belsante*, John Patrick Selph, Jessica Lloyd, Divya Ajay, George Webster, Ngoc-Bich Le, Andrew Peterson, Durham, NC V3-02 ROBOTIC-ASSISTED LAPAROSCOPIC PLACEMENT OF BLADDER NECK ARTIFICIAL URINARY SPHINCTER IN A MALE Stephen Blakely*, Henry Okafor, Gennady Bratslavsky, Dimitriy Nikolavsky, Syracuse, NY V3-03 SINGLE PERINEAL INCISION: A NOVEL TECHNIQUE FOR ARTIFICIAL URINARY SPHINCTER PLACEMENT Cooper Benson*, Hajar Ayoub, O. Lenaine Westney, Houston, TX V3-04 SIMPLE MALE URETHRAL SLING REVISION TECHNIQUE James H. Masterson, Yokosuka, Japan, Eugene Y. Rhee*, San Diego, CA V3-05 INFLATABLE PENILE PROSTHESIS REMOVAL AND REPLACEMENT WITH CORPORAL RECONSTRUCTION Robert Kovell*, Ahmed Aboumohamed, Patrick McKenzie, Ryan Terlecki, Winston- Salem, NC 98

111 V3-06 A NEW TECHNIQUE FOR REMOVAL OF CHRONICALLY IMPLANTED NEUROMODULATOR LEADS Christopher Pulford*, Zhamshid Okhunov, Gamal Ghoniem, Orange, CA V3-07 POVIDONE IODINE RECTAL PREPARATION AT TIME OF PROSTATE NEEDLE BIOPSY IS A SIMPLE AND REPRODUCIBLE MEANS TO REDUCE RISK OF PROCEDURAL INFECTION Mikhail Regelman*, Jay Raman, Hershey, PA V3-08 A SIMPLIFIED NO-FLIP SHANG RING CIRCUMCISION TECHNIQUE WITH TOPICAL (EMLA) ANESTHESIA IN ADOLESCENTS AND ADULTS Aaron Bernie*, New York, NY, Yifeng Peng, Wuhu, China, People s Republic of, Philip Li, Richard Lee, New York, NY, Chao Jia, Benhai Yang, Wuhu, China, People s Republic of, Quentin Awori, New York, NY, Nian Qing Lu, Nanjing, China, People s Republic of, Mark Barone, Marc Goldstein, New York, NY V3-09 EPIDIDYMOVASOSTOMY: A TWO-SUTURE INTUSSUSCEPTION APPROACH Tariq, S. Hakky*, Gavin Langille, Aravind Chandrashekar, Alexander,W. Pastuszak, Ranjith Ramasamy, Larry,I. Lipshultz, Houston, TX V3-10 LESS GONADECTOMY FOR ANDROGEN INSENSITIVITY SYNDROME (AIS) Anibal W.Branco*, Luciano C.Stunitz, Sandro Nichele, Julio C. Foiatto, Juliano D. Scheffer, Marcio Gatti, Kleber Stelmasuk, Curitiba, Brazil V3-11 ROBOTIC-ASSISTED EPIGASTRIC ARTERY HARVEST: A NOVEL APPROACH TO PENILE REVASCULARIZATION Michael Aberger*, Katie Murray, Joshua Broghammer, David Duchene, Kansas City, KS V3-12 COMPARISON OF THE DIFFERENT TECHNIQUES FOR LASER ENUCLEATION OF THE PROSTATE: PVEP, HOLEP, THUVEP David Leavitt*, New Hyde Park, NY, Christopher Netsch, Hamburg, Germany, Marawan El Tayeb, Michael Borofsky, Indianapolis, IN, Christian Tiburtius, Hamburg, Germany, Bilal Chughtai, New York, NY, Arthur Smith, New Hyde Park, NY, Alexis Te, New York, NY, James Lingeman, Indianapolis, IN, Andreas Gross, Hamburg, Germany, Zeph Okeke, New Hyde Park, NY V3-13 THULIUM VAPOENUCLEATION OF THE PROSTATE: SURGICAL TECHNIQUE FROM VAPORIZATION TO VAPOENUCLEATION David Leavitt*, New Hyde Park, NY, Christian Tiburtius, Christopher Netsch, Hamburg, Germany, Zeph Okeke, New Hyde Park, NY, Thomas Herrmann, Hannover, Germany, Arthur Smith, New Hyde Park, NY, Andreas Gross, Hamburg, Germany V3-14 TRANSURETHRAL BIPOLAR ENUCLEATION OF THE PROSTATE, A NOVEL TECHNIQUE FOR BLADDER OUTLET OBSTRUCTION James M Tracey*, Jonathan N Warner, Ann Arbor, MI SATURDAY Saturday, May 16, 2015 SOCIETY FOR BASIC UROLOGIC RESEARCH (SBUR) Room New Orleans Morial Convention Center 1:00 pm - 3:30 pm 1:00 INTRODUCTION Donald Vander Griend, Susan Kasper 1:10 PENILE STEM-PROGENITOR CELLS: EFFICACY FOR ERECTILE DYSFUNCTION THERAPY Tom Lue 1:35 INDUCTION OF HUMAN EMBRYONIC AND INDUCED PLURIPOTENT STEM CELLS INTO UROTHELIUM Eric Kurzrock 2:00 MESENCHYMAL STEM CELLS AS A VECTOR FOR THE INFLAMMATORY PROSTATE MICROENVIRONMENT John Isaacs 2:25 PROSTATE EPITHELIAL LINEAGE HIERARCHY Li Xin 2:50 CONTROL OF HUMAN PROSTATE CANCER STEM CELL PROLIFERATION AND DIFFERENTIATION Susan Kasper 3:15 OPEN DISCUSSION AND CONCLUDING REMARKS 3:30 ADJOURN *Presenting author 99

112 Saturday, May 16, 2015 SECOND OPINION CASES Hall New Orleans Morial Convention Center Moderators: Gopal Badlani and Steven Campbell 1:00 pm - 5:00 pm 12:55 INTRODUCTIONS 1:00 NON-INVASIVE BLADDER CANCER Panel Leader: Mark Soloway Discussants: Yair Lotan, Mark Schoenberg 1:30 SMALL RENAL MASSES Panel Leader: Steven Campbell Discussants: Brian Lane, David Canes 2:00 PENILE RECONSTRUCTION, ERECTILE DYSFUNCTION, IMPLANTS Panel Leader: Tom Lue Discussants: Gerard Henry, Yoram Vardi 2:30 REFRACTORY OVERACTIVE BLADDER AND FEMALE INCONTINENCE Panel Leader: Gary Lemack Discussants: Ariana Smith, David Ginsberg 3:00 DIFFICULT STONE CASES Panel Leader: Dean Assimos Discussants: Michael Wong, Margaret Pearle 3:30 PROSTATE CANCER Panel Leader: Peter Carroll Discussants: Howard Scher, Anthony D Amico 4:00 CHRONIC PELVIC PAIN SYNDROME Panel Leader: J. Curtis Nickel Discussants: Michel Pontari, Daniel Shoskes 4:30 MALE INCONTINENCE Panel Leader: Craig Comiter Discussants: Eugene Rhee, Ajay Singla Saturday, May 16, 2015 UROLOGY CARE BY THE APN/PA: MAXIMIZING PATIENT OUTCOMES Room New Orleans Morial Convention Center 1:00 pm - 5:30 pm 1:00 WELCOME AND INTRODUCTION Director: Susan Flick 1:05 UROLOGIC CANCER SCREENING RECOMMENDATIONS FOR 2015 USE OF GENETIC TESTING MRI IMAGING PRIOR TO AND AFTER DIAGNOSING PROSTATE CANCER (NCCN GUIDELINE CHANGES) Robert Abouassaly, Lee Ponsky 3:05 BREAK 3:30 OUTPATIENT UROLOGIC ONCOLOGY: PRIMER Anne Calvaresi, Edouard Trabulsi 2:05 PANEL DISCUSSION - MALE URINARY INCONTINENCE AND SEXUAL REHABILITATION PROGRAM Todd Doran, Allen Seftel Saturday, May 16, 2015 INNOVATIONS IN UROLOGY - AUA AND THE ENDOUROLOGICAL SOCIETY Science & Technology Hall Booth New Orleans Morial Convention Center 2:00 pm - 4:00 pm 2:00 WELCOME AND INTRODUCTION Moderator: Bodo Knudsen 2:05 LECTURE ON GRANTS PROCESS AND AVAILABILITY Ziya Kirkali 2:15 SBIR GRANT AND HOW HE BENEFITTED/USED IT Hassan Razvi 2:30 TALK ON STARTUPS, LESSONS LEARNED, AND ALTERNATIVES TO SBIR Errol Singh 2:45 KEYNOTE LECTURE: THE COLLABORATION PARADOX, INVENTING SOLUTIONS IN A HYPER-CONNECTED ENVIRONMENT John Abele 3:05 CORPORATE VIEW ON PATENTS Robert Behl 3:20 S HIGHLIGHTING INNOVATION PROJECTS FROM ENGINEERING AND UROLOGY 3:30 PANEL DISCUSSION Moderator: Christopher Loose Panelists: Maurice Garcia, Errol Singh, Hassan Razvi, Ziya Kirkali, William Roberts 100

113 Saturday, May 16, 2015 AUA-EURASIAN UROLOGY PLATFORM (EUP) JOINT MEETING PROGRAM Room New Orleans Morial Convention Center 2:55 pm - 7:30 pm 2:55 OPENING REMARKS Society Chair: Ates Kadioglu 3:00 URO-ONCOLOGY SESSION Moderators: Mevlana Derya Balbay, Bulent Semerci TO SCREEN OR NOT TO SCREEN IN PROSTATE CANCER Douglas Scherr 3:20 CASTRATE RESISTANT PROSTATE CANCER: AN UPDATE Laurence Klotz 3:40 CASE DISCUSSIONS ON PROSTATE CANCER Moderator: Oner Sanli Panelists: Laurence Klotz, Fatih Atug, Raja Khauli, Douglas Scherr 4:00 ENDOUROLOGY SESSION Moderator: Burak Turna NEW CONCEPTS IN THE PATHOPHYSIOLOGY OF STONE DISEASE Stephen Nakada 4:15 ESWL IS NOT DEAD; HOW TO IMPROVE THE SUCCESS RATE James Lingeman 4:30 RESIDUAL FRAGMENTS: SURVEILLANCE OR TREATMENT Kemal Sarica 4:45 STANDARD TO MICRO PERC - HAS THE MINIATURIZATION COME TO AN END Thomas Knoll 5:00 CASE DISCUSSIONS ON URINARY STONE DISEASE Moderator: Murat Binbay Panelists: Sulcek Guven, Stephen Nakada, Thomas Knoll 5:30 ROBOTIC UROLOGIC SURGERY SESSION CHALLENGING SITUATIONS DURING ROBOTIC PROSTATECTOMY: TIPS & TRICKS Vipul Patel 5:40 COMPLICATIONS: MALFUNCTION, BLEEDING, VASCULAR INJURY, ETC Mohamad Allaf 5:50 NEW ROBOTIC SYSTEMS AND DEVELOPING SURGICAL TECHNIQUES Volkan Tugcu 6:00 AUA-TURKISH ASSOCIATION OF UROLOGY- POSTER SESSION 7:30 ADJOURN SATURDAY Saturday, May 16, :00 pm - 5:30 pm JOINT PROGRAM OF THE HUNGARIAN (HUA) AND POLISH (PTU) UROLOGICAL ASSOCIATIONS Room New Orleans Morial Convention Center 3:00 WELCOME AND INTRODUCTIONS Peter Tenke 3:05 NEUROSTIMULATION IN UROLOGY Jerzy B. Gajewski 3:15 PROSTATE CANCER MARKER PANEL WITH SINGLE CELL SENSITIVITY IN URINE Gyorgy Petrovics 3:25 TARGETING GASTRIN-RELEASING PEPTIDE RECEPTORS IN PROSTATE CANCER - FROM BASIC RESEARCH TO CLINICAL APPLICATION Ferenc Rick 3:35 NEW DEVELOPMENTS IN GENETIC PROFILING OF PROSTATE CANCER NEW CLINICAL APPLICATIONS FOR THE OCOTYPE DX ASSAY Bela Denes 3:45 FREQUENT OVEREXPRESSION OF ETS- RELATED GENE-1 (ERG1) IN PROSTATE CANCER TRANSCRIPTOME: THE DECADE IN REVIEW Albert Dobi 3:55 THE ROLE OF INTRAOPERATIVE FROZEN SECTION DURING LAPAROSCOPIC RADICAL PROSTATECTOMY Péter Tenke 4:05 HEALTH-RELATED QUALITY OF LIFE IN BPH/ LUTS: A CROSS-SECTIONAL STUDY FROM HUNGARY Ágnes Kovács, Fanni Rencz, Valentin Brodszky 4:15 SUCCESSFUL TREATMENT OF INCONTINENCE WITH PROLAPSE: WHY LAPAROSCOPY? Zsolt Domján 4:25 PROGNOSTIC AND PREDICTIVE BIOMARKERS FOR DEXRYPTION OF TUMOR HETEROGENEITY IN URINARY BLADDER CANCER Péter Nyirády 4:35 QUESTION OF MASCULINITY OR JUST A PRISON COURAGE? Zoltán Bajory *Presenting author 101

114 4:45 POLISH UROLOGICAL ASSOCIATION ON THEIR WAY TO COOPERATE WITH HUA AND AUA Piotr L. Chlosta 4:55 LAPAROSCOPIC RADICAL CYSTECTOMY: TECHNIQUE, RESULTS AND LIMITATIONS Piotr L. Chlosta 5:15 TISSUE ENGINEERING IN RECONSTRUCTIVE UROLOGY Tomasz Drewa 5:25 CLOSING REMARKS 5:30 ADJOURN 5:05 CLINICAL VALUE OF EXTENDED LND DURING ENDOSCOPIC RADICAL PROSTATECTOMY Jakub Dobruch Saturday, May 16, :30 pm - 5:30 pm Moderated Poster Session 29 TRAUMA/RECONSTRUCTION: URETER, BLADDER, EXTERNAL GENITALIA AND UROTRAUMA II Room New Orleans Morial Convention Center Moderators: Sean Elliott and Jerilyn Latini MP29-01 MULTI-INSTITUTIONAL STUDY OF ROBOTIC BUCCAL MUCOSA GRAFT URETEROPLASTY: INITAL RESULTS Lee C Zhao*, Yuka Yamaguchi, Darren J Bryk, New York, NY, Michael M Maddox, Mary K Powers, New Orleans, LA, Andrew Harbin, Ziho Lee, Laura Giusto, Philadelphia, PA, Benjamin R Lee, New Orleans, LA, Daniel D Eun, Philadelphia, PA, Michael D Stifelman, New York, NY MP29-02 PREOPERATIVE PAD USAGE AND ELEVATED BMI ARE INDEPENDENTLY ASSOCIATED WITH FAILURE OF MALE TRANSOBTURATOR SLINGS IN OTHERWISE WELL SELECTED PATIENTS Logan Zemp*, Nathan Hoy, Keith Rourke, Edmonton, Canada MP29-03 PENILE PROSTHESIS PLACEMENT IN PATIENTS WITH A HISTORY OF TOTAL PHALLIC CONSTRUCTION Jack Zuckerman*, Kate Smentkowski, Dave Gilbert, Ramon Virasoro, Jeremy Tonkin, Gerald Jordan, Kurt McCammon, Norfolk, VA MP29-04 THE LOSS OF PTEN CONSEQUENT TO URETERAL OBSTRUCTION CONTRIBUTES TO RENAL FIBROSIS Sevann Helo*, Rohan Samarakoon, Amy Dobberfuhl, Paul Higgins, Albany, NY MP29-05 GRACILIS MUSCLE INTERPOSITION FLAP REPAIR OF URINARY FISTULAE: PELVIC RADIATION IS ASSOCIATED WITH PERSISTENT URINARY INCONTINENCE AND DECREASED QUALITY OF LIFE Valary T. Raup*, St Louis, MO, Jairam R. Eswara, Boston, MA, Kerry Madison, Julio Geminiani, Avory M. Heningburg, Steven B. Brandes, St Louis, MO MP29-06 RECONSTRUCTIVE SURGERY FOR URO- RECTAL AND PERINEAL FISTULAE Simon Bugeja*, Anastasia Frost, Enrique Fes, Stella Ivaz, Daniela E Andrich, Anthony R Mundy, London, United Kingdom MP29-07 COMPLICATIONS ASSOCIATED WITH CLEAN INTERMITTENT SELF CATHETERISATION IN PATIENTS WITH ARTIFICIAL URINARY SPHINCTER FOR THE TREATMENT OF NEUROPATHIC BLADDER DYSFUNCTION Anastasia Frost*, Andrew Cole, Michael Fadel, Simon Bugeja, Daniela Andrich, Anthony Mundy, London, United Kingdom MP29-08 INDICATIONS AND TIMING OF REVISION SURGERY IN PATIENTS HAVING HAD MULTIPLE ARTIFICIAL URINARY SPHINCTERS Anastasia Frost*, Simon Bugeja, Daniela Andrich, Anthony Mundy, London, United Kingdom MP29-09 VESICOVAGINAL FISTULA REPAIR 27 YEAR EXPERIENCE Christopher Zappavigna*, Sender Herschorn, Toronto, Canada MP29-10 RHABDOMYOLYSIS AFTER MAJOR UROLOGIC SURGERY: INCIDENCE, RISK FACTORS AND OUTCOMES Joseph J. Pariser*, Shane M. Pearce, Sanjay G. Patel, Vignesh T. Packiam, Blake B. Anderson, Arieh L. Shalhav, Gregory T. Bales, Norm D. Smith, Chicago, IL MP29-11 URETERAL RECONSTRUCTION WITH ILEUM: LONG TERM FOLLOW-UP OF RENAL FUNCTION Joshua Roth*, Richard Bihrle, Matthew Mellon, Indianapolis, IN MP29-12 USE OF THE ILEAL URETER FOR RADIATION-INDUCED URETERAL STRICTURES Joshua Roth*, Richard Bihrle, Matthew Mellon, Indianapolis, IN MP29-13 CORPOROPLASTY WITH SMALL INTESTINE SUBMUCOSA IN PATIENTS WITH PEYRONIE S DISEASE Ramon Virasoro, Oscar A. Storme*, Kenneth J. Delay, Jeremy B. Tonkin, Jack M. Zuckerman, Kurt A. Mccammon, Gerald H. Jordan, Norfolk, VA 102

115 MP29-14 MANAGEMENT OF PUBIC OSTEOMYELITIS FOLLOWING RADIATION THERAPY FOR PROSTATE CANCER McCabe C. Kenny*, Andrew P. Windsperger, Brian J. Flynn, Ty T. Higuchi, Aurora, CO MP29-15 CLINICAL OUTCOMES OF URETEROILEAL ANASTOMOTIC STRICTURE MANAGEMENT Marcelino Rivera*, Boyd Viers, Patrick Cockerill, Robert Tarrell, Prabin Thapa, Igor Frank, Stephen Boorjian, Amy Krambeck, Rochester, MN MP29-16 INCIDENCE AND RISK FACTORS OF URETEROENTERIC ANASTOMOTIC STRICTURE FOLLOWING RADICAL CYSTECTOMY WITH URINARY DIVERSION Boyd Viers*, Amy Krambeck, Marcelino Rivera, R. Jeffrey Karnes, Robert Tarrell, Prabin Thapa, R. Houston Thompson, Matthew Tollefson, Stephen Boorjian, Rochester, MN MP29-17 LONG-TERM OUTCOMES IN THE MANAGEMENT OF TRAUMATIC URETHRAL DISRUPTION INJURIES Niels V Johnsen*, Stephen Mock, W Stuart Reynolds, Roger R Dmochowski, Douglas F Milam, Melissa R Kaufman, Nashville, TN MP29-18 PREFABRICATION OF NEUROMUSCULAR JUNCTION FOR ACCELERATED RECOVERY OF MUSCLE FUNCTION In Kap Ko, Sang Jin Lee*, John Jackson, Anthony Atala, James Yoo, Winston Salem, NC MP29-19 BUILDING VIABLE TISSUES USING A 3-D BIOPRINTER FOR SURGICAL RECONSTRUCTION Hyun-Wook Kang, Sang Jin Lee*, John Jackson, James Yoo, Anthony Atala, Winston Salem, NC MP29-20 PERIOPERATIVE OUTCOMES FOLLOWING OPEN AND MINIMALLY INVASIVE SACRAL COLPOPEXY. ANALYSIS OF THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM (NSQIP) DATABASE Ahmed Sarhan*, Ahmad Shabsigh, Ketul Shah, Columbus, OH SATURDAY *Presenting author 103

116 Saturday, May 16, 2015 Moderated Poster Session 30 STONE DISEASE: SURGICAL THERAPY III Room New Orleans Morial Convention Center Moderators: Ben Chew and Michael Ferrandino 3:30 pm - 5:30 pm NUMBER TITLE NUMBER TITLE MP30-01 PATIENTS ARE AT RISK FOR PYELOVENOUS BACKFLOW DURING PERCUTANEOUS NEPHROSTOLITHOTOMY Muhannad Alsyouf*, Roger Li, Michelle Lightfoot, Herbert Hodgson, Nigel Gillespie, Kristene Myklak, Daniel Faaborg, Javier L. Arenas, Gaudencio Olgin, D. Duane Baldwin, Loma Linda, CA MP30-02 A NOVEL DOSIMETER FOR MEASURING THE AMOUNT OF RADIATION EXPOSURE DURING PERCUTANEOUS NEPHROLITHOTOMY: INSTADOSE Emrah Yuruk*, Istanbul, Turkey, Gokhan Gureser, Ankara, Turkey, Murat Tuken, Kasim Ertas, Ege Can Serefoglu, Istanbul, Turkey MP30-03 IS PREOPERATIVE ANTIBIOTIC PROPHYLAXIS FOR HIGH-RISK PATIENTS NECESSARY BEFORE PERCUTANEOUS NEPHROLITHOTOMY? A RETROSPECTIVE REVIEW OF 7 VS 2 VS 0 DAY THERAPY Jeffrey Larson*, Aaron Potretzke, Alana Desai, Brian Benway, St. Louis, MO MP30-04 X-RAY FREE DOPPLER ULTRASOUND GUIDED PERCUTANEOUS NEPHROLITHOTOMY: THE LARGEST SAMPLE CASES EXPERIENCE FROM CHINA Bo Xiao, Jianxing Li*, Weiguo Hu, Bo Yang, Liang Chen, Beijing, China, People s Republic of MP30-05 A PROSPECTIVE EVALUATION OF THE SURGEON PERSPECTIVE FOR DETERMINING STONE-FREE STATUS AFTER PERCUTANEOUS NEPHROLITHOTOMY Ahmed Harraz*, Yasser Osman, Osama Mahmoud, Amr Elsawy, Islam Fakhreldin, Ahmed El-Nahas, Ahmed Shoma, Ahmed Shokeir, Mansoura, Egypt MP30-06 ACUTE KIDNEY INJURY AFTER PERCUTANEOUS NEPHROLITHOTOMY FOR STONES IN A SOLITARY KIDNEY Ahmed EL-Nahas, Diaa-Eldin Taha*, Hussien Ali, Mohamed Zahran, Mahmoud Othman, Ahmed Harraz, Ahmed Mosbah, Ahmed Shokeir, Mansoura, Egypt MP30-07 ASSESSMENT OF STONE COMPLEXITY FOR PCNL: A SYSTEMATIC REVIEW OF THE EVIDENCE John Withington*, London, United Kingdom, James Armitage, Cambridge, United Kingdom, Will Finch, Norwich, United Kingdom, Stuart Irving, Norfolk, United Kingdom, Oliver Wiseman, Cambridge, United Kingdom, Jonathan Glass, London, United Kingdom, Neil Burgess, Norwich, United Kingdom MP30-08 CAN ACTIVITIES OF DAILY LIVING PREDICT FOR COMPLICATIONS FOLLOWING PERCUTANEOUS NEPHROLITHOTOMY? David Leavitt*, Shamus Moran, Piruz Motamedinia, Michael Siev, Mathew Fakhoury, Manaf Alom, David Hoenig, Arthur Smith, Zeph Okeke, New Hyde Park, NY MP30-09 URETERIC STENT VERSUS PERCUTANEOUS NEPHROSTOMY FOR ACUTE URETERAL OBSTRUCTION - CLINICAL OUTCOME AND QUALITY OF LIFE: A BI-CENTER PROSPECTIVE STUDY Tomer Erlich*, Ramat gan, Israel, Ohad Shoshany, Shay Golan, Pinhas Livne, David Lifshitz, Petach Tikva, Israel, Barak Rosenzweig, Alon Eisner, Nir Kleinman, Yoram Mor, Jacob Ramon, Harry Winkler, Ramat gan, Israel MP30-10 INTRAOPERATIVE NOISE POLLUTION AND ITS EFFECT UPON COMMUNICATION DURING PERCUTANEOUS NEPHROSTOLITHOTOMY Kristene Myklak*, Hayley Mowery, Muhannad Alsyouf, Roger Li, Michelle Lightfoot, Chase Atiga, David Tryon, Herbert Hodgson, Carol Conceicao, Daniel Faaborg, Javier L. Arenas, Nazih Khater, Herbert C. Ruckle, D. Daniel Baldwin, D. Duane Baldwin, Loma Linda, CA MP30-11 PERINEPHRIC FAT DISTRIBUTION AND ANATOMICAL CONSIDERATIONS WHEN PERFORMING PERCUTANEOUS NEPHROLITHOTOMY IN OBESE PATIENTS TAREK ALZAHRANI*, Daniela Ghiculete, Alaina Garbens, Kenneth Pace, R.J. D A. Honey, Toronto, Canada MP30-12 POST PERCUTANEOUS NEPHROLITHOTOMY, WHAT DEFINES CLINICAL INSIGINIFICANT RESIDUAL FRAGMENTS Tze Ying, Benjamin Lim*, Wai Loon Yam, Sey Kiat Lim, Foo Cheong Ng, Kok Kit Ng, Singapore, Singapore 104

117 MP30-13 PREOPERATIVE FACTORS AFFECTING RADIATION TIME DURING PERCUTANEOUS NEPHROLITHOTOMY: A MULTI-INSTITUTIONAL ANALYSIS Zhamshid Okhunov*, Orange, CA, Vincent Bird, Arash Akhavein, Gainesville, FL, Daniel Moreira, Arvin George, Sammy Elsamra, Hempstead, NY, Brian Duty, Portland, OR, Michael Del Junco, Orange, CA, Fotima Asquarova, Michael Rothberg, Mantu Gupta, New York, NY, Chad Tracy, Mark Newton, Iowa City, IA, Kevan Sternberg, Benjamin King, Burlington, VT, Edan Shapiro, New York, NY, Jorge Moreno, Mexico City, Mexico, Christopher Pulford, Orange, CA, Juan Carlos Rosales, Caracas, Venezuela, Arun Srinivasan, Philadelphia, PA, Yasser Noureldin, Sero Andonian, Montreal, Canada, Nazih Khater, Duane Baldwin, Loma Linda, CA, Khurshid Ghani, Maksim Shlykov, Ann Arbor, MI, Ramy Youssef, Orange, CA, Brian Shinsky, Madison, WI, Justin Friedlander, Philadelphia, PA, Steven Nakada, Madison, WI, Stuart Wolf Jr., Ann Arbor, MI, Arthur D. Smith, Zeph Okeke, Hempstead, NY, Jaime Landman, Orange, CA MP30-14 UPPER POLE UROLOGIST-OBTAINTED PERCUTANEOUS RENAL ACCESS FOR PCNL IS SAFE AND EFFICACIOUS Amar Patel*, Don Bui, John Pattaras, Kenneth Ogan, Atlanta, GA MP30-15 PREDICTORS OF HOSPITAL READMISSION AFTER PERCUTANEOUS NEPHROLITHOTOMY: ANALYSIS OF MORE THAN 700 CONSECUTIVE PATIENTS FROM A TERTIARY REFERRAL CENTER Yasser Osman, Ahmed Harraz, Diaa-Eldin Taha*, Amr Elsawy, Nasr El-Tabey, Ahmed El-Nahas, Ahmed Shoma, Ahmed Shokeir, Mansoura, Egypt MP30-16 PROGNOSTIC FACTORS OF POSTOPERATIVE COMPLICATIONS IN PERCUTANEOUS NEPHROLITHOTOMY Fabio C Vicentini*, Carlos H Watanabe-Silva, Vinicius Meneguete, Rodrigo Perrela, Claudio B Murta, Joaquim F A Claro, São Paulo, Brazil MP30-17 NATURAL HISTORY OF RESIDUAL FRAGMENTS FOLLOWING PERCUTANEOUS NEPHROSTOLITHOTOMY Kyle Wood*, Marc Colaco, Juan Mainez, Ilya Gorbachinsky, Miguel Osorio, Eliud Sanchez, Majid Mirzazadeh, Winston-Salem, NC, Dean Assimos, Birmingham, AL, Jorge Gutierrez- Aceves, Winston-Salem, NC MP30-18 COMPLIANCE WITH GUIDELINES FOR ANTIBIOTICS AFTER PERCUTANEOUS NEPHROLITHOTOMY DOES NOT INCREASE INFECTIOUS COMPLICATIONS: A RETROSPECTIVE COHORT STUDY Sameer Deshmukh*, Seth Bechis, Boston, MA, Kevan Sternberg, Benjamin King, Burlington, VT, Brian Eisner, Boston, MA MP30-19 IMPACT OF THE GUY S STONE SCORE ON SUCESS RATES FOR PERCUTANEOUS NEPHROLITHOTOMY Fabio C Vicentini*, Carlos Watanabe-Silva, Thiago Ac Ferreira, Claudio B Murta, Joaquim F A Claro, São Paulo, Brazil MP30-20 MAJOR POSTOPERATIVE COMPLICATIONS AFTER PERCUTANEOUS NEPHROLITHOTOMY (PCNL) IN A SINGLE TERTIARY REFERRAL CENTRE Daniel Olvera-Posada*, Thomas Tailly, Philippe Violette, Husain Alenezi, John Denstedt, Hassan Razvi, London, Canada SATURDAY Saturday, May 16, 2015 Moderated Poster Session 31 BENIGN PROSTATIC HYPERPLASIA: BASIC RESEARCH Room New Orleans Morial Convention Center Moderator: Robert Getzenberg 3:30 pm - 5:30 pm NUMBER TITLE NUMBER TITLE MP31-01 FUNCTIONAL MRNA - MICRORNA REGULATORY MODULES IDENTIFIED USING COMPREHENSIVE MOLECULAR CHARACTERIZATION OF BLADDER OUTLET OBSTRUCTION Katia Monastyrskaya*, Ali Hashemi Gheinani, Bern, Switzerland, Hubert Rehrauer, Catharine Aquino Fournier, Zurich, Switzerland, Irene Keller, Rémy Bruggmann, Fiona C. Burkhard, Bern, Switzerland MP31-02 SELECTIVE 1A-ADRENOCEPTOR BLOCKER SILODOSIN AMELIORATES VENTRAL PROSTATIC ENLARGEMENT IN THE SPONTANEOUSLY HYPERTENSIVE RAT : POSSIBLE ROLE OF THE PROSTATIC BLOOD FLOW Shogo Shimizu*, Nankoku, Japan, Panagiota Tsounapi, Yonago, Japan, Takahiro Shimizu, Youichirou Higashi, Kumiko Nakamura, Felix Holmstrom, Nankoku, Japan, Masashi Honda, Yonago, Japan, Keiji Inoue, Motoaki Saito, Nankoku, Japan *Presenting author 105

118 MP31-03 DIFFERENCES IN THE CONTRACTILITY OF HUMAN ISOLATED PROSTATIC URETHRA TO OXYTOCIN AND NOREPINEPHRINE IN BENIGN PROSTATIC HYPERPLASIA: POTENTIAL ROLE OF OXYTOCIN IN BPH Stewart McCallum, Collegeville, PA, Celine Rouget, Moez Rekik, TOULOUSE, France, Philippe Camparo, Henry Botto, Suresnes, France, Pascal Rischmann, Philippe Lluel, Stefano Palea, Timothy Westfall*, TOULOUSE, France MP31-04 CD8 T CELLS PROMOTE PROLIFERATION OF BENIGN PROSTATIC HYPERPLASIA EPITHELIAL CELLS IN THE CONDITION OF LOW ANDROGEN Yang Yang*, Shuai Hu, Yu Fan, Yun Cui, Mengkui Sun, Jie Jin, Beijing, China, People s Republic of MP31-05 UROTHELIAL DYSFUNCTION AND CHRONIC INFLAMMATION IN PATIENTS WITH BLADDER OUTLET OBSTRUCTION AND DIFFERENT BLADDER DYSFUNCTION AND DIFFERENT BLADDER OUTLET OBSTRUCTION DEGREE Chung-Cheng Wang*, New Taipei City, Taiwan, Jia-Hui Chang, Hann-Chorng Kuo, Hualien, Taiwan MP31-06 UPREGULATION OF PHOSPHODIESTERASE TYPE 5 IN THE HYPERPLASTIC PROSTATE: A RAT MODEL STUDY Wenhao Zhang, Ping Chen, Devendra Singh Negi, Zhuo Li, Keke Zhao, Qi Mao, Xinhua Zhang*, Wuhan, China, People s Republic of MP31-07 EFFECT OF DUTASTERIDE ON INTRAPROSTATIC LEVELS OF ESTROGENS AND ANDROGENS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA Itsuhiro Takizawa*, Niigata, Japan, Fumio Ishizaki, Nagaoka, Japan, Yoshimichi Miyashiro, Kawasaki, Japan, Takeshi Komeyama, Hideo Morishita, Nagaoka, Japan, Tsutomu Nishiyama, Niigata, Japan MP31-08 A TISSUE SPECIFIC ROLE FOR LIGAND INDEPENDENT ARV7 SIGNALING IN BENIGN PROSTATE PATHOGENESIS Tyler M. Bauman*, Emily A. Ricke, Wei Huang, William A. Ricke, Madison, WI MP31-09 THE EFFECTS OF CURRENTLY USED ANTI-HYPERTENSIVES ON THE CONTRACTILITY OF THE HUMAN PROSTATE GLAND Betty Exintaris*, Basu Chakrabarty, Brad Wittmer, Melissa Papargiris, Sarah Wilkinson, Mark Frydenberg, Nathan Lawrentschuk, John Pedersen, Tim Nottle, Andrew Ryan, Sam Norden, Gail Risbridger, Melbourne, Australia MP31-10 ADDITIVE CONTRACTIONS BY THROMBOXANE A2 AND ENDOTHELIN-1 ARE STRONGER THAN NOREPINEPHRINE-INDUCED CONTRACTIONS IN HUMAN PROSTATE SMOOTH MUSCLE Martin Hennenberg*, Alice C. Acevedo, Alexander Tamalunas, Yiming Wang, Beata Rutz, Frank Strittmatter, Raphaela Waidelich, Christian G. Stief, Christian Gratzke, Munich, Germany MP31-11 IMPACT OF TESTOSTERONE DEFICIENCY ON BLADDER SMOOTH MUSCLE FUNCTION IN MALE RATS WITH BLADDER OUTLET OBSTRUCTION Masafumi Kita*, Kazumi Hashizume, Naoki Wada, Seiji Matsumoto, Hidehiro Kakizaki, Asahikawa, Japan MP31-12 TAMSULOSIN IMPROVES MEMORY FUNCTION BY ACTIVATING NMDA RECEPTORS IN RAT HIPPOCAMPUS Kyung Jin Chung*, Chang Hee Kim, Kwang Taek Kim, Jin Gyu Oh, Tae Beom Kim, Han Jung, Incheon, Korea, Republic of, Kwang Ho You, GwangMyeong, Korea, Republic of, Young Sam Cho, Sung Tae Cho, Seoul, Korea, Republic of, Sang Jin Yoon, Khae Hawn Kim, Incheon, Korea, Republic of MP31-13 UPREGULATED EXPRESSION OF NLRP1 AND DOWNSTREAM CYTOKINES SUPPORT A ROLE OF INFLAMMASOME PATHWAY IN PROSTATIC INFLAMMATION ASSOCIATED WITH BPH Pradeep Tyagi*, Mahendra Kashyap, Subrata Pore, Zhou Wang, Naoki Yoshimura, Pittsburgh, PA MP31-14 CHANGES IN APOPTOSIS RELATED PROTEINS IN THE BLADDER AFTER PARTIAL BLADDER OUTLET OBSTRUCTION RELIEF Ki Hak Song, Chong koo Sul, Yong gil Na, Jae sung Lim, Ju Hyun Shin, Jong mok Park*, Daejeon, Korea, Republic of MP31-15 GENE EXPRESSION PROFILING REVEALS MOLECULAR SUBTYPES OF BENIGN PROSTATIC HYPERPLASIA Keyan Salari*, Seth Bechis, Rongbin Ge, Jian Hong, Aleksander Otsetov, Zongwei Wang, Shahin Tabatabaei, Aria Olumi, Boston, MA MP31-16 SEROTONIN INHIBITS PROSTATE GROWTH DOWN REGULATING ANDROGEN RECEPTORS: EVIDENCE FOR A NOVEL THEORY FOR BPH Emanuel Carvalho-Dias*, Olga Martinho, Paulo Mota, Estêvão Lima, Jorge Correia- Pinto, Braga, Portugal MP31-17 ROLE OF PHYSICAL ACTIVITY IN THE PREVENTION OF BPH THROUGH INHIBITION OF PROSTATIC IGF1/AKT PROLIFERATIVE AXIS: AN EXPERIMENTAL STUDY IN RATS Fernando Fróes Fonseca*, André M Oliveira, Sabrina T Reis, Kátia R Leite, William C Nahas, Miguel Srougi, Alberto A Antunes, São Paulo, Brazil 106

119 MP31-18 TESTOSTERONE MODIFIES ALTERATIONS TO DETRUSOR MUSCLE AFTER PARTIAL BLADDER OUTLET OBSTRUCTION IN MICE Andrew Flum*, Diana Bowen, Grace Delos Santos, Natalie Kukulka, Paula Firmiss, Robert Dettman, Edward Gong, Chicago, IL MP31-19 ESTROGEN RECEPTOR-ALPHA IS NECESSARY FOR HORMONAL INDUCTION OF PROSTATE GROWTH IN MALE MICE Tristan Nicholson*, Jalissa Wynder, William Ricke, Madison, WI MP31-20 THE EFFECT OF SYSTEMIC INFLAMMATION ON PROSTATE VOLUME: A STUDY OF SERUM MAKERS Ryan Werntz*, Wesley Stoller, Brittany Holzhammer, Jackilen Shannon, Mark Garzotto, Portland, OR SATURDAY Saturday, May 16, 2015 Moderated Poster Session 32 3:30 pm - 5:30 pm GENERAL & EPIDEMIOLOGICAL TRENDS & SOCIOECONOMICS: PRACTICE PATTERNS, COST EFFECTIVENESS IV Room New Orleans Morial Convention Center Moderator: David Miller NUMBER TITLE NUMBER TITLE MP32-01 VALIDATION OF NATURAL-LANGUAGE- PROCESSING AS AN AUTOMATED METHOD FOR IDENTIFYING RADICAL CYSTECTOMIES PERFORMED FOR BLADDER CANCER Hung-Jui Tan*, Robin Clarke, Arnold I. Chin, Alan L. Kaplan, Mark S. Litwin, Christopher S. Saigal, Karim Chamie, Andrew D. Hackbarth, Los Angeles, CA MP32-02 BASELINE UTILIZATION AND OUTCOMES OF INPATIENT SURGICAL CARE FOR HOSPITALS PARTICIPATING IN ACCOUNTABLE CARE ORGANIZATIONS Scott Hawken*, Lindsey Herrel, Chandy Ellimoottil, Zachary Montgomery, Zaojun Ye, David Miller, Ann Arbor, MI MP32-06 DOES THE OWNERSHIP OF RADIATION ONCOLOGY SERVICES AFFECT UROLOGISTS PRACTICE PATTERNS FOR THE TREATMENT OF PROSTATE CANCER? Deborah Kaye*, Theodore DeWeese, Heather Chalfin, Bruce Trock, Zhaoyong Feng, Misop Han, Baltimore, MD MP32-07 THE DRIVING FORCES AND COST OF READMISSIONS AND DEATHS IN POST- OPERATIVE RADICAL CYSTECTOMY PATIENTS AT 30 DAY AND 90 DAY READMISSIONS Danny Lascano*, Jamie S Pak, Daniel Kabat, LaMont J Barlow, G. Joel DeCastro, William Gold, James M McKiernan, New York, NY MP32-03 TRENDS IN THE DELIVERY OF UROLOGIC PROCEDURAL CARE BY ADVANCED PRACTICE PROVIDERS Matthew Uhlman*, Thomas Gruca, Bradley Erickson, Iowa City, IA MP32-04 EMERGENCY DEPARTMENT REVISITS FOR PATIENTS WITH KIDNEY STONES Charles Scales, Jr.*, Li Lin, Durham, NC, Christopher Saigal, Carol Bennett, Ninez Ponce, Carol Mangione, Mark Litwin, Los Angeles, CA MP32-05 SOCIETAL COSTS AFTER UPPER TRACT UROLOGIC SURGERY Peter Chang*, Peter R Renehan, Kimberly Taylor, Ostap Dovirak, Arie Carneiro, Kyle McAnally, Catrina Crociani, Boston, MA, Andrew Percy, Richmond, VA, Andrew A Wagner, Boston, MA MP32-08 READMISSIONS AFTER MAJOR UROLOGIC CANCER SURGERY Jeffrey Leow*, Julian Hanske, Christian Meyer, Boston, MA, Giorgio Gandaglia, Milan, Italy, Marianne Schmid, Hamburg, Germany, Jesse Sammon, Firas Abdollah, Mani Menon, Detroit, MI, Maxine Sun, Montreal, Canada, Joachim Noldus, Herne, Germany, Adam Kibel, Quoc-Dien Trinh, Boston, MA MP32-09 USING LEAN METHODOLOGY FOR UROLOGY PATIENT CALL CENTER IMPROVEMENT AT A SINGLE ACADEMIC INSTITUTION Thomas Tieu*, Bradford Stevenson, Teri Baldini, Tobias S. Kohler, Springfield, IL, Christopher Gonzalez, Chicago, IL, Kevin T. McVary, Springfield, IL MP32-10 MEASURING THE TRUE COST OF TREATING SMALL RENAL MASSES: AN ASSESSMENT OF TIME-DRIVEN ACTIVITY-BASED-COSTING Aaron Laviana*, Chandan Kundavaram, Hung-Jui Tan, Michael Burke, Douglas Niedzwiecki, Nisheeta Setlur, Christopher Saigal, Jim Hu, Los Angeles, CA *Presenting author 107

120 MP32-11 THE DIFFERENCE A YEAR CAN MAKE: ACADEMIC PRODUCTIVITY OF RESIDENTS IN 5 VERSUS 6-YEAR UROLOGY PROGRAMS Julia B Finkelstein*, Jason P Van Batavia, New York, NY, James S Rosoff, New Haven, CT MP32-12 HOW SURGEONS EARN THEIR KEEP: DATA FROM THE CMS DATA RELEASE Aaron Laviana*, Jim Hu, Steven Lerman, Kwan Lorna, William Aronson, Carol Bennett, Jonathan Bergman, Los Angeles, CA MP32-13 FREQUENCY OF UTILIZATION AND REIMBURSEMENT OF VARIOUS DIAGNOSTIC TESTS AND TREATMENTS FOR TESTICULAR CANCER Austin Barber*, Mohamed Kamel, Ehab Eltahawy, Rodney Davis, Little Rock, AR MP32-14 OBSERVING SHARED DECISION-MAKING IN THE UROLOGY CLINIC: A PILOT STUDY AMONG MEN WITH PROSTATE CANCER Alan L Kaplan*, Josemanuel D Saucedo, Los Angeles, CA, Glyn Elwyn, Hanover, NH, Catherine M Crespi, Los Angeles, CA, Masahito Jimbo, Ann Arbor, CA, Christopher S Saigal, Los Angeles, CA MP32-15 READMISSION INTENSITY AFTER HIGH- RISK SURGERY Bruce Jacobs*, Pittsburgh, PA, Chang He, Benjamin Li, Michael Hu, Alex Helfand, Naveen Krishnan, Brent Hollenbeck, Ann Arbor, MI, Jonathan Helm, Bloomington, IN, Mariel Lavieri, Ted Skolarus, Ann Arbor, MI MP32-17 CHOOSING WISELY PROSTATE CANCER SCREENING, DIAGNOSIS, AND TREATMENT AMONG THE ELDERLY MEN IN ISRAEL Liat Shavit Grievink*, Petah Tikva, Israel, Moshe Hoshen, Becca Feldman, Ran Balicer, Tel Aviv, Israel, Jack Baniel, Eli Rosenbaum, David Margel, Petah Tikva, Israel MP32-18 A COMPARISON BETWEEN UROLOGY AND OTHER SPECIALITIES IN THE UTILIZATION OF TWITTER AT INTERNATIONAL CONFERENCES Amanda S Chung*, Kit H Lee, Henry H Woo, Sydney, Australia MP32-19 HOSPITAL UTILIZATION & TRAVEL PATTERNS OF INPATIENT UROLOGICAL SURGERY PATIENTS IN NEW YORK STATE: HAVE TRAVEL PATTERNS CHANGED SINCE 1982? Khawaja Bilal*, New York, NY, Mark Finkelstein, New York City, NY, Rajiv Jeyadevan, New York, NY, Michael Palese, New York City, NY MP32-20 TAKING THE PROCEDURE TO THE PATIENT: INCREASING ACCESS TO UROLOGIC PROCEDURAL CARE THROUGH OUTREACH Matthew Uhlman*, Thomas Gruca, Bradley Erickson, Iowa City, IA MP32-16 TRENDS IN MESH USE IN PELVIC ORGAN PROLAPSE REPAIR Lily Wang*, Bashir Al Hussein Al Awamlh, Tina Schubert, Melissa Laudano, Daniel Lee, Wesley Davidson, Michael Schulster, Fujun Zhao, Bilal Chughtai, Richard Lee, New York, NY Saturday, May 16, 2015 Moderated Poster Session 33 STONE DISEASE: BASIC RESEARCH I Room New Orleans Morial Convention Center Moderators: John Denstedt and Saeed Khan 3:30 pm - 5:30 pm NUMBER TITLE NUMBER TITLE MP33-01 MINERAL GRADIENTS IN HUMAN RENAL PAPILLAE WITH AND WITHOUT RANDALL S PLAQUE Sunita Ho*, San Francisco, CA, Frances Allen, Andrew Minor, Berkeley, CA, Sabra Djomehri, Ling Chen, Thomas Chi, Krishna Ramaswamy, Marshall Stoller, San Francisco, CA MP33-02 TRANSCRIPTOME OF TAMM-HORSFALL PROTEIN-DEFICIENT KIDNEYS REVEALS SECONDARY EVENTS THAT MAY CONTRIBUTE TO INTRA-RENAL CALCINOSIS Yan Liu, Ellen Shapiro, Herbert Lepor, Xue- Ru Wu*, New York, NY MP33-03 OXALOBACTER FORMIGENES COLONIZATION NORMALIZES OXALATE EXCRETION IN A GASTRIC BYPASS MODEL OF HYPEROXALURIA Benjamin Canales*, Marguerite Hatch, Gainesville, FL 108

121 MP33-04 HETEROGENEOUS NUCLEATION DRIVES THE FORMATION OF NON-CALCIUM URINARY STONES IN HUMANS AND DROSOPHILA MELANOGASTER Thomas Chi*, San Francisco, CA, Gregory Tasian, Philadelphia, PA, Tiffany Zee, Sven Lang, Gulinuer Muteliefu, Novato, CA, David Killilea, Oakland, CA, Arnold Kahn, Pankaj Kapahi, Novato, CA, Marshall Stoller, San Francisco, CA MP33-05 IN VITRO STUDY ON URETERAL SMOOTH MUSCLE CONTRACTILITY WITH TAMSULOSIN, NIFEDIPINE, AND TERPENE MIXTURE (ROWATINEX Ç) jea whan Lee*, Tae Hoon Oh, Whi-An Kwon, Seung Chol Park, Hee Jong Jeong, Ill Young Seo, Iksan city, Korea, Republic of MP33-06 A NEW PORCINE MODEL OF ENTERIC HYPEROXALURIA MIMICS EFFECTS OF HIGH OXALATE ABSORPTION IN HUMANS Kristina L Penniston*, David A Bennett, Leema M John, Elizabeth L Zars, Thomas D Crenshaw, Madison, WI MP33-07 CLINICAL AND METABOLIC RISK FACTORS FOR PLUG FORMATION AMONG IDIOPATHIC CALCIUM OXALATE STONE FORMERS Marcelino Rivera*, Patrick Cockerill, Eric Bergstralh, Ramila Mehta, Lisa Vaughan, John Lieske, Amy Krambeck, Rochester, MN MP33-08 PROGESTERONE SURGE DECREASES THE SEVERITY OF URETERAL STENT RELATED SYMPTOMS IN FEMALE PATIENTS Emrah Yuruk*, Aykut Colakerol, Ege Can Serefoglu, Istanbul, Turkey MP33-09 HUMAN MONOCYTE-DERIVED MACROPHAGES ARE ABLE TO DESTROY KIDNEY STONES Sergei Kusmartsev*, Paul Dominguez Gutierrez, Benjamin Canales, Johannes Vieweg, Saeed Khan, Gainesville, FL MP33-10 QUANTITATIVE INVESTIGATION OF ZINC, SELENIUM, STRONTIUM AND LEAD IN HUMAN URINARY CALCULI BY USING INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION SPECTROMETRY Mahmoud El-Naggar*, Al Ain, United Arab Emirates, Bedeir Ali-El-Dein, Mansoura, Egypt, Sanjeev Mehta, Ahmedabad, India, Naimat Alsaigh, Al ain, United Arab Emirates, Manoj Monga, Ohio, OH MP33-11 CALCIUM IS MORE EFFECTIVE THAN VITAMIN B6 AT REDUCING OXALATE EXCRETION IN A GASTRIC BYPASS MODEL OF HYPEROXALURIA Christopher Monsour*, Jesse Gregory, Marguerite Hatch, Saeed Khan, Benjamin Canales, Gainesville, FL MP33-12 A NOVEL WET COUPLING DESIGN FOR CONTEMPORARY ELECTROMAGNETIC LITHOTRIPTERS: ELIMINATION OF COUPLING DEFECTS AND IMPROVEMENT OF COMMINUTION EFFICIENCY Fernando Cabrera*, Richard Shin, Daniel Concha, Jaclyn Lautz, Georgy Sankin, Durham, NC, Ramy Youseff, Irvine, CA, Charles Scales, Michael Lipkin, Glenn Preminger, F. Hadley Cocks, Walter Simmons, Pei Zhong, Durham, NC MP33-13 HYPERCALCIURIA AND MIGRATION OF INFLAMMATORY MACROPHAGES PLAY KEY ROLES FOR KIDNEY STONE FORMATION IN METABOLIC SYNDROME Kazumi Taguchi*, Nagoya, Japan, Rei Unno, Naogya, Japan, Yasuhiro Fujii, Shuzo Hamamoto, Ryosuke Ando, Atsushi Okada, Takahiro Yasui, Keiji Fujita, Keiichi Tozawa, Yutaro Hayashi, Kenjiro Kohri, Nagoya, Japan MP33-14 SEASONAL VARIATION OF 25- HYDROXYCHOLECALCIFEROL AND SERUM AND URINE ELECTROLYTES IN A POPULATION OF PATIENTS WITH STONE DISEASE David Crawley*, David Chalmers, Farmington, CT, David O Sullivan, Plainville, CT, Wilner Samson, Hartford, CT, Edward Myer, Middletown, CT MP33-15 MITOCHONDRIAL COLLAPSE DEPENDS ON CYCLOPHILIN D IN RENAL TUBULAR CELLS PROMOTES KIDNEY STONE FORMATION Yasuhiko Ito*, Takahiro Yasui, Kazuhiro Niimi, Shoichiro Iwatsuki, Takashi Hamakawa, Kazumi Taguchi, Yasuhiro Fujii, Yasuhiko Hirose, Shuzo Hamamoto, Atsushi Okada, Yukihiro Umemoto, Keiichi Tozawa, Kenjiro Kohri, Nagoya, Japan MP33-16 ARE SPOT URINARY DIPSTICK PH VALUES RELIABLY COMPARABLE TO COMMERCIAL 24-HOUR URINARY PH? William Shi*, Daniel L Miller, David L Wenzler, Angela Wang, Roger L Sur, San Diego, CA MP33-17 THE PREVENTIVE EFFECTS OF OXALATE- DEGRADING ENZYME ON THE OXALATE KIDNEY STONES IN INTESTINAL HYPEROXALURIA RAT Qiangqiang Ge, Zhong Chen*, Zhangqun Ye, Wuhan, China, People s Republic of MP33-18 THE ROLE OF RENAL TUBULAR CELL INJURY IN THE EARLY PERIOD OF RENAL CRYSTAL FORMATION IDENTIFIED FROM THE CELL INJURY-INHIBITING EFFECT OF GREEN TEA Masahito Hirose*, Konan, Japan, Rika Banno, Kazuhiro Kanemoto, Konan City, Japan, Atsushi Okada, Takahiro Yasui, Nagoya City, Japan, Takeshi Sakakura, Konan City, Japan, Keiichi Tozawa, Kenjiro Kohri, Nagoya City, Japan SATURDAY *Presenting author 109

122 MP33-19 THE RELATION BETWEEN CALCIUM OXALATE STONE DISEASE AND SERUM ANTIOXIDANT ENZYME LEVELS Omer Cakir*, Damla Arisan, Serdar Arisan, Ahmet Muslumanoglu, Istanbul, Turkey Saturday, May 16, 2015 Podium Session 17 BLADDER CANCER: NON-INVASIVE II Room New Orleans Morial Convention Center Moderators: Gary Steinberg and Brant Inman 3:30 pm - 5:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 3:30 PD17-01 NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN 1 (NRAMP1) GENE POLYMORPHISMS AND RESPONSE TO BACILLUS CALMETTE-GUERIN THERAPY IN ASIAN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS Jen-Hwei Sng, Yew Koon Lim, Zi Ting Wang, Lata Raman Nee Mani, Yiong Huak Chan, Ma Thin Mar Win, Ratha Mahendran, Edmund Chiong*, Singapore, Singapore 3:40 PD17-02 IS INTRAVESICAL BCG ALONE STILL THE ONLY TRULY EFFECTIVE INTRAVESICAL THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER? Savino Mauro Di Stasi*, Rome, Italy, Claus Riedl, Baden, Austria, Antonella Giannantoni, Perugia, Italy, Cristian Verri, Francesco Celestino, Francesco De Carlo, Rome, Italy, Francesco Masedu, Marco Valenti, L Aquila, Italy 3:50 PD17-03 TUMOR BUDDING, A NOVEL PROGNOSTIC INDICATOR FOR PREDICTING STAGE PROGRESSION IN T1 BLADDER TUMORS Keishiro Fukumoto*, Eiji Kikuchi, Shuji Mikami, Kazuyuki Yuge, Ogihara Koichiro, Kazuhiro Matsumoto, Shinya Morita, Kazunobu Shinoda, Takeo Kosaka, Ryuichi Mizuno, Toshiaki Shinojima, Hiroshi Asanuma, Akira Miyajima, Mototsugu Oya, Tokyo, Japan 4:00 PD17-04 MOST PATIENTS WITH CARCINOMA IN SITU OF THE BLADDER ARE NOT RECEIVING INTRAVESICAL BACILLE CALMETTE-GUERIN (BCG) Phillipe Nabbout*, Oklahoma City, OK, Sean Elliott, Oluwakayode Adejoro, Minneapolis, MN, Joel Slaton, Oklahoma City, OK 4:10 PD17-05 BACILLUS CALMETTE-GUERIN INTRAVESICAL INSTILLATION THERAPY IS NECESSARY FOR PATIENTS WITH A SECOND TRANSURETHRAL RESECTION PATHOLOGY OF PT0 Keitaro Iida*, Etani Toshiki, Taku Naiki, Ryosuke Ando, Noriyasu Kawai, Keiichi Tozawa, Kenjiro Kohri, Nagoya, Aichi, Japan 4:20 PD17-06 RANDOMIZED PHASE II TRIAL OF INTRAVESICAL ADENOVIRAL MEDIATED INTERFERON- GENE THERAPY WITH THE EXCIPIENT SYN3 (RAD-IFN /SYN3) IN PATIENTS WITH BCG REFRACTORY OR RELAPSING HIGH GRADE (HG) NON MUSCLE INVASIVE BLADDER CANCER (NMIBC) Daniel Canter*, Elkins Park, PA, Stephen Boorjian, Rochester, MN, Kenneth Ogan, Atlanta, GA, Neal Shore, Myrtle Beach, SC, Trinity Bivalacqua, Baltimore, MD, Bernard Bochner, New York City, NY, Tracy Downs, Madison, WI, Leonard Gomella, Philadelphia, PA, Robert Grubb III, St. Louis, MO, Brant Inman, Durham, NC, Ashish Kamat, Houston, TX, Larry Karsh, Denver, CO, Tracey Krupski, Charlottesville, VA, Seth Lerner, Houston, TX, Yair Lotan, Dallas, TX, Matthew Milowsky, Chapel Hill, NC, Mark Schoenberg, Bronx, NY, Robert Svatek, San Antonio, TX, Michael Woods, Chapel Hill, NC, Colin Dinney, Houston, TX 4:30 PD17-07 IMPACT OF BLADDER NECK INVOLVEMENT ON PROGRESSION IN PATIENTS WITH PRIMARY NON-MUSCLE- INVASIVE BLADDER CANCER: A MULTICENTER VALIDATION STUDY Yasuhisa Fujii*, Shingo Moriyama, Minato Yokoyama, Junji Yonese, Tokyo, Japan, Akira Noro, Saitama, Japan, Chizuru Arisawa, Tokyo, Japan, Shinji Morimoto, Tsuchiura, Japan, Tetsuo Okuno, Toride, Japan, Satoshi Kitahara, Tama, Japan, Fumitaka Koga, Tokyo, Japan, Yasuyuki Sakai, Masahito Suzuki, Kashiwa, Japan, Katsushi Nagahama, Ichikawa, Japan, Toshifumi Izutani, Mishima, Japan, Kazutaka Saito, Kazunori Kihara, Tokyo, Japan 4:40 PD17-08 REFRAINING FROM SMOKING FOR 15 YEARS OR MORE REDUCED THE RISK OF TUMOR RECURRENCE IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS Koichiro Ogihara*, Eiji Kikuchi, Kazuyuki Yuge, Nobuyuki Tanaka, Kazuhiro Matsumoto, Akira Miyajima, Mototsugu Oya, Tokyo, Japan 110

123 4:50 PD17-09 DECADE-LONG EXPERIENCE WITH INTRAVESICAL DOCETAXEL IN THE MANAGEMENT OF NON-MUSCLE- INVASIVE BLADDER CANCER (NMIBC) REFRACTORY TO BCG THERAPY LaMont Barlow*, Danny Lascano, James McKiernan, Mitchell Benson, New York, NY 5:00 PD17-10 MONOPOLAR VERSUS BIPOLAR TRANSURETHRAL RESECTION OF NON- MUSCLE INVASIVE BLADDER CANCER: A SINGLE CENTER RANDOMIZED CONTROLLED TRIAL Ahmed M. Mansour*, Ahmed A. Shokeir, Mohammed Tharwat, Bedeir Ali-El-Dein, Yasser Osman, Mansoura, Egypt 5:10 PD17-11 THE IMPACT OF DIFFERENT BCG STRAINS ON OUTCOME IN A LARGE COHORT OF T1G3 PATIENTS TREATED WITH BCG Paolo Gontero*, turin, Italy, Richard Sylvester, Bruxelles, Belgium, Francesca Pisano, Turin, Italy, Guido Dalbagni, New York, NY, Sharok Shariat, Vienna, Austria, Jeffrey Karnes, rochester, NY, Steven joniau, leuven, Belgium, Vincenzo Serretta, Palermo, Italy, Jouan Palou, Barcelona, Spain, Savino Di Stasi, Rome, Italy, Stephane Larrè, Oxford, United Kingdom, Renzo Colombo, Milan, Italy, Marek Babjuk, Praga, Czech Republic, Per Uno Malmstrom, Uppsala, Sweden, Jaques Irani, Poitiers, France, Nuria Malats, madrid, Spain, Jack Baniel, Tel Aviv, Israel, Tommaso Cai, Trento, Italy, Eugene Cha, New York, NY, Petere Ardelt, Freiburg, Germany, Jhon varkarakis, Atene, Greece, Riccardo Bartoletti, Florence, Italy, Marthin Sphan, Wurtzburg, Germany, J Alfred Witjes, Nijmegen, Netherlands 5:20 PD17-12 PATIENT COMPLIANCE WITH INTRAVESICAL MAINTENANCE PROTOCOLS FOR NON-MUSCLE INVASIVE BLADDER CANCER Alex Helfand*, Tel Aviv, Israel, Liat Shavit Grievink, Daniel Kedar, Ofer Yossepowitch, Andrei Nadu, Eli Rosenbaum, Jack Baniel, David Margel, Petah Tikva, Israel SATURDAY Saturday, May 16, 2015 Podium Session 18 TECHNOLOGY & INSTRUMENTS: LAPAROSCOPY AND ROBOTICS: MALIGNANT DISEASE II Room New Orleans Morial Convention Center Moderators: Ravi Munver and Gunter Janetschek 3:30 pm - 5:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 3:30 PD18-01 IMPROVEMENT IN CONTINENCE AND QUALITY OF LIFE IN MEN WITH SEVERE LUTS VIA HYPOTHERMIC COOLING Adam Gordon, Cody Arbuckle, Douglas Skarecky, Blanca Morales, Thomas Ahlering*, Orange, CA 3:40 PD18-02 SURGEON HUMAN CAPITAL DEPRECIATION: THE IMPACT OF DAYS OFF BETWEEN CASES ON PERIOPERATIVE AND FUNCTIONAL OUTCOMES FOR ROBOTIC-ASSISTED LAPAROSCOPIC PROSTATECTOMY Shane Pearce*, Joseph Pariser, Sanjay Patel, Blake Anderson, Scott Eggener, Gregory Zagaja, Chicago, IL 3:50 PD18-03 CONSOLE-INTEGRATED REAL-TIME THREE-DIMENSIONAL IMAGE OVERLAY NAVIGATION FOR ROBOT-ASSISTED PARTIAL NEPHRECTOMY WITH SELECTIVE ARTERIAL CLAMPING: EARLY SINGLE-CENTER EXPERIENCE WITH 25 CASES Junya Furukawa*, Hideaki Miyake, Kazushi Tanaka, Masato Fujisawa, Kobe, Japan *Presenting author 111

124 4:00 PD18-04 DEVELOPMENT OF AN ARM SUPPORT SYSTEM TO IMPROVE ERGONOMICS IN LAPAROSCOPIC SURGERY STUDY DESIGN AND PROVISIONAL RESULTS Benjamin Steinhilber, Sascha Hoffmann, Tubingen, Germany, Kristian Karlovic, Stefan Pfeffer, Thomas Maier, Stuttgart, Germany, Omar Hallasheh, Stefan Kruck, Robert Seibt, Monika Rieger, Tubingen, Germany, Michael Heidingsfeld, Ronny Feuer, Oliver Sawodny, Stuttgart, Germany, Ralf Rothmund, Tubingen, Germany, Karl-Dietrich Sievert*, Tubingen-Lubeck, Germany 4:10 PD18-05 ROBOTIC NEPHRECTOMY IS NOT COSTLIER THAN STANDARD LAPAROSCOPY WHEN A ROBOT IS AVAILABLE Ronney Abaza*, Dublin, OH, Iahn Gonsenhauser, Geoffrey Box, David Sharp, Ahmad Shabsigh, Columbus, OH 4:20 PD18-06 APPLYING CLINICAL PATHWAY TO ROBOTIC CYSTECTOMY ALLOWS SHORTEST POSSIBLE LENGTH OF STAY Ronney Abaza*, Dublin, OH 4:30 PD18-07 FLOW DYNAMICS IN A DRAINED URETERAL BIOMIMETIC MODEL miki Haifler*, Jacob Ramon, Harry Winkler, Nir Kleinmann, Ramat gan, Israel 4:40 PD18-08 ROBOTIC VERSUS LAPAROSCOPIC PARTIAL NEPHRECTOMY: A SYSTEMATIC REVIEW AND META-ANALYSIS Jeffrey Leow*, Yew Lam Chong, Keng Siang Png, Singapore, Singapore 4:50 PD18-09 THE ROLE OF THE ASSISTANT DURING ROBOT-ASSISTED PARTIAL NEPHRECTOMY: DOES EXPERIENCE MATTER? John A. Brockman*, Aaron M. Potretzke, Jeffrey A. Larson, Joel Vetter, R. Sherburne Figenshau, Samuel B Bhayani, Brian M. Benway, Saint Louis, MO 5:00 PD18-10 DRAINING URETERS OBSTRUCTED BY MALIGNANT DISEASES WITH TANDEM STIFF URETERAL STENTS INITIAL CLINICAL EXPERIENCE miki Haifler*, Jacob Ramon, Harry Winkler, Nir Kleinmann, Ramat gan, Israel 5:10 PD18-11 A LAPAROSCOPIC COMBINATION WITH COMPARABLE ERGONOMIC RESULTS TO ROBOTIC SURGERY, TESTED IN AN EXPERIMENTAL LAPAROSCOPIC RADICAL PROSTATECTOMY SETTING Theodoros Tokas*, Ali Serdar Gözen, Alexandra Tschada, Jens Rassweiler, Heilbronn, Germany 5:20 PD18-12 USE OF HYALURONIC ACID- CARBOXYMETHYLCELLULOSE ADHESION BARRIER ON THE NEUROVASCULAR BUNDLE DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY: LONG TERM OUTCOMES Rutveej Patel*, Parth Modi, Isaac Kim, New Brunswick, NJ Saturday, May 16, 2015 Podium Session 19 TECHNOLOGY & INSTRUMENTS: SURGICAL EDUCATION & SKILLS ASSESSMENT III Room New Orleans Morial Convention Center Moderators: Lee Richstone and Cassio Andreoni 3:30 pm - 5:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 3:30 PD19-01 THE VALUE OF OPEN CONVERSION SIMULATIONS DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY: IMPLICATIONS FOR ROBOTIC TRAINING CURRICULUMS Fabio Zattoni*, Padua, Italy, Vidit Sharma, Rochester, MN, Andrea Guttilla, Alessandro Crestani, Francesco Cattaneo, Fabrizio Dal Moro, Filiberto Zattoni, Padua, Italy 3:40 PD19-02 USING THE WISDOM OF CROWDS: VALIDATION THROUGH THE BASIC LAPAROSCOPIC UROLOGIC SURGERY (BLUS) CURRICULUM Thomas Lendvay*, Seattle, WA, Timothy Kowalewski, Robert Sweet, Minneapolis, MN, Ashleigh Menhadji, Boston, MA, Timothy Averch, Pittsburgh, PA, Geoffrey Box, Columbus, OH, Timothy Brand, Tacoma, WA, Michael Fearrandino, Durham, NC, Jihad Kaouk, Cleveland, OH, Bodo Knudsen, Columbus, OH, Jamie Landman, Orange, CA, Benjamin Lee, New Orleans, LA, Bradley Schwartz, Springfield, IL, Bryan Comstock, Seattle, WA, Elspeth McDougall, Vancouver, Canada 112

125 3:50 PD19-03 LARGE-SCALE EVIDENCE OF CONSTRUCT VALIDITY: THE BASIC LAPAROSCOPIC UROLOGIC SKILLS (BLUS) INITIATIVE Timothy Kowalewski, Robert Sweet, Minneapolis, MN, Ashleigh Menhadji, Boston, MA, Timothy Averch, Pittsburgh, PA, Geoffrey Box, Columbus, OH, Timothy Brand, Tacoma, WA, Michael Fearrandino, Durham, NC, Jihad Kaouk, Cleveland, OH, Bodo Knudsen, Columbus, OH, Jamie Landman, Orange, CA, Benjamin Lee, New Orleans, LA, Bradley Schwartz, Springfield, IL, Bryan Comstock, Seattle, WA, Cory Schaffhausen, Minneapolis, MN, Elspeth McDougall, Vancouver, Canada, Thomas Lendvay*, Seattle, WA 4:00 PD19-04 VALIDATION OF LAPAROSCOPIC TRAINING CURRICULUM: THE BASIC LAPAROSCOPIC UROLOGIC SKILLS (BLUS) INITIATIVE Timothy Kowalewski, Robert Sweet, Minneapolis, MN, Ashleigh Menhadji, Boston, MA, Timothy Averch, Pittsburgh, PA, Geoffrey Box, Columbus, OH, Timothy Brand, Tacoma, WA, Michael Fearrandino, Durham, NC, Jihad Kaouk, Cleveland, OH, Bodo Knudsen, Columbus, OH, Jamie Landman, Orange, CA, Benjamin Lee, New Orleans, LA, Bradley Schwartz, Springfield, IL, Elspeth McDougall, Vancouver, Canada, Thomas Lendvay*, Seattle, WA 4:10 PD19-05 HIGH-VOLUME ASSESSMENT OF SURGICAL VIDEOS VIA CROWD-SOURCING: THE BASIC LAPAROSCOPIC UROLOGIC SKILLS (BLUS) INITIATIVE Timothy Kowalewski, Robert Sweet, Minneapolis, MN, Ashleigh Menhadji, Boston, MA, Timothy Averch, Pittsburgh, PA, Geoffrey Box, Columbus, OH, Timothy Brand, Tacoma, WA, Michael Fearrandino, Durham, NC, Jihad Kaouk, Cleveland, OH, Bodo Knudsen, Columbus, OH, Jamie Landman, Orange, CA, Benjamin Lee, New Orleans, LA, Bradley Schwartz, Springfield, IL, Bryan Comstock, Seattle, WA, Cory Schaffhausen, Minneapolis, MN, Elspeth McDougall, Vancouver, Canada, Thomas Lendvay*, Seattle, WA 4:20 PD19-06 VIDEO-BASED PEER REVIEW OF ROBOT- ASSISTED RADICAL PROSTATECTOMY IN A STATEWIDE QUALITY IMPROVEMENT COLLABORATIVE Khurshid Ghani*, David Miller, Ann Arbor, MI, Brian Lane, Grand Rapids, MI, Richard Sarle, Dearborn, MI, Andrew Brachulis, Susan Linsell, Tae-Kyung Kim, Ann Arbor, MI, Deepansh Dalela, Detroit, MI, James Montie, Ann Arbor, MI, Bryan Comstock, Tom Lendvay, Seattle, MI, James Peabody, Detroit, MI 4:30 PD19-07 VALIDATION OF A TRAINING MODEL FOR INTRACORPOREAL BOWEL ANASTOMOSIS IN ROBOTIC SURGERY (BARS) Friedrich-Carl von Rundstedt*, Selcuk Silay, Monty Aghazadeh, Alvin Goh, Houston, TX 4:40 PD19-08 PROFICIENCY-BASED ROBOTIC TRAINING CURRICULUM YIELDS IMPROVEMENTS IN ROBOTIC CLINICAL PERFORMANCE: A RANDOMIZED CONTROLLED STUDY Monty Aghazadeh, Miguel Mercado, Michael Pan, Neel Srikishen*, Brian Miles, Richard Link, Brian Dunkin, Alvin Goh, Houston, TX 4:50 PD19-09 INTERNATIONAL UROLOGY JOURNAL CLUB ON TWITTER- A GROWING EDUCATIONAL FORUM Isaac Thangasamy*, Brisbane, Australia, Michael Leveridge, Kingston, Canada, Benjamin Davies, Pittsburgh, PA, Brian Stork, Muskegon, MI, Stacy Loeb, New York, NY, Henry Woo, Sydney, Australia 5:00 PD19-10 IMPLEMENTATION OF A WEB-BASED, PROCEDURE-SPECIFIC, ROBOTIC TRAINING EXPERIENCE LOG WITH FEEDBACK AND LONGITUDINAL REPORTING FEATURES Ryan Thorwarth*, Maywood, IL, Marcus Quek, Mawyood, IL, Gopal Gupta, Maywood, IL 5:10 PD19-11 SURGEON PERFORMANCE AND DISTRACTIONS IN THE OPERATING ROOM: A RANDOMIZED, CONTROLLED, CROSSOVER TRIAL Ryan Speir*, Timothy Brand, Tacoma, WA, Richard Greene, El Paso, TX 5:20 PD19-12 THE IMPACT OF REMOTE MONITORING AND SUPERVISION ON RESIDENT TRAINING USING NEW ACGME & ABU UROLOGY MILESTONE CRITERIA Ilan Safir*, Adam Shrewsberry, Kenneth Ogan, Chad Ritenour, Catrina White, Jane Kimberl, Jerry Sullivan, Muta Issa, Atlanta, GA SATURDAY *Presenting author 113

126 Saturday, May 16, 2015 Podium Session 20 INFECTIONS/INFLAMMATION OF THE GENITOURINARY TRACT: INTERSTITIAL CYSTITIS Room New Orleans Morial Convention Center Moderators: Robert Evans and John Krieger 3:30 pm - 5:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 3:30 PD20-01 TANEZUMAB REDUCES PAIN IN WOMEN WITH INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME J. Curtis Nickel*, Kingston, Canada, John Krieger, Seattle, WA, Ian Mills, Tim Crook, Tadworth, United Kingdom, Anamaria Jorga, New York, NY, Gary Atkinson, Tadworth, United Kingdom, Michael Smith, Northbrook, IL 3:40 PD20-02 INTRAVESICAL BOTULINUM TOXIN A SINGLE INJECTIONS CAN REDUCE BLADDER PAIN IN TREATMENT OF INTERSTITIAL CYSTITIS / BLADDER PAIN SYNDROME REFRACTORY TO CONVENTIONAL TREATMENT - A PROSPECTIVE, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL Jia-Fong Jhang*, Hui-Ling Tseng, Hann- Chorng Kuo, Hualien, Taiwan, Yuh-Chen Kuo, Taipei, Taiwan, Yao-Chou Tsai, New Taipei City, Taiwan 3:50 PD20-03 PILOT STUDY EVALUATING SAFETY AND FEASIBILITY OF INTRAVESICAL INSTILLATION OF BOTULINUM TOXIN IN HYDROGEL-BASED SLOW RELEASE DELIVERY SYSTEM IN PBS/IC PATIENTS Kobi Stav, Zeriffin, Israel, Yuri Vinshtok, Michal Jeshurun, Neely Ivgy-May, Tami Gerassi, Raanana, Israel, Amnon Zisman*, Zeriffin, Israel 4:00 PD20-04 ROLE OF SPINAL ASTROCYTIC ACTIVATION IN PAIN PATHOGENESIS IN RATS WITH CYCLOPHOSPHAMIDE- INDUCED CYSTITIS Xiangfu Zhou, Bolong Liu*, Wenbiao Li, Guangzhou, China, People s Republic of, Shaojun Tang, Galveston, TX, Minzhi Su, Guangzhou, China, People s Republic of 4:10 PD20-05 HERPES SIMPLEX VIRUS (HSV) VECTOR- MEDIATED GENE DELIVERY OF PROTEIN PHOSPHATASE 1 REDUCES BLADDER OVERACTIVITY AND Tsuyoshi Majima*, Hiroki Okada, Katsumi Kadekawa, Kenichi Mori, Naoki Kawamorita, Pittsburgh, PA, Momokazu Gotoh, Nagoya, Japan, William Goins, Joseph Glorioso, Justus Cohen, Naoki Yoshimura, Pittsburgh, PA 4:20 PD20-06 COMPARATIVE PILOT STUDY OF IMPLANTATION TECHNIQUES FOR PUDENDAL NEUROMODULATION: TECHNICAL AND CLINICAL OUTCOME IN FIRST 20 PATIENTS WITH CHRONIC PELVIC PAIN Arndt van Ophoven*, Kai Heinze, Herne, Germany, Romed Hoermann, Helga Fritsch, Innsbruck, Austria, Rolf Dermietzel, Bochum, Germany 4:30 PD20-07 ALTERATIONS IN CONNECTIVITY ON FMRI WITH PROVOCATION OF LOWER URINARY TRACT SYMPTOMS IN UROLOGIC CHRONIC PELVIC PAIN SYNDROMES Natalia Kleinhans, Claire Yang*, Eric Strachan, Dedra Buchwald, Kenneth Maravilla, Seattle, WA 4:40 PD20-08 THE IMPACT OF COMORBID CHRONIC PAIN SYNDROMES ON SEXUAL ACTIVITY AND DYSPAREUNIA AFTER PELVIC ORGAN PROLAPSE REPAIR Priyanka Gupta*, Michael Ehlert, Royal Oak, MI, James Payne, Rochester, MI, Kim A. Killinger, Judith A. Boura, Melissa Fischer, Larry T. Sirls, Royal Oak, MI 4:50 PD20-09 ALTERED MICROBIOME IN CHRONIC PELVIC PAIN PATIENTS David Klumpp*, Chicago, IL, Andrea Braudmeier- Fleming, Springfield, IL, Ryan Yaggie, Laurie Bachrack, Sarah Flury, Darlene Marko, Chicago, IL, Matthew Berry, Michael Welge, Colleen Bushell, Bryan White, Urbana-Champaign, IL, Anthony Schaeffer, Chicago, IL 5:00 PD20-10 PROSPECTIVE, MULTICENTER, RANDOMIZED CLINICAL TRIAL COMPARING THE EFFECT OF HYDRODISTENTION AND TRANSURTHRAL FULGURATION OF BLADDER IN INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME PATIENTS Jang Hwan Kim*, Sang Woon Kim, Sang Hyun Jee, Kyu Sung Lee, Myung Soo Choo, Seoul, Korea, Republic of, Joon Chul Kim, Buchan, Korea, Republic of, Sung Yong Cho, Ju Tae Seo, Seoul, Korea, Republic of, Jong Bo Choi, Suwon, Korea, Republic of, Seung June Oh, Seoul, Korea, Republic of 5:10 PD20-11 ENDOSCOPIC INJECTION OF TRIAMCINOLONE A SIMPLE, MINIMALLY INVASIVE, AND EFFECTIVE THERAPY FOR HUNNER S LESIONS Sonia Bahlani*, Alexandra King, Robert Moldwin, New Hyde Park, NY 114

127 5:20 PD20-12 MICROVASCULAR INJURY IN KETAMINE- INDUCED BLADDER DYSFUNCTION Chih-Chieh Lin*, An-Hang Yang, Alex T.L. Lin, Kuang-Kuo Chen, Taipei, Taiwan Saturday, May 16, 2015 Video Session 4 3:30 pm - 5:30 pm ROBOTICS PROSTATE/NOVEL IMAGING The videos in this session as well as the video libraries from the Annual Meetings may be viewed in the Surgical Video Library and purchased in the Products Store during the Annual Meeting. Both are located in Registration Hall B2. All years of the Surgical Video Library may also be purchased online at Room New Orleans Morial Convention Center Moderators: Misop Han and J. Kellogg Parsons SATURDAY NUMBER TITLE NUMBER TITLE V4-01 PERINEAL ROBOT ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (P-RALP) Oktay Akca*, Peter Caputo, Humberto Laydner, Homayoun Zargar, Daniel Ramirez, Juan Jimenez, Hiury Andrade, Robert J Stein, Cleveland, OH, Selami Albayrak, Istanbul, Turkey, Kenneth Angermeier, Jihad H Kaouk, Cleveland, OH V4-02 LAPAROSCOPIC RADICAL PROSTATECTOMY IN INTERMEDIATE AND HIGH RISK PROSTATE CANCER. INDOCYANINE GREEN-GUIDED PELVIC LYMPH NODE DISSECTION Sebastián Valverde Martínez, Salamanca, Spain, Miguel Ramírez Backhaus*, José Rubio Briones, José Luis Domínguez Escrig, Juan Casanova, Alvaro Gómez Ferrer, Solsona Narbón Eduardo, Valencia, Spain V4-03 TECHNIQUE AND OUTCOMES OF BLADDER NECK INTUSSUSCEPTION DURING ROBOTIC-ASSISTED RADICAL PROSTATECTOMY: A PARALLEL COMPARATIVE TRIAL Aaron Laviana*, Hung-Jui Tan, Siwei Xiong, Ryan Chuang, Eric Treat, Los Angeles, CA, Patrick Walsh, Baltimore, MD, Jim Hu, Los Angeles, CA V4-04 TECHNICAL ASPECTS OF ROBOT- ASSISTED LAPAROSCOPIC PROSTATECTOMY IN LARGE PROSTATES (>75G) Everaerts Wouter*, Ken Chow, Melbourne, Australia, Hans Pottel, Leuven, Belgium, Andrew Ryan, Marni Basto, Justin Peters, Daniel Moon, Anthony Costello, Declan Murphy, Melbourne, Australia V4-05 ROBOTIC ASSISTED RADICAL PROSTATECTOMY BLADDER NECK RECONSTRUCTION WITH ANTERIOR AND POSTERIOR INTUSSUSCEPTION Fernando Bianco*, igor kislinger, Isabel Lopez, Marilin Nicholson, Hialeah, FL V4-06 ANTERIOR SUSPENSION OF POSTERIOR RECONSTRUCTION SUTURE- A NOVEL TECHNIQUE TO IMPROVE EARLY RETURN OF URINARY CONTINENCE FOLLOWING ROBOT-ASSISTED RADICAL PROSTATECTOMY Vineet Agrawal*, Ahmed Ghazi, Jean Joseph, Rochester, NY V4-07 USE OF INTRA-OPERATIVE INDOCYANINE GREEN AND FIREFLY TECHNOLOGY TO VISUALIZE THE LANDMARK ARTERY FOR NERVE SPARING ROBOT ASSISTED RADICAL PROSTATECTOMY Anup Kumar*, Srinivas Samavedi, Anthony Bates, Rafael Coelho, Bernardo Rocco, Jeff Marquinez, Cathy Jenson, Kenneth Palmer, Vipul Patel, Celebration, FL V4-08 DEHYDRATED HUMAN AMNIOTIC MEMBRANE ALLOGRAFT NERVE WRAP AROUND THE PROSTATIC NEUROVASCULAR BUNDLE ACCELERATES EARLY RETURN TO CONTINENCE AND POTENCY FOLLOWING RADICAL ROBOT ASSISTED RADICAL PROSTATECTOMY : A PROPENSITY SCORE MATCHED ANALYSIS Anup Kumar*, Srinivas Samavedi, Anthony Bates, Rafael Coelho, Bernardo Rocco, Jeff Marquinez, Ignacio Camacho, Cathy Jenson, Kenneth Palmer, Vipul Patel, Celebration, FL V4-09 TRANSPERINEAL PROSTATE BIOPSY WITH NEW MAPPING SOFTWARE Nelson Stone*, New York, NY, Vassilios Skouteris, Athens, Greece, Paul Arangua, E. David Crawford, Aurora, CO V4-10 ROBOTIC-ASSISTED LAPAROSCOPIC URETERAL REIMPLANTATION: OUR TECNIQUE AND OUTCOMES Daniel Zainfeld*, Andrew Windsperger, Moben Mirza, David Duchene, Kansas City, KS *Presenting author 115

128 V4-11 STEP-BY-STEP ROBOTIC URETEROURETEROSTOMY: TIPS AND TRICKS TO OPTIMIZE OUTCOMES Hiury Andrade*, Jihad Kaouk, Homayoun Zargar, Peter Caputo, Cleveland, OH, Jayram Krishnan, Las Vegas, NV, Oktay Akca, Daniel Ramirez, Luis Felipe Brandao, Georges- Pascal Haber, Robert Stein, Cleveland, OH V4-12 ROBOTIC REPAIR FOR RECTOURETHRAL FISTULA: A NEW TECHNIQUE Rene Sotelo*, Oswaldo Carmona, Robert De Andrade, Caracas, Venezuela, David Canes, Burlington, MA, Victor Machuca, Luciano Nuñez, Eric Saenz, Luis Medina, Carlos Marrugo, Marino Cabrera, Caracas, Venezuela V4-13 POSTERIOR APPROACH TO ROBOTIC SIMPLE PROSTATECTOMY Brian Cronson*, Andrew Harbin, Laura Giusto, Anuj Desai, Ziho Lee, Joshua Kaplan, Blake Moore, Daniel Eun, Philadelphia, PA V4-14 ROBOT ASSISTED MILLIN PROSTATECTOMY Giuseppe Simone*, Rocco Papalia, Mariaconsiglia Ferriero, Riccardo Mastroianni, Salvatore Guaglianone, Michele Gallucci, Rome, Italy 116

129 MP Moderated Poster Session, PD Podium Session Sunday, May 17, 2015 Plenary Session PLENARY I - SUNDAY Great New Orleans Morial Convention Center 7:30 am - 12:00 pm 7:25 WELCOME AND ANNOUNCEMENTS AUA Secretary: Gopal Badlani 7:30 HIGHLIGHTS: ONCOLOGY RESEARCH PROGRAM Johannes Vieweg 7:40 HIGHLIGHTS: RESEARCH IN BENIGN DISEASES PROGRAM George Christ 7:50 STATE-OF-THE-ART LECTURE: HORMONE THERAPY FOR MEN WITH INFERTILITY Craig Niederberger 8:05 CRITICAL DISCUSSION: FERTILITY PRESERVATION IN CANCER PATIENTS Critical Discussant: Jay Sandlow Presenters: Robert Brannigan Kirk Lo SUNDAY 8:25 PANEL DISCUSSION: OPTIMAL MANAGEMENT OF ISCHEMIC PRIAPISM Moderator: Ira Sharlip Panelists: Ricardo Munarriz David Ralph Arthur Burnett 8:50 STATE-OF-THE-ART LECTURE: PDE5 INHIBITORS SIDE AFFECTS: MYTHS VS. REALITY Gregory Broderick 9:05 JOHN K. LATTIMER LECTURE: INTEGRATING THE DIGITAL UNIVERSE OF DATA TO BUILD MORE PREDICTIVE MODELS OF CANCER Eric Schadt 9:25 STATE-OF-THE-ART LECTURE: MANAGEMENT OF URINARY INCONTINENCE POST PROSTATE CANCER TREATMENT & URETHROPLASTY Kurt McCammon 9:40 STATE-OF-THE-ART LECTURE: SURGICAL MANAGEMENT OF ADULT BURIED PENIS Richard Santucci 9:55 AUA GUIDELINE: PEYRONIE S DISEASE Ajay Nehra 10:05 BEST : PI-01: RECTOURETHRAL FISTULAS SECONDARY TO PROSTATE CANCER TREATMENT: MANAGEMENT AND OUTCOMES Catherine Harris*, Benjamin Breyer, San Francisco, CA, Ramon Virasoro, Virginia Beach, VA, Alex Vanni, Burlington, MA, Daniela Andrich, London, United Kingdom, Gerald Jordan, Virginia Beach, VA, Leonard Zinman, Burlington, MA, Anthony Mundy, London, United Kingdom, Jack McAninch, San Francisco, CA 10:13 BEST : PI-02: AGE AND OBESITY PROMOTE METHYLATION AND SUPPRESSION OF 5-ALPHA REDUCTASE 2 IMPLICATIONS FOR PERSONALIZED THERAPY IN BPH Seth Bechis*, Alexander Otsetov, Rongbin Ge, Zongwei Wang, Mark Vangel, Chin-Lee Wu, Shahin Tabatabaei, Aria Olumi, Boston, MA 10:21 BEST : PI-03: SCROTAL ULTRASOUND FOR PAIN: LOW FREQUENCY OF ABSOLUTE SURGICAL INDICATIONS James Kashanian, Christopher D. Morrison*, Daniel J. Mazur, Chicago, IL, Marah C. Hehemann, Maywood, IL, Daniel T. Oberlin, Mohammed Said, Chicago, IL, Valary Raup, St. Louis, MO, Brian Trinh, Andrew Choi, Robert E. Brannigan, Chicago, IL 10:30 HIGHLIGHTS: SOCIETY FOR PEDIATRIC UROLOGY (SPU) PROGRAM Martin A. Koyle 10:40 JOHN DUCKETT MEMORIAL LECTURE: MINIMALLY INVASIVE SURGERY IN PEDIATRIC UROLOGY: PRESENT & FUTURE Chung Kwong Yeung 11:00 PANEL DISCUSSION: SIMULATION IN SURGICAL EDUCATION Moderator: Elspeth McDougall Panelists: Patrick McKenna Max Maizels Thomas Lendvay *Presenting author 117

130 11:25 STATE-OF-THE-ART LECTURE: MODERN MANAGEMENT OF THE NEWBORN WITH DISORDERS OF SEXUAL DEVELOPMENT (DSD) David Diamond 11:40 POINT-COUNTERPOINT: RECENT RANDOMIZED CONTROLLED TRIALS HAVE CHANGED MY PRACTICE Moderator: Steven Skoog Debaters: Antoine Khoury (Pro) Anthony Caldamone (Con) 12:00 SESSION CONCLUDES Sunday, May 17, 2015 Plenary Session PLENARY II - SUNDAY Hall New Orleans Morial Convention Center 10:00 am - 12:20 pm 9:55 WELCOME AND ANNOUNCEMENTS 10:00 AMERICAN BOARD OF UROLOGY UPDATE Ian Thompson 10:10 JOURNAL OF UROLOGY LECTURE: USING NEW KNOWLEDGE TO CHANGE CLINICAL PRACTICE Introduction: William Bohnert Presenter: Joseph Smith 10:30 RISING STAR REPORT: OPTIMIZING SURVIVORSHIP AND DECISION-MAKING IN LOW RISK BLADDER CANCER Introduction: Carolyn Best Presenter: Matthew Nielsen LATE BREAKING S 10:45 PII-LBA1: USING THE THERMAL ENERGY OF CONVECTIVELY DELIVERED WATER VAPOR FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS DUE TO BENIGN PROSTATIC HYPERPLASIA: THE REZUM II STUDY Kevin McVary*, Springfield, IL, Lance Mynderse, Rochester, MN, Steven Gange, Salt Lake City, UT, Marc Gittelman, Aventura, FL, Kenneth Goldberg, Lewisville, TX, Kalpesh Patel, Tucson, AZ, Neal Shore, Myrtle Beach, SC, Richard Levin, Baltimore, MD, Michael Rousseau, Cincinnati, OH, Randolf Beahrs, Woodbury, MN, Jed Kaminetsky, New York, NY, Barrett Cowan, Denver, CO, Christopher Cantrill, San Antonio, TX, James Ulchaker, Cleveland, OH, Claus Roehrborn, Dallas, TX 10:52 PII-LBA2: VALIDATION OF A NOVEL NON-INVASIVE URINE EXOSOME GENE EXPRESSION ASSAY TO PREDICT HIGH-GRADE PROSTATE CANCER IN PATIENTS UNDERGOING INITIAL BIOPSY WITH AN EQUIVOCAL PSA James McKiernan*, Michael Donovan, New York, NY, Vince O Neill, Cambridge, MA, Stefan Bentink, Mikkel Noerholm, Martinsried, Germany, Susan Belzer, St. Paul, MN, Johan Skog, Cambridge, MA, Alan Partin, Baltimore, MD, Gerald Andriole, St. Louis, MO, Gordon Brown, Vorhees, NJ, James Cochran, Dallas, TX, John Wei, Livonia, MI, Ian Thompson, San Antonio, TX, Peter Carroll, San Francisco, CA 10:59 PII-LBA3: GLYPICAN-1 AS A BIOMARKER FOR PROSTATE CANCER Neal Shore*, Myrtle Beach, SC, Raoul Concepcion, Nashville, TN, Daniel Saltzstein, San Antonio, TX, Thomas Paivanas, Annandale, VA, Jennifer Beebe-Dimmer, Julie Ruterbusch, Detroit, MI, Irene Justiniano, Hubert Mazure, Aline Nocon, Julie Soon, Quach Truong, Sandra Wissmueller, Douglas Campbell, Bradley Walsh, Macquarie Park, Australia 11:06 PII-LBA4: TERRAIN TRIAL: PROSTATE-SPECIFIC ANTIGEN KINETICS AND QUALITY OF LIFE RESULTS OF ENZALUTAMIDE VERSUS BICALUTAMIDE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER Neal Shore*, Myrtle Beach, SC, Axel Heidenreich, Aachen, Germany, Arnauld Villers, Lille, France, Laurence Klotz, Toronto, Canada, Maha Hussain, Ann Arbor, MI, Lawrence Karsh, Denver, CO, Steve van Os, Benoit Baron, Leiden, Netherlands, Fong Wang, David Forer, San Francisco, CA, Simon Chowdhury, London, United Kingdon, Robert D. Siemens, Kingston, Canada 11:13 PII-LBA5: EVIDENCE OF SUPERIOR QUALITY OF LIFE AFTER ROBOTIC PROSTATECTOMY: RESULTS FROM A POPULATION-BASED ANALYSIS Brock O Neil*, Tatsuki Koyama, JoAnn Rudd, Nashville, TN, Peter Albertsen, Farmington, CT, Matthew Cooperberg, San Francisco, CA, Michael Goodman, Atlanta, GA, Sheldon Greenfield, Irvine, CA, Ann Hamilton, Los Angeles, CA, Karen Hoffman, Houston, TX, Richard Hoffman, Albuquerque, NM, Sherrie Kaplan, Irvine, CA, Janet Stanford, Seattle, WA, Antoinette Stroup, New Brunswick, NJ, Xiao-Cheng Wu, New Orleans, LA, Matthew Resnick, Daniel Barocas, David Penson, Nashville, TN 118

131 11:20 PII-LBA6: EFFECT OF TESTOSTERONE SOLUTION ON TOTAL TESTOSTERONE, SEX DRIVE AND ENERGY IN HYPOGONADAL MEN Gerald Brock*, London, Canada, Darell Heiselman, Indianapolis, IN, Mario Maggi, Florence, Italy, Sae Woong Kim, Seoul, Korea, Republic of, José Maria Rodríguez Vallejo, Madrid, Spain, Hermann Behre, Halle, Germany, John McGettigan, Tucson, AZ, Sherie Dowsett, Jack Knorr, Xiao Ni, Kraig Kinchen, Indianapolis, IN 11:27 PII-LBA7: IN TWO PHASE III STUDIES, ENDROXAL (ENCLOMIPHENE CITRATE) SIGNIFICANTLY IMPROVES TOTAL TESTOSTERONE LEVELS COMPARED TO ANDROGEL 1.62%, WITHOUT SUPPRESSION OF SPERMATOGENESIS AND TESTICULAR FUNCTION IN OVERWEIGHT MALES WITH SECONDARY HYPOGONADISM Andrew McCullough*, Albany, NY, Edward Kim, Knoxville, TN, Michael Wyllie, Banbury, United Kingdom 11:34 PII-LBA8: USE OF LINEAR DISCRIMINANT ANALYSIS IN A URINE-BASED TEST FOR BLADDER CANCER DIAGNOSIS Ellen Wallace, Sunnyvale, CA, Kathleen E. Mach, Stanford, CA, Leena McCann, Sunnyvale, CA, Lai Yi Mandy Sin*, Ruchika Mohan, Stanford, CA, Malini Satya, Huilin Wei, Jun Zhang, Chris Lykke, Russell Higuchi, Sunnyvale, CA, Joseph C. Liao, Stanford, CA 11:41 PII-LBA9: EFFICACY AND SAFETY OF MIRABEGRON ADD-ON TREATMENT TO SOLIFENACIN IN INCONTINENT OAB SUBJECTS WITH AN INADEQUATE RESPONSE TO INITIAL 4-WEEK SOLIFENACIN MONOTHERAPY Marcus Drake*, Bristol, UK, Ahmet Adil Esen, Izmir, Turkey, Stavros Athanasiou, Athens, Greece, Claire Herholdt, Surrey, UK, Roberta Baronio, Leiden, Netherlands, Tahir Saleem, Moses Huang, Emad Siddiqui, Surrey, UK, Scott MacDiarmid, Greensboro, NC SUNDAY 11:48 PII-LBA10: A MULTICENTER PHASE 2 STUDY OF ENZALUTAMIDE (ENZA) VERSUS BICALUTAMIDE (BIC) IN MEN WITH NONMETASTATIC (M0) OR METASTATIC (M1) CASTRATION-RESISTANT PROSTATE CANCER (CRPC): THE STRIVE TRIAL David Penson, Nashville, TN, Andrew Armstrong, Durham, NC, Raoul Concepcion, Nashville, TN, Neeraj Agarwal, Salt Lake City, UT, Fong Wang, Kenneth Wu, San Francisco, CA, Andree Amelsberg, Northbrook, IL, De Phung, Leiden, The Netherlands, Celestia Higano*, Seattle, WA 11:55 PANEL DISCUSSION: AUA, OBAMACARE AND THE PAYER: CURRENT EFFORTS AND FUTURE CHALLENGES Moderator: David Penson Panelists: Norm Smith Christopher Gonzalez Martin Dineen 12:20 SESSION CONCLUDES Sunday, May 17, 2015 SWIU ANNUAL BREAKFAST MEETING Room New Orleans Morial Convention Center 6:30 am - 9:00 am 6:30 BREAKFAST BUFFET 6:45 PRESIDENT S WELCOME Leslie Rickey 6:50 AUA UPDATE William Gee 7:00 ACHIEVING LEADERSHIP ROLES Tonette Krousel-Wood 8:00 SWIU AWARD PRESENTATIONS 8:20 ANNUAL BUSINESS MEETING 8:45 NETWORKING 9:00 ADJOURN *Presenting author 119

132 Sunday, May 17, 2015 Moderated Poster Session 34 STONE DISEASE: BASIC RESEARCH II Room New Orleans Morial Convention Center Moderators: Erdal Erturk and Evangelos Liatsikos 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP34-01 RENAL HISTOPATHOLOGY AFTER CALCIUM OXALATE STONE INDUCTION: CRYSTALLURIC AND TUBULAR EFFECTS OF HIGH URINARY OXALATE EXCRETION IN A SWINE MODEL Kristina L Penniston*, Denise J Schwahn, Thomas D Crenshaw, Stephen Y Nakada, Madison, WI MP34-02 GENE EXPRESSION PROFILE OF RANDALL S PLAQUE IN IDIOPATHIC CAOX STONE FORMERS SUGGESTS DYSREGULATION OF M -RELATED GENES Kazumi Taguchi*, Nagoya, Japan, Rei Unno, Naogya, Japan, Yasuhiro Fujii, Taku Naiki, Shuzo Hamamoto, Ryosuke Ando, Kazuhiro Kanemoto, Atsushi Okada, Takahiro Yasui, Keiichi Tozawa, Yutaro Hayashi, Kenjiro Kohri, Nagoya, Japan MP34-03 CAN STATIN USE REDUCE THE RISK OF UPPER URINARY TRACT STONE IN PATIENTS WITH DYSLIPIDEMIA? A NATION-WIDE POPULATION-BASED AND WITH AN 8-YEAR FOLLOW-UP STUDY Hsiao-Jen Chung*, Alex T.L. Lin, Yi-Hsiu Huang, Chih-Chieh Lin, Yu-Hua Fan, Tzeng- Ji Chen, Kuang-Kuo Chen, Taipei, Taiwan MP34-04 INHIBITION OF GLYCOLATE OXIDASE REDUCES URINARY OXALATE EXCRETION IN A MOUSE MODEL OF PRIMARY HYPEROXALURIA TYPE 1 Xingsheng Li, John Knight*, Sonia Fargue, Birmingham, AL, William Querbes, Kevin Fitzgerald, Boston, MA, Ross P Holmes, Birmingham, AL MP34-05 N-METHYL-4-ISOLEUCINE CYCLOSPORINE, AN INHIBITOR OF MITOCHONDRIAL CYCLOPHILIN D ACTIVATION, PREVENTS KIDNEY STONE FORMATION BY ALLEVIATING OXIDATIVE STRESS IN RENAL TUBULAR CELLS Takahiro Yasui*, Kazuhiro Niimi, Atsushi Okada, Kazumi Taguchi, Yasuhiro Fujii, Yasuhiko Hirose, Yasuhiko Ito, Shuzo Hamamoto, Masahito Hirose, Keiichi Tozawa, Shoichi Sasaki, Yutaro Hayashi, Kenjiro Kohri, Nagoya, Japan MP34-06 INHIBITION OF NUCLEATION AND GROWTH OF CYSTINE CRYSTALS IN URINE Daryl Chrzan, Berkeley, CA, Krishna Ramaswamy*, San Francisco, CA, David Killilea, Oakland, CA, Tiffany Zee, Novato, CA, Thomas Chi, San Francisco, CA, Pankaj Kapahi, Arnold Kahn, Novato, CA, Marshall Stoller, San Francisco, CA MP34-07 INTRAVITAL IMAGING OF THE DROSOPHILA MELANOGASTER MODEL OF HUMAN NEPHROLITHIASIS Sohrab Naushad Ali*, Dajung Kim, Thomas Tailly, Hassan Razvi, Hon Leong, London, Canada MP34-08 LITHOTRIPSY PERFORMANCE OF TRADITIONAL AND SPECIAL DESIGNED LASER FIBERS Peter Kronenberg*, Amadora, Portugal, Olivier Traxer, Paris, France MP34-09 OXALOBACTER FORMIGENES COLONIZATION IN A HYPEROXALURIC RAT MODEL OF GASTRIC BYPASS INCREASES BENEFICIAL GUT BACTERIA AND ACTS AS A KEYSTONE SPECIES Ryan Chastain-Gross*, Gary Wang, Eric Li, Marguerite Hatch, Benjamin Canales, Gainesville, FL MP34-10 THE EFFECT OF INSULIN USE IN TYPE II DIABETES ON 24 HOUR URINE PARAMETERS Ethan B Fram, Saman Moazami*, Bronx, NY, David M Hoenig, New Hyde Park, NY, Joshua M Stern, Bronx, NY MP34-11 EXPRESSION OF NNT APPEARS TO SUPPRESS KIDNEY STONE FORMATION IN C57BL/6 MOUSE SUBSTRAINS Masayuki Usami*, Rei Unno, Shoichiro Iwatsuki, Takashi Hamakawa, Yasuhiro Fujii, Kazumi Taguchi, Yasuhiko Hirose, Shuzo Hamamoto, Ryosuke Ando, Atsushi Okada, Takahiro Yasui, Keiichi Tozawa, Kenjiro Kohri, Nagoya, Japan MP34-12 SERUM PARAOXANASE-1 GENE POLYMORPHISM AND ENZYME ACTIVITY IN PATIENTS WITH UROLITHIASIS Asuman Gedikbasi, Arda Atar*, Erkan Sonmezay, Zeynep Kusku Kiraz, Semra Abbasoglu, Ali Ihsan Tasci, Volkan Tugcu, Istanbul, Turkey MP34-13 PPAR- / AGONISTS HAVE DIFFERENT EFFECTS ON RENAL CRYSTAL FORMATION IN HYPEROXALURIC ANIMAL MODELS Kazumi Taguchi*, Nagoya, Japan, Rei Unno, Naogya, Japan, Yasuhiro Hirose, Shuzo Hamamoto, Takahiro Kobayashi, Ryosuke Ando, Atsushi Okada, Yasunori Itoh, Takahiro Yasui, Keiichi Tozawa, Yutaro Hayashi, Kenjiro Kohri, Nagoya, Japan 120

133 MP34-14 INHIBITION OF CALCIUM OXALATE CRYSTALLIZATION AND DIMINUTION OF OXALATE INDUCED RENAL TUBULAR EPITHELIAL CELL INJURY IN VITRO BY TERMINALIA ARJUNA Amisha Mittal*, Simran Tandon, Solan, India, Surender K. Singla, Chandigarh, India, Chanderdeep Tandon, Noida, India MP34-15 INCREASED RISK FOR CHRONIC KIDNEY DISEASE IN KIDNEY STONE FORMERS: A FOLLOW-UP STUDY IN JAPANESE MEN Ryosuke Ando*, Teruo Nagaya, Sadao Suzuki, Kazumi Taguchi, Atsushi Okada, Takahiro Yasui, Keiichi Tozawa, Kenjiro Kohri, Nagoya, Japan MP34-16 PATIENTS WITH CYSTINURIA HAVE ALKALINE URINE DUE TO RENAL LOSS OF SULFATE PRECURSORS Daniel Wollin*, David Goldfarb, New York, NY, John Asplin, Chicago, IL MP34-17 OXALATE CONCENTRATIONS IN HUMAN GASTROINTESTINAL FLUID Thanmaya Reddy*, John Knight, Ross P Holmes, Lisa Harvey, April LE Mitchem, Charles Mel Wilcox, Klaus Monkemuller, Dean G Assimos, Birmingham, AL MP34-18 IN VITRO STUDY, THE ROLE OF RHO- KINASE IN URETERAL SMOOTH MUSCLE RELAXATION WITH TAMSULOSIN AND TERPENE MIXURE (ROWATINEX Ç) jea whan Lee*, Tae Hoon Oh, Whi-An Kwon, Seung Chol Park, Hee Jong Jeong, Ill Young Seo, Iksan city, Korea, Republic of MP34-19 SURGICAL FACTORS CONTRIBUTING TO THE ACUTE REDUCTION IN RENAL FUNCTION AFTER PERCUTANEOUS NEPHROLITHOTOMY Rajash Handa*, Cynthia Johnson, Bret Connors, Jessica Mandeville, Ehud Gnessin, Amy Krambeck, Naeem Bhojani, Marawan El Tayeb, Andrew Evan, James Lingeman, Indianapolis, IN MP34-20 TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL ANTAGONISM ABOLISHES INCREASED URETER IN VIVO PERISTALSIS CAUSED BY UROTHELIAL DAMAGE IN RATS Philipp Weinhold*, Munich, Germany, Luca Villa, Milan, Italy, Frank Strittmatter, Christian G. Stief, Christian Gratzke, Munich, Germany, Francesco Montorsi, Fabio Benigni, Petter Hedlund, Milan, Italy SUNDAY Sunday, May 17, 2015 Moderated Poster Session 35 KIDNEY CANCER: EVALUATION AND STAGING I Room New Orleans Morial Convention Center Moderators: Allan Pantuck and Li-Ming Su 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP35-01 PROTEOMIC STRATIFICATION OF CLEAR CELL RENAL CELL CARCINOMA UTILIZING THE CANCER GENOME ATLAS (TCGA) WITH EXTERNAL VALIDATION Samuel Kaffenberger*, Giovanni Ciriello, Andrew Winer, Martin Voss, New York, NY, Jodi Maranchie, Pittsburgh, PA, Pheroze Tamboli, Houston, TX, Kimryn Rathmell, Chapel Hill, NC, Toni Choueiri, Boston, MA, Robert Motzer, Jonathan Coleman, Paul Russo, Chris Sander, James Hsieh, Ari Hakimi, New York, NY MP35-02 PRETREATMENT NEUTROPHIL-TO- LYMPHOCYTE RATIO CAN PREDICT TUMOR AGGRESSIVENESS IN NEWLY DIAGNOSED RENAL LESIONS Boyd Viers*, R. Houston Thompson, Stephen Boorjian, Christine Lohse, Bradley Leibovich, Matthew Tollefson, Rochester, MN MP35-03 RADIOGENOMICS OF CLEAR CELL RENAL CELL CARCINOMA: ASSOCIATIONS BETWEEN IMAGING, MOLECULAR ALTERATIONS AND PATHOLOGIC FEATURES Andrew G. Winer, Andreas Hoetker, Michael J. Vacchio*, Emily C. Zabor, Irina Ostravnaya, Paul Russo, James J. Hsieh, Oguz Akin, A. Ari Hakimi, New York, NY MP35-04 FIBEROPTIC CONFOCAL LASER ENDOMICROSCOPY OF SMALL RENAL MASSES: TOWARDS REAL TIME OPTICAL DIAGNOSTIC BIOPSY Li-Ming Su*, Robert Allan, Kellie Ritari, Patrick Tomeny, Christopher Carter, Gainesville, FL MP35-05 IN-VIVO, PERCUTANEOUS, NEEDLE BASED, OPTICAL COHERENCE TOMOGRAPHY OF RENAL MASSES Peter Wagstaff*, Daniel de Bruin, Alexandre Ingels, Patricia Zondervan, Otto van Delden, Ton van Leeuwen, Jeroen van Moorselaar, Jean de la Rosette, Pilar Laguna, Amsterdam, Netherlands *Presenting author 121

134 MP35-06 ESTABLISHMENT OF A FISH BASED ANALYSIS FOR INDIVIDUAL RISK ASSESSMENT OF CCRCC PATIENTS ON TISSUE MICRO ARRAYS Julia Grimm, Homburg, Germany, Arndt Hartmann, Erlangen, Germany, Martin Janssen, Homburg, Germany, Christine Stoehr, Frank Kunath, Erlangen, Germany, Michael Stöckle, Kerstin Junker*, Homburg, Germany MP35-07 THE EFFECTS OF NON-NEOPLASTIC RENAL PARENCHYMAL ABNORMALITIES ON RENAL FUNCTIONAL OUTCOMES AFTER PARTIAL NEPHRECTOMY Oktay Akca*, Homayoun Zargar, Hiury Andrade, Daniel Ramirez, Peter Caputo, Khaled Fareed, Robert J Stein, Jihad H Kaouk, Cleveland, OH MP35-08 HISTOPATHOLOGICAL EVALUATION OF NON-NEOPLASTIC RENAL PARENCHYMA IS MORE PROMISING THAN SOPHISTICATED FILM TECHNOLOGY FOR THE PREDICTION OF POST-PARTIAL NEPHRECTOMY RENAL FUNCTION Takehiro Sejima*, Noriya Yamaguchi, Hideto Iwamoto, Toshihiko Masago, Shuichi Morizane, Masashi Honda, Atsushi Takenaka, Yonago, Japan MP35-09 MANAGEMENT OF SUSPICIOUS LIPID POOR RENAL MASSES IN THE TUBEROUS SCLEROSIS COMPLEX PATIENT WITH MULTIPLE RENAL LESIONS Adam Feldman*, Michael Kurtz, Michael Blute, Elizabeth Thiele, Chin-Lee Wu, Michael Gee, Gregory Walker, Elahna Paul, Boston, MA MP35-10 TUMOR CAPSULE PROPERTIES OF PAPILLARY RENAL CELL CARCINOMA Chandra K. Flack*, Dibson D. Gondim, Adam C. Calaway, Joseph M. Jacob, Muhammad T. Idrees, Ronald S. Boris, Indianapolis, IN MP35-11 SIGNIFICANT ELEVATION AND SUBTYPE DIFFERENCES OF PLASMATIC KISSPEPTIN IN PATIENTS WITH SMALL RENAL TUMOURS Marcus Horstmann*, Felix Krause, Daniel Steinbach, Martina Walter, Marc-Oliver Grimm, Jena, Germany MP35-12 A NOVEL APPROACH FOR IDENTIFYING AGGRESSIVE CYSTIC RENAL CELL CARCINOMA USING SOLID VOLUME SCORE AND ENHANCEMENT Shervin Badkhshan*, Chirag Doshi, Brian Quaranto, Jay Amin, Nicholas Georgalas, Michael Mungillo, Terrence Creighton, Thomas Schwaab, Eric Kauffman, Buffalo, NY MP35-13 UTILITY OF A VOLUMETRIC COMPUTER AIDED DIAGNOSTIC (CAD) BASED ALGORITHM ASSESSING RELATIVE LESION ENHANCEMENT TO DISCRIMINATE MALIGNANT AND BENIGN SMALL RENAL MASSES ON FOUR-PHASE MDCT Heidi Coy*, Jonathan Young, Michael Douek, Moe Moe Ko, War War Ko, Pechin Lo, Matthew Brown, Jonathan Goldin, Steven Raman, Los Angeles, CA MP35-14 COMMONLY-USED COST-EFFECTIVE PRE- OPERATIVE INFLAMMATORY MARKERS PROVIDE PROGNOSTIC INFORMATION IN PATIENTS WITH LOCALIZED CLEAR CELL RENAL CELL CARCINOMA Yoram Baum*, Claire De la Calle, Dattatraya Patil, Anna Bausum, Jonathan Huang, Mehrdad Alemozaffar, John Pattaras, Peter Nieh, Kenneth Ogan, Viraj Master, Atlanta, GA MP35-15 PRETHERAPEUTIC PLASMA FIBRINOGEN LEVEL IS AN INDEPENDENT SURVIVAL PREDICTOR IN RENAL CELL CARCINOMA Takeshi Sasaki*, Tsu, Mie, Japan, Takehisa Onishi, Ise, Mie, Japan, Yoshiki Sugimura, Tsu, Mie, Japan MP35-16 PILOT STUDY EVALUATING 99M TC- SESTAMIBI SPECT/CT FOR THE DIFFERENTIATION OF ONCOCYTOMA FROM RENAL CELL CARCINOMA Michael Gorin*, Steven Rowe, Jennifer Gordetsky, Mark Ball, Phillip Pierorazio, Jonathan Epstein, Mehrbod Javadi, Mohamad Allaf, Baltimore, MD MP35-17 MULTI-QUADRANT BIOPSY TECHNIQUE DECREASES SAMPLING ERROR IN LARGE HETEROGENEOUS RENAL TUMORS Jennifer E. Heckman*, Timothy Ziemlewicz, Sara Best, Meghan Lubner, Louis Hinshaw, David F. Jarrard, Tracy Downs, Wei Huang, Fred T. Lee, Jr, Stephen Y. Nakada, E. Jason Abel, Madison, WI MP35-18 SARCOPENIA IS INDEPENDENTLY ASSOCIATED WITH INCREASED MORTALITY FOLLOWING RADICAL NEPHRECTOMY FOR LOCALIZED RENAL CELL CARCINOMA Sarah Psutka*, Michael Moynagh, Grant Schmit, R. Houston Thompson, Stephen Boorjian, Suzanne Stewart, Christine Lohse, John Cheville, Bradley Leibovich, Matthew Tollefson, Rochester, MN MP35-19 THE IMPACT OF EXCESS FAT MASS ON MORTALITY AFTER RADICAL NEPHRECTOMY FOR RENAL CELL CARCINOMA: BEYOND BODY MASS INDEX Sarah Psutka*, Michael Moynagh, Grant Schmit, R. Houston Thompson, Stephen Boorjian, Suzanne Stewart, Christine Lohse, John Cheville, Bradley Leibovich, Matthew Tollefson, Rochester, MN MP35-20 PLASMA FIBRINOGEN LEVEL INDEPENDENTLY PREDICTS THE PROGNOSIS OF PATIENTS WITH NON- METASTATIC RENAL CELL CARCINOMA Jun Obata*, Nobuyuki Tanaka, Ryuichi Mizuno, Shinya Morita, Kazunobu Shinoda, Takeo Kosaka, Toshiaki Shinojima, Eiji Kikuchi, Hiroshi Asanuma, Akira Miyajima, Mototsugu Oya, Tokyo, Japan 122

135 Sunday, May 17, 2015 Moderated Poster Session 36 BLADDER CANCER: BASIC RESEARCH I Room New Orleans Morial Convention Center Moderators: Vinata Lokeshwar and Jay Shah 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP36-01 MITOCHONDRIAL DNA CONTENT AS RISK FACTOR FOR BLADDER CANCER AND ITS ASSOCIATION WITH MITOCHONDRIAL DNA POLYMORPHISMS Stephen Williams*, Yanquing Ye, Maosheng Huang, David Cheng, Ashish Kamat, Xia Pu, Colin Dinney, Xifeng Wu, Houston, TX MP36-02 POLYMORPHISMS OF MEMBRANE TRANSPORTING GENE SLCO1B3 AND DETOXIFICATION ENZYME NAT2 ASSOCIATE WITH BLADDER CANCER SUSCEPTIBILITY IN SMOKERS Naohiro Fujimoto*, Hoai Bui, Tatsuhiko Kubo, Kitakyushu, Japan, Hisato Inatomi, Fukutsu, Japan, Ryoichi Hamasuna, Kitakyushu, Japan MP36-03 PLECTIN ANCHORING INVADOPODIA TO VIMENTIN INTERMEDIATE FILAMENT IS A CRITICAL MOLECULAR STEP FOR BLADDER CANCER CELL INVASION AND EXTRAVASATION FOR METASTASIS Mihoko Sutoh Yoneyama*, Shingo Hatakeyama, Hirosaki, Japan, Tomonori Habuchi, Takamitsu Inoue, Akita, Japan, Toshiya Nakamura, Tomihisa Funyu, Hirosaki, Japan, Gerhard Wiche, Vienna, Austria, Chikara Ohyama, Shigeru Tsuboi, Hirosaki, Japan MP36-04 GENE AMPLIFICATION AND OVEREXPRESSION OF CYP2A6 IN EARLY STAGE OF INVASIVE BLADDER CANCER Kazuhiro Kanemoto*, Katsuhiro Fukuta, Noriyasu Kawai, Keiichi Tozawa, Nagoya, Japan, Masako Ochiai, Koji Okamoto, Hiromi Sakamoto, Teruhiko Yoshida, Yae Kanai, Masaru Katoh, Hitoshi Nakagama, Tokyo, Japan, Kenjiro Kohri, Nagoya, Japan MP36-05 OVEREXPRESSION OF THE LONG NONCODING RNA LOC IMPAIRS IN VITRO BLADDER CANCER CELL PROLIFERATION BY REGULATING P53 yiping zhu*, hailiang zhang, dingwei ye, shanghai, China, People s Republic of MP36-06 P63 EXPRESSION IN BLADDER CANCER VERSUS CHRONIC BILHARZIAL BLADDER Khaled Mursi*, Ayman Agag, Olfat Hammam, Essam Riad, Mahmoud Daw, Cairo, Egypt MP36-07 ROLE OF ADIPOSE TISSUE IN BLADDER CANCER PROGRESSION Nisha Hariharan*, Teresa Johnson-Pais, Robert Svatek, Keith Ashcraft, Robin Leach, San Antonio, TX MP36-08 MICRORNA-144-5P FUNCTIONS AS TUMOUR SUPPRESSOR THROUGH TARGETING CYCLIN E1 AND CYCLIN E2 THAT ARE POTENTIAL PROGNOSTIC MARKERS IN BLADDER CANCER Ryosuke Matsushita*, Kagoshima city, Japan, Naohiko Seki, Chiba city, Japan, Takeshi Chiyomaru, Satoru Inoguchi, Tomoaki Ishihara, Toshihiko Itesako, Shuichi Tatarano, Hirofumi Yoshino, Kagoshima city, Japan, Yusuke Goto, Rika Nishikawa, Chiba city, Japan, Hideki Enokida, Masayuki Nakagawa, Kagoshima city, Japan MP36-09 SCHISTOSOMA HAEMATOBIUM EGG- INDUCED BLADDER UROTHELIAL ABNORMALITIES ARE MODULATED BY P53 IN A GENDER-DEPENDENT FASHION Jared Honeycutt, Stanford, CA, Olfat Hammam, Giza, Egypt, Michael Hsieh*, Washington, DC MP36-10 MIR-99A ACTS AS TUMOR SUPPRESSOR VIA TARGETING TO MTOR IN HUMAN BLADDER CANCER CELLS Te-Fu Tsai*, Ji-Fan Lin, Yi-Chia Lin, Kuang- Yu Chou, Hung-En Chen, Thomas I.S. Hwang, Taipei, Taiwan MP36-11 AUTOPHAGY IS ACTIVATED IN HUMAN BLADDER CANCER AND REQUIRED FOR CANCER CELL GROWTH Thomas I.S. Hwang*, Ji-Fan Lin, Yi-Chia Lin, Te-Fu Tsai, Hung-En Chen, Kuang-Yu Chou, Taipei, Taiwan MP36-12 CLONALITY OF BLADDER TUMORS FOLLOWING RADICAL NEPHROURETERECTOMY AGAINST THE FIELD DEFECT HYPOTHESIS Eugene Cha*, John Sfakianos, Sasinya Scott, Paari Murugan, Gopa Iyer, Ronak Shah, Aditya Bagrodia, Neil Desai, Dean Bajorin, Jonathan Rosenberg, Michael Berger, Hikmat Al-Ahmadie, Bernard Bochner, Jonathan Coleman, David Solit, New York, NY MP36-13 DEEP SEQUENCING OF MICRORNA EXPRESSION SIGNATURE OF BLADDER CANCER: THE FUNCTIONAL SIGNIFICANCE OF MIR-145/145* AND ITS REGULATED MOLECULAR PATHWAYS Satoru Inoguchi*, Kagoshima, Japan, Naohiko Seki, Chiba, Japan, Takeshi Chiyomaru, Ryosuke Matsushita, Tomoaki Ishihara, Hirofumi Yoshino, Kagoshima, Japan, Yusuke Goto, Rika Nishikawa, Chiba, Japan, Hideki Enokida, Masayuki Nakagawa, Kagoshima, Japan SUNDAY *Presenting author 123

136 MP36-14 TOLL-LIKE RECEPTOR 4-DEPENDENT, URINE-INDUCED ACTIVATION OF THE STRESS SENSOR INOSITOL-REQUIRING PROTEIN 1 (IRE1) PATHWAY IN BLADDER CANCER Daniel Nguyen*, Huixian Liu, James Chrystal, Thomas Flynn, Douglas Scherr, New York, NY MP36-15 MICRORNA-218 INHIBITS BLADDER CANCER CELL PROLIFERATION, MIGRATION AND INVASION BY TARGETING BMI-1 Pengchao Li*, Qiang Lu, Jun Tao, Chao Qin, Nanjing, China, People s Republic of MP36-16 THE ROLE OF P63 AND P53MUTANT IN THE REGULATION OF DNA REPAIR, MUTATOR AND INVASIVE PHENOTYPE OF BLADDER CANCER CELLS Mao-wen Weng*, Hsiang-Tsui Wang, Hyun- Wook Lee, Tuxedo Park, NY, William C. Huang, Herbert Lepor, Xue-Ru Wu, New York City, NY, Moon-shong Tang, Tuxedo Park, NY MP36-17 CANONICAL NOTCH2 SIGNALING PROMOTES TUMOR GROWTH AND METASTASIS IN BLADDER CANCER THROUGH CELL CYCLE PROGRESSION, DEDIFFERENTIATION AND EMT Tetsutaro Hayashi*, Kilian Gust, Wolfgang Jäger, Shannon Awrey, Na Li, Manuel Altamirano-Dimas, Ralph Buttyan, Ladan Fazli, vancouver, Canada, Akio Matsubara, Hiroshima, Japan, Peter Black, Vancouver, Canada MP36-18 TOBACCO SMOKE NITROSAMINE BLADDER CARCINOGENIC MECHANISMS: INDUCING MUTAGENIC DNA ADDUCTS INHIBITING DNA REPAIR AND ENHANCING MUTATION SUSCEPTIBILITY hyun-wook lee*, Tuxedo Park, NY MP36-19 RAS ACTIVATION SYNERGIZES WITH P53 DEFICIENCY TO PROVOKE EPITHELIAL- MESENCHYMAL TRANSITION FORMING CANCER PROGENITOR CELLS AND TRIGGERING BASAL SUBTYPE MUSCLE INVASIVE BLADDER CANCER Feng He, Yan Liu, Jonathan Melamed, Herbert Lepor, Moon-shong Tang, Chuanshu Huang, Xue-Ru Wu*, New York, NY MP36-20 DEFINING THE MOLECULAR DRIVERS OF HIGH-GRADE NON-INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER Haiping Zhou, Yan Liu, Herbert Lepor, Moonshong Tang, Chuanshu Huang, Xue-Ru Wu*, New York, NY Sunday, May 17, 2015 Moderated Poster Session 37 PROSTATE CANCER: BASIC RESEARCH I Room New Orleans Morial Convention Center Moderators: Ralph Buttyan and Natasha Kyprianou 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP37-01 GLI3 EXPRESSION INFLUENCES ANDROGEN RECEPTOR ACTIVITY AND FUNCTION IN ANDROGEN GROWTH- INDEPENDENT PROSTATE CANCER Na Li, Sarah Truong, Mannan Nouri, Ralph Buttyan*, Vancouver, Canada MP37-02 ERG/AKR1C3/AR CONSTITUTES A FEED- FORWARD LOOP FOR AR SIGNALING IN PROSTATE CANCER CELLS Katelyn Powell, Louie Semaan, Mary Conley- LaComb, Detroit, MI, Irfan Asangani, Yi-Mi Wu, Ann Arbor, MI, Julia Williams, Kingston, Canada, Jeremy Squire, Sao Paolo, Brazil, Krishna Maddipati, Michael Cher*, Sreenivasa Chinni, Detroit, MI MP37-03 INFILTRATING NEUTROPHILS PROMOTE PROSTATE CANCER PROLIFERATION VIA ALTERATION OF IL8-ANDROGEN RECEPTOR SIGNALING Shuai Hu*, Yun Cui, Xin Li, Beijing, China, People s Republic of, Shuyuan Yeh, Rochester, NY, Jie Jin, Yinglu Guo, Beijing, China, People s Republic of, Chawnshang Chang, Rochester, NY MP37-04 ANDROGEN RECEPTOR POSITIVE STROMAL CELLS REGULATE PROSTATE CANCER PROLIFERATION THROUGH NON-CANONICAL WNT SIGNALING Sayuri Takahashi*, Ichiro Takada, Tokyo, Japan, Naoki Terada, Kyoto, Japan, Yukio Homma, Tokyo, Japan, Robert H. Getzenberg, Memphis, TN MP37-05 ERP46 MEDIATES PROSTATE CANCER TUMORIGENESIS Wilhelmina Duivenvoorden, Stephanie Federov, Sarah Hopmans, Jehonathan Pinthus*, Hamilton, Canada 124

137 MP37-06 TARGETED SEQUENCING OF PROSTATE CANCER CIRCULATING TUMOR CELLS AND COMPARISON WITH MATCHED CELL FREE DNA AND PROSTATE TUMORS Brian Hu*, Los Angeles, CA, Stephen Liu, Washington, DC, Yucheng Xu, Los Angeles, CA, Paul Dempsey, William Strauss, Westlake Village, CA, Kristopher Wentzel, Tong Xu, Jacek Pinski, Tanya Dorff, Timothy Triche, Los Angeles, CA, Jessamine Winer Jones, Westlake Village, CA, Inderbir Gill, David Quinn, Amir Goldkorn, Los Angeles, CA MP37-07 UP REGULATION OF AMINOACID TRANSPORTER LAT1 DURING ANDROGEN DEPRIVATION THERAPY CONTRIBUTES TO ACQUISITION OF CASTRATION RESISTANCE IN PROSTATE CANCER CELLS Min Hui Xu*, Shinichi Sakamoto, Shuhei Kamda, Mayuko Kato, Akira Kurozumi, Rika Nishikawa, Yusuke Goto, Miki Fuse, Yoshikatu Kanai, Naohiko Seki, Tomohiko Ichikawa, Chiba, Japan MP37-08 USING THE CLINICO-GENETIC MODEL FOR PREDICTING LYMPH NODE INVASION BY GENOME-BASED BIOMARKERS FROM EXOME ARRAY AMONG PROSTATE CANCER PATIENTS Jong Jin Oh*, Seongnam-si, Korea, Republic of, Seunghyun Park, Seoul, Korea, Republic of, Sang Eun Lee, Sung Kyu Hong, Sangchul Lee, Hak Min Lee, Jeung Geun Lee, Seongnam-si, Korea, Republic of, Sungroh Yoon, Seoul, Korea, Republic of, Seok-soo Byun, Seongnam-si, Korea, Republic of MP37-09 A MULTIPARAMETRIC MOLECULAR CLASSIFIER FOR IMPROVED PREDICTION OF PROSTATE CANCER PROGNOSIS Raisa Pompe*, Stefan Kraft, Philipp Gild, Martina Kluth, Ronald Simon, Pierre Tennstedt, Markus Graefen, Guido Sauter, Thorsten Schlomm, Hamburg, Germany MP B6 MAB: APPLICATIONS FOR PROSTATE CANCER STAGING, INTRA- OPERATIVE GUIDANCE AND EVALUATION OF TREATMENT BY IN VIVO IMAGING OF HK2 Daniel Thorek, Baltimore, MD, Katharina Braun, Herne, Germany, Jason Lewis, Peter Scardino, Hans Lilja, Steven Larson, David Ulmert*, New York, NY MP37-11 TERT PROMOTER METHYLATION IS A PAN-CANCER BIOMARKER WITH PROGNOSTIC SIGNIFICANCE IN PROSTATE CANCER PATIENTS Ricardo Leao*, Toronto, Canada, Pedro Castelo-Branco, Faro, Portugal, Tatiana Lipman, Brittany Campbell, Aryeh Price, Cindy Zhang, Toronto, Canada, Ana Gomes, Hugo Coelho, Coimbra, Portugal, Robert G. Bristow, Toronto, Canada, Michal Schweiger, Berlin, Germany, Robert J. Hamilton, Alexandre R. Zlotta, Toronto, Canada, Arnaldo Figueiredo, Coimbra, Portugal, Helmut Klocker, Innsbruck, Austria, Holger Sulttmann, Heidelberg, Germany, Uri Tabori, Toronto, Canada MP37-12 INSULIN-LIKE GROWTH FACTOR-I INDUCES CLU EXPRESSION THROUGH TWIST1 TO PROMOTE PROSTATE CANCER GROWTH Ario Takeuchi*, Masaki Shiota, Seiji Naito, Fukuoka, Japan, Michael Cox, Martin Gleave, Amina Zoubeidi, Vancouver, Canada MP37-13 ACCELERATED CELL PROLIFERATION AND ENHANCED RESISTANCE TO DOCETAXEL BY INHIBITION OF 4E- BINDING PROTEIN 1 EXPRESSION IN HUMAN CASTRATION-RESISTANT PROSTATE CANCER PC3 CELLS Hiromoto Tei*, Hideaki Miyake, Masato Fujisawa, Kobe, Japan MP37-14 RNA INTERFERENCE-MEDIATED KNOCKDOWN OF CHD1 IN HUMAN PROSTATE XENOGRAFT TUMORS ALTERS TUMOR GROWTH AND METASTATIC BEHAVIOR Su Jung Oh*, Derya Tilki, Hüseyin Sirma, Ronald Simon, Tobias Lange, Hamburg, Germany MP37-15 THE CARDIOVASCULAR SERUM MARKER OX-LDL MAY PROMOTE METASTASIS IN PROSTATE CANCER Xiaojian Qin*, Fangning Wan, Yao Zhu, Hailiang Zhang, Bo Dai, Guohai Shi, Dingwei Ye, Shanghai, China, People s Republic of MP37-16 A NKX3.1 BINDING SITE POLYMORPHISM IN THE L-PLASTIN PROMOTER LEADS TO DIFFERENTIAL GENE EXPRESSION IN HUMAN PROSTATE CANCER Jian Huang, Changhao Chen*, Tianxin Lin, Wang He, Xu Chen, guangzhou, China, People s Republic of MP37-17 DISTINCT EXPRESSION FEATURES OF PMEPA1 AND ITS ISOFORM STAG1 IN PROSTATE CANCER Hua Li*, Lakshmi Ravindranath, Yongmei Chen, Rockville, MD, David McLeod, Bethesda, MD, Isabell Sesterhenn, Silver Spring, MD, Albert Dobi, Shiv Srivastava, Gyorgy Petrovics, Rockville, MD MP37-18 SOX2 IS ASSOCIATED WITH EXTRACAPSULAR EXTENSION FOLLOWING RADICAL PROSTATECTOMY FOR PROSTATE CANCER Blake Anderson*, Steven Kregel, Gladell Paner, Gregory Zagaja, Donald Vander Griend, Chicago, IL MP37-19 AXIN2 EXPRESSION PREDICTS PROSTATE CANCER RECURRENCE AND MEDIATES AN INVASIVE, TUMORIGENIC PHENOTYPE Brian Hu*, Los Angeles, CA, Adrian Fairey, Edmonton, Canada, Anisha Madhav, Dongyun Yang, Meng Li, Susan Groshen, Craig Stephens, Philip Kim, Navneet Virk, Lina Wang, Sue Ellen Martin, Los Angeles, CA, Nicholas Erho, Elai Davicioni, San Diego, CA, Robert Jenkins, Rochester, MN, Robert Den, Philadelphia, PA, Tong Xu, Yucheng Xu, Inderbir Gill, David Quinn, Amir Goldkorn, Los Angeles, CA SUNDAY *Presenting author 125

138 MP37-20 NEOADJUVANT ANDROGEN DEPRIVATION THERAPY INDUCES SENESCENCE IN RADICAL PROSTATECTOMY SPECIMENS Michael L. Blute, Jr.*, Jennifer Wagner, Nathan Damaschke, Bing Yang, Madison, WI, Martin Gleave, Ladan Fazli, Vancouver, Canada, Wei Huang, David F. Jarrard, Madison, WI Sunday, May 17, 2015 Moderated Poster Session 38 STONE DISEASE: SURGICAL THERAPY IV Room New Orleans Morial Convention Center Moderators: Mantu Gupta and R. John Honey 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP38-01 UROLITHIASIS IN PREGNANCY: A COST- EFFECTIVENESS ANALYSIS OF URETEROSCOPIC MANAGEMENT VERSUS SERIAL URETERAL STENTING Kevin Wymer*, Chicago, IL, Beth Plunkett, Sangtae Park, Evanston, IL MP38-02 WITHDRAWN MP38-03 EFFECT OF STEP-WISE VOLTAGE RAMPING ON RENAL DAMAGE AND TREATMENT OUTCOME FOLLOWING EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY (ESWL) OF KIDNEY STONES: RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL Veronika Skuginna*, Daniel P. Nguyen, Roland Seiler, George N. Thalmann, Beat Roth, Bern, Switzerland MP38-04 IMPACTED STONE MODEL USED TO COMPARE HYDROPHILIC GUIDEWIRE EFFICACY Daniel Faaborg*, Jacob Khouri, Kristene Myklak, Muhannad Alsyouf, Duane Baldwin, Loma Linda, CA MP38-05 THE MODERN ERA STRUVITE STONE: PATTERNS OF URINARY INFECTION AND COLONIZATION Adam De Fazio*, Haresh Thummar, Michael Rothberg, Piruz Motamedinia, Gina Badalato, Mantu Gupta, New York, NY MP38-06 ULTRA LOW DOSE CT-KUB TO DETECT KIDNEY STONES WITH 44% LESS RADIATION: IS THE PLAIN RADIOGRAPH OBSOLETE? Ben H. Chew*, Patrick McLaughlin, Ryan F. Paterson, Elspeth M. McDougall, James Nugent, Allen V. Rowley, Jean Buckley, Charles Zwirewich, Vancouver, Canada MP38-07 COMPARISON OF FLEXIBLE URETERORENOSCOPIC LITHOTRIPSY AND RETROPERITONEAL LAPAROSCOPIC URETEROLITHOTOMY FOR TREATMENT OF UNILATERAL LARGE (>15 MM) UPPER URETERAL STONE: A SIX YEAR RETROSPECTIVE STUDY Volkan Tugcu, Selcuk Sahin, Arda Atar*, Ramazan Kocakaya, Mithat Eksi, Ali Tasci, Istanbul, Turkey MP38-08 DETERMINANTS OF HEALTH-RELATED QUALITY OF LIFE FOR PATIENTS AFTER URINARY LITHOTRIPSY: URETEROSCOPIC VERSUS SHOCK WAVE LITHOTRIPSY Shuzo Hamamoto*, Takahiro Yasui, Nagoya, Japan, Naoko Okuda, Satoshi Koiwa, Toyota, Japan, Atsushi Okada, Nagoya, Japan, Hiroyuki Kamiya, Yoshihiro Hashimoto, Toyota, Japan, Keiichi Tozawa, Nagoya, Japan, Yutaka Iwase, Toyota, Japan, Kenjiro Kohri, Nagoya, Japan MP38-09 EXCELLENT TREATMENT OUTCOMES CAN BE ACHIEVED FOR URETERAL STONES BY OPTIMIZING EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY (ESWL) PARAMETERS. RESULTS OF A PROSPECTIVE, RANDOMIZED TRIAL Stefanie Hnilicka*, Daniel P. Nguyen, Rolf Schmutz, Bernhard Kiss, Roland Seiler, George N. Thalmann, Beat Roth, Bern, Switzerland MP38-10 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY VERSUS FLEXIBLE URETEROSCOPY FOR THE MANAGEMENT OF UPPER TRACT URINARY STONES IN CHILDREN:A CASE- CONTROL NON RANDOMIZED STUDY benoit peyronnet*, alexis arnaud, lauranne tondut, lucas freton, gaetan berquet, gregory verhoest, olivier azzis, benjamin fremond, karim bensalah, Rennes, France 126

139 MP38-11 IS AN INCREASE IN THE NUMBER OF SHOCK WAVES PER SESSION EFFECTIVE AND SAFE IN EXTRACORPOREAL LITHOTRIPSY? A RANDOMIZED, PROSPECTIVE AND COMPARATIVE STUDY Alberto Budía*, José Daniel López-Acón, Marta Trassierra, Pilar Bahílo, Ariana Álvarez, Francisco Boronat, Valencia, Spain MP38-12 EFFECTS OF ENDOUROLOGICAL PROCEDURES ON ERECTILE FUNCTION: A PROSPECTIVE COHORT STUDY Ashraf Mosharafa*, Mohammed Tawfik, Mahmoud Abdelhamid, Omar Abdelrazzak, Cairo, Egypt MP38-13 FACTORS ASSOCIATED WITH NEED FOR RETREATMENT FOLLOWING SHOCKWAVE LITHOTRIPSY: A LARGE MULTI-INSTITUTIONAL COHORT STUDY Jonathan Witten*, Solange Mongoue- Tchokote, Brian Duty, Portland, OR MP38-14 IMPACT OF COLIC PAIN AS A SIGNIFICANT FACTOR FOR PREDICTING THE STONE FREE RATE OF ONE-SESSION SHOCK WAVE LITHOTRIPSY FOR TREATING URETER STONES: A BAYESIAN LOGISTIC REGRESSION MODEL ANALYSIS Hae Do Jung*,, Korea, Republic of, Doo Yong Chung, Kang Su Cho, Dae Hun Lee, Seoul, Korea, Republic of, Ki Soo Lee, Tae Nam Kim, Korea, Republic of, Young Deuk Choi, Joo Yong Lee, Seoul, Korea, Republic of, Dong Hyuk Kang, Yangpyeong, Korea, Republic of, Jang Hee Han, Ho Won Kang, Seoul, Korea, Republic of MP38-15 THE NOVEL K.U.B GRADING SYSTEM FOR STRATIFYING SURGICAL COMPLEXITY IN PATIENTS WITH ENTOMBED JJ STENTS Javier L. Arenas*, Albert Lee, Phillip Stokes, Roger Li, Muhannad Alsyouf, Michelle Lightfoot, D. Duane Baldwin, Loma Linda, CA MP38-16 OUTCOMES OF UROLITHIASIS TREATMENT IN PATIENTS WITH RENAL INSUFFICIENCY Haresh Thummar*, Usama Khater, New York, NY, V Joshi, P Kansagra, Rajkot, India, mantu gupta, new York, NY MP38-17 LAPAROASSISTED PERCUTANEOUS NEPHROLITHOTOMY: EXPERIENCE AND OUTCOMES Helena Vila Reyes*, Carlos Torrecilla Ortiz, Miguel Angel Lopez Costea, Sergi Colom Feixas, Francesc Vigues Julia, Eladio Franco Miranda, Barcelona, Spain MP38-18 PROSPECTIVE EVALUATION OF THE SAFETY AND EFFICACY OF SPINAL ANESTHESIA VS. GENERAL ANESTHESIA FOR PERCUTANEOUS NEPHROLITHOTOMY (PCNL) Haresh Thummar*, New York, NY, Usama Khater, Nw York, NY, Rachael Shapiro, New Yorkk, NY, Balaji reddy, Mantu Gupta, new York, NY MP38-19 EFFECTS OF SEDATION ON KIDNEY POSITION IN THE SUPINE AND PRONE POSITIONS Natalia Hernandez*, Florian Fintelmann, Hosam Attaya, Yan Song, Brian Eisner, Boston, MA MP38-20 MICRO-PERCUTANEOUS NEPHROLITHOTOMY FOR THE TREATMENT OF MODERATE SIZED KIDNEY STONES; OUR CLINICAL EXPERIENCES IN FIRST 100 CASES FROM A SINGLE CENTER Tuna Karatag, Ibrahim Buldu, Ramazan Inan, Mustafa Okan Istanbulluoglu*, Konya, Turkey SUNDAY Sunday, May 17, 2015 Moderated Poster Session 39 KIDNEY CANCER: BASIC RESEARCH I Room New Orleans Morial Convention Center Moderators: Gopal Gupta and Hari Koul 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP39-01 IN VITRO PERFORMANCE OF SORAFENIB-LOADED PLGA AND LIPOSOME NANOPARTICLES AS A DELIVERY SYSTEM IN THE TREATMENT OF RENAL CELL CARCINOMA James Liu*, Benjawan Boonkaew, Sree Harsha Mandava, Jaspreet Arora, Michael Maddox, Srinivas Chava, Cameron Callaghan, Srikanta Dash, Vijay John, Benjamin Lee, New Orleans, LA MP39-02 OVEREXPRESSION OF MPS1 IN CLEAR CELL RENAL CELL CARCINOMA (CCRCC) CONFERS TUMOR SELECTIVITY ON HEAT SHOCK PROTEIN-90 (HSP90) INHIBITORS Mourad Abouelleil, Diana Dunn, Mark Woodford, Syracuse, NY, Sandra Jensen, Gaithersburg, MD, Mahmoud Chehab, Alosh Madala, Tiffany Caza, Steve Landas, Syracuse, NY, William G. Stetler-Stevenson, Gaithersburg, MD, Len Neckers, Bethesda, MD, Dimitra Bourboulia, Gennady Bratslavsky, Mehdi Mollapour*, Syracuse, NY *Presenting author 127

140 MP39-03 WITHDRAWN MP39-04 IL-6 RECEPTOR ANTIBODY ENHANCES THE EFFECT OF TKI AGAINST RENAL CELL CARCINOMA Kei Ishibashi*, Hitoshi Kubo, Yoshiyuki Kojima, Fukushima, Japan, Tobias Haber, Joachim W Thüroff, Walburgis Brenner, Mainz, Germany MP39-05 INHIBITION OF CARBONIC ANHYDRASE IX CONFERS RADIATION SENSITIVITY TO RENAL CELL CARCINOMA Jehonathan Pinthus*, Sarah Hopmans, Daniel Gallino, Carrie Gerdes, Diana Glennie, Thomas Farrell, Hamilton, Canada MP39-06 ENHANCED CELL PROLIFERATION AND INCREASED RESISTANCE TO MAMMALIAN TARGET OF RAPAMYCIN INHIBITORS BY INHIBITION OF 4E- BINDING PROTEIN 1 EXPRESSION IN HUMAN RENAL CELL CARCINOMA ACHN CELLS Akira Miyazaki*, Hideaki Miyake, Masato Fujisawa, Kobe, Japan MP39-07 ACCELERATION OF PROTEINURIA WITHOUT SIGNIFICANT IMPACT ON RENAL FUNCTION AND ITS PROTECTION BY ANGIOTENSIN II RECEPTOR BLOCKER IN RATS TREATED WITH AXITINIB Satoshi Imai*, Hideaki Miyake, Masato Fujisawa, Kobe, Japan MP39-08 CLUSTERIN INHIBITION USING OGX-011 SYNERGISTICALLY ENHANCES ANTITUMOR ACTIVITY OF TEMSIROLIMUS IN A HUMAN RENAL CELL CARCINOMA MODEL Masatomo Nishikawa*, Hideaki Miyake, Kobe, Japan, Martin Gleave, Vancouver, Canada, Masato Fujisawa, Kobe, Japan MP39-09 RAPAMYCIN INHIBITS FLCN-DEFICIENT RENAL TUMOR GROWTH IN MICE Jindong Chen*, Shuhui Si, Rochester, NY, Xueying Li, Zunyi, China, People s Republic of, Yan Li, Beijing, China, People s Republic of, Susan Schoen, Rochester, NY, Bin Tean Teh, Singapore, Singapore, Guan Wu, Rochester, NY MP39-10 EFFECT OF OBESITY AND ADIPONECTIN SIGNALING IN PATIENTS WITH RENAL CELL CARCINOMA TREATED WITH SURGERY Ryuichi Itoh*, Akita, Japan, Shintaro Narita, Akita, Akita, Japan, Mingguo Huang, Hiroshi Tsuruta, Susumu Akihama, Mitsuru Saito, Takamitsu Inoue, Norihiko Tsuchiya, Shigeru Satoh, Tomonori Habuchi, Akita, Japan MP39-11 DECREASING SURVIVIN BY YM155 REVERSES RAPAMYCIN RESISTANCE IN RENAL CANCER Hidekazu Koike*, Takashi Nitta, Yoshitaka Sekine, Yoshiyuki Miyazawa, Haruo Kato, Yosuke Furuya, Yasuhiro Shibata, Kazuto Ito, Kazuhiro Suzuki, Maebashi, Japan MP39-12 CARBONIC ANHYDRASE X, A NOVEL PUTATIVE TUMOR SUPPRESSOR SILENCED BY PROMOTER CPG METHYLATION, SUPPRESSES GROWTH AND INVASIVENESS OF RENAL CELL CARCINOMA Lian Zhang*, Yu Fan, Lu Wang, Qian Zhang, Jie Jin, Beijing, China, People s Republic of MP39-13 DEVELOPMENT OF A NOVEL METHOD FOR DETECTING RENAL CELL CARCINOMA CIRCULATING TUMOR CELLS Michael Gorin*, Mark Ball, Baltimore, MD, Darren Davis, Houston, TX, Phillip Pierorazio, Hans Hammers, Kenneth Pienta, Mohamad Allaf, Baltimore, MD MP39-14 BOILING HISTOTRIPSY ABLATION OF IN VIVO RENAL CARCINOMA IN THE EKER RAT George R. Schade*, Yak-Nam Wang, Samantha D Andrea, Joo Ha Hwang, Daniel W. Lin, Michael R. Bailey, Tatiana D. Khokhlova, Seattle, WA MP39-15 NEOVASCULARITY IS A PROGNOSTIC MARKER IN RENAL CELL CARCINOMA Tyler Bauman*, Wei Huang, E. Jason Abel, Madison, WI MP39-16 ATTRACTIVE STRATEGY FOR TREATMENT OF ADVANCED RENAL CELL CARCINOMA BASED ON VERSICAN EXPRESSION Yozo Mitsui*, San Francisco, CA, Inik Chang, Seoul, Korea, Republic of, Naoko Arichi, Miho Hiraki, Hiroaki Yasumoto, Izumo, Japan, Shinichiro Fukuhara, Hiroshi Hirata, Soichiro Yamamura, Varahram Shahryari, Guoren Deng, Ruzhu Lan, Sharanjot Saini, Shahana Majid, San Francisco, CA, Hiroaki Shiina, Izumo, Japan, Rajvir Dahiya, Tanaka Yuichirio, San Francisco, CA 128

141 MP39-17 A NOVEL COMBINATORIAL THERAPY IN RENAL CELL CARCINOMA: SILENCING SEMAPHORIN 3C IN COMBINATION WITH SUNITINIB Takashi Dejima*, Vancouver, Canada, Ario Takeuchi, Fukuoka, Japan, Tabitha Tombe, Kevin Tam, Vancouver, Canada, Seiji Naito, Fukuoka, Japan, Martin Gleave, Christopher Ong, Vancouver, Canada MP39-18 EFFECT OF OBESITY ON THE PERIPHERAL IMMUNE SIGNATURE IN RENAL CELL CARCINOMA Laura Bertrand*, Lewis J. Thomas, Megan T. Bing, Gal Wald, Kenneth G. Nepple, James A. Brown, Lyse A. Norian, Iowa City, IA MP39-19 INHIBITION OF TELOMERE REPEAT BINDING FACTORS INDUCE APOPTOSIS AND REDUCES PROLIFERATION IN RENAL CELL CARCINOMA Deeksha Pal, Shrawan K Singh*, Rajendra Prasad, Chandigarh, India MP39-20 MOLECULAR MECHANISM UNDERLYING CYTOTOXIC ACTIVITY OF AXITINIB IN SUNITINIB-RESISTANT HUMAN RENAL CELL CARCINOMA ACHN CELLS Akira Miyazaki*, Hideaki Miyake, Masato Fujisawa, Kobe, Japan SUNDAY Sunday, May 17, 2015 Moderated Poster Session 40 PEDIATRICS: TESTIS & VARICOCELES, STONES Room New Orleans Morial Convention Center Moderators: Christopher Cooper and Walid Farhat 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP40-01 IS TAMSULOSIN EFFECTIVE AFTER SHOCKWAVE LITHOTRIPSY FOR PEDIATRIC RENAL STONES? A RANDOMIZED CONTROLLED STUDY Ahmed Shahat, Ahmad Elderwy, Ahmed Safwat*, Ahmed Badawy, Yasser Abdelsalam, Mohamed Sayed, Hisham Hammouda, Assiut, Egypt MP40-02 IDENTIFICATION OF NATURALLY OCCURRING CALCIUM-OXALATE BINDING PROTEINS IN HUMAN URINE THAT PREVENT CRYSTAL ADHESION IN AN IN VITRO MODEL OF KIDNEY STONE FORMATION Joel Koenig*, Scott Manson, Qiusha Guo, Katelynn Moore, Paul Austin, Saint Louis, MO MP40-03 TRANS-SCROTAL NEAR INFRARED SPECTROSCOPY IN THE EMERGENCY DEPARTMENT TO DIAGNOSE TESTICULAR TORSION IN PEDIATRIC PATIENTS PRESENTING WITH ACUTE SCROTUM Bruce Schlomer*, Dallas, TX, Melise Keays, Ottowa, Canada, Gwen Grimsby, Dallas, TX, Candace Granberg, Rochester, MN, Daniel DaJusta, Columbus, OH, Berk Bergu, Ankar, Turkey, Lauren Ostrov, Kunj Sheth, Martinez Hill, Emma Sanchez, Rong Huang, Clanton Harrison, Micah Jacobs, Helim Hennes, Linda Baker, Dallas, TX MP40-04 EMBRYONIC TESTIS CONTAINS VASCULAR ENDOTHELIAL PRECURSOR CELLS- A NEW INSIGHT Pankaj Dangle*, Elina Mukherjee, Sunder Sims-Lucas, Pittsburgh, PA MP40-05 DOES NEAR INFRARED SPECTROSCOPY IMPROVE TWIST SCORE IN THE DIAGNOSIS OF TESTICULAR TORSION? Kunj R. Sheth*, Dallas, TX, Melise Keays, Ottawa, Canada, Gwen Grimsby, Dallas, TX, Candice Granbery, Rochester, MN, Daniel G. DaJusta, Columbus, OH, Lauren Ostrov, Martinez Hill, Emma Sanchez, Clanton Harrison, Micah Jacobs, Rong Huang, Dallas, TX, Berk Burgu, Ankara, Turkey, Halim Hennes, Bruce Schlomer, LA Baker, Dallas, TX MP40-06 THE IMPACT OF VARICOCELE CORRECTION ON SEMEN ANALYSIS IN THE ADOLESCENT Casey Seideman*, Ricardo Palmerola, Ronnie Fine, Jordan Gitlin, Lane Palmer, Lake Success, NY MP40-07 RECURRENCE OF SYMPTOMATIC KIDNEY STONES DIAGNOSED DURING CHILDHOOD Gregory Tasian*, Angela Kalmus, Susan Furth, Philadelphia, PA MP40-08 MEDICAL EXPULSIVE THERAPY FOR PEDIATRIC UROLITHIASIS: SYSTEMATIC REVIEW AND META-ANALYSIS Nermarie Velasquez, Daniel Zapata, Hsin- Hsiao Wang, John Wiener, Michael Lipkin, Jonathan Routh*, Durham, NC MP40-09 SURGICAL OUTCOMES FOR PEDIATRIC UROLITHIASIS: INCREASED RETREATMENT RATES WITH SHOCKWAVE LITHOTRIPSY COMPARED TO URETEROSCOPY Hsin-Hsiao Wang*, Rohit Tejwani, John Wiener, Jonathan Routh, Durham, NC *Presenting author 129

142 MP40-10 COMPLETE BLOOD COUNT PARAMETERS AS A PREDICTOR OF TESTICULAR SURVIVAL FOLLOWING ACUTE TESTICULAR TORSION IN CHILDREN Cagatay E. Afsarlar*, Engin Yilmaz, Yilmaz Aslan, Jason Au, Irina Stanasel, David Roth, Chester J. Koh, Houston, TX MP40-11 PROSPECTIVE ASSESSMENT OF PEDIATRIC RADIATION EXPOSURE: THE PEDIATRIC UROLOGY RADIATION SAFETY EVALUATION (PURSE) STUDY Anne Dudley*, Moira Dwyer, Pankaj Dangle, Omaya Banihani, Heidi Stephany, Glenn Cannon, Francis Schneck, Michael Ost, Pittsburgh, PA MP40-12 THE EFFECT OF RACE AND SKIN COLOR ON NEAR-INFRARED SPECTROSCOPY READINGS IN PEDIATRIC PATIENTS WITH UNILATERAL ACUTE SCROTUM Lauren Ostrov*, Gwen Grimsby, Vani Menon, Dallas, TX, Melise Keays, Ottawa, Canada, Kunj Sheth, Dallas, TX, Candace Granberg, Rochester, MN, Daniel DaJusta, Columbus, OH, Martinez Hill, Emma Sanchez, Rong Huang, Dallas, TX, Berk Burgu, Ankara, Turkey, Clanton Harrison, Micah Jacobs, Halim Hennes, Bruce Schlomer, Linda Baker, Dallas, TX MP40-13 LAPAROSCOPIC INTRA-ABDOMINAL PATENT PROCESS VAGINALIS LIGATION IN PEDIATRIC UROLOGY PRACTICE Nima Baradaran*, Case Wood, Michaella Prasad, Andrew Stec, Charleston, SC MP40-14 ACHIEVING A STONE-FREE PEDIATRIC PERCUTANEOUS NEPHROLITHOTRIPSY: DOES AGE MATTER? jonathan riddell*, Syracuse, NY, gerald mingin, benjamin king, burlington, VT, devin halleran, Syracuse, NY, nazih khater, loma linda, CA, hassan razvi, london, Canada MP40-15 RENAL TUBULAR INJURY IN PEDIATRIC NEPHROLITHIASIS: PROTEOMIC EVIDENCE Larisa Kovacevic*, Hong Lu, Joseph A. Caruso, Yegappan Lakshmanan, Detroit, MI MP40-16 DOES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY CAUSE HEARING IMPAIRMENT IN CHILDREN? Murat Tuncer*, Cahit Sahin, Ozgur Yazici, Alper Kafkasli, Ýstanbul, Turkey, Akif Turk, Konya, Turkey, Banu A. Erdogan, Gokhan Faydaci, Kemal Sarica, Ýstanbul, Turkey MP40-17 INCIDENCE AND RISK FACTORS OF RECURRENCE AFTER HYDROCELE REPAIR IN CHILDREN Jae Min Chung*, Ja Yoon Ku, Yangsan-si, Gyeongsangnam-do, Korea, Republic of, Ho Kyung Seo, Jeong Zoo Lee, Moon Kee Chung, Korea, Republic of, Sang Don Lee, Yangsan-si, Gyeongsangnam-do, Korea, Republic of MP40-18 OUTCOME ANALYSIS OF LOWER POLE STONES IN CHILDREN Joana Dos Santos*, Paul Bowlin, Fahad Alyami, Walid Farhat, Toronto, Canada MP40-19 METABOLIC STONE WORK-UP IN CHILDREN: WHAT DOES IT TELL US AND HOW IS IT UTILIZED? Douglas Storm*, Ambika Kattula, Kathleen Kieran, Cooper Christopher, Iowa City, IA MP40-20 TESTICULAR MICROLITHIASIS IN ASYMTOMATIC BOYS. WHAT IS THE APPROPRIATE FOLLOW-UP? Alison Keenan*, Aaron Carroll, Richard Rink, Mark Cain, Benjamin Whittam, William Bennett, Indianapolis, IN Sunday, May 17, 2015 Podium Session 21 TECHNOLOGY & INSTRUMENTS: LAPAROSCOPY AND ROBOTICS: BENIGN DISEASE Room New Orleans Morial Convention Center Moderators: Jaime Landman and Monish Aron 8:00 am - 10:00 am TIME NUMBER TITLE TIME NUMBER TITLE 8:00 PD21-01 INTELLIGENT PERCUTANEOUS NEPHROSTOMY (PCN) INSERTION SYSTEM WHICH CAN DETECT THE NEEDLE S PENETRATION OF LUNG OR INTESTINE: IN VITRO STUDY Chang Hee Kim*, Incheon, Korea, Republic of, Kwon Soo Chun, Houston, TX, Kwang Taek Kim, Kyung Jin Chung, Incheon, Korea, Republic of, Kwang Ho You,, Korea, Republic of, Khae Hawn Kim, Sang Jin Yoon, Incheon, Korea, Republic of 8:10 PD21-02 SURGICAL CRISIS: IS THE ROBOT FRIEND OR FOE? Courtney K. Rowe*, Jeffrey J. Leow, Ye Wang, Boston, MA, Benjamin I. Chung, Palo Alto, CA, Quoc D. Trinh, Adam S. Kibel, Richard N. Yu, Steven L. Chang, Boston, MA 130

143 8:20 PD21-03 COSMETIC IMPACT OF PORT VERSUS PORTLESS NEEEDLESCOPIC SURGERY-A PROSPECTIVE, RANDOMIZED, SINGLE- BLINDED STUDY Javier L. Arenas*, Janna Vassantachart, Jacob Martin, Jonathan Maldonado, Michael Lee, Alexander Yeo, Albert Lee, Muhannad Alsyouf, Steven Engebretsen, Michael E. Hill, Gaudencio Olgin, Michelle Lightfoot, Roger Li, D. Duane Baldwin, Loma Linda, CA 8:30 PD21-04 MATCHED COMPARISON OF PRIMARY VERSUS SALVAGE LAPAROSCOPIC PYELOPLASTY (LP) Sapan Ambani*, Ann Arbor, MI, David Yang, Indianapolis, IN, J. Stuart Wolf, Jr., Ann Arbor, MI 8:40 PD21-05 COMPLICATIONS OF TRANSVAGINAL NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY (NOTES) IN UROLOGY Zhang Guoxi, Liu Quanliang, Zou xiaofeng*, Yuan Yuanhu, Xiao Rihai, Liu Folin, Xue Yijun, Ganzhou, China, People s Republic of 8:50 PD21-06 PERIOPERATIVE OUTCOMES, COMPLICATIONS, AND EFFICACY OF ROBOTIC ASSISTED PROLAPSE REPAIR Michael Ehlert*, Priyanka Gupta, Jamie Bartley, Kim A. Killinger, Jason Gilleran, Melissa Fischer, Royal Oak, MI 9:00 PD21-07 FACTORS AFFECTING ROBOTIC OPERATIVE TIMES IN A LARGE COHORT OF PATIENTS AT A SINGLE INSTITUTION Juzar Jamnagerwalla*, Lauren Wood, Ken Catchpole, Catherine Bresee, Los Angeles, CA, Bruno Gross, Bryan, TX, Stephanie Chu, Karyn Eilber, Jennifer Anger, Los Angeles, CA 9:10 PD21-08 ADVANTAGES AND TECHNICAL CHALLENGES OF LIGHTED URETERAL STENTS DURING LAPAROSCOPIC BOWEL SURGERY Danny Huynh*, Lucas Hockman, Jerry Trulson, Mark Wakefield, Columbia, MO 9:20 PD21-09 PRACTICE PATTERNS OF LAPAROSCOPIC PYELOPLASTY AMONG AMERICAN UROLOGISTS Matthias D Hofer*, Joceline S Liu, Daniel T Oberlin, Jaclyn Milose, Sarah C Flury, Chicago, IL, Allen F Morey, Dallas, TX, Chris M Gonzalez, Chicago, IL 9:30 PD21-10 A RANDOMIZED CONTROLLED TRIAL FOR PAIN CONTROL IN LAPAROSCOPIC UROLOGIC SURGERY: 0.25% BUPIVACAINE VERSUS LONG-ACTING LIPOSOMAL BUPIVACAINE Richard Knight*, APO,, Paul Walker, Baton Rouge, LA, Kirk Keegan, Stephen Overholser, Timothy Baumgartner, James Ebertowski, James Aden, Michael White, San Antonio, TX 9:40 PD21-11 THE DYNAMIC URINE VIBRATION HALTER: A NEW OUTPATIENT DEVICE FOR REMOTE PATIENT MONITORING OF UROFLOW Jerry Blaivas, Matthew Benedon, New York, NY, James Weinberger, Los Angeles, CA, Yosi Rozenberg, Lior Ravid, Herzliya, Israel, Jonathan Vapnek*, New York, NY 9:50 PD21-12 LONG-TERM OUTCOMES OF ROBOT- ASSISTED LAPAROSCOPIC PYELOPLASTY FOR URETEROPELVIC JUNCTION OBSTRUCTION Heather L Hopf*, Clinton D Bahler, Chandru P Sundaram, Indianapolis, IN SUNDAY Sunday, May 17, 2015 Podium Session 22 TRAUMA/RECONSTRUCTION: URETHRAL RECONSTRUCTION (INCLUDING STRICTURE) III Room New Orleans Morial Convention Center Moderators: John Spirnak and Alex Vanni 8:00 am - 10:00 am TIME NUMBER TITLE TIME NUMBER TITLE 8:00 PD22-01 THE NON-TRANSECTING TECHNIQUE FOR BULBAR URETHRAL STRICTURES Simon Bugeja*, Felix Campos, Anastasia Frost, Enrique Fes, Daniela E Andrich, Anthony R Mundy, London, United Kingdom 8:10 PD22-02 TRANSECTED VS NON-TRANSECTED BULBAR URETHROPLASTY RESULTS IN SIMILAR STRICTURE RESOLUTION RATE IN PRIMARY REPAIR OF BULBAR URETHRAL STRICTURES Kirk Anderson*, Catherine Cooper, Aurora, CO, Dmitriy Nikolavsky, Syracuse, NY, Brian Flynn, Aurora, CO *Presenting author 131

144 8:20 PD22-03 HOW DIMINISHED CAVERNOSAL ARTERIAL BLOOD FLOW AFFECTS THE SUCCESS OF ANASTAMOTIC URETHROPLASTY AFTER PELVIC FRACTURE URETHRAL INJURY Craig Hunter*, Walid Shahrour, Pankaj Joshi, Sandesh Surana, Vikram shah Batra, Sanjay Kulkarni, Pune, India 8:30 PD22-04 SALVAGE OF RECURRENT BULBAR URETHRAL STRICTURE BY REPEAT EXCISION AND PRIMARY ANASTOMOTIC URETHROPLASTY Jordan Siegel*, Arabind Panda, Timothy Tausch, Matthew Meissner, Alexandra Klein, Allen Morey, Dallas, TX 8:40 PD22-05 PERINEAL URETHROSTOMY: A DEFINITIVE CURE FOR ADVANCED URETHRAL STRICTURE DISEASE Michael Belsante*, George Webster, John Patrick Selph, Michael Granieri, Divya Ajay, Andrew Peterson, Durham, NC 8:50 PD22-06 RE-OPERATIVE ABDOMINO-PERINEAL RECONSTRUCTIVE SURGERY Simon Bugeja*, Anastasia Frost, Daniela E Andrich, Anthony R Mundy, London, United Kingdom 9:00 PD22-07 INCIDENCE, TIMING, AND MANAGEMENT OF URETHRAL STRICTURE FOLLOWING PRIMARY RADIATION THERAPY FOR PROSTATE CANCER Timothy Baumgartner*, James Ebertowski, Edith Canby-Hagino, Steven Hudak, San Antonio, TX 9:10 PD22-08 MALE ANTERIOR URETHRAL STRICTURES ARE COMMONLY TREATED WITHOUT IMAGING OR BEING OFFERED URETHROPLASTY Justin De Grado*, Rachel Quinn, Joel Gelman, Orange, CA 9:20 PD22-09 RESURFACING THE PENIS OF THE HYPOSPADIAS CRIPPLE Mina Fam*, Newark, NJ, Moneer Hanna, New York, NY 9:30 PD22-10 HYPOSPADIAS REPAIR OF 223 ADOLSCENTS AND ADULTS: LESSONS LEARNED Moneer Hanna*, Great Neck, NY, Gina Cambareri, Sa Diego, CA 9:40 PD22-11 DONOR SITE COMPLICATIONS FOLLOWING URETHROPLASTY WITH ORAL MUCOSAL GRAFT: ANALYSIS OF 442 PATIENTS WITH URETHRAL STRICTURE Abhishek Pandey*, Cristina Raita, Jörn Beier, Hansjörg Keller, Hof, Germany 9:50 PD22-12 A RANDOMIZED TRIAL ON PERIOPERATIVE PAIN AND MORBIDITY: NON-CLOSURE VERSUS CLOSURE OF THE BUCCAL MUCOSA HARVEST SITE DURING URETHROPLASTY Armin Soave*, Roland Dahlem, Jessica Langetepe, Phillip Reiss, Matthias Müller, Katharina Kuhlencord, Malte Vetterlein, Marie Kuhl, Clemens Rosenbaum, Phillip Marks, Michael Rink, Oliver Engel, Silke Riechardt, Margit Fisch, Sascha Ahyai, Hamburg, Germany Sunday, May 17, 2015 Podium Session 23 BLADDER CANCER: DETECTION AND SCREENING I Room New Orleans Morial Convention Center Moderators: Daniel Canter and Robert Grubb 8:00 am - 10:00 am TIME NUMBER TITLE TIME NUMBER TITLE 8:00 PD23-01 ASSESSMENT OF A MULTIPLEX URINARY PROTEIN PANEL FOR THE DETECTION OF UROTHELIAL AND SQUAMOUS CELL CARCINOMA OF THE URINARY BLADDER Ahmed M. Mansour*, Amr Elsawy, Amira Awadallah, Nehal Elsherbiny, Ahmed A. Shokeir, Hassan Abol-Enein, Mansoura, Egypt, Charles J Rosser, Hawaii, HI 8:10 PD23-02 LONG-TERM OUTCOMES OF HIGH RISK BLADDER CANCER SCREENING COHORT Nathan Starke*, Nirmish Singla, Ahmed Q Haddad, Yair Lotan, Dallas, TX 8:20 PD23-03 A NOVEL URINE CYTOLOGY STAIN FOR THE DETECTION AND MONITORING OF UROTHELIAL CARCINOMA Ofer Yossepowitch*, Petach Tikva, Israel, Yoram Mor, Ramat Gan, Israel, Ofer Nativ, Haifa, Israel, Ilan Leibovitch, Kfar Sava, Israel, Ofer Gofrit, Jerusalem, Israel, Haim Matzkin, Tel Aviv, Israel, Uri Lindner, Rehovot, Israel, Ami Sidi, Holon, Israel, Michael Cohen, Afula, Israel 8:30 PD23-04 THE POTENTIAL UTILITY OF CHEMOKINE CXCL1 (GRO ) AS A NOVEL DIAGNOSTIC AND PROGNOSTIC MARKER FOR BLADDER CANCER Takashi Kobayashi*, Yoshiyuki Matsui, Takuro Sunada, Takahiro Inoue, Tomomi Kamba, Osamu Ogawa, Kyoto, Japan 132

145 8:40 PD23-05 CIRCULATING TUMOR CELLS IN BLADDER CANCER: OPTIMIZATION OF DETECTION AND INVESTIGATION OF THEIR DIAGNOSTIC AND PROGNOSTIC ROLES Bedeir Ali-El-Dein*, Mahmoud Laymon, Mahmoud Zakaria, Romayla Abdel-Raouf, Hekmat El-Naggar, Nasr El-Tabey, Ahmed El-Hefnawy, Tamer S Barakat, Samer El- Halwagy, Mona A Abdel-Rahim, Mohamed Abdel-Hamid, Zakaria Lotfy, El-Houssiny I Ibrahiem, Atallah A Shaaban, Mansoura, Egypt 8:50 PD23-06 ROGNOSTIC VALUE OF SERUM CYFRA 21-1 IN PATIENTS WITH T1G3 OR MUSCLE INVASIVE BLADDER CANCER Akihiro Yano*, Hironori Sugiyama, Eiken Cho, Hideki Takeshita, Yohei Okada, Hideki Nagamatsu, Makoto Morozumi, Satoru Kawakami, Takumi Yamada, Kawagoe, Japan 9:00 PD23-07 A PROSPECTIVE TRANSLATIONAL STUDY OF MICRORNA-519A DETECTION AS A URINE MARKER IN OUTPATIENTS WITH MACROSCOPIC HEMATURIA: A PROMISING CANDIDATE MICRORNA FROM DEEP SEQUENCING SIGNATURE OF UROTHELIAL CARCINOMA Hideki Enokida*, Yasutoshi Yamada, Satoru Inoguchi, Tomoaki Ishihara, Shuichi Tatarano, Toshihiko Itesako, Kagoshima, Japan, Naohiko Seki, Chiba, Japan, Masayuki Nakagawa, Kagoshima, Japan 9:10 PD23-08 POTENTIAL BLOOD-BASED TUMOR MARKERS FOR NON-MUSCLE-INVASIVE UROTHELIAL BLADDER CARCINOMA Daher Chade*, Leopoldo Ribeiro-Filho, Mauricio Cordeiro, Pedro Filipecki, Claudio Murta, Miguel Srougi, William Nahas, Sao Paulo, Brazil 9:20 PD23-09 EPITHELIAL TUMOR MARKERS (CA 125, CA 19-9 AND CEA) TRENDS IN PATIENTS UNDERGOING TREATMENT FOR INVASIVE BLADDER CANCER Soroush T.Bazargani*, Swar Shah, Los Angeles, CA, Hamed Ahmadi, Portland, OR, Anne Schuckman, Jie Cai, gus miranda, tanya Dorff, sarmad sadeghi, David Quinn, Hooman Djaladat, Siamak Daneshmand, Los Angeles, CA 9:30 PD23-10 URINARY TRACT INFECTION IS ASSOCIATED WITH WORSE BLADDER CANCER OUTCOMES IN THE MEDICARE POPULATION: IMPLICATIONS FOR SEX DISPARITIES Kyle Richards*, Madison, WI, Sandra Ham, Joshua Cohn, Gary Steinberg, Chicago, IL 9:40 PD23-11 VARIATION IN EVALUATION OF HEMATURIA BY GENDER, RACE, AND RISK FACTORS FOR BLADDER CANCER Jacob Ark*, JoAnn Alvarez, Nashville, TN, Jeffrey Bassett, Anaheim, CA, Tatsuki Koyama, Chaochen You, Shenghua Ni, William Blot, David Penson, Daniel Barocas, Nashville, TN 9:50 PD23-12 HEMATURIA PRACTICE PATTERNS IN THE PRIMARY CARE SETTING Lisa Parrillo*, Justin Ziemba, Matthew Sterling, Alida Gertz, Phillip Mucksavage, Thomas Guzzo, Philadelphia, PA SUNDAY Sunday, May 17, 2015 Podium Session 24 URODYNAMICS/INCONTINENCE/FEMALE UROLOGY: INCONTINENCE: EVALUATION (URODYNAMIC TESTING) Room New Orleans Morial Convention Center Moderator: Donna Deng 8:00 am - 10:00 am TIME NUMBER TITLE TIME NUMBER TITLE 8:00 PD24-01 PROOF-OF-CONCEPT FOR DATA FUSION OF URETHRAL PRESSURE DATA AND MRI Mario Klünder, Stuttgart, Germany, Susanne Will, Tuebingen, Germany, Karl-Dietrich Sievert*, Luebeck, Germany, Bastian Amend, Tuebingen, Germany, Ronny Feuer, Oliver Sawodny, Stuttgart, Germany, Ulrich Kramer, Arnulf Stenzl, Tuebingen, Germany, Michael Ederer, Stuttgart, Germany 8:10 PD24-02 EVALUATION OF SYMPTOM SCORE AND IN VITRO CONTRACTILE PROPERTIES OF DETRUSOR IN WOMAN WITH LOWER URINARY TRACT SYMPTOMS (LUTS) / COMPARISON OF SCORES AND CONTRACTILE PROPERTIES WITH OR WITHOUT DETRUSOR OVERACTIVITY (DO) Nobuhiro Kushida*, Fukushima, Japan, Osamu Yamaguchi, Koriyama, Japan, Yoshiyuki Kojima, Fukushima, Japan, Fry Christopher, Guildford, United Kingdom *Presenting author 133

146 8:20 PD24-03 IDENTIFICATION OF INNERVATION ZONES OF THE PELVIC FLOOR MUSCLE FROM NONINVASIVE HIGH-DENSITY INTRA-VAGINAL/RECTAL SURFACE EMG RECORDINGS Yun Peng, Houston, TX, Jinbao He, Ningbo, China, People s Republic of, Rose Khavari, Timothy Boone, Yingchun Zhang*, Houston, TX 8:30 PD24-04 NON INVASIVE VELOCITY-FLOW VIDEOURODYNAMICS USING DOPPLER ULTRASONOGRAPHY DETECTION OF PERIODIC DETRUSOR ARREST DURING MICTURITION IN MEN UNDERACTIVE BLADDER SYNDROME Hideo Ozawa*, Okayama, Japan, Michael Chancellor, Royal Oak, MI, Atsushi Nagai, Kurashiki, Japan, Hiromi Kumon, Okayama, Japan 8:40 PD24-05 THE INTERACTION BETWEEN URINARY INCONTINENCE (UI), RECURRENT LOWER URINARY TRACT INFECTION (UTI), AND AGING IN MICE Zhina Sadeghi*, Johnathan Kenyon, Albert Park, Michael Kavran, Adonis Hijaz, Cleveland, OH, Thomas Hannan, St. Louis, MO, Firouz Daneshgari, Cleveland, OH 8:50 PD24-06 PLUNG AS A SURROGATE MEASURE FOR ABDOMINAL PRESSURE IN URODYNAMICS FOR PATIENTS WITH STRESS URINARY INCONTINENCE PRELIMINARY DATA Harpreet Wadhwa*, Whitney Halgrimson, Chicago, IL, Francesco Marson, Torino, Italy, William Kobak, Ervin Kocjancic, Chicago, IL 9:00 PD24-07 DOES A POSITIVE URINE DIPSTICK OR URINE CULTURE AT THE TIME OF URODYNAMIC EVALUATION PREDICT POST-PROCEDURAL FEBRILE URINARY TRACT INFECTION? Lynne Lapicz, Stephen Canon, Ashay Patel, Ismael Zamilpa*, Little Rock, AR 9:10 PD24-08 WIRELESS IMPLANTABLE RECHARGEABLE BLADDER PRESSURE SENSOR: CYSTOSCOPIC IMPLANTATION AND AMBULATORY DATA COLLECTION Iryna Makovey*, Steve Majerus, Robert Karam, Brett Hanzlicek, Matthew Streicher, Hui Zhu, Margot Damaser, Cleveland, OH 9:20 PD24-09 ASSOCIATION BETWEEN OVERACTIVE BLADDER AND RISK OF FALLS AMONG MEDICARE ELDERLY FEE-FOR-SERVICE PATIENTS Ravishankar Jayadevappa*, Sumedha Chhatre, Diane Newman, Alan Wein, Philadelphia, PA 9:30 PD24-10 INVESTIGATION OF TYPES OF SITUATIONS THAT TRIGGER URGE URINARY INCONTINENCE Becky Clarkson*, Neil Resnick, Pittsburgh, PA, Kathleen O Connell, New York, NY 9:40 PD24-11 THE ARTIFICIAL URINARY SPHINCTER IS SUPERIOR TO A SECONDARY TRANSOBTURATOR MALE SLING IN CASES OF A PRIMARY SLING FAILURE Divya Ajay*, John Selph, Michael Belsante, Ngoc-Bich Le, Durham, NC, Aaron Lentz, Raleigh, NC, George Webster, Andrew Peterson, Durham, NC 9:50 PD24-12 LOW CYSTOMETRIC CAPACITY IS ASSOCIATED WITH MALE TRANSOBTURATOR SLING FAILURE AND DOES NOT CORRELATE WITH THE VOIDING DIARY; PRE-OPERATIVE URODYNAMICS ARE HELPFUL IN THE EVALUATION OF URINARY INCONTINENCE Divya Ajay*, John Selph, Michael Belsante, Haijing Zhang, Durham, NC, Aaron Lentz, Raleigh, NC, Ngoc-Bich Le, George Webster, Andrew Peterson, Durham, NC Sunday, May 17, 2015 Video Session 5 8:00 am - 10:00 am RENAL ONCOLOGY The videos in this session as well as the video libraries from the Annual Meetings may be viewed in the Surgical Video Library and purchased in the Products Store during the Annual Meeting. Both are located in Registration Hall B2. All years of the Surgical Video Library may also be purchased online at Room New Orleans Morial Convention Center Moderators: Jay Raman and Timothy Masterson NUMBER TITLE NUMBER TITLE V5-01 TOTALLY LAPAROSCOPIC RADICAL NEPHRECTOMY WITH THROMBECTOMY LEVEL IV Cesar Britto*, Christophe Anselmo, Paulo Renato Costa, Daniel Oliveira, Ronnie Lima, Thiago Grossi, Hernani Gadelha Jr, Stefferson Duarte, Rafael Coelho, Paulo Medeiros, NATAL, Brazil V5-02 ROBOTIC-ASSISTED RADICAL NEPHRECTOMY FOR 12 CM TUMOUR WITH INFERIOR VENA CAVA THROMBUS EXTENSION Marco Puglisi*, Kamran Ahmed, Ben Challacombe, London, United Kingdom 134

147 V5-03 HAND-ASSISTED LAPAROSCOPIC NEPHRECTOMY FOR RENAL CELL CARCINOMA WITH LEVEL ONE RENAL VEIN THROMBOSIS Daniel Yong*, Keng-Siang Png, Singapore, Singapore V5-04 RESECTABLE PHYSICAL 3-D MODELS UTILIZING 3-D PRINTER TECHNOLOGY FOR ROBOTIC PARTIAL NEPHRECTOMY Michael Maddox*, Allison Feibus, Benjamin Lee, Julie Wang, Raju Thomas, Jonathan Silberstein, New Orleans, LA V5-05 3D LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR COMPLEX RENAL MASS George Abraham*, Kerala, India, Datson George P, Vijay Radhakrishnan, Krishanu Das, cochin, India V MM OFF-CLAMP PARTIAL NEPHRECTOMY: PROS, CONS, TIPS AND TRICKS Juan Antonio Peña, Nicolás Nervo, Esteban Emiliani, Pavel Gavrilov, Ivan Schwartzmann, Alberto Breda, Juan Palou, Humberto Villavicencio, Oscar Rodríguez Faba*, Barcelona, Spain V5-07 OFF-CLAMP LAPAROSCOPIC PARTIAL NEPHRECTOMY IN A HORSESHOE KIDNEY Juan Antonio Peña, Mario Oliveira, Pavel Gavrilov, Oscar Rodríguez Faba*, Nicolás Nervo, Ivan Schwartzmann, Juan Palou, Humberto Villavicencio, Barcelona, Spain V5-08 ZERO ISCHEMIA LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR T2 KIDNEY CANCER USING A SALINE-JET DISSECTOR Andrew Kennedy-Smith*, Stephanie Manning, Wellington, New Zealand V MM LAPAROSCOPIC OFF-CLAMP RENAL TUMORECTOMY USING HYDRODISSECTION Juan Antonio Peña, Ivan Schwartzmann, Pavel Gavrilov, Pablo Juárez del Dago, Oscar Rodríguez Faba*, Alberto Breda, Juan Palou, Humberto Villavicencio, Barcelona, Spain V5-10 SELECTIVE RENAL ARTERY CLAMPING: RIGHT ROBOTIC ASSISTED HEMI- NEPHRECTOMY AND EN BLOC ANDRENALECTOMY IN A DUPLICATED SYSTEM Mark Ferretti*, John Phillips, Valhalla, NY V5-11 OFF-CLAMP PARTIAL NEPHRECTOMY Jeffrey Larson*, Aaron Potretzke, Sam Bhayani, Robert Figenshau, St. Louis, MO V5-12 CALIBRATION OF NOVEL 12MM LAPAROSCOPIC HIGH INTENSITY ULTRASOUND PROBE FOR ABLATION OF RENAL NEOPLASMS Jason C Sea*, Orlando, FL, Clinton D Bahler, Naren Sanghvi, Chandru P Sundaram, Indianapolis, IN V5-13 THE USE OF ARGON BEAM COAGULATION DURING ROBOTIC PARTIAL NEPHRECTOMY IN AN ANIMAL MODEL Andrew Harbin*, Kumar Nadhan, James Mooney, Daniel Eun, Philadelphia, PA V5-14 INTRAMURAL TUNNEL URETERECTOMY FOR TREATMENT OF UPPER TRACT UROTHELIAL TUMOR Alexander Tsivian, Yury Stanevsky*, Holon, Israel, Matvey Tsivian, Durham, NC, Shalva Benjamin, Ami Sidi, Holon, Israel SUNDAY Sunday, May 17, 2015 UROLOGIC CARE FOR THE ALLIED HEALTH PROFESSIONAL Room New Orleans Morial Convention Center 8:00 am - 5:00 pm 8:00 WELCOME AND INTRODUCTION Director: Louis Koncz 8:05 ANDROGEN DEPRIVATION THERAPY AND BONE HEALTH Tracey Krupski 9:00 PEELING BACK THE ONION: INTERSTITIAL CYSTITIS AND PELVIC PAIN Marina Ruzimovsky 10:00 FEMALE SEXUAL DYSFUNCTION Tricia Zubert 11:00 TESTOSTERONE REPLACEMENT THERAPY Jacob Rajfer 12:00 BREAK 1:00 AUA CONSENSUS STATEMENT ON ADVANCED PRACTICE PROVIDERS Timothy Brand 2:00 CODING: ICD-10 AND COMMON CODING PROBLEMS Mark Painter 3:00 OVERACTIVE BLADDER AND INCONTINENCE Kathleen Kobashi 4:00 MANAGEMENT OF SMALL RENAL MASSES Jaime Landman 4:50 CLOSING REMARKS Director: Louis Koncz *Presenting author 135

148 Sunday, May 17, :00 am - 1:30 pm UROLOGIC ONCOLOGY FORUM: DEVELOPMENT OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN UROLOGIC ONCOLOGY Room New Orleans Morial Convention Center 10:00 WELCOME AND INTRODUCTION Peter Clark 10:05 MICRORNAS: BIOMARKERS AND THERAPEUTIC TARGETS IN PROSTATE CANCER Fazlul Sarkar 10:20 PROTEOMIC PROFILING IN PROSTATE CANCER Andrei Drabovich 10:35 DTC AND CTC THE LIQUID BIOPSY SUCCESSES AND CHALLENGES Robert Vesella 10:50 USING ORGANOID TECHNOLOGY TO GENERATE PATIENT-DERIVED IN VITRO MODELS Yu Chen 11:05 Q&A 11:10 SCREENING FOR LETHAL PROSTATE CANCER USING PSA AND RELATED BLOOD BIOMARKERS Hans Lilja 11:25 EXPLOITING THE EPIGENETIC FIELD EFFECT TO IMPROVE PROSTATE CANCER DIAGNOSIS David Jarrard 11:40 HISTOLOGIC APPROACHES TO PERSONALIZING PROSTATE CANCER PROGNOSIS Michael Donovan 11:55 Q&A 12:00 PERSONALIZING PROSTATE CANCER TREATMENT Tomasz Beer 12:15 BIOMARKERS IN DRUG DEVELOPMENT: VALIDATION AND UTILITY FOR PROGNOSTICATION AND PREDICTION Howard Scher 12:30 Q&A 12:35 THE RAPID EVOLUTION OF TISSUE-BASED RNA EXPRESSION ASSAYS TO IMPROVE PROSTATE CANCER PROGNOSIS AND DECISION MAKING Matthew Cooperberg 12:50 THE USE OF CURRENTLY AVAILABLE BLOOD BIOMARKERS TO ACCURATELY IDENTIFY THE RISK OF AGGRESSIVE PROSTATE CANCER Mitchell Steiner 1:05 THE CHALLENGES AND OPPORTUNITIES FOR GENOMIC TESTING FOR MEN WITH LOCALIZED PROSTATE CANCER P. George Febbo 1:20 Q&A 1:30 ADJOURN Sunday, May 17, 2015 INTERNATIONAL PROSTATE FORUM Room New Orleans Morial Convention Center 10:00 am - 4:00 pm Program Chairs: John Davis, Neal Shore 10:15 IPF2015 PROSTATE CANCER CONTROVERSIES John Davis, Neal Shore 10:30 SESSION I: WHAT IS CLINICALLY SIGNIFICANT PROSTATE CANCER? OPTIMAL DETECTION AND RISK ASSESSMENT STRATEGIES Moderators: Richard Babaian, Arturo Mendoza-Valdes WHOM TO BIOPSY: THE ROLE FOR PSA AND NOVEL BIOMARKERS Stacy Loeb 10:45 NEWLY DIAGNOSED PROSTATE CANCER: THE ROLE OF GENOMIC ASSAYS Peter Carroll 11:00 THE ROLE FOR MULTI-PARAMETRIC MRI: INDICATIONS AND IMPLEMENTATION? Samir Taneja 11:15 MEN S HEALTH CLINIC: PROSTATE AND MALE HEALTH EVALUATION IN THE UROLOGY CLINIC S. Larry Goldenberg 11:30 DISCUSSION 11:45 LUNCH BREAK 1:00 SESSION II: KEYNOTE SPEAKER: PROSTATE CANCER IMPACTFUL RESEARCH - HOW SHOULD YOUR CLINIC ADAPT? Moderator: Tsuneharu Miki Presenter: Peter Albertsen 1:30 SESSION III: WORKSHOP - IMPROVING YOUR INTERVENTIONAL PARADIGM Moderator: Badar Mian ROBOTIC RADICAL PROSTATECTOMY - MAXIMIZING EFFICACY AND QUALITY Moderator: M. Derya Balbay Presenter: Vipul Patel 136

149 1:45 SELECTION FOR NERVE SPARING CANDIDATES - NOMOGRAMS, IMAGING, OR FROZEN SECTION? Markus Graefen 2:00 OLIGOMETASTASES & LYMPH NODE MANAGEMENT: LESSONS LEARNED FROM TEMPLATES, LYMPHOSCINTIGRAPHY, AND SALVAGE STRATEGIES George Thalmann 2:15 DISCUSSION 2:25 SESSION IV: ADVANCES IN SYSTEMIC THERAPY Moderators: Satoru Takahashi, Ziya Kirkali PROSTATE CANCER IMMUNOTHERAPY - WHY NOW? Charles Drake 2:40 TECHNOLOGY UPDATE FOR IMAGING IN ADVANCED PROSTATE CANCER: ARE THERE GLOBAL VARIATIONS? Bertrand Tombal 3:00 THE ANDROGEN-ANDROGEN RECEPTOR PATHWAY RECENT PROGRESS AND FUTURE GOALS Martin Gleave 3:20 KEY CLINICAL TRIAL UPDATES IN CASTRATION RESISTANT PROSTATE CANCER WHAT SHOULD I KNOW? Noel Clarke 3:40 DISCUSSION 4:00 ADJOURN SUNDAY Sunday, May 17, 2015 Moderated Poster Session 41 STONE DISEASE: MEDICAL THERAPY Room New Orleans Morial Convention Center Moderators: Kenneth Pace and Stephen Nakada 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP41-01 A RANDOMIZED DOUBLE-BLINDED PLACEBO CONTROLLED STUDY EVALUATING THE EFFICACY OF INTRA NASAL KETOROLAC IN TREATING POST- OPERATIVE PAIN IN AMBULATORY URETEROSCOPIC SURGERY Kara L Watts*, Nair Singh, Amaresh Vydynathan, Irene Kho, Zhenmei Zhang, Bronx, NY, David M Hoenig, New Hyde Park, NY, Joshua Stern, Bronx, NY MP41-02 INFERENCE OF SHOCK RATE AND POWER ON EFFECTIVE AND EFFICIENT KIDNEY STONE FRAGMENTATION WITH EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY (ESWL) James Hayes*, Ray Kirk, Ann Richardson, Christchurch, New Zealand MP41-03 ALENDRONATE HAS A PREVENTIVE EFFECT FOR UROLITHIASIS RECURRENCE IN MEN AND POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS Takahiro Yasui*, Atsushi Okada, Kazumi Taguchi, Masayuki Usami, Yasuhiro Fujii, Kazuhiro Niimi, Shuzo Hamamoto, Masahito Hirose, Ryosuke Ando, Yasunori Itoh, Keiichi Tozawa, Yutaro Hayashi, Kenjiro Kohri, Nagoya, Japan MP41-04 CONSEQUENCES OF NON-ADHERENCE TO SELECTIVE MEDICAL THERAPY AMONG PATIENTS WITH KIDNEY STONES Casey Dauw, Yooni Yi*, Maggie Bierlein, Abdul Alruwaily, Khurshid Ghani, J. Stuart Wolf, Jr., John Hollingsworth, Ann Arbor, MI MP41-05 PERINATAL OUTCOMES WITH TAMSULOSIN THERAPY FOR SYMPTOMATIC UROLITHIASIS George Bailey*, Lisa Vaughan, Eric Bergstralh, Carl Rose, Amy Krambeck, Rochester, MN MP41-06 ADMINISTRATION OF THE SELECTIVE ALPHA 1A ADRENOCEPTOR ANTAGONIST SILODOSIN FACILITATES EXPULSION OF SIZE 5-10 MM DISTAL URETERAL STONES, AS COMPARED TO CONTROL Yasunori Itoh*, Atsushi Okada, Kazumi Taguchi, Yasuhiko Hirose, Yasuhiro Fujii, Takahiro Kobayashi, Masayuki Usami, Shuzo Hamamoto, Masahito Hirose, Takahiro Yasui, Keiichi Tozawa, Shoichi Sasaki, Yutaro Hayashi, Kenjiro Kohri, Nagoya, Japan MP41-07 TRENDS IN UROLOGICAL INTERVENTION FOR RENAL STONE DISEASE IN ENGLAND: EVIDENCE FROM HOSPITAL EPISODES STATISTICS (HES) DATABASE Bhaskar Kumar Somani*, Ed Chegdy, Southampton, United Kingdom, Ghulam Nabi, Dundee, United Kingdom *Presenting author 137

150 MP41-08 RANDOMIZED CONTROLLED TRIAL OF TWO VITAMIN D REPLETION PROTOCOLS TO ASSESS IMPACT ON CALCIUM EXCRETION IN STONE FORMERS Matthew Ferroni*, Kevin Rycyna, Timothy Averch, Michelle Semins, Pittsburgh, PA MP41-09 A PROSPECTIVE RANDOMIZED STUDY TO EVALUATE THE OUTCOME OF ALPHA BLOCKERS AND THE COMBINATION WITH METHYLPREDNISOLONE IN MEDICAL EXPULSIVE THERAPY FOR LOW ER URETERAL STONES Waleed Shabana, Mohamed Teleb, Tamer Dawod, Mahmoud Eladl*, Zagazig, Egypt MP41-10 QUALITY OF ACUTE CARE FOR PATIENTS WITH UPPER TRACT STONES IN THE UNITED STATES Charles Scales, Durham, NC, Jonathan Bergman, Stacey Carter, Greg Jack, Christopher Saigal, Mark Litwin, Los Angeles, CA MP41-11 NSAIDS FOR ACUTE UROLITHIASIS: UNDERUTILIZED ANALGESICS WITH POTENTIAL FOR COST SAVINGS Courtney K. Rowe*, Deborah S. Hess, James S. Hwong, Francisco J. Gelpi- Hammerschmidt, Boston, MA, Benjamin I. Chung, Palo Alto, CA, Steven L. Chang, Boston, MA MP41-12 DIPSTICK SPOT URINE PH DOES NOT ACCURATELY REPRESENT 24 HOUR URINE PH MEASURED BY AN ELECTRODE Mohamed Omar*, Carl Sarkissian, li Jianbo, Manoj Monga, Cleveland, OH MP41-13 VITAMIN D REPLACEMENT IN RECURRENT RENAL STONE FORMERS WITH HYPERCALCIURIA DOES NOT INCREASE URINE CALCIUM EXCRETION OR RENAL STONE GROWTH Luke McGuinness*, Robert Calvert, Vinita Mishra, Liverpool, United Kingdom MP41-14 IMPACT OF URINE PH ON URINARY SUPERSATUATION OF CALCIUM OXALATE Jodi A. Antonelli, Naim Maalouf*, Jodi A. Antonelli, Monica S.C. Morgan, Adam Cohen, John Pointdexter, Beverley Adams-Huet, Khashayar Sakhaee, Margaret S. Pearle, Dallas, TX MP41-15 FLUID BOLUS FOR RENAL COLIC: CURRENT PRACTICE Sarah Tarplin*, Benjamin Larson, Michael Byrne, Manoj Monga, Cleveland, OH MP41-16 PREDICTORS OF URINARY TRACT INFECTION IN PATIENTS WITH URETERAL STENTS TREATED WITH URETEROSCOPY Amihay Nevo*, Lifshitsz David, Jack Baniel, Petach Tikva, Israel MP41-17 EFFECTS OF TAMSULOSIN, SOLIFENACIN MONOTHERAPY AND COMBINATION THERAPY FOR THE RELIEF OF URETERAL STENT-RELATED SYMPTOMS: AN OPEN-LABEL RANDOMIZED CONTROLLED TRIAL Jinsung Park*, Daejeon, Korea, Republic of, Changhee You, Chuncheon, Korea, Republic of, Deok Hyun Han, Dong Wook Shin, Seoul, Korea, Republic of MP41-18 RELATIONSHIP BETWEEN DIETARY PROTEIN INTAKE AND URINE OXALATE Jonathan Shoag*, New York, NY, Yan Song, Natalia Hernandez, Boston, MA, Joshua Halpern, Sameer Mittal, New York, NY, Brian Eisner, Boston, MA MP41-19 CONTEMPORARY SURVEY OF ENDOUROLOGISTS PRACTICES OF ASSESSMENT AND MEDICAL MANAGEMENT OF STONE DISEASE Richard Matulewicz, Barry McGuire*, Rian Zuccarino-Crowe, Robert Nadler, Kent Perry, Chicago, IL MP41-20 DO PATIENTS REMEMBER DIETARY RECOMMENDATIONS FOR STONE PREVENTION? Margaret L Wertheim*, R Allan Jhagroo, Kristina L Penniston, Madison, WI 138

151 Sunday, May 17, 2015 Moderated Poster Session 42 PROSTATE CANCER: LOCALIZED I Room New Orleans Morial Convention Center Moderators: Gerald Andriole, Jr. and Damien Bolton 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP42-01 NO SIGNIFICANT IMPROVEMENT IN PATIENT OUTCOMES WHEN STRICTER ACTIVE SURVEILLANCE CRITERIA ARE APPLIED: A COMPARISON OF CONTEMPORARY ACTIVE SURVEILLANCE PROTOCOLS Maria Komisarenko*, Narhari Timilshina, Shabbir Alibhai, Neil Fleshner, Alexandre Zlotta, Robert Hamilton, Girish Kulkarni, Antonio Finelli, Toronto, Canada MP42-08 INSTITUTION OF A WEB-BASED PATIENT- REPORTED OUTCOMES (PRO) SYSTEM FOR RADICAL PROSTATECTOMY IN A STATEWIDE QUALITY IMPROVEMENT COLLABORATIVE Khurshid Ghani*, Tae-Kyung Kim, Ann Arbor, MI, Patrick Hurley, Southfield, MI, Jay Starr, Traverse City, MI, Susan Linsell, Ann Arbor, MI, James Peabody, Detroit, MI, James Montie, David Miller, Ann Arbor, MI, Michael Cher, Detroit, MI MP42-02 EXTENSION OF BASELINE PROSTATE ACUTE AND CHRONIC INFLAMMATION IS ASSOCIATED WITH LOWER INCIDENCE OF PROSTATE CANCER ON REPEAT BIOPSY Daniel Moreira*, Rochester, MN, Gerald Andriole, St Louis, MO, Ramiro Castro- Santamaria, King of Prussia, PA, Stephen Freedland, Durham, NC MP42-03 UTILITY OF ANTERIOR ZONE BIOPSY IN ACTIVE SURVEILLANCE OF PROSTATE CANCER Allison Glass*, Neil Pugashetti, Marc A. Dall Era, Christopher P. Evans, Stanley A. Yap, Sacramento, CA MP42-04 ACTIVE SURVEILLANCE: WHEN CAN PATIENTS STOP WORRYING? Ridwan Alam*, H. Ballentine Carter, Patricia Landis, Jonathan I. Epstein, Mufaddal Mamawala, Baltimore, MD MP42-05 A STATEWIDE INTERVENTION TO REDUCE HOSPITALIZATIONS AFTER PROSTATE BIOPSY Paul R Womble*, Susan M. Linsell, Yuqing Gao, Zaojun Ye, James E. Montie, Ann Arbor, MI, Brian R. Lane, Grand Rapids, MI, Frank N. Burks, Royal Oak, MI, David C. Miller, Ann Arbor, MI MP42-06 THE UPTAKE OF ACTIVE SURVEILLANCE IN PROSTATE CANCER: RESULTS OF A POPULATION BASED-STUDY Patrick O. Richard*, Shabbir Alibhai, David Urbach, Neil E. Fleshner, Narhari Timilshina, Laurence Klotz, Antonio Finelli, Toronto, Canada MP42-07 IMPACT OF SURGICAL APPROACH ON ERECTILE FUNCTION RECOVERY FOLLOWING BILATERAL NERVE SPARING-RADICAL PROSTATECTOMY: RESULTS FROM A RANDOMIZED CONTROLLED TRIAL OF TADALAFIL VERSUS PLACEBO (REACTT) Martin Schostak*, Magdeburg, Germany, Markus Graefen, Hamburg, Germany, Christian Kriegel, Leipzig, Germany, Uwe Michl, Hamburg, Germany, Antonio Martin Morales, Malaga, Spain, Peter J. Pommerville, Vancouver, Canada, Martina Manning, Hartwig Büttner, Carsten Henneges, Bad Homburg, Germany, Jens-Uwe Stolzenburg, Leipzig, Germany MP42-09 SHOULD INCLUSION CRITERIA FOR ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER BE MORE STRINGENT? : FROM AN INTERIM ANALYSIS OF PRIAS-JAPAN Mikio Sugimoto*, Hiromi Hirama, Yoshiyuki Kakehi, Kagawa, Japan, Prias-Japan Study Group -, -, Japan MP42-10 EXPANDING USE OF ACTIVE SURVEILLANCE: DATA FROM THE NATIONAL PROSTATE CANCER REGISTER (NPCR) OF SWEDEN Stacy Loeb*, New York, NY, Yasin Folkvaljon, Uppsala, Sweden, Ola Bratt, Helsingborg, Sweden, David Robinson, Pär Stattin, Umeå, Sweden MP42-11 ACTIVE SURVEILLANCE ACCEPTANCE RATE AMONG AFRICAN AMERICAN MEN WITH LOW RISK PROSTATE CANCER AT A TERTIARY CARE CENTER Ibraheem Malkawi*, Scott Hughes, Roy Miller, Ranko Miocinovic, detroit, MI MP42-12 CANCER OF THE PROSTATE RISK ASSESSMENT SCORE FOLLOWING BIOPSY GLEASON UPGRADE DURING PROSTATE CANCER ACTIVE SURVEILLANCE IS ASSOCIATED WITH ADVERSE PATHOLOGY AT PROSTATECTOMY Michael Leapman*, Niloufar Ameli, Carissa Chu, Ahmed Hussein, Christopher Welty, Matthew Cooperberg, Peter Carroll, San Francisco, CA MP42-13 A PROSPECTIVE STUDY OF HEALTH- RELATED QUALITY OF LIFE OUTCOMES FOR LOW-RISK PROSTATE CANCER PATIENTS MANAGED BY ACTIVE SURVEILLANCE OR RADIATION THERAPY John S. Banerji*, Seattle, WA, Lauren M. Hurwitz, Jennifer Cullen, Rockville, MD, Katherine Odem-Davis, Erika M. Wolff, Katherine Levie, Khanh N. Pham, Christopher R. Porter, Seattle, WA SUNDAY *Presenting author 139

152 MP42-14 FAIR AND BALANCED? HOW THE MEDIA REPORTED THE PIVOT AND SPCG-4 PROSTATE CANCER TREATMENT TRIALS Joseph Yared*, Kevin Koo, Elias Hyams, Lebanon, NH MP42-15 IMPACT OF RACE ON SELECTING APPROPRIATE PATIENTS FOR ACTIVE SURVEILLANCE WITH SEEMINGLY LOW RISK PROSTATE CANCER Eugene J. Pietzak, III*, Keith Van Arsdalen, Kinnari Patel, S. Bruce Malkowicz, Alan J. Wein, Thomas J. Guzzo, Philadelphia, PA MP42-16 CONTEMPORARY PATIENTS WITH BIOPSY GLEASON 3 4 PROSTATE CANCER: ELIGIBILITY FOR ACTIVE SURVEILLANCE Ohseong Kwon*, Hakmin Lee, Jung Ki Jo, Young Ik Lee, Jong Jin Oh, Sangchul Lee, Seong Jin Jeong, Seok-Soo Byun, Sang Eun Lee, Sung Kyu Hong, Seongnam, Korea, Republic of MP42-17 PREDICTORS OF PATHOLOGICAL UPGRADING AND UPSTAGING IN PATIENTS ELIGIBLE FOR ACTIVE SURVEILLANCE SUBMITTED TO RADICAL PROSTATECTOMY Ana Maria Autran-Gomez*, Paris, France, Fernando P Secin, Buenos Aires, Argentina, Arjun Sivaraman, Rafael Sanchez Salas, Paris, France, Juan I Monzo, Buenos Aires, Argentina, Dominique Prapotnich, Eric Barret, Francois Rozet, Marc Galiano, Annick Mombet, Nathalia Cathala, Xavier Cathelineau, Paris, France MP42-19 DECISION AIDS FOR LOCALIZED PROSTATE CANCER TREATMENT CHOICE: SYSTEMATIC REVIEW AND META-ANALYSIS Philippe D Violette*, Woodstock, Canada, Thomas Agoritsas, Hamilton, Canada, Jarno Riikonen, Tampere, Finland, Henrikki Santti, Helsinki, Finland, Paul Alexander, Hamilton, Canada, Arnav Agarwal, Toronto, Canada, Neera Bhatnagar, Hamilton, Canada, Philipp Dahm, Minneapolis, MN, Victor Montori, Rochester, MN, Gordon H Guyatt, Hamilton, Canada, Kari Tikkinen, Helsinki, Finland MP42-20 PATHOLOGIC OUTCOMES OF CANDIDATES FOR ACTIVE SURVEILLANCE UNDERGOING RADICAL PROSTATECTOMY: RESULTS FROM A CONTEMPORARY TURKISH PATIENT COHORT Ilker Tinay*, Istanbul, Turkey, Guven Aslan, Izmir, Turkey, Ali Riza Kural, Istanbul, Turkey, Haluk Ozen,, Turkey, Bulent Akdogan, Ankara, Turkey, Asif Yildirim, Istanbul, Turkey, Ozdal Dillioglugil, Kocaeli, Turkey, Tarik Esen, Istanbul, Turkey, Ferruh Zorlu, Izmir, Turkey, Levent Turkeri, Istanbul, Turkey MP42-18 PATIENTS ELIGIBLE FOR ACTIVE SURVEILLANCE WHO CHOSE TO UNDERGO PROSTATECTOMY: THE DIFFERENCE BETWEEN PROSTATE CANCER FEATURES ON BIOPSY AND FINAL PATHOLOGIC REPORT Benjamin Katz*, Sue-Jean Yu, Elton Llukani, Andrew Lightfoot, Kelly Monahan, Alice McGill, David Lee, Philadelphia, PA Sunday, May 17, 2015 Moderated Poster Session 43 SEXUAL FUNCTION/DYSFUNCTION/ANDROLOGY: EVALUATION I Room New Orleans Morial Convention Center Moderators: Allen Seftel and Raphael Carrion 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP43-01 REAL AND PERCEIVED MAGNITUDE OF CURVATURE AMONG PATIENTS AFFECTED BY PENILE CURVATURE: ACQUIRED PENILE CURVATURE (APC) VS CONGENITAL PENILE CURVATURE (CPC) ARE THERE ANY DIFFERENCES? Giovanni Chiriacò, Nicola Pavan*, Michele Rizzo, Paolo Umari, Gaetano Chiapparrone, Giovanni Liguori, Carlo Trombetta, Trieste, Italy MP43-02 ANATOMIC LOCATION OF CAVERNOSAL ARTERY IMAGING DURING DOPPLER PENILE ULTRASOUND IMPACTS VASCULAR DIAGNOSIS Matthew Pagano*, Peter Stahl, New York, NY MP43-03 ENDOTHELIAL DYSFUNCTION DETECTED BY PERIPHERAL ARTERIAL TONOMETRY IS MORE PREVALENT IN MEN WITH ERECTILE DYSFUNCTION Charles Peyton*, Robert Kovell, Jung Kim, Ryan Terlecki, Winston Salem, NC 140

153 MP43-04 UROFLOW STOP TEST AT TIME OF CATHETER REMOVAL IS A NOVEL AND STRONG PREDICTOR OF EARLY RECOVERY OF ERECTILE FUNCTION FOLLOWING ROBOTIC-ASSISTED RADICAL PROSTATECTOMY (RARP): A PILOT STUDY Abdullah Alenizi*, Marc Bienz, Anwar Alesawi, Naif Al-Hathal, Serge Benayoun, Thierry Lebeau, Kevin c Zorn, Assaad El- Hakim, Montreal, Canada MP43-05 SEXUAL AND GENITAL HEALTH AWARENESS AMONG MALES ATTENDING YOUTH HEALTH CLINICS Alexander W. Pastuszak*, Peggy B. Smith, Allyssa Abacan, Larry I. Lipshultz, Dolores J. Lamb, Ruth Buzi, Houston, TX MP43-06 SEXUAL FUNCTION CHANGES IN BLADDER CANCER PATIENTS UNDERGOING CYSTECTOMY Lindsey Herrel*, Rujuta Umarji, Cheryl Lee, Ann Arbor, MI, Heather Goltz, David Latini, Houston, TX, Daniela Wittmann, Ann Arbor, MI MP43-07 VASCULAR RISK FACTORS DO NOT PREDICT PENILE DOPPLER DUPLEX ULTRASOUND RESULTS IN OLDER MEN Kelly A. Chiles*, Christian J. Nelson, John P. Mulhall, New York, NY MP43-08 THE RELATIONSHIP BETWEEN VASECTOMY AND SEXUAL FREQUENCY David Guo*, Shufeng Li, Michael Eisenberg, Palo Alto, CA MP43-09 FAILURE TO ATTAIN STRETCHED PENILE LENGTH AFTER INTRACAVERNOSAL INJECTION OF A VASODILATOR AGENT IS PREDICTIVE OF VENO-OCCLUSIVE DYSFUNCTION ON PENILE DUPLEX DOPPLER ULTRASONOGRAPHY Faysal A Yafi*, Ian R McCoslin, Russell P Libby, Carrie A Stewart, Premsant Sangkum, Suresh Sikka, Wayne JG Hellstrom, New Orleans, LA MP43-10 HIGH-PRECISION EVALUATION OF SYSTEMIC ENDOTHELIAL FUNCTION IN THE COMPLEX DIAGNOSIS OF ERECTILE DISORDERS Oleg Apolikhin, Evgeny Efremov, Yaroslav Melnik, Stepan Krasnyak*, Moscow, Russian Federation MP43-11 A NOVEL AND CHEAP VASOACTIVE DRUG COMBINATION FOR PHARMACOLOGICAL ERECTION Shivam Priyadarshi*, Jaipur, India MP43-12 FACTORS CAUSING EJACULATION PROBLEMS: ANALYSES FROM THE TURKISH SOCIETY OF ANDROLOGY, MALE SEXUAL HEALTH STUDY GROUP murat dincer*, Istanbul, Turkey, selahittin cayan, Mersin, Turkey, Ramazan Asci, Samsun, Turkey, Onder Yaman, Ankara, Turkey, Ege Can Serefoglu, Ates Kadioglu, Istanbul, Turkey MP43-13 ERECTILE FUNCTION IN PATIENTS AFTER RADICAL PROSTATECTOMY IN HIGH-RISK PROSTATE CANCER: RECOVERY AND OUTCOME ANALYSIS Ashwin Sridhar, Tet Yap, John Hines, Senthil Nathan, Tim Briggs, John Kelly, Paul Cathcart*, Suks Minhas, London, United Kingdom MP43-14 STUDY OF THE RISK FACTORS ASSOCIATED WITH PREMATURE EJACULATION Seong Hyun Lee, See Min Choi*, Sol Yoon, Jae Hwi Choi, Sung Chul Kam, Jeong Seok Hwa, Ky Hyun Chung, Jae Seog Hyun, Jinju, Korea, Republic of MP43-15 OUTCOMES OF FOR CAUSE PROSTATE BIOPSY IN MEN WITH HYPOGONADISM Daniel Shoskes*, Yagil Barazani, Khaled Fareed, Edmund Sabanegh, Cleveland, OH MP43-16 PREVALENCE AND PREDICTORS OF EJACULATORY DYSFUNCTION IN MEN PRESENTING FOR ANDROLOGICAL EVALUATION Matthew Pagano*, Alison Levy, Adam De Fazio, Peter Stahl, New York, NY MP43-17 ASSESSMENT OF THE MALE SEXUAL QUOTIENT SCALE RELIABILITY TO EVALUATE SEXUAL FUNCTION OF MEN WITH SPINAL CORD INJURY Eduardo Miranda*, Cristiano Gomes, Jose de Bessa Júnior, Jose de Castro Filho, Carlos Bellucci, Linamara Battistella, Tarcisio Barros Filho, Fabricio Carvalho, Carmita Abdo, Homero Bruschini, William Nahas, Miguel Srougi, Sao Paulo, Brazil MP43-18 ASSESSING THE IMPACT OF AUDIO- VISUAL SEXUAL STIMULATION (AVSS) ON THE NEED FOR REPEAT VASOACTIVE AGENT INJECTION DURING PENILE DUPLEX DOPPLER ULTRASONOGRAPHY Lawrence C. Jenkins*, Joseph Narus, Amparo Camacho, Christian J. Nelson, John P. Mulhall, New York, NY MP43-19 HOW IS DELAYED EJACULATION TREATED IN NORTH AMERICA? Michael Butcher*, Springfield, IL, Charles Welliver, Albany, NY, Daniel Sadowski, Botchway Albert, Tobias Köhler, Springfield, IL MP43-20 ENDOTHELIAL DYSFUNCTION IN PATIENTS OF ERECTILE DYSFUNCTION USING SHORT-TERM LOW DOSE TADALAFIL : A DOUBLE BLIND RANDOMIZED CONTROL TRIAL Ravimohan Mavuduru*, Pawan Kundal, Smita Pattanaik, Shrawan Singh, Arup Mandal, Chandigarh, India SUNDAY *Presenting author 141

154 Sunday, May 17, 2015 Moderated Poster Session 44 KIDNEY CANCER: EVALUATION AND STAGING II Room New Orleans Morial Convention Center Moderators: J. Stuart Wolf, Jr. and John Libertino 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP44-01 A PROGNOSTIC MODEL FOR OVERALL SURVIVAL IN PATIENTS WITH METASTATIC CLEAR CELL RENAL CARCINOMA: RESULTS FROM CALGB (ALLIANCE) Hyung Kim*, Los Angeles, CA, Susan Halabi, Durham, NC, Ping Li, Los Angeles, CA, Greg Mayhew, Durham, NC, Jeff Simko, San Francisco, CA, Andrew Nixon, Durham, NC, Eric Small, San Francisco, CA, Brian Rini, Cleveland, OH, Michael Morris, New York, NY, Mary-Ellen Taplin, Boston, MA, Daniel George, Durham, NC MP44-02 IS GFR ENOUGH TO DEFINE CHRONIC KIDNEY DISEASE IN KIDNEY CANCER PATIENTS? Kelly O Donnell*, Conrad Tobert, Brad Boelkins, Sabrina Noyes, Samer Kirmiz, Mwafa Tourojman, George Ghareeb, Joseph Giovanucci, Grand Rapids, MI, Sevag Demirjian, Cleveland, OH, Brian Lane, Grand Rapids, MI MP44-03 IS THE ASSOCIATION BETWEEN KIDNEY CANCER AND HEMODIALYSIS DIFFERENT FROM PERITONEAL DIALYSIS? - A NATIONWIDE POPULATION-BASED STUDY Eric Yi-Hsiu Huang*, Hsiao-Jen Chung, Yu- Hua Fan, Ruo-Shin Peng, Yen-Hwa Chang, Alex T.L. Lin, Kuang-Kuo Chen, Taipei, Taiwan MP44-04 NEPHRON-SPARING SURGERY PROTECTS FROM CHRONIC KIDNEY DISEASE RELATIVE TO RADICAL NEPHRECTOMY BUT DOES NOT IMPACT ON OTHER-CAUSES MORTALITY: LONG- TERM (MORE THAN 10 YEARS) SURVIVAL AND FUNCTIONAL OUTCOMES IN PATIENTS WITH A T1A-T1B RENAL MASS Umberto Capitanio*, Milan, Italy, Carlo Terrone, Novara, Italy, Alessandro Antonelli, Brescia, Italy, Andrea Minervini, Florence, Italy, Cristian Fiori, Turin, Italy, Luisa Zegna, Novara, Italy, Maria Furlan, Brescia, Italy, Giorgio Gandaglia, Paolo Capogrosso, Milan, Italy, Carini Marco, Florence, Italy, Claudio Simeone, Brescia, Italy, Roberto Bertini, Francesco Montorsi, Milan, Italy MP44-05 EXPLORATION OF PREDICTIVE FACTORS OF POST-PARTIAL NEPHRECTOMY RENAL FUNCTION: HOST FACTORS, RATHER THAN SURGICAL FACTORS, MAY BE USEFUL PREDICTORS IN THE POST-OPERATIVE STABLE PERIOD Takehiro Sejima*, Noriya Yamaguchi, Hideto Iwamoto, Toshihiko Masago, Shuichi Morizane, Masashi Honda, Atsushi Takenaka, Yonago, Japan MP44-06 CAN PROTEINURIA ON A SIMPLE PREOPERATIVE URINARY DIPSTICK PREDICT LONG TERM RENAL FUNCTIONAL CHANGES IN PATIENTS UNDERGOING PARTIAL NEPHRECTOMY? Louis Krane*, Matt Heavner, James T Rague, Ahmed Aboumohamed, Ashok K Hemal, Winston Salem, NC MP44-07 A CRITICAL ANALYSIS AND VALIDATION OF THE RENAL CELL CARCINOMA BIOMARKER LITERATURE USING THE CANCER GENOME ATLAS (TCGA) Samuel Kaffenberger*, Irina Ostrovnaya, Andrew Winer, Victor Reuter, Jonathan Coleman, Paul Russo, James Hsieh, Ari Hakimi, New York, NY MP44-08 PRE-OPERATIVE MODIFIED GLASGOW PROGNOSTIC SCORE AS AN INDEPENDENT PROGNOSIS FACTOR IN A LARGE U.S. POPULATION Yoram Baum*, Claire De la Calle, Dattatraya Patil, Rachel Schwartz, Jonathan Huang, Kenneth Ogan, Mehrdad Alemozaffar, John Pattaras, Peter Nieh, Viraj Master, Atlanta, GA MP44-09 DOES WARM ISCHEMIC TIME REALLY AFFECT THE LATE KIDNEY FUNCTION AND OVERALL SURVIVAL AFTER PARTIAL NEPHRECTOMY? Jae Seung Chung*, Busan, Korea, Republic of, Seok-Soo Byun, Sang Eun Lee, Sung Kyu Hong, Sang Chul Lee, Seongnam, Korea, Republic of, Cheol Kwak, Sung Hoo Hong, Seoul, Korea, Republic of, Yong June Kim, Chungbuk National University Hospital, Korea, Republic of, Seok-Ho Kang, Seoul, Korea, Republic of MP44-10 TREATMENT TRENDS OF SMALL RENAL MASSES IN PATIENTS OF ADVANCED AGE Shan Dong*, Jonathan E. Kiechle, Simon P. Kim, Robert Abouassaly, Edward E. Cherullo, Lee Ponsky, Cleveland, OH, Cary P. Gross, New Haven, CT, Nilay D. Shah, Rochester, MN, Hui Zhu, Cleveland, OH MP44-11 PROGNOSTIC SIGNIFICANCE OF DEGREE OF RENAL VEIN INVOLVEMENT IN PATIENTS WITH PATHOLOGIC T3A RENAL CELL CARCINOMA Myungsun Shim*, Myungchan Park, Aram Kim, Mooyoung Sohn, Jaeyoon Jung, In Gab Jeong, Cheryn Song, Choung-Soo Kim, Hanjong Ahn, Seoul, Korea, Republic of 142

155 MP44-12 ENUCLEO-RESECTION VERSUS WEDGE RESECTION FOR SMALL RENAL MASSES: COMPARATIVE ANALYSIS OF VOLUME PRESERVATION AND CHANGES IN RENAL FUNCTION Adam Kadlec*, Robert Blackwell, Timothy Durso, Marcus Quek, Gopal Gupta, Maywood, IL MP44-13 OUTCOMES OF SURGICALLY TREATED T4M0, T4M1, AND M1 PATIENTS WITH RENAL CELL CARCINOMA Michael Daugherty*, Gennady Bratslavsky, Syracuse, NY MP44-14 PARANEOPLASTIC SYNDROMES ARE ASSOCIATED WITH ADVERSE PROGNOSIS AMONG PATIENTS WITH RENAL CELL CARCINOMA UNDERGOING NEPHRECTOMY Daniel Moreira*, Boris Gershman, Christine Lohse, Stephen Boorjian, John Cheville, Bradley Leibovich, R. Houston Thompson, Rochester, MN MP44-15 ANATOMICAL SCORING SYSTEM FOR ASSESSING PARTIAL NEPHRECTOMY TECHNICAL COMPLEXITY Massimiliano Spaliviero*, Bing Ying Poon, Christoph A. Karlo, Giuliano B. Guglielmetti, Pier Luigi Di Paolo, Felix Campos-Juanatey, Melanie L. Bernstein, Daniel D. Sjoberg, Paul Russo, Jonathan A. Coleman, Oguz Akin, Karim A. Touijer, New York, NY MP44-16 PREDICTORS OF NON-DIAGNOSTIC RENAL MASS BIOPSY Michael Blute*, Joel Prince, Eric Bultman, Louis Hinshaw, Anna Drewry, Sara Best, Fred T. Lee, Jr, Timothy Ziemlewicz, Meghan Lubner, Fangfang Shi, Stephen Y. Nakada, E. Jason Abel, Madison, WI MP44-17 THE SIGNIFICANCE OF SYMPTOMATOLOGY: ANALYSIS FROM THE INTERNATIONAL RENAL CELL CARCINOMA-VENOUS THROMBUS CONSORTIUM (IRCC-VTC) Jamie S Pak*, Danny Lascano, Julia B Finkelstein, James M McKiernan, G Joel DeCastro, New York, NY, Umberto Capitanio, Milan, Italy, Joaquín A Carballido, Madrid, Spain, Venancio Chantada, Coruña, Spain, Thomas Chromecki, Graz, Austria, Gaetano Ciancio, Miami, FL, Siamak Daneshmand, Los Angeles, CA, Christopher P Evans, Sacramento, CA, Paolo Gontero, Turin, Italy, Javier González, Madrid, Spain, Axel Haferkamp, Frankfurt, Germany, Markus Hohenfellner, Heidelberg, Germany, William C Huang, New York, NY, Theresa M Koppie, Portland, OR, Estefanía L Espinós, Madrid, Spain, Adam Lorentz, Atlanta, GA, Juan I Martínez-Salamanca, Madrid, Spain, Dario Martul, Coruña, Spain, Alon Y Mass, New York, NY, Viraj A Master, Atlanta, GA, Carmen Mir, Miami, FL, Francesco Montorsi, Milan, Italy, Giacomo Novara, Padua, Italy, Padraic O Malley, New York, NY, Sascha Pahernik, Heidelberg, Germany, Juan Palou, Barcelona, Spain, José LP Moreno, Valencia, Spain, Raj S Pruthi, Chapel Hill, NC, Oscar R Faba, Barcelona, Spain, Paul Russo, Douglas S Scherr, New York, NY, Shahrokh F Shariat, Vienna, Austria, Martin Spahn, Würzburg, Germany, Carlo Terrone, Novara, Italy, Derya Tilki, Sacramento, CA, Cesar V Donoso, Valencia, Spain, Daniel Vergho, Würzburg, Germany, Eric M Wallen, Chapel Hill, NC, Richard Zigeuner, Graz, Austria, John A Libertino, Burlington, MA MP44-18 CLINICAL SIGNIFICANCE OF NUTRITIONAL PROGNOSTIC INDEX IN PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA Yoshio Ohno*, Jun Nakashima, Makoto Ohori, Naoya Satake, Takeshi Kashima, Tatsuo Gondo, Yoshihiro Nakagami, Masaaki Tachibana, Tokyo, Japan MP44-19 IMPACT OF REDUCED GFR AND PROTEINURIA ON OVERALL SURVIVAL OF RENAL CANCER PATIENTS Mwafa Tourojman*, Sabrina Noyes, Kelly O Donnell, Samer Kirmiz, Conrad Tobert, Brad Boelkins, George Ghareeb, Joseph Giovanucci, Brian Lane, Grand Rapids, MI MP44-20 CAN MORPHOLOGIC FEATURES OF VENA CAVAL TUMOR THROMBUS ON CT OR MRI BE A PROGNOSTIC FACTOR AFTER SURGICAL TREATMENT OF RENAL CELL CARCINOMA WITH IVC THROMBUS? Don kyoung Choi*, Hwang Gyun Jeon, Byong Chang Jeong, Seong Soo Jeon, Hyun Moo Lee, Han-Yong Choi, Chang Wook Jeong, Cheol Kwak, Cheryn Song, Jinsoo Chung, Sung Kyu Hong, Sung-Hoo Hong, Seong Il Seo, Seoul, Korea, Republic of SUNDAY *Presenting author 143

156 Sunday, May 17, 2015 Moderated Poster Session 45 BLADDER CANCER: BASIC RESEARCH II Room New Orleans Morial Convention Center Moderators: Piyush Agarwal and Jason Gee 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP45-01 HIGH ALDO-KETO REDUCTASE 1C1 EXPRESSION IN METASTATIC BLADDER CANCER CELLS ASSOCIATED WITH INVASIVE POTENTIAL AND DRUG RESISTANCE Ryuji Matsumoto*, Masumi Tsuda, Takashige Abe, Satoru Maruyama, Kunihiko Tsuchiya, Naoto Miyajima, Nobuo Shinohara, Shinya Tanaka, Sapporo, Japan MP45-02 INVESTIGATION OF A NON-INVASIVE DIAGNOSTIC ASSAY TO DETECT ALTERED EXPRESSION OF MICRORNA IN EXFOLIATED UROTHELIAL CARCINOMA CELLS Gabriel B. Saltzman*, Chicago, IL, Travis B. Sullivan, Dylan Lavery, Jason R. Gee, John A. Libertino, Kimberly M. Rieger-Christ, Burlington, MA MP45-03 TARGETING OF BIOMARKERS OF BLADDER CANCER METASTASIS BY 4-METHYLUMBELLIFERONE Juan Chipollini*, Ronny Racine, Luis Lopez, Soum Lokeshwar, Travis Yates, Vinata Lokeshwar, Miami, FL MP45-07 SYNTHETIC INTRAVESICAL IMMUNOMODULATORY MOLECULES AS POTENTIAL ALTERNATIVES TO BACILLUS CALMETTE-GUERIN (BCG) AGAINST NON-MUSCLE-INVASIVE BLADDER CANCER Gabriela R. Passos, Karen L. Ferrari, Isadora O. Gilli, Juliana A. de Camargo, Mariana A. Davi, Mariana F. G. Fazuoli, Athanase Billis, Leonardo O. Reis*, Campinas, Brazil MP45-08 GMCSF AND IFN GENE THERAPY IMPROVED RESPONSE TO BCG IMMUNOTHERAPY IN A MURINE MODEL OF BLADDER CANCER Sin Mun Tham*, Abirami R, Kesavan Esuvaranathan, Ratha Mahendran, Singapore, Singapore MP45-09 EMETINE DIHYDROCHLORIDE PREFERENTIALLY INHIBITS HIF1 AND HIF2 EXPRESSION IN BLADDER CANCER CELLS Kimberly E Foreman, Deval Patel, Valerie Davidson, Paul Kuo, Robert Flanigan, Gopal N Gupta*, Maywood, IL MP45-04 ANDROGEN DEPRIVATION THERAPY PREVENTS RECURRENCE OF BLADDER CANCER Koji Izumi*, Mastaka Taguri, Yokohama, Japan, Hiroshi Miyamoto, Baltimore, MD, Yusuke Ito, Yasuhide Miyoshi, Masatoshi Moriyama, Tetsuo Murai, Hiroyuki Hayashi, Yoshiaki Inayama, Yokohama, Japan, Yoji Nagashima, Tokyo, Japan, Satoshi Morita, Kyoto, Japan, Hiroji Uemura, Yokohama, Japan MP45-05 T0 DISEASE: THE POTENTIAL OF AVOIDING CYSTECTOMIES THROUGH MIRNA PROFILES IN CELL-FREE URINE Chintan Patel*, Shiv Patel, Travis Sullivan, Burlington, MA, Alexa Meyer, James McKiernan, New York, NY, John Libertino, Kimberly Christ, Burlington, MA MP45-06 COMPARISON BETWEEN WHOLE MOUNT TISSUE PREPARATIONS AND VIRTUAL TISSUE MICROARRAY SAMPLES FOR MEASUREMENT OF KI-67 AND APOPTOSIS INDICES IN HUMAN BLADDER CANCERS Hisashi Oshiro*, Tokyo, Japan, Bogdan Czerniak, Houston, Armenia, Kentaro Sakamaki, Yokohama, Japan, Koji Tsuta, Tokyo, Japan, Jolanta Bondaruk, Afsaneh Keyhani, Colin Dinney, Houston, Armenia, Takeshi Nagai, Tokyo, Japan, Ashish Kamat, Houston, Armenia MP45-10 CORRELATION BETWEEN FIBRONECTIN GENE EXPRESSION AND LOCAL TOXICITY INDUCED BY ADJUVANT INTRAVESICAL THERAPY Vincenza Alonge, Cristina Scalici Gesolfo, Fabrizio Di Maida, Giuseppe Cicero, Palermo, Italy, Antonina Graziella Cangemi, Palermo, Italy, Antonio Russo, Michele D Arienzo, Rosalinda Allegro, Vincenzo Serretta*, Palermo, Italy MP45-11 PHARMACOGENETIC ASSOCIATION BETWEEN COMBINED EFFECTS OF GSTP1 AND GSTO1 GENETIC POLYMORPHISMS AND INTRAVESICAL INSTILLATION SENSITIVENESS OF BLADDER CANCER PATIENTS Qiang Lu*, Pengchao Li, Jun Tao, Chao Qin, Nanjing, China, People s Republic of MP45-12 PROGNOSTIC IMPACT OF TUMOR ASSOCIATED MACROPHAGES IN PATIENTS WITH TRANSITIONAL CELL BLADDER CANCER Bo Wang, Shaoxu Wu, Zhuowei Liu, Wen Dong, Wang He, Xiaoliang Dong, Tianxin Lin, Jian Huang*, Guangzhou, China, People s Republic of 144

157 MP45-13 N-ACETYLCYSTEINE-MEDIATED AUTOPHAGY INHIBITION LEADS TO CYTOCHROME-C INDEPENDENT CASPASE-9 ACTIVATION DURING OXIDATIVE STRESS IN UROTHELIAL CARCINOMA OF URINARY BLADDER Rani Ojha, Shrawan K Singh*, Vivekanand Jha, Chandigarh, India MP45-14 COMPARISON OF DIFFERENT ANALYTICAL PLATFORMS FOR THE IDENTIFICATION OF TUMOR DNA IN THE URINE OF BLADDER CANCER PATIENTS Matthew J Resnick*, Nashville, TN, Richard D Abramson, Carl Yoshizawa, Redwood City, CA, Po N Lam, Syracuse, NY, Neal Shore, Myrtle Beach, SC, Haluk Tezcan, Redwood City, CA MP45-15 MIR-137 INHIBITED SP1 PROTEIN TRANSLATION AND MEDIATED ANTI- CANCER ACTIVITY OF ISORHAPONTIGENIN (ISO) Dongyun Zhang*, Chuanshu Huang, Xingruo Zeng, Zhou Xu, Tuxedo, NY, Xue-ru Wu, New York, NY, Moon-Shong Tang, Tuxedo, NY MP45-16 NON-MUSCLE INVASIVE BALDDER CANCER: CIRCULATING TUMOR CELLS AND PROGNOSTIC SIGNIFICANCE Gian Maria Busetto*, Riccardo Giovannone, Gabriele Antonini, Paola Gazzaniga, Vincenzo Gentile, Ettore De Berardinis, Roma, Italy MP45-17 COMPARISON OF THE PROGNOSTIC AND PREDICTIVE VALUE OF THE BIOMARKERS ERCC1 AND KI67 IN PATIENTS ENROLLED IN TWO RANDOMIZED STUDIES OF NEOADJUVANT CHEMOTHERAPY WITH OR WITHOUT CYSTECTOMY Tammer Hemdan*, Ulrika Segersten, Per-Uno Malmström, Uppsala, Sweden MP45-18 EXPRESSION OF FOXP3 2 IN BLADDER CANCER EPITHELIAL CELLS IMPARTS RESISTANCE TO CHEMOTHERAPY AND INVERSELY CORRELATES TO SURVIVAL Hanwei Zhang, Elizabeth Peek, Jane Lee, Kelvin Zhang, Xiaoyan Wang, Jiaoti Huang, Gang Li, Matteo Pellegrini, Arnold Chin*, Los Angeles, CA MP45-19 UPREGULATION OF ISOENZYME M2 OF PYRUVATE KINASE IN BLADDER CANCER: IMPLICATION IN TUMOR INITIATION, PROGRESSION AND THERAPEUTIC TARGETING Haiping Zhou, Kuo-How Huang, Yan Liu, Feng He, Xing Wang, Lan Mo, Herbert Lepor, Moon-shong Tang, Chuanshu Huang, Xue-Ru Wu*, New York, NY MP45-20 PDK4 A POSSIBLE THERAPEUTIC TARGET FOR HIGH GRADE BLADDER CANCER Andrew Mikhalyuk*, Dharamainder Choudhary, Carol Pilbeam, John Taylor, III, Farmington, CT SUNDAY Sunday, May 17, 2015 Moderated Poster Session 46 PROSTATE CANCER: BASIC RESEARCH II Room New Orleans Morial Convention Center Moderators: Christopher Evans and K. C. Balaji 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP46-01 AKR1C3 ACTIVATION AND INTRACRINE ANDROGENS CONFER RESISTANCE TO ENZALUTAMIDE Chengfei Liu, Wei Lou, Yezi Zhu, Joy Yang, Christopher Evans, Allen Gao*, Sacramento, CA MP46-02 UP-REGULATION OF GLUCOSE METABOLISM BY NF- B2/P52 MEDIATES ENZALUTAMIDE RESISTANCE IN PROSTATE CANCER CELLS Yuanyuan Cui, Nagalakshmi Nadiminty, Chengfei Liu, Wei Lou, Allen Gao*, Sacramento, CA MP46-03 NF-KAPPAB2/P52:C-MYC:HNRNPA1 REGULATORY PATHWAY CONTROLS EXPRESSION OF ANDROGEN RECEPTOR SPLICE VARIANTS AND ENZALUTAMIDE SENSITIVITY IN PROSTATE CANCER Nagalakshmi Nadiminty*, Ramakumar Tummala, Chengfei Liu, Wei Lou, Christopher Evans, Allen Gao, Sacramento, CA *Presenting author 145

158 MP46-04 REAL TIME IN VIVO MOLECULAR IMAGING OF NF- B IN PROSTATE CANCER: ROLE AS PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET Eugene Vykhovanets, Sanjeev Shukla, Eswar Shankar, Olena Vykhovanets, Gregory MacLennan, Sanjay Gupta*, Cleveland, OH MP46-05 INHIBITION OF CONSTITUTIVELY ACTIVE STAT3 AND AR VARIANTS REVERSES ENZALUTAMIDE RESISTANCE IN ADVANCED PROSTATE CANCER CELLS Chengfei Liu*, Wei Lou, Yezi Zhu, Christopher Evans, Allen Gao, Sacramento, CA MP46-06 ABLATION OF INTRATUMORAL ANDROGENESIS IN PROSTATE TUMOR CELL XENOGRAFTS BY A HEDGEHOG SIGNALING INHIBITOR Amy A Lubik, Mazyar Ghaffari, Hans Adomat, Vancouver, Canada, Eva Corey, Seattle, WA, Emma Guns, Michael E Cox, Ralph Buttyan*, Vancouver, Canada MP46-07 EFFECT OF A HISTONE DNA DEMETHYLASE ON CRPC CELL LINES, A POTENTIAL THERAPEUTIC APPLICATION Thenappan Chandrasekar*, Joy C. Yang, Sacramento, CA, Min Xie, Sheng Ding, San Francisco, CA, Michael G. Rosenfeld, La Jolla, CA, Christopher P. Evans, Sacramento, CA MP46-08 THE TYRPHOSTIN, NT157, SUPPRESSES INSULIN RECEPTOR SUBSTRATES AND AUGMENTS THERAPEUTIC RESPONSE OF PROSTATE CANCER Naokazu Ibuki*, Hirakata, Japan, Mazyar Ghaffari, Vancouver, Canada, Hadas Reuveni, Jerusalem, Israel, Mitaly Pandey, Ladan Fazli, Vancouver, Canada, Haruhito Azuma, Takatsuki, Japan, Martin Gleave, Vancouver, Canada, Alexander Levitzki, Jerusalem, Israel, Michael Cox, Vancouver, Canada MP46-09 METFORMIN INDUCES ER STRESS- DEPENDENT APOPTOSIS THROUGH MIR P/NNAT PATHWAY IN PROSTATE CANCER Jian Yang, Yuqi Guo, Xin Li*, New York, NY MP46-10 UTILIZING INSULIN IN THE TREATMENT OF PROSTATE CANCER WITH BKM120 ABROGATES THE THERAPEUTIC EFFECT OF PI3K PATHWAY INHIBITION Lily Wang*, David Nanus, Lewis Cantley, New York, NY MP46-11 TARGETING RIBOSOMAL S6 KINASES/Y- BOX BINDING PROTEIN-1 SIGNALING IMPROVES CELLULAR SENSITIVITY TO TAXANE IN PROSTATE CANCER Masaki Shiota*, Momoe Itsumi, Akira Yokomizo, Ario Takeuchi, Kenjiro Imada, Eiji Kashiwagi, Junichi Inokuchi, Katsunori Tatsugami, Takeshi Uchiumi, Seiji Naito, Fukuoka, Japan MP46-12 USING THE NOVEL SELECTIVE LYSINE- SPECIFIC DEMETHYLASE 1 INHIBITOR NCL1 TO IMPAIR PROSTATE CANCER GROWTH Toshiki Etani*, Taku Naiki, Keitaroh Iida, Ryosuke Ando, Daichi Kobayashi, Noriyasu Kawai, Keiichi Tozawa, Kenjiro Kohri, Nagoya, Japan MP46-13 NITRONE-BASED THERAPY FOR TREATMENT OF A MURINE MODEL OF HUMAN CASTRATION RESISTANT PROSTATE CANCER Joel Slaton*, Carole Davis, Nataliya Smith, Debbie Saunders, Rober Hurst, Rheal Towner, Oklahoma City, OK MP46-14 CAPSAICIN REDUCES THE METASTATIC BURDEN IN THE TRANSGENIC ADENOCARCINOMA OF THE MOUSE PROSTATE (TRAMP) MODEL Natalie Venier, Toshihiro Yamamoto*, Linda Sugar, Toronto, Canada, Hans Adomat, Vancouver, Canada, Neil Fleshner, Vasundara Venkateswaran, Laurence Klotz, Toronto, Canada MP46-15 LIPID NANOPARTICLE SIRNA POTENTLY SILENCES CLUSTERIN AND DELAYS PROGRESSION WHEN COMBINED WITH ANDROGEN RECEPTOR CO-TARGETING IN ENZALUTAMIDE RESISTANT PROSTATE CANCER Yoshiaki Yamamoto*, Paulo Lin, Fan Zhang, Eliana Beraldi, Yoshihisa Kawai, Jeffrey Leong, Vancouver, Canada, Hideyasu Matsuyama, Ube, Japan, Pieter Cullis, Martin Gleave, Vancouver, Canada MP46-16 CASTRATION-INDUCED ACCELERATION OF BONE METASTASIS PREVENTED BY RANK INHIBITOR OSTEOPROTEGERIN IN MURINE CASTRATION-RESISTANT PROSTATE CANCER MODEL Koichiro Takayama*, Takamitsu Inoue, Shintaro Narita, Mingguo Huang, Yoko Mitobe, Hiroshi Tsuruta, Susumu Akihama, Mitsuru Saito, Norihiko Tsuchiya, Tomonori Habuchi, Akita, Japan MP46-17 TARGETING MULTIPLE FUNCTIONS OF E3 UBIQUITIN LIGASE-1 (WWP1) SIGNALING BY MIR-452 INHIBITS CANCER CELL MIGRATION AND INVASION IN PROSTATE CANCER Yusuke Goto*, Akira Kurozumi, Rika Nishikawa, Mayuko Kato, Shinichi Sakamoto, Chiba, Japan, Satoko Kojima, Yukio Naya, Ichihara, Japan, Hideki Enokida, Masayuki Nakagawa, Kagoshima, Japan, Tomohiko Ichikawa, Naohiko Seki, Chiba, Japan MP46-18 CD8 T CELLS INHIBIT THE INTERLEUKIN- 15 (IL-15) INDUCED CYTOTOXIC ACTIVITY OF NK AND NKT CELLS TOWARD TUMOUR CELLS IN THE PROSTATE CANCER MICROENVIRONMENT Oussama Elhage*, Christina Sakellariou, Richard A Smith, Christine Galustian, Prokar Dasgupta, London, United Kingdom 146

159 MP46-19 MICRODISTRIBUTION OF ALPHA PARTICLE EMITTING RADIUM-223 DICHLORIDE IN MODELS OF PROSTATE CANCER BONE METASTASIS Diane Abou, Baltimore, MD, David Ulmert, New York, NY, Robert Hobbs, Ryan Riddle, Daniel Thorek*, Baltimore, MD MP46-20 CARMUSTINE AND SELENITE COMBINATION THERAPY EFFECTIVELY INHIBITS CASTRATION RESISTANT PROSTATE CANCER IN PRECLINICAL MODELS Vijayalakshmi Thamilselvan*, Mani Menon, Sivagnanam Thamilselvan, Detroit, MI Sunday, May 17, 2015 Moderated Poster Session 47 KIDNEY CANCER: BASIC RESEARCH II Room New Orleans Morial Convention Center Moderator: W. Marston Linehan 10:30 am - 12:30 pm SUNDAY NUMBER TITLE NUMBER TITLE MP47-01 OVEREXPRESSED MIR-27A-3P IS AS INDEPENDENT PROGNOSTIC FACTOR FOR RECURRENCE IN CLEAR CELL RENAL CELL CARCINOMA Wataru Nakata*, Motohide Uemura, Toshiro Kinouchi, Takuji Hayashi, Kyosuke Matsuzaki, Norihiko Kawamura, Atsunari Kawashima, Takeshi Ujike, Akira Nagahara, Kazutoshi Fujita, Kentaro Jingushi, Kazutake Tsujikawa, Norio Nonomura, Suita, Japan MP47-02 MICRORNA MIR-200B IS DOWN- REGULATED AND SUPPRESSES METASTASIS BY TARGETING LAMA4 IN RENAL CELL CARCINOMA Zhong yuan Zhang*, Xue song Li, Wei Zhao, Bo xing Su, Xiao chun Zhang, Li qun Zhou, Zhi qian Zhang, Beijing, China, People s Republic of MP47-03 ADIPOQ GENE POLYMORPHISM IS ASSOCIATED WITH CLEAR CELL RENAL CELL CARCINOMA Guiming Zhang*, Chengyuan Gu, Yao Zhu, Shanghai, China, People s Republic of, Lei Luo, Dahai Dong, Qingdao, China, People s Republic of, Fangning Wan, Xiaojian Qin, Hailiang Zhang, Guohai Shi, Bo Dai, Shanghai, China, People s Republic of, Lijiang Sun, Qingdao, China, People s Republic of, Dingwei Ye, Shanghai, China, People s Republic of MP47-04 EXAMINATION OF GENOMIC COPY NUMBER ALTERATIONS IN RENAL CELL CARCINOMA WITH SARCOMATOID FEATURES Timothy Ito*, Jianming Pei, Essel Dulaimi, Craig Menges, Philip Abbosh, Marc Smaldone, David Chen, Richard Greenberg, Alexander Kutikov, Rosalia Viterbo, Robert Uzzo, Joseph Testa, Philadelphia, PA MP47-05 ANDROGEN RECEPTOR MRNA EXPRESSION IS ASSOCIATED WITH PROGNOSIS IN LOCALIZED RENAL CELL CARCINOMA Parth Modi*, Yun-Sok Ha, Geuntaek Lee, New Brunswick, NJ, Han-Jong Ahn, Seoul, Korea, Republic of, Wun-Jae Kim, Cheongju, Korea, Republic of, Isaac Kim, New Brunswick, NJ MP47-06 BRCA1 ASSOCIATED PROTEIN-1 (BAP-1) LOSS IN CCRCC: MOLECULAR CORRELATIONS AND VALIDATION AS A PROGNOSTIC FACTOR Nils Kroeger*, Greifswald, Germany, Payal Kapur, Dallas, TX, Jiaoti Huang, Arie Belldegrun, Los Angeles, CA, James Brugarolas, Dallas, TX, Allan Pantuck, Los Angeles, CA MP47-07 OVEREXPRESSION OF SIRT7 EXHIBITS ONCOGENIC PROPERTY AND SERVES AS A PROGNOSTIC FACTOR IN CLEAR CELL RENAL CELL CARCINOMA Xue Yijun, Zou xiaofeng*, Zhang Guoxi, Yuan Yuanhu, Xiao Rihai, Wu Gengqing, Wang Xiaoning, Ganzhou, Jiangxi Province, China, People s Republic of MP47-08 THE METHYLATION OF SOX7 AND ITS FUNCTION AS A TUMOR SUPPRESSOR IN RENAL CELL CANCER Lu Wang*, Qian Zhang, Lian Zhang, beijing, China, People s Republic of, Tingxiu Xiang, chongqing, China, People s Republic of, Yu Fan, beijing, China, People s Republic of, Ben Xu, beijng, China, People s Republic of, Qian Tao, hongkng, China, People s Republic of, Jie Jin, beijing, China, People s Republic of *Presenting author 147

160 MP47-09 MOLECULAR CHARACTERIZATION OF SARCOMATOID CLEAR CELL RENAL CELL CARCINOMA Roy Mano*, William Lee, Alexander Sankin, Michael Chevinsky, Patricia Wang, Almedina Djesevic, Robert Motzer, Emily Cheng, Paul Russo, Dayna Oschwald, Umeshkumar Bhanot, Satish Tickoo, A Ari Hakimi, James Hsieh, New York, NY MP47-10 MICRORNA EXPRESSION PROFILES FOR RENAL MASS BIOPSY: A NOVEL TOOL TO AID IN THE STRATIFICATION OF PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA Drew Palmer*, Casey Kowalik, Patrick Teebagy, Kari Bailey, Shiv Patel, Travis Sullivan, John Dugan, John Libertino, Kimberly Rieger-Christ, Burlington, MA MP47-11 CANDIDATE BIOMARKER FOR BONE MORPHOGENETIC PROTEIN 2 PREDICTS RENAL CELL CARCINOMA PROGRESSION VIA ITS PROMOTER CPG HYPERMETHYLATION Yozo Mitsui*, San Francisco, CA, Naoko Arichi, Miho Hiraki, Hiroaki Yasumoto, Izumo, Japan, Shinichiro Fukuhara, San Francisco, CA, Inik Chang, Seoul, Korea, Republic of, Hiroshi Hirata, Soichiro Yamamura, Varahram Shahryari, Guoren Deng, Ruzhu Lan, Sharanjot Saini, Shahana Majid, Rajvir Dahiya, Tanaka Yuichirio, San Francisco, CA, Hiroaki Shiina, Izumo, Japan MP47-12 MIR-646 IN CLEAR CELL RENAL CARCINOMA CORRELATED WITH TUMOUR METASTASIS BY TARGETING THE NIN ONE BINDING PROTEIN Wei Li*, Shanghai, China, People s Republic of, Yuanyuan Zhang, Winston Salem, NC, Min Liu, Jianping Che, Junhua Zheng, Shanghai, China, People s Republic of MP47-13 MUTATIONAL AND PROGNOSTIC ASSOCIATIONS OF IMMUNE CELL SIGNATURES IN CLEAR CELL RENAL CELL CARCINOMA Andrew Winer*, Yasin Senbabaoglu, Samuel Kaffenberger, Jonathan Coleman, Paul Russo, Chris Sander, James Hsieh, Ari Hakimi, New York, NY MP47-14 MUTATION ANALYSIS OF AGGRESSIVE CHROMOPHOBE RENAL CELL CANCER PATIENTS Jozefina Casuscelli*, William Lee, Patricia Wang, Paul Russo, Jonathan A. Coleman, New York, NY, Allan Pantuck, Los Angeles, CA, R. Houston Thompson, Rochester, MN, Victor E. Reuter, A. Ari Hakimi, James J Hsieh, New York, NY MP47-16 PRETREATMENT PERIPHERAL BLOOD MONOCYTE SUBSET SIGNATURE IN STAGE IV RENAL CELL CARCINOMA PATIENTS PREDICTS OUTCOME TO DENDRITIC CELL VACCINATION Jason Muhitch*, Alexander Wald, Mohammad Habiby Kermany, Joseph Tario, Anand Sharda, Buffalo, NY, Marc Ernstoff, Hanover, NH, Thomas Schwaab, Buffalo, NY MP47-17 REDUCED TERE1 (UBIAD1) PROTEIN EXPRESSION ASSOCIATES WITH MALIGNANT BUT NOT BENIGN RENAL CANCERS. ECTOPIC TERE1 EXPRESSION INDUCES SXR TARGET GENES REGULATING BONE REMODELING: RELEVANCE TO BONE METASTASIS William Fredericks*, Frank Rauscher III, Priti Lal, S. Bruce Malkowicz, Philadelphia, PA MP47-18 LYMPH NODE STROMAL CELLS ENHANCE RENAL CELL CARCINOMA GROWTH, TRANSMIGRATION, AND METASTASIS IN AN ORTHOTOPIC XENOGRAFT MODEL John Nelson*, Jessie Gills, Ravan Moret, Xin Zhang, Grace Maresh, Ashley Richman, M Liss Hudson, Marc Matrana, Ryan Hedgepeth, Shams Halat, Stephen Bardot, Li Li, New Orleans, LA, Christudas Morais, Glenda Gobe, David Johnson, Brisbane, Australia MP47-19 URINE AND SERUM METABOLOMICS ANALYSES MAY DISTINGUISH BENIGN AND MALIGNANT RENAL NEOPLASMS Oluyemia Falegan, Calgary, Canada, Mark Ball, Baltimore, MD, Rustem Shaykhutdinov, Calgary, Canada, Michael Gorin, Phillip Pierorazio, George Netto, Mohamad Allaf*, Baltimore, MD, Hans Vogel, Eric Hyndman, Calgary, Canada MP47-20 IDENTIFICATION OF ACTIONABLE TARGETS IN CHROMOPHOBE RENAL CELL CARCINOMA DETECTED BY MULTIPLATFORM MOLECULAR ANALYSIS Philip Abbosh*, Philadelphia, PA, Sherri Millis, Nancy Doll, Adam Hauben, Sandeep Reddy, Phoenix, AZ, Daniel Geynisman, Robert Uzzo, Philadelphia, PA MP47-15 A NOVEL ELISA FOR THE QUANTITATIVE MEASUREMENT OF URINARY AQUAPORIN-1 IN PATIENTS WITH RENAL CANCER Jaime H Noguez*, Cleveland, OH, Shilpa Sreedharan, Fei Lian, Viraj Master, Kenneth Ogan, John Pattaras, Rebecca S Arnold, John A Petros, James C Ritchie, Atlanta, GA 148

161 Sunday, May 17, 2015 Podium Session 25 BLADDER CANCER: DETECTION AND SCREENING II Room New Orleans Morial Convention Center Moderators: Edward Messing and Joseph Liao 10:30 am - 12:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 10:30 PD25-01 MOLECULAR IMAGING OF ORTHOTOPIC MOUSE BLADDER CANCER MODEL USING A CD47 ANTIBODY Dimitar V. Zlatev*, Lei Kang, Mark Hsu, Ying Pan, Kathleen E. Mach, Jens-Peter Volkmer, Irving L. Weissman, Joseph C. Liao, Stanford, CA 10:40 PD25-02 DIAGNOSTIC ACCURACY OF PROBE BASED CONFOCAL LASER ENDOMICROSCOPY IN BLADDER CANCER Seong Uk Jeh, Hae Do Jung*, Jong Kyou Kwon, Ho Won Kang, Joo Yong Lee, Kang Su Cho, Won Sik Ham, Yong Jin Kang, Young Deuk Choi, seoul, Korea, Republic of 10:50 PD25-03 AN ELECTRONIC NOSE SYSTEM DETECTS BLADDER CANCER IN URINE SPECIMEN: FIRST RESULTS OF A PILOT STUDY Marcus Horstmann*, Daniel Steinbach, Claudia Fischer, Astrid Enkelmann, Marc- Oliver Grimm, Andreas Voss, Jena, Germany 11:00 PD25-04 VIRTUAL 3D BLADDER RECONSTRUCTION FROM WHITE LIGHT CYSTOSCOPY Kristen L. Lurie*, Dimitar V. Zlatev, Roland Angst, Stanford, CA, Jiyang Gao, Bejing, China, People s Republic of, Sydney Li, Kathleen E. Mach, Audrey K. Ellerbee, Joseph C. Liao, Stanford, CA 11:10 PD25-05 CLINICAL CORRELATIONBETWEEN INCIDENTALLY DETECTED BLADDER WALL THICKENING ON COMPUTED TOMOGRAPHY SCAN AND CYSTOSCOPY Sin Woo Lee*, Joon Hyung Park, Sang Eun Lee, Yong Hyo Choi, Jae Yong Jeong, Sae Bin Jung, Don Kyoung Choi, Hyun Hwan Sung, hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Han- Yong Choi, Hyun Moo Lee, Seoul, Korea, Republic of 11:20 PD25-06 PRE-OPERATIVE INCIDENCE OF DEEP VENOUS THROMBOSIS IN BLADDER CANCER PATIENTS PRIOR TO UNDERGOING RADICAL CYSTECTOMY John Schomburg*, Ayman Soubra, Badrinath Konety, Minneapolis, MN 11:40 PD25-08 A MODEL TO OPTIMIZE FOLLOW-UP CARE AND REDUCE HOSPITAL READMISSIONS AFTER RADICAL CYSTECTOMY Naveen Krishnan*, Xiang Liu, Michael Hu, Kedi Wu, Ann Arbor, MI, Jonathan Helm, Bloomington, IN, Alex Helfand, Benjamin Li, Alexandra Zalewski, Chang He, Ann Arbor, MI, Bruce Jacobs, Pittsburgh, PA, Brent Hollenbeck, Mariel Lavieri, Ted Skolarus, Ann Arbor, MI 11:50 PD25-09 CAN WE PREVENT READMISSIONS FOLLOWING TRANSURETHRAL RESECTION OF BLADDER TUMOR? A MULTIVARIATE ANALYSIS OF A LARGE SINGLE INSTITUTION S EXPERIENCE Rachel Moses*, Eric Raffin, Faddy Ghali, Margaret Menkov, Elias Hyams, Lebanon, NH 12:00 PD25-10 RESIDENT INVOLVEMENT IN ENDOSCOPIC BLADDER CANCER SURGERY IS ASSOCIATED WITH INADEQUATE PATHOLOGY SPECIMENS AND PROLONGED TIME TO CYSTECTOMY Derek Bos*, Hamilton, Canada, Christopher Allard, Boston, MA, Shawn Dason, Vladimir Ruzhynsky, Anil Kapoor, Bobby Shayegan, Hamilton, Canada 12:10 PD25-11 TURBT: THE EFFECT OF OPERATIVE DURATION ON POST-OPERATIVE COMPLICATIONS IN 10,526 PATIENTS Richard Matulewicz*, Vidit Sharma, Barry McGuire, Daniel Oberlin, John Kim, Kent Perry, Robert Nadler, Chicago, IL 12:20 PD25-12 PREDICTING RISK OF BCG RELATED SIDE EFFECTS USING URINARY CYTOKINES COMBINED WITH PRE- EXISTING URINARY SYMPTOMS Hajar I. Ayoub*, Ashish M. Kamat, Colin P. Dinney, H. Barton Grossman, Ferran Prat, Houston, TX, Joseph Briggman, waltham, MA, Bryan Fellman, Diana Urbauer, Roosevelt Anderson, Shanna Pretzsch, O. Lenaine Westney, Houston, TX SUNDAY 11:30 PD25-07 SIGNIFICANTLY INCREASED LONG-TERM RISK OF BLADDER CANCER AFTER SOLID ORGAN TRANSPLANTATION Kara L Watts*, Ethan B Fram, Mark Schoenberg, Farhang Rabbani, Bronx, NY *Presenting author 149

162 Sunday, May 17, 2015 Podium Session 26 SEXUAL FUNCTION/DYSFUNCTION/ANDROLOGY: SURGICAL THERAPY I Room New Orleans Morial Convention Center Moderators: TBD 10:30 am - 12:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 10:30 PD26-01 INCREASED PENILE LENGTH AFTER INFLATABLE PENILE PROSTHESIS REPLACEMENT Paul Chung*, Jordan Siegel, R. Carrington Mason, Timothy Tausch, Allen Morey, Dallas, TX 10:40 PD26-02 A REVIEW OF MICROORGANISMS ISOLATED AT SALVAGE OR EXPLANT OF IPPS: ARE WE COVERING THE CORRECT BUGS? Martin Gross*, Boston, MA, Francois Eid, New York City, NY, Christopher Yang, Ross Simon, Daniel Martinez, Rafael Carrion, Tampa, FL, Paul Perito, Coral Gables, FL, Nelson Bennett, Burlington, MA, Laurence Levine, Chicago, IL, Jason Greenfield, Arlington, TX, Ricardo Munarriz, Boston, MA 10:50 PD26-03 BEYOND THE PUMP: USE OF MAGNETIC INDUCTION TO ACTIVATE A PENILE PROSTHESIS Alberto Colombo, Springfield, IL, Brian Le*, Madison, WI, Kevin McVary, Springfield, IL 11:00 PD26-04 IMPROVED INFECTION OUTCOMES AFTER MULCAHY SALVAGE PROCEDURE AND REPLACEMENT OF INFECTED IPP WITH MALLEABLE PROSTHESIS Martin Gross*, Boston, MA, Francois Eid, New York City, NY, Christopher Yang, Ross Simon, Daniel Martinez, Rafael Carrion, Tampa, FL, Paul Perito, Coral Gables, FL, Laurence Levine, Chicago, IL, Jason Greenfield, Arlington, TX, Ricardo Munarriz, Boston, MA 11:10 PD26-05 THE DECLINE OF INPATIENT PENILE PROSTHESIS: ANALYSIS OF THE TRENDS AND COMPLICATIONS OF INPATIENT PENILE PROSTHESIS IMPLANTATION USING NATIONAL INPATIENT SAMPLE FROM Amjad Alwaal*, Catherine Harris, Ahmed Hussein, Thomas Sanford, Charles McCulloch, Jack McAninch, Benjamin Breyer, San Francisco, CA 11:20 PD26-06 IMPLANT LENGTH BASELINE CHARACTERISTIC CORRELATIONS Nelson Bennett*, Burlington, MA, Anthony Bella, Ottawa, Canada, Gerard Henry, Shreveport, LA, Edward Karpman, Mountain View, CA, Will Brant, Salt Lake City, UT, LeRoy Jones, San Antonio, TX, Bryan Kansas, Austin, TX, Tobias Kohler, Springfield, IL, Mohit Khera, Houston, TX 11:30 PD26-07 RACIAL AND AGE DIFFERENCES IN IMPLANTATION OF INFLATABLE PENILE PROSTHESIS FOR ERECTILE DYSFUNCTION (ED) IN THE PROSTATE CANCER SURVIVOR Divya Ajay*, Durham, NC, Shubham Gupta, Lexington, KY, John Selph, Michael Belsante, Ngoc-Bich Le, Andrew Peterson, Durham, NC 11:40 PD26-08 SCROTOPLASTY AT TIME OF PENILE IMPLANT IS AT HIGH RISK FOR DEHISCENCE IN DIABETICS Randy Sulaver, II*, Springfield, IL, Robert Welliver, Albany, NY, Michael Kottwitz, Luke Frederick, Brittney Hanerhoff, Danuta Dynda, Tobias Kohler, Springfield, IL 11:50 PD26-09 FACTORS INVOLVED IN THE REMOVAL OR REPLACEMENT OF PENILE PROSTHESES Bobby Najari*, Daniel Lee, Wesley Davison, Bashir Al Hussein Al Awamlh, Fujun Zhao, John Mulhall, Darius Paduch, Bilal Chughtai, Richard Lee, New York, NY 12:00 PD26-10 OUTCOMES OF IPP PLACEMENT BY SURGICAL APPROACH, PENOSCROTAL VS INFRAPUBIC, RESULTS FROM A PROSPECTIVE MULTICENTER STUDY Edward Karpman*, Mountain View, CA, Anthony Bella, Ottawa, Canada, William Brant, Salt Lake City, UT, Brian Christine, Homewood, AL, Bryan Kansas, Austin, TX, LeRoy Jones, Sa Antonio, TX, Tobias Kohler, Springfield, IL, Nelson Bennett, Burlington, MA, Mohit Khera, Houston, TX, Gerard Henry, Shreveport, LA 12:10 PD26-11 DEFINING THE UTILITY OF SALVAGE SURGERY FOR INFECTED PENILE IMPLANTS Raanan Tal*, Kazuhito Matsushita, Nelson Bennett, John P. Mulhall, New York, NY 12:20 PD26-12 PENILE PROSTHESIS INSERTION AFTER RADIAL FOREARM FREE FLAP NEOPHALLUS Joseph J. Pariser*, Rena D. Malik, Lawrence J. Gottlieb, Gregory T. Bales, Chicago, IL 150

163 Sunday, May 17, 2015 Podium Session 27 URODYNAMICS/INCONTINENCE/FEMALE UROLOGY: FEMALE INCONTINENCE - THERAPY I Room New Orleans Morial Convention Center Moderators: TBD 10:30 am - 12:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 10:30 PD27-01 ADVANCING CARE FOR OVERACTIVE BLADDER: A TAILORED LEARNING APPROACH TO IMPROVE CLINICAL DECISION-MAKING Simi Hurst*, New York, NY, Justin Barnes, Evan Rhodes, Birmingham, AL 10:40 PD27-02 DOES PATIENT AGE AFFECT THE OUTCOMES AND PATIENT REPORTED HEALTH RELATED QUALITY OF LIFE (HRQOL) AFTER SACRAL NEUROMODULATION? Tyler Lu, Jaspreet Singh Parihar*, Bianca Chendrimada, Hari SGR Tunuguntla, New Brunswick, NJ 10:50 PD27-03 COMPARATIVE EFFECTIVENESS OF THREE DIFFERENT TEACHING METHODS IN BEHAVIORAL THERAPY PROGRAM FOR FEMALE OVERACTIVE BLADDER: A RANDOMIZED CONTROLLED TRIAL Elif Gezginci, Emine Iyigun, Sercan Yilmaz*, Emin Aydur, Ankara, Turkey 11:00 PD27-04 OUTCOMES OF BILATERAL LEAD PLACEMENT FOR STAGE I OF SACRAL NEUROMODULATION TRIAL Adrienne Quirouet*, Ashley King, Howard Goldman, Raymond Rackley, Courtenay Moore, Sandip Vasavada, Cleveland, OH 11:10 PD27-05 THE USE OF ONABOTULINUMTOXINA FOR TREATMENT OF OVERACTIVE BLADDER IN OLDER PATIENTS Anne Sammarco*, Elizabeth Ferry, Dhruti Patel, Penny Benchek, Elias Kikano, Adonis Hijaz, Sangeeta Mahajan, Cleveland, OH 11:20 PD27-06 REAL-WORLD PATTERNS OF OVERACTIVE BLADDER (OAB) CARE IN THE UNITED STATES (US) BASED ON AN OBSERVATIONAL STUDY Howard Goldman*, Cleveland, OH, Jennifer Anger, Beverly Hills, CA, Canan Esinduy, Kelly Zou, David Russell, Xuemei Luo, Fady Ntanios, Martin Carlsson, New York, NY, J. Quentin Clemens, Ann Arbor, MI 11:30 PD27-07 EVALUATION OF QUALITY OF LIFE IMPROVEMENTS AT 36 MONTHS IN SUBJECTS WITH OVERACTIVE BLADDER TREATED WITH SACRAL NEUROMODULATION USING THE INTERSTIM SYSTEM Steven Siegel*, Woodbury, MN, Jason Bennett, Grand Rapids, MI, Jeffrey Mangel, Cleveland, OH, Craig Comiter, Stanford, CA, Samuel Zylstra, Whitinsville, MA, Erin Bird, Temple, TX, Tomas L. Griebling, Kansas City, KS, Suzette E. Sutherland, Seattle, WA, Daniel Culkin, Oklahoma City, OK, Karen Noblett, Riverside, CA, Fangyu Kan, Lindsey Guanella, Minneapolis, MN 11:40 PD27-08 REAL WORLD RETENTION RATES AFTER INTRAVESICAL ONABOTULINUMTOXINA FOR IDIOPATHIC OVERACTIVE BLADDER Olufenwa Milhouse*, Marta Johnson, Leah Gross, Steven Siegel, Woodbury, MN 11:50 PD27-09 DOES THE USE OF A DEDICATED OPERATING SPACE AND SURGICAL TEAM REDUCE INFECTION RATES FOR FIRST STAGE SACRAL NEUROMODULATION? Julie Jenks*, Eskinder Solomon, Bashir Mukhtar, Mahreen Pakzad, Rizwan Hamid, Tamsin Greenwell, Jeremy Ockrim, London, United Kingdom 12:00 PD27-10 IMPACT OF NUMBER OF ACTIVE ELECTRODES AT TIME OF SACRAL TINED LEAD PLACEMENT ON VOLTAGE THRESHOLDS AND CLINICAL OUTCOMES Jason Gilleran*, Kim Killinger, Judith Boura, Michael Ehlert, Priyanka Gupta, Cheryl Wolfert, Jamie Bartley, Kenneth Peters, Royal Oak, MI 12:10 PD27-11 THERAPEUTIC EFFECTS OF A SELECTIVE ANDROGEN RECEPTOR MODULATOR, GSK A ON STRESS URINARY INCONTINENCE IN OVARIECTOMIZED RATS Katsumi Kadekawa*, Pittsburgh, PA, Naoki Kawamorita, Sendai, Japan, Philip Turnbull, Alan Russell, Sundeep Chandra, Joanna Barton, Durham, NC, Naoki Yoshimura, Pittsburgh, PA SUNDAY 12:20 PD27-12 MIRABEGRON DOES NOT DECREASE URINARY NEUROTROPHINS LEVELS IN OVERACTIVE BLADDER PATIENTS DESPITE SYMPTOMATIC IMPROVEMENT Tiago Antunes-Lopes*, Ana Ferreira, Carvalho-Barros Sérgio, Daniel Costa, Rui Pinto, João Silva, Silva Carlos, Francisco Cruz, Porto, Portugal *Presenting author 151

164 Sunday, May 17, 2015 Video Session 6 10:30 am - 12:30 pm UROLITHIASIS The videos in this session as well as the video libraries from the Annual Meetings may be viewed in the Surgical Video Library and purchased in the Products Store during the Annual Meeting. Both are located in Registration Hall B2. All years of the Surgical Video Library may also be purchased online at Room New Orleans Morial Convention Center Moderators: Altan Ilkay and Roger Low NUMBER TITLE NUMBER TITLE V6-01 ROBOT ASSISTED FLEXIBLE URETEROSCOPIC LASER LITHOTRIPSY, WITH AVICENNA ROBOFLEX Jens Rassweiler*, Heillbronn, Germany, Remzi Saglam, ANKARA, Turkey, Olivier Traxer, Paris, France, A. Sinan Kabakci, Zafer Tokatli, Abdurrahim Imamoglu, Ankara, Turkey, Glenn Preminger, Durham, NC V6-02 ROBOTIC PYELOLITHOTOMY IN ECTOPIC PELVIC KIDNEY: SIDE DOCKING IN SUPINE POSITION AND A FOUR-ARM APPROACH Ahmad Al-Marzouq*, Rawan Al-Yousef, Saad Aldousari, Kuwait City, Kuwait V6-03 LAPAROSCOPIC ROBOT-ASSISTED PYELOLITHOTOMY IN AN ECTOPIC RIGHT PELVIC KIDNEY Dorit Zilberman*, Nir Kleinmann, Assaf Barel, Harry Winkler, Jacob Ramon, Ramat-Gan, Israel V6-04 THE SIMPORTAL FLUORO-LESS C-ARM TRAINER (CAT): AN INNOVATIVE TRAINING DEVICE FOR PERCUTANEOUS KIDNEY ACCESS Domenico Veneziano*, Minneapolis, MN, Arthur Smith, New York, NY, Troy Reihsen, David Hananel, Jack Stubbs, Jason Speich, Robert Sweet, Minneapolis, MN V6-05 CAPSULE TO CALCULUS OPTICAL DISSECTION FOR TRACT CREATION DURING DIFFICULT PERCUATANEOUS NEPHROLITHOTOMY (PCNL) Haresh Thummar*, new york, NY, Usama Khater, ne york, NY, Kasmira Gupta, Larchmont, NY, Mantu Gupta, New York, NY V6-06 FLUOROSCOPIC ROADMAPPING FOR ENDOUROLOGY Jared Wachterman*, Kevan Sternberg, Burlington, VT V6-07 RETROGRADE PERCUTANEOUS NEPHROSTOMY a ESTABLISHMENT OF PERCUTANEOUS RENAL CHANNEL HOLMIUM LASER WIRE PUNCTURE FROM RENAL CALYX TO THE SKIN UNDER VISUALIZED OF FLEXIBLE URETEROSCOPE (A REPORT OF 12 CASES AND TYPICAL MEDICAL SURGERY VIDEO) Zhao-kui Qu*, Yancheng, China, People s Republic of, Ming Chen, Nanjing, China, People s Republic of, Xiao-jun Jin, Jing Zhou, Yu-mei Pan, Quan Wang, Shao-bo Xu, Jian-bo Ji, Feng Wang, Bo Jiang, Hai-yan Chen, Xiang-liang Yin, Yancheng, China, People s Republic of V6-08 LARGE UPPER-CALYX STONE: CAN SUPRA-TWELFTH PCNL APPROACH BE AVOIDED? Jose Agudelo*, Euro Arias, Nasser Ktech, Jhonan Chirinos, Manuel Riveros, Luis Sanchez, Eduardo Pena, Ricardo Montiel, Maracaibo, Venezuela V6-09 TECHNIQUE FOR ENDOSCOPIC REMOVAL OF CALCIFIED PERMANENT SUTURE AFTER PYELOPLASTY Sean McAdams*, Robert Sweet, Kyle Anderson, Minneapolis, MN V6-10 ULTRASOUND-GUIDED PERCUTANEOUS NEPHROLITHOTOMY FOR STAGHORN STONE IN CROSSED-FUSED ECTOPIC PELVIC KIDNEY Haresh Thummar*, Usama Khater, New York, NY, v Joshi, rajkot, India, Mantu Gupta, New York, NY V6-11 THE CIRCLE NEPHROSTOMY TUBE: AN ATTRACTIVE NEPHROSTOMY DRAINAGE SYSTEM FOLLOWING COMPLEX PERCUTANEOUS NEPHROLITHOTOMY Marawan El Tayeb*, Michael S. Borofsky, James E. Lingeman, Indianapolis, IN V6-12 THE NEW STONE AGE: URETEROSCOPIC STONE DUSTING WITH A 120-WATT HOLMIUM LASER Duncan R. Morhardt*, James Tracey, J. Stuart Wolf, Jr., Khurshid R. Ghani, Ann Arbor, MI V6-13 MICROURETEROSCOPY: MINIATURIZATION FOR THE TREATMENT OF URETERAL STONES Juan-Pablo Caballero-Romeu*, Juan-Antonio Galán-Llopis, Alejandro Garcia-Segui, Aleixandre Verges, Araceli Amorós-Torres, Elche, Spain V6-14 STRIPPERS, SCISSORS AND LASER FIBER TIPS Peter Kronenberg*, Amadora, Portugal, Olivier Traxer, Paris, France 152

165 Sunday, May 17, 2015 SOCIETY FOR THE STUDY OF MALE REPRODUCTION (SSMR) La Nouvelle New Orleans Morial Convention Center 12:00 pm - 5:00 pm 12:00 REPROS SPONSORED LUNCH SYMPOSIUM: CLOMIPHENE - A NEW TWIST (NON-CME) INTRODUCTION Society President: Edward Kim 12:05 CLOMIPHENE: BACKGROUND AND USE IN INFERTILE MEN Wayne Hellstrom 12:20 ENCLOMIPHENE: EFFECT ON HORMONAL PROFILES AND METABOLIC PARAMETERS Andrew McCullough 12:40 ENCLOMIPHENE: SAFETY AND SPERM STUDIES Edward Kim 12:55 Q&A (CME PORTION OF PROGRAM BEGINS) 1:00 INTRODUCTION: ACHIEVING, MAINTAINING AND USING HEALTHY SPERM: ALPHA TO OMEGA Michael Eisenberg 1:10 WHAT S MALE GOT TO DO WITH IT: MALE CONTRIBUTION TO EMBRYO DEVELOPMENT Douglas Carrell 1:30 RECURRENT PREGNANCY LOSS: MALE CONTRIBUTIONS TO A COUPLE S PROBLEM Kathleen Hwang 1:50 TESTICULAR VS. EJACULATED, FRESH VS. FROZEN: SPERM AND MALE FACTORS THAT IMPACT IVF SUCCESS Peter Schlegel 2:10 Q&A 2:20 IVF: RISKS TO THE MOTHER Sissy Sartor 2:40 IVF: RISKS TO OFFSPRING James Smith 3:00 Q&A 3:10 BREAK 3:25 MALE REJUVENATION: WHAT IS IT AND WHO MAY BENEFIT Thomas Walsh 3:45 DANGERS OF MALE REJUVENATION: IT S NOT A FOUNTAIN OF YOUTH Robert Oates 4:05 Q&A 4:20 CHALLENGING CASES Sheldon Marks, Edmund Sabanegh, Eric Seaman 5:00 ADJOURN SUNDAY Sunday, May 17, 2015 SOCIETY OF UROLOGIC ROBOTIC SURGERY (SURS) Napoleon Hilton New Orleans Riverside 12:45 pm - 5:00 pm 12:45 WELCOME AND INTRODUCTION OF PROGRAM Society Chair: James Porter 1:00 SESSION I: ROBOTIC TRAINING AND PROGRAM DEVELOPMENT SURGICAL SKILLS ASSESSMENT: USING THE WISDOM OF CROWDS Thomas Lendvay 1:15 SUCCESSFUL DEVELOPMENT OF HIGH QUALITY ROBOTIC PROGRAMS: PLANNING, TRAINING, CREDENTIALING STANDARDS AT KAISER PERMANENTE 1:30 QUALITY OUTCOMES IN ROBOTIC SURGERY Jay Bishoff 1:45 QUESTIONS AND DISCUSSION 1:55 SESSION II: ROBOTIC SURGERY-PROSTATE CANCER INTRAOPERATIVE EVALUATION OF SURGICAL MARGINS DURING ROBOTIC PROSTATECTOMY Nicolo Buffi 2:10 POSTERIOR APPROACH FOR ROBOTIC PROSTATECTOMY Vito Pansadoro 2:25 ROBOTIC VS. LAPAROSCOPIC PROSTATECTOMY DEBATE LAPAROSCOPIC PROSTATECTOMY- OUTCOMES AND ADVANTAGES Douglas Dahl 2:35 ROBOTIC PROSTATECTOMY Thomas Ahlering 2:45 REBUTTAL-LAPAROSCOPIC PROSTATECTOMY Douglas Dahl 2:50 REBUTTAL-ROBOTIC PROSTATECTOMY Thomas Ahlering 2:55 QUESTIONS AND DISCUSSION 3:05 SESSION III: ROBOTIC SURGERY-KIDNEY CANCER *Presenting author 153

166 OBJECTIFYING DECISION-MAKING IN THE PATIENT WITH RENAL MASS Alexander Kutikov 3:20 CONTEMPORARY OPEN PARTIAL NEPHRECTOMY Paul Russo 3:35 ROBOTIC PARTIAL NEPHRECTOMY Michael Stifelman 3:50 QUESTIONS AND DISCUSSION 4:00 SESSION IV: ROBOTIC SURGERY-BLADDER AND TESTIS CANCER ROBOTIC CYSTECTOMY AND DIVERSION Monish Aron 4:15 WHY USE A ROBOT FOR LAPAROSCOPIC NEPHRECTOMY? Ronney Abaza 4:30 SURS BUSINESS MEETING 5:00 ADJOURN Sunday, May 17, 2015 AUA/AACU HEALTH POLICY FORUM Room New Orleans Morial Convention Center 1:00 pm - 3:00 pm 1:00 AUA HEALTH POLICY LECTURE: FUTURE OF PAYMENT POLICY Barbara Levy 2:00 AACU HOFFMAN LECTURE 2:45 Q&A Sunday, May 17, 2015 Moderated Poster Session 48 PROSTATE CANCER: DETECTION AND SCREENING I Room New Orleans Morial Convention Center Moderator: Kevin Loughlin 1:00 pm - 3:00 pm NUMBER TITLE NUMBER TITLE MP48-01 PREVALENCE OF ANTIBIOTIC RESISTANCE IN FECAL FLORA BEFORE TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY AND CLINICAL IMPACT OF TARGETED ANTIBIOTIC PROPHYLAXIS Turhan Caskurlu, Ozgur Arikan, Asif Yildirim*, Berrin Tanidir, Cengiz Canakci, Yavuz Onur Danacioglu, Ramazan Gokhan Atis, Cenk Gurbuz, Bulent Erol, Haluk Vahaboglu, Istanbul, Turkey MP48-02 FLUORESCENCE SPECTROSCOPY CAN INCREASE DIAGNOSTIC YIELD OF PROSTATE BIOPSIES E. David Crawford*, Edward A. Jasion, Yongjun Liu, Aurora, CO, John Daily, Boulder, CO, Paul Arangua, Clifford Jones, Aurora, CO, S. Russell Nash, Centennial, CO, Priya Werahera, Aurora, CO MP48-04 HOW RELIABLE IS A NEGATIVE MRI/TRUS FUSION BIOPSY? THE NEGATIVE PREDICTIVE VALUE OF TARGETED BIOPSY FOR PROSTATE CANCER Rachael Sussman*, Washington, DC, Michele Fascelli, Thomas Frye, Arvin George, Steven Abboud, Raju Chelluri, Richard Ho, Anna Brown, Sandeep Sankineni, Maria Merino, Ismail Turkbey, Peter Choyke, Bradford Wood, Peter Pinto, Bethesda, MD MP48-05 ASSESSMENT OF TUMOUR AGGRESSIVENESS IN TRANPERINEAL MRI/ULTRASOUND-FUSION BIOPSY IN COMPARISON TO TRANSRECTAL SYSTEMATIC PROSTATE BIOPSY Angelika Borkowetz*, Stefan Zastrow, Ivan Platzek, Marieta Toma, Michael Froehner, Rainer Koch, Manfred Wirth, Dresden, Germany MP48-03 CONTRAST ENHANCED ULTRASOUND WITH PARAMETRIC MAPS FOR THE DETECTION OF PROSTATE CANCER Arnoud Postema*, Amsterdam, Netherlands, Peter Frinking, Plan-les-Ouates, Switzerland, Martijn Smeenge, Theo De Reijke, Jean De la Rosette, Amsterdam, Netherlands, Francois Tranquart, Plan-les-Ouates, Switzerland, Hessel Wijkstra, Amsterdam, Netherlands MP48-06 COMPARATIVE ASSESSMENT OF GLEASON SCORING OF PROSTATE BIOPSIES OBTAINED BY STANDARD TRUS AND MRI-TRUS AT FOLLOW UP IN ACTIVE SURVEILLANCE PATIENTS Max Jackson, Peter Haddock, Ilene Staff, Ryan Dorin, Stuart Kesler, Michael O Loughlin, Anoop Meraney, Joseph Wagner*, Hartford, CT 154

167 MP48-07 RACIAL VARIATION IN POSITIVE PROSTATE NEEDLE BIOPSIES WITH TEMPLATES THAT INCLUDE THE TRANSITION ZONE Justin Levy*, Allison H. Feibus, Krishnarao Moparty, Ian McCaslin, Michael M. Maddox, Oliver Sartor, Jonathan L. Silberstein, New Orleans, LA MP48-08 EARLY OUTCOMES OF COMBINATION MRI-TARGETED AND SATURATION TRANS-PERINEAL BIOPSY IN RESTAGING LOW-RISK PROSTATE CANCER FOR ACTIVE SURVEILLANCE Kae Jack Tay*, Kenneth Chen, Yan Mee Law, Henry Ho, John Yuen, Christopher Cheng, Singapore, Singapore MP48-09 RESULTS OF TRANSPERINEAL MAPPING BIOPSY OF THE PROSTATE Vasileios Skouteris*, Marios Metsinis, Athanassios Dounis, Thomas Georgiadis, Ioulia Evangelou, Dimitrios Papaioannou, Savvas Papadopoulos, Michael Skouteris, Spyros Yarmenitis, Georgios Zacharopoulos, Athens, Greece, Nelson Stone, New York, NY MP48-10 INCLUSION OF THE EXTREME ANTERIOR APICAL NEEDLE BIOPSIES IN THE STANDARD 12 CORE BIOPSY TEMPLATE AT THE INITIAL DETECTION OF PROSTATE CANCER Ayman S. Moussa*, Giza, Egypt, Ahmed El- Shafei, Cairo, Egypt, Ahmad Aref Al- Dessoukey, Ahmed Abdel-bary, Amr Masoud, Giza, Egypt, Amr Abd El-Hakium, Cairo, Egypt MP48-11 PROSPECTIVE RANDOMIZED CONTROLLED STUDY TO ASSESS THE EFFECT OF PERINEAL REGION CLEANSING WITH POVIDONE IODINE BEFORE TRANSRECTAL NEEDLE BIOPSY OF THE PROSTATE ON INFECTIOUS COMPLICATIONS Younis Taher*, haluk ozen, bulent akdogan, serhat unal, serkan dogan, Ankara, Turkey MP48-12 MULTIPARAMETRIC MRI INCREASES THE EFFICIENCY OF THE STANDARD 12-CORE TRUS-GUIDED REPEATED BIOPSIES Lucas Regis*, Pol Servian, Ana Celma, Ricardo Lopez, S Roche, Jacques Planas, Jose Placer, Ines DeTorres, Juan Morote, Barcelona, Spain MP48-13 IDENTIFICATION OF PATHOLOGICALLY FAVORABLE DISEASE IN INTERMEDIATE RISK PROSTATE CANCER PATIENTS: IMPLICATIONS FOR SELECTION OF ACTIVE SURVEILLANCE CANDIDATES Giorgio Gandaglia*, Nazareno Suardi, Marco Bianchi, Nicola Fossati, Federico Dehò, Giuseppe Zanni, Milan, Italy, Firas Abdollah, Detroit, MI, Umberto Capitanio, Emanuele Zaffuto, Milan, Italy, Shahrokh F. Shariat, Vienna, Austria, Pierre Karakiewicz, Montreal, Canada, Francesco Montorsi, Alberto Briganti, Milan, Italy MP48-14 TRANSRECTRAL ULTRASOUND GUIDED BIOPSY VERSUS TRANSPERINEAL TEMPLATE PROSTATE BIOPSIES IN DIAGNOSIS OF PROSTATE CANCER IN MEN WITH PREVIOUS NEGATIVE TRANSRECTRAL ULTRASOUND GUIDED BIOPSY Shady Nafie*, John Dormer, Masood Khan, Leicester, United Kingdom MP48-15 EVALUATING THE CLINICAL UTILITY OF TRANSPERINEAL TEMPLATE PROSTATE MAPPING BIOPSY Yaalini Shanmugabavan*, Alex Freeman, Charles Jameson, Massimo Valerio, Mark Emberton, Hashim Uddin Ahmed, London, United Kingdom MP48-16 CLINICAL UTILITY OF TRANSPERINEAL TEMPLATE GUIDED MAPPING BIOPSY OF PROSTATE AFTER NEGATIVE MAGNETIC RESONANCE IMAGING GUIDED TRANSRECTAL BIOPSY Arjun Sivaraman*, Rafael Sanchez Salas, Eric Barret, Marc Galiano, Francois Rozet, Dominique Prapotnich, Nathalia Cathala, Annick Mombet, Facundo Uriburu Pizarro, Arie Carneiro, Steeve Doizi, Xavier Cathelineau, Paris, France MP48-17 ANTERIOR PROSTATE CANCER: CLINICOPATHOLOGIC CHARACTERIZATION WITH BIOPSY CORRELATION Martin Magers*, Tianyu Zhan, Aaron Udager, Brent Hollenbeck, John Wei, David Miller, Jeffrey Montgomery, Javed Siddiqui, Felix Feng, Daniel Hamstra, Alon Weizer, Todd Morgan, Arul Chinnaiyan, Ganesh Palapattu, Hui Jiang, Rohit Mehra, Ann Arbor, MI MP48-18 DIAGNOSTIC PERFORMANCE OF MULTIPARAMETRIC MRI IN PROSTATE CANCER: PER CORE ANALYSIS OF TWO PROSPECTIVE ULTRASOUND/MRI FUSION BIOPSY DATASETS Giuseppe Simone*, Rome, Italy, Alessandro Giacobbe, Devis Collura, Turin, Italy, Rocco Papalia, Salvatore Guaglianone, Gian Luca Muto, Michele Gallucci, Rome, Italy, Giovanni Muto, Turin, Italy, Mariaconsiglia Ferriero, Rome, Italy MP48-19 COGNITIVE MRI-ECHO FUSION BIOPSY OF THE PROSTATE IS A VALUABLE FIRST STEP IN DIAGNOSING PROSTATE CANCER Paul Westerveld, Jessica Vriesema, Huib van den Hout, Jeroen Veltman, Erik Cornel*, Hengelo, Netherlands MP48-20 WEIGHTED GLEASON SCORES DO NOT OUTPERFORM STANDARD CLINICAL GLEASON SCORES IN PREDICTING PATHOLOGIC GLEASON SCORE, MARGIN STATUS AND RECURRENCE IN PATIENTS WITH DISCORDANT PROSTATE BIOPSIES Max Jackson, Peter Haddock, Antonio Cusano, Ilene Staff, Joseph Wagner*, Hartford, CT SUNDAY *Presenting author 155

168 Sunday, May 17, 2015 Moderated Poster Session 49 BLADDER CANCER: BASIC RESEARCH III Room New Orleans Morial Convention Center Moderators: Jeffrey Gingrich and Leonardo Reis 1:00 pm - 3:00 pm NUMBER TITLE NUMBER TITLE MP49-01 FOXA1 LOSS IS ASSOCIATED WITH POOR PROGNOSIS AND SEX-DEPENDENT PHENOTYPES FOLLOWING GENETIC INACTIVATION Opal Lin-Tsai Reddy, Justin Cates, Lan Gellert, Nashville, TN, Hironobu Yamashita*, Hershey, PA, John Taylor III, Farmington, CT, Joseph Smith Jr., Sam Chang, Nashville, TN, Michael Cookson, Oklahoma City, OK, Daniel Barocas, Magdalena Grabowska, Magdalena Grabowska, Fei Ye, Nashville, TN, Xue-Ru Wu, New York, NY, Yajun Yi, Robert Matusik, Nashville, TN, Klaus Kaestner, Philadelphia, PA, Peter Clark, Nashville, TN, David DeGraff, Hershey, PA MP49-02 RELATIONSHIPS BETWEEN C-FES EXPRESSION AND MALIGNANT AGGRESSIVENESS IN BLADDER CANCER IN VIVO AND IN VITRO Akihiro Asai*, Yasuyoshi Miyata, Kensuke Mitsunari, Tomohiro Matsuo, Kojiro Ohba, Hideki Sakai, Nagasaki, Japan MP49-03 RELATIONSHIP BETWEEN INCREASED EXPRESSION OF AXL-GAS6 SIGNAL CASCADE AND PROGNOSIS IN UPPER URINARY TRACT UROTHELIAL CARCINOMA Seiya Hattori*, Eiji Kikuchi, Takeo Kosaka, Akira Miyajima, Shuji Mikami, Mototsugu Oya, Tokyo, Japan MP49-04 CRITICAL ROLES OF A NUCLEOLAR PROTEIN DDX31 IN BLADDER CARCINOGENESIS DEPENDING ON P53 MUTATION STATUS Kei Daizumoto*, Tomoya Fukawa, Hisanori Uehara, Toyomasa Katagiri, Hiro-omi Kanayama, Tokushima, Japan MP49-05 A NOVEL LONG NONCODING RNA CONTRIBUTES TO THE MAINTENANCE OF SELF-RENEWAL IN BLADDER CANCER STEM-LIKE CELLS Tianxin Lin*, Guangzheng Zhong, Yang Peng, Guangzhou, China, People s Republic of MP49-06 STAT3 ACTIVATION STATUS CONTRIBUTES TO THE DIFFERENTIAL RESPONSES OF METASTATIC AND NO- METASTATIC HUMAN BLADDER CANCER CELLS TO MIR-145 INHIBITION OF ANCHORAGE-INDEPENDENT GROWTH THROUGH REGULATION OF FOXO1 EXPRESSION guosong jiang*, Jingxia Li, Moon-Shong Tang, Tuxedo, NY, Xue-Ru Wu, New York, NY, Chuanshu Huang, Tuxedo, NY MP49-07 CANONICAL WNT PATHWAY TUMOR PROGRESSION IS MEDIATED BY THE LONG NON-CODING RNA HOTAIR IN BLADDER CANCER Claudia Berrondo*, Jonathan Flax, Edward Messing, Carla Beckham, Rochester, NY MP49-08 UROTHELIAL CELLS UNDERGO EPITHELIAL TO MESENCHYMAL TRANSITION AFTER EXPOSURE TO MUSCLE INVASIVE BLADDER CANCER EXOSOMES Carrie Franzen*, Kristin Greco, Robert Blackwell, Kimberly Foreman, Gopal Gupta, Maywood, IL MP49-09 ACTIVATION OF IFN/STAT1 SIGNALING IN CISPLATIN/GEMCITABINE RESISTANT BLADDER CANCER Tetsutaro Hayashi*, Roland Seiler, Robert H Bell, Susan Ettinger, Kendric Wang, Shannon Awrey, Kilian Gust, Wolfgang Jäger, Tilman Todenhoefer, Manuel Altamirano-Dimas, Vancouver, Canada, Akio Matsubara, Hiroshima, Japan, Colin Collins, Peter Black, Vancouver, Canada MP49-10 KNOCKDOWN OF GLYCOPROTEIN-130 INHIBITS BLADDER CANCER PROGRESSION AND MIGRATION Darryl T. Martin*, New Haven, CT, Jill M. Steinbach, Louisville, KY, Marcia A. Wheeler, Cayce B. Nawaf, W. Mark Saltzman, Robert M. Weiss, New Haven, CT MP49-11 TREHALOSE 6,6 DIMYCOLATE CYTOTOXICITY IN BOTH BCG SENSITIVE AND BCG RESISTANT CELL LINES OCCURS VIA A BCG DISTINCT PATHWAY Gopitkumar Shah*, Justin Benabdallah, Fanghong Chen, Guangjian Zhang, Balaraman Kalyanaraman, William See, Milwaukee, WI MP49-12 EFFECT OF BCG EXPOSURE ON ENZYMATIC REGULATORS OF CELLULAR OXIDATIVE STRESS IN UROTHELIAL CARCINOMA CELLS Gopitkumar Shah*, Fanghong Chen, Guangjian Zhang, Balaraman Kalyanaraman, William See, Milwaukee, WI 156

169 MP49-13 LIM-SH3 DOMAIN PROTEIN 1 KNOCKDOWN INHIBITS CELL GROWTH AND ENHANCES ACTIVITY OF CISPLATIN IN BLADDER CANCER Takashi Dejima*, Vancouver, Canada, Ario Takeuchi, Fukuoka, Japan, Tetsutaro Hayashi, Jeffrey Leong, Tabitha Tombe, Kevin Tam, Htoo Oo, Peter Black, Vancouver, Canada, Seiji Naito, Fukuoka, Japan, Martin Gleave, Christopher Ong, Vancouver, Canada MP49-14 SYSTEMIC TRANSDUCTION OF P16 INK4A ANTITUMOR PEPTIDE INHIBITS LUNG METASTASIS OF MBT-2 BLADDER TUMOR CELL LINE IN MICE Toru Shimazui*, Kasama, Japan, Kazuhiro Yoshikawa, Nagakute, Japan, Jun Miyazaki, Kazuhiko Uchida, Tsukuba, Japan, Atsushi Yamauchi, Mikinobu Ohtani, Kasama, Japan, Hiroyuki Nishiyama, Tsukuba, Japan MP49-15 LOSS OF ZKSCAN3 IN BLADDER CANCER PROMOTES CELL PROLIFERATION, MIGRATION, AND INVASION Takashi Kawahara, Eiji Kashiwagi*, Baltimore, MD, Yi Li, Rochester, NY, Yichun Zheng, George Netto, Hitoshi Ishiguro, Hiroshi Miyamoto, Baltimore, MD MP49-16 ENZALUTAMIDE INHIBITS ANDROGEN RECEPTOR-POSITIVE BLADDER CANCER CELL GROWTH Takashi Kawahara, Hiroki Ide*, Eiji Kashiwagi, Leonardo Reis, Yichun Zheng, Hiroshi Miyamoto, Baltimore, MD MP49-17 NEURAL STEM CELLS AND GOLD NANOPARTICLES AS NOVEL TREATMENT FOR BLADDER CANCER EARLY IN VITRO STUDIES Ali Zhumkhawala*, Revathi Tirughana- Sambandan, Rachael Mooney, Jacob Berlin, Karen Aboody, Jonathan Yamzon, Duarte, CA MP49-18 IDENTIFICATION OF EXTRACELLULAR VESICLE PERIOSTIN AS A URINARY BIOMARKER OF MUSCLE INVASIVE BLADDER CANCER Christopher Silvers, Rochester, NY, Miyamoto Hiroshi, Baltimore, MD, Chia-Hao Wu, Edward Messing, Yi-Fen Lee*, Rochester, NY MP49-19 EMP2 AS A NOVEL TARGET OF BLADDER CANCER IMMUNOTHERAPY wujiang liu*, jie jin, liqun Zhou, Yinglu Guo, beijing, China, People s Republic of MP49-20 SYNERGISTIC EFFECT OF TARGETED COMBINATION THERAPY IN BLADDER CANCER MODEL USING HSP90 INHIBITORS Raju Chelluri*, Piyush K. Agarwal, Leonard M. Neckers, Armine K. Smith, Bethesda, MD SUNDAY Sunday, May 17, 2015 Moderated Poster Session 50 KIDNEY CANCER: EVALUATION AND STAGING III Room New Orleans Morial Convention Center Moderators: Pilar Laguna Pes and Michael Blute, Sr. 1:00 pm - 3:00 pm NUMBER TITLE NUMBER TITLE MP50-01 RESULTS FROM A MULTI- INSTITUTIONAL, PROSPECTIVE CLINICAL TRIAL OF DELAYED INTERVENTION AND SURVEILLANCE FOR SMALL RENAL MASSES: THE DISSRM REGISTRY Phillip Pierorazio*, Michael Johnson, Mark Ball, Michael Gorin, Baltimore, MD, Peter Chang, Andrew Wagner, Boston, MA, James McKiernan, New York, NY, Bruce Trock, Mohamad Allaf, Baltimore, MD MP50-02 IS FOLLOW UP BEYOND 2 YEARS NECESSARY FOR PT1A RENAL CELL CARCINOMA TREATED WITH NEPHRON SPARING SURGERY? AN ASSESSMENT OF LATE RECURRENCES AND SURVEILLANCE COSTS Kamran Zargar-Shoshtari*, Tim Kim, Ross Simon, Pranav Sharma, Binglin Yue, Hui-Yi Lin, Julio M Pow-Sang, Michael Poch, Philippe E Spiess, Wade J Sexton, Tampa, FL MP50-03 HYBRID KIDNEY TUMOR PATHOLOGY IS ASSOCIATED WITH INCREASING TUMOR STAGE AND GRADE Neil J. Kocher*, Chris Rjepaj, Erik Lehman, Jay D. Raman, Hershey, PA MP50-04 HYPERTENSION IS THE PRIMARY COMPONENT OF METABOLIC SYNDROME ASSOCIATED WITH RENAL TUMOR PATHOLOGY Neil J. Kocher*, Chris Rjepaj, Erik Lehman, Jay D. Raman, Hershey, PA MP50-05 VOLUMETRIC MEASUREMENT OF COMPENSATORY HYPERTROPHY IN THE CONTRALATERAL NORMAL KIDNEY BY THE TUMOR GROWTH Bong Hee Park*, Uijeongbu, Korea, Republic of, Byong Chang Jeong, Seong Soo Jeon, Seong Il Seo, Hyun Moo Lee, Han Yong Choi, Hwang Gyun Jeon, Seoul, Korea, Republic of *Presenting author 157

170 MP50-06 COMPARATIVE ANALYSIS OF SMOKING AS A RISK FACTOR AMONG RENAL CELL CARCINOMA HISTOLOGIC SUBTYPES Neel Patel*, Kristopher Attwood, Terrance Creighton, Diana Mehedint, Michael Hanzly, Thomas Schwaab, Eric Kauffman, Buffalo, NY MP50-07 THE ASSOCIATION BETWEEN OBESITY AND INCIDENCE OF TOTAL AND FATAL RENAL CELL CARCINOMA IN TWO PROSPECTIVE COHORTS Mark A Preston*, Jed-Sian Cheng, Alejandro Sanchez, Boston, MA, Rebecca E Graff, San Francisco, CA, Dayron Rodriguez, Adam S Feldman, Glen W Barrisford, Seth Bechis, Michael L Blute, Meir Stampfer, Steven L Chang, Edward Giovannucci, Laurence Albiges, Toni K Choueiri, Eunyoung Cho, Kathryn M Wilson, Boston, MA MP50-08 DIAGNOSTIC SUCCESS AND PREDICTION OF TUMOR SUBTYPE OF RENAL MASS BIOPSY IMPROVES WITH EXPERIENCE: LONGITUDINAL RESULTS IN A SINGLE SERIES COHORT OF 1233 TUMORS David Kuppermann*, Christopher B. Allard, Manish Dhyani, Dayron Rodriguez, Alejandro Sanchez, Sameer Deshmukh, Francis J. McGovern, Matthew Wszolek, Michael L. Blute, Rosemary Tambouret, Chin-Lee Wu, Anthony Samir, Adam S. Feldman, Boston, MA MP50-09 ROLE OF REPEAT BIOPSY IN THE FOLLOW-UP OF RENAL LESIONS WITH A PRIOR NON-DIAGNOSTIC BIOPSY OF THE SAME MASS David Kuppermann*, Manish Dhyani, Dayron Rodriguez, Sameer Deshmukh, Francis J. McGovern, Michael L. Blute, Rosemary Tambouret, Chin-Lee Wu, Ronald S. Arellano, Anthony Samir, Adam S. Feldman, Boston, MA MP50-10 INCIDENCE AND RISK FACTORS FOR PERIOPERATIVE THROMBOEMBOLIC EVENTS AMONG PATIENTS WITH RENAL CELL CARCINOMA AND INFERIOR VENA CAVA TUMOR THROMBUS Boyd Viers*, Stephen Boorjian, Christine Lohse, Sarah Psutka, Griffin Morrisson, Bradley Leibovich, R. Houston Thompson, Rochester, MN MP50-11 LOW-YIELD OF SURVEILLANCE IMAGING AFTER SURGERY FOR T1 KIDNEY CANCER Michael Feuerstein*, John Musser, Matthew Kent, Michael Chevinsky, Eugene Cha, Simon Kimm, William Hilton, Timothy Donahue, Jonathan Coleman, Sherri Donat, Paul Russo, New York, NY MP50-12 THE USE OF RENAL NEPHROMETRY SCORES FOR PREDICTING TUMOR UPGRADING BETWEEN CORE BIOPSIES AND SURGICAL SPECIMENS: A PROSPECTIVE EX VIVO STUDY Guiming Zhang*, Yao Zhu, Hualei Gan, Hongkai Wang, Guohai Shi, Hailiang Zhang, Bo Dai, Chaofu Wang, Dingwei Ye, Shanghai, China, People s Republic of MP50-13 CAN ONCOCYTOMAS BE SAFELY MONITORED BY SURVEILLANCE? Patrick O. Richard*, Michael A.S. Jewett, Jaimin R. Bhatt, Narhari Timilshina, Andrew J. Evans, Antonio Finelli, Toronto, Canada MP50-14 CLINICAL STAGE I RENAL MASS UPSTAGING TO PATHOLOGICAL T3A DISEASE PORTENDS A WORSE PROGNOSIS ONLY WHEN SINUS FAT INVASION IS PRESENT Sumit De*, Robert Uzzo, Elizabeth Handorf, David Chen, Rosalia Viterbo, Richard Greenberg, Nikhil Waingankar, Mohammed Haseebuddin, Marc Smaldone, Alexander Kutikov, Philadelphia, PA MP50-15 EVALUATION OF DE NOVO HYPERTENSION AFTER ROBOTIC PARTIAL NEPHRECTOMY: A SINGLE CENTER ANALYSES Oktay Akca*, Homayoun Zargar, Peter Caputo, Daniel Ramirez, Riccardo Autorino, Luis Felipe Brandao, Humberto Laydner, Hiury Andrade, Robert J Stein, Jihad H Kaouk, Cleveland, OH MP50-16 MULTIPLE PRIMARY MALIGNANCIES IN RENAL CORTICAL NEOPLASMS: AN UPDATED EVALUATION Katie S. Murray*, Emily C. Zabor, Massimiliano Spaliviero, Paul Russo, Wassim M. Bazzi, John E. Musser, A. Ari Hakimi, Melanie L. Bernstein, Guido Dalbagni, Jonathan A. Coleman, Helena Furberg, New York, NY MP50-17 INCIDENCE OF HYBRID TUMORS FOUND IN EXCISED RENAL MASSES: A MULTI- INSTITUTIONAL ANALYSIS David Fumo*, Khaled Shahrour, Toledo, OH, Ravi Munver, Hackensack, NJ, Samay Jain, Toledo, OH MP50-18 OBSTRUCTIVE SLEEP APNEA AND HIGH FUHRMAN GRADE IN PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA TREATED WITH NEPHRECTOMY Antoni Vilaseca Cabo*, Emily A. Vertosick, Daniel P. Nguyen, Renato B. Corradi, New York, NY, Mireia Musquera, Meritxell Pérez Márquez, Barcelona, Spain, Nicola Fossati, Daniel D. Sjoberg, New York, NY, Ramón Farré, Josep M. Montserrat, Barcelona, Spain, Nicole E. Benfante, Paul Russo, New York, NY, Antonio Alcaraz Asensio, Barcelona, Spain, Karim A. Touijer, New York, NY 158

171 MP50-19 CONTRAST-ENHANCED ULTRASOUND FOR SURVEILLANCE OF RADIOFREQUENCY-ABLATED RENAL TUMORS: RESULTS FROM A PROSPECTIVE PILOT STUDY Christopher Allard*, Boston, MA, Andu Coret, Shawn Dason, Anil Kapoor, Hamilton, Canada MP50-20 INCREASED THYROID CANCER RISK IN PATIENTS WITH KIDNEY CANCERS Emrullah Yilmaz*, Tejas Suresh, Benjamin Gartrell, Bronx, NY, Ashutossh Naaraayan, New Rochelle, NY, Antonio Di Cristofano, Eric Epstein, Howard Strickler, Bronx, NY, Marston Linehan, Bethesda, MD, Steven Libutti, Missak Haigentz, Reza Ghavamian, Bronx, NY Sunday, May 17, 2015 Moderated Poster Session 51 1:00 pm - 3:00 pm SUNDAY SEXUAL FUNCTION/DYSFUNCTION/ANDROLOGY: EVALUATION II Room New Orleans Morial Convention Center Moderators: Hossein Sadeghi-Nejad and Irwin Goldstein NUMBER TITLE NUMBER TITLE MP51-01 LH SUPPRESSION AND SERUM TESTOSTERONE IS POSITIVELY ASSOCIATED WITH FEWER HYPOGONADAL SYMPTOMS IN MEN ON TESTOSTERONE SUPPLEMENTATION Jason Scovell*, Christina Mai, Michael Mederos, Ranjith Ramasamy, Dolores Lamb, Larry Lipshultz, Houston, TX MP51-06 INCREASED PREVALENCE OF HYPOPROLACTINEMIA IN MEN TAKING TESTOSTERONE SUPPLEMENTATION THERAPY Aravind Chandrashekar*, Tariq Hakky, Jason Scovell, Ranjith Ramasamy, Alexander Pastuszak, Dolores Lamb, Larry Lipshultz, Houston, TX MP51-02 PREVALENCE OF LOW TESTOSTERONE IN A POPULATION BASED, NATIONALLY REPRESENTATIVE SURVEY James Dupree*, Chang He, Dana Ohl, Ann Arbor, MI, Larry Lipshultz, Houston, TX, Aruna Sarma, Ann Arbor, MI MP51-03 TESTOSTERONE STUDIES: REAL-WORLD METHODOLOGICAL CHALLENGES Kelly A. Chiles*, Christian J. Nelson, Keith O Brien, John P. Mulhall, New York, NY MP51-04 ASSOCIATION BETWEEN TESTOSTERONE, VITAMIN D AND CARDIOVASCULAR RISK Rupa Iyengar*, Cynara Maceda, Heather Beebe, Laura Crowley, New York, NY, Mark Woodward, Oxford, United Kingdom, Natan Bar-chama, Mary Ann McLaughlin, New York, NY MP51-05 DEFINING THE INCIDENCE OF POLYCYTHEMIA IN MEN USING INTRAMUSCULAR TESTOSTERONE SUPPLEMENTATION Serkan Deveci*, Patrick Teloken, Keith O Brien, Patricia Guhring, Marilyn Parker, Joseph Narus, John P. Mulhall, New York, NY MP51-07 DEVELOPMENT OF DE NOVO HYPOGONADISM IN PATIENTS UNDERGOING RENAL SURGERY FOR CORTICAL NEOPLASM: A MULTICENTER ANALYSIS Omer Raheem*, Song Wang, Hak Lee, Jason Woo, San Diego, CA, Reza Mehrazin, Jim Wan, Anthony Patterson, Tennessee, TN, Ithaar Derweesh, San Diego, CA MP51-08 CURRENT PRACTICES OF MEASURING AND REFERENCE RANGE REPORTING OF FREE AND TOTAL TESTOSTERONE IN THE UNITED STATES Margaret Le*, David Flores, Eric Gourley, Danica May, Ajay Nangia, Kansas City, KS MP51-09 CHARACTERIZING TESTOSTERONE AND BONE DENSITY PROFILES OF MEN AFTER STEM CELL TRANSPLANT Kelly A. Chiles*, Molly Maloy, Kara Mosesso, Christian J. Nelson, Ann Jakubowski, John P. Mulhall, New York, NY MP51-10 DYSLIPIDEMIA AND OTHER METABOLIC SYNDROME TRAITS ARE ASSOCIATED WITH LOW TESTOSTERONE LEVEL IN MEN REGARDLESS THEIR AGE Amanda Soares, Feira de Santana, Brazil, Fabio Torricelli, Sao Paulo, Brazil, Ricardo Tiraboschi*, Victor Paschoalin, Carlos Belucci, Jose Murillo Bastos-Netto, Feira de Santana, Brazil, Cristiano Gomes, Sao Paulo, Brazil, Jose Bessa, Jr., Feira de Santana, Brazil *Presenting author 159

172 MP51-11 DOES HYPOGONADISM (OR LOW T) PRESENT DIFFERENTLY IN THE INFERTILE MALE? Helen R Levey*, Janet E Kukreja, Rochester, NY, Ranjith Ramasamay, Houston, TX, Victor Kucherov, Justin Budnik, Chunkit Fung, David Gentile, Jeanne Obrien, Rochester, NY MP51-12 LOW SERUM TESTOSTERONE LEVEL IS ASSOCIATED WITH BRACHIAL-ANKLE PULSE WAVE VELOCITY IN PATIENTS WITH SYMPTOM OF LATEONSET HYPOGONADISM Akira Tsujimura*, Shin-ichi Hisasue, Bunkyo- Ku, Tokyo, Japan, Yoshiaki Kumamoto, Kazuhiro Kobayashi, Tokyo, Japan, Shigeo Horie, Bunkyo-Ku, Tokyo, Japan MP51-13 BULBOCAVERNOSUS MUSCLE AREA AS A MARKER OF ANDROGENIZATION Nikhil Gupta*, New Hyde Park, NY, Amin Herati, New York, NY, Yuki Yamashita, New Hyde Park, NJ, Bruce Gilbert, New Hyde Park, NY MP51-14 CONTEMPORARY PRESCRIBING PATTERNS OF TESTOSTERONE REPLACEMENT THERAPY IN HYPOGONADAL PATIENTS WITH A HISTORY OF PROSTATE CANCER Victor Lizarraga*, Mohit Khera, Houston, TX MP51-15 LARGE PROSTATIC CALCULI MAY WORSEN ERECTILE DYSFUNCTION AND LOWER URINARY TRACT SYMPTOMS IN MIDDLE AGED MEN Sung Dae Kim*, Jung-Sik Huh, Young Joo Kim, Kyung Kgi Park, Jeju, Korea, Republic of, Dong Wan Sohn, Seoul, Korea, Republic of, Hee Jong Kim, Jeju, Korea, Republic of MP51-16 ABNORMAL CALCULATED FREE TESTOSTERONE DOES NOT PREDICT EJACULATORY DYSFUNCTION OR SEXUAL SATISFACTION Michael Kottwitz*, Springfield, IL, Joel F Koenig, St. Louis, MO, Bradford Stevenson, Randy Sulaver, Georgia Mueller, Tobias S Kohler, Springfield, IL MP51-17 ORGASMIC FUNCTION RELIES ON TESTOSTERONE LEVELS - RESULTS OF A CROSS-SECTIONAL STUDY IN MEN SEEKING MEDICAL HELP FOR ERECTILE DYSFUNCTION Eugenio Ventimiglia*, Paolo Capogrosso, Luca Boeri, Alessandro Serino, Giovanni La Croce, Giulia Castagna, Angela Pecoraro, Marco Paciotti, Roberta Scano, Dana Kuefner, Milan, Italy, Rocco Damiano, Catanzaro, Italy, Francesco Montorsi, Andrea Salonia, Milan, Italy MP51-18 ONE OUT OF TEN PATIENTS SUBMITTED TO RADICAL PROSTATECTOMY COMPLAINS OF POSTOPERATIVE PAINFUL ORGASM Paolo Capogrosso*, Alessandro Serino, Luca Boeri, Giovanni La Croce, Eugenio Ventimiglia, Angela Pecoraro, Marco Paciotti, Giulia Castagna, Elena Farina, Giorgio Gandaglia, Alberto Briganti, Milan, Italy, Rocco Damiano, Catanzaro, Italy, Francesco Montorsi, Andrea Salonia, Milan, Italy MP51-19 COLOR DUPLEX DOPPLER ULTRASOUND (CDDU): CAN WE CATEGORIZE CAVERNOUS VENOUS OCCLUSIVE DISEASE (CVOD) AS MILD, MODERATE AND SEVERE? Ram Pathak*, Russell Chavers, Bhupendra Rawal, Gregory Broderick, Jacksonville, FL MP51-20 AN ENHANCED ULTRASOUND TECHNIQUE FOR FUNCTIONAL EVALUATION OF SPERMATOGENESIS Yuki Yamashita*, Amin S. Herati, Gideon Richards, Oksana Yaskiv, Sleiman R. Ghorayeb, Bruce R. Gilbert, New Hyde Park, NY Sunday, May 17, 2015 Moderated Poster Session 52 SEXUAL FUNCTION/DYSFUNCTION/ANDROLOGY: BASIC RESEARCH I Room New Orleans Morial Convention Center Moderators: Trinity Bivalacqua and Run Wang 1:00 pm - 3:00 pm NUMBER TITLE NUMBER TITLE MP52-01 NANOTECHNOLOGY IMPROVED ADIPOSE DERIVED STEM CELL THERAPY IN ERECTILE DYSFUNCTION IN POST RADICAL PROSTATECTOMY ANIMAL MODEL Haocheng Lin*, Nadeem Dhanani, Hubert Tseng, Glauco Souza, Run wang, Houston, TX MP52-02 REGENERATION OF RAT CORPUS CAVERNOSA TISSUE AFTER TRANSPLANTATION OF CD 133 CELLS DERIVED FROM HUMAN BONE MARROW AND PLACEMENT OF BIODEGRADABLE GEL SPONGE SHEET Shogo Inoue*, Shunsuke Shinmei, Koichi Shoji, Mitsuru Kajiwara, Jun Teishima, Akio Matsubara, Hiroshima, Japan 160

173 MP52-03 THE PERICYTES AS A CELLULAR REGULATOR OF PENILE ERECTION AND A NOVEL THERAPEUTIC TARGET FOR ERECTILE DYSFUNCTION Guo Nan Yin, Nando Dulal Das, Min Ji Choi, Kang-Moon Song, Mi-Hye Kwon, Jiyeon Ock, Anita Limanjaya, Kalyan Ghatak, Woo Jean Kim, Soo-Hwan Park, Incheon, Korea, Republic of, Jae Seog Hyun, Jinju, Korea, Republic of, Ji-Kan Ryu*, Jun-Kyu Suh, Incheon, Korea, Republic of MP52-04 SELECTIVE 1A -ADRENERGIC MODULATION ENHANCES ERECTILE RESPONSES IN RATS AFTER CAVERNOUS NERVE INJURY AND IMPROVES NEUROGENIC AND PDE5 INHIBITOR RESPONSES IN HUMAN AND RAT CAVERNOSAL TISSUE Juan Ignacio Martínez-Salamanca*, Madrid, Spain, José M La Fuente, Porto, Portugal, Eduardo Martínez-Salamanca, Argentina Fernández, Madrid, Spain, Augusto J Pepe- Cardoso, Amadora, Portugal, Joaquín Carballido, Javier Angulo, Madrid, Spain MP52-05 BILATERAL CAVERNOUS NERVE INJURY INDUCES TEMPORAL INCREASE OF TNF- AND RECRUITMENT OF MACROPHAGES IN THE MAJOR PELVIC GANGLION IN VIVO Hotaka Matsui*, Johanna L. Hannan, Baltimore, MD, Maarten Albersen, Emmanuel Weyne, Leuven, Belgium, Xiaopu Liu, Arthur L. Burnett, Ahmet Hoke, Trinity J. Bivalacqua, Baltimore, MD MP52-06 LOW INTENSITY EXTRACORPORAL SHOCK WAVES THERAPY IMPROVES ERECTILE FUNCTION IN DIABETIC TYPE II RATS INDEPENDENTLY OF NO/CGMP PATHWAY Rana Assaly, Miguel Laurin, Diane Gorny, Montigny-le-Bretonneux, France, Micheline Kergoat, Chilly Mazarin, France, Jacques Bernabé, Montigny-Le-Bretonneux, France, Yoram Vardi, Haifa, Israel, Francois Giuliano, Garches, France, Delphine Behr-Roussel*, Montigny-Le-Bretonneux, France MP52-07 EXPRESSION AND DISTRIBUTION OF CANNABINOID RECEPTORS IN THE HUMAN SEMINAL VESICLES Giovanni la Croce, Ariana Bettiga, Massimo Freschi, Francesco Montorsi, Milano, Italy, Markus Kuczyk, Stefan Ückert*, Hannover, Germany, Petter Hedlund, Milano, Italy MP52-08 SAC-1004, A VASCULAR LEAKAGE BLOCKER, RESTORES ERECTILE FUNCTION BY ENHANCING HEALTHY ANGIOGENESIS IN THE STREPTOZOTOCIN-INDUCED DIABETIC MOUSE Kang-Moon Song, Dulguun Batbold, Soo- Hwan Park*, Jin-Mi Park, Mi-Hye Kwon, Anita Limanjaya, Kalyan Ghatak, Jiyeon Ock, Guo Nan Yin, Ji-Kan Ryu, Jun-Kyu Suh, Incheon, Korea, Republic of MP52-09 HUMAN TISSUE KALLIKREIN 1 IMPROVES ERECTILE FUNCTION OF AGED RAT BY ACTIVATION OF NITRIC OXIDE/CYCLIC GUANOSINE MONOPHOSPHATE AND INHIBITION OF RHO-KINASE SIGNALINGS IN THE CORPUS CAVERNOSUM Yang Luan, Tao Wang, Ya Ruan*, Yan Zhang, Jun Yang, Ming Li, Rui Chen, Shao Wang, Ji Liu, Zhang Ye, Wuhan, China, People s Republic of MP52-10 GENOME-WIDE PROFILING OF LONGNONCODING RIBONUCLEIC ACID EXPRESSION PATTERNS IN CORPUS CAVERNOSUM OF DIABETIC RATS WITH ERECTILE DYSFUNCTION BY MICROARRAY Wen Song, Yang Luan*, Jun Yang, Rui Chen, Qing Ling, Ming Li, Tao Wang, Shao Wang, Ji Liu, Zhang Ye, Wuhan, China, People s Republic of MP52-11 ASSOCIATION OF URINARY PTHALATE METABOLITES WITH ERECTILE DYSFUNCTION IN DIFFERENT RACIAL AND ETHNIC GROUPS IN THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES) David S. Lopez*, Houston, TX, Konstantinos T. Tsilidis, Ioannina, Greece, Shailesh Advani, Run Wang, Mike Hernandez, Elaine Symanski, Steven Canfield, Houston, TX MP52-12 MECHANISM OF CAVERNOUS NERVE REGENERATION BY SONIC HEDGEHOG Christopher Bond, Chicago, IL, Daniel Harrington, Houston, TX, Samuel Stupp, Carol Podlasek*, Chicago, IL MP52-13 THE EFFECT OF PARTIAL BLADDER OUTLET OBSTRUCTION (PBOO) SEVERITY AND HYPERCHOLESTEROLEMIA ON ERECTILE FUNCTION IN RATS Serap Gur*, Nur Bayatli, Didem Yilmaz, Ankara, Turkey MP52-14 EXPRESSIONS OF VAGINAL PHOSPHODIESTERASE 5 AND NITRIC OXIDE SYNTHASE IN FEMALE SEXUAL DYSFUNCTION Kang Jun Cho*, Jang Hwan Kim, Seoul, Korea, Republic of, Jong Bo Choi, Suwon, Korea, Republic of, Seung-June Oh, Kyu-Sung Lee, Myung-Soo Choo, Seoul, Korea, Republic of, Young Ho Kim, Bucheon, Korea, Republic of, Joon Chul Kim, Seoul, Korea, Republic of MP52-15 MICROSCOPIC EVALUATION OF TISSUE REMODELING AFTER PENILE GIRTH ENHANCEMENT USING BIODEGRADABLE SCAFFOLDS Miroslav Djordjevic*, Uros Bumbasirevic, Tamara Kravic, Tamara Martinovic, Marta Bizic, Vladimir Kojovic, Marko Majstorovic, Borko Stojanovic, Belgrade, Serbia SUNDAY *Presenting author 161

174 MP52-16 TESTOSTERONE REGULATES THE EXPRESSION AND FUNCTIONAL ACTIVITY OF SPHINGOSINE-1- PHOSPHATE RECEPTORS IN THE RAT CORPUS CAVERNOSUM Xinhua Zhang*, Wuhan, China, People s Republic of, Michael DiSanto, Camden, NJ, Wenhao Zhang, Ping Chen, Wuhan, China, People s Republic of MP52-17 EXPRESSION AND DISTRIBUTION OF THE TRANSIENT RECEPTOR POTENTIAL CATIONIC CHANNEL A1 (TRPA1) IN HUMAN PENILE ERECTILE TISSUE AND THE SEMINAL VESICLES Stefan Ückert*, Hannover, Germany, Andreas Bannowsky, Osnabrück, Germany, Markus Kuczyk, Hannover, Germany, Petter Hedlund, Milano, Italy MP52-18 ROLE OF FIBROBLAST GROWTH FACTOR RECEPTORS IN LEYDIG CELL DEVELOPMENT Andres Correa*, Kenneth Walker, Daniel Bushnel, Caitlin Schaefer, Julia Schaffer, Carlton Bates, Pittsburgh, PA MP52-19 NOVEL MUTATIONS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE IN CHINESE PATIENTS WITH CONGENITAL ABSENCE OF VAS DEFERENS Yan Zhang*, Ping Yuan, Xiaojian Yang, Qipeng Sun, Xiao Wu, Hao Zhang, Bin Zhang, Xin Gao, Guangzhou, China, People s Republic of MP52-20 EFFECTS OF VITAMIN D RESTRICTION DURING PERI AND POSTNATAL LIFE ON PENIS MORPHOLOGY IN WISTAR RATS OFFSPRING Flavia Fernandes-Lima, Pamella Campos- Silva, Diogo B. De Souza, Waldemar S. Costa, Francisco J. B. Sampaio, Bianca M. Gregorio*, Rio de Janeiro, Brazil, Fernanda A. M. Nascimento, MACAÉ, Brazil Sunday, May 17, 2015 Moderated Poster Session 53 PROSTATE CANCER: STAGING I Room New Orleans Morial Convention Center Moderators: Murugesan Manoharan and Steven Canfield 1:00 pm - 3:00 pm NUMBER TITLE NUMBER TITLE MP53-01 THE RELATIONSHIP OF OBESITY, PATHOLOGIC GLEASON GRADE AND PROSTATE CANCER TUMOR VOLUME AT THE TIME OF RADICAL PROSTATECTOMY RESULTS FROM THE SEARCH DATABASE Zachary Klaassen*, Augusta, GA, Lauren E. Howard, Durham, NC, Martha K. Terris, Augusta, GA, William J. Aronson, Los Angeles, CA, Matthew R. Cooperberg, San Francisco, CA, Christopher L. Amling, Portland, OR, Christopher J. Kane, San Diego, CA, Stephen J. Freedland, Durham, NC MP53-02 IS CLINICAL STAGE T2C PROSTATE CANCER INTERMEDIATE OR HIGH-RISK DISEASE? Zachary Klaassen*, Augusta, GA, Abhay A. Singh, Lauren E. Howard, Durham, NC, Zhaoyong Feng, Bruce Trock, Baltimore, MD, Martha K. Terris, Augusta, GA, William J. Aronson, Los Angeles, CA, Matthew R. Cooperberg, San Francisco, CA, Christopher L. Amling, Portland, OR, Christopher J. Kane, San Diego, CA, Alan Partin, Misop Han, Baltimore, MD, Stephen J. Freedland, Durham, NC MP53-03 MULTIPARAMETRIC MRI IMPROVES PREDICTIVE ACCURACY OF CLINICAL NOMOGRAMS FOR EXTRACAPSULAR EXTENSION OF PROSTATE CANCER Tom Feng*, Ali Afshar, Los Angeles, CA, Steven Smith, Richmond, VA, Jonathan Wu, Daniel Luthringer, Rola Saouaf, Hyung Kim, Los Angeles, CA MP53-04 SIGNIFICANT INTER-INSTITUTIONAL VARIATIONS IN RACIAL DISPARITIES AMONG AFRICAN-AMERICAN MEN ELIGIBLE FOR PROSTATE CANCER ACTIVE SURVEILLANCE Michael Dinizo*, Weichung Shih, Amirali Salmasi, Izak Faiena, Parth Modi, New Brunswick, NJ, Misop Han, Alan W. Partin, Baltimore, MD, Daniel Eun, Adam Reese, Elton Llukani, Laura Giosto, Sean Wessel, Edourad Trabulsi, Costas Lallas, Philadelphia, PA, Bertram Yuh, Timothy Wilson, Duarte, CA, Daniel Marchalik, Jonathan Hwang, Washington, DC, Shilajit Kundu, William Catalona, Drew Flum, Scott Eggener, Edris Negron, Chicago, IL, Isaac Yi Kim, New Brunswick NJ, NJ 162

175 MP53-05 PREDICTIVE VALUE OF TERTIARY GLEASON SCORE Domenico Gabriele, Torino, Italy, Enrico Bollito, Francesco Porpiglia, Orbassano, Italy, Paolo Gontero, Torino, Italy, Fabio Venzano, Cuneo, Italy, Delia Genesi, Cirié, Italy, Marco Manzo, Alessandro Giacobbe*, Caterina Guiot, Torino, Italy MP53-06 DOES PATHOLOGIC UPSTAGING FROM CLINICAL LOW-RISK PROSTATE CANCER CONFER WORSE SURVIVAL? Evan Kovac*, Chad Reichard, Andrew Stephenson, Cleveland, OH MP53-07 NEED FOR A SURGICAL TEMPLATE IN SALVAGE LYMPHADENECTOMY FOR NODAL RECURRENCE OF PROSTATE CANCER: IS PELVIC INVOLVEMENT PREDICTIVE OF RETROPERITONEAL POSITIVITY? Guglielmo Melloni, Marco Oderda, Marco Falcone, Stefania Munegato, Turin, Italy, Hannes Van De Bosche, Steven Deconinck, Leuven, Belgium, Fabio Zattoni, Robert Jeffrey Karnes, Rochester, MN, Steven Joniau, Leuven, Belgium, Paolo Gontero*, Turin, Italy MP53-08 THE DIAGNOSTIC VALUE OF 68 GA- LABELLED PSMA-LIGAND PET/CT IN MEN WITH RECURRENT PROSTATE CANCER Boris Hadaschik*, Ali Afshar-Oromieh, Jan Radtke, Silvan Boxler, Matthias Eder, Klaus Kopka, Jürgen Debus, Markus Hohenfellner, Uwe Haberkorn, Heidelberg, Germany MP53-09 A SIMPLER MODIFIED GLEASON SCORE PERFORMS SLIGHTLY BETTER THAN THE STANDARD ONE Domenico Gabriele, Torino, Italy, Enrico Bollito, Orbassano, Italy, Carlo Terrone, Paolo De Angelis, Novara, Italy, Alessandro Giacobbe*, Torino, Italy, Luca Bellei, Ivrea, Italy, Manuela Graziano, Asti, Italy, Patrizia Gamba, Torino, Italy, Pietro Gabriele, Candiolo, Italy MP53-10 PREOPERATIVE MP-MRI IN PATIENTS WITH LOCALIZED PROSTATE CANCER: IS THERE A ROLE IN THE BEST CHOICE OF THERAPEUTIC APPROACH? Francesco Porpiglia, Matteo Manfredi*, Fabrizio Mele, Orbassano (Turin), Italy, Filippo Russo, Daniele Regge, Candiolo (Turin), Italy, Agostino De Pascale, Orbassano (Turin), Italy, Stefano Cirillo, Torino, Italy, Enrico Bollito, Mauro Papotti, Cristian Fiori, Orbassano (Turin), Italy MP53-11 CLOSE SURGICAL MARGINS AFTER RADICAL PROSTATECTOMY MIMIC BIOCHEMICAL RECURRENCE RATES OF POSITIVE MARGINS Edan Shapiro, Michael Whalen*, New York, NY, William Berg, Stony Brook, NY, Michael Rothberg, Valhalla, NY, Solomon Woldu, Arindam RoyChoudhury, Ari Bergman, New York, NY, Trushar Patel, Tampa, FL, Ketan Badani, New York, NY MP53-12 LONG TERM ONCOLOGICAL OUTCOMES OF APICAL POSITIVE SURGICAL MARGINS AT RADICAL PROSTATECTOMY IN THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) COHORT Harpreet Wadhwa*, Chicago, IL, Martha Terris, Augusta, GA, William Aronson, Los Angeles, CA, Christopher Kane, La Jolla, CA, Christopher Amling, Portland, OR, Matthew Cooperberg, San Francisco, CA, Stephen Freedland, Durham, NC, Michael Abern, Chicago, IL MP53-13 IS DOMINANT TUMOR NODULE SIZE A SIGNIFICANT PREDICTOR OF ADVERSE OUTCOME IN PROSTATE CANCER? A STUDY OF 487 WHOLE MOUNT RADICAL PROSTATECTOMY CASES Laura Favazza*, Alpa Shah, Sean Williamson, Mireya Diaz-Insua, Craig Rogers, Hans Stricker, James Peabody, Mani Menon, Nilesh Gupta, Detroit, MI MP53-14 VITAMIN D DEFICIENCY PREDICTS ADVERSE PATHOLOGY AT TIME OF RADICAL PROSTATECTOMY Diana K. Bowen*, Gregory A. Jordan, Tyler J. Maiers, Chicago, IL, Rick A. Kittles, Tucson, AZ, Adam B. Murphy, Chicago, IL MP53-15 BIOPSY RESULTS AMONG MEN UNDERGOING REPEAT MRI- ULTRASOUND FUSION TARGETED BIOPSIES Michael Fenstermaker*, Neil Mendhiratta, Xiaosong Meng, Andrew B. Rosenkrantz, Richard Huang, Fang-Ming Deng, Ming Zhou, William C. Huang, Herbert Lepor, Samir S. Taneja, New York, NY MP53-16 ONCOLOGIC OUTCOMES IN MEN WITH METASTASIS TO THE PROSTATIC ANTERIOR FAT PAD LYMPH NODES: A MULTI-INSTITUTION INTERNATIONAL STUDY Isaac Kim*, New Brunswick, NJ, Yun-Sok Ha, Daegu, Korea, Republic of, Parth Modi, Amirali Salmasi, Jaspreet Parihar, Neal Patel, Izak Faiena, Michael May, New Brunswick, NJ, Daivd Lee, Elton Llukani, Philadelphia, PA, Tuliao Patrick, Koon Ho Rha, Seoul, Korea, Republic of, Thomas Ahlering, Douglas Skarecky, Orange, CA, Hanjong Ahn, Seung- Kwon Choi, Seoul, Korea, Republic of, Sejun Park, Ulsan, Korea, Republic of, Seong Soo Jeon, Seoul, Korea, Republic of, Yen-Chuan Ou, Taichung, Taiwan, Daniel Eun, Varsha Manucha, Philadelphia, PA, David Albala, Syracuse, NY, Ketan Badani, New York, NY, Bertram Yuh, Nora Ruel, Duarte, CA, Tae Gyun Kwon, Daegu, Korea, Republic of, Daniel Marchalik, Jonathan Hwang, Washington, DC, Wun-Jae Kim, Cheongju, Korea, Republic of SUNDAY *Presenting author 163

176 MP53-17 CLINICAL VALIDATION OF THE 2005 ISUP GLEASON GRADING SYSTEM IN A COHORT OF INTERMEDIATE AND HIGH RISK MEN UNDERGOING RADICAL PROSTATECTOMY Ashley Ross, Stephania Bezerra, Sheila Faraj, Baltimore, MD, Kasra Yousefi, Vancouver, Canada, Helen Fedor, Stephanie Glavaris, Misop Han, Alan Partin, Elizabeth Humphreys, Jeffrey Tosoian, Michael H. Johnson, Baltimore, MD, Elai Davicioni, Vancouver, Canada, Bruce Trock, Edward Schaeffer, George Netto*, Baltimore, MD MP53-18 ASSOCIATION BETWEEN A 17-GENE GENOMIC PROSTATE SCORE AND MULTI- PARAMETRIC PROSTATE MRI IN MEN WITH LOW AND INTERMEDIATE RISK PROSTATE CANCER (PCA) Michael Leapman*, Antonio Westphalen, Niloufar Ameli, San Francisco, CA, Jeffrey Lawrence, Phillip Febbo, Redwood City, CA, Matthew Cooperberg, Peter Carroll, San Francisco, CA MP53-19 GENETIC BASIS FOR A GREATER PROGRESSION RATE TO A HIGHER GRADE OF LOW RISK PROSTATE CANCER AMONG AFRICAN AMERICANS COMPARED TO EUROPEAN AMERICANS: IMPACT ON ACTIVE SURVEILLANCE RECOMMENDATIONS Isaac Powell*, Greg Dyson, Aliccia Bollig- Fischer, Detroit, MI MP53-20 ACCURACY OF MRI-TARGETED BIOPSY TO RECLASSIFY GLEASON GRADE IN MEN ON ACTIVE SURVEILLANCE Pedro Recabal*, Melissa Assel, Dan Lee, Oguz Akin, Jonathan Coleman, Alan Thong, Justin Lee, James Eastham, Evis Salas, Peter Scardino, Alberto Vargas, Behfar Ehdaie, New YOrk, NY Sunday, May 17, 2015 Podium Session 28 URODYNAMICS/INCONTINENCE/FEMALE UROLOGY: FEMALE INCONTINENCE - THERAPY II Room New Orleans Morial Convention Center Moderators: Jerry Blaivas and Angelo Gousse TIME NUMBER TITLE TIME NUMBER TITLE 1:00 PD28-01 STILL DRY! LONGEVITY OF DEFLUX URETHRAL BULKING INJECTIONS FOR URINARY STRESS INCONTINENCE Catherine Hobbs*, Steve Foley, Reading, United Kingdom 1:10 PD28-02 MANAGEMENT OF URINARY INCONTINENCE IN WOMEN AFTER ORTHOTOPIC NEOBLADDER DIVERSION George Bailey*, Andrew Blackburne, Deborah Lightner, Rochester, MN 1:20 PD28-03 TEACHING MID-URETHRAL SLING SURGERY TO RESIDENTS: IS IT SLOWING US DOWN? Ali Reza Sharif Afshar*, Lauren Wood, Los Angeles, CA, Jennifer Anger, Beverly Hills, CA, Catherine Bresee, Los Angeles, CA, Bruno Gross, Bryan, TX, Eugene Shkolyar, Los Angeles, CA, Karyn Eilber, Beverly Hills, CA 1:30 PD28-04 MANAGEMENT OF COMPLICATIONS IN USE OF URETHRAL BULKING AGENTS IN WOMEN FOR STRESS URINARY INCONTINENCE A SYSTEMATIC- ANALYSIS Majdee Islam, Columbia, MO, Harpreet Wadhwa*, Ryan Dobbs, Ervin Kocjancic, Chicago, IL 1:00 pm - 3:00 pm 1:40 PD28-05 LONG-TERM OUTCOMES OF MIDURETHRAL AND PUBOVAGINAL SLINGS FOR STRESS URINARY INCONTINENCE IN A TERTIARY REFERRAL SETTING Kevin Gioia*, Katherine Odem-Davis, John Massman III, Erika Wolff, Alvaro Lucioni, Una Lee, Kathleen Kobashi, Seattle, WA 1:50 PD28-06 OUTCOMES OF AUTOLOGOUS RECTUS FASCIA PUBOVAGINAL SLING FOR SEVERE INTRINSIC SPHINCTER DEFICIENCY AND/OR RECURRENT STRESS URINARY INCONTINENCE: UP TO 11-YEAR FOLLOW-UP Eugene W. Lee*, Seattle, WA, Andrew Chang, Stony Brook, NY, Una J. Lee, Alvaro Lucioni, John D. Massman, Erika M. Wolff, Fred E. Govier, Kathleen C. Kobashi, Seattle, WA 2:00 PD28-07 THE IMPACT OF OBESITY ON OUTCOMES AFTER RETROPUBIC MIDURETHRAL SLING FOR FEMALE STRESS URINARY INCONTINENCE Umar Karaman*, Kevin Campbell, Clifton F. Frilot II, Alex Gomelsky, Shreveport, LA 2:10 PD28-08 THE EFFECT OF TIME TO REVISION OF AN OBSTRUCTING SYNTHETIC MID- URETHRAL SLING ON REOPERATION FOR STRESS URINARY INCONTINENCE Nitya Abraham*, Bronx, NY, Iryna Makovey, Ashley King, Howard B. Goldman, Sandip Vasavada, Cleveland, OH 164

177 2:20 PD28-09 A POPULATION BASED ASSESSMENT OF THE RISK FACTORS FOR MESH REMOVAL OR REVISION AFTER FEMALE INCONTINENCE PROCEDURES Blayne Welk*, London, Canada, Hana a Al- Hothi, Doha, Qatar, Jennifer Winick-Ng, London, Canada 2:30 PD28-10 SUCCESS AND COMPLICATIONS OF PUBOVAGINAL SLING WITH HUMAN CADAVERIC DERMAL TISSUE AND WITH A MINIMUM 10-YEAR FOLLOW-UP Serge Marinkovic*, Detroit, MI 2:50 PD28-12 HOLMIUM LASER EXCISON OF GENITOURINARY MESH EXPOSURE FOLLOWING ANTI INCONTINENCE SURGERY: MINIMUM 6 MONTH FOLLOW UP Christina Ogle*, Brian Linder, Daniel Elliott, Rochester, MN 2:40 PD28-11 CHANGES IN URINARY STORAGE SYMPTOMS FOLLOWING SURGICAL TREATMENT FOR FEMALE STRESS URINARY INCONTINENCE Zachary Panfili, William Parker*, Kansas City, KS, Alexander Gomelsky, Shreveport, LA, Priya Padmanabhan, Kansas City, KS SUNDAY Sunday, May 17, 2015 Podium Session 29 KIDNEY CANCER: SURGICAL THERAPY I Room New Orleans Morial Convention Center Moderators: Rene Sotelo and Abhay Rane 1:00 pm - 3:00 pm TIME NUMBER TITLE TIME NUMBER TITLE 1:00 PD29-01 PREDICTING RENAL PARENCHYMAL LOSS FOLLOWING NEPHRON SPARING SURGERY Solomon Woldu*, Alexa Meyer, Aaron Weinberg, Justin Matulay, New York, NY, Gregory Thoreson, Dallas, TX, Phillip Pierorazio, Baltimore, MD, Mitchell Benson, G. Joel DeCastro, James McKiernan, New York, NY 1:10 PD29-02 SURGICAL MANAGEMENT OF RENAL CELL CARCINOMA IN OCTOGENARIANS AND NONAGENARIANS: DEFINING APPROPRIATE TREATMENT STANDARDS Zachary Klaassen*, Rita P. Jen, Augusta, GA, John M. DiBianco, Roseau, Dominica, Lael Reinstatler, Daniel Belew, Qiang Li, Rabii Madi, Martha K. Terris, Augusta, GA 1:20 PD29-03 NEPHROMETRY SCORES AND THEIR RELATION TO PERI-OPERATIVE AND POST-OPERATIVE OUTCOMES AFTER ROBOTIC PARTIAL NEPHRECTOMY Renato B Corradi, Emily Vertosick, Daniel P Nguyen, Antoni Vilaseca, Daniel D Sjoberg, Maximiliano Spaliviero, Karim A Touijier, Paul Russo, Jonathan A Coleman, Renato Corradi*, New York, NY 1:30 PD29-04 HISPANO-AMERICAN EXPERIENCE IN MINIMALLY INVASIVE PARTIAL NEPHRECTOMY Fernando Pablo Secin*, Buenos Aires, Argentina, Octavio Castillo Cadiz, Santiago de Chile, Chile, Patricio Aitor García Marchiñena, Alberto Jurado Navarro, Agustin Rovegno, Anamaria Autran, Buenos Aires, Argentina, Oscar Rodriguez Faba, Joan Palou Redorta, Barcelona, Spain, Jose Rozanec, Marcelo Featherstone, Pablo Holst, Buenos Aires, Argentina, Luciano Nuñez Bragayrac, Rene Sotelo, Caracas, Venezuela, Ricardo Faveretto, Stenio Zequi, San Pablo, Brazil, Mario Álvarez Maestro, Luis Martinez Piñeiro, Madrid, Spain, Gustavo Villoldo, Alberto Villaronga, Buenos Aires, Argentina, Diego Abreu Clavijo, Montevideo, Uruguay, Ivar Vidal Mora, Santiago de Chile, Chile, Diana Finkelstein, Juan Ignacio Monzo Gardiner, Buenos Aires, Argentina, Oscar Schatloff, Santiago de Chile, Chile, Andres Hernandez Porras, Tijuana, Mexico, Félix Santaella Torres, Distrito Federal, Mexico, Rodolfo Sanchez Salas, Hugo Alberto Davila, Caracas, Venezuela, Humberto Villavicencio Mavrich, Barcelona, Spain 1:40 PD29-05 MAJOR UROLOGIC PROCEDURES IN JEHOVAH S WITNESS POPULATION: A STUDY OF SAFETY AND FEASIBILITY Siamak Daneshmand*, Los Angeles, CA, Antoin Douglawi, Alhambra, CA *Presenting author 165

178 1:50 PD29-06 ONCOLOGIC SURVEILLANCE FOLLOWING SURGICAL RESECTION FOR RENAL CELL CARCINOMA: A NOVEL RISK-BASED APPROACH Suzanne Stewart*, R. Houston Thompson, Stephen Boorjian, Sarah Psutka, Christine Lohse, John Cheville, Bradley Leibovich, Igor Frank, Rochester, MN 2:00 PD29-07 AGE IS THE PRIMARY PREDICTOR OF RENAL MASS OBSERVATION Matthew Maurice*, Robert Abouassaly, Simon Kim, Hui Zhu, Cleveland, OH 2:10 PD29-08 PREDICTIVE FACTORS FOR THE DEVELOPMENT OF RENAL INSUFFICIENCY FOLLOWING PARTIAL NEPHRECTOMY AND SUBSEQUENT RENAL FUNCTION RECOVERY Kyo Chul Koo, Dae Keun Kim*, Sang Un Park, Kwang Hyun Kim, Seoul, Korea, Republic of, Woo Jin Bang, Chuncheon, Korea, Republic of, Hyung Joon Kim, Daejeon, Korea, Republic of, Sung Yul Park, Seoul, Korea, Republic of, Changhee Yoo, Chuncheon, Korea, Republic of, Byung Ha Chung, Seoul, Korea, Republic of, Jin Seon Cho, Chuncheon, Korea, Republic of, Koon Ho Rha, Seoul, Korea, Republic of 2:20 PD29-09 EXTENDED FOLLOW-UP OF CHRONIC KIDNEY DISEASE DUE TO SURGICAL REMOVAL OF NEPHRONS: IMPACT ON SURVIVAL AND FUNCTIONAL STABILITY Sevag Demirjian*, Cleveland, OH, Brian Lane, Grand Rapids, MI, Ithar Derweesh, La Jolla, CA, Toshio Takagi, Zhiling Zhang, Liliya Velet, Cesar Ercole, Amr Fergany, Steven Campbell, Cleveland, OH 2:30 PD29-10 ONCOLOGIC OUTCOMES AFTER PARTIAL NEPHRECTOMY WITHOUT HILAR CLAMPING Rocco Papalia*, Giuseppe Simone, Mariaconsiglia Ferriero, Riccardo Mastroianni, Costantini Manuela, Del Giudice Francesco, Rome, Italy, Al-Rawashdah Samer Fathi, Maw tah, Jordan, Pompeo Vincenzo, Salvatore Guaglianone, Gallucci Michele, Rome, Italy 2:40 PD29-11 RELATIONSHIP BETWEEN RENAL OXYGENATION AND FUNCTION AFTER PARTIAL NEPHRECTOMY Satoshi Inoue*, Yasuhito Funahashi, Naoto Sassa, Yasushi Yoshino, Ryohei Hattori, Momokazu Gotoh, Nagoya, Japan 2:50 PD29-12 COMPARISON OF ONCOLOGICAL OUTCOMES OF DISTAL URETERAL PT2 UROTHELIAL CARCINOMA MANAGED BY NEPHROURETERECTOMY, SEGMENTAL URETERECTOMY OR ENDOSCOPIC SURGERY Laurent Nison*, Pierre Colin, Lille, France, Mesut Remzi, Korneuburg, Austria, Shahrokh F. Shariat, Tobias Klatte, Vienna, Austria, Rachid Yakoubi, Gregory Bozzini, Lille, France, Umberto Capitanio, Milan, Italy, Marek Babjuk, Prague, Czech Republic, Axel. S Merseburger, Hanover, Germany, Eugene Cha, New York, NY, Hans Martin Fritsche, Regensburg, Germany, Giacomo Novara, Padua, Italy, Francesco Montorsi, Milan, Italy, Milan Hora, Prague, Czech Republic, Morgan Rouprêt, Paris, France Sunday, May 17, 2015 Podium Session 30 PROSTATE CANCER: LOCALIZED II Room New Orleans Morial Convention Center Moderators: Thomas Ahlering and Kevin Zorn 1:00 pm - 3:00 pm TIME NUMBER TITLE TIME NUMBER TITLE 1:00 PD30-01 MR-US FUSION BIOPSY TO DIAGNOSE PROSTATE CANCER: FIRST 1000 MEN AT UCLA Christopher Filson*, Daniel Margolis, Jiaoti Huang, Shyam Natarajan, Patricia Lieu, Frederick Dorey, Robert Reiter, Leonard Marks, Los Angeles, CA 1:10 PD30-02 MRI-TRUS GUIDED FUSION BIOPSY TO DETECT PROGRESSION ON ACTIVE SURVEILLANCE FOR LOW AND INTERMEDIATE RISK PROSTATE CANCER Thomas P. Frye*, Nabeel Shakir, Steven Abboud, Arvin K. George, Maria Merino, Peter Choyke, Baris Turkbey, Bradford Wood, Peter A. Pinto, Bethesda, MD 1:20 PD30-03 PREDICTING UNFAVORABLE PROSTATE CANCER IN ACTIVE SURVEILLANCE CANDIDATES TREATED WITH RADICAL PROSTATECTOMY: A POPULATION- BASED STUDY Nicola Fossati, Justin K. Lee, New York, NY, Quoc-Dien Trinh, Boston, MA, Jesse Sammon, Akshay Sood, Detroit, MI, Alessandro Larcher, Marco Bianchi, Giorgio Guazzoni*, Milan, Italy, Pierre I Karakiewicz, Montreal, Canada, Shahrokh F. Shariat, Vienna, Austria, Francesco Montorsi, Alberto Briganti, Milan, Italy, Mani Menon, Firas Abdollah, Detroit, MI 166

179 1:30 PD30-04 COMPARING ONCOLOGIC OUTCOMES OF DIFFERENT DEFINITIVE TREATMENTS FOR PROSTATE CANCER AFTER A PERIOD OF ACTIVE SURVEILLANCE Michael Whalen*, Danny Lascano, Jamie Pak, David Ahlborn, Justin Matulay, James McKiernan, Mitchell Benson, Sven Wenske, New York, NY 1:40 PD30-05 WISDOM OF THE CROWDS: USE OF CROWDSOURCING TO ASSESS SURGICAL SKILL OF ROBOT-ASSISTED RADICAL PROSTATECTOMY IN A STATEWIDE SURGICAL COLLABORATIVE James Peabody*, Detroit, MI, David Miller, Ann Arbor, MI, Brian Lane, Grand Rapids, MI, Richard Sarle, Dearborn, MI, Andrew Brachulis, Susan Linsell, Tae-Kyung Kim, Ann Arbor, MI, Deepansh Dalela, Mani Menon, Detroit, MI, James Montie, Ann Arbor, MI, Bryan Comstock, Tom Lendvay, Seattle, MI, Khurshid Ghani, Ann Arbor, MI 1:50 PD30-06 MORTALITY RISK FACTORS IN EUROPEAN PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY. COMPETING RISK ANALYSIS WITH 15-YEARS FOLLOW UP Katharina Boehm*, Burkhard Beyer, Hamburg, Germany, Alessandro Larcher, Milan, Italy, Jonas Schiffmann, Hamburg, Germany, Pierre Karakiewicz, Montreal, Canada, Georg Salomon, Hartwig Huland, Hamburg, Germany 2:00 PD30-07 ADHERENCE TO EUROPEAN ASSOCIATION OF UROLOGY GUIDELINE RECOMMENDATION FOR PELVIC LYMPH NODE DISSECTION IN AN EUROPEAN HIGH-VOLUME CENTER Sami-Ramzi Leyh-Bannurah*, Jonas Schiffman, Alexander Haese, Georg Salomon, Thomas Steuber, Thorsten Schlomm, Burkhard Beyer, Uwe Michl, Hans Heinzer, Hartwig Huland, Markus Graefen, Lars Budäus, Hamburg, Germany, Pierre Karakiewicz, Montreal, Canada 2:10 PD30-08 CANCER-CONTROL OUTCOMES IN PATIENTS WITH CLINICALLY HIGH-RISK PROSTATE CANCER (PCA) TREATED WITH ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP): A MULTI- INSTITUTIONAL DATABASE ANALYSIS Firas Abdollah*, Akshay Sood, Jesse Sammon, Dane Klett, Daniel Pucheril, Detroit, MI, Burkhard Beyer, Hamburg, Germany, Nicola Fossati, Giorgio Gandaglia, Milan, Italy, Craig Rogers, Hans Stricker, Wooju Jeong, James Peabody, Detroit, MI, Alexander Haese, Hamburg, Germany, Francesco Montorsi, Milan, Italy, Markus Graefen, Hamburg, Germany, Alberto Briganti, Milan, Italy, Mani Menon, Detroit, MI 2:20 PD30-09 THE EFFECT OF ANDROGEN DEPRIVATION THERAPY FOR LOCALIZED PROSTATE CANCER ON CARDIOVASCULAR MORBIDITY ACCORDING TO LIFE EXPECTANCY Marianne Schmid*, Hamburg, Germany, Jesse Sammon, Detroit, MI, Gally Reznor, Boston, MA, Victor Kapoor, Detroit, MI, Jaqueline Speed, Boston, MA, Firas Abdollah, Akshay Sood, Detroit, MI, Felix Chun, Hamburg, Germany, Adam Kibel, Boston, MA, Mani Menon, Detroit, MI, Margit Fisch, Hamburg, Germany, Maxine Sun, Montreal, Canada, Quoc-Dien Trinh, Boston, MA 2:30 PD30-10 EXTERNAL VALIDATION OF THE CAPRA- S SCORE TO PREDICT BIOCHEMICAL RECURRENCE, METASTASIS AND MORTALITY AFTER RADICAL PROSTATECTOMY IN A EUROPEAN COHORT Philipp Mandel*, Burkhard Beyer, Dirk Pehrke, Thorsten Schlomm, Hartwig Huland, Markus Graefen, Derya Tilki, Hamburg, Germany 2:40 PD30-11 FATAL FAMILY HISTORY OF PROSTATE CANCER AND APPARENT MODE OF DISEASE TRANSMISSION: INDEPENDENT PREDICTORS OF RADICAL PROSTATECTOMY OUTCOMES? Kathleen Herkommer*, Simon Heister, Juergen Gschwend, Munich, Germany, Martina Kron, Ulm, Germany 2:50 PD30-12 RACIAL DISPARITIES IN THE SURGICAL CARE OF LOCALIZED PROSTATE CANCER Marianne Schmid*, Hamburg, Germany, Christian Meyer, Gally Reznor, Julian Hanske, Boston, MA, Jesse Sammon, Firas Abdollah, Akshay Sood, Deepansh Dalela, Detroit, MI, Brandon Mahal, Adam Kibel, Boston, MA, Felix Chun, Hamburg, Germany, Paul Nguyen, Boston, MA, Mani Menon, Detroit, MI, Margit Fisch, Hamburg, Germany, Quoc-Dien Trinh, Boston, MA SUNDAY *Presenting author 167

180 Sunday, May 17, 2015 Video Session 7 1:00 pm - 3:00 pm PEDIATRICS The videos in this session as well as the video libraries from the Annual Meetings may be viewed in the Surgical Video Library and purchased in the Products Store during the Annual Meeting. Both are located in Registration Hall B2. All years of the Surgical Video Library may also be purchased online at Room New Orleans Morial Convention Center Moderators: Mohan Gundeti and Richard Schlussel NUMBER TITLE NUMBER TITLE V7-01 BLADDER TRAINING FOR KIDS Mandy Rickard*, Natasha Brownrigg, Jennifer DCruz, Jorge DeMaria, Luis Braga, Hamilton, Canada V7-02 ROBOTIC PARTIAL NEPHRECTOMY FOR A COMPLEX HILAR MASS IN A 14 YEAR OLD BOY Abhishek Srivastava*, Aryeh Keehn, Amanda North, Reza Ghavamian, Bronx, NY V7-03 ROBOT ASSISTED LAPAROSCOPIC RENAL CALYCEAL DIVERTICULECTOMY Joel Koenig*, Saint Louis, MO, Gino Vricella, St. Louis, MO V7-04 MULTI-INSTITUTIONAL BLADDER EXSTROPHY CONSORTIUM: COMPLETE PRIMARY REPAIR OF EXSTROPHY Joseph G. Borer*, Evalynn Vasquez, Anthony J. Schaeffer, Boston, MA, Douglas A. Canning, Philadelphia, PA, John V. Kryger, Michael E. Mitchell, Milwaukee, WI V7-05 IMMEDIATE LAPAROSCOPIC RECONSTRUCTION OF AN ACUTE IATROGENIC VESICO-VAGINAL FISTULA BY A NEO-VAGINAL DILATOR IN A PATIENT WITH MAYER-ROKITANSKY- KÜSTER-HAUSER-SYNDROME Wael Khoder*, Christian Stief, Maximiliane Burgmann, Alexander Burges, Munich, Germany V7-06 ROBOTIC CONVERSION OF CECOSTOMY TUBE TO MALONE ANTEGRADE CONTINENCE ENEMA (ACE), SURGICAL TECHNIQUE Mourad Abouelleil*, Raju Chelluri, Jonathan Riddell, Syracuse, NY V7-07 COMBINED ROBOTIC AND OPEN APPROACH TO EXCISION OF ACCESSORY BLADDER AND URETHRAL TRIPLICATION Diana K. Bowen, Alex P. Glaser*, Jonathan W. Bush, Earl Y. Cheng, Edward M. Gong, Chicago, IL V7-08 ROBOT-ASSISTED LAPAROSCOPIC LOWER TO UPPER PYELOURETEROSTOMY IN THE PEDIATRIC PATIENT Ashley Wietsma*, Patricia Cho, Richard Yu, Boston, MA V7-09 ROBOT-ASSISTED LAPAROSCOPIC URETEROCALICOSTOMY IN THE PEDIATRIC PATIENT Ashley Wietsma*, Patricia Cho, Richard Yu, Boston, MA V7-10 COMBINED LAPAROSCOPIC PYELOLITHOTOMY AND CYSTOLITHOTOMY IN A PEDIATRIC PATIENT Paul Bowlin*, Fahad Alyami, Walid Farhat, Toronto, Canada V7-11 ROBOT-ASSISTED REPAIR OF A CIRCUMCAVAL URETER IN A CHILD Hubert Swana, Celebration, FL, Diego Aguilar*, Orlando, FL, Alberto DuBoy, Tampa, FL, Mark Rich, Orlando, FL V7-12 A NOVEL LAPAROSCOPIC SURGICAL METHOD FOR COEXISTENCE OF TESTICULAR VARICOCELE AND IPSILATERAL HYDROCELE Nobuhiro Takahashi*, Shoji Kudo, Hideki Kobayashi, Satoshi Azuma, Tatsuya Miyamoto, Hidenori Zakohji, Masayuki Takeda, Chuo, Japan V7-13 ROBOTIC ASSISTED LAPAROSCOPIC ORCHIOPEXY: PRELIMINARY RESULTS OF AN INITIAL CASE SERIES Dana Point*, John Michael DiBianco, Osama Al-Omar, Morgantown, WV V7-14 ROBOT-ASSISTED LAPAROSCOPIC NEPHROURETERECTOMY IN A 9-YEAR- OLD GIRL WITH OBSTRUCTED HEMIVAGINA IPISILATERAL RENAL ANOMALY Amanda Saltzman*, Christopher Roth, New Orleans, LA 168

181 Sunday, May 17, :00 pm - 3:00 pm RESEARCH FORUM: SESSION I FUNDING OPPORTUNITIES AND GRANTWRITING GUIDANCE FOR EARLY-CAREER INVESTIGATORS Room New Orleans Morial Convention Center 1:00 COURSE OVERVIEW AND GOALS Carolyn Best 1:05 NIDDK TRAINING & RESEARCH MECHANISMS Tracy Rankin 1:17 DOD/CDMRP FUNDING OPPORTUNITIES FOR UROLOGIC RESEARCH AND TRAINING Melissa Cunningham 1:29 AUA AND UROLOGY CARE FOUNDATION OPPORTUNITIES Carolyn Best 1:41 OTHER EXTERNAL FUNDING SOURCES 1:53 STRATEGIES FOR OBTAINING FUNDING WHEN FUNDS ARE TIGHT/BRIDGE FUNDING Matthew Fraser 2:05 PERSPECTIVES FROM AN EARLY-CAREER INVESTIGATOR William Roberts 2:17 PERSPECTIVES FROM A SENIOR INVESTIGATOR Peter Clark 2:29 Q&A 2:55 CLOSING REMARKS Carolyn Best 3:00 ADJOURN SUNDAY Sunday, May 17, 2015 RESEARCH FORUM: SESSION II EARLY CAREER INVESTIGATOR SHOWCASE Room New Orleans Morial Convention Center 3:00 pm - 5:30 pm 3:00 EARLY CAREER INVESTIGATORS POSTER VIEWING 3:30 PROGRAM INTRODUCTION Carolyn Best 3:35 THE IMPACT OF CARE COORDINATION ON RADICAL PROSTATECTOMY OUTCOMES John Hollingsworth 3:45 A NEWLY IDENTIFIED ROLE FOR INTERLEUKIN-22 IN BLADDER IMMUNITY Michael Hsieh 3:55 THE CUPID STUDY: CARDIO-UROLOGIC PATHOLOGY/PREVALENCE INTERPLAY DETERMINATION STUDY Tobias Kohler 4:05 DEVELOPMENT AND VALIDATION OF THE BLADDER UTILITY SYMPTOM SCALE (BUSS) Girish Kulkarni 4:15 ACCELERATING RECOVERY OF NORMAL URETERAL FUNCTION FOLLOWING OBSTRUCTIVE UROPATHY Dirk Lange 4:25 LOW OSTEOCALCIN LEVELS IS AN INDEPENDENT FACTOR ASSOCIATED WITH ANDROGEN DEFICIENCY Brian Le 4:35 BASELINE PROSTATE SPECIFIC ANTIGEN (PSA) LEVEL IN MIDLIFE PREDICTS LETHAL PROSTATE CANCER Mark Preston 4:45 RESTORING FERTILITY FOR MEN AND BOYS FACING STERILIZING CANCER THERAPY James Smith 4:55 DEVELOPMENTAL TRANSCRIPTION FACTORS AND PROSTATE CANCER PROGRESSION Donald Vander Griend 5:05 AUA/UROLOGY CARE FOUNDATION RESEARCH ACTIVITIES Carolyn Best 5:20 PRESENTATION OF AWARDS 5:30 ADJOURN Sunday, May 17, 2015 SOCIETY FOR INFECTION AND INFLAMMATION IN UROLOGY (SIIU) Room New Orleans Morial Convention Center 1:00 pm - 4:30 pm 1:00 OPENING COMMENTS Society Chair: Dean Tripp 2:10 INTRO OF SIIU INVITED SPEAKERS 1:10 TALKS FROM THE FLOOR *Presenting author 169

182 2:15 THE URINARY TRACT MICROBIOME: WHAT WE THINK WE KNOW Michael Freeman 2:35 THE URINARY TRACT MICROBIOME: WHAT WE RE LEARNING FROM NEXT GENERATION TECHNOLOGIES Jennifer Anger 3:10 DEBATE/ QUESTIONS FROM THE FLOOR 3:35 SIIU GENERAL MEETING 4:30 ADJOURN 2:55 PRESENTATION OVERVIEW AND REFLECTIONS J. Curtis Nickel Sunday, May 17, 2015 Live Surgery Program LIVE SURGERY II Hall New Orleans Morial Convention Center Moderators: Amy Krambeck and Nicole Miller 1:00 pm - 4:30 pm 1:00 PROSTATIC URETHRAL LIFT FOR BPH Surgeon: Daniel Rukstalis Panelist: Eugene Rhee 1:30 PLASMA BUTTON BIPOLAR (BIPOLAR TURBT WITH NBI IMAGING) Surgeons: Raju Thomas, Jonathan Silberstein Panelists: Harry Herr, Mark Soloway 3:30 MINI INVASIVE PERCUTANEOUS NEPHROLITHOTOMY Surgeon: Jorge Gutierrez-Aceves Panelists: Amy Krambeck, Nicole Miller 2:30 PDD CYSTOSCOPY AND RESECTION OF BLADDER TUMORS Surgeon: Anne Schuckman Panelists: Harry Herr, Mark Soloway Sunday, May 17, 2015 History Forum I HISTORY OF UROLOGY I (PODIUM) Room New Orleans Morial Convention Center 1:00 pm - 4:40 pm TIME NUMBER TITLE TIME NUMBER TITLE 1:00 FRI-01 LIGHTS, CAMERA, ACTION: WIRT DAKIN AND THE INTRODUCTION OF FILM AS A UROLOGIC TRAINING TOOL Unwanaobong Nseyo*, San Diego, CA, Leonard Marks, Los Angeles, CA 1:10 FRI-02 FOREIGN BODIES IN THE BLADDER- MEDICAL CURIOSITIES THROUGH THE AGES Friedrich Moll*, Thorsten Halling, Heiner Fangerau, Cologne, Germany 1:20 FRI-03 CANDIRU: THE URETHRAL INVADER FISH - MYTHS AND FACTS Marios Hadjipavlou*, Portsmouth, United Kingdom, June Tay, London, United Kingdom, Yiannis Philippou, Basildon, United Kingdom 1:30 FRI-04 CLOACAL EXSTROPHY: A HISTORY OF GENDER REASSIGNMENT Jennifer Gordetsky*, David Joseph, Birmingham, AL 1:40 FRI-05 CURIOSITY OR CURE? THE CASE OF SURGICAL CASTRATION Barbara Chubak*, Paul Gittens, Bronx, NY 1:50 FRI-06 GENITAL BEADING: A HISTORICAL SPEED BUMP ON THE ROAD TO SEXUAL SATISFACTION Casey McCraw*, John DiBianco, Zachary Klaassen, Ronald Lewis, Martha Terris, Augusta, GA 2:00 FRI-07 HOW A RECORDING COMPANY, A BAND AND A NOBEL LAUREATE DEVELOPED COMPUTED TOMOGRAPHY Sutchin R. Patel*, Madison, WI, Nicholas A. Rotker, Anthony A. Caldamone, Providence, RI 2:10 FRI-08 ERECTILE DYSFUNCTION: A HISTORICAL REVIEW OF TREATMENT OPTIONS WITH A FOCUS ON THE DEVELOPMENT OF THE INFLATABLE PENILE PROSTHESIS Amanda Saltzman, Kristi L. Hebert*, Kristen Gurtner, Eric Laborde, New Orleans, LA 2:20 FRI-09 THE CURIOUS CASE OF DR. LEVI HAMMOND: TRANSPLANTATION GALORE OF 1911 Pamela Baron*, David Schulsinger, Yefim Sheynkin, Stony Brook, NY 170

183 2:30 FRI-10 MITOMYCIN-C: HISTORICAL ASPECTS OF THE DISCOVERY OF MOST COMMONLY USED CHEMOTHERAPY AGENT IN UROLOGY Hemant Nemade*, Hussein Tukmatchy, Basildon, United Kingdom, Peter Thompson, London, United Kingdom 2:40 FRI-11 THE UROLOGICAL DRAWINGS OF LEONARDO DA VINCI Giorgio Bozzini*, Dario Ratti, Carlo Marenghi, Elisabetta Finkelberg, Luca Carmignani, Milano San Donato M.se, Italy 2:50 THE 2014 AUA EARL NATION RETROSPECTROSCOPE AWARD Effie Poulakou-Rebelakou for Syphilis Impact On Late Works of Classical Music Composers 3:00 BICKNELL LECTURE David K.C. Cooper, MD, PHD, FRCS: Cross- Species Kidney Transplantation History, Experimental Progress, and Clinical Potential 3:30 FRI-12 THE FAULT IN OUR PVRS Lawrence Wyner*, Huntington, WV 3:40 FRI-13 THE BURDEN OF SEGREGATION, FROM THE MISSOURI COMPROMISE TO THE PROTESTS IN FERGUSON, MO - OBSTACLES TO BECOMING A BLACK SURGEON/ UROLOGIST Steven Brandes*, Saint Louis, MO, Julio Geminiani, Stephen Marshall, St. Louis, MO 3:50 FRI-14 ERASTUS B WOLCOTT: A PIONEER IN RENAL SURGERY AND WISCONSIN MEDICINE Sara Best*, Madison, WI 4:00 FRI-15 A HISTORY OF TRADITIONAL CHINESE MEDICINE (TCM) AND ITS CURRENT ROLE IN UROLITHAISIS Li June Tay*, London, United Kingdom, Di Gu, Guangzhou, Guangdong, China, People s Republic of, Robert Gray, Peter Thompson, London, United Kingdom 4:10 FRI-16 WERNER FORSSMANN A NOBEL PRIZE WINNER AND HIS POLITICAL ATTITUDE BEFORE AND AFTER 1945 Lisa-Maria Packy*, Matthis Krischel, Dominik Groß, Aachen, Germany 4:20 FRI-17 FRACTURED FAIRY TALES- UROLOGIST IN THE MIDDLE Michael Moran*, McComb, MS 4:30 FRI-18 ROBERT BENJAMIN GREENBLATT AND HIS MANY PURSUITS: AN UNLIKELY FOUNDER OF THE TESTOSTERONE PELLET Zachary Klaassen*, Lael Reinstatler, Casey O. McCraw, Roger Chen, Martha K. Terris, Durwood E. Neal, Jr, Ronald W. Lewis, Arthur M. Smith, Augusta, GA SUNDAY Sunday, May 17, 2015 History Forum II HISTORY OF UROLOGY II (POSTER) Room New Orleans Morial Convention Center 4:40 pm - 5:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 4:40 FRII-01 BEHIND THE NAME: THE HISTORICAL PERSPECTIVE OF THE PATHOLOGIZING OF ATYPICAL SEXUAL DEVELOPMENT Matthew Truesdale*, Hillary Copp, San Francisco, CA 4:43 FRII-02 PEARLS OF WISDOM: A HISTORY OF MALE GENITAL ORNAMENTATION Justina Tam*, Wai Lee, Howard L. Adler, Stony Brook, NY 4:46 FRII-03 CASTRATION OF SEXUAL OFFENDERS IN THE UNITED STATES Ariel Schulman*, Ruben Pinkhasov, Ciril Godec, David Silver, Brooklyn, NY 4:49 FRII-04 SIR PERCIVALL POTT AND SOOT WART: THE EFFECTS OF SCROTAL CANCER ON CHILD LABOR LAWS IN THE BRITISH EMPIRE Drew Palmer*, Kari Bailey, Shiv Patel, Burlington, MA 4:52 FRII-05 THE OLDEST RETAINED URETERAL STENT: A HISTORY OF THE URETERAL STENT Rishi Modh*, James Mason, Akira Yamamoto, Thomas Stringer, Vincent Bird, Gainesville, FL 4:55 FRII-06 THE LIFE AND CONTRIBUTIONS OF JOAQUÍN MARÍA ALBARRÁNY DOMÍNGUEZ Ricardo Palmerola*, Richard Ashley, New Hyde Park, NY 4:58 FRII-07 THE HISTORY OF PELVIC ORGAN PROLAPSE FROM ANTIQUITY TO PRESENT DAY John Mattimore*, Stony Brook, NY, Philippa Cheetham, Aaron Katz, Garden City, NY 5:01 FRII-08 EDWARD CANNY RYALL: THE LOST UROLOGIST William Gallagher*, Emma Sabin, Jonathen Goddard, Leicester, United Kingdom *Presenting author 171

184 5:04 FRII-09 FROM ULTRASOUND TO HIGH INTENSITY FOCUSSED ULTRASOUND : A BRIEF HISTORY OF ULTRASOUND AS A THERAPEUTIC MODALITY Michael Wanis*, Marios Hadjipavlou, Portsmouth, United Kingdom 5:07 FRII-10 A TRIBUTE TO SIR DAVID INNES WILLIAMS: THE FOUNDER OF PEDIATRIC UROLOGY Mohit Sirohi*, New York, NY, Aizid Hashmat, Brooklyn, NY, Harris Nagler, Zafar Khan, New York, NY 5:10 FRII-11 A HISTORICAL PERSPECTIVE ON THE DISCOVERY OF THE PROSTATE Alberto Coscione*, Michalis Varnavas, Arun Sujenthiran, Samer Katmawi-Sabbagh, London, United Kingdom 5:16 FRII-13 NOT LACKING IN TESTICULAR FORTITUDE: THE EUNUCHS OF IMPERIAL CHINA Roger Chen*, Zachary Klaassen, Casey McCraw, Durwood Neal, Martha Terris, Arthur Smith, Ronald Lewis, Augusta, GA 5:19 FRII-14 SEXUAL MEDICINE AND THE SIXTH SENSE : EVOLUTION OF THE MALE SEXUAL CASE HISTORY Susanne Quallich*, Dana Ohl, David Bloom, Ann Arbor, MI 5:13 FRII-12 HISTORY OF THE TRANSURETHRAL RESECTION OF THE PROSTATE: THE GOLD STANDARD AND ITS ROLE IN THE 21ST CENTURY Marcus Austenfeld*, Ajay Nangia, Kansas City, KS Sunday, May 17, 2015 KOREAN WORLD UROLOGIC CONGRESS (KWUC) Room New Orleans Morial Convention Center 1:00 pm - 5:00 pm 1:00 OPENING REMARKS Society President: Myung-Soo Choo 1:10 MANAGEMENT OF MUSCLE-INVASIVE BLADDER CANCER Moderator: Hong-Sup Kim CURRENT TREATMENT OF VARIANT HISTOLOGY Ashish Kamat 1:25 KOREAN CONTEMPORARY MULTI- INSTITUTIONAL DATA ON TREATMENT OUTCOME AFTER RADICAL CYSTECTOMY IN BLADDER CANCER PATIENTS Sun Il Kim 1:40 ROBOTIC INTRA-CORPOREAL DIVERSION Mihir Desai 1:55 CASE DISCUSSION: HIGH RISK BLADDER CANCER Presenter: Seok-Ho Kang Panelists: Ho Kyung Seo, Byong Chang Jeong 2:20 COFFEE BREAK 2:40 MANAGEMENT OF PROSTATE CANCER Moderator: Hanjong Ahn MANAGEMENT OF POSITIVE SURGICAL MARGIN AFTER RADICAL PROSTATECTOMY Arieh Shalhav 2:55 CYTOREDUCTIVE PROSTATECTOMY IN METASTATIC PROSTATE CANCER Isaac Kim 3:10 PATHOLOGIC FINDINGS OF MULTI- INSTITUTIONAL DATA IN KOREA Jun Cheon 3:25 CASE DISCUSSION: LOCALLY ADVANCED PROSTATE CANCER Presenter: Dong-Deuk Kwon Panelists: Hong Koo Ha, Sang-Heon Cheon 3:50 PEDIATRIC UROLOGY Moderator: Sang Won Han RECONSTRUCTIVE SURGICAL OPTIONS IN PEDIATRIC NEUROGENIC BLADDER Barry Kogan 4:05 ANTIMICROBIAL PROPHYLAXIS FOR CHILDREN WITH VESICO-URETERAL REFLUX Antoine Khoury 4:20 LONG-TERM OUTCOME OF PEDIATRIC PYELOPLASTY Kwanjin Park 4:35 CASE DISCUSSION: OPTIMAL MANAGEMENT OF VESICO-URETERAL REFLUX IN THE ERA OF DELAYED VCUG Presenter: Yong Seung Lee Panelists: Sang Don Lee, Kun Kim 5:00 CLOSING REMARKS ADJOURN 172

185 Sunday, May 17, 2015 GERIATRIC UROLOGICAL SOCIETY (GUS) Room New Orleans Morial Convention Center 1:00 pm - 5:30 pm 1:00 WELCOME AND INTRODUCTIONS Society Chair: Tomas Griebling 1:05 STATE-OF-THE-ART PLENARY PANEL: CONSIDERATIONS FOR RECONSTRUCTIVE UROLOGY IN GERIATRIC PATIENTS (INCLUDING URINARY INCONTINENCE, PELVIC ORGAN PROLAPSE, URETHRAL DISEASE, AND TRAUMA) Moderator: Tomas Griebling Panelists: Theodore Johnson, J. Christian Winters, Joshua Broghammer, Allen Morey, Tracey Wilson 2:30 CASE PRESENTATIONS, QUESTIONS AND DISCUSSION 3:15 BREAK 3:30 INTERNATIONAL ROUNDTABLE: GERIATRIC UROLOGY IN GLOBAL CONTEXT Moderator: Ananias Diokno 4:15 QUESTIONS AND DISCUSSION 4:30 PAPERS SUBMITTED FOR PRESENTATION AT THE GERIATRIC UROLOGICAL SOCIETY Moderator: Ananias Diokno 5:15 QUESTIONS AND DISCUSSION 5:30 ADJOURN SUNDAY Sunday, May 17, :00 pm - 5:00 pm BRITISH ASSOCIATION OF UROLOGICAL SURGEONS (BAUS) / BJU INTERNATIONAL (BJUI) / UROLOGICAL SOCIETY OF AUSTRALIA AND NEW ZEALAND (USANZ) Room New Orleans Morial Convention Center 2:00 URO-ONCOLOGY Chairman: Mark Frydenberg UPDATE IN THE CONTEMPORARY MANAGEMENT OF UPPER TRACT TCC Stephen Boorjian 2:15 THE ROLE OF FOCAL THERAPY IN LOCALISED PROSTATE CANCER, PRELIMINARY AUSTRALIAN RESULTS Phillip Stricker 2:30 THE ROLE OF PET PSMA IN THE STAGING AND RE-STAGING OF MEN WITH PROSTATE CANCER Declan Murphy 2:45 BRCA 1/2 MUTATIONS, EVIDENCE BASED IMPLICATIONS FOR SCREENING AND ACTIVE SURVEILLANCE Damien Bolton 3:00 SURGERY FOR HIGH RISK PROSTATE CANCER INCLUDING METASTATIC DISEASE Daniel Moon 3:15 RESULTS FROM THE VICTORIAN TRANS- PERINEAL PROSTATE BIOPSY COLLABORATIVE GROUP Jeremy Grummet 3:30 AFTERNOON TEA 4:00 TECHNOLOGICAL ADVANCES Chairman: Mark Speakman ADVANCES IN THE MANAGEMENT OF LUTS/ BPH Henry Woo 4:15 BJUI GUEST SPEAKER: THE EVIDENCE FOR PARTIAL NEPHRECTOMY FOR THE MANAGEMENT OF RCC Ben Challacombe 4:30 WHAT IS THE EVIDENCE TO SUPPORT ROBOTIC CYSTECTOMY FOR TCC BLADDER? Prokar Dasgupta 4:45 THE ROLE OF MINIMALLY INVASIVE SURGERY FOR RETROPERITONEAL LYMPH NODE DISSECTION David Nicol 5:00 ADJOURN BJUI RECEPTION Sunday, May 17, 2015 JAPANESE UROLOGICAL ASSOCIATION (JUA) Room New Orleans Morial Convention Center 2:00 pm - 5:00 pm 2:00 OPENING REMARKS AUA Secretary: Gopal Badlani 2:05 PROSTATE CANCER - PARADIGM SHIFT IN THE TREATMENT OF CASTRATION RESISTANT PROSTATE CANCER Moderators: Hirotsugu Uemura, Robert Reiter *Presenting author 173

186 LECTURE 1: IMMUNOTHERAPY OF CASTRATE-RESISTANT PROSTATE CANCER: PROGRESS AND NEW PARADIGMS Takahiro Kimura 2:15 LECTURE 2: EMERGING NEW DRUGS AND REGIMENS FOR CASTRATE RESISTANT PROSTATE CANCER (CRPC) A. Oliver Sartor 2:30 PANEL DISCUSSION: TREATMENT OF CRPC- WHAT IS THE BEST MANAGEMENT Panelists: Natasha Kyprianou, Shinichi Sakamoto, Teruo Inamoto, A. Oliver Sartor 3:00 RENAL CELL CARCINOMA Moderators: Masatoshi Eto, Robert Flanigan LECTURE 1: PREDICTING OCCULT MULTIFOCALITY OF RENAL CELL CARCINOMA Dipen Parekh 3:10 LECTURE 2: HOW TO ASSESS THE RESPONSE TO TARGETED THERAPIES IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA Nobuo Shinohara 3:50 BREAK 4:05 AGING MALE Moderators: Yoshiyuki Kakehi, Tomas Griebling 4:05 LECTURE 1: TESTOSTERONE LEVELS, DEPRESSIVE SYMPTOMS, AND FALLS IN OLDER MEN Shigeo Horie 4:15 LECTURE 2: METABOLIC SYNDROME AND LOWER URINARY TRACT SYMPTOMS (LUTS) Kevin McVary 4:25 PANEL DISCUSSION: APPROACHES TO COMPLICATED CASES OF MALE LUTS Panelists: Koji Shiraishi, Ajay Singla, Eiji Kikuchi, Tomas Griebling 4:55 CLOSING REMARKS Seiji Naito 5:00 ADJOURN 3:20 PANEL DISCUSSION: WHAT IS YOUR CHOICE OF TREATMENT FOR THIS SITUATION Panelists: Robert Flanigan, Dipen Parekh, Kazutaka Saito, Motohide Uemura, Katsunori Tatsugami Sunday, May 17, 2015 AUA/FDA/SUO WORKSHOP Room New Orleans Morial Convention Center 2:00 pm - 6:00 pm 2:00 INTRODUCTION AND WELCOME Co-Chairs: Jonathan Jarow, Peter Scardino 2:05 FDA REGULATORY ISSUES IN PARTIAL GLAND ABLATION Jonathan Jarow 2:20 SESSION 1: PARTIAL GLAND ABLATION FOR PROSTATE CANCER Moderators: Peter Scardino, Peter Carroll 2:25 OVERVIEW OF TECHNOLOGY USED IN PARTIAL GLAND ABLATION IN PROSTATE CANCER Jonathan Coleman 2:32 SUMMARY OF CONSENSUS REPORTS ON PARTIAL GLAND ABLATION IN PROSTATE CANCER: INDICATIONS Hashim Ahmed 2:39 PANEL DISCUSSION: THE BENEFITS AND RISKS OF PARTIAL GLAND ABLATION IN PROSTATE CANCER FOR VARIOUS PATIENT GROUPS Panelists: James Kiefert, Peter Kellogg, Eric Klein, Mark Emberton, Adam Kibel 3:25 SESSION 2: IMAGING TO AID PATIENT SELECTION AND GUIDE TREATMENT Moderators: Mark Emberton, Gerald Andriole 3:27 PERFORMANCE CHARACTERISTICS OF MPMRI AT CENTERS OF EXCELLENCE Peter Choyke 3:34 PATHOLOGIC CONSIDERATIONS IN PARTIAL GLAND ABLATION Jonathan Epstein 3:41 SUMMARY OF CONSENSUS REPORTS ON PARTIAL GLAND ABLATION IN PROSTATE CANCER: THE ROLE OF IMAGING IN PARTIAL GLAND ABLATION AND OPTIMAL BIOPSY TECHNIQUES Leonard Marks 3:48 PANEL DISCUSSION: ROLE OF MRI IN PATIENT SELECTION AND ENDPOINT DETERMINATION Panelists: Behfar Ehdaie, Peter Pinto, Hebert Vargas 4:23 BREAK 4:33 SESSION 3: DESIGNING CLINICAL TRIALS TO MEASURE OUTCOMES IN PARTIAL GLAND ABLATION Moderators: Samir Taneja, Laurence Klotz 4:35 MEASURING CANCER-SPECIFIC OUTCOMES: DEFINING VALID SHORT-TERM AND INTERMEDIATE ENDPOINTS IN PARTIAL GLAND ABLATION? Scott Eggener 174

187 4:42 MEASURING PATIENT-CENTERED OUTCOMES IN PARTIAL GLAND ABLATION: DEFINING A MINIMUM SET Martin Sanda 4:49 SUMMARY OF CONSENSUS REPORTS ON PARTIAL GLAND ABLATION IN PROSTATE CANCER: CLINICAL TRIAL DESIGNS (PART) Freddie Hamdy 4:56 PANEL DISCUSSION: HOW TO ASSESS THIS TECHNOLOGY FOR CLINICAL ADOPTION AND REGULATORY APPROVAL Panelists: Thomas Polascik, Howard Sandler, Michael Cookson, Craig Pynn, Terrance Kungel 5:55 CONCLUSION 6:00 ADJOURN Sunday, May 17, :00 INTRODUCTIONS AND WELCOME 2:10 OVERVIEW OF OUTCOMES OF NIDDK WORKSHOP: RESEARCH NEEDS FOR EFFECTIVE TRANSITION IN LIFELONG CARE OF CONGENITAL GENITOURINARY CONDITIONS Tamara Bavendam 2:30 CASE PRESENTATIONS CASE 1: FEMALE WITH RECURRENT CYSTITIS AND VESICOURETERAL REFLUX IN CHILDHOOD SEEKING CONSULTATION FOR PREGNANCY MANAGEMENT Case Presenter: Martin A. Koyle Panelists: Ariella Friedman, David Ginsberg UROLOGICAL CONGENITALISM FORUM Grand Salon 21 & Hilton New Orleans Riverside 2:00 pm - 6:00 pm 3:30 CASE 2: MALE WITH MYELOMENINGOCELE MANAGED WITH ILEAL CONDUIT SEEKING CONTINENT DIVERSION Case Presenter: Stephanie Kielb Panelists: John Thomas, Jeremy Myers 4:30 CASE 3: FEMALE WITH BLADDER EXSTROPHY PRESENTS 6 WEEKS PREGNANT Case Presenter: Dan Wood Panelists: John Gearhart, Margit Fisch 5:30 SUMMARY AND TAKE-HOME MESSAGES SUNDAY Sunday, May 17, 2015 R. FRANK JONES UROLOGICAL SOCIETY Room New Orleans Morial Convention Center 2:00 pm - 7:45 pm 2:00 WELCOME AND PRESIDENT S UPDATE Society President: Kevin Billups 2:10 IMPLICATIONS OF CHRONIC SLEEP DISORDERS ON MEN S HEALTH Charlene Gamaldo 2:35 AUDIENCE RESPONSE/QUESTIONS AND ANSWERS 2:40 UPDATE FROM THE AUA EDUCATION COUNCIL Cheryl Lee 2:50 REPORT: AUA LEGISLATIVE AFFAIRS COMMITTEE UPDATE Brian Stone, Chiledum Ahaghotu 3:10 NEW PARADIGMS FOR EARLY DETECTION OF CARDIOMETABOLIC RISK IN MEN: EMERGING ROLE OF ED AND TRT Martin Miner 3:25 AUDIENCE RESPONSE/QUESTIONS AND ANSWERS 3:30 HEPATITIS C INFECTION AMONG AFRICAN AMERICAN MEN: REVISITING STD S AS AN EMERGING PARADIGM IN MEN S HEALTH R. Douglas Bruce 3:55 AUDIENCE RESPONSE/QUESTIONS AND ANSWER 4:00 BREAK 4:15 MINORITY MEN S HEALTH SYMPOSIUM Moderator: Charles Modlin INTRODUCTION Charles Modlin 4:25 MEDICAL ASPECTS OF MEN S HEALTH Kevin Billups 4:55 IMPACT OF SOCIAL DETERMINANTS ON MEN S HEALTH Roland Thorpe 5:15 MASCULINITY AND ITS IMPACT ON HEALTH BEHAVIORS Derek Griffith 5:35 IMPLICATIONS OF POLICY & PROGRAM REFORM April Young 5:55 Q & A/PANEL DISCUSSION: IMPLEMENTING MINORITY MEN S HEALTH AT THE COMMUNITY LEVEL 6:30 CONCLUDING REMARKS 6:45 RECEPTION *Presenting author 175

188 Sunday, May 17, 2015 SOCIEDAD ARGENTINA DE UROLOGIA (SAU) Room New Orleans Morial Convention Center 2:55 pm - 6:00 pm 2:55 APERTURA DEL SIMPOSIO (INTRODUCTION) 3:00 LOS RESULTADOS ECONÓMICOS DEL TRATAMIENTO DE LA LITIASIS URINARIA (ECONOMIC OUTCOMES OF TREATMENT OF UROLITHIASIS) Speaker: Norberto Bernardo Moderators: Alejandro Nolazco, Miguel Rivero 3:15 ESTENOSIS DE LA URETRA SECUNDARIAS A LA CIRUGÍA DESOBSTRUCTIVA POR HPB (URETHRAL STRICTURES SECONDARY TO BPH-LUTS SURGERY) Speaker: Carlos Giudice Moderators: Claudio Koren, Norberto Lafos 3:30 LAS ESTRATEGIAS Y LAS CONSIDERACIONES EN LA PLANIFICACIÓN Y LA REALIZACIÓN DE LA NEFRECTOMÍA PARCIAL (STRATEGIES AND CONSIDERATIONS IN PLANNING AND PERFORMING PARTIAL NEPHRECTOMY) Speaker: Jose Juan Rozanec Moderators: Adrian Momesso, Angel Martin Piana 3:45 LAS COMPLICACIONES EN LA PROSTATECTOMIA RADICAL LAPAROSCÓPICA: CÓMO EVITARLAS Y CÓMO RESOLVERLAS (COMPLICATIONS IN LAPAROSCOPIC RADICAL PROSTATECTOMY: HOW TO AVOID AND HOW TO RESOLVE THEM) Speaker: Gonzalo Vitagliano Moderators: Carlos Ameri, Martin Del Sordo 4:00 LAS COMPLICACIONES CON LA CIRUGÍA ROBÓTICA: CÓMO EVITARLAS Y CÓMO RESOLVERLAS (ROBOTIC SURGERY COMPLICATIONS: HOW TO AVOID AND MANAGE THEM) Speaker: Antonio Villamil Moderators: Fernando Secin, Juan Carlos Tejerizo 4:30 LA TERAPIA MULTIFOCAL PARA MEJORAR LA CALIDAD DE VIDA EN LOS PACIENTES CON LUTS (MULTIFOCAL THERAPY TO IMPROVE THE QUALITY OF LIFE IN PATIENTS WITH LUTS) Speaker: Osvaldo Mazza Moderator: Miguel Costa 5:00 MESA REDONDA: CÁNCER DE PRÓSTATA AVANZADO (ROUND TABLE: ADVANCED PROSTATE CANCER) INTRODUCIÓN (INTRODUCTION) Miguel Costa 5:10 ACTUALIZACIONES CLAVE EN CPRCM: DE ESMO A ASCO GU (KEY UPDATES IN MCRPC: FROM ESMO TO ASCO GU) Speaker: Antonio Alcaraz Moderator: Miguel Costa 5:30 PUNTO Y CONTRAPUNTO: TERAPIAS NOVELES VS TERAPIAS TRADICIONALES COMO TRATAMIENTO HORMONAL DE ELECCIÓN AL DIAGNÓSTICO DE CPRC (POINT - COUNTER-POINT: NEW THERAPIES VS TRADITIONAL THERAPIES AS HORMONAL TREATMENT OF CHOICE FOR MCRPC ) Speakers: Antonio Alcaraz, Claudio Alberto Graziano, Ricardo Nardone, Carlos Scorticati Moderator: Miguel Costa 5:50 CONCLUSIONES (CONCLUSIONS) Moderators: Antonio Alcaraz, Miguel Costa 6:00 ADJOURN Sunday, May 17, 2015 ASSOCIATION FRANCAISE D UROLOGIE (AFU) Room New Orleans Morial Convention Center 3:30 pm - 5:30 pm 3:30 WELCOME BY THE AFU DELEGATE Emmanuel Chartier-Kastler 3:35 LOW RISK PROSTATE CANCER DIAGNOSIS AND MANAGEMENT Laurence Klotz, Guillaume Ploussard 5:25 CONCLUSION OF THE MEETING AND SUMMARY BY THE PRESIDENT OF AFU Jean-Luc Descotes 5:30 ADJOURN 4:30 MALE URINARY INCONTINENCE MANAGEMENT Daniel Elliott, Xavier Game 176

189 Sunday, May 17, 2015 Moderated Poster Session 54 PEDIATRICS: URINARY TRACT INFECTIONS/VESICOURETERAL REFLUX Room New Orleans Morial Convention Center Moderators: Joseph Ortenberg and Abhishek Seth 3:30 pm - 5:30 pm NUMBER TITLE NUMBER TITLE MP54-01 SIGNIFICANT PREDICTORS OF CHRONIC KIDNEY DISEASE DURING POST- PUBERTAL PERIODS IN PATIENTS WITH VESICOURETERAL REFLUX Minyong Kang, Seoul, Korea, Republic of, Hae Won Lee,, Korea, Republic of, Kwanjin Park*, Seoul, Korea, Republic of MP54-02 MULTI-INSTITUTIONAL ANALYSIS AND VALIDATION OF THE VESICOURETERAL REFLUX INDEX (VURX) Angela M. Arlen*, Iowa City, IA, Aaron D. Weiss, Michael Garcia-Roig, Traci Leong, Atlanta, GA, Christopher S. Cooper, Iowa City, IA, Andrew J. Kirsch, Atlanta, GA MP54-03 COST EFFECTIVENESS OF ANTIMICROBIAL PROPHYLAXIS FOR CHILDREN IN THE RIVUR TRIAL Casey Seideman*, Lake Success, NY, Yair Lotan, Dallas, TX, Lane Palmer, Lake Success, NY MP54-04 THE NEW DIAGNOSTIC APPROACH USING URETERAL JET ANGLE MEASUREMENT IN CHILDREN WITH URINARY TRACT INFECTION Zenichi Matsui*, Hiroshi Asanuma, Hiroyuki Satoh, Yujiro Aoki, Kei Sakurabayashi, Ryuichi Mizuno, Mototsugu Oya, Tokyo, Japan MP54-05 THE FATE OF PRIMARY OBSTRUCTIVE MEGAURETER (POM): A PROSPECTIVE OUTCOME ANALYSIS OF 72 INFANTS Luis Braga*, Jennifer DCruz, Forough Farrokhyar, Mandy Rickard, Hamilton, Canada, Armando Lorenzo, Toronto, Canada MP54-06 RISK FACTORS FOR CATHETER- ASSOCIATED URINARY TRACT INFECTION IN A PEDIATRIC INSTITUTION Nora Lee, Daniel Marchalik*, Washington, DC, Andrew Lipsky, New York, NY, H. Gil Rushton, Hans Pohl, Xiaoyan Song, Washington, DC MP54-07 INCIDENCE, ADMISSION RATES AND ECONOMIC BURDEN OF PEDIATRIC EMERGENCY DEPARTMENT VISITS FOR URINARY TRACT INFECTION Akshay Sood*, Frank Penna, Sriram Eleswarapu, Daniel Pucheril, Dane Klett, Abd-El-Rahman Abd-El-Barr, Firas Abdollah, Yegappan Lakshmanan, Mani Menon, Detroit, MI, Quoc-Dien Trinh, Boston, MA, Jesse Sammon, Jack Elder, Detroit, MI MP54-08 INCIDENCE AND RISK FACTORS FOR POSITIVE URINE CULTURE AT THE TIME OF PEDIATRIC UROLOGIC SURGERY Michael A Maccini*, David Chalmers, Jeffrey B Campbell, Aurora, CO MP54-09 ANTIMICROBIAL EXPOSURE AND UROPATHOGEN RESISTANCE: AN ANALYSIS OF INDIVIDUAL PATIENT DATA FROM RCTS ON ANTIBIOTIC PROPHYLAXIS AND THE PREVENTION OF UTI Rachel Sharon Selekman*, Daniel J Shapiro, Hillary L Copp, San Francisco, CA MP54-10 THE IMPACT OF OBESITY ON FEBRILE URINARY TRACT INFECTION AND RENAL SCARRING IN CHILDREN WITH VESICOURETERAL REFLUX Ji Yong Ha*, Hye Jin Byun, Wonho Jung, Byung Hoon Kim, Chol Hee Park, Chun Il Kim, Daegu, Korea, Republic of, Kyung Seop Lee, Gyeongju, Korea, Republic of, Jae Ho Kim,, Korea, Republic of MP54-11 READMISSION, UNPLANNED EMERGENCY ROOM VISITS, AND SURGICAL RETREATMENT RATES AFTER VESICOURETERAL REFLUX PROCEDURES Hsin-Hsiao Wang*, Rohit Tejwani, John Wiener, Jonathan Routh, Durham, NC MP54-12 DETERMINANTS OF PRACTICE PATTERNS IN PEDIATRIC UTI MANAGEMENT Rachel Sharon Selekman*, Hillary L Copp, San Francisco, CA MP54-13 DOES PERCEPTION OF CATHETERIZATION LIMIT ITS USE IN PEDIATRIC UTI? Rachel Sharon Selekman*, Melissa T Sanford, San Francisco, CA, Lauren N Ko, Boston, MA, Hillary L Copp, San Francisco, CA MP54-14 WHAT DO PREOPERATIVE AND INTRAOPERATIVE URINE CULTURES PROVIDE FOR PEDIATRIC PATIENTS UNDERGOING URETERAL REIMPLANTATION FOR VESICOURETERAL REFLUX? Daniel Hettel*, Bradley Gill, Audrey Rhee, Cleveland, OH MP54-15 WHAT IS THE INCIDENCE OF DEFLUX CALCIFICATION ON ULTRASOUND? Julia B Finkelstein*, Mark V Silva, Jennifer J Ahn, Jason P Van Batavia, Shumyle Alam, Pasquale Casale, New York, NY SUNDAY *Presenting author 177

190 MP54-16 DOES ENDOSCOPIC PUNCTURE OF URETEROCELE PROVIDE NOT ONLY AN INITIAL SOLUTION, BUT ALSO A DEFINITE TREATMENT IN ALL CHILDREN? OVER THE 25 YEARS OF EXPERIENCE Stanislav Kocherov*, Shahar Rotem, Amicur Farkas, Boris Chertin, Jerusalem, Israel MP54-17 BEYOND VUR GRADING AND SURGICAL TECHNIQUE: PATIENT-BASED PARAMETERS SIGNIFICANT FOR SUCCESS OF ENDOSCOPIC ANTIREFLUX SURGERY Gina Cambareri*, George Chiang, Madhu Alagiri, San Diego, CA MP54-18 THE ROLE OF PROPHYLACTIC ANTIBIOTICS AFTER LAPAROSCOPIC PYELOPLASTY WITH URETERAL STENT PLACEMENT IN CHILDREN Matthew Ferroni*, Kevin Rycyna, Moira Dwyer, Francis Schneck, Michael Ost, Steven Docimo, Heidi Stephany, Glenn Cannon, Pittsburgh, PA MP54-19 COMPARISON OF COST AND COMPLICATIONS IN OPEN VERSUS ROBOTIC URETERAL REIMPLANTATION IN AMERICAN CHILDREN S HOSPITALS Benjamin Whittam*, William Bennett, Alison Keenan, Konrad Szymanski, Aaron Carroll, Richard Rink, Mark Cain, Indianapolis, IN MP54-20 INCIDENCE OF DEXTRANOMER- HYALURONIC ACID SITE CALCIFICATION IS GREATER THAN EXPECTED Tyler Kern, Steven Lerman, Bernard Churchill, Jennifer Singer*, Los Angeles, CA Sunday, May 17, 2015 Moderated Poster Session 55 PROSTATE CANCER: BASIC RESEARCH III Room New Orleans Morial Convention Center Moderators: David Jarrard and Jill Macoska 3:30 pm - 5:30 pm NUMBER TITLE NUMBER TITLE MP55-01 CYTOPLASMIC FOXO1 NEGATIVELY REGULATES ERK TO OVERCOME TAXOL RESISTANCE IN PROSTATE CANCER Chunwu Pan*, Shanghai, China, People s Republic of, Jian An, Yunqian Pan, Liguo Wang, Jun Zhang, Rochester, MN, Jun Qi, Shanghai, China, People s Republic of, Haojie Huang, Rochester, MN MP55-02 PROSTATE ADENOCARCINOMAS COMPARED WITH NON-TUMOR PROSTATE TISSUE. EXPRESSION OF COLLAGEN, ELASTIC SYSTEM FIBERS, SMOOTH MUSCLE CELLS AND VESSELS, ACCORDING TO THE GLEASON SCORE Carla Gallo, Waldemar Costa*, Francisco Sampaio, Clarice Osorio, Rio de Janeiro, Brazil MP55-03 PATHOLOGICAL ROLES OF HUR EXPRESSION IN PROSTATE CANCER Kensuke Mitsunari*, Yasuyoshi Miyata, Akihiro Asai, Tomohiro Matsuo, Kojiro Ohba, Kosuke Takehara, Hideki Sakai, Nagasaki, Japan MP55-04 THERMOTHERAPY WITH MAGNETIC CATIONIC LIPOSOMES POWERFULLY SUPPRESSES PROSTATE CANCER BONE METASTASIS IN A NOVEL RAT MODEL Daichi Kobayashi*, Noriyasu Kawai, Keitaro Iida, Toshiki Etani, Taku Naiki, Ryosuke Ando, Keiichi Tozawa, Tohru Mogami, Kenjiro Kohri, Nagoya, Japan MP55-05 CHARACTERISATION OF IMMUNE INFILTRATES IN MALIGNANT AND BENIGN PROSTATE TISSUES Dixon (Teck Sing) Woon*, Genevieve Whitty, Manvendra Saxena, Damien Bolton, Ian Davis, Heidelberg, Australia MP55-06 GALECTIN-3 IS A THERAPEUTIC TARGET FOR CASTRATION-RESISTANT PROSTATE CANCER Tomoharu Fukumori*, Tsogt-Ochir Dondoo, Kei Daizumoto, Tomoya Fukawa, Yasuyo Yamamoto, Kunihisa Yamaguchi, Masayuki Takahashi, Hiro-omi Kanayama, Tokushima, Japan MP55-07 FLAVONOIDS ENHANCE TRAIL SENSITIVITY IN PROSTATE CANCER CELLS BY TARGETING ADENINE NUCLEOTIDE TRANSLOCASE-2 masakatsu oishi*, takashi ueda, terukazu nakamura, yoshio naya, fumiya hongo, kazumi kamoi, koji okihara, tsuneharu miki, kyoto, Japan MP55-08 GENOMIC DELETION OF CHROMOSOME 12P IS AN INDEPENDENT PROGNOSTIC MARKER IN PROSTATE CANCER Raisa Pompe*, Martina Kluth, Sarah Minner, Philipp Gild, Ronald Simon, Pierre Tennstedt, Markus Graefen, Guido Sauter, Thorsten Schlomm, Hamburg, Germany 178

191 MP55-09 PRE-CLINICAL EVALUATION OF THE NOVEL THERAPIES OF THE CASTRATION-RESISTANT PROSTATE CANCER David Charbit, Ihsan El Sayed, Alexandra Masson-Lecomte, Carolina Saldana, Laurent Salomon, Francis Vacherot, Alexandre De La Taille*, Creteil, France MP55-10 EPIGENETIC REGULATION OF THE 3P22 TUMOR SUPPRESSOR DLEC1 IN HUMAN PROSTATE CANCER ASSOCIATED WITH ITS PROGNOSIS Lian Zhang, Yu Fan*, Beijing, China, People s Republic of, Lili Li, Zhaohui Wang, Hong Kong, China, People s Republic of, Qian Zhang, Beijing, China, People s Republic of, Qian Tao, Hong Kong, China, People s Republic of, Jie Jin, Beijing, China, People s Republic of MP55-11 SYNTHETIC LETHAL METABOLIC TARGETING OF CELLULAR SENESCENCE IN PROSTATE CANCER WITH METFORMIN Michael L. Blute, Jr.*, Bing Yang, Nathan Damaschke, Dudley Lamming, F. Michael Hoffman, David F. Jarrard, Madison, WI MP55-12 THE PROTON-ASSISTED AMINO ACID TRANSPORTER 4 (PAT4/SLC36A4) IS UP- REGULATED IN PROSTATE CANCER Daniel Stevens*, Claire Verrill, Richard Bryant, Chad McKee, Helen Turley, Shih- Jung Fan, Sumeth Perera, Clive Wilson, Adrian L Harris, Freddie C Hamdy, Deborah CI Goberdhan, Oxford, United Kingdom MP55-13 TRIPTOLIDE INHIBIT CASTRATE RESISTANT AND ENZALUTAMIDE RESISTANT PROSTATE CANCER GROWTH BY DECREASING ANDROGEN RECEPTOR FULL LENGTH AND SPLICE VARIANTS EXPRESSION Sumit Isharwal*, Shrey Modi, Usman Barlass, Minneapolis, MN, Rohit Chugh, Mineapolis, MN, Sulagna Banerjee, Vikas Dudeja, Ashok Saluja, Badrinath Konety, Minneapolis, MN MP55-14 METFORMIN USE AND METABOLIC SIGNALING IN MEN UNDERGOING PROSTATE NEEDLE BIOPSY Brian Winters*, Sarah Holt, Xiaotun Zhang, Colm Morrissey, Daniel Lin, Stephen Plymate, Jonathan Wright, Seattle, WA MP55-15 INVOLVEMENT OF MIR-181B-MEDIATED EZH2/IGF-1R SIGNALLING PATHWAY IN THE GROWTH AND ENERGY METABOLISM OF PROSTATE CANCER Tao Tao*, Chunhui Liu, Yeqing Huang, Han Guan, Ming Chen, Nanjing, China, People s Republic of MP55-16 BLOCKING THE INTRACRINE BACK- CONVERSION PATHWAY WITH ABIRATERONE IN PROSTATE CANCER CELLS Takashi Ando*, Itsuhiro Takizawa, Fumio Ishizaki, Keisuke Takeda, Niigata City, Japan, Yoshimichi Miyashiro, Kawasaki City, Japan, Noboru Hara, Tsutomu Nishiyama, Niigata City, Japan MP55-17 EFFECT OF EPIGENETIC MODIFICATION AND IMMUNOMODULATION ON MURINE PROSTATE CANCER AND DENDRITIC CELLS Jay Sulek*, Shaoqing Zhou, Albert Petrossian, Samuel Robinson, Ekaterine Goliadze, Georgi Guruli, Richmond, VA MP55-18 RACE IMPACTS ETS FAMILY TRANSCRIPTION FACTOR EXPRESSION IN PROSTATE CANCER: DATA FROM A MULTI-INSTITUTIONAL COHORT Farzana Faisal*, Debasish Sundi, Ashley Ross, Baltimore, MD, Eric Klein, Cleveland, OH, Robert Den, Adam Dicker, Philadelphia, PA, Voleak Choeurng, Nicholas Erho, Mohammed Alshalalfa, Elai Davicioni, Vancouver, Canada, Tamara Lotan, Edward Schaeffer, Baltimore, MD MP55-19 SUPPRESSION OF AUTOPHAGY BY CHLOROQUINE POTENTIATES THE ANTI- CANCER EFFECT OF DOCETAXEL ON CASTRATION-RESISTANT PROSTATE CANCER CELLS Wen Song, Jun Yang*, Yang Cai, Yang Luan, Li Wu, Xia Liu, Tao Wang, Shao Wang, Ji Liu, Zhang Ye, Wuhan, China, People s Republic of MP55-20 ESTABLISHMENT OF LUCAP CELL LINES BY ORGANOID IN VITRO CULTURE TECHNOLOGY Catherine Dowling*, Dong Gao, Samuel Kaffenberger, Youxin Guan, Qi Fan Zhang, Devan Murphy, New York, NY, Holly Nguyen, Eva Corey, Seattle, WA, Yu Chen, New York, NY SUNDAY *Presenting author 179

192 Sunday, May 17, 2015 Moderated Poster Session 56 PROSTATE CANCER: LOCALIZED III Room New Orleans Morial Convention Center Moderators: Thomas Guzzo and Joel Nelson 3:30 pm - 5:30 pm NUMBER TITLE NUMBER TITLE MP56-01 SIZE-ADJUSTED QUANTITATIVE GLEASON SCORE AS A PREDICTOR OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY Nicholas Donin, Fang-Ming Deng, Ruth Pe Benito, Jinhua Wang, Jonathan Melamed, Ming Zhou, Herbert Lepor*, New York, NY MP56-02 HEAD TO HEAD COMPARISON OF CONDITIONAL ONCOLOGICAL OUTCOMES AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH INTERMEDIATE AND HIGH RISK PROSTATE CANCER Marco Bianchi*, Nicola Fossati, Giorgio Gandaglia, Rayan Matloob, Milan, Italy, Firas Abdollah, Detroit, MI, Umberto Capitanio, Federico Dehò, Vincenzo Scattoni, Milan, Italy, Shahrokh F. Shariat, Vienna, Austria, Pierre Karakiewicz, Montreal, Canada, Francesco Montorsi, Alberto Briganti, Milan, Italy MP56-03 NUMBER OF LYMPH NODES REMOVED AT RADICAL PROSTATECTOMY FOR NODE NEGATIVE PROSTATE CANCER: A POTENTIAL MARKER OF DISEASE PERSISTENCE IN PATIENTS WITH EARLY BIOCHEMICAL FAILURE Marco Bianchi*, Nicola Fossati, Nazareno Suardi, Giorgio Gandaglia, Paolo Dell Oglio, Umberto Capitanio, Milan, Italy, Firas Abdollah, Detroit, MI, Andrea Gallina, Milan, Italy, Shahrokh F. Shariat, Vienna, Austria, Federico Dehò, Andrea Salonia, Milan, Italy, Pierre Karakiewicz, Montreal, Canada, Francesco Montorsi, Alberto Briganti, Milan, Italy MP56-04 RECURRENCE PATTERN IN LYMPH NODE POSITIVE PROSTATE CANCER PATIENTS AFTER EXTENDED PELVIC LYMPHADENECTOMY AND RADICAL PROSTATECTOMY THE NATURAL COURSE OF DISEASE Silvan Boxler*, Tobias Gross, George N. Thalmann, Urs E. Studer, Martin Spahn, Bern, Switzerland MP56-05 EARLY POST-OPERATIVE PSA AFTER RADICAL PROSTATECTOMY IS A MAJOR PREDICTOR OF PROGRESSION AND DEATH IN PATIENTS WITH LYMPH NODE METASTASES. RESULTS FROM A TERTIARY CARE CENTER Alessandro Nini*, Marco Bianchi, Nazareno Suardi, Giorgio Gandaglia, Paolo Dell Oglio, Renzo Colombo, Milan, Italy, Firas Abdollah, Detroit, MI, Vito Cucchiara, Milan, Italy, Shahrokh F. Shariat, Vienna, Austria, Pierre Karakiewicz, Montreal, Canada, Francesco Montorsi, Alberto Briganti, Milan, Italy MP56-06 ASSOCIATION BETWEEN PROVIDER- LEVEL FACTORS AND LYMPH NODE DISSECTION OUTCOMES DURING RADICAL PROSTATECTOMY: A NATIONAL CANCER DATABASE ANALYSIS Jonathan E Kiechle*, Cleveland, OH, Elyn Wang, James B Yu, Cary P Gross, New Haven, CT, Robert Abouassaly, Edward E Cherullo, Cleveland, OH, Marc C Smaldone, Philadelphia, PA, Nilay D Shah, Rochester, MN, Quoc-Dien Trinh, Boston, MA, Maxine Sun, Montreal, Canada, Simon P Kim, Cleveland, OH MP56-07 ONCOLOGICAL OUTCOMES IN HIGH-RISK PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: COMPARING GLEASON 8 VERSUS 9,10 DISEASE Weichen Xu*, Jie Cai, Gary Lieskovsky, Siamak Daneshmand, Hooman Djaladat, Los Angeles, CA MP56-08 IMPACT OF INTRAOPERATIVE FROZEN SECTIONS OF THE URETHRA ON SURGICAL MARGINS AND ONCOLOGIC OUTCOME IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY Georgios Hatzichristodoulou*, Munich, Germany, Stefan Wagenpfeil, Homburg, Germany, Kathleen Herkommer, Jürgen Gschwend, Hubert Kübler, Munich, Germany MP56-09 EXPRESSION PROFILE OF CD44S, CD44V6, AND CD44V10 IN LOCALIZED PROSTATE CANCER: IMPACT ON PROGNOSTIC OUTCOMES FOLLOWING RADICAL PROSTATECTOMY Hiromoto Tei*, Hideaki Miyake, Masato Fujisawa, Kobe, Japan MP56-10 LONG-TERM SURVIVAL PATTERNS OF YOUNG PATIENTS WITH HIGH RISK PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY. RESULTS OF A MULTI INSTITUTIONAL, CONDITIONAL SURVIVAL ANALYSIS Marco Bianchi*, Milan, Italy, R. Jeffrey Karnes, Rochester, MN, Steven Joniau, Leuven, Belgium, Giorgio Gandaglia, Milan, Italy, Martin Spahn, Bern, Switzerland, Paolo Gontero, Turin, Italy, Lorenzo Tosco, Leuven, Belgium, Rafael Sanchez Salas, Xavier Cathelineau, Paris, France, Burkhard Kneitz, Wurzburg, Germany, Felix K. H. Chun, Hamburg, Germany, Pierre Karakiewicz, Montreal, Canada, Markus Graefen, Hamburg, Germany, Piotr Chlosta, Krakow, Poland, Giansilvio Marchioro, Novara, Italy, Detlef Frohneberg, Karlsruhe, Germany, Hein Van Poppel, Leuven, Belgium, Francesco Montorsi, Alberto Briganti, Milan, Italy 180

193 MP56-11 PROGNOSTIC VALUE OF FOCAL POSITIVE SURGICAL MARGINS AFTER RADICAL PROSTATECTOMY Ki Bom Kim*, In jae Lee, Tae jin Kim, Jong Jin Oh, Sangchul Lee, Seong-Jin Jeong, Sung Kyu Hong, Seok-Soo Byun, Seongnamsi, Korea, Republic of, Choong Hee Noh, Seoul, Korea, Republic of, Sang Eun Lee, Seongnam-si, Korea, Republic of MP56-12 THE ROLE OF PERINEURAL INVASION AS A PROGNOSTIC TOOL IN PROSTATE CANCER Udit Singhal*, Louis Lu, Ted Skolarus, Ganesh Palapattu, Jeffrey Montgomery, Alon Weizer, Brent Hollenbeck, David Miller, Jason Chan, Rohit Mehra, Scott Tomlins, Daniel Hamstra, Felix Feng, Todd Morgan, Ann Arbor, MI MP56-13 ADIPOSIS IS AN INDEPENDENT RISK- FACTOR FOR DEVELOPING HIGH-RISK PROSTATE CANCER - A PROSPECTIVE STUDY Thomas J. Schnoeller*, Ulm, Germany, Andres J. Schrader, Münster, Germany, Florian Jentzmik, Ulm, Germany, Julie Steinestel, Münster, Germany MP56-14 PREDICTORS AND ONCOLOGIC OUTCOMES OF PT0 PROSTATE CANCER IN RADICAL PROSTATECTOMY SPECIMENS Daniel Moreira*, Boris Gershman, Stephen Boorjian, R. Houston Thompson, Igor Frank, Matthew Tollefson, Matthew Gettman, Rachel Carlson, Laureano Rangel, R. Jeffrey Karnes, Rochester, MN MP56-15 LYMPHOVASCULAR INVASION IS SIGNIFICANTLY ASSOCIATED WITH BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY EVEN IN PATIENTS WITH PT2N0 NEGATIVE RESECTION MARGIN Koji Mitsuzuka*, Sendai, Japan, Shintaro Narita, Akita, Japan, Takuya Koie, Hirosaki, Japan, Yasuhiro Kaiho, Sendai, Japan, Norihiko Tsuchiya, Akita, Japan, Takahiro Yoneyama, Hirosaki, Japan, Narihiko Kakoi, Sadafumi Kawamura, Tatsuo Tochigi, Natori, Japan, Tomonori Habuchi, Akita, Japan, Chikara Ohyama, Hirosaki, Japan, Yoichi Arai, Sendai, Japan MP56-16 VERY LONG TERM OUTCOMES OF RADICAL PROSTATECTOMY IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER. RESULTS FROM A SINGLE INSTITUTION SERIES Giorgio Gandaglia*, Nazareno Suardi, Marco Bianchi, Paolo Dell Oglio, Umberto Capitanio, Nicola Fossati, Milan, Italy, Firas Abdollah, Detroit, MI, Marco Moschini, Milan, Italy, Pierre Karakiewicz, Montreal, Canada, Patrizio Rigatti, Francesco Montorsi, Alberto Briganti, Milan, Italy MP56-17 UNDERTREATMENT OF MEN IN THEIR SEVENTIES WITH HIGH RISK, NON- METASTATIC PROSTATE CANCER Pär Stattin*, Umeå, Sweden, Marie Hjälm Eriksson, Stockholm, Sweden, Ingela Franck Lissbrant, Gothenburg, Sweden, Yasin Folkvaljon, Uppsala, Sweden, Olof Akre, Stefan Carlsson, Stockholm, Sweden, Linda Drevin, Uppsala, Sweden, Daniel Makarov, Stacy Loeb, New York, NY, Ola Bratt, Helsinborg, Sweden MP56-18 NON-SURGICALLY RELATED CAUSES OF ERECTILE DYSFUNCTION AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY: RESULTS FROM A SINGLE INSTITUTION SERIES Giorgio Gandaglia*, Nazareno Suardi, Vito Cucchiara, Milan, Italy, Firas Abdollah, Detroit, MI, Roberto Bertini, Renzo Colombo, Andrea Salonia, Nicola Fossati, Milan, Italy, Maxine Sun, Montreal, Canada, Marta Picozzi, Milan, Italy, Shahrokh F. Shariat, Vienna, Austria, Francesco Montorsi, Alberto Briganti, Milan, Italy MP YEAR MORTALITY AFTER RADICAL PROSTATECTOMY IN THE PROSTATE- SPECIFIC ANTIGEN SCREENING ERA Neil Mendhiratta*, Ted Lee, Herbert Lepor, New York, NY MP56-20 HYPOGONADISM AND VARICOCELE STATUS AS RISK FACTORS FOR ADVERSE PATHOLOGIC FEATURES AT RADICAL PROSTATECTOMY Bobby Najari*, Ashley Winter, Matthew Katz, Douglas Scherr, Marc Goldstein, New York, NY SUNDAY *Presenting author 181

194 Sunday, May 17, 2015 Moderated Poster Session 57 KIDNEY CANCER: SURGICAL THERAPY II Room New Orleans Morial Convention Center Moderators: Robert Uzzo and Casey Ng 3:30 pm - 5:30 pm NUMBER TITLE NUMBER TITLE MP57-01 COST-EFFECTIVE MANAGEMENT OF SMALL RENAL MASSES: THE ROLE OF TUMOR BIOPSY Michael Rydberg*, Chicago, IL, Sangtae Park, Evanston, IL MP57-02 THE USE OF HEMOSTATIC AGENTS DOES NOT PREVENT HEMORRHAGIC COMPLICATIONS OF ROBOTIC PARTIAL NEPHRECTOMY benoit peyronnet*, zineddine khene, gregory verhoest, romain mathieu, Rennes, France, benjamin pradere, Tours, France, mathieu roumiguie, jean-baptiste beauval, Toulouse, France, alexandra masson-lecomte, Créteil, France, christophe vaessen, hervé baumert, Paris, France, stéphane droupy, Nimes, France, alexandre de la taille, Créteil, France, jean-christophe bernhard, Bordeaux, France, nicolas doumerc, Toulouse, France, morgan roupret, Paris, France, karim bensalah, Rennes, France MP57-03 NON-ISCHEMIC LAPAROSCOPIC PARTIAL NEPHRECTOMY USING 1318-NM DIODE LASER FOR SMALL EXOPHYTIC RENAL TUMORS Ahmed Magdy*, Katharina Bretterbauer, Michael Mitterberger, Günter Janetschek, Salzburg, Austria MP57-04 PREDICTORS OF SURGICAL APPROACH FOR TREATMENT OF RENAL CELL CARCINOMA Manish Patel*, Stephen Strahan, Albert Bang, Justin Vass, David Smith, Sydney, Australia MP57-05 MATCHED PAIR ANALYSIS OF TRANSPERITONEAL VERSUS RETROPERITONEAL ROBOTIC PARTIAL NEPHRECTOMY Sevan Stepanian*, Ashraf Haddad, Jason Kowitz, Cindy Fuller, James Porter, Seattle, WA MP57-06 NONOPERATIVE MANAGEMENT DRIVES RENAL MASS BIOPSY IN THE MODERN ERA Matthew Maurice*, Hui Zhu, Simon Kim, Robert Abouassaly, Cleveland, OH MP57-07 WHO DIES FROM NEPHRECTOMY AND WHY DO THEY DIE? - THE IDENTIFICATION OF RISK FACTORS FOR PERIOPERATIVE DEATH FOLLOWING NEPHRECTOMY A NATIONAL STUDY Archie Fernando*, Sarah Fowler, Tim O Brien, London, United Kingdom MP57-08 SIGNIFICANCE OF GERIATRIC NUTRITIONAL RISK INDEX AS A PROGNOSTIC PREDICTOR IN PATIENTS WITH NON-METASTATIC RENAL CELL CARCINOMA UNDERGOING SURGICAL RESECTION Hiromoto Tei*, Hideaki Miyake, Masato Fujisawa, Kobe, Japan MP57-09 COMPARISON OF THE OPEN AND ROBOTIC APPROACH IN PARTIAL NEPHRECTOMY FOR HIGHLY COMPLEX TUMORS (RENAL NEPHROMETRY SCORE 10) benoit peyronnet*, tarek fardoun, Rennes, France, thibaut benoit, mathieu roumiguie, Toulouse, France, gregory verhoest, Rennes, France, jean-baptiste beauval, michel soulie, nicolas doumerc, Toulouse, France, karim bensalah, Rennes, France MP57-10 INITIAL CLINICAL EXPERIENCE WITH PERCUTANEOUS IRREVERSIBLE ELECTROPORATION OF KIDNEY TUMORS Monica Morgan, Aaron Lay*, Asim Ozayar, Jeffrey Gahan, Clayton Trimmer, Jeffrey Cadeddu, Dallas, TX MP57-11 PERCUTANEOUS ENDOSCOPIC RESECTION OF UPPER TRACT UROTHELIAL NEOPLASMS WITH TUMOR BURDEN >1.5 CM: 5-YEAR SINGLE CENTER EXPERIENCE Joel E. Abbott*, Detroit, MI, Julio G. Davalos, Baltimore, MD MP57-12 NO PROVEN BENEFIT OF POSTOPERATIVE DRAINAGE AFTER ROBOTIC PARTIAL NEPHRECTOMY benoit peyronnet*, zineddine khene, Rennes, France, benjamin pradere, Tours, France, gregory verhoest, romain mathieu, Rennes, France, mathieu roumiguie, jean-baptiste beauval, Toulouse, France, christophe vaessen, hervé baumert, Paris, France, stéphane droupy, Nimes, France, alexandre de la taille, Créteil, France, jean-christophe bernhard, Bordeaux, France, nicolas doumerc, Toulouse, France, morgan roupret, Paris, France, karim bensalah, Rennes, France 182

195 MP57-13 LAPAROSCOPIC VERSUS PERCUTANEOUS CRYOABLATION FOR T1 RENAL MASSES: AN ITALIAN MULTICENTRIC STUDY Bernardino de Concilio*, Calogero Cicero, Dario del biondo, Guglielmo Zeccolini, Bassano del Grappa, Italy, Fulvio Laganà, Alessandro Pinzani, Dolo, Italy, Piero Pellegrini, Tiziano Stocca, Gorizia, Italy, Luca Balestreri, Martina Urbani, Aviano, Italy, Giovanni Carbognin, Negrar, Italy, Giuseppe Casarrubea, Fabio Zattoni, Padova, Italy, Davide Barbisan, Franco Merlo, Treviso, Italy, Salvatore Siracusano, Fulvio Stacul, Trieste, Italy, Antonio Celia, Bassano del Grappa, Italy MP57-14 INTRAOPERATIVE MOLECULAR DIAGNOSTIC IMAGING CAN IDENTIFY RENAL CELL CARCINOMA DURING NEPHRECTOMY Thomas Guzzo*, Jane Keating, Jack Jiang, Elizabeth DeJesus, Sunil Singhal, Philadelphia, PA MP57-15 EN BLOC LIGATION OF RENAL VESSELS DURING LAPAROSCOPIC NEPHRECTOMY AND NEPHROURETERECTOMY Mariam Hult*, Mikkel Fode, Claus Dahl, Nessn Azawi, Roskilde, Denmark MP57-16 ANTIPLATELET/ANTICOAGULATION THERAPY DOES NOT INCREASE IMMEDIATE COMPLICATIONS IN PATIENTS UNDERGOING ROBOTIC PARTIAL NEPHRECTOMY (RPN) Andrew Leone*, George Turini, Joseph Brito, Timothy Tran, Joseph Renzulli, Gyan Pareek, Dragan Golijanin, Providence, RI MP57-17 COMPARISON OF SURVIVAL RATES IN STAGE ONE RENAL CELL CARCINOMA BETWEEN PARTIAL NEPHRECTOMY AND RADICAL NEPHRECTOMY PATIENTS ACCORDING TO AGE DISTRIBUTION Toshio Takagi*, Tsunenori Kondo, Kenji Omae, Junpei Iizuka, Hirohito Kobayashi, Yasunobu Hashimoto, Kazunari Tanabe, Tokyo, Japan MP57-18 ZERO ISCHEMIA LAPAROSCOPIC PARTIAL NEPHRECTOMY: PRELIMINARY EXPERIENCE Roberto Sanseverino*, Umberto Di Mauro, Oliver Intilla, Tommaso Realfonso, Carmine Cicalese, Carmine Cicalese, Giorgio Napodano, Nocera Inferiore, Italy MP57-19 NOVEL PREDICTORS OF EFFICACY IN PERCUTANEOUS RADIOFREQUENCY ABLATION OF RENAL CELL CARCINOMA: R.E.N.A.L. NEPHROMETRY SCORE AND RENAL CELL CARCINOMA SUBTYPE Timothy McClure*, Columbus, OH, Allan Pantuck, James Sayre, Steve Raman, Los Angeles, CA MP57-20 VARIANT HISTOLOGY DOES NOT PREDICT SURVIVAL OUTCOMES AFTER RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA: RESULTS FROM THE CANADIAN UPPER TRACT COLLABORATION Lucas Dean*, Adrian Fairey, Niels Jacobsen, Edmonton, Canada, Simon Tanguay, Montreal, Canada, Ricardo Rendon, David Bell, Halifax, Canada, Jonathan Izawa, Joseph Chin, London, Canada, Anil Kapoor, Bobby Shayegan, Edward Matsumoto, Hamilton, Canada, Peter Black, Alan So, Vancouver, Canada, Jean-Baptiste Lattouf, Fred Saad, Montreal, Canada, Darrel Drachenberg, Winnipeg, Canada, Ilias Cagiannos, Ottawa, Canada, Louis Lacombe, Yves Fradet, Quebec City, Canada, Wassim Kassouf, Montreal, Canada SUNDAY Sunday, May 17, 2015 Podium Session 31 BLADDER CANCER: INVASIVE I Room New Orleans Morial Convention Center Moderator: Manish Vira 3:30 pm - 5:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 3:30 PD31-01 SURVEILLANCE STRATEGIES IN BLADDER CANCER FOLLOWING RADICAL CYSTECTOMY: A SYSTEMATIC REVIEW AND META-ANALYSIS Suzanne Stewart*, Fares Alahdab, Khalid Benkhadra, Zhen Wang, Atsushi Sorita, Stephen Boorjian, Igor Frank, Mohammad Murad, Rochester, MN 3:40 PD31-02 PERFORMANCE STATUS AS A SIGNIFICANT PREDICTOR FOR BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY Nobuyuki Hinata*, Akira Miyazaki, Masatomo Nishikawa, Hiromoto Tei, Hideaki Miyake, Masato Fujisawa, Kobe, Japan *Presenting author 183

196 3:50 PD31-03 IMPAIRMENT FREE SURVIVAL: A RELEVANT CLINICAL ENDPOINT FOR BLADDER CANCER PATIENTS UNDERGOING CYSTECTOMY Cheryl Lee*, Stephanie Daignault-Newton, Linda Drnek, Michael Englesbe, Khaled Hafez, Brent Hollenbeck, Pearl Lee, Jeffrey Montgomery, Todd Morgan, Michael Termanjian, Alon Weizer, Ann Arbor, MI 4:00 PD31-04 ROBOTIC SALVAGE CYSTECTOMY IS SAFE: MULTI-INSTITUTIONAL PERIOPERATIVE OUTCOMES Neel Srikishen*, Houston, TX, Andre Abreu, Los Angeles, CA, Monty Aghazadeh, Michael Pan, Houston, TX, Gus Miranda, Monish Aron, Los Angeles, CA, Brian Miles, Houston, TX, Inderbir Gill, Mihir Desai, Los Angeles, CA, Alvin Goh, Houston, TX 4:10 PD31-05 SALVAGE RADICAL CYSTECTOMY AFTER IRRADIATION FOR MUSCLE INVASIVE BLADDER CANCER IN QUÉBEC: A POPULATION-BASED ANALYSIS OF OUTCOMES Ahmed S. Zakaria Ahmed*, Fabiano Santos, Wassim Kassouf, Simon Tanguay, Armen Aprikian, Montreal, Canada 4:20 PD31-06 TEMPORAL TRENDS AND PREDICTORS OF THE RECEIPT OF ADEQUATE LYMPHADENECTOMY AT RADICAL CYSTECTOMY FOR BLADDER CANCER Alexander Cole*, Boston, MA, Deepansh Dalela, Detroit, MI, Christian Meyer, Julian Hanske, Boston, MA, Mani Menon, Detroit, MI, Adam Kibel, Quoc-Dien Trinh, Boston, MA 4:30 PD31-07 DIFFERENCES IN LYMPH NODE COUNT AT RADICAL CYSTECTOMY WITH A STANDARDIZED SURGICAL TEMPLATE DO NOT INFLUENCE LONG-TERM SURVIVAL FOR BLADDER CANCER Elisabeth E. Fransen van de Putte*, Tom J.N. Hermans, Erik van Werkhoven, Laura S. Mertens, Richard P. Meijer, Axel Bex, Henk G. van der Poel, Bas W.G. van Rhijn, Simon Horenblas, Amsterdam, Netherlands 4:40 PD31-08 SARCOMATOID CARCINOMA AND CARCINOSARCOMA HISTOLOGY OF BLADDER CANCER PORTEND A SIGNIFICANTLY WORSE PROGNOSIS THAN UROTHELIAL CARCINOMA Susan MacDonald*, Mark Schoenberg, Farhang Rabbani, Bronx, NY 4:50 PD31-09 CLINICAL FACTORS PREDICTING PATHOLOGICAL POSITIVE LYMPH NODES IN CLINICALLY NODE NEGATIVE PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY Kamran Zargar-Shoshtari*, Tampa, FL, Homayoun Zargar, Vancouver, Canada, Colin P Dinney, Houston, TX, Cesar E Ercole, Cleveland, OH, Hamidreza Abdi, Vancouver, Canada, Evan Kovac, Jorge A Garcia, Andrew J Stephenson, Cleveland, OH, Jay B Shah, Houston, TX, Peter Black, Vancouver, Canada, Philippe E Spiess, Tampa, FL 5:00 PD31-10 OUTCOMES FOLLOWING POST- CYSTECTOMY RECURRENCE OF BLADDER CANCER BASED ON METASTATIC SITE Anirban P. Mitra*, David I. Quinn, Los Angeles, CA, Eila C. Skinner, Stanford, CA, Tanya B. Dorff, Anne K. Schuckman, Siamak Daneshmand, Los Angeles, CA 5:10 PD31-11 NEOADJUVANT DOSE-DENSE METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN FOR MUSCLE-INVASIVE BLADDER CANCER Elisabeth E. Fransen van de Putte*, Laura S. Mertens, Richard P. Meijer, Michiel S. van der Heijden, J. Martijn Kerst, Andries M. Bergman, Simon Horenblas, Bas W.G. van Rhijn, Amsterdam, Netherlands 5:20 PD31-12 PDL1 STATUS IN MUSCLE INVASIVE UROTHELIAL BLADDER CARCINOMA (MIBC) IN THE CONTEXT OF NEOADJUVANT CISPLATIN BASED CHEMOTHERAPY Alexander Baras*, Maria Angelica Mendoza, Gunes Guner, Nilay Gandhi, Jen-Jane Liu, Janis Taube, Trinity Bivalacqua, George Netto, Baltimore, MD 5:30 PD31-13 PERI-OPERATIVE MORTALITY AND LONG- TERM SURVIVAL AFTER PARTIAL VERSUS RADICAL CYSTECTOMY FOR MUSCLE INVASIVE BLADDER CANCER Malek Meskawi*, Montreal, Canada, Alessandro Larcher, Milan, Italy, Roger Valdivieso, Vincent Trudeau, Montreal, Canada, Katharina Boehm, Jonas Schiffmann, Hamburg, Germany, Maxine Sun, Pierre Karakiewicz, Montreal, Canada 184

197 Sunday, May 17, 2015 Podium Session 32 PROSTATE CANCER: STAGING II Room New Orleans Morial Convention Center Moderators: John Davis and Paul Lange 3:30 pm - 5:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 3:30 PD32-01 COMPARISON OF MRI-US FUSION TARGETED BIOPSY AND SYSTEMATIC PROSTATE BIOPSY: SINGLE INSTITUTION EXPERIENCE IN 604 PATIENTS Xiaosong Meng*, Andrew B. Rosenkrantz, Neil Mendhiratta, Michael Fenstermaker, Richard Huang, New York, NY, James Wysock, Flushing, NY, Marc Bjurlin, Susan Marshall, Fang-Ming Deng, Jonathan Melamed, Ming Zhou, William C. Huang, Herbert Lepor, Samir S. Taneja, New York, NY 3:40 PD32-02 OPTIMAL SAMPLING NUMBER IN MRI- TARGETED BIOPSY Noboru Numao*, Masaya Ito, Yusuke Uchida, Takayuki Nakayama, Masaharu Inoue, Manabu Tatokoro, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara, Tokyo, Japan 3:50 PD32-03 OUTCOMES OF MRI-US FUSION TARGETED PROSTATE BIOPSY IN MEN WITH HISTORY OF PREVIOUS NEGATIVE BIOPSY: IMPROVED CANCER DETECTION AND RISK STRATIFICATION Neil Mendhiratta*, Andrew B Rosenkrantz, Xiaosong Meng, Michael Fenstermaker, Richard Huang, New York, NY, James S Wysock, Flushing, NY, Fang-Ming Deng, Jonathan Melamed, Ming Zhou, William C Huang, Herbert Lepor, Samir S Taneja, New York, NY 4:00 PD32-04 CAN CONFIRMATORY BIOPSY BE SKIPPED FOR ACTIVE SURVEILLANCE PATIENTS WITH NEGATIVE MRI FINDINGS AND A LOW NUMBER OF POSITIVE CORES ON DIAGNOSTIC BIOPSY? Prassannah Satasivam*, Biny Ying Poon, Hebert Alberto Vargas, Andrew Vickers, James Eastham, New York, NY 4:10 PD32-05 GRADE CONCORDANCE OF TARGETED MRI-ULTRASOUND FUSION TARGETED PROSTATE BIOPSY RESULTS WITH FINAL PATHOLOGY FOLLOWING RADICAL PROSTATECTOMY Michael Fenstermaker*, Neil Mendhiratta, Xiaosong Meng, Fang-Ming Deng, Ming Zhou, Andrew B. Rosenkrantz, Richard Huang, Susan Marshall, New York, NY, James S. Wysock, Flushing, NY, Marc Bjurlin, William C. Huang, Herbert Lepor, Samir S. Taneja, New York, NY 4:20 PD32-06 DETECTION RATES OF 68GALLIUM- LABELLED LIGAND OF PSMA PET/CT AND PET/MRI IN 332 CONSECUTIVE PATIENTS WITH BIOCHEMICAL RECURRENCY AFTER RADICAL PROSTATECTOMY Tobias Maurer*, Veronika Beck, Ambros Beer, Michael Souvatzoglou, Konstantin Holzapfel, Hubert Kübler, Jürgen Erich Gschwend, Hans-Jürgen Wester, Bernhard Haller, Markus Schwaiger, Matthias Eiber, Munich, Germany 4:30 PD32-07 PREOPERATIVE LYMPH NODE STAGING IN INTERMEDIATE TO HIGH-RISK PROSTATE CANCER PATIENTS USING 68GA-HBED-PSMA PET HYBRID IMAGING A PATIENT- AND FIELD-BASED ANALYSIS Tobias Maurer*, Lisa Pähr, Michael Souvatzoglou, Gregor Weirich, Hubert Kübler, Hans-Jürgen Wester, Bernhard Haller, Markus Schwaiger, Jürgen Erich Gschwend, Matthias Eiber, Munich, Germany 4:40 PD32-08 CHOLINE PET/CT SCAN FOR THE DETECTION OF NODAL RELAPSES OF PROSTATE CANCER AFTER BIOCHEMICAL RECURRENCE: RESULTS FROM A MULTICENTRIC STUDY Marco Oderda, Paolo Gontero*, Guglielmo Melloni, Stefania Munegato, Marco Falcone, Turin, Italy, Hannes Van De Bosche, Steven Deconinck, Leuven, Belgium, Fabio Zattoni, Robert Jeffrey Karnes, Rochester, MN, Steven Joniau, Leuven, Belgium 4:50 PD32-09 VERY LONG-TERM ONCOLOGICAL OUTCOMES OF PATIENTS TREATED WITH RADICAL PROSTATECTOMY FOR NODE POSITIVE PROSTATE CANCER: A MULTI-INSTITUTIONAL, CONDITIONAL SURVIVAL ANALYSIS Marco Moschini*, Alberto Briganti, Marco Bianchi, Nicola Fossati, Nazareno Suardi, Andrea Gallina, Giorgio Gandaglia, Cesare Cozzarini, Umberto Capitanio, Milan, Italy, Firas Abdollah, Detroit, MI, Francesco Montorsi, Milan, Italy, R. Jeffrey Karnes, Rochester, MN 5:00 PD32-10 POSITIVE SURGICAL MARGINS IN RADICAL PROSTATECTOMY PATIENTS DO NOT PREDICT LONG-TERM ONCOLOGICAL OUTCOMES: RESULTS FROM SEARCH Prabhakar Mithal*, Rochester, NY, Lauren Howard, Durham, NC, William Aronson, Los Angeles, CA, Martha Terris, Augusta, GA, Matthew Cooperberg, San Francisco, CA, Christopher Kane, San Diego, CA, Christopher Amling, Portland, OR, Stephen Freedland, Durham, NC SUNDAY *Presenting author 185

198 5:10 PD32-11 SIGNIFICANT REDUCTION IN THERAPEUTIC BURDEN FROM USE OF CCP TEST IN TREATMENT DECISIONS AMONG NEWLY DIAGNOSED PROSTATE CANCER PATIENTS IN A LARGE PROSPECTIVE REGISTRY Neal Shore*, Myrtle Beach, SC, Judd Boczko, White Plains, NY, Naveen Kella, San Antonio, TX, Brian J. Moran, Westmont, IL, Fernando J. Bianco, Miami Lakes, FL, E. David Crawford, Aurora, CO, Alison Sibley, Kirstin M. Roundy, Rajesh Kaldate, Charles Grier, Michael K. Brawer, Salt Lake City, UT, Mark L. Gonzalgo, Miami, FL 5:20 PD32-12 PROSTATE ATYPIA: DOES REPEAT BIOPSY DETECT CLINICALLY SIGNIFICANT PROSTATE CANCER? Ryan Dorin, Hartford, CT, Scott Wiener*, Cory Harris, Farmington, CT, Joseph Wagner, Hartford, CT Sunday, May 17, 2015 Podium Session 33 KIDNEY CANCER: BASIC RESEARCH III Room New Orleans Morial Convention Center Moderators: Jodi Maranchie and Guan Wu 3:30 pm - 5:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 3:30 PD33-01 THE VIABILITY, METABOLISM AND VASCULARIZATION OF RENAL CELL CARCINOMA CELL LINES AND XENOGRAFTS CAN BE TARGETED THROUGH INHIBITION OF ENDOGENOUS HYDROGEN SULFIDE PRODUCTION Eric Sonke*, Megan Verrydt, Carl O. Postenka, Siddika Pardhan, Chantalle J. Willie, Clarisse Mazzola, Ian Lobb, Ann F. Chambers, Nicholas E. Power, Hon S. Leong, Alp Sener, London, Canada 3:40 PD33-02 OVERCOMING THE OBSTACLE OF INTRATUMOR GENETIC HETEROGENEITY IN RENAL CELL CARCINOMA THROUGH ULTRA DEEP SEQUENCING OF POOLED REGIONAL TUMOR DNA Alex Sankin*, Andrew Winer, A. Ari Hakimi, Elizabeth Wei, Michael Chevinsky, Tarik Silk, Christopher Jakubowski, Fred Jacques, Jeremy Durack, Jonathan Coleman, Michael Berger, Paul Russo, James Hsieh, New York, NY 3:50 PD33-03 TREATMENT OF THE PRIMARY TUMOR WITH VASCULAR-TARGETED PHOTODYNAMIC THERAPY (VTP) OVERCOMES RESISTANCE TO SYSTEMIC PD-1/PD-L1 INHIBITION: EFFECTS ON PRIMARY TUMOR CONTROL AND PREVENTION OF LUNG METASTASIS IN A PRE-CLINICAL RCC MODEL Matthew O Shaughnessy*, Katie Murray, Stephen LaRosa, Sebastien Monette, Kwanghee Kim, Renato Beluco Corradi Fonseca, New York, NY, Avigdor Scherz, Rehovot, Israel, Jonathan Coleman, New York, NY 4:00 PD33-04 INVERSE RELATIONSHIP BETWEEN INSULIN RECEPTOR EXPRESSION AND CANCER PROGRESSION IN RENAL CELL CARCINOMA: CLINICAL AND EXPERIMENTAL EVALUATION Makoto Takahashi*, Takamitsu Inoue, Mingguo Huang, Hiroshi Tsuruta, Mitsuru Saito, Shintaro Narita, Norihiko Tsuchiya, Tomonori Habuchi, Akita, Japan 4:10 PD33-05 TUMOR-SUPPRESSIVE MICRORNA-29S- MEDIATED NOVEL MOLECULAR PATHWAYS IN RENAL CELL CARCINOMA Shuichi Tatarano*, Kagoshima, Japan, Rika Nishikawa, Chiba, Japan, Takeshi Chiyomaru, Hideki Enokida, Satoru Inoguchi, Tomoaki Ishihara, Hirofumi Yoshino, Kagoshima, Japan, Naohiko Seki, Chiba, Japan, Masayuki Nakagawa, Kagoshima, Japan 4:20 PD33-06 A RETROSPECTIVE COHORT STUDY OF RENAL CANCER MOLECULAR HETEROGENEITY AND DNA METHYLATION PROGNOSTIC MARKERS Alexander Laird*, Duncan Sproul, Grant Stewart, Fiach O Mahony, Edinburgh, United Kingdom, Antony Riddick, Cambridge, United Kingdom, Richard Meehan, Edinburgh, United Kingdom, David Harrison, St Andrew s, United Kingdom 4:30 PD33-07 WITHDRAWN 4:40 PD33-08 PAZOPANIB, SUNITINIB, AND AXITINIB REDUCE EXPANSION OF IN VITRO INDUCED SUPPRESSIVE MACROPHAGES Raman Unnikrishnan*, Patricia Rayman, Yu Yang, Claudia Marcela Diaz-Montero, James Finke, Cleveland, OH 186

199 4:50 PD33-09 LOSS OF 5-HYDROXYMETHYLCYTOSINE FACILITATES THE ESTABLISHMENT OF UNIQUE ABERRANT DNA METHYLATION PATTERN TO PROMOTE KIDNEY TUMORIGENESIS Liqun Zhou*, Zhongqiang Guo, Xuesong Li, Beijing, China, People s Republic of 5:00 PD33-10 RADIATION THERAPY IMPROVES IMMUNOGENICITY OF HUMAN RENAL CELL CARCINOMA Jason Muhitch*, Mohammad Habiby Kermany, Lilia Heit, Alexander Wald, Mary Hensen, Scott Abrams, Timothy Winslow, Anurag Singh, Thomas Schwaab, Buffalo, NY 5:10 PD33-11 METABOLIC MODULATION WITH DICHLOROACETATE REVERSES THE WARBURG EFFECT AND REDUCES THE GROWTH OF CLEAR CELL RENAL CELL CARCINOMA IN VITRO AND IN VIVO Adam Kinnaird*, Peter Dromparis, Roxane Paulin, Bruno Saleme, Trevor Stenson, Desmond Pink, John Lewis, Evangelos Michelakis, Edmonton, Canada 5:20 PD33-12 ABERRANT ACTIVATION OF GLI1/2 VIA THE PHOSPHOINOSITIDE 3-KINASE/AKT PATHWAY AND ITS THERAPEUTIC VALUE IN CLEAR-CELL RENAL CELL CARCINOMA Jiancheng Zhou*, Kaijie Wu, Guodong Zhu, Xinyang Wang, Dalin He, Xi an, China, People s Republic of SUNDAY Sunday, May 17, 2015 Video Session 8 3:30 pm - 5:30 pm BLADDER ONCOLOGY/TESTIS/TRANSPLANTATION/TRAUMA The videos in this session as well as the video libraries from the Annual Meetings may be viewed in the Surgical Video Library and purchased in the Products Store during the Annual Meeting. Both are located in Registration Hall B2. All years of the Surgical Video Library may also be purchased online at Room New Orleans Morial Convention Center Moderators: Reza Ghavamian and Andrew James NUMBER TITLE NUMBER TITLE V8-01 ROBOTIC RPLND USING THE DAVINCI XI Ashraf Haddad, James Porter*, Seattle, WA V8-02 MANAGEMENT OF CHALLENGING URETHRO-ILEAL ANASTOMOSIS DURING ROBOTIC INTRACORPOREAL NEOBLADDER FORMATION Nima Almassi*, Homayoun Zargar, Vishnu Ganesan, Amr Fergany, Georges Pascal Haber, Cleveland, OH V8-03 STEP-BY-STEP TECHNIQUE FOR ROBOTIC INTRACORPOREAL BOWEL ANASTOMOSIS AND DEVELOPMENT OF A SIMULATION TRAINING MODEL Friedrich-Carl von Rundstedt*, Selcuk Silay, Monty Aghazadeh, Alvin Goh, Houston, TX V8-04 ROBOTIC-ASSISTED LAPAROSCOPIC PARTIAL CYSTECTOMY WITH DIVERTICULECTOMY, DISTAL URETERECTOMY WITH URETERONEOCYSTOTOMY, AND BILATERAL PELVIC LYMPHADENECTOMY FOR MALIGNANT DISEASE IN A BLADDER DIVERTICULUM Jed-sian Cheng*, Boston, MA, Glen Barrisford, Santa Rosa, CA, Mahdi Zangi, Shahin Tabatabaei, Boston, MA V8-05 CONCOMITANT HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) AND LAPAROSCOPIC ROBOT- ASSISTED BLADDER DIVERTICULECTOMY FOR TREATMENT OF A LARGE BLADDER TUMOR Adam C Calaway*, David Y Yang, Jessica E Paonessa, James E Lingeman, Ronald S Boris, Indianapolis, IN V8-06 BLUE LIGHT CYSTOSCOPY: THE USC EXPERIENCE Siamak Daneshmand*, Los Angeles, CA, Mehrdad Alemozaffar, Atlanta, GA, Hooman Djaladat, Anne Schuckman, Los Angeles, CA V8-07 EN BLOC BLADDER TUMOR RESECTION: BACK TO ONCOLOGIC BASICS Piruz Motamedinia*, New Hyde Park, NY, Alexey Martov, Moscow, Russian Federation, Zeph Okeke, Arthur Smith, New Hyde Park, NY V8-08 LASER EN BLOC RESECTION OF BLADDER TUMORS: A EUROPEAN MULTI- CENTER STUDY TO EVALUATE SAFETY, EFFICACY AND OUTCOME Mathias Wolters*, Mario Kramer, Axel Merseburger, Hannover, Germany, Markus Riedl, Armin Leitenberger, Wolfsburg, Germany, Alexey Martov, Nikolay Baykov, Moscow, Russian Federation, Markus Kuczyk, Hannover, Germany, Andreas Gross, Hamburg, Germany, David Leavitt, Arthur Smith, New York, NY, Thomas Herrmann, Hannover, Germany *Presenting author 187

200 V8-09 ROBOTIC-ASSISTED INGUINAL LYMPHADENECTOMY: EARLY OUTCOMES AND TECHNICAL MODIFICATIONS Alexander M. Helfand*, Jeffrey S. Montgomery, Alon Z. Weizer, Todd M. Morgan, Ann Arbor, MI V8-10 ROBOTIC ANTERIOR PELVIC EXENTERATION WITH INTRACORPOREAL ILEAL CONDUIT IN A PATIENT WITH HISTORY OF KIDNEY PANCREAS TRANSPLANTATION Yaw Nyame*, Paurush Babbar, Daniel Greene, Homayoun Zargar Shoshtari, Venkatesh Krishnamurthi, Georges-Pascal Haber, Cleveland, OH V8-11 ROBOTIC PARTIAL AND RADICAL NEPHRECTOMY IN RENAL ALLOGRAFT: DEMONSTRATION OF TECHNIQUE Haidar Abdul-Muhsin*, Nitin Katariya, Erik Castle, Phoenix, AZ V8-12 MALFUNCTION OF LINEAR CUTTING STAPLER IN KIDNEY SURGERY Rene Sotelo*, Caracas, Venezuela, Erik Castle, Scottsdale, AZ, Robert De Andrade, Luis Medina, Leonardo Brunacci, Oscar Martín, Igor Kislinger, Nelson Ramírez-Troche, David Canes, Caracas, Venezuela, Paul Andrews, Scottsdale, AZ, Camilo Giedelman, Hernán Aponte, Bogota, Colombia V8-13 ACUTE INSERTION OF PENILE PROSTHESES FOR REFRACTORY ISCHEMIC PRIAPISM Paul Chung*, Timothy Tausch, Jordan Siegel, James Flemons, Allen Morey, Dallas, TX V8-14 ROBOTIC SALVAGE CYSTECTOMY: TIPS AND TRICKS Neel Srikishen*, Michael Pan, Monty Aghazadeh, Brian Miles, Alvin Goh, Houston, TX 188

201 MP Moderated Poster Session, PD Podium Session Monday, May 18, 2015 Plenary Session PLENARY I - MONDAY Great New Orleans Morial Convention Center 7:30 am - 12:15 pm 7:28 WELCOME AND ANNOUNCEMENTS 7:30 HIGHLIGHTS: THE SCIENCE OF FEMALE PELVIC HEALTH Toby Chai 7:40 STATE-OF-THE-ART LECTURE: EFFECTS OF MUSCLE CELL THERAPY IN A NONHUMAN PRIMATE MODEL OF CHRONIC INTRINSIC URINARY SPHINCTER DEFICIENCY J. Koudy Williams 7:55 POINT-COUNTERPOINT: REFRACTORY OVERACTIVE BLADDER (OAB) WITH PELVIC ORGAN PROLAPSE (POP) Moderator: Kathleen Kobashi Debaters: Sandip Vasavada (Con) E. Ann Gormley (Pro) 8:15 POINT-COUNTERPOINT: OCCULT SUI: WHAT HAVE CLINICAL TRIALS TAUGHT US? Moderator: Firouz Daneshgari Debaters: Stephen Kraus (Con) Howard Goldman (Pro) 8:35 PRESIDENTIAL ADDRESS: LEARNING FROM YESTERDAY, LIVING FOR TODAY AND LOOKING FORWARD TO TOMORROW William Bohnert MONDAY 8:55 RAMON GUITERAS LECTURE: TWO DECADES OF INNOVATION IN MINIMALLY INVASIVE UROLOGIC ONCOLOGIC SURGERY: THE BEST IS YET TO COME Inderbir Gill 9:15 CRITICAL DISCUSSION: RENAL URETEROSCOPY FOR STONES: TO DUST OR TO BASKET Critical Discussant: Gerhard Fuchs Presenters: Ojas Shah (Dust) Mitchell Humphreys (Basket) 9:35 PANEL DISCUSSION: MINIMALLY INVASIVE URETERAL RECONSTRUCTION Moderator: Ashok Hemal Panelists: Jihad Kaouk Louis Kavoussi Mihir Desai 10:00 AUA GUIDELINE UPDATE: CASTRATION-RESISTANT PROSTATE CANCER William Lowrance 10:10 BEST : PI-04: DURABLE REDUCTIONS IN URINARY INCONTINENCE WITH LONG-TERM ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH OVERACTIVE BLADDER SYNDROME: FINAL RESULTS OF 3.5-YEAR STUDY Victor Nitti*, New York, NY, Dirk De Ridder, Leuven, Belgium, David Sussman, Stratford, NJ, Peter Sand, Evanston, IL, Karl-Dietrich Sievert, Lubeck, Germany, Christopher Chapple, Sheffield, United Kingdom, Brenda Jenkins, Irvine, CA, Yan Zheng, Bridgewater, NJ, Sidney Radomski, Toronto, Canada 10:17 BEST : PI-05: IS RETROPUBIC MID-URETHRAL SLING SAFE AND EFFECTIVE FOR PATIENTS WITH VALSALVA VOIDING? Blake Anderson*, Joseph Pariser, Shane Pearce, Gregory Bales, Chicago, IL, Doreen Chung, New York, NY 10:25 STATE-OF-THE-ART LECTURE: UROLOGICAL ASSOCIATION OF ASIA (UAA) LECTURE: IMPACT OF CHRONIC PROSTATIC INFLAMMATION ON BPH/LUTS Yoshiyuki Kakehi 10:45 STATE-OF-THE-ART LECTURE: PATHOPHYSIOLOGY AND MANAGEMENT OF URIC ACID STONES Naim Maalouf 11:00 STATE-OF-THE-ART LECTURE: ANTIBIOTIC STEWARDSHIP Florian Wagenlehner 11:15 STATE-OF-THE-ART LECTURE: THE BEERS CRITERIA FOR POTENTIALLY INAPPROPRIATE MEDICATION USE IN OLDER ADULTS Tomas Griebling *Presenting author 189

202 11:30 PANEL DISCUSSION: SPECIAL CONSIDERATIONS FOR TREATING OAB IN THE ELDERLY: A PRACTICAL APPROACH Moderator: Kevin Pranikoff Panelists: E. Camille Vaughan Hann-Chorng Kuo Matthias Oelke 11:55 AUA GUIDELINE: INTERSTITIAL CYSTITIS GUIDELINE AMENDMENT Philip Hanno 12:05 STATE-OF-THE-ART LECTURE: CATHETER ASSOCIATED URINARY TRACT INFECTIONS: DEFINITIONS AND SIGNIFICANCE IN THE UROLOGIC PATIENT. AN AUA WHITE PAPER Timothy Averch 12:15 SESSION CONCLUDES Monday, May 18, 2015 Plenary Session PLENARY II - MONDAY Hall New Orleans Morial Convention Center 10:00 am - 12:00 pm 9:58 WELCOME AND ANNOUNCEMENTS 10:00 EUROPEAN ASSOCIATION OF UROLOGY (EAU) LECTURE: EARLY DETECTION OF PROSTATE CANCER: THE EUROPEAN VIEW Per-Anders Abrahamsson 10:20 POINT-COUNTERPOINT: NEOADJUVANT CHEMOTHERAPY SHOULD BE THE STANDARD IN BULKY INGUINAL NODES IN PENILE CANCER Moderator: Philippe Spiess Debaters: Lance Pagliaro (Pro) Sukhbinder Minhas (Con) 10:40 POINT-COUNTERPOINT: INTERMITTENT VS. MAXIMAL ADT: TRANSLATING RANDOMIZED TRIALS IN CLINICAL PRACTICE Moderator: Robert Flanigan Debaters: Maha Hussain (Maximal ADT) Laurence Klotz (Intermittent) 11:00 STATE-OF-THE-ART LECTURE: MRI & MR FUSION BIOPSY Samir Taneja 11:15 PANEL DISCUSSION: REDEFINING THE ROLE OF CHEMOTHERAPY IN THE PROSTATE CANCER SEQUENCING STORY IN CRPC Moderator: Martin Gleave Panelists: Christopher Logothetis Axel Heidenreich Robert Reiter 11:45 STATE-OF-THE-ART LECTURE: PROSTATE CANCER REGISTRY: AN UPDATE Matthew Cooperberg 12:00 SESSION CONCLUDES 190

203 Monday, May 18, 2015 Moderated Poster Session 58 BLADDER CANCER: INVASIVE II Room New Orleans Morial Convention Center Moderators: Joseph Chin and Marcus Quek 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP58-01 NEUTOROPHIL-TO-LYMPHOCYTE RATIO (NLR) MIGHT BE A NEW PROGNOSIS MARKER IN BLADDER CANCER PATIENTS AFTER RADICAL CYSTECTOMY Takashi Kawahara*, Kazuhiro Furuya, Kazuhide Makiyama, Noboru Nakaigawa, Yokohama, Japan, Hiroshi Miyamoto, Baltimore, MD, Masahiro Yao, Hiroji Uemura, Yokohama, Japan MP58-02 PRE-CHEMOTHERAPY NEUTROPHIL-TO- LYMPHOCYTE RATIO CORRELATES WITH CANCER-SPECIFIC AND OVERALL MORTALITY IN PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA Satoru Taguchi*, Tohru Nakagawa, Akihiko Matsumoto, Yasushi Nagase, Taketo Kawai, Yoshinori Tanaka, Kanae Yoshida, Sachi Yamamoto, Yutaka Enomoto, Yorito Nose, Toshikazu Sato, Akira Ishikawa, Yukari Uemura, Tetsuya Fujimura, Hiroshi Fukuhara, Haruki Kume, Yukio Homma, Tokyo, Japan MP58-03 IDENTIFICATION OF SPECIFIC METHYLATION-BASED BIOMARKERS FOR THE ASSESSMENT OF THE METASTATIC RISK OF MUSCLE INVASIVE BLADDER CANCER Beatrice Stubendorff, Homburg, Germany, Kerstin Wilhelm, Jena, Germany, Kathleen Posselt, Dresden, Germany, James Catto, Sheffield, United Kingdom, Elke Schaeffeler, Matthias Schwab, Stuttgart, Germany, Arndt Hartmann, Erlangen, Germany, Susanne Füssel, Vladimir Novotny, Dresden, Germany, Mieczyslaw Gajda, Marc-Oliver Grimm, Jena, Germany, Michael Stöckle, Kerstin Junker*, Homburg, Germany MP58-04 MUTATION IN MUC6 PREDICTS OVERALL AND RECURRENCE-FREE SURVIVAL FOLLOWING RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER Brian Cross*, William LaFramboise, Jeffrey Gingrich, Somak Roy, Benjamin Davies, Rajiv Dhir, Pittsburgh, PA MP58-05 SIGNIFICANCE OF PREOPERATIVE BUTYRYLCHOLINESTERASE AS AN INDEPENDENT PREDICTOR OF SURVIVAL IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY Takuya Koie*, Chikara Ohyama, Hayato Yamamoto, Shingo Hatakeyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Kazuyuki Mori, Hiromichi Iwamura, Yuta Kojima, Tendo Satoh, Naoki Fujita, Jotaro Mikami, Hirosaki, Japan MP58-06 USING ANALYTIC MORPHOMICS TO UNDERSTAND SHORT-TERM CONVALESCENCE AFTER BLADDER SURGERY Amy Luckenbaugh*, Brent Hollenbeck, Jeffrey Montgomery, Cheryl Lee, Rodney Dunn, Michael Englesbe, Stewart Wang, Ann Arbor, MI MP58-07 TUMOR PD-L1 AND LYMPHOCYTIC INFILTRATE FOXP3 STATUS IN NON- MUSCLE INVASIVE UROTHELIAL CARCINOMA OF BLADDER (NMIBC) Gunes Guner, Maria Angelica Mendoza Rodriguez, Alexander Baras, Jen-Jane Liu, Sheila Friedrich Faraj, Nilda Gonzales- Roibon, Noah M Hahn, Charles Drake, Trinity J Bivalacqua, Janis Taube, Baltimore, MD, Katayoon Rezaei, Washington, DC, George Netto*, Baltimore, MD MP58-08 FAVORABLE SURVIVAL OUTCOMES AFTER A CHEMORADIATION-BASED MULTIMODAL APPROACH AGAINST MUSCLE-INVASIVE BLADDER CANCER WITH HIGH KI-67 EXPRESSION Soichiro Yoshida*, Kenji Tanabe, Fumitaka Koga, Masaharu Inoue, Shuichiro Kobayashi, Junichiro Ishioka, Tomoki Tamura, Emiko Sugawara, Kazutaka Saito, Takumi Akashi, Yasuhisa Fujii, Kazunori Kihara, Bunkyo-ku, Tokyo, Japan MP58-09 THE PATHOLOGIC FEATURES IN RADICAL CYSTECTOMY SPECIMENS OF PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY FOR BLADDER CANCER: IS TUMOR REGRESSION IMPORTANT? Nooshin Karamzadeh Dashti*, Rafael E. Jimenez, Igor Frank, Stephen A. Boorjian, R. Houston Thompson, Brian A. Costello, R. Jeffrey Karnes, John C. Cheville, Rochester, MN MP58-10 THE ASSOCIATION OF CIRCULATING TUMOR CELLS AND VARIANT HISTOLOGY ON OUTCOMES IN UROTHELIAL CARCINOMA OF THE BLADDER TREATED WITH RADICAL CYSTECTOMY Armin Soave, Sabine Riethdorf, Lars Weisbach, Sarah Minner, Oliver Engel, Luis A. Kluth, Felix K. Chun, Roland Dahlem, Klaus Pantel, Margit Fisch, Michael Rink*, Hamburg, Germany MONDAY *Presenting author 191

204 MP58-11 DOES SQUAMOUS DIFFERENTIATION PORTEND WORSE OUTCOMES IN UROTHELIAL BLADDER CANCER? David Y Yang, M Francesca Monn, Hristos Z Kaimakliotis, Jane S Cho*, K Clint Cary, Jose A Pedrosa, Richard Bihrle, Liang Cheng, Michael O Koch, Indianapolis, IN MP58-12 DOES LOW RISK MUSCLE INVASIVE BLADDER CANCER ACTUALLY EXIST? Eugene Pietzak, III*, Matthew Sterling, S. Bruce Malkowicz, Thomas Guzzo, Philadelphia, PA MP58-13 OUTCOME REPORTING AFTER RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER USING ONCOLOGICAL TRIFECTA AND PENTAFECTA Atiqullah Aziz*, Michael Rink, Marianne Schmid, Felix Chun, Roland Dahlem, Hamburg, Germany, Shahrokh F. Shariat, Vienna, Austria, Margit Fisch, Hamburg, Germany, Matthias May, Straubing, Germany MP58-14 A NOVEL TOOL TO PREDICT OUTCOMES FOLLOWING RADICAL CYSTECTOMY USING AGE AND CO-MORBIDITY STATUS Jasmir Nayak*, Sarah Holt, John Gore, Jonathan Wright, Mathew Mossanen, Atreya Dash, Seattle, WA MP58-15 PREDICTING SURVIVAL AFTER RADICAL CYSTECTOMY: VALIDATION OF THE SPARC SCORE Brian Hu*, Los Angeles, CA, Manuel Eisenberg, Stephen Boorjian, Igor Frank, Rochester, MN, Leo Dalag, Kamran Movassaghi;, Los Angeles, CA, Prabin Thapa, Rochester, MN, Gus Miranda, Siamak Daneshmand, Los Angeles, CA MP58-16 PREDICTION OF CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RADICAL CYSTECTOMY FOR BLADDER CANCER USING ARTIFICIAL NEURAL NETWORKS Philipp Nuhn, Munich, Germany, Atiqullah Aziz, Hamburg, Germany, Matthias May, Straubing, Germany, Michael Staehler, Munich, Germany, Michael Gierth, Regensburg, Germany, Jörg Ellinger, Stefan C. Müller, Bonn, Germany, Florian Wagenlehner, Wolfgang Weidner, Giessen, Germany, Rudolf Moritz, Edwin Herrmann, Münster, Germany, Florian Hartmann, Marc- Oliver Grimm, Jena, Germany, Chris Protzel, Oliver Hakenberg, Rostock, Germany, Lukas Lusuardi, Günter Janetschek, Salzburg, Austria, Murat Gördük, Jan Roigas, Berlin, Germany, Maximilian Burger, Regensburg, Germany, Margit Fisch, Hamburg, Germany, Christian G. Stief, Munich, Germany, Patrick Bastian, Düsseldorf, Germany, Tobias Grimm, Alexander Buchner*, Munich, Germany MP58-17 CASE-LOAD IS NOT ASSOCIATED WITH SURGICAL OUTCOMES OF RADICAL CYSTECTOMY. A NATION-WIDE STUDY OF CURRENT PRACTICE Borja Lopez*, Carlos Llorente, Virginia Hernández, Enrique De la Peña, Madrid, Spain, Elia Pérez-Fernández, m, Spain, Maria A. Gogorcena, Madrid, Spain MP58-18 OUTCOME OF METASTATIC UROTHELIAL CARCINOMA IN GC ERA: PROGNOSTIC FACTORS FROM REAL-WORLD CLINICAL PRACTICE IN JAPAN Junji Ishizaki*, asahikawa, Japan, Takashige Abe, Keita Minami, Ryuji Matsumoto, Toru Harabayashi, Sapporo, Japan, Ataru Sazawa, Obihiro, Japan, Tango Mochizuki, Satoshi Chiba, Asahikawa, Japan, Tomoshige Akino, Sapporo, Japan, Masahi Murakumo, Kushiro, Japan, Naoto Miyajima, kunihiko Tsuchiya, Satoru Maruyama, Nobuo Shinohara, Sapporo, Japan MP58-19 FUNCTIONAL OUTCOMES FOLLOWING RADICAL CYSTECTOMY IN WOMEN WITH BLADDER CANCER: A SYSTEMATIC REVIEW Peter Greene*, E. Sophie Spencer, Matthew Lyons, Raj Pruthi, Eric Wallen, Michael Woods, Matthew Nielsen, Chapel Hill, NC, Cheryl Lee, Ann Arbor, MI, Angela Smith, Chapel Hill, NC MP58-20 PREDICTION OF LOCOREGIONAL RECURRENCE AFTER RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER Atiqullah Aziz*, Hamburg, Germany, Michael Froehner, Dresden, Germany, Matthias May, Straubing, Germany, Michael Rink, Felix Chun, Margit Fisch, Hamburg, Germany, Vladimir Novotny, Dresden, Germany 192

205 Monday, May 18, 2015 Moderated Poster Session 59 KIDNEY CANCER: SURGICAL THERAPY III Room New Orleans Morial Convention Center Moderators: Christopher Wood and Jose Karam 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP59-01 IMPACT OF BLOOD TRANSFUSIONS ON ONCOLOGICAL OUTCOMES OF SURGICALLY TREATED LOCALIZED RENAL CELL CARCINOMA Matvey Tsivian, Melissa Mendez*, Durham, NC, Michael Abern, Chicago, IL, Peter Qi, Edward Rampersaud, Thomas Polascik, Durham, NC MP59-02 IMPACT OF URETEROSCOPY PRIOR TO NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA ON ONCOLOGIC OUTCOMES Alex Sankin*, Amy Tin, Roy Mano, Michael Chevinsky, Chris Jakubowski, Eugene Cha, Alyssa Yee, Fara Friedman, Daniel Sjoberg, Behfar Ehdaie, Jonathan Coleman, New York, NY MP59-03 AN EVALUATION OF THE TIMING OF SURGICAL COMPLICATIONS FOLLOWING NEPHRECTOMY Akshay Sood*, Victor Kapoor, Firas Abdollah, Jesse Sammon, Craig Rogers, Dane Klett, Wooju Jeong, Ali Dabaja, Detroit, MI, Marianne Schmid, Adam Kibel, Boston, MA, James Peabody, Mani Menon, Detroit, MI, Quoc-Dien Trinh, Boston, MA MP59-04 OPTIMAL TREATMENT FOR 4-10CM RENAL CELL CARCINOMA: A SURVEY OF ENDOUROLOGISTS AND UROLOGIC ONCOLOGISTS Sara Best, Michael Blute*, Madison, WI, Brian Lane, Grand Rapids, MI, E. Jason Abel, Madison, WI MP59-05 ANALYSIS OF FACTORS AFFECTING POST-OPERATIVE SPLIT RENAL FUNCTION AFTER PARTIAL NEPHRECTOMY USING R.E.N.A.L. NEPHROMETRY SCORE Masafumi Kita*, Kazumi Hashizume, Masaki Watanabe, Junichi Hori, Naoki Wada, Makoto Azumi, Tatsuya Iwata, Seiji Matsumoto, Hidehiro Kakizaki, Asahikawa, Japan MP59-06 CONTEMPORARY SERIES UTILIZING MINIMALLY INVASIVE TECHNIQUES FOR ENUCLEATION VS. TRADITIONAL PARTIAL NEPHRECTOMY Michael Hanzly*, Daniel Abbotoy, Terrance Creighton, Hyung Kim, Eric C. Kauffman, Thomas Schwaab, Buffalo, NY MP59-07 DEFINING THE MALIGNANT POTENTIAL OF ONCOCYTIC RENAL NEOPLASMS Chandra K. Flack*, Adam C. Calaway, Dibson D. Gondim, Muhammad T. Idrees, Ronald S. Boris, Indianapolis, IN MP59-08 POPULATION-BASED COMPARISON OF CANCER SPECIFIC MORTALITY AFTER LOCAL TUMOR ABLATION OR NON- ACTIVE TREATMENT FOR T1A KIDNEY CANCER: A COMPETING RISK ANALYSIS Vincent Trudeau*, Alessandro Larcher, Malek Meskawi, Roger Valdivieso, Katharina Boehm, Zhe Tian, Montreal, Canada, Nicola Fossati, Nicolò Buffi, Giovanni Lughezzani, Giorgio Guazzoni, Milan, Italy, Pierre Karakiewicz, Maxine Sun, Montreal, Canada MP59-09 IS IT SAFE TO CONTINUE ASPIRIN DURING LAPAROSCOPIC PARTIAL NEPHRECTOMY? Michael Siev*, Paras Shah, David Leavitt, Simpa Salami, New Hyde Park, NY, Vinoth Birabaharan, Hempstead, NY, Mathew Fakhoury, Old Westbury, NY, Manaf Alom, Jessica Kreshover, Lee Richstone, Manish Vira, Louis Kavoussi, New Hyde Park, NY MP59-10 SARCOPENIA AS A PREDICTOR OF SURVIVAL AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA Pranav Sharma*, Kamran Zargar-Shoshtari, Jamie Caracciolo, Mayer Fishman, Michael Poch, Julio Pow-Sang, Wade Sexton, Philippe Spiess, Tampa, FL MP59-11 FIBRIN SEALANTS DOES NOT IMPACT PERIOPERATIVE BLOOD TRANSFUSIONS RATE IN PATIENTS UNDERGOING PARTIAL NEPHRECTOMY Yasmin Abu-Ghanem*, Zohar Dotan, Yizhak Kaver, Jacob Ramon, Tel Hashomer, Israel MP59-12 FUNCTIONAL & TRIFECTA OUTCOMES IN SOLITARY KIDNEY: UNCLAMPED VS CLAMPED PARTIAL NEPHRECTOMY Andre Luis de Castro Abreu*, Los Angeles, CA, Rocco Papalia, Rome, Italy, Inderbir Gill, Los Angeles, CA, Giuseppe Simone, Mariaconsiglia Ferriero, Riccardo Mastroianni, Rome, Italy, Kelvin Wong, Raed Azhar, Raj Satkunasivam, Charles Metcalfe, Osamu Ukimura, Monish Aron, Mihir Desai, Los Angeles, CA, Michele Gallucci, Rome, Italy MP59-13 TREATMENT OF THE SMALL RENAL MASS: LESS IS MORE Dena Moskowitz*, Orange, CA, Jenny Chang, Argyrios Ziogas, Hoda Anton-Culver, Ralph Clayman, Irvine, CA MP59-14 OUTCOMES OF RADICAL NEPHRECTOMY FOR RENAL MASSES IN PATIENTS WITH END STAGE RENAL DISEASE Ravi Barod*, Alex Borchert, Deepansh Dalela, Detroit, MI, Craig Rogers, Plymouth, MI MONDAY *Presenting author 193

206 MP59-15 PERIOPERATIVE AND FUNCTIONAL OUTCOMES OF ROBOT-ASSISTED PARTIAL NEPHRECTOMY FOR RENAL TUMORS >4 CM IN A MULTI- INSTITUTIONAL, MULTI-NATIONAL COHORT Deepansh Dalela*, Ravi Barod, Akshay Sood, Detroit, MI, Rajesh Ahlawat, Gurgaon, India, Sudhir Rawal, Delhi, India, Ben Challacombe, London, United Kingdom, Francesco Porpiglia, Torino, Italy, Daniel Moon, Melbourne, Australia, Nicolomaria Buffi, Alessandro Larcher, Milan, Italy, Dipen Parekh, Miami, FL, Giacomo Novara, Alessandro Volpe, Alex Mottrie, Aalst, Belgium, Ronney Abaza, Dublin, OH, Craig Rogers, Plymouth, MI MP59-16 COMPARATIVE EFFECTIVENESS OF LOCAL TUMOR DESTRUCTION VERSUS NEPHRECTOMY IN PATIENTS OLDER THAN 75 YEARS OLD FOR SMALL RENAL MASSES Maxine Sun*, Alessandro Larcher, Zhe Tian, Montreal, Canada, Shahrokh Shariat, New York, NY, Luc Valiquette, Fred Saad, Pierre Karakiewicz, Montreal, Canada MP59-17 RECOVERY IN RENAL FUNCTION AFTER RADICAL NEPHRECTOMY AND ITS NEGATIVE PREDICTIVE FACTORS : A MULTICENTER LONGITUDINAL STUDY Naoko Kawamura*, Tokyo, Japan MP59-18 COMPREHENSIVE ASSESSMENT OF CONTEMPORARY SHORT-, INTERMEDIATE-, AND LONG-TERM ENDPOINTS AFTER EITHER PARTIAL NEPHRECTOMY OR MINIMALLY-INVASIVE RADICAL NEPHRECTOMY Maxine Sun*, Montreal, Canada, Giorgio Gandaglia, Milan, Italy, Jonas Schiffmann, Montreal, Canada, Simon Kim, New Haven, CT, Alessandro Larcher, Montreal, Canada, Shahrokh Shariat, New York, NY, Fred Saad, Pierre Karakiewicz, Montreal, Canada MP59-19 POPULATION-BASED ASSESSMENT OF TREATMENT MODALITIES IN THE ELDERLY WITH LOCALIZED RENAL CELL CARCINOMA: THE UPDATE Maxine Sun*, Alessandro Larcher, Michael McCormarck, Montreal, Canada, Shahrokh Shariat, New York, NY, Luc Valiquette, Fred Saad, Pierre Karakiewicz, Montreal, Canada MP59-20 SURGICAL RESECTION OF ISOLATED RETROPERITONEAL LYMPH NODE RECURRENCE OF RCC: RESULTS FROM A MULTI-INSTITUTIONAL INTERNATIONAL COHORT Christopher Russell*, Philippe E. Spiess, Tampa, FL, Wassim Kassouf, Montreal, Canada, Thomas Schwaab, Buffalo, NY, David D Buethe, Jasreman Dhilon, Wade J. Sexton, Michael Poch, Julio Powsang, Tampa, FL, Simon Tanguay, Montreal, Canada, Sarah P. Psutka, Houston Thompson, Bradley Leibovich, Rochester, MN, Michael Hanzly, Buffalo, NY, Stephen Boorjian, Rochester, MN Monday, May 18, 2015 Moderated Poster Session 60 PROSTATE CANCER: DETECTION AND SCREENING II Room New Orleans Morial Convention Center Moderators: Chris Bangma and J. Stephen Jones 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP60-01 PREVALENCE OF NON-RECOMMENDED SCREENING FOR PROSTATE CANCER AND BREAST CANCER IN THE UNITED STATES Firas Abdollah*, Jesse Sammon, Akshay Sood, Dane Klett, Daniel Pucheril, Detroit, MI, Paul Nguyen, Toni Choueiri, Adam Kibel, Mark Preston, Boston, MA, Mani Menon, Detroit, MI, Joel Weissman, Quoc-Dien Trinh, Boston, MA MP60-02 SINGLE NUCLEOTIDE POLYMORPHISMS IN SLC45A3 AND KLK3 ARE CORRELATED WITH SERUM PSA LEVELS AND ARE POTENTIAL BIOMARKERS FOR DETECTING PROSTATE CANCER Naoki Terada*, Chikashi Terao, Koji Yoshimura, Takashi Kobayashi, Yoshiyuki Matsui, Takahiro Inoue, Tomomi Kamba, Fumihiko Matsuda, Osamu Ogawa, Kyoto, Japan MP60-03 PROSTATE CANCER IN THE ELDERLY Barry Stein*, Albany, NY 194

207 MP60-04 QUANTITATIVE ASSESSMENT OF T2- WEIGHTED MRI TO BETTER IDENTIFY PATIENTS WITH PROSTATE CANCER IN A SCREENING POPULATION Ahmad Algohary*, Satish Viswanath, Prateek Prasanna, Shivani Pahwa, Vikas Gulani, Cleveland, OH, Daniel Moses, Ronald Shnier, Maret Böhm, Anne-Maree Haynes, Phillip Brenner, Warick Delprado, James Thompson, Marley Pulbrock, Phillip Stricker, Sydney, Australia, Lee Ponsky, Anant Madabhushi, Cleveland, OH MP60-05 DETERMINED FREE SERUM TESTOSTERONE REFLECTS BETTER THAN TOTAL TESTOSTERONE THE RISK OF PROSTATE CANCER DETECTION Lucas Regis*, Pol Servian, Cristian Isalt, Ana Celma, Jacques Planas, Jose Placer, Ines DeTorres, R Ferrer, Juan Morote, Barcelona, Spain MP60-06 THE PERFORMANCE OF THE 4KSCORE FOR PREDICTING HIGH-GRADE CANCER ON BIOPSY OF THE PROSTATE DOES NOT DEPEND ON THE AGE OF THE PATIENT Sanoj Punnen*, Miami, FL, Dan Sjoberg, New York, NY, Steve Zappala, Andover, MI, Dipen Parekh, Miami, FL MP60-07 CONFIGURATION AND VALIDATION OF A NOVEL PROSTATE DISEASE NOMOGRAM PREDICTING PROSTATE BIOPSY OUTCOME: A PROSPECTIVE STUDY CORRELATING CLINICAL INDICATORS AMONG FILIPINO ADULT MALES WITH ELEVATED PSA LEVEL Michael Chua*, Patrick Tanseco, Jonathan Mendoza, Josefino Castillo, Marcelino Morales Jr, Saturnino Luna Jr, Quezon City, Philippines MP60-08 PROSTATE HEALTH INDEX IS AN EFFECTIVE MARKER FOR RISK STRATIFICATION OF PROSTATE CANCER PATIENTS E. David Crawford*, Paul Arangua, Clifford Jones, Wendy Poage, Aurora, CO, Nelson Stone, New York, NY, Francisco G. La Rosa, Aurora, CO, Stacy Loeb, New York, NY, Priya N. Werahera, Aurora, CO MP60-09 DOES OBESITY MODIFY THE ABILITY OF PRE-BIOPSY PSA TO DETECT PROSTATE CANCER ON REPEAT BIOPSY? RESULTS FROM THE REDUCE STUDY Adriana C. Vidal*, Lauren E. Howard, Durham, NC, Daniel M. Moreira, Rochester, NC, Ramiro Castro-Santamaria, King of Prussia, PA, Gerald L. Andriole, St. Louis, MO, Stephen J. Freedland, Durham, NC MP60-10 SHOULD SCREENING FOR PROSTATE CANCER START BEFORE THE AGE OF 55? Sigrid Carlsson*, Melissa Assel, David Ulmert, New York, NY, Axel Gerdtsson, Malmö, Sweden, Jonas Hugosson, Gothenburg, Sweden, Andrew Vickers, Hans Lilja, New York, NY MP60-11 SHOULD A NORMAL MULTIPARAMETRIC MRI PRECLUDE PROSTATE BIOPSY? Christopher Filson*, Daniel Margolis, Jiaoti Huang, Shyam Natarajan, Patricia Lieu, Frederick Dorey, Leonard Marks, Los Angeles, CA MP60-12 DOES LARGER TUMOR VOLUME EXPLAIN THE HIGHER PROSTATE SPECIFIC ANTIGEN LEVELS IN BLACK MEN WITH PROSTATE CANCER RESULTS FROM THE SEARCH DATABASE Zachary Klaassen*, Augusta, GA, Lauren E. Howard, Durham, NC, Martha K. Terris, Augusta, GA, William J. Aronson, Los Angeles, CA, Matthew R. Cooperberg, San Francisco, CA, Christopher L. Amling, Portland, OR, Christopher J. Kane, San Diego, CA, Stephen J. Freedland, Durham, NC MP60-13 EVIDENCE OF PROSTATE CANCER REVERSE STAGE MIGRATION TOWARD MORE ADVANCED DISEASE AT DIAGNOSIS Sean Wessel*, Adam Reese, Philadelphia, PA MP60-14 ARE LOWER PSA LEVELS IN OBESE MEN DUE TO HEMODILUTION OR LOW ANDROGENS? RESULTS FROM REDUCE Zachary Klaassen*, Augusta, GA, Lauren E. Howard, Durham, NC, Daniel M. Moreira, Rochester, MN, Gerald L. Andriole, Jr, St. Louis, MO, Martha K. Terris, Augusta, GA, Stephen J. Freedland, Durham, NC MP60-15 LOW PERCENTAGE OF FREE PROSTATE- SPECIFIC ANTIGEN IS A STRONG PREDICTOR OF LATER DETECTION OF PROSTATE CANCER AMONG MEN WITH SERUM LEVELS OF TOTAL PSA 4.0 NG/ ML OR LESS Mitsuharu Sasaki*, Yamagata-shi, Japan, Shigeto Ishidoya, Sendai-shi, Japan, Kenji Numahata, Yamagata-shi, Japan, Yoichi Arai, Sendai-shi, Japan MP60-16 THE RELATIONSHIP OF BASELINE PROSTATE SPECIFIC ANTIGEN LEVELS AND RISK OF FUTURE PROSTATE BIOPSY POSITIVE FOR ADENOCARCINOMA AND ITS VARIANCE BY RACE Daniel Verges*, William Andrew Sterling, William Atallah, Jeremy Weedon, Nicholas Karanikolas, Brooklyn, NY MP60-17 DOES ATYPICAL SMALL ACINAR PROLIFERATION ON 1ST REPEAT BIOPSY INCREASE PROSTATE CANCER DETECTION? Ahmed Elshafei, Cleveland, OH, Ayman S. Moussa*, Giza, Egypt, Heather Neifert, Ganesh Kartha, J.Stephen Jones, Cleveland, OH MONDAY *Presenting author 195

208 MP60-18 PCP-SMART STUDY AND PCRD INDEX: INTRODUCTION AND RESULTS OF A NOVEL MATHEMATICAL SIMULATION MODELING METHOD, DEVISED TO PREDICT THE OUTCOME OF PROSTATE BIOPSY Evangelos Spyropoulos*, Dimitrios Kotsiris, Aggelos Panagopoulos, Athens, Greece, Stamatios Mavrikos, Athens, Grenada, Evangelos Hatziplis, Ioannis Galanakis, Athens, Greece MP60-19 THE ASSOCIATION BETWEEN METABOLIC SYNDROME AND ADVANCED PROSTATE CANCER IN CHINESE PATIENTS RECEIVING RADICAL PROSTATECTOMY Guiming Zhang*, Yao Zhu, Shanghai, China, People s Republic of, Dahai Dong, Qingdao, China, People s Republic of, Chengtao Han, Chengyuan Gu, Weijie Gu, Xiaojian Qin, Shanghai, China, People s Republic of, Lijiang Sun, Qingdao, China, People s Republic of, Dingwei Ye, Shanghai, China, People s Republic of MP60-20 CAN SERUM ADIPOKINES PREDICT THE OUTCOME OF PROSTATE BIOPSIES? AN ASSESSMENT OF THE UTILITY OF SERUM ADIPOKINES IN 2,404 PATIENTS Aza Mohammed*, Bimal Bhindi, Michael Jewett, Alexandre Zlotta, Neil Fleshner, Girish Kulkarni, Toronto, Canada Monday, May 18, 2015 Moderated Poster Session 61 PROSTATE CANCER: BASIC RESEARCH IV Room New Orleans Morial Convention Center Moderators: Brett Carver and Stephen Boorjian 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP61-01 FUNCTIONAL ROLE OF THE KALLIKREIN 6 REGION OF THE KALLIKREIN LOCUS IN GENETIC PREDISPOSITION FOR AGGRESSIVE (GLEASON 8) PROSTATE CANCER: FINE-MAPPING AND METHYLATION STUDY IN A CANADIAN COHORT AND THE SWISS ARM OF THE EUROPEAN RANDOMIZED STUDY FOR Laurent Briollais, Hilmi Ozcelik, Toronto, Canada, Maciej Kwiatkowski, Aarau, Switzerland, Jingxiong Xu, Sevtap Savas, Ekaterina Olkhov-Mitsel, Toronto, Canada, Franz Recker, Aarau, Switzerland, Cynthia Kuk, Sally Hanna, Neil E Fleshner, Tristan Juvet, Matt Friedlander, Hong Li, Karen Chadwick, John Trachtenberg, Ants Toi, Theodorus H van der Kwast, Eleftherios P Diamandis, Bharati Bapat, Alexandre R. Zlotta*, Toronto, Canada MP61-02 COPY NUMBER VARIATION OF GSTT1 AND GSTM1 AND THE RISK OF PROSTATE CANCER IN A CARIBBEAN POPULATION OF AFRICAN DESCENT Laurent Brureau*, Elise Emeville, Cedric Broquere, Severine Ferdinand, Pascal Blanchet, Luc Multigner, Marc Romana, Pointe-à-Pitre, Guadeloupe MP61-03 NEURAL STEM CELLS AND GOLD NANOPARTICLES AS NOVEL TREATMENT FOR PROSTATE CANCER EARLY IN VITRO STUDIES Ali Zhumkhawala*, Revathi Tirughana- Sambandan, Rachael Mooney, Jacob Berlin, Karen Aboody, Jonathan Yamzon, Duarte, CA MP61-04 GENOMIC PROFILING OF KCONFAB MEN WITH A BRCA MUTATION STATUS AND PROSTATE CANCER Ania Sliwinski*, Heather Thorne, Damien Bolton, Gail Risbridger, Renea Taylor, David Clouston, Victoria, Australia MP61-05 IL-15 INCREASES NK FUNCTIONS IN THE PCA-LYMPHOCYTE MICROENVIRONMENT BY A PROFOUND INCREASE IN SHEDDING OF MICA FROM PCA CELLS A NOVEL PARADIGM Christina Alexandra Sakellariou*, Oussama Elhage, London, United Kingdom, Osamu Ukimura, Inderbir Gill, Los Angeles, CA, Richard Smith, Christine Galustian, Prokar Dasgupta, London, United Kingdom MP61-06 INCREASED PVT1 EXPRESSION CORRELATES WITH ADVANCED STAGE AND HORMONE RESISTANCE OF PROSTATE CANCER Ayman Soubra*, Badrinath Konety, Anindya Bagchi, Minneapolis, MN 196

209 MP61-07 SERUM MICRORNA ANALYSIS: A MINIMALLY INVASIVE ASSAY CORRELATED WITH UPGRADING IN PATIENTS WITH LOW-RISK PROSTATE CANCER Kari Bailey*, Christopher Lebeis, Drew Palmer, Shiv Patel, Travis Sullivan, David Canes, Alireza Moinzadeh, John A. Libertino, Kimberly M. Reiger-Christ, Burlington, MA MP61-08 THE TERE1 (UBIAD1) PROTEIN INDUCES OSTEO-MIMETIC EXPRESSION IN PROSTATE CANCER CELL LINES: RELEVANCE TO BONE METASTASIS William Fredericks*, Frank Rauscher III, S. Bruce Malkowicz, Philadelphia, PA MP61-09 PROMOTER-TARGETED DOUBLE-STRAND RNA DUPLEX ENHANCES DPYSL3 GENE EXPRESSION IN PROSTATE CANCER CELLS William Parker*, Qingting Hu, Jiang Wencong, J. Brantley Thrasher, Benyi Li, Kansas City, KS MP61-10 SILENCING OF PMEPA1 IS ASSOCIATED WITH ACTIVATION OF AR SIGNALING IN HUMAN PROSTATE CANCER AND CASTRATION RESISTANT TUMOR GROWTH IN NUDE MOUSE Hua Li*, Elizabeth Umeda, Yingjie Song, Denise Young, Lakshmi Ravindranath, Ahmed A. Mohamed, Yongmei Chen, Shashwat Sharad, Gyorgy Petrovics, Rockville, MD, David G. McLeod, Bethesda, MD, Isabell Sesterhenn, Silver Spring, MD, Taduru Sreenath, Albert Dobi, Shiv Srivastava, Rockville, MD MP61-11 SPINK1 DEFINES A MOLECULAR SUBTYPE OF PROSTATE CANCER MEN WITH MORE RAPID PROGRESSION FROM BIOCHEMICAL RECURRENCE TO DEATH IN AN AT RISK, NATURAL HISTORY COHORT Michael Johnson*, Ashley Ross, Baltimore, MD, Mohammed Alshalalfa, Nicholas Erho, Kasra Yousefi, Voleak Choerung, San Diego, CA, Stephanie Glavaris, Helen Fedor, Misop Han, Elizabeth Humphreys, Alan Partin, Stephania Bezerra, Sheila Faraj, George Netto, Bruce Trock, Baltimore, MD, Elai Davicioni, San Diego, CA, Edward Schaeffer, Baltimore, MD MP61-12 AN ANDROGEN RECEPTOR SPLICE VARIANT-TARGETED COMBINATION THERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER USING EPI-002 AND A PI3K/MTOR DUAL INHIBITOR Minoru Kato*, Marianne D. Sadar, Vancouver, Canada MP61-13 DEVELOPMENT OF A MOLECULAR IMAGING SYSTEM BASED ON THE TRANSCRIPTIONAL ACTIVITY OF THE DD3/PCA3 NON-CODING RNA FOR IMAGING SPECIFICALLY THE PROSTATE CANCER CELLS Pallavi Jain*, Bertrand Neveu, Yves Fradet, Frederic Pouliot, quebec city, Canada MP61-14 MICROCT ANALYSIS REVEALED BONE REGION-SPECIFIC LOCALIZATION OF OSTEOLYTIC VERSUS OSTEOBLASTIC LESIONS IN PCSD1, A NEW PATIENT- DERIVED XENOGRAFT MODEL OF BONE METASTATIC PROSTATE CANCER Christina Jamieson*, La Jolla, CA, Takeshi Hirata, Okayama, Japan, Seung Chol Park, Iksan, Korea, Republic of, Christina N. Wu, Michelle Muldong, Elana Godebu, Amy Strasner, Jason R. Woo, Omer Raheem, Tomonori Yamaguchi, La Jolla, CA, Hiromi Kumon, Okayama, Japan, Nicholas A. Cacalano, Los Angeles, CA, Catriona H.M. Jamieson, Koichi Masuda, Anna A. Kulidjian, Christopher J. Kane, La Jolla, CA MP61-15 USE OF A NOVEL NEAR-INFRARED IMAGING AGENT FOR INTRA-OPERATIVE PROSTATE CANCER DETECTION Jonathan E Kiechle*, Xinning Wang, Shan Dong, Steve S Huang, Warren DW Heston, Lee E Ponsky, James P Basilion, Cleveland, OH MP61-16 ETHNIC DIFFERENCES OF ERG ONCOGENIC ALTERATION IN PROSTATE CANCER: CONCLUSIONS FROM 1139 WHOLE MOUNT PROSTATES Albert Dobi*, Rockville, MD, Michael Degon, James Farrell, Wagner Baptiste, Bethesda, MD, Denise Young, Youngmei Chen, Gyorgy Petrovics, Jennifer Cullen, Rockville, MD, Jacob Kagan, Sudhir Srivastava, Inger Rosner, David G. McLeod, Bethesda, MD, Shiv Srivastava, Rockville, MD, Isabell Sesterhenn, Silver Spring, MD MP61-17 CELL-FREE DNA AS A PROGNOSTIC MARKER FOR RESPONSE TO TAXAN- BASED CHEMOTHERAPY IN PROSTATE CANCER (CAP) PATIENTS David Pfister*, Alexandra Kienel, Daniel Porres, Timur Kuru, Axel Heidenreich, Aachen, Germany MP61-18 ELK-1 PROMOTES PROSTATE CANCER PROGRESSION AND SILODOSIN THAT INACTIVATES ELK-1 IN PROSTATE CANCER CELLS INCREASES SENSITIVITY TO GEMCITABINE Takashi Kawahara, Baltimore, MD, Ali Aljarah, Baghdad, Iraq, Eiji Kashiwagi*, Yichun Zheng, Baltimore, MD, Yi Li, Rochester, NY, Hitoshi Ishiguro, Hiroshi Miyamoto, Baltimore, MD MP61-19 A NOVEL STRATEGY TO OPTIMISE TREATMENT OF DOCETAXEL-RESISTANT PROSTATE CANCER Dara Lundon*, Maria Prencipe, Amanda O Neill, Sinead Ahearne, Padraig Doolan, Stephen Madden, Dublin, Ireland, Colm Morrissey, Seattle, WA, John Fitzpatrick, William Watson, Dublin, Ireland MONDAY *Presenting author 197

210 MP61-20 EVALUATION OF ANDROGEN RECEPTOR FUNCTION IN AFRICAN AMERICAN AND CAUCASIAN AMERICAN PROSTATE CANCERS Aaron Brothers*, Bethesda, MD, Denise Young, Youngmei Chen, Gyorgy Petrovics, Jennifer Cullen, Rockville, MD, Inger Rosner, David G. McLeod, Bethesda, MD, Albert Dobi, Shiv Srivastava, Rockville, MD, Isabell Sesterhenn, Silver Spring, MD Monday, May 18, 2015 Podium Session 34 PROSTATE CANCER: LOCALIZED IV Room New Orleans Morial Convention Center Moderator: Ketan Badani 8:00 am - 10:00 am TIME NUMBER TITLE TIME NUMBER TITLE 8:00 PD34-01 MR-US FUSION BIOPSY VS. TRUS SATURATION PROSTATE BIOPSY IN ACTIVE SURVEILLANCE Chad A. Reichard*, Samuel C. Haywood, Andrei Purysko, J. Stephen Jones, Eric A. Klein, Andrew Stephenson, Cleveland, OH 8:10 PD34-02 OUTCOMES OF MRI-US FUSION TARGETED BIOPSY IN THE RISK STRATIFICATION OF ACTIVE SURVEILLANCE CANDIDATES Xiaosong Meng*, Andrew B. Rosenkrantz, Neil Mendhiratta, Michael Fenstermaker, Richard Huang, New York, NY, James Wysock, Flushing, NY, Fang-Ming Deng, Jonathan Melamed, Ming Zhou, William C. Huang, Herbert Lepor, Samir S. Taneja, New York, NY 8:20 PD34-03 TIMING OF THE CONFIRMATORY BIOPSY IN PROSTATE CANCER ACTIVE SURVEILLANCE: ANALYSIS OF THE CANARY PROSTATE CANCER ACTIVE SURVEILLANCE STUDY (PASS) Liam C. Macleod*, William J. Ellis, Lisa F. Newcomb, Yingye Zheng, Seattle, WA, James D. Brooks, Palo Alto, CA, Peter R. Carroll, San Francisco, CA, Martin E. Gleave, Vancouver, Canada, Raymond S. Lance, Virginia Beach, VA, Peter S. Nelson, Seattle, WA, Ian M. Thompson, San Antonio, TX, Andrew A. Wagner, Boston, MA, John T. Wei, Ann Arbor, MI, Hui-Yu Yang, Daniel W. Lin, Seattle, WA 8:30 PD34-04 FREQUENCY OF PSA TESTING IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER Leonard Bokhorst*, Arnout Alberts, Rotterdam, Netherlands, Yoshiyuki Kakehi, Kagawa, Japan, Antti Rannikko, Helsinki, Finland, Tom Pickles, Vancouver, Canada, Riccardo Valdagni, Milan, Italy, Chris Bangma, Monique Roobol, Rotterdam, Netherlands 8:40 PD ALPHA REDUCTASE INHIBITORS IN PATIENTS ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER: IMPACT ON DISEASE PROGRESSION AND CURATIVE INTERVENTION Andre Luis de Castro Abreu*, Inderbir Gill, Los Angeles, CA, Duke Bahn, Ventura, CA, Sunao Shoji, Arnaud Marien, Jie Cai, Sameer Chopra, Raed Azhar, Kelvin Wong, Charles Metcalfe, Raj Satkunasivam, Osamu Ukimura, Los Angeles, CA 8:50 PD34-06 THE EFFECT OF NSAID USE ON DISEASE PROGRESSION IN PATIENTS ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER Gautum Agarwal*, Joseph Spuches, Adam Luchey, Trushar Patel, Julio Pow-Sang, Tampa, FL 9:00 PD34-07 CAN GLEASON 7 PROSTATE CANCER EVER BE LOW-RISK? RESULTS FROM THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) DATABASE Kathleen McGinley*, Xizi Sun, Lauren Howard, Durham, NC, William Aronson, Los Angeles, CA, Martha Terris, Augusta, GA, Christopher Kane, La Jolla, CA, Christopher Amling, Portland, OR, Matthew Cooperberg, San Francisco, CA, Stephen Freedland, Durham, NC 9:10 PD34-08 TREATMENT DECISION-MAKING PATTERNS AMONG LOW RISK PROSTATE CANCER PATIENTS MANAGED ON ACTIVE SURVEILLANCE IN AN EQUAL ACCESS HEALTH CARE SETTING Daniel Kim*, Bethesda, MD, Lauren Hurwitz, Jennifer Cullen, Rockville, MD, Jane Hudak, Maryellen Colston, Judith Travis, Bethesda, MD, Sally Elsamanoudi, Rockville, MD, Inger Rosner, Bethesda, MD 198

211 9:20 PD34-09 COMPARISON OF PATHOLOGIC OUTCOMES IN MEN WITH FAVORABLE- RISK PROSTATE CANCER UNDERGOING DELAYED SURGERY AFTER ACTIVE SURVEILLANCE VERSUS IMMEDIATE SURGERY Jeffrey Tosoian, Debasish Sundi, Bruce Trock, Patricia Landis, Jonathan Epstein, Edward Schaeffer, Mufaddal Mamawala*, H. Ballentine Carter, Baltimore, MD 9:30 PD34-10 OUTCOMES FOLLOWING IMMEDIATE VERSUS DELAYED RADICAL PROSTATECTOMY AMONG PATIENTS ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER Pauline Filippou*, Christopher Welty, Janet Cowan, Peter Carroll, San Francisco, CA 9:40 PD34-11 PATTERNS OF CARE FOR MEN WITH PROSTATE CANCER UNDERGOING ACTIVE SURVEILLANCE AS INITIAL MANAGEMENT Stacy Loeb*, Dawn Walter, Sasha Dewitt, Heather T. Gold, Danil V. Makarov, New York, NY 9:50 PD34-12 EMOTIONAL DISTRESS PREDICTS CHOOSING SURGERY OVER ACTIVE SURVEILLANCE IN CLINICALLY LOCALIZED PROSTATE CANCER PATIENTS Heather Orom*, Willie Underwood, D. Lynn Homish, Buffalo, NY, Deepak Kapoor, Melville, NY, Christian Nelson, New York, NY, Zvi Schiffman, Houston, TX, Juan Reyna, San Antonio, TX Monday, May 18, 2015 Podium Session 35 KIDNEY CANCER: ADVANCED I Room New Orleans Morial Convention Center Moderator: Viraj Master and Shin Egawa 8:00 am - 10:00 am MONDAY TIME NUMBER TITLE TIME NUMBER TITLE 8:00 PD35-01 HOW LONG SHOULD BE EXTENDED FOLLOW UP AFTER SURGERY FOR RENAL CANCER? RETROSPECTIVE ANALYSIS OF A COHORT OF PATIENTS WITH MORE THAN 10 YEARS OF FOLLOW UP Francesca Carobbio*, Alessandro Antonelli, Mario Sodano, Maria Furlan, Giacomo Galvagni, Alberto Cozzoli, Tiziano Zanotelli, Claudio Simeone, Brescia, Italy 8:30 PD35-04 EFFECTS OF PERIOPERATIVE VARIABLES ON TIMING OF ADJUVANT RCC THERAPY: RESULTS FROM THE ASSURE TRIAL (ECOG 2805) Robert Uzzo*, Philadelphia, PA, Judith Manola, Boston, MA, Christopher Kane, San Diego, CA, Christopher Wood, Houston, TX, Michael Jewett, Toronto, Canada, Robert DiPaola, New Brunswick, NJ, Naomi Haas, Philadelphia, PA 8:10 PD35-02 EARLY TUMOR SHRINKAGE UNDER FIRST-LINE TYROSINE KINASE INHIBITOR AS A SURROGATE ENDPOINT OF OVERALL SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA Hideaki Miyake*, Ken-ichi Harada, Masato Fujisawa, Kobe, Japan 8:20 PD35-03 THE IMPACT OF CHANGE IN SERUM C- REACTIVE PROTEIN LEVEL ON THE PREDICTION OF EFFECTS OF MOLECULAR TARGETED THERAPY IN METASTATIC RENAL CELL CARCINOMA PATIENTS Jun Teishima*, Kohei Kobatake, Hiroyuki Kitano, Takashi Babasaki, Hirotaka Nagamatsu, Keisuke Hieda, Shunsuke Shinmei, Koichi Shoji, Shogo Inoue, Tetsutaro Hayashi, Mitsuru Kajiwara, Koji Mita, Akio Matsubara, Hiroshima, Japan 8:40 PD35-05 MULTICENTER VALIDATION OF PREDICTIVE MODEL FOR POSTSURGICAL RECURRENCE IN NON-METASTATIC RCC WITH THROMBUS Michael L. Blute, Jr.*, Madison, WI, Timothy A. Masterson, Indianapolis, IN, Viraj A. Master, Atlanta, GA, Vitaly Margulis, Dallas, TX, C. Adam Lorentz, Atlanta, GA, Tyler Bauman, Kristin Zorn, Madison, WI, Jose A. Karam, Christopher G. Wood, Houston, TX, E. Jason Abel, Madison, WI 8:50 PD35-06 VENA CAVOSCOPY IN THE ASSESSMENT OF INTRALUMINAL VENA CAVAL TUMOR INVOLVEMENT Jeffrey Loh-Doyle*, Sumeet Syan-Bhanvadia, Eli Thompson, Mukul Patil, Hooman Djaladat, Siamak Daneshmand, Los Angeles, CA 9:00 PD35-07 EVALUATION AND MANAGEMENT OF RENAL FOSSA RECURRENCE FOLLOWING NEPHRECTOMY FOR RENAL CELL CARCINOMA Sarah Psutka*, Mark Heidenreich, Stephen Boorjian, G. Christopher Bailey, John Cheville, Suzanne Stewart, Christine Lohse, Thomas Atwell, Brian Costello, Bradley Leibovich, R. Houston Thompson, Rochester, MN *Presenting author 199

212 9:10 PD35-08 POLYMORPHISMS IN VEGFA, VEGFR1, -2 AND -3 ARE ASSOCIATED WITH RESPONSE AND OUTCOME OF SUNITINIB-TREATED METASTATIC RENAL CELL CARCINOMA PATIENTS Juana Dornbusch, Dresden, Germany, Martina Walter, Jena, Germany, Andrea Gottschalk, Dresden, Germany, Alice Obaje, Jena, Germany, Kerstin Junker, Carsten-Henning Ohlmann, Homburg/Saar, Germany, Matthias Meinhardt, Aristeidis Zacharis, Stefan Zastrow, Dresden, Germany, Marc-Oliver Grimm, Jena, Germany, Stefanie J. Klug, Susanne Fuessel*, Manfred P. Wirth, Dresden, Germany 9:20 PD35-09 HIGH-DOSE INTERLEUKEN-2 FOR METASTATIC RENAL CELL CARCINOMA: CONTEMPORARY UTILIZATION TRENDS IN THE UNITED STATES Christopher Allard*, Francisco Gelpi- Hammerschmidt, Lauren Harshman, Boston, MA, Izak Faiena, Parth Modi, New Brunswick, NJ, Benjamin Chung, Stanford, CA, Eric Singer, New Brunswick, NJ, Steven Chang, Boston, MA 9:30 PD35-10 EVEROLIMUS FOR RENAL ANGIOMYOLIPOMA ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX: EFFICACY AND SAFETY AFTER 3.5 YEARS OF TREATMENT IN THE EXIST-2 STUDY John Bissler*, Memphis, TN, J Kingswood, Brighton, United Kingdom, Elzbieta Radzikowska, Warsaw, Poland, Bernard Zonnenberg, Utrecht, Netherlands, Michael Frost, St. Paul, MN, Elena Belousova, Moscow, Russian Federation, Matthias Sauter, Munich, Germany, Norio Nonomura, Osaka, Japan, Susanne Brakemeier, Berlin, Germany, Petrus de Vries, Cape Town, South Africa, Noah Berkowitz, East Hanover, NJ, Severine Peyrard, Rueil-Malmaison, France, Klemens Budde, Berlin, Germany 9:40 PD35-11 PREOPERATIVE MULTIVARIABLE PROGNOSTIC MODELS FOR PREDICTION OF SURVIVAL AND MAJOR COMPLICATIONS FOLLOWING SURGICAL RESECTION OF RENAL CELL CARCINOMA WITH SUPRAHEPATIC CAVAL TUMOR THROMBUS Ahmed Q Haddad*, Dallas, TX, Bradley C. Leibovich, Rochester, MN, E. Jason Abel, madison, WI, Jun Hang Luo, Laura-Maria Krabbe, Dallas, TX, R Houston Thompson, Rochester, MN, Jennifer Heckman, Madison, WI, Megan Merrill, Houston, TX, Bishoy Gayed, Arthur I Sagalowsky, Dallas, TX, Stephen A. Boorjian, Rochester, MN, Christopher G. Wood, Houston, TX, Vitaly Margulis, Dallas, TX 9:50 PD35-12 NEOADJUVANT SUNITINIB IS ASSOCIATED WITH IMPROVED ONCOLOGIC OUTCOMES FOR PATIENTS WITH TUMOR THROMBUS IN RENAL CELL CARCINOMA: A MULTICENTER ANALYSIS Hak Lee*, San Diego, CA, Juan Jimenez, Cleveland, OH, Song Wang, Omer Raheem, Kyle Gillis, Amy Alagh, Christopher J. Kane, San Diego, CA, Michael LIss, San Antonio, TX, Frederick Millard, San Diego, CA, Brian Lane, Grand Rapids, MI, Steven Campbell, Cleveland, OH, Ithaar Derweesh, San Diego, CA Monday, May 18, 2015 Podium Session 36 SEXUAL FUNCTION/DYSFUNCTION/ANDROLOGY: BASIC RESEARCH II Room New Orleans Morial Convention Center Moderators: Johanna Hannan and Carol Podlasek 8:00 am - 10:00 am TIME NUMBER TITLE TIME NUMBER TITLE 8:00 PD36-01 A ROLE FOR CTDSPL IN FIBROSIS AND PLAQUE CALCIFICATION IN PEYRONIE S DISEASE Alexander W. Pastuszak*, Juan Bournat, Larry I. Lipshultz, Dolores J. Lamb, Houston, TX 8:10 PD36-02 INCREASED VASCULAR REMODELING AND CALCIFICATION OF CORONARY AND INTERNAL PUDENDAL ARTERIES FROM MEN WITH CARDIOVASCULAR DISEASE Johanna L Hannan*, Jesse M Hall, Baltimore, MD, Jacob M Fox, Patrick M Kennedy, Mackenzie J Clarkson, H Wayne Lambert, Morgantown, WV, Trinity J Bivalacqua, Baltimore, MD 200

213 8:20 PD36-03 BLUNTED NNOS EXPRESSION IN THE HYPOTHALAMIC PARAVENTRICULAR NUCLEUS CONTRIBUTE TO DIABETES- ASSOCIATED MALE SEXUAL BEHAVIOR DISORDER: CENTRAL ROLE OF TNF- Ting Long*, Shantou, China, People s Republic of, Yuanyuan Zhang, Winston Salem, NC, Huanhuan Wang, Xiaohong Ye, Hongjie Qiao, Danian Qin, Shantou, China, People s Republic of 8:30 PD36-04 TNF- INHIBITS NEURITE OUTGROWTH FROM THE MAJOR PELVIC GANGLION BY INDUCING M1/M2 MACROPHAGES EX VIVO Hotaka Matsui*, Johanna L. Hannan, Xiaopu Liu, Ahmet Hoke, Trinity J. Bivalacqua, Baltimore, MD 8:40 PD36-05 PIOGLITAZONE ENHANCES SURVIVAL AND REGENERATION OF PELVIC GANGLIA NEURONS AFTER CAVERNOSAL NERVE INJURY Eric Katz*, Daniel Heidenberg, Nora Haney, Taylor Peak, George Lasker, Margaret Knoedler, Daniel Rittenberg, Bashir Rezk, Ahmed Moustafa, Zakaria Abd Elmageed, Faysal Yafi, Suresh Sikka, Asim Abdel Mageed, Wayne Hellstrom, New Orleans, LA 8:50 PD36-06 EFFICACY OF ROLIPRAM LOADED NANOSPHERES IN LOCALIZED DELIVERY TO SITES OF NERVE INJURY FOR PREVENTION OF POST-PROSTATECTOMY ERECTILE DYSFUNCTION USING A RAT MODEL OF CAVERNOUS NERVE INJURY Neal Patel*, Amirali H. Salmasi, Michael Dinizo, Izak Faiena, New Brunswick, NJ, Ritu Goyal, Piscataway, NJ, Geun Taek Lee, New Brunswick, NJ, Johanna L. Hannan, Trinity J. Bivalacqua, Baltimore, MD, Joachim Kohn, Piscataway, NJ, Isaac Y. Kim, New Brunswick, NJ 9:00 PD36-07 TADALAFIL PREVENT PENILE NEURONAL NITRIC OXIDE SYNTHASE LEVELS WHICH DECREASE WITH CHRONIC PAROXETINE TREATMENT Abdullah Gul, Levent Kabasakal, Duygu Sultan Celik, Atilla Semercioz, Ege Can Serefoglu*, Istanbul, Turkey 9:10 PD36-08 LOW OSTEOCALCIN LEVELS ARE AN INDEPENDENT FACTOR ASSOCIATED WITH ANDROGEN DEFICIENCY Brian Le*, Madison, WI, Haolin Chen, Kevin Billups, Arthur L. Burnett, Barry Zirkin, Baltimore, MD 9:20 PD36-09 LOW-INTENSITY PULSED ULTRASOUND RECOVERS ERECTILE FUNCTION IN STREPTOZOTOCIN-INDUCED DIABETIC RATS Hongen Lei, Yongde Xu, Ruili Guan, Zhezhu Gao, Zhongcheng Xin*, Beijing, China, People s Republic of 9:30 PD36-10 MICROANATOMY AND INNERVATION PATTERNS OF THE SPERMATIC CORD IN HUMANS Koji Shiraishi*, Shintaro Oka, Hideyasu Matsuyama, Ube, Japan 9:40 PD36-11 THE DIABETES MELLITUS-INDUCED DYSFUNCTION ON SEMINAL VESICLES AND VAS DEFERENS IN THE RAT MODEL Panagiota Tsounapi*, Masashi Honda, Yonago, Japan, Fotios Dimitriadis, Thessaloniki, Greece, Shogo Shimizu, Nankoku, Japan, Michiyo Iguchi, Masaki Imanishi, Shinji Matsunaga, Bunya Kawamoto, Katsuya Hikita, Kuniyasu Muraoka, Takehiro Sejima, Yonago, Japan, Motoaki Saito, Nankoku, Japan, Nikolaos Sofikitis, Ioannina, Greece, Shuhei Tomita, Atsushi Takenaka, Yonago, Japan 9:50 PD36-12 THE SPACE ENVIRONMENT INDUCES THE ENHANCEMENT OF CAVEOLIN EXPRESSION AND LEADS TO GERM CELL APOPTOSIS Hideyuki Kamisawa*, Kentaro Mizuno, Satoshi Kurokawa, Yoshinobu Moritoki, Hidenori Nishio, Akihiro Nakane, Tetsuji Maruyama, Keiji Fujita, Shoichi Sasaki, Yutaro Hayashi, Nagoya, Japan, Yoshiyuki Kojima, Fukushima, Japan, Kenjiro Kohri, Nagoya, Japan MONDAY Monday, May 18, 2015 Podium Session 37 SEXUAL FUNCTION/DYSFUNCTION/ANDROLOGY: MEDICAL AND NON-SURGICAL THERAPY I Room New Orleans Morial Convention Center Moderator: Dana Ohl 8:00 am - 10:00 am TIME NUMBER TITLE TIME NUMBER TITLE 8:00 PD37-01 ASSOCIATION BETWEEN TESTOSTERONE THERAPY AND THROMBOTIC EVENTS IN ELDERLY MEN Ranjith Ramasamy*, Jason Scovell, Michael Mederos, Renzhong Ran, Lakshay Jain, Dolores Lamb, Larry Lipshultz, Houston, TX 8:10 PD37-02 PHASE 2 RESULTS OF NOVEL ORAL TESTOSTERONE REPLACEMENT THERAPY (TSX-002) IN SYMPTOMATIC HYPOGONAGAL MEN Michael Oefelein*, Bakersfield, CA, Guru Betageri, Pomona, CA *Presenting author 201

214 8:20 PD37-03 ASSOCIATION OF FREE TESTOSTERONE WITH HYPOGONADAL SYMPTOMS IN MEN WITH NEAR NORMAL TOTAL TESTOSTERONE LEVELS Nathan Wilken, Jason Scovell, Ranjith Ramasamy*, Dolores Lamb, Larry Lipshultz, Houston, TX 8:30 PD37-04 LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE (TU) IN HYPOGONADAL MEN WITH CARDIOVASCULAR DISEASES (CVD): OBSERVATIONAL DATA FROM A REGISTRY STUDY Ahmad Haider*, Karim Sultan Haider, Bremerhaven, Germany, Gheorghe Doros, Abdulmaged Traish, Boston, MA 8:40 PD37-05 THE IMPACT OF TESTOSTERONE SUPPLEMENTATION THERAPY ON THE INTERNATIONAL INDEX OF ERECTILE FUNCTION: BEYOND THE LEVELS OF TESTOSTERONE Jason Scovell*, Aravind Chandrashekar, Tariq Hakky, Bryan Pham, Dolores Lamb, Larry Lipshultz, Houston, TX 8:50 PD37-06 NEEDLE-FREE SUBCUTANEOUS SELF INJECTION FOR TESTOSTERONE SUPPLEMENTATION THERAPY Jeffrey Marotte*, Wilson Alobuia, Rochelle Frazier, Conway, AR, Richard Stout, Tigard, OR 9:00 PD37-07 TESTOSTERONE GEL TREATMENT SIGNIFICANTLY AMELIORATES URINARY URGENCY AND SLEEP DISTURBANCE: DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL Shin-ichi Hisasue*, Hisamitsu Ide, Akira Tsujimura, Naoya Nagaya, Masaki Kimura, Amr Abdelhamed, Masato Shirai, Satoru Muto, Raizo Yamaguchi, Shigeo Horie, Tokyo, Japan 9:10 PD37-08 EFFICACY AND PHARMACOKINETICS OF LPCN 1021, A NOVEL ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT), IN HYPOGONADAL MEN: STUDY OF ANDROGEN REPLACEMENT (SOAR) Jed C. Kaminetsky*, New York, NY, Anthony DelConte, Philadelphia, PA, Adrian S. Dobs, Baltimore, MD, Christina Wang, Pavan Yadav, Torrance, CA, Srinivasan Venkateshwaran, Nachiappan Chidambaram, Satish Nachaegari, Mahesh Patel, Salt Lake City, UT, Martin M. Miner, Providence, RI 9:20 PD37-09 PREVALENCE OF BONE DENSITY DEFICIENCIES IN MEN PRESENTING FOR HYPOGONADISM TREATMENT: DO WE NEED TO WORRY? Joseph Ellen*, Igor Sorokin, Clay Mechlin, Charles Welliver, Andrew McCullough, Albany, NY 9:30 PD37-10 ERECTILE FUNCTION AFTER RADICAL PROSTATECTOMY DO PATIENTS RETURN TO BASELINE? Mikkel Fode*, Roskilde and Herlev, Denmark, Anders Frey, Henrik Jakobsen, Jens Sønksen, Herlev, Denmark 9:40 PD37-11 STATIN THERAPY MAY IMPROVE LONG- TERM SEXUAL FUNCTION AFTER RADICAL PROSTATECTOMY Alon Mass*, Vinay Prabhu, Darren Bryk, Herbert Lepor, Lee Zhao, New York, NY 9:50 PD37-12 DAILY TADALAFIL DOES NOT INCREASE PRIAPISM RATES IN AN INTRACAVERNOSAL INJECTION (ICI) REHABILITATION PROGRAM, AFTER RADICAL PROSTATECTOMY (RP) Eduardo Miranda*, Sao Paulo, Brazil, Serkan Deveci, Lawrence Jenkins, Joseph Narus, John Mulhall, New York, NY Monday, May 18, 2015 Video Session 9 8:00 am - 10:00 am ROBOTICS RENAL The videos in this session as well as the video libraries from the Annual Meetings may be viewed in the Surgical Video Library and purchased in the Products Store during the Annual Meeting. Both are located in Registration Hall B2. All years of the Surgical Video Library may also be purchased online at Room New Orleans Morial Convention Center Moderators: Matthew Gettman and Jeremy Tonkin NUMBER TITLE NUMBER TITLE V9-01 ROBOTIC PARTIAL NEPHRECTOMY FOR MULTIPLE RENAL TUMORS Deepansh Dalela*, Ravi Barod, Detroit, MI, Craig Rogers, Plymouth, MI V9-02 SELECTIVE CLAMPING OF THE SEGMENTARY ARTERY IN ROBOTIC PARTIAL NEPHRECTOMY OPERATION Omer Aytaç, Hasan Tavukçu, Haluk Kulaksizoglu, Fatih Atug*, Istanbul, Turkey 202

215 V9-03 ROBOTIC ENUCLEO-RESECTION OF SMALL RENAL MASSES: A SAFE AND ONCOLOGICALLY SOUND ALTERNATIVE TO TRADITIONAL PARTIAL NEPHRECTOMY Robert Blackwell*, Gopal Gupta, Maywood, IL V9-04 PARTIAL NEPHRECTOMY IN PATIENTS WITH MULTIPLE RENAL LESIONS AMENABLE TO NEPHRON SPARING SURGERY Aryeh Keehn*, Reza Ghavamian, Bronx, NY V9-05 ROBOTIC PARTIAL NEPHRECTOMY WITH INTRACORPOREAL RENAL HYPOTHERMIA USING ICE SLUSH Daniel Ramirez*, Homayoun Zargar, Jayram Krishnan, Peter Caputo, Oktay Akca, Jihad H. Kaouk, Cleveland, OH V9-06 ROBOTIC PARTIAL NEPHRECTOMY FOR HILAR TUMORS: ZERO ISCHEMIA OR EARLY UNCLAMPING? benoit peyronnet*, quentin alimi, tarek fardoun, romain mathieu, gregory verhoest, karim bensalah, Rennes, France V9-07 FAST BUT NOT FURIOUS - IMPROVE YOUR SURGICAL SKILLS FOR THE RACE AGAINST TIME DURING ROBOTIC- ASSISTED PARTIAL NEPHRECTOMY USING A VALIDATED PERFUSED TRAINING MODEL Philipp Markus Huber*, George N. Thalmann, Frédéric D. Birkhäuser, Bern, Switzerland, Andrew J. Hung, Monish Aron, Inderbir S. Gill, Mihir M. Desai, Los Angeles, CA, Pascal Zehnder, Bern, Switzerland V9-08 ROBOTIC-ASSISTED LAPAROSCOPIC PARTIAL NEPHRECTOMY AND IPSILATERAL PYELOLITHOTOMY IN INTRARENAL PELVIS Wai Lee*, Justina Tam, Abram D Amato, Pamela Sue Baron, Wayne Waltzer, Anthony Corcoran, Stony Brook, NY V9-09 NOVEL ROBOTIC SYSTEM FOR SINGLE PORT PARTIAL NEPHRECTOMY: INITIAL EXPERIENCE AND TECHNIQUE Daniel Ramirez*, Cleveland, OH, Vincent Flammand, Arnauld Villers, Lille, France, Jihad H. Kaouk, Cleveland, OH V9-10 SIMULATED INANIMATE MODEL FOR PHYSICAL LEARNING EXPERIENCE (SIMPLE) FOR ROBOTIC PARTIAL NEPHRECTOMY USING A 3-D PRINTED KIDNEY MODEL Ahmed Ghazi*, Jonathan Stone, Braden Candela, Michael Richards, Jean Joseph, Rochester, NY V9-11 ROBOT-ASSISTED PARTIAL NEPHRECTOMY FOR RENAL CELL CARCINOMA AND MANAGEMENT OF VENOUS TUMOR THROMBUS Firas Petros*, Edward Nickerson, Geoffrey Box, Columbus, OH V9-12 ROBOTIC-ASSISTED PYELOPLASTY IN TWO PATIENTS WITH DUPLEX KIDNEYS AND LOWER POLE URETERO-PELVIC JUNCTION OBSTRUCTION BUT DIFFERING DISTANCE TO THE URETERAL JUNCTION Thomas von Rütte*, Frédéric D. Birkhäuser, George N. Thalmann, Pascal Zehnder, Bern, Switzerland V9-13 ROBOT-ASSISTED LAPAROSCOPIC FLAP PYELOPLASTY FOR AN EXTENDED URETERAL STRICTURE: KEY STEPS AND COMPLICATIONS Heather Hopf*, Clinton Bahler, Chandru Sundaram, Indianapolis, IN V9-14 A NOVEL DEVICE FOR INTRAPERITONEAL CAMERA CLEANING: ROBOTIC SURGERY WITH FLOSHIELD TECHNOLOGY Julie Wang*, Philip Dorsey, Michael Maddox, Benjamin Lee, New Orleans, LA MONDAY *Presenting author 203

216 Monday, May 18, 2015 Moderated Poster Session 62 PROSTATE CANCER: LOCALIZED V Room New Orleans Morial Convention Center Moderators: Douglas Dahl and Herbert Lepor 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP62-01 FUNCTIONAL OUTCOMES IN PATIENTS WITH CLINICALLY HIGH-RISK PROSTATE CANCER (PCA) TREATED WITH ROBOT- ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP) Firas Abdollah*, Daniel Pucheril, Jesse Sammon, Akshay Sood, Dane Klett, Detroit, MI, Nicola Fossati, Giorgio Gandaglia, Nazareno Suardi, Giorgio Guazzoni, Manuela Tutolo, Milan, Italy, Craig Rogers, Hans Stricker, Wooju Jeong, James Peabody, Detroit, MI, Francesco Montorsi, Alberto Briganti, Milan, Italy, Mani Menon, Detroit, MI MP62-02 PENTAFECTA OUTCOMES PLUS EVALUATION OF IMMEDIATE CONTINENCE AFTER ROBOTIC, EXTRAPERITONEAL, RADICAL PROSTATECTOMY TECHNIQUE WITH COMPLETE PRESERVATION OF THE VEIL OF APHRODITE Andrea Boni*, Perugia, Italy, Giovanni Cochetti, Francesco Barillaro, Cottini Emanuele, Perugia - Terni, Italy, Emanuele Lepri, Perugia, Italy, Ettore Mearini, Perugia -Terni, Italy MP62-03 ROBOT ASSISTED RADICAL PROSTATECTOMY IN HIGH RISK PROSTATE CANCER Benjamin Katz*, Sue-Jean Yu, Andrew Lightfoot, Giovanni Greaves, Elton Llukani, Alice McGill, Kelly Monahan, David Lee, Philadelphia, PA MP62-04 COMPARATIVE EFFECTIVENESS OF ROBOT ASSISTED VS. OPEN RADICAL PROSTATECTOMY IN INTERMEDIATE AND HIGH RISK PATIENTS Giorgio Gandaglia*, Nazareno Suardi, Nicola Fossati, Alessandro Larcher, Elena Farina, Marta Picozzi, Irene Locatelli, Andrea Gallina, Milan, Italy, Vincenzo Mirone, Naples, Italy, Giorgio Guazzoni, Francesco Montorsi, Alberto Briganti, Milan, Italy MP62-05 SYSTEMATIC ASSESSMENT OF POSITIVE SURGICAL MARGINS FEATURES IN OPEN VS. ROBOT ASSISTED RADICAL PROSTATECTOMY: IS THERE A DIFFERENCE? Giorgio Gandaglia*, Nazareno Suardi, Paolo Dell Oglio, Stefano Luzzago, Walter Cazzaniga, Umberto Capitanio, Marco Bianchi, Nicola Fossati, Milan, Italy, Shahrokh F. Shariat, Vienna, Austria, Massimo Freschi, Milan, Italy, Pierre Karakiewicz, Montreal, Canada, Francesco Montorsi, Alberto Briganti, Milan, Italy MP62-06 ROBOTIC VERSUS OPEN SALVAGE RADICAL PROSTATECTOMIES: A TWO CENTRE STUDY Sanchia Goonewardene*, London, United Kingdom, Faith McMeekin, Bristol, United Kingdom, Matt Brown, London, United Kingdom, Raj Persad, Bristol, United Kingdom, Rick Popert, London, United Kingdom, David Gillatt, Bristol, United Kingdom MP62-07 PREDICTORS OF READMISSION FOLLOWING OPEN AND MINIMALLY INVASIVE RADICAL PROSTATECTOMY USING THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM (NSQIP) DATABASE Ahmed Sarhan*, David Sharp, Ahmad Shabsigh, Columbus, OH MP62-08 SIGNIFICANT REDUCTION IN POSITIVE SURGICAL MARGINS AND BIOCHEMICAL RECURRENCE RISK AT 2 YEARS NOTED EARLIER FOR ROBOTIC PROSTATECTOMY: COMPREHENSIVE EVALUATION AND CUSUM ANALYSIS OF ONCOLOGICAL OUTCOMES Arjun Sivaraman*, Rafael Sanchez Salas, Dominique Prapotnich, Paris, France, Fabien Olivier, Kaixin Yu, Christian Doudeau, Stéphane David, Velizy, France, Eric Barret, Paris, France, Fernando P Secin, Buenos Aires, Argentina, Alexandre Ingels, Francois Rozet, Marc Galiano, Annick Mombet, Nathalia Cathala, Xavier Cathelineau, Paris, France MP62-09 LAPAROENDOSCOPIC SINGLE-SITE RADICAL PROSTATECTOMY VS CONVENTIONAL LAPAROSCOPIC RADICAL PROSTATECTOMY: A PROSPECTIVE RANDOMIZED CLINICAL TRIAL Gang Zhu*, Pengjie Wu, Yaqun Zhang, Shengjie Liu, Bin Jin, Jianlong Wang, Hong Ma, Xin Chen, Yaoguang Zhang, Ben Wan, Jianye Wang, Beijing, China, People s Republic of MP62-10 LESS (LAPAROENDOSCOPIC SINGLE SITE SURGERY) RADICAL PROSTATECTOMY USING NEEDLE FORCEPS (ENDO RELIEF) Hidetoshi Akita*, Akihiro Nakane, Takahiro Kobayashi, Kenji Yamada, Ryosuke Ando, Yutaro Tanaka, Takehiko Okamura, Anjo, Japan, Takahiro Yasui, Kenjiro Kohri, Nagoya, Japan 204

217 MP62-11 IMPROVED LOCAL CONTROL IS ASSOCIATED WITH BETTER LONG TERM SURVIVAL FOLLOWING PROSTATE BRACHYTHERAPY Nelson Stone*, Richard Stock, New York, NY MP62-12 NOMOGRAMS PREDICTING 15-YEAR PROSTATE CANCER SPECIFIC MORTALITY AND PROSTATE CANCER RECURRENCE FOLLOWING DEFINITIVE BRACHYTHERAPY WITH OR WITHOUT EXTERNAL BEAM RADIATION FOR THE TREATMENT OF LOCALIZED PROSTATE CANCER Adnan Ali*, Nelson Stone, Richard Stock, Ashutosh Tewari, New York, NY MP62-13 PRIOR BLADDER OUTFLOW SURGERY OR LARGE PROSTATE VOLUME DOES NOT ADVERSELY AFFECT BIOCHEMICAL RECURRENCE-FREE SURVIVAL IN LOW DOSE RATE PROSTATE BRACHYTHERAPY: AN INTERMEDIATE TERM ANALYSIS Áine Goggins*, Hidekazu Yamamoto, London, United Kingdom, Peter Acher, Southend, United Kingdom, Stephen Morris, Ronald Beaney, Ben Challacombe, Rick Popert, London, United Kingdom MP62-14 LONG-TERM RESULTS OF POST- PROSTATECTOMY RADIOTHERAPY: A LARGE INSTITUTIONAL EXPERIENCE Rebecca Clayman*, Adam Feldman, Sigolene Galland, Douglas Dahl, Francis McGovern, Aria Olumi, Alec Eidelman, Andrzej Niemierko, William Shipley, Anthony Zietman, Jason Efstathiou, Boston, MA MP62-15 YOUNG AGE PREDICTS FOR TRANSIENT ELEVATION IN PSA AFTER DEFINITIVE STEREOTACTIC BODY RADIATION THERAPY FOR PROSTATE CANCER Seth Blacksburg*, Matthew Witten, Aaron Katz, Jonathan Haas, Mineola, NY MP62-16 FACTORS AFFECTING METASTASIS AND LONG-TERM SURVIVAL FOLLOWING PROSTATE BRACHYTHERAPY Nelson Stone*, Richard Stock, New York, NY MP62-17 PREDICTIVE FACTORS OF OUTCOME FOLLOWING SALVAGE RADIOTHERAPY ALONE FOR PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY Wan Song*, Hwang Gyun Jeon, Hyun Hwan Sung, Seoul, Korea, Republic of, Deok Hyun Han,, Korea, Republic of, Joon Hyung Park, Young Hyo Choi, Sang Eun Lee, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Han Yong Choi, Hyun Moo Lee, Seoul, Korea, Republic of MP62-18 SURVIVAL AFTER RADICAL PROSTATECTOMY OR RADIOTHERAPY AS PRIMARY TREATMENT IN PATIENTS WITH NON-METASTASIZED PROSTATE CANCER Christian Gratzke*, Martin Dörr, Kathleen Herkommer, Ralf Oberneder, Helmut Baur, Volker Beer, Claus Belka, Gabriele Schubert- Fritschle, Dieter Hölzel, Jürgen Gschwend, Christian Stief, Jutta Engel, Munich, Germany MP62-19 FOCAL CRYOTHERAPY DELIVERS SIMILAR ONCOLOGICAL CONTROL WITH SIGNIFICANTLY IMPROVED ERECTILE FUNCTION RECOVERY RATES OVER A WHOLE GLAND APPROACH Melissa Mendez*, Thomas Polascik, Niccolo Passoni, Durham, NC, Julio Pow-Sang, Tampa, FL, Ahmed El-Shafei, J. Stephen Jones, Cleveland, OH MP62-20 IMPACT OF A PREOPERATIVELY ESTIMATED PROSTATE VOLUME USING TRANSRECTAL ULTRASONOGRAPHY ON SURGICAL AND ONCOLOGICAL OUTCOMES IN A SINGLE SURGEON S EXPERIENCE WITH ROBOT-ASSISTED RADICAL PROSTATECTOMY Yosuke Hirasawa*, Jun Nakashima, Takeshi Hashimoto, Yoshihiro Nakagami, Yoshio Ohno, Makoto Ohori, Kunihiko Yoshioka, Masaaki Tachibana, Tokyo, Japan MONDAY *Presenting author 205

218 Monday, May 18, 2015 Moderated Poster Session 63 KIDNEY CANCER: SURGICAL THERAPY IV Room New Orleans Morial Convention Center Moderators: Bradley Leibovich and William Huang 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP63-01 MODIFIED FRAILTY INDEX PREDICTS MORTALITY AND ADVERSE OUTCOMES IN PATIENTS UNDERGOING RENAL SURGERY: ANALYSIS OF THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM (NSQIP) DATABASE Jamie S Pak*, Danny Lascano, Julia B Finkelstein, Mark V Silva, G Joel DeCastro, James M McKiernan, Mitchell C Benson, New York, NY MP63-02 HOW A DONOR NEPHRECTOMY POPULATION CAN HELP CLARIFY THE EFFECTS OF WARM RENAL ISCHEMIA DURING PARTIAL NEPHRECTOMY Roger Li, Herbert C. Ruckle, Muhannad Alsyouf*, Michelle Lightfoot, Jared Schober, David Tryon, Kristene Myklak, David Culpepper, Daniel Faaborg, Phillip Stokes, Javier L. Arenas, D. Duane Baldwin, Loma Linda, CA MP63-03 END STAGE RENAL DISEASE AFTER SURGERY IN PATIENTS WITH NORMAL PREOPERATIVE KIDNEY FUNCTION: THE EFFECT OF NEPHRON-SPARING SURGERY IN DELAYING THE ONSET OF THE DISEASE Umberto Capitanio*, Milan, Italy, Carlo Terrone, Novara, Italy, Alessandro Antonelli, Brescia, Italy, Andrea Minervini, Florence, Italy, Francesco Porpiglia, Turin, Italy, Alessadro Volpe, Novara, Italy, Maria Furlan, Brescia, Italy, Alberto Briganti, Paolo Capogrosso, Milan, Italy, Sergio Serni, Florence, Italy, Claudio Simeone, Brescia, Italy, Roberto Bertini, Francesco Montorsi, Milan, Italy MP63-04 CLINICAL AND PATHOLOGICAL LYMPH NODE PROGRESSION IN PATIENTS WITH A CT1-T2 N0 M0 RENAL MASS: SHALL WE FOREVER DISCARD THE USE OF LYMPH NODE DISSECTION IN LOW RISK PATIENTS? Umberto Capitanio*, Ettore Di Trapani, Rayan Matloob, Paolo Capogrosso, Massimo Freschi, Cristina Carenzi, Andrea Salonia, Andrea Russo, Andrea Gallina, Roberto Bertini, Alberto Briganti, Francesco Montorsi, Milan, Italy MP63-05 ROBOTIC INFERIOR VENA CAVA THROMBECTOMY AND RADICAL NEPHRECTOMY FOR LEVEL II AND III THROMBI: THE USC EXPERIENCE Charles Metcalfe*, Andre Abreu, Raj Satkunasivam, Raed Azhar, Kelvin Wong, Los Angeles, CA, Yi Sun, ShangHai, China, People s Republic of, Andre Berger, Monish Aron, Mihir Desai, Inderbir Gill, Los Angeles, CA MP63-06 TRIFECTA OUTCOMES OF ROBOTIC PARTIAL NEPHRECTOMY FOR T1B RENAL MASSES: A MULTI- INSTITUTIONAL ANALYSIS Homayoun Zargar*, Cleveland, OH, Craig Rogers, Detroit, MI, Sam Bhayani, St Louis, MO, Mohamad Allaf, Baltimore, MD, Jeffrey A Larson, St Louis, MO, Ravi Barod, Detroit, MI, Alon Mass, New York, NY, Michael h Johnson, Baltimore, MD, Michael Stifelman, New York, NY, Jihad H. Kaouk, Cleveland, OH MP63-07 EXTERNAL VALIDATION OF DIAMETER- AXIAL-POLAR SCORING IN PREDICTING SURGICAL OUTCOMES OF PARTIAL NEPHRECTOMY FOR RENAL TUMORS Linhui Wang*, zhenjie wu, shanghai, China, People s Republic of MP63-08 PHASE 3 RANDOMIZED TRIAL OF INTRAVENOUS MANNITOL VERSUS PLACEBO PRIOR TO RENAL ISCHEMIA DURING PARTIAL NEPHRECTOMY: IMPACT ON RENAL FUNCTIONAL OUTCOMES Massimiliano Spaliviero*, Nicholas E. Power, Katie S. Murray, Paul Russo, Daniel D. Sjoberg, Nicole E. Benfante, Arony J Sun, Melanie L. Bernstein, Karim A. Touijer, Guido Dalbagni, Jonathan A. Coleman, New York, NY MP63-09 LONG TERM TUMOUR SPECIFIC SURVIVAL IN PATIENTS UNDERGOING SURGICAL MANAGEMENT FOR RENAL CELL CARCINOMA ASSOCIATED WITH AN INFERIOR VENA CAVA THROMBUS Wael Khoder*, Armin Becker, Therese Schülze, Christian Stief, Alexander Kretschmer, Raphaela Waidelich, Munich, Germany MP63-10 MINIMUM 5 YEAR FOLLOW-UP AFTER ROBOTIC PARTIAL NEPHRECTOMY : A MULTI-INSTITUTIONAL ANALYSIS Homayoun Zargar*, Cleveland, OH, Mohamad Allaf, Baltimore, MD, Craig Rogers, Detroit, MI, Michael Stifelman, New York, NY, Sam Bhayani, St Louis, MO, Alon Mass, New York, NY, Ravi Barod, Detroit, MI, Michael h Johnson, Baltimore, MD, Jeffrey A Larson, St Louis, MO, Jihad H. Kaouk, Cleveland, OH MP63-11 NATIONAL TRENDS IN THE PERFORMANCE OF NEPHRO- URETERECTOMY Kurt Drury*, M Francesca Monn, Clinton D Bahler, Eric M DeRoo, Chandru P Sundaram, Indianapolis, IN 206

219 MP63-12 NON CLEAR CELL RENAL CELL CARCINOMAS: ONCOLOGICAL OUTCOME AFTER NEPHRON SPARING SURGERY BASED ON AN INTERNATIONAL MULTICENTER STUDY Pierre Bigot*, Angers, France, Jean Christophe Bernhard, Bordeaux, France, Inderbir Gill, Los Angeles, CA, Grégory Verhoest, Rennes, France, Boris Reix, Lille, France, Evren Suer, Ankara, Turkey, Masatoshi Eto, Kumamoto, Japan, François Xavier Nouhaud, Toulouse, France, Vincent Flammand, Lille, France, Ilker Gökce, Ankara, Turkey, Toru Matsugasumi, Los Angeles, CA, Jean Baptiste Beauval, Toulouse, France, Yvonne Chowaniec, Jérôme Rigaud, Nantes, France, Claire Lenormand, Christian Pfister, Rouen, France, Jean François Hetet, Nantes, France, Guillaume Ploussard, Paris, France, Nam Son Vuong, Bordeaux, France, Eduard Baco, Oslo, Norway, Morgan Rouprêt, Priscilla Léon, Paris, France, Adnan El Bakhri, Stéphane Larré, Reims, France, Xavier Tillou, Arnaud Doerfler, Caen, France, Aurélien Descazeau, Limoges, France, Philippe Sebe, Paris, France, Nicolas Koutlidis, Alexandre Schneider, Dijon, France, Abdel Rahmène Azzouzi, Angers, France, Michel Soulié, Toulouse, France, Karim Bensalah, Rennes, France, Jean Jacques Patard, Le Kremlin Bicêtre, France MP63-13 INCIDENCE OF MAJOR COMPLICATIONS FOR LAPAROSCOPIC RADICAL AND ROBOTIC PARTIAL NEPHRECTOMY: A MATCH-PAIRED ANALYSIS Oliver Ko*, Daniel Ramirez, Homayoun Zargar, Oktay Akca, Cleveland, OH, Andrew McElroy, Rootstown, OH, Georges-Pascal Haber, Jihad Kaouk, Robert Stein, Cleveland, OH MP63-14 FUNCTIONAL RECOVERY FROM EXTENDED WARM ISCHEMIA ASSOCIATED WITH PARTIAL NEPHRECTOMY Cesar Ercole*, Liliya Velet, Zhiling Zhang, Erick Remer, Maria Mir, Toshio Takagi, Sevag Demirjian, Steven Campbell, Cleveland, OH MP63-15 THE SUBCLASSIFICATION OF PAPILLARY RENAL CELL CARCINOMA DOES NOT AFFECT ONCOLOGICAL OUTCOMES AFTER NEPHRON SPARING SURGERY Pierre Bigot*, Angers, France, Jean Christophe Bernhard, Bordeaux, France, Inderbir Gill, Los Angeles, CA, Grégory Verhoest, Rennes, France, Boris Reix, Lille, France, Evren Suer, Ankara, Turkey, Masatoshi Eto, Kumamoto, Japan, François Xavier Nouhaud, Toulouse, France, Vincent Flammand, Lille, France, Ilker Gökce, Ankara, Turkey, Toru Matsugasumi, Los Angeles, CA, Jean Baptiste Beauval, Toulouse, France, Claire Lenormand, Rouen, France, Yvonne Chowaniec, Jérôme Rigaud, Nantes, France, Christian Pfister, Rouen, France, Jean François Hetet, Nantes, France, Guillaume Ploussard, Paris, France, Nam Son Vuong, Bordeaux, France, Eduard Baco, Oslo, Norway, Morgan Rouprêt, Priscilla Léon, Paris, France, Adnan El Bakhri, Stéphane Larré, Reims, France, Xavier Tillou, Arnaud Doerfler, Caen, France, Aurélien Descazeau, Limoges, France, Philippe Sebe, Paris, France, Nicolas Koutlidis, Alexandre Schneider, Dijon, France, Abdel Rahmène Azzouzi, Angers, France, Michel Soulié, Toulouse, France, Karim Bensalah, Rennes, France, Jean Jacques Patard, Le Kremlin Bicêtre, France MP63-16 ANALYSIS OF THE IMPACT OF ADHERENT PERI-RENAL FAT ON PERI- OPERATIVE OUTCOMES OF ROBOTIC PARTIAL NEPHRECTOMY Zine-Eddine Khene*, Benoit Peyronnet, Romain Mathieu, Tarek Frdoun, Gregory Verhoest, Karim Bensalah, Rennes, France MP63-17 TRENDS OF ACUTE KIDNEY INJURY AFTER RADICAL OR PARTIAL NEPHRECTOMY FOR RENAL CELL CARCINOMA Marianne Schmid*, Hamburg, Germany, Praful Rafi, London, United Kingdom, Nandita Krishna, Boston, MA, Akshay Sood, Deepansh Dalela, Detroit, MI, Felix Chun, Hamburg, Germany, Adam Kibel, Boston, MA, Mani Menon, Detroit, MI, Paul Nguyen, Toni Choueiri, Boston, MA, Margit Fisch, Hamburg, Germany, Quoc-Dien Trinh, Boston, MA MP63-18 SURGICAL TREATMENT IN 1,084 CONSECUTIVE RENAL LESIONS IN A SINGLE TERTIARY REFERRAL UNITED KINGDOM CENTER TARGETED OUTCOME MEASURES USING A NOVEL DECISION TREE PLATFORM Sashi Kommu*, Robert Mcarthur, Rajesh Nair, Meghana Kulkarni, Prasanna Sooriakumaran, Panos Tsavalas, Samer Katmawi-Sabbagh, Pieter le Roux, Christopher Anderson, London, United Kingdom MONDAY *Presenting author 207

220 MP63-19 PREDICTORS OF READMISSION FOLLOWING OPEN AND MINIMALLY INVASIVE PARTIAL NEPHRECTOMY USING THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM (NSQIP) DATABASE Ahmed Serhan, Ahmad Shabsigh*, Columbus, OH MP63-20 DEVELOPMENT AND EXTERNAL VALIDATION OF A PATHOLOGICAL NODAL STAGING SCORE FOR PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA Malte Rieken*, Basel, Switzerland, Stephen Boorjian, Rochester, MN, Luis Kluth, Hambug, Germany, Evanguelos Xylinas, Paris, France, Umberto Capitanio, Alberto Briganti, Milan, Italy, R. Houston Thompson, Bradley Leibovich, Rochester, MN, Laura- Maria Krabbe, Vitaly Margulis, Dallas, TX, Jay Raman, Mikhail Regelman, Hershey, PA, Tobias Klatte, Vienna, Austria, Alexander Bachmann, Basel, Switzerland, Pierre Karakiewicz, Montreal, Canada, Morgan Rouprêt, Paris, France, Richard Lee, Mithat Gönen, New York, NY, Shahrokh Shariat, Vienna, Austria Monday, May 18, 2015 Moderated Poster Session 64 BLADDER CANCER: NATURAL HISTORY AND PATHOPHYSIOLOGY Room New Orleans Morial Convention Center Moderators: Arthur Sagalowsky and Scott Tagawa 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP64-01 EXPRESSION PROFILE OF EPITHELIAL- MESENCHYMAL TRANSITION MARKERS IN RADICAL CYSTECTOMY SPECIMENS: COMPARATIVE STUDY BETWEEN UROTHELIAL AND BILHARZIAL SQUAMOUS CELL CARCINOMAS OF THE BLADDER Satoshi Imai, Hideaki Miyake*, Hosney Behnsawy, Masato Fujisawa, Kobe, Japan MP64-02 COMPARISON OF GENETIC ALTERATIONS FROM THE CANCER GENOME ATLAS BLADDER CANCER ANALYSIS AND A PROSPECTIVE SET OF HIGH-GRADE UROTHELIAL CARCINOMA TUMORS USING A CLINICAL LABORATORY IMPROVEMENT AMENDMENTS-CERTIFIED NEXT GENERATION SEQUENCING ASSAY Aditya Bagrodia*, Gopa Iyer, Eugene Cha, Mariel Boyd, Ahmet Zehir, Donavan Cheng, David Hyman, Hikmat Al-Ahmadie, Richard Bambury, Maria Arcila, Marc Ladanyi, Agnes Viale, Berger Michael, Bernard Bochner, Jonathan Rosenberg, Dean Bajorin, David Solit, New York, NY MP64-03 THE ACCURACY OF SELF-REPORTED SMOKING STATUS AMONG BLADDER CANCER PATIENTS Alan Thong*, Helena Furberg, Stacey Petruzella, Emily Zabor, Jamie Ostroff, Bernard Bochner, New York, NY MP64-04 EFFECT OF METFORMIN USE ON RISK OF BLADDER CANCER Abdo Kabarriti*, Ben Boursi, Ronac Mamtani, Thomas Guzzo, Kevin Haynes, Yu-Xiao Yang, S. Bruce Malkowicz, Philadelphia, PA MP64-05 SELF-REPORTED FINASTERIDE USE IS ASSOCIATED WITH DECREASED INCIDENCE OF BLADDER CANCER: DATA FROM THE PROSTATE, LUNG, COLORECTAL, & OVARIAN CANCER STUDY Edwin E. Morales*, San Antonio, TX, Sonja Grill, Munchen, Germany, Nicholas A. Freidberg, Ian M. Thompson III, Robert S. Svatek, Dharam Kaushik, Donna P. Ankerst, Michael A. Liss, San Antonio, TX MP64-06 PREOPERATIVE NUTRITIONAL STATUS AS A PREDICTOR OF RADICAL CYSTECTOMY POST OPERATIVE COMPLICATIONS: A NATIONAL COMPARISON Richard Matulewicz*, Apas Aggarwal, John Kim, Shilajit Kundu, Chicago, IL MP64-07 SIMPLIFIED FRAILTY INDEX PREDICTS ADVERSE OUTCOMES IN RADICAL CYSTECTOMY: AN ANALYSIS OF THE ACS- NSQIP DATABASE Danny Lascano*, Jamie S Pak, Michael J Lipsky, Julia B Finkelstein, Mitchell C Benson, G. Joel DeCastro, James M McKiernan, New York, NY 208

221 MP64-08 ESTABLISHING A CARE COORDINATION PATHWAY FOR BLADDER CANCER CYSTECTOMY PATIENTS Jason Bourque*, Kevin Chan, Timothy Wilson, Clayton Lau, Bertram Yuh, jonathan yamzon, Finly Zachariah, Laura Crocitto, Duarte, CA MP64-09 DECREASE IN LONG-TERM DISEASE- SPECIFIC SURVIVAL WITH PERIOPERATIVE BLOOD TRANSFUSION FOLLOWING RADICAL CYSTECTOMY Bethany K. Burge*, Robert H. Blackwell, Evan Carlos, Robert C. Flanigan, Gopal N. Gupta, Marcus L. Quek, Maywood, IL MP64-10 PERIOPERATIVE BLOOD TRANSFUSION IN BLADDER CANCER PATIENTS UNDERGOING RADICAL CYSTECTOMY IS ASSOCIATED WITH INCREASED MORBIDITY AND LENGTH OF STAY BUT NOT ADVERSE ONCOLOGIC OUTCOMES Heather Chalfin*, Jen-Jane Liu, Nilay Gandhi, Zhaoyong Feng, Bruce Trock, Steven Frank, Trinity Bivalacqua, Baltimore, MD MP64-11 PROPHYLACTIC MESH PLACEMENT AT RADICAL CYSTECTOMY TO PREVENT PARASTOMAL HERNIAS: TECHNIQUE AND EARLY COMPLICATIONS Timothy Donahue*, Bethesda, MD, Eugene K. Cha, Hebert A. Vargas-Alvarez, Guido Dalbagni, Bernard H. Bochner, New York, NY MP64-12 POSTOPERATIVE ATRIAL FIBRILLATION FOLLOWING RADICAL CYSTECTOMY PREDICTS FUTURE CARDIOVASCULAR EVENTS Robert Blackwell*, Chandy Ellimoottil, Petar Bajic, Matthew Zapf, Anai Kothari, Paul Kuo, Robert Flanigan, Marcus Quek, Gopal Gupta, Maywood, IL MP64-13 HEALTHCARE-ASSOCIATED INFECTIONS FOLLOWING CYSTECTOMY: ROOM FOR IMPROVEMENT Jesse Sammon*, Dane Klett, Firas Abdollah, Akshay Sood, Daniel Pucheril, Detroit, MI, Julian Hanske, Christian Meyer, Boston, MA, James Peabody, Mani Menon, Detroit, MI, Quoc-Dien Trinh, Boston, MA MP64-14 OUTPATIENT CHEMOPROPHYLAXIS AND RATE OF DEEP VENOUS THROMBOSIS FOLLOWING RADICAL CYSTECTOMY John Schomburg*, Ayman Soubra, Badrinath Konety, Minneapolis, MN MP64-15 RENAL FUNCTIONAL OUTCOMES AFTER RADICAL CYSTECTOMY AND THE INCREASED RISK OF CHRONIC KIDNEY DISEASE Danny Lascano*, Alexa Meyer, Elizabeth Hagan, Jamie S Pak, LaMont J. Barlow, G. Joel DeCastro, James M. McKiernan, New York, NY MP64-16 CRITICAL ANALYSIS OF HOSPITAL READMISSION AND COST BURDEN AFTER ROBOT-ASSISTED RADICAL CYSTECTOMY Kristina Wittig*, Nora Ruel, Bob Hawks, Kevin Chan, Clayton Lau, Timothy Wilson, Bertram Yuh, Duarte, CA MP64-17 LACK OF IMPROVEMENT IN RADICAL CYSTECTOMY OUTCOMES OVER 20 YEARS? Hristos Kaimakliotis*, Jane S. Cho, M. Francesca Monn, Jose A. Pedrosa, Paul Gellhaus, K. Clint Cary, Liang Cheng, Richard Bihrle, Michael O. Koch, Indianapolis, IN MP64-18 ADVERSE ONCOLOGIC OUTCOMES OF SQUAMOUS CELL CARCINOMA OF BLADDER AS COMPARED TO UROTHELIAL CARCINOMA Teodora Kurteva*, Mark Schoenberg, Farhang Rabbani, Bronx, NY MP64-19 THE NATURAL HISTORY OF NON- MUSCLE INVASIVE, NESTED VARIANT OF UROTHELIAL CARCINOMA Abhijith Mally*, Amy Tin, Eugene Cha, Sherri Donat, Harry Herr, Bernard Bochner, Daniel Sjoberg, Guido Dalbagni, New York, NY MP64-20 COMPLETE PATHOLOGIC RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR BLADDER CANCER: THE EFFECT OF PRE- TREATMENT CLINICAL STAGE William Parker*, Kansas City, KS, Phil Ho, Jonathon Melquist, Houston, TX, Hadley Wyre, Moben Mirza, Jeffrey Holzbeierlein, Kansas City, KS, Ashish Kamat, Houston, TX, Eugene Lee, Kansas City, KS MONDAY *Presenting author 209

222 Monday, May 18, 2015 Moderated Poster Session 65 BLADDER CANCER: INVASIVE III Room New Orleans Morial Convention Center Moderators: Michael Koch and Masayuki Nakagawa 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP65-01 PELVIC LYMPH NODE DISSECTION ON THE CONTRALATERAL SIDE CAN BE LIMITED IN STRICTLY UNILATERALLY LOCATED BLADDER CANCER Bernhard Kiss*, Michael Paerli, Daniel Schöndorf, George N. Thalmann, Beat Roth, Bern, Switzerland MP65-02 A PHASE III SURGICAL TRIAL TO EVALUATE THE BENEFIT OF A STANDARD VERSUS AN EXTENDED PELVIC LYMPHADENECTOMY PERFORMED AT TIME OF RADICAL CYSTECTOMY FOR MUSCLE INVASIVE UROTHELIAL CANCER: SWOG S1011 (NCT # ) Seth P. Lerner*, Houston, TX, Catherine M Tangen, Seattle, WA, Robert S. Svatek, San Antonio, TX, Theresa M Koppie, Portland, OR, Ajjai Alva, Ann Arbor, MI, Francisco G La Rosa, Aurora, CO, Sumanta K Pal, Duarte, CA, Siamak Daneshmand, Los Angeles, CA, Colin PN Dinney, Houston, TX, Adam S Kibel, Boston, MA, Kamal Pohar, Columbus, OH, Daniel J Canter, Philadpelphia, PA, Wassim Kassouf, Montreal, Canada, Rick Bangs, Seattle, WA, Ian M Thompson, San Antonio, TX MP65-03 DIFFERENCES IN THE DISTRIBUTION OF RECURRENCE LOCATIONS BETWEEN PATIENTS WHO UNDERGO OPEN AND ROBOT-ASSISTED RADICAL CYSTECTOMY FOR BLADDER CANCER Daniel Nguyen*, Bashir Al Hussein Al Awamlh, Xian Wu, Igor Inoyatov, Abimbola Ayangbesan, Bishoy Faltas, Paul Christos, Padraic O Malley, Douglas Scherr, New York, NY MP65-04 ONCOLOGICAL AND FUNCTIONAL OUTCOMES IN MUSCLE-INVASIVE BLADDER CANCER PATIENTS UNDERGOING BLADDER-SPARING TREATMENT CONSISTING OF LOW-DOSE CHEMORADIOTHERAPY AND CONSOLIDATIVE PARTIAL CYSTECTOMY Yasuhisa Fujii*, Kazunori Kihara, Hajime Tanaka, Manabu Tatokoro, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Tokyo, Japan MP65-05 DETERMINING THE OPTIMAL TIMING FOR RADICAL CYSTECTOMY AFTER NEOADJUVANT CHEMOTHERAPY Chinedu Mmeje*, Cooper Benson, Graciela Nogueras-Gonzalez, Isuru Jayaratna, Neema Navai, Jianjun Gao, Arlene Siefker-Radtke, Ashish Kamat, Colin Dinney, Jay Shah, Houston, TX MP65-06 A MULTI-INSTITUTIONAL ANALYSIS OF OUTCOMES IN PATIENTS WITH CLINICALLY NODE POSITIVE UROTHELIAL BLADDER CANCER TREATED WITH INDUCTION CHEMOTHERAPY AND RADICAL CYSTECTOMY Kamran Zargar-Shoshtari*, Tampa, FL, Homayoun Zargar, Vancouver, Canada, Adrian S Fairey, Los Angeles, CA, Laura S Mertens, Amsterdam, Netherlands, Colin P Dinney, Houston, TX, Maria C Mir, Cleveland, OH, Laura-Maria Krabbe, Dallas, TX, Michael S Cookson, Oklahoma, OK, Niels-Erik Jacobsen, Edmonton, Canada, Nilay Gandhi, Baltimore, MD, Joshua Griffin, Kansas City, KS, Jeffrey S Montgomery, Ann Arbor, MI, Nikhil Vasdev, Newcastle Upon Tyne, United Kingdom, Evan Y Yu, Seattle, WA, Evanguelos Xylinas, New York, NY, Nicholas J. Campain, Exeter, United Kingdom, Wassim Kassouf, Montreal, Canada, Marc A. Dall Era, Sacramento, CA, Jo-An Seah, Toronto, Canada, Pranav Sharma, Tampa, FL, Cesar E Ercole, Cleveland, OH, Simon Horenblas, Amsterdam, Netherlands, Srikala S Sridhar, Toronto, Canada, John S McGrath, Jonathan Aning, Exeter, United Kingdom, Shahrokh F Shariat, Vienna, Austria, Jonathan L Wright, Seattle, WA, Andrew C Thorpe, Newcastle Upon Tyne, United Kingdom, Todd M Morgan, Ann Arbor, MI, Jeff M Holzbeierlein, Kansas City, KS, Trinity J Bivalacqua, Baltimore, MD, Scott North, Edmonton, Canada, Daniel A Barocas, Nashville, TN, Yair Lotan, Dallas, TX, Jorge A Garcia, Andrew J Stephenson, Cleveland, OH, Jay B Shah, Houston, TX, Bas W van Rhijn, Amsterdam, Netherlands, Siamak Daneshmand, Los Angeles, CA, Philippe E Spiess, Tampa, FL, Peter Black, Vancouver, Canada MP65-07 DIFFERENCES IN THE RECURRENCE PATTERN AFTER NEOADJUVANT CHEMOTHERAPY COMPARED TO SURGERY ALONE IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER Hiromichi Iwamura*, Takuya Koie, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Chikara Ohyama, Hirosaki, Japan 210

223 MP65-08 A PHARMACODYNAMIC PHASE 0/I STUDY OF ORAL RAPAMYCIN IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR BLADDER CANCER Aashish Kabra*, Essel Marie de Leon, Carolina Livi, Martin Javors, Marlo Nicolas, David Henkes, Dave Sharp, Tyler Curiel, Robert Svatek, San Antonio, TX MP65-09 IMPACT OF PERIOPERATIVE CHEMOTHERAPY ON SURVIVAL IN PATIENTS WITH ADVANCED PRIMARY URETHRAL CANCER: RESULTS OF THE INTERNATIONAL COLLABORATION ON PRIMARY URETHRAL CARCINOMA Georgios Gakis*, Tübingen, Germany, Todd Morgan, Ann Arbor, MI, Siamak Daneshmand, Tübingen, CA, Kirk Keegan, Harras Zaid, Nashville, TN, Jan Hrbacek, Prague,, Bedeir Ali-El-Dein, Mansoura, Egypt, Rebecca Clayman, Boston, MA, Tilman Todenhöfer, Tübingen, Germany, Sigolene Galland, Boston, MA, Kola Olugbade Jr., Ann Arbor, MI, Michael Rink, Hamburg-Eppendorf, Germany, Hans-Martin Fritsche, Maximillian Burger, Regensburg, Germany, Sam Chang, Nashville, TN, Marko Babjuk, Prague, Czech Republic, George Thalmann, Bern, Switzerland, Arnulf Stenzl, Tübingen, Germany, Jason Efstathiou, Boston, MA MP65-10 DELAYED RADICAL CYSTECTOMY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A NATIONWIDE ANALYSIS Harman Maxim Bruins*, Katja Aben, Tom Arends, Toine van der Heijden, Fred Witjes, Nijmegen, Netherlands MP65-11 GENDER DISPARITY IN SURVIVAL FROM BLADDER CANCER CAN NOT BE EXPLAINED BY LATE PRESENTATION OR DIFFERENCES IN TREATMENT Manish Patel*, Albert Bang, David Gillett, David Smith, Sydney, Australia MP65-12 CHANGING PATTERNS OF CARE AMONG PATIENTS WITH STAGE T1 UROTHELIAL CANCER OF THE BLADDER Phillipe Nabbout*, Oklahoma City, OK, Sean Elliott, Oluwakayode Adejoro, Minneapolis, MN, Joel Slaton, Oklahoma City, OK MP65-13 BROADER SPECTRUM ANTIMICROBIAL PROPHYLAXIS INCLUDING FUNGAL COVERAGE SIGNIFICANTLY REDUCES INFECTIOUS COMPLICATIONS AFTER RADICAL CYSTECTOMY Joseph J. Pariser*, Blake B. Anderson, Shane M. Pearce, Zhe Han, Chicago, IL, Benjamin D. Brielmaier, Franklin, TN, Emily Landon, Jennifer C. Pisano, Gary D. Steinberg, Norm D. Smith, Chicago, IL MP65-14 INCIDENCE AND RISK FOR CLOSTRIDIUM DIFFICILE INFECTIOUS COLITIS IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR BLADDER CANCER Kashyap Shatagopam*, Nick Liu, M. Francesca Monn, Clinton Bahler, Hristos Kaimakliotis, K. Clint Cary, Ronald Boris, Matthew Mellon, Timothy Masterson, Richard Bihrle, Richard Foster, Thomas Gardner, Michael House, Michael Koch, Indianapolis, IN MP65-15 EXTENDED-DURATION ENOXAPARIN LOWERS THROMBOEMBOLIC EVENTS AFTER RADICAL CYSTECTOMY COMPARED TO INPATIENT-ONLY SUBCUTANEOUS HEPARIN Joseph J. Pariser*, Shane M. Pearce, Blake B. Anderson, Vivek N. Prachand, Norm D. Smith, Gary D. Steinberg, Chicago, IL MP65-16 ADMINISTRATION OF POSTOPERATIVE PARENTERAL NUTRITION DOES NOT AFFECT ONCOLOGICAL OUTCOMES AFTER RADICAL CYSTECTOMY (RC) IN BLADDER CANCER PATIENTS Alvaro Vidal Faune*, Bernhard Kiss, Fiona C. Burkhard, Urs E. Studer, George N. Thalmann, Beat Roth, Bern, Switzerland MP65-17 CYSTECTOMY ENHANCED RECOVERY PATHWAY: REDUCTION IN LENGTH OF STAY WITHOUT INCREASED MORBIDITY OR READMISSIONS Janet Baack Kukreja*, Maureen Kiernan, Bethany Schempp, Adriana Hontar, Ahmed Ghazi, Hani Rashid, Guan Wu, Edward Messing, Rochester, NY MP65-18 CLINICAL CHARACTERISTICS AND POSTOPERATIVE 30-DAY COMPLICATIONS ASSOCIATED WITH NEOBLADDER AT THE TIME OF CYSTECTOMY: DATA FROM THE NSQIP DATA BASE Ryan Werntz*, Yiyi Chen, Joshua Buehler, Christopher Amling, Theresa Koppie, Portland, OR MP65-19 AN EVALUATION OF THE TIMING OF SURGICAL COMPLICATIONS FOLLOWING RADICAL CYSTECTOMY Akshay Sood*, Naveen Kachroo, Firas Abdollah, Jesse Sammon, Dane Klett, Wooju Jeong, Detroit, MI, Adam Kibel, Marianne Schmid, Boston, MA, James Peabody, Mani Menon, Detroit, MI, Quoc-Dien Trinh, Boston, MA MP65-20 DETERMINANTS OF OPERATIVE TIME FOR BLADDER CANCER PATIENTS UNDERGOING RADICAL CYSTECTOMY Christopher Filson*, Aaron Laviana, Hung-Jui Tan, Karim Chamie, Jim Hu, Los Angeles, CA MONDAY *Presenting author 211

224 Monday, May 18, 2015 Moderated Poster Session 66 PROSTATE CANCER: BASIC RESEARCH V Room New Orleans Morial Convention Center Moderators: Mark Garzotto and Douglas Scherr 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP66-01 SPOP MUTATION LEADS TO GENOMIC INSTABILITY IN PROSTATE CANCER Christopher Barbieri*, Gunther Boysen, New York, NY, Davide Prandi, Trento, Italy, Sung- Suk Chae, Arun Dahiya, Srilakshmi Nataraj, Mirjam Blattner, Clarisse Marotz, Limei Xu, Julie Huang, New York, NY, Paola Lecca, Trento, Italy, Sagar Chhangawala, Pengbo Zhou, Andrea Sboner, New York, NY, Francesca Demichelis, Trento, Italy, Yariv Houvras, Mark Rubin, New York, NY MP66-02 INHIBITION OF LIM-SH3 DOMAIN PROTEIN1 AUGMENTS THE ANTI- CANCER EFFECT OF ENZALUTAMIDE IN PROSTATE CANCER Takashi Dejima*, Vancouver, Canada, Ario Takeuchi, Fukuoka, Japan, Jeffrey Leong, Tabitha Tombe, Kevin Tam, Vancouver, Canada, Seiji Naito, Fukuoka, Japan, Martin Gleave, Christopher Ong, Vancouver, Canada MP66-03 NEXT-GENERATION SEQUENCING OF CIRCULATING EXOSOMAL RNA FROM METASTATIC CASTRATE RESISTANT PROSTATE CANCER PATIENTS Elisa Ledet*, Ratish Gambhira, Aryeneesh Dotiwala, Diptasri Mandal, Oliver Sartor, New Orleans, LA MP66-04 CABAZITAXEL INHIBITS THE PROLIFERATION OF HUMAN CASTRATION-REFRACTORY PROSTATE CANCER CELLS IN VITRO AND ENHANCES THE ANTI-TUMOR PROPERTIES OF THE ANGIO-INHIBITORY PIGMENT EPITHELIUM-DERIVED FACTOR IN VIVO WITH A GREATER EFFICACY THAN DOCETAXEL Thomas Nelius*, Courtney Jarvis, Dalia Martinez-Marin, Stephanie Filleur, Lubbock, TX MP66-05 PRETREATMENT SYSTEMIC INFLAMATORY RESPONSE PARAMETERS DO NOT PREDICT THE OUTCOME IN MEN WITH PROSTATE CANCER UNDERGOING RADICAL PROSTATECTOMY Cédric Poyet*, Jean-Pascal Adank, Etienne Keller, Ashkan Mortezavi, Tenzin Rabgang, Bettina Pfister, Tullio Sulser, Thomas Hermanns, Zürich, Switzerland MP66-06 OPTIMIZATION OF NANOSTRING PLATFORM FOR EVALUATION OF PROSTATE CANCER BIOMARKERS AND THERAPEUTIC TARGETS IN FFPE SPECIMENS Wusheng Yan, Denise Young, Yingjie Song, Yongmei Chen, Shilpa Katta, Lakshmi Ravindranath, Jocelyn Lee, Alagarsamy Srinivasan, Jennifer Cullen, Jacob Kagan, Sudhir Srivastava, Sudhir Srivastava, Albert Dobi, Rockville, MD, Inger Rosner, David G. McLeod, Bethesda, MD, Isabell A. Sesterhenn, Silver Spring, MD, Shiv Srivastava, Gyorgy Petrovics*, Rockville, MD MP66-07 TARGETING ANDROGEN RECEPTOR N- TERMINAL DOMAIN FOR PROSTATE CANCER IMAGING AND THERAPY Yusuke Imamura*, Amy H. Tien, Nasrin R. Mawji, Jian Kun Zhong, Jinhe Pan, Kuo- Shyan Lin, Raymond J. Andersen, Marianne D. Sadar, Vancouver, Canada MP66-08 DUAL PATHWAY INHIBITION IN PROSTATE CANCER Eugine Lee, Susan Ha, Susan Logan*, New York, NY MP66-09 REGULATION OF INTRATUMORAL ANDROGEN SYNTHESIS IN PROSTATE CANCER BY THE DAB2IP/AKR1C3 SIGNALING AXIS Kaijie Wu*, Xi an, China, People s Republic of, Bin Wang, Dallas, TX, Jiancheng Zhou, Xi an, China, People s Republic of, Jer-Tsong Hsieh, Dallas, TX, Dalin He, Xi an, China, People s Republic of MP66-10 CHARACTERIZATION OF SUSCEPTIBILITY LOCI IN HEREDITARY PROSTATE CANCER FAMILIES USING COPY NUMBER VARIATION AND LINKAGE ANALYSIS Elisa Ledet, Kirsten Wood*, New Orleans, LA, Joan Bailey-Wilson, Baltimore, MD, Oliver Sartor, New Orleans, LA, Marilyn Li, Houston, TX, Diptasri Mandal, New Orleans, LA MP66-11 ANDROGEN RECEPTOR SPLICE VARIANTS DIMERIZE TO ACTIVATE GENE TRANSCRIPTION Yang Zhan, Duo Xu, Yanfeng Qi, Bo Cao, Oliver Sartor, Yan Dong*, New Orleans, LA 212

225 MP66-12 A NOVEL CELL BASED MULTIPLEX BIOMARKER ASSAY FOR PROSTATE CANCER DETECTION IN URINE Shyh-Han Tan*, Kristen P Nickens, Rockville, MD, Amina Ali, Bethesda, MD, Tatiana Scoggin, Concord, CA, Lakshmi Ravindranath, Rockville, MD, David G. McLeod, Bethesda, MD, David Tacha, Concord, CA, Shiv Srivastava, Rockville, MD, Isabell Sesterhenn, Silver Spring, MD, Gyorgy Petrovics, Rockville, MD MP66-13 METFORMIN REPRESSES CANCER CELLS VIA ALTERNATE PATHWAYS IN N- CADHERIN WILD TYPE AND N-CADHERIN DEFICIENT CELLS Rongbin Ge, Zongwei Wang, Shulin Wu, Yangjia Zhuo, Aleksandar Otsetov, Boston, MA, Chao Cai, Weide Zhong, Guangzhou, China, People s Republic of, Chin-lee Wu, Aria Olumi*, Boston, MA MP66-14 IDENTIFYING NOVEL NUCLEAR TRANSPORTER OF AR AND AR(VARIANT) IN CRPC CELLS: POTENTIAL IMPLICATIONS IN THERAPY Mohammad Saleem*, Austin, MN, Badrinath Konety, Minneapolis, MN, Aijaz Parray, Hifzur Siddique, Austin, MN, Robert Matusik, Nashville, TN, Mikihik NAITO, Tokyo, Japan, Alyssa Langfald, Austin, MN MP66-15 INHIBITION OF ERG ACTIVITY IN PATIENT DERIVED PROSTATE CANCER XENOGRAFTS USING THE SMALL MOLECULE INHIBITOR YK Brian Winters*, Lisha Brown, Ilsa Coleman, Seattle, WA, Tsion Minas, Washington, DC, Xiaotun Zhang, Lori Kollath, Holly Nguyen, Peter Nelson, Eva Corey, Seattle, WA, Aykut Uren, Washington, DC, Colm Morrissey, Seattle, WA MP66-16 ANATOMIC TUMOR LOCATION NOT RACIAL BACKGROUND IMPACTS ETS FAMILY TRANSCRIPTION FACTOR AND SPINK1 EXPRESSION IN PROSTATE CANCER Farzana Faisal*, Debasish Sundi, Ashley Ross, Baltimore, MD, Voleak Choeurng, Nicholas Erho, Mohammed Alshalalfa, Elai Davicioni, Vancouver, Canada, Tamara Lotan, Edward Schaeffer, Baltimore, MD MP66-17 MICRORNA-224 IS DOWN-REGULATED IN PROSTATE CANCER AND MEDIATES TUMOR-SUPPRESSIVE EFFECTS IN VITRO Felix Bienert, Kati Erdmann*, Susanne Fuessel, Manfred P. Wirth, Dresden, Germany MP66-18 THE EFFECT OF METFORMIN ON OSTEOMIMICRY AND CANCER-INDUCED BONE DISEASE IN THE PROSTATE CANCER-BONE MICROENVIRONMENT IN VITRO AND IN VIVO Jessica Whitburn*, James Aylward, Siobhan Webb, Srinivasa Rao, Freddie Hamdy, Claire Edwards, Oxford, United Kingdom MP66-19 REDUCED AUTOPHAGY LEVELS ARE ASSOCIATED WITH A HIGHER GLEASON SCORE, TUMOR STAGE AND AN INCREASED RATE OF PROSTATE CANCER SPECIFIC DEATH Ashkan Mortezavi*, Souzan Salemi, Niels Rupp, Thomas Hermanns, Tullio Sulser, Peter J Wild, Daniel Eberli, Zurich, Switzerland MP66-20 SIURO-PRIAS-ITA PROJECT: FIVE YEAR EXPERIENCE ON ACTIVE SURVEILLANCE Rocco Papalia*, Michele Gallucci, Rome, Italy, Giario Conti, Como, Italy, Giuseppe Martorana, Bologna, Italy, Roberto Sanseverino, Nocera Inferiore, Italy, Ezio Frego, Marco Tanello, Desenzano, Italy, Pierpaolo Graziotti, Rozzano, Italy, Andrea Turci, Cesena, Italy, Pasquale Ditonno, Bari, Italy, Maurizio Colecchia, Milano, Italy, Michelangelo Fiorentino, Bologna, Italy, Rodolfo Montironi, Torrette di Ancona, Italy, Carlo Patriarca, Como, Italy, Maria Rosa Raspollini, Firenze, Italy, Tiziana Magnani, Milano, Italy, Chris Bangma, Rotterdam, Netherlands, Riccardo Valdagni, Milano, Italy MONDAY Monday, May 18, 2015 Podium Session 38 PROSTATE CANCER: DETECTION AND SCREENING III Room New Orleans Morial Convention Center Moderator: Hans Lilja 10:30 am - 12:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 10:30 PD38-01 HETEROGENEITY OF RECOMMENDED PSA SCREENING PRACTICES IN MEN AGED IN THE UNITED STATES Jesse Sammon*, Firas Abdollah, Akshay Sood, Dane Klett, Daniel Pucheril, James Peabody, Mani Menon, Detroit, MI, Quoc- Dien Trinh, Boston, MA 10:40 PD38-02 METASTATIC PROSTATE CANCER IN THE MODERN ERA OF PSA SCREENING Philip Fontenot*, Avinash Nehra, Hadley Wyre, Moben Mirza, Jeffrey Holzbeierlein, J. Brantley Thrasher, Peter Van Veldhuizen, Eugene Lee, Kansas City, KS *Presenting author 213

226 10:50 PD38-03 THE 4KSCORE IS ASSOCIATED WITH MORE ADVANCED DISEASE AT RADICAL PROSTATECTOMY; RESULTS FROM A MULTI-INSTITUTIONAL PROSPECTIVE TRIAL Sanoj Punnen*, Miami, FL, Stephen Zappala, Andover, MA, Dan Sjoberg, New York, NY, Vinita Mathur, Michael Reeve, Dipen Parekh, Miami, FL 11:00 PD38-04 PCA3- BASED NOMOGRAM FOR PREDICTING PROSTATE CANCER AND HIGH GRADE CANCER ON INITIAL TRANSRECTAL GUIDED BIOPSY Ahmed Elshafei*, Cleveland, OH, K. Kent Chevli, Michael Duff, Cheektowaga, NY, Peter Walter, Cleveland, OH, Margaret Suraf, Cheektowaga, NY, Ayman S. Moussa, Giza, Egypt, Gao Tianming, Shih-Chieh Chueh, J.Stephen Jones, Cleveland, OH 11:10 PD38-05 MAGNETIC RESONANCE IMAGING/ULTRASOUND FUSION-GUIDED BIOPSY DETECTS CLINICALLY SIGNIFICANT PROSTATE CANCER IN THE CENTRAL GLAND CORRELATING WITH INDEX LESION Michele Fascelli*, Thomas Frye, Arvin George, Steven Abboud, Raju Chelluri, Richard Ho, Annerleim Walton Diaz, Sandeep Sankineni, Maria Merino, Baris Turkbey, Peter Choyke, Bradford Wood, Peter Pinto, Bethesda, MD 11:20 PD38-06 UNDERSTANDING THE USE OF PROSTATE BIOPSY AMONG MEN WITH LIMITED LIFE EXPECTANCY Firas Abdollah*, Detroit, MI, Zaojun Ye, David Miller, Susan Linsell, James Montie, Ann Arbor, MI, James Peabody, Detroit, MI, Khurshid Ghani, Ann Arbor, MI 11:30 PD38-07 GENETIC CORRECTION OF PSA CAN REDUCE THE NUMBER OF MEN DIAGNOSED WITH POTENTIALLY INSIGNIFICANT PROSTATE CANCER: RESULTS FROM A SURGICAL AND ACTIVE SURVEILLANCE COHORT James Kearns*, Chicago, IL, Brian Helfand, Evanston, IL, Kimberly Roehl, Chicago, IL, Kristian Novakovic, Evanston, IL, Phillip Cooper, William Catalona, Chicago, IL 11:40 PD38-08 PERFORMANCE OF IN-BORE MR-GUIDED TARGETED PROSTATE BIOPSY FOR DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: A MULTICENTER STUDY Ely Felker*, Stephanie Lee-Felker, Los Angeles, CA, John Feller, Stuart May, Palm Springs, CA, Robert Princenthal, Martin Cohen, Thousand Oaks, CA, David Lu, Daniel Margolis, Grace Kim, Steven Raman, Los Angeles, CA 11:50 PD38-09 PROSTATE BIOPSY COMPLICATIONS, A DUAL ANALYSIS Franklin Gaylis*, Ryan Nasseri, Logan Fink, Renee Calabrese, Brandon Bosse, Paul Dato, Edward Cohen, San Diego, CA 12:00 PD38-10 EXTERNAL VALIDATION OF UPDATED NOMOGRAM PREDICTING PROSTATE CANCER ON INITIAL TRANSRECTAL ULTRASOUND GUIDED BIOPSY Ahmed Elshafei*, Cleveland, OH, Ayman S. Moussa, Beni -Suef, Egypt, Asmaa Hatem, Cleveland, OH, K. Kent Chevli, Michael Duff, William Geary, Peter Walter, Margaret Suraf, Cheektowaga, NY, Gao Tianming, Andrew Stephenson, Eric Klein, J.Stephen Jones, Cleveland, OH 12:10 PD38-11 ADVERSE PATHOLOGY YET UNDETECTABLE ULTRASENSITIVE PSA: IS ADJUVANT RADIATION REALLY NECESSARY? Ross Simon*, Lauren Howard, Stephen Freedland, Durham, NC, William Aronson, Los Angeles, CA, Martha Terris, Augusta, GA, Christopher Kane, San Diego, CA, Christopher Amling, Portland, OR, Matthew Cooperberg, San Francisco, CA, Adriana Vidal, Durham, NC 12:20 PD38-12 [11C]CHOLINE PET/CT PREDICTS SURVIVAL IN HORMONE NAÏVE PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY Maria Picchio*, Giampiero Giovacchini, Luigi Gianolli, Nazareno Suardi, Milan, Italy, Firas Abdollah, Detroit, MI, Andrea Gallina, Vito Cucchiara, Giorgio Gandaglia, Marco Bianchi, Vincenzo Scattoni, Francesco Montorsi, Alberto Briganti, Milan, Italy 12:30 PD38-13 REPEAT BIOPSY RATES FOR PREMALIGNANT LESIONS IN A STATEWIDE QUALITY IMPROVEMENT COLLABORATIVE Frank Burks*, Dinesh Telang, Royal Oak, MI, Alice Liu, Yuqing Gao, Susan Linsell, James Montie, David Miller, Khurshid Ghani, Ann Arbor, MI 214

227 Monday, May 18, 2015 Podium Session 39 BENIGN PROSTATIC HYPERPLASIA: EPIDEMIOLOGY AND NATURAL HISTORY Room New Orleans Morial Convention Center Moderators: Henry Woo and Naoya Masumori 10:30 am - 12:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 10:30 PD39-01 SEXUAL FUNCTION ASSOCIATED WITH LOWER URINARY TRACT SYMPTOMS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA: MTOPS COHORT OF CROSS-SECTIONAL AND LONGITUDINAL DATA Michael Butcher*, Springfield, IL, Chyng-Wen Fwu, Silver Spring, MD, Ziya Kirkali, Bethesda, MD, Tobias Köhler, Springfield, IL, Pamela Burrows, Rockville, MD, Paul Eggers, John Kusek, Bethesda, MD, Kevin McVary, Springfield, IL 10:40 PD39-02 ESTROGEN, BUT NOT TESTOSTERONE, IS ASSOCIATED WITH LOWER URINARY TRACT SYMPTOMS AT BASELINE AND FOLLOWING TREATMENT WITH TADALAFIL: ANALYSIS OF POOLED CLINICAL TRIALS DATA Martin Miner*, Providence, RI, Kathryn Egan, Gayatri Ranganathan, Minhyung Suh, Watertown, MA, Claus Roehrborn, Dallas, TX, Gary Wittert, Adelaide, Australia, David Wong, Xiao Ni, Indianapolis, IN, Raymond Rosen, Watertown, MA 10:50 PD39-03 ASSOCIATION OF PROSTATE BLOOD FLOW WITH MALE LOWER URINARY TRACT SYMPTOMS Kuan-Yu Wu*, Yao-Lin Kao, Chan-Jung Liu, Yin-Chien Ou, Yuh-Shyan Tsai, Tzong-Shin Tsai, Yat-Ching Tong, Tainan, Taiwan 11:00 PD39-04 ASSOCIATION OF URINE CHEMOKINES WITH CLINICAL ATTRIBUTES OF BPH/LUTS PATIENTS Pradeep Tyagi*, Pittsburgh, PA, Jay H. Fowke, Saundra Motley, Nashville, TN, Mahendra Kashyap, Subrata Pore, Zhou Wang, Naoki Yoshimura, Pittsburgh, PA 11:10 PD39-05 WORSENED URINARY STORAGE SYMPTOMS AND DECREASED QUALITY OF LIFE PREDICTS LOW TESTOSTERONE IN A CARDIOLOGY CLINIC POPULATION Michael Kottwitz*, Springfield, IL, Joel F Koenig, St. Louis, MO, Bradford Stevenson, Randy Sulaver, Georgia Mueller, Tobias S Kohler, Springfield, IL 11:20 PD39-06 IMPAIRED SLEEP QUALITY PREDICTS MORE SIGNIFICANT LOWER URINARY TRACT SYMPTOMS IN MALE SHIFT WORKERS Alexander W. Pastuszak*, Jason Scovell, Justin Badal, Aravind Chandrashekar, Tariq S. Hakky, Ranjith Ramasamy, Dolores J. Lamb, Larry I. Lipshultz, Houston, TX 11:30 PD39-07 ABDOMINAL AORTIC ATHEROMATOSIS AND LOWER URINARY TRACT SYMPTOMS IN MEN Gabriel Gouvea*, Jose Ricardo Silvino, Priscila Kuriki, Viviane Tabone, Raquel Conceicao, Rogerio Simonetti, Valdemar Ortiz, Roberto Soler, Sao Paulo, Brazil 11:40 PD39-08 VOIDING PARAMETERS IN ELDERLY MALES WITH 5 YEAR FOLLOWUP- WHAT HAPPENS TO MEN WITH ELEVATED POSTVOID RESIDUAL URINE? Giovanni Losco, Lewis Chan*, Vincent Tse, Vasi Naganathan, Robert Cumming, Sydney, Australia 11:50 PD39-09 STATIN DRUG USE AND RISK OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA (BPH): RESULTS FROM THE PROSTATE CANCER PREVENTION TRIAL Darshan Patel*, James Hotaling, Jeremy Myers, William Brant, Salt Lake City, UT, Jeannette Schenk, Seattle, WA 12:00 PD39-10 CHANGES IN BODY MASS INDEX AND METABOLIC SYNDROME ARE ASSOCIATED WITH PROSTATE GROWTH RATE OVER A 5 YEAR PERIOD Yoon Soo Kyung*, Dalsan You, In Gab Jeong, Taekmin Kwon, Chunwoo Lee, Seungbong Han, Hong-Kyu Kim, Choung-Soo Kim, Myungchan Park, Chanwoo Lee, Sangjun Yoo, Seoul, Korea, Republic of 12:10 PD39-11 PEAK URINE FLOW PREDICTS DEVELOPMENT OF SYMPTOMATIC BPH IN MEN WITH MILD TO NO URINARY SYMPTOMS: RESULTS FROM REDUCE Ross Simon*, Lauren Howard, Durham, NC, Daniel Moreira, Rochester, MN, Stephen Freedland, Durham, NC, Claus Roehrborn, Dalllas, TX, Adriana Vidal, Durham, NC 12:20 PD39-12 THE CO-OCCURRING SYNDROME - OVERLAP OF ED AND BPH AND THEIR CLINICAL CORRELATES IN AGING MEN: RESULTS FROM THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY Arthur L. Burnett*, Baltimore, MD, Kathryn Egan, Minhyung Suh, Watertown, MA, Kevin T. McVary, Springfield, IL, Claus Roehrborn, Dallas, TX, David Wong, Xiao Ni, Indianapolis, IN, Raymond Rosen, Watertown, MA MONDAY *Presenting author 215

228 Monday, May 18, 2015 Podium Session 40 SEXUAL FUNCTION/DYSFUNCTION/ANDROLOGY: SURGICAL THERAPY II Room New Orleans Morial Convention Center Moderators: Lawrence Hakim and Ronald Lewis 10:30 am - 12:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 10:30 PD YEAR OUTCOMES OF THE ZEN TRIAL: THE MEDTRONIC ZOTAROLIMUS- ELUTING PERIPHERAL STENT SYSTEM FOR THE TREATMENT OF ED IN MALES WITH SUB-OPTIMAL RESPONSE TO PDE5 INHIBITORS Tobias Kohler*, Springfield, IL, Irwin Goldstein, San Diego, CA 10:40 PD40-02 PREDICTING ERECTILE DYSFUNCTION (ED) AFTER DORSAL PLAQUE INCISION AND GRAFTING IN MEN WITH BASELINE NORMAL ERECTILE HEMODYNAMICS Raanan Tal*, Judy Choi, Byron Alex, Stefan Flores, Christian J. Nelson, John P. Mulhall, New York, NY 10:50 PD40-03 TARGETED ROBOTIC ASSISTED MICROSURGICAL DENERVATION OF THE SPERMATIC CORD FOR THE TREATMENT OF CHRONIC SCROTAL CONTENT PAIN: SINGLE CENTER, LARGE SERIES REVIEW Bayo Tojuola*, Ibrahim Kartal, Jamin Brahmbhatt, Sijo Parekattil, Clermont, FL 11:00 PD40-04 SALVAGE ULTRASOUND GUIDED TARGETED MICROCRYOABLATION OF THE PERI-SPERMATIC CORD FOR PERSISTENT CHRONIC SCROTAL CONTENT PAIN AFTER MICROSURGICAL DENERVATION OF THE SPERMATIC CORD Bayo Tojuola*, Ibrahim Kartal, Jamin Brahmbhatt, Sijo Parekattil, Clermont, FL 11:10 PD40-05 SUB-URETHRAL SLING SURGERY FOR STRESS INCONTINENCE MAY RESULT IN ORGASMIC DYSFUNCTION THROUGH DIRECT INJURY TO ANTERIOR VAGINAL WALL, PERI-URETHRAL PROSTATIC TISSUE Nicole Szell*, Detroit, MI, Rose Hartzell, Deborah Cohen, Sue Goldstein, Joshua Gonzalez, Irwin Goldstein, San Diego, CA 11:20 PD40-06 EFFECT OF OPERATIVE LOCAL ANESTHESIA ON POSTOPERATIVE PAIN OUTCOMES OF INFLATABLE PENILE PROSTHESIS : PROSPECTIVE COMPARISON OF TWO MEDICATIONS Marilin Nicholson*, Fernando Bianco, Angel Perez, Edward Gheiler, Hialeah, FL 11:30 PD40-07 THE CARRION CAST: AN UPDATE ON THE USAGE OF THE INTRACORPORAL ANTIMICROBIAL DOPED SPACER FOR THE TREATMENT OF PENILE IMPLANT INFECTION Daniel Martinez*, Eihab Alhammali, Tariq Hakky, Tampa, FL, Paul Perito, Miami, FL, Justin Parker, Rafael Carrion, Tampa, FL 11:40 PD40-08 SURGICAL MANAGEMENT OF ERECTILE DYSFUNCTION IN THE VETERANS AFFAIRS (VA) POPULATION John Lacy*, Jonathan Walker, Shubham Gupta, David Preston, Lexington, KY 11:50 PD40-09 FACTORS CORRELATING WITH SEXUAL INTEREST AND FUNCTION IN LONG- TERM COLORECTAL CANCER SURVIVORS Hajar I. Ayoub*, Y. Nancy You, Hop Sanderson Tran Cao, Chung-Yuan Hu, Christina Bailey, George Chang, Miguel Rodriguez-Bigas, John Skibber, O. Lenaine Westney, Houston, TX 12:00 PD40-10 PENILE IMPLANTS WHY ARE MEN DISSATISFIED? Tobias Kohler*, Springfield, IL, Anthony Bella, Ottawa, Canada, Edward Karpman, Mountain View, CA, William Brant, Salt Lake City, UT, Brian Christine, Homewood, AL, LeRoy Jones, San Antonio, TX, Bryan Kansas, Austin, TX, Nelson Bennett, Burlington, MA, Mohit Khera, Houston, TX, Gerard Henry, Shreveport, LA 12:10 PD40-11 CONSERVATIVE THERAPY IS A FEASIBLE AND EFFECTIVE OPTION IN PATIENTS WITH LOCALIZED INFECTION AFTER PENILE IMPLANT SURGERY Mohamad Habous*, Jedda, Saudi Arabia, Osama Laban, Tabouk, Saudi Arabia, Osama Abdelwahab, Benha, Egypt, Richard Santucci, Detroit, MI, Saad Mahmoud, Jedda, Saudi Arabia, John Mulhall, New York, NY 12:20 PD40-12 COMPARISON OF TWO DIFFERENT APPROACHES IN CLITORAL RECONSTRUCTION DURING M TO F SEX REASSIGNMENT SURGERY Giovanni Liguori, Trieste, Italy, Paolo Umari*, Duino-Aurisina, Italy, Nicola Pavan, Michele Rizzo, Trieste, Italy, Milos Petrovic, Izola, Slovenia, Stefano Bucci, Giorgio Mazzon, Giangiacomo Ollandini, Carlo Trombetta, Trieste, Italy, Emanuele Belgrano, Duino- Aurisina, Italy 216

229 Monday, May 18, 2015 Podium Session 41 BLADDER CANCER: STAGING Room New Orleans Morial Convention Center Moderators: Cheryl Lee and Reza Ghavamian 10:30 am - 12:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 10:30 PD41-01 TISSUE IS THE ISSUE: THE IMPACT AND BENEFIT OF PATHOLOGICAL REVIEW FOR UROTHELIAL CARCINOMA OF THE BLADDER AT A TERTIARY CARE CANCER CENTER Adam Luchey*, Neal Manimala, Shohreh Dickinson, Jasreman Dhillon, Gautum Agarwal, Scott Gilbert, Philippe Spiess, Wade Sexton, Julio Pow-Sang, Michael Poch, Tampa, FL 10:40 PD41-02 A NEW PROPOSAL FOR T1, HIGH GRADE (HG) BLADDER CANCER (BCA) MICRO- STAGING DEFINITION Rodolfo Fausto Hurle, Milan, Italy, Carlo Patriarca, Como, Italy, Luisa Pasini*, Pier Giuseppe Colombo, Milan, Italy, Giario Natale Conti, Como, Italy, Massimo Freschi, Fabio Capogrosso, Marco Moschini, Milan, Italy, Lucia Ferrari, Como, Italy, Massimo Maffezzini, Maurizio Colecchia, Tiziana Magnani, Milan, Italy, Andrea Conti, Como, Italy, Renzo Colombo, Milan, Italy 10:50 PD41-03 PROGNOSTIC VALUE OF THE PATTERNS OF PROGRESSION IN T1G3 BLADDER CANCER ACCORDING TO THE TIMING OF RECURRENCE Oscar Rodríguez Faba*, Joan Palou, Josep Maria Gaya, Antonio Rosales, Ruben Parada, Esteban Emiliani, Humberto Villavicencio, Barcelona, Spain 11:00 PD41-04 UROTHELIAL BLADDER PTX TUMOURS. HOW TO PREDICT POSITIVITY OF THE IMMEDIATE SECOND TUR Carles Xavier Raventós Busquets*, Ignacio Arroyo Soto, Carles Gasanz Serrano, Juan María Bastarós Hernández, Fernando Lozano Palacio, Jordi Temprana Salvador, Inés De Torres Ramírez, Miguel Angel López pacios, Juan Morote Robles, Barcelona, Spain 11:10 PD41-05 FINAL PATHOLOGIC STAGE AFTER NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY FOR BLADDER CANCER: DOES PT0 PREDICT BETTER SURVIVAL THAN PTA/PTIS/PT1? Homayoun Zargar*, Vancouver, Canada, Kamran Zargar-Shoshtari, Tampa, FL, Adrian S Fairey, Los Angeles, CA, Laura S Mertens, Amsterdam, Netherlands, Colin P Dinney, Houston, TX, Maria C Mir, Cleveland, OH, Laura-Maria Krabbe, Dalls, TX, Michael S Cookson, Oklahoma, OK, Niels-Erik Jacobsen, Edmonton, Canada, Nilay Gandhi, Baltimore, MD, Joshua Griffin, Kansas, KS, Jeffrey S Montgomery, An Arbor, MI, Nikhil Vasdev, Newcastle upon Tyne, United Kingdom, Evan Y Yu, Seattle, WA, Evanguelos Xylinas, New York, NY, Nicholas J. Campain, Exeter, United Kingdom, Wassim Kassouf, Montreal, Canada, Marc A. Dall Era, Sacramento, CA, Jo-An Seah, Toronto, Canada, Cesar E Ercole, Cleveland, OH, Simon Horenblas, Amsterdam, Netherlands, Srikala S Sridhar, Toronto, Canada, John S McGrath, Exeter, United Kingdom, Jonathan Aning, Newcastle upon Tyne, United Kingdom, Shahrokh F Shariat, Vienna, Austria, Jonathan L Wright, Seattle, WA, Andrew C Thorpe, Newcastle upon Tyne, United Kingdom, Todd M Morgan, An Arbor, MI, Jeff M Holzbeierlein, Kansas, KS, Trinity J Bivalacqua, Baltimore, MD, Scott North, Edmonton, Canada, Daniel A Barocas, Nashville, TN, Yair Lotan, Dalls, TX, Jorge A Garcia, Andrew J Stephenson, Cleveland, OH, Jay B Shah, Houston, TX, Bas W Van Rhijn, Amsterdam, Netherlands, Siamak Daneshmand, Los Angeles, CA, Philippe E Spiess, Tampa, FL, Peter C Black, Vancouver, Canada 11:20 PD41-06 CLINICAL VALUE OF IMMUNOHISTOCHEMICALLY DETECTED LYMPHOVASCULAR INVASION IN TRANSURETHRAL BLADDER TUMOR RESECTION SPECIMEN FOR BLADDER CANCER STAGING BEFORE RADICAL CYSTECTOMY Tatsuo Gondo*, Jun Nakashima, Rie Inoue, Takeshi Hashimoto, Yoshio Ohno, Makoto Ohori, Toshitaka Nagao, Masaaki Tachibana, Tokyo, Japan MONDAY *Presenting author 217

230 11:30 PD41-07 PROGNOSTIC SIGNIFICANCE OF LYMPHO-VASCULAR INVASION IN PATIENTS WITH SQUAMOUS CELL CARCINOMA IN COMPARISON TO UROTHELIAL CARCINOMA OF THE BLADDER Kyle Spradling*, Orange, CA, Hassan Abol- Enein, Ahmed Mosbah, Mansoura, Egypt, Zhamshid Okhunov, Jaime Landman, Orange, CA, Ahmed Shokeir, Mohamed Ghoneim, Mansoura, Egypt, Ramy Youssef, Orange, CA 11:40 PD41-08 CAN BLADDER CANCER GENE EXPRESSION SIGNATURES BE USED TO PREDICT LYMPH NODE METASTASIS AT THE TIME OF RADICAL CYSTECTOMY? Roland Seiler*, Lucia Lam, Nicolas Erho, Elai Davicioni, Vancouver, Canada, Anirban P Mitra, Los Angeles, CA, Eila C Skinner, Stanford, CA, Sia Daneshmand, Los Angeles, CA, Peter C Black, Vancouver, Canada 11:50 PD41-09 FACTORS DETERMINING LYMPH NODE YIELD DURING RADICAL CYSTECTOMY WITH PELVIC LYMPHADENECTOMY BEFORE AND AFTER IMPLEMENTING NODE-PACKETING Anirban P. Mitra*, Los Angeles, CA, Eila C. Skinner, Stanford, CA, Anne K. Schuckman, Siamak Daneshmand, Los Angeles, CA 12:00 PD41-10 THE IMPACT OF TUMOR STAGE ON CANCER SPECIFIC SURVIVAL IN PATIENTS WITH NODE POSITIVE UROTHELIAL CANCER OF THE BLADDER Christopher Welty*, Thomas Sanford, San Francisco, CA, Jonathan Wright, Seattle, WA, Peter Carroll, Maxwell Meng, Sima Porten, San Francisco, CA 12:10 PD41-11 EVALUATION OF A BREAST CANCER SPECIFIC CIRCULATING TUMOR CELL (CTC) PLATFORM IN DIFFERENT STAGES OF BLADDER CANCER REFLECTS A COMMON MOLECULAR BACKGROUND Tilman Todenhöfer*, Vancouver, Canada, Jörg Hennenlotter, Natalie Dorner, Gunthild Beger, Valentina Gerber, Georgios Gakis, Simone Bier, Steffen Rausch, Johannes Mischinger, Stefan Aufderklamm, Tuebingen, Germany, Natalie Feniuk, Doreen Schellbach, Langenhagen, Germany, Arnulf Stenzl, Christian Schwentner, Tuebingen, Germany 12:20 PD41-12 THE DIAGNOSTIC ACCURACY OF 18F- FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY IN STAGING MUSCLE- INVASIVE BLADDER CANCER PATIENTS Ayman Soubra*, Daniel Hayward, Robert Goldfarb, Philipp Dahm, Jerry Froelich, Badrinath Konety, Minneapolis, MN Monday, May 18, 2015 Video Session 10 10:30 am - 12:30 pm ROBOTICS BENIGN DISEASE The videos in this session as well as the video libraries from the Annual Meetings may be viewed in the Surgical Video Library and purchased in the Products Store during the Annual Meeting. Both are located in Registration Hall B2. All years of the Surgical Video Library may also be purchased online at Room New Orleans Morial Convention Center Moderators: Joseph Del Pizzo and Ramakrishna Venkatesh NUMBER TITLE NUMBER TITLE V10-01 INTRAURETERAL INDOCYANINE GREEN TO FACILITATE ROBOTIC URETEROLYSIS IN PATIENTS WITH URETERAL OBSTRUCTION DUE TO RETROPERITONEAL FIBROSIS Ziho Lee*, Andrew Harbin, Joshua Kaplan, Daniel Eun, Philadelphia, PA V10-02 ROBOT-ASSISTED LAPAROSCOPIC YV- PLASTY IN PATIENTS WITH REFRACTORY BLADDER NECK CONTRACTURE Jan Hohenhorst*, Michael Musch, Anne Pailliart, Heinrich Löwen, Darko Kröpfl, Essen, Germany V10-03 FISTULECTOMY AND FULL THICKNESS ADVENCEMENT FLAP FOR RECTO- NEOBLADDER FISTULA Roberto Ballestero, Marcos Gómez, Sergio Zubillaga, Truán David, Jose Ignacio Del Valle, Jose Antonio Portillo, Miguel Correas, Enrique Ramos, Mario Dominguez, Enrique Mediavilla, Javier Fuentes, Cesar Jesús Ballardo, Guillermo Velilla, Jose Luis Gutiérrez*, Santander, Spain V10-04 ROBOTIC PYELOPLASTY USING BARBED SUTURE: TECHNIQUE, CONTROVERSIES AND CONSIDERATIONS Sapan Ambani*, J. Stuart Wolf, Jr., Khurshid Ghani, Ann Arbor, MI 218

231 V10-05 ROBOT ASSISTED BLADDER AUGMENTATION AND BILATERAL URETERAL REIMPLANTATION Antonio Wenceslao Villamil*, David Chavez Ramos, Carlos Fernando Andrade Becerra, Matias Ignacio Gonzalez, Oscar Hector Damia, Gabriel Andres Favre, Juan Carlos Tejerizo, Buenos aires, Argentina, Erik Castle, Phoenix, AZ V10-06 ROBOTIC AUGMENTED ANASTOMOTIC URETEROPLASTY WITH BUCCAL MUCOSA GRAFT INTERPOSITION: A NOVEL TECHNIQUE FOR THE REPAIR OF URETERAL STRICTURE Darren J Bryk*, Yuka Yamaguchi, Sarah A Mitchell, Michael D Stifelman, Lee C Zhao, New York, NY V10-07 STEP-BY-STEP APPROACH FOR ROBOTIC INTRACORPOREAL CONTINENT ILEOCECAL AUGMENTATION CYSTOPLASTY Samit Soni*, Monty Aghazadeh, Victor Lizarraga, Rose Khavari, Alvin Goh, Houston, TX V10-08 ROBOT-ASSISTED ARTIFICIAL URINARY SPHINCTER IMPLANTATION IN A MALE FOR NEUROGENIC STRESS URINARY INCONTINENCE Cedric Goes*, Anne-Françoise Spinoit, Nicolaas Lumen, Karel Everaert, Ghent, Belgium V10-09 ROBOT-ASSISTED LAPAROSCOPIC BLADDER NECK SLING IN MALE EPISPADIAS IN THE PEDIATRIC PATIENT Patricia Cho*, Ashley Wietsma, Richard Yu, Marc Cendron, Boston, MA V10-10 ROBOT-ASSISTED URETEROILEAL REIMPLANTATION FOR POST- CYSTECTOMY ANASTOMOTIC STRICTURE Arie Carneiro, Ostap Dovirak*, Josh Kaplan, Peter Chang, Andrew A. Wagner, Boston, MA V10-11 ROBOTIC URETEROLYSIS AND SKELETONIZATION OF THE RENAL HILUM FOR SEVERE CASE OF INTRACTABLE CHYLURIA Jay Sulek*, Andrew Colhoun, Joseph Habibi, Lance Hampton, Richmond, VA V10-12 SINGLE SITE ROBOTIC URETEROPIELOPLASTY IN AN INVERTED KIDNEY Roberto Ballestero, Sergio Zubillaga, Truán David, Jose Ignacio Del Valle, Jose Antonio Portillo, Miguel Correas, Enrique Ramos, Mario Dominguez, Enrique Mediavilla, Javier Fuentes, Cesar Jesús Carrión, Guillermo Velilla, Jose Luis Gutiérrez*, Santander, Spain V10-13 A NOVEL TECHNIQUE OF ROBOTIC- ASSISTED SIMPLE CYSTECTOMY DURING ROBOTIC-ASSISTED URINARY DIVERSION FOR BENIGN INDICATIONS Granville Lloyd*, Madison, WI V10-14 ROBOTIC NEPHROLITHOTOMY: VARIOUS TECHNIQUES FOR EXTRACTION Matthew Sterling*, Phillip Mucksavage, Philadelphia, PA MONDAY Monday, May 18, 2015 YOUNG UROLOGISTS FORUM: THE PRESCRIPTION FOR FINANCIAL HEALTH Room New Orleans Morial Convention Center 12:00 pm - 1:30 pm 12:00 WELCOME & INTRODUCTIONS Program Chair: Jennifer Yates 12:05 RECOGNITION OF YOUNG UROLOGISTS OF THE YEAR Jennifer Yates 1:15 QUESTION & ANSWER Ronald Paprocki 1:30 ADJOURN 12:15 PRESENTATION Ronald Paprocki Monday, May 18, 2015 RESEARCH ON CALCULUS KINETICS SOCIETY (ROCK) Room New Orleans Morial Convention Center 12:00 pm - 5:00 pm 12:00 INDUSTRY SPONSORED LUNCH SYMPOSIUM (NON-CME) 1:00 INTRODUCTION David Goldfarb 1:05 SESSION 1: UROLOGIC INTERVENTIONS FOR STONE DISEASE Moderator: John Denstedt DEBATE: PCNL FOR THE 2 CM STONE Glenn Preminger *Presenting author 219

232 1:20 DEBATE: URS FOR THE 2 CM STONE Michael Lipkin 1:35 METHODS TO IMPROVE STONE-FREE RATES WITH URS Dean Assimos 1:50 MICRO, MINI, MACRO: WHAT SPEAR TO CHOOSE FOR PCNL Ojas Shah 2:00 MANAGEMENT OF STONES IN PREGNANCY Vernon Pais 2:15 DISCUSSION 2:30 SESSION 2: MEDICAL MANAGEMENT OF KIDNEY STONES Moderator: Kristina Penniston QUALITY OF CARE FOR PATIENTS WITH METABOLIC STONE DISEASE John Hollingsworth 2:45 DEBATE: GUIDELINES SHOULD BE BASED ON RANDOMIZED CONTROLLED TRIALS Margaret Pearle 3:00 DEBATE: GUIDELINES SHOULD BE BASED ON ALL THE DATA David Goldfarb 3:15 NEGLECTED METABOLIC VARIABLES ON THE 24H URINE REPORT John Asplin 3:30 DISCUSSION 3:45 BREAK 4:00 SESSION 3: CONTROVERSIES IN IMAGING OF STONES Moderator: Brian Matlaga SMITH-BINDMAN R ET AL IN NEJM: PRO U/S FIRST Marshall Stoller 4:15 SMITH-BINDMAN R ET AL IN NEJM: CON: CT FIRST Brian Eisner 4:30 THEY RE BOTH WRONG Mathew Sorensen 4:45 DISCUSSION 5:00 ADJOURN Monday, May 18, 2015 AUA/BRAZILIAN/PORTUGUESE UROLOGY PROGRAM (BPUP) La Nouvelle New Orleans Morial Convention Center 12:15 pm - 5:10 pm 12:15 WELCOME AND INTRODUCTION Fernando Kim, William Bohnert 12:30 MORE THAN TWO DECADES OF MINIMALLY INVASIVE SURGERY; DO WE NEED ROBOTICS? Louis Kavoussi 12:50 ASSOCIATED AND Q&A 1:05 WHAT DO WE HAVE AVAILABLE TO TREAT METASTATIC PROSTATE CANCER? E. David Crawford 1:25 ASSOCIATED AND Q&A 1:40 USE OF PRE-OPERATIVE ABX IN UROLOGY: WHEN AND WHICH ONE? J. Quentin Clemens 2:00 ASSOCIATED AND Q&A 2:15 CONTEMPORARY MANAGEMENT OF HYPERACTIVE BLADDER (BOTULINUM TOXIN, POSTERIOR TIBIAL NERVE STIMULATION, ACH MEDS) John Stoffel 2:35 ASSOCIATED AND Q&A 2:50 SUPERFICIAL BLADDER CANCER TREATMENT: BCG, SURGERY OR RADIATION? Sam Chang 3:10 ASSOCIATED AND Q&A 3:25 MANAGEMENT OF UPPER TRACT URINARY STONE: ESWL VS. URS Timothy Averch 3:45 ASSOCIATED AND Q&A 4:00 WHAT IS THE OPTIMAL THERAPY FOR LOWER URINARY TRACT SYMPTOMS WITH LARGE BPH >100GM? Wilson Moline 4:20 ASSOCIATED AND Q&A 4:35 IS IT SAFE TO REPLACE TESTOSTERONE IN OLDER PATIENTS AND THOSE TREATED FOR PROSTATE CANCER? John Mulhall 4:55 ASSOCIATED AND Q&A 5:10 ADJOURN 220

233 Monday, May 18, 2015 RUSSIAN UROLOGY PROGRAM (IRUS) Room New Orleans Morial Convention Center 12:30 pm - 5:40 pm 12:30 WELCOME FROM THE IRUS Lev Elterman 12:35 RUSSIAN UROLOGICAL ASSOCIATION WELCOME Dmitry Pushkar 12:40 RECONSTRUCTIVE UROLOGY Moderator: Alexei Zhivov CURRENT URETHRAL RECONSTRUCTION AND SURGICAL OUTCOMES Jack McAninch 1:00 TRANSECTING VS NON-TRANSECTING URETHROPLASTY Sergey Kotov 1:15 MALE INCONTINENCE: DIFFICULT SITUATIONS POST IMPLANTATION Brian Flynn 1:35 HYPOSPADIAS REPAIR OUTCOMES Barry Kogan 1:55 FEMALE PELVIC FLOOR RECONSTRUCTION Victor Nitti 2:15 PANEL OF EXPERTS DISCUSSION OF INTERESTING CASES 2:45 BREAK 2:55 ENDOUROLOGY SOCIETY INTRODUCTION OF RUSSIAN ENDOUROLOGY SOCIETY Society Chair: Zhamshid Okhunov 3:00 POINT COUNTERPOINT: ROLE OF BIOPSY MANAGEMENT OF SMALL RENAL MASSES Debater - Pro: Jaime Landman Debater - Con: Bradley Leibovich 3:25 BREAK 3:35 UROLOGIC ONCOLOGY Moderator: Vsevolod Matveev STATE OF KIDNEY CANCER CARE Steven Campbell 3:55 MINIMALLY INVASIVE INGUINAL LYMPHADENECTOMY FOR PENILE CANCER Alejandro Rodriguez 4:10 PROSTATE CANCER CARE IN RUSSIA Evgeniy Veliev 4:30 OPEN VS. ROBOTIC CYSTECTOMY Igor Frank 4:50 FOCAL THERAPY FOR PROSTATE CANCER Rafael Sanchez-Salas 5:10 PANEL OF EXPERTS DISCUSSION OF INTERESTING CASES 5:40 ADJOURN MONDAY Monday, May 18, 2015 AUA TOWN HALL 2015: TESTOSTERONE: TOO MUCH OR NOT ENOUGH? Hall New Orleans Morial Convention Center 1:00 pm - 3:00 pm 1:00 PANEL DEBATE: TESTOSTERONE, EXPERT PANEL TAKES ON QUESTIONS RAISED BY THE FDA Moderator: Ajay Nangia TESTOSTERONE IS BEING OVERPRESCRIBED AND T ADVERTISING IS INAPPROPRIATE Panelist - Agree: Mark Sigman Panelist - Disagree: Martin Miner AGE DISCRIMINATION OR AGE SPECIFIC PRECAUTIONS: WILL NEW GUIDELINES FROM THE FDA PROTECT ELDERLY MALE PATIENTS OR CONDEMN THEM TO LIVE WITH THE SYMPTOMS OF HYPOGONADISM Panelist - Protect: Glenn Cunnigham Panelist - Condemn: Adrian Dobs TESTOSTERONE INCREASES CARDIOVASCULAR MORBIDITY Panelist - Agree: Shehzad Basaria Panelist - Disagree: Mario Maggi 1:40 ANDROGEN THERAPEUTICS: ARE YOU AN EXPERT PROVIDER? Moderator: Gregory Broderick THERAPEUTIC OPTIONS AND BEST PRACTICES IN MANAGEMENT John Mulhall ERYTHROCYTOSIS COULD THIS BE THE KEY TO CARDIOVASCULAR RISK Wayne Hellstrom ANABOLIC STEROIDS, A CANDID CONVERSATION BETWEEN PATIENT AND PHYSICIAN Tobias Kohler, Chad Schaive 2:20 ANDROGEN TOWN HALL: EXPERT ANSWERS FOR THE UROLOGIC COMMUNITY Moderator: Ridwan Shabsigh Panelists: Mario Maggi, Mark Hirsch, Arthur Burnett, Mohit Khera, John Mulhall *Presenting author 221

234 Monday, May 18, 2015 Moderated Poster Session 67 BLADDER CANCER: INVASIVE IV Room New Orleans Morial Convention Center Moderators: S. Machele Donat and Khurshid Guru 1:00 pm - 3:00 pm NUMBER TITLE NUMBER TITLE MP67-01 SARCOPENIA AS A PREDICTOR OF CANCER-SPECIFIC AND OVERALL SURVIVAL AFTER RADICAL CYSTECTOMY: IS THERE A GENDER INFLUENCE? Ahmed Harraz*, Yasser Osman, Mahmoud Laymon, Islam Fakhreldin, Osama Mahmoud, Mona El-Deeb, Ahmed Mosbah, Hassan Abol-Enein, Atallah Shaaban, Mansoura, Egypt MP67-02 ABCDE: A RISK SCORE FOR PROLONGED HOSPITALIZATION AMONG PATIENTS UNDERGOING RADICAL CYSTECTOMY Boris Gershman*, Sarah Psutka, Stephen Boorjian, Matthew Tollefson, Daniel Moreira, Prabin Thapa, Robert Tarrell, R. Houston Thompson, Igor Frank, Rochester, MN MP67-03 ASSOCIATION OF BODY MASS INDEX AND REOPERATION FOLLOWING RADICAL CYSTECTOMY: RESULTS FROM A MULTI-INSTITUTIONAL DATASET Sij Hemal*, Louis Krane, Winston-Salem, NC, Kyle A RIchards, Madison, WI, Michael Liss, San Antonio, TX, A Karim Kader, San Diego, CA, Ronald Davis, Winston Salem, NC MP67-04 IMPACT OF BODY MASS INDEX ON THE ONCOLOGICAL OUTCOMES OF PATIENTS TREATED WITH RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER Yohann Rouscoff*, Nice, France, Yohan Dabi, Nicolas Barry Delongchamps, Djillali Saighi, Marc Zerbib, Michael Peyromaure, Evanguelos Xylinas, Paris, France MP67-05 THE IMPACT OF PREOPERATIVE HYPOALBUMINEMIA ON PERIOPERATIVE OUTCOMES AFTER RADICAL CYSTECTOMY IN 1,262 PATIENTS Christian Meyer*, Julian Hanske, Boston, MA, Marianne Schmid, Hamburg, Germany, Deepansh Dalela, Jesse Sammon, Firas Abdollah, Mani Menon, Detroit, MI, Joachim Noldus, Herne, Germany, Margit Fisch, Felix Chun, Hamburg, Germany, Adam Kibel, Quoc-Dien Trinh, Boston, MA MP67-06 POST-OPERATIVE WOUND INFECTIONS AND STEROID USE ARE INDEPENDENT RISK FACTORS FOR MIDLINE FASCIAL DEFECTS IN PATIENTS AFTER RADICAL CYSTECTOMY WITH ILEAL CONDUIT Hajar I. Ayoub*, Andrew Pisters, Houston, TX, Diego Aguilar Palacios, Cuenca, Ecuador, Wei Wei, Colin P. Dinney, H. Barton Grossman, Ashish M. Kamat, Jay B. Shah, O. Lenaine Westney, Houston, TX MP67-07 NEOADJUVANT CHEMOTHERAPY (NAC) HAS NO ADVERSE EFFECT ON RADICAL CYSTECTOMY (RC) OR PERIOPERATIVE COMPLICATIONS Mohammed Haseebuddin*, Philadelphia, PA, Reza Mehrazin, New York, NY, Edouard Trabulsi, Karthik Devarajan, Yu-Ning Wong, Jean Hoffman-Censits, Costas Lallas, Rosalia Viterbo, Alexander Kutikov, Marc Smaldone, Richard Greenberg, Robert Uzzo, Elizabeth Plimack, David Chen, Philadelphia, PA MP67-08 MEDICAL COMORBIDITIES, NOT NEOADJUVANT CHEMOTHERAPY, AFFECTS DECLINE IN RENAL FUNCTION FOLLOWING RADICAL CYSTECTOMY AND ELIGIBILITY FOR PLATINUM BASED ADJUVANT CHEMOTHERAPY Mohammed Haseebuddin*, Daniel Parker, Zack Piotrowski, Brian Egleston, Nikhil Wainganker, Rosalia Viterbo, Alexander Kutikov, Marc Smaldone, Richard Greenberg, David Chen, Robert Uzzo, Philadelphia, PA MP67-09 PREDICTORS OF WOUND DEHISCENCE IN A PROSPECTIVE DATASET OF 2,556 CYSTECTOMIES Christian Meyer*, Julian Hanske, Boston, MA, Deepansh Dalela, Detroit, MI, Daniel Pucheril, Boston, MA, Marianne Schmid, Hamburg, Germany, Jesse Sammon, Mani Menon, Detroit, MI, Felix Chun, Hamburg, Germany, Joachim Noldus, Herne, Germany, Margit Fisch, Hamburg, Germany, Quoc-Dien Trinh, Boston, MA MP67-10 INCREASED INFECTIOUS COMPLICATIONS IN TRANSFUSED PATIENTS AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER Jen-Jane Liu*, Bryan Maxwell, Max Kates, Hiten Patel, Gregory Joice, Nilay Gandhi, Charles Drake, Steve Frank, Trinity Bivalacqua, Baltimore, MD MP67-11 NUTRITIONAL PREDICTORS OF PERIOPERATIVE COMPLICATIONS AND MORTALITY FOLLOWING RADICAL CYSTECTOMY: A POPULATION-BASED ANALYSIS Sarah Psutka*, Kristine Thomsen, Elizabeth Habermann, Matthew Tollefson, Rochester, MN MP67-12 THE MODIFIED FRAILTY INDEX AS A MARKER OF ADVERSE OUTCOMES DURING CYSTECTOMY FOR UROTHELIAL CANCER Max Kates*, Hiten Patel, Gregory Joice, Jeffrey Tosoian, Nikolai Sopko, Jen-Jane Liu, Phillip Pierorazio, Trinity Bivalacqua, Baltimore, MD 222

235 MP67-13 GASTROINTESTINAL COMPLICATIONS FOLLOWING RADICAL CYSTECTOMY USING ENHANCED RECOVERY PROTOCOL Siamak Daneshmand*, Soroush T.Bazargani, Los Angeles, CA, Hamed Ahmadi, Portland, OR, Gus Miranda, Jie Cai, Anne Schuckman, Hooman Djaladat, Los Angeles, CA MP67-14 WHITE BLOOD CELL COUNT AT DISCHARGE FOLLOWING RADICAL CYSTECTOMY ASSOCIATES WITH RISK FOR READMISSION Philip Abbosh*, Timothy Ito, Jason Mannion, Andrew McIntosh, Mark Dziemianowicz, Nikhil Waingankar, Mohammed Haseebuddin, David Chen, Richard Greenberg, Rosalia Viterbo, Alexander Kutikov, Robert Uzzo, Marc Smaldone, Philadelphia, PA MP67-15 READMISSION RATE AFTER RADICAL CYSTECTOMY IN PATIENTS MANAGED FOLLOWING THE ENHANCED RECOVERY AFTER SURGERY PROTOCOLS Emanuela Altobelli*, Stanford, CA, Maurizio Buscarini, Rome, Italy, Harcharan Gill, Eila Skinner, Stanford, CA MP67-16 DETERMINING THE BEST COMPLETE BLOOD COUNT-BASED BIOMARKER FOR ONCOLOGIC OUTCOMES FOLLOWING RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER Bimal Bhindi*, Thomas Hermanns, Yanliang Wei, Julie Yu, Arnoud Templeton, Aidan Noon, Jaimin Bhatt, Patrick Richard, Michael A.S. Jewett, Robert Hamilton, Antonio Finelli, Neil Fleshner, Alexandre Zlotta, Girish Kulkarni, Toronto, Canada MP67-17 PERIOPERATIVE CHARACTERISTICS OF ROBOTIC VERSUS OPEN CYSTECTOMY IN THE ELDERLY POPULATION Brian Winters*, Prashoban Bremjit, Bruce Dalkin, Daniel Lin, William Ellis, John Gore, Michael Porter, Jonathan Harper, Jonathan Wright, Seattle, WA MP67-18 A DECADE OF ROBOTIC CYSTECTOMY: SURGICAL CHARACTERISTICS AND ONCOLOGIC OUTCOMES Ali Zhumkhawala*, Spencer Kozinn, Kevin Chan, Clayton Lau, Nora Ruel, Jonathon Yamzon, Bertram Yuh, Mark Kawachi, Timothy Wilson, Duarte, CA MP67-19 ONCOLOGICAL OUTCOMES OF TOTALLY INTRACORPOREAL ROBOT-ASSISTED RADICAL CYSTECTOMY: RESULTS FROM THE ERUS SCIENTIFIC WORKING GROUP Justin Collins*, Abolfazl Hosseini, Stockholm, Sweden, Martin Schumacher, Aarau, Switzerland, Abdullah Canda, Ankara, Turkey, Carl Wijburg, Arnhem, Netherlands, Christian Schwentner, Arnulf Stenzl, Tubingen, Germany, Derya Balbay, Istanbul, Turkey, Karel Decaestecker, Ghent, Belgium, Sebastian Edeling, Saša Pokupic, Hannover, Germany, Khurshid Guru, Buffalo, NY, Alexander Mottrie, Aalst, Belgium, Peter Wiklund, Stockholm, Sweden MP67-20 QUALITY OF LIFE ASSESSMENT WITH ORTHOTOPIC ILEAL NEOBLADDER RECONSTRUCTION AFTER RADICAL CYSTECTOMY: RESULTS FROM A PROSPECTIVE ITALIAN MULTICENTER OBSERVATIONAL STUDY Paolo Verze*, Ciro Imbimbo, Vincenzo Mirone, Naples, Italy, Salvatore Siracusano, Trieste, Italy, Mauro Niero, Maria Angela Cerruto, Cristina Lonardi, Walter Artibani, Verona, Italy, Pierfrancesco Bassi, Rome, Italy, Massimo Iafrate, Padova, Italy, Marco Racioppi, Rome, Italy, Renato Talamini, Stefano Ciciliato, Laura Toffoli, Francesco Visalli, Trieste, Italy, Davide Massidda, Carolina D elia, Giovanni Cacciamani, Davide De Marchi, Verona, Italy, Tommaso Silvestri, Trieste, Italy, Massimiliano Creta, Naples, Italy, Emanuele Belgrano, Trieste, Italy MONDAY *Presenting author 223

236 Monday, May 18, 2015 Moderated Poster Session 68 BLADDER CANCER: BASIC RESEARCH IV Room New Orleans Morial Convention Center Moderators: Robert Hurst and Shahrokh Shariat 1:00 pm - 3:00 pm NUMBER TITLE NUMBER TITLE MP68-01 THE LONG NON-CODING RNA HOTAIR MODULATES EXOSOME CONTENT AND FUNCTION IN BLADDER CANCER TUMOR PROGRESSION Claudia Berrondo*, Jonathan Flax, Edward Messing, Carla Beckham, Rochester, NY MP68-02 IMPACT OF 2004 ISUP WHO CLASSIFICATION ON BLADDER CANCER GRADING AND POTENTIAL IMPACT ON TREATMENT Soum Lokeshwar*, Roberto Ruiz Cordero, Merce Jorda, Miami, FL, Mark Soloway, Aventura, FL MP68-03 CANCER STEM-LIKE CELLS AND EPITHELIAL MESENCHYMAL TRANSITION IS RESPONSIBLE FOR FAILURE IN BACILLUS CALMETTE-GUERIN THERAPY FOR PRIMARY CARCINOMA IN SITU Masaomi Kuwada*, Yoshitomo Chihara, Makito Miyake, Satoshi Anai, Nobumichi Tanaka, Hiroki Kuniyasu, Kiyohide Fujimoto, Kashihara, Japan MP68-04 A FIVE GENE DNA METHYLATION BIOMARKER PANEL SENSITIVELY DETECTS BLADDER CANCER AND DISCRIMINATES BETWEEN HIGH GRADE AND LOW GRADE DISEASE IN VOIDED URINE Thomas Hermanns*, Ekaterina Olkhov-Mitsel, Andrea Savio, Bethany Gill, Jenna Sykes, Bimal Bhindi, Tristan Juvet, Cynthia Kuk, Aidan Noon, Toronto, Canada, Ricardo Rendon, Halifax, Canada, David Waltregny, Liege, Belgium, Theodorus H van der Kwast, Antonio Finelli, Neil E Fleshner, Kirk Lo, Bharati Bapat, Alexandre R Zlotta, Toronto, Canada MP68-05 RESOLVING INTER-PATHOLOGIST VARIATION IN THE ASSIGNMENT OF GRADE USING WHOLE TRANSCRIPTOME ANALYSIS FOR PATIENTS WITH UROTHELIAL BLADDER CANCER Aidan Noon*, Yu Liu, Jess Shen, Cynthia Kuk, Thomas Hermanns, Azar Azad, Joan Sweet, Toronto, Canada, Eva Comperat, Paris, France, Theodorus H van der Kwast, Toronto, Canada, James WF Catto, Sheffield, United Kingdom, Alexandre R Zlotta, Jeffrey L Wrana, Toronto, Canada MP68-06 TISSUE-BASED DNA METHYLATION PROFILING ESTABLISHES A NOVEL PANEL OF BIOMARKERS FOR DISCRIMINATION OF HIGH-GRADE VERSUS LOW-GRADE BLADDER CANCER Andrea Savio, Ekaterina Olkhov-Mitsel*, Ken Kron, Thomas Hermanns, Toronto, Canada, Bas van Rhijn, Amsterdam, Netherlands, Alexandre Zlotta, Theodorus van der Kwast, Bharati Bapat, Toronto, Canada MP68-07 THE MEDIATOR COMPLEX SUBUNIT MED12 IS IMPLICATED IN THE PROGRESSION OF UROTHELIAL CELL CARCINOMA OF THE BLADDER Isabella Syring*, Niklas Klümper, Zaki Shaikhibrahim, Anne Offermann, Martin Braun, Mario Deng, Diana Böhm, Angela Queisser, Anne von Mäßenhausen, Jörg Ellinger, Stefan C. Müller, Sven Perner, Bonn, Germany MP68-08 CONNEXIN 43 EXPRESSION PREDICTS POOR PROGRESSION-FREE SURVIVAL IN PATIENTS WITH NON-MUSCLE INVASIVE UROTHELIAL BLADDER CANCER Cédric Poyet*, Lorenz Buser, Filip Roudnicky, Michael Detmar, Thomas Hermanns, Doris Mannhard, Tullio Sulser, Holger Moch, Peter Wild, Zürich, Switzerland MP68-09 INSULIN RECEPTOR IS OVEREXPRESSED IN TUMOR BLOOD VESSELS AND PREDICTS WORSE OUTCOME IN BLADDER CANCER Cédric Poyet*, Filip Roudnicky, Peter Wild, Lothar Dieterich, Lorenz Buser, Chien Ho, Tullio Sulser, Vivianne Otto, Michael Detmar, Zürich, Switzerland MP68-10 EXPRESSION OF TFAP2C IS ASSOCIATED WITH THE BASAL MOLECULAR SUBTYPE OF BLADDER CANCER AND INCREASED TUMOR AGGRESSIVENESS Hironobu Yamashita*, Zongyu Zheng, Vasty Osei Amponsa, Jay Raman, David DeGraff, Hershey, PA MP68-11 A PHASE 1B STUDY OF PEMBROLIZUMAB (PEMBRO; MK-3475) FOR ADVANCED UROTHELIAL CANCER Shilpa Gupta*, Tampa, FL, Peter O Donnell, Chicago, IL, Elizabeth R. Plimack, Philadelphia, PA, Ranaan Berger, Tel Hashomer, Israel, Bruce Montgomery, Seattle, WA, Karl Heath, Marisa Dolled- Filhart, Kumudu Pathiraja, Christine K. Gause, Jonathan Cheng, Rodolfo Perini, Whitehouse Station, NJ, Joaquim Bellmunt, Boston, MA 224

237 MP68-12 UTILIZING DNA METHYLATION MARKERS TO PREDICT BLADDER CANCER STAGE Chris Duymich, Leonard Dalag, Hooman Djaladat*, Sameer Chopra, Kamran Movassaghi, Siamak Daneshmand, Peter Jones, Gangning Liang, Los Angeles, CA MP68-13 ESTROGEN RECEPTOR ALPHA PREVENTS BLADDER CANCER VIA INPP4B INHIBITED AKT PATHWAY IN VITRO AND IN VIVO Chiuan-Ren Yeh*, Iawen Hsu, Rochester, NY, Hiroshi Miyamoto, Baltimore, MD, Xue- Ru Wu, New York, NY, Chawnshang Chang, Elizabeth Guancial, Edward M. Messing, Shuyuan Yeh, Rochester, NY MP68-14 EXTRACELLULAR VESICLES AS BIOMARKERS AND DIAGNOSTICS IN BLADDER CANCER Christopher Silvers, Chia-Hao Wu, Peng-Nien Yin, Yu-Ru Liu, Edward Messing, Yi-Fen Lee*, Rochester, NY MP68-15 LYMPH NODE STROMAL CELLS PROMOTE HIGH GRADE UROTHELIAL CELL CARCINOMA CANCER IMPLANTATION, GROWTH, ANGIOGENESIS, AND METASTASIS IN AN ORTHOTOPIC PATIENT-DERIVED XENOGRAFT MODEL Jessie Gills*, John Nelson, Xin Zhang, New Orleans, LA, Grace Manesh, Brisbane, Australia, Shams Halat, New Orleans, LA, Ashley Richman, Brisbane, Australia, Mark Matrana, Stephen Bardot, Li Li, New Orleans, LA MP68-16 ASSOCIATION OF GENETIC VARIANTS WITH THE OCCURRENCE OF BLADDER CANCER IN AN ARSENIC-EXPOSED POPULATION Mario I Fernandez*, Cecilia Vial, Santiago, Chile, Patricio Valdebenito, Eduardo Chaparro, Antofagasta, Chile, Karena Espinoza, Gabriela Repetto, Santiago, Chile MP68-17 NOVEL INTRAVESICAL THERAPIES IDENTIFIED FROM HIGH THROUGHPUT SCREENING Keidren Lewi*, Achuth Nair, Reema Railkar, Sam Brancato, Iawen Hsu, Quentin Li, Bethesda, MD, Xiaohu Zhang, Rajarshi Guha, Rockville, MD, Andrea Apolo, Bethesda, MD, Dan Theodorescu, Denver, CO, Craig Thomas, Marc Ferrer, Rockville, MD, Piyush Agarwal, Bethesda, MD MP68-18 MOLECULAR ANALYSIS OF UROTHELIAL TUMORS IN PATIENTS WITH AND WITHOUT METASTASIS STRATIFIED BY T STAGE Tom Sanford*, Christopher Welty, Max Meng, Sima Porten, San Francisco, CA MP68-19 FACTORS ASSOCIATED WITH SURGICAL SITE INFECTIONS FOLLOWING RADICAL CYSTECTOMY Ehab Elzayat*, Ilias Cagiannos, Luke T. Lavallée, Sonya Cnossen, Ranjeeta Mallick, Christopher Morash, Rodney H. Breau, Ottawa, Canada MP68-20 EXPRESSION OF PDL1 (B7-H1) BEFORE AND AFTER NEOADJUVANT CHEMOTHERAPY IN UROTHELIAL CARCINOMA Ajjai Alva, Andrew McDaniel, Tianyu Zhan, Hong Xiao, Arul Chinnaiyan, Hui Jiang, Cheryl Lee*, Rohit Mehra, Ann Arbor, MI MONDAY Monday, May 18, 2015 Moderated Poster Session 69 KIDNEY CANCER: ADVANCED II Room New Orleans Morial Convention Center Moderator: Nathan Lawrentschuk 1:00 pm - 3:00 pm NUMBER TITLE NUMBER TITLE MP69-01 NANOTECHNOLOGY COMBINATION THERAPY: SORAFENIB BOUND GOLD NANORODS PRODUCES HIGHER TREATMENT RESPONSE WHEN COMBINED WITH LASER THERMAL ABLATION IN A RENAL CELL CARCINOMA ANIMAL MODEL Cameron Callaghan*, Sree Harsha Mandava, Donna Peralta, New Orleans, LA, Mostafa Bouljihad, Covington, LA, Srikanta Dash, James Liu, Matthew A. Tarr, Micheal MP69-02 SURVIVAL COMPARISON ANALYSIS OF TWO HISTORICAL COHORTS OF METASTATIC RENAL CELL CARCINOMA PATIENTS (CYTOKINE THERAPY VS. TARGETED AGENTS) - A EUROPEAN SINGLE-CENTER EXPERIENCE OVER 26 YEARS Georg C. Hutterer*, Silvia Golbeck, Edvin Mrsic, Daniel Krieger, Angelika Bezan, Johanna Jesche, Karl Pummer, Richard Zigeuner, Martin Pichler, Graz, Austria Maddox, Benjamin Lee, New Orleans, LA *Presenting author 225

238 MP69-03 CLINICAL OUTCOME OF SINGLE NUCLEOTIDE POLYMORPHISMS ON PHARMACOKINETIC GENES IN JAPANESE METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH SUNITINIB Kazuyuki Numakura*, Norihiko Tsuchiya, Makoto Takahashi, Hiroshi Tsuruta, Susumu Akihama, Mitsuru Saito, Tkamitsu Inoue, Shintaro Narita, Mingguo Huang, Shigeru Satoh, Tomonori Habuchi, Akita, Japan MP69-04 NUTRITIONAL SCREENING IS STRONGLY ASSOCIATED WITH OVERALL SURVIVAL IN PATIENTS TREATED WITH TARGETED AGENTS FOR ADVANCED RENAL CELL CARCINOMA Gu Weijie*, Zhu Yao, Ye Dingwei, Shanghai, China, People s Republic of MP69-05 EVALUATION OF POST-OPERATIVE COMPLICATIONS AND PROLONGED LENGTH OF STAY FOLLOWING CYTOREDUCTIVE NEPHRECTOMY Boris Gershman*, Daniel Moreira, Stephen Boorjian, Christine Lohse, John Cheville, Brian Costello, Bradley Leibovich, R. Houston Thompson, Rochester, MN MP69-06 HIGH GLASGOW PROGNOSTIC SCORE: POTENTIAL MARKER TO PREDICT TARGET RESISTANCE IN METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH SUNITINIB guohai shi*, Shanghai, China, People s Republic of MP69-07 IMPACT OF TARGETED AGENTS ON RENAL FUNCTION IN PATIENTS WITH METASTATIC RCC Yuta Kojima*, Jotaro Mikami, Shingo Hatakeyama, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yashuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Hirosaki, Japan MP69-08 SYSTEMATIC REVIEW AND META- ANALYSIS OF TARGETED THERAPY FOR OVERALL SURVIVAL, COMPLETE RESPONSE AND QUALITY OF LIFE FOR METASTATIC RENAL CELL CARCINOMA Yong Han, New Haven, CT, Ashley Wietsma*, Baltimore, MD, Cary Gross, New Haven, CT, Nilay Shah, Rochester, MN, Robert Abouassaly, Cleveland, OH, Marc Smaldone, Philadelphia, PA, Stephen Boorjian, Rochester, MN, Christopher Hoimes, Matthew Cooney, Simon Kim, Cleveland, OH MP69-09 THE CLINICAL BENEFIT OF METASTASECTOMY IN METASTATIC RENAL CELL CARCINOMA IN THE ERA OF TARGETED MOLECULAR THERAPY Hironori Fukuda*, Tsunenori Kondo, Kenji Omae, Toshio Takagi, Junpei Iizuka, Kazunari Tanabe, Tokyo, Japan MP69-10 ASSESSMENT OF EFFICACY, SAFETY AND QUALITY OF LIFE OF 110 PATIENTS TREATED WITH SUNITINIB AS FIRST-LINE THERAPY FOR METASTATIC RENAL CELL CARCINOMA: EXPERIENCE IN REAL WORLD CLINICAL PRACTICE IN JAPAN Ken-ichi Harada, Hideaki Miyake*, Masato Fujisawa, Kobe, Japan MP69-11 CARBONIC ANHYDRASE IX ASSAY: A PARADIGM SHIFT IN DIAGNOSIS OF MALIGNANT CYSTIC RENAL LESIONS Himesh Gandhi*, Appu Thomas, Balagopal T Nair, Vinoth Kumar Lakshmanan, Kochi, India MP69-12 THE ASSOCIATION OF STATIN THERAPY WITH CLINICOPATHOLOGIC OUTCOMES AND SURVIVAL AMONG PATIENTS WITH LOCALIZED RENAL CELL CARCINOMA UNDERGOING NEPHRECTOMY Boyd Viers*, R. Houston Thompson, Sarah Psutka, Christine Lohse, Bradley Leibovich, Matthew Tollefson, Stephen Boorjian, Rochester, MN MP69-13 IMPACT OF METASTASECTOMY ON PROGNOSIS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA IN THE TARGETED THERAPY ERA Dalsan You*, Chunwoo Lee, In Gab Jeong, Sang Hoon Song, Kun Suk Kim, Cheryn Song, Jae-Lyun Lee, Bumsik Hong, Hanjong Ahn, Choung-Soo Kim, Seoul, Korea, Republic of MP69-14 PERIOPERATIVE AND RENAL FUNCTIONAL OUTCOMES OF PARTIAL NEPHRECTOMY FOR COMPLEX RENAL SCORE WITH OR WITHOUT PRE- SURGICAL SUNITINIB: A MULTICENTER ANALYSIS Hak Lee*, San Diego, CA, Juan Jimenez, Cleveland, OH, Song Wang, Omer Raheem, Kyle Gillis, Amy Alagh, Christopher J. Kane, San Diego, CA, Michael LIss, San Antonio, TX, Frederick Millard, San Diego, CA, Brian Lane, Grand Rapids, MI, Steven Campbell, Cleveland, OH, Ithaar Derweesh, San Diego, CA MP69-15 SUNITINIB PRIOR TO CYTOREDUCTIVE NEPHRECTOMY IN METASTATIC CLEAR CELL CARCINOMA Nima Baradaran*, Harry Drabkin, Stephen Savage, Charleston, SC MP69-16 ASSOCIATION BETWEEN PLASMA CONCENTRATION OF AXITINIB AND TREATMENT OUTCOME IN ADVANCED RENAL CELL CARCINOMA PATIENTS Norihiko Tsuchiya*, Nobuhiro Fujiyama, Ryoma Igarashi, Naoko Honma, Shintaro Narita, Takamitsu Inoue, Kazuyuki Numakura, Susumu Akihama, Mitsuru Saito, Shigeru Satoh, Masatomo Miura, Tomonori Habuchi, Akita, Japan 226

239 MP69-17 THE RELATIONSHIP BETWEEN THE TIMING OF MAXIMUM TUMOR SHRINKAGE DURING 1ST-LINE TARGETED THERAPY AND OVERALL SURVIVAL OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA Takafumi Yagisawa*, Tsunenori Kondo, Kazuhiko Yoshida, Kenji Omae, Toshio Takagi, Junpei Iizuka, Hirohito Kobayashi, Yasunobu Hashimoto, Kazunari Tanabe, Tokyo, Japan MP69-18 GENETIC CHARACTERIZATION OF METASTATIC RENAL CELL CARCINOMA LACKING PRIMARY RENAL MASS Elizabeth Y. Wei*, Yingbei Chen, James J. Hsieh, New York, NY MP69-19 EXTENDED ANALYSES OF PHASE II CLINICAL TRIAL OF SORAFENIB PLUS INTERFERON-ALPHA TREATMENT FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA IN JAPAN Masatoshi Eto*, Yoshiaki Kawano, Kumamoto, Japan, Yoshihiko Hirao, Nara, Japan, Koji Mita, Hiroshima, Japan, Yoichi Arai, Sendai, Japan, Taiji Tsukamoto, Sapporo, Japan, Katsuyoshi Hashine, Matsuyama, Japan, Akio Matsubara, Hiroshima, Japan, Tomoaki Fujioka, Morioka, Japan, Go Kimura, Tokyo, Japan, Nobuo Shinohara, Sapporo, Japan, Katsunori Tatsugami, Fukuoka, Japan, Shiro Hinotsu, Kyoto, Japan, Seiji Naito, Fukuoka, Japan MP69-20 INTENSIVE LOCAL THERAPY TO BONE LESIONS MAY IMPROVE SURVIVAL IN RENAL CELL CARCINOMA PATIENTS WITH BONE METASTASIS Hiroshi Fukushima*, Fumitaka Koga, Yasukazu Nakanishi, Kenichi Tobisu, Tokyo, Japan MONDAY Monday, May 18, 2015 Moderated Poster Session 70 KIDNEY CANCER: SURGICAL THERAPY V Room New Orleans Morial Convention Center Moderators: Riccardo Autorino and Karim Touijer 1:00 pm - 3:00 pm NUMBER TITLE NUMBER TITLE MP70-01 EXTIRPATIVE TREATMENT OF UPPER URINARY TRACT UROTHELIAL CARCINOMA: A 15-YEAR COMPREHENSIVE REVIEW Lynn Paik*, Michael Grasso, Bobby Alexander, Andrew Fishman, New York, NY MP70-02 CATABOLIC EFFECTS OF SURGICAL APPROACHES MEASURED BY WEIGHT CHANGE IN PATIENTS UNDERGOING PARTIAL NEPHRECTOMY Homayoun Zargar*, Cleveland, BC, Oktay Akca, Hiury Andrade, Peter C Caputo, Daniel Ramirez, Robert J Stein, Khaled Fareed, Jihad H. Kaouk, Cleveland, OH MP70-03 POSITIVE SURGICAL MARGINS ARE ASSOCIATED WITH INCREASED RISK OF RECURRENCE AFTER PARTIAL NEPHRECTOMY FOR LOCALIZED RENAL TUMORS Daniel Moreira, Paras Shah*, Manaf Alom, New Hyde Park, NY, Zhamshid Okhunov, Irvine, CA, Sameer Chopra, Los Angeles, CA, Aria Razmaria, Chicago, IL, Arvin George, Christopher Hartman, Oksana Yaskiv, New Hyde Park, NY, Mihir Desai, Los Angeles, CA, Joph Steckel, Manish Vira, Lee Richstone, New Hyde Park, NY, Jaime Landman, Irvine, CA, Arieh Shalhav, Chicago, IL, Inderbir Gill, Los Angeles, CA, Louis Kavoussi, New Hyde Park, NY MP70-04 ASSOCIATION OF MODIFIABLE AND NON- MODIFIABLE RISK FACTORS WITH PERINEPHRIC ADIPOSE TISSUE: IMPLICATIONS FOR PARTIAL NEPHRECTOMY Ronak Gor*, Robert Uzzo, Tianyu Li, Timothy Ito, Philip Abbosh, Daniel Canter, Justin Friedlander, Jay Simhan, Steven Sterious, David Chen, Rosalia Viterbo, Richard Greenberg, Marc Smaldone, Alexander Kutikov, Serge Ginzburg, Philadelphia, PA *Presenting author 227

240 MP70-05 PREDICTORS OF OPEN CONVERSION DURING MINIMALLY INVASIVE RENAL SURGERY IN ENGLAND Rajesh Nair*, Robert Gray, Christopher J Anderson, Sarah Fowler, Tim S O Brien, Pieter J Le Roux, London, United Kingdom MP70-06 BLOOD TRANSFUSION AND TIMING FOLLOWING OPEN AND MINIMALLY INVASIVE NEPHRECTOMY Ruben Pinkhasov*, Ariel Schulman, Zuhair Alhussaini, Mark Cogburn, Ciril Godec, David Silver, Brooklyn, NY MP70-07 NATIONAL PRACTICE PATTERNS AND OUTCOMES OF ABLATIVE TECHNIQUES USED TO TREAT PATIENTS WITH STAGE I KIDNEY CANCER Hung-Jui Tan*, Andrew T. Lenis, Aaron A. Laviana, Jim C. Hu, Los Angeles, CA MP70-08 PARTIAL NEPHRECTOMY FOR T2 RENAL MASSES: NATIONAL TRENDS AND ONCOLOGIC EFFICACY Shaheen Alanee, Max Nutt*, Aaron Moore, Bradley Holland, Danuta Dynda, Andy Wilber, Wiley Jenkins, Ahmed El-Zawahry, Bradley Schwartz, Springfield, IL MP70-09 GUIDELINE-ADAPTED USE OF NEPHRON- SPARING SURGERY FOR RENAL CELL CARCINOMA - A CONFIRMATORY TREND ANALYSIS OVER THE LAST DECADE IN TWO EUROPEAN REFERRAL CENTERS Christian Meyer*, Boston, MA, Jens Hansen, Andreas Becker, Marianne Schmid, Hamburg, Germany, Quoc-Dien Trinh, Boston, MA, Thomas Chromecki, Manuela-Christine Kainz, Georg Hutterer, Karin Kampel-Kettner, Johanne Jesche, Graz, Austria, Margit Fisch, Hamburg, Germany, Richard Zigeumer, Graz, Austria, Chun Felix, Hamburg, Germany MP70-10 ROBOTIC MULTIPLEX PARTIAL NEPHRECTOMY: COMPARISON OF RENAL FUNCTION OUTCOMES STRATIFIED BY CHRONIC KIDNEY DISEASE STAGE Ryan Hankins*, Washington, DC, Annerleim Walton-Diaz, Adam Metwalli, Bethesda, MD MP70-11 RADIOGRAPHIC PREDICTORS OF THE NEED FOR INFERIOR VENA CAVAL RESECTION DURING NEPHRECTOMY FOR PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS Sarah Psutka*, Stephen Boorjian, R. Houston Thompson, Grant Schmit, John Schmitz, Thomas Bower, Suzanne Stewart, Christine Lohse, John Cheville, Bradley Leibovich, Rochester, MN MP70-12 IS CONCOMITANT HEPATIC RESECTION FOR LOCALLY ADVANCED OR METASTATIC RENAL CELL CARCINOMA AT THE TIME OF NEPHRECTOMY SAFE? A MATCHED COHORT STUDY Sarah Psutka*, R. Houston Thompson, Stephen Boorjian, John Cheville, Suzanne Stewart, Christine Lohse, Brian Costello, Florencia Que, Bradley Leibovich, Rochester, MN MP70-13 OPEN PARTIAL NEPHRECTOMY: ONE NIGHT LENGTH OF STAY IS SAFE AND COST EFFECTIVE Mohit Sirohi*, Kyrollis Attalla, Harris Nagler, Erik Goluboff, New York, NY MP70-14 THE ONCOLOGIC IMPACT OF POSITIVE VASCULAR WALL SURGICAL MARGINS IN PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS UNDERGOING NEPHRECTOMY Sarah Psutka*, R. Houston Thompson, Stephen Boorjian, Christine Lohse, Suzanne Stewart, Alonso Carrasco, John Cheville, Bradley Leibovich, Rochester, MN MP70-15 INCREASING COMPLEXITY OF TUMOR THROMBI IN RENAL CELL CARCINOMA OVER 40 YEARS OF EXPERIENCE Sarah Psutka*, R. Houston Thompson, Stephen Boorjian, Christine Lohse, Suzanne Stewart, John Cheville, Bradley Leibovich, Rochester, MN MP70-16 COMPLICATIONS AFTER ROBOTIC- ASSISTED PARTIAL NEPHRECTOMY AT 5 UNITED STATES CENTERS: ANALYSIS OF 1838 CASES Jeffrey Larson*, Saint Louis, MO, Jihad Kaouk, Cleveland, OH, Craig Rogers, Detroit, MI, Michael Stifelman, New York, NY, Mohamad Allaf, Michael Johnson, Baltimore, MD, Homayoun Zargar, Cleveland, OH, Alon Mass, New York, NY, Ravi Barod, Detroit, MI, Sam Bhayani, St. Louis, MO MP70-17 TUMOR SIZE PREDICTS HIGH-GRADE PATHOLOGY IN PT1A RENAL CELL CANCER Jeffrey Larson*, Saint Louis, MO, Jihad Kaouk, Cleveland, OH, Craig Rogers, Detroit, MI, Michael Stifelman, New York, NY, Mohamad Allaf, Michael Johnson, Baltimore, MD, Homayoun Zargar, Cleveland, OH, Alon Mass, New York, NY, Ravi Barod, Detroit, MI, Sam Bhayani, St. Louis, MO MP70-18 RACIAL DIFFERENCES IN HISTOLOGIC SUBTYPE OF RENAL CELL CARCINOMA IN PT1A RENAL CELL CANCER Jeffrey Larson*, Saint Louis, MO, Jihad Kaouk, Cleveland, OH, Craig Rogers, Detroit, MI, Michael Stifelman, New York, NY, Mohamad Allaf, Michael Johnson, Baltimore, MD, Homayoun Zargar, Cleveland, OH, Alon Mass, New York, NY, Ravi Barod, Detroit, MI, Sam Bhayani, St. Louis, MO 228

241 MP70-19 CRITICAL COMPARISON OF PERIOPERATIVE, HEMOSTATIC AND FUNCTIONAL OUTCOMES OF TWO RUNNING TECHNIQUES OF RECONSTRUCTIVE RENORRHAPHY IN MINIMAL INVASIVE NEPHRON SPARING SURGERY Alaa Hamada*, Abdulrahman Babaeer, Kelly Dragon, Boston, MA, Akshay Bhandari, Miami Beach, MA, Ingolf Tuerk, Boston, MA MP70-20 RENAL LESIONS IN THE 80 AND OVER AGE GROUP - TARGETED TREATMENT AND OUTCOMES BY POOLED AND SIGNATURED APPROACH IN A U.K. TERTIARY REFERRAL RENAL CANCER CENTER Sashi Kommu*, Prasanna Sooriakumaran, Robert Mcarthur, Rajesh Nair, Meghana Kulkarni, Eleni Anastasiadis, A Pai, Pieter le Roux, Christopher Anderson, London, United Kingdom Monday, May 18, 2015 Podium Session 42 STONE DISEASE: NEW TECHNOLOGY Room New Orleans Morial Convention Center Moderator: Darren Beiko 1:00 pm - 3:00 pm MONDAY TIME NUMBER TITLE TIME NUMBER TITLE 1:00 PD42-01 REPORT ON THE FEASIBILITY OF ULTRASOUND TO REPOSITION KIDNEY STONES IN HUMANS Jonathan Harper*, Barbrina Dunmire, Bryan Cunitz, Franklin Lee, Ryan Hsi, Jeff Thiel, Seattle, WA, James Lingeman, Indianapolis, IN, Michael Coburn, Houston, TX, Hunter Wessells, Mathew Sorensen, Michael Bailey, Seattle, WA 1:10 PD42-02 A PRECLINICAL IMAGE-GUIDED THERAPY SYSTEM FOR BURST WAVE LITHOTRIPSY Adam Maxwell*, Bryan Cunitz, Wayne Kreider, Michael Bailey, Oleg Sapozhnikov, Franklin Lee, Mathew Sorensen, Jonathan Harper, Seattle, WA 1:20 PD42-03 ROBUST AUTOMATIC RENAL STONE DETECTION IN ULTRASONIC LIVE STREAMS FOR IMPROVING EXTRACORPOREAL SHOCK WAVE THERAPY Werner Pomwenger*, Peter Ott, Stefan Wegenkittl, Reinhold Zimmermann, Salzburg, Austria, Olaf Gleibe, Axel Koch, Tägerwilen, Switzerland 1:30 PD42-04 INITIAL EXPERIENCE AND COMPARATIVE EFFICACY OF THE URETRON: A NEW INTRACORPOREAL ULTRASONIC LITHOTRIPTOR Michael S. Borofsky*, Marawan M. El Tayeb, James E. Lingeman, Indianapolis, IN 1:40 PD42-05 LONG-PULSE VERSUS SHORT-PULSE LASER LITHOTRIPSY PERFORMANCE Peter Kronenberg*, Amadora, Portugal, Olivier Traxer, Paris, France 1:50 PD42-06 BALL TIPPED HOLMIUM:YAG OPTICAL FIBERS FOR FLEXIBLE URETEROSCOPY: IS THERE A DIFFERENCE? Sarah Tarplin*, Cleveland, OH, Nolan Farrell, Columbus, OH, Manoj Monga, Cleveland, OH, Bodo Knudsen, Columbus, OH 2:00 PD42-07 THE EFFECT OF CLEAVE TECHNIQUE AND LITHOTRIPSY DURATION ON LASER FIBER POWER OUTPUT Brandon Peplinski*, Daniel Faaborg, Edna Miao, Muhannad Alsyouf, Kristene Myklak, D. Duane Baldwin, Loma Linda, CA 2:10 PD42-08 COMPARISION OF LOW POWER/HIGH FREQUENCY HOLMIUM LASER SETTINGS WITH CONVENTIONAL SETTINGS ON URETERAL AND RENAL STONE FRAGMENTATION EFFICIENCY Leonard Glickman*, Ravi Munver, Hackensack, NJ 2:20 PD42-09 ENDOSCOPIC VALVES AND IRRIGATION DEVICES: A COMPARATIVE ANALYSIS Sarah Tarplin*, Michael Byrne, Manoj Monga, Sri Sivalingam, Cleveland, OH 2:30 PD42-10 A SMART KIDNEY STONE BASKET WITH FORCE FEEDBACK Zahra Najafi, Akron, OH, Thomas Tieu, Springfield, IL, Ajay M. Mahajan, Akron, OH, Bradley F. Schwartz*, Springfield, IL 2:40 PD42-11 A MECHANICAL COMPARISON OF NEW URETERAL ACCESS SHEATHS: TERUMO GLIDEWAY VS. BOSTON SCIENTIFIC NAVIGATOR HD Sarah Tarplin*, Cleveland, OH, Nolan Farrell, Columbus, OH, Michael Byrne, Manoj Monga, Cleveland, OH *Presenting author 229

242 2:50 PD42-12 A URETERAL ACCESS SHEATH MODIFIED WITH A SCALE REDUCING RADIATION FLUOROSCOPY DURING RETROGRADE INTRARENAL SURGERY: A RANDOMIZED AND FEASIBILITY TRIAL Guohua Zeng*, Zhijian Zhao, Wenqi Wu, Wen Zhong, Guangzhou, China, People s Republic of Monday, May 18, 2015 Podium Session 43 PROSTATE CANCER: LOCALIZED VI Room New Orleans Morial Convention Center Moderators: Vipul Patel and Craig Rogers 1:00 pm - 3:00 pm TIME NUMBER TITLE TIME NUMBER TITLE 1:00 PD43-01 LONG-TERM COMPARATIVE MORTALITY OUTCOMES ACROSS DIFFERENT PRIMARY TREATMENTS FOR PROSTATE CANCER Matthew Cooperberg*, Peter Carroll, San Francisco, CA 1:10 PD43-02 COMPARATIVE EFFECTIVENESS OF SURGERY AND RADIATION THERAPY FOR HIGH RISK PROSTATE CANCER PATIENTS Ravishankar Jayadevappa*, Sumedha Chhatre, Alan Wein, S Bruce Malkowicz, David Lee, Philadelphia, PA 1:20 PD43-03 COMPARATIVE ANALYSIS OF ONCOLOGIC OUTCOMES FOR OPEN VS. ROBOT-ASSISTED RADICAL PROSTATECTOMY IN HIGH-RISK PROSTATE CANCER: PREDICTION OF FAVORABLE DISEASE AFTER RADICAL PROSTATECTOMY Seung-Kwon Choi*, Myungsun Shim, Aram Kim, Muyoung Sohn, Donghyun Lee, Myungchan Park, Cheryn Song, Hanjong Ahn, Seoul, Korea, Republic of 1:30 PD43-04 COMPARING THE 8-YEAR ONCOLOGIC OUTCOMES OF OPEN AND ROBOT- ASSISTED RADICAL PROSTATECTOMY FOR HIGH RISK PROSTATE CANCER Vidit Sharma*, Marco Moschini, Fabio Zattoni, Matthew K Tollefson, Stephen A Boorjian, R. Houston Thompson, Igor Frank, Matthew T Gettman, R. Jeffrey Karnes, Rochester, MN 1:40 PD43-05 ARE LYMPH NODE DISSECTIONS BEING PERFORMED IN PATIENTS WITH BIOPSY PROVEN GLEASON 6 DISEASE ANALYSIS OF THE SEER DATABASE Michael Daugherty*, Gennady Bratslavsky, Oleg Shapiro, Syracuse, NY 1:50 PD43-06 EXTENDED VS LIMITED PELVIC LYMPHADENECTOMY DURING RADICAL PROSTATECTOMY FOR INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER: A PROSPECTIVE RANDOMIZED TRIAL Jean F P Lestingi*, Jose Pontes Jr, Leonardo L Borges, Juliana Ravanini, Giuliano B Guglielmetti, Mauricio D Cordeiro, Rafael F Coelho, William C Nahas, Sao Paulo, Brazil 2:00 PD43-07 URINARY DRAINAGE FOLLOWING ROBOT-ASSISTED RADICAL PROSTATECTOMY: A PROSPECTIVE RANDOMIZED CLINICAL TRIAL COMPARING TRANSURETHRAL VS. SUPRAPUBIC CATHETERIZATION Nina Harke*, Michael Godes, Jawid Habibzada, Katarina Urbanova, Henrik Zecha, Jorn H. Witt, Gronau, Germany 2:10 PD43-08 THE EFFECT OF PRIOR TURP ON COMPLICATIONS AND LONG-TERM OUTCOMES AFTER RADICAL PROSTATECTOMY: A 25-YEAR SINGLE INSTITUTION EXPERIENCE Vidit Sharma*, Marco Moschini, Fabio Zattoni, Matthew K Tollefson, Stephen A Boorjian, R. Houston Thompson, Igor Frank, Matthew T Gettman, R. Jeffrey Karnes, Rochester, MN 2:20 PD43-09 ONCOLOGICAL AND FUNCTIONAL OUTCOMES FOR AFRICAN AMERICANS UNDERGOING ROBOTIC ASSISTED RADICAL PROSTATECTOMY Eugene Pietzak, III, Sylvia Yu, Jeremy Bonzo*, Benjamin Katz, David I. Lee, Philadelphia, PA 2:30 PD43-10 VARIATION IN SURGICAL TREATMENT OF PROSTATE CANCER IN AFRICAN AMERICAN PATIENTS Rachel Moses*, Nino Dsebisashvili, Philip Goodney, Elias Hyams, Lebanon, NH 2:40 PD43-11 CHARACTERISTICS AND MANAGEMENT OF MEN DEVELOPING LATE BIOCHEMICAL RECURRENCE (LBCR) FOLLOWING RADICAL PROSTATECTOMY (RP) Elton Llukani*, Herbert Lepor, New York, NY 2:50 PD43-12 EFFECT OF TREATMENT DELAY ON LONG- TERM OUTCOMES IN MEN UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER Udit Singhal*, Louis Lu, Ted Skolarus, Ganesh Palapattu, Jeffrey Montgomery, Alon Weizer, Brent Hollenbeck, David Miller, Rohit Mehra, James Montie, Scott Tomlins, Lakshmi Kunju, Daniel Hamstra, Felix Feng, Todd Morgan, Ann Arbor, MI 230

243 Monday, May 18, 2015 Podium Session 44 PROSTATE CANCER: DETECTION AND SCREENING IV Room New Orleans Morial Convention Center Moderator: John Lynch 1:00 pm - 3:00 pm TIME NUMBER TITLE TIME NUMBER TITLE 1:00 PD44-01 THE PROSTATE GENETIC SCORE (PGS) STRATIFIES BASELINE RISK OF PROSTATE CANCER AND IMPROVES PSA PERFORMANCE IN THE PLCO TRIAL Michael Liss*, San Antonio, TX, Jianfeng Xu, Winston-Salem, NC, Haitio Chen, Shanghai, China, People s Republic of, A. Karim Kader, San Diego, CA 2:00 PD44-07 EFFECTIVENESS OF SERUM PSA, URINE PCA3 AND URINE TMPRSS2:ERG FUSION AS A NOVEL URINARY BIOMARKER PANEL IN CLINICAL PRACTICE John Wei*, Javed Siddiqui, Rabia Siddiqui, Arul M. Chinnaiyan, Lakshmi P. Kunju, Rohit Mehra, Debbie Snyder, Scott A. Tomlins, Ann Arbor, MI 1:10 PD44-02 TRENDS IN PSA UTILIZATION BY PRIMARY CARE PHYSICIANS: IMPACT OF THE USPSTF RECOMMENDATION Ryan Werntz*, Ann Martinez Acevedo, Michael Conlin, Christopher Amling, Portland, OR 1:20 PD44-03 MAGNETIC RESONANCE IMAGING-BASED PROSTATE CANCER SCREENING CAN INCREASE THE DETECTION OF HIGH GRADE DISEASE: A COMPARISON OF CONTEMPORARY STUDY POPULATIONS Simpa Salami*, Anna Marie Sonstegard, Oksana Yaskiv, New Hyde Park, NY, Baris Turkbey, Bethesda, MD, Robert Villani, Eran Ben-Levi, New Hyde Park, NY, Carl Olsson, Melville, NY, Pina Sanelli, Ardeshir Rastinehad, New Hyde Park, NY 1:30 PD44-04 COST OF PROSTATE MRI-US FUSION A DECISION ANALYSIS COMPARING COST EFFECTIVENESS OF SYSTEMATIC TRANSRECTAL ULTRASOUND GUIDED BIOPSY AND MRI-ULTRASOUND FUSION PROSTATE BIOPSY IN THE INITIAL AND REPEAT BIOPSY SETTING Meenakshi Davuluri*, Syracuse, NY, Andrew Toler, Manchester, NH, Andrij Wojtowycz, Gennady Bratslavsky, Srinivas Vourganti, Syracuse, NY 1:40 PD44-05 CONTEMPORARY NATIONAL TRENDS OF PROSTATE CANCER SCREENING AMONG PRIVATELY INSURED PATIENTS IN THE UNITED STATES Simon Kim*, Cleveland, OH, R. Jeffrey Karnes, Rochester, MN, Cary Gross, New Haven, CT, Holly Van Houten, Rochester, MI, Robert Abouassaly, Cleveland, OH, Nilay Shah, Rochester, MN 1:50 PD44-06 CONFIDENCE IN BIOPSY FINDINGS IN THE ERA OF MRI-TARGETED PROSTATE SAMPLING Arvin George*, Bethesda, NY, Nabeel Shakir, M. Minhaj Siddiqui, Soroush Rais-Bahrami, Thomas Frye, Steven Abboud, Michele Fascelli, Richard Ho, Raju Chelluri, Peter L. Choyke, Baris Turkbey, Bradford J. Wood, Peter A. Pinto, Bethesda, MD 2:10 PD44-08 ABNORMAL DIGITAL RECTAL EXAMINATION (DRE) OF THE PROSTATE INCREASES THE LIKELIHOOD OF FUTURE HIGH GRADE PROSTATE CANCER DIAGNOSIS IN PATIENTS WITH INITIAL BENIGN PROSTATE BIOPSY Marios Hadjipavlou*, Portsmouth, Hampshire, United Kingdom, Ahmed Mohamed, Redhill, Surrey, United Kingdom, Sri Sriprasad, Sanjeev Madaan, Dartford, Kent, United Kingdom, Shahid Khan, Abhay Rane, Redhill, Surrey, United Kingdom 2:20 PD44-09 THE USE OF ACTIVE SURVEILLANCE IN A CANADIAN HEALTH REGION Octav Christea*, Andrew Stokl, Joshua Montroy, Sonya Cnossen, Ranjeeta Mallick, Ilias Cagiannos, Christopher Morash, Rodney H. Breau, Ottawa, Canada 2:30 PD44-10 CORRELATION BETWEEN DIAMETER OF PROSTATE CANCER FOCI ON MULTIPARAMETRIC PROSTATE MRI AND WHOLE MOUNT HISTOPATHOLOGY: STRATIFIED BY PI-RADS AND GLEASON SCORE Pooria Khoshnoodi*, Nelly Tan, Daniel J. A. Margolis, Wei-Chan Lin, Somrach Thamtorawat, David Y. Lu, Jiaoti Huang, Robert E. Reiter, Steven S. Raman, Los Angeles, CA 2:40 PD44-11 UNDERSTANDING THE PERFORMANCE OF ACTIVE SURVEILLANCE SELECTION CRITERIA IN REAL-WORLD PRACTICE Scott Hawken*, Paul Womble, Lindsey Herrel, Zaojun Ye, Susan Linsell, James Montie, David Miller, Ann Arbor, MI 2:50 PD44-12 FEASIBILITY AND INITIAL RESULTS OF 18 FLUOROCHOLINE PET/MRI/TRUS FUSION PROSTATE BIOPSY Jeffrey Montgomery*, Matthew Davenport, Lakshmi Kunju, Charles Meyer, Ganesh Palapattu, Todd Morgan, Alon Weizer, David Miller, Brent Hollenbeck, Morand Piert, Ann Arbor, MI MONDAY *Presenting author 231

244 Monday, May 18, 2015 Podium Session 45 SEXUAL FUNCTION/DYSFUNCTION/ANDROLOGY: MEDICAL AND NON-SURGICAL THERAPY II Room New Orleans Morial Convention Center Moderators: TBD TIME NUMBER TITLE TIME NUMBER TITLE 1:00 PD45-01 A PROSPECTIVE EVALUATION OF FACTORS AFFECTING SERUM TESTOSTERONE LEVELS AFTER TESTOPEL THERAPY IN PATIENTS WITH LATE ONSET HYPOGONADISM (LOH): A SINGLE CENTRE EXPERIENCE Amit Chakrabarty*, Fenton, MO, Anup Gupta, Kissimmee, FL 1:10 PD45-02 COMPARISON OF THE EFFICACY OF CLOMIPHENE CITRATE VERSUS TESTOSTERONE SUPPLEMENTATION IN TREATING SYMPTOMS OF HYPOGONADISM Nathan Wilken, Jason Scovell, Ranjith Ramasamy*, Dolores Lamb, Larry Lipshultz, Houston, TX 1:20 PD45-03 LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS SUSTAINABLY IMPROVES ERECTILE FUNCTION AND METABOLIC CONTROL IN HYPOGONADAL MEN WITH TYPE 2 DIABETES MELLITUS (T2DM) Ahmad Haider*, Karim Sultan Haider, Bremerhaven, Germany, Gheorghe Doros, Abdulmaged Traish, Boston, MA 1:30 PD45-04 INCIDENCE OF PROSTATE CANCER AND EFFECTS ON PROSTATE-RELATED PARAMETERS UNDER LONG-TERM THERAPY WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) IN HYPOGONADAL MEN FOR UP TO 84 MONTHS: REAL-LIFE EXPERIENCE FROM AN OBSERVATIONAL REGISTRY STUDY Ahmad Haider*, Karim Sultan Haider, Bremerhaven, Germany, Gheorghe Doros, Abdulmaged Traish, Boston, MA 1:40 PD45-05 THE ROLE OF TESTOSTERONE SUPPLEMENTAL THERAPY IN OPIOID- INDUCED HYPOGONADISM: A COLLABORATIVE, PROSPECTIVE ANALYSIS Omer Raheem*, Joe Acevedo, David Sisul, T. Mike Hsieh, San Diego, CA 1:50 PD45-06 LONG-TERM EFFECTS ON ERECTILE FUNCTION UPON TREATMENT UP TO 11 YEARS WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) IN HYPOGONADAL MEN WITH TYPE 2 DIABETES MELLITUS (T2DM): REAL-LIFE DATA FROM AN OBSERVATIONAL REGISTRY STUDY Aksam Yassin*, Yousef Al Mehmadi, Norderstedt-Hamburg, Germany 1:00 pm - 3:00 pm 2:00 PD45-07 A COMPARISON OF ESTRADIOL LEVELS AND GYNECOMASTIA RATES IN HYPOGONADAL MEN USING CLOMIPHENE CITRATE VERSUS TRANSDERMAL TESTOSTERONE Clarisse R Mazzola*, Edoardo Miranda, Joseph Narus, John P. Mulhall, New York City, NY 2:10 PD45-08 COMPARISON OF CLOMIPHENE CITRATE AND TRANSDERMAL TESTOSTERONE REPLACEMENT THERAPY IN THEIR INFLUENCE ON HORMONAL AND METABOLIC CHANGES IN THE TREATMENT OF HYPOGONADISM Daniel Lee, Long Island City, NY, Adrien Bernstein*, Alex Sarkisian, Matthew Wosnitzer, Ashley Winter, Darius Paduch, New York, NY 2:20 PD45-09 SCROTOX: SALVAGE PERI-SPERMATIC CORD BOTULINUM-A TOXIN INJECTIONS FOR PATIENTS WITH REFRACTORY CHRONIC SCROTAL CONTENT PAIN AFTER MICROSURGICAL DENERVATION OF THE SPERMATIC CORD Bayo Tojuola*, Ibrahim Kartal, Jamin Brahmbhatt, Sijo Parekattil, Clermont, FL 2:30 PD45-10 THE SAFETY AND EFFICACY OF LI-ESWT IN 604 PATIENTS FOR ERECTILE DYSFUNCTION: SUMMARY OF CURRENT AND EVOLVING EVIDENCE Robert Feldman*, Middlebury CT, CT, Bela Denes, Laguna Beach, CA, Boaz Appel, Haifa, Israel, Satya Srini Vasan, Bangalore, India, Tamar Shultz, Gaithersburg, MD, Arthur Burnett, Baltimore, MD 2:40 PD45-11 SEVERE OBSTRUCTIVE SLEEP APNOEA SYNDROME AND ERECTILE DYSFUNCTION: A PROSPECTIVE RANDOMISED STUDY TO COMPARE SILDENAFIL VS. NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE Antonio Luigi Pastore*, Giovanni Palleschi, Luigi Silvestri, Latina, Italy, Alessandro Zucchi, Elisabetta Costantini, Perugia, Italy, Antonio Carbone, Latina, Italy 2:50 PD45-12 AVANAFIL EFFICACY WITHIN 15 MINUTES OF DOSING IN MEN WITH MILD TO SEVERE ERECTILE DYSFUNCTION BY DEMOGRAPHIC AND BASELINE CLINICAL CHARACTERISTICS Laurence H. Belkoff*, Bala Cynwyd, PA, James P. Tursi, Jonathan Uy, Ted M. Smith, Chesterbrook, PA, LeRoy A. Jones Jr, San Antonio, TX 232

245 Monday, May 18, 2015 Video Session 11 1:00 pm - 3:00 pm ADRENAL/SINGLE PORT SURGERY/LESS/NOTES The videos in this session as well as the video libraries from the Annual Meetings may be viewed in the Surgical Video Library and purchased in the Products Store during the Annual Meeting. Both are located in Registration Hall B2. All years of the Surgical Video Library may also be purchased online at Room New Orleans Morial Convention Center Moderators: Jay Bishoff and Chandru Sundaram NUMBER TITLE NUMBER TITLE V11-01 NOTES-ASSISTED LAPAROSCOPIC TRANSVESICAL BLADDER DIVERTICULECTOMY Ahmed Magdy*, Michael Mitterberger, Günter Janetschek, Salzburg, Austria V11-02 ROBOTIC ASSISTED REDO PARTIAL NEPHRECTOMY AND PARTIAL ADRENALECTOMY Pranav Sharma, Kirsten Janosek Albright, Ravi Barod*, Craig Rogers, Detroit, MI V11-03 EXTRAPERITONEAL LAPAROSCOPIC APPROACH AND TECHNOLOGY FOR RESECTION OF COMPLICATE RETROPERITONEAL TUMOR IN SUPINE POSITION Qiang Lu*, Pengchao Li, Jun Tao, Chao Qin, Changjun Yin, Nanjing, China, People s Republic of V11-04 ROBOTIC RIGHT ADRENALECTOMY FOR PHEOCHROMOCYTOMA Timothy Brock*, Wesley White, Knoxville, TN V11-05 LAPAROENDOSCOPIC SINGLE-SITE PARTIAL CYSTECTOMY COMBINED WITH CYSTOSCOPY FOR BLADDER PARAGANGLIOMA Teruhiko Tsuru*, Ryuichi Hirota, Fumiyasu Jo, Keita Takimoto, Tetsuya Yoshida, Susumu kageyama, Mitsuhiro Narita, Akihiro Kawauchi, Otsu, Japan V11-06 LAPAROSCOPIC RESECTION OF PARAAORTIC OR PARACAVAL NEUROGENIC TUMORS Takashige Abe*, Sapporo, Japan, Ataru Sazawa, Obihiro, Japan, Toru Harabayashi, Naoto Miyajima, Kunihiko Tsuchiya, Satoru Maruyama, Nobuo Shinohara, Sapporo, Japan V11-07 SUCCESSFUL EXCISION OF RETROCAVAL TUMOR BY RETROPERITONEOSCOPIC APPROACH IN TWO PATIENTS Tomonori Habuchi*, Takamitsu Inoue, Ryuichi Ito, Akita, Japan, Yasushi Ichimura, Naoko Kawata, Mito, Japan, Norihiko Tsuchiya, Akita, Japan, Masahiro Iinuma, Mito, Japan V11-09 CASE REPORT OF A LAPAROSCOPIC EXCISION OF PARA-AORTIC PHEOCHROMOCYTOMA BY LIGATION OF LEFT RENAL VEIN WITHOUT COMPROMISING RENAL FUNCTION Bruno Benigno*, Gustavo Guimaraes, Rodrigo Campos, Ricardo Favaretto, Charles Zurstrassen, Sao Paulo, Brazil V11-10 MINI LAPAROSCOPIC PYELOPLASTY OF A RETROCAVAL URETER Anibal W.Branco*, Luciano C.Stunitz, Sandro Nichele, Julio C. Foiatto, Juliano D. Scheffer, Marcio Gatti, Kleber Stelmasuk, Curitiba, Brazil V11-11 TRANS-UMBILICAL LAPAROENDOSCOPIC SINGLE-SITE EXCISION OF URACHAL REMNANT WITH PERITONEAL REPAIR Yuji Maeda*, Manami Tsutsumiuchi, Yukinosuke Oshinoya, Kenichi Nagano, Hakusan, Japan V11-12 LAPARAOENDOSCOPIC SINGLE-SITE SURGERY (LESS) NEPHRECTOMY: STEP BY STEP TECHNIQUE Aly Abdel-Karim*, Elsaid Yahyia, Salah Elsalmy, Alexandria, Egypt V11-13 LAPAROENDOSCOPIC SINGLE SITE NEPHROURETERECTOMY: TECHNIQUE & INITIAL EXPERIENCE Jenna She, Alison Rutledge, Albert Tiu*, New Lambton, Australia V11-14 LAPARO-ENDOSCOPIC SINGLE SITE (LESS) PLUS ONE PORT (POP) RADICAL PROSTATECTOMY Alexander Tsivian, Roman Bass, Yury Stanevsky*, Holon, Israel, Matvey Tsivian, Durham, NC, Mohammed Shahwan, Dmitry Khunovitch, Shalva Benjamin, Ami Sidi, Holon, Israel MONDAY V11-08 LAPAROSCOPIC NEPHRON-SPARING EXCISION OF HILAR PARAGANGLIOMA: TIPS AND TECHNIQUE Rajeev Kumar*, Pragnesh Desai, Niren Rao, New Delhi, India *Presenting author 233

246 Monday, May 18, 2015 EGYPTIAN UROLOGICAL SOCIETY (EUA) Room New Orleans Morial Convention Center 1:00 pm - 4:00 pm 1:00 WELCOME Society President: Mohamed Eissa AUA President: William Bohnert 1:10 SESSION I Chairmen: Mohamed Eissa, Ibrahim Mokhless, Mostafa Shamaa IS PRIMARY ADT APPROPRIATE FOR LOCALIZED PROSTATE CANCER? James Mohler 1:30 RETROPERITONEAL ROBOTIC SURGERY James Porter 1:50 REFRACTORY OAB, WHAT DO WE KNOW Bassem Wadie 2:10 COFFEE BREAK 2:20 SESSION II 2:50 SESSION III Chairmen: Magdy El-Akkad, Osama Abou Farha, Abdel Abouzeid URETHRAL STRICTURES FROM HAMILTON RUSSELL TO THE PRESENT Gerald Jordan 3:10 ORGAN PRESERVATION SURGERIES IN BLADDER CANCER Nabil Bissada 3:30 DEBATE: VASCULAR CONTROL DURING LAPAROSCOPIC DONOR NEPHRECTOMY: STAPLERS VERSUS CLIPS Moderator: Ahmed Mansour Debaters: Jim Hu, Mahesh Desai 4:00 ADJOURN PANEL: CASE SCENARIOS IN BLADDER CANCER - A PANEL DISCUSSION Moderator: Mark Soloway Panelists: Mohamed Rahman, Amr Nowier, Ahmed Morsi Monday, May 18, 2015 UROLOGIC SOCIETY FOR TRANSPLANTATION AND RENAL SURGERY (USTRS) Room New Orleans Morial Convention Center 1:00 pm - 5:00 pm 12:00 INDUSTRY LUNCH PROGRAM - TBD (NON- CME) 1:00 INTERNATIONAL HOUR: PERSPECTIVES ON KIDNEY TRANSPLANTATION (CHINA, REPUBLIC OF KOREA, JAPAN, CUBA) Woong Kyu Han, Kazunari Tanabe, Octavio Manuel De La Concepcion Gomez 2:00 COMMON AND NOT SO COMMON ASPECTS OF DIFFERENT KIDNEY TRANSPLANT PROGRAMS IN EUROPE Enrique Lledo-Garcia, Arnaldo Figueiredo 2:30 DISCUSSION 2:45 BREAK 3:00 THE LIVING DONOR SOFTWARE PROJECT Claus Niemann 3:30 HISTOTRIPSY OF RENAL LESIONS William Roberts 4:00 RESIDENT AND FELLOW PRESENTATIONS ANDREW NOVICK AWARD 5:00 USTRS BUSINESS MEETING Monday, May 18, 2015 AMERICAN SOCIETY FOR MEN S HEALTH (ASMH) La Nouvelle New Orleans Morial Convention Center 1:00 pm - 5:30 pm 11:45 (NON-CME PORTION OF THE PROGRAM) INDUSTRY SPONSORED LUNCH PROGRAM (CME PORTION OF THE PROGRAM COMMENCES) 1:00 WELCOME & INTRODUCTION Program Chair: Culley Carson 1:15 ADVANCES IN BPH/LUTS Moderator: Culley Carson MEDICAL TREATMENT FOR MALE BPH/LUTS AND ASSOCIATED OAB Steven Kaplan 1:30 NEW OPTIONS FOR THE TREATMENT OF BPH/ LUTS Kevin McVary 1:45 PANEL DISCUSSION 2:15 CONTROVERSIES IN PROSTATE CANCER Moderator: Ajay Nehra 234

247 PSA: WHO TO TEST WITH CURRENT GUIDELINES Gerald Andriole 2:30 ACTIVE SURVEILLANCE: DATA AND OUTCOMES Matthew Nielsen 2:45 WHAT UROLOGISTS NEED TO KNOW ABOUT CRPC MANAGEMENT E. David Crawford 3:00 PSA SCREENING: PRIMARY CARE PERSPECTIVE Matt Rosenberg 3:15 REHABILITATION AFTER PROSTATE CANCER TREATMENT Moderator: Allen Seftel EVALUATION & MANAGEMENT OF POST TREATMENT INCONTINENCE Kurt McCammon 3:30 RECENT DATA ON POST TREATMENT ED REHABILITATION Anthony Bella 3:45 TESTOSTERONE REPLACEMENT AFTER PROSTATE CANCER TREATMENT Mohit Khera 4:00 PANEL DISCUSSION 4:15 CONTROVERSIES IN TESTOSTERONE AND CVD Moderator: Culley Carson EPIDEMIOLOGIC DATA FOR HYPOGONADISM, TRT & CV HEALTH Thomas Walsh 4:30 CLINICAL PERSPECTIVE OF CVD AND TRT Martin Miner 4:45 FDA PANEL DELIBERATIONS FOR TRT & CVD Culley Carson 4:55 PANEL DISCUSSION 5:00 MEN S HEALTH CLINIC: ESTABLISHMENT OF A MEN S HEALTH PROGRAM Edward Karpman 5:30 ADJOURN MONDAY Monday, May 18, :15 pm - 5:00 pm PAN AFRICAN UROLOGICAL SURGEONS ASSOCIATION (PAUSA)/CARIBBEAN UROLOGICAL ASSOCIATION (CURA) Room New Orleans Morial Convention Center 1:15 WELCOME REMARKS (PAUSA PRESIDENT, CURA PRESIDENT, AUA PRESIDENT) 1:30 SESSION 1 Chairmen: Mobile Kampanga, Ajibola Jeje UPDATE ON PIUTA CENTRES Serigne Gueye 1:45 CONTEMPORARY SURGICAL MANAGEMENT OF ADRENAL TUMORS Markarand Khochika 2:00 SESSION 2: SURGICAL TECHNIQUES URETHRAL RECONSTRUCTION Chairmen: Elijah Kehinde, Sunny Mante TIPS ON URETHRAL RECONSTRUCTION Sanjay Kulkarni 2:10 FAILED HYPOSPADIAS REPAIR Guido Barbagli 2:20 REPAIR OF PAN-URETHRAL STRICTURES: THE CARIBBEAN EXPERIENCE Trevor Tulloch 2:30 RECONSTRUCTIVE UROLOGY IN SUB- SAHARAN AFRICA Medina Ndoye 3:00 COFFEE BREAK 3:20 SESSION 3: UNUSUAL CASES Chair: Serigne Gueye BLADDER CANCER E. Oluwabunmi Olapade-Olaopa 3:40 SESSION 4 Chairmen: Mohammed Eissa, Alexander Nwofor PAUSA 2015 CONGRESS Mobile Kampanga 3:50 UPDATE ON THE AFRICAN JOURNAL OF UROLOGY Elijah Kehinde 4:00 TBD Emmanuel Abara 4:10 DISCUSSION 4:30 SESSION 5: AOB 5:00 ADJOURN PAUSA/CURA BUSINESS MEETING Program Chair: E. Oluwabunmi Olapade-Olaopa 2:40 PANEL DISCUSSION ON ADULT AND PEDIATRIC URETHRAL RECONSTRUCTION *Presenting author 235

248 Monday, May 18, :30 pm - 5:40 pm SOCIETÀ ITALIANA DI UROLOGIA (SIU) / AMERICAN UROLOGICAL ASSOCIATION (AUA) JOINT MEETING Room New Orleans Morial Convention Center 2:30 WELCOME AND INTRODUCTION Society President: Maurizio Brausi Society Secretary General: Vincenzo Mirone 2:35 THE KIDNEY CANCER SESSION: MINIMALLY INVASIVE PARTIAL NEPHRECTOMY: ROBOTIC VS LAPAROSCOPIC APPROACH Chairmen: Giuseppe Ludovico, Giuseppe Morgia STATE OF THE ART LECTURE: PARTIAL NEPHRECTOMY NOVEL TECHNIQUES: ZERO ISCHEMIA AND TISSUE SPARING John Libertino 2:55 POINT/COUNTERPOINT: ROBOTIC ASSISTED PARTIAL NEPHRECTOMY PRO AND CONS James Porter 3:15 POINT/COUNTERPOINT: LAPAROSCOPIC PARTIAL NEPHRECTOMY: LIGHTS AND SHADOWS Francesco Porpiglia 3:35 THE BLADDER CANCER SESSION Chairmen: Maurizio Brausi, Donata Villari STATE OF THE ART LECTURE: THE USE OF THE BOWEL FOR BLADDER SUBSTITUTION OVER THE YEARS Jason Gee 4:15 POINT/COUNTERPOINT: THE ILEAL RESERVOIR: HAUTMAN NEOBLADDER FORMED ENTIRELY WITH STAPLES Giuseppe Carrieri 4:35 THE MEN S HEALTH SESSION Chairmen: Ridwan Shabsigh, Vincenzo Mirone STATE OF THE ART LECTURE: THE STATE OF MEN S HEALTH AROUND THE WORLD Ridwan Shabsigh 4:55 POINT/COUNTERPOINT DEBATE: WHY THE UROLOGIST SHOULD BE THE GUARDIAN OF MEN S HEALTH Paolo Verze 5:15 POINT/COUNTERPOINT: UROLOGIC MALIGNANCIES AND MEN S HEALTH: WHAT S THE IMPACT? Riccardo Autorino 5:35 GOLDEM ITALIAN AT AUA 2015 AWARD Elisabetta Costantini 5:40 ADJOURN 3:55 POINT/COUNTERPOINT DEBATE: THE COLONIC RESERVOIR: SIGMOID ORTHOTOPIC NEOBLADDER VS THE ILEAL RESERVOIR: HAUTMAN NEOBLADDER FORMED ENTIRELY WITH STAPLES Giulio Nicita Monday, May 18, 2015 ENDOCRINE FORUM Room New Orleans Morial Convention Center Moderators: Larry Lipshultz and Abraham Morgentaler 3:00 pm - 5:30 pm 3:00 DEBATE: THE FDA IS RIGHT TO RESTRICT INDICATIONS FOR TESTOSTERONE THERAPY Debater - Pro: Toby Chai Debater - Con: Mark Sigman 3:30 QUESTIONS AND ANSWERS 3:40 GENETIC MARKERS ARE ESSENTIAL IN THE ASSESSMENT OF A PROSTATE BIOPSY Debater - Pro: Eric Klein Debater - Con: Neal Shore 4:10 QUESTIONS AND ANSWERS 4:35 QUESTIONS AND ANSWERS 4:40 DEBATE: MRI FUSION IS THE NEW STANDARD FOR PROSTATE BIOPSY Debater - Pro: Peter Pinto Debater - Con: S. Larry Goldenberg 5:20 QUESTIONS AND ANSWERS 5:30 ADJOURN 4:20 INFERTILITY AS A MARKER OF MEN S HEALTH Michael Eisenberg 236

249 Monday, May 18, 2015 LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) Room New Orleans Morial Convention Center 3:30 pm - 5:30 pm 3:30 KEYNOTE PRESENTATION FROM LOUISIANA GOVERNOR BOBBY JINDAL 5:30 ADJOURN 4:30 UPDATE ON THE ASSOCIATION AND NEW LUGPA INITIATIVES Society Chair: Gary Kirsh Monday, May 18, 2015 Moderated Poster Session 71 BENIGN PROSTATIC HYPERPLASIA: EVALUATION AND SYMPTOMS Room New Orleans Morial Convention Center Moderators: Lori Lerner and Richard Babayan 3:30 pm - 5:30 pm NUMBER TITLE NUMBER TITLE MP71-01 SERUM VITAMIN D LEVELS AND PROSTATE VOLUME Yaw Nyame*, Cleveland, OH, Richard Kalu, Chicago, IL, Ganesh Kartha, Cleveland, OH, Tyler Maiers, Diana Bowen, Chicago, IL, Rick Kittles, Tucson, AZ, Adam Murphy, Chicago, IL MP71-02 HOW TO CONNECT ANY SMARTPHONE WITH CYSTOSCOPE IN ENDOSCOPIC EVALUATION OF BENIGN PROSTATIC HYPERPLASIA ERNESTO III ARADA*, Dasmarinas City, Cavite, Philippines MP71-03 WAIST CIRCUMFERENCE CAN BE PREDICTIVE OF POSTOPERATIVE STORAGE LUTS AFTER SURGERY FOR BENIGN PROSTATIC HYPERPLASIA Mauro Gacci, Arcangelo Sebastianelli, Matteo Salvi, Florence, Italy, Cosimo De Nunzio, Andrea Tubaro*, Rome, Italy, Linda Vignozzi, Florence, Italy, Giovanni Corona, Bologna, Italy, Kevin T McVary, Chicago, IL, Steven A Kalan, New York, NY, Mario Maggi, Marco Carini, Sergio Serni, Florence, Italy MP71-04 SIMPLE MODIFICATION OF BLADDER OUTLET OBSTRUCTION INDEX FOR BETTER PREDICTION OF ENDOSCOPICALLY PROVEN PROSTATIC OBSTRUCTION Jang Hee Han, Seoul, Korea, Republic of, Ho Song Yu, Gwangju, Korea, Republic of, Joo Yong Lee, Joohan Kim, Jong Kyu Kwon, Ho Chul Choi*, Kang Su Cho, Seoul, Korea, Republic of MP71-05 ENUCLEATION OF THE TRANSITION ZONE AND THE EFFECT ON PSA IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS Osayuki Nehikhare*, Giancarlo Marra, Sohel Samad, Janette Kinsella, Oliver Brunckhorst, Kamran Ahmed, Ben Challacombe, Rick Popert, London, United Kingdom MP71-06 ASSOCIATION OF AUA-SS SUBSCALES WITH POST LASER PROSTATECTOMY URINARY INCONTINENCE Abdulrahman Alruwaily*, Rabia Siddiqui, Maggie Bierlein, Sara Lenherr, John Wei, Ann Arbor, MI MP71-07 VALIDATION OF A NEW SOUND-BASED METHOD FOR RECORDING VOIDING PARAMETERS USING SIMULTANEOUS UROFLOWMETRY Jan Krhut, Marcle Gärtner, Radek Sýkora, Petr Hurtík, Michal Burda, Ostrava, Czech Republic, Katarína Zvarová, Bratislava, Czech Republic, Peter Zvara*, Burlington, VT MP71-08 METABOLIC PROFILE CAN BE A LEADING PATHOGENETIC FACTOR FOR BENIGN PROSTATIC ENLARGEMENT Mauro Gacci, Matteo Salvi, Arcangelo Sebastianelli, Florence, Italy, Cosimo De Nunzio, Rome, Italy, Linda Vignozzi, Florence, Italy, Giovanni Corona, Bologna, Italy, Tommaso Jaeger, Tommaso Chini, Florence, Italy, Giorgio Ivan Russo, Catania, Italy, Mario Maggi, Florence, Italy, Giuseppe Morgia, Catania, Italy, Andrea Tubaro*, Rome, Italy, Marco Carini, Sergio Serni, Florence, Italy MP71-09 FUNCTIONAL ANALYSIS OF PATIENT OUTCOMES FOLLOWING DIFFERENT SURGICAL INTERVENTIONS FOR BENIGN PROSTATE HYPERPLASIA THROUGH THE ADMINISTRATION OF AN INDEPENDENT SURVEY Haidar Abdul-Muhsin*, Mark Tyson, Paul Andrews, Erik Castle, Robert Ferrigni, Wolter Christopher, Swanson Scott, Mitchell Humphreys, Phoenix, AZ MP71-10 PREDICTORS OF PROSTATE CANCER IN PATIENTS UNDERGOING HOLMIUM LASER ENUCLEATION OF THE PROSTATE FOR SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA Mohamed Elkoushy*, Ahmed Elshal, Mostafa Elhilali, Montreal, Canada MONDAY *Presenting author 237

250 MP71-11 URINARY SYMPTOMS AND MEDICATIONS USED IN MEN ATTENDING A NATIONAL HEALTH SCREENING PROGRAM Nelson Stone*, New York, NY, Wendy Poage, E. David Crawford, Aurora, CO MP71-12 INCREASE OF FRAMINGHAM RISK IS ASSOCIATED WITH SEVERITY OF LOWER URINARY TRACT SYMPTOMS: CONFIRMING RELATIONSHIP BETWEEN BOTH DISEASES Giorgio Ivan Russo*, Tommaso Castelli, Salvatore Privitera, Eugenia Fragalà, Vincenzo Favilla, Giulio Reale, Daniele Urzì, Sebastiano Cimino, Giuseppe Morgia, Catania, Italy MP71-13 A VISUAL ANALOG OF THE INTERNATIONAL PROSTATE SYMPTOM SCORE IS A MORE ACCURATE TOOL IN ASSESSING LOWER URINARY TRACT SYMPTOMS IN MEN Rachel Sharon Selekman*, Catherine R Harris, Pauline Filippou, Thomas Chi, Amjad Alwaal, Sarah D Blaschko, Benjamin N Breyer, San Francisco, CA MP71-14 VIDEOURODYNAMIC ANALYSIS OF MEN WITH LOWER URINARY TRACT DYSFUNCTION AND LARGE POSTVOID RESIDUAL URINE VOLUME Jia-Fong Jhang*, Dong-Ling Tang, Hann- Chorng Kuo, Hualien, Taiwan, Yao-Chou Tsai, New Taipei City, Taiwan MP71-15 PROSTATE MORPHOLOGY ROLE IN PATIENTS WITH BENIGN PROSTATE HYPERPLASIA AND THE RESPONSE TO MEDICAL THERAPY Rafael Nunez-Nateras*, Eric Wisenbaugh, Haidar Abdul-Muhsin, Mark Tyson, Erik Castle, Paul Andrews, Mitchell Humphreys, Phoenix, AZ MP71-16 GENERATION DIFFERENCE ON THE ASSOCIATION BETWEEN LOWER URINARY TRACT SYMPTOMS AND LATE- ONSET HYPOGONADISM SYMPTOMS: ANALYSIS OF 1398 HEALTHY YOUNG AND ELDERLY ADULTS Hiroshi Kiuchi*, Tetsuji Soda, Kentaro Takezawa, Shinichiro Fukuhara, Yasushi Miyagawa, Suita, Osaka, Japan, Akira Tsujimura, Tokyo, Japan, Tetsuya Takao, Osaka, Japan, Norio Nonomura, Suita, Osaka, Japan MP71-17 LOWER URINARY TRACT SYMPTOMS AND RISK OF INCIDENT NON-SPINE FRACTURE AMONG OLDER US MEN Lynn Marshall, Jodi Lapidus, Portland, OR, Jack Wiedrick, Portland, OR, OR, Kathleen Holton, Washington, D.C., DC, Elizabeth Barrett Connor, J Kellogg Parsons*, La Jolla, CA MP71-18 LOW-VOLUME PROSTATE IN BENIGN PROSTATIC HYPERPLASIA (BPH): A RISK FACTOR FOR SYMPTOMATIC BLADDER DIVERTICULA REQUIRING SURGICAL TREATMENT Eduardo Muracca Yoshinaga*,.sao paulo, Brazil, Elcio Nakano, Giovanni S Marchini, Renato Hajime Oyama, Paulo Cordeiro, William C Nahas, Miguel Srougi, Alberto A Antunes, Sao Paulo, Brazil MP71-19 MEN WITH MODERATE TO SEVERE LOWER URINARY TRACT SYMPTOMS HAVE A HIGHER ESTIMATED RISK OF DEVELOPING TYPE 2 DIABETES Jose Ricardo Silvino*, Gabriel Gouvea, Priscila Kuriki, Viviane Tabone, Raquel Conceicao, Rogerio Simonetti, Valdemar Ortiz, Roberto Soler, Sao Paulo, Brazil MP71-20 INTRAVESICAL PROSTATIC PROTRUSION CAN BE THE GOOD PREDICTING FACTOR ON STORAGE FUNCTION IN PATIENTS WITH BENIGN PROSTATIC ENLARGEMENT FROM THE PERSPECTIVE OF URODYNAMIC STUDY Yoshihisa Matsukawa*, Shun Takai, Kazuna Matsuo, Shohei Ishida, Tokunori Yamamoto, Momokazu Gotoh, Nagoya, Japan 238

251 Monday, May 18, 2015 Moderated Poster Session 72 BLADDER CANCER: INVASIVE V Room New Orleans Morial Convention Center Moderators: Hassan Abol-Enein and Eila Skinner 3:30 pm - 5:30 pm NUMBER TITLE NUMBER TITLE MP72-01 RADICAL CYSTECTOMY VERSUS BLADDER-SPARING TREATMENT FOR PATIENTS WITH MUSCLE-INVASIVE UROTHELIAL CARCINOMA OF THE URINARY BLADDER: A COMPARATIVE EFFECTIVENESS POPULATION-BASED STUDY Maxine Sun*, Montreal, Canada, Giorgio Gandaglia, Milan, Italy, Alessandro Larcher, Michael McCormarck, Montreal, Canada, Shahrokh Shariat, New York, NY, Luc Valiquette, Fred Saad, Pierre Karakiewicz, Montreal, Canada MP72-02 OUTCOME OF PATIENTS WITH MICROPAPILLARY BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY WITH/WITHOUT NEOADJUVANT CHEMOTHERAPY Mario I Fernandez*, Stephen B Williams, Daniel L Willis, Rebecca S Slack, Rian Dickstein, Sahil Parikh, Arlene O Siefker- Radtke, Charles C Guo, Bogdan A Czerniak, Jay B Shah, Louis L Pisters, H Barton Grossman, Colin P Dinney, Ashish M Kamat, Houston, TX MP72-03 RADICAL CYSTECTOMY FOR BLADDER CANCER IN PATIENTS WITH AND WITHOUT A HISTORY OF PELVIC IRRADIATION: A COMPARISON OF SURVIVAL OUTCOMES AND DIVERSION- RELATED COMPLICATIONS Daniel Nguyen*, Bashir Al Hussein Al Awamlh, Bishoy Faltas, Padraic O Malley, Abimbola Ayangbesan, Igor Inoyatov, Shiyi Jin, Douglas Scherr, New York, NY MP72-04 IMPACT OF THE SITE OF RECURRENCE AFTER RADICAL CYSTECTOMY ON SURVIVAL: DIFFERENT SITES FOR DIFFERENT OUTCOMES Marco Moschini*, Nazareno Suardi, Marco Bianchi, Vito Cucchiara, Stefano Luzzago, Milan, Italy, Francesco D Amato, Vincenzo Serretta, Palermo, Italy, Alberto Briganti, Milan, Italy, Shahrokh F. Shariat, Vienna, Austria, Rocco Damiano, Catanzaro, Italy, Jeffrey Karnes, Rochester, MN, Francesco Montorsi, Renzo Colombo, Milan, Italy MP72-05 COSTS ASSOCIATED WITH BLADDER CANCER: A DESCRIPTIVE POPULATION- BASED STUDY AMONG PATIENTS WHO UNDERWENT RADICAL CYSTECTOMY IN THE PROVINCE OF QUEBEC, CANADA Fabiano Santos*, Alice Dragomir, Ahmed Zakaria, Wassim Kassouf, Armen Aprikian, Montreal, Canada MP72-06 THE LONG NON-CODING RNA SNHG18 PROMOTES PPAR FUNCTION AND LUMINAL GENE EXPRESSION IN MUSCLE-INVASIVE BLADDER CANCER Andrea Ochoa*, Jianping Zhang, Woonyoung Choi, Houston, TX, Gabriel Malouf, Paris, France, Erika Thompson, John Weinstein, Nizar Tannir, Colin Dinney, David McConkey, Xiaoping Su, Houston, TX MP72-07 NOMOGRAM PREDICTING CANCER SPECIFIC MORTALITY (CSM) AFTER NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY FOR MUSCLE- INVASIVE BLADDER CANCER (BC): RESULTS OF AN INTERNATIONAL CONSORTIUM Maria Carmen Mir*, Cesar Ercole, Andrew Stephenson, Cleveland, OH MP72-08 GEMCITABINE AND CISPLATIN NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE UROTHELIAL CARCINOMA: PREDICTING RESPONSE AND ASSESSING OUTCOMES Nilay Gandhi*, Alexander Baras, Enrico Munari, Sheila Faraj, Baltimore, MD, Leonardo Reis, Unicamp, Brazil, Jen-Jane Liu, Max Kates, Mohammad Hoque, Baltimore, MD, David Berman, Kingston, Canada, Noah Hahn, Mario Eisenberger, George Netto, Baltimore, MD, Mark Schoenberg, Bronx, NY, Trinity Bivalacqua, Baltimore, MD MP72-09 ADJUVANT CISPLATIN LEADS TO A LARGER DECLINE IN GFR THAN NEOADJUVANT CISPLATIN IN RADICAL CYSTECTOMY PATIENTS Danny Lascano*, Alexa Meyer, Elizabeth Hagan, Jamie S Pak, LaMont J. Barlow, G. Joel DeCastro, James M. McKiernan, New York, NY MP72-10 PHASE I STUDY OF INTRAVESICAL RECOMBINANT FOWLPOX-GM-CSF (RF- GM-CSF) OR RECOMBINANT FOWLPOX- TRICOM (RF-TRICOM) IN PATIENTS WITH BLADDER CARCINOMA PRIOR TO UNDERGOING CYSTECTOMY Robert Weiss, Mark Stein, Tina Mayer, Amir Salmasi*, Isaac Kim, Robert DiPaola, Edmund Lattime, New Brunswick, NJ MP72-11 OUTCOMES FOLLOWING RADICAL CYSTECTOMY FOR PLASMACYTOID UROTHELIAL CARCINOMA: DEFINING THE NEED FOR IMPROVED LOCAL CANCER CONTROL Patrick Cockerill*, John Cheville, Stephen Boorjian, Andrew Blackburne, Prabin Thapa, Robert Tarrell, Igor Frank, Rochester, MN MONDAY *Presenting author 239

252 MP72-12 OUTCOMES OF RADICAL CYSTECTOMY IN POTENTIAL CANDIDATES FOR BLADDER PRESERVATION THERAPY Eugene Pietzak, III*, Matthew Sterling, S. Bruce Malkowicz, Thomas Guzzo, Philadelphia, PA MP72-13 OUTCOMES OF RADICAL CYSTECTOMY IN PATIENTS WITH BLADDER CANCER AND UNCONTROLLED DIABETES: A POPULATION-BASED STUDY Izak Faiena*, Viktor Dombrovskiy, Raymond Sultan, Amirali Salmasi, Eric Singer, Robert Weiss, New Brunswick, NJ MP72-14 CLINICAL LYMPHADENOPATHY (CN ) IN RADICAL CYSTECTOMY(RC)PATIENTS: A TRANSATLANTIC COLLABORATION Marco Moschini*, Milan, Italy, Sia Daneshmand, Los Angeles, CA, Alberto Briganti, Milan, Italy, Brian Hu, Gus Miranda, Los Angeles, CA, Igor Frank, Rochester, MN, Renzo Colombo, Francesco Montorsi, Milan, Italy, Jeffrey Karnes, Rochester, MN MP72-15 THE INTERVAL BETWEEN DIAGNOSIS AND RADICAL CYSTECTOMY DOES NOT IMPACT THE OUTCOMES OF PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY Evanguelos Xylinas*, Paris, France, Kamran Zargar-Shoshtari, Tampa, FL, Jay Shah, houston, TX, Homayoun Zargar, Vancouver, Canada, Adrian Fairey, Los Angeles, CA, Laura Mertens, Amsterdam, Netherlands, Maria Mir, Jorge Garcia, Andrew Stephenson, Cleveland, OH, Laura-Maria Krabbe, Dallas, TX, Michael Cookson, Oklahoma, OK, Yair Lotan, Dallas, TX, Niels-Erik Jacobsen, Edmonton, Canada, Nilai Gandhi, Baltimore, MD, Joshua Griffin, Kansas, KS, Jeffrey Montgomery, Ann Harbor, MI, Nikhil Vasdev, Newcastle Upon Tyne, United Kingdom, Evan Yu, Seattle, WA, Nicholas Campain, Exeter, United Kingdom, Wassim Kassouf, Montreal, Canada, Marc Dall Era, Sacramento, CA, Jo- An Seah, Toronto, Canada, Cesar Ercole, Cleveland, OH, Simon Horenblas, Amsterdam, Netherlands, Srikala Sridhar, Toronto, Canada, Jonathan McGrath, Exeter, United Kingdom, Jonathan Aning, Newcastle Upon Tyne, United Kingdom, Jonathan Wright, Seattle, WA, Andrew Thorpe, Newcastle Upon Tyne, United Kingdom, Todd Morgan, Ann Harbor, MI, Jeff Holzbeierlein, Kansas, KS, Trinity Bivalacqua, Baltimore, MD, Scott North, Edmonton, Canada, Daniel Barocas, Nashville, TN, Siamak Daneshmand, Los Angeles, CA, Bass Van Rhijn, Amsterdam, Netherlands, Philippe Spiess, Tampa, FL, Colin Dinney, houston, TX, Peter Black, Vancouver, Canada, Shahrokh Shariat, Vienna, Austria MP72-16 MANAGEMENT OF UNRESECTABLE BLADDER CANCER DIAGNOSED AT TIME OF PLANNED CYSTECTOMY Kashyap Shatagopam*, Hristos Kaimakliotis, Jose Pedrosa, Paul Gellhaus, Michael Koch, Indianapolis, IN MP72-17 RADICAL CYSTECTOMY PRACTICES AMONG URO-ONCOLOGISTS: A STATE OF THE ART SURVEY Evan Kovac*, Cleveland, OH, Kamran Zargar-Shoshtari, Tampa, FL, Homayoun Zargar, Cesar Ercole, Andrew Stephenson, Cleveland, OH MP72-18 PREVALENCE AND COVARIATES OF MUSCLE INVASIVE BLADDER CANCER (MIBC) SURVIVORS INFORMATIONAL AND SUPPORTIVE CARE NEEDS: RESULTS FROM A NATIONAL SURVEY SUPPORTED BY THE BLADDER CANCER ADVOCACY NETWORK (BCAN) Nihal Mohamed*, New york, NY MP72-19 THE IMPACT OF HEALTH RELATED QUALITY OF LIFE ON CYSTECTOMY PATIENTS USING THE MEDICAL HEALTH OUTCOMES STUDY Brian Winters*, George Schade, Sarah Holt, John Gore, Atreya Dash, Michael Porter, Jonathan Wright, Seattle, WA MP72-20 PLASMACYTOID VARIANT OF UROTHELIAL CARCINOMA IS ASSOCIATED WITH E-CADHERIN LOSS Byron Lee*, Gopa Iyer, S. Paul Gao, Emmet Jordan, Sasinya Scott, Aravind Bhayankara, Ricardo Ramirez, Joseph Hreiki, Jonathan Rosenberg, Dean Bajorin, Bernard Bochner, Michael Berger, David Solit, Hikmat Al- Ahmadie, New York, NY 240

253 Monday, May 18, 2015 Moderated Poster Session 73 PROSTATE CANCER: ADVANCED I Room New Orleans Morial Convention Center Moderator: Daniel Petrylak 3:30 pm - 5:30 pm NUMBER TITLE NUMBER TITLE MP73-01 ANAMEM: PROSPECTIVE AND OBSERVATIONAL STUDY TO EVALUATE COGNITIVE CHANGES IN PROSTATE CANCER PATIENTS UNDERGOING LUTEINIZING HORMONE-RELEASING HORMONE ANALOGUE TREATMENT Juan Morote*, Barcelona, Spain, Ángel Tabernero, Madrid, Spain, José Luis Álvarez- Ossorio, Cádiz, Spain, Juan Pablo Ciria, San Sebastián, Spain, José Luis Domínguez- Escrig, Valencia, Spain, Fernando Vázquez, Granada, Spain, Javier C. Angulo, Madrid, Spain, Francisco Javier López, Murcia, Spain, Ramón De la Iglesia, Lorca, Spain, Jesús Romero, Alicante, Spain MP73-02 PATIENT UNDERSTANDING REGARDING END-OF-LIFE PROSTATE CANCER AND PERSPECTIVES REGARDING COST/BENEFIT OF CURRENT TREATMENT PARADIGMS Tarik Benidir*, Antonio Finelli, Rob Hamilton, Karen Hersey, Anthony Joshua, Girish Kulkarni, Alexandre Zlotta, Neil Fleshner*, Toronto, Canada MP73-03 REGIONAL DIFFERENCES IN CARDIOVASCULAR STATUS AND EVENTS IN PROSTATE CANCER PATIENTS TREATED WITH A LUTEINISING HORMONE-RELEASING HORMONE AGONIST VS ANTAGONIST: RESULTS OF A POOLED ANALYSIS Michael Borre*, Aarhus, Denmark, Tom Keane, Charleston, SC, Zsolt Bosnyak, Anders Malmberg, Anders Neijber, Copenhagen, Denmark MP73-04 THE ASSOCIATION BETWEEN STATIN USE AND OUTCOMES IN PATIENTS INITIATING ANDROGEN DEPRIVATION THERAPY Robert Hamilton*, Toronto, Canada, Keyue Ding, Kingston, Canada, Juanita Crook, Kelowna, Canada, Christopher O Callaghan, Kingston, Canada, Celestia Higano, Seattle, WA, David Dearnaley, London, United Kingdom, Eric Horwitz, Philadelphia, PA, Larry Goldenberg, Vancouver, Canada, Mary Gospodarawicz, Laurence Klotz, Toronto, Canada MP73-05 CARDIOVASCULAR EVENT RISK AS A FUNCTION OF BASELINE RISK FACTORS IN PROSTATE CANCER PATIENTS TREATED WITH DEGARELIX OR LUTEINISING HORMONE-RELEASING HORMONE AGONISTS Igle de Jong*, Groningen, Netherlands, Asa Tivesten, Gothenburg, Sweden, Alexandre de la Taille, Creteil, France, Francesco Montorsi, Milan, Italy, Anders Malmberg, Copenhagen, Denmark, Bo-Eric Persson, Uppsala, Sweden MP73-06 STRATIFICATION OF CONTEMPORARY PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR HIGH-RISK PROSTATE CANCER Jung Ki Jo*, Ha Rim Kook, Tae Jin Kim, Hakmin Lee, Seong Jin Jeong, Seok-Soo Byun, Sang Eun Lee, Sung Kyu Hong, Seongnam-si, Korea, Republic of MP73-07 BONE MANAGEMENT OF PROSTATE CANCER: FRAX TOOL COMBINATION WITH BMD CAN REDUCE UNNECESSARY TREATMENT Shusei Fusayasu*, Takashi Kawahara, Yokohama, Japan, Hiroshi Miyamoto, Baltimore, MD, Masahiro Yao, Hiroji Uemura, Yokohama, Japan MP73-08 PROGRESSION TO CASTRATE RESISTANCE AND CANCER-SPECIFIC MORTALITY IN TREATMENT-NAIVE PATIENTS INITIALLY DIAGNOSED WITH METASTATIC PROSTATE CANCER: PROGNOSTIC IMPACTS OF THE SITE OF METASTASIS AND PAIN Kyo Chul Koo*, Ho Chul Choi, Sang Un Park, Ki Hong Kim, Koon Ho Rha, Sung Joon Hong, Byung Ha Chung, Seoul, Korea, Republic of MP73-09 TYPE OF ANDROGEN DEPRIVATION THERAPY AFFECTS METABOLIC CONDITION AND ADIPOSE TISSUE DISTRIBUTION Shingo Hatakeyama*, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Hirosaki, Japan MONDAY *Presenting author 241

254 MP73-10 BONE TURNOVER MARKER LEVELS AND OUTCOMES IN MEN WITH PROSTATE CANCER AND BONE METASTASES TREATED WITH BONE ANTIRESORPTIVE AGENTS Neal Shore*, Myrtle Beach, SC, Matthew R. Smith, Boston, MA, Allan Lipton, Hershey, PA, Janet E. Brown, Sheffield, United Kingdom, Stephane Oudard, Paris, France, Michael Carducci, Baltimore, MD, Fred Saad, Montreal, Canada, Ronaldo Damiao, Rio de Janeiro, Brazil, Li Zhu, Douglas Warner, Thousand Oaks, CA, Karim Fizazi, Villejuif, France MP73-11 ANDROGEN DEPRIVATION THERAPY AND INCREASED NON-CANCER MORTALITY IN PROSTATE CANCER PATIENTS: ANALYSIS OF THE NUMBER NEEDED TO HARM Firas Abdollah*, Jesse Sammon, Akshay Sood, Daniel Pucheril, Dane Klett, Detroit, MI, Maxine Sun, Montreal, Canada, Ayal Aizer, Toni Choueiri, Boston, MA, Jim Hu, Los Angeles, CA, Simon Kim, New Haven, CT, Adam Kibel, Paul Nguyen, Boston, MA, Mani Menon, Detroit, MI, Quoc-Dien Trinh, Boston, MA MP73-12 UNSUSPECTED METASTASES FOUND DURING SCREENING FOR A TRIAL OF PATIENTS WITH NON-METASTATIC CASTRATION RESISTANT PROSTATE CANCER E. David Crawford*, Aurora, CO, Jannell R. DePalantino, Horsham, PA, Philip W. Kantoff, Boston, MA, Neal Shore, Myrtle Beach, SC, Willie Underwood, Buffalo, NY, Vijay Reddy, Horsham, PA, Jim Wang, Raritan, NJ, Suneel Mundle, Zane Yang, Tracy McGowan, Horsham, PA, Charles J. Ryan, San Francisco, CA MP73-13 BUDGET IMPACT ANALYSIS OF ENZALUTAMIDE FOR TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER FROM A US PAYER PERSPECTIVE Ken O Day*, Palm Harbor, FL, Cat N. Bui, Scott Flanders, Northbrook, IL, Nina Oestreicher, Peter Francis, San Francisco, CA, Linda Posta, Northbrook, IL, Breanna Popelar, Palm Harbor, FL, Hong Tang, Northbrook, IL, Mark Balk, San Francisco, CA MP73-14 PROSTATE CANCER AND ANDROGEN DEPRIVATION THERAPY-IS IT THE RIGHT MANAGEMENT? Sanchia Goonewardene*, London, United Kingdom, Debbie Sharp, Bristol, United Kingdom, Raj Persad, London, United Kingdom MP73-15 PROSTATE-SPECIFIC ANTIGEN HALF- LIFE IDENTIFIED AT THE FIRST FOLLOW UP TIME IS AN EARLY PROGNOSTIC FACTOR OF NEWLY DIAGNOSED METASTATIC PROSTATE CANCER Ki Hong Kim*, Kyung Seok Han, Sung Joon Hong, Seoul, Korea, Republic of MP73-16 SOLID DEPOT, CONTINUOUS RELEASE, SUBCUTANEOUS LEUPROLIDE ACETATE FORMULATIONS LASTING 1-6 MONTHS ACHIEVE AND MAINTAIN SERUM TESTOSTERONE LEVELS BELOW 20NG/ DL IN 4 OPEN LABEL, FIXED DOSE STUDIES Neal D. Shore*, Myrtle Beach, SC, John A. McLane, David Osborne, Alex Yang, Ft. Collins, CO, E. David Crawford, Aurora, CO MP73-17 QUALITY OF ADVANCED CANCER CARE IN AN INTEGRATED UROLOGY/PALLIATIVE CARE CLINIC Aaron Laviana*, Carol Bennett, Josemanuel Saucedo, Jonathan Bergman, Los Angeles, CA MP73-18 SARCOPENIC OBESITY ASSOCIATED WITH ANDROGEN DEPRIVATION THERAPY IN PATIENTS WITH PROSTATE CANCER Koji Mitsuzuka*, Sendai, Japan, Atsushi Kyan, Shirakawa, Japan, Kazuhiko Orikasa, Kesen-numa, Japan, Tomonori Sato, Shirakawa, Japan, Minoru Miyazato, Okinawa, Japan, Shintaro Narita, Akita, Japan, Takuya Koie, Hirosaki, Japan, Tomonori Habuchi, Akita, Japan, Chikara Ohyama, Hirosaki, Japan, Yoichi Arai, Sendai, Japan MP73-19 PRIMARY ANDROGEN DEPRIVATION THERAPY INCREASES ALL CAUSE MORTALITY IN POPULATIONS MATCHED BY COMORBIDITY ADJUSTED LIFE EXPECTANCY AND DISEASE RISK Jesse Sammon*, Firas Abdollah, Detroit, MI, Gally Reznor, Boston, MA, Daniel Pucheril, Akshay Sood, Dane Klett, Detroit, MI, Julian Hanske, Christian Meyer, Boston, MA, Mani Menon, Detroit, MI, Quoc-Dien Trinh, Boston, MA MP73-20 INTERMITTENT VERSUS CONTINUOUS ANDROGEN DEPRIVATION IN PATIENTS WITH RELAPSING OR LOCALLY ADVANCED PROSTATE CANCER: A PHASE 3B RANDOMIZED STUDY (ICELAND) Claude Schulman, Brussels, Belgium, Erik Cornel, Hengelo, Netherlands, Vsevolod Matveev, Moscow, Russian Federation, Jan Schraml, Usti nad Laben, Czech Republic, Henri Bensadoun, Lormont, France, Wolfgang Warnack, Hagenow, Germany, Raj Persad, Bristol, United Kingdom, Marek Salagierski, Lodz, Poland, Francisco Gomez Viega, A Coruna, Spain, Edwina Baskin-Bey, Beatriz Lopez, Leiden, Netherlands, Bertrand Tombal*, Brussels, Belgium 242

255 Monday, May 18, 2015 Moderated Poster Session 74 INFERTILITY: THERAPY Room New Orleans Morial Convention Center Moderators: TBD 3:30 pm - 5:30 pm NUMBER TITLE NUMBER TITLE MP74-01 VASECTOMY REVERSAL PRACTICE PATTERN: AN ANALYSIS OF AMERICAN BOARD OF UROLOGY CASE LOG Unwanaobong Nseyo*, Nishant Patel, Tung- Chin Hsieh, San Diego, CA MP74-02 INTRA-OPERATIVE FINDINGS INFLUENCE DECISION MAKING IN VASECTOMY REVERSAL PROCEDURES - SURVEY OF FELLOWSHIP-TRAINED, HIGH-VOLUME SURGEONS Aravind Chandrashekar*, Houston, TX, James Dupree, Ann Arbor, MI, Ranjith Ramasamy, Jason Scovell, Miguel Craig, Tariq Hakky, Alexander W. Pastuszak, Larry Lipshultz, Houston, TX MP74-03 THE SIGNIFICANCE OF LIGHT MICROSCOPY FINDINGS AT THE TIME OF VASOEPIDIDYMOSTOMY Kevin Ostrowski*, Nicholas Tadros, Jason Hedges, Eugene Fuchs, Portland, OR MP74-04 A SIMPLE AMBULATORY MINI-INCISION SUPERMICROSURGICAL VASOVASOSTOMY UNDER LOCAL ANESTHESIA : USING A SPECIALLY DESIGNED DOUBLE-RINGED CLAMP WITHOUT ANY ACCESSORY DEVICES Hyun Joon Moon*, Seoul, Korea, Republic of MP74-05 PRACTICE PATTERNS IN SURGICAL STERILIZATION: AN ANALYSIS OF US UROLOGIST SURGICAL LOGS Daniel T. Oberlin*, James Kashanian, Marah Hehemann, Chicago, IL, Christopher Deibert, Jay I. Sandlow, Milwaukee, WI, Sarah C. Flury, Robert E. Brannigan, Chicago, IL MP74-06 THE PRIVATES STUDY: PAIN RATES IN VASECTOMY AND TESTING TO ENSURE STERILITY Bradley Holland*, Springfield, IL, Charles Welliver, Albany, NY, Michael Kottwitz, Danuta Dynda, Georgia Mueller, Tobias S Kohler, Springfield, IL MP74-07 POST-VASECTOMY SEMEN ANALYSIS OPTIMAL TIMING AND FINANCIAL IMPLICATIONS OF REPEAT TESTING Veeru Kasivisvanathan*, Osayuki Nehikhare, Ahayla Kadirvelarasan, Yasir Ali, Nathan Golban, Sinthu Kulendran, Theo Malthouse, Yousif Ali, Ben Challacombe, Paul Hegarty, Majed Shabbir, London, United Kingdom MP74-08 IMPORTANCE OF INTRAOPERATIVE ASSESSMENT OF SPERM IDENTIFICATION IN PREDICTING THE FINAL SPERM RETRIEVAL OUTCOME WITH MICRODISSECTION TESTICULAR SPERM EXTRACTION Khalid Alrabeeah*, Audrey Wachter, Evelyne Boulet, Simon Phillips, Naif AlHathal, Francois Bissonnette, Isaac Jacques Kadoch, Armand Zini, Montreal, Canada MP74-09 A COMPARISON OF IVF OUTCOMES OF INTRACYTOPLASMIC SPERM INJECTION USING SURGICALLY RETRIEVED TESTICULAR OR FROZEN-THAWED TESTICULAR SPERMATOZOA Mehmet Ali Tufekci, Mehmet Murad Basar*, Zafer Atayurt, Tugba Senel, Semra Kahraman, Istanbul, Turkey MP74-10 COMPARISON OF FRESH VERSUS FROZEN TESTICULAR SPERM FOR INTRACYTOPLASMIC SPERM INJECTION IN PATIENTS WITH NONOBSTRUCTIVE AZOOSPERMIA Mustafa Bakircioglu*, Meral Gultomruk, Mustafa Bahceci, Istanbul, Turkey MP74-11 MICRODISSECTION TESTICULAR SPERM EXTRACTION OUTCOMES FOR MOSAIC AND NON-MOSAIC KLINEFELTER SYNDROME PATIENTS Bobby Najari*, Michael Schulster, Gianpiero Palermo, Zev Rosenwaks, Peter Schlegel, New York, NY MP74-12 IS THERE ANY ROLE OF MEDICAL TREATMENT OR VARICOCELE REPAIR IN INFERTILE MEN WHO FAILED INITIAL TESTICULAR SPERM EXTRACTION? Selahittin Çayan*, Mersin, Turkey, Abdullah Tok, Turan Çetin, Adana, Turkey MP74-13 PREDICTORS OF SUCCESS AFTER MICROSCOPIC SUBINGUINAL VARICOCELECTOMY Dane Johnson*, Brooke Harnisch, Andrew Zganjar, Jay Sandlow, Milwaukee, WI MP74-14 EFFICACY OF MICROSURGICAL SUBINGUINAL VARICOCELECTOMY USING INDOCYANINE GREEN FLUORESCENCE ANGIOGRAPHY Yasuhiro Shibata*, Sota Kurihara, Yoshiyuki Miyazawa, Haruo Kato, Hidekazu Koike, Kazuto Ito, Tetsuya Nakamura, Kazuhiro Suzuki, Maebashi, Japan MONDAY *Presenting author 243

256 MP74-15 ORAL PROBENECID IMPROVES SPERM MOTILITY IN MEN WITH SPINAL CORD INJURY (SCI) Emad Ibrahim*, Teodoro Aballa, Juan Pablo de Rivero Vaccari, Robert Keane, W. Dalton Dietrich, Charles Lynne, Nancy Brackett, Miami, FL MP74-16 DEVELOPMENT OF A PRACTICAL ANIMAL MODEL FOR HUMAN SPERMATOGONIAL STEM CELL TRANSPLANTATION Ahmed Hussein*, Giza, Egypt, Matthew Abad-Santos, Jared Rosen, Pamela Yango, Nam Tran, James Smith, San Francisco, CA MP74-17 POTENTIAL OF OPTICAL COHERENCE TOMOGRAPHY (OCT) AND PROBE-BASED CONFOCAL LASERENDOMICROSCOPY (PCLE) IN THE INVESTIGATION OF THE TESTIS A FEASIBILITY STUDY Matthias Trottmann*, Munich, Germany, Sabine Kölle, Dublin, Ireland, Christian Homann, Herbert Stepp, Daniel Döring, Regina Leeb, Sven Reese, Christian G. Stief, Ronald Sroka, Munich, Germany MP74-19 A PROSPECTIVE STUDY OF NATURAL PREGNANCY RATES IN CLEARED MALE FACTOR COUPLES Daniel H. Shin*, Los Angeles, CA, Emily S. Christensen, Paul J. Turek, San Francisco, CA MP74-20 WHO IS THE MOST SUITABLE CANDIDATE FOR CLOMIPHENE TREATMENT? FINDINGS OF AN OBSERVATIONAL SURVEY IN A COHORT OF PRIMARY INFERTILE MEN Luca Boeri*, Alessandro Serino, Eugenio Ventimiglia, Giovanni La Croce, Paolo Capogrosso, Marco Paciotti, Angela Pecoraro, Silvia Ippolito, Giulia Castagna, Roberta Scano, Dana Kuefner, Milan, Italy, Rocco Damiano, Catanzaro, Italy, Francesco Montorsi, Andrea Salonia, Milan, Italy MP74-18 TESTOSTERONE (T) PROFILES OF MEN AFTER TESTIS SPERM EXTRACTION (TESE) Lawrence C. Jenkins*, New York, NY, Coskun Kacagan, Duzce, Turkey, Christian J. Nelson, John P. Mulhall, New York, NY Monday, May 18, 2015 Moderated Poster Session 75 STONE DISEASE: EVALUATION I Room New Orleans Morial Convention Center Moderators: Bodo Knudsen and Robert Marcovich 3:30 pm - 5:30 pm NUMBER TITLE NUMBER TITLE MP75-01 DEFINITIVE URETERAL STONE TREATMENT (DUST) SCORE PREDICTS OUTCOMES OF URETEROSCOPIC INTERVENTION IN ACUTE OBSTRUCTIVE UROPATHY SECONDARY TO UROLITHIASIS Timothy Tran*, Simone Thavaseelan, Gyan Pareek, Providence, RI MP75-04 THE EFFECT OF STONE PREVENTION COUNSELING AT THE INITIAL CONSULTAION ON 24-HOUR URINE COLLECTION RESULTS ( CLINIC EFFECT ) Tarek Alzahrani*, Daniela Ghiculete, Kenneth Pace, Jason Y. Lee, R.J. D A. Honey, Toronto, Canada MP75-02 DO PATIENT AND STONE FACTORS DIFFER BETWEEN CALCIUM PHOSPHATE STONES AND OTHER METABOLIC STONES UNDERGOING PERCUTANEOUS NEPHROLITHOTOMY? Benjamin King*, Burlington, VT, Nazikh Khater, Duane Baldwin, Loma Linda, CA, Jared Wachterman, Peter Callas, Burlington, VT, Jaime Landman, Irvine, CA, Mark Plante, Burlington, VT, Zhamshid Okhunov, Irivine, CA, Kevan Sternberg, Burlington, VT MP75-03 IMPACT OF THE PATIENT POSITION IN THE OUTCOMES OF PERCUTANEOUS NEPHROLITHOTOMY FOR COMPLEX STONES Fabio C. Vicentini*, Carlos H. Watanabe, Marcelo Hisano, Rodrigo Perrela, Claudio C. Murta, Joaquim F. A. Claro, Sao Paulo, Brazil MP75-05 DO WE REALLY NEED TO WEAR PROPER EYE PROTECTION WHEN USING HOLMIUM:YAG LASER DURING ENDOUROLOGICAL PROCEDURES? RESULTS FROM LAB TEST ON PIG EYES Luca Villa*, Jonathan Cloutier, Eva Compérat, Frederic Charlotte, Olivier Traxer, Paris, France MP75-06 ACUTE URINARY STONE INCIDENCE AS A FUNCTION OF TEMPERATURE AND LAG LENGTH IN A SUBTROPICAL CLIMATE Jessica Goetz*, San Antonio, TX, Sonja Grill, Munich, Germany, Donna Ankerst, Timothy Tseng, San Antonio, TX 244

257 MP75-07 OVER OR UNDER 24-HOUR URINE COLLECTION: CAN ADJUSTMENTS BE MADE TO AVOID REPEAT COLLECTION? Tom Sanford*, Krishna Ramaswamy, Tom Chi, Marshall Stoller, San Francisco, CA MP75-08 GEOGRAPHIC LOCATION IS IMPORTANT FOR INITIAL EVALUATION OF UROLITHIASIS Ethan B Fram*, Bronx, NY, Matthew D Sorensen, Vincent G Bird, Gainesville, FL, Joshua M Stern, Bronx, NY MP75-09 HOW MUCH INFORMATION IS LOST WHEN ONLY ONE 24-HOUR URINE IS COLLECTED AS PART OF THE INITIAL METABOLIC EVALUATION? Abdulrahman Alruwaily*, Casey Dauw, Maggie Bierlein, Ann Arbor, MI, John Asplin, Chicago, IL, Ghani Khurshid, J Stuart Wolf Jr, John Hollingsworth, Ann Arbor, MI MP75-10 PATIENT EDUCATION AND THE IMPACT ON URETEROSCOPY EXPERIENCE Nathan Grunewald*, Carley Davis, Jonathan Amos, Milwaukee, WI MP75-11 SHARED DECISION MAKING FOR SURGICAL STONE DISEASE Abdullahi Abdulwahab-Ahmed, Robert Brown, Mohamed Omar*, Sarah Tarplin, Manoj Monga, Cleveland, OH MP75-12 A SINGLE DOSE OF INTRAOPERATIVE ANTIBIOTICS IS SUFFICIENT TO PREVENT URINARY TRACT INFECTION DURING URETEROSCOPY Ben H. Chew, Ryan Flannigan, Vancouver, Canada, Michael P. Kurtz, Boris Gershman, Boston, MA, Olga Arsovsksa, Ryan F. Paterson, Vancouver, Canada, Brian Eisner, Boston, MA, Dirk Lange*, Vancouver, Canada MP75-13 STONE CULTURE FOR PATIENTS UNDERGOING FLEXIBLE URETEROSCOPY (FURS) AND LASER STONE FRAGMENTATION FOR RENAL STONE DOES IT ADD ANYTHING TO MANAGEMENT? Rehan Khan*, Sarah Hunt, Holly Bekarma, Alison Ramsay, Sarath Krishna Nalagatla, Airdrie, United Kingdom MP DAY COMPLICATIONS RATES AFTER URETEROSCOPY AND LASER LITHOTRIPSY: WHAT ARE THE PREDICTORS? Oluwaseun Akinola*, Erin Corsini, Charles Welliver Jr, Mark White, Albany, NY MP75-15 THE CONSEQUENCES OF DELAYING STONE TREATMENT Justin Friedlander, Nicholas Kavoussi*, Shuvro De, Asim Ozayar, Nabeel Shakir, Jodi Antonelli, Margaret Pearle, Dallas, TX MP75-16 CAN WE REDUCE UNPLANNED READMISSIONS AND EMERGENCY DEPARTMENT VISITS FOLLOWING URETEROSCOPY/LASER LITHOTRIPSY? A MULTIVARIATE ANALYSIS OF A LARGE, SINGLE INSTITUTION S EXPERIENCE Rachel Moses*, Faddy Ghali, Margaret Menkov, Vernon Pais, Jr., Elias Hyams, Lebanon, NH MP75-17 IN VIVO RADIATION EXPOSURE DUE TO URINARY CALCULI IMAGING: SINGLE ENERGY CT VS. LOW DOSE CT VS. DUAL SOURCE DUAL ENERGY CT (DECT) Maria Jepperson, Joseph Cernigliaro, Ibrahim El-Sayed, William Haley, David Thiel, Abby Taylor*, Jacksonville, FL MP75-18 TIPS AND TRICKS TO DIFFERENTIATE DISTAL URETERAL STONES FROM PHLEBOLITHS ON COMPUTERIZED TOMOGRAPHY Yiloren Tanidir*, Ahmet Sahan, Mehmet Kazim Asutay, Ferhad Talibzade, Ilker Tinay, Ferruh Simsek, Istanbul, Turkey MP75-19 A NEW SCORING SYSTEM FOR PREDICTING UNCOMPLICATED URETERAL STONES WITHOUT RADIOLOGICAL IMAGES IN THE EMERGENCY ROOM: A RETROSPECTIVE SINGLE-CENTER STUDY Hiroki Fukuhara*, Hiroshi Kakizaki, Sakata, Japan, Osamu Ichiyanagi, Yamagata, Japan, Hisashi Kaneko, Takuya Yamanobe, Shouko Nakayama, Sakata, Japan, Yoshihiko Tomita, Yamagata, Japan MP75-20 ALGORITHM CORRECTING FOR STONE SIZE DECREASES MISCHARACTERIZATION OF CALCIUM OXALATE STONES Yaniv Larish*, Leonard Glickman, New York, NY MONDAY *Presenting author 245

258 Monday, May 18, 2015 Podium Session 46 PROSTATE CANCER: DETECTION AND SCREENING V Room New Orleans Morial Convention Center Moderators: Alan Nieder and Alan Partin 3:30 pm - 5:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 3:30 PD46-01 TUMOR VOLUME LESS THAN 2.5 ML IS A SIGNIFICANT CUT OFF VALUE OF PROGNOSIS IN HIGH RISK PROSTATE CANCER PATIENTS Shinichi Sakamoto*, Ayumi Muroi, Nobusghige Takeshita, Ken Wakai, Shuhei Kamda, Takeshi Namekawa, Miki Fuse, Koji Kawamura, Takashi Imamoto, Naoki Nihei, Tomohiko Ichikawa, Chiba, Japan 4:30 PD46-07 URINARY DNA METHYLATION BIOMARKERS: A NON-INVASIVE METHOD FOR PROSTATE CANCER MONITORING Fang Zhao*, Danny Vesprini, Ekaterina Olkhov-Mitsel, Darko Zdravic, Alexandre Zlotta, Vasundara Venkateswaran, Andrew Loblaw, Theodorus Van Der Kwast, Neil Fleshner, Laurence Klotz, Bharati Bapat, Toronto, Canada 3:40 PD46-02 MULTICENTER EVALUATION OF THE PROSTATE HEALTH INDEX (PHI) FOR DETECTION OF AGGRESSIVE PROSTATE CANCER IN BIOPSY-NAÏVE MEN Claire de la Calle*, Dattatraya Patil, Atlanta, GA, John Wei, Ann Arbor, MI, Douglas Scherr, New York, NY, Lori Sokoll, Daniel Chan, Baltimore, MD, Javed Siddiqui, Ann Arbor, MI, Juan Miguel Mosquera, Mark Rubin, New York, NY, Martin Sanda, Atlanta, GA 3:50 PD46-03 PROSTATE CANCER DETECTION AFTER THREE NEGATIVE SCREENS WITH A 4- YEAR INTERVAL. ERSPC ROTTERDAM Monique Roobol*, Daan Nieboer, ERSPC study group Rotterdam, Rotterdam, Netherlands 4:00 PD46-04 TREATMENT AND SURVIVAL IN MEN UNDER AGE 55 YEARS DIAGNOSED WITH GLEASON 8-10 PROSTATE CANCER: IMPLICATIONS OF PSA SCREENING Brian Winters, Sarah Holt, Daniel Lin, Michael Porter, Heather Cheng, Jonathan Wright*, Seattle, WA 4:10 PD46-05 MULTI-CENTER PROSPECTIVE STUDY OF URINE RNA TESTING AS A STRATEGY FOR PROSTATE CANCER SCREENING: COLLABORATION BETWEEN UROLOGY, PRIMARY CARE, AND COMMUNITY OUTREACH Dattatraya Patil*, Claire de la Calle, Atlanta, GA, Brandi Weaver, Robin Leach, Ian Thompson, San Antonio, TX, Lori Sokoll, Daniel Chan, Baltimore, MD, Jack Groskopf, Santa Clara, CA, J. Jacques Carter, Boston, MA, Mersiha Torlak, Martin Sanda, Atlanta, GA 4:20 PD46-06 PSA BASED SCREENING FOR PROSTATE CANCER: STARTING TOO LATE AND NON-COMPLIANCE, LIMITING THE NUMBER OF SCREENING VISITS, NEGATIVELY AFFECT PC MORTALITY REDUCTION Monique Roobol*, ERSPC study group Rotterdam, Rotterdam, Netherlands 4:40 PD46-08 PROSPECTIVE STUDY OF PRE-BIOPSY MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING (MPMRI) COMPARED TO TRANSPERINEAL TEMPLATE MAPPING BIOPSY (TTMB) FOR DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: IS IT ACCURATE ENOUGH TO GUIDE SELECTION OF MEN FOR BIOPSY James Thompson*, Ron Shnier, Daniel Moses, Phillip Brenner, Warick Delprado, Minh Tran, Lee Ponsky, Maret Boehm, Andrew Hayen, Phillip Stricker, Sydney, Australia 4:50 PD46-09 RISK STRATIFICATION OF AGGRESSIVE PROSTATE CANCER BASED ON COMBINED EPIGENETIC AND CLINICAL DATA OF MEN WITH INITIAL CANCER- NEGATIVE BIOPSIES Alan W Partin*, Baltimore, MD, Leander Van Neste, Maastricht, Netherlands, Grant D Stewart, Edinburgh, United Kingdom, Joseph Bigley, Irvine, CA, David J Harrison, St Andrews, United Kingdom, Wim Van Criekinge, Ghent, Belgium, Jonathan I Epstein, Baltimore, MD 5:00 PD46-10 STANDARDIZED MAGNETIC RESONANCE IMAGING READING FOR PREDICTION OF EXTRAPROSTATIC EXTENSION AND PROSTATECTOMY OUTCOME IN PATIENTS WITH LOW-, INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER Jan Philipp Radtke*, Maya Müller-Wolf, Martin Freitag, Constantin Schwab, Gencay Hatiboglu, Wilfried Roth, Matthias Roethke, Heinz-Peter Schlemmer, Markus Hohenfellner, Boris Hadaschik, Dogu Teber, Heidelberg, Germany 5:10 PD46-11 LOW DOSE SPINAL SADDLE BLOCK ANESTHESIA IS ASSOCIATED WITH INCREASED PATIENT TOLERANCE OF AND WILLINGNESS TO HAVE A REPEAT PROSTATE BIOPSY Anselm Obi*, Paul Nnodi, Abakaliki, Nigeria 246

259 5:20 PD46-12 PROSTATE CANCER UPGRADING AT PROSTATECTOMY: A POPULATION- BASED ANALYSIS OF > 25,000 MEN Brian Winters, George Schade, Sarah Holt, Daniel Lin, William Ellis, Bruce Dalkin, Jonathan Wright*, Seattle, WA Monday, May 18, 2015 Podium Session 47 PROSTATE CANCER: LOCALIZED VII Room New Orleans Morial Convention Center Moderators: J. Brantley Thrasher and Byung Ha Chung 3:30 pm - 5:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 3:30 PD47-01 CHARACTERISTICS OF ANTERIOR PREDOMINANT PROSTATE CANCER AND THE USEFULNESS OF MULTIPARAMETRIC MRI IN DIAGNOSIS Seung-Kwon Choi*, Myungsun Shim, Myungchan Park, Aram Kim, Muyoung Sohn, Donghyun Lee, Sahyun Park, Seoul, Korea, Republic of, Sejun Park, Ulsan, Korea, Republic of, Sang Hoon Song, Cheryn Song, Jun Hyuk Hong, Choung-Soo Kim, Hanjong Ahn, Seoul, Korea, Republic of 3:40 PD47-02 IMPROVED PRE-RADICAL PROSTATECTOMY RISK STRATIFICATION USING PSA DENSITY Christopher Welty*, Michael Leapman, Jonathan Brajtbord, Janet Cowan, Matthew Cooperberg, Peter Carroll, San Francisco, CA 3:50 PD47-03 EXPRESSION OF CYTOPLASMIC ER 1 AND NUCLEAR ER 2 IS ASSOCIATED WITH POOR OUTCOMES FOLLOWING RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER George R. Schade*, Sarah K. Holt, Xiaotun Zhang, Jonathan L. Wright, Shan Shan Zhao, Suzanne Kolb, Hung-Ming Lam, Seattle, WA, Linda Levin, Yuet-Kin Leung, Shuk-Mei Ho, Cincinnati, OH, Janet Stanford, Seattle, WA 4:00 PD47-04 PATHOLOGICAL FEATURES OF THE INDEX AND NON-INDEX LESIONS IN RADICAL PROSTATECTOMY SPECIMENS: IMPLICATIONS FOR FOCAL THERAPY Kent Kanao*, Nagakute, Japan, Keishi Kajikawa, Nagoya, Japan, Ikuo Kobayashi, Shingo Morinaga, Hiroyuki Muramatsu, Genya Nishikawa, Takahiko Yoshizawa, Yoshiharu Kato, Masahito Watanabe, Kenji Zennami, Kogenta Nakamura, Makoto Sumitomo, Nagakute, Japan 4:10 PD47-05 PROSPECTIVE COMPARISON OF ONCOLOGICAL OUTCOMES BETWEEN FOCAL CRYOTHERAPY VERSUS FOCAL HIGH-INTENSITY FOCUSED ULTRASOUND IN LOCALIZED PROSTATE CANCER Youness Ahallal*, Eric Barret, Rafael Sanchez-Salas, Marc Galiano, Francois Rozet, Xavier Cathelineau, Paris, France 4:20 PD47-06 INTERMEDIATE PROSTATE CANCER TREATED BY FOCUSED ULTRASOUND ABLATION: PROSPECTIVE MULTICENTRIC LONG-TERM RESULTS IN 1300 PATIENTS sebastien Crouzet*, Lyon, France, Andreas Blana, Fuerth, Germany, Stephen Thuroff, Munich, Germany, Roman Ganzer, Roman Ganzer, Christian Chaussy, Regensburg, Germany, Albert Gelet, Lyon, France 4:30 PD47-07 SEVERE URINARY ADVERSE EVENTS AFTER HIGH VS. LOW DOSE RATE PROSTATE BRACHYTHERAPY: A POPULATION-BASED ANALYSIS Daniel Liberman*, Stephanie Jarosek, Beth Virnig, Sean Elliott, Minneapolis, MN 4:40 PD47-08 IRREVERSIBLE ELECTROPORATION (IRE) AS A LOCALIZED TREATMENT FOR PROSTATE CANCER: A REPORT ON SAFETY AND OUTCOMES Katie Murray*, John Musser, New York, NY, Joseph Mashni, Gilbert, AZ, Govindarajan Srimathveeravalli, Jeremy Durack, Stephen Solomon, Jonathan Coleman, New York, NY 4:50 PD47-09 WHOLE SURFACE FROZEN SECTION OF THE PROSTATE AS ONCOLOGIC PARAMETER TO INTRAOPERATIVELY TAILOR TREATMENT AND MINIMIZE POSITIVE MARGIN RATE Christian von Bodman*, Max Schulmeyer, Marko Brock, Björn Löppenberg, Florian Roghmann, Katharina Braun, Herne, Germany, Florian Sommerer, Bochum, Germany, Joachim Noldus, Rein Jüri Palisaar, Herne, Germany 5:00 PD47-10 IMPACT OF METABOLIC SYNDROME ON STAGE, GRADE AND OVERALL FAILURE IN MEN UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER Bimal Bhindi*, Wen Xie, Girish Kulkarni, Robert Hamilton, Shabbir Alibhai, Robin Kalnin, Michael Nesbitt, Antonio Finelli, Alexandre Zlotta, John Trachtenberg, Neil Fleshner, Toronto, Canada MONDAY *Presenting author 247

260 5:10 PD47-11 PREDICTORS OF QUALITY OF LIFE IN MEN WITH LOCALIZED PROSTATE CANCER: THE ROLE OF TREATMENT DECISION MAKING SATISFACTION, NEUROTICISM, AND SEXUAL FUNCTIONING David Victorson*, Evanston, IL, Nathaniel Sufrin, Brian T. Helfand, Kristian R. Novakovic, Glenview, IL, Joseph J. Pariser, Chicago, IL, Michael McGuire, Charles Brendler, Glenview, IL 5:20 PD47-12 LONG TERM IMPACT OF A PROSTATE CANCER COMMUNITY OF PRACTICE AND REGIONAL DIAGNOSTIC CENTER Christopher Morash*, Luke T. Lavallée, Octav Cristea, Robin Morash, Jennifer Smylie, Dean A. Fergusson, Ilias Cagiannos, Michael Fung-Kee- Fung, Rodney H. Breau, Ottawa, Canada Monday, May 18, 2015 Podium Session 48 SEXUAL FUNCTION/DYSFUNCTION/ANDROLOGY: PEYRONIE S DISEASE Room New Orleans Morial Convention Center Moderator: Anthony Bella 3:30 pm - 5:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 3:30 PD48-01 PEYRONIE S DISEASE FOLLOWING RADICAL PROSTATECTOMY: INCIDENCE IN A POPULATION WITH FORMAL PRE OPERATIVE ASSESSMENT John Sullivan*, Dublin, Ireland, Raanan Tal, Matthias Heck, Melanie Bernstein, Christian Nelson, John Mulhall, New York, NY 3:40 PD48-02 SUBCORONAL APPROACH TO INFLATABLE PENILE PROSTHESIS IMPLANTATION Aaron Weinberg*, New York, NY, Christopher Deibert, Milwaukee, WI, Matthew Pagano, New York, NY, Paulo Egydio, São Paulo, Brazil, Robert Valenzuela, New York, NY 3:50 PD48-03 LONG-TERM RESULTS AFTER PARTIAL PLAQUE EXCISION AND GRAFTING WITH COLLAGEN FLEECE IN PEYRONIE S DISEASE Georgios Hatzichristodoulou*, Scarlet Fiechtner, Jürgen Gschwend, Munich, Germany, Sven Lahme, Pforzheim, Germany 4:00 PD48-04 EFFECTS OF COLLAGENASE TREATMENT ON BIOMECHANICAL PROPERTIES OF PEYRONIE S PLAQUES Thomas Schmid*, Vincent Wang, Elizabeth Shewman, Chicago, IL, Michael McLane, James Tursi, Malvern, PA, Laurence Levine, Chicago, IL 4:10 PD48-05 TRENDS IN THE TREATMENT OF PEYRONIE S DISEASE: AN ANALYSIS OF CASE LOGS FROM AMERICAN UROLOGISTS Daniel T. Oberlin*, Joceline S. Liu, Richard S. Matulewicz, Matthias D. Hofer, Jaclyn Milrose, Sarah C. Flury, Chicago, IL, Allen F. Morey, Dallas, TX, Christopher M. Gonzalez, Chicago, IL 4:20 PD48-06 OUTCOMES ASSOCIATED WITH COLLAGENASE CLOSTRIDIUM HISTOLYTICUM TREATMENT FOR PEYRONIE S DISEASE BY DURATION OF DISEASE Laurence A. Levine*, Chicago, IL, Martin K. Gelbard, Burbank, CA, James P. Tursi, Ted M. Smith, Gregory J. Kaufman, Kimberly Gilbert, Chesterbrook, PA, Jed Kaminetsky, John P. Mulhall, New York, NY 4:30 PD48-07 CHANGES IN THE EFFECTS OF PEYRONIE S DISEASE AFTER TREATMENT WITH COLLAGENASE CLOSTRIDIUM HISTOLYTICUM ACCORDING TO MEN WITH PEYRONIE S DISEASE AND THEIR FEMALE SEXUAL PARTNERS Irwin Goldstein*, San Diego, CA, Dean Knoll, Nashville, TN, Larry I. Lipshultz, Houston, TX, James P. Tursi, Ted M. Smith, Gregory J. Kaufman, Kimberly Gilbert, Chesterbrook, PA, Raymond C. Rosen, Watertown, MA, Chris G. McMahon, St. Leonards, New South Wales, Australia 4:40 PD48-08 THE NESBIT PROCEDURE FOR PEYRONIE S DISEASE : >SEVEN YEAR FOLLOW UP Tet Yap*, Raheem Amr, Spilotros Marco, De Luca Francesco, Saad Abumelha, Marc Lucky, Giulio Garaffa, Nim Christopher, Suks Minhas, Ralph David, London, United Kingdom 4:50 PD48-09 VERSATILE ALGORITHMIC APPROACH FOR DEFINITIVE STRAIGHTENING WITHOUT MODELING DURING PENILE PROSTHESIS SURGERY Timothy Tausch*, Paul Chung, Jordan Siegel, Alexandra Klein, Allen Morey, Dallas, TX 5:00 PD48-10 MUST: MULTIPLE SLICE TECHNIQUE FOR PENILE LENGTHENING AND WIDENING WITHOUT GRAFTING DURING PENILE PROSTHESIS INSERTION Paulo Egydio*, Franklin Kuehhas, Sao Paulo, Brazil, Robert Valenzuela, New York, NY 248

261 5:10 PD48-11 PENILE CURVATURE SECONDARY TO PEYRONIE S DISEASE WITH PENILE PROSTHESIS AND RELAXING INCISIONS WITHOUT LOSS OF LENGTH Aaron Weinberg*, New York, NY, Christopher Deibert, Milwaukee, WI, Matthew Pagano, New York, NY, Paulo Egydio, São Paulo, Brazil, Robert Valenzuela, New York, NY 5:20 PD48-12 RELATIONSHIP OF FACTORS ASSOCIATED WITH PEYRONIE S DISEASE (PD) THAT AFFECT PD BOTHER AND ERECTILE DYSFUNCTION Ege Serefoglu*, Mehmet Berktas, Istanbul, Turkey, Faysal Yafi, New Orleans, LA, Ted Smith, Gregory Kaufman, Genzhou Liu, Chesterbrook, PA, Wayne Hellstrom, New Orleans, LA Monday, May 18, 2015 Podium Session 49 KIDNEY CANCER: SURGICAL THERAPY VI Room New Orleans Morial Convention Center Moderator: Amr Fergany TIME NUMBER TITLE TIME NUMBER TITLE 3:30 PD49-01 IDENTIFYING PATIENTS AT HIGH RISK OF PERI-OPERATIVE DEATH FROM SIMULTANEOUS UROLOGICAL AND CARDIAC SURGERY FOR TUMOURS INVOLVING THE INFERIOR VENA CAVA (IVC) Archie Fernando*, Sheena Patel, Kay Thomas, Conal Austin, Tim O Brien, London, United Kingdom 3:40 PD49-02 ROBOTIC PARTIAL NEPHRECTOMY VERSUS LAPAROSCOPIC PARTIAL NEPHRECTOMY: COMPARISON OF THE LEARNING CURVES benoit peyronnet*, damien chaste, zineddine khene, romain mathieu, gregory verhoest, karim bensalah, Rennes, France 3:50 PD49-03 MORTALITY, MORBIDITY AND HEALTHCARE EXPENDITURES AFTER LOCAL TUMOR ABLATION OR PARTIAL NEPHRECTOMY FOR T1A KIDNEY CANCER Alessandro Larcher*, Maxine Sun, Malek Meskawi, Katharina Boehm, Roger Valdivieso, Jonas Schiffmann, Zhe Tian, Vincent Trudeau, Montreal, Canada, Nicola Fossati, New York, NY, Nicolò Buffi, Francesco Montorsi, Giorgio Guazzoni, Milan, Italy, Pierre Karakiewicz, Montreal, Canada 3:30 pm - 5:30 pm 4:10 PD49-05 COMPARISON OF RENAL FUNCTION DETRIMENTS AFTER LOCAL TUMOR ABLATION OR PARTIAL NEPHRECTOMY FOR RENAL CELL CARCINOMA Alessandro Larcher*, Malek Meskawi, Katharina Boehm, Roger Valdivieso, Vincent Trudeau, Zhe Tian, Montreal, Canada, Nicola Fossati, New York, NY, Giovanni Lughezzani, Nicolò Buffi, Giorgio Guazzoni, Francesco Montorsi, Milan, Italy, Maxine Sun, Pierre Karakiewicz, Montreal, Canada 4:20 PD49-06 DELAYED INTERVENTION OF SMALL RENAL MASSES ON ACTIVE SURVEILLANCE Mohit Gupta*, Paul Crispen, Gainesville, FL 4:30 PD49-07 IMPACT OF AORTIC CALCIFICATION BURDEN ON RENAL FUNCTION RECOVERY IN RCC PATIENTS AFTER RADICAL NEPHRECTOMY Ken Fukushi*, Shingo Hatakeyama, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Hirosaki, Japan MONDAY 4:00 PD49-04 PERIOPERATIVE ASPIRIN USE ASSOCIATED WITH INCREASED RISK FOR BLEEDING COMPLICATION FOLLOWING PARTIAL NEPHRECTOMY Timothy Ito*, Robert Uzzo, Philip Abbosh, Nikhil Waingankar, Mohammed Haseebuddin, David Chen, Marc Smaldone, Richard Greenberg, Daniel Canter, Rosalia Viterbo, Alexander Kutikov, Serge Ginzburg, Philadelphia, PA *Presenting author 249

262 4:40 PD49-08 TRENDS IN THE USE OF PARTIAL NEPHRECTOMY FOR CT1 RENAL TUMORS: ANALYSIS OF A 10-YR EUROPEAN MULTICENTER DATASET Giuseppe Simone*, turin, Italy, Cosimo De Nunzio, Isabella Sperduti, Rome, Italy, Luca Cindolo, Vasto, Italy, Devis Collura, Turin, Italy, Sabine Brookman-May, Munich, Germany, Rocco Papalia, Mariaconsiglia Ferriero, Costantino Leonardo, Rome, Italy, Orietta Dalpiaz, Graz, Austria, Michele Lodde, Emanuela Trenti, Bolzano, Italy, Stefan Hatzl, Graz, Austria, Antonio Pastore, Giovanni Palleschi, Latina, Italy, Giuseppe Lotrecchiano, Luigi Salzano, Benevento, Italy, Antonio Carbone, Latina, Italy, Ottavio De Cobelli, Milan, Italy, Andrea Tubaro, Rome, Italy, Luigi Schips, Vasto, Italy, Richard Zigeuner, Graz, Austria, Giovanni Muto, turin, Italy, Michele Gallucci, Rome, Italy 4:50 PD49-09 MATCHED ANALYSIS OF CANCER- SPECIFIC SURVIVALS BETWEEN PAPILLARY TYPE-2 VERSUS CLEAR-CELL RENAL CELL CARCINOMA Giuseppe Simone*, Rocco Papalia, Mariaconsiglia Ferriero, Manuela Costantini, Riccardo Mastroianni, Salvatore Guaglianone, Michele Gallucci, Rome, Italy 5:10 PD49-11 SURGICAL CHRONIC KIDNEY DISEASE APPEARS TO BE A DISTINCT SUBTYPE OF CHRONIC KIDNEY DISEASE BASED ON MORTALITY RISKS FOLLOWING RENAL SURGERY Ronak Gor*, Robert Uzzo, Tianyu Li, Mohammed Haseebuddin, Nikhil Waingankar, Serge Ginzburg, Marc Smaldone, Alexander Kutikov, Philadelphia, PA 5:20 PD49-12 CLINICOPATHOLOGIC CHARACTERISTICS AND SURVIVAL FOR ADULT RENAL SARCOMA: A POPULATION-BASED STUDY Daniel Moreira*, Boris Gershman, R. Houston Thompson, Scott Okuno, Steven Robinson, Bradley Leibovich, Stephen Boorjian, Rochester, MN 5:00 PD49-10 TECHNIQUE, TUMOR SIZE OR INHERENT PATIENT COMORBIDITIES: WHAT DRIVES LONG-TERM RENAL FUNCTIONAL OUTCOMES IN PATIENTS UNDERGOING PARTIAL NEPHRECTOMY? Louis Krane*, James T Rague, Ahmed Aboumohamed, Ashok K Hemal, Winston Salem, NC Monday, May 18, 2015 Video Session 12 3:30 pm - 5:30 pm RECONSTRUCTION The videos in this session as well as the video libraries from the Annual Meetings may be viewed in the Surgical Video Library and purchased in the Products Store during the Annual Meeting. Both are located in Registration Hall B2. All years of the Surgical Video Library may also be purchased online at Room New Orleans Morial Convention Center Moderators: Richard Lee and Hadley Wood NUMBER TITLE NUMBER TITLE V12-01 LAPAROSCOPIC OMENTOPLASTY TO SUPPORT ANASTOMOTIC URETHROPLASTY IN COMPLEX AND REDO PELVIC FRACTURE URETHRAL DEFECT PATIENTS Sanjay B. Kulkarni*, Walid Shahrour, Pankaj Joshi, Craig Hunter, Sandesh Surana, pune, India, Guido Barbagli, Arezzo, Italy V12-02 PEDICLE PREPUTIAL TUBE FOR PELVIC FRACTURE URETHRAL DEFECT AND ISCHEMIC BULBAR URETHRA Craig Hunter*, Walid Shahrour, Pankaj Joshi, Sandesh Surana, Sanjay Kulkarni, Pune, India V12-03 IN-SITU ROBOTIC ILEAL NEOBLADDER: TIPS TO AVOID COMPLICATIONS Jayram Krishnan*, Las Vegas, NV, Daniel Ramirez, Jihad Kaouk, Cleveland, OH V12-04 ONE-STAGE RECONSTRUCTION OF OBLITERATIVE DISTAL ANTERIOR URETHRAL STRICTURES WITH CIRCULAR BUCCAL MUCOSA GRAFT Fikret Fatih Onol*, Sinasi Yavuz Onol, Ahmet Bindayi, Ahmet Tahra, Ugur Boylu, Eyüp Veli Küçük, Istanbul, Turkey 250

263 V12-05 THE PATIO-REPAIR FOR URETHROCUTANEOUS FISTULA: PRESERVE THE TRACT AND TURN IT INSIDE OUT Jennifer Kranz*, Petra Anheuser, Joachim Steffens, Eschweiler, Germany, Peter Malone, Reading, United Kingdom V12-06 RETROPERITONEAL LAPAROSCOPIC REIMPLANTATION OF THE LEFT RENAL VEIN FOR NUTCRACKER SYNDROME Ming Chen*, Tao Tao, Bin Xu, Lei Zhang, Shu-qiu Chen, Xiao-wen Zhang, Yu Yang, Nanjing, China, People s Republic of V12-07 TOTALLY INTRACORPOREAL ROBOT- ASSISTED VESCICA ILEALE PADOVANA (VIP) USING STAPLERS: A STEPWISE APPROACH Rocco Papalia*, Giuseppe Simone, Mariaconsiglia Ferriero, Riccardo Mastroianni, Salvatore Guaglianone, Gallucci Michele, Rome, Italy V12-08 EXTRAPERITONEAL ROBOT-ASSISTED REPAIR OF A PELVIC FRACTURE ASSOCIATED URETHRAL INJURY Vineet Agrawal, Helen R Levey*, Robert Davis, Jean Joseph, Rochester, NY V12-09 COMPLEX ROBOTIC URETEROPLASTY USING BUCCAL MUCOSAL ONLAY GRAFT FOR TREATMENT OF 3CM PROXIMAL URETERAL STRICTURE Carrie Stewart*, Michael Maddox, Michael Ellis, Benjamin Lee, New Orleans, LA V12-10 HAND-ASSISTED LAPAROSCOPIC RIGHT COLON MOBILIZATION FOR CONTINENT CUTANEOUS ILEAL CECOCYSTOPLASTY Travis Pagliara*, Daniel Liberman, Sean Elliott, Minneapolis, MN V12-11 ROBOTIC ILEAL URETER: STEP BY STEP Sameer Chopra*, Charles Metcalfe, Andre Luis de Castro de Abreu, Raj Satkunasivam, Raed A. Azhar, Inderbir Gill, Monish Aron, Mihir Desai, Andre K. Berger, Los Angeles, CA V12-12 TWO-STAGE URETHROPLASTY WITH PREFABRICATED GRACILIS-BUCCAL MUCOSA COMPOSITE FLAP Stephen Blakely, Henry Okafor*, Dmitriy Nikolavsky, Syracuse, NY V12-13 URETHROLYSIS FOR SYNTHETIC PERI- URETHRAL BULKING AGENT COLLECTION Tony Nimeh*, William Kobak, Whitney Halgrimson, Ervin Kocjancic, Chicago, IL V12-14 SYNCHRONOUS PANNICULECTOMY AND ILEAL CONDUIT REVISION FOR OBESE PATIENTS WITH STOMAL STENOSIS Michael Garcia-Roig*, David Pan, Devendar Katkoori, Murugesan Manoharan, Miami, FL MONDAY Monday, May 18, 2015 SWIU WOMEN LEADERS IN UROLOGY FORUM Grand Salon Hilton New Orleans Riverside 5:00 pm - 6:00 pm 5:00 CONTROVERSIES IN SUI EVALUATION AND TREATMENT Moderator: Leslie Rickey Panelists: Melissa Kaufman, Una Lee, Donna Deng Monday, May 18, 2015 AQUA REGISTRY FORUM Jefferson Hilton New Orleans Riverside 5:30 pm - 7:00 pm 5:30 OPENING REMARKS J. Quentin Clemens 5:35 AQUA VIDEO SHOW 5:40 HOW REGISTRY CAN BENEFIT SURGICAL SPECIALTY, SPECIALTY SOCIETY AND HEALTHCARE SYSTEM David Hoyt 6:00 EXPERIENCE WITH IMPLEMENTING A REGISTRY FROM A PHYSICIAN PERSPECTIVE William Rich 6:20 PANEL DISCUSSION Moderator: J. Quentin Clemens Panelists: Mathew Cooperberg, David Hoyt, William Rich, Tim Parr (software), Diane Bieri (General Counsel), Alec Koo (Site Representative-Skyline Urology) 6:35 AUDIENCE QUESTIONS 6:45 CLOSING REMARKS J. Stuart Wolf 7:00 ADJOURN *Presenting author 251

264 NOTES

265 MP Moderated Poster Session, PD Podium Session Tuesday, May 19, 2015 Plenary Session PLENARY I - TUESDAY Great New Orleans Morial Convention Center 7:30 am - 4:00 pm 7:28 WELCOME AND ANNOUNCEMENTS 7:30 STATE-OF-THE-ART LECTURE: CONTEMPORARY UPDATE ON TREATMENT OF NON INVASIVE BLADDER CANCER Sam Chang 7:45 STATE-OF-THE-ART LECTURE: BACILLUS CALMETTE-GUERIN (BCG) REFRACTORY CARCINOMA IN SITU (CIS) OF THE BLADDER Michael Cookson 8:00 SOCIÉTÉ INTERNATIONALE D UROLOGIE (SIU) LECTURE: REDEFINING OPTIMAL SURGICAL MANAGEMENT OF MUSCLE INVASIVE BLADDER CANCER Peter Black 8:20 POINT-COUNTERPOINT: NEOADJUVANT CHEMOTHERAPY FOR MIBC IS BEST Moderator: Colin Dinney Debaters: Badrinath Konety (Con) Ralph devere White (Pro) 8:40 STATE-OF-THE-ART LECTURE: RAPAMYCIN IMPROVES T CELL IMMUNITY IN CANCER Robert Svatek 8:55 STATE-OF-THE-ART LECTURE: MANAGEMENT OF RADIATION INDUCED URETERAL STRICTURES Hadley Wyre 9:10 PANEL DISCUSSION: CHEMOTHERAPY VS. RPLND FOR STAGE II NSGCT DISEASE Moderator: Joel Sheinfeld Panelists: Richard Foster Andrew Stephenson Timothy Masterson TUESDAY 9:35 STATE-OF-THE ART LECTURE: VASECTOMY AND PROSTATE CANCER - RECENT DEVELOPMENT: A CRITICAL ANALYSIS Thomas Walsh 9:50 BEST : PI-06: TCF21, A NOVEL METASTASIS SUPPRESSOR, PROMOTES THE ACQUISITION OF A LUMINAL PHENOTYPE IN HUMAN BLADDER CANCER Isuru Jayaratna*, Houston, TX, Sima Porten, San Francisco, CA, Beat Roth, Bern, Switzerland, Tiewei Cheng, Jonathan Melquist, Woonyoung Choi, Shanna Pretzsch, Jolanta Bondaruk, Charles Guo, Bogdan Czerniak, David McConkey, Colin Dinney, Houston, TX 9:57 BEST : PI-07: A TRANSPLANT-BASED SURGICAL APPROACH MAY IMPROVE POSTOPERATIVE COMPLICATIONS IN CASES OF RENAL CELL CARCINOMA AND TUMOR THROMBUS Estefania Linares Espinós*, Javier González, Juan I. Martínez-Salamanca, Madrid, Spain, Giacomo Novara, Padua, Italy, Roberto Bertini, Milan, Italy, Joaquín Carballido, Madrid, Spain, Thomas Chromecki, Graz, Germany, Gaetano Ciancio, Miami, FL, Siamak Daneshmand, Los Angeles, CA, Christopher Evans, Sacramento, CA, Paolo Gontero, Turin, Italy, Alex Haferkamp, Frankfurt, Germany, Markus Hohenfellner, Heidelberg, Germany, William C. Huang, New York, NY, Theresa Koppie, Portland, OR, Danny Lascano, New York, NY, Adam Lorentz, Atlanta, GA, Alon Y. Mass, New York, NY, Viraj Master, Atlanta, GA, James McKiernan, New York, NY, Carmen Mir, Miami, FL, Carrie Mlynarczyk, New York, NY, Francesco Montorsi, Milan, Italy, Hao Nguyen, Sacramento, CA, Sascha Pahernik, Heidelberg, Germany, Juan Palou, Barcelona, Spain, Raj Pruthi, Chapel Hill, NC, Oscar Rodríguez-Faba, Barcelona, Spain, Paul Russo, Douglas S. Scherr, New York, NY, Shahrokh Shariat, Vienna, Austria, Martin Spahn, Wuzburg, Germany, Carlo Terrone, Novara, Italy, Derya Tilki, Sacramento, CA, Daniel Vergho, Wuzburg, Germany, Eric Wallen, Chapel Hill, NC, Richard Zigeuner, Graz, Austria, John A. Libertino, Burlington, MA 10:04 BEST : PI-08: COMBINING URINE PCA3 AND TMPRSS2:ERG TESTS TO REFINE PROSTATE CANCER DETECTION - VALIDATION STUDY AND HEALTH ECONOMIC ANALYSIS Martin Sanda*, Atlanta, GA, Ziding Feng, Houston, TX, John Wei, Ann Arbor, MI, David Howard, Atlanta, GA, Mark Rubin, New York, NY, Jack Groskopf, San Diego, CA, Lori Sokoll, Daniel Chan, Baltimore, MD, Meredith Regan, Boston, MA, Dattatraya Patil, Atlanta, GA, Simpa Salami, Manhasset, NY, Javed Siddiqui, Ann Arbor, MI, Douglas Scherr, New York, NY, Jacob Kagan, Sudhir Srivastava, Bethesda, MD, Ian Thompson, San Antonio, TX, Aaron Joon, Houston, TX, Arul Chinnayian, Scott Tomlins, Ann Arbor, MI 10:11 BEST : PI-09: PRECLINICAL TESTING OF SMALL MOLECULE HIF2 INHIBITOR IN ZEBRAFISH AND MOUSE MODELS OF VHL-DEFICIENT RENAL CELL CARCINOMA Meike Schneider*, Ana Metelo, Haley Noonan, Xiang Li, Jing Youngnam, Nick Olson, Rania Baker, Charlestown, MA, Lee Kamentsky, Cambridge, MA, Yiyun Zhang, Charlestown, MA, Anne Carpenter, Cambridge, MA, Jing-Ruey Yeh, Randall Peterson, Othon Iliopoulos, Charlestown, MA *Presenting author 253

266 10:18 BEST : PI-10: DECLINING RATES OF RETROPERITONEAL LYMPH NODE DISSECTION FOR STAGE I NON-SEMINOMATOUS GERM CELL TUMORS: RESULTS FROM THE NATIONAL CANCER DATABASE Mohammed Haseebuddin*, Elizabeth Handorf, Alexander Kutikov, Nikhil Wainganker, Yu-Ning Wong, Elizabeth Plimack, Robert Uzzo, Marc Smaldone, Philadelphia, PA 10:30 PANEL DISCUSSION: A DECADE OF FOLLOW UP: WHAT LESSONS HAVE WE LEARNED? 10:30 MID URETHRAL SLING Carl Klutke 10:40 ARTIFICIAL URINARY SPHINCTER Timothy Boone 10:50 PERCUTANEOUS SURGERY FOR STONES Jorge Gutierrez-Aceves 11:00 CYSTECTOMY FOR INVASIVE BLADDER CANCER Oliver Hakenberg 11:10 CONTINENT DIVERSIONS Joachim Thüroff 11:20 SCREENING FOR PROSTATE CANCER Fritz Schroder 11:30 ROBOTIC PROSTATECTOMY Mani Menon 11:40 CHANGES IN PROSTATE GRADING Jonathan Epstein 11:50 PARTIAL NEPHRECTOMY Paul Russo 12:00 BREAK 1:00 HIGHLIGHTS OF THE AUA S NATIONAL CURRICULUM FOR MEDICAL STUDENT EDUCATION Paul Turek 1:08 TOP 3 AWARD WINNING VIDEOS TAKE HOME MESSAGES 1:30 PROSTATE CANCER Gyung Sung 1:40 BASIC SCIENCE RESEARCH Sunil Sudarshan 1:50 INFECTION/INFLAMMATION Majid Mirzazadeh 2:00 INFERTILITY/ANDROLOGY Ranjith Ramasamy 2:10 STONE DISEASE/ENDOUROLOGY Benjamin Canales 2:20 TRANSPLANTATION/VASCULAR SURGERY Dicken Ko 2:30 PENILE, TESTIS AND URETHRAL CANCER Makarand Khochikar 2:40 TRAUMA/RECONSTRUCTION/DIVERSION Robert Kovell 2:50 SEXUAL FUNCTION/DYSFUNCTION Landon Trost 3:00 FEMALE UROLOGY/INCONTINENCE/URODYNAMICS Gamal Ghoniem 3:10 BPH/LUTS Richard Lee 254

267 3:20 MINIMALLY INVASIVE SURGERY (LAPAROSCOPY/ROBOTICS) Benjamin Lee 3:30 OUTCOMES ANALYSIS Karim Chamie 3:40 KIDNEY CANCER Gennady Bratslavsky 3:50 BLADDER CANCER Amar Singh 4:00 SESSION CONCLUDES Tuesday, May 19, 2015 Plenary Session PLENARY II - TUESDAY Hall New Orleans Morial Convention Center 10:00 am - 12:05 pm 9:58 WELCOME AND ANNOUNCEMENTS 10:00 STATE-OF-THE-ART LECTURE: SHARED DECISION MAKING Danil Makarov 10:15 STATE-OF-THE-ART LECTURE: AUA CENSUS REPORT J. Quentin Clemens 10:30 CRITICAL DISCUSSION: A KIDNEY TRANSPLANT ROTATION IS A WASTE OF TIME FOR A UROLOGY RESIDENT Critical Discussant: Michael Coburn Presenters: Leonard Gomella Patrick Luke TUESDAY 10:50 STATE-OF-THE-ART LECTURE: UROLOGIC ASPECTS OF ADULT POLYCYSTIC KIDNEY DISEASE Paul Andrews 11:05 STATE-OF-THE-ART LECTURE: ULTRASOUND PROPULSION OF STONES Michael Bailey, Jonathan Harper 11:20 STATE-OF-THE-ART LECTURE: ROLE OF ROBOTIC SURGERY IN RENAL TRANSPLANTATION Rajesh Ahlawat 11:35 STATE-OF-THE-ART LECTURE: UPDATE ON RADIUM RA 223 DICHLORIDE THERAPY, POST FDA APPROVAL Erik Mittra 11:50 STATE-OF-THE-ART LECTURE: CONSENSUS STATEMENT ON ADVANCED PRACTICE PROVIDERS Aaron Spitz 12:05 SESSION CONCLUDES Tuesday, May 19, 2015 Moderated Poster Session 76 INFERTILITY: BASIC RESEARCH, PHYSIOLOGY, PATHOPHYSIOLOGY Room New Orleans Morial Convention Center Moderators: Dolores Lamb and Marc Goldstein 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP76-01 EXPRESSION AND ROLE OF LEPTIN UNDER HYPOXIC CONDITIONS IN HUMAN TESTIS: ORGANOTYPIC IN-VITRO CULTURE EXPERIMENT AND CLINICAL STUDY ON PATIENTS WITH VARICOCELE Kai Ni, Klaus Steger, Giessen, Germany, Hao Yang, Hongxiang Wang, Kai Hu, Bin Chen*, Shanghai, China, People s Republic of MP76-02 SPERM PROTAMINE MRNA RATIO AND DNA FRAGMENTATION INDEX REPRESENT RELIABLE CLINICAL BIOMARKERS FOR MEN WITH VARICOCELE AFTER MICROSURGICAL VARICOCELE LIGATION Kai Ni, Klaus Steger*, Giessen, Germany, Hao Yang, Hongxiang Wang, Kai Hu, Bin Chen, Shanghai, China, People s Republic of *Presenting author 255

268 MP76-03 CORRELATIONS BETWEEN HISTOPATHOLOGY, PROTAMINE-MRNA EXPRESSION AND SPERM RETRIEVAL OUTCOME IN TESTICULAR BIOPSIES FROM SUBFERTILE MEN Adrian Pilatz, Hans-Christian Schuppe, Julia Wolf, Judith Fechner, Thorsten Diemer, Martin Bergmann, Wolfgang Weidner, Klaus Steger*, Giessen, Germany MP76-04 SPERMATOGENESIS OF TUMOR- BEARING TESTES IN GERM CELL TESTICULAR CANCER PATIENTS Keisuke Suzuki*, Takeshi Shin, Yukihito Shimomura, Toshiyuki Iwahata, Ryo Sato, Koujiro Nishio, Hiroshi Yagi, Gaku Arai, Shigehiro Soh, Hiroshi Okada, Koshigaya, Japan MP76-05 LENGTH OF INFERTILITY AFFECTS SEMINAL PARAMETERS - FINDINGS OF A CROSS-SECTIONAL SURVEY IN WHITE- EUROPEAN MEN PRESENTING FOR PRIMARY COUPLE S INFERTILITY Eugenio Ventimiglia*, Luca Boeri, Paolo Capogrosso, Giovanni La Croce, Alessandro Serino, Giulia Castagna, Angela Pecoraro, Marco Paciotti, Roberta Scano, Alberto Briganti, Milan, Italy, Francesco Cantiello, Rocco Damiano, Catanzaro, Italy, Francesco Montorsi, Andrea Salonia, Milan, Italy MP76-06 WHOLE-EXOME SEQUENCING IDENTIFIES NOVEL HOMOZYGOUS MUTATION IN NPAS2 IN FAMILY WITH NONOBSTRUCTIVE AZOOSPERMIA Ranjith Ramasamy*, Houston, TX, Emre Bakircioglu, Istanbul, Turkey, Cenk Cengiz, Ender Karaca, Jason Scovell, Matthew Bainbridge, James Lupski, Dolores Lamb, Houston, TX MP76-07 ANTIOXIDANTS ADMINISTRATION MANAGED TO RESCUE TESTICULAR CELLS DNA OXIDATIVE DAMAGE AND APOPTOSIS BILATERALLY, IN THE UNILATERALLY CRYPTORCHIDIZED RAT MODEL Panagiota Tsounapi*, Masashi Honda, Yonago, Japan, Fotios Dimitriadis, Thessaloniki, Greece, Shogo Shimizu, Nankoku, Japan, Michiyo Iguchi, Masaki Imanishi, Shinji Matsunaga, Bunya Kawamoto, Katsuya Hikita, Kuniyasu Muraoka, Takehiro Sejima, Yonago, Japan, Motoaki Saito, Nankoku, Japan, Nikolaos Sofikitis, Ioannina, Greece, Shuhei Tomita, Atsushi Takenaka, Yonago, Japan MP76-08 THE EFFECT OF BOSENTAN, AN ENDOTHELIN-1 RECEPTOR ANTAGONIST ON TESTICULAR TISSUE OXIDANT AND ANTIOXIDANT LEVELS IN DIABETIC RATS Erdal Alkan, Istanbul, Turkey, RüstemAnýl Urgan, Erzurum, Turkey, Mehmet Murad Basar*, Istanbul, Turkey, Zekai Halýcý, Erzurum, Turkey, Mevlana Derya Balbay, Istanbul, Turkey, Harun Un, Agri, Turkey, Hasan Tarik Atmaca, Kirikkale, Turkey MP76-09 DIFFERENTIATING KLINEFELTER SYNDROME FROM OTHER ETIOLOGIES OF AZOOSPERMIA USING MICRORNA Jennifer Reifsnyder*, Anna Mielnik, Peter Schlegel, Darius Paduch, New York, NY MP76-10 MSH5 DEFICIENCIES IN A SUBSET OF NOA MEN Koji Chiba*, Alex Ridgeway, Larry Lipshultz, Houston, TX, Masato Fujisawa, Kobe, Japan, Dolores Lamb, Houston, TX MP76-11 IDENTIFICATION OF SPERMATOGENICALLY ACTIVE REGIONS IN RAT TESTIS BY USING NARROW BAND IMAGING SYSTEM Noritoshi Enatsu*, Hideaki Miyake, Masato Fujisawa, Kobe city, Japan MP76-12 GRANDPATERNAL AGE AND SEMEN QUALITY: EVIDENCE FROM THE UTAH POPULATION DATABASE James Hotaling, Ross Anderson*, Heidi Hanson, Darshan Patel, Jeffrey Redshaw, Chong Zhang, Angela Presson, Kenneth Aston, Douglas Carrell, Ken Smith, Salt Lake City, UT MP76-13 EFFECTS OF PERINATAL AND/OR POSTNATAL HIGH-FAT DIET ON TESTICULAR MORPHOLOGY AND SPERM PARAMETERS IN ADULT WISTAR RATS Pamella Campos-Silva, Flavia Fernandes- Lima, Angelo Fernandes-Neto, Diogo B. De Souza, Waldemar S. Costa, Francisco J. B. Sampaio, Rio de Janeiro, Brazil, Fernanda A. M. Nascimento, Macaé, Brazil, Bianca M. Gregorio*, Rio de Janeiro, Brazil MP76-14 POSTTRANSLATIONAL MODIFICATIONS BY SUMOYLATION AFFECT ACTIVITY OF SERTOLI CELL SIGNALLING NETWORKS Keisuke Okada*, KeumSil Hwang, Patricia Morris, New York, NY MP76-15 DIETARY HABITS AND REPRODUCTIVE HEALTH - RESULTS OF A SOCIOLOGICAL CASE-CONTROL STUDY Luca Boeri*, Alessandro Galdini, Roberta Scano, Eugenio Ventimiglia, Alessandro Serino, Paolo Capogrosso, Giovanni La Croce, Giulia Castagna, Silvia Ippolito, Luca Valsecchi, Enrico Papaleo, Massimo Candiani, Francesco Montorsi, Andrea Salonia, Milan, Italy MP76-16 IMPACT OF PRECISE MODULATION OF REACTIVE OXYGEN SPECIES LEVELS ON SPERMATOZOA PROTEINS IN INFERTILE MEN Rakesh Sharma*, Ashok Agarwal, Ahmet Ayaz, Edmund Sabanegh, Cleveland, OH MP76-17 SUPPLEMENTATION OF CRYOMEDIUM WITH CATALASE AND N-ACETYL CYSTEINE IMPROVES HUMAN SPERM POST-THAW MOTILITY Yoshitomo Kobori*, Craig Niederberger, Gail Prins, Chicago, IL 256

269 MP76-18 MALE INFERTILITY AND SINGLE NUCLEOTIDE POLYMORPHISMS OF THE NOVEL SEX-LINKED TESTIS-SPECIFIC RETROTRANSPOSED PGAM4 GENE Yasushi Miyagawa*, Tetsuji Soda, Kentaro Takezawa, Shinichiro Fukuhara, Hiroshi Kiuchi, Suita, Japan, Hidenobu Okuda, Victoria, Australia, Hiromitsu Tanaka, Sasebo, Japan, Norio Nonomura, Suita, Japan MP76-19 DNA FRAGMENTATION MAPPING OF THE MALE GENITAL TRACT Ashley Winter*, Bobby Najari, Gianpiero Palermo, Darius Paduch, Marc Goldstein, New York, NY MP76-20 HUMAN SPERM MIRNA PROFILE IN PATIENTS WITH NORMOZOOSPERMIA AND TERATOZOOSPERMIA Amin Herati*, Anna Mielnik, Peter Schlegel, Darius Paduch, New York, NY Tuesday, May 19, 2015 Moderated Poster Session 77 PROSTATE CANCER: DETECTION AND SCREENING VI Room New Orleans Morial Convention Center Moderators: Robert Weiss and Manfred Wirth 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP77-01 NATURAL HISTORY OF PROSTATIC LESIONS ON SERIAL MULTIPARAMETRIC MRI Samrad Ghavimi, Richard Savdie*, Hamidreza Abdi, Silvia Chang, Alison Harris, Lindsay Machan, Martin Gleave, Alan So, Larry Goldenberg, Peter Black, Vancouver, Canada MP77-04 MEN UNDER THE AGE OF 55 YEARS HAVE SIMILAR PROSTATE CANCER PATHOLOGY AS OLDER MEN: IMPLICATIONS FOR THE AUA SCREENING POLICY Nandu Dantanarayana*, Tania Hossack, Paul Cozzi, Andrew Brooks, Howard Lau, Warwick Delprado, Manish Patel, Sydney, Australia MP77-02 THE ANTITHROMBOTIC AGENTS DO NOT NEED TO DISCONTINUE PRIOR TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY: A SINGLE CENTER EXPERIENCE Kuniaki Tanabe*, Yasuhiro Maki, Kyoko Koike, Hirohito Kobayashi, Ebina-shi, Japan, Takashi Arai, Kita-Kyushu-shi, Japan, Yukihiro Kondo, Bunkyo-ku, Japan, Tomotaka Hattori, Naoki Kawamura, Ebina-shi, Japan MP77-03 GLEASON SCORE UPGRADING TO 8-10 PREDICTS BIOCHEMICAL RECURRENCE IN MEN UNDERGOING RADICAL PROSTATECTOMY: ANALYSIS ON 7310 HIGH-RISK PATIENTS FROM THE EMPACT DATABASE Marco Oderda, Paolo Gontero*, Giancarlo Marra, Turin, Italy, Rafael Sanchez-Salas, Paris, France, Joachen Walz, Hamburg, Germany, Patrick Bastian, Muinchen, Germany, Felix Chun, Hamburg, Germany, Henk Van Der Poel, Amsterdam, Netherlands, Markus Graefen, Hamburg, Germany, Bertrand Tombal, Leuven, Belgium, Giansilvio Marchioro, Novara, Italy, Piotr Chlosta, Kielce, Poland, Lorenzo Tosco, Leuven, Belgium, Marco Bianchi, Alberto Briganti, Milan, Italy, Martin Spahn, Bern, Switzerland, Robert Jeffrey Karnes, Rochester, MN, Steven Joniau, Leuven, Belgium MP77-05 IS RACE PREDICTIVE OF A FUTURE PROSTATE CANCER DIAGNOSIS AFTER AN INITIAL NEGATIVE BIOPSY? William A. Sterling*, Jeffrey P. Weiss, David Schreiber, Nicholas Karanikolas, Jeremy Weedon, Komal Mehta, William Atallah, Ari Bergman, Brooklyn, NY MP77-06 FATE OF PATHOLOGICAL GLEASON SCORE 7 (3 4) IN CANDIDATES FOR ACTIVE SURVEILLANCE; ROYAL MARSDEN HOSPITAL CRITERIA Jung Ki Jo*, In Jae Lee, Tae Jin Kim, Kwang Mo Kim, Young Ik Lee, Hakmin Lee, Sangchul Lee, Seong Jin Jeong, Sung Kyu Hong, Seok-Soo Byun, Sang Eun Lee, Jong Jin Oh, Seongnam-si, Korea, Republic of MP77-07 THE PREVALENCE OF PROSTATE BIOPSY GLEASON SCORE > 7(3 4) EXCEEDS 40% IN YOUNG PUERTO RICAN MEN SCREENED FOR PROSTATE CANCER: A CASE FOR EARLY DETECTION BEFORE AGE 55 IN THIS POPULATION Patricia Maymi*, Ricardo Sanchez-Ortiz, San Juan, PR MP77-08 EMPIRIC ANTIBIOTICS FOR AN ELEVATED PROSTATE-SPECIFIC ANTIGEN (PSA) LEVEL: A META- ANALYSIS ON 862 PATIENTS Stefano Picozzi, Dario Ratti, Stefano Casellato, Elisabetta Finkelberg, Giorgio Bozzini, Carlo Marenghi, Serena Maruccia, Luca Carmignani*, San Donato Milanese, Italy TUESDAY *Presenting author 257

270 MP77-09 LONG-TERM RISK OF PROSTATE CANCER IS DIRECTLY RELATED TO BASELINE PSA: Kara Choate, Jonathan Gelfond, Donna Ankerst*, Javier Hernandez, Robin Leach, Ian Thompson Jr., San Antonio, TX MP77-10 THE INFLUENCE OF PHYSICIAN RECOMMENDATION ON PSA SCREENING Daniel Pucheril*, Deepansh Dalela, Jesse Sammon, Akshay Sood, Detroit, MI, Maxine Sun, Montreal, Canada, Julian Hanske, Christian Meyer, Quoc-Dien Trinh, Boston, MA, Mani Menon, Firas Abdollah, Detroit, MI MP77-11 PROSTATIC CAPSULAR INVASION: CAN PREOPERATIVE MP-MRI PREDICT THE PATHOLOGICAL ANALYSIS? Francesco Porpiglia, Matteo Manfredi*, Fabrizio Mele, Orbassano (Turin), Italy, Filippo Russo, Daniele Regge, Candiolo (Turin), Italy, Agostino De Pascale, Orbassano (Turin), Italy, Stefano Cirillo, Torino, Italy, Enrico Bollito, Mauro Papotti, Cristian Fiori, Orbassano (Turin), Italy MP77-12 CONTEMPORARY PATTERNS OF SELF- REPORTED PSA SCREENING IN U.S. VETERANS Daniel Pucheril*, Jesse Sammon, Akshay Sood, Firas Abdollah, Detroit, MI, Toni Choueiri, Julian Hanske, Christian Meyer, Paul Nguyen, Adam Kibel, Boston, MA, Mani Menon, Detroit, MI, Joel Weissmann, Quoc- Dien Trinh, Boston, MA MP77-13 DEFICIENCIES IN PSA SCREENING PRACTICES IN BLACK MEN AGED IN THE UNITED STATES Jesse Sammon*, Firas Abdollah, Akshay Sood, Dane Klett, Daniel Pucheril, James Peabody, Mani Menon, Detroit, MI, Quoc- Dien Trinh, Boston, MA MP77-14 OUTCOMES OF MRI-US FUSION TARGETED PROSTATE BIOPSY IN MEN WITHOUT HISTORY OF PREVIOUS BIOPSY: REDUCTION OF OVER- DETECTION AND IMPROVED RISK STRATIFICATION Neil Mendhiratta*, Andrew B Rosenkrantz, Xiaosong Meng, Michael Fenstermaker, Richard Huang, New York, NY, James S Wysock, Flushing, NY, Fang-Ming Deng, Jonathan Melamed, Ming Zhou, William C Huang, Herbert Lepor, Samir S Taneja, New York, NY MP77-15 PRESENCE OF MRI SUSPICIOUS LESION PREDICTS CLINICALLY SIGNIFICANT PROSTATE CANCER FOR BIOPSY NAÏVE PATIENTS Eric H Kim*, Adam J Rensing, Joel M Vetter, Kathryn J Fowler, Gerald L Andriole, John K. Weaver, St. Louis, MO MP77-16 THE USE OF DECISIONAL AIDS FOR PROSTATE CANCER SCREENING: A META-ANALYSIS Jody Purifoy*, Benjamin Schurhamer, Matthew Katz, Sheila Thomas, Barbara Pate, Rodney Davis, Little Rock, AR MP77-17 PERFORMANCE OF URINARY BIOMARKER PCA3 AMONG MEN UNDERGOING TARGETED MRI- ULTRASOUND FUSION BIOPSY Michael Fenstermaker*, Neil Mendhiratta, Xiaosong Meng, Andrew B. Rosenkrantz, Richard Huang, Fang-Ming Deng, Ming Zhou, William C. Huang, Herbert Lepor, Samir S. Taneja, New York, NY MP77-18 OUTCOMES OF MRI-US FUSION TARGETED PROSTATE BIOPSY IN MEN WITH HISTORY OF PROSTATIC INTRAEPITHELIAL NEOPLASIA AND/OR ATYPICAL SMALL ACINAR PROLIFERATION: EVIDENCE FOR AN ALTERATION OF CURRENT PRACTICE Neil Mendhiratta*, Andrew B Rosenkrantz, Xiaosong Meng, Michael Fenstermaker, Richard Huang, New York, NY, James S Wysock, Flushing, NY, Fang-Ming Deng, Ming Zhou, William C Huang, Herbert Lepor, Samir S Taneja, New York, NY MP77-19 BASELINE PSA LEVELS IN MEN AGED ARE INFLUENCED BY RACE, BODY MASS INDEX (BMI) AND WAIST-CIRCUMFERENCE: A CROSS- SECTIONAL POPULATION-BASED STUDY USING THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES, ) Mark A Preston*, Julie L Batista, Samuel F Peisch, Sarah Markt, Taylor Medwig, Kathryn M Wilson, Quoc-Dien Trinh, Adam S Kibel, Meir Stampfer, Lorelei A Mucci, Boston, MA MP77-20 AMONG MEN WITH LOW-GRADE PROSTATE CANCER ON PROSTATE BIOPSY, THE 4KSCORE PREDICTS MORE AGGRESSIVE PROSTATE CANCER AT PROSTATECTOMY Sanoj Punnen*, Miami, FL, Stephen Zappala, Andover, MA, Dan Sjoberg, New York, NY, Vinita Mathur, Michael Reeve, Dipen Parekh, Miami, FL 258

271 Tuesday, May 19, 2015 Moderated Poster Session 78 PROSTATE CANCER: LOCALIZED VIII Room New Orleans Morial Convention Center Moderator: Jean Joseph 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP78-01 CONTEMPORARY MANAGEMENT OF PROSTATE CANCER PATIENTS SUITABLE FOR ACTIVE SURVEILLANCE: A POPULATION-BASED STUDY Nicola Fossati, Justin K. Lee, New York, NY, Quoc-Dien Trinh, Boston, MA, Jesse Sammon, Akshay Sood, Detroit, MI, Alessandro Larcher, Giorgio Gandaglia, Giorgio Guazzoni*, Milan, Italy, Pierre I Karakiewicz, Montreal, Canada, Shahrokh F. Shariat, Vienna, Austria, Francesco Montorsi, Alberto Briganti, Milan, Italy, Mani Menon, Firas Abdollah, Detroit, MI MP78-02 RELATIONSHIP BETWEEN THE CONTINUITY AND DISCONTINUITY OF TWO POSITIVE CORES IN PROSTATE BIOPSY SPECIMENS FOR THE PREDICTION OF LOW-RISK PROSTATE CANCER AND IDENTIFICATION OF CANDIDATES FOR ACTIVE SURVEILLANCE Sangjun Yoo*, Chanwoo Lee, Mooyoung Sohn, Chunwoo Lee, Seoul, Korea, Republic of, Sungwoo Hong, Hyung Jee Kim, Cheonan, Korea, Republic of, Sang Hoon Song, Kun Suk Kim, Dalsan You, Taekmin Kwon, In Gab Jeong, Seoul, Korea, Republic of, Sungchan Park, Kyung Hyun Moon, Ulsan, Korea, Republic of, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim, Seoul, Korea, Republic of MP78-03 ASSOCIATION BETWEEN NUMBER OF PROSTATE BIOPSIES AND PATIENT- REPORTED FUNCTIONAL OUTCOMES AFTER RADICAL PROSTATECTOMY: IMPLICATIONS FOR ACTIVE SURVEILLANCE PROTOCOLS Christopher Anderson*, Amy Tin, Daniel Sjoberg, John Mulhall, Jaspreet Sandhu, Karim Touijer, Vincent Laudone, James Eastham, Peter Scardino, Behfar Ehdaie, New York, NY MP78-04 INFLUENCE OF RADICAL PROSTATECTOMY ON SERUM BIOAVAILABLE TESTOSTERONE LEVEL IN JAPANESE PATIENTS WITH LOCALIZED PROSTATE CANCER: A LONGITUDINAL STUDY Shoichiro Iwatsuki*, Shoichi Sasaki, Yasue Kubota, Hiroki Kubota, Hiroyuki Kamiya, Yukihiro Umemoto, Kenjiro Kohri, Nagoya, Japan MP78-05 OPEN VERSUS ROBOT-ASSISTED RADICAL PROSTATECTOMY: A CONTEMPORARY ANALYSIS OF AN ALL- PAYER DISCHARGE DATABASE Jeffrey Leow*, Christian Meyer, Julian Hanske, Boston, MA, Marianne Schmid, Hamburg, Germany, Benjamin Chung, Stanford, CA, Quoc-Dien Trinh, Steven Chang, Boston, MA MP78-06 PROPHYLACTIC ANTIBIOTIC TREATMENT FOR LAPAROSCOPIC ROBOT ASSISTED RADICAL PROSTATECTOMY DID THE AUA GUIDELINES MAKE A CHANGE? Miki Haifler*, Tel Aviv, Israel, Yoram Mor, Zohar Dotan, Dorit Zilberman, Ramat gan, Israel MP78-07 SALVAGE RADICAL PROSTATECTOMY FOR LOCALLY RECURRENT PROSTATE CANCER AFTER PRIMARY RADIOTHERAPY: A LARGE INSTITUTIONAL SERIES WITH 15 YEAR FOLLOW UP Vidit Sharma*, Eugene D Kwon, Laureano J Rangel, R. Jeffrey Karnes, Rochester, MN MP78-08 LONG-TERM MORBIDITY AND ONCOLOGICAL OUTCOMES OF SALVAGE CRYOTHERAPY OF RADIO-RECURRENT PROSTATE CANCER Michele Billia*, Khurram Mutahir Siddiqui, Clarisse R. Mazzola, Christopher Goodman, Andrew Williams, Joseph Chin, London, Canada MP YEARS BIOCHEMICAL RECURRENCE AND OVERALL SURVIVAL RATES AFTER RADICAL PROSTATECTOMY OR HIGH DOSE RADIATION BRACHYTHERAPY WITH ADDITIONAL EXTERNAL BEAM IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER Katharina Boehm*, Hans Lesmana, Jonas Schiffmann, Hamburg, Germany, Alessandro Larcher, Milan, Italy, Rudolf Schwarz, Derya Tilki, Hamburg, Germany MP78-10 CONTEMPORARY USE OF ADJUVANT AND SALVAGE RADIOTHERAPY FOLLOWING RADICAL PROSTATECTOMY IN THE STATE OF MICHIGAN Todd Morgan*, David Miller, Khurshid Ghani, Felix Feng, Susan Linsell, Yuqing Gao, James Montie, Ann Arbor, MI, Michael Cher, Detroit, MI TUESDAY *Presenting author 259

272 MP78-11 PERIRECTAL HYDROGEL SPACER APPLICATION IN MEN RECEIVING PROSTATE RADIOTHERAPY: A PROSPECTIVE MULTICENTER RANDOMIZED CONTROLLED TRIAL Christopher Pieczonka*, Neil Mariados, Syracuse, NY, John Sylvester, East Bradenton, FL, Phillip Aliotta, Christopher Skomra, Cheektowaga, NY, Larry Karsh, Brian Smith, Denver, CO, Richard Hudes, Owings Mills, MD, David Beyer, Phoenix, AZ, Steven Kurtzman, Al Tiara, Campbell, CA, Jeffrey Bogart, Syracuse, NY, Alex Hsi, Poulsbo, WA, C. Garo Gholodian, Reno, NV, Lee Ponsky, Rodney Ellis, Cleveland, OH, Mark Logsdon, Seth Rosenthal, Sacramento, CA, Kevin Forsythe, Springfeild, OR, Hong Zhang, Rochester, NY, Edward Soffen, Freehold, NJ, Neal Shore, Myrtle Beach, SC, Constantine Mantz, Fort Meyers, FL, Peter Nieh, Atlanta, GA, Misop Han, Baltimore, MD MP78-12 ASSOCIATION OF CIGARETTE SMOKING AND SMOKING CESSATION WITH BIOCHEMICAL RECURRENCE IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY FOR PROSTATE CANCER Malte Rieken*, Basel, Switzerland, Luis Kluth, Hambug, Germany, Harun Fajkovic, Vienna, Austria, Pierre Karakiewicz, Montreal, Canada, Yair Lotan, Dallas, TX, Christian Seitz, Vienna, Austria, Alberto Briganti, Milan, Italy, Morgan Rouprêt, Paris, France, Wolfgang Loidl, Linz, Austria, Richard Lee, New York, NY, Quoc-Dien Trinh, Boston, MA, Peter Nyirady, Budapest, Hungary, Alexander Bachmann, Basel, Switzerland, Gholam-Reza Pourmand, Tehran, Islamic Republic of Iran, Shahrokh Shariat, Vienna, Austria MP78-13 PROGNOSTIC VALUE OF TUMOR VOLUME ON DISEASE PROGRESSION OF PATIENTS TREATED WITH RADICAL PROSTATECTOMY FOR NODE POSITIVE PROSTATE CANCER Alessandro Nini*, Giorgio Gandaglia, Umberto Capitanio, Vincenzo Scattoni, Emanuele Zaffuto, Marco Bianchi, Nicola Fossati, Massimo Freschi, Milan, Italy, Francesco Cantiello, Rocco Damiano, Catanzaro, Italy, Vincenzo Mirone, Naples, Italy, Francesco Montorsi, Alberto Briganti, Milan, Italy MP78-14 REDUCING DECISIONAL CONFLICT IN MEN MAKING TREATMENT DECISIONS ABOUT LOCALIZED PROSTATE CANCER David Johnson*, Dana Mueller, Mary Dunn, Angela Smith, Michael Woods, Eric Wallen, Raj Pruthi, Matthew Nielsen, Chapel Hill, NC MP78-15 BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: WHO IS AT RISK OF DYING FROM PROSTATE CANCER? Nazareno Suardi*, Giorgio Gandaglia, Paolo Dell Oglio, Umberto Capitanio, Niccolò M. Passoni, Marco Bianchi, Milan, Italy, Firas Abdollah, Detroit, MI, Pierre Karakiewicz, Montreal, Canada, Sharokh Shariat, Vienna, Austria, Giorgio Guazzoni, Francesco Montorsi, Alberto Briganti, Milan, Italy MP78-16 GLYCEMIC CONTROL STATUS AS A INDEPENDENT PROGNOSTIC FACTOR FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY Hakmin Lee*, Ha Rim Kook, Seok-Soo Byun, Sang Eun Lee, Sung Kyu Hong, Seongnam, Korea, Republic of MP78-17 IDENTIFYING THE MOST INFORMATIVE PREDICTION-TOOL FOR CANCER SPECIFIC MORTALITY AFTER RADICAL PROSTATECTOMY: COMPARATIVE ANALYSIS OF THREE COMMONLY USED PREOPERATIVE PREDICTION MODELS Katharina Boehm*, Hamburg, Germany, Alessandro Larcher, Milan, Italy, Jonas Schiffmann, Samy Leyh-Bannurah, Uwe Michl, Hamburg, Germany, Thomas Steuber, Ha, Germany, Lars Budaeus, Hamburg, Germany MP78-18 IMPACT OF CAPSULAR INCISION DURING RADICAL PROSTATECTOMY ON BIOCHEMICAL RECURRENCE RATES Philipp Mandel*, Pierre Tennstedt, Luis Kluth, Alexander Haese, Hartwig Huland, Markus Graefen, Derya Tilki, Hamburg, Germany MP78-19 PREDICTING PATHOLOGIC OUTCOMES IN PATIENTS UNDERGOING ROBOT- ASSISTED RADICAL PROSTATECTOMY FOR HIGH-RISK PROSTATE CANCER: A PREOPERATIVE NOMOGRAM Firas Abdollah*, Dane Klett, Akshay Sood, Jesse Sammon, Daniel Pucheril, Deepansh Dalela, Mireya Diaz, James Peabody, Detroit, MI, Quoc-Dien Trinh, Boston, MA, Mani Menon, Detroit, MI MP78-20 OPEN RADICAL PROSTATECTOMY IN TRANSPLANT PATIENTS Burkhard Beyer*, Thomas Steuber, Philipp Schriefer, Uwe Michl, Hans Heinzer, Thorsten Schlomm, Hartwig Huland, Markus Graefen, Derya Tilki, Hamburg, Germany 260

273 Tuesday, May 19, 2015 Moderated Poster Session 79 TRANSPLANTATION & VASCULAR SURGERY: RENAL TRANSPLANTATION & VASCULAR SURGERY I Room New Orleans Morial Convention Center Moderators: David Goldfarb and Mark Jordan 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP79-01 VITRIFICATION OF METANEPHROS: WOULD IT BE THE FUTURE NEPHRO- BIOBANK TO PROVIDE AN UNLIMITED SUPPLY OF KIDNEYS FOR THE HUMAN BEING? Cesar Vera-Donoso*, Paterna, Spain, Joaquín García-Domínguez, Silvia Vicente- Ferrer, Estrella Jimenez-Trigos, José Vicente- Antón, Francisco Marco-Jiménez, Valencia, Spain MP79-02 LAPAROSCOPIC NEPHRECTOMY WITH AUTOTRANSPLANTATION: SAFETY, EFFICACY AND LONG-TERM DURABILITY Geraldine Tran*, Krishna Ramaswamy, Thomas Chi, Maxwell Meng, Anobel Odisho, Chris Freise, Marshall Stoller, San Francisco, CA MP79-03 WAG THE DOG?: PSA SCREENING IN KIDNEY TRANSPLANT CANDIDATES Daniel Canter*, Wynnewood, PA, Gerardo Vitiello, Blayne Sayed, Ken Ogan, Nicole Turgeon, Atlanta, GA MP79-04 NATIONAL TRENDS AND RACIAL DISPARITIES IN LIVING KIDNEY DONATION: ANALYSIS OF THE UNITED NETWORK OF ORGAN SHARING Akshay Sood*, Firas Abdollah, Dane Klett, Wooju Jeong, James Peabody, Detroit, MI, Quoc-Dien Trinh, Boston, MA, Mani Menon, Jesse Sammon, Detroit, MI MP79-05 RESECTION OF THE INFERIOR VENA CAVA WITHOUT GRAFTING IN ADVANCED UROLOGIC MALIGNANCY Jeffrey Loh-Doyle*, Sumeet Syan-Bhanvadia, Eli Thompson, Mukul Patil, Siamak Daneshmand, Los Angeles, CA MP79-06 VOLUME SUPERSEDES SPECIALTY DURING RENAL TRANSPLANTATION Aaron Laviana*, Diana Kang, Hung-Jui Tan, Jim Hu, Los Angeles, CA MP79-07 USEFULNESS OF KIDNEY PREIMPLANTATION BIOPSIES FROM DECEASED DONORS FOR KIDNEY TRANSPLANT ALLOCATION David Lorente Garcia*, Enrique Trilla Herrera, Cristian Isalt Lemonche, Lucas Regis Placido, Pol Servian Vives, Moreso Mateos Francesc, Daniel Seron Micas, Clara Garcia Carro, Maria Teresa Salcedo, Juan Morote Robles, Barcelona, Spain MP79-08 SURGICAL MANAGEMENT OF RENAL ARTERY STENOSIS DUE TO TAKAYASU S AORTOARTERITIS:RESULTS FROM A TERTIARY CARE CENTER IN SOUTH INDIA John S. Banerji*, Antony Devasia, Nitin S. Kekre, Vellore, India, Ninan K. Chacko, Dhaka, Bangladesh, Ganesh Gopalakrishnan, Coimbatore, India MP79-09 DO ANTICOAGULANT AND ANTIPLATELET AGENTS PREVENT ACUTE GRAFT THROMBOSIS IN RENAL TRANSPLANTATION? A META-ANALYSIS OF CASE SERIES STUDIES Rodrigo Guerra*, Paulo Kawano, Joao Amaro, Regina El Dib, Botucatu, Brazil MP79-10 SILDENAFIL ACTIVATES NRF2 DEPENDENT ANTI-OXIDANT GENES AND ANTI-APOPTOTIC BCL-2 GENE AND INHIBITS PRO-INFLAMMATORY CYTOKINES GENES IN RAT MODEL OF RENAL ISCHEMIA/REPERFUSION INJURY Mohamed Zahran*, Abdelaziz Hussein, Ahmed Harraz, Amira Awadalla, Shery Khater, Nashwa Barakat, Ahmed Shokeir, Mansoura, Egypt MP79-11 IMPROVING MATCHING STRATEGIES IN KIDNEY PAIRED DONATION: THE 7-YEAR EVOLUTION OF A WEB-BASED VIRTUAL MATCHING SYSTEM David Fumo*, Victor Kapoor, Toledo, OH, Laurie Reece, Jonathan Kopke, Maumee, OH, Stanislaw Stepkowski, Toledo, OH, Susan Rees, Maumee, OH, Michael Rees, Toledo, OH MP79-12 HOW LONG IS TOO LONG? AN ANALYSIS OF THE IMPACT OF BRIDGE DONOR WAITING TIME ON PAIRED DONATION TRANSPLANTS David Fumo*, Timothy Suttle, Ryan Flynn, Toledo, OH, Laurie Reece, Maumee, OH, Stanislaw Stepkowski, Michael Rees, Toledo, OH, Jonathan Kopke, Maumee, OH MP79-13 POST-OPERATIVE INTRAVENOUS HEPARIN INFUSION IMPROVES SHORT AND LONG TERM SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANT OUTCOMES Patrick Anderson*, Ghaleb Aboalsamh, Amira Al Abbassi, Vivian McAlister, Patrick Luke, Alp Sener, London, Canada TUESDAY *Presenting author 261

274 MP79-14 MINIMALLY INVASIVE KIDNEY TRANSPLANTATION: PERIOPERATIVE CONSIDERATIONS AND KEY 6-MONTH OUTCOMES Akshay Sood*, Detroit, MI, Prasun Ghosh, Gurgaon, India, Wooju Jeong, Mahendra Bhandari, Detroit, MI, Rajesh Ahlawat, Gurgaon, India, Mani Menon, Detroit, MI MP79-15 UROLOGICAL COMPLICATIONS IN PEDIATRIC PATIENTS UNDERGOING RENAL TRANSPLANTATION Irina Stanasel*, Cagatay Afsarlar, Houston, TX, Hoang Lee, Temple, TX, Abhishek Seth, Chester Koh, Patricio Gargollo, Edmond Gonzales, David Roth, Nicolette Janzen, Houston, TX MP79-16 HEAT SHOCK PROTEIN 90 IS A POTENTIAL NEW BIOMARKER OF SEVERE ACUTE REJECTION AFTER RENAL TRANSPLANTATION Takeshi Maehana*, Toshiaki Tanaka, Hiroshi Kitamura, Nobuyuki Fukuzawa, Satoshi Takahashi, Sapporo, Japan, Hideki Ishida, Tokyo, Japan, Hiroshi Harada, Sapporo, Japan, Kazunari Tanabe, Tokyo, Japan, Naoya Masumori, Sapporo, Japan MP79-18 DOES ROUTINE URETERAL STENTING IN KIDNEY TRANSPLANTATION REALLY REDUCE URETERAL COMPLICATION RATES? Samuel C. Haywood*, Chad A. Reichard, Daniel A. Shoskes, Cleveland, OH MP79-19 OUTCOME OF RENAL TRANSPLANT IN PEDIATRIC PATIENTS WITH OBSTRUCTIVE UROPATHY AND VOIDING DYSFUNCTION Ismail Saad, Mostafa Sheba*, Hesham Badawy, Fatina Fadel, Cairo, Egypt MP79-20 THE IMPACT OF URETERAL COMPLICATIONS AFTER PEDIATRIC RENAL TRANSPLANTATION Julia B Finkelstein*, Jamie S Pak, Jennifer J Ahn, Jason P Van Batavia, Mark V Silva, Namrata G Jain, Shumyle Alam, New York, NY MP79-17 FOLLOW UP AFTER 4 YEARS OF URETERAL STENOSIS IN TRANSPLANT KIDNEY MANAGED WITH LONG-TERM THERMO-EXPANDABLE METALLIC STENT Helena Vila Reyes*, Lluis Riera Canals, Joan Dominguez Elias, Laia Pujol Galarza, Eladio Franco Miranda, Barcelona, Spain Tuesday, May 19, 2015 Moderated Poster Session 80 STONE DISEASE: EVALUATION II Room New Orleans Morial Convention Center Moderator: Duane Baldwin 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP80-01 HOW OFTEN ARE OBSTRUCTING URETERAL STONES ASSOCIATED WITH NORMAL URINE DIPSTICK AND SERUM WBC? Yan Song, Natalia Hernandez*, Andrew Stamm, Brian Eisner, Boston, MA MP80-02 INCREASED URINARY CALCIUM EXCRETION IS MORE COMMON IN YOUNGER STONE FORMERS Balaji Reddy*, Haresh Thummar, Usama Khater, Rachel Shapiro, Lynn Cochran, Mantu Gupta, New York, NY MP80-03 KIDNEY STONE INCIDENCE RATES AMONG CHILDREN AND ADULTS IN SOUTH CAROLINA FROM Gregory Tasian*, Michelle Ross, Lihai Song, Philadelphia, PA, Christopher Saigal, Los Angeles, CA, Ron Keren, Susan Furth, Philadelphia, PA MP80-04 CULTURING THE RIGHT MICROORGANISMS IN PATIENTS UNDERGOING PERCUTANEOUS NEPHROLITHOTOMY (PCNL) AND FLEXIBLE URETEROSCOPY (FURS) FOR RENAL STONES CAN WE DO ANY MORE? Rehan Khan*, Sarah Hunt, Holly Bekarma, Alison Ramsay, Sarath Krishna Nalagatla, Airdrie, United Kingdom MP80-05 PREDICTORS OF SEPTIC SHOCK IN PATIENTS WITH OBSTRUCTIVE PYELONEPHRITIS DUE TO CALCULI Jodi Antonelli*, Monica Morgan, Justin Friedlander, Niccolo Passoni, Adam Cohen, Daniel Mollengarten, Jeffrey Shoss, Clayton Trimmer, Sanjeeva Kalva, Yair Lotan, Margaret Pearle, Dallas, TX 262

275 MP80-06 NEPHROLITHIASIS IN ISRAEL EPIDEMIOLOGICAL CHARACTERISTICS OF RETURN PATIENTS Yasmin Abu-Ghanem, Tomer Erlich, Nir Kleinmann, Harry Winkler, Dorit Zilberman*, Ramat Gan, Israel MP80-07 VITAMIN D AND SERUM LIPID PROFILE: ASSOCIATION WITH 24-HOUR URINE PARAMETERS Aaron Potretzke*, Jeffrey Larson, Joel Vetter, Alana Desai, St. Louis, MO MP80-08 METABOLIC CHARACTERISTICS OF BRUSHITE STONE FORMERS Tracy Marien*, S. Duke Herrell, Nicole Miller, Nashville, TN MP80-09 RISK OF CHRONIC KIDNEY DISEASE IN BRUSHITE STONE FORMERS COMPARED TO IDIOPATHIC CALCIUM OXALATE STONE FORMERS AT LONG-TERM FOLLOW-UP Christopher Jaeger*, Daniel Yelfimov, Amy Krambeck, Rochester, MN MP80-10 URETEROSCOPIC GRADING SYSTEM FOR RENAL PAPILLAE: IMPLICATIONS ON ETIOLOGY OF STONE FORMATION AND RECURRENCE Blake Anderson*, Shane Pearce, Anna Zisman, Elaine Worcester, Fredric Coe, Glenn Gerber, Chicago, IL MP80-11 COMPARISION OF EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY VERSUS URETEROSCOPY HOLMIUM LASER LITHOTRIPSY IN THE MANAGEMENT OF URETERAL STONES: A COST- EFFECTIVENESS ANALYSIS Alberto Budía*, Vicent Caballer, José Daniel López-Acón, David Vivas-Consuelo, María Ángeles Conca, Pilar Bahílo, Marta Trassierra, Valencia, Spain MP80-12 COST ANALYSIS OF URETERAL STENTING AFTER UNCOMPLICATED URETEROSCOPIC LASER LITHOTRIPSY FOR UROLITHIASIS: A DECISION MODEL ANALYSIS Hin Yu Vincent Tu*, Edward Matsumoto, Hamilton, Canada MP80-13 DOES THE PEAK INSPIRATORY PRESSURE INCREASE IN THE PRONE POSITION? AN ANALYSIS RELATED TO BMI Michael Siev*, Piruz Motamedinia, David Leavitt, David Hoenig, Arthur Smith, Zeph Okeke, New Hyde Park, NY MP80-14 SLEEP POSTURE COULD PREDICT THE SIDE OF UNILATERAL UROLITHIASIS FORMATION Wei-Ming Cheng*, Tuz-Hao Huang, Yu-Hua Fan, Alex T. L. Lin, Kuang-Kuo Chen, Shi- Chuan Chang, Taipei City, Taiwan MP80-15 CAN FUNCTIONAL STUDIES BE OBVIATED IN MANAGEMENT OF URETERIC CALCULUS? A RANDOMIZED STUDY Raman Tanwar, Nikhil Khattar, Rishi Nayyar*, Rajeev Sood, New Delhi, India MP80-16 RISING INCIDENCE OF HYPEROXALURIA IN STONE-FORMING PATIENTS: CHRONOLOGICAL AND GEOGRAPHICAL DIFFERENCES Kyle Spradling*, Zhamshid Okhunov, Melissa Suarez, Jaime Landman, Ramy Youssef, Orange, CA MP80-17 DO 24-HOUR URINE SUPERSATURATIONS PREDICT STONE COMPOSITION? Mohamed Omar*, Cleveland, OH, Alaa El Mahdy, Ahmed Gamal, Cairo, Egypt, Manoj Monga, Cleveland, OH MP80-18 GENETIC DIAGNOSIS TRIAL BY SINGLE NUCLEOTIDE POLYMORPHISM ANALYSIS FROM A CASE-CONTROL STUDY, USING THREE NOVEL LOCI ASSOCIATED WITH SUSCEPTIBILITY TO UROLITHIASIS FROM A GENOME-WIDE ASSOCIATION STUDY (GWAS) Takahiro Yasui*, Atsushi Okada, Masayuki Usami, Shuzo Hamamoto, Ryosuke Ando, Yasunori Itoh, Keiichi Tozawa, Shoichi Sasaki, Yutaro Hayashi, Nagoya, Japan, Yoshikazu Sato, Sapporo, Japan, Yoshihito Higashi, Kenjiro Kohri, Nagoya, Japan MP80-19 URINE PROTEOMIC ANALYSIS IN CYSTINURIC PATIENTS WITH RENAL STONES Larisa Kovacevic*, Hong Lu, Yegappan Lakshmanan, Joseph A Caruso, Detroit, MI, David Goldfarb, New York, New York MP80-20 PROCALCITONIN SHOWS SUPERIOR SPECIFICITY IN PREDICTING INFECTION IN THE SETTING OF OBSTRUCTIVE URETERAL CALCULI Dimitri Papagiannopoulos*, Patrick Whelan, Waseem Ahmad, James Rybak, Dino Rumoro, Leslie Deane, Ajay Nehra, Chicago, IL TUESDAY *Presenting author 263

276 Tuesday, May 19, 2015 Moderated Poster Session 81 URODYNAMICS/INCONTINENCE/FEMALE UROLOGY: FEMALE UROLOGY Room New Orleans Morial Convention Center Moderators: Paulo Palma and Nitin Kekre 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP81-01 A NOVEL ROLE OF EPITHELIAL PERMEABILITY IN VISCERAL ORGAN CROSS TALK Alexander Parker*, Ehsan Mohommadi, Karl Tyler, Robert E. Hurst, Beverley Greenwood- Van Meerveld, Oklahoma City, OK MP81-02 ABNORMAL SENSORY PROTEIN EXPRESSION AND UROTHELIAL DYSFUNCTION IN HUMAN KETAMINE RELATED CYSTITIS Yao-Chou Tsai*, New Taipei City, Taiwan, Jia-Fong Jhang, Hsiu-Chen Huang, Hann- Chorng Kuo, Hualien, Taiwan MP81-03 PREDICTIVE FACTORS FOR A SUCCESSFUL ONABOTULINUMTOXINA INJECTION TREATMENT FOR REFRACTORY INTERSTITIAL CYSTITIS/ BLADDER PAIN SYNDROME Yuh-Chen Kuo*, Taipei, Taiwan, Dong-Ling Tang, Hann-Chorng Kuo, Hualien, Taiwan MP81-04 STRESS AND OVERACTIVE BLADDR SYMPTOMS H. Henry Lai*, Vivien Gardner, Joel Vetter, Gerald Andriole, St Louis, MO MP81-05 TRANSVAGINAL MESH IN THE MEDIA FOLLOWING THE 2011 FDA UPDATE Kevin Koo*, E. Ann Gormley, Lebanon, NH MP81-06 CHANGES IN FEMALE UROLOGIC CASE DISTRIBUTION WITH NEW SUBSPECIALTY CERTIFICATION AND SURGEON GENDER Joceline S. Liu*, Johnathan Doolittle, Matthias D. Hofer, Sarah C. Flury, Stephanie J. Kielb, Chicago, IL MP81-07 MANAGEMENT OF PATIENTS SEEKING CARE FOR STRESS URINARY INCONTINENCE OVER THE PAST FOUR YEARS: HAVE RATES OF MESH SLINGS DECREASED? Aqsa Khan*, Nirit Rosenblum, Benjamin Brucker, Victor Nitti, New York City, NY MP81-08 HOW WELL CAN UROLOGY TRAINEES DETECT SUBURETHRAL MESH USING TRANSLABIAL ULTRASOUND IN COMPARISON TO A RADIOLOGIST? Daniel Faaborg*, Andrea Staack, Glen Rouse, Muhannad Alsyouf, Kristene Myklak, Roger Li, Loma Linda, CA MP81-09 SURGEONS ATTITUDES TOWARDS SLING TENSIONING DURING SURGERY FOR FEMALE STRESS URINARY INCONTINENCE Ali Borazjani*, Javier Pizarro, Howard Goldman, Cleveland, OH MP81-10 LONG-TERM RESULTS OF SALVAGE AUTOLOGOUS FASCIAL SLING PLACEMENT FOLLOWING FAILED SYNTHETIC MIDURETHRAL SLING FOR STRESS URINARY INCONTINENCE IN WOMEN Steven Petrou, Andrew Davidiuk*, Bhupendra Rawal, David Thiel, Jacksonville, FL MP81-11 INTIAL RETENTION AFTER MACROPLASTIQUE INJECTION AS A PREDICTOR OF SUCCESS Himanshu Aggarwal*, Philippe Zimmern, Dallas, TX MP81-12 CLINICAL COURSE OF URINARY INCONTINENCE IN WOMEN WITH TYPE I DIABETES: LONGITUDINAL FINDINGS FROM DCCT/EDIC Sarah K. Holt*, Seattle, WA, J. Quentin Clemens, Ann Arbor, MI, James Hotaling, Salt Lake City, UT, Alan M. Jacobsen, Mineola, NY, Barbara H. Braffett, Patricia A. Cleary, Rockville, MD, Hunter Wessells, Seattle, WA, Aruna V. Sarma, and the DCCT/ EDIC Research Group, Ann Arbor, MI MP81-13 OUTCOMES OF TREATMENT OF STRESS URINARY INCONTINENCE ASSOCIATED WITH FEMALE URETHRAL DIVERTICULA Drew Freilich*, Ross Rames, Charleston, SC, Ahmed El-Zawahry, Springfield, IL, Eric Rovner, Charleston, SC, Michelle Koski, San Marcos, CA MP81-14 FEMALE URETHRAL STRICTURE: MORE COMMON THAN YOU THINK Marco Spilotros*, Eskinder Solomon, Mahreen Pakzad, Rizwan Hamid, Jeremy Ockrim, Tamsin Greenwell, London, United Kingdom MP81-15 LONG-TERM OUTCOME OF URETHROVAGINAL FISTULA REPAIR Dominic Lee, Philippe Zimmern*, Dallas, TX MP81-16 SELF IMAGING AND SEXUAL FUNCTION AFTER MARTIUS FLAP SURGERY George Kasyan*, Nataliya Tupikina, Yury Kupriyanov, Boris Godunov, Dmitry Pushkar, Moscow, Russian Federation MP81-17 SOLVENT DEHYDRATED DERMAL ALLOGRAFT (AXIS ) AUGMENTED CYSTOCELE REPAIR: LONGITUDINAL LONG-TERM RESULTS Saad Juma, Encinitas, CA, Omer Raheem*, San Diego, CA 264

277 MP81-18 ABDOMINAL VS LAPAROSCOPIC SACROCOLPOPEXY: A RANDOMIZED CONTROLLED TRIAL Manuel Di Biase*, Luigi Mearini, Alessandro Zucchi, Michele Del Zingaro, Amelia Pietropaolo, Eleonora Salvini, Antonella Giannantoni, Elisabetta Costantini, Perugia, Italy MP81-19 PREDICTORS OF READMISSION FOLLOWING OPEN AND MINIMALLY INVASIVE SACRAL COLPOPEXY USING THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM (NSQIP) DATABASE Ahmed Sarhan*, Ahmad Shabsigh, Ketul Shah, Columbus, OH MP81-20 THE LONG-TERM SAFETY, TRENDS AND RE-INTERVENTIONS IN THE SURGICAL MANAGEMENT OF STRESS URINARY INCONTINENCE Bilal Chughtai, Adrien Bernstein*, Jessica Buck, Jialin Mao, Abby Isaacs, Richard Lee, Alexis Te, Steven Kaplan, Art Sedrakyan, New York, NY Tuesday, May 19, 2015 Moderated Poster Session 82 PROSTATE CANCER: ADVANCED II Room New Orleans Morial Convention Center Moderator: Neal Shore 8:00 am - 10:00 am NUMBER TITLE NUMBER TITLE MP82-01 LONG-TERM OUTCOMES OF VERY HIGH RISK PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY WITH OR WITHOUT ADJUVANT TREATMENTS. RESULTS OF A COMPETING RISKS, MULTI INSTITUTIONAL ANALYSIS Marco Bianchi*, Milan, Italy, R. Jeffrey Karnes, Rochester, MN, Steven Joniau, Leuven, Belgium, Giorgio Gandaglia, Milan, Italy, Martin Spahn, Bern, Switzerland, Paolo Gontero, Turin, Italy, Rafael Sanchez Salas, Xavier Cathelineau, Paris, France, Burkhard Kneitz, Wurzburg, Germany, Felix K. H. Chun, Hamburg, Germany, Pierre Karakiewicz, Montreal, Canada, Markus Graefen, Hamburg, Germany, Giansilvio Marchioro, Novara, Italy, Detlef Frohneberg, Karlsruhe, Germany, Hein Van Poppel, Leuven, Belgium, Francesco Montorsi, Alberto Briganti, Milan, Italy MP82-02 LONG-TERM OUTCOMES OF PATIENTS WITH SEMINAL VESICLE INVASION AT RADICAL PROSTATECTOMY: THE IMPORTANCE OF A MULTIMODAL APPROACH TO INCREASE PATIENT SURVIVAL Marco Moschini*, Milan, Italy, R. Jeffrey Karnes, Rochester, MN, Nazareno Suardi, Cesare Cozzarini, Giorgio Gandaglia, Nicola Fossati, Marco Bianchi, Emanuele Zaffuto, Alessandro Larcher, Milan, Italy, Firas Abdollah, Detroit, MI, Francesco Montorsi, Alberto Briganti, Milan, Italy MP82-03 SALVAGE LYMPH NODE DISSECTION FOR CLINICALLY RECURRENT PROSTATE CANCER: WHICH PATIENTS DO BENEFIT FROM THIS APPROACH? Nazareno Suardi*, Giorgio Gandaglia, Marco Bianchi, Ettore Di Trapani, Alessandro Nini, Vito Cucchiara, Walter Cazzaniga, Stefano Luzzago, Marta Picozzi, Roberto Bertini, Francesco Montorsi, Alberto Briganti, Milan, Italy MP82-04 PELVIC EXENTERATION IN PATIENTS WITH NON-METASTATIC, LOCALLY ADVANCED CASTRATION-RESISTANT PROSTATE CANCER Timothy F. Donahue*, Bethesda, MD, Michael J. Morris, Susan F. Slovin, Howard I. Scher, Peter T. Scardino, Bernard H. Bochner, New York, NY MP82-05 A COMPARISON OF DIFFERENT TREATMENT OPTIONS FOR LYMPH NODE-POSITIVE PROSTATE CANCER AT RADICAL PROSTATECTOMY Derya Tilki*, Pierre Tennstedt, Thomas Steuber, Patrick Tober, Christian Meyer, Rudolf Schwarz, Markus Graefen, Hartwig Huland, Sascha Ahyai, Hamburg, Germany MP82-06 TEMPLATE-BASED SALVAGE EXTENDED PELVIC LYMPH NODE DISSECTION IN RECURRENT PROSTATE CANCER WITH LYMPH NODE METASTASES Daniar Osmonov, Alexey Aksenov*, Carsten Maik Naumann, Moritz Hamann, Klaus-Peter Jünemann, Kiel, Germany TUESDAY *Presenting author 265

278 MP82-07 DOES LOCAL TREATMENT OF THE PRIMARY TUMOR IMPROVE SURVIVAL OF METASTATIC PROSTATE CANCER PATIENTS? RESULTS FROM A POPULATION-BASED STUDY Nicola Fossati, New York, NY, Quoc-Dien Trinh, Boston, MA, Jesse Sammon, Akshay Sood, Detroit, MI, Alessandro Larcher, Milan, Italy, Maxine Sun, Pierre I Karakiewicz, Montreal, Canada, Giorgio Guazzoni*, Francesco Montorsi, Alberto Briganti, Milan, Italy, Mani Menon, Firas Abdollah, Detroit, MI MP82-08 BIOCHEMICAL RECURRENCE FREE SURVIVAL OF ACTIVE SURVEILLANCE CANDIDATE ACCORDING TO THE ADVERSE PATHOLOGIC OUTCOMES OF AFTER RADICAL PROSTATECTOMY Juhyun Park*, Songzhe Piao, Sung Yong Cho, Seung Bae Lee, Hyeon Jeong, Chang Wook Jeong, Ja Hyeon Ku, Cheol Kwak, Hyeon Hoe Kim, Seoul, Korea, Republic of MP82-09 PROSTATE SPECIFIC MEMBRANE ANTIGEN ANTIBODY DRUG CONJUGATE (PSMA ADC) IN PATIENTS (PTS) WITH PROGRESSIVE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) FOLLOWING ABIRATERONE AND/OR ENZALUTAMIDE (ABI/ENZ): RESULTS FROM A PHASE 2 STUDY Daniel Petrylak*, New Haven, CT, Nicholas Vogelzang, Las Vegas, NV, Kamal Chatta, Seattle, WA, Mark Fleming, Norfolk, VA, David Smith, Ann Arbor, MI, Leonard Appleman, Pittsburgh, PA, Arif Hussain, Baltimore, MD, Manuel Modiano, Parminder Singh, Tucson, AZ, Scott Tagawa, New York, NY, Ira Gore, Birmingham, AL, Ed McClay, Encinitas, CA, Anthony Mega, Providence, RI, Oliver Sartor, New Orleans, LA, Brad Somer, Memphis, TN, Raymond Wadlow, Fairfax, VA, Neal Shore, Myrtle Beach, SC, Nancy Stambler, Vincent DiPippo, Robert Israel, Tarrytown, NY MP82-10 PSMA-RADIOGUIDED SURGERY: INTRODUCING MOLECULAR SURGERY IN PATIENTS WITH RECURRENT PROSTATE CANCER Tobias Maurer*, Martina Weineisen, Hans- Jürgen Wester, Margret Schottelius, Asli Okur, Gregor Weirich, Hubert Kübler, Markus Schwaiger, Jürgen Erich Gschwend, Benjamin Frisch, Matthias Eiber, Munich, Germany MP82-11 IMPACT OF TUMOR VOLUME PERCENTAGE TO PROSTATE VOLUME ON THE RISK OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY Ohseong Kwon, Hakmin Lee, Jung Ki Jo, Young Ik Lee, Ki Bom Kim, In Jae Lee, Seongnam, Korea, Republic of, Choong Hee Noh, Seoul, Korea, Republic of, Jeong Hyun Kim, Chuncheon, Korea, Republic of, Jong Jin Oh, Sangchul Lee, Sung Kyu Hong, Seok-Soo Byun, Sang Eun Lee, Seong Jin Jeong*, Seongnam, Korea, Republic of MP82-12 OUTCOMES OF SALVAGE PROSTATE CRYOABLATION AFTER PRIMARY EXTERNAL BEAM RADIATION OR BRACHYTHERAPY: IS THERE A DIFFERENCE? Matthew Ingham*, Norfolk, VA, Ahmed El- Shafei, Cleveland, OH, Robert Given, Norfolk, VA, Stephen Jones, Cleveland, OH MP82-13 REDUCTION IN EARLY BIOCHEMICAL RECURRENCE INTERMEDIATE RISK PATIENTS UNDERGOING ROBOT- ASSISTED EXTENDED PELVIC LYMPHADENECTOMY FOR PROSTATE CANCER Bertram Yuh*, Pasadena, CA, Nora Ruel, Timothy Wilson, Duarte, CA MP82-14 THE PATTERN OF RECURRENT PROSTATE CANCER IN PN POST RADICAL PROSTATECTOMY HAS INDEPENDENT PROGNOSTIC CAPABILITY Marco Moschini*, Fabio Zattoni, Rochester, MN, Alberto Briganti, Milan, Italy, Eugene Kwon, Jeffrey Karnes, Rochester, MN MP82-15 DOES EARLY ANDROGEN DEPRIVATION THERAPY AFTER BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY INCREASE OVERALL SURVIVAL? RESULTS FROM SEARCH Stephen Freedland*, Lauren Howard, Durham, NC, Christopher Amling, Portland, OR, Matthew Cooperberg, San Francisco, CA, Christopher Kane, San Diego, CA, Martha Terris, Augusta, GA, William Aronson, Los Angeles, CA MP82-16 LONG-TERM CLINICAL RECURRENCE RATE IN PROSTATE CANCER (PCA) PATIENTS WITH ADVERSE PATHOLOGICAL CHARACTERISTICS AT ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP) Firas Abdollah*, Akshay Sood, Dane Klett, Jesse Sammon, Daniel Pucheril, Detroit, MI, Burkhard Beyer, Hamburg, Germany, Nicola Fossati, Giorgio Gandaglia, Nazareno Suardi, Milan, Italy, Craig Rogers, Wooju Jeong, James Peabody, Detroit, MI, Alexander Haese, Hamburg, Germany, Francesco Montorsi, Milan, Italy, Markus Graefen, Hamburg, Germany, Alberto Briganti, Milan, Italy, Mani Menon, Detroit, MI MP82-17 ONCOLOGICAL OUTCOMES IN PN1 PROSTATE CANCER (PCA) PATIENTS TREATED WITH ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP) Firas Abdollah*, Daniel Pucheril, Jesse Sammon, Akshay Sood, Dane Klett, Detroit, MI, Burkhard Beyer, Hamburg, Germany, Nicola Fossati, Giorgio Gandaglia, Nazareno Suardi, Milan, Italy, Hans Stricker, Wooju Jeong, James Peabody, Detroit, MI, Alexander Haese, Hamburg, Germany, Francesco Montorsi, Milan, Italy, Markus Graefen, Hamburg, Germany, Alberto Briganti, Milan, Italy, Mani Menon, Detroit, MI 266

279 MP82-18 EFFECT OF NEOADJUVANT DOCETAXEL CHEMOTHERAPY COMBINED WITH ADJUVANT CHEMOTHERAPY COMPARED WITH RADICAL PROSTATECTOMY ALONE IN PATIENTS WITH HIGH RISK PROSTATE CANCER Wansuk Kim*, Busan, Korea, Republic of, Cheryn Song, Hanjong Ahn, Seoul, Korea, Republic of MP82-19 CAN MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING PREDICT BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY? IMPLICATIONS FOR PREOPERATIVE STAGING AND SURGICAL PLANNING Richard Ho*, Arvin George, Thomas Frye, Steven Abboud, Raju Chelluri, Michele Fascelli, Nabeel Shakir, Annerleim Walton- Diaz, Sandeep Sankineni, Maria Merino, Baris Turkbey, Peter Choyke, Peter Pinto, Bethesda, MD MP82-20 PREOPERATIVE MULTIPARAMETRIC PROSTATE MRI IDENTIFIES PATIENTS AT RISK FOR LYMPH NODE INVOLVEMENT AT RADICAL PROSTATECTOMY Annerleim Walton Diaz, Steven Abboud*, Arvin George, Raju Chelluri, Michele Fascelli, Richard Ho, Thomas P Frye, Sandeep Sankineni, Maria J Merino, Baris Turkbey, Bradford J Wood, Peter L Choyke, Peter A Pinto, Bethesda, MD Tuesday, May 19, 2015 Podium Session 50 URODYNAMICS/INCONTINENCE/FEMALE UROLOGY: PELVIC PROLAPSE Room New Orleans Morial Convention Center Moderators: Shlomo Raz and Priya Padmanabhan 8:00 am - 10:00 am TUESDAY TIME NUMBER TITLE TIME NUMBER TITLE 8:00 PD50-01 BONE MORPHOGENETIC PROTEIN 1 IS UPREGULATED IN WOMEN WITH PELVIC ORGAN PROLAPSE Ali Borazjani*, Nathan Kow, Samantha Harris, Beri Ridgeway, Margot Damaser, Cleveland, OH 8:10 PD50-02 IMPACT OF MRI DEFECOGRAPHY ON CLINICAL EVALUATION AND SURGICAL MANAGEMENT OF PELVIC ORGAN PROLAPSE Maude Carmel*, Gaurav Khatri, April Bailey, Philippe Zimmern, Dallas, TX 8:20 PD50-03 SEXUAL FUNCTION IN FEMALE PATIENTS WHO UNDERWENT PELVIC FLOOR RECONSTRUCTION WITH FOLLOW-UP FOR A MINIMUM OF 5 YEARS Katsuhiko Sato*, Fuminori Sacurai, Akiko Ito, Yasutaka Murata, Daisaku Ashikari, Daisuke Obinata, Junichi Mochida, Kenya Yamaguchi, Satoru Takahashi, Tokyo, Japan 8:30 PD50-04 TRANSVAGINAL MESH INCREASES THE RISK OF BLEEDING AND ORGAN SURGICAL SITE INFECTION IN VAGINAL PELVIC RECONSTRUCTION SURGERY: RESULTS FROM A MULTI-INSTITUTIONAL PROSPECTIVELY MAINTAINED DATASET Devin Haddad*, Louis Krane, Gopal Badlani, Majid Mirzazadeh, Winston-Salem, NC 8:40 PD50-05 SURGICAL MANAGEMENT OF ICS/IUGA CLASS 1-4 TRANSVAGINAL MESH (TVM) PROLAPSE KIT COMPLICATIONS: 8-YEAR REVIEW OF 82 PATIENTS FROM A SINGLE CENTER Kirk Anderson*, Paul Knoll, Nicholas Westfall, Aurora, CO, Ketul Shah, Columbus, OH, Brian Flynn, Aurora, CO 8:50 PD50-06 PROLAPSE RECURRENCE AFTER TRANSVAGINAL MESH REMOVAL Tanner Rawlings*, Rebecca Lavelle, Burhan Coskun, Feras Alhalabi, Alana Christie, Philippe Zimmern, Dallas, TX 9:00 PD50-07 CYSTOCELE REPAIR WITH NON-FROZEN CADAVERIC FASCIA LATA: LONG-TERM RESULTS Jennifer Sung*, Los Angeles, CA, Kulwant Singh, Fontana, CA, Sharron Mee, Gary Leach, Los Angeles, CA 9:10 PD50-08 PREDICTORS OF REGRET AFTER COLPOCLEISIS FOR PELVIC ORGAN PROLAPSE: A SYSTEMATIC REVIEW Juzar Jamnagerwalla*, Karyn Eilber, Los Angeles, CA, Samantha Jagannathan, Saint Louis, MO, Niv Hakami-Majd, Eugene Shkolyar, Jennifer Anger, Los Angeles, CA 9:20 PD50-09 ASSESSMENT OF RATES OF CONCOMITANT SLING PLACEMENT AT TIME OF PELVIC ORGAN PROLAPSE SURGERY SINCE RELEASE OF THE 2011 FDA HEALTH NOTIFICATION Erin Ohmann*, Aqsa Khan, Benjamin Brucker, Scott Smilen, Nirit Rosenblum, Victor Nitti, New York, NY *Presenting author 267

280 9:30 PD50-10 ASSESSING THE LEARNING CURVE OF ROBOTIC SACROCOLPOPEXY Brian Linder*, Mallika Anand, Amy Weaver, Joshua Woelk, Christopher Klingele, Emanuel Trabuco, John Occhino, John Gebhart, Rochester, MN 9:40 PD50-11 PROLAPSE REPAIR WITH AND WITHOUT APICAL RESUSPENSION - PRACTICE PATTERNS AMONGST CERTIFYING AMERICAN UROLOGISTS Joceline S. Liu*, Matthias D. Hofer, Stephanie J. Kielb, Sarah C. Flury, Chicago, IL 9:50 PD50-12 COMPARISON OF OPERATIVE AND PERIOPERATIVE OUTCOMES BETWEEN ROBOTIC ASSISTED PROLAPSE REPAIR AND TRANSVAGINAL MESH REPAIR Priyanka Gupta*, Michael Ehlert, Kim A. Killinger, Judith A. Boura, Royal Oak, MI, Renee Cholyway, Brian Odom, Rochester, MI, Melissa Fischer, Jamie Bartley, Jason Gilleran, Larry T. Sirls, Royal Oak, MI Tuesday, May 19, 2015 Moderated Poster Session 83 PROSTATE CANCER: LOCALIZED IX Room New Orleans Morial Convention Center Moderators: Arieh Shalhav and William Catalona 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP83-01 TRANSPERINEAL MRI-TARGETED BIOPSY VERSUS TRANSPERINEAL TEMPLATE PROSTATE MAPPING BIOPSY IN THE DETECTION OF LOCALISED RADIO- RECURRENT PROSTATE CANCER Abi Kanthabalan*, Mohammed Abl-Azzeez, Manit Arya, Alex Freeman, Clare Allen, Alex kirkham, Shonit Punwani, Mark Emberton, Hashim Ahmed, London, United Kingdom MP83-02 COMBINATION OF MULTI-PARAMETRIC MAGNETIC RESONANCE IMAGING (MP- MRI) AND TRANSPERINEAL TEMPLATE- GUIDED MAPPING BIOPSY (TTMB) OF THE PROSTATE TO IDENTIFY CANDIDATES FOR HEMI-ABLATIVE FOCAL THERAPY Minh Tran*, James Thompson, Maret Boehm, Marley Pulbrook, Daniel Moses, Ron Shnier, Phillip Brenner, Warick Delprado, Anne- Maree Haynes, Richard Savdie, Phillip Stricker, Sydney, Australia MP83-03 NATURAL HISTORY OF MEN WITH A POSITIVE PROSTATE BIOPSY THAT IS OVERTURNED TO NEGATIVE AFTER A SECOND PATHOLOGICAL OPINION Eduardo Hernandez-Cardona*, Juan Serrano- Olmo, Ricardo Sanchez-Ortiz, San Juan, PR MP83-04 POTENTIAL FOR FAILURE OF FOCAL PROSTATE HEMI-ABLATION STRATEGIES Padraic O Malley*, Bashir Al Hussein Al Awamlh, Alexander M Sarkisian, Shiyi Jin, Daniel P Nguyen, Richard Lee, Douglas S Scherr, Christopher E Barbieri, Michael P Hermann, New York, NY MP83-05 THE EFFECT OF NERVE-SPARING ON URINARY CONTINENCE AFTER RADICAL PROSTATECTOMY: IS IT THE PRESERVATION OF THE NEUROVASCULAR BUNDLES OR THE SURGICAL TECHNIQUE WHICH LEADS TO IMPROVED CONTINENCE RATES? Derya Tilki*, Sascha Ahyai, Pierre Tennstedt, Markus Graefen, Hartwig Huland, Uwe Michl, Hamburg, Germany MP83-06 IS INVERSE STAGE MIGRATION A SUSTAINING PHENOMENON IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY? Andreas Becker*, Luis Kluth, Jens Hansen, Christian Meyer, Pierre Tennstedt, Lars Budaeus, Thomas Steuber, Felix K.H. Chun, Hamburg, Germany MP83-07 SALVAGE RADICAL PROSTATECTOMY FOR RECURRENT PROSTATE CANCER: VERIFICATION OF EAU GUIDELINE CRITERIA Philipp Mandel*, Thomas Steuber, Sascha Ahyai, Hamburg, Germany, Maximilian Kriegmair, Mannheim, Germany, Jonas Schiffmann, Hans Heinzer, Uwe Michl, Thorsten Schlomm, Alexander Haese, Hartwig Huland, Markus Graefen, Derya Tilki, Hamburg, Germany MP83-08 THIRTY YEARS OF RADICAL PROSTATECTOMIES AT A SINGLE TERTIARY CARE REFERRAL CENTER Paolo Dell Oglio*, Nazareno Suardi, Giovanni Lughezzani, Giorgio Gandaglia, Marco Bianchi, Nicola Fossati, Giuliana Lista, Roberta Lucianò, Massimo Freschi, Milan, Italy, Vincenzo Mirone, Naples, Italy, Giorgio Guazzoni, Patrizio Rigatti, Francesco Montorsi, Alberto Briganti, Milan, Italy 268

281 MP83-09 TO PREDICT A GOOD CANDIDATE WHO UNDERGO A PERMANENT IODINE-125 SEED IMPLANTATION IN RESPECT OF URINARY MORBIDITY FROM THE RESULTS OF A NATIONWIDE COHORT STUDY IN JAPAN Nobumichi Tanaka*, Kashihara, Japan, Atsunori Yorozu, Tokyo, Japan, Shinichiro Maruo, Shinsuke Kojima, Kobe, Japan, Toshio Ohashi, Tokyo, Japan, Norihisa Katayama, Okayama, Japan, Shiro Saito, Takushi Dokiya, Tokyo, Japan, Masanori Fukushima, Kobe, Japan, Hidetoshi Yamanaka, Takasaki, Japan, Kiyohide Fujimoto, Kashihara, Japan MP83-10 EXPRESSION OF ANDROGEN AND GLUCOCORTICOID RECEPTORS IN RESIDUAL CANCER CELLS AFTER NEOADJUVANT CHEMOHORMONAL THERAPY WITH DOCETAXEL FOR HIGH- RISK LOCALIZED PROSTATE CANCER Shintaro Narita*, Akita, Akita, Japan, Taketoshi Nara, Mingguo Huang, Hiroshi Tsuruta, Susumu Akihama, Mitsuru Saito, Takamitsu Inoue, Norihiko Tsuchiya, Shigeru Satoh, Tomonori Habuchi, Akita, Japan MP83-11 LONG-TERM PATIENT-REPORTED FUNCTIONAL OUTCOMES FOLLOWING OPEN, LAPAROSCOPIC, AND ROBOTIC- ASSISTED RADICAL PROSTATECTOMY PERFORMED BY HIGH VOLUME SURGEONS Boris Gershman*, Sarah Psutka, Rochester, MN, Francis McGovern, Douglas Dahl, Shahin Tabatabaei, Boston, MA, Matthew Gettman, Igor Frank, Rachel Carlson, Rochester, MN, Michael Barry, Michael Blute, Boston, MA, R. Jeffrey Karnes, Rochester, MN MP83-12 SALVAGE ROBOT-ASSISTED RADICAL PROSTATECTOMY FOR RECURRENT PROSTATE CANCER Andre Luis de Castro Abreu*, Monish Aron, Noah Swann, Los Angeles, CA, Srinivas Samavedi, Anthony Bates, Sanket Chauhan, Celebration, FL, Sameer Chopra, Raed Azhar, Kelvin Wong, Raj Satkunasivam, Charles Metcalfe, Los Angeles, CA, Tadzia Thurn, Celebration, FL, Osamu Ukimura, Mihir Desai, Inderbir Gill, Los Angeles, CA, Vipul Patel, Celebration, FL MP83-13 COMPARATIVE MORBIDITY OF ABLATIVE ENERGY BASED SALVAGE TREATMENTS FOR RADIO-RECURRENT PROSTATE CANCER Khurram Siddiqui*, Michele Billia, Clarisse R. Mazzola, Andrew Williams, London, Canada, Ali Al Zahrani, Dammam, Saudi Arabia, Joseph Chin, London, Canada MP83-14 PSYCHOSOCIAL DISTRESS, FEAR OF PROGRESSION AND NEED FOR PSYCHOSOCIAL TREATMENT IN SPORADIC AND FAMILIAL PROSTATE CANCER PATIENTS Kathleen Herkommer*, Anna Willms, Birgit Marten-Mittag, Peter Herschbach, Juergen Gschwend, Andreas Dinkel, Munich, Germany MP83-15 THE IMPACT OF NOT DETERMINABLE SURGICAL MARGINS AFTER RADICAL PROSTATECTOMY Sascha Ahyai*, Pierre Tenstedt, Felix Chun, Thorsten Schlomm, Corinna Widmer, Guido Sauter, Hartwig Huland, Markus Graefen, Derya Tilki, Hamburg, Germany MP83-16 HETEROGENEITY IN D AMICO LOW-RISK PROSTATE CANCER: DIFFERENCES IN UPGRADING AND UPSTAGING ACCORDING TO ACTIVE SURVEILLANCE ELIGIBILITY Sami-Ramzi Leyh-Bannurah*, Jonas Schiffman, Hans Heinzer, Georg Salomon, Thorsten Schlomm, Stefan Steurer, Guido Sauter, Burkhard Beyer, Katharina Boehm, Derya Tilki, Uwe Michl, Hartwig Huland, Markus Graefen, Lars Budäus, Hamburg, Germany, Pierre Karakiewicz, Montreal, Canada MP83-17 IMPACT OF INTRA-OPERATIVE TRANSFUSION ON SURVIVAL OF PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER UNDERGOING RADICAL PROSTATECTOMY Marco Moschini*, Milan, Italy, R. Jeffrey Karnes, Rochester, MN, Nazareno Suardi, Giorgio Gandaglia, Marco Bianchi, Nicola Fossati, Ettore Di Trapani, Andrea Gallina, Umberto Capitanio, Andrea Salonia, Francesco Montorsi, Alberto Briganti, Milan, Italy MP83-18 LYMPHATIC VESSEL INVASION PREDICTS BIOCHEMICAL RECURRENCE IN ORGAN CONFINED PROSTATE CANCER. RESULTS OF 2316 EUROPEAN PATIENTS WITHOUT LYMPHNODE DISSECTION Katharina Boehm*, Meike Adam, Hamburg, Germany, Alessandro Larcher, Milan, Italy, Jonas Schiffmann, Hamburg, Germany, Pierre Karakiewicz, Montreal, Canada, Hartwig Huland, Georg Salomon, Hamburg, Germany MP83-19 REAL-WORLD USE OF EPIC FOR CLINICAL PRACTICE (EPIC-CP) TO ASSESS PATIENT-REPORTED PROSTATE CANCER QUALITY-OF-LIFE IN THE CLINICAL SETTING Peter Chang*, Arie Carneiro, Ostap Dovirak, Kimberly Taylor, Catrina Crociani, Kyle McAnally, Boston, MA, Andrew Percy, Richmond, VA, Martin G Sanda, Atlanta, GA, Andrew A Wagner, Boston, MA TUESDAY *Presenting author 269

282 MP83-20 DISCORDANCE BETWEEN LOCATION OF POSITIVE CORES IN BIOPSY AND LOCATION OF POSITIVE SURGICAL MARGIN FOLLOWING RADICAL PROSTATECTOMY Ji Won Kim*, Dong Yeub Ham, Woo Suk Choi, Hyoung Keun Park, Sung Hyun Paick, Hyeong Gon Kim, Young Soo Lho, Seoul, Korea, Republic of Tuesday, May 19, 2015 Moderated Poster Session 84 KIDNEY CANCER: SURGICAL THERAPY VII Room New Orleans Morial Convention Center Moderators: Ithaar Derweesh and Vitaly Margulis 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP84-01 ISCHEMIA DURING NEPHRON-SPARING SURGERY RESULTS IN DECREASE OF OVERALL AND SPLIT FUNCTION OF THE KIDNEY Oleksandr Stakhovskyi*, Oleg Voylenko, Iurii Vitruk, Eduard Stakhovsky, Kiev, Ukraine MP84-02 DIFFERING KIDNEY FUNCTION OUTCOMES FOLLOWING KIDNEY CANCER SURGERY IN THE VETERANS HEALTH ADMINISTRATION Remy Lamberts*, Stanford, CA, I-Chun Thomas, Palo Alto, CA, Benjamin Chung, Geoffrey Sonn, Alice Fan, Sandy Srinivas, Todd Wagner, Glen Chertow, James Brooks, John Leppert, Stanford, CA MP84-03 CLINICAL, PATHOLOGICAL AND RENAL FUNCTIONAL OUTCOMES OF PARTIAL AND RADICAL NEPHRECTOMY IN ELDERLY PATIENTS Yajie An, Mark Ball*, Michael Gorin, Phillip Pierorazio, Mohamad Allaf, Baltimore, MD MP84-04 GENDER AND RACIAL DISPARITIES IN UTILIZATION OF PARTIAL NEPHRECTOMY FOR RENAL MASSES Shane Pearce*, Zoe Steinberg, Chicago, IL, Richard Zigeuner, Graz, Austria, Chaidir Mochtar, Jakarta, Indonesia, Guillermo Gueglio, Buenos Aires, Argentina, Arieh Shalhav, Scott Eggener, Chicago, IL, M. Pilar Laguna, Amsterdam, Netherlands MP84-05 VARIATION IN SURGICAL MARGIN STATUS BY SURGICAL APPROACH AMONG PATIENTS UNDERGOING PARTIAL NEPHRECTOMY FOR SMALL RENAL MASSES Jonathan E. Kiechle, Robert Abouassaly, William Tabayoyong*, Shan Dong, Cleveland, OH, Marc C. Smaldone, Philadelphia, PA, Edward E. Cherullo, Cleveland, OH, Cary P. Gross, New Haven, CT, Nilay D. Shah, Rochester, MN, Hui Zhu, Simon P. Kim, Cleveland, OH MP84-06 HISTOLOGY IMPACTS SURVIVAL OUTCOMES IN CONTEMPORARY PATIENTS UNDERGOING PRIMARILY PARTIAL NEPHRECTOMY FOR RENAL CELL CARCINOMA Daniel Nguyen*, Emily Vertosick, Renato Beluco Corradi, Antoni Vilaseca, Daniel Sjoberg, Nicole Benfante, Paul Russo, New York, NY MP84-07 RISK STRATIFICATION FOR ADVERSE OUTCOMES FOLLOWING RENAL MASS EXCISION Timothy Ito*, Philip Abbosh, Nikhil Waingankar, Mohammed Haseebuddin, Serge Ginzburg, Daniel Canter, David Chen, Richard Greenberg, Rosalia Viterbo, Alexander Kutikov, Marc Smaldone, Robert Uzzo, Philadelphia, PA MP84-08 PATHOLOGICAL UPSTAGING OF CLINICAL T1 RENAL CELL CARCINOMA: A MULTI-INSTITUTIONAL ANALYSIS OF OUTCOMES Jasmir Nayak*, Seattle, WA, Premal Patel, Jennifer Bjazevic, Winnipeg, Canada, Olli Saarela, Toronto, Canada, Zhihui Liu, Toronto, ON, Anil Kapoor, Hamilton, Canada, Simon Tanguay, Montreal, Canada, Antonio Finelli, Toronto, Canada, Ricardo Rendon, Halifax, Canada, Ron Moore, Edmonton, Canada, Rodney Breau, Ottawa, Canada, Jun Kawakami, Calgary, Canada, Peter Black, Vancouver, Canada, Darrel Drachenberg, Winnipeg, Canada MP84-09 MULTICENTER VALIDATION OF ABILITY OF SURGEON ASSESSMENT OF RENAL PRESERVATION IN COMPARISON TO MEASUREMENT WITH 3D IMAGE ANALYSIS Conrad Tobert*, Iowa City, IA, Toshio Takagi, Cleveland, OH, Michael Liss, Hak Lee, Ithaar Derweesh, San Diego, CA, Steven Campbell, Cleveland, OH, Brian Lane, Grand Rapids, MI 270

283 MP84-10 THE CONTEMPORARY INCIDENCE AND CONSEQUENCES OF RHABDOMYOLYSIS FOLLOWING RENAL SURGERY: A POPULATION-BASED ANALYSIS Francisco Gelpi-Hammerschmidt*, Ilker Tinay, Christopher Allard, Boston, MA, Li-Ming Su, Gainesville, FL, Mark Preston, Adam Kibel, Ye Wang, Deborah Hess, James Hwong, Boston, MA, Benjamin Chung, Stanford, CA, Steven Chang, Boston, MA MP84-11 NUTRITIONAL PREDICTORS OF PERIOPERATIVE COMPLICATIONS AND MORTALITY FOLLOWING RADICAL NEPHRECTOMY: A POPULATION-BASED ANALYSIS Sarah Psutka*, Kristine Thomsen, Elizabeth Habermann, Matthew Tollefson, Rochester, MN MP84-12 PATIENT-REPORTED QUALITY OF LIFE AND CONVALESCENCE AFTER MINIMALLY INVASIVE KIDNEY CANCER SURGERY Peter Chang*, Boston, MA, Jialin Mao, New York, NY, Kimberly Taylor, Ostap Dovirak, Arie Carneiro, Kyle McAnally, Catrina Crociani, Boston, MA, Andrew Percy, Richmond, VA, Andrew A Wagner, Boston, MA MP84-13 SELECTIVE ANGIOEMBOLIZATION FOR RENAL VASCULAR LESIONS FOLLOWING PARTIAL NEPHRECTOMY DOES NOT AFFECT CLINICAL AND RENAL FUNCTION OUTCOMES: A MATCHED SERIES COMPARISON Ilana Jacobs*, Asim Ozayar, Monica Morgan, Clayton Trimmer, Jeffrey Cadeddu, Jeffrey Gahan, Dallas, TX MP84-14 VARIABILITY IN GROWTH KINETICS OF SMALL RENAL MASSES ON ACTIVE SURVEILLANCE Hiten Patel*, Michael Johnson, Baltimore, MD, Peter Chang, Andrew Wagner, Boston, MA, James McKiernan, New York, NY, Mohamad Allaf, Philip Pierorazio, Baltimore, MD MP84-15 NATIONAL TRENDS OF LOCAL ABLATIVE THERAPY AMONG YOUNG PATIENTS WITH SMALL RENAL MASSES Jonathan E Kiechle*, Shan Dong, Robert Abouassaly, Hui Zhu, Edward E Cherullo, Cleveland, OH, Nilay D Shah, Rochester, MN, Dean Nakamoto, Cleveland, OH, Marc C Smaldone, Philadelphia, PA, Matthew M Cooney, Simon P Kim, Cleveland, OH MP84-16 CLINICAL RELEVANCE OF THE SMALL RENAL MASS AND IMPLICATION ON CLINICAL MANAGEMENT IN THE ELDERLY PATIENT Douglas Russell*, Mitchell Wachtel, Heiko de Riese, Allan Haynes, Werner de Riese, Lubbock, TX MP84-17 CONTEMPORARY PRACTICE PATTERNS FOR PATIENTS WITH STAGE IV RENAL CELL CARCINOMA: A NATIONAL CANCER DATABASE ANALYSIS Zachary Piotrowski*, Elizabeth Handorf, Alexander Kutikov, Nathan Peffer, Nikhil Wainganker, Mohammed Haseebuddin, Philadelphia, PA, Anthony Corcoran, East Setauket, NY, Simon Kim, Cleveland, OH, Stephen Boorjian, Rochester, MN, Robert Uzzo, Marc Smaldone, Philadelphia, PA MP84-18 SURGICAL MANAGEMENT FOR LOCAL RETROPERITONEAL RECURRENCE FOR RENAL CELL CARCINOMA AFTER RADICAL NEPHRECTOMY Arun Thomas*, Mehrad Adibi, Borregales Leonardo, Ly Hoang, Pheroze Tamboli, Surena Matin, Wood Christopher, Jose Karam, Houston, TX MP84-19 EXTENT OF LYMPH NODE DISSECTION IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA IS ASSOCIATED WITH BETTER SURVIVAL Dominic Tang*, Nashville, TN, Sanjay Patel, Chicago, IL, Daniel Barocas, Matthew Resnick, Sam Chang, Nashville, TN MP84-20 CHANGING PRACTICE PATTERNS FOR THE MANAGEMENT OF UPPER TRACT UROTHELIAL CARCINOMA WITH NEPHROURETERECTOMY: A 10-YEAR POPULATION-BASED ANALYSIS Francisco Gelpi-Hammerschmidt*, Christopher Allard, Jeffrey Leow, Ye Wang, Boston, MA, Benjamin Chung, Stanford, CA, Steven Chang, Boston, MA TUESDAY *Presenting author 271

284 Tuesday, May 19, 2015 Moderated Poster Session 85 TRANSPLANTATION & VASCULAR SURGERY: RENAL TRANSPLANTATION & VASCULAR SURGERY II Room New Orleans Morial Convention Center Moderators: Peter Bretan and Puneet Sindhwani NUMBER TITLE NUMBER TITLE MP85-01 GRAFT OUTCOME DISPARITY IN A SINGLE RENAL TRANSPLANT CENTER BASED ON RECIPIENT GEOGRAPHIC ORIGIN Weikai Qu, Ryan Flynn*, David Fumo, Timothy Suttle, Steven Selman, Michael Rees, Jorge Ortiz, Toledo, OH MP85-02 OPTIMAL MANAGEMENT OF DISTAL URETERIC STRICTURE FOLLOWING RENAL TRANSPLANTATION: A SYSTEMATIC REVIEW Justin Kwong*, Danielle Schiefer, Ghaleb Anas, Jason Archambault, Patrick Luke, Alp Sener, London, Canada MP85-03 PROSPECTIVE MEASUREMENT OF PLASMA NEUTROPHIL GELATINASE- ASSOCIATED LIPOPROTEIN IN LIVING KIDNEY DONOR NEPHRECTOMY Young Eun Yoon*, Seoul, Korea, Republic of, Kyung Hwa Choi, Seongnam-si, Korea, Republic of, Kwang Hyun Kim, Seung Choul Yang, Woong Kyu Han, Seoul, Korea, Republic of MP85-04 PREDICTIVE RISK FACTORS OF POST- TRANSPLANT HIGH-GRADE CMV REACTIVATION IN CMV-SEROPOSITIVE PATIENTS IN THE MODERN IMMUNOSUPPRESSIVE ERA Mitsuru Saito*, Shigeru Satoh, Hiroshi Tsuruta, Susumu Akihama, Takamitsu Inoue, Shintaro Narita, Norihiko Tsuchiya, Tomonori Habuchi, Akita, Japan MP85-05 RADICAL PROSTATECTOMY IN RENAL TRANSPLANT RECIPIENTS: COMPARISON OF FEASIBILITY AND PERIOPERATIVE OUTCOMES BASED ON SURGICAL APPROACH Benjamin A Sherer*, Krishnan Warrior, Oyedolamu Olaitan, Ajay Nehra, Leslie A Deane, Chicago, IL MP85-06 INCIDENCE AND MANAGEMENT OF BLADDER CANCER AFTER RENAL TRANSPLANTATION: A MULTIINSTITUTIONAL ANALYSIS Oscar Rodríguez Faba*, Claudia Caliolo, Joan Palou, Barcelona, Spain, Carlo Terrone, Novara, Italy, Javier Burgos, Enrique Lledó, Madrid, Spain, Alberto Breda, Barcelona, Spain MP85-07 RENAL TRANSPLANTATION AFTER RENAL TUMOUR EXCISION: A SYSTEMATIC REVIEW Jinna Yao*, Howard MH Lau, Richard Allen, Henry CC Pleass, Vincent WT Lam, Sydney, Australia 10:30 am - 12:30 pm MP85-08 INCIDENCE OF PROSTATE CANCER AFTER SOLID ORGAN TRANSPLANTATION AS A FUNCTION OF TIME Ethan B Fram*, Kara L Watts, Farhang Rabbani, Bronx, NY MP85-09 PREDICTIVE FACTORS AND FORMULA OF CHRONIC RENAL INSUFFICIENCY AFTER RADICAL NEPHRECTOMY Thibaut Benoit*, Xavier Game, Rouvellat Philippe, Nicolas Doumerc, Mathieu Roumiguie, Jean Baptiste Beauval, Michel Soulie, Pascal Rischmann, Bernard Malavaud, Toulouse, France MP85-10 PROSTATE CANCER SCREENING AND TREATMENT OF RENAL TRANSPLANT CANDIDATES: A SURVEY OF US TRANSPLANT CENTERS Greg Gin*, John Sfakianos, Reza Mehrazin, Susan Lerner, Courtney Phillips, New York, NY MP85-11 ARE KIDNEY TRANSPLANT PATIENTS WITH CLOSTRIDIUM DIFFICILE COLITIS AT INCREASED RISK FOR REJECTION? Chad A. Reichard*, Samuel C. Haywood, Daniel A. Shoskes, Cleveland, OH MP85-12 RISK FACTORS OF LOWER URINARY TRACT DYSFUNCTION AND SYMPTOMS AFTER SUCCESSFUL RENAL TRANSPLANTATION Takahiko Mitsui*, Ken Morita, Daiki Iwami, Takeya Kitta, Yukiko Kanno, Kimihiko Moriya, Nobuo Shinohara, Sapporo, Japan MP85-13 DYSLIPIDEMIA IN THE FIRST YEAR AFTER KIDNEY TRANSPLANTATION: INCIDENCE, CLINICAL CHARACTERISTICS, PHARMACOKINETICS OF IMMUNOSUPPRESSIVE DRUGS, AND RELATED GENOMIC POLYMORPHISMS Kazuyuki Numakura*, Shigeru Satoh, Norihiko Tsuchiya, Komine Naoki, Mitsuru Saito, Tkamitsu Inoue, Shintaro Narita, Hideaki Kagaya, Masatomo Miura, Tomonori Habuchi, Akita, Japan MP85-14 IS THERE A ROLE FOR PRECONDITIONING THE KIDNEY BEFORE WARM ISCHEMIA WITH SILDENAFIL? Khaled Mursi*, Mohamed El-Ghoneimy, Mohamed Badawy, Olfat Hammam, Soheir Mansy, Tarek Leithy, Ahmed Morsy, Cairo, Egypt 272

285 MP85-15 NEPHRECTOMY INDUCED CHRONIC KIDNEY DISEASE (CKD) AND THE HEALTH-RELATED QUALITY OF LIFE (HRQOL) OF LIVING KIDNEY DONORS (LKDS) Xiao Han*, Singapore, Singapore, Yu Ming Lim, Scotland, United Kingdom, Lata Raman, Bee Choo Tai, Hersharan Kaur, Ting Hui, Angeline Goh, Anantharaman Vathsala, Ho Yee Tiong, Singapore, Singapore MP85-16 TRANSIENT LYMPHOPENIA BREAKS COSTIMULATORY BLOCKADE-BASED TRANSPLANT TOLERANCE AND INITIATES ALLOGRAFT REJECTION Shoichi Iida*, Tokyo, Japan, Toshihiro Suzuki, Chiba, Japan, Kazunari Tanabe, Tokyo, Japan, Anna Valujskikh, Robert Fairchild, Cleveland, OH, Ryo Abe, Chiba, Japan MP85-17 IS PATIENT S BMI A DETERMINANT OF MORBIDITY IN RENAL TRANSPLANTATION? Vanessa Queruel*, Rémi Kabore, Adeline Guillaume, Karine Moreau, Karen Leffondre, Lionel Couzi, Pierre Merville, Alice Quinart, Julien Rogier, Patrick Tauzin-Fin, Jean-Marie Ferriere, Jean-Christophe Bernhard, BORDEAUX, France MP85-18 HEALTH-RELATED QUALITY OF LIFE (QOL) AFTER RADICAL RETROPUBIC PROSTATECTOMY (RRP) FOR LOCALIZED PROSTATE CANCER (PC) IN KIDNEY TRANSPLANT PATIENTS (KTX): LONG TERM RESULTS Ioannis Antonopoulos*, Bianca Moraes, Kleiton Ribeiro, Affonso Piovesan, Hideki Kanashiro, William Nahas, Sao Paulo, Brazil MP85-19 TREATMENT OF TRANSPLANT URETER STRICTURES WITH URETERAL DILATION AND URETERONEOCYSTOSTOMY: OUTCOMES FROM A 14 YEAR EXPERIENCE John Stoffel*, Randall Sung, Gary Faerber, James Shields, Stuart Wolf, Yihung Huang, Ann Arbor, MI MP85-20 NO IMPACT OF COLD ISCHEMIA TIME, OPERATIVE TIME, OR TIME OF DAY TRANSPLANT PERFORMED ON DECEASED DONOR RENAL TRANSPLANT GRAFT SURVIVAL WITH ALEMTUZUMAB INDUCTION Pamela Baron*, Felix Cheung, Michael Ernst, Bennet Hong, George Zhou, Carrie Lindower, Wayne Waltzer, Frank Darras, Stony Brook, NY TUESDAY Tuesday, May 19, 2015 Moderated Poster Session 86 PROSTATE CANCER: DETECTION AND SCREENING VII Room New Orleans Morial Convention Center Moderators: Daniel Barocas and William Aronson 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP86-01 INFECTIOUS COMPLICATIONS OF PROSTATE BIOPSY: THE CHANGES IN ANTIBIOTICS RESISTANCE PATTERNS THE REVIEW OF 10-YEAR PERIOD Ales Cermak*, Natalia Mareckova, Dalibor Pacik, Roman Wasserbauer, Brno, Czech Republic MP86-02 PREDICTIVE VALUE OF PATHOLOGIC PARAMETERS AND ERG ONCOPROTEIN EXPRESSION IN THE STRATIFICATION OF PROSTATE CANCER RISK ASSOCIATED WITH HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA (HGPIN) DIAGNOSIS IN PROSTATE NEEDLE BIOPSY Rajal Shah*, Irving, TX, Savvas Mendrinos, Union, NJ MP86-03 PREDICTION OF OVERALL AND CLINICALLY SIGNIFICANT CANCER RISK ON MRI-TARGETED AND SYSTEMATIC PROSTATE BIOPSY USING PREBIOPSY NOMOGRAMS Marc Bjurlin*, James Wysock, New York, NY, Saradwata Sakar, Rajesh Venkataraman, Grass Valley, CA, Xiaosong Meng, Michael Fenstermaker, Neil Mendhiratta, Gregory Fernandez, Andrew Rosenkrantz, Samir Taneja, New York, NY MP86-04 NOVEL TECHNIQUES OF THREE- DIMENSIONALLY DOCUMENTED BIOPSY- MAPPING ALLOW SERIAL MONITORING OF CELL-CYCLE PROGRESSION BY RE- VISITING CANCER FOCI Osamu Ukimura*, Mitchell Gross, Andre Luis de Castro Abreu, Raed Azhar, Toru Matsugasumi, Manju Aron, Inderbir Gill, Los Angeles, CA *Presenting author 273

286 MP86-05 FAILURE OF PROSTATE SPECIFIC ANTIGEN DECREASE BY FIFTY PERCENT FROM BASELINE FOLLOWING 5 ALPHA REDUCTASE INHIBITOR IS ASSOCIATED WITH HIGH POSITIVE RATE OF PROSTATE CANCER AT SUBSEQUENT BIOPSY IN REAL-LIFE SETTING Kenya Yamaguchi*, Akiko Ito, Daisaku Ashikari, Yasutaka Murata, Daisuke Obinata, Tsuyoshi Matsui, Katsuhiko Sato, Junichi Mochida, Yataro Yamanaka, Satoru Takahashi, Tokyo, Japan MP86-06 IMPACT OF PSA SCREENING ON STAGE MIGRATION OF PROSTATE CANCER: TRENDS IN CLINICOPATHOLOGIC CHARACTERISTICS OVER THE PAST 14 YEARS Myungsun Shim*, Myungchan Park, Aram Kim, In Gab Jeong, Cheryn Song, Choung- Soo Kim, Hanjong Ahn, Seoul, Korea, Republic of MP86-07 ASSOCIATION OF METFORMIN USE WITH PROSTATE CANCER INCIDENCE IN A PROSPECTIVE SCREENING TRIAL (ERSPC AARAU) Marco Randazzo*, Thomas Hermanns, Cedric Poyet, Zürich, Switzerland, Josef Beatrice, Andreas Huber, Rainer Grobholz, Aarau, Switzerland, Lukas Manka, Braunschweig, Germany, Stephen Wyler, Franz Recker, Maciej Kwiatkowski, Aarau, Switzerland MP86-08 CONFIRMATION: ANALYSIS OF PSA TRENDS HELPS IDENTIFY DEADLY PROSTATE CANCERS PRIOR TO BIOPSY R. Jeffrey Karnes*, Rochester, MN, Stacy Loeb, New York, NY, Preston C. Sprenkle, New Haven, CT, Christopher Morrell, Baltimore, MD, F. Roy MacKintosh, Lori Rawson, Reno, NV, Thomas Neville, Incline Village, NV MP86-09 INCIDENTAL FINDINGS ON MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING OF THE PROSTATE: PREVALENCE AND CLINICAL RELEVANCE Tatiana Martins*, Yves Bohrer, Thais Mussi, Ronaldo Baroni, São Paulo, Brazil MP86-10 CLINICAL PROSTATE CANCER RISK PREDICTION DERIVED FROM TARGETED BIOPSY Michael Leapman*, Katsuto Shinohara, Niloufar Ameli, Maxwell Meng, Matthew Cooperberg, Peter Carroll, San Francisco, CA MP86-11 PROSTATE SPECIFIC ANTIGEN VELOCITY AS A PREDICTIVE BIOMARKER IN A PROSPECTIVE PROSTATE CANCER SCREENING STUDY OF MEN WITH GENETIC PREDISPOSITION Christina G Selkirk*, Evanston, IL, Christos Mikropoulos, Sibel Saya, Elizabeth Bancroft, Tokhir Dadaev, Sutton, United Kingdom, Charles Brendler, Evanston, IL, Elizabeth Page, Daniel A Leongamornlert, Natalie Taylor, Edward J Saunders, Clara Cieza- Borrela, The IMPACT study collaborators, Sutton, United Kingdom, Sue Moss, London, United Kingdom, Zsofia Kote-Jarai, Sutton, United Kingdom, Brian T Helfand, Evanston, IL, Rosalind A Eeles, Sutton, United Kingdom MP86-12 REDEFINING THE DIGITAL RECTAL EXAMINATION OF THE PROSTATE Dara Lundon*, Dublin, Ireland, Stacy Loeb, New York, NY, Robert Foley, William Watson, Padraig Daly, Nicholas Hegarty, Kiaran O Malley, David Galvin, John Fitzpatrick, Dublin, Ireland MP86-13 INCREASED PROSTATE CANCER DETECTION WITH MAGNETIC RESONANCE IMAGING-ULTRASOUND FUSION BIOPSY IN MEN REQUIRING REPEAT BIOPSY Ramkishen Narayanan, Buffalo, NY, K. Kent Chevli*, David Cipolla, William Geary, Margaret Suraf, Michael Duff, Cheektowaga, NY MP86-14 DOES A SECOND CONFIRMATORY PSA ABOVE 4.0NG/ML LEAD TO THE DIAGNOSIS OF MORE CLINICALLY SIGNIFICANT PROSTATE CANCER? Ryan Werntz*, Wesley Stoller, Mark Garzotto, Portland, OR MP86-15 CREATION OF THE TORONTO BIOPSY AVOIDANCE TOOLS (T-BAT) WITH CLINICAL PARAMETER-ONLY AND ADIPOKINE BIOMARKER-AUGMENTED VERSIONS Bimal Bhindi*, Aza Mohammed, Haiyan Jiang, Robert Hamilton, Ants Toi, Antonio Finelli, John Trachtenberg, Alexandre Zlotta, Theodorus van der Kwast, Andrew Evans, Neil Fleshner, Girish Kulkarni, Toronto, Canada MP86-16 FATE OF PROSTATE CANCER ANTIGEN 3 (PCA3) LEVELS MORE THAN 100: DOES INFLAMMATION PLAY A ROLE?? Thamir Alkasab*, Girish Kulkarni, Robert Hamilton, Alexander Zlotta, Antonio Finelli, Michael Jewett, Neil Fleshner, Toronto, Canada MP86-17 CLINICALLY SIGNIFICANT INCIDENTAL PROSTATE CANCER DETECTED IN RADICAL CYSTOPROSTATECTOMY SPECIMENS Swar Shah*, Soroush Bazaragani, Gus Miranda, Hooman Djaladat, Anne Schuckman, Siamak Daneshmand, Los Angeles, CA 274

287 MP86-18 MRI TARGETED BIOPSY MAY ENHANCE DIAGNOSTIC PERFORMANCE OF SIGNIFICANT PROSTATE CANCER DETECTION COMPARED TO STANDARD TRANSRECTAL ULTRASOUND GUIDED BIOPSY: A SYSTEMATIC REVIEW AND META-ANALYSIS Ivo Schoots, Monique Roobol*, Arnout Alberts, Daan Nieboer, Chris Bangma, Ewout Steyerberg, Myriam Hunink, Rotterdam, Netherlands MP86-20 HIGH GRADE INTRAEPITHELIAL NEOPLASIA (HGPIN) IN AFRICAN AMERICAN MEN: SHOULD IMMEDIATE RE-BIOPSY BE RECOMMENDED? Ibraheem Malkawi*, Min Jun, Lira Chowdhury, Ranko Miocinovic, Detroit, MI MP86-19 IN-BORE MRI-GUIDED TARGETED PROSTATE BIOPSY (MRGTBX): PI RADS BASED PROSTATE CANCER DETECTION AND GLEASON UPGRADING ON 3T COMPARED TO TRUS BIOPSY IN MEN WITH ELEVATED PSA Wei Chan Lin*, Nelly Tan, Pooria Khoshnoodi, Daniel Margolis, David Lu, Steven Raman, Los Angeles, CA Tuesday, May 19, 2015 Moderated Poster Session 87 PROSTATE CANCER: ADVANCED III Room New Orleans Morial Convention Center Moderators: Joseph Renzulli, II and Thomas Keane NUMBER TITLE NUMBER TITLE MP87-01 DO PRIMARY HORMONAL THERAPY OUTCOMES PREDICT SUBSEQUENT RESPONSE TO ABIRATERONE OR ENZALUTAMIDE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER? Jonathan Hung, Rochester, MI, Andrew R. Taylor, George W. Divine, Detroit, MI, Jason M. Hafron*, Troy, MI, Clara Hwang, Detroit, MI MP87-02 PROGNOSTIC VALUE OF NEUTROPHIL- TO-LYMPHOCYTE RATIO AND ESTABLISHMENT OF NOVEL RISK STRATIFICATION MODEL IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS TREATED WITH DOCETAXEL CHEMOTHERAPY Yoshihiro Nakagami*, Jun Nakashima, Yoshio Ohno, Ohori Makoto, Masaaki Tachibana, Tokyo, Japan MP87-03 EVALUATION OF THE ER AGONIST, GTX-758 (250 MG DAILY), IN MEN WITH METASTATIC (MCRPC) AND NON- METASTATIC CASTRATION RESISTANT PROSTATE CANCER (NMCRPC) Evan Yu*, Seattle, WA, Michael Hancock, Memphis, TN, Tamás Babicz, Nyíregyháza, Hungary, William Aronson, Los Angeles, CA, Zsuzsanna Pápai, Lajos Géczi, Budapest, Hungary, Robert Getzenberg, Memphis, TN 10:30 am - 12:30 pm MP87-04 TIMING OF SALVAGE ANDROGEN DEPRIVATION THERAPY FOLLOWING PROSTATE RADIOTHERAPY DOES NOT ADVERSELY AFFECT ALL-CAUSE OR PROSTATE CANCER SPECIFIC SURVIVAL Daniel Sagalovich*, Michael Leapman, John Sfakianos, Simon Hall, Richard Stock, Nelson Stone, New York, NY MP87-05 INCREASING USE OF HOSPICE SERVICES FOR METASTATIC PROSTATE CANCER MODERATES THE ECONOMIC BURDEN OF HOSPITAL ADMISSIONS FOR METASTATIC PROSTATE CANCER Jesse Sammon*, Akshay Sood, Firas Abdollah, Dane Klett, Detroit, MI, Matthew Hayn, Adam Kibel, Boston, MA, James Peabody, Detroit, MI, Briony Varda, Boston, MA, Mani Menon, Detroit, MI, Quoc-Dien Trinh, Boston, MA MP87-06 NADIR TESTOSTERONE AFTER LONG- TERM FOLLOW-UP PREDICTS PROGNOSIS OF PROSTATE CANCER PATIENTS TREATED WITH COMBINED ANDROGEN BLOCKADE Shuhei Kamada*, Shinichi Sakamoto, Keisuke Ando, Ayumi Muroi, Miki Fuse, Koji Kawamura, Takashi Imamoto, Chiba city, Japan, Hiroyoshi Suzuki, Sakura city, Japan, Maki Nagata, Yokohama city, Japan, Naoki Nihei, Chiba city, Japan, Koichiro Akakura, Tokyo, Japan, Tomohiko Ichikawa, Chiba city, Japan TUESDAY *Presenting author 275

288 MP87-07 PROGNOSTIC FACTORS FOR OVERALL SURVIVAL IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER TREATED BY INTERMITTENT CHEMOTHERAPY WITH DOCETAXEL AND PREDNISOLONE Shintaro Narita*, Akita, Akita, Japan, Takuya Koie, Hirosaki, Japan, Shigeyuki Yamada, Kazuhiko Orikasa, Sendai, Japan, Shigeki Matsuo, Akita, Japan, Hiroshi Aoki, Shigeto Ishidoya, Sendai, Japan, Senji Hoshi, Yamagata, Japan, Norihiko Tsuchiya, Akita, Japan, Chikara Ohyama, Hirosaki, Japan, Yoichi Arai, Sendai, Japan, Tomonori Habuchi, Akita, Japan MP87-08 IS COMPUTERIZED TOMOGRAPHY A NECESSARY PART OF A PROSTATE CANCER METASTATIC WORKUP? RESULTS FROM SEARCH Brian Hanyok*, Lauren Howard, Durham, NC, Christopher Amling, Portland, OR, William Aronson, Los Angeles, CA, Matthew Cooperberg, San Francisco, CA, Christopher Kane, San Diego, CA, Martha Terris, Augusta, GA, Stephen Freedland, Durham, NC MP87-09 WHEN IS AN EQUIVOCAL BONE SCAN NOT REALLY EQUIVOCAL? RESULTS FROM SEARCH Brian Hanyok*, Lauren Howard, Durham, NC, Christopher Amling, Portland, OR, William Aronson, Los Angeles, CA, Matthew Cooperberg, San Francisco, CA, Christopher Kane, San Diego, CA, Martha Terris, Augusta, GA, Stephen Freedland, Durham, NC MP87-10 ALP AND BONE SCAN FLARE FOLLOWING ENZALUTAMIDE TREATMENT OF CASTRATION RESISTANT PROSTATE CANCER (CRPC) WITH BONE METASTASIS Senji Hoshi*, Kunihisa Nezu, Hidenori Kanno, Teppei Ookubo, Mituharu Sasaki, Kenji Numahata, Kiyotugu Hoshi, Satoru Kanto, Isoji Sasagawa, Yamagata, Japan, Yuuichi Ishizuka, Hideaki Izumi, Kunio Ono, Ishinomaki, Japan, Vladimir Bilim, Niigata, Japan MP87-11 ALKALINE PHOSPHATASE VELOCITY AS A PREDICTOR OF BONE METASTASIS AND OVERALL SURVIVAL IN CASTRATE RESISTANT PROSTATE CANCER PATIENTS Timothy Donahue*, Inger Rosner, Bethesda, MD, Jennifer Cullen, Huai-Ching Kuo, Lauren Hurwitz, Yongmei Chen, Rockville, MD, Melanie Bernstein, Jonathan Coleman, Daniel Danila, New York, NY, Adam Metwalli, Bethesda, MD MP87-12 RADIUM-223 DICHLORIDE IN EXPANDED- ACCESS SETTING IN THE UNITED STATES: OVERALL AND CONCURRENT EXPERIENCE WITH ABIRATERONE OR ENZALUTAMIDE Neal Shore*, Myrtle Beach, SC, Nicholas Vogelzang, Las Vegas, NV, Daniel Fernandez, Tampa, FL, Michael Morris, New York, NY, Andrei Iagaru, Stanford, CA, Alan Brown, Fort Myers, FL, Christopher Sweeney, Matthew R. Smith, Boston, MA, Adam P. Dicker, Yu-Ning Wong, Philadelphia, PA, Keith Bangerter, Jeremy Gratt, Oana Petrenciuc, Whippany, NJ, Oliver Sartor, New Orleans, LA MP87-13 IMPACT OF PRE-TREATMENT PSA LEVEL ON CANCER CONTROL AFTER EARLY SALVAGE RADIATION THERAPY POST RADICAL PROSTATECTOMY: NEED FOR PATIENT STRATIFICATION ACCORDING TO PROSTATE CANCER FEATURES Nicola Fossati*, Milan, Italy, R. Jeffrey Karnes, Rochester, MN, Cesare Cozzarini, Claudio Fiorino, Milan, Italy, Steven Joniau, Leuven, Belgium, Wolfgang Hinkelbein, Berlin, Germany, Karin Haustermans, Leuven, Belgium, Bertrand Tombal, Brussels, Belgium, Shahrokh F. Shariat, Vienna, Austria, Pierre I. Karakiewicz, Montreal, Canada, Gregor Goldner, Vienna, Austria, Francesco Montorsi, Milan, Italy, Hein Van Poppel, Leuven, Belgium, Thomas Wiegel, Ulm, Germany, Alberto Briganti, Milan, Italy MP87-14 ADJUVANT RADIOTHERAPY IN PROSTATE CANCER PATIENTS TREATED WITH SURGERY: THE IMPACT OF AGE AND TUMOR CHARACTERISTICS Firas Abdollah*, Dane Klett, Akshay Sood, Jesse Sammon, Detroit, MI, Quoc-Dien Trinh, Boston, MA, Francesco Montorsi, Alberto Briganti, Milan, Italy, James Peabody, Detroit, MI, Pierre Karakiewicz, Montreal, Canada, Mani Menon, Detroit, MI, Maxine Sun, Montreal, Canada MP87-15 RANDOMIZED PHASE 2 STUDY EVALUATING OPTIMAL SEQUENCING OF SIPULEUCEL-T AND ANDROGEN DEPRIVATION THERAPY (STAND) IN BIOCHEMICALLY RECURRENT PROSTATE CANCER: PRELIMINARY CLINICAL OUTCOMES Adam Kibel*, Boston, MA, Charles Drake, Baltimore, MD, George Adams, Homewood, AL, Lawrence Karsh, Denver, CO, Aymen Elfiky, Boston, MA, Neal Shore, Myrtle Beach, SC, Nicholas Vogelzang, Las Vegas, NV, John Corman, Robert Tyler, Johnathan Maher, Todd DeVries, Nadeem Sheikh, Seattle, WA, Emmanuel Antonarakis, Baltimore, MD 276

289 MP87-16 NOVEL ANTIANDROGEN ARN-509 IN HIGH-RISK NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER Neal D. Shore*, Myrtle Beach, SC, Emmanuel S. Antonarakis, Baltimore, MD, Charles J. Ryan, San Francisco, CA, William R. Berry, Raleigh, NC, Glenn Liu, Madison, WI, Celestia Higano, Seattle, WA, Edna Chow Maneval, San Diego, CA, Rajesh Bandekar, Spring House, PA, Carla J. de Boer, Leiden, Netherlands, Mary B. Todd, Raritan, NJ, Margaret K. Yu, Los Angeles, CA, Dana E. Rathkopf, New York, NY, Matthew R. Smith, Boston, MA MP87-17 EXPLORING THE INCIDENCE OF ABIRATERONE ACETATE WITHDRAWAL RESPONSES Rajasree Pia Chowdry*, Brian Lewis, Elisa Ledet, Jonathan Silberstein, Oliver Sartor, New Orleans, LA MP87-18 ASSESSMENT OF CORTICOSTEROID (CS)- ASSOCIATED ADVERSE EVENTS (AES) WITH LONG-TERM (LT) EXPOSURE TO LOW-DOSE PREDNISONE (P) GIVEN WITH ABIRATERONE ACETATE (AA) TO METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PATIENTS (PTS) Leonard G. Gomella*, Philadelphia, PA, Kim N. Chi, Vancouver, Canada, Johann S. de Bono, Sutton, United Kingdom, Karim Fizazi, Villejuif, France, Kurt Miller, Berlin, Germany, Dana E. Rathkopf, New York, NY, Charles J. Ryan, San Francisco, CA, Howard I. Scher, New York, NY, Neal D. Shore, Myrtle Beach, SC, Peter De Porre, Beerse, Belgium, Anil Londhe, Tracy McGowan, Horsham, PA, Nonko Pelhivanov, Raritan, NJ, Robert Charnas, Los Angeles, CA, Mary B. Todd, Raritan, NJ, Bruce Montgomery, Seattle, WA MP87-19 EFFECT OF ABIRATERONE ACETATE AND LOW DOSE PREDNISONE ON PROSTATE- SPECIFIC ANTIGEN IN PATIENTS WITH NON-METASTATIC CASTRATION- RESISTANT PROSTATE CANCER: THE RESULTS FROM IMPACT OF A BIRATERONE ACETATE IN PROSTATE- SPECIFIC ANTIGEN CORE STUDY Charles J. Ryan*, San Francisco, CA, E. David Crawford, Aurora, CO, Neal D. Shore, Myrtle Beach, SC, Willie Underwood, Buffalo, NY, Jim Wang, Jannell DePalantino, Anil Londhe, Zane Yang, Shawn Black, Tracy McGowan, Horsham, PA, Philip W. Kantoff, Boston, MA MP87-20 ANDROGEN RECEPTOR VARIANT-7 PLAYS AN ESSENTIAL ROLE IN DEVELOPMENT AND PROGRESSION OF CASTRATION-RESISTANT PROSTATE CANCER Yuanyuan Qu*, Dingwei Ye, Bo Dai, Hailiang Zhang, Yao Zhu, Shanghai, China, People s Republic of TUESDAY Tuesday, May 19, 2015 Moderated Poster Session 88 URODYNAMICS/INCONTINENCE/FEMALE UROLOGY: MALE INCONTINENCE: THERAPY Room New Orleans Morial Convention Center Moderators: TBD 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP88-01 OVEREXPRESSION OF NEUROTROPHINS IN BLADDER OVERACTIVITY IS MODULATED BY EXPRESSION OF MICRORNAS Subrata Pore*, Mahendra Kashyap, Naoki Yoshimura, Pradeep Tyagi, Pittsburgh, PA MP88-02 DEVELOPMENT OF A NOVEL ARTIFICIAL URINARY SPHINCTER (AUS): THE PRECISION MEDICAL DEVICES (PMD) FLOW CONTROL DEVICE (FCD) FOR MANAGEMENT OF SPHINCTERIC DEFICIENCY USING BLUETOOTH TECHNOLOGY Angelo Gousse, Miramar, FL, Peter Sayet, Fort Lauderdale, FL, Christopher Gomez*, Miami, FL *Presenting author 277

290 MP88-03 ARGUS-T DEVICE IN MALE URINARY INCONTINENCE: SHORT-TERM RESULTS IN 182 PATIENTS Salvatore Siracusano*, Trieste, Italy, Alexander Kugler, Gottingen, Germany, Michele Favro, Novara, Italy, Carlo Tallarigo, San Bonifacio - Verona, Italy, Francesco Visalli, Stefano Ciciliato, Trieste, Italy, Mauro Saccomanni, San Bonifacio - Verona, Italy, Laura Toffoli, Tommaso Silvestri, Renato Talamini, Trieste, Italy MP88-04 URINARY INCONTINENCE AND SATISFACTION WITH TREATMENTS AFTER ROBOTIC ASSISTED RADICAL PROSTATECTOMY Avinash Chennamsetty*, Hafron Jason, Royal Oak, MI, Behdod Poushanchi, Scott Pew, Rochester, MI, Jay Hollander, Kim Killinger, Mary Coffey, Kenneth Peters, Royal Oak, MI MP88-05 RETROPUBIC INTRACORPOREAL PLACEMENT OF SUBURETHRAL AUTOLOGOUS SLING DURING ROBOTIC RADICAL PROSTATECTOMY TO IMPROVE EARLY URINARY CONTINENCE RECOVERY: PRELIMINARY DATA Matteo Ferrari*, Matteo Luigi Zanoni, Mattia Nicola Sangalli, Fabio Fabbri, Massimo Ghezzi, Francesco Cristiano Sozzi, Patrizio Rigatti, Andrea Cestari, Milan, Italy MP88-06 THE MECHANISM OF ACTION OF THE MALE TRANSOBTURATOR SLING IS VIA INCREASED FUNCTIONAL LENGTH OF THE MEMBRANOUS URETHRA: A PROSPECTIVE, CONTROLLED STUDY USING DYNAMIC MRI John Patrick Selph*, Mustafa Bashir, Shubham Gupta, Michael J. Belsante, Durham, NC, Timothy Brand, Timothy Tausch, Tacoma, WA, Jessica Lloyd, Zachariah Goldsmith, Andrew Peterson, Durham, NC MP88-07 OBESITY IS ASSOCIATED WITH MALE TRANSOBTURATOR SLING FAILURE Divya Ajay*, John Selph, Michael Belsante, Durham, NC, Aaron Lentz, Raleigh, NC, Ngoc-Bich Le, George Webster, Andrew Peterson, Durham, NC MP88-08 EFFICACY AND SAFETY OF THE ADVANCE XP MALE SLING IN THE LONG- TERM FOLLOW-UP: RESULTS FROM A PROSPECTIVE TRIAL Alexander Kretschmer*, Markus Grabbert, Christian G. Stief, Ricarda M. Bauer, Munich, Germany MP88-09 ADVANCE XP MALE SLING: OUTCOME OF A PROSPECTIVE MULTICENTER STUDY Ricarda Bauer*, Benedikt Klehr, Munich, Germany, Christian Gozzi, Brixen, Italy, Alexander Kretschmer, Munich, Germany, Peter Rehder, Innsbruck, Austria, Florian May, Dachau, Germany, Christian Stief, Munich, Germany, Roland Homberg, Hamm, Germany, Peter Gebhartl, Voecklabruck, Austria MP88-10 IMPACT OF RADIOTHERAPY ON URINARY CONTINENCE AND QOL AFTER RADICAL PROSTATECTOMY Joanne Nyarangi-Dix*, Johannes Steimer, Hildegard Jakobi, Boris Hadaschik, Markus Hohenfellner, Heidelberg, Germany MP88-11 EXTERNAL BEAM RADIATION THERAPY AFTER MALE TRANSOBTURATOR SLING PLACEMENT INCREASES FAILURE RATES Divya Ajay*, John Selph, Michael Belsante, Ngoc-Bich Le, Durham, NC, Aaron Lentz, Raleigh, NC, George Webster, Andrew Peterson, Durham, NC MP88-12 EFFECTS OF RADIATION THERAPY ON DEVICE SURVIVAL AMONG INDIVIDUALS WITH ARTIFICIAL URINARY SPHINCTERS Marcelino Rivera*, Matthew Ziegelmann, Brian Linder, Boyd Viers, Laureano Rangel, Daniel Elliott, Rochester, MN MP88-13 MALE SLING AND ARTIFICIAL URETHRAL SPHINCTER FOR INCONTINENCE AMONGST CERTIFYING AMERICAN UROLOGISTS Joceline S. Liu*, Matthias D. Hofer, Jaclyn Milose, Daniel T. Oberlin, Sarah C. Flury, Chicago, IL, Allen F. Morey, Dallas, TX, Chris M. Gonzalez, Chicago, IL MP88-14 ARTIFICIAL URINARY SPHINCTER OUTCOMES IN OCTOGENARIANS Matthew J Ziegelmann*, Brian J Linder, Joshua Piotrowski, Boyd R Viers, David Barrett, Daniel S Elliott, Rochester, MN MP88-15 LOCATION OF AUS PRESSURE REGULATING BALLOON: FUNCTIONAL OUTCOMES OF HIGH SUBMUSCULAR POSITION ARE EQUIVALENT TO SPACE OF RETZIUS Nirmish Singla*, Jay Simhan, Jordan Siegel, Timothy Tausch, Allen Morey, Dallas, TX MP88-16 A PROSPECTIVE EVALUATION OF COMPLICATIONS AFTER ARTIFICIAL URINARY SPHINCTER PLACEMENT AND THEIR IMPACT ON DEVICE SURVIVAL Brian Linder*, Joshua Piotrowski, Matthew Zieglemann, Tanner Miest, Marcelino Rivera, Christina Ogle, Daniel Elliott, Rochester, MN MP88-17 NATIONAL MULTI-INSTITUTIONAL COMPARISON OF 30-DAY POSTOPERATIVE COMPLICATION AND READMISSION RATES FOR MALE URETHRAL SLINGS AND ARTIFICIAL URINARY SPHINCTERS Benjamin Breyer*, Amjad Alwaal, Catherine Harris, Thomas Gaither, Jack McAninch, Isabel Allen, San Francisco, CA MP88-18 DOES USE OF A SECOND CUFF IMPROVE ARTIFICIAL SPHINCTER EFFECTIVENESS? EVALUATION USING A COMPARATIVE CADAVER MODEL Madeleine Manka*, E. James Wright, Baltimore, MD 278

291 MP88-19 POST-OPERATIVE ANTIBIOTICS AFTER PRIMARY ARTIFICIAL URINARY SPHINCTER PLACEMENT DO NOT REDUCE INFECTION OR EROSION RATES J. Patrick Selph*, Michael Belsante, Divya Ajay, Aaron Lentz, George Webster, Ngoc- Bich Le, Andrew Peterson, Durham, NC MP88-20 SUCCESS RATES OF ARTIFICIAL URINARY SPHINCTER PLACEMENT FOLLOWING URETHROPLASTY Christopher Powell*, Travis Dum, Kansas City, KS, William Brant, Salt Lake City, UT, Joshua Broghammer, Kansas City, KS Tuesday, May 19, 2015 Moderated Poster Session 89 URODYNAMICS/INCONTINENCE/FEMALE UROLOGY: NON-NEUROGENIC VOIDING DYSFUNCTION Room New Orleans Morial Convention Center Moderators: Alan Wein and Deborah Lightner 10:30 am - 12:30 pm NUMBER TITLE NUMBER TITLE MP89-01 PUDENDAL NEUROMODULATION AFTER FAILED SACRAL STIMULATION Kenneth M. Peters*, Kim A. Killinger, Michael Ehlert, Priyanka Gupta, Jamie Bartley, Cheryl Wolfert, Judith A. Boura, Jason Gilleran, Royal Oak, MI MP89-02 SINGLE CENTER EXPERIENCE: SACRAL NEUROMODULATION REPROGRAMMING RATES Sara Lenherr*, Cynthia Stroup, Heather Crossley, Samuel Kaufman, Anne Cameron, John Stoffel, Ann Oldendorf, J. Quentin Clemens, Ann Arbor, MI MP89-03 THE IMPACT OF PRIOR BACK SURGERY ON UROLOGIC DIAGNOSES AND NEUROMODULATION OUTCOMES Priyanka Gupta*, Michael Ehlert, Jamie Bartley, Kim A. Killinger, Judith A. Boura, Jason Gilleran, Cheryl Wolfert, Kenneth M. Peters, Royal Oak, MI MP89-04 LONG-TERM EFFICACY OF SACRAL NERVE STIMULATION IMPLANTATION FOR NON-OBSTRUCTIVE URINARY RETENTION REFRACTORY TO MEDICAL THERAPY Charles Snyder*, James Cummings, Majdee Islam, Woodson Smelser, Columbia, MO MP89-05 CHARACTERISTICS OF SEASONAL VARIATIONS IN NOCTURIA Jin Wook Kim, Du Geon Moon, Young Tae Moon, Kyung Do Kim, Soon Chul Myung, Tae Hyoung Kim, In Ho Chang, Byung Hoon Chi, Se Young Choi, Seung Hyun Ahn, Jae Duck Choi, Jung Hoon Kim, Min Su Kim*, Jong Kyu Kwon, Seoul, Korea, Republic of, Seo Yeon Lee, Kyunggido, Korea, Republic of MP89-06 WHEN NOCTURIA IMPROVES, WHAT GETS BETTER? Joshua Aizen, Jonathan Gerber*, Komal Mehta, Jeffrey P. Weiss, Brooklyn, NY MP89-07 A NOMOGRAM FOR EVALUATION OF DETRUSOR CONTRACTILITY IN WOMEN Francoise Valentini*, Pierre Nelson, Paris, France MP89-08 UNDERACTIVE BLADDER IS NOT A SYMPTOM COMPLEX Melissa Laudano, Matthew Benedon, Michael Stern, Jerry Blaivas*, New York, NY MP89-09 COEXISITING DEPRESSIVE SYMPTOMS DO NOT LIMIT THE BENEFITS OF CHRONIC NEUROMODULATION Luke Edwards*, Jonathon Fergus, Peters Kenneth, Mike Ehlert, Priyanka Gupta, Jason Gilleran, Jamie Bartley, Kim Killinger, Judith Boura, Cheryl Wolfert, Janice Tomakowski, Royal Oak, MI MP89-10 THE IMPACT OF BASELINE FUNCTIONAL BLADDER CAPACITY ON NEUROMODULATION OUTCOMES Michael Ehlert*, Kim A. Killinger, Judith A. Boura, Jason Gilleran, Priyanka Gupta, Cheryl Wolfert, Jamie Bartley, Kenneth M. Peters, Royal Oak, MI MP89-11 CT-GUIDED SACRAL NEUROMODULATION S3 -A NEW TARGETED APPROACH AFTER INITIAL TREATMENT FAILURE: THE FIRST 10 PATIENTS Sophina Trubel*, Elsbethen, Austria, Elena Esra Foditsch, Günter Janetschek, Reinhold Posch-Zimmermann, Salzburg, Austria MP89-12 DOES A LOWER VOLTAGE ATTAINED FOR GOOD BELLOWS AND IPSILATERAL PLANTAR FLEXION WITH TINED LEAD PLACEMENT PORTEND A BETTER OUTCOME FOR OVERACTIVE BLADDER SYMPTOMS WITH SACRAL NEUROMODULATION? Serge Marinkovic*, Detroit, MI TUESDAY *Presenting author 279

292 MP89-13 ONABOTULINUMTOXIN A IN PATIENTS WITH A HISTORY OF PRIOR PELVIC RADIATION THERAPY David Flores*, Kansas City, KS, Stephen Mock, Nashville, TN, Joshua Broghammer, Tomas Griebling, Kansas City, KS, Roger Dmochowski, Nashville, TN, Priya Padmanabhan, Kansas City, KS MP89-14 COMPARISON OF ULTRASTRUCTURAL FEATURES IN FEMALE AND MALE BLADDER OUTLET OBSTRUCTION A POTENTIAL ROLE FOR DIAGNOSTIC DETRUSOR MUSCLE BIOPSY Audrey Wang, Susan Brammah, Vincent Tse, Lewis Chan*, Sydney, Australia MP89-15 NOMOGRAMS ALLOWING EVALUATION OF BLADDER OUTLET OBSTRUCTION (BOO) IN MEN FROM FREE UROFLOWS (FF) Francoise Valentini*, Pierre Nelson, Paris, France MP89-16 ASSOCIATIONS BETWEEN HUMAN AUTONOMIC NERVOUS SYSTEM ACTIVITY AND URINARY FREQUENCY USING 24-HOUR AMBULATORY ELECTROCARDIOGRAPHY Seiji Matsumoto*, Yuichiro Kawamura, Nobuyuki Sato, Naoyuki Hasebe, Hidehiro Kakizaki, Asahikawa, Japan MP89-18 TURP/KTPLAP: AN EFFECTIVE TREATMENT FOR MEN WITH DETRUSOR UNDERACTIVITY (DU) & BLADDER OUTLET OBSTRUCTION (BOO) Michael Tyler*, Matthew Benedon, Joshua Aizen, Anand Badri, Jeffrey Weiss, Jerry Blaivas, New York, NY MP89-19 INCREASE OF SUBMUCOSAL INFLAMMATION AND DECREASE OF UROTHELIAL BARRIER FUNCTION ARE FOUND IN PATIENTS WITH DETRUSOR UNDERACTIVITY - AN IMMUNOHISTOCHEMISTRY STUDY Shiu-Dong Chung*, New Taipei City, Taiwan, Jia-Hui Chang, Hann-Chorng Kuo, Hualien, Taiwan MP89-20 BDNF OVEREXPRESSION ALTERS THE PHENOTYPE OF CHOLINERGIC NEURONS IN RAT BLADDER Mahendra Kashyap*, Subrata Pore, Willam C Degroat, Christopher J Chermansky, Naoki Yoshimura, Pradeep Tyagi, Pittsburgh, PA MP89-17 DIFFERENT INJECTION NUMBER OF INTRAVESICAL ONABOTULINUMTOXINA INJECTION FOR OVERACTIVE BLADDER SYNDROME DOES NOT AFFECT TREATMENT OUTCOME - A PROSPECTIVE RANDOMIZED COMPARATIVE STUDY Chun-Hou Liao*, New Taipei City, Taiwan, Jing-Hui Tian, Hann-Chorng Kuo, Hualien, Taiwan Tuesday, May 19, 2015 Podium Session 51 STONE DISEASE: EVALUATION III Room New Orleans Morial Convention Center Moderators: Patrick Mufarrij and Matthew Dunn 10:30 am - 12:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 10:30 PD51-01 MULTI-CENTRE EVALUATION AND COMPARISON OF STONE SCORING SYSTEMS IN PREDICTING OUTCOMES AFTER PERCUTANEOUS NEPHROLITHOTOMY Thomas Tailly*, London, Canada, Zhamshid Okhunov, Irvine, CA, Brandon Nadeau, Melissa Huynh, Daniel Olvera-Posada, Husain Alenezi, Philippe Violette, London, Canada, Arash Akhavein, Gainesville, FL, Kevin Labadie, Irvine, CA, Justin Amann, London, Canada, Vincent Bird, Gainesville, FL, Jaime Landman, Irvine, CA, John Denstedt, Hassan Razvi, London, Canada 10:40 PD51-02 THE NATURAL HISTORY OF ASYMPTOMATIC RENAL STONES: A SYSTEMATIC REVIEW AND META- ANALYSIS Khurshid Ghani*, Abdulrahman Alruwaily, Mary Rogers, Maggie Bierlein, Whitney Townsend, Casey Dauw, J. Stuart Wolf, Jr, John Hollingsworth, Ann Arbor, MI 10:50 PD51-03 LEISURE TIME PHYSICAL ACTIVITY, SMOKING AND RISK OF RECENT UROLITHIASIS Michael Soueidan*, Susan J. Bartlett, Yasser A. Noureldin, Ross E. Andersen, Sero Andonian, Montreal, Canada 280

293 11:00 PD51-04 HYPERCALCIURIA: EVALUATION OF GENDER DIFFERENCE AND METABOLIC ABNORMALITIES John Lynam*, Omar Ayyash, Ahmadullah Daud, Ilan Kafka, Stephen Jackman, Timothy Averch, Pittsburgh, PA 11:10 PD51-05 THE BURDEN OF KIDNEY STONES IN PRIMARY CARE Melissa Mendez*, Michael Lipkin, Glenn Preminger, Charles Scales, Durham, NC 11:20 PD51-06 THE PERCPETION OF HAVING RENAL CALCULI MAY AFFECT DISEASE- SPECIFIC HEALTH-RELATED QUALITY OF LIFE IN ASYMPTOMATIC STONE PATIENTS Kristina L Penniston*, Brian C Sninsky, Stephen Y Nakada, Madison, WI 11:30 PD51-07 NUTRITIONAL INTAKE ASSESSMENT IN PATIENTS WITH UROLITHIASIS: A DECISION IMPACT ANALYSIS Avory Heningburg, Nashville, TN, Alana Desai, Alethea Paradis, Joel Vetter, Adrienne Kuxhausen, Leslie McIntosh, Anthony Juehne, Gerald Andriole, Brian Benway*, Saint Louis, MO 11:40 PD51-08 VITAMIN D DEFICIENCY TREATED WITH WEEKLY 50,000 IU VITAMIN D SUPPLEMENTATION INCREASES RENAL STONE RISK Sangtae Park*, Natalie Fahey, Brittany Lapin, Jaclyn Pruitt, Chi Wang, Evanston, IL 11:50 PD51-09 HIGH PREVALENCE OF KIDNEY STONES IN PEDIATRIC PATIENTS WITH ASTHMA Ganesh Kartha*, Suzy Comhair, Manoj Monga, Serpil C Erzurum, Cleveland, OH 12:00 PD51-10 OVERUTILIZATION OF CT IMAGING IN PATIENTS WITH KNOWN URINARY TRACT CALCULI Daniel Zainfeld*, Andrew Arther, Bradley Wilson, Jeffrey Holzbeirlein, David Duchene, Kansas City, KS 12:10 PD51-11 FACTORS PREDICTING SURGICAL INTERVENTION IN PEDIATRIC NEPHROLITHIASIS PATIENTS Esther Jun, Peter D. Metcalfe*, Todd R. Alexander, Edmonton, Canada 12:20 PD51-12 LOW URINE PH AND ASSOCIATED HYPOCITRATURIA ARE RISK FACTORS FOR URINARY STONE FORMATION IN ELDERLY STONE PATIENTS Young-Won Kim, Sung Pil Seo, Yunbyung Chae, Cheongju, Korea, Republic of, In- Chang Cho, Seoul, Korea, Republic of, Hoon Jang, Daejun, Korea, Republic of, Tong- Wook Kim, Cheongju, Korea, Republic of, Hyung-Jee Kim, Cheonan, Korea, Republic of, Won Tae Kim*, Yong-June Kim, Seok Joong Yun, Wun-Jae Kim, Sang-Cheol Lee, Cheongju, Korea, Republic of TUESDAY Tuesday, May 19, 2015 Podium Session 52 INFERTILITY: EVALUATION Room New Orleans Morial Convention Center Moderator: Ates Kadioglu 10:30 am - 12:30 pm TIME NUMBER TITLE TIME NUMBER TITLE 10:30 PD52-01 CYSTIC FIBROSIS TRANSMEMBRANE REGULATOR (CFTR) GENE SEQUENCING IDENTIFIES DIFFERENT MUTATIONS WHEN COMPARED WITH ROUTINE MUTATION SCREENING IN AZOOSPERMIC MEN Alexander W. Pastuszak*, Evan P. Wenker, Tariq S. Hakky, Aravind Chandrashekar, Ranjith Ramasamy, Dolores J. Lamb, Larry I. Lipshultz, Houston, TX 10:40 PD52-02 ULTRA-STRUCTURAL DEFECTS IN IMMOTILE SPERM: CHARACTERIZATION OF ELECTRON MICROSCOPY FINDINGS Ryan Flannigan*, Vancouver, Canada, Jared M. Bieniek, Brendan Mullen, Ethan D. Grober, Kirk C. Lo, Keith A. Jarvi, Toronto, Canada 10:50 PD52-03 CYTOGENETIC ABNORMALITIES IN MEN WITH SUBFERTILITY. ANALYSIS OF THE FREQUENCY OF ABNORMALITIES AND DETERMINATION OF A THRESHOLD SPERM CONCENTRATION FOR GENETIC TESTING Amr Abdel Raheem*, Francesco De Luca, Saad Abumelha, Tet Yap, Fahd Almashat, Giulio Garaffa, Nim Christopher, Suks Minhas, David Ralph, London, United Kingdom 11:00 PD52-04 FLUORESCENCE IN-SITU HYBRIDIZATION DETECTS INCREASED SPERM ANEUPLOIDY IN MEN WITH RECURRENT PREGNANCY LOSS Ranjith Ramasamy*, Jason Scovell, Houston, TX, Jason Kovac, Indianapolis, IN, Peter Cook, Larry Lipshultz, Dolores Lamb, Houston, TX *Presenting author 281

294 11:10 PD52-05 THE CLINICAL VALUE OF ASSESSING SPERM CHROMOSOMAL ANEUPLOIDY IN COUPLES UNDERGOING FAILED INTRACYTOPLASMIC SPERM INJECTION (ICSI) AND ITS CORRELATION WITH SEMEN PARAMETERS Fahad AlMashat*, Tet Yap, Shabana Bora, George Rozis, Saad Abumelha, Hossam Abdalla, Yau Thum, Suks Minhas, London, United Kingdom 11:20 PD52-06 LOW BIRTH WEIGHT IS ASSOCIATED WITH A HIGHER RATE OF HEALTH- SIGNIFICANT COMORBIDITIES AND WORSE SEMINAL PARAMETERS RESULTS OF A CROSS-SECTIONAL STUDY IN PRIMARY INFERTILE PATIENTS Luca Boeri, Paolo Capogrosso, Eugenio Ventimiglia, Alessandro Serino, Giovanni La Croce, Angela Pecoraro*, Marco Paciotti, Silvia Ippolito, Giulia Castagna, Roberta Scano, Milan, Italy, Rocco Damiano, Catanzaro, Italy, Francesco Montorsi, Andrea Salonia, Milan, Italy 11:30 PD52-07 TIME FOR PUBLIC HEALTH ACTION ON INFERTILITY: UPDATES FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION Lee Warner*, steve schrader, Richard Wang, atlanta, GA 12:00 PD52-10 VALIDATION OF THE AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE GUIDELINES/RECOMMENDATIONS IN CAUCASIAN-EUROPEAN MEN PRESENTING FOR COUPLE S INFERTILITY Eugenio Ventimiglia*, Giovanni La Croce, Paolo Capogrosso, Luca Boeri, Alessandro Serino, Giulia Castagna, Angela Pecoraro, Marco Paciotti, Silvia Ippolito, Dana Kuefner, Roberta Scano, Milan, Italy, Rocco Damiano, Catanzaro, Italy, Francesco Montorsi, Andrea Salonia, Milan, Italy 12:10 PD52-11 EFFICACY OF STANDARDIZED NURSING FERTILITY COUNSELING ON SPERM BANKING RATES IN CANCER PATIENTS Katherine Rotker*, Hari Vigneswaran, Danly Omil-Lima, Grayson Baird, Mark Sigman, Kathleen Hwang, Providence, RI 12:20 PD52-12 THE IMPACT OF HYPERTENSION AND ANTIHYPERTENSIVES ON SEMEN QUALITY David Guo*, Shufeng Li, Barry Behr, Michael Eisenberg, Palo Alto, CA 11:40 PD52-08 INEQUITY BETWEEN MALE AND FEMALE INFERTILITY COVERAGE IN STATE INSURANCE LAWS James Dupree*, Ann Arbor, MI, Ryan Dickey, Larry Lipshultz, Houston, TX 11:50 PD52-09 OUT OF POCKET COSTS OF MALE INFERTILITY CARE AND ASSOCIATED FINANCIAL STRAIN Peter Elliott*, Los Angeles, CA, Matthew Abad-Santos, Patti Katz, James Smith, San Francisco, CA 282

295 2015 Annual Meeting Exhibits (as of April 9, 2015) Booth(s) Booth(s) Booth(s) 21st Century Oncology LLC 1006 Empower Pharmacy 2147 Medispec Ltd DSystems, Simbionix Products 953 EMS Electro Medical Systems S.A. 907 Medivation, Inc. 561 A&E Endoscopy 1821 Encore, Inc MedReviews, LLC 1457 A.M.I. Gmbh 2443 Endo Pharmaceuticals Inc. 117 Med-Sonics 1550 Abbott Molecular 2437 Endo Pharmaceuticals Inc. 937 Medtronic 825 AbbVie 1323 Endocure Technologies 1952 Merck & Co., Inc 2417 Accordion Medical 261 Endourological Society, Inc meridianemr and UroChartEHR 509 Actavis Pharma 1917 Enovative Technologies 2204 Metamark Genetics, Inc Advanced Endoscopy Devices, Inc ERBE USA, Inc Mianyang Meike Electronic Equipment Allergan 517 Essia Health 2017 Co., Ltd 2110 AllMeds Specialty Practice Services 1461 Ethicon Biosurgery 2203 Microsurgery Instruments, Inc AmbiMedInc European Association of Urology 1940 MIM Software Inc American College of Cryo Surgery 2302 Exact Imaging (formerly Imagistx) 917 MiMedx 1446 American Medical Endoscopy / Strauss Ferring Pharmaceuticals Inc Mimic Technologies, Inc. 755 Surgical 857 First Quality Products 2201 Ministry Health Care 1918 AMS, an Endo International Company 1337 FMD, LLC 941 Miraca Life Sciences 1927 AnazaoHealth Corporation 1448 Galil Medical USA 801 Mission Pharmacal Company 1701 Ashlar Medical, LLC 1758 GE Healthcare 1016 MMS-USA, Inc ASSI-Accurate Surgical & Scientific Inst 1652 Genentech 2619 Modernizing Medicine 2027 Astellas Pharma US 1017 GenomeDx Biosciences 2529 Myriad Genetic Laboratories, Inc AUA History Booth 637 Genomic Health, Inc Nanovibronix 2408 AUA RESIDENTS BOWL 1401 Global Medical Endoscopy, Inc National Institute of Diabetes & AUA Resource Center 1529 Global Men s Health Digestive & Kidney Diseases 2644 Augmenix 761 Foundation-Panama Summit 1856 Neomedics 2208 Bard 301 Greenwald Surgical Company, Inc. 945 NeoTract, Inc Bavarian Nordic 1753 Hawaiian Moon 2057 New York Section, AUA 2522 Bayer HealthCare 2225 Healthmate International, LLC 2719 NextMed 1837 Beckman Coulter, Inc HealthTronics 309 North Central/South Central/ Beijing Weili New Century Science & Histosonics, Inc Southeastern Sections AUA 1762 Technology Co Hitachi Aloka Medical 1601 Northgate Technologies 864 Best Medical International 863 HRA Healthcare Research & Analytics 2114 Nurse Rosie Products 2246 Biobot Surgical PTE LTD 2617 ICU Theater 1043 NxThera, Inc biolitec biomedical technology, GmbH 353 Imprimis Pharmaceuticals, Inc Nymox Pharmaceutical Corporation 1825 BK Ultrasound 747 INEX Surgical Inc Olympus America Inc. 101 Bolang Endoscope 2306 Infinite Therapeutics 2053 OPKO Health INC Boston Scientific 137 InPracSys 1653 Optical Integrity, Inc Bostwick Laboratories 2137 Intellisphere LLC 1548 Orascoptic 2202 Business & Beignets 1961 International Kidney Stone Institute 2006 Otto Trading 1930 Byram Healthcare 2265 International Society For Sexual Pacific Edge 1922 Calcula Technologies Inc 2112 Medicine 1827 Patient Prompt 2206 Canadian Urological Association 2010 Intl. Continence Society 1561 PercuVision, LLC 2523 Care Credit 2308 Intuitive Surgical 317 PersonalizeDx 1450 CareCloud 1920 Invivo 1541 PFM Medical 2021 Caresono Technology Co., Ltd. 862 IU Kelley School of Business, Photocure 1001 Carilion Clinic 2304 Physican MBA 2524 Physician Owned Surgery Centers 2717 Case Recruiters 2009 IVUmed 1026 PracticeLink.com 2248 Cellay Inc Janssen Biotech, Inc Profound Medical 1659 Chinese Urological Association 1865 Japanese Urological Association 1962 Progenics Pharmaceuticals, Inc Citizens Memorial Hospital 2156 Kaiser Permanente 1024 Progressive Medical Inc Clarus Medical, Clearwater, Inspektor 1560 KARL STORZ Endoscopia - Latino Prometheus Laboratories Inc Cogentix Medical 1523 America 453 Prostate Conditions Education Council 1046 Colegio Mexicano de Urología KARL STORZ Endoscopy - America, Inc Prostate Conditions Education Council 1048 Nacional A.C Keeler Instruments Inc. 949 Prosurg, Inc Coloplast Corp. 445 Klein Surgical, Inc 1044 Pulse Systems Inc Community Health Systems 1858 Koelis 2108 QDX Pathology Services 647 Confederacion Americana de Urologia1859 LABORIE 607 Quanta System SPA 553 Convergent Laser Technologies 807 Leiter s Compounding 2307 Quill/Surgical Specialties 2400 Cook Medical 1201 LEONI Fiber Optics, Inc Raja and Associates 2539 CoreTherm Medical, Inc LifePoint Hospitals 2023 Realton Corporation 1760 Corinth MedTech 1357 LISA Laser USA 2237 REFLEXONIC, LLC 701 CryoLife 1926 LocumTenens.com 2419 Retrophin 2412 CS Surgical, Inc 1849 LP Surgical Fibers (formerly Laser Richard Wolf Medical Instruments 837 C-SATS, Inc 2518 Peripherals) 2200 Richard Wolf Medical Instruments 943 Cubist Pharmaceuticals 1953 Lumenis, Inc Rocamed 2445 dbmedx, Inc Magic Race LLC 601 Rose Micro Solutions 1052 Dendreon 437 Mallinckrodt Pharmaceuticals 2005 Rose Micro Solutions 1852 Designs for Vision, Inc Marina Medical Instruments 2152 Rose Micro Solutions 1916 Dianon-Litholink Corporation 1040 MasterPharm Compuounding Rose Micro Solutions 2537 Direx 359 Pharmacy 2636 Russer Brasil Ltda 2117 Dornier MedTech 151 MaxiFlex, LLC 2103 SafeOp Surgical, Inc 1759 Dr. Fuji 2310 McAirlaids Inc Sagent Pharmaceuticals 905 Dysaer 2253 Mcube Technology Co., Ltd Samsung Electronics America 2207 Ecleris USA 2352 MDxHealth 2125 Sanofi 1347 EDAP-TMS 925 Med Fibers, Inc. 963 ScribeAmerica 2300 Edgepark Medical Supplies/UroMed 2402 Meda Co., LTD 1455 Sedation Systems LLC 2631 Egyptian Urological Association 1956 MedEvolve 2255 SH Medical Corporation 1654 Eigen 817 Medical Imaging Innovations 1054 Shenzhen Huikang Medical Apparatus Elite Medical Scribes 2718 Medical Lasers Direct 2244 Co. LTD ELMED Medical Systems 161 Medifix Inc Siemens Healthcare 337 Elsevier 1801 Mediplus 1559 Sigma Tau Pharmaceuticals

296 Signostics Limited 2736 Simulated Surgical Systems, LLC 1454 Snap On Optics 1944 Snap On Optics 2313 Sociedad Argentina de Urologia 1857 Sociedad Dominicana de Urologia 1863 Sociedad Mexicana de Urologia, A.C Sociedad Peruana de Urologia 1958 Sociedade Brasileira de Urologia 1855 Societe Internationale D Urologie 1028 Society of Government Service Urologists 1563 Society of Nuclear Medicine and Molecular Imaging 1854 Sonacare Medical 501 Sontec Instruments 1000 Sony Electronics 2154 Special Surgery Resources & Repair, Inc SpermCheck 2410 Springer 2629 SRS Medical Corp Staff Care 2305 Stryker Endoscopy 957 Supramedical LLC 961 Surgical Tables, Inc SurgiQuest 461 SurgiTel/General Scientific 2301 Swan Valley Medical 901 TaeWoong Medical Co., LTD Tecnofarma 2353 Teleflex 1447 The Prometheus Group 2217 TheraCoat 1351 Thomas Health Systems Physician Parmers 2721 Tolmar Pharmaceuticals 2245 TOTO 1355 Townsend Surgical 1817 United Endoscopy 1900 United Medical Systems, Inc Universal Hospital Services 1757 University Compounding Pharmacy 2047 UroGPO 2728 UroGyn Medical, Inc Urology Times 1829 UroPath Diagnostics 1946 USMD, Inc Utah Medical Products, Inc Vantage Oncology 2421 Vascular Technology 653 Vasectomystore.com 2143 VasectoPeaz, a product of FrozenPeaz 1546 Verathon Medical 1909 Vesiflo, Inc Vox Scripta LLC 2716 Well Lead Medical Co. Ltd. 860 WeShare 2519 Western Section, AUA 1565 Wiley 2406 Wolters Kluwer Health 2303 Xodus Medical 2101 Zephyr Surgical Implants 2109 ZyDoc Transcription

297 A Aaron, Lorne MP1-03 Abacan, Allyssa MP43-05 Abad-Santos, Matthew MP74-16, PD52-09 Aballa, Teodoro MP74-15 Abara, Emmanuel Okechukwu p235 Abaza, Ronney MP59-15, PD18-05, PD18-06, p154 Abbas, Mahmoud MP26-04 Abbasoglu, Semra MP34-12 Abbosh, Philip MP47-04, MP47-20, MP67-14, MP70-04, MP84-07, PD49-04 Abbotoy, Daniel MP59-06 Abbott, Joel E. MP57-11 Abboud, Steven MP14-16, MP17-13, MP48-04, MP82-19, MP82-20, PD4-10, PD30-02, PD38-05, PD44-06 Abboudi, Hamid MP23-20 Abd El-Hakium, Amr MP48-10 Abd Elmageed, Zakaria PD36-05 Abdalla, Hossam PD52-05 Abdel Mageed, Asim PD36-05 Abdel Raheem, Amr PD52-03 Abd-El-Barr, Abd-El-Rahman MP54-07 Abdel-Bary, Ahmed MP48-10 Abdel-Gawad, Mahmoud PD4-01 Abdelhamed, Amr PD37-07 Abdel-Hamid, Mohamed MP38-12, PD23-05 Abdel-Karim, Aly V11-12 Abdel-Mageed, Asim MP15-19 Abdel-Rahim, Mona A. PD23-05 Abdel-Raouf, Romayla PD23-05 Abdelrazzak, Omar MP38-12 Abdelsalam, Yasser MP40-01 Abdelsayed, George MP14-01 Abdelwahab, Osama MP3-08, PD40-11 Abdi, Hamid MP1-07 Abdi, Hamidreza MP77-01, PD31-09 Abdo, Carmita MP43-17 Abdollah, Firas MP4-14, MP4-16, MP9-08, MP9-14, MP24-06, MP32-08, MP48-13, MP54-07, MP56-02, MP56-03, MP56-05, MP56-16, MP56-18, MP59-03, MP60-01, MP62-01, MP64-13, MP65-19, MP67-05, MP73-11, MP73-19, MP77-10, MP77-12, MP77-13, MP78-01, MP78-15, MP78-19, MP79-04, MP82-02 Abdul-Muhsin, Haidar MP71-09, MP71-15, PD5-11, V8-11 Abdulwahab-Ahmed, Abdullahi MP75-11 Abe, Ryo MP85-16 Abe, Takashige MP45-01, MP58-18, V11-06 Abedi, Garen PD7-04, PD13-04 Abel, E. Jason MP26-08, MP26-09, MP35-17, MP39-15, MP44-16, MP59-04, PD4-08, PD35-05, PD35-11, p10 Abele, John p100 Aben, Katja MP65-10 Aberger, Michael V3-11 Abern, Michael MP14-13, MP53-12, MP59-01 MP Moderated Poster Session, PD Podium Session FRI-II History Forum I-II, p page AUTHOR INDEX Abl-Azzeez, Mohammed MP83-01 Aboalsamh, Ghaleb MP79-13 Abol-Enein, Hassan MP67-01, PD23-01, PD41-07, p58, p59, p237 Aboody, Karen MP49-17, MP61-03 Abou, Diane MP46-19 Abou Farha, Osama p234 Abouassaly, Robert MP16-10, MP44-10, MP56-06, MP57-06, MP69-08, MP84-05, MP84-15, PD29-07, PD44-05, p100 Abouelleil, Mourad MP39-02, V7-06 Aboumarzouk, Omar MP28-10 Aboumohamed, Ahmed MP7-03, MP44-06, PD9-09, PD49-10, V3-05 Abouzeid, Abdel p234 Abraham, George V5-05 Abraham, Nitya PD28-08, V2-01 Abrahamsson, Per-Anders p190 Abrams, Paul p21 Abrams, Scott PD33-10 Abramson, Richard D. MP45-14 Abrate, Alberto MP6-07 Abreu Clavijo, Diego PD29-04 Abreu, Andre MP63-05, PD31-04 Abreu, Andre Luis De Castro MP86-04, PD9-07 Abshire, Caleb PD15-10 Abu-Ghanem, Yasmin MP59-11, MP80-06 Abumelha, Saad PD48-08, PD52-03, PD52-05 Acevedo, Alice C. MP31-10 Acevedo, Joe PD45-05 Acher, Peter MP62-13 Ackerman, Anicka MP20-14 Ackerman, Anne L. MP11-17 Ackerman, Lenny V2-03 Acuna, Juan MP26-15 Adam, Meike MP83-18 Adams, George MP87-15 Adams, George W. MP6-12 Adams-Huet, Beverley MP41-14 Adank, Jean-Pascal MP66-05 Adejoro, Oluwakayode MP10-07, MP65-12, PD17-04 Aden, James PD21-10 Adibi, Mehrad MP84-18 Adler, Howard L. FRII-02 Adomat, Hans MP46-06, MP46-14 Adsul, Prajakta MP18-15 Advani, Shailesh MP52-11 Afari, Niloofar MP27-04 Afiadata, Achankeng MP14-17, MP16-20 Afsarlar, Cagatay MP40-10, MP79-15 Afshar, Ali MP53-03 Afshar, Kourosh p59 Afshar-Oromieh, Ali MP53-08 Agag, Ayman MP36-06 Agarwal, Arnav MP42-19 Agarwal, Ashok MP76-16 Agarwal, Gautum PD34-06, PD41-01 Agarwal, Neeraj PII-LBA10 Agarwal, Piyush MP49-20, MP68-17, p144 Aggarwal, Apas MP5-18, MP64-06 Aggarwal, Himanshu MP81-11, PD10-05 Aghazadeh, Monty PD19-07, PD19-08, PD31-04, V8-03, V8-14, V10-07 Agoritsas, Thomas MP Agrawal, Madhu p58 Agrawal, Vineet MP3-05, MP23-13, V4-06, V12-08 Agudelo, Jose V6-08 Aguilar Palacios, Diego MP67-06 Aguilar, Diego V7-11 Aguiniga, Lizath MP12-02 Ahaghotu, Chiledum p175 Ahallal, Youness MP3-04, PD47-05 Aharony, Shachar MP12-05, PD1-08 Ahearn, Thomas MP6-15 Ahearne, Sinead MP61-19 Ahin, Ali Feyzullah MP7-20 Ahlawat, Rajesh MP59-15, MP79-14, p255 Ahlborn, David PD30-04 Ahlering, Thomas MP53-16, PD18-01, p153, p166 Ahmad, Nida MP19-03, MP19-11 Ahmad, Waseem MP80-20 Ahmad, Yaser MP22-15, MP22-19 Ahmadi, Hamed MP5-06, MP27-10, MP67-13, PD23-09 Ahmed Taha-Neto, Khaled MP22-16 Ahmed, Abdullahi PD8-05 Ahmed, Abul-Fotouh MP18-02, MP38-02 Ahmed, Ahmed S. Zakaria PD31-05 Ahmed, Hashim MP48-15, MP83-01, p174 Ahmed, Kamran MP22-05, MP22-09, MP23-02, MP23-05, MP23-16, MP23-20, MP71-05, V5-02 Ahn, Hanjong MP44-11, MP53-16, MP69-13, MP78-02, MP82-18, MP86-06, PD43-03, PD47-01, p172 Ahn, Han-Jong MP47-05 Ahn, Jennifer J. MP25-19, MP54-15, MP79-20 Ahn, Seung Hyun MP89-05 Ahn, Tai Young MP19-19 Aho, Tevita Futo MP13-04 Ahyai, Sascha MP3-16, MP15-15, PD22-12, MP82-05, MP83-05, MP83-07, MP83-15 Aikawa, Ken MP12-17 Aitken, Karen J. MP19-05, MP20-02, MP21-15 Aizawa, Masataka MP2-19 Aizawa, Naoki MP8-06, MP12-03 Aizen, Joshua MP89-06, MP89-18 Aizer, Ayal MP73-11 Ajay, Divya MP88-07, MP88-11, MP88-19, PD22-05, PD24-11, PD24-12, PD26-07, V3-01 Akaihata, Hidenori MP12-17 Akakura, Koichiro MP87-06 Akashi, Takumi MP58-08 Akbulut, Mehmet Fatih MP28-20 Akca, Oktay MP35-07, MP50-15, MP63-13, MP70-02, V4-01, V4-11, V9-05 Akdogan, Bulent MP42-20, MP48-11 Akhavein, Arash MP30-13, PD51-01 Akihama, Susumu MP39-10, MP46-16, MP69-03, MP69-16, MP83-10, MP85-04 Akin, Oguz MP35-03, MP44-15, MP53-20 Akino, Hironobu MP12-04 Akino, Tomoshige MP58-18 Akinola, Oluwaseun MP75-14

298 Akita, Hidetoshi MP62-10 Akiyama, Yoshiyuki MP8-06, MP12-03 Akre, Olof MP4-19, MP56-17 Aksenov, Alexey MP82-06 Al Abbassi, Amira MP79-13 Al Hussein Al Awamlh, Bashir MP6-02, MP32-16, MP65-03, MP72-03, MP83-04, PD2-02, PD26-09 Al Mehmadi, Yousef MP27-03, PD45-06 Al Salhi, Yazan MP18-20 Al Zahrani, Ali MP83-13 Alagh, Amy MP69-14, PD35-12 Alagiri, Madhu MP54-17 Alahdab, Fares PD31-01 Al-Ahmadie, Hikmat MP7-13, MP36-12, MP64-02, MP72-20 Alam, Asher MP13-04 Alam, Ridwan MP42-04 Alam, Shumyle MP54-15, MP79-20 Alanee, Shaheen MP4-20, MP9-06, MP70-08 Albala, David MP1-19, MP53-16, p12 Albayrak, Selami MP28-16, V4-01 Albersen, Maarten MP18-19, MP19-16, MP19-18, MP21-06, MP52-05, PD2-05 Albert, Botchway MP43-19 Albertini, Aline PD5-04 Alberts, Arnout MP86-18, PD34-04 Albertsen, Peter PII-LBA5, p58, p136 Albiges, Laurence MP50-07 Albisinni, Simone MP9-20, MP27-19 Albo, Michael p44 Alcaraz Asensio, Antonio MP50-18 Alcaraz, Antonio p176 Al-Dessoukey, Ahmad Aref MP48-10 Aldousari, Saad V6-02 Alemozaffar, Mehrdad MP35-14, MP44-08, V8-06 Alenezi, Husain MP30-20, PD51-01 Alenizi, Abdullah MP13-16, MP43-04 Alesawi, Anwar MP43-04 Alex, Byron PD40-02 Alexander, Bobby MP70-01 Alexander, Paul MP42-19 Alexander, Richard PD6-03 Alexander, Todd R. PD51-11 Alexandrov, Assen V2-05 Alford, Scott MP5-14, MP23-07 Algaba, Ferran PD7-10 Algohary, Ahmad MP60-04 Alhalabi, Feras PD50-06 Alhammali, Eihab PD40-07 Alhathal, Naif MP74-08 Al-Hathal, Naif MP43-04 Al-Hothi, Hana A PD28-09 Alhussaini, Zuhair MP70-06 Ali, Adnan MP62-12 Ali, Amina MP66-12 Ali, Hussien MP30-06 Ali, Sahirzeeshan MP6-18 Ali, Sohrab Naushad MP34-07 Ali, Yasir MP74-07 Ali, Yousif MP74-07 Alibhai, Shabbir MP4-05, MP42-01, MP42-06, PD47-10 Ali-El-Dein, Bedeir MP33-10, MP65-09, PD9-02, PD17-10, PD23-05 Alimi, Quentin V9-06 Aliotta, Phillip MP78-11 Aljarah, Ali MP61-18 Alkan, Erdal MP76-08 Alkaram, Ahmed PD7-11 Alkasab, Thamir MP86-16 Alkattan, Abdulaziz PD1-05, PD10-02 Allaf, Mohamad MP35-16, MP39-13, MP47-19, MP50-01, MP63-06, MP63-10, MP70-16, MP70-17, MP70-18, MP84-03, MP84-14, PD15-11, p101 Allan, Robert MP35-04 Allard, Christopher MP5-11, MP50-08, MP50-19, MP84-10, MP84-20, PD25-10, PD35-09 Allegro, Rosalinda MP45-10 Alleluia, Vincent MP23-09 Allen, Clare MP83-01 Allen, Frances MP11-04, MP33-01 Allen, Isabel MP9-12, MP88-17 Allen, Richard MP85-07 Almallah, Zaki p12 Al-Marzouq, Ahmad V6-02 Almashat, Fahad PD52-05 Almashat, Fahd PD52-03 Almassi, Nima V8-02 Al-Matar, Ashraf MP14-08 Alobuia, Wilson PD37-06 Alom, Manaf MP18-01, MP30-08, MP59-09, MP70-03, V2-08 Al-Omar, Osama V7-13 Alonge, Vincenza MP26-18, MP45-10 Alrabeeah, Khalid MP74-08 Alruwaily, Abdul MP16-19, MP41-04 Alruwaily, Abdulrahman MP3-18, MP71-06, MP75-09, PD51-02 Alsaigh, Naimat MP33-10 Al-Sayed, Fahmy MP2-10 Alshalalfa, Mohammed MP6-09, MP55-18, MP61-11, MP66-16 Alsikafi, Nejd PD14-08 Alsyouf, Muhannad MP28-15, MP30-01, MP30-10, MP38-04, MP38-15, MP63-02, MP81-08, PD15-09, PD21-03, PD42-07 Altamirano-Dimas, Manuel MP36-17, MP49-09 Althof, Stanley p56 Altobelli, Emanuela MP20-10, MP67-15 Altok, Muammer MP7-20 Alva, Ajjai MP65-02, MP68-20 Álvarez Maestro, Mario PD29-04 Álvarez, Ariana MP38-11 Alvarez, Joann MP27-11, PD23-11 Álvarez-Ossorio, José Luis MP73-01 Alwaal, Amjad MP15-03, MP71-13, MP88-17, PD26-05 Alyami, Fahad MP40-18, V7-10 Al-Yousef, Rawan V6-02 Alzahrani, Tarek MP30-11, MP75-04, PD13-08 Amann, Justin PD51-01 Amaro, Joao MP79-09 Ambani, Sapan PD21-04, V10-04, p18 Ameli, Niloufar MP42-12, MP53-18, MP86-10 Amelsberg, Andree PII-LBA10 Amend, Bastian MP19-13, PD24-01 Ameri, Carlos p176 Ameye, Filip MP9-20, MP27-19, PD5-08, 286 PD5-10 Amin, Ali MP14-17 Amin, Jay MP35-12 Amling, Christopher MP4-17, MP14-12, MP53-01, MP53-02, MP53-12, MP60-12, MP65-18, MP82-15, MP87-08, MP87-09, PD32-10, PD34-07, PD38-11, PD44-02 Amon-Sesmero, Jose p9 Amorós-Torres, Araceli V6-13 Amos, Jonathan MP75-10 Amparore, Daniele MP3-04 Amr, Raheem PD2-01, PD48-08 Amundsen, Cindy MP8-04 An, Jian MP55-01 An, Yajie MP84-03 Anai, Satoshi MP68-03 Anand, Ajay PD16-07 Anand, Mallika PD50-10 Anas, Ghaleb MP85-02 Anastasiadis, Eleni MP70-20 Andersen, Raymond J. MP66-07 Andersen, Ross E. PD51-03 Anderson, Blake MP29-10, MP37-18, MP65-13, MP65-15, MP80-10, PD18-02, PI-05 Anderson, Christopher MP63-18, MP70-05, MP70-20, MP78-03 Anderson, Jeff PD1-05, PD10-02 Anderson, Kirk PD22-02, PD50-05 Anderson, Kyle V6-09 Anderson, Patrick MP79-13 Anderson, Paul PD5-02, p20 Anderson, Roger MP14-10 Anderson, Roosevelt PD25-12 Anderson, Ross MP76-12 Anderson, Shane p10 Andersson, Karl-Erik MP8-06, p21, p78 Ando, Keisuke MP87-06 Ando, Ryosuke MP33-13, MP34-02, MP34-11, MP34-13, MP34-15, MP41-03, MP46-12, MP55-04, MP62-10, MP80-18, PD17-05 Ando, Takashi MP55-16 Andonian, Sero MP30-13, PD51-03, p10 Andrade Becerra, Carlos Fernando V10-05 Andrade, Hiury MP35-07, MP50-15, MP70-02, V4-01, V4-11 Andrade, José Lamartine De Andrade MP8-09 Andreoni, Cassio p112 Andrews, Paul MP4-11, MP71-09, MP71-15, V8-12, p255 Andrich, Daniela MP29-06, MP29-07, MP29-08, PD14-03, PD14-11, PD22-01, PD22-06, PI-01, p20 Andriole, Gerald MP1-13, PD6-01, PII- LBA2, MP42-02, MP60-09, MP60-14, MP77-15, MP81-04, PD51-07, p11, p139, p174, p235 Anger, Jennifer MP24-13, MP24-15, PD21-07, PD27-06, PD28-03, PD50-08, p11, p84, p170 Angermeier, Kenneth PD14-10, V4-01, p13, p20 Angst, Roland PD25-04 Angulo, Javier MP52-04, MP73-01 Anheuser, Petra V12-05

299 Anikst, Victoria MP20-10 Aning, Jonathan MP65-06, MP72-15, PD41-05 Anjikar, Chandrashekar PD4-01 Anjiki, Haruki MP11-06 Anjum, Faqar MP28-18 Ankerst, Donna MP64-05, MP75-06, MP77-09 Anselmo, Christophe V5-01 Anson-Cartwright, Lynn MP10-10 Antolak, Stanley p10 Antonarakis, Emmanuel MP87-15, MP87-16, p85 Anton-Culver, Hoda MP59-13 Antonelli, Alessandro MP44-04, MP63-03, PD35-01 Antonelli, Jodi MP27-07, MP41-14, MP41-14, MP75-15, MP80-05, PD13-12 Antonini, Gabriele MP45-16 Antonopoulos, Ioannis MP85-18 Antunes, Alberto A. MP3-12, MP8-07, PD5-04, MP21-10, MP31-17, MP71-18 Antunes-Lopes, Tiago PD27-12 Aoki, Hiroshi MP87-07 Aoki, Yoshitaka MP12-04 Aoki, Yujiro MP54-04 Apfelbeck, Maria MP26-17, PD9-04 Apodaca, Gerard MP21-04 Apolikhin, Oleg MP43-10 Apolo, Andrea MP68-17 Aponte, Hernán V8-12 Appel, Boaz PD45-10 Appleman, Leonard MP82-09 Aprikian, Armen MP72-05, PD12-01, PD31-05 Aquino Fournier, Catharine MP31-01 Arada III, Ernesto MP23-01, MP71-02 Arai, Gaku MP76-04 Arai, Takashi MP77-02 Arai, Yoichi MP2-19, MP56-15, MP60-15, MP69-19, MP73-18, MP87-07, PD3-02 Arakawa, Soichi PD8-08, PD8-10 Araki, Isao MP27-02 Arangua, Paul MP6-06, MP48-02, MP60-08, V4-09 Arbuckle, Cody PD18-01 Archambault, Jason MP85-02 Arcila, Maria MP64-02 Ardelt, Petere PD17-11 Arellano, Ronald S. MP50-09 Arenas, Javier L. MP30-01, MP30-10, MP38-15, MP63-02, PD15-09, PD21-03 Arends, Tom MP65-10 Arias, Euro V6-08 Arichi, Naoko MP11-06, MP39-16, MP47-11 Arikan, Ozgur MP48-01 Arisan, Damla MP33-19 Arisan, Serdar MP33-19 Arisawa, Chizuru PD17-07 Ark, Jacob PD23-11 Arlen, Angela M. MP54-02 Armagan, Abdullah PD13-09 Armenakas, Noel p10 Armitage, James MP30-07 Armstrong, Andrew PII-LBA10 Arnaud, Alexis MP38-10 Arnold, Rebecca S. MP47-15 Arnouk, Alex MP7-01 Aron, Manju MP86-04 Aron, Monish MP15-20, MP23-15, MP59-12, MP63-05, MP83-12, PD9-07, PD31-04, V9-07, V12-11, p9, p72, p130 Aronen, Hannu MP17-07 Aronson, William MP4-17, MP6-08, MP14-12, MP32-12, MP53-01, MP53-02, MP53-12, MP60-12, MP82-15, MP87-03, MP87-08, MP87-09, PD32-10, PD34-07, PD38-11, p273 Arora, Jaspreet MP39-01, PD15-10 Arreola, Manuel PD4-03 Arroyo Soto, Ignacio PD41-04 Arsovsksa, Olga MP75-12 Arther, Andrew PD51-10 Artibani, Walter MP67-20, PD9-03 Arulraja, Evangeline MP14-11 Arya, Manit MP83-01 Asai, Akihiro MP49-02, MP55-03 Asai, Seiji PD4-07 Asakuma, Junichi MP7-11 Asangani, Irfan MP37-02 Asano, Takako MP7-11 Asano, Tomohiko MP7-11 Asanuma, Hiroshi MP35-20, MP54-04, PD17-03 Asci, Ramazan MP43-12 Ashcraft, Keith MP36-07 Ashikari, Daisaku MP86-05, PD50-03 Ashley, Richard FRII-06, MP3-06 Aslan, Guven MP42-20 Aslan, Yilmaz MP40-10 Asplin, John MP34-16, MP75-09, p220 Asquarova, Fotima MP30-13 Assaly, Rana MP52-06 Assel, Melissa MP2-13, MP10-13, MP53-20, MP60-10 Assimos, Dean MP28-08, MP30-17, MP34-17, PD13-03, p13, p100, p220 Aston, Kenneth MP76-12 Asutay, Mehmet Kazim MP75-18 Atala, Anthony MP8-03, MP21-08, MP29-18, MP29-19, p44, p56 Atallah, William MP60-16, MP77-05 Atar, Arda MP34-12, MP38-07 Atayurt, Zafer MP74-09 Athanasiou, Stavros PII-LBA9 Atiga, Chase MP30-10 Atis, Ramazan Gokhan MP48-01 Atkinson, Gary PD20-01 Atmaca, Hasan Tarik MP76-08 Attalla, Kyrollis MP70-13 Attaya, Hosam MP38-19 Attwood, Kristopher MP4-07, MP50-06 Atug, Fatih V9-02, p9, p101 Atwell, Thomas PD35-07 Au, Jason MP40-10 Aufderklamm, Stefan MP1-16, PD41-11 Auffenberg, Gregory MP27-20 Auge, Brian p94 Austenfeld, Marcus FRII-12 Austin, Conal PD49-01 Austin, J. Christopher p18 Austin, Paul MP40-02, p13, p59 Autieri, Domenico MP18-20 Autorino, Riccardo MP3-04, MP50-15, p57, p227, p Autran, Anamaria PD29-04 Autran-Gomez, Ana Maria MP42-17 Auvinen, Anssi PD6-02, PD6-09 Avelino, Antonio MP8-20 Averch, Timothy MP27-07, MP41-08, PD19-02, PD19-03, PD19-04, PD19-05, PD51-04, p190, p220 Aviram, Galit PD13-10 Awadalla, Amira MP79-10, PD23-01 Awamleh, Bashir MP16-02 Awori, Quentin V3-08 Awrey, Shannon MP36-17, MP49-09 Ayangbesan, Abimbola MP65-03, MP72-03 Ayaz, Ahmet MP76-16 Aydin, Abdullatif MP22-09, MP23-05, MP23-16 Aydur, Emin PD27-03 Aylward, James MP66-18 Ayoub, Hajar MP67-06, PD25-12, PD40-09, V3-03 Ayres, Benjamin MP10-16 Aytaç, Omer V9-02 Ayyash, Omar PD51-04 Azad, Azar MP68-05 Azadzoi, Kazem MP8-08 Azawi, Nessn MP57-15 Azhar, Raed MP3-03, MP15-20, MP59-12, MP63-05, MP83-12, MP86-04, PD9-07, PD34-05, V12-11 Aziz, Atiqullah MP2-10, MP2-12, MP58-13, MP58-16, MP58-20 Azuma, Haruhito MP7-02, MP46-08 Azuma, Satoshi V7-12 Azumi, Makoto MP59-05 Azzis, Olivier MP38-10 Azzouzi, Abdel Rahmène MP63-12, MP63-15 B Baack Krukreja, Janet E. MP26-14, MP51-11 Baack Kukreja, Janet MP65-17, p11 Babaeer, Abdulrahman MP70-19 Babaian, Richard p136 Babasaki, Takashi PD35-03 Babayan, Richard p237 Babbar, Paurush V8-10 Babcook, Melissa MP8-05 Babicz, Tamás MP87-03 Babjuk, Marek PD17-11, PD29-12 Babjuk, Marko MP26-04, MP65-09 Bach, Thorsten MP13-10, MP13-11, MP13-12 Bachir, Souid M. MP28-12 Bachmann, Alexander MP3-20, MP63-20, MP78-12, PD5-08, PD5-10 Bachrack, Laurie PD20-09 Backman, Vadim MP1-20 Baco, Eduard MP63-12, MP63-15 Bacro, Thierry PD7-08 Badal, Justin PD39-06 Badalato, Gina MP38-05 Badani, Ketan MP1-09, MP53-11, MP53-16, PD13-11, p198 Badawy, Ahmed MP40-01 Badawy, Hesham MP79-19 Badawy, Mohamed MP85-14 Badhiwala, Niraj PD5-05

300 Badkhshan, Shervin MP4-07, MP35-12 Badlani, Gopal MP3-09, MP22-13, PD5-07, PD50-04, p18, p58, p71, p100, p117, p173 Badran, Yasser MP18-02, MP38-02 Badri, Anand MP89-18 Bae, Jaehyun MP16-11 Bagchi, Anindya MP61-06 Bagley, Demetrius H. MP23-14, p13 Bagli, Darius MP19-05, MP20-02, MP21-15 Bagrodia, Aditya MP2-06, MP7-07, MP7-13, MP7-17, MP11-16, MP36-12, MP64-02 Bahceci, Mustafa MP74-10 Bahílo, Pilar MP38-11, MP80-11 Bahlani, Sonia PD20-11 Bahler, Clinton MP11-13, MP63-11, MP65-14, PD3-09, PD15-03, PD15-05, PD21-12, V5-12, V9-13 Bahn, Duke PD34-05 Baik, Seung MP13-07 Bailey, April PD50-02 Bailey, Christina PD40-09 Bailey, G. Christopher PD35-07 Bailey, George MP41-05, PD28-02 Bailey, Howard MP26-01 Bailey, Kari FRII-04, MP7-01, MP47-10, MP61-07 Bailey, Michael MP17-01, MP39-14, PD42-01, PD42-02, p255 Bailey-Wilson, Joan MP66-10 Bainbridge, Matthew MP76-06 Baird, Grayson PD52-11 Bajic, Petar MP64-12 Bajorin, Dean MP7-13, MP10-01, MP10-05, MP10-12, MP10-13, MP10-19, MP11-16, MP36-12, MP64-02, MP72-20 Bajory, Zoltan p101 Baker, L. A. MP40-05 Baker, Linda MP40-03, MP40-12 Baker, Rania PI-09 Bakircioglu, Emre MP76-06 Bakircioglu, Mustafa MP74-10 Balaji, K. C. p145 Balbay, Mevlana Derya MP18-18, MP67-19, MP76-08, p101, p137 Baldini, Teri MP16-04, MP32-09 Baldwin, D. Daniel MP30-10 Baldwin, D. Duane MP28-15, MP30-01, MP30-10, MP38-15, MP63-02, PD15-09, PD21-03, PD42-07 Baldwin, Duane MP30-13, MP38-04, MP75-02, p262 Bales, Gregory T. MP18-03, MP29-10, PD26-12, PI-05 Balestreri, Luca MP57-13 Balicer, Ran MP32-17 Balk, Mark MP73-13 Ball, Mark MP35-16, MP39-13, MP47-19, MP50-01, MP84-03, PD15-11 Ballardo, Cesar Jesús V10-03 Ballestero, Roberto V10-03, V10-12 Ballesteros, Ceasar MP23-01 Ballow, Daniel MP22-10 Balog, Brian M. MP8-10 Balthazar, Andrea PD8-11 Bambury, Richard MP64-02 Banaei, Niaz MP20-10 Bancroft, Elizabeth MP86-11 Bandekar, Rajesh MP87-16 Banerjee, Sulagna MP55-13 Banerji, John S. MP10-15, MP42-13, MP79-08 Banez, Lionel MP14-13 Bang, Albert MP57-04, MP65-11 Bang, Woo Jin PD29-08 Bangerter, Keith MP87-12 Bangma, Chris MP66-20, MP86-18, PD34-04, p194 Bangs, Rick MP65-02 Baniel, Jack MP28-14, MP32-17, MP41-16, PD11-12, PD17-11, PD17-12 Banihani, Omaya MP40-11 Banno, Rika MP33-18 Bannowsky, Andreas MP17-15, MP52-17 Bantleon, Rüdiger MP11-19 Bapat, Bharati MP6-14, MP61-01, MP68-04, MP68-06, PD46-07 Baptiste, Wagner MP61-16 Baradaran, Nima MP40-13, MP69-15 Barakat, Nashwa MP79-10 Barakat, Tamer S. PD23-05 Baran, Caner MP28-16 Baras, Alexander MP58-07, MP72-08, PD31-12 Barazani, Yagil MP43-15 Barbagli, Guido MP19-15, PD14-10, V12-01, p11, p235 Barbe, Mary MP12-05 Barbee, R. Wayne MP12-15, MP12-16 Barber, Austin MP32-13 Barber, Neil MP3-01, MP13-14, PD5-08, PD5-10 Barbieri, Christopher MP6-02, MP17-12, MP66-01, MP83-04 Barbisan, Davide MP57-13 Bar-Chama, Natan MP51-04 Bardot, Stephen MP47-18, MP68-15 Barel, Assaf V6-03 Barillaro, Francesco MP62-02 Barinova, Mariya MP17-20 Barkin, Jack MP3-02 Barlass, Usman MP55-13 Barlow, Lamont MP4-15, MP26-11, MP26-13, MP32-07, MP64-15, MP72-09, PD17-09 Barnes, Justin PD27-01 Barney, Shane MP26-15 Barocas, Daniel MP5-07, PD6-05, MP20-12, PD12-03, PD12-06, MP27-11, PD23-11, PII-LBA5, MP49-01, MP65-06, PD41-05, MP72-15, MP84-19, p9, p12, p273 Barod, Ravi MP59-14, MP59-15, MP63-06, MP63-10, MP70-16, MP70-17, MP70-18, V9-01, V11-02 Baron, Benoit PII-LBA4 Baron, Pamela FRI-09, MP85-20, V9-08 Baron, Thomas MP27-06 Barone, Hugo MP3-12 Barone, Mark V3-08 Baroni, Ronaldo MP86-09 Baronio, Roberta PII-LBA9 Barret, Eric MP42-17, MP48-16, MP62-08, PD Barrett Connor, Elizabeth MP71-17 Barrett, David MP88-14 Barrisford, Glen V8-04 Barrisford, Glen W. MP5-11, MP50-07 Barros Filho, Tarcisio MP43-17 Barry Delongchamps, Nicolas MP67-04 Barry, Michael MP83-11 Bartlett, Susan J. PD51-03 Bartley, Jamie MP89-01, MP89-03, MP89-09, MP89-10, PD21-06, PD27-10, PD50-12 Bartoletti, Riccardo PD17-11 Barton, Joanna PD27-11 Bartsch Jr., Georg MP8-11 Basar, Mehmet Murad MP74-09, MP76-08 Basaria, Shehzad p221 Bascom, Alexandra MP15-13 Bashir, Mustafa MP88-06 Basilion, James P. MP61-15 Baskin, Avi S. MP16-09 Baskin-Bey, Edwina MP73-20 Bass, Roman V11-14 Bassett, Jeffrey PD23-11 Bassett, Mitchell MP14-13, PD11-02 Bassi, Pierfrancesco MP67-20, PD9-03 Bastarós Hernández, Juan María PD41-04 Bastarós, Juan M. MP6-01 Bastian, Patrick MP58-16, MP77-03 Basto, Marni V4-04 Bastos-Netto, Jose Murillo MP51-10 Batbold, Dulguun MP52-08 Bates, Anthony MP83-12, V4-07, V4-08 Bates, Carlton MP52-18 Batista, Julie L. MP77-19 Batra, Vikram Shah MP15-14, PD14-09, PD22-03 Batson, Jacob PD4-03 Battistella, Linamara MP43-17 Bauer, Ricarda M. MP88-08, MP88-09 Baum, Yoram MP35-14, MP44-08 Bauman, Tyler MP6-10, MP31-08, MP39-15, PD35-05 Baumert, Hervé MP13-19, MP57-02, MP57-12 Baumgarten, Lyle MP17-02 Baumgartner, Timothy MP16-01, PD21-10, PD22-07 Baumunk, Daniel MP14-19 Baur, Helmut MP62-18 Bausum, Anna MP35-14 Bavaria, Tom PD10-01 Bavendam, Tamara p175 Bayatli, Nur MP52-13 Baykov, Nikolay MP26-04, V8-08 Bayne, David MP17-05 Bazaragani, Soroush MP86-17, PD9-01 Bazargani, Soroush MP5-06, MP67-13, PD23-09 Bazzi, Wassim M. MP50-16 Beachy, Philip p70 Beahrs, Randolf PII-LBA1 Beaney, Ronald MP62-13 Beatrice, Josef MP86-07 Beaudry, Guillaume MP1-03 Beauval, Jean-Baptiste MP57-02, MP57-09, MP57-12, MP63-12, MP63-15, MP85-09

301 Bechis, Seth MP5-11, MP30-18, MP31-15, PI-02, MP50-07 Beck, Veronika PD32-06 Beckel, Jonathan MP21-16 Becker, Andreas MP3-16, MP70-09, MP83-06 Becker, Armin MP63-09 Beckham, Carla MP49-07, MP68-01 Beckler, Carlee MP15-20 Bedard, Philippe MP10-10 Beebe, Heather MP51-04 Beebe-Dimmer, Jennifer MP14-15, PII- LBA3 Beer, Ambros PD32-06 Beer, Tomasz p136 Beer, Volker MP62-18 Beger, Gunthild PD41-11 Behl, Robert p100 Behnsawy, Hosney MP64-01 Behr, Barry PD52-12 Behr-Roussel, Delphine MP52-06, PD1-03 Behre, Hermann PII-LBA6 Beier, Jörn PD22-11 Beiko, Darren p229 Bekarma, Holly MP75-13, MP80-04 Bekelman, Justin PD12-04 Belew, Daniel PD29-02 Belgrano, Emanuele MP67-20, PD9-03, PD40-12 Belka, Claus MP62-18 Belkoff, Laurence H. PD45-12 Bell, David MP57-20 Bell, Robert H. MP49-09 Bella, Anthony PD26-06, PD26-10, PD40-10, p55, p235, p248 Belldegrun, Arie MP47-06 Bellei, Luca MP53-09 Bellmunt, Joaquim MP68-11 Bello, Fernando MP22-09, MP23-05 Bellott-Mcgrath, Gabriel MP16-17 Bellucci, Carlos MP43-17 Belousova, Elena PD35-10 Belsante, Michael MP25-11, MP88-06, MP88-07, MP88-11, MP88-19, PD22-05, PD24-11, PD24-12, PD26-07, V3-01 Beltran, Luis MP1-10 Belucci, Carlos MP51-10 Beluco Corradi, Renato MP84-06, PD33-03 Belzer, Susan PII-LBA2 Benabdallah, Justin MP49-11 Benayoun, Serge MP43-04 Benchek, Penny PD27-05 Benedon, Matthew MP15-10, MP89-08, MP89-18, PD21-11 Benejam, Joan PD5-08, PD5-10 Benfante, Nicole MP7-07, MP50-18, MP63-08, MP84-06 Benham, Aaron MP10-07 Benidir, Tarik MP73-02 Benigni, Fabio MP34-20 Benigno, Bruno V11-09 Benjamin, Pradère MP13-15, PD5-09 Benjamin, Shalva V5-14, V11-14 Benkhadra, Khalid PD31-01 Ben-Levi, Eran MP11-10, MP17-09, PD44-03 Bennett, Carol MP32-04, MP32-12, MP73-17 Bennett, David A. MP33-06 Bennett, Jason PD27-07 Bennett, Nelson PD26-02, PD26-06, PD26-10, PD26-11, PD40-10, p55 Bennett, William MP40-20, MP54-19 Benoit, Peyronnet MP13-15, PD5-09 Benoit, Thibaut MP57-09, MP85-09 Bensadoun, Henri MP73-20 Bensalah, Karim MP2-06, MP2-09, MP2-12, MP3-19, MP7-01, MP7-09, MP13-13, MP13-18, MP38-10, MP57-02, MP57-09, MP57-12, MP63-12, MP63-15, MP63-16, PD49-02, V9-06 Benson, Cooper MP65-05, V3-03 Benson, Mitchell MP1-09, PD17-09, PD29-01, PD30-04, MP4-15, MP14-03, MP25-19, MP63-01, MP64-07, p18 Bentink, Stefan PII-LBA2 Benway, Brian MP30-03, PD18-09, PD51-07 Beraldi, Eliana MP46-15 Berg, William MP53-11 Berger, Andre MP15-20, V12-11, MP63-05, PD9-07 Berger, Delaney MP1-19 Berger, Michael MP7-13, MP36-12, MP72-20, PD33-02 Berger, Ranaan MP68-11 Berges, Richard MP3-01, PD16-08 Bergman, Andries M. PD31-11 Bergman, Ari MP53-11, MP77-05 Bergman, Jonathan MP32-12, MP41-10, MP73-17 Bergmann, Martin MP76-03 Bergstralh, Eric MP24-07, MP33-07, MP41-05 Bergu, Berk MP40-03 Berkowitz, Noah PD35-10 Berktas, Mehmet PD48-12 Berlin, Jacob MP49-17, MP61-03 Berman, David MP5-02, MP72-08 Bernabé, Jacques MP52-06, PD1-03 Bernardo, Norberto p176 Bernat, Jennifer MP27-12, MP27-17 Berney, Daniel MP1-10 Bernhard, Jean-Christophe MP23-15, MP57-02, MP57-12, MP63-12, MP63-15, MP85-17 Bernie, Aaron V3-08 Bernstein, Adrien MP81-20, PD45-08 Bernstein, Melanie MP10-12, MP44-15, MP50-16, MP63-08, MP87-11, PD48-01 Berquet, Gaetan MP38-10 Berrondo, Claudia MP49-07, MP68-01 Berry, Katherine MP23-10 Berry, Matthew PD20-09 Berry, William R. MP87-16 Bertini, Roberto MP4-16, MP44-04, MP56-18, MP63-03, MP63-04, MP82-03, PI-07 Bertrand, Laura MP39-18 Bessa Jr., Jose MP51-10 Best, Carolyn p17, p18, p118, p169 Best, Sara FRI-14, MP20-09, MP35-17, MP44-16, MP59-04, p10 Betageri, Guru PD Bettiga, Ariana MP52-07 Beverly, Devon MP14-11 Bex, Axel PD31-07 Beyer, Burkhard MP4-14, MP9-04, MP78-20, MP82-16, MP82-17, MP83-16, PD30-06, PD30-07, PD30-08, PD30-10 Beyer, David MP78-11 Bezan, Angelika MP69-02 Bezerra, Stephania MP53-17, MP61-11 Bhandari, Akshay MP70-19, PD2-08 Bhandari, Mahendra MP79-14 Bhanot, Umeshkumar MP47-09 Bharadwaj, S. MP21-08 Bhatnagar, Neera MP42-19 Bhatt, Deep MP15-17 Bhatt, Jaimin MP50-13, MP67-16 Bhattacharyya, Pallab PD1-12 Bhayani, Samuel MP63-06, MP63-10, MP70-16, MP70-17, MP70-18, PD18-09, V5-11, p12, p58 Bhayankara, Aravind MP72-20 Bhindi, Bimal MP60-20, MP67-16, MP68-04, MP86-15, PD47-10 Bhojani, Naeem MP3-15, MP13-14, MP34-19 Bhowmick, Neil MP20-04 Bianchi, Gianpaolo MP19-15 Bianchi, Marco MP4-16, MP48-13, MP56-02, MP56-03, MP56-05, MP56-10, MP56-16, MP62-05, MP72-04, MP77-03, MP78-13, MP78-15, MP82-01, MP82-02, MP82-03, MP83-08, MP83-17, PD30-03, PD32-09, PD38-12 Bianco, Fernando PD32-11, PD40-06, V4-05 Bienert, Felix MP66-17 Bieniek, Jared M. PD52-02 Bienvenu, James V2-09 Bienz, Marc MP13-14, MP13-16, MP43-04 Bier, Simone MP1-16, PD41-11 Bieri, Diane p251 Bierlein, Maggie MP3-18, MP16-19, MP41-04, MP71-06, MP75-09, PD51-02 Biewenga, Eric PD15-08 Bigley, Joseph MP6-12, PD46-09 Bigot, Pierre MP63-12, MP63-15 Bihrle, Richard MP10-08, MP10-17, MP29-11, MP29-12, MP58-11, MP64-17, MP65-14 Bilal, Khawaja MP32-19, PD12-12 Bilim, Vladimir MP87-10 Billia, Michele MP78-08, MP83-13 Billis, Athanase MP45-07 Billups, Kevin PD36-08, p175 Binbay, Murat MP28-20, p101 Bindayi, Ahmet V12-04 Bing, Megan T. MP39-18 Bini, Vittorio MP6-07 Birabaharan, Vinoth MP59-09 Birbe, Ruth PD4-09 Bird, Erin PD27-07 Bird, Vincent FRII-05, MP27-07, MP30-13, MP75-08, PD51-01 Birder, Lori MP21-04, MP21-16, PD7-05, p17, p73 Birkhäuser, Frédéric D. V9-07, V9-12

302 Bishoff, Jay p10, p153, p233 Bissada, Nabil MP10-07, p234 Bissler, John PD35-10 Bissonnette, Francois MP74-08 Bitker, Marc-Olivier PD10-11 Bivalacqua, Trinity MP19-16, MP19-18, MP21-06, MP52-05, MP58-07, MP64-10, MP65-06, MP67-10, MP67-12, MP72-08, MP72-15, PD17-06, PD31-12, PD36-02, PD36-04, PD36-06, PD41-05, p55, p84, p160 Biyani, Chandra Shekhar MP28-10 Bizic, Marta MP52-15 Bjazevic, Jennifer MP84-08 Björklund, Johan MP4-19 Bjurlin, Marc MP18-16, MP86-03, PD32-01, PD32-05 Blachon, Jean-Luc PD1-03 Black, Peter MP1-07, MP36-17, MP49-09, MP49-13, MP57-20, MP65-06, MP72-15, MP77-01, MP84-08, PD31-09, PD41-05, PD41-08, p253 Black, Shawn MP87-19 Blackburne, Andrew MP72-11, PD28-02 Blacksburg, Seth MP62-15 Blackwell, Robert MP18-11, MP44-12, MP49-08, MP64-09, MP64-12, PD4-05, V9-03 Bladou, Franck PD12-01 Blaheta, Roman MP8-11 Blaivas, Jerry MP15-10, MP89-08, MP89-18, PD21-11, p21, p164 Blakely, Stephen V3-02, V12-12 Blana, Andreas PD47-06 Blanchard, Shawnna MP16-07 Blanchet, Pascal MP61-02 Blankstein, Udi MP22-07 Blaschke, Simon MP14-19 Blaschko, Sarah D. MP71-13 Blattner, Mirjam MP66-01 Bloom, David FRII-14, p59 Blot, William PD23-11 Blute, Michael MP26-08, MP26-09, MP35-09, MP37-20, MP44-16, MP50-07, MP50-08, MP50-09, MP55-11, MP59-04, MP83-11, PD35-05, p58, p157 Blute Jr., Robert MP5-16, PD12-05 Bochner, Bernard MP7-13, MP11-16, MP36-12, MP64-02, MP64-03, MP64-11, MP64-19, MP72-20, MP82-04, PD9-11, PD17-06, p44 Bock, Cathryn MP14-15 Boczko, Judd PD32-11 Bodakci, Mehmet Nuri PD13-09 Boehm, Katharina MP59-08, MP78-09, MP78-17, MP83-16, MP83-18, PD30-06, PD31-13, PD49-03, PD49-05 Boehm, Maret MP83-02, PD46-08 Boelkins, Brad MP44-02, MP44-19 Boeri, Luca MP4-10, MP51-17, MP51-18, MP74-20, MP76-05, MP76-15, PD52-06, PD52-10 Bogache, William MP3-02 Bogart, Jeffrey MP78-11 Böhm, Diana MP68-07 Böhm, Maret MP60-04 Bohnert, William p118, p189, p220, p234 Bohrer, Yves MP86-09 Bokhorst, Leonard PD34-04 Bolduc, Stephane p17, p44 Bolenz, Christian MP2-06, MP2-09, MP7-09 Bollig-Fischer, Aliccia MP53-19 Bollito, Enrico MP53-05, MP53-09, MP53-10, MP77-11 Bolton, Damien MP22-01, MP55-05, MP61-04, PD5-01, p139, p173 Bolton, Sue MP14-15 Bond, Christopher MP52-12 Bonds, Roger p57 Bondaruk, Jolanta MP45-06, PI-06 Bonham, Michael MP1-01 Boni, Andrea MP62-02, PD10-04 Boniol, Mathieu MP4-09 Bonkat, Gernot MP3-20 Bonzo, Jeremy MP10-09, PD43-09 Boone, Timothy MP21-20, PD1-05, PD10-02, PD24-03, p254 Boonkaew, Benjawan MP39-01 Boorjian, Stephen MP20-19, MP20-20, MP24-07, MP29-15, MP29-16, MP35-02, MP35-18, MP35-19, MP44-14, MP50-10, MP56-14, MP58-09, MP58-15, MP59-20, MP63-20, MP67-02, MP69-05, MP69-08, MP69-12, MP70-11, MP70-12, MP70-14, MP70-15, MP72-11, MP84-17, PD12-09, PD17-06, PD29-06, PD31-01, PD35-07, PD35-11, PD43-04, PD43-08, PD49-12, p12, p58, p173, p196 Booth, Christopher MP5-02 Bora, Shabana PD52-05 Borazjani, Ali MP8-10, MP81-09, PD50-01 Borchert, Alex MP59-14 Bordier, Benoit MP13-17 Borer, Joseph G. V7-04 Borges, Fernando PD5-01, PD43-06 Borgmann, Hendrik MP8-11 Borin, James p57, p79 Boris, Ronald MP3-15, MP35-10, MP59-07, MP65-14, V8-05 Borisko, Elyse PD7-08 Borkowetz, Angelika MP17-10, MP48-05 Borofsky, Michael PD42-04, V3-12, V6-11 Borok, Jenna MP24-15 Boronat, Francisco MP38-11 Borre, Michael MP73-03 Bos, Derek PD25-10 Bosch, Ruud MP14-04 Bosl, George MP10-01, MP10-05, MP10-12, MP10-13, MP10-19, p11 Bosnyak, Zsolt MP73-03 Boss, Andreas MP19-14 Bosse, Brandon PD38-09 Bostrom, Peter J. MP17-07 Bota, Maria MP4-09 Bottaro, Donald P. MP6-17 Bottero, Danilo MP26-05 Botto, Henry MP31-03 Boulet, Evelyne MP74-08 Boulet, Sheree MP24-11 Bouljihad, Mostafa MP15-19, MP69-01 Boura, Judith MP89-01, MP89-03, MP89-09, MP89-10, PD20-08, PD27-10, PD50-12 Bourboulia, Dimitra MP Bournat, Juan PD36-01 Bourque, Jason MP64-08 Boursi, Ben MP5-08, MP14-14, MP64-04 Boute, Maaike MP23-03 Bowen, Diana MP31-18, MP71-01 Bowen, Diana K. MP53-14, V7-07 Bower, Thomas MP70-11 Bowlin, Paul MP40-18, V7-10 Box, Geoffrey PD18-05, PD19-02, PD19-03, PD19-04, PD19-05, V9-11, p19 Boxler, Silvan MP53-08, MP56-04 Boyce, Susie MP6-20 Boyd, Mariel MP64-02 Boylan, Colm MP17-14 Boyle, Peter MP4-09 Boylu, Ugur V12-04 Boysen, Gunther MP66-01 Boz, Mustafa Yucel MP28-16 Bozkurt, Ozan MP25-08 Bozzini, Giorgio FRI-11, MP18-19, MP77-08, PD2-05 Bozzini, Gregory MP7-01, MP7-05, MP7-06, PD29-12 Brachulis, Andrew PD19-06, PD30-05 Brackett, Nancy MP74-15 Bradley, Catherine MP27-04 Braffett, Barbara H. MP81-12 Braga, Luis MP54-05, V7-01 Brahmbhatt, Jamin PD40-03, PD40-04, PD45-09 Brajtbord, Jonathan MP5-01, PD15-12, PD47-02 Brakemeier, Susanne PD35-10 Brammah, Susan MP89-14 Brancato, Sam MP68-17 Branco, Anibal W. V3-10, V11-10 Brand, Timothy MP88-06, PD19-02, PD19-03, PD19-04, PD19-05, PD19-11, p135 Brandao, Luis Felipe MP50-15, V4-11 Brandes, Steven FRI-13, MP15-07, MP18-08, MP18-09, MP29-05, PD11-01 Brannigan, Robert E. PI-03, MP74-05, p12, p18, p117 Brant, William MP88-20, PD11-02, PD11-08, PD26-06, PD26-10, PD39-09, PD40-10 Brasel, Alicia MP5-15 Bratslavsky, Gennady MP39-02, MP44-13, PD3-03, PD43-05, PD44-04, V3-02, p57, p255 Bratt, Ola MP42-10, MP56-17 Braudmeier-Fleming, Andrea PD20-09 Braun, Katharina MP37-10, PD47-09 Braun, Martin MP68-07 Brausi, Maurizio p23, p236 Brawer, Michael MP1-08, MP1-10, PD32-11 Breau, Rodney H. MP68-19, PD44-09, PD47-12, MP84-08 Brechtel, Anette MP27-14 Breda, Alberto MP85-06, PD13-05, V5-06, V5-09, p56 Breen, Kieran J. MP6-20 Brehmer, Marianne PD13-05 Bremjit, Prashoban MP67-17 Brendler, Charles MP1-20, MP86-11,

303 PD47-11, MP84-08 Brenner, Phillip MP60-04, MP83-02, PD46-08 Brenner, Walburgis MP39-04 Bresee, Catherine MP24-15, PD21-07, PD28-03 Bretan, Peter p272 Bretterbauer, Katharina MP57-03 Brewer, Katherine PD9-11 Brewin, James MP22-09, MP23-05 Breyer, Benjamin MP9-12, MP15-03, MP15-17, MP18-04, PI-01, MP71-13, MP88-17, PD11-02, PD14-07, PD26-05 Brielmaier, Benjamin D. MP65-13 Briganti, Alberto MP2-12, MP4-14, MP4-16, MP24-06, MP48-13, MP51-18, MP56-02, MP56-03, MP56-05, MP56-10, MP56-16, MP56-18, MP62-01, MP62-04, MP62-05, MP63-03, MP63-04, MP63-20, MP72-04, MP72-14, MP76-05, MP77-03, MP78-01, MP78-12, MP78-13, MP78-15, MP82-01, MP82-02, MP82-0 Briggman, Joseph PD25-12 Briggs, Tim MP43-13 Briollais, Laurent MP61-01 Bristow, Robert G. MP37-11 Britez, Lucas PD11-10 Brito, Joseph MP57-16 Britto, Cesar V5-01 Brock, Gerald PII-LBA6, p55 Brock, Marko PD47-09 Brock, Timothy V11-04 Brockman, John A. PD18-09 Broderick, Gregory MP51-19, p9, p55, p56, p117, p221 Brodszky, Valentin p101 Broghammer, Joshua MP88-20, MP89-13, PD14-08, V3-11, p173 Brookman-May, Sabine PD49-08 Brooks, Andrew MP77-04 Brooks, David C. MP5-04, MP5-13, PD9-09 Brooks, James MP1-17, MP6-13, MP84-02, PD34-03, p85 Brooks, Jillene MP8-04 Broquere, Cedric MP61-02 Brotherhood, Hilary PD13-07 Brothers, Aaron MP61-20 Brown, Alan MP87-12 Brown, Anna MP48-04 Brown, Elizabeth T. MP15-12, PD11-04, PD14-05 Brown, Gordon PII-LBA2, p72 Brown, J. Quincy PD15-01 Brown, James A. MP39-18 Brown, Janet E. MP73-10 Brown, Kevin MP23-06 Brown, Lisha MP66-15 Brown, Matt MP62-06 Brown, Matthew MP35-13 Brown, Robert MP75-11 Brown, Thomas PD5-01 Brownrigg, Natasha V7-01 Broxmeyer, Hal MP19-20 Bruce, Mark MP21-07 Bruce, R. Douglas p175 Bruce, Richard MP11-02 Brucker, Benjamin MP81-07, PD50-09 Brugarolas, James MP11-14, MP47-06 Bruggmann, Rémy MP31-01 Bruins, Harman Maxim MP65-10 Brunacci, Leonardo V8-12 Brunckhorst, Oliver MP22-09, MP23-05, MP23-20, MP71-05 Brureau, Laurent MP61-02 Bruschini, Homero MP43-17 Bruyere, Frank PD5-08, PD5-10 Bryant, Richard MP55-12 Bryk, Darren MP15-11, MP29-01, PD37-11, V10-06 Bucci, Stefano PD40-12 Buchner, Alexander MP26-17, MP58-16, PD9-04 Buchwald, Dedra PD8-09, PD20-07 Buck, Andrew PD4-12 Buck, Jessica MP81-20 Buckley, Jean MP38-06 Buckley, Jill MP15-02, p18, p95 Budaeus, Lars MP78-17, MP83-06 Budäus, Lars MP83-16, PD30-07 Budde, Klemens PD35-10 Budía, Alberto MP38-11, MP80-11 Budnik, Justin MP51-11 Buehler, Joshua MP65-18 Buerki, Christine MP1-11 Buethe, David D. MP59-20 Buffi, Nicolò MP6-07, MP59-08, MP59-15, PD49-03, PD49-05, p153 Buffington, Phillip MP4-03 Bugeja, Simon MP29-06, MP29-07, MP29-08, PD14-03, PD14-11, PD22-01, PD22-06 Bui, Cat N. MP73-13 Bui, Don MP30-14 Bui, Hoai MP36-02 Buldu, Ibrahim MP38-20, PD13-09 Bultman, Eric MP44-16 Bumbasirevic, Uros MP52-15 Burda, Michal MP71-07 Burge, Bethany K. MP64-09 Burger, Maximillian MP2-10, MP58-16, MP65-09 Burges, Alexander V7-05 Burgess, Neil MP30-07 Burgmann, Maximiliane V7-05 Burgos, Javier MP85-06 Burgu, Berk MP40-05, MP40-12 Burke, Emily MP1-01 Burke, Michael MP32-10 Burkhard, Fiona C. MP31-01, MP65-16 Burks, David p13 Burks, Frank MP42-05, PD12-02, PD38-13, p13, p73 Burnett, Arthur MP4-09, MP52-05, PD36-08, PD39-12, PD45-10, p12, p55, p117, p221 Burrows, Pamela PD39-01 Bury, Matthew MP19-03, MP19-11 Buscarini, Maurizio MP20-10, MP67-15 Buse, Stephan V2-05 Buser, Lorenz MP68-08, MP68-09 Busetto, Gian Maria MP45-16 Bush, Jonathan W. V7-07 Bush, Nicol p12, p20 Bushell, Colleen PD20-09 Bushnel, Daniel MP Butcher, Michael MP43-19, PD39-01, p73 Butler, Christi MP14-17 Büttner, Hartwig MP42-07 Buttyan, Ralph MP36-17, MP37-01, MP46-06, p124 Buzi, Ruth MP43-05 Byrne, Michael MP41-15, PD42-09, PD42-11 Byun, Hye Jin MP54-10 Byun, Seok-Soo MP37-08, MP42-16, MP44-09, MP56-11, MP73-06, MP77-06, MP78-16, MP82-11 C Caballer, Vicent MP80-11 Caballero-Romeu, Juan-Pablo V6-13 Cabrera, Fernando MP20-14, MP28-09, MP33-12 Cabrera, Marino V4-12 Cacalano, Nicholas A. MP61-14 Cacciamani, Giovanni MP67-20, PD9-03 Cadeddu, Jeffrey MP11-14, MP57-10, MP84-13, p96 Cagiannos, Ilias MP57-20, MP68-19, PD44-09, PD47-12 Cai, Chao MP66-13 Cai, Jie MP5-06, MP27-10, MP56-07, MP67-13, PD9-07, PD23-09, PD34-05 Cai, Tommaso PD17-11 Cai, Yang MP55-19 Caicedo, Juan Ignacio MP25-16 Cain, Mark MP40-20, MP54-19, p11 Cakir, Omer MP33-19 Calabrese, Renee PD38-09 Calaway, Adam C. MP35-10, MP59-07, V8-05 Caldamone, Anthony A. FRI-07, p118 Caldovic, Ljubica MP20-07, MP20-08 Caliolo, Claudia MP85-06 Callaghan, Cameron MP39-01, MP69-01, PD15-10 Callas, Peter MP75-02 Calvaresi, Anne p100 Calvert, Robert MP41-13 Calves, Jehanne MP13-13, MP13-18 Camacho, Amparo MP43-18 Camacho, Ignacio V4-08 Cambareri, Gina MP54-17, PD22-10 Cameron, Anne P. MP89-02, PD1-09, PD10-07, PD10-09, PD10-12, V2-02, p84 Campain, Nicholas MP65-06, MP72-15, PD41-05 Camparo, Philippe MP31-03 Campbell, Brittany MP37-11 Campbell, Bruce p11 Campbell, Douglas PII-LBA3 Campbell, Jeffrey B. MP54-08 Campbell, Kevin PD28-07 Campbell, Logan MP9-08, MP24-20 Campbell, Marian MP23-06 Campbell, Steven MP63-14, MP69-14, MP84-09, PD29-09, PD35-12, p12, p18, p100, p221 Campeau, Lysanne p18 Campos, Felix PD14-11, PD22-01 Campos Jr., Olávio MP8-09 Campos, Rodrigo V11-09 Campos-Juanatey, Felix MP44-15

304 Campos-Silva, Pamella MP52-20, MP76-13 Canakci, Cengiz MP48-01 Canales, Benjamin MP33-03, MP33-09, MP33-11, MP34-09, PD4-03, p254 CAnary Pathology Team Investigating Tissue Biomarkers (CAPIT) MP1-17, MP6-13 Canby-Hagino, Edith PD22-07 Cancel-Tassin, Géraldine MP7-12 Canda, Abdullah MP67-19 Candela, Braden MP23-09, V9-10 Candiani, Massimo MP76-15 Canes, David MP7-01, MP61-07, V4-12, V8-12, p100 Canfield, Steven MP52-11, p162 Cangemi, Antonina Graziella MP45-10 Canning, Douglas A. V7-04, p18 Cannon, Glenn MP40-11, MP54-18 Canon, Stephen PD24-07 Canter, Daniel MP16-12, MP24-05, MP65-02, MP70-04, MP79-03, MP84-07, PD17-06, PD49-04, p132 Cantiello, Francesco MP76-05, MP78-13 Cantley, Lewis MP46-10 Cantrill, Christopher PII-LBA1 Cantwell, Anthony MP3-02 Cao, Bo MP66-11 Capitán, Carlos MP13-20, PD5-08, PD5-10 Capitanio, Umberto MP44-04, MP44-17, MP48-13, MP56-02, MP56-03, MP56-16, MP62-05, MP63-03, MP63-04, MP63-20, MP78-13, MP78-15, MP83-17, PD29-12, PD32-09 Capogrosso, Fabio PD41-02 Capogrosso, Paolo MP4-10, MP44-04, MP51-17, MP51-18, MP63-03, MP63-04, MP74-20, MP76-05, MP76-15, PD52-06, PD52-10 Capolicchio, Gianpaolo p17 Caputo, Peter MP35-07, MP50-15, MP70-02, V4-01, V4-11, V9-05 Caracciolo, Jamie MP59-10 Carballido, Joaquín MP44-17, MP52-04, PI-07 Carbognin, Giovanni MP57-13 Carbone, Antonio MP18-20, PD9-12, PD45-11, PD49-08 Carducci, Michael MP73-10 Caremel, Romain MP12-05 Carenzi, Cristina MP63-04 Carini, Marco MP71-03, MP71-08 Caris, Christien PD16-08 Carlos, Evan MP64-09 Carlos, Silva PD27-12 Carlson, Rachel MP6-05, MP56-14, MP83-11 Carlsson, Martin PD27-06 Carlsson, Sigrid MP60-10 Carlsson, Stefan MP4-19, MP56-17 Carmel, Maude PD50-02 Carmignani, Luca FRI-11, MP77-08 Carmona, Oswaldo V4-12 Carneiro, Arie MP32-05, MP48-16, MP83-19, MP84-12, V10-10 Carneiro, Bruno D.B. MP22-16 Carney, Kenneth p13 Carobbio, Francesca PD35-01 Carons, Akin V2-08 Carons, Akinwunmi V2-07 Carpenter, Anne PI-09 Carrasco, Alonso MP70-14 Carrell, Douglas MP76-12, p153 Carrier, Serge p55 Carrieri, Giuseppe p51, p236 Carrión, Cesar Jesús V10-12 Carrion, Rafael MP23-11, PD26-02, PD26-04, PD40-07, p55, p140 Carro, Clara Garcia MP79-07 Carroll, Aaron MP40-20, MP54-19 Carroll, Peter MP1-05, PD6-06, PD12-11, MP24-08, PD15-12, PII-LBA2, MP42-12, MP53-18, PD34-03, PD34-10, PD41-10, PD43-01, PD47-02, MP86-10, p100, p136, p174 Carson, Culley p30, p234, p235 Carter, Christopher MP35-04 Carter, H. Ballentine MP1-15, MP9-02, MP24-16, MP42-04, PD6-04, PD34-09 Carter, J. Jacques PD46-05 Carter, Stacey MP41-10 Caruso, Carla MP7-09 Caruso, Joseph A. MP40-15, MP80-19 Carvalho, Fabricio MP43-17 Carvalho, Raphael Farias MP21-09 Carvalho, Vitalino p71 Carvalho-Dias, Emanuel MP31-16 Carver, Brett MP10-01, MP10-05, MP10-12, MP10-13, MP10-19, p11, p196 Carvo, Ingrid MP11-14 Cary, K. Clint MP10-08, MP10-17, MP58-11, MP64-17, MP65-14 Casale, Pasquale MP54-15 Casanova, Juan V4-02 Casarrubea, Giuseppe MP57-13 Casellato, Stefano MP77-08 Caskurlu, Turhan MP25-12, MP48-01 Castagna, Giulia MP4-10, MP51-17, MP51-18, MP74-20, MP76-05, MP76-15, PD52-06, PD52-10 Castaldo, Luigi MP26-05 Casteels, Cindy PD7-02 Castelblanco, Diana MP25-16 Castellan, Miguel p17, p31 Castelli, Tommaso MP26-16, MP71-12, PD10-03 Castelo-Branco, Pedro MP37-11 Castiglione, Fabio MP15-16, MP19-16, MP19-18 Castillejos-Molina, Ricardo A. MP25-18 Castillo Cadiz, Octavio PD29-04 Castillo, Alex MP24-01 Castillo, Josefino MP60-07 Castillo, Octavio MP3-04 Castle, Erik MP4-11, MP71-09, MP71-15, PD15-08, V8-11, V8-12, V10-05, p10, p72 Castro Neves, Oseas PD3-04 Castro-Nallar, Eduardo MP20-07, MP20-08 Castro-Santamaria, Ramiro MP1-13, MP42-02, MP60-09, PD6-01 Casuscelli, Jozefina MP47-14 Catalona, William MP53-04, PD38-07, p11, p72, p268 Cataño, Juan Guillermo MP Catanzaro, Mario MP10-11 Catchpole, Ken PD21-07 Cates, Justin MP49-01 Cathala, Nathalia MP42-17, MP48-16, MP62-08 Cathcart, Paul MP43-13 Cathelineau, Xavier MP42-17, MP48-16, MP56-10, MP62-08, MP82-01, PD47-05 Cattaneo, Francesco PD19-01 Catto, James MP58-03, MP68-05, p44 Cavalcanti, Andre p20 Çayan, Selahittin MP43-12, MP74-12 Caza, Tiffany MP39-02 Cazzaniga, Walter MP4-16, MP62-05, MP82-03 CEASAR Investigators MP27-11, PD12-03 Cecchi, Fabiola MP6-17 Celestino, Francesco PD17-02 Celia, Antonio MP3-04, MP57-13 Celik, Duygu Sultan PD36-07 Celma, Ana MP13-06, MP48-12, MP60-05 Cendron, Marc V10-09 Cengiz, Cenk MP76-06 Cerantola, Yannick PD12-01 Ceriotti, Ferruccio MP6-07 Cermak, Ales MP86-01 Cernigliaro, Joseph MP75-17 Cerqueira, João Batista MP21-09 Cerruto, Maria Angela MP67-20, PD9-03 Cervigni, Mauro p13 Cesario, Stacy MP20-09 Cestari, Andrea MP88-05 Çetin, Turan MP74-12 Cha, Eugene MP2-13, MP7-07, MP7-13, MP7-17, MP36-12, MP50-11, MP59-02, MP64-02, MP64-11, MP64-19, PD17-11, PD29-12 Chabrier, Pierre-Etienne PD1-03 Chacko, Ninan K. MP79-08 Chade, Daher PD23-08 Chadwick, Karen MP61-01 Chae, Sung-Suk MP66-01 Chae, Yunbyung PD51-12 Chai, Toby p43, p73, p189, p236 Chakrabarty, Amit PD45-01 Chakrabarty, Basu MP31-09 Chalasani, Venu PD5-06 Chalfin, Heather MP24-16, MP32-06, MP64-10 Challacombe, Ben MP22-05, MP23-02, MP23-20, MP59-15, MP62-13, MP71-05, MP74-07, V5-02, p12, p173 Chalmers, David MP33-14, MP54-08 Chambers, Ann F. PD33-01 Chamie, Karim MP24-01, MP32-01, MP65-20, p255 Chamssuddin, Abdou Khair p58 Chan, Daniel PD46-02, PD46-05, PI-08 Chan, Jason MP56-12 Chan, Kevin MP64-08, MP64-16, MP67-18 Chan, Lewis MP89-14, PD39-08 Chan, Peter p11, p71 Chan, Philip A. MP25-10 Chan, Yiong Huak PD17-01 Chancellor, Michael MP11-18, MP20-17, PD24-04, p10, p17, p44 Chander, Ashok MP1-19

305 Chandra, Sundeep PD27-11 Chandrasekar, Thenappan MP46-07 Chandrashekar, Aravind MP51-06, MP74-02, PD37-05, PD39-06, PD52-01, V3-09 Chang, Andrew PD28-06 Chang, Anthony p12 Chang, Chawnshang MP37-03, MP68-13 Chang, George PD40-09 Chang, Huiyi MP19-12 Chang, In Ho MP89-05 Chang, Inik MP39-16, MP47-11 Chang, Jenny MP59-13 Chang, Jia-Hui MP20-16, MP31-05, MP89-19, PD1-02 Chang, Peter MP32-05, MP50-01, MP83-19, MP84-12, MP84-14, PD3-12, V10-10 Chang, Sam MP5-07, MP49-01, MP65-09, MP84-19, PD6-05, PD12-06, p11, p220, p253 Chang, Shi-Chuan MP80-14 Chang, Silvia MP77-01 Chang, Steven MP9-08, MP78-05, MP84-10, MP84-20, PD35-09 Chang, Steven L. MP41-11, MP50-07, PD12-10, PD21-02 Chang, Wei-Chiao MP21-02 Chang, Yen-Hwa MP44-03 Changfeng, Tai MP12-01 Chantada, Venancio MP44-17 Chaparala, Hemant MP11-03, PD8-05 Chaparro, Eduardo MP68-16 Chapin, Brian p58 Chapman, David W. PD14-04 Chapman, Doug MP24-13 Chapple, Christopher MP3-01, MP21-07, PI-04, p66 Charbit, David MP55-09 Charchenko, Cameron PD13-07 Charlotte, Frederic MP75-05 Charnas, Robert MP87-18 Chartier-Kastler, Emmanuel PD1-01, PD10-10, PD10-11, PD11-09, p176 Chastain-Gross, Ryan MP34-09 Chaste, Damien PD49-02 Chatelineau, Xavier MP3-04 Chatta, Kamal MP82-09 Chau, Joey MP23-15 Chauhan, Sanket MP83-12 Chaussy, Christian PD47-06 Chava, Srinivas MP39-01 Chavers, Russell MP51-19 Chavez Ramos, David V10-05 Che, Jianping MP47-12 Chee, Justin p20 Cheetham, Philippa FRII-07 Chegdy, Ed MP41-07 Chehab, Mahmoud MP39-02 Chelluri, Raju MP14-16, MP17-13, MP48-04, MP49-20, MP82-19, MP82-20, PD4-10, PD38-05, PD44-06, V7-06 Chen, Bin MP76-01, MP76-02 Chen, Changhao MP37-16 Chen, Chung-Hsin MP2-11 Chen, David MP24-03, MP24-05, MP47-04, MP50-14, MP67-07, MP67-08, MP67-14, MP70-04, MP84-07, PD49-04 Chen, Fanghong MP49-11, MP49-12 Chen, Haitio PD44-01 Chen, Hai-Yan V6-07 Chen, Haolin PD36-08 Chen, Hung-En MP36-10, MP36-11 Chen, Jindong MP39-09 Chen, Jing-Liang MP20-16 Chen, Kenneth MP48-08 Chen, Kuang-Kuo MP3-10, MP34-03, MP44-03, MP80-14, PD20-12 Chen, Liang MP30-04 Chen, Ling MP11-04, MP33-01 Chen, Mang MP15-06 Chen, Min MP11-07 Chen, Ming MP55-15, V6-07, V12-06 Chen, Ming-Tsun p70 Chen, Peng MP10-03 Chen, Ping MP31-06, MP52-16 Chen, Roger FRI-18, FRII-13 Chen, Rui MP52-09, MP52-10 Chen, Sheng-Fu PD1-02 Chen, Shu-Qiu V12-06 Chen, Su-E MP21-02 Chen, Tzeng-Ji MP34-03 Chen, Wei MP21-08 Chen, Xin MP62-09 Chen, Xu MP37-16 Chen, Yangzhi MP3-07 Chen, Yingbei MP69-18 Chen, Yiyi MP65-18 Chen, Yongmei MP37-17, MP61-10, MP66-06, MP87-11 Chen, Youngmei MP61-16, MP61-20 Chen, Yu MP55-20, p136 Chen, Zhong MP33-17 Chendrimada, Bianca PD27-02 Cheng, Christopher MP48-08 Cheng, David MP36-01 Cheng, Donavan MP64-02 Cheng, Earl Y. V7-07, p17 Cheng, Emily MP47-09 Cheng, Heather PD46-04 Cheng, Jed-Sian MP5-11, MP50-07, V8-04 Cheng, Jonathan MP68-11 Cheng, Liang MP58-11, MP64-17 Cheng, Tiewei PI-06 Cheng, Wei-Ming MP80-14 Chennamsetty, Avinash MP88-04 Cheon, Jun p172 Cheon, Sang-Hyeon p172 Cher, Michael MP37-02, MP42-08, MP78-10, p70 Cherbinsky, Leonid MP17-04 Chermansky, Christopher J. MP12-14, MP89-20 Chertin, Boris MP16-14, MP54-16 Chertow, Glen MP84-02 Cherullo, Edward E. MP44-10, MP56-06, MP84-05, MP84-15 Cheung, Douglas MP15-04 Cheung, Felix MP85-20 Cheung, Patrick MP14-08 Cheville, John C. MP35-18, MP35-19, MP44-14, MP58-09, MP69-05, MP70-11, MP70-12, MP70-14, MP70-15, MP72-11, PD29-06, PD35-07 Chevinsky, Michael MP10-12, MP47-09, MP50-11, MP59-02, PD Chevli, K. Kent MP86-13, PD38-04, PD38-10 Chew, Ben H. MP38-06, MP75-12, PD13-01, PD13-07, p56, p58, p104 Chew, Daniel MP8-15 Chhangawala, Sagar MP66-01 Chhatre, Sumedha PD24-09, PD43-02 Chi, Byung Hoon MP89-05 Chi, Kim N. MP87-18 Chi, Thomas MP11-04, MP17-05, MP33-01, MP33-04, MP34-06, MP71-13, MP75-07, MP79-02, PD4-06 Chiang, Abraham MP24-20 Chiang, George MP54-17 Chiang, Ini MP19-02 Chiapparrone, Gaetano MP43-01 Chiba, Koji MP76-10 Chiba, Satoshi MP58-18 Chibber, Percy p71 Chidambaram, Nachiappan PD37-08 Chien, Gary W. MP14-01 Chihara, Yoshitomo MP68-03 Chiles, Kelly A. MP43-07, MP51-03, MP51-09 Chin, Arnold MP45-18 Chin, Arnold I. MP32-01 Chin, Joseph MP57-20, MP78-08, MP83-13, p191 Chin, Peter MP3-02, PD5-01, p20 China, Toshiyuki MP26-07 Chini, Tommaso MP71-08 Chinnaiyan, Arul MP48-17, MP68-20, PI-08, PD44-07 Chinni, Sreenivasa MP37-02 Chiong, Edmund PD17-01 Chipollini, Juan MP45-03 Chiriacò, Giovanni MP43-01, PD11-11 Chirinos, Jhonan V6-08 Chisholm, Rosaline MP16-06 Chiyomaru, Takeshi MP36-08, MP36-13, PD33-05 Chlosta, Piotr MP56-10, MP77-03, p102 Cho, Deok-Hyun MP18-06 Cho, Doug MP16-01 Cho, Eiken MP2-04, PD23-06 Cho, Eunyoung MP50-07 Cho, In-Chang PD51-12 Cho, Jane S. MP10-08, MP10-17, MP58-11, MP64-17 Cho, Jin Seon PD29-08 Cho, Kang Jun MP52-14 Cho, Kang Su MP38-14, MP71-04, PD25-02 Cho, Min Chul MP13-01, MP13-07 Cho, Patricia V7-08, V7-09, V10-09 Cho, Steven p84 Cho, Sung Tae MP3-17, MP31-12 Cho, Sung Yong MP13-07, MP28-01, MP82-08, PD16-10, PD20-10 Cho, Young Sam MP12-09, MP31-12 Choate, Kara MP77-09 Chocolaty, Matus PD2-01 Choerung, Voleak MP61-11 Choeurng, Voleak MP1-04, MP1-11, MP1-12, MP6-03, MP55-18, MP66-16 Choi, Andrew PI-03 Choi, Don Kyoung MP44-20, PD25-05 Choi, Haesun p12 Choi, Han Yong MP7-04, MP50-05,

306 MP62-17 Choi, Han-Yong MP44-20, PD25-05 Choi, Ho Chul MP71-04, MP73-08 Choi, Jae Duck MP89-05 Choi, Jae Hwi MP43-14 Choi, Jae Young MP3-13, MP18-06 Choi, Jong Bo MP52-14, PD16-10, PD20-10 Choi, Judy PD40-02 Choi, Judy M. MP11-17, V2-03 Choi, Kyung Hwa MP85-03 Choi, Min Ji MP52-03 Choi, Se Young MP89-05 Choi, See Min MP43-14 Choi, Seock Hwan MP18-06 Choi, Seung-Kwon MP53-16, PD43-03, PD47-01 Choi, Woo Suk MP83-20 Choi, Woonyoung MP72-06, PI-06 Choi, Yong Hyo PD25-05 Choi, Young Deuk MP38-14, PD25-02 Choi, Young Hyo MP7-04, MP62-17 Cholyway, Renee PD50-12 Chong, Yew Lam PD18-08 Choo, Myung Soo PD20-10 Choo, Myung-Soo MP3-14, MP19-06, MP52-14, PD16-10, p172 Chopra, Sam PD5-06 Chopra, Sameer MP15-20, MP68-12, MP70-03, MP83-12, PD34-05, V12-11 Chou, Chieh-Lung p71 Chou, Kuang-Yu MP36-10, MP36-11 Choudhary, Dharamainder MP45-20 Choudhury, Muhammad p12 Choueiri, Toni MP35-01, MP50-07, MP60-01, MP63-17, MP73-11, MP77-12 Chouhan, Jyoti MP16-15 Chow Maneval, Edna MP87-16 Chow, George p71 Chow, Ken V4-04 Chowaniec, Yvonne MP63-12, MP63-15 Chowdhury, Lira MP86-20 Chowdhury, Simon PII-LBA4 Chowdry, Rajasree Pia MP87-17 Choyke, Peter MP6-17, MP14-16, MP17-13, MP48-04, MP82-19, MP82-20, PD4-10, PD30-02, PD38-05, PD44-06, p13, p19, p57 Christ, George p17, p20, p117, p174 Christ, Kimberly MP45-05 Christe, Andreas PD13-02 Christea, Octav PD44-09 Christensen, Emily S. MP74-19 Christie, Alana PD8-02, PD10-05, PD50-06 Christine, Brian PD26-10, PD40-10, p55 Christopher, Nim PD2-01, PD48-08, PD52-03 Christos, Paul MP65-03 Christudass, Christhunesa MP6-18 Chromecki, Thomas MP44-17, MP70-09, PI-07 Chrystal, James MP36-14 Chrzan, Daryl MP34-06 Chu, Carissa MP42-12 Chu, David MP18-17 Chu, Haitao MP9-11 Chu, Peggy p70 Chu, Stephanie PD21-07 Chua, Michael MP60-07 Chuang, Kai-Wen MP18-01, V2-08 Chuang, Ryan J. MP24-09, V4-03 Chuang, Shu-Mien MP21-02 Chubak, Barbara FRI-05 Chueh, Shih-Chieh PD38-04 Chugh, Rohit MP55-13 Chughtai, Bilal MP13-14, MP32-16, MP81-20, PD2-02, PD26-09, V3-12, p25 Chun, Felix MP2-10, MP3-16, MP9-08, MP24-20, MP56-10, MP58-10, MP58-13, MP58-20, MP63-17, MP67-05, MP67-09, MP77-03, MP82-01, MP83-06, MP83-15, PD30-09, PD30-12 Chun, Jji-Youn PD16-10 Chun, Kwon Soo PD21-01 Chung, Amanda S. MP32-18 Chung, Benjamin MP41-11, MP78-05, MP84-02, MP84-10, MP84-20, PD12-10, PD21-02, PD35-09 Chung, Byung Ha MP1-18, MP73-08, PD29-08, p247 Chung, Doo Yong MP38-14 Chung, Doreen PI-05 Chung, Eric MP15-08 Chung, Ho Seok MP20-11 Chung, Hsiao-Jen MP3-10, MP34-03, MP44-03 Chung, Jae Il MP13-09, MP25-04 Chung, Jae Min MP40-17 Chung, Jae Seung MP13-09, MP44-09 Chung, Jinsoo MP44-20 Chung, Ky Hyun MP43-14 Chung, Kyung Jin MP3-17, MP31-12, PD21-01 Chung, Moon Kee MP40-17 Chung, Paul PD26-01, PD48-09, V8-13 Chung, Peter MP10-10 Chung, Shiu-Dong MP89-19 Chung, Sung Kwang MP18-06 Churchill, Bernard MP54-20 Churilla, Thomas MP24-05 Ci, Weimin MP2-01 Ciancio, Gaetano MP44-17, PI-07 Cicalese, Carmine MP57-18, MP57-18 Cicero, Calogero MP57-13 Cicero, Giuseppe MP45-10 Ciciliato, Stefano MP67-20, MP88-03, PD9-03 Cieza-Borrela, Clara MP86-11 Ciftci, Seyfettin PD2-03 Cimino, Sebastiano MP26-16, MP71-12, PD10-03 Cindolo, Luca PD49-08 Cipolla, David MP86-13 Ciria, Juan Pablo MP73-01 Ciriello, Giovanni MP35-01 Cirillo, Stefano MP53-10, MP77-11 Clark, Peter MP49-01, p11, p18, p136, p169 Clark, William MP6-08 Clarke, Noel p137 Clarke, Robin MP32-01 Clarkson, Becky MP12-10, PD24-10 Clarkson, Mackenzie J. PD36-02 Claro, Joaquim F. A. MP30-16, MP30-19, 294 MP75-03 Clayman, Ralph MP59-13, p13, p44 Clayman, Rebecca MP26-12, MP62-14, MP65-09 Clayton, Doug p57 Cleary, Patricia A. MP81-12 Clemens, J. Quentin MP9-05, MP24-13, MP81-12, MP89-02, PD1-09, PD10-07, PD10-09, PD10-12, PD27-06, V2-02, p12, p220, p251, p255 Climo, Michael MP25-03 Clouston, David MP61-04 Cloutier, Jonathan MP7-19, MP17-06, MP75-05 Cnossen, Sonya MP68-19, PD44-09 Coburn, Michael PD42-01, p10, p20, p255 Cochetti, Giovanni MP62-02 Cochran, James PII-LBA2 Cochran, Lynn MP80-02 Cockerill, Patrick MP6-05, MP29-15, MP33-07, MP72-11 Cocks, F. Hadley MP33-12 Coe, Fredric MP80-10 Coelho, Ana MP8-20 Coelho, Hugo MP37-11 Coelho, Rafael PD43-06, V4-07, V4-08, V5-01, p12, p72 Coeurdacier, Pierre MP13-13, MP13-18 Coffey, Mary MP88-04 Coffield, K. Scott PD5-01 Cogburn, Mark MP70-06 Cohen, Adam MP41-14, MP80-05, PD13-12 Cohen, Andrew J. MP14-18 Cohen, Avraham MP16-14 Cohen, Benjamin MP9-13 Cohen, Daniel MP16-06 Cohen, Deborah PD40-05 Cohen, Edward PD38-09 Cohen, Justus PD20-05 Cohen, Martin PD38-08 Cohen, Michael MP17-04, PD23-03 Cohen, Seth MP11-17, V2-03, p55 Cohn, Joshua PD23-10 Colaco, Marc MP16-18, MP28-02, MP30-17 Colakerol, Aykut MP33-08 Cole, Alexander PD31-06 Cole, Alexander P. MP4-19 Cole, Andrew MP29-07 Colecchia, Maurizio MP66-20, PD41-02 Coleman, Ilsa MP66-15 Coleman, Jonathan MP2-13, MP2-15, MP7-07, MP7-13, MP7-17, MP35-01, MP36-12, MP44-07, MP44-15, MP47-13, MP47-14, MP50-11, MP50-16, MP53-20, MP59-02, MP63-08, MP87-11, PD29-03, PD33-02, PD33-03, PD47-08, p174 Colhoun, Andrew MP12-15, MP12-16, MP25-03, V10-11 Colin, Pierre MP2-07, MP7-01, MP7-05, MP7-06, PD29-12 Collins, Colin MP49-09 Collins, Justin MP67-19 Collura, Devis MP48-18, PD49-08 Colom Feixas, Sergi MP38-17 Colombo, Alberto PD26-03 Colombo, Pier Giuseppe PD41-02

307 Colombo, Renzo MP26-18, MP26-19, MP56-05, MP56-18, MP72-04, MP72-14, PD17-11, PD41-02 Colston, Maryellen MP14-05, PD34-08 Comhair, Suzy PD51-09 Comiter, Craig PD27-07, p12, p18, p100 Compérat, Eva MP2-07, MP7-05, MP7-12, MP68-05, MP75-05, PD10-10 Comstock, Bryan PD19-02, PD19-03, PD19-05, PD19-06, PD30-05 Conca, María Ángeles MP80-11 Conceicao, Carol MP30-10, PD15-09 Conceicao, Raquel MP71-19, PD39-07 Concepcion, Raoul PII-LBA3, PII-LBA10, p9 Concha, Daniel MP33-12 Conley-Lacomb, Mary MP37-02 Conlin, Michael PD6-08, PD44-02 Connor, Sarah E. MP16-09 Connors, Bret MP34-19 Consigliere, David V2-13 Constantini, Elisabetta V2-12 Conte, Antonella PD10-04 Conti, Andrea PD41-02 Conti, Giario MP66-20 Conti, Giario Natale PD41-02 Conti, Simon MP28-13 Coogan, Christopher p10 Cook, Peter PD52-04 Cookson, Michael MP49-01, MP65-06, MP72-15, PD6-05, PD9-05, PD41-05, p10, p12, p175, p253 Cooney, Matthew MP69-08, MP84-15 Cooper, Catherine PD22-02 Cooper, Christopher S. MP40-19, MP54-02, p13, p129 Cooper, David p171 Cooper, Phillip PD38-07 Cooperberg, Matthew MP1-05, MP4-17, PD6-06, MP14-12, PII-LBA5, MP42-12, MP53-01, MP53-02, MP53-12, MP53-18, PD32-10, MP60-12, PD34-07, PD38-11, PD43-01, PD47-02, MP82-15, MP86-10, MP87-08, MP87-09, p13, p136, p190, p251 Copp, Hillary FRII-01, MP54-09, MP54-12, MP54-13 Corbel, Luc MP13-13, MP13-18 Corbett, Sean MP20-13 Corcoran, Anthony MP84-17, V9-08 Corcos, Jacques MP12-05, PD1-08 Cordeiro, Mauricio PD23-08, PD43-06 Cordeiro, Paulo MP3-12, MP71-18 Coret, Andu MP50-19 Corey, Eva MP46-06, MP55-20, MP66-15 Corman, John MP6-08, MP87-15 Cornel, Erik MP48-19, MP73-20 Cornfeld, Daniel MP17-08 Cornu, Jean-Nicolas MP7-19 Corona, Giovanni MP71-03, MP71-08 Corradi, Renato MP50-18, PD29-03, PD29-03 Corradini, Francesca MP19-15 Correa, Andres MP52-18 Correas, Miguel V10-03, V10-12 Correia-Pinto, Jorge MP31-16 Corsini, Erin MP75-14 Coscione, Alberto FRII-11, MP10-16 Coskun, Burhan PD50-06 Costa, Daniel MP17-11, PD27-12 Costa, Miguel p176 Costa, Paulo Renato V5-01 Costa, Waldemar MP52-20, MP55-02, MP76-13 Costantini, Elisabetta MP81-18, PD45-11, p236 Costantini, Manuela PD49-09 Costello, Anthony V4-04 Costello, Brian MP58-09, MP69-05, MP70-12, PD35-07 Couri, Bruna M. MP8-10 Couzi, Lionel MP85-17 Cowan, Barrett PD5-01, PII-LBA1 Cowan, Janet PD34-10, PD47-02 Coward, Robert MP17-02 Cox, Lindsey PD10-09, V2-02 Cox, Michael MP37-12, MP46-06, MP46-08 Coy, Heidi MP35-13 Cozzarini, Cesare MP82-02, MP87-13, PD32-09 Cozzi, Paul MP77-04 Cozzoli, Alberto PD35-01 Craig, Miguel MP74-02 Crawford, David MP6-06, MP24-10, MP48-02, MP60-08, MP71-11, MP73-12, MP73-16, MP87-19, PD2-04, PD32-11, V4-09, p13, p220, p235 Crawford, Thomas p10, p57 Crawley, David MP33-14 Creighton, Chad p19 Creighton, Terrance MP35-12, MP50-06, MP59-06 Crenshaw, Thomas D. MP33-06, MP34-01 Crespi, Catherine M. MP32-14 Crestani, Alessandro PD19-01 Creta, Massimiliano MP67-20 Crisci, Alfonso MP28-08 Crispen, Paul PD49-06 Cristea, Octav PD47-12 Cristofanilli, Massimo p70 Crociani, Catrina MP32-05, MP83-19, MP84-12, PD3-12 Crocitto, Laura MP64-08 Cronson, Brian V4-13 Crook, Juanita MP73-04 Crook, Julia MP5-14 Crook, Tim PD20-01 Cross, Brian MP58-04 Crossley, Heather MP89-02, PD14-12 Crouzet, Sebastien PD47-06 Crowley, Laura MP51-04 Cruz, Francisco MP8-20, PD27-12 Cruz, Yolanda MP12-13 Cucchiara, Vito MP4-16, MP56-05, MP56-18, MP72-04, MP82-03, PD38-12 Cui, Nuan MP12-19 Cui, Tao MP5-13 Cui, Yuanyuan MP46-02 Cui, Yun MP31-04, MP37-03 Culha, Melih PD2-03 Culkin, Daniel MP10-07, MP28-08, PD27-07 Cullen, Jennifer MP1-05, MP14-05, MP42-13, MP61-16, MP61-20, MP66-06, MP87-11, PD Cullis, Pieter MP46-15 Culpepper, David MP63-02 Cumming, Robert PD39-08 Cummings, James MP89-04 Cunitz, Bryan PD42-01, PD42-02 Cunningham, Glenn p221 Cunningham, Melissa p169 Curiel, Tyler MP65-08 Currie, Katharine PD1-06 Cusano, Antonio MP48-20 Cussenot, Olivier MP2-07, MP7-05, MP7-06, MP7-12, PD10-10 Cuypers, Maarten MP14-04 Cuzick, Jack MP1-08, MP1-10 Czerniak, Bogdan MP45-06, MP72-02, PI-06 D Dabaja, Ali MP59-03 Dabi, Yohan MP67-04 Dadaev, Tokhir MP86-11 Daels, Francisco p9 Daggulli, Mansur PD13-09 Dahiya, Arun MP66-01 Dahiya, Rajvir MP39-16, MP47-11 Dahl, Claus MP57-15 Dahl, Douglas MP62-14, MP83-11, p11, p153, p204 Dahlem, Roland MP2-10, MP15-15, MP58-10, MP58-13, PD22-12 Dahm, Philipp MP42-19, PD41-12 Dai, Bo MP14-20, MP37-15, MP47-03, MP50-12, MP87-20 Dai, Yutian p71 Daignault-Newton, Stephanie PD31-03 Daily, John MP48-02 Daizumoto, Kei MP49-04, MP55-06 DaJusta, Daniel MP40-03, MP40-05, MP40-12 Dal Moro, Fabrizio PD19-01 Dalag, Leo MP58-15 Dalag, Leonard MP68-12 Dalbagni, Guido MP7-07, MP7-13, MP7-17, MP11-16, MP50-16, MP63-08, MP64-11, MP64-19, PD9-11, PD17-11 Dalela, Deepansh MP9-08, MP24-20, MP59-14, MP59-15, MP63-17, MP67-05, MP67-09, MP77-10, MP78-19, PD19-06, PD30-05, PD30-12, PD31-06, V9-01 Dalkin, Bruce MP27-08, MP67-17, PD46-12 Dall Era, Marc MP1-06, MP42-03, MP65-06, MP72-15, PD41-05 Dalpiaz, Orietta PD49-08 Daly, Padraig MP86-12 Damaschke, Nathan MP37-20, MP55-11 Damaser, Margot MP8-10, MP8-16, PD24-08, PD50-01, p17, p73 D Amato, Abram V9-08 D Amato, Francesco MP26-19, MP72-04 Damia, Oscar H. PD11-10, V10-05 Damiano, Rocco MP4-10, MP51-17, MP51-18, MP72-04, MP74-20, MP76-05, MP78-13, PD52-06, PD52-10 Damiao, Ronaldo MP73-10 D Amico, Anthony p11, p100 Danacioglu, Yavuz Onur MP48-01 d Ancona, Frank PD5-08, PD5-10

308 D Andrea, Samantha MP39-14 Daneshgari, Firouz MP8-05, MP21-18, PD24-05, p189 Daneshmand, Sia MP72-14, PD41-08 Daneshmand, Siamak MP5-06, MP10-02, MP10-18, MP24-04, MP27-10, MP44-17, MP56-07, MP58-15, MP65-02, MP65-06, MP65-09, MP67-13, MP68-12, MP72-15, MP79-05, MP86-17, PD2-09, PD9-01, PD9-06, PD23-09, PD29-05, PD31-10, PD35-06, PD41-05, PD41-09, V8-06, PI-07, p13 Dang, Brian MP18-15 Dangle, Pankaj MP40-04, MP40-11 Danila, Daniel MP87-11 Dantanarayana, Nandu MP77-04 D Arienzo, Michele MP45-10 Darras, Frank MP85-20 Darwish, Oussama MP18-15 Darwish-Yassine, May MP14-07, MP27-12, MP27-17 Das, Anurag p44, p71 Das, Krishanu V5-05 Dasgupta, Prokar MP22-05, MP22-09, MP23-02, MP23-05, MP23-16, MP23-20, MP46-18, MP61-05, p173 Dash, Atreya MP24-18, MP58-14, MP72-19 Dash, Srikanta MP39-01, MP69-01 Daskivich, Timothy MP9-01, PD12-08, p92 Dason, Shawn MP50-19, PD25-10 Dato, Paul PD38-09 Datta, Amrita MP15-19 Daud, Ahmadullah PD51-04 Daugherty, Michael MP44-13, PD3-03, PD43-05 Dauw, Casey MP16-19, MP41-04, MP75-09, PD51-02 Davalos, Julio G. MP57-11 Davenport, Matthew PD44-12 Davi, Mariana MP45-07 Davicioni, Elai MP1-04, MP1-11, MP1-12, MP6-03, MP6-09, MP37-19, MP53-17, MP55-18, MP61-11, MP66-16, PD41-08 David, Lifshitsz MP41-16 David, Ralph PD2-01, PD48-08 David, Stéphane MP62-08 David, Truán V10-03, V10-12 Davidiuk, Andrew MP81-10 Davidson, Terence MP21-03 Davidson, Valerie MP45-09 Davidson, Wesley MP32-16 Davies, Benjamin MP58-04, PD19-09 Davies, Kelvin MP8-13, p56 Davila, Hugo Alberto PD29-04, p72 Davila-Aponte, Jennifer MP20-13 Davis, Carley MP75-10 Davis, Carole MP11-15, MP46-13 Davis, Darren MP39-13 Davis, Ian MP55-05 Davis, John p9, p136, p185 Davis, Robert V12-08 Davis, Rodney MP32-13, MP77-16 Davis, Ronald MP67-03, PD8-03 Davison, Wesley PD2-02, PD26-09 Davuluri, Meenakshi PD44-04 Daw, Mahmoud MP36-06 Dawod, Tamer MP28-11, MP41-09, PD16-06 Dayton, Paul MP17-02 DCCT/EDIC Research Group MP81-12 DCruz, Jennifer MP54-05, V7-01 De Andrade, Robert V4-12, V8-12 De Angelis, Paolo MP53-09 De Berardinis, Ettore MP45-16 de Bessa Júnior, Jose MP43-17 de Boer, Carla J. MP87-16 de Bono, Johann S. MP87-18 de Bruin, Daniel MP35-05 de Camargo, Juliana A. MP45-07 De Carlo, Francesco PD17-02 de Castro Abreu, Andre Luis MP59-12, MP83-12, PD34-05 de Castro Filho, Jose MP43-17 De Cobelli, Ottavio PD49-08 de Concilio, Bernardino MP57-13 De Fazio, Adam MP38-05, MP43-16 De Grado, Justin PD22-08 de Groat, William MP8-17, MP8-18, MP12-07 de Jong, Igle MP73-05 De la Calle, Claire MP35-14, MP44-08, PD46-02, PD46-05 De la Concepcion Gomez, Octavio Manuel p234 De la Iglesia, Ramón MP73-01 De la Peña, Enrique MP13-20, MP58-17 de la Rosette, Jean MP28-08, MP35-05, MP48-03, p13 De La Taille, Alexandre MP7-05, MP55-09, MP57-02, MP57-12, MP73-05, PD16-08 de Leon, Essel Marie MP65-08 De Luca, Francesco PD52-03 De Marchi, Davide MP67-20, PD9-03 De Marzo, Angelo MP4-02, MP6-15 De Morais, Carlos MP6-15 De Nunzio, Cosimo MP71-03, MP71-08, PD49-08 De Pascale, Agostino MP53-10, MP77-11 de Petriconi, Robert PD11-05 De Porre, Peter MP87-18 De Reijke, Theo MP48-03 De Ridder, Dirk MP19-16, MP19-18, MP21-06, PD7-02, PD7-07, PI-04, p44 de Riese, Heiko MP84-16 de Riese, Werner MP84-16 de Rivero Vaccari, Juan Pablo MP74-15 De Souza, Diogo B. MP52-20, MP76-13 De Torres Ramírez, Inés PD41-04 de Torres, Inés MP6-01 de Vries, Anna Helena MP23-03 De Vries, Marieke MP14-04 de Vries, Petrus PD35-10 De, Elise Billings p13 De, Elise J.B. MP12-08, PD7-11 De, Shuvro MP75-15 De, Sumit MP50-14 Deacon, Stephen MP21-07 Dean, Lucas MP57-20 Dean, Wendy MP27-05 Deane, Leslie MP80-20, MP85-05 Dearnaley, David MP73-04 Debus, Jürgen MP53-08 Decaestecker, Karel MP DeCastro, G. Joel MP14-03, MP24-19, MP26-11, MP26-13, MP32-07, MP44-17, MP63-01, MP64-07, MP64-15, MP72-09, PD9-10, PD29-01 DeCobelli, Ottavio MP26-05 Deconinck, Steven MP53-07, PD32-08 Deeren, Susan MP20-09 Degon, Michael MP61-16 Degoski, Danielle MP8-04 DeGraff, David MP7-09, MP49-01, MP68-10 Degroat, William MP12-01, MP12-14, MP89-20 Dehò, Federico MP48-13, MP56-02, MP56-03 Deibert, Christopher MP74-05, PD48-02, PD48-11 Deitte, Lori PD4-03 Dejesus, Elizabeth MP57-14 Dejima, Takashi MP39-17, MP49-13, MP66-02 Dekuyper, Peter MP9-20, MP27-19 Del Biondo, Dario MP57-13 Del Junco, Michael MP22-14, MP30-13, PD7-04, PD13-04 Del Moral, Sergio MP25-18 Del Pizzo, Joseph p218 Del Popolo, Giulio PD1-01 Del Sordo, Martin p176 Del Valle, Jose Ignacio V10-03, V10-12 Del Zingaro, Michele MP81-18 Delacroix, Scott p45 Delancey, John Oliver MP27-20 Delay, Kenneth J. MP29-13 Delconte, Anthony PD37-08 Delgado-Olguin, Paul MP19-05 D Elia, Carolina PD9-03, MP67-20 Della Negra, Emmanuel MP13-13, MP13-18 Dell Oglio, Paolo MP6-07, MP56-03, MP56-05, MP56-16, MP62-05, MP78-15, MP83-08 Delos Santos, Grace MP8-02, MP19-08, MP31-18 Delprado, Warwick MP60-04, MP77-04, MP83-02, PD46-08 Demaria, Jorge V7-01 Demarzo, Angelo MP6-09 Demichelis, Francesca MP66-01, p70 Demir, Omer MP25-08 Demirjian, Sevag MP44-02, MP63-14, PD29-09 Dempsey, Paul MP37-06 Den, Robert MP1-12, MP6-03, MP6-09, MP37-19, MP55-18 Denardi, Fernandes MP22-16 Denes, Béla MP1-01, MP1-06, PD45-10, p101 Deng, Chunhua MP8-03 Deng, Donna p84, p133, p251 Deng, Fang-Ming MP53-15, MP56-01, MP77-14, MP77-17, MP77-18, PD4-11, PD32-01, PD32-03, PD32-05, PD34-02 Deng, Guoren MP39-16, MP47-11 Deng, Kangli MP8-16 Deng, Mario MP68-07 Deng, Xiaoyan MP1-07 Denstedt, John MP30-20, PD51-01, p11, p85, p108, p219

309 Denys, Pierre PD1-03, PD10-11, PD11-09 DePalantino, Jannell MP73-12, MP87-19 Dermietzel, Rolf PD20-06 DeRoo, Eric MP63-11, PD15-05 DeRosa, Raffaella MP9-16 Deruyver, Yves MP21-06, PD7-02, PD7-07 Derweesh, Ithaar MP51-07, MP69-14, MP84-09, PD15-08, PD35-12, p270 Derweesh, Ithar PD29-09 Desai, Alana MP20-15, MP30-03, MP80-07, PD51-07 Desai, Anuj V4-13 Desai, Janak p58 Desai, Mahesh MP3-03, MP28-08, p9, p58, p71, p79, p234 Desai, Mihir MP3-03, MP15-20, MP59-12, MP63-05, MP70-03, MP83-12, PD9-07, PD31-04, V9-07, V12-11, p71, p72, p172, p189 Desai, Neil MP36-12 Desai, Pragnesh V11-08 Descazeau, Aurélien MP63-12, MP63-15 Descotes, Jean Luc MP7-05, p176 Deshmukh, Sameer MP30-18, MP50-08, MP50-09 Detmar, Michael MP68-08, MP68-09 Detorres, Ines MP48-12, MP60-05 Dettman, Robert MP8-02, MP19-08, MP31-18 Devarajan, Karthik MP67-07 Devasia, Antony MP79-08 Deveci, Serkan MP51-05, PD37-12 devere White, Ralph p253 Devries, Todd MP87-15 Dewan, Kalyan MP25-20 Deweese, Theodore MP32-06 Dewitt, Sasha PD34-11 Dewulf, Karel MP21-06, PD7-07 Dhanani, Nadeem MP52-01 Dhilon, Jasreman MP59-20, PD41-01 Dhir, Rajiv MP58-04 D Hulst, Pieter PD2-05, MP15-16 Dhyani, Manish MP50-08, MP50-09 Di Biase, Manuel MP81-18, V2-12 Di Carlo, Heather MP22-08 Di Cristofano, Antonio MP50-20 Di Grazia, Massimo PD11-11 Di Maida, Fabrizio MP26-18, MP45-10 Di Mauro, Umberto MP57-18 Di Paolo, Pier Luigi MP44-15 Di Rosa, Alessandro PD10-03 Di Stasi, Savino PD17-11 Di Stasi, Savino Mauro PD17-02 Di Trapani, Ettore MP19-18, MP63-04, MP82-03, MP83-17 Diamandis, Eleftherios P. MP61-01 Diamond, David p59, p118 Diaz, Edward MP19-03, MP19-11 Diaz, Gustavo PD2-08 Diaz, Mireya MP78-19 Diaz-Insua, Mireya MP53-13 Diaz-Montero, Claudia Marcela PD33-08 DiBianco, John FRI-06, MP5-09, MP9-10, PD29-02 DiBianco, John Michael V7-13 Dick, Andrew MP9-01 Dicker, Adam MP1-12, MP6-03, MP6-09, MP55-18, MP87-12 Dickey, Ryan PD52-08 Dickinson, Shohreh PD41-01 Dickstein, Rian MP72-02 Diehl, Nancy MP5-14 Dielubanza, Elodi MP5-18 Diemer, Thorsten MP76-03 Dieter, Alexis MP8-04 Dieterich, Lothar MP68-09 Dietrich, W. Dalton MP74-15 Dighe, Manjiri MP17-01 Diiorio, Daren PD6-05 Dijkema, Geerke MP8-10 Dillioglugil, Ozdal MP42-20 Dimaggio, Paul MP16-03 Dimitrakoff, Jordan p89 Dimitriadis, Fotios MP76-07, PD36-11 Dimitrov, Ivan MP11-14 Dincer, Murat MP43-12, PD2-06 Dineen, Martin p119 Ding, Jie PD16-01 Ding, Keyue MP73-04 Ding, Sheng MP46-07 Dingwei, Ye MP10-06, MP69-04 Dinizo, Michael MP53-04, PD36-06 Dinkel, Andreas MP83-14 Dinney, Colin MP26-14, MP36-01, MP45-06, MP65-02, MP65-05, MP65-06, MP67-06, MP72-02, MP72-06, MP72-15, PD17-06, PD25-12, PD31-09, PD41-05, PI-06, p253 Diokno, Ananias p173 DiPaola, Robert MP72-10, PD35-04 DiPippo, Vincent MP82-09 DiSanto, Michael MP52-16, p56 Ditonno, Pasquale MP66-20 Divakaran, Pranav MP15-08 Divine, George W. MP87-01 Divrik, Rauf Taner MP7-20 Dixon, C. p86 Djajadiningrat, Rosa MP5-10, MP10-11 Djaladat, Hooman MP5-06, MP10-18, MP27-10, MP56-07, MP67-13, MP68-12, MP86-17, PD2-09, PD9-01, PD9-06, PD23-09, PD35-06, V8-06 Djesevic, Almedina MP47-09 Djomehri, Sabra MP11-04, MP33-01 Djordjevic, Miroslav MP52-15 Dmochowski, Roger MP15-12, MP29-17, MP89-13, PD11-04, PD14-05 Dobberfuhl, Amy MP12-08, MP29-04, PD7-11 Dobbs, Ryan PD28-04 Dobi, Albert MP37-17, MP61-10, MP61-16, MP61-20, MP66-06, p101 Dobruch, Jakub p102 Dobs, Adrian S. PD37-08, p221 Docimo, Steven MP54-18 Doerfler, Arnaud MP63-12, MP63-15 Dogan, Serkan MP48-11 Dogra, P. N. MP28-05, PD16-07 Doizi, Steeve MP48-16 Dokiya, Takushi MP83-09 Dolat, Maryellen MP12-15 Doll, Andreas MP6-01 Doll, Nancy MP47-20 Dolled-Filhart, Marisa MP68-11 Dombrovskiy, Viktor MP72-13 Dominguez Elias, Joan MP79-17 Domínguez Escrig, José Luis V Dominguez Gutierrez, Paul MP33-09 Dominguez, Mario V10-03, V10-12 Domínguez-Escrig, José Luis MP73-01 Domjan, Zsolt p101 Donahue, Timothy MP11-16, MP50-11, MP64-11, MP82-04, MP87-11 Donalisio Da Silva, Rodrigo MP18-10, MP18-14 Donat, S. Machele PD9-11, p222 Donat, Sherri MP50-11, MP64-19 Dondoo, Tsogt-Ochir MP55-06 Dong, Dahai MP47-03, MP60-19 Dong, Pei MP10-03 Dong, Qiang p71 Dong, Shan MP44-10, MP61-15, MP84-05, MP84-15 Dong, Wen MP45-12 Dong, Xiaoliang MP45-12 Dong, Yan MP6-04, MP6-11, MP66-11 Donin, Nicholas MP56-01 D Onofrio, Alberto MP4-09 Donoso, Cesar V. MP44-17 Donovan, Michael PII-LBA2, p136 Doolan, Padraig MP61-19 Doolittle, Johnathan MP81-06 Doran, Todd p100 Dorey, Frederick MP11-05, MP60-11, PD30-01 Dorff, Tanya MP37-06, PD23-09, PD31-10 Dorin, Ryan MP23-04, MP48-06, PD32-12 Döring, Daniel MP74-17 Dormer, John MP48-14 Dornbusch, Juana PD35-08 Dorner, Natalie PD41-11 Doros, Gheorghe MP27-03, PD37-04, PD45-03, PD45-04 Dörr, Martin MP62-18 Dorsey, Philip V9-14 Dos Santos, Joana MP40-18 Doshi, Chirag MP35-12 Dotan, Zohar MP59-11, MP78-06 Dotiwala, Aryeneesh MP66-03 Doudeau, Christian MP62-08 Douek, Michael MP35-13 Douglawi, Antoin PD29-05 Doumerc, Nicolas MP57-02, MP57-09, MP57-12, MP85-09 Dounis, Athanassios MP48-09 Dovirak, Ostap MP32-05, MP83-19, MP84-12, PD3-12, V10-10 Dowling, Catherine MP10-13, MP10-19, MP55-20 Downs, Tracy MP26-01, MP26-08, MP26-09, MP35-17, PD17-06, p84 Dowsett, Sherie PII-LBA6 Drabkin, Harry MP69-15 Drabovich, Andrei p136 Drachenberg, Darrel MP57-20, MP84-08 Drago, Andrew MP9-09 Dragomir, Alice MP72-05, PD12-01 Dragon, Kelly MP70-19 Drake, Charles MP4-02, MP58-07, MP67-10, MP87-15, p137 Drake, Elise MP23-06 Drake, Marcus PII-LBA9, p21 Dray, Elizabeth MP18-11 Dreicer, Robert MP6-08 Drevin, Linda MP56-17 Drewa, Tomasz p102

310 Drewry, Anna MP44-16 Drnek, Linda PD31-03 Droller, Michael p23 Dromparis, Peter PD33-11 Drouin, Sarah MP7-01, MP7-12 Droupy, Stéphane MP57-02, MP57-12 Dru, Christopher MP20-04 Drury, Kurt MP63-11 Dsebisashvili, Nino MP4-18, PD43-10 Duarte, Stefferson V5-01 Dube, Hitesh MP11-13 Dubin, Andrew H. MP12-08 Dubin, Justin PD4-04 Duboy, Alberto V7-11 Duchene, David PD51-10, V3-11, V4-10, p83 Dudeja, Vikas MP55-13 Dudley, Anne MP40-11 Duel, Barry p17, p31 Duff, Michael MP86-13, PD38-04, PD38-10 Duffy, Simon MP1-07 Dugan, John MP47-10 Dugi, Daniel p20 Duivenvoorden, Wilhelmina MP37-05 Dukic, Ivo PD8-04 Dulaimi, Essel MP47-04 Dulal Das, Nando MP52-03 Dum, Travis MP88-20 Dunkin, Brian PD19-08 Dunmire, Barbrina MP17-01, PD42-01 Dunn, Diana MP39-02 Dunn, Mary MP78-14 Dunn, Matthew p280 Dunn, Rodney MP5-20, MP24-17, MP58-06 Dupree, James MP51-02, MP74-02, PD52-08 Durack, Jeremy PD33-02, PD47-08 Durinka, Joel MP9-19 Durrani, Mohammad M. MP22-11 Durso, Timothy MP44-12 Dutta, Pinaki PD4-02 Duty, Brian MP30-13, MP38-13, p10 Duvdevani, Mordechai MP28-08 Duymich, Chris MP68-12 Dwyer, Moira MP40-11, MP54-18 Dy, Jun MP23-01 Dynda, Danuta MP4-20, MP9-06, MP70-08, MP74-06, PD26-08 Dyson, Greg MP53-19 Dziemianowicz, Mark MP67-14 E Easaw, Saumya MP9-09 Eastham, James MP6-16, MP53-20, MP78-03, PD6-10, PD32-04 Ebbing, Jan MP3-20 Eberli, Daniel MP19-10, MP19-14, MP21-19, MP66-19, PD8-01 Ebertowski, James MP16-01, PD21-10, PD22-07 Ebot, Ericka MP6-15, PD6-07 Edeling, Sebastian MP67-19 Edelman, Arthur I. MP16-14 Eder, Matthias MP53-08 Ederer, Michael PD24-01 Eduardo, Solsona Narbón V4-02 Edwards, Claire MP66-18 Edwards, James PD6-08 Edwards, Luke MP89-09 Edwards, Todd MP27-04, PD14-07 Eeles, Rosalind A. MP86-11 Efremov, Evgeny MP43-10 Efstathiou, Jason MP26-12, MP62-14, MP65-09 Egan, Kathryn PD39-02, PD39-12 Egawa, Shin p199 Eggener, Scott MP4-12, MP53-04, MP84-04, PD15-04, PD18-02, p59, p174 Eggers, Paul PD39-01 Egi, Hiroyuki MP22-17 Egleston, Brian MP67-08 Egydio, Paulo PD48-02, PD48-10, PD48-11 Ehdaie, Behfar MP14-09, MP27-13, MP53-20, MP59-02, MP78-03, PD6-10, p174 Ehlert, Michael MP89-01, MP89-03, MP89-09, MP89-10, PD20-08, PD21-06, PD27-10, PD50-12 Eiber, Matthias MP82-10, PD32-06, PD32-07 Eibofner, Frank MP11-19 Eid, Francois PD26-02, PD26-04 Eidelman, Alec MP62-14 Eifler Jr., John B. PD6-05 Eilber, Karyn MP24-15, PD21-07, PD28-03, PD50-08, p11 Eisenberg, Manuel MP58-15 Eisenberg, Michael MP24-11, MP43-08, PD52-12, p153, p236 Eisenberger, Mario MP72-08 Eisner, Alon MP30-09 Eisner, Brian MP20-14, MP30-18, MP38-19, MP41-18, MP75-12, MP80-01, p220 Eissa, Mohamed p234, p235 Eksi, Mithat MP38-07 El Bakhri, Adnan MP63-12, MP63-15 El Dib, Regina MP79-09 El Mahdy, Alaa MP80-17 El Sayed, Ihsan MP55-09 El Tayeb, Marawan MP3-15, MP34-19, PD42-04, V3-12, V6-11 Eladl, Mahmoud MP38-02, MP41-09 El-Akkad, Magdy p234 El-Assmy, Ahmed MP13-03, PD5-12 El-Azab, Ahmed PD10-06 El-Bilsha, Mona A. PD9-02 El-Deeb, Mona MP67-01 Elder, Jack MP54-07, PD13-11, p44 Elder, Robert V2-09 Elderwy, Ahmad MP40-01 Eleswarapu, Sriram MP54-07 Elfiky, Aymen MP87-15 El-Ghoneimy, Mohamed MP85-14 Elhage, Oussama MP46-18, MP61-05 El-Hakim, Assaad MP43-04 El-Halwagy, Samer PD23-05 El-Hefnawy, Ahmed PD23-05 Elhilali, Mostafa MP13-05, MP71-10 Elhosni, Khaled MP13-16 El-Kappany, Hamdy PD5-12 Elkoushy, Mohamed MP13-05, MP71-10 Ellen, Joseph PD37-09 Ellerbee, Audrey K. PD Ellimoottil, Chandy MP9-18, MP24-17, MP32-02, MP64-12 Ellinger, Jörg MP58-16, MP68-07 Elliott, Christopher MP28-13 Elliott, Daniel MP88-12, MP88-14, MP88-16, PD28-12, p176 Elliott, Peter MP14-01, PD52-09 Elliott, Sean MP9-11, MP10-07, MP15-09, MP15-17, MP27-18, MP65-12, PD10-08, PD11-06, PD14-06, PD14-08, PD17-04, PD47-07, V12-10, p20, p102 Ellis, Michael V12-09 Ellis, Rodney MP78-11 Ellis, William MP67-17, PD34-03, PD46-12 Elmer-Dewitt, Molly MP17-05 El-Naggar, Hekmat PD23-05 El-Naggar, Mahmoud MP33-10 El-Nahas, Ahmed MP13-03, MP27-01, MP30-05, MP30-06, MP30-15, PD5-12 El-Nashar, Sherif PD10-06 Elrashidy, Rania MP21-18 Elsaadany, Mohamed MP27-01 Elsalmy, Salah V11-12 Elsamanoudi, Sally MP14-05, PD34-08 Elsamra, Sammy MP3-06, MP30-13, PD4-04, p9 Elsawy, Amr MP30-05, MP30-15, PD23-01 El-Sayed, Ibrahim MP75-17 Elshafei, Ahmed MP60-17, PD38-04, PD38-10 El-Shafei, Ahmed MP48-10, MP62-19, MP82-12 Elshal, Ahmed MP13-03, MP13-05, MP71-10, PD5-12 Elsherbiny, Nehal PD23-01 Elsobky, Emad PD4-01 El-Tabey, Nasr MP30-15, PD23-05 Eltahawy, Ehab MP23-10, MP32-13 Elterman, Lev p221 Elwyn, Glyn MP32-14 El-Zawahry, Ahmed MP4-20, MP70-08, MP81-13 Elzayat, Ehab MP68-19 Emanuele, Cottini MP62-02 Emara, Amr MP13-14 Emberton, Mark MP48-15, MP83-01, p12, p44, p174 Emeville, Elise MP61-02 Emiliani, Esteban PD41-03, V5-06 Eminaga, Okyaz MP2-09 Enatsu, Noritoshi MP76-11 Endo, Jun MP11-08 Endo, Kazuyuki MP17-16 Engebretsen, Steven PD21-03 Engel, Jutta MP62-18 Engel, Oliver MP2-10, MP15-15, MP58-10, PD22-12 Englesbe, Michael MP58-06, PD31-03 Enkelmann, Astrid PD25-03 Enokida, Hideki MP36-08, MP36-13, MP46-17, PD23-07, PD33-05 Enomoto, Yutaka MP58-02 Epperly, Michael MP21-12 Epstein, Eric MP50-20 Epstein, Jonathan MP1-15, MP6-18, MP9-02, MP35-16, MP42-04, PD6-04, PD34-09, PD46-09, p174, p254

311 Epstein, Mara MP5-16, MP16-20, PD12-05 Ercole, Cesar MP63-14, MP65-06, MP72-07, MP72-15, MP72-17, PD29-09, PD31-09, PD41-05 Erdmann, Kati MP66-17 Erdogan, Banu MP40-16 Erho, Nicolas MP1-04, MP6-09, MP37-19, MP55-18, MP61-11, MP66-16, PD41-08 Erickson, Bradley MP15-09, MP15-17, MP32-03, MP32-20, PD14-06, PD14-08, p63 Erlich, Tomer MP30-09, MP80-06 Ernest, Alexander MP9-16 Ernst, Michael MP85-20 Ernstoff, Marc MP47-16 Erokwu, Bernadette MP8-05 Erol, Bulent MP25-12, MP48-01 ERSPC Study Group Rotterdam PD46-03, PD46-06 Ertas, Kasim MP30-02 Erturk, Erdal p120 Erzurum, Serpil C. PD51-09 Eschenroeder, Andrew PD5-07 Esen, Adil MP25-08 Esen, Ahmet Adil PII-LBA9 Esen, Tarik MP42-20 Esfahani, Ehsan MP22-11 Eshghi, Majid p12 Esinduy, Canan MP24-13, PD27-06 Espinós, Estefanía L. MP44-17 Espinoza, Karena MP68-16 Espiritu, Patrick MP2-15 Esuvaranathan, Kesavan MP45-08 Eswara, Jairam R. MP15-07, MP18-08, MP18-09, MP29-05, PD11-01 Etani, Toshiki MP46-12, MP55-04 Eto, Masatoshi MP63-12, MP63-15, MP69-19, p174 Ettinger, Susan MP49-09 Eugenio, Evercita MP9-03 Eun, Daniel MP3-05, MP29-01, MP53-04, MP53-16, V4-13, V5-13, V10-01 Eure, Greg R. MP13-02, MP13-16 Evan, Andrew MP34-19 Evangelou, Ioulia MP48-09 Evans, Andrew MP86-15 Evans, Andrew J. MP50-13 Evans, Austin J. MP5-09 Evans, Christopher MP42-03, MP44-17, MP46-01, MP46-03, MP46-05, MP46-07, PI-07, p145 Evans, Robert p114 Evelyne, Castel-Lacanal PD1-04 Everaert, Karel V10-08 Everaerts, Wouter PD7-07 Exintaris, Betty MP31-09 Ezeagu, Raphael MP26-14 F Faaborg, Daniel MP28-15, MP30-01, MP30-10, MP38-04, MP63-02, MP81-08, PD15-09, PD42-07 Faba, Oscar R. MP44-17 Fabbri, Fabio MP88-05 Faber, Frank MP1-16 Faber, Kenneth MP10-18 Fabian, Debra MP16-05 Fabrizio, Michael MP14-02 Fadel, Fatina MP79-19 Fadel, Michael MP29-07 Faerber, Gary MP85-19 Fagelson, James MP3-02 Fahey, Natalie MP23-18, PD51-08 Faiena, Izak MP53-04, MP53-16, MP72-13, PD35-09, PD36-06 Fairchild, Robert MP85-16 Fairey, Adrian MP15-13, MP37-19, MP57-20, MP65-06, MP72-15, PD41-05 Faisal, Farzana MP55-18, MP66-16 Fajkovic, Harun MP2-12, MP78-12 Fakhoury, Mathew MP18-01, MP30-08, MP59-09 Fakhreldin, Islam MP30-05, MP67-01 Falcone, Marco MP53-07, PD32-08 Falegan, Oluyemia MP47-19 Faltas, Bishoy MP65-03, MP72-03 Fam, Mina PD22-09 Fan, Alice MP84-02 Fan, Richard MP17-08 Fan, Shih-Jung MP55-12 Fan, Yu MP31-04, MP39-12, MP47-08, MP55-10 Fan, Yue MP6-20 Fan, Yu-Hua MP3-10, MP34-03, MP44-03, MP80-14 Fan, Yunhua MP9-11, PD10-08 Fang, Dong MP2-01, MP2-02, MP2-03 Fang, Justin MP22-10 Fangerau, Heiner FRI-02 Fantasia, Jennifer MP14-17, MP16-20 Fantus, Richard Jacob MP18-16 Fantus, Richard Joseph MP18-16 Farahat, Yasser p58 Faraj, Sheila MP53-17, MP61-11, MP72-08 Fardoun, Tarek MP57-09, V9-06 Fareed, Khaled MP35-07, MP43-15, MP70-02 Fargue, Sonia MP34-04 Farhat, Omar MP23-18 Farhat, Walid MP40-18, V7-10, p129 Farid, Nechiche MP28-12 Farina, Elena MP51-18, MP62-04 Faris, Sarah MP15-17 Farkas, Amicur MP54-16 Farré, Ramón MP50-18 Farrell, James MP61-16 Farrell, John MP25-15 Farrell, Nolan PD42-06, PD42-11 Farrell, Thomas MP39-05 Farrokhyar, Forough MP54-05 Fascelli, Michele MP14-16, MP17-13, MP48-04, MP82-19, MP82-20, PD4-10, PD38-05, PD44-06 Favaretto, Ricardo V11-09 Favazza, Laura MP53-13 Faveretto, Ricardo PD29-04 Favilla, Vincenzo MP26-16, MP71-12, PD10-03 Favorito, Luciano MP28-07 Favre, Gabriel A. PD11-10, V10-05 Favro, Michele MP88-03 Faydaci, Gokhan MP40-16 Fazili, Anees MP23-09, MP23-13 Fazli, Ladan MP6-13, MP36-17, MP37-20, 299 MP46-08 Fazuoli, Mariana F. G. MP45-07 Fearrandino, Michael PD19-02, PD19-03, PD19-04, PD19-05 Featherstone, Marcelo PD29-04 Febbo, Phillip George MP1-01, MP1-05, MP53-18, p136 Fechner, Judith MP76-03 Federov, Stephanie MP37-05 Fedor, Helen MP1-04, MP1-11, MP53-17, MP61-11 Fehm, Tanja MP1-16 Fehr, Jan PD8-01 Feibus, Allison MP22-03, MP22-04, MP48-07, V5-04 Feldman, Adam MP5-11, MP35-09, MP50-07, MP50-08, MP50-09, MP62-14, p85 Feldman, Becca MP32-17 Feldman, Darren MP10-01, MP10-05, MP10-12, MP10-13, MP10-19 Feldman, Michael MP6-03 Feldman, Robert PD45-10 Felix, Chun MP70-09 Felker, Ely PD38-08 Feller, John PD38-08 Fellman, Bryan PD25-12 Feng, Changyong MP23-09, MP23-12, MP23-13 Feng, Chenchen MP39-03, PD33-07 Feng, Felix MP1-14, MP6-09, MP48-17, MP56-12, MP78-10, PD43-12 Feng, Tom MP24-15, MP53-03 Feng, Zhaoyong MP4-13, MP24-16, MP32-06, MP53-02, MP64-10 Feng, Ziding MP1-17, MP6-13, PI-08 Feniuk, Natalie PD41-11 Fennouri, Mohammed MP13-19 Fenstermaker, Michael MP5-12, MP5-17, MP53-15, MP77-14, MP77-17, MP77-18, MP86-03, PD4-11, PD32-01, PD32-03, PD32-05, PD34-02 Ferdinand, Severine MP61-02 Fergany, Amr PD29-09, V8-02, p249 Fergus, Jonathon MP89-09 Fergusson, Dean A. PD47-12 Fernandes-Lima, Flavia MP52-20, MP76-13 Fernandes-Neto, Angelo MP76-13 Fernández, Argentina MP52-04 Fernandez, Daniel MP87-12 Fernandez, Gregory MP86-03 Fernandez, Mario I. MP68-16, MP72-02 Fernando, Archie MP57-07, PD49-01 Ferrandino, Michael MP14-13, MP20-14, MP28-09, p104 Ferrari, Karen L. MP45-07 Ferrari, Lucia PD41-02 Ferrari, Matteo MP88-05 Ferreira, Ana PD27-12 Ferreira, Thiago Ac MP30-19 Ferrer, Marc MP68-17 Ferrer, R. MP60-05 Ferretti, Mark V5-10 Ferriere, Jean-Marie MP85-17 Ferriero, Mariaconsiglia MP48-18, MP59-12, PD3-06, PD9-08, PD29-10, PD49-08, PD49-09, V4-14, V12-07 Ferrigni, Robert MP71-09

312 Ferro, Matteo MP26-05 Ferroni, Matthew MP8-18, MP15-06, MP41-08, MP54-18 Ferry, Elizabeth PD27-05 Fes, Enrique MP29-06, PD14-03, PD14-11, PD22-01 Feuer, Ronny PD18-04, PD24-01 Feuerlain, Sebastian MP16-07 Feuerstein, Michael MP50-11 Fichtner, Jan MP14-19 Fiechtner, Scarlet PD48-03 Fierer, Joshua MP25-17 Figenshau, R. Sherburne PD18-09 Figenshau, Robert V5-11 Figlin, Robert p70 Figueiredo, Arnaldo MP37-11, p234 Filipecki, Pedro PD23-08 Filippou, Pauline MP71-13, PD4-06, PD34-10 Filleur, Stephanie MP66-04 Filson, Christopher MP11-05, MP24-01, MP27-15, MP60-11, MP65-20, PD30-01 Finch, Will MP30-07 Findeiss, Laura p12 Fine, Ronnie MP40-06 Finelli, Antonio MP4-05, MP42-01, MP42-06, MP50-13, MP67-16, MP68-04, MP73-02, MP84-08, MP86-15, MP86-16, PD47-10 Fink, Logan PD38-09 Finke, James PD33-08 Finkelberg, Elisabetta FRI-11, MP77-08 Finkelstein, Diana PD29-04 Finkelstein, Julia MP24-19, MP32-11, MP44-17, MP54-15, MP63-01, MP64-07, MP79-20, PD9-10 Finkelstein, Mark MP32-19, PD12-12 Finn, Stephen MP6-15 Fintelmann, Florian MP38-19 Fiorentino, Michelangelo MP6-15, MP66-20 Fiori, Cristian MP44-04, MP53-10, MP77-11 Fiorica, Thomas MP22-11 Fiorino, Claudio MP87-13 Firmiss, Paula MP31-18 Firoozi, Farzeen V2-07, V2-08 Fisch, Margit MP2-10, MP2-12, MP3-16, MP9-08, MP15-15, MP24-20, MP58-10, MP58-13, MP58-16, MP58-20, MP63-17, MP67-05, MP67-09, MP70-09, PD22-12, PD30-09, PD30-12, p175 Fischer, Claudia PD25-03 Fischer, Katherine MP16-15 Fischer, Kimberly PD15-08 Fischer, Melissa PD20-08, PD21-06, PD50-12 Fischer, Sean MP4-17 Fischer, Tom MP14-19 Fisher, Gabrielle MP1-08, MP1-10 Fishman, Andrew MP70-01 Fishman, Mayer MP59-10, p85 Fitzgerald, Gordon MP5-16 Fitzgerald, Kevin MP34-04 Fitzgerald, Noel M. MP6-20 Fitzpatrick, John MP4-09, MP6-20, MP61-19, MP86-12 Fizazi, Karim MP73-10, MP87-18 Flack, Chandra K. MP35-10, MP59-07 Flammand, Vincent MP63-12, MP63-15, V9-09 Flanders, Scott MP73-13 Flanigan, Robert MP18-11, MP45-09, MP64-09, MP64-12, PD4-05, p174, p190 Flannigan, Ryan MP75-12, PD52-02 Flask, Chris MP8-05 Flax, Jonathan MP49-07, MP68-01 Fleming, Mark MP82-09 Fleming, Steven MP14-10 Flemons, James V8-13 Fleshner, Neil MP1-03, MP4-05, MP6-14, MP42-01, MP42-06, MP46-14, MP60-20, MP61-01, MP67-16, MP68-04, MP73-02, MP86-15, MP86-16, PD46-07, PD47-10, p27 Fletcher, Sophie PD1-05, PD8-07, PD10-02 Flick, Susan p100 Flood, Hugh MP18-12 Florencio, Luis MP23-01 Flores, David MP51-08, MP89-13, PD11-03 Flores, Stefan PD40-02 Flores-Mireles, Ana Lidia MP20-15 Flum, Andrew MP8-02, MP19-08, MP31-18 Flum, Drew MP53-04 Flury, Sarah MP15-01, MP74-05, MP81-06, MP88-13, PD20-09, PD21-09, PD48-05, PD50-11 Flynn, Brian MP11-13, MP29-14, PD22-02, PD50-05, p221 Flynn, Ryan MP9-19, MP79-12, MP85-01 Flynn, Thomas MP36-14 Fode, Mikkel MP57-15, PD37-10 Foditsch, Elena Esra MP89-11 Foiatto, Julio C. V3-10, V11-10 Foley, Robert MP86-12 Foley, Steve PD28-01 Folin, Liu PD21-05 Folkvaljon, Yasin MP4-19, MP42-10, MP56-17, PD6-10 Fomin, Dmitry MP17-19 Fonseca, Fernando F. MP8-07, MP21-10 Fontana, Dario MP26-19 Fontenot, Philip PD38-02 Fontugne, Jacqueline MP17-12 Foreman, Kimberly MP45-09, MP49-08 Forer, David PII-LBA4 Foroohar, Mani MP1-19 Forsythe, Kevin MP78-11 Fossati, Nicola MP4-14, MP4-16, MP6-07, MP24-06, MP48-13, MP50-18, MP56-02, MP56-03, MP56-16, MP56-18, MP59-08, MP62-01, MP62-04, MP62-05, MP78-01, MP78-13, MP82-02, MP82-07, MP82-16, MP82-17, MP83-08, MP83-17, MP87-13, PD30-03, PD30-08, PD32-09, PD49-03, PD49-05 Foster, Richard MP10-08, MP10-17, MP65-14, p253 Fougere, Renee PD1-06 Fourcade, Alexandre MP13-13, MP13-18 Fournier, Georges MP13-13, MP Fowke, Jay H. PD39-04 Fowler, Kathryn J. MP77-15 Fowler, Sarah MP57-07, MP70-05 Fox, Jacob M. PD36-02 Fradet, Vincent MP1-03 Fradet, Yves MP1-03, MP57-20, MP61-13 Fragalà, Eugenia MP26-16, MP71-12, PD10-03 Fram, Ethan B. MP34-10, MP75-08, MP85-08, PD25-07 Francesc, Moreso Mateos MP79-07 Francesco, De Luca PD48-08 Francesco, Del Giudice PD29-10 Francis, Peter MP73-13 Franck Lissbrant, Ingela MP56-17 Franck, Bruyère MP13-15, PD5-09 Franco, Israel p59 Franco Miranda, Eladio MP38-17, MP79-17 Frank Lissbrant, Ingela F. PD6-10 Frank, Igor MP24-07, MP29-15, MP56-14, MP58-09, MP58-15, MP67-02, MP72-11, MP72-14, MP83-11, PD12-09, PD29-06, PD31-01, PD43-04, PD43-08, p221 Frank, Jennifer MP14-06 Frank, Steven MP64-10, MP67-10 Franken, Jan PD7-02 Fransen Van De Putte, Elisabeth E. PD31-07, PD31-11 Franzen, Carrie MP49-08 Fraser, Matthew MP8-04, p37, p169 Frazier, Rochelle PD37-06 Frdoun, Tarek MP63-16 Frederick, Luke PD26-08 Fredericks, William MP47-17, MP61-08 Freedland, Stephen MP1-13, MP4-17, MP14-06, MP14-11, MP14-12, MP14-13, MP42-02, MP53-01, MP53-02, MP53-12, MP60-09, MP60-12, MP60-14, MP82-15, MP87-08, MP87-09, PD6-01, PD32-10, PD34-07, PD38-11, PD39-11 Freedman, Sheldon PD5-01 Freeman, Alex MP48-15, MP83-01 Freeman, Michael p170 Frego, Ezio MP66-20 Freidberg, Nicholas A. MP64-05 Freilich, Drew MP81-13 Freise, Chris MP79-02 Freitag, Martin PD46-10 Fremond, Benjamin MP38-10 Frendl, Daniel MP5-16, PD12-05 Frendl, David MP16-20 Freschi, Massimo MP52-07, MP62-05, MP63-04, MP78-13, MP83-08, PD41-02 Freton, Lucas MP38-10 Freund, Patrick PD1-10 Frey, Anders PD37-10 Frick, Kevin MP24-16 Friðriksson, Jón Ö. PD6-10 Friedlander, Justin MP30-13, MP70-04, MP75-15, MP80-05 Friedlander, Matt MP61-01 Friedman, Ariella A. MP22-20, p175 Friedman, Fara MP2-13, MP59-02 Friedrich Faraj, Sheila MP58-07 Frilot II, Clifton F. PD8-11, PD28-07

313 Frinking, Peter MP48-03 Frisch, Benjamin MP82-10 Fritsch, Helga PD20-06 Fritsche, Hans-Martin MP2-10, MP2-12, MP65-09, PD29-12 Froehner, Michael MP17-10, MP48-05, MP58-20 Froelich, Jerry PD41-12 Fróes Fonseca, Fernando MP31-17 Fröhlich, Maryna PD8-01 Frohneberg, Detlef MP56-10, MP82-01 Frost, Anastasia MP29-06, MP29-07, MP29-08, PD14-03, PD14-11, PD22-01, PD22-06 Frost, Michael PD35-10 Fry, Christopher PD24-02 Frydenberg, Mark MP31-09, p21, p173 Frye, Thomas MP9-06, MP14-16, MP17-13, MP48-04, MP82-19, MP82-20, PD4-10, PD30-02, PD38-05, PD44-06 Fu, Xiaoyong MP17-03 Fuchs, Eugene MP74-03 Fuchs, Gerhard p189 Fuentes, Javier V10-03, V10-12 Fuessel, Susanne MP66-17, PD35-08 Fujii, Yasuhiro MP33-13, MP33-15, MP34-02, MP34-05, MP34-11, MP41-03, MP41-06 Fujii, Yasuhisa MP2-18, MP11-12, MP58-08, MP65-04, PD3-08, PD15-02, PD15-06, PD17-07, PD32-02 Fujikawa, Hiroshi MP17-16 Fujimoto, Kiyohide MP68-03, MP83-09 Fujimoto, Naohiro MP36-02 Fujimura, Tetsuya MP20-18, MP58-02 Fujioka, Tomoaki MP69-19 Fujisawa, Masato MP10-14, MP17-17, MP37-13, MP39-06, MP39-07, MP39-08, MP39-20, MP56-09, MP57-08, MP64-01, MP69-10, MP76-10, MP76-11, PD8-08, PD8-10, PD18-03, PD31-02, PD35-02 Fujita, Kazutoshi MP7-14, MP47-01 Fujita, Keiji MP33-13, PD36-12 Fujita, Naoki MP58-05 Fujita, Yasunori MP8-06 Fujiyama, Nobuhiro MP69-16 Fujiyoshi, Akira MP27-02 Fukawa, Tomoya MP49-04, MP55-06 Fukuda, Hironori MP69-09 Fukuda, Mitsunori PD7-12 Fukuda, Shohei PD15-06 Fukuhara, Hiroki MP75-19 Fukuhara, Hiroshi MP20-18, MP58-02 Fukuhara, Shinichiro MP8-19, MP39-16, MP47-11, MP71-16, MP76-18 Fukui, Iwao MP26-10 Fukui, Naotaka PD15-06 Fukumori, Tomoharu MP55-06 Fukumoto, Keishiro PD17-03 Fukumoto, Tetsuya PD4-07 Fukushi, Ken PD49-07 Fukushima, Hiroshi MP11-11, MP69-20 Fukushima, Masanori MP83-09 Fukuta, Katsuhiro MP36-04 Fukuyo, Tsuneo PD15-02 Fukuzawa, Nobuyuki MP79-16 Fulgham, Pat p10, p64 Fuller, Benjamin MP26-08, MP26-09 Fuller, Cindy MP57-05 Fuller, Natalie MP19-03, MP19-11 Fumo, David MP50-17, MP79-11, MP79-12, MP85-01 Funahashi, Yasuhito MP25-05, PD29-11 Funahashi, Yasuto MP19-17, MP20-05 Fung, Chunkit MP51-11 Fung, Steve PD1-05, PD10-02 Fung-Kee-Fung, Michael PD47-12 Funk, Russell J. MP5-19 Funyu, Tomihisa MP36-03 Furberg, Helena MP50-16, MP64-03 Furlan, Maria MP44-04, MP63-03, PD35-01 Furth, Susan MP40-07, MP80-03 Furukawa, Junya PD18-03 Furuya, Kazuhiro MP58-01 Furuya, Yosuke MP39-11 Fusayasu, Shusei MP73-07 Fuse, Miki MP37-07, MP87-06, PD3-10, PD46-01 Fushimi, Hiroaki MP7-14 Fushimi, Kiyohide MP20-18 Füssel, Susanne MP58-03 Fwu, Chyng-Wen PD39-01 G Gabale, Salil MP16-05 Gaballah, Mohamed MP27-01 Gabay, Judith MP16-14 Gabriele, Domenico MP53-05, MP53-09 Gabriele, Pietro MP53-09 Gacci, Mauro MP71-03, MP71-08 Gadda, Giulio Maria MP6-07 Gaddy, Jacquelyne MP5-15 Gadelha Jr., Hernani V5-01 Gahan, Jeffrey MP23-17, MP57-10, MP84-13 Gaither, Thomas MP9-12, MP15-17, MP88-17, PD11-02 Gajda, Mieczyslaw MP58-03 Gajewski, Jerzy p101 Gakis, Georgios MP1-16, MP2-10, MP2-12, MP65-09, PD41-11 Galanakis, Ioannis MP60-18 Galán-Llopis, Juan-Antonio V6-13 Galdini, Alessandro MP76-15 Galiano, Marc MP42-17, MP48-16, MP62-08, PD47-05 Gallagher, William FRII-08 Galland, Sigolene MP62-14, MP65-09 Gallina, Andrea MP26-18, MP26-19, MP56-03, MP62-04, MP63-04, MP83-17, PD32-09, PD38-12 Gallino, Daniel MP39-05 Gallo, Carla MP55-02 Gallo, Gaetano MP3-04 Gallucci, Michele MP48-18, MP59-12, MP66-20, PD3-06, PD9-08, PD49-08, PD49-09, V4-14 Galustian, Christine MP46-18, MP61-05 Galvagni, Giacomo PD35-01 Galvin, David MP86-12 Gamal, Ahmed MP80-17 Gamal, Wael MP28-04 Gamaldo, Charlene p175 Gamba, Patrizia MP53-09 Gambhira, Ratish MP Gamé, Xavier PD1-04, MP85-09, PD10-10, p176 Gan, Hualei MP50-12 Gandaglia, Giorgio MP4-14, MP4-16, MP32-08, MP44-04, MP48-13, MP51-18, MP56-02, MP56-03, MP56-05, MP56-10, MP56-16, MP56-18, MP59-18, MP62-01, MP62-04, MP62-05, MP72-01, MP78-01, MP78-13, MP78-15, MP82-01, MP82-02, MP82-03, MP82-16, MP82-17, MP83-08, MP83-17, PD30-08, PD32- Gandhi, Himesh MP69-11 Gandhi, Nilai MP72-15 Gandhi, Nilay MP64-10, MP65-06, MP67-10, MP72-08, PD31-12, PD41-05 Ganesan, Vishnu V8-02 Gange, Steven PD5-01, PII-LBA1 Ganpule, Arvind p9 Ganzer, Roman PD47-06, PD47-06 Gao, Allen MP46-01, MP46-02, MP46-03, MP46-05, p70 Gao, Dong MP55-20 Gao, Jianjun MP65-05 Gao, Jiyang PD25-04 Gao, S. Paul MP72-20 Gao, Xiaofeng p70 Gao, Xiaosong MP25-02 Gao, Xin MP52-19 Gao, Yuqing MP5-20, MP42-05, MP78-10, PD12-02, PD38-13 Gao, Zhezhu PD36-09 Garaffa, Giulio PD2-01, PD48-08, PD52-03 Garbens, Alaina MP30-11 Garcia Cruz, Eduardo MP18-19 García Marchiñena, Patricio Aitor PD29-04 Garcia, Cindy PD5-06 Garcia, David Lorente MP79-07 Garcia, Jorge MP65-06, MP72-15, PD31-09, PD41-05 Garcia, Maurice PD15-12, p100 Garcia-Contreras, Marta MP19-07 García-Domínguez, Joaquín MP79-01 Garcia-Mora, Arturo p11 Garcia-Roig, Michael MP54-02, V12-14 Garcia-Segui, Alejandro V6-13 García-Verdugo, José MP19-07 Gardner, Matthew PD12-09 Gardner, Thomas MP65-14, PD15-03 Gardner, Vivien MP81-04 Garg, Prashant Raj PD4-02 Gargollo, Patricio MP79-15 Garrison, Spencer A. MP5-19 Gärtner, Marcle MP71-07 Gartrell, Benjamin MP50-20 Garzotto, Mark MP31-20, MP86-14, PD6-08, p212 Gasanz Serrano, Carles PD41-04 Gaspar, Patrícia MP21-09 Gasser, Thomas MP3-20 Gaston, Sandra M. MP6-12 Gatti, Marcio V3-10, V11-10 Gau, Vincent MP20-10 Gause, Christine K. MP68-11 Gauthier, Christian MP21-16 Gavrilov, Pavel V5-06, V5-07, V5-09

314 Gaya, Josep Maria PD7-10, PD41-03 Gayed, Bishoy PD35-11 Gaylis, Franklin PD38-09 Gazzaniga, Paola MP45-16 Ge, Qiangqiang MP33-17 Ge, Rongbin MP31-15, PI-02, MP66-13 Gearhart, John MP22-08, p175 Geary, William MP86-13, PD38-10 Gebhart, John PD50-10 Gebhartl, Peter MP88-09 Géczi, Lajos MP87-03 Gedikbasi, Asuman MP34-12 Gee, Jason MP26-01, MP45-02, p144, p236 Gee, Michael MP35-09 Gee, William p119 Gelbard, Martin K. PD48-06 Gelet, Albert PD47-06 Gelfond, Jonathan MP77-09 Gellert, Lan MP49-01 Gellhaus, Paul MP64-17, MP72-16 Gelman, Joel PD22-08, p73 Gelpi-Hammerschmidt, Francisco MP41-11, MP84-10, MP84-20, PD12-10, PD35-09 Geminiani, Julio FRI-13, MP18-08, MP29-05 Genesi, Delia MP53-05 Gengqing, Wu MP47-07 Genna, Vincenzo MP19-15 Gentile, David MP51-11 Gentile, Vincenzo MP45-16 Georgalas, Nicholas MP35-12 George P, Datson V5-05 George, Arvin MP14-16, MP17-13, MP30-13, MP48-04, MP70-03, MP82-19, MP82-20, PD4-10, PD30-02, PD38-05, PD44-06 George, Daniel MP44-01 Georgiadis, Thomas MP48-09 Geraghty, Robert MP28-10 Gerassi, Tami PD20-03 Gerber, Glenn MP80-10 Gerber, Jonathan MP89-06 Gerber, Valentina PD41-11 Gerdes, Carrie MP39-05 Gerdtsson, Axel MP60-10 Gerke, Travis MP6-15 Gershman, Boris MP14-17, MP24-07, MP44-14, MP56-14, MP67-02, MP69-05, MP75-12, MP83-11, PD49-12 Gertz, Alida PD23-12 Gessner, Ryan MP17-02 Gettman, Matthew MP24-07, MP56-14, MP83-11, PD12-09, PD43-04, PD43-08, p13, p202 Getzenberg, Robert MP37-04, MP87-03, p105 Geynisman, Daniel MP47-20 Gezginci, Elif PD27-03 Ghadessi, Mercedeh MP1-11 Ghaffar, Momin MP28-09 Ghaffari, Mazyar MP46-06, MP46-08 Ghali, Faddy MP75-16, PD25-09 Ghani, Khurshid MP5-20, MP16-19, MP30-13, MP41-04, MP42-08, MP78-10, PD12-02, PD13-03, PD13-11, PD19-06, PD30-05, PD38-06, PD38-13, PD51-02, V6-12, V10-04 Ghareeb, George MP44-02, MP44-19 Ghatak, Kalyan MP52-03, MP52-08 Ghavamian, Reza MP50-20, V7-02, V9-04, p9, p187, p217 Ghavimi, Samrad MP77-01 Ghazi, Ahmed MP23-09, MP23-12, MP23-13, MP65-17, V4-06, V9-10, p10 Gheiler, Edward PD40-06 Ghezzi, Massimo MP88-05 Ghiculete, Daniela MP30-11, MP75-04, PD13-08 Ghobish, Ammar MP38-02 Gholami, Shahram PD5-01 Gholodian, C. Garo MP78-11 Ghoneim, Mohamed PD41-07 Ghoniem, Gamal MP19-12, PD7-04, V3-06, p254 Ghorayeb, Sleiman R. MP51-20 Ghosh, Prasun MP79-14 Ghosh, Sunita MP15-13 Giacobbe, Alessandro MP48-18, MP53-05, MP53-09 Gianluigi, Taverna MP26-05 Giannantoni, Antonella MP81-18, PD10-04, PD17-02 Gianolli, Luigi PD38-12 Giardina, Raimondo PD10-03 Giddens, Jonathan PD5-01 Giedelman, Camilo V8-12, p72 Gierth, Michael MP58-16 Gifford, Marshall p57 Gilbert, Bruce MP51-13, MP51-20, p10 Gilbert, Dave MP29-03 Gilbert, Kimberly PD48-06, PD48-07 Gilbert, Scott PD41-01 Gild, Philipp MP37-09, MP55-08 Gill, Bethany MP68-04 Gill, Bradley MP54-14 Gill, Harcharan MP67-15, p71 Gill, Inderbir MP14-10, MP15-20, MP23-08, MP23-15, MP37-06, MP37-19, MP59-12, MP61-05, MP63-05, MP63-12, MP63-15, MP70-03, MP83-12, MP86-04, PD9-06, PD9-07, PD31-04, PD34-05, V9-07, V12-11, p20, p72, p189 Gill, Jeff MP24-12 Gillatt, David MP62-06 Gilleran, Jason MP89-01, MP89-03, MP89-09, MP89-10, PD21-06, PD27-10, PD50-12, p84 Gillespie, Nigel MP30-01 Gillett, David MP65-11 Gilli, Isadora MP45-07 Gilling, Peter PD5-02, p10, p25 Gillis, Kyle MP69-14, PD35-12 Gills, Jessie MP47-18, MP68-15 Gin, Greg MP85-10 Gingrich, Jeffrey MP58-04, p154 Ginka, Bhavani PD16-03 Ginsberg, David p12, p100, p175 Ginsberg, Phillip MP15-05 Ginzburg, Serge MP70-04, MP84-07, PD49-04, PD49-11 Gioia, Kevin PD28-05 Giosto, Laura MP53-04 Giovacchini, Giampiero PD38-12 Giovanardi, Michael MP Giovannone, Riccardo MP45-16 Giovannucci, Edward MP6-15, MP50-07, PD6-07 Giovanucci, Joseph MP44-02, MP44-19 Giraldi, Annamaria p55 Girard, Frederic MP13-19 Gires, Benoit MP13-13, MP13-18 Giser, David MP17-04 Gitlin, Jordan MP40-06 Gittelman, Marc PII-LBA1, p44 Gittens, Paul FRI-05 Giubellino, Alessio MP6-17 Giudice, Carlos p176 Giuliano, Francois MP52-06, PD1-03 Giusti, Guido PD10-04, PD13-10 Giusto, Laura MP29-01, V4-13 Given, Robert MP14-02, MP82-12 Glaser, Alex P. V7-07 Glasgow, Sean MP18-05 Glass, Allison MP42-03 Glass, Jonathan MP30-07 Glass, Tyler PD4-12 Glavaris, Stephanie MP1-11, MP53-17, MP61-11 Gleave, Martin MP1-07, MP37-12, MP37-20, MP39-08, MP39-17, MP46-08, MP46-15, MP49-13, MP66-02, MP77-01, PD34-03, p19, p137, p190 Gleibe, Olaf PD42-03 Glennie, Diana MP39-05 Glickman, Leonard MP75-20, PD42-08 Gliga, Louise PD10-05 Glorioso, Joseph PD20-05 Gnessin, Ehud MP34-19 Gobe, Glenda MP47-18 Goberdhan, Deborah C. I. MP55-12 Gobet, Rita MP21-19 Goddard, Jonathen FRII-08 Godebu, Elana MP61-14 Godec, Ciril FRII-03, MP70-06 Godes, Michael PD43-07 Godunov, Boris MP17-20, MP81-16 Goes, Cedric V10-08 Goetz, Jessica MP75-06 Gofrit, Ofer PD23-03 Goggins, Áine MP62-13 Gogoi, Nirjan PD5-08, PD5-10 Gogorcena, Maria A. MP58-17 Goh Ting Hui, Angeline MP85-15 Goh, Alvin PD19-07, PD19-08, PD31-04, V8-03, V8-14, V10-07 Goins, William PD20-05 Gökce, Ilker MP63-12, MP63-15 Golan, Shay MP30-09 Golban, Nathan MP74-07 Golbeck, Silvia MP69-02 Gold, Heather MP5-12, MP9-03, PD34-11 Gold, William MP24-19, MP32-07 Goldberg, Hanan MP28-14, PD11-12 Goldberg, Kenneth PII-LBA1 Goldenberg, S. Larry MP9-07, MP73-04, MP77-01, p10, p136, p236 Goldfarb, David MP34-16, MP80-19, p219, p220, p261 Goldfarb, Robert MP9-11, PD10-08, PD41-12 Goldin, Jonathan MP35-13 Goldkorn, Amir MP37-06, MP37-19

315 Goldman, Howard MP24-13, MP81-09, PD1-12, PD27-04, PD27-06, PD28-08, V2-01, p9, p189 Goldner, Gregor MP87-13 Goldsmith, Zachariah MP88-06 Goldstein, Andrew p12, p55 Goldstein, Irwin PD40-01, PD40-05, PD48-07, p12, p55, p159 Goldstein, Marc MP56-20, MP76-19, V3-08, p11, p255 Goldstein, Susan p55 Goldstein, Sue PD40-05 Goliadze, Ekaterine MP55-17 Golijanin, Dragan MP14-17, MP57-16 Golomb, Dor MP28-14 Goltz, Heather MP43-06 Goluboff, Erik MP70-13 Gomella, Leonard MP87-18, PD4-09, PD17-06, p255 Gomelsky, Alex PD8-11, PD28-07, p69 Gomelsky, Alexander PD28-11, p84 Gomes, Ana MP37-11 Gomes, Cristiano MP43-17, MP51-10 Gómez Ferrer, Alvaro V4-02 Gomez, Christopher MP88-02 Gómez, Marcos V10-03 Gomez, Reynaldo PD14-10 Gomez-Amaya, Sandra PD7-05 Gomez-Sancha, Fernando MP13-17 Gondim, Dibson D. MP35-10, MP59-07 Gondo, Tatsuo MP44-18, PD41-06 Gönen, Mithat MP63-20 Gong, Edward MP8-02, MP19-08, MP31-18, V7-07 Gonsenhauser, Iahn PD18-05 Gontero, Paolo MP44-17, MP53-05, MP53-07, MP56-10, MP77-03, MP82-01, PD17-11, PD32-08, PI-07 Gonultas, Serkan MP26-06 Gonzaga-Silva, Lúcio Flávio MP21-09 Gonzales, Edmond MP79-15 Gonzales-Roibon, Nilda MP58-07 Gonzalez, Christopher MP15-01, MP16-04, MP16-16, MP32-09, MP88-13, PD14-10, PD21-09, PD48-05, p119 Gonzalez, Edmond p59 González, Javier MP44-17, PI-07 Gonzalez, Joshua PD40-05 Gonzalez, Matias I. PD11-10, V10-05 Gonzalez, Ricardo R. MP13-02, MP13-16, p41 Gonzalez-Ramos, Samantha D. MP8-10 Gonzalgo, Mark L. PD32-11, p44 Goodman, Christopher MP78-08 Goodman, Michael MP14-10, PII-LBA5 Goodman, Phyllis MP4-02 Goodney, Philip MP4-18, PD43-10 Goonewardene, Sanchia MP62-06, MP73-14 Gopalakrishnan, Ganesh MP79-08 Gor, Ronak MP15-05, MP70-04, PD49-11 Gorbachinsky, Ilya MP28-02, MP30-17 Gordetsky, Jennifer FRI-04, MP35-16 Gordon, Adam PD18-01 Gördük, Murat MP58-16 Gore, Ira MP82-09 Gore, John MP24-18, MP27-08, MP58-14, MP67-17, MP72-19, p85 Gorin, Michael MP35-16, MP39-13, MP47-19, MP50-01, MP84-03, PD15-11 Gormley, E. Ann MP81-05, p71, p189 Gorny, Diane MP52-06 Gosalbez, Rafael p17 Gospodarawicz, Mary MP73-04 Goto, Yusuke MP36-08, MP36-13, MP37-07, MP46-17 Gotoh, Momokazu MP19-17, MP20-05, MP25-05, MP71-20, PD20-05, PD29-11 Gottlieb, Lawrence J. PD26-12 Gottschalk, Andrea PD35-08 Gourley, Eric MP51-08 Gousse, Angelo MP88-02, p11, p164 Gouvea, Gabriel MP71-19, PD39-07 Govier, Fred E. PD28-06 Goyal, Ritu PD36-06 Gözen, Ali Serdar PD18-11 Gozzi, Christian MP88-09 Grabbert, Markus MP26-17, MP88-08, PD9-04 Grabowska, Magdalena MP49-01, MP49-01 Grady, Richard p12, p18 Graefen, Markus MP4-14, MP9-04, MP37-09, MP42-07, MP55-08, MP56-10, MP77-03, MP78-18, MP78-20, MP82-01, MP82-05, MP82-16, MP82-17, MP83-05, MP83-07, MP83-15, MP83-16, PD30-07, PD30-08, PD30-10, p137 Grafeille, Vivien MP13-13, MP13-18 Graff, Rebecca E. MP50-07 Graham, Stuart PD5-08, PD5-10 Granberg, Candace MP40-03, MP40-12 Granbery, Candice MP40-05 Granger, Benjamin MP2-07, PD10-11 Granieri, Michael PD22-05 Grant, Dolores MP14-06, MP14-11 Grasso, Michael MP70-01, p13, p35 Gratt, Jeremy MP87-12 Gratze, Christian MP3-01 Gratzke, Christian MP18-19, MP31-10, MP34-20, MP62-18, p44 Graves, Amy MP5-07, PD11-04, PD12-06 Gray, Robert FRI-15, MP70-05 Graziano, Claudio Alberto p176 Graziano, Manuela MP53-09 Graziotti, Pierpaolo MP66-20 Greaves, Giovanni MP62-03 Greco, Kristin MP49-08 Green, Elizabeth PD2-07, PD2-12 Green, James MP16-06 Green, Travis MP22-10 Greenberg, David MP1-10 Greenberg, Richard MP24-03, MP24-05, MP47-04, MP50-14, MP67-07, MP67-08, MP67-14, MP70-04, MP84-07, PD49-04 Greene, Damien MP3-01 Greene, Daniel V8-10 Greene, Peter MP5-05, MP16-16, MP24-02, MP58-19 Greene, Richard PD19-11 Greenfield, Jason PD26-02, PD26-04 Greenfield, Sheldon PII-LBA5 Greenwell, Tamsin MP81-14, PD27-09 Greenwood-Van Meerveld, Beverley 303 MP81-01 Gregg, Justin R. MP20-12 Gregorio, Bianca M. MP52-20, MP76-13 Gregory, Jesse MP33-11 Griebling, Tomas MP89-13, PD27-07, p12, p17, p173, p174, p189 Grier, Charles PD32-11 Griffin, Joshua MP65-06, MP72-15, PD41-05 Griffith, Derek p175 Griffith, James MP27-04 Griffith, John MP22-18 Griffiths, Derek MP12-10 Grill, Sonja MP64-05, MP75-06 Grimm, Julia MP35-06 Grimm, Marc-Oliver MP35-11, MP58-03, MP58-16, PD5-08, PD5-10, PD25-03, PD35-08 Grimm, Tobias MP26-17, MP58-16, PD9-04 Grimsby, Gwen MP40-03, MP40-05, MP40-12 Grizzle, William E. MP6-12 Groah, Suzanne MP20-07, MP20-08 Grob, B. Mayer MP25-03 Grober, Ethan D. PD52-02 Grobholz, Rainer MP86-07 Groshen, Susan MP37-19 Groskopf, Jack PD46-05, PI-08 Gross, Andreas MP13-10, MP13-11, MP13-12, V3-12, V3-13, V8-08, p10, p51 Gross, Bruno PD21-07, PD28-03 Gross, Cary MP9-03, MP44-10, MP56-06, MP69-08, MP84-05, PD44-05 Groß, Dominik FRI-16 Gross, Leah PD27-08 Gross, Martin PD26-02, PD26-04, p58 Gross, Michael MP17-04, MP86-04 Gross, Tobias MP56-04 Grossi, Thiago V5-01 Grossman, H. Barton MP67-06, MP72-02, PD25-12 Groth, Travis p17, p31 Grözinger, Gerd MP11-19 Grubb III, Robert PD17-06, p132 Gruber, Caden MP22-14 Gruca, Thomas MP32-03, MP32-20 Grummet, Jeremy p173 Grunert, Richard PD2-05 Grunewald, Nathan MP75-10 Gschwend, Juergen MP83-14, PD30-11 Gschwend, Jürgen MP56-08, MP62-18, MP82-10, PD32-06, PD32-07, PD48-03 Gu, Chengyuan MP1-02, MP47-03, MP60-19 Gu, Di FRI-15 Gu, Weijie MP60-19 Guaglianone, Salvatore MP48-18, PD3-06, PD9-08, PD29-10, PD49-09, V4-14, V12-07 Guan, Han MP55-15 Guan, Ruili PD36-09 Guan, Youxin MP55-20 Guancial, Elizabeth MP68-13 Guanella, Lindsey PD27-07 Guazzoni, Giorgio MP6-07, MP24-06, MP59-08, MP62-01, MP62-04, MP78-01, MP78-15, MP82-07,

316 MP83-08, PD30-03, PD49-03, PD49-05 Gubbiotti, Marilena PD10-04 Gueglio, Guillermo MP84-04 Guerra, Rodrigo MP79-09 Guerrios, Lourdes MP14-11 Gueye, Serigne M. p235 Guglielmetti, Giuliano B. MP44-15, PD43-06 Gugliotta, Antonio MP22-16 Guha, Rajarshi MP68-17 Guhring, Patricia MP51-05 Guillaume, Adeline MP85-17 Guillotreau, Julien MP13-17 Guimaraes, Gustavo V11-09 Guimaraes, Vanessa MP21-10 Guiot, Caterina MP53-05 Gul, Abdullah PD36-07 Gulani, Vikas MP60-04 Gulmi, Frederick p10 Gultomruk, Meral MP74-10 Gumpeni, Naveen MP17-12 Gumper, Iwona PD7-12 Gundeti, Mohan p168 Guner, Gunes MP58-07, PD31-12 Guns, Emma MP46-06 Guo, Charles C. MP72-02, PI-06 Guo, David MP43-08, PD52-12 Guo, Qiusha MP40-02 Guo, Sanwei MP3-20 Guo, Xuemei PD7-12 Guo, Yinglu MP37-03, MP49-19 Guo, Yuqi MP46-09 Guo, Zhongqiang MP2-02, PD33-09 Guoxi, Zhang MP47-07, PD21-05 Gupta, Anup PD45-01 Gupta, Gopal MP6-17, MP18-11, MP44-12, MP45-09, MP49-08, MP64-09, MP64-12, PD4-05, PD19-10, V9-03, p127 Gupta, Kasmira V6-05 Gupta, Kavita MP9-15 Gupta, Mantu MP30-13, MP38-05, MP38-16, MP38-18, MP80-02, V6-05, V6-10, p71, p126 Gupta, Mohit PD49-06 Gupta, Narmada P. PD16-07 Gupta, Nikhil MP3-06, MP51-13 Gupta, Nilesh MP53-13 Gupta, Priyanka MP89-01, MP89-03, MP89-09, MP89-10, PD20-08, PD21-06, PD27-10, PD50-12 Gupta, Rajan MP28-05 Gupta, Sanjay MP8-05, MP46-04 Gupta, Shilpa MP68-11 Gupta, Shubham MP88-06, PD26-07, PD40-08 Gur, Serap MP52-13 Guralnick, Michael PD1-07 Gurbuz, Cenk MP48-01 Gürbüz, Mehmet Cenk V2-04 Gurbuz, Zafer Gokhan MP28-20 Gurel, Bora MP4-02 Gureser, Gokhan MP30-02 Gursky, Amy PD10-07 Gurtner, Kristen FRI-08 Guru, Khurshid MP22-05, MP22-11, MP23-02, MP67-19, p10, p222 Guru, Kurshid MP4-07 Guruli, Georgi MP55-17 Gust, Kilian MP8-11, MP36-17, MP49-09 Gustaffson, Leon MP19-09 Gustafson, Diedra MP18-10, MP18-14 Gutiérrez, Jose Luis V10-03, V10-12 Gutierrez-Aceves, Jorge MP28-02, MP30-17, p9, p72, p170, p254 Gutin, Alexander MP1-10 Guttilla, Andrea PD19-01 Guven, Sulcek p101 Guy, Laurent MP7-05 Guyatt, Gordon H. MP42-19 Guzelburc, Vahit MP28-16 Guzzo, Thomas MP5-08, MP9-15, MP10-09, MP14-14, MP26-03, MP42-15, MP57-14, MP58-12, MP64-04, MP72-12, PD23-12, p180 Gvozdev, Mikhail MP17-20 H Ha, Hong Koo p172 Ha, Ji Yong MP54-10, PD16-12 Ha, Seung Beom MP13-01, MP13-07 Ha, Susan MP66-08 Ha, Yun-Sok MP18-06, MP47-05, MP53-16 Haas, Christopher MP26-11, MP26-13 Haas, Gabriel p45 Haas, Jonathan MP62-15 Haas, Naomi PD35-04 Haber, Georges-Pascal MP63-13, V4-11, V8-02, V8-10 Haber, Tobias MP39-04 Haberkorn, Uwe MP53-08 Habermann, Elizabeth MP67-11, MP84-11 Habibi, Joseph MP12-15, V10-11 Habiby Kermany, Mohammad MP47-16, PD33-10 Habibzada, Jawid PD43-07 Habous, Mohamad MP3-08, PD40-11 Habuchi, Tomonori MP36-03, MP39-10, MP46-16, MP56-15, MP69-03, MP69-16, MP73-18, MP83-10, MP85-04, MP85-13, MP87-07, PD33-04, V11-07 Hach, Carolin V2-05 Hackbarth, Andrew D. MP32-01 Hackett, Nicholas MP5-18 Hadaschik, Boris MP53-08, MP88-10, PD46-10 Haddad, Ahmed MP2-06, MP17-11, PD23-02, PD35-11 Haddad, Ashraf MP57-05, V8-01 Haddad, Devin MP3-09, MP5-04, MP22-13, PD5-07, PD9-09, PD50-04 Haddad, Zaid MP6-03 Haddock, Peter MP48-06, MP48-20 Hadjiolova, Krassimira PD7-12 Hadjipavlou, Marios FRI-03, FRII-09, MP28-18, PD44-08 Hadj-Moussa, Miriam PD14-12 Haese, Alexander MP4-14, MP78-18, MP82-16, MP82-17, MP83-07, PD30-07, PD30-08 Haferkamp, Axel MP8-11, MP44-17 Haferkamp, Alex PI-07 Hafez, Khaled PD31-03 Hafron, Jason MP20-17, MP87-01 Haga, Nobuhiro MP Hagan, Elizabeth MP64-15, MP72-09 Hagedorn, Judith C. PD2-10 Haggstrom, David MP27-12, MP27-17 Hagiuda, Jyun MP2-14 Hagiwara, Kiichi MP26-10 Hagiwara, Masayuki MP2-14 Hahn, Noah MP58-07, MP72-08 Hai, Mahmood A. MP13-02, MP13-16 Haider, Ahmad PD37-04, PD45-03, PD45-04 Haider, Karim Sultan PD37-04, PD45-03, PD45-04 Haifler, Miki MP78-06, PD18-07, PD18-10 Haigentz, Missak MP50-20 Haince, Jean-François MP1-03 Haines, Trevor PD14-01 Haitel, Andrea MP2-06, MP7-09 Hajime Oyama, Renato MP71-18 Hakami-Majd, Niv PD50-08 Hakenberg, Oliver MP58-16, p254 Hakim, Lawrence p55, p216 Hakimi, A. Ari MP7-13, MP35-01, MP35-03, MP44-07, MP47-09, MP47-13, MP47-14, MP50-16, PD33-02 Hakky, Tariq MP23-11, MP51-06, MP74-02, PD37-05, PD39-06, PD40-07, PD52-01, V3-09 Halabi, Susan MP44-01 Halat, Shams MP47-18, MP68-15 Haldar, Subhash MP20-04 Haley, William MP75-17 Halgrimson, Whitney PD24-06, V2-12, V12-13 Hall, Jesse M. PD36-02 Hall, Simon MP87-04 Hallasheh, Omar PD18-04 Haller, Bernhard PD32-06, PD32-07 Halleran, Devin MP40-14 Halling, Thorsten FRI-02 Halpern, Joshua MP41-18 Halýcý, Zekai MP76-08 Ham, Dong Yeub MP83-20 Ham, Sandra PD23-10 Ham, Won Sik PD25-02 Hamada, Alaa MP70-19 Hamakawa, Takashi MP33-15, MP34-11 Hamamoto, Shuzo MP33-13, MP33-15, MP34-02, MP34-05, MP34-11, MP34-13, MP38-08, MP41-03, MP41-06, MP80-18 Hamann, Moritz MP82-06, PD5-08, PD5-10 Hamasuna, Ryoichi MP36-02 Hamdy, Freddie MP55-12, MP66-18, p175 Hamid, Rizwan MP81-14, PD27-09 Hamilton, Ann MP14-10, PII-LBA5 Hamilton, Blake MP28-19 Hamilton, Robert MP4-05, MP10-10, MP37-11, MP42-01, MP67-16, MP73-02, MP73-04, MP86-15, MP86-16, PD47-10 Hammad, Fayez PD11-07 Hammam, Olfat MP36-06, MP36-09, MP85-14 Hammers, Hans MP39-13 Hammett, Jessica MP19-12 Hammouda, Hisham MP40-01 Hampson, Lindsay MP9-12, MP18-04,

317 MP24-08, PD12-11 Hampton, Lance V10-11 Hamstra, Daniel MP48-17, MP56-12, PD43-12 Han, Chengtao MP60-19 Han, Deok Hyun MP41-17, MP62-17 Han, Hui MP10-03 Han, Jang Hee MP38-14, MP71-04 Han, Justin PD14-10 Han, Kyung Seok MP73-15 Han, Misop MP1-11, MP4-13, MP24-16, MP32-06, MP53-02, MP53-04, MP53-17, MP61-11, MP78-11, PD15-11, p31, p115 Han, Sang Won MP17-18, p172 Han, Seungbong PD39-10 Han, Woong Kyu MP85-03, p234 Han, Xiao MP85-15, V2-13 Han, Yong MP69-08 Han, Zhe MP65-13 Hananel, David MP23-19, V6-04 Hanci, Volkan MP25-12 Hancock, Joel MP28-19 Hancock, Michael MP87-03 Handa, Rajash MP34-19 Handorf, Elizabeth MP24-03, MP24-05, MP50-14, MP84-17, PD12-04, PD12-07, PI-10 Hanerhoff, Brittney PD26-08 Haney, Nora PD36-05 Hankins, Ryan MP70-10 Hanley, Janet MP9-01, MP9-05 Hanna, Moneer PD22-09, PD22-10 Hanna, Sally MP61-01 Hannan, Johanna L. MP52-05, PD36-02, PD36-04, PD36-06, p200 Hannan, Thomas PD24-05 Hannemann, Alex MP24-15 Hannick, Jessica MP19-03, MP19-11 Hanno, Philip p13, p190 Hansel, Donna p84 Hansen, Jens MP70-09, MP83-06 Hanske, Julian MP32-08, MP64-13, MP67-05, MP67-09, MP73-19, MP77-10, MP77-12, MP78-05, PD30-12, PD31-06 Hanson, Gregory p9 Hanson, Heidi MP76-12 Hanyok, Brian MP87-08, MP87-09 Hanzlicek, Brett MP8-16, PD24-08 Hanzly, Michael MP50-06, MP59-06, MP59-20 Haque, Ehetesham MP3-11 Hara, Isao MP2-17, MP7-16, MP19-01 Hara, Kouji PD4-07 Hara, Noboru MP55-16 Hara, Shinji MP11-06 Harabayashi, Toru MP58-18, V11-06 Harada, Hiroshi MP79-16 Harada, Ken-Ichi MP69-10, PD35-02 Harbin, Andrew MP3-05, MP29-01, PD6-11, V4-13, V5-13, V10-01 Hariharan, Nisha MP36-07 Haring, Antti PD6-09 Harke, Nina PD43-07 Harnisch, Brooke MP74-13 Harper, Jonathan MP17-01, MP22-12, MP67-17, PD42-01, PD42-02, p57, p255 Harrah, Tim p56 Harraz, Ahmed MP30-05, MP30-06, MP30-15, MP67-01, MP79-10, PD9-02 Harrington, Daniel MP52-12 Harris, Adrian L. MP55-12 Harris, Alison MP77-01 Harris, Catherine MP5-01, MP15-03, PI-01, MP71-13, MP88-17, PD26-05 Harris, Cory PD32-12 Harris, Samantha PD50-01 Harrison, Clanton MP40-03, MP40-05, MP40-12 Harrison, David PD33-06, PD46-09 Harrison, Teresa MP14-01 Harshman, Lauren PD35-09 Hartman, Christopher MP70-03, V2-07, V2-08 Hartmann, Arndt MP35-06, MP58-03 Hartmann, Florian MP58-16 Harty, William MP20-01 Hartzell, Rose PD40-05 Hartzler, Andrea MP27-08 Harvey, Lisa MP34-17 Hasebe, Naoyuki MP89-16 Haseebuddin, Mohammed MP24-03, MP24-05, MP50-14, MP67-07, MP67-08, MP67-14, MP84-07, MP84-17, PD12-04, PD12-07, PD49-04, PD49-11, PI-10 Hashemi Gheinani, Ali MP31-01 Hashida, Kazunobu MP11-08 Hashimoto, Akio MP11-08, MP17-16 Hashimoto, Takeshi MP62-20, PD41-06 Hashimoto, Yashuhiro MP69-07 Hashimoto, Yasuhiro MP16-13, MP58-05, MP65-07, MP73-09, PD16-05, PD49-07 Hashimoto, Yasunobu MP2-17, MP57-17, MP69-17 Hashimoto, Yoshihiro MP38-08 Hashine, Katsuyoshi MP69-19 Hashizume, Kazumi MP31-11, MP59-05, PD16-11 Hashmat, Aizid FRII-10 Hatakeyama, Shingo MP16-13, MP36-03, MP58-05, MP65-07, MP69-07, MP73-09, PD16-05, PD49-07 Hatch, Marguerite MP33-03, MP33-11, MP34-09 Hatem, Asmaa PD38-10 Hatiboglu, Gencay PD46-10 Hatipoglu, Namik Kemal PD13-09 Hatsukami, Dorothy p85 Hattori, Kazunori p75 Hattori, Minoru MP22-17 Hattori, Ryohei PD29-11 Hattori, Seiya MP49-03 Hattori, Tomotaka MP77-02 Hatzichristodoulou, Georgios MP56-08, PD48-03 Hatziplis, Evangelos MP60-18 Hatzl, Stefan PD49-08 Hauben, Adam MP47-20 Hauser, Paul MP11-15 Haustermans, Karin MP87-13 Hautmann, Richard PD11-05, p81 Havighurst, Tom MP26-01 Hawken, Scott MP9-18, MP32-02, PD44-11 Hawks, Bob MP Hawley, Sarah MP6-13, MP14-07, MP27-12, MP27-17 Hayashi, Hiroyuki MP45-04 Hayashi, Takuji MP47-01 Hayashi, Tatsuro MP26-10 Hayashi, Tetsutaro MP36-17, MP49-09, MP49-13, PD35-03 Hayashi, Yukio MP8-12 Hayashi, Yutaro MP33-13, MP34-02, MP34-05, MP34-13, MP41-03, MP41-06, MP80-18, PD36-12 Hayen, Andrew PD46-08 Hayes, James MP6-16, MP41-02 Hayn, Matthew MP87-05 Haynes, Allan MP84-16 Haynes, Anne-Maree MP60-04, MP83-02 Haynes, Kevin MP5-08, MP14-14, MP64-04 Hayward, Daniel PD41-12 Haywood, Samuel C. MP79-18, MP85-11, PD34-01 Hazan, Danny PD11-12 He, Chang MP14-07, MP32-15, MP51-02, PD10-07, PD25-08 He, Dalin MP66-09, PD33-12 He, Feng MP20-03, MP36-19, MP45-19 He, Jinbao PD24-03 He, Qiqi MP8-05 He, Wang MP37-16, MP45-12 He, Zhisong MP2-01 Healey, Jessica MP27-06 Healy, Kelly A. MP23-14 Heath, Karl MP68-11 Heaton, John p17 Heavner, Matt MP44-06 Heavner, Matthew G. MP16-18 Heber, David MP6-08 Hebert, Kristi FRI-08, V2-10 Heck, Matthias PD48-01 Heckman, Jennifer MP11-02, MP35-17, PD35-11 Heckman, Michael MP5-14 Hedgepeth, Ryan MP47-18 Hedges, Jason MP74-03 Hedlund, Petter MP19-16, MP19-18, MP34-20, MP52-07, MP52-17 Hegarty, Nicholas MP86-12 Hegarty, Paul MP74-07 Hehemann, Marah PI-03, MP74-05 Heidenberg, Daniel PD36-05 Heidenreich, Axel PII-LBA4, MP61-17, p190 Heidenreich, Mark PD35-07 Heidingsfeld, Michael PD18-04 Heilbrun, Lance MP14-15 Heinlein, Jonathan MP10-07 Heinze, Kai PD20-06 Heinzer, Hans MP78-20, MP83-07, MP83-16, PD30-07 Heiselman, Darell PII-LBA6 Heister, Simon PD30-11 Heit, Lilia PD33-10 Helenowski, Irene PD8-06 Helfand, Alex MP32-15, PD17-12, PD25-08 Helfand, Alexander M. MP14-07, V8-09 Helfand, Brian MP1-20, MP14-18, MP86-11, PD38-07, PD47-11 Hellstrom, Wayne MP15-19, MP43-09,

318 PD36-05, PD48-12, p13, p20, p55, p153, p221 Helm, Jonathan MP32-15, PD25-08 Helo, Sevann MP29-04 Hemal, Ashok MP7-03, MP44-06, PD13-03, PD13-11, PD49-10, p58, p71, p189 Hemal, Sij MP67-03, PD5-07, PD8-03 Hemdan, Tammer MP45-17 Hen, Yaniv MP16-14 Heney, Niall M. MP26-12 Heningburg, Avory MP29-05, PD11-01, PD51-07 Henkes, David MP65-08 Henneges, Carsten MP42-07 Hennenberg, Martin MP31-10 Hennenlotter, Jörg MP1-16, PD41-11 Hennes, Halim MP40-05, MP40-12 Hennes, Helim MP40-03 Henriksen, Carl PD4-03 Henry, Gerard PD26-06, PD26-10, PD40-10, p55, p57, p58, p100 Hensen, Mary PD33-10 Herati, Amin MP51-13, MP51-20, MP76-20 Herholdt, Claire PII-LBA9 Herkommer, Kathleen MP56-08, MP62-18, MP83-14, PD30-11 Hermann, Michael P. MP6-02, MP83-04 Hermanns, Thomas MP66-05, MP66-19, MP67-16, MP68-04, MP68-05, MP68-06, MP68-08, MP86-07 Hermans, Tom J.N. PD31-07 Hernandez Porras, Andres PD29-04 Hernandez, Javier MP77-09 Hernandez, Mike MP52-11 Hernandez, Natalia MP38-19, MP41-18, MP80-01 Hernandez, Ray MP1-19 Hernández, Virginia MP13-20, MP58-17 Hernández-Andreu, José MP19-07 Hernandez-Cardona, Eduardo MP83-03 Herr, Harry MP64-19, PD9-11, p72, p170 Herrel, Lindsey MP9-17, MP9-18, MP16-08, MP32-02, MP43-06, PD44-11 Herrell, S. Duke MP80-08 Herrera, Enrique Trilla MP79-07 Herrera-Caceres, Jaime O. MP25-18 Herrmann, Edwin MP58-16 Herrmann, Thomas MP26-04, V3-13, V8-08 Herschbach, Peter MP83-14 Herschorn, Sender MP14-08, MP29-09, PD1-01, PD14-02, p21 Hersey, Karen MP73-02 Hess, Deborah MP41-11, MP84-10, PD12-10 Heston, Warren DW MP61-15 Hetet, Jean François MP63-12, MP63-15 Hettel, Daniel MP54-14 Hicks, Jennifer MP25-15 Hicks, Jessica MP6-15 Hieda, Keisuke MP22-17, PD35-03 Higano, Celestia MP73-04, MP87-16, PII-LBA10 Higashi, Yoshihito MP80-18 Higashi, Youichirou MP31-02 Higgins, Paul MP29-04 Higuchi, Russell PII-LBA8 Higuchi, Ty T. MP29-14 Hijaz, Adonis PD24-05, PD27-05, p75 Hikita, Katsuya MP76-07, PD36-11 Hill, Julie PD7-06 Hill, Martinez MP40-03, MP40-05, MP40-12 Hill, Michael E. PD21-03 Hilton, William MP50-11 Hinata, Nobuyuki PD31-02 Hindley, Richard PD5-08, PD5-10 Hines, John MP43-13 Hinkelbein, Wolfgang MP87-13 Hinotsu, Shiro MP69-19 Hinshaw, Louis MP35-17, MP44-16 Hinz, Stefan MP14-19 Hiraiwa, Shinichiro MP11-08 Hiraki, Miho MP39-16, MP47-11 Hirama, Hiromi MP42-09 Hirao, Yoshihiko MP69-19 Hiraoka, Takeo MP11-06 Hirasawa, Yosuke MP62-20 Hirata, Hiroshi MP39-16, MP47-11 Hirata, Takeshi MP61-14 Hirohashi, Yoshihiko MP19-01 Hirose, Masahito MP33-18, MP34-05, MP41-03, MP41-06 Hirose, Yasuhiko MP33-15, MP34-05, MP34-11, MP41-06 Hirose, Yasuhiro MP34-13 Hiroshi, Miyamoto MP49-18 Hirota, Ryuichi V11-05 Hirsch, Mark p221 Hisamatsu, Takashi MP27-02 Hisano, Marcelo MP75-03 Hisasue, Shin-Ichi MP26-07, MP51-12, PD37-07 Hjälm Eriksson, Marie MP56-17 Hnilicka, Stefanie MP38-09, PD13-02 Ho, Andrew MP1-01, MP6-08 Ho, Chien MP68-09 Ho, Henry MP48-08 Ho, Phil MP64-20 Ho, Richard MP14-16, MP17-13, MP48-04, MP82-19, MP82-20, PD4-10, PD38-05, PD44-06 Ho, Shuk-Mei PD47-03 Ho, Sunita MP11-04, MP33-01 Hoang, Ly MP84-18 Hoang, Richard MP22-07 Hobbs, Catherine PD28-01 Hobbs, Robert MP46-19 Hockenberry, Mark MP9-15 Hockman, Lucas PD21-08 Hodgson, Herbert MP28-15, MP30-01, MP30-10 Hoebeke, Piet PD2-05 Hoenig, David MP30-08, MP34-10, MP41-01, MP80-13, p13 Hoermann, Romed PD20-06 Hoetker, Andreas MP35-03 Hofer, Matthias D. MP15-01, MP81-06, MP88-13, PD21-09, PD48-05, PD50-11 Hoffman, F. Michael MP55-11 Hoffman, Karen MP27-11, PII-LBA5 Hoffman, Richard PII-LBA5 Hoffman-Censits, Jean MP67-07 Hoffmann, Sascha PD18-04 Hofmann, Martin MP Hogan, Brad MP1-19 Hohenfellner, Markus MP44-17, MP53-08, MP88-10, PD46-10, PI-07 Hohenhorst, Jan V10-02 Hoimes, Christopher MP69-08 Hoke, Ahmet MP52-05, PD36-04 Holland, Bradley MP70-08, MP74-06 Holland, Ronen MP28-14 Hollander, Jay MP88-04 Hollenbeck, Brent MP1-14, MP24-17, MP32-15, MP48-17, MP56-12, MP58-06, PD25-08, PD31-03, PD43-12, PD44-12 Hollingsworth, John MP5-19, MP16-19, MP41-04, MP75-09, PD51-02, p31, p169, p220 Hollowell, Courtney MP9-09 Holmes, Ross P. MP34-04, MP34-17 Holmstrom, Felix MP31-02 Holst, Pablo PD29-04 Holt, Sarah MP24-18, MP55-14, MP58-14, MP72-19, MP81-12, PD46-04, PD46-12, PD47-03 Holton, Kathleen MP71-17 Holzapfel, Konstantin PD32-06 Holzbeierlein, Jeffrey MP64-20, MP65-06, MP72-15, PD11-03, PD38-02, PD41-05, PD51-10, p12, p46, p85 Hölzel, Dieter MP62-18 Holzhammer, Brittany MP31-20 Homann, Christian MP74-17 Homberg, Roland MP88-09 Homish, D. Lynn PD34-12 Homma, Yukio MP8-06, MP12-03, MP20-18, MP37-04, MP58-02, PD3-05 Honda, Masashi MP21-01, MP31-02, MP35-08, MP44-05, MP76-07, PD36-11 Honeck, Patrick MP13-08 Honey, R. J. D A. MP30-11, MP75-04, PD13-08, p126 Honeycutt, Jared MP36-09 Hong, Barry MP27-04 Hong, Bennet MP85-20 Hong, Bumsik MP69-13 Hong, Jeong Hee MP7-04 Hong, Jian MP31-15 Hong, Jun Hyuk MP22-02, MP78-02, PD47-01 Hong, Sung Hoo MP44-09 Hong, Sung Joon MP1-18, MP73-08, MP73-15 Hong, Sung Kyu MP37-08, MP42-16, MP44-09, MP44-20, MP56-11, MP73-06, MP77-06, MP78-16, MP82-11 Hong, Sung-Hoo MP44-20 Hong, Sungwoo MP78-02 Hongo, Fumiya MP55-07 Honig, Stanton MP24-11, p10 Honma, Naoko MP69-16 Hontar, Adriana MP65-17 Hooda, Mohammad p85 Hoogenes, Jen MP17-14 Hopf, Heather PD21-12, V9-13 Hopmans, Sarah MP37-05, MP39-05 Hoque, Mohammad MP72-08 Hora, Milan PD29-12 Horenblas, Simon MP5-10, MP10-11,

319 MP65-06, MP72-15, PD31-07, PD31-11, PD41-05 Hori, Junichi MP59-05 Horie, Shigeo MP26-07, MP51-12, PD16-02, PD37-07, p174 Horiguchi, Akio MP7-11 Hornberger, Brad p10 Hornberger, John MP1-06 Horst, Maya MP21-19 Horstmann, Marcus MP35-11, PD25-03 Horuz, Rahim MP28-16 Horwitz, Eric MP24-05, MP73-04, PD12-07 Hoshen, Moshe MP32-17 Hoshi, Kiyotugu MP87-10 Hoshi, Senji MP87-07, MP87-10 Hossack, Tania MP77-04 Hossain, Tohid Mohammad Saiful p85 Hosseini, Abolfazl MP67-19 Hotaling, James MP24-11, MP76-12, MP81-12, PD11-02, PD11-08, PD39-09 Hou, Xiaoling PD8-09 House, Margaret MP26-01 House, Michael MP65-14 Houvras, Yariv MP66-01 Howard, David PI-08 Howard, Lauren MP4-17, MP14-06, MP14-11, MP14-12, MP53-01, MP53-02, MP60-09, MP60-12, MP60-14, MP82-15, MP87-08, MP87-09, PD6-01, PD32-10, PD34-07, PD38-11, PD39-11 Hoy, Nathan MP29-02 Hoyo, Catherine MP14-06, MP14-11 Hoyt, David p251 Hoyt, Michael MP27-15 Hrbacek, Jan MP65-09 Hreiki, Joseph MP72-20 Hristov, Kiril L. PD7-09 Hsi, Alex MP78-11 Hsi, Ryan MP22-12, PD42-01 Hsieh, James MP35-01, MP35-03, MP44-07, MP47-09, MP47-13, MP47-14, MP69-18, PD33-02 Hsieh, Jer-Tsong MP66-09 Hsieh, Michael MP20-07, MP20-08, MP36-09, p169 Hsieh, T. Mike PD45-05 Hsieh, Tung-Chin MP74-01 Hsu, Iawen MP68-13, MP68-17 Hsu, Mark PD25-01 Hu, Brian MP10-02, MP24-04, MP37-06, MP37-19, MP58-15, MP72-14, PD2-09 Hu, Chung-Yuan PD40-09 Hu, Jim MP24-09, MP32-10, MP32-12, MP65-20, MP70-07, MP73-11, MP79-06, PD6-11, PD12-08, V4-03, p234 Hu, Kai MP76-01, MP76-02 Hu, Michael MP32-15, PD25-08 Hu, Qingting MP61-09 Hu, Shuai MP31-04, MP37-03 Hu, Weiguo MP30-04, PD4-06 Huang, Alison p17 Huang, Chao-Yuan MP2-11 Huang, Chuanshu MP36-19, MP36-20, MP45-15, MP45-19, MP49-06 Huang, Eric MP3-10, MP28-03 Huang, Eric Yi-Hsiu MP44-03 Huang, Haojie MP55-01 Huang, Hsiu-Chen MP81-02 Huang, Jian MP37-16, MP45-12 Huang, Jiaoti MP11-05, MP45-18, MP47-06, MP60-11, PD7-04, PD30-01, PD44-10 Huang, Jonathan MP35-14, MP44-08 Huang, Julie MP66-01 Huang, Kuo-How MP45-19 Huang, Maosheng MP36-01 Huang, Mingguo MP39-10, MP46-16, MP69-03, MP83-10, PD33-04 Huang, Moses PII-LBA9 Huang, Richard MP53-15, MP77-14, MP77-17, MP77-18, PD4-11, PD32-01, PD32-03, PD32-05, PD34-02 Huang, Rong MP40-03, MP40-05, MP40-12 Huang, Steve S. MP61-15 Huang, Tuz-Hao MP80-14 Huang, Wei MP6-10, MP26-01, MP31-08, MP35-17, MP37-20, MP39-15 Huang, William C. MP36-16, MP44-17, MP53-15, MP77-14, MP77-17, MP77-18, PD4-11, PD32-01, PD32-03, PD32-05, PD34-02, PI-07, p20, p71, p206 Huang, Yeqing MP55-15 Huang, Yexiang MP21-18 Huang, Yi-Hsiu MP34-03 Huang, Yihung MP85-19 Huber, Andreas MP86-07 Huber, Johannes MP27-14 Huber, Philipp Markus V9-07 Hubosky, Scott p13 Hudak, Jane MP14-05, PD34-08 Hudak, Steven MP18-05, MP27-05, PD22-07 Hudes, Richard MP78-11 Hudson, M Liss MP47-18 Hueber, Pierre-Alain MP13-14, MP13-16 Huet, Romain MP3-19, MP13-13, MP13-18 Hughes, Amanda MP28-02 Hughes, Monty PD7-08 Hughes, Scott MP42-11 Hugosson, Jonas MP60-10 Huh, Jung-Sik MP51-15 Huland, Hartwig MP9-04, MP78-18, MP78-20, MP82-05, MP83-05, MP83-07, MP83-15, MP83-16, MP83-18, PD30-06, PD30-07, PD30-10 Hulbert, William p18 Hult, Mariam MP57-15 Hultgren, Scott MP20-15 Humphreys, Elizabeth MP1-11, MP4-13, MP24-16, MP53-17, MP61-11 Humphreys, Mitchell MP71-09, MP71-15, PD5-11, PD13-01, PD13-07, p189 Hung, Andrew MP23-08, MP23-15, V9-07 Hung, Jonathan MP87-01 Hunink, Myriam MP86-18 Hunt, David E. MP21-17 Hunt, Sarah MP75-13, MP80-04 Hunter, Craig MP15-14, PD14-09, PD22-03, V12-01, V12-02 Hupertan, Vincent MP7-06 Hurle, Rodolfo MP26-04 Hurle, Rodolfo Fausto MP26-05, PD Hurley, Patrick MP18-07, MP42-08 Hurley, Stephen MP9-09 Hurst, Robert MP11-15, MP46-13, MP81-01, p224 Hurst, Simi PD27-01 Hurtado-Coll, Antonio MP6-13 Hurtík, Petr MP71-07 Hurwitz, Lauren MP14-05, MP42-13, MP87-11, PD34-08 Husain, Fatima p18 Husmann, Douglas p59 Hussain, Arif MP82-09 Hussain, Maha PII-LBA4, p190 Hussein, Abdelaziz MP79-10 Hussein, Ahmed MP42-12, MP74-16, PD26-05 Hutterer, Georg MP70-09 Hutterer, Georg C. MP69-02 Huynh Le Maux, Amélie PD1-03 Huynh, Danny PD21-08 Huynh, Melissa PD51-01 Hwa, Jeong Seok MP43-14 Hwang, Christina MP22-14, PD13-04 Hwang, Clara MP87-01 Hwang, Eric MP23-08, MP23-15 Hwang, Eu Chang MP20-11 Hwang, Jonathan MP3-05, MP53-04, MP53-16 Hwang, Joo Ha MP39-14 Hwang, Kathleen MP25-10, PD52-11, p153 Hwang, Keumsil MP76-14 Hwang, Thomas I.S. MP36-10, MP36-11 Hwong, James MP41-11, MP84-10, PD12-10 Hyams, Elias MP4-18, MP42-14, MP75-16, PD25-09, PD43-10 Hyman, David MP64-02 Hynan, Linda MP2-06 Hyndman, Eric MP47-19 Hypolite, Joseph PD7-03 Hyun, Jae Seog MP43-14, MP52-03 I Iafrate, Massimo MP67-20, PD9-03 Iagaru, Andrei MP87-12 Ian, Lap Hong p71 Ibrahiem, El-Housseiny PD5-12 Ibrahiem, El-Houssiny I. PD23-05 Ibrahim, Emad MP74-15 Ibrahim, Fadi MP20-02 Ibuki, Naokazu MP46-08 Ichihara, Koji MP8-06, MP12-03 Ichikawa, Tomohiko MP37-07, MP46-17, MP87-06, PD3-10, PD46-01 Ichimura, Yasushi V11-07 Ichiyanagi, Osamu MP75-19 Ide, Hiroki MP2-08, MP49-16 Ide, Hisamitsu PD16-02, PD37-07 Idrees, Muhammad T. MP35-10, MP59-07 Ieda, Takeshi MP26-07 Igarashi, Ryoma MP69-16 Igawa, Tsukasa MP2-20 Igawa, Yasuhiko MP8-06, MP12-03 Igel, Michael p10 Igel, Todd MP5-14, MP23-07 Iguchi, Michiyo MP76-07, PD36-11 Ihara, Tatsuya MP8-14 Ihrig, Andreas MP27-14

320 Iida, Keitaro MP55-04, PD17-05 Iida, Keitaroh MP46-12 Iida, Shoichi MP85-16 Iinuma, Masahiro V11-07 Iizuka, Junpei MP2-17, MP57-17, MP69-09, MP69-17 Ikari, Osamu MP22-16 Ikeda, Youko MP21-12, PD7-05 Ikegami, Kentaro MP8-12 Ilce, Zekeriya MP18-18 Iliopoulos, Othon PI-09 Ilkay, Altan p152 Im, Young Jae MP17-18 Imada, Kenjiro MP46-11 Imai, Atsushi MP16-13, MP58-05, MP65-07, MP69-07, MP73-09, PD16-05, PD49-07 Imai, Satoshi MP39-07, MP64-01 Imai, Yuki MP8-14 Imamoglu, Abdurrahim V6-01 Imamoto, Takashi MP87-06, PD3-10, PD46-01 Imamura, Yusuke MP66-07 Imanishi, Masaki MP76-07, PD36-11 Imbimbo, Ciro MP67-20, PD9-03 Imnadze, Mariam MP10-01 IMPACT Study Collaborators MP86-11 In Gab, Jeong MP22-02 Inamoto, Teruo MP7-02, p174 Inan, Ramazan MP38-20 Inatomi, Hisato MP36-02 Inayama, Yoshiaki MP45-04 Incrocci, Luca p55 Incze, Peter PD5-01 Ingels, Alexandre MP35-05, MP62-08 Ingham, Matthew MP14-02, MP82-12 Inman, Brant MP14-13, PD17-06, p110 Inoguchi, Satoru MP36-08, MP36-13, PD23-07, PD33-05 Inokuchi, Junichi MP46-11 Inoue, Keiji MP21-01, MP31-02 Inoue, Masaharu MP58-08, PD32-02 Inoue, Rie PD41-06 Inoue, Ryo MP7-02 Inoue, Satoshi PD29-11 Inoue, Shogo MP22-17, MP52-02, PD35-03 Inoue, Takahiro MP5-03, MP60-02, PD23-04 Inoue, Takamitsu MP36-03, MP39-10, MP46-16, MP69-16, MP83-10, MP85-04, PD33-04, V11-07 Inoue, Tkamitsu MP69-03, MP85-13 Inoyatov, Igor MP65-03, MP72-03 Intenzo, Charles PD4-09 Intilla, Oliver MP57-18 Ioritani, Naomasa MP2-19 Ippolito, Silvia MP4-10, MP74-20, MP76-15, PD52-06, PD52-10 Irani, Jacques MP7-05 Irani, Jaques PD17-11 Irving, Stuart MP30-07 Irwin, Brian p57 Isaacs, Abby MP81-20 Isaacs, John p99 Isaacs, William p19 Isalt, Christian MP13-06 Isalt, Cristian MP60-05 Iscaife, Alexandre PD5-04 Isharwal, Sumit MP55-13 Ishibashi, Kei MP12-17, MP39-04 Ishida, Hideki MP79-16 Ishida, Shohei MP71-20 Ishidoya, Shigeto MP60-15, MP87-07, PD3-02 Ishiguro, Hitoshi MP49-15, MP61-18 Ishihara, Tomoaki MP36-08, MP36-13, PD23-07, PD33-05 Ishikawa, Akira MP58-02 Ishikawa, Yudai MP7-15 Ishioka, Junichiro MP2-18, MP11-12, MP58-08, MP65-04, PD3-08, PD15-02, PD32-02 Ishizaki, Fumio MP31-07, MP55-16 Ishizaki, Junji MP58-18 Ishizuka, Yuuichi MP87-10 Islam, AKM Anwarul p85 Islam, F. p86 Islam, Faisal MP3-11 Islam, Ghazi Shahinul MP3-11 Islam, Majdee MP89-04, PD28-04 Islam, M. W. p86 Israel, Robert MP82-09 Issa, Muta MP4-04, MP16-05, MP16-17, PD19-12 Istanbulluoglu, Mustafa Okan MP38-20, PD13-09 Itesako, Toshihiko MP36-08, PD23-07 Ito, Akihiro MP2-19, PD3-02 Ito, Akiko MP86-05, PD50-03 Ito, Hideaki MP12-04 Ito, Hiroki MP8-06, MP12-03 Ito, Kazuto MP39-11, MP74-14 Ito, Keiichi MP7-11 Ito, Masafumi MP8-06 Ito, Masaya MP2-18, MP11-12, PD15-02, PD32-02 Ito, Ryuichi V11-07 Ito, Timothy MP47-04, MP67-14, MP70-04, MP84-07, PD49-04 Ito, Yasuhiko MP33-15, MP34-05 Ito, Yusuke MP45-04 Itoh, Kyogo MP2-20 Itoh, Ryuichi MP39-10 Itoh, Yasunori MP34-13, MP41-03, MP41-06, MP80-18 Itsumi, Momoe MP46-11 Ivaz, Stella MP29-06, PD14-03, PD14-11 Ivgy-May, Neely PD20-03 Iwahata, Toshiyuki MP76-04 Iwami, Daiki MP85-12 Iwamoto, Hideto MP35-08, MP44-05 Iwamura, Hiromichi MP58-05, MP65-07 Iwase, Yutaka MP38-08 Iwata, Tatsuya MP59-05 Iwatsuki, Shoichiro MP33-15, MP34-11, MP78-04 Iyengar, Rupa MP51-04 Iyer, Gopa MP7-13, MP36-12, MP64-02, MP72-20 Iyigun, Emine PD27-03 Izard, Jason MP5-02, MP27-08 Izawa, Jonathan MP57-20 Izumi, Hideaki MP87-10 Izumi, Koji MP45-04 Izutani, Toshifumi PD J Jack, Greg MP41-10 Jackman, Stephen PD51-04 Jackson, John MP29-18, MP29-19 Jackson, Max MP48-06, MP48-20 Jacob, Joseph M. MP35-10 Jacobs, Bruce MP32-15, PD25-08, p87 Jacobs, Ilana MP23-17, MP84-13 Jacobs, Micah MP40-03, MP40-05, MP40-12 Jacobsen, Alan M. MP81-12 Jacobsen, Niels MP57-20, MP65-06, MP72-15, PD41-05 Jacobsen, Steven J. MP14-01 Jacobson, Kim PD8-04 Jacques, Fred PD33-02 Jacques, Line MP12-05 Jaeger, Christopher MP80-09 Jaeger, Tommaso MP71-08 Jagannathan, Samantha PD50-08 Jäger, Wolfgang MP36-17, MP49-09 Jain, Deepak p56 Jain, Lakshay PD37-01 Jain, Namrata G. MP79-20 Jain, Pallavi MP61-13 Jain, Samay MP50-17 Jakobi, Hildegard MP88-10 Jakobler, Daniela MP13-10, MP13-11, MP13-12 Jakobsen, Henrik PD37-10 Jakubowski, Ann MP51-09 Jakubowski, Chris MP59-02 Jakubowski, Christopher PD33-02 Jamaer, Caroline PD2-05 Jamaspishvili, Tamara MP1-17 Jambor, Ivan MP17-07 James, Andrew p187 Jameson, Charles MP48-15 Jamieson, Catriona H. M. MP61-14 Jamieson, Christina MP61-14 Jamnagerwalla, Juzar PD21-07, PD50-08 Janak, Jud MP27-05 Janetschek, Guenter MP26-04 Janetschek, Günter MP57-03, MP58-16, MP89-11, V11-01, p111 Jang, Hoon PD51-12 Jang, Mei-Yu MP21-02 Jang, Myoung Jin MP19-19 Janicki, Joseph MP20-17 Janosek Albright, Kirsten V11-02 Janssen, Martin MP35-06, PD3-01 Janzen, Nicolette MP79-15 Jarc, Anthony MP23-15 Jarosek, Stephanie MP9-11, MP27-18, PD47-07 Jarow, Jonathan p174 Jarrard, David F. MP26-08, MP26-09, MP35-17, MP37-20, MP55-11, p84, p85, p136, p178 Jarrett, Thomas p9, p35 Jarvi, Keith A. PD52-02 Jarvis, Courtney MP66-04 Jasion, Edward A. MP48-02 Jason, Hafron MP88-04 Javadi, Mehrbod MP35-16 Javors, Martin MP65-08 Jaworowski, Sol MP16-14 Jaworski, Paulo MP18-10

321 Jayadevan, Rajiv PD12-12 Jayadevappa, Ravishankar PD24-09, PD43-02 Jayaratna, Isuru MP65-05, PI-06 Jee, Sang Hyun PD20-10 Jegou, David MP9-20, MP27-19 Jeh, Seong Uk PD25-02 Jeje, Emmanuel Ajibola p235 Jeldres, Claudio MP11-09, MP24-04 Jen, Rita P. MP5-09, MP9-10, PD29-02 Jenkins, Brenda PD1-01, PI-04 Jenkins, Lawrence MP43-18, MP74-18, PD37-12 Jenkins, Michael MP17-03 Jenkins, Rober MP6-09 Jenkins, Robert MP37-19 Jenkins, Sarah PD12-09 Jenkins, Wiley MP9-06, MP70-08 Jenks, Julie PD27-09 Jensen, Drew MP16-07 Jensen, Sandra MP39-02 Jenson, Cathy V4-07, V4-08 Jentzmik, Florian MP56-13 Jeon, Hwang Gyun MP7-04, MP44-20, MP50-05, MP62-17, PD25-05 Jeon, Seong Soo MP7-04, MP44-20, MP50-05, MP53-16, MP62-17, PD25-05 Jeong, Byong Chang MP7-04, MP44-20, MP50-05, MP62-17, PD25-05, p172 Jeong, Chang Wook MP6-19, MP28-01, MP44-20, MP82-08 Jeong, Hee Jong MP33-05, MP34-18 Jeong, Hyeon MP28-01, MP82-08, PD16-10 Jeong, In Gab MP19-19, MP44-11, MP69-13, MP78-02, MP86-06, PD39-10 Jeong, Jae Yong MP7-04, PD25-05 Jeong, Jeongyun MP3-14 Jeong, Seong-Jin MP42-16, MP56-11, MP73-06, MP77-06, MP82-11 Jeong, Wooju MP4-14, MP59-03, MP62-01, MP65-19, MP79-04, MP79-14, MP82-16, MP82-17, PD30-08 Jepperson, Maria MP75-17 Jerde, Travis MP19-20 Jesche, Johanna MP69-02 Jesche, Johanne MP70-09 Jeshurun, Michal PD20-03 Jessen, Jan PD13-05 Jewett, Michael MP10-10, MP50-13, MP60-20, MP67-16, MP86-16, PD35-04 Jeyadevan, Rajiv MP32-19 Jha, Vivekanand MP45-13 Jhagroo, R. Allan MP41-20 Jhang, Jia-Fong MP20-16, MP71-14, MP81-02, PD20-02 Ji, Jian-Bo V6-07 Jia, Chao V3-08 Jianbo, Li MP41-12 Jiang, Bo V6-07 Jiang, Guosong MP49-06 Jiang, Haiyan MP86-15 Jiang, Hui MP48-17, MP68-20, p56 Jiang, Jack MP57-14 Jiang, Zhong MP14-17 Jimbo, Masahito MP32-14 Jimenez, Juan MP69-14, PD35-12, V4-01 Jimenez, Rafael E. MP58-09 Jimenez-Trigos, Estrella MP79-01 Jiménez-Valladolid, Isabel M. MP13-20 Jin, Bin MP62-09 Jin, Chao MP1-07 Jin, Jie MP31-04, MP37-03, MP39-12, MP47-08, MP49-19, MP55-10 Jin, Shiyi MP16-02, MP72-03, MP83-04 Jin, Xiao-Jun V6-07 Jingushi, Kentaro MP47-01 Jo, Fumiyasu V11-05 Jo, Jung Ki MP42-16, MP73-06, MP77-06, MP82-11 John, Leema M. MP33-06 John, Vijay MP39-01, PD15-10 Johnsen, Niels V. MP29-17 Johnson, Cynthia MP34-19 Johnson, Dane MP74-13, PD1-07 Johnson, David MP47-18, MP78-14 Johnson, Marta PD27-08 Johnson-Mitchell, Marta p72 Johnson, Michael MP1-04, MP1-11, MP1-12, MP6-03, MP50-01, MP53-17, MP61-11, MP63-06, MP63-10, MP70-16, MP70-17, MP70-18, MP84-14 Johnson, Theodore p12, p173 Johnson-Pais, Teresa MP36-07 Joice, Gregory MP67-10, MP67-12 Jones, Clifford MP6-06, MP48-02, MP60-08 Jones Jr., Leroy A. PD45-12 Jones, Leroy PD26-06, PD26-10, PD40-10 Jones, LeRoy p55 Jones, Peter MP68-12 Jones, Stephen MP60-17, MP62-19, MP82-12, PD1-12, PD34-01, PD38-04, PD38-10, p9, p194 Joniau, Steven MP9-20, MP15-16, MP19-16, MP19-18, MP27-19, MP53-07, MP56-10, MP77-03, MP82-01, MP87-13, PD2-05, PD17-11, PD32-08, p53 Joo, Kwan Joong MP12-09 Joon, Aaron PI-08 Jorda, Merce MP68-02, p11 Jordan, Emmet MP72-20 Jordan, Gerald MP29-03, MP29-13, PI-01, p234 Jordan, Gregory A. MP53-14 Jordan, Mark p261 Jorga, Anamaria PD20-01 Joseph, David FRI-04 Joseph, Jean MP3-05, MP23-09, V4-06, V9-10, V12-08, p259 Joshi, Manher PD1-01 Joshi, Panjak PD14-10 Joshi, Pankaj MP15-14, PD14-09, PD22-03, V12-01, V12-02 Joshi, Shreyas PD2-07, PD2-12 Joshi, V. MP38-16, V6-10 Joshua, Anthony MP73-02 Jovanovic, Borko PD8-06 Joyner, Byron MP22-12, p18 Juan, Yung-Shun MP21-02 Juárez Del Dago, Pablo PD7-10, V5-09 Juárez, Margarita MP Juárez, Raúl MP12-13 Juehne, Anthony PD51-07 Juma, Saad MP81-17, p44 Jun, Esther PD51-11 Jun, Min MP86-20 Jünemann, Klaus-Peter MP17-15, MP82-06, PD1-01 Jung, Hae Do MP38-14, PD25-02 Jung, Han MP3-17, MP31-12 Jung, Hee Chang MP3-13 Jung, Jaeyoon MP44-11 Jung, Sae Bin PD25-05 Jung, Seung Il MP20-11 Jung, Wonho MP54-10, PD16-12 Junker, Kerstin MP35-06, MP58-03, PD35-08 Jurado Navarro, Alberto PD29-04 Justiniano, Irene PII-LBA3 Juvet, Tristan MP61-01, MP68-04 K Kabakci, A. Sinan V6-01 Kabarriti, Abdo MP5-08, MP14-14, MP64-04 Kabasakal, Levent PD36-07 Kabat, Daniel MP24-19, MP32-07 Kabha, Maharan PD13-10 Kabir, Jahangir MP3-11 Kabore, Rémi MP85-17 Kabra, Aashish MP65-08 Kacagan, Coskun MP74-18 Kachroo, Naveen MP65-19 Kadasne, Ravi PD4-01 Kadekawa, Katsumi MP12-18, MP25-05, PD1-11, PD20-05, PD27-11 Kader, A. Karim MP67-03, PD8-03, PD44-01 Kadioglu, Ates MP43-12, PD2-06, p59, p101, p281 Kadirvelarasan, Ahayla MP74-07 Kadlec, Adam MP44-12 Kadoch, Isaac Jacques MP74-08 Kadowaki, Sayaka MP27-02 Kaestner, Klaus MP49-01 Kaffenberger, Samuel MP7-07, MP7-17, MP35-01, MP44-07, MP47-13, MP55-20 Kafka, Ilan PD51-04 Kafkasli, Alper MP40-16 Kagan, Jacob MP61-16, MP66-06, PI-08 Kagaya, Hideaki MP85-13 Kageyama, Susumu V11-05 Kageyama, Yukio PD15-06 Kähkönen, Esa MP17-07 Kahn, Arnold MP33-04, MP34-06 Kahraman, Semra MP74-09 Kaiho, Yasuhiro MP2-19, MP56-15, PD3-02 Kaimakliotis, Hristos MP10-08, MP10-17, MP58-11, MP64-17, MP65-14, MP72-16 Kainz, Manuela-Christine MP70-09 Kaisar, Ibrahim MP3-11 Kajbafzadeh, A. MP20-06 Kajbafzadeh, Abdol-Mohammad MP19-04 Kajikawa, Keishi PD47-04 Kajiwara, Mitsuru MP52-02, PD35-03 Kakehi, Yoshiyuki MP42-09, PD34-04, p174, p189

322 Kakizaki, Hidehiro MP31-11, MP59-05, MP89-16, PD16-11 Kakizaki, Hiroshi MP75-19 Kakoi, Narihiko MP56-15 Kakuda, Toshio PD4-07 Kalan, Steven A. MP71-03 Kaldate, Rajesh PD32-11 Kalejaiye, Ayo PD8-04 Kallajoki, Markku MP17-07 Kalmus, Angela MP40-07 Kalnin, Robin PD47-10 Kalu, Richard MP71-01 Kalva, Sanjeeva MP80-05 Kalyanaraman, Balaraman MP49-11, MP49-12 Kam, Sung Chul MP43-14 Kamada, Shuhei MP87-06 Kamat, Ashish MP26-14, MP36-01, MP45-06, MP64-20, MP65-05, MP67-06, MP72-02, PD17-06, PD25-12, p11, p44, p172 Kamba, Tomomi MP5-03, MP60-02, PD23-04 Kamda, Shuhei MP37-07, PD46-01 Kamei, Jun MP8-06, MP12-03, MP20-18 Kamel, Mohamed MP23-10, MP32-13 Kamentsky, Lee PI-09 Kamimura, Noritaka PD16-05 Kaminetsky, Jed PII-LBA1, PD37-08, PD48-06 Kamisawa, Hideyuki PD36-12 Kamiya, Hiroyuki MP38-08, MP78-04 Kamoi, Kazumi MP55-07 Kampanga, Mobile p235 Kampel-Kettner, Karin MP70-09 Kan, Fangyu PD27-07 Kan, Kathleen MP22-18 Kanai, Anthony MP21-12, MP21-16, PD7-05 Kanai, Yae MP36-04 Kanai, Yoshikatu MP37-07 Kanao, Kent PD47-04 Kanashiro, Hideki MP85-18 Kanayama, Hiro-Omi MP49-04, MP55-06 Kanda, Toshihiro PD15-06 Kandemir, Emre MP28-20 Kane, Christopher MP4-17, MP14-12, MP53-01, MP53-02, MP53-12, MP60-12, MP61-14, MP69-14, MP82-15, MP87-08, MP87-09, PD32-10, PD34-07, PD35-04, PD35-12, PD38-11, p53 Kaneko, Hisashi MP75-19 Kaneko, Shuji MP12-03 Kanemoto, Kazuhiro MP33-18, MP34-02, MP36-04 Kang, Diana MP11-17, MP79-06, V2-03 Kang, Dong Hyuk MP38-14 Kang, Dong Il MP13-09, MP25-04 Kang, Ho Won MP38-14, PD25-02 Kang, Hyun-Wook MP29-19 Kang, Jian MP4-08 Kang, Lei PD25-01 Kang, Min Yong MP13-01 Kang, Minyong MP6-19, MP28-01, MP54-01 Kang, Pil Moon MP13-09, MP25-04 Kang, Seok-Ho MP44-09, p172 Kang, Taek Won MP20-11 Kang, Yong Jin Kanno, Hidenori Kanno, Yukiko Kansagra, P. Kansas, Bryan PD25-02 MP87-10 MP85-12 MP38-16 PD26-06, PD26-10, PD40-10 MP83-01 MP87-10 MP73-12, MP87-19 PD39-03 MP35-07, MP50-15, MP63-06, MP63-10, MP63-13, MP70-02, MP70-16, MP70-17, MP70-18, PD19-02, PD19-03, PD19-04, PD19-05, V4-01, V4-11, V9-05, V9-09, V12-03, p57, p189 Kanthabalan, Abi Kanto, Satoru Kantoff, Philip W. Kao, Yao-Lin Kaouk, Jihad Kapahi, Pankaj MP33-04, MP34-06 Kapila, Akshita MP20-02 Kaplan, Adam MP20-14 Kaplan, Alan L. MP32-01, MP32-14 Kaplan, Josh V10-10 Kaplan, Joshua V4-13, V10-01 Kaplan, Sherrie PII-LBA5 Kaplan, Steven MP81-20, p9, p97, p234 Kapoor, Anil MP50-19, MP57-20, MP84-08, PD25-10 Kapoor, Deepak PD34-12 Kapoor, Victor MP9-08, MP59-03, MP79-11, PD30-09 Kappa, Stephen PD2-07, PD2-12 Kapur, Payal MP2-06, MP7-09, MP11-14, MP47-06 Karaca, Ender MP76-06 Karakiewicz, Pierre MP24-06, MP48-13, MP56-02, MP56-03, MP56-05, MP56-10, MP56-16, MP59-08, MP59-16, MP59-18, MP59-19, MP62-05, MP63-20, MP72-01, MP78-01, MP78-12, MP78-15, MP82-01, MP82-07, MP83-16, MP83-18, MP87-13, MP87-14, PD30-03, PD30-06, PD30-07, PD31-13, PD49-03, PD4 Karam, Jose MP2-06, MP7-09, MP84-18, PD35-05, p193 Karam, Robert PD24-08 Karaman, Umar PD28-07 Karamzadeh Dashti, Nooshin MP58-09 Karanikolas, Nicholas MP60-16, MP77-05 Karatag, Tuna MP38-20, PD13-09 Kardos, Steven V. MP17-08 Karl, Alexander MP26-17, PD9-04 Karlo, Christoph A. MP44-15 Karlovic, Kristian PD18-04 Karmonik, Christof PD1-05, PD10-02 Karnes, Jeffrey MP6-05, MP6-09, MP14-17, MP24-07, MP29-16, MP53-07, MP56-10, MP56-14, MP58-09, MP72-04, MP72-14, MP77-03, MP78-07, MP82-01, MP82-02, MP82-14, MP83-11, MP83-17, MP86-08, MP87-13, PD12-09, PD17-11, PD32-08, PD32-09, PD43-04, PD43-08, PD44-05 Karpman, Edward PD26-06, PD26-10, PD40-10, p55, p235 Karppa, Elina PD6-02 Karram, Mickey p9 Karrison, Theodore PD Karsh, Larry MP78-11, PD17-06 Karsh, Lawrence PII-LBA4, MP87-15, p13 Kartal, Ibrahim PD40-03, PD40-04, PD45-09 Kartha, Ganesh MP60-17, MP71-01, PD51-09 Kashanian, James PI-03, MP74-05 Kashima, Takeshi MP44-18 Kashiwagi, Eiji MP7-14, MP46-11, MP49-15, MP49-16, MP61-18 Kashyap, Mahendra MP12-14, MP25-07, MP31-13, MP88-01, MP89-20, PD1-11, PD39-04 Kasivisvanathan, Veeru MP74-07 Kasper, Susan p99 Kasprenski, Matthew MP16-01, MP18-05 Kassouf, Wassim MP2-09, MP57-20, MP59-20, MP65-02, MP65-06, MP72-05, MP72-15, PD12-01, PD31-05, PD41-05 Kassouf, Wes p11, p84 Kasyan, George MP17-20, MP81-16 Katagiri, Toyomasa MP49-04 Katariya, Nitin V8-11 Katayama, Norihisa MP83-09 Katebian, Behrod MP5-06 Kates, Max MP9-02, MP67-10, MP67-12, MP72-08 Katkoori, Devendar V12-14 Katmawi-Sabbagh, Samer FRII-11, MP63-18 Kato, Haruo MP39-11, MP74-14 Kato, Mayuko MP37-07, MP46-17 Kato, Minoru MP61-12 Kato, Yoshiharu PD47-04 Katoh, Masaru MP36-04 Katoh, Shinnosuke MP2-19 Katta, Shilpa MP66-06 Kattula, Ambika MP40-19 Katz, Aaron FRII-07, MP1-01, MP6-08, MP62-15, p44 Katz, Benjamin MP3-05, MP42-18, MP62-03, PD43-09 Katz, Eric PD36-05 Katz, Matthew MP56-20, MP77-16 Katz, Patti PD52-09 Kauffman, Eric MP4-07, MP35-12, MP50-06, MP59-06 Kaufman, Ariel p72 Kaufman, Gregory PD48-06, PD48-07, PD48-12 Kaufman, Melissa MP15-12, MP29-17, PD2-07, PD2-12, PD11-04, PD14-05, p251 Kaufman, Ronald p13 Kaufman, Samuel MP5-19, MP89-02 Kaula, Norbert p11 Kaur, Hersharan MP85-15 Kaushik, Dharam MP27-16, MP64-05 Kava, Bruce p19 Kavaler, Elizabeth p10 Kaver, Yizhak MP59-11 Kavoussi, Louis MP3-06, MP59-09, MP70-03, p9, p189, p220 Kavoussi, Nicholas MP75-15, PD13-12 Kavran, Michael MP21-18, PD24-05 Kawachi, Mark MP67-18 Kawaguchi, Toshiaki PD16-05

323 Kawahara, Takashi MP49-15, MP49-16, MP58-01, MP61-18, MP73-07 Kawai, Noriyasu MP36-04, MP46-12, MP55-04, PD17-05 Kawai, Taketo MP58-02 Kawai, Yoshihisa MP46-15 Kawakami, Jun MP84-08 Kawakami, Satoru MP2-04, PD23-06 Kawamorita, Naoki PD20-05, PD27-11 Kawamoto, Bunya MP76-07, PD36-11 Kawamura, Koji MP87-06, PD3-10, PD46-01 Kawamura, Naoki MP77-02 Kawamura, Naoko MP59-17 Kawamura, Norihiko MP47-01 Kawamura, Sadafumi MP56-15 Kawamura, Yuichiro MP89-16 Kawano, Keizou MP7-15 Kawano, Paulo MP79-09 Kawano, Yoshiaki MP69-19 Kawasaki, Yoshihide PD3-02 Kawashima, Atsunari MP47-01 Kawata, Naoko V11-07 Kawauchi, Akihiro MP27-02, V11-05 Kaye, Deborah MP6-17, MP32-06 Keane, Robert MP74-15 Keane, Tom MP73-03, p275 Kearney, Gary P. MP6-12 Kearns, James MP1-20, PD38-07 Keating, Jane MP57-14 Keays, Melise MP40-03, MP40-05, MP40-12 Kedar, Daniel PD11-12, PD17-12 Keegan, Kirk MP65-09, PD21-10 Keehn, Aryeh MP8-13, V7-02, V9-04 Keeley, Francis PD8-04 Keenan, Alison MP40-20, MP54-19 Kehinde, Elijah O. p235 Keihani, Sorena MP19-04 Kekre, Nitin S. MP79-08, p264 Kella, Naveen MP1-19, PD15-03, PD32-11 Keller, Daniel MP19-10 Keller, Etienne MP66-05 Keller, Hansjörg PD22-11 Keller, Irene MP31-01 Kelley, Jeremy MP16-01 Kellogg, Peter p174 Kelly, John MP43-13 Kelly, Rachel PD6-07 Kelp, Alexandra MP19-13 Kennedy, Patrick M. PD36-02 Kennedy-Smith, Andrew V5-08 Kenny, Mccabe C. MP29-14 Kent, Matthew MP50-11 Kenton, Kimberly p11 Kenyon, Johnathan PD24-05 Keren, Ron MP80-03 Kergoat, Micheline MP52-06 Kern, Tyler MP54-20 Kerst, J. Martijn PD31-11 Kesler, Stuart MP48-06 Kessler, Thomas M. MP12-06, MP12-11, MP12-20, PD1-10 Keyhani, Afsaneh MP45-06 Khalil, Dina MP2-06 Khan, Aqsa MP81-07, PD50-09 Khan, Atif MP22-11 Khan, Farooq MP13-04 Khan, Masood MP48-14 Khan, Muhammad MP22-09, MP23-05, MP23-16, MP23-20 Khan, Rehan MP75-13, MP80-04 Khan, S. A. p85 Khan, Saeed MP33-09, MP33-11, p108 Khan, Shahid MP22-09, MP23-05, PD44-08 Khan, Zafar FRII-10 Khater, Nazih MP30-10, MP30-13, MP40-14 Khater, Nazikh MP75-02 Khater, Shery MP79-10 Khater, Usama MP38-16, MP38-18, MP80-02, V6-05, V6-10 Khatri, Gaurav PD50-02 Khattar, Nikhil MP80-15 Khauli, Raja p58, p101 Khavari, Rose PD1-05, PD8-07, PD10-02, PD24-03, V10-07 Khene, Zine-Eddine MP57-02, MP57-12, MP63-16, PD49-02 Khera, Mohit MP51-14, PD26-06, PD26-10, PD40-10, p13, p56, p221, p235 Khismatullin, Damir PD15-10 Kho, Irene MP41-01 Khochikar, Makarand p235, p254 Khoder, Wael MP63-09, V7-05 Khokhlova, Tatiana D. MP39-14 Khorramirouz, Reza MP19-04 Khoshnoodi, Pooria MP86-19, PD44-10 Khouri, Jacob MP38-04 Khoury, Antoine p118, p172 Khoyilar, Cyrus PD7-04 Khunovitch, Dmitry V11-14 Khurshid, Ghani MP75-09 Kibel, Adam MP9-08, MP9-14, MP24-20, MP32-08, MP59-03, MP60-01, MP63-17, MP65-02, MP65-19, MP67-05, MP73-11, MP77-12, MP77-19, MP84-10, MP87-05, MP87-15, PD21-02, PD30-09, PD30-12, PD31-06, p10, p11, p174 Kida, Jun MP8-01, PD7-01 Kiechle, Jonathan E. MP44-10, MP56-06, MP61-15, MP84-05, MP84-15 Kiefert, James p174 Kielb, Stephanie J. MP81-06, PD50-11, p175 Kienel, Alexandra MP61-17 Kieran, Kathleen MP40-19 Kiernan, Maureen MP65-17 Kihara, Kazunori MP2-18, MP7-15, MP11-12, MP58-08, MP65-04, PD3-08, PD15-02, PD15-06, PD17-07, PD32-02 Kikano, Elias PD27-05 Kikuchi, Eiji MP2-08, MP2-14, MP7-10, MP35-20, MP49-03, PD17-03, PD17-08, p174 Kikugawa, Tadahiko PD4-07 Kil, Paul MP14-04 Kilday, Patrick MP14-01 Kilicarslan, Rukiye MP28-16 Killilea, David MP33-04, MP34-06 Killinger, Kim MP88-04, MP89-01, MP89-03, MP89-09, MP89-10, PD20-08, PD21-06, PD27-10, PD50-12 Kim, Aram MP44-11, MP86-06, PD43-03, PD Kim, Bo Hyun MP19-19 Kim, Bum Soo MP18-06 Kim, Bup Wan MP18-06 Kim, Byung Hoon MP54-10, PD16-12 Kim, Chang Hee MP31-12, PD21-01 Kim, Choung-Soo MP19-19, MP22-02, MP44-11, MP69-13, MP78-02, MP86-06, PD39-10, PD47-01 Kim, Chun Il MP54-10, PD16-12 Kim, Dae Keun PD29-08 Kim, Dajung MP34-07 Kim, Daniel MP14-05, PD34-08 Kim, Duk MP25-09 Kim, Eric H. MP77-15 Kim, Edward PII-LBA7, p153 Kim, Fernando MP18-10, MP18-14, p220 Kim, Grace PD38-08 Kim, Hee Jong MP51-15 Kim, Hogyoung MP15-19 Kim, Hong-Kyu PD39-10 Kim, Hong-Sup p172 Kim, Hyeon Hoe MP6-19, MP82-08 Kim, Hyeong Gon MP83-20 Kim, Hyun Tae MP18-06 Kim, Hyung MP44-01, MP53-03, MP59-06 Kim, Hyung Jee MP78-02 Kim, Hyung Joon PD29-08 Kim, Hyung Suk MP13-01 Kim, Hyung-Jee PD51-12 Kim, Isaac MP47-05, MP53-04, MP53-16, MP72-10, PD18-12, PD36-06, p172 Kim, Jae Ho MP54-10 Kim, Jaeheon MP16-11 Kim, Ja-Hong MP11-17 Kim, Jang Hwan MP52-14, PD16-10, PD20-10 Kim, Jayoung MP27-04 Kim, Jeong Hyun MP82-11 Kim, Jeong Kwon MP13-01 Kim, Ji Won MP83-20 Kim, Jin Wook MP89-05 Kim, John MP5-18, MP64-06, PD25-11 Kim, Joohan MP71-04 Kim, Joon Chul MP52-14, PD16-10, PD20-10 Kim, Jung MP43-03 Kim, Jung Hoon MP89-05 Kim, Khae Hawn MP3-17, MP31-12, PD21-01 Kim, Ki Bom MP56-11, MP82-11 Kim, Ki Hong MP1-18, MP73-08, MP73-15 Kim, Kun p172 Kim, Kun Suk MP19-19, MP69-13, MP78-02 Kim, Kwang Hyun MP85-03, PD29-08 Kim, Kwang Mo MP77-06 Kim, Kwang Sik MP20-01 Kim, Kwang Taek MP3-17, MP31-12, PD21-01 Kim, Kwanghee PD33-03 Kim, Kyung Do MP89-05 Kim, Kyungmann MP26-01 Kim, Min Su MP89-05 Kim, Myong MP13-01 Kim, Myung-Joon MP17-18 Kim, Namkug MP22-02 Kim, Noel p12, p55 Kim, Philip MP2-13, MP7-13, MP37-19

324 Kim, Sae Woong PII-LBA6 Kim, Sang Woon PD20-10 Kim, Seong Cheol MP13-09 Kim, Simon MP44-10, MP56-06, MP57-06, MP59-18, MP69-08, MP73-11, MP84-05, MP84-15, MP84-17, PD12-04, PD29-07, PD44-05 Kim, Soo Woong MP13-07 Kim, Steve p18 Kim, Sun Il p172 Kim, Sung PD4-09 Kim, Sung Dae MP51-15 Kim, Sungjin MP16-12 Kim, Sun-Ouck MP20-11 Kim, Tae Beom MP3-17, MP31-12 Kim, Tae Heon MP3-14 Kim, Tae Hyoung MP89-05 Kim, Tae Jin MP56-11, MP73-06, MP77-06 Kim Tae Nam MP38-14 Kim, Tae-Hwan MP18-06 Kim, Tae-Kyung MP42-08, PD19-06, PD30-05 Kim, Tim MP50-02 Kim, Tong-Wook PD51-12 Kim, Wan Seok MP13-09 Kim, Wan Suk MP25-04 Kim, Wansuk MP82-18 Kim, Won Tae PD51-12 Kim, Woo Jean MP52-03 Kim, Wun-Jae MP47-05, MP53-16, PD51-12 Kim, Yeong Uk MP3-13 Kim, Yong-June MP44-09, PD51-12 Kim, Young Ho MP52-14 Kim, Young-Ho MP16-11 Kim, Young Joo MP51-15 Kim, Young-Won PD51-12 Kimberl, I. Jane MP16-05 Kimberl, Jane PD19-12 Kimbrell, Hillary PD15-01 Kimm, Simon MP50-11 Kimura, Go MP69-19 Kimura, Masaki PD37-07 Kimura, Takahiro p174 Kinchen, Kraig PII-LBA6 King, Alexandra PD20-11 King, Ashley PD27-04, PD28-08 King, Benjamin MP30-13, MP30-18, MP40-14, MP75-02 Kingswood, J. PD35-10 Kinnaird, Adam PD14-04, PD33-11 Kinouchi, Toshiro MP47-01 Kinsella, Janette MP71-05, p12 Kira, Satoru MP8-14 Kiremit, Murat Can MP28-16 Kirimanjeswara, Girish MP25-20 Kirk, Peter PD14-12 Kirk, Ray MP41-02 Kirkali, Ziya PD39-01, p100, p137 Kirkham, Alex MP83-01 Kirmiz, Samer MP44-02, MP44-19 Kirpekar, Deepak p71 Kirsch, Andrew J. MP54-02 Kirsh, Gary p237 Kirshenbaum, Eric PD4-05 Kislinger, Igor V4-05, V8-12 Kiss, Bernhard MP38-09, MP65-01, MP65-16 Kissin, Dmitry MP24-11 Kita, Masafumi MP31-11, MP59-05 Kitahara, Satoshi PD17-07 Kitamura, Hiroshi MP79-16 Kitamura, Kosuke PD16-02 Kitano, Hiroyuki PD35-03 Kitta, Takeya MP85-12 Kittles, Rick MP53-14, MP71-01 Kiuchi, Hiroshi MP8-19, MP71-16, MP76-18 Klaassen, Zachary FRI-06, FRI-18, FRII-13, MP5-09, MP9-10, MP53-01, MP53-02, MP60-12, MP60-14, PD13-11, PD29-02 Klatte, Tobias MP7-01, MP63-20, PD29-12 Klausner, Adam MP12-15, MP12-16 Klehr, Benedikt MP88-09 Klein, Alexandra PD22-04, PD48-09 Klein, Eric MP1-05, MP1-12, MP6-03, MP6-09, MP55-18, PD34-01, PD38-10, p9, p44, p58, p174, p236 Klein, Jan MP26-04 Klein, Robert MP6-16 Kleinhans, Natalia PD20-07 Kleinman, Nir MP30-09, MP80-06, PD18-07, PD18-10, V6-03 Klett, Dane MP4-14, MP9-08, MP9-14, MP54-07, MP59-03, MP60-01, MP62-01, MP64-13, MP65-19, MP73-11, MP73-19, MP77-13, MP78-19, MP79-04, MP82-16, MP82-17, MP87-05, MP87-14, PD6-12, PD30-08, PD38-01 Klingele, Christopher PD50-10 Klocker, Helmut MP37-11 Klotz, Laurence MP4-06, MP14-08, PII- LBA4, MP42-06, MP46-14, MP73-04, PD46-07, p12, p58, p101, p174, p176, p190 Klug, Stefanie J. PD35-08 Klümper, Niklas MP68-07 Klumpp, David MP12-02, PD20-09 Klünder, Mario PD24-01 Kluth, Luis MP2-10, MP2-12, MP3-16, MP15-15, MP58-10, MP63-20, MP78-12, MP78-18, MP83-06 Kluth, Martina MP37-09, MP55-08 Klutke, Carl p254 Klyushnenkova, Elena PD6-03 Kneebone, Roger MP22-09, MP23-05 Kneitz, Burkhard MP56-10, MP82-01 Knezevic, Dejan MP1-05 Knight, John MP34-04, MP34-17 Knight, Richard PD21-10 Knispel, Helmut PD5-08, PD5-10 Knoedler, Margaret PD36-05 Knoll, Dean PD48-07 Knoll, Paul PD50-05 Knoll, Thomas MP13-08, PD13-05, p11, p101 Knopf, Kevin MP1-19 Knorr, Jack PII-LBA6 Knudsen, Bodo PD13-01, PD13-07, PD19-02, PD19-03, PD19-04, PD19-05, PD42-06, p11, p100, p244 Ko, Dicken p254 Ko, In Kap MP29-18 Ko, Joan MP Ko, Lauren N. MP54-13 Ko, Moe Moe MP35-13 Ko, Oliver MP63-13 Ko, War War MP35-13 Ko, Young Hwii MP3-13 Kobak, William PD24-06, V12-13 Kobashi, Kathleen PD28-05, PD28-06, p135, p189 Kobatake, Kohei PD35-03 Kobayashi, Daichi MP46-12, MP55-04 Kobayashi, Hideki V7-12 Kobayashi, Hirohito MP2-17, MP57-17, MP69-17, MP77-02 Kobayashi, Ikuo PD47-04 Kobayashi, Kazuhiro MP51-12 Kobayashi, Shuichiro MP58-08 Kobayashi, Takahiro MP34-13, MP41-06, MP62-10 Kobayashi, Takashi MP5-03, MP60-02, PD23-04 Kobori, Yoshitomo MP76-17 Koca, Osman MP7-20 Kocakaya, Ramazan MP38-07 Koch, Axel PD42-03 Koch, Michael MP58-11, MP64-17, MP65-14, MP72-16, PD15-03, p210 Koch, Rainer MP17-10, MP48-05 Kocher, Neil J. MP50-03, MP50-04 Kocherov, Stanislav MP16-14, MP54-16 Kocjancic, Ervin PD24-06, PD28-04, V2-12, V12-13 Kodama, Ronald MP14-08 Kodama, Yoshiki MP2-17, MP7-16 Koechlin, Alice MP4-09 Koenig, Joel MP40-02, MP51-16, PD39-05, V7-03 Koff, Stephen p59 Koga, Fumitaka MP11-11, MP58-08, MP69-20, PD17-07 Kogan, Barry p18, p59, p172, p221 Koh, Chester MP40-10, MP79-15 Kohan, Alfred PD1-01 Kohjimoto, Yasuo MP7-16, MP19-01 Köhler, Tobias MP16-04, MP27-06, MP32-09, MP43-19, MP51-16, MP74-06, PD26-06, PD26-08, PD26-10, PD39-01, PD39-05, PD40-01, PD40-10, p9, p56, p98, p169, p221 Kohn, Joachim PD36-06 Kohri, Kenjiro MP33-13, MP33-15, MP33-18, MP34-02, MP34-05, MP34-11, MP34-13, MP34-15, MP36-04, MP38-08, MP41-03, MP41-06, MP46-12, MP55-04, MP62-10, MP78-04, MP80-18, PD17-05, PD36-12 Koichiro, Ogihara PD17-03 Koie, Takuya MP16-13, MP56-15, MP58-05, MP65-07, MP69-07, MP73-09, MP73-18, MP87-07, PD16-05, PD49-07 Koike, Chiaki MP11-06 Koike, Hidekazu MP39-11, MP74-14 Koike, Kyoko MP77-02 Koiwa, Satoshi MP38-08 Kojima, Satoko MP46-17 Kojima, Shinsuke MP83-09 Kojima, Toshio MP8-06 Kojima, Yoshiyuki MP12-17, MP39-04,

325 PD24-02, PD36-12 Kojima, Yuta MP58-05, MP69-07 Kojovic, Vladimir MP52-15 Kolb, Suzanne PD47-03 Koldewijn, Evert MP23-03 Kolesar, Jill MP26-01 Kollath, Lori MP66-15 Kölle, Sabine MP74-17 Kollias, Spyros MP12-06, MP12-20, PD1-10 Komai, Yoshinobu PD3-08 Komeyama, Takeshi MP31-07 Komisarenko, Maria MP4-05, MP42-01 Kommu, Sashi MP63-18, MP70-20 Komura, Kazumasa MP7-02 Koncz, Louis p135 Kondo, Makoto MP8-19 Kondo, Tsunenori MP2-17, MP7-16, MP57-17, MP69-09, MP69-17 Kondo, Yukihiro MP77-02 Konety, Badrinath MP55-13, MP61-06, MP64-14, MP66-14, PD25-06, PD41-12, p58, p59, p71, p85, p253 Koo, Alec MP4-03, p251 Koo, Kevin MP27-09, MP42-14, MP81-05 Koo, Kyo Chul MP1-18, MP73-08, PD29-08 Kook, Ha Rim MP73-06, MP78-16 Kopecky, Steve p11 Kopka, Klaus MP53-08 Kopke, Jonathan MP79-11, MP79-12 Kopp, Ryan MP6-16, MP10-12 Koppie, Theresa MP44-17, MP65-02, MP65-18, PI-07, p11 Koren, Claudio p176 Kosaka, Takeo MP7-10, MP35-20, MP49-03, PD17-03 Kosarek, Christopher MP22-10 Koski, Michelle MP81-13 Kössler, Robert MP14-19 Kotarinos, Rhonda p10 Kote-Jarai, Zsofia MP86-11 Kothari, Anai MP18-11, MP64-12, PD4-05 Kotov, Sergey p221 Kotsiris, Dimitrios MP60-18 Kottwitz, Michael MP51-16, MP74-06, PD5-03, PD26-08, PD39-05 Koul, Hari p127 Kouno, Hidaka MP2-14 Koutlidis, Nicolas MP63-12, MP63-15 Kouzoukas, Dimitrios E. MP21-17 Kovac, Evan MP53-06, MP72-17, PD31-09 Kovac, Jason PD52-04 Kovacevic, Larisa MP40-15, MP80-19 Kovacs, Agnes p101 Kovell, Robert MP5-04, MP5-13, MP43-03, PD9-09, V3-05, p254 Kow, Nathan PD50-01 Kowalczyk, Keith PD6-11 Kowalewski, Timothy PD19-02, PD19-03, PD19-04, PD19-05 Kowalik, Casey MP47-10 Kowitz, Jason MP57-05 Koyama, Tatsuki PD12-03, MP27-11, PD23-11, PII-LBA5 Koyle, Martin p117, p175 Kozinn, Spencer MP67-18 Kozirovsky, Mariana MP15-11 Kozminski, Michael A. MP1-14 Krabbe, Laura-Maria MP2-06, MP2-09, MP7-01, MP7-09, MP63-20, MP65-06, MP72-15, PD35-11, PD41-05 Kraft, Stefan MP37-09 Krambeck, Amy MP29-15, MP29-16, MP33-07, MP34-19, MP41-05, MP80-09, PD13-01, PD13-07, p13, p170 Kramer, Andrew p20, p55 Kramer, Mario MP26-04, V8-08 Kramer, Ulrich MP11-19, PD24-01 Kramolowsky, Eugene MP28-06 Krane, Louis MP3-09, MP7-03, MP22-13, MP44-06, MP67-03, PD3-11, PD8-03, PD49-10, PD50-04 Kranz, Jennifer V12-05 Krasnyak, Stepan MP43-10 Krassioukov, Andrei PD1-06 Kraus, Stephen p11, p13, p189 Krause, Felix MP35-11 Kravic, Tamara MP52-15 Krebs, Jörg MP11-20 Kregel, Steven MP37-18 Kreibich, Gert PD7-12 Kreider, Wayne PD42-02 Kreshover, Jessica MP59-09, p10 Kretschmer, Alexander MP26-17, MP63-09, MP88-08, MP88-09, PD9-04 Krhut, Jan MP71-07 Kriegel, Christian MP42-07 Krieger, Daniel MP69-02 Krieger, John MP27-04, PD8-09, PD20-01, p12, p114 Kriegmair, Maximilian MP83-07 Krischel, Matthis FRI-16 Krishna, Nandita MP63-17 Krishnamurthi, Venkatesh MP9-13, V8-10 Krishnan, Jayram V4-11, V9-05, V12-03 Krishnan, Naveen MP14-07, MP32-15, PD25-08 Kristal, Alan MP4-02 Kriteman, Lewis S. MP13-02, MP13-16 Krlin, Ryan V2-10 Kroeger, Nils MP47-06 Kron, Ken MP6-14, MP68-06 Kron, Martina PD30-11 Kronenberg, Peter MP34-08, PD42-05, V6-14 Kröpfl, Darko V10-02 Kropp, Bradley p17, p31, p59 Krousel-Wood, Tonette p119 Kruck, Stefan PD18-04 Krueger, Sarah MP20-17 Krupski, Tracey MP16-07, MP20-13, PD17-06, p135 Kryger, John V. V7-04, p17, p31 Ktech, Nasser V6-08 Ku, Ja Hyeon MP6-19, MP13-07, MP82-08 Ku, Ja Yoon MP40-17 Kuang, Mei MP8-10 Kübler, Hubert MP56-08, MP82-10, PD32-06, PD32-07 Kubo, Hitoshi MP39-04 Kubo, Tatsuhiko MP36-02 Kubota, Hiroki MP78-04 Kubota, Yasue MP78-04 Kubota, Yoshinobu MP Kucherov, Victor MP51-11 Küçük, Eyüp Veli V2-04, V12-04 Kucukgergin, Canan PD2-06 Kucuktopcu, Onur MP28-20 Kuczyk, Markus MP26-04, MP52-07, MP52-17, V8-08 Kudo, Shoji V7-12 Kuefner, Dana MP51-17, MP74-20, PD52-10 Kuehhas, Franklin PD48-10 Kugler, Alexander MP88-03 Kuhl, Marie PD22-12 Kuhlencord, Katharina PD22-12 Kühs, Ursula MP1-16 Kuk, Cynthia MP61-01, MP68-04, MP68-05 Kukulka, Natalie MP8-02, MP31-18 Kulaksizoglu, Haluk V9-02 Kulendran, Sinthu MP74-07 Kulidjian, Anna A. MP61-14 Kulkarni, Girish MP4-05, MP14-08, MP42-01, MP60-20, MP67-16, MP73-02, MP86-15, MP86-16, PD47-10, p169 Kulkarni, Meghana MP10-16, MP63-18, MP70-20 Kulkarni, Ravindra p56 Kulkarni, Sanjay MP15-14, PD14-09, PD14-10, PD22-03, V12-01, V12-02, p11, p71, p235 Kulkulna, Natalie MP19-08 Kullmann, F. Aura MP21-04, MP21-16 Kumamoto, Yoshiaki MP51-12 Kumar, Anup V4-07, V4-08 Kumar, Rajeev MP28-05, V11-08, p39 Kumar, Santhosh MP11-01 Kume, Haruki MP20-18, MP58-02, PD3-05 Kumon, Hiromi MP11-18, MP61-14, PD24-04 Kun Zhong, Jian MP66-07 Kunath, Frank MP35-06 Kundal, Pawan MP43-20 Kundavaram, Chandan MP32-10 Kundu, Shilajit MP5-18, MP10-19, MP27-20, MP53-04, MP64-06, PD8-06 Kungel, Terrance p175 Kuniyasu, Hiroki MP68-03 Kunju, Lakshmi PD43-12, PD44-07, PD44-12 Kuntz, Nicholas MP28-09 Kuo, Hann-Chorng MP20-16, MP21-14, MP31-05, MP71-14, MP81-02, MP81-03, MP89-17, MP89-19, PD1-02, PD20-02, p190 Kuo, Huai-Ching MP14-05, MP87-11 Kuo, Paul MP18-11, MP45-09, MP64-12, PD4-05 Kuo, Tzy-Mey MP24-02 Kuo, Yuh-Chen MP81-03, PD20-02 Kuppen, Malou MP23-03 Kuppermann, David MP50-08, MP50-09 Kupriyanov, Yury MP81-16 Kural, Ali Riza MP42-20, p83 Kurihara, Sota MP74-14 Kuriki, Priscila MP71-19, PD39-07 Kuroda, Kenji MP7-11 Kurokawa, Satoshi PD36-12 Kurozumi, Akira MP37-07, MP46-17

326 Kurteva, Teodora MP64-18 Kurtz, Michael MP35-09, MP75-12 Kurtzman, Steven MP78-11 Kuru, Timur MP61-17 Kurzrock, Eric p99 Kusek, John PD39-01 Kushida, Nobuhiro MP12-17, PD24-02 Kusku Kiraz, Zeynep MP34-12 Kusmartsev, Sergei MP33-09 Kusumi, Yasuo PD16-05 Kusumoto, Hiroki MP19-01 Kutikov, Alexander MP24-03, MP24-05, MP47-04, MP50-14, MP67-07, MP67-08, MP67-14, MP70-04, MP84-07, MP84-17, PD12-04, PD12-07, PD49-04, PD49-11, PI-10, p13, p33 Kuwada, Masaomi MP68-03 Kuwayama, Tomohiro MP21-07 Kuxhausen, Adrienne MP24-12, MP24-14, PD5-05, PD51-07 Kwak, Cheol MP6-19, MP44-09, MP44-20, MP82-08 Kwan, Lorna MP16-09, MP24-01, MP27-15, MP32-12 Kwiatkowski, Maciej MP61-01, MP86-07 Kwon, Chil Hun MP12-09 Kwon, Dongdeuk MP20-11 Kwon, Dong-Deuk p172 Kwon, Eugene MP78-07, MP82-14 Kwon, Jong Kyou PD25-02 Kwon, Jong Kyu MP71-04, MP89-05 Kwon, Mi-Hye MP52-03, MP52-08 Kwon, Ohseong MP42-16, MP82-11 Kwon, Se Yun MP18-06 Kwon, Tae Gyun MP18-06, MP53-16 Kwon, Taekmin MP78-02, PD39-10 Kwon, Whi-An MP33-05, MP34-18 Kwong, Justin MP85-02 Kwong, Yiu Ming p70, p71 Kyan, Atsushi MP2-19, MP73-18, PD16-05 Kyoshi Hidaka, Alexandre PD3-04 Kyprianou, Natasha p70, p124, p174 Kyung, Yoon Soo MP22-02, PD39-10 L La Croce, Giovanni MP4-10, MP51-17, MP51-18, MP52-07, MP74-20, MP76-05, MP76-15, PD52-06, PD52-10 La Fuente, José M. MP52-04 La Rosa, Francisco G. MP6-06, MP60-08, MP65-02 Labadie, Kevin PD51-01 Laban, Osama MP3-08, PD40-11 Laborde, Eric FRI-08 Labossiere, Joseph MP15-04 Lacefield, Evan MP23-10 Lacombe, Louis MP57-20 Lacy, John PD40-08, p57 Ladanyi, Marc MP64-02 Laddha, Abhishek MP3-03 Lafos, Norberto p176 LaFramboise, William MP58-04 Laganà, Fulvio MP57-13 Laguna, M. Pilar MP84-04 Laguna, Pilar MP35-05 Laguna Pes, Pilar p56, p157 Lahme, Sven PD48-03 Lai, Caroline M. MP20-12 Lai, Henry MP27-04, MP81-04, PD8-09, p49, p70 Lai, Julie MP9-01, MP9-05, PD1-09, PD10-12 Laird, Alexander PD33-06 Lakin, Charles MP21-03 Lakshmanan, Vinoth Kumar MP69-11 Lakshmanan, Yegappan MP40-15, MP54-07, MP80-19 Lal, Priti MP6-03, MP47-17 Lallas, Costas MP7-01, MP53-04, MP67-07 Lam Van-Ba, Ornella MP12-05, PD1-08 Lam, Hung-Ming PD47-03 Lam, Lucia MP1-04, MP1-11, PD41-08 Lam, Po N. MP45-14 Lam, Vincent MP28-18, MP85-07 Lamarre, Neil MP21-12 Lamb, Dolores MP43-05, MP51-01, MP51-06, MP76-06, MP76-10, PD36-01, PD37-01, PD37-03, PD37-05, PD39-06, PD45-02, PD52-01, PD52-04, p255 Lambert, H. Wayne PD36-02 Lamberts, Remy MP28-13, MP84-02 Lamers, Romy MP14-04 Lamington, Rajat E. MP4-15 Lammers, Wim PD11-07 Lamming, Dudley MP55-11 Lamoureux, Rebecca H. PD4-03 Lamy, Laurent MP13-19 Lan, Ruzhu MP39-16, MP47-11 Lance, Raymond MP14-02, PD34-03 Lanchbury, Jerry MP1-10 Landas, Steve MP39-02 Landis, J. Richard PD8-09 Landis, Patricia MP1-15, MP9-02, MP42-04, PD6-04, PD34-09 Landis, Richard MP27-04 Landman, Jaime MP7-18, MP22-14, MP30-13, MP70-03, MP75-02, MP80-16, PD7-04, PD13-04, PD19-02, PD19-03, PD19-04, PD19-05, PD41-07, PD51-01, p12, p19, p57, p130, p135, p221 Landon, Bruce E. MP5-19 Landon, Emily MP65-13 Lane, Brian MP5-20, MP42-05, MP44-02, MP44-19, MP59-04, MP69-14, MP84-09, PD19-06, PD29-09, PD30-05, PD35-12, p12, p13, p100 Lane, Felicia MP19-12 Lang, Sven MP33-04 Lange, Dirk MP75-12, p56, p169 Lange, Paul p185 Lange, Tobias MP37-14 Langetepe, Jessica PD22-12 Langfald, Alyssa MP66-14 Langford, Carolyn p72, p73 Langille, Gavin V3-09 Lapicz, Lynne PD24-07 Lapidus, Jodi MP71-17 Lapin, Brittany MP14-18, PD51-08 Larcher, Alessandro MP6-07, MP24-06, MP59-08, MP59-15, MP59-16, MP59-18, MP59-19, MP62-04, MP72-01, MP78-01, MP78-09, MP78-17, MP82-02, MP82-07, 314 MP83-18, PD30-03, PD30-06, PD31-13, PD49-03, PD49-05 Larish, Yaniv MP75-20 Larner, Tim PD5-08, PD5-10 Larosa, Stephen PD33-03 Larré, Stéphane MP63-12, MP63-15, PD17-11 Larson, Benjamin MP41-15 Larson, Jeffrey MP20-15, MP30-03, MP63-06, MP63-10, MP70-16, MP70-17, MP70-18, MP80-07, PD18-09, V5-11 Larson, Steven MP37-10 Lascano, Danny MP4-15, MP14-03, MP24-19, MP32-07, MP44-17, MP63-01, MP64-07, MP64-15, MP72-09, PD17-09, PD30-04, PI-07 Lasker, George PD36-05 Latini, David MP43-06, p56 Latini, Jerilyn p102 Lattime, Edmund MP72-10 Lattouf, Jean-Baptiste MP57-20 Lau, Clayton MP64-08, MP64-16, MP67-18 Lau, Howard MP77-04, MP85-07 Laudano, Melissa MP32-16, MP89-08 Laudone, Vincent MP78-03 Laurin, Miguel MP52-06 Lautz, Jaclyn MP33-12 Lavallée, Luke T. MP68-19, PD47-12 Lavelle, Rebecca PD10-05, PD50-06 Lavery, Dylan MP45-02 Lavi, Arnon MP17-04 Laviana, Aaron MP24-09, MP32-10, MP32-12, MP65-20, MP70-07, MP73-17, MP79-06, V4-03 Lavieri, Mariel MP32-15, PD25-08 Lavigueur-Blouin, Hugo MP13-14 Law, Michael MP9-07 Law, Yan Mee MP48-08 Lawrence, Anna p20 Lawrence, Jeffrey MP1-01, MP1-05, MP53-18 Lawrentschuk, Nathan MP22-01, MP31-09, p225 Lay, Aaron MP11-14, MP23-17, MP57-10 Laydner, Humberto MP3-04, MP50-15, V4-01 Laymon, Mahmoud PD23-05, MP67-01 Lazzeri, Massimo MP6-07, MP19-15, PD14-10 le Roux, Pieter MP63-18, MP70-05, MP70-20 Le, Brian PD26-03, PD36-08, p169 Le, Margaret MP51-08 Le, Ngoc-Bich MP88-07, MP88-11, MP88-19, PD24-11, PD24-12, PD26-07, V3-01 Leach, Gary PD50-07 Leach, Robin MP36-07, MP77-09, PD46-05 Leao, Ricardo MP37-11 Leapman, Michael MP24-10, MP42-12, MP53-18, MP86-10, MP87-04, PD15-12, PD47-02 Leavitt, David MP3-06, MP30-08, MP59-09, MP80-13, V3-12, V3-13, V8-08 Lebeau, Thierry MP43-04

327 Lebeis, Christopher MP61-07 Lebret, Thierry MP7-05 Lecca, Paola MP66-01 Ledet, Elisa MP6-11, MP66-03, MP66-10, MP87-17 Lee, Albert MP38-15, PD21-03 Lee, Andy MP8-18 Lee, Benjamin MP22-03, MP22-04, MP39-01, MP69-01, PD15-01, PD15-10, PD19-02, PD19-03, PD19-04, PD19-05, V5-04, V9-14, V12-09, p13, p255 Lee, Benjamin R. MP29-01 Lee, Byron MP7-13, MP11-16, MP72-20 Lee, Chanwoo MP22-02, MP78-02, PD39-10 Lee, Cheng-Ling PD1-02 Lee, Cheryl MP43-06, MP58-06, MP58-19, MP68-20, PD31-03, p11, p18, p175, p217 Lee, Chunwoo MP19-19, MP69-13, MP78-02, PD39-10 Lee, Dae Hun MP38-14 Lee, Daivd MP53-16 Lee, Dan MP53-20 Lee, Daniel MP17-12, MP32-16, PD2-02, PD26-09, PD45-08 Lee, David MP3-05, MP42-18, MP62-03, PD43-02, PD43-09 Lee, Derek PD4-03 Lee, Dominic MP81-15, p71 Lee, Dong-Gi MP25-01 Lee, Donghyun PD43-03, PD47-01 Lee, Eugene MP64-20, PD28-06, PD38-02 Lee, Eugine MP66-08 Lee, Franklin MP17-01, PD42-01, PD42-02 Lee Jr., Fred T. MP35-17, MP44-16 Lee, George MP1-15, MP6-18 Lee, Geun Taek PD36-06 Lee, Geuntaek MP47-05 Lee, Gilho MP25-09 Lee, Hae Won MP54-01 Lee, Hak MP51-07, MP69-14, MP84-09, PD35-12 Lee, Hak Min MP37-08 Lee, Hakmin MP42-16, MP73-06, MP77-06, MP78-16, MP82-11 Lee, Hoang MP79-15 Lee, Hyun Moo MP7-04, MP44-20, MP50-05, MP62-17, PD25-05 Lee, Hyung-Lae MP25-01 Lee, Hyun-Wook MP36-16, MP36-18 Lee, In Jae MP56-11, MP77-06, MP82-11 Lee, Jae-Lyun MP69-13 Lee, Jane MP45-18 Lee, Jason MP22-07, MP75-04 Lee, Jea Whan MP33-05, MP34-18 Lee, Jeong Woo MP28-01 Lee, Jeong Zoo MP40-17 Lee, Jeung Geun MP37-08 Lee, Jocelyn MP66-06 Lee, Joo Yong MP38-14, MP71-04, PD25-02 Lee, Jun Ho MP25-01 Lee, Jun Nyung MP18-06 Lee, Justin MP14-09, MP27-13, MP53-20, MP78-01, PD30-03 Lee, Ki Soo MP38-14 Lee, Kit H. MP32-18 Lee, Kwang Soo MP13-07 Lee, Kyu Sung PD20-10 Lee, Kyung Seop MP54-10 Lee, Kyu-Sung MP3-14, MP52-14, PD16-10 Lee, Michael PD21-03 Lee, Mi-Jung MP17-18 Lee, Nora MP54-06 Lee, Pearl PD31-03 Lee, Richard MP6-02, MP32-16, MP63-20, MP78-12, MP81-20, MP83-04, PD2-02, PD26-09, V3-08, p250, p254 Lee, Sang Chul MP44-09 Lee, Sang Don MP40-17, p172 Lee, Sang Eun MP7-04, MP37-08, MP42-16, MP44-09, MP56-11, MP62-17, MP73-06, MP77-06, MP78-16, MP82-11, PD25-05 Lee, Sang Jin MP29-18, MP29-19 Lee, Sang-Cheol PD51-12 Lee, Sangchul MP37-08, MP42-16, MP56-11, MP77-06, MP82-11 Lee, Seo Yeon MP89-05 Lee, Seong Hyun MP43-14 Lee, Seung Bae MP28-01, MP82-08, PD16-10 Lee, Sin Woo MP7-04, PD25-05 Lee, Ted MP56-19 Lee, Una PD28-05, PD28-06, p84, p251 Lee, Wai FRII-02, V9-08 Lee, William MP47-09, MP47-14 Lee, Wonjin MP16-11 Lee, Yi-Fen MP49-18, MP68-14 Lee, Yi-Lun MP21-02 Lee, Yong Seung MP17-18, p172 Lee, Young Ik MP42-16, MP77-06, MP82-11 Lee, Young Ju MP13-01 Lee, Yuna MP14-08 Lee, Ziho MP29-01, V4-13, V10-01 Leeb, Regina MP74-17 Lee-Felker, Stephanie PD38-08 Leffondre, Karen MP85-17 Lehman, Erik MP50-03, MP50-04 Lehman, Kathleen MP25-20 Lei, Hongen PD36-09 Leibovich, Bradley MP35-02, MP35-18, MP35-19, MP44-14, MP50-10, MP59-20, MP63-20, MP69-05, MP69-12, MP70-11, MP70-12, MP70-14, MP70-15, PD29-06, PD35-07, PD35-11, PD49-12, p58, p206, p221 Leibovitch, Ilan PD23-03 Leiria, Luiz O. MP8-07 Leite, Kátia MP31-17 Leite, Katia R. MP8-07, MP21-10 Leitenberger, Armin MP26-04, V8-08 Leithy, Tarek MP85-14 Leitner, Lorenz MP12-06, MP12-11, MP12-20, PD1-10 Lemack, Gary PD10-05, V2-06, p100 Lemon, Kathryn MP21-12 Lemonche, Cristian Isalt MP79-07 Lendvay, Thomas MP17-01, PD19-02, PD19-03, PD19-04, PD19-05, PD19-06, PD30-05, p18, p117, p153 Lenero-Llaca, Enrique p Lenherr, Sara MP3-18, MP71-06, MP89-02 Lenis, Andrew T. MP70-07 Lenormand, Claire MP63-12, MP63-15 Lentz, Aaron MP88-07, MP88-11, MP88-19, PD24-11, PD24-12 Léon, Priscilla MP2-07, MP7-05, MP7-06, MP7-12, MP63-12, MP63-15, PD10-11, PD11-09 Leonard, Michael p17 Leonardo, Borregales MP84-18 Leonardo, Costantino PD49-08 Leone, Andrew MP14-17, MP57-16 Leong, Hon MP34-07, PD33-01 Leong, Jeffrey MP46-15, MP49-13, MP66-02 Leong, Traci MP54-02 Leongamornlert, Daniel A. MP86-11 Leow, Jeffrey MP32-08, MP78-05, MP84-20, PD18-08, PD21-02 Lepor, Herbert MP5-17, MP20-03, MP21-11, MP33-02, MP36-16, MP36-19, MP36-20, MP45-19, MP53-15, MP56-01, MP56-19, MP77-14, MP77-17, MP77-18, PD4-11, PD32-01, PD32-03, PD32-05, PD34-02, PD37-11, PD43-11, p204 Leppert, John MP28-13, MP84-02, PD15-07 Lepri, Emanuele MP62-02 Lerman, Steven MP32-12, MP54-20 Lerner, Lori p10, p237 Lerner, Seth PD17-06, MP65-02 Lerner, Susan MP85-10 Lesmana, Hans MP78-09 L Esperance, James PD15-08 Lestingi, Jean F. P. PD43-06 Letendre, Julien MP7-19 Leung, Yuet-Kin PD47-03 Lev, Genady MP16-14 Levanovich, Peter MP20-17 Leveillee, Raymond p11 Leveridge, Michael MP5-02, PD19-09 Levey, Helen R. MP51-11, V12-08 Levie, Katherine MP42-13 Levin, Linda PD47-03 Levin, Richard PII-LBA1 Levin, Robert M. MP12-08 Levine, Laurence PD26-02, PD26-04, PD48-04, PD48-06, p9, p21, p55 Levinson, Jared C. MP4-15 Levitzki, Alexander MP46-08 Levy, Alison MP43-16 Levy, Barbara p154 Levy, Justin MP48-07 Lewi, Keidren MP68-17 Lewis, Brian MP87-17 Lewis, Jason MP37-10 Lewis, John PD33-11 Lewis, Ronald FRI-06, FRI-18, FRII-13, MP9-10, p20, p55, p216 Leyh-Bannurah, Sami-Ramzi MP83-16, PD30-07 Leyh-Bannurah, Samy MP78-17 Lho, Young Soo MP83-20 Li, Alex MP1-07 Li, Benjamin MP32-15, PD25-08 Li, Benyi MP61-09, p70 Li, Chunmei MP11-07

328 Li, Eric MP34-09 Li, Gang MP45-18 Li, Hong MP61-01 Li, Hua MP37-17, MP61-10 Li, Hung Keng MP28-03 Li, Jianhong MP14-17 Li, Jianxing MP30-04, PD4-06 Li, Jingxia MP49-06 Li, Li MP47-18, MP68-15 Li, Lili MP55-10 Li, Marilyn MP66-10 Li, Meng MP37-19 Li, Ming MP52-09, MP52-10 Li, Na MP36-17, MP37-01 Li, Pengchao MP2-05, MP36-15, MP45-11, PD13-06, V11-03 Li, Philip V3-08, p71 Li, Ping MP44-01 Li, Qiang MP5-09, MP9-10, PD29-02 Li, Quentin MP68-17 Li, Roger MP30-01, MP30-10, MP38-15, MP63-02, MP81-08, PD21-03 Li, Shufeng MP43-08, PD52-12 Li, Song MP21-08 Li, Sydney PD25-04 Li, Tianyu MP70-04, PD49-11 Li, Wei MP47-12 Li, Wenbiao PD20-04 Li, Xiang PI-09 Li, Xin MP37-03, MP46-09 Li, Xingsheng MP34-04 Li, Xue Song MP47-02 Li, Xuesong MP2-01, MP2-02, MP2-03, PD33-09 Li, Xueying MP39-09 Li, Yan MP39-09 Li, Yi MP49-15, MP61-18 Li, Yonghong MP10-03 Li, Zaishang MP10-03 Li, Zhuo MP31-06 Lian, Fei MP47-15 Liang, Gangning MP68-12 Liang, Jessie PD8-11 Liang, Lili p71 Liao, Chun-Hou MP89-17 Liao, Joseph C. MP20-10, PD15-07, PII- LBA8, PD25-01, PD25-04, p149 Liatsikos, Evangelos PD13-05, p11, p57, p120 Liauw, Stanley MP4-12, p11 Libby, Russell P. MP43-09 Liberman, Daniel MP27-18, PD10-08, PD11-06, PD14-08, PD47-07, V12-10 Libertino, John MP44-17, MP45-02, MP45-05, MP47-10, MP61-07, PI-07, p142, p236 Libutti, Steven MP50-20 Lieber, David MP27-06 Liechti, Martina D. PD1-10 Lieske, John MP33-07, p13 Lieskovsky, Gary MP56-07 Lieu, Patricia MP11-05, MP27-15, MP60-11, PD30-01 Lifshitz, David MP28-14, MP30-09 Lightfoot, Andrew MP42-18, MP62-03 Lightfoot, Michelle MP30-01, MP30-10, MP38-15, MP63-02, PD21-03 Lightner, Deborah PD12-09, PD28-02, p279 Liguori, Giovanni MP43-01, PD40-12 Lilja, Hans MP37-10, MP60-10, p136, p213 Lilly, Meredith MP19-08 Lim Tze Ying, Benjamin MP30-12 Lim, Jae Sung MP31-14 Lim, Sey Kiat MP30-12 Lim, Yew Koon PD17-01 Lim, Yu Ming MP85-15 Lima Pompeo, Antonio Carlos PD3-04 Lima, Danielly Karla Leal De MP8-09 Lima, Estêvão MP31-16 Lima, Ronnie V5-01 Lima, Salvador Vilar Correia MP8-09 Limanjaya, Anita MP52-03, MP52-08 Lin, Alex MP3-10, MP28-03, MP34-03, MP44-03, MP80-14, PD20-12 Lin, Chia-Hsiang p70 Lin, Chih-Chieh MP34-03, PD20-12 Lin, Daniel MP39-14, MP55-14, MP67-17, PD34-03, PD46-04, PD46-12, p11, p21 Lin, Danli MP8-16 Lin, Haocheng MP52-01 Lin, Hui-Yi MP50-02 Lin, Ji-Fan MP36-10, MP36-11 Lin, Jing-Hui MP21-14 Lin, Kuo-Shyan MP66-07 Lin, Li MP32-04 Lin, Paulo MP46-15 Lin, Teng Lung p70 Lin, Tianxin MP37-16, MP45-12, MP49-05 Lin, Wei-Chan MP86-19, PD44-10 Lin, Yi-Chia MP36-10, MP36-11 Lin, Yu-Kuan MP7-01 Linares, Estefania PI-07 Linder, Brian MP20-19, MP20-20, MP88-12, MP88-14, MP88-16, PD28-12, PD50-10 Linder, Vincent MP6-04 Lindner, Uri PD23-03 Lindower, Carrie MP85-20 Linehan, Marston MP6-17, MP50-20, p19, p147 Ling, Qing MP52-10 Lingeman, James MP3-15, MP34-19, PD42-01, PD42-04, V3-12, V6-11, V8-05, p13, p44, p101 Link, Richard PD19-08, p9 Linsell, Susan MP5-20, MP42-05, MP42-08, MP78-10, PD12-02, PD19-06, PD30-05, PD38-06, PD38-13, PD44-11, p13 Lin-Tsai Reddy, Opal MP49-01 Lipkin, Michael MP20-14, MP28-09, MP33-12, MP40-08, PD51-05, p10, p220 Lipman, Tatiana MP37-11 Lipnharski, Izabella PD4-03 Lippman, Scott MP4-02 Lipshultz, Larry MP51-01, MP51-02, MP51-06, MP74-02, MP76-10, PD37-01, PD37-03, PD37-05, PD45-02, PD52-04, PD52-08, p12, p44, p236 Lipshultz, Larry I. MP23-11, MP43-05, PD36-01, PD39-06, PD48-07, PD52-01, V3-09 Lipsky, Andrew MP54-06 Lipsky, Michael J. MP Lipton, Allan MP73-10 Lira, Mariana Montenegro De Melo MP8-09 Liss, Michael MP15-02, MP25-17, MP64-05, MP67-03, MP69-14, MP84-09, PD8-03, PD35-12, PD44-01 Lista, Giuliana MP6-07, MP83-08 Litwin, Mark MP9-01, MP16-09, MP24-01, MP27-15, MP32-01, MP32-04, MP41-10, PD12-08, p18, p87 Liu, Alice PD12-02, PD38-13 Liu, Bolong PD20-04 Liu, Chan-Jung PD39-03 Liu, Chengfei MP46-01, MP46-02, MP46-03, MP46-05 Liu, Chunhui MP55-15 Liu, Dennis p19 Liu, Genzhou PD48-12 Liu, Glenn MP87-16 Liu, Guihua MP8-03, MP21-08 Liu, Guiming MP8-05, MP21-18 Liu, Huixian MP36-14 Liu, James MP39-01, MP69-01, PD15-10 Liu, Jen-Jane MP58-07, MP64-10, MP67-10, MP67-12, MP72-08, PD31-12 Liu, Ji MP52-09, MP52-10, MP55-19 Liu, Jiamin MP11-02 Liu, Jin MP2-01, MP2-03 Liu, Joceline S. MP15-01, MP81-06, MP88-13, PD21-09, PD48-05, PD50-11 Liu, Liyang MP6-14 Liu, Min MP47-12 Liu, Ming MP11-07 Liu, Nick MP65-14 Liu, Shengjie MP62-09 Liu, Stephen MP37-06 Liu, Wujiang MP49-19 Liu, Xia MP55-19 Liu, Xiang PD25-08 Liu, Xiaopu MP52-05, PD36-04 Liu, Xichun MP6-11 Liu, Yan MP20-03, MP21-11, MP33-02, MP36-19, MP36-20, MP45-19 Liu, Yongjun MP48-02 Liu, Yu MP68-05 Liu, Yuan MP16-12 Liu, Yu-Ru MP68-14 Liu, Zhihui MP84-08 Liu, Zhuowei MP10-03, MP45-12 Liu, Ziyue MP17-01 Livi, Carolina MP65-08 Livne, Pinhas MP30-09 Lizarraga, Victor MP51-14, V10-07 Ljungberg, Inger MP20-07, MP20-08 Lledó, Enrique MP85-06 Lledo-Garcia, Enrique p234 Llorente, Carlos MP13-20, MP58-17 Lloyd, Granville MP20-09, V10-13 Lloyd, Jessica MP88-06, V3-01 Lloyd, Robert MP27-04 Lluel, Philippe MP31-03 Llukani, Elton MP42-18, MP53-04, MP53-16, MP62-03, PD43-11 Lo, Kirk MP68-04, PD52-02, p117 Lo, Mary MP14-10 Lo, Pechin MP35-13 Lo, Richard p70 Lobb, Ian PD33-01

329 Loblaw, Andrew MP4-06, PD46-07 Lobo, Jennifer MP16-07 Locatelli, Irene MP62-04 Loda, Massimo MP6-15 Lodde, Michele PD49-08 Loeb, Stacy MP4-19, MP5-12, MP6-06, MP42-10, MP56-17, MP60-08, MP86-08, MP86-12, PD19-09, PD34-11, p10, p11, p27, p136 Logan, Susan MP66-08 Logothetis, Christopher p190 Logsdon, Mark MP78-11 Loh-Doyle, Jeffrey MP79-05, PD35-06 Lohse, Christine MP35-02, MP35-18, MP35-19, MP44-14, MP50-10, MP69-05, MP69-12, MP70-11, MP70-12, MP70-14, MP70-15, PD29-06, PD35-07 Loidl, Wolfgang MP78-12, PD5-08, PD5-10 Lokeshwar, Soum MP45-03, MP68-02 Lokeshwar, Vinata MP45-03, p123 Lonardi, Cristina MP67-20, PD9-03 Londhe, Anil MP87-18, MP87-19 Long, Christopher MP18-17 Long, Ting PD36-03 Loose, Christopher p100 Lopater, Jonathan MP13-19 Lopez Costea, Miguel Angel MP38-17 López Pacios, Miguel Angel MP13-06, PD41-04 López Pacios, Miguel Ángel Lopez, Aristeo PD15-07 Lopez, Beatriz MP73-20 Lopez, Borja MP13-20, MP58-17 Lopez, David S. MP52-11 López, Francisco Javier MP73-01 Lopez, Isabel V4-05 Lopez, Luis MP45-03 Lopez, Ricardo MP48-12 López-Acón, José Daniel MP38-11, MP80-11 Löppenberg, Björn PD47-09 Lorente, David MP13-06 Lorentz, Adam MP44-17, PD35-05, PI-07 Lorenzo, Armando MP54-05, p59 Losa, Andrea MP6-07 Losco, Giovanni PD39-08 Lotan, Tamara MP1-17, MP6-13, MP6-15, MP55-18, MP66-16 Lotan, Yair MP2-06, MP2-09, MP7-09, MP7-18, MP17-11, MP54-03, MP65-06, MP72-15, MP78-12, MP80-05, PD17-06, PD23-02, PD41-05, p100 Lotfy, Zakaria PD23-05 Lotrecchiano, Giuseppe PD49-08 Lou, Wei MP46-01, MP46-02, MP46-03, MP46-05 Loughlin, Kevin p10, p154 Loutochin, Oleg MP12-05 Lovegrove, Catherine MP22-05, MP23-02 Low, Roger p152 Lowe, Franklin p44 Löwen, Heinrich V10-02 Lowrance, William p10, p189 Lowry, Patrick p9 Lozano Palacio, Fernando PD41-04 Lu, David MP86-19, PD38-08, PD44-10 Lu, Hong MP40-15, MP80-19 Lu, Jianxin MP25-02 Lu, Lan MP8-05 Lu, Louis MP1-14, MP56-12, PD43-12 Lu, Nian Qing V3-08 Lu, Qiang MP2-05, MP36-15, MP45-11, PD13-06, V11-03 Lu, Ruixiao MP1-01 Lu, Shuyan MP3-07 Lu, Tyler PD27-02 Luan, Yang MP52-09, MP52-10, MP55-19 Lubbad, Loay PD11-07 Lubik, Amy A. MP46-06 Lubner, Meghan MP11-02, MP35-17, MP44-16, PD4-08 Lucas, Steven M. PD15-03 Luchey, Adam PD34-06, PD41-01 Lucia, M. Scott MP4-02, p13 Lucianò, Roberta MP83-08 Lucioni, Alvaro PD28-05, PD28-06 Luckenbaugh, Amy MP26-02, MP58-06 Luckmann, Roger MP16-20 Lucky, Marc PD48-08 Lucon, Antonio M. PD5-04 Ludovico, Giuseppe p236 Ludwig, Tim MP15-15 Ludwig, Wesley PD15-11 Lue, Tom p56, p70, p99, p100 Lughezzani, Giovanni MP6-07, MP59-08, MP83-08, PD49-05 Luis De Castro De Abreu, Andre MP15-20, V12-11 Luke, Patrick MP79-13, MP85-02, p255 Lumen, Nicolaas V10-08 Luna Jr., Saturnino MP60-07 Lundon, Dara MP61-19, MP86-12 Lundy, Scott PD2-10 Luo, Jun Hang PD35-11 Luo, Lei MP47-03 Luo, Xuemei MP24-13, PD27-06 Lupski, James MP76-06 Lurie, Kristen L. PD25-04 Lustik, Michael MP9-16 Lusuardi, Lukas MP26-04, MP58-16 Luthringer, Daniel MP53-03 Luzzago, Stefano MP4-16, MP62-05, MP72-04, MP82-03 Lykke, Chris PII-LBA8 Lynam, John PD51-04 Lynch, John PD6-11, p231 Lynne, Charles MP74-15 Lyon, Timothy MP15-06 Lyons, Matthew MP5-05, MP16-16, MP24-02, MP58-19 M Ma, Fei MP21-17 Ma, Hong MP62-09 Ma, Hongshen MP1-07 Maalouf, Naim MP41-14, p189 Maarouf, Aref MP18-02, MP38-02 Maatz, Philipp MP27-14 Macairan, Malu MP27-15 Macalalag, Michael MP23-01 Maccini, Michael A. MP54-08 MacDiarmid, Scott PII-LBA9 MacDonald, Susan MP10-04, PD31-08 MacDonald, Theresa MP17-12 Maceda, Cynara MP51-04 Mach, Kathleen MP20-10, PD15-07, PII- 317 LBA8, PD25-01, PD25-04 Machado, Marcílio Romero MP8-09 Machan, Lindsay MP77-01 Machuca, Victor V4-12 Mackillop, William MP5-02 Mackintosh, F. Roy MP86-08 Maclennan, Gregory MP17-03, MP46-04 Macleod, Liam C. PD34-03 Macnab, Andrew MP20-06 MacNamara, Fergal MP18-12 MacNeil, Sheila p73 Macoska, Jill p178 Madaan, Sanjeev PD44-08 Madabhushi, Anant MP1-15, MP6-18, MP60-04 Madala, Alosh MP39-02, PD3-03 Maddala, Tara MP1-05 Madden, John PD4-12 Madden, Stephen MP61-19 Madden-Fuentes, Ramiro MP25-11 Maddipati, Krishna MP37-02 Maddox, Michael MP22-03, MP22-04, MP29-01, MP39-01, MP48-07, MP69-01, PD15-01, PD15-10, V5-04, V9-14, V12-09 Madhav, Anisha MP37-19 Madhuranthakam, Ananth MP11-14 Madi, Rabii MP5-09, MP9-10, PD13-11, PD29-02 Madison, Kerry MP15-07, MP29-05 Maeda, Yuji V11-11 Maehana, Takeshi MP79-16 Maekawa, Shigekatsu PD3-05 Maffezzini, Massimo PD41-02 Magdy, Ahmed MP57-03, V11-01 Magers, Martin MP48-17 Maggi, Mario PII-LBA6, MP71-03, MP71-08, p221 Magi-Galluzzi, Cristina MP6-09 Magnani, Tiziana MP66-20, PD41-02 Mahajan, Ajay M. PD42-10 Mahajan, Sangeeta PD27-05 Mahal, Brandon PD30-12 Mahar, Alyson MP14-08 Mahdy, Ayman V2-11, V2-14 Mahendran, Ratha MP45-08, PD17-01 Maher, Johnathan MP87-15 Mahmoud, Osama MP30-05, MP67-01 Mahmoud, Saad PD40-11 Mai, Christina MP51-01 Maidaa, Michael PD9-06 Maier, Thomas PD18-04 Maiers, Tyler MP53-14, MP71-01 Mainez, Juan MP30-17 Maizels, Max p117 Majerus, Steve PD24-08 Majid, Shahana MP39-16, MP47-11 Majima, Tsuyoshi MP25-05, PD20-05 Majstorovic, Marko MP52-15 Majumder, Kaustav MP9-14 Makarov, Daniel MP56-17 Makarov, Danil MP5-12, MP9-03, PD34-11, p255 Maki, Yasuhiro MP77-02 Makiyama, Kazuhide MP58-01 Makoto, Ohori MP87-02 Makovey, Iryna PD24-08, PD28-08 Malaeb, Bahaa PD14-12 Malats, Nuria PD17-11

330 Malavaud, Bernard MP85-09 Maldonado, Jonathan PD21-03 Malik, Rena D. PD26-12 Maliski, Sally L. MP16-09 Malkawi, Ibraheem MP15-18, PD14-10, MP42-11, MP86-20 Malkowicz, S. Bruce MP5-08, MP10-09, MP14-14, MP26-03, MP42-15, MP47-17, MP58-12, MP61-08, MP64-04, MP72-12, PD43-02 Malkowicz, Stanley p90 Mallick, Ranjeeta MP68-19, PD44-09 Mally, Abhijith MP64-19 Malmberg, Anders MP73-03, MP73-05 Malmström, Per-Uno MP45-17, PD17-11 Malone, Peter V12-05 Malouf, Gabriel MP72-06 Maloy, Molly MP51-09 Malthouse, Theo MP74-07 Malykhina, Anna PD7-03, PD10-01 Mamatani, Ronac MP14-14 Mamawala, Mufaddal MP9-02, MP42-04, PD6-04, PD34-09 Mamedov, Alezandre MP4-06 Mammen, Kim p72 Mamtani, Ronac MP5-08, MP64-04 Manak, Michael MP1-19 Mandal, Arup MP43-20 Mandal, Diptasri MP66-03, MP66-10 Mandava, Sree MP15-19, PD15-01 Mandava, Sree Harsha MP39-01, MP69-01, PD15-10 Mandel, Philipp MP78-18, MP83-07, PD30-10 Mandeville, Jessica MP34-19 Manesh, Grace MP68-15 Maneval, Charles MP1-20 Manfredi, Matteo MP53-10, MP77-11 Mangahas, Jeremiah MP23-01 Mangel, Jeffrey PD27-07 Manger, Jules MP16-07 Mangione, Carol MP32-04 Manimala, Neal PD41-01 Manka, Lukas MP86-07 Manka, Madeleine MP88-18 Mannhard, Doris MP68-08 Manning, Martina MP42-07 Manning, Stephanie V5-08 Mannion, Jason MP67-14 Mano, Roy MP10-05, MP47-09, MP59-02, PD11-12 Manoharan, Murugesan V12-14, p162 Manola, Judith PD35-04 Manson, Scott MP40-02 Mansour, Ahmed M. PD17-10, PD23-01, p234 Mansy, Soheir MP85-14 Mante, Sunny p235 Mantz, Constantine MP78-11 Manucha, Varsha MP53-16 Manuela, Costantini PD29-10 Manzo, Marco MP53-05 Mao, Jialin MP81-20, MP84-12, PD3-12 Mao, Qi MP31-06 Mao, Xiangming p71 Maranchie, Jodi MP35-01, p186 Maravilla, Kenneth PD20-07 Marchalik, Daniel MP53-04, MP53-16, MP54-06 Marchini, Giovanni S. MP71-18 Marchioro, Giansilvio MP56-10, MP77-03, MP82-01 Marco, Carini MP44-04 Marco, Spilotros PD48-08 Marco-Jiménez, Francisco MP79-01 Marcovich, Robert p244 Mareckova, Natalia MP86-01 Marenghi, Carlo FRI-11, MP77-08 Maresh, Grace MP47-18 Margel, David MP32-17, PD17-12 Margolis, Daniel MP11-05, MP60-11, MP86-19, PD30-01, PD38-08, PD44-10 Margreiter, Markus MP18-19 Margulis, Vitaly MP2-06, MP2-09, MP2-12, MP7-01, MP7-09, MP11-14, MP63-20, PD35-05, PD35-11, p10, p270 Mariados, Neil MP78-11 Marien, Arnaud PD34-05 Marien, Tracy MP28-17, MP80-08, PD13-07 Marik, Irina MP3-16 Marinho, Lucas MP21-09 Marinkovic, Serge MP89-12, PD28-10 Mariño, Angela Marcela MP25-16 Marko, Darlene PD20-09 Marks, Leonard FRI-01, MP11-05, MP27-15, MP60-11, PD30-01, p72, p174 Marks, Phillip PD22-12 Marks, Sheldon p9, p153 Markt, Sarah MP77-19 Marmar, Joel p10 Marotte, Jeffrey PD37-06 Marotz, Clarisse MP66-01 Marples, Brian MP20-17 Marquinez, Jeff V4-07, V4-08 Marra, Giancarlo MP71-05, MP77-03 Marroig, Bruno MP28-07 Marrugo, Carlos V4-12 Marshall, Lynn MP71-17 Marshall, Stephen FRI-13 Marshall, Susan PD32-01, PD32-05 Marson, Francesco PD24-06 Marten-Mittag, Birgit MP83-14 Martin Morales, Antonio MP42-07 Martin, Darryl T. MP49-10 Martin, Jacob PD21-03 Martin, Niels MP9-15 Martín, Oscar V8-12 Martin, Sue Ellen MP37-19 Martinez Acevedo, Ann PD44-02 Martinez Piñeiro, Luis PD29-04 Martinez, Daniel MP23-11, PD26-02, PD26-04, PD40-07 Martinez-Marin, Dalia MP66-04 Martínez-Piñeiro, Luis PD16-08 Martínez-Salamanca, Eduardo MP52-04 Martínez-Salamanca, Juan I. MP18-19, MP44-17, MP52-04, PI-07 Martinho, Olga MP31-16 Martinovic, Tamara MP52-15 Martins Lopes, Nathalia MP18-10 Martins, Fransisco PD14-10 Martins, Tatiana MP86-09 Martirosian, Petros MP11-19 Martorana, Giuseppe MP66-20 Martov, Alexey MP26-04, V8-07, V Martul, Dario MP44-17 Martyn-Hemphill, Clarissa MP16-06 Maruccia, Serena MP77-08 Maruo, Shinichiro MP83-09 Maruyama, Satoru MP45-01, MP58-18, V11-06 Maruyama, Tetsuji PD36-12 Masago, Toshihiko MP35-08, MP44-05 Masedu, Francesco PD17-02 Mashni, Joseph PD47-08 Masiach, Alon MP17-04 Mason, James FRII-05, PD4-03 Mason, R. Carrington PD26-01 Masoud, Amr MP48-10 Masoumi, Ahmad MP19-04 Mass, Alon MP63-06, MP63-10, MP70-16, MP70-17, MP70-18, PD37-11, MP44-17, PI-07 Massanyi, Eric MP22-08 Massidda, Davide MP67-20 Massman III, John PD28-05 Massman, John D. PD28-06 Masson-Lecomte, Alexandra MP55-09, MP57-02 Massoud, Walid MP13-19 Master, Viraj MP16-12, MP35-14, MP44-08, MP44-17, MP47-15, PD35-05, PI-07, p85, p199 Masterson, James H. V3-04 Masterson, Timothy MP10-08, MP10-17, MP65-14, PD35-05, p12, p134, p253 Mastroianni, Riccardo MP59-12, PD3-06, PD29-10, PD49-09, V4-14, V12-07 Mastukawa, Yoshihisa MP19-17 Masuda, Hitoshi MP26-10 Masuda, Koichi MP61-14 Masumori, Naoya MP79-16, p215 Mathieu, Romain MP3-19, MP13-13, MP13-18, MP57-02, MP57-12, MP63-16, PD49-02, V9-06 Mathieu, Roumiguie PD1-04 Mathur, Vinita MP6-04, MP77-20, PD38-03 Matin, Surena MP2-15, MP84-18, p11 Matlaga, Brian R. PD13-01, p13, p220 Matloob, Rayan MP56-02, MP63-04 Matrana, Marc MP47-18 Matrana, Mark MP68-15 Matsubara, Akio MP22-17, MP36-17, MP49-09, MP52-02, MP69-19, PD35-03 Matsuda, Fumihiko MP60-02 Matsuda, Tadashi p86 Matsugasumi, Toru MP63-12, MP63-15, MP86-04 Matsui, Hiroki MP20-18 Matsui, Hotaka MP52-05, PD36-04 Matsui, Tsuyoshi MP86-05 Matsui, Yoshiyuki MP5-03, MP60-02, PD23-04 Matsui, Zenichi MP54-04 Matsukawa, Yoshihisa MP20-05, MP71-20 Matsumoto, Akihiko MP58-02 Matsumoto, Edward MP57-20, MP80-12 Matsumoto, Kazuhiro PD17-03, PD17-08 Matsumoto, Ryuji MP45-01, MP58-18 Matsumoto, Seiji MP31-11, MP59-05, MP89-16, PD16-11

331 Matsumoto-Miyai, Kazumasa MP8-19 Matsumura, Nagahide MP7-16, MP19-01 Matsunaga, Shinji MP76-07, PD36-11 Matsuo, Kazuna MP71-20 Matsuo, Shigeki MP87-07 Matsuo, Tomohiro MP49-02, MP55-03 Matsuoka, Yoh MP2-18, MP11-12, MP65-04, PD3-08, PD15-02, PD32-02 Matsushita, Kazuhito PD26-11 Matsushita, Ryosuke MP36-08, MP36-13 Matsuta, Yosuke MP8-17 Matsuya, Hidekazu MP8-01, PD7-01 Matsuyama, Hideyasu MP7-02, MP46-15, PD36-10 Matsuzaki, Kyosuke MP47-01 Mattimore, John FRII-07 Matulay, Justin PD9-10, PD29-01, PD30-04 Matulewicz, Richard MP41-19, MP64-06, PD8-06, PD25-11, PD48-05 Matusik, Robert MP49-01, MP66-14 Matveev, Vsevolod MP73-20, p221 Matzkin, Haim PD13-10, PD23-03 Maurer, Tobias MP82-10, PD32-06, PD32-07 Maurice, Matthew MP57-06, PD29-07 Mavrikos, Stamatios MP60-18 Mavuduru, Ravimohan MP43-20 Mawji, Nasrin R. MP66-07 Maxwell, Adam PD42-02 Maxwell, Bryan MP67-10 May, Danica MP51-08 May, Florian MP88-09 May, Matthias MP58-13, MP58-16, MP58-20 May, Michael MP53-16 May, Stuart PD38-08 Mayer, Tina MP72-10 Mayhew, Greg MP44-01 Maymi, Patricia MP77-07 Mazur, Daniel J. MP25-06, PI-03 Mazure, Hubert PII-LBA3 Mazza, Osvaldo p176 Mazzola, Clarisse MP78-08, MP83-13, PD33-01, PD45-07 Mazzon, Giorgio PD40-12 McAdams, Sean V6-09 McAlister, Vivian MP79-13 McAnally, Kyle MP32-05, MP83-19, MP84-12 McAninch, Jack MP15-03, MP18-04, PI-01, MP88-17, PD26-05, p221 Mcarthur, Robert MP63-18, MP70-20 McCabe, John MP23-16 McCallum, Stewart MP31-03 McCammon, Kurt MP14-02, MP29-03, MP29-13, p9, p20, p117, p235 McCann, Leena PII-LBA8 McCants, Alden PD7-08 McCaslin, Ian MP48-07 McClay, Ed MP82-09 McClung, Christopher PD14-08 McClure, Timothy MP57-19 McConkey, David MP72-06, PI-06, p19 McCormarck, Michael MP59-19, MP72-01 McCormick, Benjamin MP28-17 McCoslin, Ian R. MP43-09 McCraw, Casey FRI-06, FRI-18, FRII-13 McCue, Peter PD4-09 McCulloch, Charles MP15-03, PD26-05 McCullough, Andrew PII-LBA7, PD37-09, p11, p55, p56, p153 McDaniel, Andrew MP68-20 McDougal, W. Scott MP26-12 McDougall, Elspeth MP38-06, PD19-02, PD19-03, PD19-04, PD19-05, p18, p117 McDowell, Zachary MP25-03, MP28-06 McElroy, Andrew MP63-13 McGettigan, John PII-LBA6 McGill, Alice MP42-18, MP62-03 McGinley, Kathleen PD34-07 McGovern, Francis MP26-12, MP50-08, MP50-09, MP62-14, MP83-11 McGowan, Tracy MP73-12, MP87-18, MP87-19 McGrath, John S. MP65-06, PD41-05 McGrath, Jonathan MP72-15 McGuinness, Luke MP41-13 McGuire, Barry MP41-19, PD25-11 McGuire, Michael MP14-18, PD47-11 McIlhenny, Craig MP22-09, MP23-05 McIntosh, Andrew MP67-14 McIntosh, Leslie PD51-07 McKee, Chad MP55-12 McKenna, Patrick MP16-16, p9, p117 McKenney, Jesse MP1-17, MP6-13 McKenzie, Patrick V3-05 McKibben, Max MP16-16 McKiernan, James MP1-09, MP4-15, MP14-03, MP24-19, MP26-11, MP26-13, MP32-07, PD17-09, PII- LBA2, MP44-17, MP45-05, MP50-01, PD29-01, PD30-04, MP63-01, MP64-07, MP64-15, MP72-09, PI-07, MP84-14, p12 McLane, John A. MP73-16 McLane, Michael PD48-04 McLaughlin, Mary Ann MP51-04 McLaughlin, Patrick MP38-06 McLellan, Dawn p17 McLeod, David MP37-17, MP61-10, MP61-16, MP61-20, MP66-06, MP66-12 McMahon, Chris G. PD48-07, p56 McMann, Leah MP9-16 McMeekin, Faith MP62-06 McNaught, Jamie PD7-06 McVary, Kevin MP4-20, PD5-01, PD5-03, MP9-06, MP16-04, MP27-06, MP32-09, PII-LBA1, PD26-03, PD39-01, PD39-12, MP71-03, p17, p44, p59, p174, p234 Meacham, Randall PD7-03, p18 Mearini, Ettore MP62-02 Mearini, Luigi MP81-18 Mechlin, Clay PD37-09 Medeiros, Paulo V5-01 Medel, Alfonso MP12-13 Mederos, Michael MP51-01, PD37-01 Mediavilla, Enrique V10-03, V10-12 Medina, Luis V4-12, V8-12 Medwig, Taylor MP77-19 Mee, Sharron PD50-07 Meehan, Richard PD33-06 Meeks, Joshua MP10-13 Mega, Anthony MP14-17, MP82-09 Mehedint, Diana MP Mehnert, Ulrich MP12-06, MP12-11, MP12-20, PD1-10 Mehra, Rohit MP1-14, MP48-17, MP56-12, MP68-20, PD43-12, PD44-07 Mehrazin, Reza MP51-07, MP67-07, MP85-10 Mehta, Akanksha MP24-11 Mehta, Komal MP77-05, MP89-06 Mehta, Ramila MP33-07 Mehta, Sanjeev MP33-10 Meierhans Ruf, Susan D. PD13-02 Meijer, Richard P. PD31-07, PD31-11 Meinhardt, Matthias PD35-08 Meissner, Matthew PD22-04 Mekel, Gabriel MP15-10 Mekkawy, Ramy MP13-03, PD5-12 Melamed, Jonathan MP36-19, MP56-01, MP77-14, PD32-01, PD32-03, PD34-02 Mele, Fabrizio MP53-10, MP77-11 Mellis, Adam PD9-05 Mellon, Matthew MP3-15, MP29-11, MP29-12, MP65-14, PD3-09 Melloni, Guglielmo MP53-07, PD32-08 Melman, Arnold MP8-13 Melnik, Yaroslav MP43-10 Melquist, Jonathon MP64-20 Melquist, Jonathan PI-06 Mench, Anna PD4-03 Mendez, Melissa MP14-13, MP59-01, MP62-19, PD4-12, PD51-05 Mendez-Probst, Carlos E. MP25-18 Mendhiratta, Neil MP53-15, MP56-19, MP77-14, MP77-17, MP77-18, MP86-03, PD4-11, PD32-01, PD32-03, PD32-05, PD34-02 Mendiola, Frederick MP23-01 Mendonça, Gustavo MP22-16 Mendoza Rodriguez, Maria Angelica MP58-07 Mendoza, Jonathan MP60-07 Mendoza, Maria Angelica PD31-12 Mendoza-Valdes, Arturo p136 Mendrinos, Savvas MP86-02 Meneguete, Vinicius MP30-16 Meng, Ke MP5-05 Meng, Max MP68-18 Meng, Maxwell MP5-01, MP24-08, MP79-02, MP86-10, PD12-11, PD41-10 Meng, Xiaosong MP53-15, MP77-14, MP77-17, MP77-18, MP86-03, PD4-11, PD32-01, PD32-03, PD32-05, PD34-02 Menges, Craig MP47-04 Menhadji, Ashleigh PD19-02, PD19-03, PD19-04, PD19-05 Menkov, Margaret MP75-16, PD25-09 Menon, Mani MP4-14, MP9-08, MP9-14, MP24-06, MP24-20, MP32-08, MP46-20, MP53-13, MP54-07, MP59-03, MP60-01, MP62-01, MP63-17, MP64-13, MP65-19, MP67-05, MP67-09, MP73-11, MP73-19, MP77-10, MP77-12, MP77-13, MP78-01, MP78-19, MP79-04, MP79-14, MP82-07, MP82-16, MP82-1, p71, p72, p254 Menon, Vani MP40-12 Meraney, Anoop MP48-06 Mercado, Miguel PD19-08 Merino, Maria MP17-13, MP48-04,

332 MP82-19, MP82-20, PD4-10, PD30-02, PD38-05 Merlo, Franco MP57-13 Merrill, Megan PD35-11 Merseburger, Axel MP26-04, PD29-12, V8-08 Mertens, Laura MP65-06, MP72-15, PD31-07, PD31-11, PD41-05 Merville, Pierre MP85-17 Meskawi, Malek MP13-16, MP59-08, PD31-13, PD49-03, PD49-05 Messing, Edward MP49-07, MP49-18, MP65-17, MP68-01, MP68-13, MP68-14, p149 Metcalfe, Charles MP15-20, MP59-12, MP63-05, MP83-12, PD9-07, PD34-05, V12-11 Metcalfe, Peter D. PD51-11, p17 Mete, Uttam PD4-02 Metelo, Ana PI-09 Metro, Michael MP15-05, p20 Metsinis, Marios MP48-09 Metwalli, Adam MP70-10, MP87-11 Metzler, Ian MP17-05 Meyer, Alexa MP4-15, MP45-05, MP64-15, MP72-09, PD29-01 Meyer, Anne-Marie MP5-05, MP24-02 Meyer, Charles PD44-12 Meyer, Christian MP32-08, MP64-13, MP67-05, MP67-09, MP70-09, MP73-19, MP77-10, MP77-12, MP78-05, MP82-05, MP83-06, PD30-12, PD31-06 Meyer-Siegler, Katherine L. MP21-17 Meyyappan, Ramasamy Chettiar p72 Mian, Badar p136 Miao, Edna MP28-15, PD42-07 Micas, Daniel Seron MP79-07 Micco, Maura MP2-13 Michael, Berger MP64-02 Michalopoulos, Steven N. MP1-06 Michaud, Jason MP20-01 Michelakis, Evangelos PD33-11 Michele, Gallucci PD29-10, V12-07 Michels, Lars MP12-06, MP12-20, PD1-10 Michl, Uwe MP42-07, MP78-17, MP78-20, MP83-05, MP83-07, MP83-16, PD30-07 Mielnik, Anna MP76-09, MP76-20 Miest, Tanner MP88-16, PD2-10 Mikami, Jotaro MP58-05, MP69-07 Mikami, Shuji MP7-10, MP49-03, PD17-03 Mikhalyuk, Andrew MP45-20 Miki, Tsuneharu MP55-07, p136 Mikropoulos, Christos MP86-11 Milam, Douglas MP15-12, MP29-17, PD2-07, PD2-12, PD11-04, PD14-05 Milam, Laurel PD11-04 Miles, Brian PD19-08, PD31-04, V8-14 Milhouse, Olufenwa PD27-08 Millan Rodriguez, Felix PD13-05 Millard, Frederick MP69-14, PD35-12 Miller, Daniel L. MP33-16 Miller, David MP1-14, MP5-20, MP9-17, MP9-18, MP16-08, MP26-02, MP32-02, MP42-05, MP42-08, MP48-17, MP56-12, MP78-10, PD12-02, PD19-06, PD30-05, PD38-06, PD38-13, PD43-12, PD44-11, PD44-12, p13, p18, p107 Miller, Jeremy PD7-12 Miller, Kennon p13, p71 Miller, Kurt MP14-19, MP87-18, PD5-08, PD5-10 Miller, Nicole MP28-17, MP80-08, PD13-01, PD13-07, p13, p170 Miller, Roy MP42-11 Miller, Zachary PD4-12 Millis, Sherri MP47-20 Mills, Ian PD20-01 Milose, Jaclyn MP15-01, MP88-13, PD21-09 Milowsky, Matthew PD17-06 Milrose, Jaclyn PD48-05 Mimata, Hiromitsu MP21-05, PD16-04 Min, Andrew MP1-19 Min, Gyeong Eun MP25-01 Min, Kweon Sik MP13-09, MP25-04 Minami, Keita MP58-18 Minami, Koichiro MP7-02 Minas, Tsion MP66-15 Miner, Martin PD37-08, PD39-02, p10, p13, p175, p221, p235 Minervini, Andrea MP44-04, MP63-03 Mingin, Gerald MP40-14 Minhas, Suks MP43-13, PD2-01, PD48-08, PD52-03, PD52-05 Minhas, Sukhbinder p10, p190 Minner, Sarah MP55-08, MP58-10 Minor, Andrew MP11-04, MP33-01 Miocinovic, Ranko MP42-11, MP86-20, p73 Mir, Carmen MP44-17, PI-07 Mir, Maria MP63-14, MP65-06, MP72-07, MP72-15, PD41-05 Miranda, Eduardo MP43-17, PD37-12, PD45-07 Miranda, Gus MP5-06, MP27-10, MP58-15, MP67-13, MP72-14, MP86-17, PD9-01, PD9-06, PD9-07, PD23-09, PD31-04 Mirone, Vincenzo MP62-04, MP67-20, MP78-13, MP83-08, p236 Mirza, Moben MP64-20, PD11-03, PD38-02, V4-10 Mirzazadeh, Majid MP3-09, MP22-13, MP30-17, PD3-11, PD50-04, p254 Mischinger, Johannes MP1-16, PD41-11 Mishra, Kirtishri p18 Mishra, Shashikant MP3-03 Mishra, Vinita MP41-13 Misrai, Vincent MP13-14, MP13-17 Mistretta, Alessandro MP6-07 Mita, Koji MP69-19, PD35-03 Mitchell, Christopher MP28-17 Mitchell, Michael E. V7-04, p17, p31 Mitchell, Sarah A. V10-06 Mitchem, April Le MP34-17 Mithal, Prabhakar PD32-10 Mitobe, Yoko MP46-16 Mitra, Anirban P. PD31-10, PD41-08, PD41-09 Mitsui, Takahiko MP85-12 Mitsui, Yozo MP11-06, MP39-16, MP47-11 Mitsunari, Kensuke MP49-02, MP55-03 Mitsuzuka, Koji MP56-15, MP Mittal, Amisha MP34-14 Mittal, Sameer MP16-02, MP41-18 Mitterberger, Michael MP57-03, V11-01 Mittra, Erik p255 Miura, Katsuyuki MP27-02 Miura, Masatomo MP69-16, MP85-13 Miura, Noriyoshi PD4-07 Miyagawa, Masao PD4-07 Miyagawa, Yasushi MP8-19, MP71-16, MP76-18 Miyajima, Akira MP2-08, MP7-10, MP35-20, MP49-03, PD17-03, PD17-08 Miyajima, Naoto MP45-01, MP58-18, V11-06 Miyake, Hideaki MP10-14, MP17-17, MP37-13, MP39-06, MP39-07, MP39-08, MP39-20, MP56-09, MP57-08, MP64-01, MP69-10, MP76-11, PD8-10, PD18-03, PD31-02, PD35-02 Miyake, Makito MP68-03 Miyamoto, Hiroshi MP7-14, MP45-04, MP49-15, MP49-16, MP58-01, MP61-18, MP68-13, MP73-07 Miyamoto, Tatsuya V7-12 Miyashiro, Yoshimichi MP31-07, MP55-16 Miyata, Yasuyoshi MP49-02, MP55-03 Miyauchi, Yuki PD4-07 Miyazaki, Akira MP17-17, MP39-06, MP39-20, PD31-02 Miyazaki, Jun MP49-14 Miyazaki, Mozomu MP8-12 Miyazaki, Yasumasa MP7-10 Miyazato, Minoru MP73-18 Miyazawa, Yoshiyuki MP39-11, MP74-14 Miyoshi, Yasuhide MP45-04 Mizoguchi, Shinsuke PD16-04 Mizuno, Hideki MP19-17, MP20-05 Mizuno, Kentaro PD36-12 Mizuno, Ryuichi MP35-20, MP54-04, PD17-03 Mlynarczyk, Carrie PI-07 Mmdouh, Ahmed MP28-04 Mmeje, Chinedu MP65-05 Mo, Lan MP45-19 Moalli, Pam p73 Moazami, Saman MP34-10 Moch, Holger MP68-08 Mochida, Junichi MP86-05, PD50-03 Mochizuki, Tango MP58-18 Mochizuki, Tsutomu MP21-13 Mochtar, Chaidir MP84-04 Mock, Stephen MP15-12, MP29-17, MP89-13, PD11-04, PD14-05 Modak, Asmita MP23-06 Modh, Rishi FRII-05, PD4-03 Modi, Parth MP47-05, MP53-04, MP53-16, PD18-12, PD35-09 Modi, Shrey MP55-13 Modiano, Manuel MP82-09 Modlin, Charles p175 Mogami, Tohru MP55-04 Mohamed, Ahmed MP61-10, PD44-08 Mohamed, Mahmoud V2-11, V2-14 Mohamed, Nihal MP72-18 Mohammad, Hoda MP21-18 Mohammed, Aza MP60-20, MP86-15 Mohan, Ruchika MP20-10, PII-LBA8 Mohcine, Azli MP28-12

333 Mohler, James MP1-05, MP4-07, p234 Mohommadi, Ehsan MP81-01 Moinzadeh, Alireza MP61-07 Mokhless, Ibrahim p234 Moldwin, Robert PD20-11, p67 Molina, Wilson MP18-10, MP18-14 Moline, Wilson p220 Moll, Friedrich FRI-02 Mollapour, Mehdi MP39-02 Mollengarten, Daniel MP80-05 Møller, Henrik MP1-08, MP1-10 Mombet, Annick MP42-17, MP48-16, MP62-08 Momesso, Adrian p176 Momozono, Hiroyuki MP17-17 Monahan, Kelly MP42-18, MP62-03 Monastyrskaya, Katia MP31-01 Monette, Sebastien PD33-03 Monga, Manoj MP11-03, MP33-10, MP41-12, MP41-15, MP75-11, MP80-17, PD8-05, PD13-01, PD42-06, PD42-09, PD42-11, PD51-09, p11 Mongoue-Tchokote, Solange MP38-13 Monkemuller, Klaus MP34-17 Monn, Francesca MP3-15, MP58-11, MP63-11, MP64-17, MP65-14, PD3-09, PD15-05 Monroe, Cyrus PD4-03 Monsour, Christopher MP33-11 Montague, Drogo p9 Montaño, Benjamin MP25-18 Montes, Melania MP6-01 Montgiat-Artus, Pierre PD11-09 Montgomery, Bruce MP68-11, MP87-18 Montgomery, Jeffrey MP1-14, MP26-02, MP48-17, MP56-12, MP58-06, MP65-06, MP72-15, PD31-03, PD41-05, PD43-12, PD44-12, V8-09 Montgomery, Zachary MP9-18, MP32-02 Montie, James MP5-19, MP5-20, MP42-05, MP42-08, MP78-10, PD12-02, PD19-06, PD30-05, PD38-06, PD38-13, PD43-12, PD44-11 Montiel, Ricardo V6-08 Montironi, Rodolfo MP66-20 Montori, Victor MP42-19 Montorsi, Francesco MP2-09, MP3-01, MP4-10, MP4-14, MP4-16, MP7-19, MP19-16, MP19-18, MP24-06, MP34-20, MP44-04, MP44-17, MP48-13, MP51-17, MP51-18, MP52-07, PD29-12, PD30-03, PD30-08, MP56-02, MP56-03, MP56-05, MP56-10, MP56-16, MP56-18, PD32-09, MP62-01, MP62-04, PD38-12, MP62-05, MP63-03, MP63-04, PD38-12, MP72-04, MP72-14, MP73-05, MP74-20, PD49-03, PD49-05, PI-07, MP76-05, MP76-15, MP78-01, MP78-13, MP78-15, MP82-01, MP82-02, MP82-03, MP82-07, MP82-16, MP82-17, MP83-08, MP83-17, MP87-13, MP87-14, PD52-06, PD52-10, p11, p59 Montroy, Joshua PD44-09 Montserrat, Josep M. MP50-18 Monzo Gardiner, Juan Ignacio PD29-04 Monzo, Juan I. MP42-17 Moon, Daniel MP59-15, V4-04, p173 Moon, Du Geon MP89-05 Moon, Hyun Joon MP74-04 Moon, Ki Hak MP3-13 Moon, Kyung Hyun MP78-02 Moon, Timothy MP20-09 Moon, Young Tae MP89-05 Mooney, James V5-13 Mooney, Rachael MP49-17, MP61-03 Moore, Aaron MP4-20, MP70-08 Moore, Blake MP28-06, V4-13 Moore, Brad MP16-17 Moore, Courtenay PD27-04, p43 Moore, Katelynn MP40-02 Moore, Malcolm MP10-10 Moore, Ron MP84-08 Moparty, Krishnarao MP48-07 Mor, Yoram MP30-09, MP78-06, PD23-03 Moraes, Bianca MP85-18 Morais, Carlos L. MP1-17, MP6-13 Morais, Christudas MP47-18 Morales, Blanca PD18-01 Morales, Edwin E. MP64-05 Morales Jr., Marcelino MP60-07 Moran, Brian J. PD32-11 Moran, Michael FRI-17 Moran, Shamus MP30-08 Morash, Christopher MP68-19, PD44-09, PD47-12 Morash, Robin PD47-12 Moreau, Karine MP85-17 Moreira, Daniel MP1-13, MP24-07, MP30-13, MP42-02, MP44-14, MP56-14, MP60-09, MP60-14, MP67-02, MP69-05, MP70-03, PD6-01, PD39-11, PD49-12 Moreno, Jorge MP30-13 Moreno, José LP MP44-17 Moreno, Vanessa MP17-13 Moret, Ravan MP47-18 Morey, Allen MP15-01, MP88-13, MP88-15, PD21-09, PD22-04, PD26-01, PD48-05, PD48-09, V8-13, p10, p20, p55, p61, p173 Morgan, Monica MP41-14, MP57-10, MP80-05, MP84-13, PD13-12 Morgan, Todd MP1-14, MP11-09, MP48-17, MP56-12, MP65-06, MP65-09, MP72-15, MP78-10, PD31-03, PD41-05, PD43-12, PD44-12, V8-09, p13 Morgans, Alicia MP27-11 Morgentaler, Abraham p9, p236 Morgia, Giuseppe MP26-16, MP71-08, MP71-12, PD10-03, p236 Morhardt, Duncan R. V6-12 Mori, Kazuyuki MP58-05 Mori, Kenichi PD16-04, PD20-05 Mori, Ken-Ichi MP21-05 Mori, Ryan PD14-10 Morimoto, Ryo PD3-02 Morimoto, Shinji MP7-15, PD17-07 Morinaga, Shingo PD47-04 Morishita, Hideo MP31-07 Morita, Ken MP85-12 Morita, Satoshi MP45-04 Morita, Shinya MP35-20, PD17-03 Moritoki, Yoshinobu PD36-12 Moritz, Rudolf MP Moriya, Kimihiko MP85-12 Moriyama, Masatoshi MP45-04 Moriyama, Shingo MP2-18, PD17-07 Morizane, Shuichi MP35-08, MP44-05 Morote Robles, Juan PD41-04 Morote, Juan MP6-01, MP13-06, MP48-12, MP60-05, MP73-01 Morozumi, Makoto MP2-04, PD23-06 Morrell, Christopher MP86-08 Morris, Michael MP44-01, MP82-04, MP87-12 Morris, Patricia MP76-14 Morris, Stephen MP62-13 Morrison, Christopher PI-03 Morrissey, Colm MP55-14, MP61-19, MP66-15 Morrisson, Griffin MP50-10 Morsi, Ahmed p234 Morsy, Ahmed MP85-14 Mortezavi, Ashkan MP21-19, MP66-05, MP66-19, PD8-01 Mosbah, Ahmed MP27-01, MP30-06, MP67-01, PD5-12, PD41-07 Moschini, Marco MP26-18, MP26-19, MP56-16, MP72-04, MP72-14, MP82-02, MP82-14, MP83-17, PD32-09, PD41-02, PD43-04, PD43-08 Moseley, William PD5-01 Moses, Daniel MP60-04, MP83-02, PD46-08 Moses, Kelvin MP5-15, MP9-10 Moses, Rachel MP4-18, MP75-16, PD25-09, PD43-10 Mosesso, Kara MP51-09 Mosharafa, Ashraf MP38-12 Moskowitz, Dena MP59-13 Mosley, Natalie MP23-06 Mosquera, Juan Miguel MP17-12, PD46-02 Moss, Sue MP86-11 Mossanen, Mathew MP58-14 Mota, Paulo MP31-16 Motamedinia, Piruz MP30-08, MP38-05, MP80-13, V8-07 Motley, Saundra PD39-04 Mottrie, Alex MP22-05, MP23-02, MP59-15 Mottrie, Alexander MP67-19 Mottrie, Alexandre p12 Motzer, Robert MP10-01, MP10-05, MP10-12, MP10-13, MP10-19, MP35-01, MP47-09 Moul, Judd MP14-13, p13 Mouraviev, Vladimir MP1-19 Mourtzinos, Arthur p66 Moussa, Ayman S. MP48-10, MP60-17, PD38-04, PD38-10 Moustafa, Ahmed PD36-05 Movassaghi, Kamran MP58-15, MP68-12 Mowery, Hayley MP30-10 Moyad, Mark p10 Moynagh, Michael MP35-18, MP35-19 Mozer, Pierre MP2-07, MP7-06, MP7-12 Mrsic, Edvin MP69-02 Mucci, Lorelei MP6-15, MP77-19, PD6-07 Muck, Tanja MP27-14 Mucksavage, Phillip PD23-12, V10-14 Mueller, Alex MP18-19 Mueller, Dana MP78-14

334 Mueller, Elizabeth p84 Mueller, Georgia MP9-06, MP51-16, MP74-06, PD39-05 Mueller, Thomas p73 Mufarrij, Patrick p280 Mugo, Elizabeth PD7-08 Muhitch, Jason MP47-16, PD33-10 Muir, Gordon PD5-08, PD5-10 Mukai, Shigeto PD8-08 Mukherjee, Elina MP40-04 Mukhtar, Bashir PD27-09 Mukhtar, Hasan MP26-01 Mulcahy, John p55 Muldong, Michelle MP61-14 Mulhall, John MP14-09, MP43-07, MP43-18, MP51-03, MP51-05, MP51-09, MP74-18, MP78-03, PD2-02, PD26-09, PD26-11, PD37-12, PD40-02, PD40-11, PD45-07, PD48-01, PD48-06, p11, p18, p55, p58, p220, p221 Mullen, Brendan PD52-02 Müller, Georg MP3-20 Müller, Matthias PD22-12 Müller, Stefan C. MP58-16, MP68-07 Müller-Wolf, Maya PD46-10 Mullins, Chris MP27-04 Multigner, Luc MP61-02 Munari, Enrico MP72-08 Munarriz, Ricardo PD26-02, PD26-04, p56, p117 Mundle, Suneel MP73-12 Mundy, Anthony MP29-06, MP29-07, MP29-08, PD14-03, PD14-11, PI-01, PD22-01, PD22-06 Munegato, Stefania MP53-07, PD32-08 Mungillo, Michael MP35-12 Munoz Del Rio, Alejandro PD4-08 Munoz, Alvaro MP21-20 Munver, Ravi MP13-14, MP50-17, PD42-08, p71, p111 Muracca Yoshinaga, Eduardo MP3-12, MP71-18 Murad, Hakm PD15-10 Murad, Mohammad PD31-01 Murai, Tetsuo MP45-04 Murakumo, Masahi MP58-18 Muramatsu, Hiroyuki PD47-04 Muraoka, Kuniyasu MP76-07, PD36-11 Murata, Yasutaka MP86-05, PD50-03 Murekeyisoni, Christine MP4-07 Muroi, Ayumi MP87-06, PD46-01 Murphy, Adam MP53-14, MP71-01 Murphy, Declan V4-04, p9, p173 Murphy, Devan MP55-20 Murphy, Gregory MP23-04 Murray, Katie MP7-07, MP7-17, MP50-16, MP63-08, PD11-03, PD33-03, PD47-08, V3-11 Mursi, Khaled MP36-06, MP85-14 Murta, Claudio MP30-16, MP30-19, MP75-03, PD23-08 Murtola, Teemu MP4-02, PD6-02, PD6-09 Murugan, Paari MP36-12 Musch, Michael V10-02 Muschter, Rolf PD5-08, PD5-10 Muslumanoglu, Ahmet MP33-19 Muslumanoglu, Ahmet Yaser MP26-06, MP28-20 Musquera, Mireia MP50-18 Musser, John MP10-13, MP10-19, MP50-11, MP50-16, PD47-08 Mussi, Thais MP86-09 Mustapha, Lounici MP28-12 Muteliefu, Gulinuer MP33-04 Muto, Gian Luca MP48-18 Muto, Giovanni MP48-18, PD49-08 Muto, Satoru MP26-07, PD16-02, PD37-07 Myer, Edward MP33-14 Myers, Jeremy MP15-09, MP15-17, PD11-02, PD11-06, PD11-08, PD14-06, PD14-08, PD39-09, p20, p175 Myers, Stacie MP5-20 Myklak, Kristene MP28-15, MP30-01, MP30-10, MP38-04, MP63-02, MP81-08, PD15-09, PD42-07 Mynderse, Lance PII-LBA1 Myung, Soon Chul MP89-05 N Na, Yong Gil MP31-14 Naaraayan, Ashutossh MP50-20 Nabbout, Phillipe MP65-12, PD17-04 Naber, Kurt p12 Nabi, Ghulam MP41-07 Nachaegari, Satish PD37-08 Nadeau, Brandon PD51-01 Nadhan, Kumar V5-13 Nadiminty, Nagalakshmi MP46-02, MP46-03 Nadler, Robert MP41-19, PD25-11, p11 Nadu, Andrei PD17-12 Nafie, Shady MP48-14 Nagahama, Katsushi PD17-07 Nagahara, Akira MP47-01 Nagai, Atsushi MP11-18, PD24-04 Nagai, Takeshi MP45-06 Nagamatsu, Hideki MP2-04, PD23-06 Nagamatsu, Hirotaka PD35-03 Nagami, Taichi MP11-06 Naganathan, Vasi PD39-08 Nagano, Kenichi V11-11 Nagao, Kazuhiro MP7-02 Nagao, Toshitaka PD41-06 Nagaraj, Shalini MP15-20 Nagase, Keiko MP12-04 Nagase, Yasushi MP58-02 Nagashima, Yoji MP45-04 Nagata, Maki MP87-06 Nagaya, Naoya PD37-07 Nagaya, Teruo MP34-15 Nagele, Udo MP26-04 Nagler, Harris FRII-10, MP70-13, p44 Nagoda, Elizabeth MP26-15 Nahas, William MP3-12, MP8-07, MP21-10, MP31-17, MP43-17, MP71-18, MP85-18, PD5-04, PD23-08, PD43-06 Naiki, Taku PD17-05, MP34-02, MP46-12, MP55-04 Nair, Achuth MP68-17 Nair, Balagopal T. MP69-11 Nair, Rajesh MP63-18, MP70-05, MP70-20 Naito, Mikihik MP66-14 Naito, Seiji MP37-12, MP39-17, MP46-11, MP49-13, MP66-02, MP69-19, p174 Najafi, Zahra PD Najari, Bobby MP56-20, MP74-11, MP76-19, PD2-02, PD26-09 Nakada, Stephen Y. MP11-02, MP27-07, MP34-01, MP35-17, MP44-16, PD51-06, p11, p18, p101, p137 Nakada, Steven MP30-13 Nakagama, Hitoshi MP36-04 Nakagami, Yoshihiro MP44-18, MP62-20, MP87-02 Nakagawa, Haruo MP2-19 Nakagawa, Ken MP2-14 Nakagawa, Masayuki MP36-08, MP36-13, MP46-17, PD23-07, PD33-05, p210 Nakagawa, Takayuki MP12-03 Nakagawa, Tohru MP20-18, MP58-02 Nakagawa, Toru PD3-05 Nakagomi, Hiroshi MP21-04, MP21-16 Nakaigawa, Noboru MP58-01 Nakamoto, Dean MP84-15 Nakamura, Kogenta PD47-04 Nakamura, Kumiko MP21-01, MP31-02 Nakamura, Leah Y. MP11-17 Nakamura, Shigenobu MP11-06 Nakamura, Terukazu MP55-07 Nakamura, Tetsuya MP74-14 Nakamura, Toshiya MP36-03 Nakane, Akihiro MP62-10, PD36-12 Nakanishi, Yasukazu MP11-11, MP69-20, PD3-08 Nakano, Elcio MP3-12, MP71-18 Nakano, Mayura MP11-08, MP17-16 Nakashima, Jun MP44-18, MP62-20, MP87-02, PD41-06 Nakata, Wataru MP47-01 Nakayama, Koichi MP19-17 Nakayama, Shouko MP75-19 Nakayama, Takayuki PD32-02 Nalagatla, Sarath Krishna MP75-13, MP80-04 Naliboff, Bruce MP27-04 Nallamothu, Brahmajee K. MP5-19 Nam, Deok Hyun MP20-11 Nam, Robert MP14-08 Namekawa, Takeshi PD3-10, PD46-01 Namima, Takashige MP2-19 Nance, Michael MP18-17 Nandanan, Naveen MP20-13 Nangia, Ajay FRII-12, MP24-11, MP51-08, p221 Nanus, David MP46-10 Naoki, Komine MP85-13 Napodano, Giorgio MP57-18 Nara, Taketoshi MP83-10 Narayanan, Ramkishen MP86-13 Nardone, Ricardo p176 Narita, Mitsuhiro V11-05 Narita, Shintaro MP39-10, MP46-16, MP56-15, MP69-03, MP69-16, MP73-18, MP83-10, MP85-04, MP85-13, MP87-07, PD33-04 Narod, Steven MP14-08 Narus, Joseph MP43-18, MP51-05, PD37-12, PD45-07 Nascimento, Fernanda A. M. MP52-20, MP76-13 Nash, S. Russell MP48-02 Nassar, Georges p58 Nasseri, Ryan PD38-09 Nataraj, Srilakshmi MP66-01

335 Natarajan, Shyam MP11-05, MP60-11, PD30-01 Nathan, Senthil MP43-13 Nativ, Ofer PD23-03 Naumann, Carsten Maik MP82-06 Navai, Neema MP26-14, MP65-05 Nawaf, Cayce B. MP17-08, MP49-10 Naya, Yoshio MP55-07 Naya, Yukio MP46-17 Nayak, Jasmir MP24-18, MP27-08, MP58-14, MP84-08 Nayan, Madhur MP10-10 Nayyar, Rishi MP80-15 Ndoye, Medina p235 Neal Jr., Durwood E. FRI-18, MP9-10, p67 Neal, Durwood FRII-13 Neckers, Len MP39-02 Neckers, Leonard M. MP49-20 Neeman, Ziv MP17-04 Negoro, Hiromitsu MP12-19 Negron, Edris MP53-04 Nehikhare, Osayuki MP71-05, MP74-07 Nehra, Ajay MP80-20, MP85-05, p12, p20, p59, p117, p234 Nehra, Avinash PD38-02 Neifert, Heather MP60-17 Neijber, Anders MP73-03 Neisius, Andreas MP20-14, MP28-09 Nelius, Thomas MP66-04 Nelson, Christian MP43-07, MP43-18, MP51-03, MP51-09, MP74-18, PD34-12, PD40-02, PD48-01, p56 Nelson, Dwight PD7-06 Nelson, Joel p180 Nelson, John MP47-18, MP68-15 Nelson, Peter MP66-15, PD34-03 Nelson, Pierre MP89-07, MP89-15 Nelson, William MP4-02 Nemade, Hemant FRI-10 Nemut, Tijen PD2-03 Nepple, Kenneth MP26-20, MP39-18 Nervo, Nicolás V5-06, V5-07 Nesbitt, Michael PD47-10 Ness, Timothy PD7-06 Netsch, Christopher MP13-10, MP13-11, MP13-12, V3-12, V3-13 Nettey, Oluwarotimi MP5-18 Netto, George MP1-11, MP7-14, MP47-19, MP49-15, MP53-17, MP58-07, MP61-11, MP72-08, PD31-12 Neveu, Bertrand MP61-13 Neville, Thomas MP86-08 Nevo, Amihay MP41-16 Newcomb, Lisa F. PD34-03 Newman, Diane PD24-09 Newmark, Jay MP6-04 Newton, Mark MP30-13 Newton, Toby MP16-06 Nezu, Kunihisa MP87-10 Ng, Casey p182 Ng, C. F. p70 Ng, Foo Cheong MP30-12 Ng, Kok Kit MP30-12 Nguyen, Daniel MP6-02, MP16-02, MP24-06, MP36-14, MP38-03, MP38-09, MP50-18, MP65-03, MP72-03, MP83-04, MP84-06, PD29-03 Nguyen, Hao PI-07 Nguyen, Holly MP55-20, MP66-15 Nguyen, Nicholas PD7-04 Nguyen, Paul MP60-01, MP63-17, MP73-11, MP77-12, PD30-12 Ni, Kai MP76-01, MP76-02 Ni, Quanhong PD1-01 Ni, Shenghua PD23-11 Ni, Xiao PII-LBA6, PD39-02, PD39-12 Nichele, Sandro V3-10, V11-10 Nichols, Craig MP10-15, MP24-04 Nicholson, Marilin PD40-06, V4-05 Nicholson, Tristan MP31-19 Nicita, Giulio p236 Nickel, J. Curtis PD20-01, p100, p170 Nickens, Kristen P. MP66-12 Nickerson, Edward V9-11 Nicol, David p173 Nicolai, Nicola MP10-11 Nicolas, Brichart MP13-15, PD5-09 Nicolas, Marlo MP65-08 NIDDK Urologic Diseases in America Project PD1-09, PD10-12 Nieboer, Daan MP86-18, PD46-03 Nieder, Alan PD2-08, p246 Niederberger, Craig MP76-17, p12, p117 Niedzwiecki, Douglas MP32-10 Nieh, Peter MP35-14, MP44-08, MP78-11 Nielsen, Matthew MP5-05, MP16-16, MP24-02, MP58-19, MP78-14, p118, p235 Niemann, Claus p234 Niemierko, Andrzej MP26-12, MP62-14 Niero, Mauro MP67-20, PD9-03 Nightingale, Kathryn PD4-12 Nigro, Mark MP20-06, PD1-06 Nihei, Naoki MP87-06, PD46-01 Niimi, Kazuhiro MP33-15, MP34-05, MP41-03 Nikolaou, Konstantin MP11-19 Nikolavsky, Dimitriy PD22-02, V3-02, V12-12 Nilsson, Per PD6-10 Nimeh, Tony V2-12, V12-13 Nini, Alessandro MP4-16, MP56-05, MP78-13, MP82-03 Nishikawa, Genya PD47-04 Nishikawa, Masatomo MP10-14, MP39-08, PD31-02 Nishikawa, Rika MP36-08, MP36-13, MP37-07, MP46-17, PD33-05 Nishimura, Kenichi PD4-07 Nishio, Hidenori PD36-12 Nishio, Koujiro MP76-04 Nishiyama, Hiroyuki MP49-14 Nishiyama, Tsutomu MP31-07, MP55-16 Nishizawa, Satoshi MP19-01 Nison, Laurent MP7-05, MP7-06, PD29-12 Nitta, Takashi MP39-11 Nitti, Victor MP81-07, PD1-01, PD50-09, PI-04, p12, p21, p84, p221 Nixon, Andrew MP44-01 Nnodi, Paul PD46-11 Noblett, Karen PD27-07 Nocon, Aline PII-LBA3 Noda, Terutaka PD4-07 Noerholm, Mikkel PII-LBA2 Noguchi, Masanori MP Nogueira, Leticia MP18-10, MP18-14 Nogueras-Gonzalez, Graciela MP65-05 Noguez, Jaime H. MP47-15 Noh, Choong Hee MP56-11, MP82-11 Nolazco, Alejandro p176 Noldus, Joachim MP32-08, MP67-05, MP67-09, PD47-09 Noma, Takahisa MP8-12 Nomi, Masashi PD8-08 Nomiya, Masanori MP8-12, MP8-14, MP12-17 Nonomura, Norio MP7-14, MP8-19, MP47-01, MP71-16, MP76-18, PD35-10 Noon, Aidan MP67-16, MP68-04, MP68-05 Noonan, Haley PI-09 Norden, Sam MP31-09 Nordling, Jorgen p13 Norian, Lyse A. MP39-18 Nork, Justin PD15-08 Noro, Akira PD17-07 North, Amanda V7-02 North, Bernard MP1-10 North, Scott MP65-06, MP72-15, PD41-05 Nose, Yorito MP58-02 Nottingham, Charles MP4-12 Nottle, Tim MP31-09 Nouhaud, François Xavier MP63-12, MP63-15 Noureldin, Yasser MP30-13, PD51-03 Nouri, Mannan MP37-01 Novakovic, Kristian MP1-20, PD38-07, PD47-11 Novara, Giacomo MP2-12, MP22-05, MP23-02, MP44-17, MP59-15, PD29-12, PI-07 Novotny, Vladimir MP58-03, MP58-20 Nowier, Amr p234 Noyes, Sabrina MP44-02, MP44-19 Nseyo, Unwanaobong FRI-01, MP74-01 Ntanios, Fady PD27-06 Nugent, James MP38-06 Nuhn, Philipp MP58-16 Numahata, Kenji MP2-19, MP60-15, MP87-10 Numakura, Kazuyuki MP69-03, MP69-16, MP85-13 Numao, Noboru MP2-18, MP11-12, MP65-04, PD3-08, PD15-02, PD32-02 Nunes, Marco A. PD5-04 Nunes-Silva, Igor PD3-04 Nuñez Bragayrac, Luciano PD29-04 Nuñez, Luciano V4-12 Nuñez, Rafael PD5-11 Nunez-Nateras, Rafael MP71-15 Nunney, Ian MP13-04 Nutt, Max MP4-20, MP70-08 Nwofor, Alexander M. E. p235 Nyame, Yaw MP71-01, V8-10 Nyarangi-Dix, Joanne MP88-10 Nyirady, Peter MP78-12, p101 O Oates, Robert p9, p153 Obaje, Alice PD35-08 Obata, Jun MP35-20 Oberlin, Daniel MP15-01, MP74-05, MP88-13, PD8-06, PD21-09, PD25-11,

336 PD48-05, PI-03 Oberneder, Ralf MP62-18 Obi, Anselm PD46-11 Obinata, Daisuke MP86-05, PD50-03 Obrien, Jeanne MP51-11 O Brien, Keith MP51-03, MP51-05 O Brien, Tim MP57-07, MP70-05, PD49-01 O Callaghan, Christopher MP73-04 Occhino, John PD50-10 Ochiai, Masako MP36-04 Ochoa, Andrea MP72-06 Ock, Jiyeon MP52-03, MP52-08 Ockrim, Jeremy MP81-14, PD27-09 O Connell, Kathleen PD24-10 O Connor, Robert PD1-07 O Day, Ken MP73-13 Odem-Davis, Katherine MP10-15, MP11-09, MP24-04, MP42-13, PD28-05 Oderda, Marco MP53-07, MP77-03, PD32-08 Odisho, Anobel MP5-01, MP18-04, MP24-08, MP79-02, PD4-06, PD12-11 Odom, Brian PD50-12 O Donnell, Kelly MP44-02, MP44-19 O Donnell, Michael MP26-20 O Donnell, Peter MP68-11 Oefelein, Michael PD37-02 Oelke, Matthias p190 Oestreicher, Nina MP73-13 Offermann, Anne MP68-07 Offit, Kenneth MP6-16 Ogan, Kenneth MP16-12, MP30-14, MP35-14, MP44-08, MP47-15, MP79-03, PD17-06, PD19-12 Ogawa, Kouhei MP11-06 Ogawa, Osamu MP5-03, MP12-19, MP60-02, PD23-04 Ogawa, Seishi PD3-05 Ogawa, Yoshihiro PD3-08 Ogihara, Koichiro PD17-08 Ogle, Christina MP88-16, PD28-12 O Grady, Thomas MP9-09 Oh, Cheol Kyu MP13-09 Oh, Jin Gyu MP31-12 Oh, Jin Hyu MP3-17 Oh, Jong Jin MP37-08, MP42-16, MP56-11, MP77-06, MP82-11 Oh, Seung June PD20-10 Oh, Seung-June MP13-07, MP52-14, PD16-10 Oh, Su Jung MP37-14 Oh, Tae Hoon MP33-05, MP34-18 Ohashi, Toshio MP83-09 Ohba, Kojiro MP49-02, MP55-03 Ohdan, Hideki MP22-17 Ohl, Dana FRII-14, MP51-02, p201 Ohlmann, Carsten PD3-01 Ohlmann, Carsten-Henning PD35-08 Ohmann, Erin PD50-09 Ohno, Tomoya MP21-07 Ohno, Yoshio MP44-18, MP62-20, MP87-02, PD41-06 Ohori, Makoto MP44-18, MP62-20, PD41-06 Ohtani, Mikinobu MP49-14 Ohyama, Chikara MP16-13, MP36-03, MP56-15, MP58-05, MP65-07, MP69-07, MP73-09, MP73-18, MP87-07, PD16-05, PD49-07 Oikawa, Masaaki MP16-13 Oishi, Masakatsu MP55-07 Ojha, Rani MP45-13 Oka, Shintaro PD36-10 Okada, Atsushi MP33-13, MP33-15, MP33-18, MP34-02, MP34-05, MP34-11, MP34-13, MP34-15, MP38-08, MP41-03, MP41-06, MP80-18 Okada, Hiroki MP8-01, MP12-12, PD7-01, PD20-05 Okada, Hiroshi MP76-04 Okada, Keisuke MP76-14 Okada, Yasunori MP7-10 Okada, Yohei MP2-04, PD23-06 Okafor, Henry V3-02, V12-12 Okamoto, Koji MP36-04 Okamoto, Teppei MP16-13 Okamura, Takehiko MP62-10 Okeke, Zeph MP3-06, MP30-08, MP30-13, MP80-13, V3-12, V3-13, V8-07 Okhunov, Zhamshid MP7-18, MP22-14, MP30-13, MP70-03, MP75-02, MP80-16, PD7-04, PD13-04, PD41-07, PD51-01, V3-06, p221 Okihara, Koji MP55-07 Okoro, Chinonyerem MP17-13 Okrongly, David MP6-04 Okuda, Hidenobu MP76-18 Okuda, Naoko MP38-08 Okuno, Scott PD49-12 Okuno, Tetsuo PD17-07 Okur, Asli MP82-10 Okwara, James MP24-20 Olaitan, Oyedolamu MP85-05 Olapade-Olaopa, E. Oluwabunmi p235 Oldendorf, Ann MP89-02 Olgin, Gaudencio MP30-01, PD21-03 Oliveira, André MP31-17 Oliveira, Andre Matos MP8-07, MP21-10 Oliveira, Daniel V5-01 Oliveira, Mario V5-07 Oliveira, Raquel MP8-20 Olivier, Fabien MP62-08 Olkhov-Mitsel, Ekaterina MP6-14, MP61-01, MP68-04, MP68-06, PD46-07 Ollandini, Giangiacomo PD40-12 O Loughlin, Michael MP48-06 Olson, Nick PI-09 Olsson, Carl PD44-03, p18 Oltra, Elisa MP19-07 Olugbade Jr., Kola MP65-09 Olumi, Aria MP31-15, PI-02, MP62-14, MP66-13 Olvera-Posada, Daniel MP30-20, PD51-01 Olweny, Ephrem PD4-04 Omae, Kenji MP2-17, MP57-17, MP69-09, MP69-17 O Mahony, Fiach PD33-06 O Malley, Kiaran MP86-12 O Malley, Martin MP10-10 O Malley, Padraic MP6-02, MP44-17, MP83-04 O Malley, Padraic MP65-03, MP72-03 Omar, Mohamed MP11-03, MP41-12, MP75-11, MP80-17, PD Omil-Lima, Danly PD52-11 O Neil, Brock PD12-03, PD12-06, PII- LBA5 O Neil, Daniel PD12-09 O Neill, Amanda MP6-20, MP61-19 O Neill, Vince PII-LBA2 Ong, Christopher MP39-17, MP49-13, MP66-02 Onishi, Takehisa MP35-15 Ono, Kunio MP87-10 Onol, Fikret Fatih V2-04, V12-04 Onol, Sinasi Yavuz V2-04, V12-04 Oo, Htoo MP49-13 Ookubo, Teppei MP87-10 Opara, Emmanuel MP8-03 Ordon, Michael MP22-07 Ordorica, Raul p20 Orikasa, Kazuhiko MP2-19, MP73-18, MP87-07 Orman, Jean MP27-05 Ornan, Afshan MP16-07 Orom, Heather MP5-15, PD34-12 Orosco, Ryan MP21-03 Ortenberg, Joseph p177 Ortiz, Jorge MP9-19, MP85-01 Ortiz, Valdemar MP71-19, PD39-07 Osborn, David PD11-04 Osborne, David MP73-16 Osbun, Nathan PD2-10 Oschwald, Dayna MP47-09 Osei Amponsa, Vasty MP68-10 O Shaughnessy, Matthew PD33-03 Oshinoya, Yukinosuke V11-11 Oshiro, Hisashi MP45-06 Osman, Yasser MP30-05, MP30-15, MP67-01, PD17-10 Osmonov, Daniar MP17-15, MP82-06 Osorio, Clarice MP55-02 Osorio, Miguel MP30-17 Ost, Michael MP40-11, MP54-18 Osther, Palle PD13-05 Ostravnaya, Irina MP35-03 Ostroff, Jamie MP64-03 Ostrov, Lauren MP40-03, MP40-05, MP40-12 Ostrovnaya, Irina MP7-13, MP44-07 Ostrovsky, Israel MP16-14 Ostrowski, Kevin MP74-03 O Sullivan, David MP33-14 Osunkoya, Adeboye MP16-17 Ota, Shozo MP2-19 Otelly, Linda MP25-17 Othman, Mahmoud MP30-06 Otsetov, Aleksander MP31-15, PI-02, MP66-13 Otsuki, Takeya MP8-01, PD7-01 Ott, Peter PD42-03 Ottaviani, Diego MP16-06 Otto, Vivianne MP68-09 Ou, Yen-Chuan MP53-16 Ou, Yin-Chien PD39-03 Oudard, Stephane MP73-10 Ouyang, Jiangyong PD7-12 Overholser, Stephen PD21-10 Owen-Smith, Jason MP5-19 Oya, Mototsugu MP2-08, MP2-14, MP7-10, MP35-20, MP49-03, MP54-04, PD17-03, PD17-08 Oyama, Nobuyuki MP12-04

337 Ozawa, Hideo Ozayar, Asim Ozcelik, Hilmi Ozen, Haluk Ozgor, Faruk Ozkan, Harun Ozkan, Levend P MP11-18, PD24-04 MP57-10, MP75-15, MP84-13 MP61-01 MP42-20, MP48-11 MP28-20 PD2-06 PD2-03 Pace, Kenneth MP22-07, MP30-11, MP75-04, PD13-08, p137 Pacha, Tarek p73 Pacik, Dalibor MP86-01 Paciotti, Marco MP4-10, MP51-17, MP51-18, MP74-20, MP76-05, PD52-06, PD52-10 Packiam, Vignesh T. MP29-10 Packy, Lisa-Maria FRI-16 Padmanabhan, Priya MP89-13, PD28-11, p84, p267 Paduch, Darius MP76-09, MP76-19, MP76-20, PD2-02, PD26-09, PD45-08 Paerli, Michael MP65-01 Pagano, Matthew MP43-02, MP43-16, PD48-02, PD48-11 Page, Elizabeth MP86-11 Page, Stephanie p17 Pagliara, Travis PD11-06, V12-10 Pagliaro, Lance p85, p190 Pahernik, Sascha MP44-17, PD5-08, PD5-10, PI-07 Pähr, Lisa PD32-07 Pahwa, Shivani MP60-04 Pai, A. MP70-20 Paick, Jae-Seung MP13-01, MP13-07 Paick, Sung Hyun MP83-20 Paik, Lynn MP70-01 Pailliart, Anne V10-02 Painter, Mark p135 Pais Jr., Vernon MP75-16, p13, p220 Paivanas, Thomas PII-LBA3 Pak, Jamie MP4-15, MP14-03, MP24-19, MP32-07, MP44-17, MP63-01, MP64-07, MP64-15, MP72-09, MP79-20, PD30-04 Pakzad, Mahreen MP81-14, PD27-09 Pal, Deeksha MP39-19 Pal, Sumanta K. MP65-02 Palacios, José Luis MP12-13 Palapattu, Ganesh MP1-14, MP48-17, MP56-12, PD43-12, PD44-12, p19, p85 Palea, Stefano MP31-03 Palermo, Gianpiero MP74-11, MP76-19, p44 Palese, Michael MP32-19, PD12-12 Palisaar, Rein Jüri PD47-09 Palleschi, Giovanni MP18-20, PD9-12, PD45-11, PD49-08 Palma, Paulo p12, p72, p264 Palmer, Christina MP9-09 Palmer, Drew FRII-04, MP47-10, MP61-07 Palmer, Kenneth V4-07, V4-08 Palmer, Lane MP22-20, MP40-06, MP54-03, p13, p59, p86 Palmeri, Mark PD4-12 Palmerola, Ricardo FRII-06, MP40-06 Palou Redorta, Joan PD29-04 Palou, Joan MP85-06, PD7-10, PD41-03 Palou, Jouan PD17-11 Palou, Juan MP44-17, V5-06, V5-07, V5-09, PI-07, p72 Pan, Chunwu MP55-01 Pan, David V12-14 Pan, Jinhe MP66-07 Pan, Michael PD19-08, PD31-04, V8-14 Pan, Shu MP17-08 Pan, Tiejun p70 Pan, Xiao-Qing PD7-03 Pan, Ying PD25-01 Pan, Yu-Mei V6-07 Pan, Yunqian MP55-01 Panackal, Arun MP11-01 Panagopoulos, Aggelos MP60-18 Panda, Arabind PD22-04 Pandey, Abhishek PD22-11 Pandey, Mitaly MP46-08 Paner, Gladell MP37-18 Panfili, Zachary PD28-11 Pang, Ran MP25-02 Pannek, Juergen MP11-20 Pansadoro, Vito p153 Pantel, Klaus MP58-10 Pantuck, Allan MP6-08, MP47-06, MP47-14, MP57-19, p121 Paonessa, Jessica E. V8-05 Papa, Nathan MP22-01 Papadopoulos, Savvas MP48-09 Papagiannopoulos, Dimitri MP80-20 Pápai, Zsuzsanna MP87-03 Papaioannou, Dimitrios MP48-09 Papaleo, Enrico MP76-15 Papalia, Rocco MP48-18, MP59-12, MP66-20, PD3-06, PD9-08, PD29-10, PD49-08, PD49-09, V4-14, V12-07 Papargiris, Melissa MP31-09 Papotti, Mauro MP53-10, MP77-11 Paprocki, Ronald p219 Paquet, Eric MP1-03 Parada, Ruben PD41-03 Paradis, Alethea PD51-07 Parajuli, Shankar P. PD7-09 Pardhan, Siddika PD33-01 Pareek, Gyan MP14-17, MP57-16, MP75-01 Parekattil, Sijo PD40-03, PD40-04, PD45-09 Parekh, Dipen MP59-15, MP60-06, MP77-20, PD38-03, p96, p174 Parent, Marie-Elise p56 Pareta, Rajesh MP8-03 Parihar, Jaspreet MP53-16, PD27-02 Parikh, Sahil MP72-02 Pariser, Joseph MP2-16, MP14-18, MP18-03, MP29-10, MP65-13, MP65-15, PD15-04, PD18-02, PD26-12, PD47-11, PI-05 Parisi, Daniel MP23-04 Park, Albert PD24-05 Park, Bong Hee MP50-05 Park, Choal Hee PD16-12 Park, Chol Hee MP54-10 Park, Emily MP1-07 Park, Heung Jae MP12-09 Park, Hyoung Keun MP83-20 Park, Jin-Mi MP52-08 Park, Jinsung MP Park, Jong Mok MP31-14 Park, Joon Hyung MP7-04, MP62-17, PD25-05 Park, Ju Hyun MP13-01, MP13-07 Park, Juhyun MP28-01, MP82-08, PD16-10 Park, Junsoo MP19-06 Park, Kwangsung MP20-11, p56 Park, Kwanjin MP54-01, p172 Park, Kyung MP17-12 Park, Kyung Kgi MP51-15 Park, Myungchan MP22-02, MP44-11, MP86-06, PD39-10, PD43-03, PD47-01 Park, Rosa MP7-08 Park, Sahyun PD47-01 Park, Sang Hyun MP13-09 Park, Sang Un MP1-18, MP73-08, PD29-08 Park, Sangtae MP23-18, MP38-01, MP57-01, PD51-08 Park, Sejun MP53-16, PD47-01 Park, Seok San MP13-09 Park, Seung Chol MP33-05, MP34-18, MP61-14 Park, Seunghyun MP37-08 Park, Soo-Hwan MP52-03, MP52-08 Park, Sung Yul PD29-08 Park, Sungchan MP78-02 Park, Sung-Woo MP4-13, MP24-16 Parker, Alexander MP4-11, MP5-14, MP81-01 Parker, Daniel MP67-08 Parker, Justin PD40-07, p55 Parker, Marilyn MP51-05 Parker, William MP61-09, MP64-20, PD11-03, PD28-11 Parkhomenko, Egor MP22-18 Parnes, Howard MP4-02, MP26-01 Parr, Tim p251 Parray, Aijaz MP66-14 Parrillo, Lisa PD23-12 Parsikia, Afshin MP9-19 Parsons, J. Kellogg MP71-17, p115 Partin, Alan MP1-11, MP4-13, PII-LBA2, MP53-02, MP53-04, MP53-17, MP61-11, PD46-09, p246 Pascal, Rischmann PD1-04 Paschoalin, Victor MP51-10 Pasini, Luisa MP26-05, PD41-02 Passoni, Niccolo MP62-19, MP78-15, MP80-05, PD13-12 Passos, Gabriela MP45-07 Pastore, Antonio PD49-08 Pastore, Antonio Luigi MP18-20, PD9-12, PD45-11 Pastuszak, Alexander MP43-05, MP51-06, MP74-02, PD36-01, PD39-06, PD52-01, V3-09, p56 Patard, Jean Jacques MP63-12, MP63-15 Pate, Barbara MP77-16 Patel, Amar MP4-04, MP16-17, MP30-14 Patel, Anup PD16-08 Patel, Ashay PD24-07 Patel, Chintan MP45-05 Patel, Darshan MP76-12, PD11-02, PD11-08, PD39-09 Patel, Deval MP45-09 Patel, Dhruti MP16-10, MP17-03, PD27-05

338 Patel, Hiten MP67-10, MP67-12, MP84-14 Patel, Kalpesh PII-LBA1 Patel, Kinnari MP42-15 Patel, Mahesh PD37-08 Patel, Manish MP57-04, MP65-11, MP77-04 Patel, Neal MP53-16, PD36-06 Patel, Neel MP50-06 Patel, Nishant MP15-02, MP28-09, MP74-01 Patel, Premal MP84-08 Patel, Rutveej PD4-04, PD18-12 Patel, Sanjay MP2-16, MP4-12, MP18-03, MP29-10, MP84-19, PD15-04, PD18-02 Patel, Sheena PD49-01 Patel, Shiv FRII-04, MP45-05, MP47-10, MP61-07 Patel, Sutchin R. FRI-07, p9 Patel, Trushar MP53-11, PD34-06 Patel, Vipul MP83-12, V4-07, V4-08, p12, p101, p137, p230 Paterson, Ryan F. MP38-06, MP75-12 Pathak, Ram MP5-14, MP23-07, MP51-19 Pathiraja, Kumudu MP68-11 Patil, Dattatraya MP4-04, MP16-17, MP35-14, MP44-08, PD46-02, PD46-05, PI-08 Patil, Mukul MP79-05, PD35-06 Patil, Pramod MP22-15 Patni, Lokesh MP22-15, MP22-19 Patriarca, Carlo MP66-20, PD41-02 Patrick, Donald MP27-04, PD14-07 Patrick, Tuliao MP53-16 Pattanaik, Smita MP43-20 Pattaras, John MP30-14, MP35-14, MP44-08, MP47-15 Patterson, Anthony MP51-07 Paul, Elahna MP35-09 Paulin, Roxane PD33-11 Pavan, Nicola MP43-01, PD40-12 Pavlov, Andrey MP17-19 Payne, Christopher p10 Payne, James PD20-08 Pe Benito, Ruth MP56-01 Peabody, James MP4-14, MP9-08, MP22-05, MP23-02, MP42-08, MP53-13, MP59-03, MP62-01, MP64-13, MP65-19, MP77-13, MP78-19, MP79-04, MP82-16, MP82-17, MP87-05, MP87-14, PD13-03, PD19-06, PD30-05, PD30-08, PD38-01, PD38-06 Peak, Taylor PD36-05 Pearce, Shane MP2-16, MP18-03, MP29-10, MP65-13, MP65-15, MP80-10, MP84-04, PD15-04, PD18-02, PI-05 Pearle, Margaret MP41-14, MP75-15, MP80-05, PD13-12, p10, p100, p220 Pecoraro, Angela MP4-10, MP51-17, MP51-18, MP74-20, MP76-05, PD52-06, PD52-10 Pedersen, John MP31-09 Pedrosa, Ivan MP11-14, MP17-11 Pedrosa, Jose MP58-11, MP64-17, MP72-16 Peek, Elizabeth MP45-18 Peffer, Nathan MP84-17 Pehrke, Dirk PD30-10 Pei, Jianming MP47-04 Peine, Sven MP2-10 Peisch, Samuel F. MP77-19 Pelger, Rob MP23-03 Pelhivanov, Nonko MP87-18 Pellegrini, Graziella MP19-15 Pellegrini, Matteo MP45-18 Pellegrini, Piero MP57-13 Pellizzoni, Sandra PD11-11 Pelman, Richard p10 Pena, Eduardo V6-08 Peña, Juan Antonio V5-06, V5-07, V5-09 Peng, Ruo-Shin MP44-03 Peng, Yang MP49-05 Peng, Yifeng V3-08 Peng, Yun PD24-03 Penna, Frank MP20-02, MP54-07 Penniston, Kristina L. MP27-07, MP33-06, MP34-01, MP41-20, PD51-06, p9, p220 Penson, David MP5-07, PD6-05, PD12-03, PD12-06, MP27-11, PD23-11, PII- LBA5, PII-LBA10, p18, p119 Pepe-Cardoso, Augusto J. MP52-04 Peplinski, Brandon MP28-15, PD15-09, PD42-07 Peralta, Donna MP69-01 Percy, Andrew MP32-05, MP83-19, MP84-12 Pereira Sampaio, Marco MP28-07 Perelman, Michael p56 Perera, Marlon MP15-08, MP22-01 Perera, Sumeth MP55-12 Pérez Márquez, Meritxell MP50-18 Perez, Angel PD40-06 Pérez-Fernández, Elia MP13-20, MP58-17 Perez-Losada, Marcos MP20-07, MP20-08 Perini, Rodolfo MP68-11 Perito, Paul PD26-02, PD26-04, PD40-07 Perkins, Colby MP24-15 Perner, Sven MP68-07 Perrela, Rodrigo MP30-16, MP75-03 Perrin, Paul MP4-09 Perrouin-Verbe, Marie-Aimée MP13-13, MP13-18 Perry, Kent MP41-19, PD25-11 Persad, Raj MP62-06, MP73-14, MP73-20 Persson, Bo-Eric MP73-05 Peskoe, Sarah MP4-02 Peters, Justin V4-04 Peters, Kenneth MP88-04, MP89-01, MP89-03, MP89-09, MP89-10, PD27-10, p12 Peterson, Andrew MP25-11, MP88-06, MP88-07, MP88-11, MP88-19, PD22-05, PD24-11, PD24-12, PD26-07, V3-01, p58 Peterson, Randall PI-09 Petkov, Georgi V. PD7-09 Petrenciuc, Oana MP87-12 Petros, Firas V9-11 Petros, John MP4-04, MP47-15 Petrossian, Albert MP55-17 Petrou, Steven MP81-10 Petrovic, Milos PD40-12 Petrovics, Gyorgy MP37-17, MP61-10, MP61-16, MP61-20, MP66-06, MP66-12, p101 Petruzella, Stacey MP Petrylak, Daniel MP82-09, p19, p241 Pettaway, Curtis MP6-08 Pettersson, Andreas MP6-15 Pew, Scott MP88-04 Peyrard, Severine PD35-10 Peyre, Sarah MP23-09, MP23-12, MP23-13 Peyromaure, Michael MP67-04 Peyronnet, Benoit MP7-01, MP38-10, MP57-02, MP57-09, MP57-12, MP63-16, PD1-04, PD49-02, V9-06 Peyton, Charles MP43-03 Pfeffer, Stefan PD18-04 Pfister, Bettina MP66-05 Pfister, Christian MP7-05, MP63-12, MP63-15 Pfister, David MP61-17 Pham, Bryan PD37-05 Pham, Khanh MP10-15, MP11-09, MP42-13 Phé, Véronique MP7-06, MP7-12, PD10-10, PD10-11, PD11-09 Philip, Joe PD8-04 Philip, Sunu MP18-07 Philippe, Marque PD1-04 Philippe, Rouvellat MP85-09 Philippou, Yiannis FRI-03 Phillips, Courtney MP85-10 Phillips, John V5-10, p12 Phillips, Sharon MP27-11, PD12-03 Phillips, Simon MP74-08 Phung, De PII-LBA10 Piana, Angel Martin p176 Piao, Songzhe MP28-01, MP82-08, PD16-10 Picaut, Philippe PD1-03 Picchio, Maria PD38-12 Pichler, Martin MP69-02 Pickhardt, Perry MP11-02, PD4-08 Pickles, Tom PD34-04 Picozzi, Marta MP56-18, MP62-04, MP82-03 Picozzi, Stefano MP77-08 Pidgeon, Connie MP16-06 Pieczonka, Christopher MP78-11 Pienta, Kenneth MP39-13 Pierorazio, Phillip MP35-16, MP39-13, MP47-19, MP50-01, MP67-12, MP84-03, MP84-14, PD29-01 Piert, Morand PD44-12 Pietropaolo, Amelia MP81-18 Pietzak III, Eugene MP10-09, MP42-15, MP58-12, MP72-12, PD43-09 Pignol, Bernadette PD1-03 Pilatz, Adrian MP76-03 Pilbeam, Carol MP45-20 Pink, Desmond PD33-11 Pinkhasov, Ruben FRII-03, MP70-06 Pinski, Jacek MP37-06 Pinthus, Jehonathan MP37-05, MP39-05 Pinto, Flávia Cristina MP8-09 Pinto, Peter MP6-17, MP14-16, MP17-13, MP48-04, MP82-19, MP82-20, PD4-10, PD30-02, PD38-05, PD44-06, p13, p57, p174, p236 Pinto, Rui PD27-12 Pinzani, Alessandro MP57-13 Piotrowski, Joshua MP88-14, MP88-16 Piotrowski, Zachary MP84-17

339 Piotrowski, Zack MP67-08 Piovesan, Affonso MP85-18 Pippi Salle, Joao Luiz p59 Pisano, Francesca PD17-11 Pisano, Jennifer C. MP65-13 Pisansky, Andrew PD10-08 Pisters, Andrew MP67-06 Pisters, Louis L. MP72-02 Pizarro, Javier MP81-09 Pizarro-Berdichevsky, Javier MP8-10 Placer, José MP6-01, MP13-06, MP48-12, MP60-05 Placido, Lucas Regis MP79-07 Planas, Jacques MP6-01, MP13-06, MP48-12, MP60-05 Plante, Mark MP75-02 Plata, Mauricio MP25-16, p72 Platz, Elizabeth MP4-02 Platzek, Ivan MP17-10, MP48-05 Pleass, Henry CC MP85-07 Plimack, Elizabeth MP67-07, MP68-11, PD12-07, PI-10 Ploumidis, Achilles MP7-19 Ploussard, Guillaume MP63-12, MP63-15, p176 Plunkett, Beth MP38-01 Plymate, Stephen MP55-14 Png, Keng Siang PD18-08 Png, Keng-Siang V5-03 Poage, Wendy MP6-06, MP24-10, MP60-08, MP71-11, PD2-04 Poch, Michael MP50-02, MP59-10, MP59-20, PD41-01 Poddar, Arjun MP14-02 Podgorski, Izabela MP14-15 Podlasek, Carol MP52-12, p56, p200 Pohar, Kamal MP65-02 Pohl, Hans MP20-07, MP20-08, MP54-06 Point, Dana V7-13 Pointdexter, John MP41-14 Pokupic, Saša MP67-19 Polackwich, Scott MP25-13 Polascik, Thomas MP14-13, MP59-01, MP62-19, PD4-12, p175 Polland, Allison MP22-18 Pommerville, Peter J. MP42-07 Pompe, Raisa MP37-09, MP55-08 Pomper, Martin p19 Pomwenger, Werner PD42-03 Ponce, Ninez MP32-04 Poniatowski, Lauren MP22-06 Ponsky, Lee MP44-10, MP60-04, MP61-15, MP78-11, PD46-08, p57, p100 Pontari, Michel MP27-04, PD8-09, p89, p100 Pontes Jr., Jose PD43-06 Ponziano, Michelle MP9-13 Poon, Bing Ying MP27-13, MP44-15 Poon, Biny Ying PD32-04 Popelar, Breanna MP73-13 Popert, Richard p12 Popert, Rick MP22-05, MP23-02, MP62-06, MP62-13, MP71-05 Pore, Subrata MP12-14, MP25-07, MP31-13, MP88-01, MP89-20, PD1-11, PD39-04 Porpiglia, Francesco MP3-04, MP53-05, MP53-10, MP59-15, MP63-03, MP77-11, p236 Porres, Daniel MP61-17 Porten, Sima MP26-14, MP68-18, PD41-10, PI-06 Porter, Christopher MP10-15, MP11-09, MP24-04, MP42-13, p48 Porter, James MP57-05, PD15-08, V8-01, p58, p153, p234, p236 Porter, Michael MP67-17, MP72-19, PD46-04, p32 Portillo, Jose Antonio V10-03, V10-12 Posch-Zimmermann, Reinhold MP89-11 Posselt, Kathleen MP58-03 Posta, Linda MP73-13 Postema, Arnoud MP48-03 Postenka, Carl O. PD33-01 Potretzke, Aaron MP20-15, MP30-03, MP80-07, PD18-09, V5-11 Pottel, Hans V4-04 Pottol, Kristy MP27-05 Potts, Bradley MP25-11 Potts, Jeannette p10 Poulakou-Rebelakou, Effie p171 Pouliot, Frederic MP61-13 Pourmand, Gholam-Reza MP78-12 Poushanchi, Behdod MP88-04 Powell, C. Thomas MP21-18 Powell, Christopher MP88-20 Powell, Isaac MP14-15, MP53-19 Powell, Katelyn MP37-02 Powell, Renee MP23-10 Power, Nicholas E. MP63-08, PD33-01 Powers, Mary K. MP29-01 Powsang, Julio MP59-20 Pow-Sang, Julio MP50-02, MP59-10, MP62-19, PD34-06, PD41-01 Poyet, Cédric MP66-05, MP68-08, MP68-09, MP86-07 Prabhu, Vinay PD37-11 Prachand, Vivek N. MP65-15 Pradere, Benjamin MP57-02, MP57-12 Prakash, Mahesh PD4-02 Prandi, Davide MP66-01 Pranikoff, Kevin p190 Prapotnich, Dominique MP42-17, MP48-16, MP62-08 Prasad, Abhaya PD14-04 Prasad, Michaella MP40-13 Prasad, Rajendra MP39-19 Prasanna, Prateek MP60-04 Prat, Ferran PD25-12 Preminger, Glenn MP20-14, MP28-09, MP33-12, PD51-05, V6-01, p10, p44, p219 Prencipe, Maria MP61-19 Presson, Angela MP76-12 Preston, David PD40-08 Preston, Mark MP5-11, MP50-07, MP60-01, MP77-19, MP84-10, p169 Pretzsch, Shanna PD25-12, PI-06 PRIAS-Japan Study Group MP42-09 Price, Aryeh MP37-11 Prince, Joel MP44-16 Princenthal, Robert PD38-08 Prins, Gail MP76-17 Privitera, Salvatore MP26-16, MP71-12, PD10-03 Priyadarshi, Shivam MP43-11 Probst, Kai PD Proietti, Silvia PD10-04, PD13-10 Protzel, Chris MP58-16, p10 Provence, Aaron PD7-09 Pruitt, Jaclyn PD51-08 Pruthi, Nicholas MP16-16 Pruthi, Raj MP5-05, MP16-16, MP24-02, MP44-17, MP58-19, MP78-14, PI-07 Pryor, Michael p58 Psutka, Sarah MP35-18, MP35-19, MP50-10, MP59-20, MP67-02, MP67-11, MP69-12, MP70-11, MP70-12, MP70-14, MP70-15, MP83-11, MP84-11, PD29-06, PD35-07 Pu, Xia MP36-01 Pu, Yeong-Shiau MP2-11 Pucheril, Daniel MP4-14, MP9-14, MP54-07, MP60-01, MP62-01, MP64-13, MP67-09, MP73-11, MP73-19, MP77-10, MP77-12, MP77-13, MP78-19, MP82-16, MP82-17, PD6-12, PD30-08, PD38-01 Pugach, Robert PD16-09 Pugashetti, Neil MP42-03 Puglisi, Marco V5-02 Pujol Galarza, Laia MP79-17 Pulbrock, Marley MP60-04, MP83-02 Pulford, Christopher MP30-13, PD13-04, V3-06 Pummer, Karl MP69-02 Punnen, Sanoj MP60-06, MP77-20, PD38-03 Punwani, Shonit MP83-01 Purifoy, Jody MP77-16 Purohit, Rajveer MP15-10 Purves, J. PD7-08 Purysko, Andrei PD34-01 Pushkar, Dmitry MP17-20, MP81-16, p221 Pycha, Armin MP2-12 Pynn, Craig p175 Q Qi, Jun MP55-01, PD16-01 Qi, Peter MP59-01 Qi, Yanfeng MP6-11, MP66-11 Qiao, Hongjie PD36-03 Qiao, Wei MP26-14 Qin, Chao MP2-05, MP36-15, MP45-11, PD13-06, V11-03 Qin, Danian PD36-03 Qin, Xiaojian MP14-20, MP37-15, MP47-03, MP60-19 Qin, Zike MP10-03 Qu, Weikai MP85-01 Qu, Yuanyuan MP87-20, PD3-07 Qu, Zhao-Kui V6-07 Quackels, Thierry MP9-20, MP27-19 Quallich, Susanne FRII-14 Quanliang, Liu PD21-05 Quaranto, Brian MP35-12 Que, Florencia MP70-12 Queisser, Angela MP68-07 Quek, Marcus MP44-12, MP64-09, MP64-12, PD19-10, p191 Querbes, William MP34-04 Queruel, Vanessa MP85-17 Quinart, Alice MP85-17 Quinn, David MP37-06, MP37-19, PD23-09, PD31-10

340 Quinn, Rachel Quirouet, Adrienne Quiroz, Lieschen R PD22-08 PD1-12, PD27-04, V2-01 p73 R, Abirami MP45-08 Rabah, Benrabah MP28-12 Rabbani, Farhang MP10-04, MP64-18, MP85-08, PD25-07, PD31-08 Rabgang, Tenzin MP66-05 Racine, Ronny MP45-03 Racioppi, Marco MP67-20, PD9-03 Rackley, Raymond PD27-04 Radhakrishnan, Vijay V5-05 Radomski, Sidney PI-04 Radtke, Jan MP53-08, PD46-10 Radzikowska, Elzbieta PD35-10 Raffin, Eric PD25-09 Rafi, Praful MP63-17 Rague, James T. MP44-06, PD49-10 Raheem, Omer MP21-03, MP51-07, MP61-14, MP69-14, MP81-17, PD35-12, PD45-05 Rahman, Mohamed p234 Rai, Bhavan MP28-10 Railkar, Reema MP68-17 Raina, Anvi MP7-03 Rais-Bahrami, Soroush PD44-06 Raita, Cristina PD22-11 Rajaganapathy, Bharathi Raja MP20-17 Rajfer, Jacob p72, p135 Ralph, David PD52-03, p9, p55, p117 Raman Nee Mani, Lata PD17-01 Raman, Jay MP2-06, MP2-09, MP2-12, MP7-01, MP7-08, MP7-09, MP25-20, MP50-03, MP50-04, MP63-20, MP68-10, V3-07, p12, p31, p134 Raman, Lata MP85-15 Raman, Steven MP11-17, MP35-13, MP57-19, MP86-19, PD38-08, PD44-10 Ramart, Patkawat MP11-17, V2-03 Ramasamay, Ranjith MP51-01, MP51-06, MP51-11, MP74-02, MP76-06, PD37-01, PD37-03, PD39-06, PD45-02, PD52-01, PD52-04, V3-09, p254 Ramaswamy, Krishna MP11-04, MP33-01, MP34-06, MP75-07, MP79-02, PD4-06 Rames, Ross MP81-13 Ramesh, D. p72 Ramírez Backhaus, Miguel V4-02 Ramirez, Daniel MP35-07, MP50-15, MP63-13, MP70-02, V4-01, V4-11, V9-05, V9-09, V12-03 Ramirez, Ricardo MP72-20 Ramírez-Troche, Nelson V8-12 Ramon, Jacob MP30-09, MP59-11, PD18-07, PD18-10, V6-03 Ramos, Enrique V10-03, V10-12 Rampersaud, Edward MP59-01 Ramsay, Alison MP75-13, MP80-04 Ran, Renzhong PD37-01 Randazzo, Marco MP86-07 Randich, Alan PD7-06 Rane, Abhay PD44-08, p57, p165 Ranganathan, Gayatri PD39-02 Rangel, Laureano MP6-05, MP56-14, MP78-07, MP88-12 Ranjan, Manish MP15-19 Rankin, Tracy p169 Rannikko, Antti PD34-04 Rao, Niren V11-08 Rao, P.P. p57 Rao, Pravin MP24-11 Rao, Srinivasa MP66-18 Rapaport, Daniel PD1-06 Rapp, David MP28-06 Rashid, Hani MP1-19, MP3-05, MP65-17, p10 Rashid, Prem MP3-02, PD5-01 Rashid, Thomas MP25-15 Raspollini, Maria Rosa MP66-20 Rassweiler, Jens MP26-04, PD18-11, V6-01, p56 Rastinehad, Ardeshir MP11-10, MP17-09, PD4-10, PD44-03, p13, p48, p57 Rathkopf, Dana E. MP87-16, MP87-18 Rathmell, Kimryn MP35-01, p19 Ratti, Dario FRI-11, MP77-08 Ratz, Paul MP12-15, MP12-16 Raup, Valary T. MP18-08, MP18-09, MP29-05, PD11-01, PI-03 Rausch, Steffen PD41-11 Rauscher III, Frank MP47-17, MP61-08 Ravanini, Juliana PD43-06 Ravenell, Joseph MP5-12 Raventós Busquets, Carles Xavier PD41-04 Ravid, Lior PD21-11 Ravindranath, Lakshmi MP37-17, MP61-10, MP66-06, MP66-12 Rawal, Bhupendra MP51-19, MP81-10 Rawal, Sudhir MP59-15 Rawandale, Ashish MP22-15, MP22-19, p94 Rawlings, Tanner PD50-06 Rawson, Lori MP86-08 Rayman, Patricia PD33-08 Raynor, Mathew MP16-16 Raz, Shlomo MP11-17, V2-03, p70, p72, p267 Raza, Syed Johar MP22-11 Raza, Johar MP22-05, MP23-02 Raza, Syed MP22-09 Razmaria, Aria MP70-03 Razvi, Hassan MP30-20, MP34-07, MP40-14, PD51-01, p100 Reale, Giulio MP71-12 Realfonso, Tommaso MP57-18 Rebbeck, Timothy MP6-03 Recabal, Pedro MP53-20 Recker, Franz MP61-01, MP86-07 Reddy, Balaji MP38-18, MP80-02 Reddy, Sandeep MP47-20 Reddy, Thanmaya MP34-17 Reddy, Vijay MP73-12 Redmond, Elaine MP18-12 Redshaw, Jeffrey MP76-12 Reece, Laurie MP79-11, MP79-12 Rees, Michael MP79-11, MP79-12, MP85-01 Rees, Susan MP79-11 Reese, Adam MP53-04, MP60-13 Reese, Jeremy MP12-01, MP12-07 Reese, Sven MP74-17 Reeve, Michael MP6-04, MP77-20, PD Regan, Meredith PI-08 Regelman, Mikhail MP63-20, V3-07 Reges, Ricardo MP21-09 Regge, Daniele MP53-10, MP77-11 Regis, Lucas MP6-01, MP13-06, MP48-12, MP60-05 Rego, Lauren PD8-02 Rehder, Peter MP88-09, p20 Rehrauer, Hubert MP31-01 Reich, Oliver p13 Reichard, Chad MP53-06, MP79-18, MP85-11, PD34-01 Reid, Julia MP1-08, MP1-10 Reifsnyder, Jennifer MP76-09 Reiger-Christ, Kimberly M. MP61-07 Reihsen, Troy MP22-06, MP23-19, V6-04 Reilly, Joseph MP6-17 Reinicke, Annette MP14-19 Reinstatler, Lael FRI-18, MP5-09, MP9-10, PD29-02 Reis, Leonardo MP7-14, MP22-16, MP45-07, MP49-16, MP72-08, p156 Reis, Sabrina T. MP8-07, PD5-04, MP21-10, MP31-17 Reiss, Phillip MP15-15, PD22-12 Reiter, Michael MP8-11 Reiter, Robert PD30-01, PD44-10, p173, p190 Reix, Boris MP63-12, MP63-15 Rekik, Moez MP31-03 Remer, Erick MP63-14 Remzi, Mesut MP2-06, MP2-09, MP2-12, MP7-09, PD29-12 Ren, Danqing p71 Ren, Jian MP8-15 Ren, Qinghu MP7-13 Renard-Penna, Raphaële MP2-07, MP7-12 Rencz, Fanni p101 Rendon, Ricardo MP57-20, MP68-04, MP84-08 Renehan, Peter R. MP32-05 Rensing, Adam MP24-14, MP77-15 Rentrop, Sarah PD8-11 Renzulli, Joseph II MP14-17, MP25-10, MP57-16, p275 Repetto, Gabriela MP68-16 Resnick, Matthew MP5-07, PD12-03, PD12-06, MP27-11, PII-LBA5, MP45-14, MP84-19, p63 Resnick, Neil MP12-10, PD24-10, p17 Retik, Alan p44, p59 Reuter, Victor MP7-13, MP44-07, MP47-14 Reuveni, Hadas MP46-08 Revenig, Louis MP16-12 Reventós, Jaume MP6-01 Reyna, Juan PD34-12 Reynolds, W. Stuart MP15-12, MP29-17, PD11-04, PD14-05 Rezaei, Katayoon MP58-07 Rezk, Bashir PD36-05 Reznicek, Daniel PD6-03 Reznor, Gally MP73-19, PD30-09, PD30-12 Rha, Koon Ho MP1-18, MP53-16, MP73-08, PD29-08, p9 Rhee, Audrey MP54-14 Rhee, Eugene Y. V3-04, p100, p170 Rhodes, Evan PD27-01

341 Riad, Essam MP36-06 Ribeiro, Kleiton MP85-18 Ribeiro-Filho, Leopoldo PD23-08 Riccetto, Cassio p12 Rich, Mark V7-11 Rich, William p251 Richard, Patrick O. MP42-06, MP50-13, MP67-16 Richards, Gideon MP51-20 Richards, Kyle MP20-09, MP67-03, PD8-03, PD23-10 Richards, Michael MP23-09, V9-10 Richardson, Ann MP41-02 Richardson, Stephen MP3-02 Richman, Ashley MP47-18, MP68-15 Richstone, Lee MP3-06, MP18-01, MP59-09, MP70-03, V2-08, p112 Rick, Ferenc p101 Rickard, Mandy MP54-05, V7-01 Ricke, Emily A. MP6-10, MP31-08 Ricke, William MP6-10, MP31-08, MP31-19, p17 Rickey, Leslie p119, p251 Riddell, Jonathan MP40-14, V7-06 Riddick, Antony PD5-08, PD5-10, PD33-06 Riddle, Ryan MP46-19 Rider, Jennifer MP6-15, PD6-07 Ridgeway, Alex MP76-10 Ridgeway, Beri PD50-01 Riechardt, Silke MP15-15, PD22-12 Riedl, Claus PD17-02 Riedl, Markus MP26-04, V8-08 Rieger, Monika PD18-04 Rieger-Christ, Kimberly MP1-19, MP45-02, MP47-10 Rieken, Malte MP3-20, MP63-20, MP78-12 Riera Canals, Lluis MP79-17 Rietbergen, John PD11-07 Riethdorf, Sabine MP58-10 Rietjens, Roma MP21-06, PD7-02 Rigamonti, Waifro PD11-11 Rigatti, Patrizio MP56-16, MP83-08, MP88-05 Rigau, Marina MP6-01 Rigaud, Jérôme MP63-12, MP63-15 Riggin, Andrew MP4-01 Rihai, Xiao MP47-07, PD21-05 Riikonen, Jarno MP42-19 Rindler, Michael PD7-12 Rini, Brian MP44-01 Rink, Michael MP2-10, MP2-12, MP58-10, MP58-13, MP58-20, MP65-09, PD22-12 Rink, Richard MP40-20, MP54-19, p11 Rioux-Leclerq, Nathalie MP2-06, MP7-09 Ripoli, Andrea MP18-20, PD9-12 Risbridger, Gail MP31-09, MP61-04 Rischmann, Pascal MP31-03, MP85-09 Ristau, Benjamin p57 Ritari, Kellie MP35-04 Ritchie, James C. MP47-15 Ritenour, Chad PD19-12, p55 Rittenberg, Daniel PD36-05 Rivera, Marcelino MP29-15, MP29-16, MP33-07, MP88-12, MP88-16, PD12-09 Rivero, Miguel p176 Riveros, Manuel V6-08 Rizzo, Michele MP43-01, PD11-11, PD40-12 Rjepaj, Chris MP7-08, MP25-20, MP50-03, MP50-04 Robain, Gilberte PD11-09 Roberts, Matthew MP15-08, MP22-01 Roberts, Richard MP6-04 Roberts, William p100, p169, p234 Robertson, Cary MP14-13 Robertson, Matthew MP9-15 Robinson, Brian MP16-03, MP17-12 Robinson, David MP4-19, MP42-10, PD6-10 Robinson, Samuel MP55-17 Robinson, Steven PD49-12 Robles, Jennifer A. MP15-07 Robles, Juan Morote MP79-07 Rocchini, Lorenzo MP26-18, MP26-19 Rocco, Bernardo V4-07, V4-08, p12 Roche, S. MP48-12 Rodriguez, Alejandro p221 Rodriguez, Dayron MP5-11, MP26-12, MP50-07, MP50-08, MP50-09 Rodriguez, Edward MP14-01 Rodriguez, Gianna M. PD10-07 Rodriguez, Larissa p12, p49, p73 Rodríguez Faba, Oscar MP85-06, PD7-10, PD29-04, PD41-03, V5-06, V5-07, V5-09, PI-07 Rodriguez-Bigas, Miguel PD40-09 Rodriguez-Vallejo, Jose Maria PII-LBA6 Roehl, Kimberly PD38-07 Roehrborn, Claus PD5-01, MP17-11, PII- LBA1, PD39-02, PD39-11, PD39-12, p9, p10, p17, p44, p72 Roelink, Johannes PD5-08, PD5-10 Roelofs, Anita MP28-08 Roethke, Matthias PD46-10 Rofsky, Neil MP17-11 Rogers, Craig MP4-14, MP53-13, MP59-03, MP59-14, MP59-15, MP62-01, MP63-06, MP63-10, MP70-16, MP70-17, MP70-18, MP82-16, PD30-08, V9-01, V11-02, p230 Rogers, Marc MP12-01, MP12-07 Rogers, Mary PD51-02 Roghmann, Florian PD47-09 Rogier, Julien MP85-17 Rohde, Jay PD13-03 Rohou, Tanguy MP3-19 Roigas, Jan MP58-16 Rollins, Andrew MP17-03 Romana, Marc MP61-02 Romanic, Diana MP22-01 Romero Otero, Javier MP18-19 Romero, Jesús MP73-01 Roobol, Monique MP86-18, PD34-04, PD46-03, PD46-06 Roppolo, James MP8-17, MP8-18, MP12-01, MP12-07 Rosales, Antonio PD41-03 Rosales, Juan Carlos MP30-13 Roscigno, Marco MP2-06, MP2-09, MP7-09 Rose, Carl MP41-05 Roseman, J. Tyler MP12-16 Rosen, Jared MP Rosen, Raymond PD39-02, PD39-12, PD48-07 Rosenbaum, Clemens MP15-15, PD22-12 Rosenbaum, Eli MP32-17, PD17-12 Rosenberg, Jonathan MP7-13, MP11-16, MP36-12, MP64-02, MP72-20 Rosenberg, Matt p235 Rosenblum, Nirit MP81-07, PD50-09, p13, p44, p84 Rosenfeld, Michael G. MP46-07 Rosenkrantz, Andrew MP53-15, MP77-14, MP77-17, MP77-18, MP86-03, PD4-11, PD32-01, PD32-03, PD32-05, PD34-02 Rosenstein, Daniel p13 Rosenthal, Seth MP78-11 Rosenwaks, Zev MP74-11 Rosenzweig, Barak MP30-09 Rosenzweig, Stephen PD4-12 Rosner, Inger MP14-05, MP61-16, MP61-20, MP66-06, MP87-11, PD34-08 Rosoff, James S. MP32-11 Ross, Ashley MP1-04, MP1-11, MP1-12, MP6-09, MP53-17, MP55-18, MP61-11, MP66-16 Ross, Lawrence MP24-11 Ross, Michelle MP80-03 Ross, Richard MP1-07 Ross, Simon MP14-06 Rosser, Charles J. PD23-01 Rossi De Vermandois, Jacopo Adolfo PD10-04 Roszhart, David MP27-06 Rotem, Shahar MP54-16 Roth, Beat MP38-03, MP38-09, MP65-01, MP65-16, PD13-02, PI-06 Roth, Christopher V7-14 Roth, David MP40-10, MP79-15 Roth, Joshua MP29-11, MP29-12 Roth, Wilfried PD46-10 Rothberg, Michael MP30-13, MP38-05, MP53-11 Rothmund, Ralf PD18-04 Rothney, Megan MP1-01 Rotker, Katherine MP14-17, PD52-11 Rotker, Nicholas A. FRI-07 Rottmar, Markus MP19-10, MP19-14 Roudnicky, Filip MP68-08, MP68-09 Rouget, Celine MP31-03 Roumeguere, Thierry MP9-20, MP27-19 Roumiguie, Mathieu MP57-02, MP57-09, MP57-12, MP85-09 Roundy, Kirstin M. PD32-11 Rouprêt, Morgan MP2-07, MP2-12, MP7-01, MP7-05, MP7-06, MP7-12, MP57-02, MP57-12, MP63-12, MP63-15, MP63-20, MP78-12, PD10-10, PD10-11, PD11-09, PD29-12 Rourke, Keith MP15-04, MP15-13, MP29-02, PD14-01, PD14-04, p17, p20 Rouscoff, Yohann MP67-04 Rouse, Glen MP81-08 Rouse, Robert V. PD15-07 Rousseau, Michael PII-LBA1 Routh, Jonathan MP40-08, MP40-09, MP54-11, p44 Rovegno, Agustin PD29-04 Rovner, Eric MP81-13, PD1-01, PD7-08, PD7-09, p12, p29, p71

342 Rowe, Courtney K. MP41-11, PD12-10, PD21-02 Rowe, Steven MP35-16 Rowley, Allen V. MP38-06 Roy, Ashoke MP16-06 Roy, Hemant MP1-20 Roy, Somak MP58-04 Roychoudhury, Arindam MP53-11 Rozanec, Jose Juan PD29-04, p176 Rozenberg, Yosi PD21-11 Rozet, Francois MP42-17, MP48-16, MP62-08, PD47-05 Rozet, François MP7-06 Rozis, George PD52-05 Ruan, Ya MP52-09 Rubenstein, Jonathan p13 Rubin, Mark MP6-02, MP17-12, MP66-01, PD46-02, PI-08 Rubinowitz, Ben p18 Rubio Briones, José V4-02 Ruckle, Herbert C. MP30-10, MP63-02, PD15-09 Rudd, JoAnn PII-LBA5 Ruel, Nora MP53-16, MP64-16, MP67-18, MP82-13 Ruffion, Alain MP7-05 Ruggieri Sr., Michael R. MP12-05, p78 Ruiz, Wily G. MP21-04 Ruiz-Cordero, Roberto MP68-02 Rukin, Nick MP28-10 Rukstalis, Daniel PD5-01, p64, p170 Rumoro, Dino MP80-20 Rupp, Niels MP66-19 Rushmer, Timothy J. MP26-08, MP26-09 Rushton, H. Gil MP54-06 Russell, Alan PD27-11 Russell, Christopher MP59-20 Russell, David MP24-13, PD27-06 Russell, Douglas MP84-16 Russo, Andrea MP19-16, MP63-04 Russo, Antonio MP45-10 Russo, Filippo MP53-10, MP77-11 Russo, Giorgio Ivan MP26-16, MP71-08, MP71-12, PD10-03 Russo, Paul MP35-01, MP35-03, MP44-07, MP44-15, MP44-17, MP47-09, MP47-13, MP47-14, MP50-11, MP50-16, MP50-18, MP63-08, MP84-06, PD29-03, PD33-02, PI-07, p154, p254 Ruterbusch, Julie PII-LBA3 Rutledge, Alison V11-13 Rutman, Matthew MP13-14 Rutz, Beata MP31-10 Ruzhynsky, Vladimir PD25-10 Ruzimovsky, Marina p135 Ryan, Andrew MP31-09, V4-04 Ryan, Charles J. MP73-12, MP87-16, MP87-18, MP87-19 Rybak, James MP80-20 Rycyna, Kevin MP15-06, MP41-08, MP54-18 Rydberg, Michael MP57-01 Ryu, Je-Guk MP20-11 Ryu, Ji-Kan MP52-03, MP52-08 S Saad, Fred MP57-20, MP59-16, MP59-18, MP59-19, MP72-01, MP73-10 Saad, Ismail MP79-19 Saarela, Olli MP84-08 Sabanegh, Edmund MP43-15, MP76-16, p12, p44, p153 Sabbagh, Robert MP1-03 Sabetkish, Nastaran MP19-04 Sabetkish, Shabnam MP19-04 Sabia, Michael p9 Sabin, Emma FRII-08 Sabirzyanova, Zukhra MP17-19 Sabnis, Ravindra B. MP3-03, p58 Saccomanni, Mauro MP88-03 Sacurai, Fuminori PD50-03 Sadar, Marianne D. MP61-12, MP66-07 Sadeghi, Sarmad PD23-09 Sadeghi, Zhina PD24-05 Sadeghi-Nejad, Hossein p9, p55, p159 Sadler, Claire MP10-18, MP24-04 Sadowski, Daniel MP9-06, MP43-19 Saenz, Eric V4-12 Safir, Ilan MP16-05, MP16-17, PD19-12 Safwat, Ahmed MP40-01 Sagalovich, Daniel MP87-04 Sagalowsky, Arthur MP2-06, MP2-09, MP7-18, PD35-11, p208 Saglam, Remzi V6-01 Sahai, Arun MP22-09, MP23-05 Sahan, Ahmet MP75-18 Sahin, Cahit MP40-16 Sahin, Selcuk MP38-07 Sahu, Mahua MP10-16 Said, Mohammed PI-03 Saigal, Christopher MP9-01, MP9-05, MP32-01, MP32-04, MP32-10, MP32-14, MP41-10, MP80-03, PD1-09, PD10-12, p82 Saighi, Djillali MP67-04 Saini, Ashish Kumar MP28-05 Saini, Sharanjot MP39-16, MP47-11 Saito, Kazutaka MP2-18, MP11-12, MP58-08, MP65-04, PD3-08, PD15-02, PD15-06, PD17-07, PD32-02, p174 Saito, Kenkichi MP7-02 Saito, Mitsuru MP39-10, MP46-16, MP69-03, MP69-16, MP83-10, MP85-04, MP85-13, PD33-04 Saito, Motoaki MP21-01, MP31-02, MP76-07, PD36-11 Saito, Shiro MP83-09 Saitz, Theodore R. MP26-06 Sajadi, Kamran p9 Sakai, Hideki MP49-02, MP55-03 Sakai, Yasuyuki PD17-07 Sakakura, Takeshi MP33-18 Sakamaki, Kentaro MP45-06 Sakamoto, Hiromi MP36-04 Sakamoto, Kyoko MP25-17 Sakamoto, Shinichi MP37-07, MP46-17, MP87-06, PD3-10, PD46-01, p174 Sakamoto, Yoshiro MP26-07 Sakano, Shigeru MP7-02 Sakar, Saradwata MP86-03 Sakellariou, Christina MP46-18 Sakellariou, Christina Alexandra MP61-05 Sakhaee, Khashayar MP41-14 Sakura, Mizuaki MP26-10 Sakurabayashi, Kei MP54-04 Salabas, Emre PD Salagierski, Marek MP73-20 Salam, Muhammad MP3-11 Salam, M.A. p85 Salami, Simpa MP11-10, MP17-09, MP59-09, PD44-03, PI-08 Salari, Keyan MP31-15 Salas, Evis MP53-20 Salcedo, Maria Teresa MP79-07 Saldana, Carolina MP55-09 Saleem, Mohammad MP66-14 Saleem, Tahir PII-LBA9 Saleemi, Mohamed Asad MP13-04 Salem, Emad MP18-02 Saleme, Bruno PD33-11 Salemi, Souzan MP19-10, MP21-19, MP66-19 Salmasi, Amirali MP53-04, MP53-16, MP72-10, MP72-13, PD36-06 Salomon, Georg MP83-16, MP83-18, PD30-06, PD30-07 Salomon, Laurent MP55-09 Salonia, Andrea MP4-10, MP7-19, MP51-17, MP51-18, MP56-03, MP56-18, MP63-04, MP74-20, MP76-05, MP76-15, MP83-17, PD52-06, PD52-10 Saltzman, Amanda FRI-08, V2-10, V7-14 Saltzman, Gabriel B. MP45-02 Saltzman, W. Mark MP49-10 Saltzstein, Daniel MP26-01, PII-LBA3 Saluja, Ashok MP55-13 Salvador, Carlos MP13-06 Salvi, Matteo MP71-03, MP71-08 Salvini, Eleonora MP81-18 Salzano, Luigi PD49-08 Samad, Sohel MP71-05 Samarakoon, Rohan MP29-04 Samavedi, Srinivas MP83-12, V4-07, V4-08 Samer Fathi, Al-Rawashdah PD29-10 Samiei, Alaleh MP19-05, MP20-02 Samir, Anthony MP50-08, MP50-09 Samir, Boumelit MP28-12 Sammarco, Anne PD27-05 Sammon, Jesse MP4-14, MP9-08, MP9-14, MP24-06, MP24-20, MP32-08, MP54-07, MP59-03, MP60-01, MP62-01, MP64-13, MP65-19, MP67-05, MP67-09, MP73-11, MP73-19, MP77-10, MP77-12, MP77-13, MP78-01, MP78-19, MP79-04, MP82-07, MP82-16, MP82-17, MP87-05, MP87-14, PD6-12, PD30-03 Sampaio, Francisco MP28-07, MP52-20, MP55-02, MP76-13 Samson, Wilner MP33-14 Sancha, Fernando p13 Sanchez Salas, Rafael MP42-17, MP48-16, MP56-10, MP62-08, MP82-01 Sanchez Salas, Rodolfo PD29-04 Sanchez, Alejandro MP5-11, MP26-12, MP50-07, MP50-08 Sanchez, Eliud MP30-17 Sanchez, Emma MP40-03, MP40-05, MP40-12 Sanchez, Luis V6-08 Sánchez, Milagros MP6-01

343 Sanchez-Ortiz, Ricardo MP77-07, MP83-03 Sanchez-Salas, Rafael MP3-04, MP77-03, PD47-05, p221 Sand, Peter PI-04 Sanda, Martin MP4-04, MP6-02, MP83-19, PD46-02, PD46-05, PI-08, p175 Sander, Chris MP35-01, MP47-13 Sandhu, Jaspreet MP14-09, MP78-03, PD9-11, p58, p71, p98 Sandler, Howard p175 Sandlow, Jay MP74-05, MP74-13, p10, p117 Sandri, Marco MP17-05 Sanelli, Pina PD44-03 Sanford, Melissa T. MP54-13 Sanford, Thomas PD26-05, PD41-10 Sanford, Tom MP68-18, MP75-07 Sangalli, Mattia Nicola MP88-05 Sanghvi, Naren V5-12 Sangkum, Premsant MP15-19, MP43-09 Sankin, Alex MP59-02, PD33-02 Sankin, Alexander MP7-07, MP7-17, MP47-09 Sankin, Georgy MP33-12 Sankineni, Sandeep MP17-13, MP48-04, MP82-19, MP82-20, PD4-10, PD38-05 Sanli, Oner p101 Sano, Masayuki MP26-10 Sanseverino, Roberto MP57-18, MP66-20 Sant, Grannum MP1-19, MP6-04, p18, p71 Santaella Torres, Félix PD29-04 Santiago-Lastra, Yahir PD10-12 Santomauro, Michael PD15-08 Santos, Fabiano MP72-05, PD31-05 Santti, Henrikki MP42-19 Santucci, Richard MP3-08, MP15-18, PD14-10, PD40-11, p57, p73, p117 Saouaf, Rola MP53-03 Sapozhnikov, Oleg PD42-02 Sarhan, Ahmed MP29-20, MP62-07, MP81-19 Sari, Utku MP25-12 Sarica, Kemal MP40-16, p101 Sarkar, Fazlul p70, p136 Sarkar, Somita MP16-06 Sarkisian, Alexander MP83-04, PD45-08 Sarkissian, Carl MP41-12 Sarle, Richard PD19-06, PD30-05 Sarma, Aruna MP51-02, MP81-12 Sartor, A. Oliver MP6-11, MP48-07, MP66-03, MP66-10, MP66-11, MP82-09, MP87-12, MP87-17, p11, p174 Sartor, Sissy p153 Sasada, Tetsuro MP2-20 Sasagawa, Isoji MP87-10 Sasaki, Mitsuharu MP60-15 Sasaki, Mituharu MP87-10 Sasaki, Shoichi MP34-05, MP41-06, MP78-04, MP80-18, PD36-12 Sasaki, Takeshi MP35-15 Sassa, Naoto PD29-11 Satake, Naoya MP44-18 Satasivam, Prassannah PD32-04 Satkunasivam, Raj MP14-10, MP15-20, MP59-12, MP63-05, MP83-12, PD9-07, PD34-05, V12-11 Sato, Akinori MP7-11 Sato, Fuminori PD16-04 Sato, Katsuhiko MP86-05, PD50-03 Sato, Nobuyuki MP89-16 Sato, Noriyuki MP19-01 Sato, Ryo MP76-04 Sato, Tomonori MP73-18 Sato, Toshikazu MP58-02 Sato, Yoshikazu MP80-18 Sato, Yusuke PD3-05 Satoh, Fuminori MP21-05 Satoh, Hiroyuki MP54-04 Satoh, Shigeru MP39-10, MP69-03, MP69-16, MP83-10, MP85-04, MP85-13 Satoh, Tendo MP58-05 Satya, Malini PII-LBA8 Saucedo, Josemanuel MP32-14, MP73-17 Saunders, Debbie MP11-15, MP46-13 Saunders, Edward J. MP86-11 Saussine, Christian PD5-08, PD5-10 Sauter, Guido MP37-09, MP55-08, MP83-15, MP83-16 Sauter, Matthias PD35-10 Savage, Stephen MP69-15 Savas, Sevtap MP61-01 Savdie, Richard MP77-01, MP83-02 Savio, Andrea MP68-04, MP68-06 Sawada, Norifumi MP8-14 Sawazaki, Harutake MP7-11 Sawodny, Oliver PD18-04, PD24-01 Saxena, Manvendra MP55-05 Saxton, James p10 Saya, Sibel MP86-11 Sayed, Blayne MP79-03 Sayed, Mohamed MP40-01 Sayegh, Christopher PD9-10 Sayet, Peter MP88-02 Sayre, James MP57-19 Sayyid, Khalid p58 Sazawa, Ataru MP58-18, V11-06 Sboner, Andrea MP17-12, MP66-01 Scales, Charles MP20-14, MP32-04, MP33-12, MP41-10, PD51-05, p19 Scalici Gesolfo, Cristina MP26-18, MP26-19, MP45-10 Scano, Roberta MP4-10, MP51-17, MP74-20, MP76-05, MP76-15, PD52-06, PD52-10 Scarborough, Patrick PD15-08 Scardino, Peter MP1-08, MP1-10, MP37-10, MP53-20, MP78-03, MP82-04, p44, p174 Scarpero, Harriette p12, p84 Scattoni, Vincenzo MP56-02, MP78-13, PD38-12 Schade, George MP39-14, MP72-19, PD46-12, PD47-03 Schadt, Eric p117 Schaefer, Caitlin MP52-18 Schaeffeler, Elke MP58-03 Schaeffer, Anthony MP12-02, MP25-06, PD20-09, V7-04, p76 Schaeffer, Edward MP1-04, MP1-11, MP1-12, MP6-03, MP6-09, MP53-17, MP55-18, MP61-11, MP66-16, PD15-11, PD34-09 Schäfers, Sebastian MP Schaffer, Julia MP52-18 Schaffhausen, Cory PD19-03, PD19-05 Schaive, Chad p221 Schatloff, Oscar PD29-04 Scheffer, Juliano D. V3-10, V11-10 Schellbach, Doreen PD41-11 Schellhammer, Paul MP14-02 Schempp, Bethany MP65-17 Schenk, Jeannette PD39-09 Schenkman, Noah MP20-13 Scher, Howard I. MP82-04, MP87-18, p100, p136 Scherr, Douglas MP6-02, MP16-02, MP36-14, MP44-17, MP56-20, MP65-03, MP72-03, MP83-04, PD46-02, PI-07, PI-08, p11, p101, p212 Scherz, Avigdor PD33-03 Schick, Fritz MP11-19 Schick, Vanessa p56 Schiefer, Danielle MP85-02 Schiff, Stephen MP14-17 Schiffman, Jonas MP83-16, PD30-07 Schiffman, Zvi PD34-12 Schiffmann, Jonas MP59-18, MP78-09, MP78-17, MP83-07, MP83-18, PD30-06, PD31-13, PD49-03 Schillebeeckx, Charlotte PD2-05 Schilling, David MP1-16 Schindele, Daniel MP14-19 Schips, Luigi PD49-08 Schlegel, Peter MP74-11, MP76-09, MP76-20, p9, p44, p153 Schlemmer, Heinz-Peter PD46-10 Schleutker, Johanna PD6-09 Schlichenmeyer, Tyler PD15-01 Schlomer, Bruce MP40-03, MP40-05, MP40-12 Schlomm, Thorsten MP37-09, MP55-08, MP78-20, MP83-07, MP83-15, MP83-16, PD30-07, PD30-10 Schlussel, Richard p168 Schmehl, Jörg MP11-19 Schmid, Marianne MP3-16, MP9-08, MP9-14, MP15-15, MP24-20, MP32-08, MP58-13, MP59-03, MP63-17, MP65-19, MP67-05, MP67-09, MP70-09, MP78-05, PD30-09, PD30-12 Schmid, Thomas PD48-04 Schmidt, Bogdana MP17-05 Schmit, Grant MP35-18, MP35-19, MP70-11 Schmitz, John MP70-11 Schmutz, Rolf MP38-09 Schneck, Francis MP40-11, MP54-18 Schneevoigt, Birte-Swantje MP26-17, PD9-04 Schneider, Alexandre MP63-12, MP63-15 Schneider, Meike PI-09 Schnoeller, Thomas J. MP56-13 Schober, Jared MP63-02 Schoen, Susan MP39-09 Schoenberg, Mark MP64-18, MP72-08, PD17-06, PD25-07, PD31-08, p100 Schomburg, John MP64-14, PD25-06 Schöndorf, Daniel MP65-01 Schoots, Ivo MP86-18 Schostak, Martin MP14-19, MP42-07, PD5-08, PD5-10

344 Schottelius, Margret MP82-10 Schout, Barbara MP23-03 Schrader, Andres J. MP56-13 Schrader, Steve PD52-07 Schraml, Jan MP73-20 Schreiber, David MP77-05 Schrepferman, Christopher p57 Schriefer, Philipp MP78-20 Schröder, Fritz p254 Schubert, Tina MP32-16 Schubert-Fritschle, Gabriele MP62-18 Schuckman, Anne MP5-06, MP67-13, MP86-17, PD9-01, PD23-09, PD31-10, PD41-09, V8-06, p170 Schulam, Peter G. MP17-08, p56 Schuler, Catherine MP12-08 Schulman, Ariel FRII-03, MP70-06 Schulman, Claude MP73-20 Schulmeyer, Max PD47-09 Schulsinger, David FRI-09 Schulster, Michael MP32-16, MP74-11 Schülze, Therese MP63-09 Schumacher, Martin MP67-19 Schuppe, Hans-Christian MP76-03 Schurhamer, Benjamin MP77-16 Schwaab, Thomas MP35-12, MP47-16, MP50-06, MP59-06, MP59-20, PD33-10 Schwab, Constantin PD46-10 Schwab, Matthias MP58-03 Schwahn, Denise J. MP34-01 Schwaiger, Markus MP82-10, PD32-06, PD32-07 Schwartz, Bradley MP70-08, PD19-02, PD19-03, PD19-04, PD19-05, PD42-10, p9 Schwartz, Michael V2-07, p10 Schwartz, Rachel MP44-08 Schwartzmann, Ivan V5-06, V5-07, V5-09 Schwarz, Juliane PD11-05 Schwarz, Rudolf MP78-09, MP82-05 Schweiger, Michal MP37-11 Schwen, Zayed MP12-01, MP12-07 Schwentner, Christian MP1-16, MP67-19, PD41-11 Scoffone, Cesare PD13-05 Scoggin, Tatiana MP66-12 Scorticati, Carlos p176 Scott, Sasinya MP7-13, MP36-12, MP72-20 Scott, Swanson MP71-09 Scovell, Jason MP51-01, MP51-06, MP74-02, MP76-06, PD8-07, PD37-01, PD37-03, PD37-05, PD39-06, PD45-02, PD52-04 Sea, Jason C. V5-12 Seabra, Miguel PD7-12 Seah, Jo-An MP65-06, MP72-15, PD41-05 Seaman, Eric p153 Sebastianelli, Arcangelo MP71-03, MP71-08 Sebe, Philippe MP63-12, MP63-15 Sebo, Thomas MP14-17 Secin, Fernando P. MP42-17, MP62-08, PD29-04, p176 Seckin, Sule PD2-06 Sedrakyan, Art MP81-20 See, William MP49-11, MP49-12 Seftel, Allen MP25-15, p9, p11, p100, p140, p235 Segersten, Ulrika MP45-17 Seguchi, Kenji MP7-11 Seibt, Robert PD18-04 Seideman, Casey MP40-06, MP54-03 Seiler, Roland MP38-03, MP38-09, MP49-09, PD41-08 Seisen, Thomas MP2-07, MP7-05, MP7-06, MP7-12 Seitz, Christian MP78-12 Sejima, Takehiro MP35-08, MP44-05, MP76-07, PD36-11 Seki, Naohiko MP36-08, MP36-13, MP37-07, MP46-17, PD23-07, PD33-05 Sekido, Noritoshi MP8-01, PD7-01 Sekine, Yoshitaka MP39-11 Selekman, Rachel Sharon MP54-09, MP54-12, MP54-13, MP71-13 Selkirk, Christina G. MP86-11 Selman, Steven MP85-01 Selph, J. Patrick MP88-19 Selph, John MP88-07, MP88-11, PD24-11, PD24-12, PD26-07 Selph, John Patrick MP25-11, MP88-06, PD22-05, V3-01 Semaan, Louie MP37-02 Semerci, Bulent p101 Semercioz, Atilla PD36-07 Semerjian, Alice MP6-17 Semins, Michelle MP41-08 Sen, Volkan MP25-08 Senbabaoglu, Yasin MP47-13 Sendogan, Furkan MP25-12 Senel, Tugba MP74-09 Sener, Alp MP79-13, MP85-02, PD33-01 Sengoku, Atsushi PD8-08 Seo, Ho Kyung MP40-17, p172 Seo, Ill Young MP33-05, MP34-18 Seo, Ju Tae PD16-10, PD20-10 Seo, Seong Il MP7-04, MP44-20, MP50-05, MP62-17, PD25-05 Seo, Sung Pil PD51-12 Seo, Won Ik MP13-09, MP25-04 Sequeiros, Tamara MP6-01 Serefoglu, Ege MP18-19, MP26-06, MP30-02, MP33-08, MP43-12, PD36-07, PD48-12 Serey-Eiffel, Sophie MP13-13, MP13-18 Sérgio, Carvalho-Barros PD27-12 Serhan, Ahmed MP63-19 Serino, Alessandro MP4-10, MP51-17, MP51-18, MP74-20, MP76-05, MP76-15, PD52-06, PD52-10 Serni, Sergio MP63-03, MP71-03, MP71-08 Serrano-Olmo, Juan MP83-03 Serretta, Vincenzo MP26-18, MP26-19, MP45-10, MP72-04, PD17-11 Servián, Pol MP13-06, MP48-12, MP60-05 Sesterhenn, Isabell MP1-05, MP37-17, MP61-10, MP61-16, MP61-20, MP66-06, MP66-12 Seth, Abhishek MP79-15, p177 Seth, Amlesh MP28-05, PD16-07 Seth, Jai MP28-18 Setlur, Nisheeta MP32-10 Setodji, Claude MP9-01, MP9-05 Severino, William MP27-06 Sexton, Wade MP50-02, MP59-10, 332 MP59-20, PD41-01 Sfakianos, John MP2-13, MP2-15, MP7-13, MP7-17, MP22-18, MP36-12, MP85-10, MP87-04 Shaaban, Atallah MP67-01, PD23-05 Shabana, Waleed MP28-11, MP41-09, PD16-06 Shabbir, Majed MP74-07 Shabsigh, Ahmad MP29-20, MP62-07, MP63-19, MP81-19, PD18-05 Shabsigh, Ridwan p11, p221, p236 Shadgan, Babak MP20-06 Shafiei, Somayeh MP22-11 Shah, Alpa MP53-13 Shah, Bhavik MP22-08 Shah, Gopitkumar MP49-11, MP49-12 Shah, Jay MP26-14, MP65-05, MP65-06, MP67-06, MP72-02, MP72-15, PD31-09, PD41-05, p11, p85, p123 Shah, Kaushik p58 Shah, Ketul MP29-20, MP81-19, PD50-05 Shah, Neel MP20-07, MP20-08 Shah, Nilay MP44-10, MP56-06, MP69-08, MP84-05, MP84-15, PD44-05 Shah, Ojas PD13-01, p13, p57, p71, p189, p220 Shah, Paras MP59-09, MP70-03, V2-07, V2-08 Shah, Rajal MP86-02 Shah, Ronak MP7-13, MP36-12 Shah, Swar MP10-02, MP23-08, MP23-15, MP86-17, PD9-01, PD23-09 Shahat, Ahmed MP40-01 Shahid, Shahab MP22-09, MP23-05 Shahrour, Khaled MP50-17 Shahrour, Walid MP15-14, PD14-09, PD22-03, V12-01, V12-02 Shahryari, Varahram MP39-16, MP47-11 Shahwan, Mohammed V11-14 Shaikhibrahim, Zaki MP68-07 Shakir, Nabeel MP17-13, MP75-15, MP82-19, PD4-10, PD30-02, PD44-06 Shalaby, Essam MP18-02, MP38-02 Shalhav, Arieh MP2-16, MP29-10, MP70-03, MP84-04, p172, p268 Shamaa, Mostafa p234 Shang, Xuejun p71 Shankar, Eswar MP46-04 Shanmugabavan, Yaalini MP48-15 Shannon, Jackilen MP31-20 Shapiro, Daniel J. MP54-09 Shapiro, Edan MP30-13, MP53-11 Shapiro, Ellen MP20-03, MP21-11, MP33-02 Shapiro, Oleg PD43-05 Shapiro, Rachael MP38-18 Shapiro, Rachel MP80-02 Sharad, Shashwat MP61-10 Sharda, Anand MP47-16 Shariat, Shahrokh MP2-06, MP2-07, MP2-09, MP2-12, MP4-16, MP7-01, MP7-05, MP7-06, MP7-09, MP7-18, MP24-06, MP44-17, MP48-13, MP56-02, MP56-03, MP56-05, MP56-18, MP58-13, MP59-16, MP59-18, MP59-19, MP62-05, MP63-20, MP65-06, MP72-01, MP72-04, MP72-15, MP78-01,

345 MP78-12, MP87-13, PD29-12, PD30-03, PD41-05, PI-07, p11, p224 Shariat, Sharok PD17-11 Shariat, Sharokh MP78-15 Sharif Afshar, Ali Reza PD28-03 Sharif, Mohamed MP22-11 Shariv, Avi MP28-14 Sharlip, Ira p10, p55, p117 Sharma, Arun MP19-03, MP19-11 Sharma, Davendra MP10-16 Sharma, Pranav MP10-11, MP50-02, MP59-10, MP65-06, V11-02 Sharma, Rakesh MP76-16 Sharma, Vidit MP6-05, MP78-07, PD19-01, PD25-11, PD43-04, PD43-08 Sharp, David MP62-07, MP65-08, PD18-05 Sharp, Debbie MP73-14 Shatagopam, Kashyap MP65-14, MP72-16 Shaves, Mark MP14-02 Shavit Grievink, Liat MP32-17, PD17-12 Shayegan, Bobby MP17-14, MP57-20, PD25-10 Shaykhutdinov, Rustem MP47-19 She, Jenna V11-13 Sheba, Mostafa MP79-19 Sheikh, Nadeem MP87-15 Sheinfeld, Joel MP10-01, MP10-05, MP10-12, MP10-13, MP10-19, p11, p72, p253 Shelton, Jeremy MP4-03, p13 Shen, Bing MP8-17, MP8-18, MP12-01, MP12-07 Shen, Jess MP68-05 Shenot, Patrick p69 Sherer, Benjamin A. MP85-05 Sherif, Hammoda MP3-08 Sherman, Scott MP9-03 Sheth, Kunj MP40-03, MP40-05, MP40-12 Shewman, Elizabeth PD48-04 Sheynkin, Yefim FRI-09 Shi, Bentao MP2-02 Shi, Fangfang MP26-08, MP26-09, MP44-16 Shi, Guohai MP14-20, MP37-15, MP47-03, MP50-12, MP69-06 Shi, William MP33-16 Shi, Yingai MP8-03 Shibata, Yasuhiro MP39-11, MP74-14 Shichman, Steven MP23-04 Shields, James MP85-19 Shigemura, Katsumi PD8-08, PD8-10 Shih, Weichung MP53-04 Shiina, Hiroaki MP11-06, MP39-16, MP47-11 Shim, Myungsun MP44-11, MP86-06, PD43-03, PD47-01 Shim, Sungryul MP16-11 Shimada, Shoichi MP8-19 Shimazui, Toru MP49-14 Shimizu, Fumitaka MP26-07 Shimizu, Shogo MP21-01, MP31-02, MP76-07, PD36-11 Shimizu, Takahiro MP21-01, MP31-02 Shimomura, Yukihito MP76-04 Shin, Bosung MP20-11 Shin, Daniel MP10-18, MP25-14, MP74-19 Shin, Dong Wook MP41-17 Shin, Ju Hyun MP31-14 Shin, Richard MP20-14, MP33-12 Shin, Takeshi MP76-04 Shinde, Sunita PD7-05 Shindel, Alan p12, p56 Shinghal, Rajesh MP28-13 Shinmei, Shunsuke MP22-17, MP52-02, PD35-03 Shinoda, Kazunobu MP35-20, PD17-03 Shinohara, Katsuto MP86-10 Shinohara, Mayuka MP21-05 Shinohara, Nobuo MP45-01, MP58-18, MP69-19, MP85-12, V11-06, p174 Shinojima, Toshiaki MP35-20, PD17-03 Shinsky, Brian MP30-13 Shintaku, Ichiro MP2-19 Shiota, Masaki MP37-12, MP46-11 Shiozawa, Shinji MP26-07 Shipley, William MP26-12, MP62-14, p44 Shirai, Masato PD37-07 Shiraishi, Koji PD36-10, p174 Shirato, Akitomi PD4-07 Shkolyar, Eugene PD28-03, PD50-08 Shlykov, Maksim MP30-13 Shnier, Ronald MP60-04, MP83-02, PD46-08 Shoag, Jonathan MP41-18 Shojaei, Sepehr MP10-02, PD2-09 Shoji, Koichi MP52-02, PD35-03 Shoji, Sunao MP11-08, MP17-16, PD34-05 Shokeir, Ahmed MP30-05, MP30-06, MP30-15, MP79-10, PD17-10, PD23-01, PD41-07, p58 Shoma, Ahmed MP30-05, MP30-15 Shore, Neal MP1-08, MP4-03, PD5-01, PD17-06, PII-LBA1, PII-LBA3, PII- LBA4, MP45-14, PD32-11, MP73-10, MP73-12, MP73-16, MP78-11, MP82-09, MP87-12, MP87-15, MP87-16, MP87-18, MP87-19, p136, p236, p265 Shoshana, Rafi MP17-04 Shoshany, Ohad MP30-09 Shoskes, Daniel MP25-13, MP43-15, MP79-18, MP85-11, p100 Shoss, Jeffrey MP80-05 Shrewsberry, Adam PD19-12 Shrotri, Nitin PD5-08, PD5-10 Shtabholtz, Yariv MP28-14 Shuch, Brian p57 Shuckman, Anne MP27-10 Shukla, Aseem MP18-17 Shukla, Sanjeev MP8-05, MP46-04 Shultz, Tamar PD45-10 Shunaigat, Abdul Naser p58 Shvili, Ya Acov MP16-14 Shy, Michael PD1-05, PD10-02 Si, Shuhui MP39-09 Siadat, Farshid MP6-14 Sibley, Alison PD32-11 Siddique, Hifzur MP66-14 Siddiqui, Emad PII-LBA9 Siddiqui, Javed MP48-17, PD44-07, PD46-02, PI-08 Siddiqui, Khurram MP78-08, MP83-13 Siddiqui, M. Minhaj MP4-01, MP17-13, PD44-06 Siddiqui, Nazema MP8-04 Siddiqui, Rabia MP3-18, MP71-06, 333 PD44-07 Siddiqui, Sameer MP18-15 Sidi, Ami PD23-03, V5-14, V11-14 Sidler, Martin MP19-05, MP21-15 Siebert, Aisha MP23-12, MP23-13 Siefker-Radtke, Arlene MP65-05, MP72-02 Siegel, Jordan MP88-15, PD22-04, PD26-01, PD48-09, V8-13 Siegel, Steven PD27-07, PD27-08, p11, p44, p73 Siemens, D. Robert MP5-02, PII-LBA4 Siemer, Stefan PD3-01 Siev, Michael MP18-01, MP30-08, MP59-09, MP80-13 Sievert, Karl-Dietrich MP3-01, MP11-19, MP19-09, MP19-13, PD18-04, PD24-01, PI-04, p37 Sigman, Mark PD52-11, p11, p221, p236 Signoretti, Sabina MP11-14 Sikka, Suresh MP15-19, MP43-09, PD36-05 Silay, Mesrur Selcuk PD13-09 Silay, Selcuk PD19-07, V8-03 Silberstein, Jonathan MP22-03, MP22-04, MP48-07, MP87-17, V5-04, p57, p170 Silk, Tarik PD33-02 Silva, João PD27-12 Silva, Mark MP14-03, MP24-19, MP54-15, MP63-01, MP79-20, PD9-10 Silveira, Marcel A. PD3-04 Silver, David FRII-03, MP70-06 Silvers, Christopher MP49-18, MP68-14 Silvestri, Luigi MP18-20, PD9-12, PD45-11 Silvestri, Tommaso MP67-20, MP88-03, PD9-03 Silvino, Jose Ricardo MP71-19, PD39-07 Simeone, Claudio MP44-04, MP63-03, PD35-01 Simhan, Jay MP70-04, MP88-15, p10, p20 Simko, Jeff MP1-17, MP6-13, MP44-01 Simmons, Garrick MP6-08 Simmons, Walter MP33-12 Simon, Jean-Pierre PD7-12 Simon, Ronald MP37-09, MP37-14, MP55-08 Simon, Ross MP4-17, MP50-02, PD26-02, PD26-04, PD38-11, PD39-11 Simone, Giuseppe MP48-18, MP59-12, PD3-06, PD9-08, PD29-10, PD49-08, PD49-09, V4-14, V12-07 Simonetti, Rogerio MP71-19, PD39-07 Simonyan, Gevorg MP17-19 Simsek, Abdulmuttalip MP28-20 Simsek, Ferruh MP75-18 Sims-Lucas, Sunder MP40-04 Sin, Mandy La Yi MP20-10 Sin, Lai Yi Mandy PII-LBA8 Sindhwani, Puneet p71, p272 Singer, Eric MP72-13, PD35-09 Singer, Jennifer MP54-20 Singh Negi, Devendra MP31-06 Singh, Abhay A. MP53-02 Singh, Amar p255 Singh, Anurag PD33-10 Singh, Balwinder MP27-16 Singh, Errol p100 Singh, Kulwant PD50-07

346 Singh, Nair MP41-01 Singh, Parminder MP82-09 Singh, Prabhjot MP28-05 Singh, Shrawan MP39-19, MP43-20, MP45-13 Singhal, Sunil MP57-14 Singhal, Udit MP1-14, MP56-12, PD43-12 Singla, Ajay p12, p72, p100, p174 Singla, Nirmish MP2-01, MP88-15, PD23-02 Singla, Surender K. MP34-14 Siracusano, Salvatore MP57-13, MP67-20, MP88-03, PD9-03 Sirls, Larry T. PD20-08, PD50-12 Sirma, Hüseyin MP37-14 Sirohi, Mohit FRII-10, MP70-13 Sisul, David PD45-05 Sivalingam, Sri MP11-03, PD42-09 Sivaraman, Arjun MP42-17, MP48-16, MP62-08 Sjoberg, Daniel MP2-13, MP6-04, MP10-13, MP14-09, MP27-13, MP44-15, MP50-18, MP59-02, MP60-06, MP63-08, MP64-19, MP77-20, MP78-03, MP84-06, PD29-03, PD38-03 Skarecky, Douglas MP53-16, PD18-01 Skeldon, Sean MP9-07 Skibber, John PD40-09 Skinner, Eila MP67-15, PD31-10, PD41-08, PD41-09, p13, p18, p239 Skog, Johan PII-LBA2 Skolarus, Ted MP1-14, MP14-07, MP27-12, MP27-17, MP32-15, MP56-12, PD25-08, PD43-12, p13, p82, p85 Skomra, Christopher MP78-11 Skoog, Steven p118 Skouteris, Michael MP48-09 Skouteris, Vasileios MP48-09 Skouteris, Vassilios V4-09 Skuginna, Veronika MP38-03 Slack, Rebecca S. MP72-02 Slater, Richard MP8-18 Slaton, Joel MP10-07, MP11-15, MP46-13, MP65-12, PD9-05, PD17-04 Slezak, Jeff MP14-01 Sliwinski, Ania MP61-04 Sloan, James C. MP3-15 Slovin, Susan F. MP82-04 Smaldone, Marc MP24-03, MP24-05, MP47-04, MP50-14, MP56-06, MP67-07, MP67-08, MP67-14, MP69-08, MP70-04, MP84-05, MP84-07, MP84-15, MP84-17, PD12-04, PD12-07, PD49-04, PD49-11, PI-10 Small, Alexander C. MP14-03 Small, Eric MP44-01 Smeenge, Martijn MP48-03 Smelser, Woodson MP89-04 Smentkowski, Kate MP29-03 Smilen, Scott PD50-09 Smith, Angela MP5-05, MP16-16, MP24-02, MP58-19, MP78-14, p10 Smith, Ariana PD10-01, p84, p100 Smith, Armine K. MP49-20 Smith, Arthur FRII-13, MP23-19, MP30-08, MP30-13, MP80-13, V3-12, V3-13, V6-04, V8-07, V8-08, p13, p58 Smith, Arthur M. FRI-18, MP9-10 Smith, Brian MP78-11 Smith, Christopher p44 Smith, Craig PD16-09 Smith, Daryn MP14-15 Smith, David MP57-04, MP65-11, MP82-09 Smith, James MP74-16, PD52-09, p153 p169 Smith Jr., Joseph MP49-01, PD6-05, p9, p118 Smith, Ken MP76-12 Smith, Matthew R. MP73-10, MP87-12, MP87-16 Smith, Michael PD20-01 Smith, Nataliya MP11-15, MP46-13 Smith, Norm MP2-16, MP29-10, MP65-13, MP65-15, p119 Smith, Peggy B. MP43-05 Smith, Richard MP46-18, MP61-05 Smith, Steven MP53-03 Smith, Ted PD45-12, PD48-06, PD48-07, PD48-12 Smith III, Thomas MP15-17, PD14-08 Smith, Zachary MP9-15 Smylie, Jennifer PD47-12 Sng, Jen-Hwei PD17-01 Sninsky, Brian C. PD51-06 Snodgrass, Warren p12 Snow-Lisy, Devon MP19-03, MP19-11 Snyder, Charles MP89-04 Snyder, Debbie PD44-07 So, Alan MP57-20, MP77-01 Soares, Amanda MP51-10 Soave, Armin MP2-10, MP2-12, MP3-16, MP15-15, MP58-10, PD22-12 Sobel, David p10 Soda, Tetsuji MP8-19, MP71-16, MP76-18 Sodano, Mario PD35-01 Soderdahl, Douglas MP27-05 Sofer, Mario PD13-10 Soffen, Edward MP78-11 Sofield, David p20 Sofikitis, Nikolaos MP76-07, PD36-11 Soh, Shigehiro MP76-04 Sohn, Dong Wan MP51-15 Sohn, Mooyoung MP44-11, MP78-02 Sohn, Muyoung PD43-03, PD47-01 Sohn, William MP5-07, PD12-03, PD12-06 Sokoll, Lori PD46-02, PD46-05, PI-08 Sokoloff, Mitchell MP5-16, MP16-20, PD12-05 Sokurenko, Evgeni MP25-17 Soler, Roberto MP71-19, PD39-07 Soliman, Tarek MP3-08 Solit, David MP7-13, MP36-12, MP64-02, MP72-20 Solomon, Eskinder MP81-14, PD27-09 Solomon, Stephen PD47-08 Soloway, Mark MP26-15, MP68-02, p100, p170, p234 Soma, Fumihiko MP2-19 Somani, Bhaskar MP28-10, MP41-07 Somer, Brad MP82-09 Sommatino, Francesco MP26-19 Sommerer, Florian PD47-09 Son Vuong, Nam MP63-12, MP Son, Hwancheol MP28-01, PD16-10 Song, Cheryn MP44-11, MP44-20, MP69-13, MP82-18, MP86-06, PD43-03, PD47-01 Song, Gang PD2-11 Song, Geehyun MP19-19 Song, Kang-Moon MP52-03, MP52-08 Song, Ki Hak MP31-14 Song, Lihai MP80-03 Song, Miho MP19-06, PD16-10 Song, Phil Hyun MP3-13 Song, Qi-Xiang MP8-16 Song, Sang Hoon MP19-19, MP69-13, MP78-02, PD47-01 Song, Wan MP62-17 Song, Wen MP52-10, MP55-19 Song, Xiaoyan MP54-06 Song, Yan MP38-19, MP41-18, MP80-01 Song, Yingjie MP61-10, MP66-06 Soni, Samit V10-07 Sonke, Eric PD33-01 Sønksen, Jens PD37-10 Sonmezay, Erkan MP28-20, MP34-12 Sonn, Geoffrey MP84-02 Sønsken, Jens MP3-01 Sonstegard, Anna Marie MP11-10, PD44-03 Sood, Akshay MP4-14, MP9-08, MP9-14, MP24-06, MP24-20, MP54-07, MP59-03, MP59-15, MP60-01, MP62-01, MP63-17, MP64-13, MP65-19, MP73-11, MP73-19, MP77-10, MP77-12, MP77-13, MP78-01, MP78-19, MP79-04, MP79-14, MP82-07, MP82-16, MP82-17, MP87-05, MP87-14, PD6-12, PD13-03 Sood, Rajeev MP80-15, PD8-12 Sood, Tanvi PD8-12 Soon, Julie PII-LBA3 Sooriakumaran, Prasanna MP63-18, MP70-20 Sopko, Nikolai MP67-12 Sorensen, Mathew MP17-01, MP75-08, PD42-01, PD42-02, p220 Sorita, Atsushi PD31-01 Sorokin, Igor PD37-09 Sosa, R. Ernest p10 Sotelo, Rene PD29-04, V4-12, V8-12, p9, p72, p165 Sotomayor, Mariano p11 Soubra, Ayman MP61-06, MP64-14, PD25-06, PD41-12 Soueidan, Michael PD51-03 Soulié, Michel MP57-09, MP63-12, MP63-15, MP85-09 Sourbeer, Katherine MP14-11 Souvatzoglou, Michael PD32-06, PD32-07 Souza, Glauco MP52-01 Soytas, Mustafa MP28-16 Sozzi, Francesco Cristiano MP88-05 Spahn, Martin MP44-17, MP56-04, MP56-10, MP77-03, MP82-01, PI-07 Spaliviero, Massimiliano MP44-15, MP50-16, MP63-08 Spaliviero, Maximiliano PD29-03 Speakman, Mark MP3-01, PD16-08, p173 Speed, Jaqueline PD30-09 Speich, Jason MP23-19, V6-04

347 Speich, John MP12-15, MP12-16 Speir, Ryan PD19-11 Spencer, Sophie MP5-05, MP16-16, MP24-02, MP58-19 Sperduti, Isabella PD49-08 Spettel, Sara MP12-08 Sphan, Marthin PD17-11 Spiess, Philippe MP2-15, MP10-11, MP23-11, MP50-02, MP59-10, MP59-20, MP65-06, MP72-15, PD31-09, PD41-01, PD41-05, p10, p85, p190 Spilotros, Marco MP81-14 Spinoit, Anne-Françoise V10-08 Spirnak, John p131 Spitz, Aaron MP25-14, p255 Spradling, Kyle MP7-18, MP22-14, MP80-16, PD7-04, PD41-07 Sprague, Bruce MP20-07, MP20-08 Sprenkle, Preston C. MP17-08, MP86-08 Sproul, Duncan PD33-06 Spruill, Laura PD7-08 Spuches, Joseph PD34-06 Spyropoulos, Evangelos MP60-18 Squire, Jeremy MP1-17, MP37-02 Sreedharan, Shilpa MP47-15 Sreenath, Taduru MP61-10 Sridhar, Ashwin MP43-13 Sridhar, Srikala MP65-06, MP72-15, PD41-05 Srikishen, Neel PD19-08, PD31-04, V8-14 Srimathveeravalli, Govindarajan PD47-08 Srinivas, Sandy MP84-02 Srinivasan, Alagarsamy MP66-06 Srinivasan, Arun MP18-17, MP30-13 Sriprasad, Sri MP28-18, PD44-08 Srivastava, Abhishek V7-02 Srivastava, Amar MP9-02 Srivastava, Shiv MP37-17, MP61-10, MP61-16, MP61-20, MP66-06, MP66-12 Srivastava, Sudhir MP61-16, MP66-06, MP66-06, PI-08 Sroka, Ronald MP74-17 Srougi, Miguel MP3-12, MP8-07, MP21-10, MP31-17, MP43-17, MP71-18, PD5-04, PD23-08 Srour, Edward MP19-20 Staack, Andrea MP81-08 Stabholz, Yariv PD11-12 Stabo, Nicholas PD4-08 Stacul, Fulvio MP57-13 Staehler, Michael MP58-16 Staff, Ilene MP48-06, MP48-20 Stahl, Peter MP43-02, MP43-16 Stakhovsky, Eduard MP84-01 Stakhovskyi, Oleksandr MP84-01 Stambler, Nancy MP82-09 Stamm, Andrew MP80-01 Stampfer, Meir MP6-15, MP50-07, MP77-19 Stanasel, Irina MP40-10, MP79-15 Stanevsky, Yury V5-14, V11-14 Stanford, Janet PII-LBA5, PD47-03 Stanton, Annette L. MP27-15 Starke, Nathan PD23-02 Starr, Jay MP42-08 Stattin, Pär MP4-19, MP42-10, MP56-17, PD6-10 Stav, Kobi PD20-03 Stearns, Gillian PD9-11 Stec, Andrew MP40-13 Steckel, Joph MP70-03 Steffens, Joachim V12-05 Steger, Klaus MP76-01, MP76-02, MP76-03 Steimer, Johannes MP88-10 Stein, Barry MP60-03 Stein, Daniel MP15-18, p73 Stein, Mark MP72-10 Stein, Robert MP35-07, MP50-15, MP63-13, MP70-02, V4-01, V4-11 Steinbach, Daniel MP35-11, PD25-03 Steinbach, Jill M. MP49-10 Steinberg, Gary MP2-16, MP65-13, MP65-15, PD23-10, p110 Steinberg, Ryan MP26-20 Steinberg, Zoe MP84-04 Steiner, Mitchell MP6-04, p136 Steinestel, Julie MP56-13 Steinhilber, Benjamin PD18-04 Stelmasuk, Kleber V3-10, V11-10 Stember, Doron p55 Stenman, Ulf-Håkan PD6-09 Stensland, Kristian PD12-12 Stenson, Trevor PD33-11 Stenzl, Arnulf MP1-16, MP2-10, MP19-13, MP65-09, MP67-19, PD24-01, PD41-11, p68 Stepanian, Sevan MP57-05 Stephany, Heidi MP40-11, MP54-18 Stephen, Betty PD11-07 Stephens, Craig MP37-19 Stephenson, Andrew MP53-06, MP65-06, MP72-07, MP72-15, MP72-17, PD31-09, PD34-01, PD38-10, PD41-05, p9, p253 Stepkowski, Stanislaw MP79-11, MP79-12 Stepp, Herbert MP74-17 Sterbis, Joseph MP9-16 Sterious, Steven MP70-04 Sterling, Matthew MP58-12, MP72-12, PD23-12, V10-14 Sterling, William A. MP60-16, MP77-05 Stern, Joshua MP41-01 Stern, Joshua M. MP34-10, MP75-08 Stern, Karen PD5-11 Stern, Mariana MP14-10 Stern, Michael MP89-08 Sternberg, Itay MP2-13 Sternberg, Kevan MP30-13, MP30-18, MP75-02, V6-06 Stetler-Stevenson, William G. MP39-02 Steuber, Thomas MP9-04, MP78-17, MP78-20, MP82-05, MP83-06, MP83-07, PD30-07 Steurer, Stefan MP83-16 Stevens, Daniel MP55-12 Stevenson, Bradford MP16-04, MP27-06, MP32-09, MP51-16, PD39-05 Steward, Os MP19-12 Stewart, Carrie MP43-09, V12-09 Stewart, Grant PD33-06, PD46-09 Stewart, Julie PD8-07 Stewart, Suzanne MP35-18, MP35-19, MP70-11, MP70-12, MP70-14, MP70-15, PD29-06, PD31-01, PD Steyerberg, Ewout MP86-18 Stief, Christian MP26-17, MP31-10, MP34-20, MP58-16, MP62-18, MP63-09, MP74-17, MP88-08, MP88-09, PD9-04, V7-05 Stifelman, Michael MP29-01, MP63-06, MP63-10, MP70-16, MP70-17, MP70-18, V10-06, p20, p72, p154 Stinchcomb, Stephanie p13 Stocca, Tiziano MP57-13 Stock, Jeffrey p18 Stock, Richard MP62-11, MP62-12, MP62-16, MP87-04 Stöckle, Michael MP35-06, MP58-03, PD3-01 Stoehr, Christine MP35-06 Stoffel, John MP26-02, MP85-19, MP89-02, PD10-07, PD11-06, p220 Stoianovici, Dan p19, p56 Stojanovic, Borko MP52-15 Stokes, Phillip MP38-15, MP63-02 Stokl, Andrew PD44-09 Stoller, Marshall MP11-04, MP17-05, MP33-01, MP33-04, MP34-06, MP75-07, MP79-02, p220 Stoller, Wesley MP31-20, MP86-14 Stolzenburg, Jens-Uwe MP42-07, PD5-08, PD5-10 Stone, Brian p175 Stone, Jonathan MP23-09, V9-10 Stone, Nelson MP6-06, MP24-10, MP48-09, MP60-08, MP62-11, MP62-12, MP62-16, MP71-11, MP87-04, PD2-04, V4-09, p13 Stone, Steven MP1-08, MP1-10 Stork, Brian PD19-09 Storm, Douglas MP40-19 Storme, Oscar A. MP29-13 Stothers, Lynn MP20-06, PD1-06 Stout, Richard PD37-06 Strachan, Eric PD20-07 Strahan, Stephen MP57-04 Strasner, Amy MP61-14 Strauss, William MP37-06 Streicher, Matthew PD24-08 Stricker, Hans MP4-14, MP53-13, MP62-01, MP82-17, PD30-08 Stricker, Phillip MP60-04, MP83-02, PD46-08, p173 Strickler, Howard MP50-20 Stringer, Matthew MP16-01 Stringer, Thomas FRII-05, p10 Strittmatter, Frank MP31-10, MP34-20 Strope, Seth MP7-07, MP24-12, MP24-14, PD5-05 Stroup, Antoinette PII-LBA5 Stroup, Cynthia MP89-02 Stroup, Sean PD15-08 Stubbs, Jack MP23-19, V6-04 Stubendorff, Beatrice MP58-03 Stublaski, Jeanne MP26-01 Studer, Urs E. MP56-04, MP65-16, p9, p20, p44, p84 Stunitz, Luciano C. V3-10, V11-10 Stupp, Samuel MP52-12 Su, Bo Xing MP2-02, MP47-02 Su, Li-Ming MP35-04, MP84-10, p20, p57, p121 Su, Minzhi PD20-04

348 Su, Wendell MP1-19 Su, Xiaoping MP72-06 Su, Xin PD7-06 Suadicani, Sylvia MP8-13, MP12-19, p18 Suardi, Nazareno MP4-16, MP48-13, MP56-03, MP56-05, MP56-16, MP56-18, MP62-01, MP62-04, MP62-05, MP72-04, MP78-15, MP82-02, MP82-03, MP82-16, MP82-17, MP83-08, MP83-17, PD32-09, PD38-12 Suarez, Melissa MP80-16 Subramanian, Hariharan MP1-20 Sudarshan, Sunil p254 Suekane, Shigetaka MP2-20 Suer, Evren MP63-12, MP63-15, PD9-07 Sufrin, Nathaniel PD47-11 Sugar, Linda MP46-14 Sugawara, Emiko MP58-08 Sugaya, Kimio MP12-18 Sugiahra, Toru MP20-18 Sugimoto, Mikio MP42-09 Sugimura, Yoshiki MP35-15 Sugiura, Shoichiro PD16-02 Sugiyama, Hironori MP2-04, PD23-06 Sugiyama, Rino MP8-06, MP12-03 Suh, Jun-Kyu MP52-03, MP52-08 Suh, Minhyung PD39-02, PD39-12 Suh, Nayoung MP19-19 Sujenthiran, Arun FRII-11 Sul, Chong Koo MP31-14 Sulaver, Randy MP51-16, PD26-08, PD39-05 Sulek, Jay MP12-16, MP25-03, MP55-17, V10-11 Sullivan, Jerry PD19-12 Sullivan, John MP6-16, PD48-01 Sullivan, Travis MP1-19, MP45-02, MP45-05, MP47-10, MP61-07 Sulser, Tullio MP19-10, MP21-19, MP66-05, MP66-19, MP68-08, MP68-09, PD8-01 Sultan, Raymond MP72-13 Sulttmann, Holger MP37-11 Sumino, Yasuhiro MP21-05, PD16-04 Sumitomo, Makoto PD47-04 Summers, Ronald M. MP11-02 Sumura, Masahiro MP11-06 Sun, Arony J. MP63-08 Sun, Lijiang MP47-03, MP60-19 Sun, Maxine MP32-08, MP56-06, MP56-18, MP59-08, MP59-16, MP59-18, MP59-19, MP72-01, MP73-11, MP77-10, MP82-07, MP87-14, PD30-09, PD31-13, PD49-03, PD49-05 Sun, Mengkui MP31-04 Sun, Qipeng MP52-19 Sun, Xizi PD34-07 Sun, Yi MP63-05 Sun, Yinghao p70 Sunada, Takuro MP5-03, PD23-04 Sundaram, Chandru MP11-13, MP63-11, PD3-09, PD15-03, PD15-05, PD21-12, V5-12, V9-13, p57, p71, p233 Sundi, Debasish MP1-11, MP4-13, MP55-18, MP66-16, PD34-09 Sung, Gyung p254 Sung, Hyun Hwan MP3-14, MP7-04, MP62-17, PD25-05 Sung, Jennifer PD50-07 Sung, Randall MP85-19 Sunyaro, Peter L. MP16-18 Sur, Roger MP20-14, MP27-07, MP28-09, MP33-16, PD13-01, PD13-07 Suraf, Margaret MP86-13, PD38-04, PD38-10 Surana, Sandesh MP15-14, PD14-09, PD22-03, V12-01, V12-02 Suresh, Tejas MP50-20 Suskind, Anne M. MP9-05 Sussman, David PI-04, p12 Sussman, Rachael MP48-04, PD6-11 Sut, Michal MP13-04 Sutcliffe, Siobhan MP4-02, MP27-04 Sutherland, Suzette E. PD27-07 Suttle, Timothy MP79-12, MP85-01 Sutton, Broderick MP21-20 Suzuki, Hiroyoshi MP87-06 Suzuki, Kazuhiro MP39-11, MP74-14 Suzuki, Keisuke MP76-04 Suzuki, Masahito PD17-07 Suzuki, Sadao MP34-15 Suzuki, Toshihiro MP85-16 Svatek, Robert MP36-07, MP64-05, MP65-02, MP65-08, PD17-06, p253 Swana, Hubert V7-11 Swann, Noah MP83-12 Swanson, Jonathan MP17-01 Swearingen, Ryan PD13-11 Sweeney, Christopher MP87-12, p13, p85 Sweet, Joan MP10-10, MP68-05 Sweet, Robert MP22-06, MP23-19, PD19-02, PD19-03, PD19-04, PD19-05, V6-04, V6-09, p86 Syan-Bhanvadia, Sumeet MP79-05, PD35-06 Sykes, Jenna MP68-04 Sýkora, Radek MP71-07 Sylvester, John MP78-11 Sylvester, Richard PD17-11 Symanski, Elaine MP52-11 Syring, Isabella MP68-07 Syun, Takai MP20-05 Syvänen, Kari MP17-07 Szamocki, Sonia MP16-06 Szell, Nicole PD40-05 Szymanski, Konrad MP54-19 Szmulewitz, Russell p11 T T, Manasa PD8-12 Taari, Kimmo PD6-02, PD6-09 Tabatabaei, Shahin MP31-15, PI-02, MP83-11, V8-04, p58, p59 Tabayoyong, William MP84-05 Tabernero, Ángel MP73-01 Tabone, Viviane MP71-19, PD39-07 Tabori, Uri MP37-11 Tacha, David MP66-12 Tachibana, Masaaki MP20-18, MP44-18, MP62-20, MP87-02, PD41-06 Tadic, Stasa MP12-10 Tadros, Nicholas MP74-03 Tagawa, Scott MP16-02, MP82-09, p208 Taguchi, Kazumi MP33-13, MP33-15, MP34-02, MP34-05, MP34-11, MP34-13, MP34-15, MP41-03, 336 MP41-06 Taguchi, Satoru MP58-02 Taguri, Mastaka MP45-04 Taha, Diaa-Eldin MP30-06, MP30-15, PD5-12, PD9-02 Taher, Younis MP48-11 Tahra, Ahmet V2-04, V12-04 Tahtali, Ibrahim Nüvit MP18-18 Tai, Bee Choo MP85-15 Tai, Changfeng MP8-17, MP8-18, MP12-07 Tai, Huai-Chin MP2-11 Tai, Yi-Sheng MP2-11 Taichman, Russell p70 Tailly, Geert p44 Tailly, Thomas MP30-20, MP34-07, PD51-01 Taimen, Pekka MP17-07 Tajiri, Takuma MP11-08 Takada, Ichiro MP37-04 Takagi, Toshio MP2-17, MP57-17, MP63-14, MP69-09, MP69-17, MP84-09, PD29-09 Takahara, Kiyoshi MP7-02 Takahashi, Makoto MP69-03, PD33-04 Takahashi, Masayuki MP55-06 Takahashi, Nobuhiro MP8-14, V7-12 Takahashi, Satoru MP12-12, MP86-05, PD50-03, p137 Takahashi, Satoshi MP79-16 Takahashi, Sayuri MP37-04 Takahata, Sohei MP26-07 Takai, Shun MP71-20 Takai, Tomoaki MP7-02 Takao, Tetsuya MP8-19, MP71-16 Takase, Kei PD3-02 Takayama, Koichiro MP46-16 Takeda, Atsushi MP2-19 Takeda, Keisuke MP55-16 Takeda, Masayuki MP8-14, MP21-13, V7-12 Takehara, Kosuke MP55-03 Takenaka, Atsushi MP35-08, MP44-05, MP76-07, PD36-11 Takeshita, Hideki MP2-04, PD23-06 Takeshita, Nobushige PD3-10, PD46-01 Takeuchi, Ario MP37-12, MP39-17, MP46-11, MP49-13, MP66-02 Takezawa, Kentaro MP8-19, MP71-16, MP76-18 Takimoto, Keita V11-05 Takizawa, Itsuhiro MP31-07, MP55-16 Tal, Raanan PD26-11, PD40-02, PD48-01 Talamini, Renato MP67-20, MP88-03, PD9-03 Talbot, Thomas R. MP20-12 Talibzade, Ferhad MP75-18 Tallarigo, Carlo MP88-03 Tam, Christopher MP15-09, MP15-17, PD14-06 Tam, Justina FRII-02, V9-08 Tam, Kevin MP39-17, MP49-13, MP66-02 Tamalunas, Alexander MP31-10 Tamboli, Pheroze MP35-01, MP84-18 Tambouret, Rosemary MP50-08, MP50-09 Tammela, Teuvo PD6-02, PD6-09 Tamura, Tomoki MP58-08 Tan, Andrew PD5-02 Tan, Hung-Jui MP24-09, MP27-15,

349 MP32-01, MP32-10, MP65-20, MP70-07, MP79-06, PD12-08, V4-03 Tan, Nelly MP86-19, PD44-10 Tan, Ronny p71 Tan, Shyh-Han MP66-12 Tan, Yeh p70 Tanabe, Kazunari MP2-17, MP57-17, MP69-09, MP69-17, MP79-16, MP85-16, p234 Tanabe, Kenji MP58-08 Tanabe, Kuniaki MP77-02 Tanaka, Hajime MP11-12, MP65-04 Tanaka, Hiromitsu MP76-18 Tanaka, Kazushi PD8-08, PD8-10, PD18-03 Tanaka, Nobumichi MP68-03, MP83-09 Tanaka, Nobuyuki MP2-08, MP7-10, MP35-20, PD17-08 Tanaka, Shinya MP45-01 Tanaka, Toshiaki MP79-16 Tanaka, Yoshinori MP58-02 Tanaka, Yutaro MP62-10 Tanda, Naoki MP7-02 Tandon, Chanderdeep MP34-14 Tandon, Simran MP34-14 Taneja, Samir MP53-15, MP77-14, MP77-17, MP77-18, MP86-03, PD4-11, PD32-01, PD32-03, PD32-05, PD34-02, p13, p19, p20, p57, p136, p174 Taneja, Sanjeev MP13-04 Tanello, Marco MP66-20 Tang, Dominic MP84-19 Tang, Dong-Ling MP71-14, MP81-03 Tang, Hong MP73-13 Tang, Moon-Shong MP36-16, MP36-19, MP36-20, MP45-15, MP45-19, MP49-06 Tang, Shaojun PD20-04 Tang, Yuan MP2-02 Tangen, Catherine M. MP65-02 Tanguay, Simon MP57-20, MP59-20, MP84-08, PD12-01, PD31-05 Tanidir, Berrin MP48-01 Tanidir, Yiloren MP75-18 Tanji, Nozomu PD4-07 Tannir, Nizar MP72-06 Tanseco, Patrick MP60-07 Tanwar, Raman MP80-15, PD8-12 Tao, Jun MP2-05, MP36-15, MP45-11, PD13-06, V11-03 Tao, Mingfang MP21-18 Tao, Qian MP47-08, MP55-10 Tao, Tao MP55-15, V12-06 Tapiero, Shlomi MP28-14 Taplin, Mary-Ellen MP44-01 Tapscott, Ashley p55 Tar, Moses MP8-13 Tareen, Basir p9 Tario, Joseph MP47-16 Tarplin, Sarah MP41-15, MP75-11, PD42-06, PD42-09, PD42-11 Tarr, Matthew A. MP69-01 Tarrell, Robert MP20-20, MP29-15, MP29-16, MP67-02, MP72-11 Tarry, Susan MP22-10 Tarry, William MP22-10 Tasci, Ali MP34-12, MP38-07 Tasian, Gregory MP33-04, MP40-07, MP80-03, p18 Tatarano, Shuichi MP36-08, PD23-07, PD33-05 Tatokoro, Manabu MP2-18, MP11-12, MP65-04, PD3-08, PD15-02, PD32-02 Tatsugami, Katsunori MP46-11, MP69-19, p174 Taube, Janis MP58-07, PD31-12 Tausch, Timothy MP88-06, MP88-15, PD22-04, PD26-01, PD48-09, V8-13 Tauzin-Fin, Patrick MP85-17 Tavlarides, Andrea MP5-14 Tavukçu, Hasan V9-02 Tawfik, Mohammed MP38-12 Tay, June FRI-03 Tay, Kae Jack MP48-08 Tay, Li June FRI-15 Taylor, Abby MP75-17 Taylor, Andrew R. MP87-01 Taylor III, John MP45-20, MP49-01 Taylor, Kimberly MP32-05, MP83-19, MP84-12, PD3-12 Taylor, Natalie MP86-11 Taylor, Renea MP61-04 Tchesnokova, Veronika MP25-17 Te, Alexis MP13-14, MP81-20, PD5-01, V3-12, p9 Teber, Dogu PD46-10, p56 Teebagy, Patrick MP47-10 Teh, Bin Tean MP39-09 Tei, Hiromoto MP37-13, MP56-09, MP57-08, PD31-02 Teishima, Jun MP22-17, MP52-02, PD35-03 Tejerizo, Juan C. PD11-10 Tejerizo, Juan Carlos V10-05, p176 Tejwani, Rohit MP40-09, MP54-11 Tekes, Aylin MP22-08 Telang, Dinesh PD12-02, PD38-13 Teleb, Mohamed MP28-11, MP41-09, PD16-06 Telegrafi, Shpetim MP15-11 Teloken, Patrick MP51-05 Templeton, Arnoud MP67-16 Temprana Salvador, Jordi PD41-04 Tenke, Peter p101 Tenstedt, Pierre MP37-09, MP55-08, MP78-18, MP82-05, MP83-05, MP83-06, MP83-15 Tepeler, Abdulkadir PD13-09 Terachi, Toshiro MP11-08, MP17-16 Terada, Naoki MP37-04, MP60-02 Terai, Kazutaka MP26-07 Terao, Chikashi MP60-02 Terlecki, Ryan MP5-04, MP5-13, MP16-18, MP43-03, PD9-09, V3-05, p73 Termanjian, Michael PD31-03 Terraciano, Daniela MP26-05 Terrasa, Jean-Baptiste MP17-06 Terris, Martha FRI-06, FRI-18, FRII-13, MP4-17, MP5-09, MP9-10, MP14-12, MP53-01, MP53-02, MP53-12, MP60-12, MP60-14, MP82-15, MP87-08, MP87-09, PD29-02, PD32-10, PD34-07, PD38-11 Terrone, Carlo MP44-04, MP44-17, MP53-09, MP63-03, MP85-06, PI-07 Testa, Joseph MP47-04 Tewari, Ashutosh MP62-12, p20, p Tezcan, Haluk MP45-14 Thakur, Madhukar PD4-09 Thalmann, George MP38-03, MP38-09, MP56-04, MP65-01, MP65-09, MP65-16, PD13-02, V9-07, V9-12, p19, p85, p137 Tham, Sin Mun MP45-08 Thamilselvan, Sivagnanam MP46-20 Thamilselvan, Vijayalakshmi MP46-20 Thamtorawat, Somrach PD44-10 Thangasamy, Isaac PD19-09 Thapa, Prabin MP29-15, MP29-16, MP58-15, MP67-02, MP72-11 Tharakan, Sasha MP18-17 Tharwat, Mohammed MP27-01, PD9-02, PD17-10 Thavaseelan, Simone MP75-01 Thellenberg, Camilla PD6-10 Theodorescu, Dan MP68-17, p19 Theveniaud, Pierre Etienne MP13-19 Thiel, David MP75-17, MP81-10 Thiel, Jeff PD42-01 Thiele, Elizabeth MP35-09 Thiruchelvam, Nikesh MP8-15 Thomas, Appu MP69-11 Thomas, Arun MP84-18 Thomas, Craig MP68-17 Thomas, I-Chun MP84-02 Thomas, James Andrew PD5-08, PD5-10 Thomas, John p175 Thomas, Kay PD49-01 Thomas, Lewis MP26-20, MP39-18 Thomas, Raju MP22-03, MP22-04, V5-04, p58, p71, p170 Thomas, Sheila MP77-16 Thompson, Eli MP79-05, PD35-06 Thompson, Erika MP72-06 Thompson, Ian MP4-02, MP6-02, PII- LBA2, PD34-03, MP64-05, MP65-02, MP77-09, PD46-05, PI-08, p12, p19, p84, p118 Thompson, James MP60-04, MP83-02, PD46-08 Thompson, Peter FRI-10, FRI-15 Thompson, R. Houston MP24-07, MP29-16, MP35-02, MP35-18, MP35-19, MP44-14, MP47-14, MP50-10, MP56-14, MP58-09, MP59-20, MP63-20, MP67-02, MP69-05, MP69-12, MP70-11, MP70-12, MP70-14, MP70-15, PD12-09, PD29-06, PD35-07, PD35-11, PD43-04, PD43-08, PD49-12 Thompson, Trevor MP14-10 Thomsen, Kristine MP67-11, MP84-11 Thong, Alan MP14-09, MP27-13, MP53-20, MP64-03 Thorek, Daniel MP37-10, MP46-19 Thoreson, Gregory PD29-01 Thorne, Heather MP61-04 Thorpe, Andrew MP65-06, MP72-15, PD5-08, PD5-10, PD41-05 Thorpe, Cameron PD11-02 Thorpe, Roland p175 Thorson, Cody MP19-12 Thorwarth, Ryan PD19-10 Thoulouzan, Maxime MP13-13, MP13-18 Thrasher, J. Brantley MP61-09, PD38-02,

350 p18, p84, p247 Thrush, Carol MP23-10 Thum, Yau PD52-05 Thumbikat, Praveen MP25-06 Thummar, Haresh MP38-05, MP38-16, MP38-18, MP80-02, V6-05, V6-10 Thurmond, Portia MP8-08 Thurn, Tadzia MP83-12 Thüroff, Joachim W. MP39-04, p254 Thuroff, Stephen PD47-06 Tian, Jing-Hui MP89-17 Tian, Zhe MP59-08, MP59-16, PD49-03, PD49-05 Tianming, Gao PD38-04, PD38-10 Tiara, Al MP78-11 Tiburtius, Christian V3-12, V3-13 Tickoo, Satish MP47-09 Tien, Amy H. MP66-07 Tierney, James MP23-06 Tieu, Thomas MP16-04, MP32-09, PD42-10 Tieva, Erwin MP16-01 Tighe, Jennifer MP1-06 Tikkinen, Kari MP42-19 Tilki, Derya MP3-16, MP37-14, MP44-17, MP78-09, MP78-18, MP78-20, MP82-05, MP83-05, MP83-07, MP83-15, MP83-16, PD30-10, PI-07 Tillou, Xavier MP63-12, MP63-15 Timilshina, Narhari MP4-05, MP42-01, MP42-06, MP50-13 Timoney, Anthony PD8-04 Tin, Amy MP59-02, MP64-19, MP78-03 Tinay, Ilker MP42-20, MP75-18, MP84-10 Ting, Jie MP9-12 Ting, Kenneth MP20-02 Tiong, Ho Yee MP85-15, V2-13 Tiraboschi, Ricardo MP51-10 Tirughana-Sambandan, Revathi MP49-17, MP61-03 Tiu, Albert V11-13 Tivesten, Asa MP73-05 Tlsty, Thea p70 Tober, Patrick MP82-05 Tobert, Conrad MP44-02, MP44-19, MP84-09 Tobias-Machado, Marcos PD3-04 Tobisawa, Yuki MP58-05, MP65-07 Tobisu, Kenichi MP11-11, MP69-20 Tochigi, Tatsuo MP2-19, MP56-15 Todd, Mary B. MP87-16, MP87-18 Todenhoefer, Tilman MP49-09 Todenhöfer, Tilman MP1-07, MP1-16, MP65-09, PD41-11 Toffoli, Laura MP67-20, MP88-03, PD9-03 Togami, Joanna p84 Toi, Ants MP61-01, MP86-15 Tojuola, Bayo PD40-03, PD40-04, PD45-09 Tok, Abdullah MP74-12 Tok, Adem MP25-12 Tokas, Theodoros PD18-11 Tokatli, Zafer V6-01 Toler, Andrew PD44-04 Tolg, Cornelia MP20-02 Tollefson, Matthew MP6-05, MP24-07, MP29-16, MP35-02, MP35-18, MP35-19, MP56-14, MP67-02, MP67-11, MP69-12, MP84-11, PD12-09, PD43-04, PD43-08, p90 Tolmachova, Tanya PD7-12 Toma, Marieta MP17-10, MP48-05 Tomakowski, Janice MP89-09 Tomaszewski, Jeffrey MP24-05 Tombal, Bertrand MP73-20, MP77-03, MP87-13, p137 Tombe, Tabitha MP39-17, MP49-13, MP66-02 Tomeny, Patrick MP35-04 Tomita, Shuhei MP76-07, PD36-11 Tomita, Yoshihiko MP75-19 Tomlins, Scott MP1-14, MP6-09, MP56-12, PD43-12, PD44-07, PI-08 Tomonaga, Tetsuro MP11-08, MP17-16 Tondut, Lauranne MP38-10 Tong, Yat-Ching PD39-03 Tonkin, Jeremy MP29-03, MP29-13, p202 Torigoe, Toshihiko MP19-01 Torlak, Mersiha PD46-05 Torrecilla Ortiz, Carlos MP38-17 Torricelli, Fabio MP51-10 Tosco, Lorenzo MP9-20, MP27-19, MP56-10, MP77-03 Toshiki, Etani PD17-05 Tosoian, Jeffrey MP1-11, MP9-02, MP53-17, MP67-12, PD6-04, PD34-09 Touijer, Karim MP44-15, MP50-18, MP63-08, MP78-03, PD29-03, p227 Tourojman, Mwafa MP44-02, MP44-19 Tovar-Perez, Jorge MP21-20 Towner, Rheal MP11-15, MP46-13 Townsend, Whitney PD51-02 Tozawa, Keiichi MP33-13, MP33-15, MP33-18, MP34-02, MP34-05, MP34-11, MP34-13, MP34-15, MP36-04, MP38-08, MP41-03, MP41-06, MP46-12, MP55-04, MP80-18, PD17-05 Trabuco, Emanuel PD50-10 Trabulsi, Edouard MP7-01, MP53-04, MP67-07, PD4-09, p40, p73, p100 Tracey, James V3-14, V6-12 Trachtenberg, John MP61-01, MP86-15, PD47-10 Tracy, Chad MP30-13 Traish, Abdul MP27-03, p9 Traish, Abdulmaged PD37-04, PD45-03, PD45-04 Tran Cao, Hop Sanderson PD40-09 Tran, Geraldine MP79-02 Tran, Minh MP83-02, PD46-08 Tran, Nam MP74-16 Tran, Timothy MP57-16, MP75-01 Tranquart, Francois MP48-03 Trassierra, Marta MP38-11, MP80-11 Travis, Judith MP14-05, PD34-08 Traxer, Olivier MP7-19, MP17-06, MP34-08, MP75-05, PD42-05, V6-01, V6-14, p13, p44 Treat, Eric V4-03 Trenti, Emanuela PD49-08 Triche, Timothy MP37-06 Trilla, Enrique MP13-06 Trimmer, Clayton MP57-10, MP80-05, MP84-13 Trinh, Brian PI-03 Trinh, Quoc D. MP9-08, MP9-14, MP24-06, MP24-20, MP32-08, 338 MP54-07, MP56-06, MP59-03, MP60-01, MP63-17, MP64-13, MP65-19, MP67-05, MP67-09, MP70-09, MP73-11, MP73-19, MP77-10, MP77-12, MP77-13, MP77-19, MP78-01, MP78-05, MP78-12, MP78-19, MP79-04, MP82-07, MP87-05, MP87-14, PD6-12, PD21-02, PD30-03, PD30-09, PD30-12, PD31-06, PD38-01, p92 Tripathi, Sushil PD4-09 Tripp, Dean p10, p169 Trock, Bruce MP1-11, MP4-13, MP6-09, MP9-02, MP24-16, MP32-06, MP50-01, MP53-02, MP53-17, MP61-11, MP64-10, PD6-04, PD34-09 Trombetta, Carlo MP43-01, PD11-11, PD40-12 Trost, Landon p55, p254 Trottmann, Matthias MP74-17 Troyer, Dean MP1-17, MP6-13 Trubel, Sophina MP89-11 Trudeau, Vincent MP59-08, PD31-13, PD49-03, PD49-05 Trudel, Dominique MP6-14 True, Lawrence MP1-17, MP6-13 Truesdale, Matthew FRII-01, MP17-05 Trujillo, Carlos Gustavo MP25-16 Trulson, Jerry PD21-08 Truong, Quach PII-LBA3 Truong, Sarah MP37-01 Trusk, Thomas PD7-08 Tryon, David MP30-10, MP63-02, PD15-09 Tsai, Te-Fu MP36-10, MP36-11 Tsai, Tzong-Shin PD39-03 Tsai, Yao-Chou MP71-14, MP81-02, PD20-02 Tsai, Yuh-Shyan PD39-03 Tsaur, Igor MP8-11 Tsavalas, Panos MP63-18 Tschada, Alexandra PD18-11 Tse, Vincent MP89-14, PD39-08 Tseng, Hubert MP52-01 Tseng, Hui-Ling PD20-02 Tseng, Timothy MP75-06 Tsiatis, Athanasios MP1-01, MP1-05 Tsilidis, Konstantinos T. MP52-11 Tsivian, Alexander V5-14, V11-14 Tsivian, Matvey MP59-01, V5-14, V11-14 Tsivian, Matvey Tsivian MP28-09 Tsounapi, Panagiota MP31-02, MP76-07, PD36-11 Tsuboi, Shigeru MP36-03 Tsuchiya, Kunihiko MP45-01, MP58-18, V11-06 Tsuchiya, Norihiko MP39-10, MP46-16, MP56-15, MP69-03, MP69-16, MP83-10, MP85-04, MP85-13, MP87-07, PD33-04, V11-07 Tsuda, Masumi MP45-01 Tsui, Johnson MP15-10 Tsuji, Yoshikazu MP19-17 Tsujikawa, Kazutake MP47-01 Tsujimura, Akira MP8-19, MP51-12, MP71-16, PD37-07 Tsukamoto, Taiji MP69-19 Tsuru, Teruhiko MP27-02, V11-05 Tsuruta, Hiroshi MP39-10, MP46-16,

351 MP69-03, MP83-10, MP85-04, PD33-04 Tsuta, Koji MP45-06 Tsutsumiuchi, Manami V11-11 Tsuyoshi, Majima MP20-05 Tu, Frank MP27-04 Tu, Hin Yu Vincent MP80-12 Tubaro, Andrea MP71-03, MP71-08, PD5-08, PD5-10, PD16-08, PD49-08 Tuerk, Ingolf MP70-19 Tufekci, Mehmet Ali MP74-09 Tugcu, Volkan MP34-12, MP38-07, p101 Tuite, Gerald F. MP12-05 Tuken, Murat MP30-02 Tukmatchy, Hussein FRI-10 Tulloch, Trevor p235 Tulman, David PD15-01 Tummala, Ramakumar MP46-03 Tuncel, Altug MP25-12 Tuncer, Murat MP40-16 Tung-Tien, Sun PD7-12 Tunuguntla, Hari Sgr PD27-02, p11 Tupikina, Nataliya MP17-20, MP81-16 Turci, Andrea MP66-20 Turek, Paul J. MP74-19, p254 Turgeon, Nicole MP79-03 Turini, George MP57-16 Turk, Akif MP40-16 Turkbey, Baris MP11-10, MP14-16, MP17-09, MP17-13, MP82-19, MP82-20, PD4-10, PD30-02, PD38-05, PD44-03, PD44-06 Turkbey, Ismail MP48-04 Turkeri, Levent MP42-20 Turley, Helen MP55-12 Turna, Burak p101 Turnbull, Philip PD27-11 Turner, Mary p18 Tursi, James PD45-12, PD48-04, PD48-06, PD48-07 Tutolo, Manuela MP62-01 Tutrone, Ronald MP3-02, PD5-01 Tward, Jonathan PD11-02 Tyagi, Pradeep MP12-14, MP20-17, MP25-07, MP31-13, MP88-01, MP89-20, PD1-11, PD39-04 Tyler, Karl MP81-01 Tyler, Michael MP89-18 Tyler, Robert MP87-15 Tyson, Mark MP4-11, MP71-09, MP71-15, PD5-11 Tzemach, Sharon MP17-04 Uchida, Kazuhiko Uchida, Toyoaki Uchida, Yusuke Uchimoto, Taizo Uchiumi, Takeshi Ückert, Stefan Udager, Aaron Uddin, Tayna Ueda, Kousuke Ueda, Takashi Uehara, Hisanori Uehara, Sho Uemura, Hiroji Uemura, Hirotsugu U MP49-14 MP11-08, MP17-16 PD32-02 MP7-02 MP46-11 MP52-07, MP52-17 MP48-17 MP9-09 MP2-20 MP55-07 MP49-04 MP26-10 MP45-04, MP58-01, MP73-07 p173 Uemura, Motohide MP47-01, p174 Uemura, Yukari MP58-02 Ueshima, Hirotsugu MP27-02 Uhlman, Matthew MP32-03, MP32-20 Ujike, Takeshi MP47-01 Ukimura, Osamu MP59-12, MP61-05, MP83-12, MP86-04, PD34-05 Ulchaker, James PII-LBA1 Ulmert, David MP37-10, MP46-19, MP60-10 Umari, Paolo MP43-01, PD11-11, PD40-12 Umarji, Rujuta MP43-06 Umbehr, Martin MP4-02 Umeda, Elizabeth MP61-10 Umemoto, Yukihiro MP33-15, MP78-04 Un, Harun MP76-08 Ün,Tk MP7-20 Unal, Serhat MP48-11 Underwood, Willie MP5-15, MP73-12, MP87-19, PD34-12 Unnikrishnan, Raman MP9-13, PD33-08 Unno, Rei MP33-13, MP34-02, MP34-11, MP34-13 Urakami, Shinji MP26-10 Urbach, David MP42-06 Urbani, Martina MP57-13 Urbanova, Katarina PD43-07 Urbauer, Diana PD25-12 Uren, Aykut MP66-15 Urgan, Rüstemanýl MP76-08 Uribe, Brittany MP22-14 Uriburu Pizarro, Facundo MP48-16 Urologic Diseases of America Project UDA MP9-05 Urzì, Daniele MP26-16, MP71-12 Usami, Masayuki MP34-11, MP41-03, MP41-06, MP80-18 Usta, Mustafa p55 Ustuner, Murat PD2-03 Utard, Guillemette MP2-07 Uy, Jonathan PD45-12 Uzzo, Robert MP24-03, MP24-05, MP47-04, MP47-20, MP50-14, MP67-07, MP67-08, MP67-14, MP70-04, MP84-07, MP84-17, PD12-04, PD12-07, PD35-04, PD49-04, PD49-11, PI-10 p12, p182 V Vacchio, Michael MP7-07, MP7-17, MP35-03 Vacherot, Francis MP55-09 Vaegler, Martin MP11-19, MP19-09, MP19-13 Vaessen, Christophe MP57-02, MP57-12 Vahaboglu, Haluk MP48-01 Valdagni, Riccardo MP66-20, PD34-04 Valdebenito, Patricio MP68-16 Valdivieso, Roger MP13-14, MP59-08, PD31-13, PD49-03, PD49-05 Valenti, Marco PD17-02 Valentini, Francoise MP89-07, MP89-15 Valenzuela, Robert PD48-02, PD48-10, PD48-11 Valeri, Antoine MP13-13, MP13-18 Valerio, Massimo MP48-15 Valiquette, Luc MP59-16, MP59-19, MP Vallo, Stefan MP8-11 Valsecchi, Luca MP76-15 Valujskikh, Anna MP85-16 Valverde Martínez, Sebastián V4-02 Van Ahlen, Hermann MP17-15 Van Arsdalen, Keith MP42-15 Van Batavia, Jason P. MP25-19, MP32-11, MP54-15, MP79-20 Van Cleynenbreugel, Ben MP9-20, MP27-19 Van Criekinge, Wim MP6-12, PD46-09 Van Damme, Nancy MP9-20, MP27-19 Van De Bosche, Hannes MP53-07, PD32-08 van Delden, Otto MP35-05 Van Den Eeden, Stephen p17 van den Hout, Huib MP48-19 Van Der Aa, Frank MP15-16, MP21-06 van der Heijden, Michiel S. PD31-11 van der Heijden, Toine MP65-10 Van der Kwast, Theodorus MP6-14, MP61-01, MP68-04, MP68-05, MP68-06, MP86-15, PD46-07 Van der Poel, Henk MP22-05, MP23-02, MP77-03, PD31-07 Van Eycken, Liesbet MP9-20, MP27-19 Van Houten, Holly PD44-05 van Leeuwen, Ton MP35-05 van Merriënboer, Jeroen MP23-03 van Moorselaar, Jeroen MP35-05 Van Neste, Leander MP6-12, PD46-09 van Ophoven, Arndt PD20-06, p13 van Os, Steve PII-LBA4 Van Poppel, Hein MP56-10, MP82-01, MP87-13 van Rhijn, Bas MP65-06, MP68-06, MP72-15, PD31-07, PD31-11, PD41-05 Van Santvoort, Ann PD7-02 Van Veldhuizen, Peter PD38-02 van Velthoven, Roland p57 van Werkhoven, Erik MP5-10, PD31-07 Van Winkle, Michael PD13-03 Vander Eeckt, Kathy MP15-16 Vander Griend, Donald MP37-18, p99, p169 Vangel, Mark PI-02 Vanni, Alex MP15-09, MP15-17, PD14-06, PD14-08, PI-01, p131 Vapnek, Jonathan PD21-11 Varda, Briony MP87-05 Vardi, Yoram MP52-06, p100 Vargas, Alberto MP53-20 Vargas, H. Alberto MP2-13, MP11-16, PD32-04 Vargas-Alvarez, Hebert A. MP64-11 Vargas, Herbert p174 Varkarakis, Jhon PD17-11 Varnavas, Michalis FRII-11 Varsanik, Jonathan MP1-19 Vasan, Satya Srini PD45-10 Vasavada, Sandip PD27-04, PD28-08, p84, p189 Vasdev, Nikhil MP65-06, MP72-15, PD41-05 Vasquez, Evalynn V7-04 Vass, Justin MP57-04 Vassantachart, Janna PD21-03 Vathsala, Anantharaman MP85-15 Vaughan, E. Camille p12, p190

352 Vaughan, Lisa MP33-07, MP41-05 Vázquez, Fernando MP73-01 vd Poll-Franse, Lonneke MP14-04 Velasquez, Nermarie MP40-08 Veldhuis, Johannes p17 Velet, Liliya MP63-14, PD29-09 Veliev, Evgeniy p221 Velilla, Guillermo V10-03, V10-12 Veltman, Jeroen MP48-19 Veltri, Robert MP1-15, MP6-18 Veneziano, Domenico MP22-06, MP23-19, V6-04 Venier, Natalie MP46-14 Venkataraman, Rajesh MP86-03 Venkatesh, Ramakrishna p218 Venkateshwaran, Srinivasan PD37-08 Venkateswaran, Vasundara MP46-14, PD46-07 Ventimiglia, Eugenio MP4-10, MP51-17, MP51-18, MP74-20, MP76-05, MP76-15, PD52-06, PD52-10 Venzano, Fabio MP53-05 Vera, Pedro L. MP21-17 Vera-Donoso, Cesar MP19-07, MP79-01 Verges, Aleixandre V6-13 Verges, Daniel MP60-16 Vergho, Daniel MP44-17, PI-07 Verhoest, Grégory MP3-19, MP13-13, MP13-18, MP38-10, MP57-02, MP57-09, MP57-12, MP63-12, MP63-15, MP63-16, PD49-02, V9-06 Verma, Sadhna p13 Verri, Cristian PD17-02 Verrill, Claire MP55-12 Verrydt, Megan PD33-01 Vertosick, Emily MP50-18, MP84-06, PD29-03 Verze, Paolo MP18-19, MP67-20, PD9-03, p236 Vesella, Robert p136 Vespirini, Danny MP4-06, PD46-07 Vetter, Joel MP7-07, MP15-07, MP18-08, MP24-12, MP24-14, MP77-15, MP80-07, MP81-04, PD5-05, PD18-09, PD51-07 Vetterlein, Malte PD22-12 Vial, Cecilia MP68-16 Viale, Agnes MP64-02 Vicente-Antón, José MP79-01 Vicente-Ferrer, Silvia MP79-01 Vicentini, Fabio C. MP30-16, MP30-19, MP75-03 Vickers, Andrew MP14-09, MP27-13, MP60-10, PD32-04 Victorson, David MP27-20, PD47-11 Vidal Faune, Alvaro MP65-16 Vidal Mora, Ivar PD29-04 Vidal, Adriana MP4-17, MP14-06, MP14-12, MP60-09, PD6-01, PD38-11, PD39-11 Viega, Francisco Gomez MP73-20 Viers, Boyd MP6-05, MP29-15, MP29-16, MP35-02, MP50-10, MP69-12, MP88-12, MP88-14, PD12-09 Vieweg, Johannes MP33-09, p117 Vigneswaran, Hari MP25-10, PD52-11 Vignozzi, Linda MP71-03, MP71-08 Vigues Julia, Francesc MP38-17 Vijai, Joseph MP6-16 Vila Reyes, Helena MP38-17, MP79-17 Vilaseca Cabo, Antoni MP50-18 Vilaseca, Antoni MP84-06, PD29-03 Villa, Luca MP7-19, MP17-06, MP34-20, MP75-05 Villamil, Antonio V10-05, p176 Villani, Robert MP11-10, MP17-09, PD44-03 Villanueva, Jeff MP3-05 Villari, Donata p236 Villaronga, Alberto PD29-04 Villavicencio Mavrich, Humberto PD29-04 Villavicencio, Humberto PD7-10, PD41-03, V5-06, V5-07, V5-09 Villeda-Sandoval, Christian MP25-18 Villers, Arnauld PII-LBA4, V9-09 Villines, Dana MP18-16 Villoldo, Gustavo PD29-04 Vincendeau, Sébastien MP3-19, MP13-13, MP13-18 Vincenzo, Pompeo PD29-10 Vinshtok, Yuri PD20-03 Violette, Philippe MP30-20, MP42-19, PD51-01 Viprakasit, Davis P. MP27-07 Vira, Manish MP59-09, MP70-03, p183 Viragh, Karoly A. MP11-17 Virasoro, Ramon MP29-03, MP29-13, PI-01, p95 Virk, Navneet MP37-19 Virnig, Beth MP9-11, MP27-18, PD47-07 Visalli, Francesco MP67-20, MP88-03, PD9-03 Viswanath, Satish MP60-04 Vitagliano, Gonzalo p176 Viterbo, Rosalia MP24-03, MP24-05, MP47-04, MP50-14, MP67-07, MP67-08, MP67-14, MP70-04, MP84-07, PD49-04 Vitiello, Gerardo MP79-03 Vitruk, Iurii MP84-01 Vivas-Consuelo, David MP80-11 Vives, Pol Servian MP79-07 Voelzke, Bryan MP15-09, MP15-17, PD2-10, PD14-06, PD14-07, PD14-08 Voets, Thomas PD7-02, PD7-07 Vogel, Hans MP47-19 Vogelzang, Nicholas MP82-09, MP87-12, MP87-15 Volkmer, Bjoern PD11-05 Volkmer, Jens-Peter PD25-01 Volpe, Alessadro MP63-03 Volpe, Alessandro MP59-15 von Bodman, Christian PD47-09 von Mä enhausen, Anne MP68-07 von Rundstedt, Friedrich-Carl PD19-07, V8-03 von Rütte, Thomas V9-12 Vorhis, Elizabeth PD4-03 Voss, Andreas PD25-03 Voss, Martin MP35-01 Vourganti, Srinivas PD44-04, p10, p57 Voylenko, Oleg MP84-01 Vricella, Gino V7-03 Vriesema, Jessica MP48-19 Vydynathan, Amaresh MP41-01 Vykhovanets, Eugene MP46-04 Vykhovanets, Olena MP W Wachtel, Mitchell MP84-16 Wachter, Audrey MP74-08 Wachterman, Jared MP75-02, V6-06 Wada, Naoki MP31-11, MP59-05, PD16-11 Wadhwa, Harpreet MP53-12, PD24-06, PD28-04 Wadie, Bassem p234 Wadlow, Raymond MP82-09 Wagenlehner, Florian MP58-16, p189 Wagenpfeil, Stefan MP56-08 Wagers, Amy p17 Wagner, Andrew MP32-05, MP50-01, MP83-19, MP84-12, MP84-14, PD3-12, PD34-03, V10-10 Wagner, Cordula MP23-03 Wagner, Jennifer MP37-20 Wagner, Joseph MP23-04, MP48-06, MP48-20, PD32-12 Wagner, Todd MP84-02 Wagstaff, Peter MP35-05 Wahlfors, Tiina PD6-09 Wai, Fan Chi p70 Waidelich, Raphaela MP31-10, MP63-09 Waingankar, Nikhil MP24-03, MP24-05, MP50-14, MP67-08, MP67-14, MP84-07, MP84-17, PD12-04, PD12-07, PD49-04, PD49-11 Wainganker, Nikhil PI-10 Wakai, Ken PD3-10, PD46-01 Wakamatsu, Daisuke MP8-01, PD7-01 Wakefield, Mark PD21-08 Wakumoto, Yoshiaki MP26-07 Wald, Alexander MP47-16, PD33-10 Wald, Gal MP39-18 Walker, Gregory MP35-09 Walker, Jennifer MP20-15 Walker, Jonathan PD40-08 Walker, Kenneth MP52-18 Walker, Paul PD21-10 Wallace, Ellen PII-LBA8 Wallace, Stephanie MP25-15 Wallen, Eric MP5-05, MP16-16, MP24-02, MP44-17, MP58-19, MP78-14, PI-07 Wallis, Christopher MP14-08 Wallwiener, Diethelm MP1-16 Walsh, Bradley PII-LBA3 Walsh, Patrick V4-03 Walsh, Thomas p153, p235, p253 Walter, Dawn MP9-03, PD34-11 Walter, Jack p20 Walter, Martina MP35-11, PD35-08 Walter, Matthias MP12-06, MP12-11, MP12-20, PD1-10 Walter, Peter PD38-04, PD38-10 Walther, Philip MP14-13 Walton-Diaz, Annerleim MP14-16, MP17-13, MP70-10, MP82-19, MP82-20, PD4-10, PD38-05 Waltregny, David MP68-04 Waltzer, Wayne MP85-20, V9-08 Walz, Joachen MP77-03 Wan, Ben MP11-07, MP62-09 Wan, Fangning MP14-20, MP37-15, MP47-03 Wan, Gang MP11-07 Wan, Jim MP51-07

353 Wang, Angela MP33-16 Wang, An-Qi PD13-07 Wang, Audrey MP89-14 Wang, Bin MP66-09 Wang, Bo MP45-12 Wang, Chaofu MP50-12 Wang, Chi PD51-08 Wang, Chi-Hsiung MP1-20, MP14-18 Wang, Christina PD37-08 Wang, Chung-Cheng MP21-14, MP31-05 Wang, Dian MP14-10 Wang, Elyn MP56-06 Wang, Feng V6-07 Wang, Fong PII-LBA4, PII-LBA10 Wang, Gary MP34-09 Wang, Hongkai MP50-12 Wang, Hongxiang MP76-01, MP76-02 Wang, Hsiang-Tsui MP36-16 Wang, Hsin-Hsiao MP40-08, MP40-09, MP54-11 Wang, Huanhuan PD36-03 Wang, Jerome MP24-15 Wang, Jianlong MP62-09 Wang, Jianye MP11-07, MP62-09 Wang, Jicheng MP8-18, MP12-01, MP12-07 Wang, Jim MP73-12, MP87-19 Wang, Jinhua MP56-01 Wang, Julie MP22-03, MP22-04, V5-04, V9-14 Wang, Kendric MP49-09 Wang, Liang MP19-20 Wang, Liguo MP55-01 Wang, Lily MP32-16, MP46-10 Wang, Lina MP37-19 Wang, Linhui MP63-07 Wang, Lu MP39-12, MP47-08 Wang, Mei PD15-01 Wang, Ming-Hsien MP20-01 Wang, Patricia MP47-09, MP47-14 Wang, Quan V6-07 Wang, Richard PD52-07 Wang, Run MP52-01, MP52-11, p55, p56, p160 Wang, Shao MP52-09, MP52-10, MP55-19 Wang, Sho-Mon MP2-11 Wang, Song MP15-02, MP51-07, MP69-14, PD35-12 Wang, Stewart MP58-06 Wang, Tao MP52-09, MP52-10, MP55-19 Wang, Vincent PD48-04 Wang, Xiaoyan MP45-18 Wang, Xing MP45-19 Wang, Xinning MP61-15 Wang, Xinyang PD33-12 Wang, Xuan MP11-07 Wang, Yak-Nam MP39-14 Wang, Ye MP84-10, MP84-20, PD21-02 Wang, Yiming MP31-10 Wang, Yves MP17-03 Wang, Zhaohui MP55-10 Wang, Zhen PD31-01 Wang, Zhiping MP8-05 Wang, Zhou MP25-07, MP31-13, PD39-04 Wang, Zi Ting PD17-01 Wang, Zongwei MP31-15, PI-02, MP66-13 Wanis, Michael FRII-09 Ward, John p12 Warde, Padraig MP10-10 Ware Jr., John MP5-16, PD12-05 Warnack, Wolfgang MP73-20 Warner, Douglas MP73-10 Warner, Jonathan PD14-10, V3-14 Warner, Lee MP24-11, PD52-07 Warrior, Krishnan MP85-05 Waseda, Yuma MP7-15 Wasserbauer, Roman MP86-01 Watanabe, Carlos H. MP75-03 Watanabe, Hiroki p136 Watanabe, Masahito PD47-04 Watanabe, Masaki MP59-05 Watanabe-Silva, Carlos MP30-16, MP30-19 Watkin, Nicholas MP10-16 Watson, R. William MP6-20 Watson, William MP61-19, MP86-12 Watts, Kara L. MP41-01, MP85-08, PD25-07 Wayne, George MP26-15 Wayne, Kevin PD9-01 Weaver, Amy PD50-10 Weaver, Brandi PD46-05 Weaver, John K. MP77-15 Webb, Siobhan MP66-18 Weber, Bryce MP20-02 Webster, George MP88-07, MP88-11, MP88-19, PD22-05, PD24-11, PD24-12, V3-01 Weedon, Jeremy MP60-16, MP77-05 Wegenkittl, Stefan PD42-03 Wei, Elizabeth MP69-18, PD33-02 Wei, Huilin PII-LBA8 Wei, John MP3-18, MP6-02, MP11-09, PII-LBA2, MP48-17, PD34-03, PD44-07, MP71-06, PD46-02, PI-08 Wei, Wei MP1-17, MP6-13, MP67-06 Wei, Xuejiao MP5-02 Wei, Yanliang MP67-16 Weidner, Wolfgang MP58-16, MP76-03, p12 Weigler, Gregory p73 Weijie, Gu MP10-06, MP69-04 Weikert, Steffen MP14-19 Wein, Alan MP10-09, MP26-03, MP42-15, PD10-01, PD24-09, PD43-02, p18, p21, p279 Weinberg, Aaron PD29-01, PD48-02, PD48-11 Weinberger, James MP15-10, PD21-11 Weineisen, Martina MP82-10 Weinhold, Philipp MP34-20 Weinreb, Jeffrey MP17-08 Weinstein, John MP72-06 Weirich, Gregor MP82-10, PD32-07 Weisbach, Lars MP58-10 Weiss, Aaron D. MP54-02 Weiss, Brian MP26-03 Weiss, Dana MP18-17 Weiss, Jeffrey MP16-15, MP77-05, MP89-06, MP89-18, p9 Weiss, Robert MP49-10, MP72-10, MP72-13, PD4-04, p257 Weissbart, Steven PD10-01, p18 Weissman, Irving L. PD25-01 Weissman, Joel MP60-01, MP77-12 Weizer, Alon MP1-14, MP2-06, MP2-09, MP7-09, MP26-02, MP48-17, MP56-12, PD31-03, PD43-12, PD44-12, V Weksberg, Rosanna MP21-15 Weld, Kyle MP16-01 Weld, Lancaster MP16-01 Welge, Michael PD20-09 Welk, Blayne PD10-03, PD28-09 Welliver, Charles MP43-19, MP74-06, MP75-14, PD5-03, PD37-09 Welliver, Robert PD26-08 Welty, Christopher MP42-12, MP68-18, PD34-10, PD41-10, PD47-02 Wen, Hui MP39-03, PD33-07 Wencong, Jiang MP61-09 Wendt-Nordahl, Gunnar MP13-08 Weng, Mao-Wen MP36-16 Wenker, Evan P. PD52-01 Wenske, Sven MP14-03, PD30-04 Wentzel, Kristopher MP37-06 Wenzler, David L. MP33-16 Werahera, Priya MP6-06, MP48-02, MP60-08 Werntz, Ryan MP31-20, MP65-18, MP86-14, PD44-02 Wertheim, Margaret L. MP41-20 Wessel, Sean MP53-04, MP60-13 Wessells, Hunter MP18-13, MP81-12, PD42-01, p11 Wester, Hans-Jürgen MP82-10, PD32-06, PD32-07 Westerman, Mary E. MP20-19 Westerveld, Paul MP48-19 Westfall, Nicholas PD50-05 Westfall, Timothy MP31-03 Westlund, Karin N. MP21-17 Westney, O. Lenaine MP67-06, PD25-12, PD40-09, V3-03, p56 Westphalen, Antonio MP53-18 Wetterauer, Ulrich MP3-01 Weyne, Emmanuel MP21-06, MP52-05, PD2-05, PD7-07 Whalen, Michael MP1-09, MP53-11, PD30-04 Wheeler, Karen MP16-07 Wheeler, Marcia A. MP49-10 Whelan, Patrick MP80-20 Whitburn, Jessica MP66-18 White, Bryan PD20-09 White, Catrina MP16-05, PD19-12 White, Mark MP75-14 White, Michael PD21-10, p73 White, Wesley V2-09, V11-04 Whitfield, Matthew MP1-19 Whittam, Benjamin MP40-20, MP54-19 Whitty, Genevieve MP55-05 Wiche, Gerhard MP36-03 Wicks, Katherine MP11-14 Wickstrom, Eric PD4-09 Widmark, Anders PD6-10 Widmer, Corinna MP83-15 Wiedrick, Jack MP71-17 Wiegel, Thomas MP87-13 Wiener, John MP40-08, MP40-09, MP54-11, p59 Wiener, Scott PD32-12 Wietsma, Ashley MP69-08, V7-08, V7-09, V10-09 Wijburg, Carl MP67-19 Wijkstra, Hessel MP48-03 Wikenheiser, Jamie PD7-04 Wiklund, Peter MP67-19

354 Wilber, Andy MP70-08 Wilcox, Charles Mel MP34-17 Wild, Peter MP66-19, MP68-08, MP68-09 Wilhelm, Kerstin MP58-03 Wilken, Nathan PD37-03, PD45-02 Wilkinson, Sarah MP31-09 Will, Susanne MP11-19, PD24-01 Wille, Mark MP9-09 Williams, Andrew MP78-08, MP83-13 Williams, David MP27-04 Williams, J. Koudy p73, p189 Williams, Julia MP37-02 Williams, Michael MP14-02 Williams, Stephen MP36-01, MP72-02 Williamson, Sean MP53-13 Willie, Chantalle J. PD33-01 Willihnganz-Lawson, Katie p17 Willis, Daniel L. MP72-02 Willms, Anna MP83-14 Wilson, Bradley PD51-10 Wilson, Clive MP55-12 Wilson, Kathryn MP6-15, PD6-07 Wilson, Kathryn M. MP50-07, MP77-19 Wilson, Leslie MP9-12 Wilson, Shandra PD7-03 Wilson, Steven p55 Wilson, Timothy MP53-04, MP64-08, MP64-16, MP67-18, MP82-13 Wilson, Tracey p84, p173 Wilson-Harris, Brittaney MP8-10 Win, Ma Thin Mar PD17-01 Wind, Alex MP23-18 Windsperger, Andrew MP29-14, V4-10 Winer Jones, Jessamine MP37-06 Winer, Andrew MP7-07, MP7-17, MP35-01, MP35-03, MP44-07, MP47-13, PD33-02 Winfield, Howard p39 Wingard, Ashley PD7-08 Winick-Ng, Jennifer PD28-09 Winkler, Alfred MP22-18 Winkler, Harry MP30-09, MP80-06, PD18-07, PD18-10, V6-03 Winslow, Timothy PD33-10 Winter, Alexander MP14-19 Winter, Ashley MP16-02, MP16-03, MP56-20, MP76-19, PD45-08 Winters, Brian MP18-13, MP18-13, MP55-14, MP66-15, MP67-17, MP72-19, PD46-04, PD46-12 Winters, J. Christian p13, p44, p84, p173 Winters, Shira PD3-11 Wirth, Manfred MP17-10, MP48-05, MP66-17, PD35-08, p257 Wiseman, Oliver MP30-07 Wisenbaugh, Eric MP71-15 Wissmueller, Sandra PII-LBA3 Withington, John MP16-06, MP30-07 Witjes, Fred MP65-10 Witjes, J. Alfred PD17-11, p11 Witjes, Wim PD16-08 Witt, Jorn H. PD43-07 Witten, Jonathan MP38-13 Witten, Matthew MP62-15 Wittert, Gary PD39-02 Wittig, Kristina MP64-16 Wittmann, Daniela MP14-07, MP27-12, MP27-17, MP43-06 Wittmer, Brad MP31-09 Witzsch, Ulrich MP14-19, PD5-08, PD5-10 Woelk, Joshua PD50-10 Wojtowycz, Andrij PD44-04 Woldu, Solomon MP53-11, PD29-01 Wolf Jr., Stuart MP30-13, MP41-04, MP75-09, PD21-04, PD51-02, V6-12, V10-04, p11, p142, p251 Wolf, Julia MP76-03 Wolf, Sacha PD6-04 Wolf, Stuart MP16-19, MP85-19 Wolfert, Cheryl MP89-01, MP89-03, MP89-09, MP89-10, PD27-10 Wolff, Erika MP10-15, MP42-13, PD28-05, PD28-06 Wolf-Johnston, Amanda MP21-04, MP21-16 Wollin, Daniel MP34-16 Wollmer, Barbara MP26-01 Wöllner, Jens MP11-20 Wölm, Jan-Henning MP8-11 Wolter, Christopher MP71-09, p84 Wolters, Mathias MP26-04, V8-08 Womble, Paul MP42-05, PD44-11 Wong, David PD39-02, PD39-12 Wong, Kelvin MP59-12, MP63-05, MP83-12, PD9-07, PD34-05 Wong, Michael p100 Wong, Pak Kin MP20-10 Wong, Yu-Ning MP67-07, MP87-12, PD12-04, PD12-07, PI-10 Woo, Henry MP3-02, MP13-17, MP32-18, PD5-06, PD19-09, p13, p173, p215 Woo, Howard V2-10 Woo, Jason MP51-07, MP61-14 Wood, Bradford MP14-16, MP17-13, MP48-04, MP82-20, PD4-10, PD30-02, PD38-05, PD44-06 Wood, Case MP40-13 Wood, Christopher MP2-06, MP2-09, MP7-09, PD35-04, PD35-05, PD35-11, MP84-18, p10, p58, p175 Wood, Dan p193 Wood, Erika L. MP26-14 Wood, Hadley p20, p250 Wood, Kirsten MP66-10 Wood, Kyle MP28-02, MP30-17, PD13-11 Wood, Lauren MP24-15, PD21-07, PD28-03 Wood, Nada MP28-06 Woodford, Mark MP39-02 Woods, Michael MP5-05, MP16-16, MP24-02, MP58-19, MP78-14, PD17-06, p10 Woodward, Mark MP51-04 Woon, Dixon (Teck Sing) MP55-05 Worcester, Elaine MP80-10 Wosnitzer, Matthew PD45-08 Wouter, Everaerts V4-04 Wrana, Jeffrey L. MP68-05 Wright, Edward p71 Wright, E. James MP88-18 Wright, Ian MP17-14 Wright, Jonathan MP24-18, MP55-14, MP58-14, MP65-06, MP67-17, MP72-15, MP72-19, PD41-05, PD41-10, PD46-04, PD46-12, PD47-03 Wszolek, Matthew MP26-12, MP50-08 Wu, Chia-Hao MP49-18, MP Wu, Chin-Lee PI-02, MP35-09, MP50-08, MP50-09, MP66-13 Wu, Christina N. MP61-14 Wu, Guan MP3-05, MP39-09, MP65-17, p10, p186 Wu, Jennifer p17 Wu, Jonathan MP53-03 Wu, Kaijie MP66-09, PD33-12 Wu, Kedi PD25-08 Wu, Kenneth PII-LBA10 Wu, Kuan-Yu PD39-03 Wu, Li MP55-19 Wu, Pengjie MP62-09 Wu, Rongpei MP8-03 Wu, Shaoxu MP45-12 Wu, Shulin MP66-13 Wu, Tony p70 Wu, Wen-Jeng MP21-02 Wu, Wenqi PD42-12 Wu, Xian MP65-03 Wu, Xiao MP52-19 Wu, Xiao-Cheng MP14-10, PII-LBA5 Wu, Xifeng MP36-01 Wu, Xue-Ru MP20-03, MP21-11, MP33-02, MP36-16, MP36-19, MP36-20, MP45-15, MP45-19, MP49-01, MP49-06, MP68-13, PD7-12 Wu, Yi-Mi MP37-02 Wu, Zhenjie MP63-07 Wyler, Stephen MP86-07 Wyllie, Michael PII-LBA7 Wymer, Kevin MP38-01 Wynder, Jalissa MP31-19 Wyner, Lawrence FRI-12 Wyre, Hadley MP64-20, PD38-02, p253 Wysock, James MP77-14, MP77-18, MP86-03, PD32-01, PD32-03, PD32-05, PD34-02 X Xi, Yin MP11-14 Xia, Shujie p71 Xiang, Tingxiu MP47-08 Xiao, Bo MP30-04 Xiao, Hong MP68-20 Xiao, Nan MP21-18 Xiao, Zhiying MP8-18, MP12-01, MP12-07 Xiaofeng, Zou MP47-07, PD21-05 Xiaoning, Wang MP47-07 Xie, Li-Ping p71, p97 Xie, M. MP21-08 Xie, Min MP46-07 Xie, Wen PD47-10 Xin, Li p99 Xin, Zhongcheng PD36-09, p71 Xiong, Gengyan MP2-01, MP2-03 Xiong, Genyan MP2-02 Xiong, Siwei V4-03 Xu, Ben MP47-08 Xu, Bin V12-06 Xu, Ding PD16-01 Xu, Duo MP66-11 Xu, Jianfeng PD44-01 Xu, Jingxiong MP61-01 Xu, Limei MP66-01 Xu, Min Hui MP37-07 Xu, Shao-Bo V6-07 Xu, Tong MP37-06, MP37-19 Xu, Weichen MP27-10, MP56-07

355 Xu, Yongde PD36-09 Xu, Yucheng MP37-06, MP37-19 Xu, Zhou MP45-15 Xue, Wei MP28-08, p71 Xylinas, Evanguelos MP2-12, MP63-20, MP65-06, MP67-04, MP72-15, PD41-05 Y Yacoub, Ramy MP20-14 Yadav, Pavan PD37-08 Yafi, Faysal MP15-19, MP43-09, PD36-05, PD48-12 Yaggie, Ryan PD20-09 Yagi, Hiroshi MP76-04 Yagihashi, Yuji PD16-05 Yagisawa, Takafumi MP69-17 Yahyia, Elsaid V11-12 Yakoubi, Rachid PD29-12 Yam, Wai Loon MP30-12 Yamada, Kenji MP62-10 Yamada, Shigeyuki MP87-07 Yamada, Takumi MP2-04, PD23-06 Yamada, Yasutoshi PD23-07 Yamaguchi, Kenya MP86-05, PD50-03 Yamaguchi, Kunihisa MP55-06 Yamaguchi, Noriya MP35-08, MP44-05 Yamaguchi, Osamu MP8-12, MP12-17, PD24-02 Yamaguchi, Raizo PD16-02, PD37-07 Yamaguchi, Seiji MP7-14 Yamaguchi, Tomonori MP61-14 Yamaguchi, Yuka MP15-11, MP29-01, V10-06 Yamamichi, Fukashi PD8-08, PD8-10 Yamamoto, Akira FRII-05, PD4-03 Yamamoto, Hayato MP16-13, MP58-05, MP65-07, MP69-07, MP73-09, PD16-05, PD49-07 Yamamoto, Hidekazu MP62-13 Yamamoto, Sachi MP58-02 Yamamoto, Shinya MP26-10 Yamamoto, Tokunori MP19-17, MP20-05, MP71-20 Yamamoto, Toshihiro MP4-06, MP46-14 Yamamoto, Yasuyo MP55-06 Yamamoto, Yoshiaki MP46-15 Yamamura, Soichiro MP39-16, MP47-11 Yaman, Onder MP43-12 Yamanaka, Hidetoshi MP83-09 Yamanaka, Yataro MP86-05 Yamanobe, Takuya MP75-19 Yamasaki, Mutsushi MP26-10 Yamashita, Hironobu MP49-01, MP68-10 Yamashita, Shinichi MP2-19 Yamashita, Yuki MP51-13, MP51-20 Yamauchi, Atsushi MP49-14 Yamoah, Kosj MP6-03 Yamzon, Jonathan MP49-17, MP61-03, MP64-08, MP67-18 Yan, Wusheng MP66-06 Yanagihara, Yutaka PD4-07 Yanagisawa, Hiromi p73 Yanagiuchi, Akihiro PD8-08 Yanes, Rafael PD2-08 Yang, Alex MP73-16 Yang, An-Hang PD20-12 Yang, Benhai V3-08 Yang, Bin MP21-08 Yang, Bing MP37-20, MP55-11 Yang, Bo MP30-04 Yang, Chi-Rei p70 Yang, Christopher PD26-02, PD26-04 Yang, Claire PD20-07, p76 Yang, David MP11-13, MP58-11, PD3-09, PD21-04, V8-05 Yang, Dongyun MP37-19 Yang, Hao MP76-01, MP76-02 Yang, Hui-Yu PD34-03 Yang, Jian MP46-09 Yang, Jing-Hua MP8-08 Yang, Joy MP46-01, MP46-07 Yang, Jun MP52-09, MP52-10, MP55-19 Yang, Seung Choul MP85-03 Yang, Xiaojian MP52-19 Yang, Yang MP31-04 Yang, Yu PD33-08, V12-06 Yang, Yu-Xiao MP5-08, MP14-14, MP64-04 Yang, Zane MP73-12, MP87-19 Yang, Zhaohai MP7-09 Yang, Zi Hua MP1-10 Yango, Pamela MP74-16 Yano, Akihiro MP2-04, PD23-06 Yao, Jinna MP85-07 Yao, Kai MP10-03 Yao, Masahiro MP58-01, MP73-07 Yao, Zhu MP10-06, MP69-04 Yap, Ronald MP27-09 Yap, Stanley A. MP42-03 Yap, Tet MP43-13, PD2-01, PD48-08, PD52-03, PD52-05 Yared, Joseph MP42-14 Yarlagadda, Vidhush PD6-05 Yarmenitis, Spyros MP48-09 Yaskiv, Oksana MP11-10, MP17-09, MP51-20, MP70-03, PD44-03 Yassin, Aksam MP27-03, PD45-06 Yassin, Dany-Jan MP27-03 Yasui, Takahiro MP33-13, MP33-15, MP33-18, MP34-02, MP34-05, MP34-11, MP34-13, MP34-15, MP38-08, MP41-03, MP41-06, MP62-10, MP80-18 Yasumizu, Yota MP7-10 Yasumoto, Hiroaki MP11-06, MP39-16, MP47-11 Yasunaga, Hideo MP20-18 Yates, Jennifer MP5-16, MP14-17, MP16-20, PD12-05, p219 Yates, Travis MP45-03 Yavuz, Ufuk PD2-03 Yazici, Ozgur MP40-16 Ye, Dingwei MP1-02, MP14-20, MP36-05, MP37-15, MP47-03, MP50-12, MP60-19, MP87-20, PD3-07 Ye, Fei MP49-01 Ye, Xiaohong PD36-03 Ye, Yanquing MP36-01 Ye, Zaojun MP9-17, MP9-18, MP16-08, MP32-02, MP42-05, PD38-06, PD44-11 Ye, Zhang MP52-09, MP52-10, MP55-19 Ye, Zhangqun MP33-17 Yee, Alyssa MP2-13, MP59-02 Yegnasubramanian, Srinivasan p70 Yeh, Chiuan-Ren MP68-13 Yeh, Jing-Ruey PI-09 Yeh, Shuyuan MP37-03, MP Yelfimov, Daniel MP80-09 Yeo, Alexander PD21-03 Yeung, C. K. p59, p117 Yi, Yajun MP49-01 Yi, Yooni MP16-19, MP41-04 Yijun, Xue MP47-07, PD21-05 Yildirim, Asif MP42-20, MP48-01 Yildiz, Turan MP18-18 Yilmaz, Didem MP52-13 Yilmaz, Emrullah MP50-20 Yilmaz, Engin MP40-10 Yilmaz, Hasan PD2-03 Yilmaz, Sercan PD27-03 Yin, Changjun PD13-06, V11-03 Yin, Guo Nan MP52-03, MP52-08 Yin, Peng-Nien MP68-14 Yin, Xiang-Liang V6-07 Yokoi, Satoshi MP8-17 Yokomizo, Akira MP46-11 Yokoyama, Masayoshi PD4-07 Yokoyama, Minato MP2-18, MP11-12, MP65-04, PD17-07, PD32-02 Yokoyama, Osamu MP8-17, MP12-04 Yonese, Junji MP11-12, PD17-07 Yonese, Jyunji MP26-10 Yoneyama, Mihoko Sutoh MP36-03 Yoneyama, Takahiro MP16-13, MP56-15, MP58-05, MP65-07, MP69-07, MP73-09, PD16-05, PD49-07 Yoneyama, Tohru MP58-05, MP65-07 Yong, Courtney PD13-07 Yong, Daniel V5-03 Yoo, Changhee PD29-08 Yoo, Eun Sang MP18-06 Yoo, James MP29-18, MP29-19 Yoo, Koo Han MP25-01 Yoo, Sangjun MP22-02, MP78-02, PD39-10 Yoon, Jang Ho MP13-09, MP25-04 Yoon, Renai PD7-04, PD13-04 Yoon, Sang Jin MP3-17, MP31-12, PD21-01 Yoon, Sangjin MP16-11 Yoon, Sol MP43-14 Yoon, Sungroh MP37-08 Yoon, Young Eun MP85-03 Yorozu, Atsunori MP83-09 Yoshida, Kanae MP58-02 Yoshida, Kazuhiko MP2-17, MP69-17 Yoshida, Soichiro MP2-18, MP11-12, MP58-08, MP65-04, PD15-02, PD15-06 Yoshida, Teruhiko MP36-04 Yoshida, Tetsuya V11-05 Yoshikawa, Kazuaki PD16-05 Yoshikawa, Kazuhiro MP49-14 Yoshikawa, Satoru MP12-12, MP21-05 Yoshimoto, Takanobu PD3-08 Yoshimura, Koji MP60-02 Yoshimura, Naoki MP12-12, MP12-14, MP12-18, MP21-05, MP25-05, MP25-07, MP31-13, MP88-01, MP89-20, PD1-11, PD16-04, PD20-05, PD27-11, PD39-04 Yoshino, Hirofumi MP36-08, MP36-13, PD33-05 Yoshino, Yasushi PD29-11 Yoshioka, Kunihiko MP62-20 Yoshiyama, Mitsuharu MP21-13 Yoshizako, Takeshi MP11-06

356 Yoshizawa, Carl MP45-14 Yoshizawa, Takahiko PD47-04 Yoshizawa, Tsuyoshi MP12-12, MP12-18 Yossepowitch, Ofer PD11-12, PD17-12, PD23-03 You, Changhee MP41-17 You, Chaochen PD6-05, PD23-11 You, Dalsan MP19-19, MP22-02, MP69-13, MP78-02, PD39-10 You, Kwang Ho MP13-07, MP31-12, PD21-01 You, Y. Nancy PD40-09 Young, April p175 Young, Denise MP61-10, MP61-16, MP61-20, MP66-06 Young, Jonathan MP35-13 Youngnam, Jing PI-09 Youseff, Ramy MP33-12 Yousefi, Kasra MP1-04, MP1-11, MP1-12, MP6-03, MP6-09, MP53-17, MP61-11 Youssef, Ramy MP7-18, MP22-14, MP28-09, MP30-13, MP80-16, PD7-04, PD41-07 Yu, Evan MP65-06, MP72-15, MP87-03, PD41-05 Yu, Ho Song MP20-11, MP71-04 Yu, James B. MP56-06 Yu, Julie MP67-16 Yu, Kaixin MP62-08 Yu, Margaret K. MP87-16 Yu, Richard PD21-02, V7-08, V7-09, V10-09 Yu, Sue-Jean MP42-18, MP62-03 Yu, Sylvia PD43-09 Yuan, Ping MP52-19 Yuan, Qing MP11-14 Yuanhu, Yuan MP47-07, PD21-05 Yuasa, Takeshi MP26-10 Yue, Binglin MP50-02 Yuen, John MP48-08 Yuge, Kazuyuki PD17-03, PD17-08 Yuh, Bertram MP53-04, MP53-16, MP64-08, MP64-16, MP67-18, MP82-13 Yuichirio, Tanaka MP39-16, MP47-11 Yun, Seok Joong PD51-12 Yuruk, Emrah MP26-06, MP30-02, MP33-08 Yyagi, Pradeep MP12-18 Z Zabbarova, Irina MP21-12, PD7-05 Zabor, Emily MP7-13, MP35-03, MP50-16, MP64-03 Zachariah, Finly MP64-08 Zacharias, Mario MP14-19 Zacharis, Aristeidis PD35-08 Zacharopoulos, Georgios MP48-09 Zafar, Nauman MP13-19 Zaffuto, Emanuele MP48-13, MP78-13, MP82-02 Zagaja, Gregory MP37-18, PD18-02 Zahnd, Whitney MP9-06 Zahran, Mohamed MP30-06, MP79-10, PD9-02 Zaid, Harras MP65-09 Zainfeld, Daniel PD11-03, PD51-10, V4-10 Zaiton, Fatma MP18-02 Zakaria, Ahmed MP72-05 Zakaria, Mahmoud PD23-05 Zakohji, Hidenori MP8-14, V7-12 Zalewski, Alexandra PD25-08 Zamilpa, Ismael PD24-07 Zangi, Mahdi V8-04 Zanni, Giuseppe MP48-13 Zanoni, Matteo Luigi MP88-05 Zanotelli, Tiziano PD35-01 Zaontz, Mark p17 Zapata, Daniel MP14-06, MP40-08 Zapf, Matthew MP18-11, MP64-12, PD4-05 Zappala, Stephen MP77-20, PD38-03 Zappala, Steve MP60-06 Zappavigna, Christopher MP29-09, PD14-02 Zargar Shoshtari, Homayoun V8-10 Zargar, Homayoun MP35-07, MP50-15, MP63-06, MP63-10, MP63-13, MP65-06, MP70-02, MP70-16, MP70-17, MP70-18, MP72-15, MP72-17, PD31-09, PD41-05, V4-01, V4-11, V8-02, V9-05 Zargar-Shoshtari, Kamran MP10-11, MP50-02, MP59-10, MP65-06, MP72-15, MP72-17, PD31-09, PD41-05 Zaridze, David G. MP4-09 Zars, Elizabeth L. MP33-06 Zastrow, Stefan MP17-10, MP48-05, PD35-08 Zattoni, Fabio MP53-07, MP57-13, MP82-14, PD19-01, PD32-08, PD43-04, PD43-08 Zattoni, Filiberto PD19-01 Zattoni, Michela MP19-15 Zdravic, Darko PD46-07 Zeccolini, Guglielmo MP57-13 Zecha, Henrik PD43-07 Zee, Tiffany MP33-04, MP34-06 Zegna, Luisa MP44-04 Zehir, Ahmet MP64-02 Zehnder, Pascal V9-07, V9-12 Zeliadt, Steven MP9-03 Zelichenko, Genady MP17-04 Zemp, Logan MP29-02 Zeng, Guohua PD42-12 Zeng, Xingruo MP45-15 Zennami, Kenji PD47-04 Zequi, Stenio PD29-04 Zerbib, Marc MP67-04 Zganjar, Andrew MP74-13 Zha, Xinmin MP12-04 Zhan, Tianyu MP48-17, MP68-20 Zhan, Yang MP66-11 Zhang, Bin MP52-19 Zhang, Chong MP76-12 Zhang, Cindy MP37-11 Zhang, Di MP1-20 Zhang, Dongyun MP45-15 Zhang, Fan MP46-15 Zhang, Guangjian MP49-11, MP49-12 Zhang, Guiming MP47-03, MP50-12, MP60-19 Zhang, Haijing PD24-12 Zhang, Hailiang MP14-20, MP36-05, MP37-15, MP47-03, MP50-12, MP87-20 Zhang, Haitao MP6-11 Zhang, Hanwei MP Zhang, Hao MP52-19 Zhang, Hong MP78-11 Zhang, Jianping MP72-06 Zhang, Jian-Ting MP19-20 Zhang, Jun PII-LBA8, MP55-01 Zhang, Kelvin MP45-18 Zhang, Lei MP2-01, V12-06 Zhang, Lian MP39-12, MP47-08, MP55-10 Zhang, Liying MP4-06 Zhang, Nan MP1-05 Zhang, Qi Fan MP55-20 Zhang, Qian MP39-12, MP47-08, MP55-10 Zhang, Wei MP11-07 Zhang, Wenhao MP31-06, MP52-16 Zhang, Xiao Chun MP47-02 Zhang, Xiaohu MP68-17 Zhang, Xiaotun MP55-14, MP66-15, PD47-03 Zhang, Xiao-Wen V12-06 Zhang, Xin MP47-18, MP68-15 Zhang, Xinhua MP31-06, MP52-16 Zhang, Yan MP52-09, MP52-19 Zhang, Yaoguang MP62-09 Zhang, Yaqiang MP25-02 Zhang, Yaqun MP62-09 Zhang, Yingchun PD24-03 Zhang, Yiyun PI-09 Zhang, Yong MP11-07 Zhang, Yuanyuan MP8-03, MP11-07, MP21-08, MP47-12, PD36-03 Zhang, Yue MP11-14 Zhang, Zhenmei MP41-01 Zhang, Zhi Qian MP47-02 Zhang, Zhiling MP63-14, PD29-09 Zhang, Zhong Yuan MP47-02 Zhao, Fang PD46-07 Zhao, Fujun MP32-16, PD2-02, PD26-09 Zhao, Keke MP31-06 Zhao, Lee MP15-11, MP29-01, PD37-11, V10-06, p20, p71 Zhao, Philip MP3-06, MP18-01 Zhao, Shan Shan PD47-03 Zhao, Shuang MP6-09 Zhao, Wei MP2-01, MP47-02 Zhao, Zhijian PD42-12 Zhao, Zuohui MP8-08 Zheng, Jean p56 Zheng, Junhua MP47-12 Zheng, Yan PI-04 Zheng, Yichun MP49-15, MP49-16, MP61-18 Zheng, Yingye PD34-03 Zheng, Zongyu MP68-10 Zhivov, Alexei p221 Zhong, Guangzheng MP49-05 Zhong, Pei MP33-12 Zhong, Weide MP66-13 Zhong, Wen PD42-12 Zhou, Amy MP14-17 Zhou, Fangjian MP10-03 Zhou, George MP85-20 Zhou, Haiping MP36-20, MP45-19 Zhou, Jiancheng MP66-09, PD33-12 Zhou, Jing V6-07 Zhou, Li MP2-01 Zhou, Li Qun MP47-02 Zhou, Liqun MP2-02, MP2-03, MP49-19, PD33-09, p70

357 Zhou, Ming MP53-15, MP56-01, MP77-14, MP77-17, MP77-18, PD4-11, PD32-01, PD32-03, PD32-05, PD34-02 Zhou, Pengbo MP66-01 Zhou, Shaoqing MP55-17 Zhou, Shaw p71 Zhou, Xiangfu PD20-04 Zhou, Xiaobo MP8-03 Zhou, Xinyao MP25-02 Zhou, Zhongxing MP3-07 Zhu, Gang MP62-09 Zhu, Guangjing MP1-15 Zhu, Guodong PD33-12 Zhu, Hui MP8-16, MP17-03, MP44-10, MP57-06, MP84-05, MP84-15, PD24-08, PD29-07 Zhu, Li MP73-10 Zhu, Yao MP1-02, MP10-11, MP14-20, MP37-15, MP47-03, MP50-12, MP60-19, MP87-20, PD3-07 Zhu, Yezi MP46-01, MP46-05 Zhu, Yiping MP36-05 Zhuang, Liyan p70 Zhumkhawala, Ali MP49-17, MP61-03, MP67-18 Zhuo, Yangjia MP66-13 Zidan, Essam M. PD9-02 Ziegelmann, Matthew MP88-12, MP88-14, MP88-16 Ziemba, Justin PD23-12 Ziemlewicz, Timothy MP35-17, MP44-16 Zietman, Anthony MP26-12, MP62-14 Zigeumer, Richard MP2-12, MP44-17, MP69-02, MP70-09, MP84-04, PD49-08, PI-07 Zilberman, Dorit MP78-06, MP80-06, V6-03 Zimmermann, David MP13-08 Zimmermann, Reinhold PD42-03 Zimmern, Philippe MP81-11, MP81-15, PD8-02, PD50-02, PD50-06, V2-06, p13, p44 Zini, Armand MP74-08 Zinman, Leonard PI-01 Ziogas, Argyrios MP59-13 Zipper, Ryan W. PD3-09 Zirkin, Barry PD36-08, p17 Zisman, Amnon PD20-03 Zisman, Anna MP80-10 Zlatev, Dimitar V. PD15-07, PD25-01, PD25-04 Zlotta, Alexandre MP4-05, MP37-11, MP42-01, MP60-20, MP61-01, MP67-16, MP68-04, MP68-05, MP68-06, MP73-02, MP86-15, MP86-16, PD46-07, PD47-10 Zondervan, Patricia MP35-05 Zonnenberg, Bernard PD35-10 Zorlu, Ferruh MP42-20 Zorn, Kevin MP13-02, MP13-14, MP13-16, MP43-04, p9, p166 Zorn, Kristin PD35-05 Zou, Jiangang MP3-07 Zou, Kelly MP24-13, PD27-06 Zoubeidi, Amina MP37-12 Zubert, Tricia p135 Zubieta, Maria E. PD11-10 Zubillaga, Sergio V10-03, V10-12 Zuccarino-Crowe, Rian MP41-19 Zucchi, Alessandro MP81-18, PD45-11 Zuckerman, Jack MP29-03, MP29-13 Zuo, Li MP3-07 Zurstrassen, Charles V11-09 Zvara, Peter MP71-07 Zvarová, Katarína MP71-07 Zweers, Peter MP11-20 Zwirewich, Charles MP38-06 Zylstra, Samuel PD

358 A ACE V7-06 Adenocarcinoma PD4-10, PD5-09, PD6-01, MP56-14, MP61-07, V11-14, MP86-17 Adenovirus MP61-13 Adrenal PD3-01, PD3-02, PD3-03, PD3-04, PD3-07, PD3-08, PD3-10, PD3-11, PD3-12, MP18-08, V5-10, V11-02, V11-06, V11-08, V11-09 Adrenergic agonists PD27-12 Adrenergic receptors MP31-10, MP89-20 Adverse events PD4-05, MP9-11, MP9-15, PD6-10, MP14-03, MP18-11, MP26-18, MP24-19, MP23-03, MP29-20, PD19-11, PD21-02, PD24-09, MP45-10, PD29-05, PD35-04, PD36-07, MP64-07, MP63-01, MP62-07, MP67-14, MP69-03, MP69-16, MP73-01, MP73-03, MP75-17, MP81-19, MP84-07, MP84-10, MP87-18, MP85-11, MP85-13, MP88-11 African Americans MP4-04, MP1-12, MP6-03, MP42-15, FRI-13, MP48-07, MP53-04, MP55-18, MP60-16, MP77-19, MP86-20 Age MP8-06, MP8-12, MP13-12, MP9-02, MP21-05, PD12-08, PD19-09, PD24-09, PD27-05, MP52-09, PD29-07, MP57-17, MP59-16, PD43-02, MP80-02, MP84-03, MP88-14, PD51-12, PI-02 Algorithms MP2-18, MP6-09, MP34-06, MP48-20, MP75-02, PD46-09, MP79-11, MP79-12 Alpha-adrenergic blockade MP24-12, MP31-09, MP31-12 Alpha-blockers PD3-09, PD6-02, MP24-14, MP27-01, PD16-03, PD16-06, PD16-07, PD16-08, MP31-02, MP40-01, MP41-06, MP41-09, MP41-17 Alpha-reductase inhibitor MP4-02, PD6-02, MP24-12, PD16-02, MP64-05, MP86-05 Alpha-subtype selective compounds MP52-04 Ambiguous genitalia FRII-01 Analgesia V3-08, PD21-10, PD40-06 Anatomy PD7-08, MP28-07, MP30-11, V4-01, MP38-19, FRI-11, FRII-11, MP50-12, PD36-10, PD38-05 Androgen MP6-10, MP6-11, MP31-04, MP31-07, MP31-08, MP31-11, MP31-15, MP37-02, MP37-03, MP37-04, MP45-04, MP46-01, MP46-06, MP47-05, MP55-13, MP55-16, MP61-06, MP61-20, PD36-08, PD37-08, MP66-08, MP66-09, MP66-11, MP76-14, MP83-10 Androgen antagonist PD12-04, MP24-07, MP37-07, MP46-03, MP46-05, PD27-11, FRII-03, MP49-16, PD30-09, MP73-14, MP87-06 Andrology MP9-07, MP31-06, MP43-10, SUBJECT INDEX FRI-11, PD37-02, PD37-06, PD45-11 Anesthesia MP5-14, MP16-01, PD46-11 Angiogenesis MP11-14, MP19-03, MP39-15, PD33-01 Animal model MP8-01, MP8-02, MP8-04, MP8-05, MP8-09, MP8-10, MP8-13, MP8-15, MP12-04, MP12-19, MP15-19, PD7-05, PD7-07, PD7-12, MP21-11, MP21-12, MP19-04, MP19-06, MP25-06, MP31-11, MP33-03, MP33-04, MP33-06, MP33-11, MP33-15, PD20-04, MP39-05, MP39-09, MP40-04, MP34-01, MP34-04, MP34-09, MP34-11, MP34-20, PD21-03, V5-12, MP46-04, MP46-12, MP46-14, PD25-01, MP49-13, MP49-14, MP55-13, PD36-08, PD36-09, MP68-13, MP69-01, MP75-05, MP85-14 Antiangiogenesis MP66-04 Antibiotics PD8-01, PD8-11, PD10-09, MP20-11, MP20-12, MP20-14, MP25-15, MP25-16, MP25-17, MP25-20, MP28-03, MP30-18, MP54-03, MP54-09, MP54-12, MP54-18, MP75-12, MP88-19 Antibody PD25-01 Anticholinergics MP27-01, MP41-17 Antineoplastic agents MP39-11, MP46-07, MP65-12, MP69-12 Antioxidants MP6-08, MP33-19, MP34-05, MP34-12, MP46-13, MP49-12, MP76-07, MP76-08 Antitumor effect MP45-15, MP46-08, MP49-11, MP49-15, MP49-16, MP49-17, MP55-19, MP61-03, MP61-18, MP66-02, MP66-04, MP69-12 Apoptosis MP36-10, MP36-11, MP37-13, MP39-06, MP39-11, MP39-19, MP45-06, MP45-13, MP46-09, MP49-11, MP49-20, PD47-08 Arteries and veins PD22-03, PD36-02, PD40-01, PD49-07 Artificial urinary sphincter MP15-12, PD10-11, V3-01, V3-02, V3-03, MP29-07, MP29-08, V10-08, MP88-12, MP88-14, MP88-15, MP88-16, MP88-18, MP88-19, MP88-20 Augmentation V10-06 Autoimmune disease MP25-11, MP79-08 Azoospermia MP74-07, MP74-08, MP74-09, MP74-10, MP76-06, MP76-09, MP76-10 B Basic research MP8-01, MP8-13, PD3-05, MP12-03, MP12-08, MP12-12, MP12-15, MP15-08, PD7-01, PD7-02, PD7-05, PD7-06, PD10-10, MP21-01, MP21-05, MP21-11, MP21-13, MP20-01, MP20-02, MP19-02, MP19-05, MP19-06, MP19-07, MP19-08, MP33-03, MP33-04, MP33-15, MP36-03, MP36-15, MP39-17, MP40-02, MP40-04, MP34-17, V5-13, MP45-02, MP47-02, MP47-09, MP47-10, MP47-12, 346 MP49-01, MP49-07, MP49-13, MP52-15, MP55-07, PD33-05, PD33-06, MP66-01, MP66-19, MP68-15, MP72-06, MP76-10, MP81-01, PD50-01, MP85-16 Behavioral modification MP8-11, PD16-10, MP41-20 Benign glands MP3-14, MP6-18, MP15-20, MP19-20 Biochemical failure MP56-03, MP66-05, MP82-19 Biochemical progression MP36-18, MP47-17, MP61-08, MP87-01 Biochemical recurrence MP4-13, MP1-14, MP6-18, MP6-19, MP6-20, MP37-18, MP37-19, MP53-04, MP53-05, MP53-09, MP53-11, MP53-13, MP56-08, MP56-09, MP56-11, MP56-15, PD32-06, PD32-08, MP62-17, PD43-11, MP82-06, MP82-08, MP82-11, MP77-03, MP78-09, MP78-12, MP87-04, MP83-18 Biofeedback PD18-04 Biologic predictors MP1-01, MP6-05, MP16-13, MP45-05, MP46-10, MP53-18, MP56-13, PD33-12, MP66-05, MP68-09, MP87-11 Biomarkers MP2-02, MP2-05, MP1-03, MP1-04, MP1-05, MP1-06, MP1-07, MP1-08, MP1-10, MP1-12, MP1-14, MP1-17, MP1-19, MP7-02, MP7-11, MP6-01, MP6-02, MP6-03, MP6-07, MP6-12, MP6-13, MP6-15, MP6-20, PD3-05, MP11-11, MP17-12, MP20-06, MP20-10, PD20-09, MP36-04, MP36-08, MP36-14, MP39-15, MP39-16, MP35-02, MP35-14, MP35-15, MP35-20, MP37-06, MP37-09, MP37-11, MP37-18, PD23-04, PD23-07, PD23-08, PD23-09, MP45-03, MP45-06, MP45-10, MP45-14, MP45-17, MP47-11, MP47-14, MP47-15, MP47-19, MP47-20, MP44-01, MP44-07, MP44-08, MP44-18, MP46-04, MP49-18, MP49-19, MP55-08, MP55-15, MP56-13, PD33-02, PD33-09, PD32-11, MP58-01, MP58-02, MP58-05, MP58-07, MP58-08, MP58-10, MP61-07, MP61-11, MP61-16, MP61-17, MP60-02, MP60-06, MP64-03, MP66-03, MP66-05, MP66-06, PD41-08, PD41-11, PD38-03, MP68-03, MP68-08, MP68-14, MP67-16, MP69-18, PD44-07, MP71-01, MP71-05, MP72-06, MP75-08, PD46-07, MP76-02, MP77-17, MP77-20, MP79-16, MP86-12, MP86-15, MP86-16, PD52-04 Biopsy MP1-15, MP5-14, MP6-02, PD4-12, V2-14, MP11-05, MP11-06, MP11-08, MP11-09, MP16-03, MP17-08, MP14-13, MP14-16, MP22-18, PD12-01, PD12-02, MP25-03, MP25-11, MP25-16, MP25-17, MP25-18, MP25-19,

359 MP25-20, V4-09, MP35-04, MP35-05, MP35-09, MP35-17, MP47-10, MP44-16, MP42-03, MP50-08, MP50-09, MP50-12, MP50-13, MP48-01, MP48-02, MP48-06, MP48-07, MP48-08, MP48-09, MP48-10, MP48-11, MP48-12, MP48-15, MP48-16, MP48-17, MP48-18, MP53-15, PD30-01, PD30-02, MP57-01, MP57-06, PD32-01, PD32-02, PD32-03, PD32-04, PD32-05, PD32-12, V8-06, MP60-05, MP60-09, MP60-11, MP60-20, PD34-01, PD34-11, PD38-06, PD38-08, PD38-09, PD38-13, PD44-06, PD44-07, PD44-08, PD44-12, PD46-03, PD46-09, PD46-11, PD46-12, MP77-02, MP77-03, MP77-05, MP77-14, MP77-15, MP77-17, MP78-02, MP78-03, MP79-07, MP86-01, MP86-04, MP86-10, MP86-13, MP86-15, MP86-18, MP86-19, MP83-04, MP83-20, PII-LBA2 Bisphosphonates MP34-07, MP41-03 Bladder MP2-08, PD1-02, MP8-07, MP8-17, MP12-09, MP12-14, PD7-02, PD8-02, PD8-09, MP21-01, MP21-10, MP21-14, MP21-17, MP20-03, MP20-07, MP20-08, MP20-17, MP19-06, MP27-20, MP31-05, PD17-05, PD17-07, PD17-08, PD20-01, PD20-02, PD20-03, PD20-11, PD24-02, PD24-08, PD24-12, FRI-02, V7-07, MP65-04, MP64-10, V10-13, MP71-14, MP72-16, V12-03, MP81-02, MP81-03, MP89-12, MP89-17, MP89-19 Bladder augmentation MP19-04, MP19-11, PD11-10, V10-05, V10-07, V12-10 Bladder cancer MP2-03, MP2-06, MP2-09, MP2-14, MP7-04, MP7-06, MP7-12, MP7-20, MP5-01, MP5-02, MP5-03, MP5-04, MP5-05, MP5-06, MP11-15, MP11-16, MP16-02, PD9-03, PD9-05, PD9-06, PD9-07, PD10-10, PD12-06, PD11-03, MP26-01, MP26-02, MP26-03, MP26-06, MP26-07, MP26-08, MP26-09, MP26-10, MP26-11, MP26-13, MP26-14, MP26-16, MP26-17, MP26-18, MP26-19, MP26-20, MP24-05, PD15-02, MP32-01, MP32-07, MP32-15, MP29-16, PD17-01, PD17-02, PD17-03, PD17-04, PD17-06, PD17-10, PD17-12, PD18-06, MP36-01, MP36-02, MP36-03, MP36-05, MP36-06, MP36-07, MP36-08, MP36-09, MP36-13, MP36-17, MP36-19, MP36-20, PD23-01, PD23-04, PD23-05, PD23-06, PD23-09, PD23-10, PD23-11, PD23-12, MP45-01, MP45-02, MP45-04, MP45-05, MP45-08, MP45-09, MP45-11, MP45-12, MP45-13, MP45-14, MP45-15, MP45-17, MP45-19, MP43-06, PD25-02, PD25-03, PD25-04, PD25-05, PD25-06, PD25-07, PD25-10, PD25-11, FRI-10, MP49-01, MP49-04, MP49-05, MP49-06, MP49-07, MP49-08, MP49-10, MP49-11, MP49-12, MP49-13, MP49-14, MP49-15, MP49-17, MP49-18, MP49-19, PD31-02, PD31-03, PD31-08, PD31-09, PD31-11, V8-02, V8-04, V8-05, V8-07, V8-08, V8-10, MP58-02, MP58-03, MP58-06, MP58-07, MP58-08, MP58-09, MP58-10, MP58-11, MP58-12, MP58-14, MP58-19, MP65-01, MP65-05, MP65-06, MP65-08, MP65-13, MP65-14, MP65-16, MP65-17, MP65-18, MP65-19, MP65-20, MP64-01, MP64-03, MP64-04, MP64-05, MP64-06, MP64-08, MP64-09, MP64-14, MP64-18, MP64-19, MP64-20, PD41-02, PD41-03, PD41-06, PD41-07, PD41-08, PD41-12, MP68-01, MP68-02, MP68-03, MP68-04, MP68-05, MP68-07, MP68-10, MP68-11, MP68-12, MP68-13, MP68-14, MP68-15, MP68-16, MP68-17, MP68-18, MP68-19, MP68-20, MP67-01, MP67-04, MP67-12, MP67-13, MP67-14, MP67-15, MP67-16, MP67-18, MP67-19, MP67-20, MP72-02, MP72-04, MP72-06, MP72-10, MP72-11, MP72-12, MP72-16, MP72-20, V12-07, MP85-06, PI-06, PII-LBA8 Bladder cells MP8-02, MP21-19, MP20-04, MP19-04, MP36-16, MP36-18 Bladder contraction MP12-04, MP12-07, PD10-04, MP21-19, V10-05 Bladder dysfunction PD1-04, MP8-01, MP8-06, MP8-08, MP8-13, MP8-14, MP12-02, MP12-08, MP12-13, MP12-17, MP12-19, PD7-01, PD7-07, PD7-11, PD10-04, MP21-07, MP21-15, MP21-19, MP21-20, MP27-11, MP31-01, PD27-02, PD27-06, V7-01, MP54-17, MP71-07, MP85-12, MP89-14, MP89-16, MP89-20 Bladder exstrophy MP22-08, FRI-04, V7-04 Bladder hyperactivity PD1-03, MP8-08, MP8-12, MP8-15, MP8-19, PD5-04, MP12-01, MP12-17, MP21-18, MP25-05, PD20-04, PD20-05, PD27-12, MP71-20, MP89-03 Bladder hypertrophy MP31-18 Bladder neck V2-02, V2-14, MP15-14, PD7-04, V4-05, V10-02 Bladder neck obstruction MP15-05, MP15-06, PD14-03, MP52-13, V10-02 Bladder obstruction PD5-08, PD5-10, PD7-11, V3-14, MP31-14, V10-02, MP89-18 Bladder reconstruction V2-09, MP19-05, MP19-10, MP18-07, PD11-09, MP29-09, V7-05, MP67-20, V11-01, V12-07, MP79-19 Bladder rupture PD17-10, FRI-12 Bladder smooth muscle MP12-15, MP12-16, MP21-16, MP21-18, MP19-05, MP19-08, MP19-10, 347 MP31-11, V11-01 Bone MP1-18, PD4-02, MP47-17, MP46-16, MP46-19, MP61-08, MP61-14, MP66-18, MP69-20, MP73-07, MP73-10 Botulinum toxin PD1-01, PD1-02, PD1-03, PD1-04, PD1-05, PD1-06, PD1-07, PD1-08, MP8-20, PD7-08, PD20-02, PD27-05, PD27-08, PD45-09, MP81-03, MP89-13, MP89-17, PI-04 BPH MP3-02, MP3-03, MP3-04, MP3-06, MP3-07, MP3-08, MP3-09, MP3-11, MP3-13, MP3-15, MP3-18, MP3-19, PD5-02, PD5-03, PD5-05, PD5-07, PD5-11, PD5-12, MP13-01, MP13-04, MP13-06, MP13-07, MP13-08, MP13-09, MP13-10, MP13-11, MP13-12, MP13-19, MP16-11, MP24-12, MP24-13, MP24-14, PD16-01, PD16-02, PD16-04, PD16-05, PD16-07, PD16-10, PD16-11, PD16-12, V3-12, MP31-06, MP31-07, MP31-15, MP31-16, MP31-19, MP31-20, V4-13, V4-14, V8-05, PD39-09, PD39-10, PD39-12, MP71-02, MP71-05, MP71-06, MP71-09, MP71-12, MP71-13, MP71-14, MP71-15, MP89-15, PI-02, PII-LBA1 Brachytherapy MP62-11, MP62-13, MP62-16, PD47-07, MP78-09, MP87-04, MP83-09 Brain PD1-10, MP8-17, MP12-06, MP12-10, MP12-20, PD36-03 C Cadherin MP49-08 Calcium MP33-01, MP33-10, MP33-14, MP41-03, MP80-07 Calcium channel blocker PD3-09, MP31-09 Calculi MP11-02, MP11-03, MP11-04, PD8-05, MP20-14, PD13-06, PD13-08, MP28-08, MP28-10, MP33-10, MP33-17, MP33-18, MP30-04, MP30-07, MP40-19, MP34-03, MP34-16, MP38-04, MP38-08, MP41-03, MP41-07, MP41-12, MP41-15, V6-07, FRI-15, MP51-15, MP54-20, V9-08, PD42-09, MP75-02, MP75-09, MP75-20, MP80-08, MP80-14, MP80-17, PD51-02, PD51-06, PD51-10 Cancer MP4-08, MP7-09, MP7-10, PD3-03, PD4-10, MP9-06, PD9-11, MP24-01, MP24-20, MP27-19, PD17-07, PD17-08, MP39-01, MP39-09, MP35-14, MP44-08, FRII-04, MP48-14, MP51-09, V8-14, MP58-18, PD35-07, MP65-04, MP65-09, MP70-03, PD47-05, MP82-09, MP84-17, MP87-10, MP85-18, PD52-11 Cardiovascular disease MP13-15, MP27-02, MP51-04, MP51-19, PD30-09, PD36-02, PD37-04, PD39-09, PD45-08, MP73-03, MP73-05, PD49-04 Castration MP14-12, MP46-16, FRI-05, FRII-13, MP66-11, MP66-14, MP73-16, MP82-04

360 Catheterization PD10-09, MP20-15, PD11-06, PD16-05, MP29-07, MP54-06, MP54-13, PD43-07 Cavernous nerve MP52-04, MP52-12 Cell lines MP19-01, MP19-15, MP39-17, MP47-05, MP49-15, MP49-16, MP55-09, MP55-20, MP66-02, MP66-08 Cells MP19-02, MP19-14, MP29-19, MP34-14 C-fiber PD20-05 Chemokines MP12-14, PD39-04 Chemotherapy MP2-18, MP2-19, MP11-16, MP10-01, MP10-14, MP16-02, MP18-09, MP26-03, MP26-11, MP26-13, MP26-20, PD17-02, PD17-09, MP45-11, MP45-17, MP45-18, MP46-11, MP46-20, MP49-09, MP49-20, MP55-01, MP55-07, MP55-19, PD31-11, PD31-12, MP58-09, MP58-18, MP61-17, MP61-18, MP65-05, MP65-06, MP65-07, MP65-08, MP65-09, MP66-04, MP66-14, PD41-05, MP68-20, MP67-06, MP67-07, MP67-08, MP72-01, MP72-02, MP72-07, MP72-08, MP72-09, MP72-15, MP82-18, MP87-02, MP87-07 Chromosomes MP37-02, MP47-04, PD52-05 Clinical protocols V3-07, MP41-12, PD27-01, MP53-02, PD35-01, MP79-13 Clinical trial MP3-02, PD8-07, MP21-07, PD17-06, PD17-09, PD20-10, MP40-12, MP47-16, MP44-01, MP41-06, PD33-10, PD35-04, MP65-02, MP62-09, MP68-11, PD43-07, PD45-12, PD42-01, MP72-10, PD48-06, PD48-07, MP82-09, MP87-15, MP87-18, MP88-08 Clusterin MP39-08, MP37-12, MP46-15 Combination therapy MP26-12, MP26-20, PD16-07, MP39-11, PD27-03, MP49-20, MP61-12, MP87-12 Complementary medicine MP24-10 Complications PD2-02, PD1-08, MP7-01, MP7-08, MP5-03, MP5-06, MP5-18, MP5-20, V2-09, MP13-14, MP13-16, MP9-04, MP9-13, MP9-15, MP9-16, MP10-17, MP16-12, MP15-13, PD8-03, PD8-05, PD9-06, PD9-08, PD9-10, PD10-12, MP22-06, MP22-07, MP18-09, PD11-02, MP26-14, MP24-18, MP25-19, MP28-08, PD15-05, MP30-06, MP30-16, MP30-20, MP29-08, MP29-10, MP38-11, PD22-06, PD25-06, MP48-11, PD28-04, PD28-09, PD28-12, MP57-02, MP57-17, MP54-15, V8-12, MP59-09, MP59-18, MP65-15, MP64-10, MP64-12, MP64-14, MP64-16, MP63-06, PD38-09, PD40-09, MP67-03, MP67-06, MP67-09, MP67-11, MP67-13, MP67-15, MP69-05, MP70-04, MP70-12, MP70-16, PD42-10, MP72-13, MP75-14, PD49-04, MP77-02, MP79-13, MP79-15, MP79-18, MP79-20, PD50-06, MP84-10, MP84-11, MP84-20, MP86-01, MP88-09 Computer assisted surgery MP23-11 Computer modeling MP11-13, PD7-04, MP22-03, MP22-04, MP27-08, MP23-09, MP34-06, MP70-04 Computerized tomography PD4-01, MP11-02, MP10-07, MP35-13, MP35-16, MP38-06, FRI-07, MP50-05, MP61-14, MP73-18, MP75-17, MP75-18, MP75-19, MP75-20, MP87-08, MP89-11, PD51-10 Contractility PD7-03, MP21-06, MP31-09, MP31-10, MP89-07 Contrast agent PD4-05, MP48-03, MP80-15 Corpus cavernosum PD2-05, PD22-03 Cost PD5-07, MP9-17, MP9-18, MP16-07, MP16-08, MP16-14, MP17-11, MP15-03, PD12-06, PD12-11, MP24-08, MP24-15, MP24-20, MP25-09, MP28-02, MP28-06, MP28-13, MP28-19, PD16-09, MP32-02, MP32-05, MP32-06, MP32-08, MP32-10, MP32-12, MP32-13, PD18-05, MP40-20, MP50-02, MP57-01, MP54-03, MP54-19, MP64-16, PD44-04, MP72-05, MP74-07, MP73-02, MP75-15, PD49-03, MP78-05, MP80-11, MP80-12, MP79-06, PD52-09, PD51-10 Cryoablation MP57-06, MP57-13, PD40-04, MP70-07, PD47-05, MP82-12, MP84-15, MP83-04 Cryotherapy MP59-08, MP62-19, PD40-04, MP78-08 Cryptorchidism MP17-18, V3-10, MP76-07 Cyst MP25-04, MP35-12 Cystectomy MP5-02, MP5-05, PD8-03, PD9-02, PD9-03, PD9-04, PD9-05, PD9-08, PD9-11, PD12-12, PD11-04, PD11-05, PD11-12, MP26-11, MP26-13, MP26-17, MP24-05, MP24-19, MP27-10, MP32-01, MP32-07, PD17-04, PD18-06, PD19-07, PD25-08, PD25-10, PD31-01, PD31-02, PD31-03, PD31-04, PD31-05, PD31-06, PD31-11, PD31-13, V8-03, V8-04, V8-14, MP58-01, MP58-06, MP58-09, MP58-12, MP58-13, MP58-15, MP58-16, MP58-19, MP58-20, MP65-01, MP65-02, MP65-05, MP65-06, MP65-07, MP65-10, MP65-12, MP65-13, MP65-14, MP65-15, MP65-16, MP65-17, MP65-19, MP65-20, MP64-01, MP64-07, MP64-08, MP64-09, MP64-13, MP64-15, MP64-17, MP64-19, PD41-06, PD41-07, PD41-09, V10-03, MP67-02, MP67-05, MP67-09, MP67-10, MP67-11, MP67-13, MP67-14, MP67-16, MP67-18, MP72-01, MP72-02, MP72-03, MP72-05, MP72-08, MP72-09, MP72-11, 348 MP72-12, MP72-14, MP72-15, MP72-16, MP72-17, MP72-18, MP72-19 Cystitis MP12-02, MP21-02, MP20-02, MP20-04, MP20-05, MP20-12, MP20-17, MP20-18, MP20-19, MP20-20, MP19-12, MP26-02, PD20-01, PD20-02, PD20-04, PD20-12, PD25-12, MP81-03 Cystocele MP81-17, PD50-07 Cystography MP17-19 Cystometry MP8-04, MP8-07, MP12-03, MP12-19 Cystoplasty PD11-08, MP29-07 Cystoscopy MP5-03, MP20-12, MP18-11, PD12-06, MP23-01, PD15-02, PD19-12, PD23-11, PD25-04, PD25-05, FRI-02, MP71-02 Cytokines PD1-11, MP21-17, MP36-07, MP36-14, MP39-18, MP37-03, MP46-18, PD25-12, MP61-05, MP60-20 Cytology MP1-20 D Decision analysis MP1-06, MP9-12, MP16-06, MP17-01, MP14-05, PD27-01, MP57-07, MP59-04, MP70-13, MP75-11, PD47-11, MP77-16, MP78-14, MP79-07, PD51-07 Detrusor MP3-16, MP13-07, MP12-15, MP12-16, PD7-03, PD7-09, MP21-06, MP89-07, MP89-08, MP89-18 Diabetes MP5-08, PD6-03, MP14-14, MP21-14, MP34-10, MP52-03, MP52-06, MP52-08, MP52-10, PD33-04, PD36-11, MP64-04, PD45-03, PD45-06, MP71-19, MP76-08, MP78-16, MP81-12, MP86-07 Diagnosis MP4-18, MP1-03, MP1-19, MP11-07, MP11-12, MP17-07, MP20-10, PD15-07, MP35-05, MP35-11, MP35-16, MP40-05, PD23-03, PD23-09, MP47-15, MP42-11, MP43-03, MP50-07, MP50-08, MP50-09, MP50-17, MP48-01, MP48-07, MP48-09, MP48-10, MP48-14, MP60-06, MP75-18, PD47-04, MP80-18 Diet MP8-06, MP26-01, MP33-06, MP33-17, MP41-18, MP41-20, MP52-20, MP64-06, MP75-04, MP76-13, PD51-03, PD51-04 Diversion PD9-02, PD9-07, PD9-09, PD11-05, PD11-10, V8-02 DNA MP36-01, MP52-19, MP68-12, MP76-17, MP76-19 Donor MP85-01, MP85-03, MP85-07, MP85-15 Doppler imaging PD4-01, MP11-18, MP17-18, MP30-04, PD24-04, MP43-02, MP43-09, MP43-18, MP54-04, PD39-03 Drug therapy MP8-14, MP27-09, MP27-10, PD16-01, PD16-08, PD15-10, MP33-17, MP39-07, MP39-09, MP39-20, MP37-17,

361 MP45-09, MP46-08, MP46-10, MP46-12, MP46-15, MP41-13, PD27-01, PD35-02, PD37-11, MP64-14, MP66-18, PD39-09, MP68-03, MP68-17, MP69-10, MP69-16, MP73-02 Duplex system V7-08 E Economics MP9-16, MP9-19, MP16-01, MP16-16, MP16-17, PD12-09, MP24-17, PD16-09, MP32-03, MP32-05, MP32-09, MP32-11, MP32-20, PD18-06, MP54-14, MP70-13, MP72-05, MP73-13 Ejaculation MP13-01, PD6-07, MP43-12, MP43-14, MP43-16, MP43-17, MP43-19, PD36-11 Electric current MP8-16 Embolization MP84-13 Endoscopy MP13-17, MP17-03, MP15-04, MP20-18, MP22-14, MP26-04, MP25-04, MP23-01, PD15-02, V3-12, PD19-12, MP34-08, PD25-10, PD25-11, V6-14, FRI-02, MP54-15, MP54-16, V8-08, PD42-05, V11-11, MP71-02 Endothelial cells PD20-12, MP36-03, MP43-03 Endourology MP5-04, PD5-06, MP20-14, MP22-09, MP18-20, PD13-05, MP28-09, MP23-03, MP23-05, MP23-14, MP30-06, PD18-10, PD19-02, PD19-03, PD19-04, PD19-05, MP38-08, MP38-12, MP41-02, V6-06, FRII-12, PD42-06, PD42-09, PD42-11, MP80-15 Epidemiology MP4-02, MP4-03, MP4-11, MP4-20, PD2-02, MP5-01, MP5-13, MP5-15, MP9-05, MP10-12, PD6-06, MP14-10, MP18-05, MP18-08, MP24-02, MP24-10, MP32-17, MP32-19, MP40-07, MP34-15, MP42-20, MP41-07, PD26-09, MP50-16, MP50-18, MP52-11, MP51-02, PD28-09, MP54-07, MP61-02, MP63-11, PD39-08, MP70-08, MP71-17, MP75-06, MP76-12, MP77-12, MP80-03, MP80-06, MP80-16, MP81-12, MP87-05, MP87-14, MP86-07, MP89-05, PD52-07 Erectile dysfunction PD2-03, PD2-10, MP14-09, MP19-19, PD14-01, PD14-08, V3-05, MP38-12, MP42-07, MP43-02, MP43-03, MP43-07, MP43-09, MP43-10, MP43-11, MP43-13, MP43-20, PD26-03, PD26-05, PD26-10, PD26-12, FRI-08, MP52-01, MP52-02, MP52-03, MP52-04, MP52-05, MP52-06, MP52-08, MP52-09, MP52-10, MP52-11, MP52-12, MP52-13, MP51-15, MP51-17, MP51-19, MP56-18, V8-13, PD36-02, PD36-04, PD36-05, PD36-06, PD36-07, PD36-09, PD37-10, PD37-11, PD37-12, MP62-19, PD39-12, PD40-01, PD40-02, PD40-07, PD40-08, PD40-09, PD40-10, PD45-03, PD45-10, PD45-11, PD45-12, PD48-01, PD48-05, PD48-08, PD48-10, PD48-12, MP78-03 Estradiol PD39-02, PD45-07 Estrogen MP31-07, MP31-19, MP68-13, MP74-20, PD47-03, MP87-03 Etiology PD8-12, MP21-02, MP25-10, MP31-16, MP34-12, MP43-07, MP75-07 Evidence-based medicine MP4-12, MP9-03, MP9-19, MP22-01, MP27-16, PD19-10, MP43-20, MP41-02, MP51-19, MP56-17 Extracellular matrix MP1-19 F Female urology V2-01, V2-03, V2-08, V2-13, MP12-08, MP22-13, MP18-11, MP24-15, MP32-16, PD21-06, PD27-03, PD28-01, PD28-03, PD28-10, MP81-05, MP81-06, MP81-07, MP81-08, MP81-09, MP81-10, MP81-11, MP81-14, MP81-20, PD50-04, PD50-05, PD50-11 Fertility MP52-18, PD36-12, MP74-16, MP74-19, MP76-12, PD52-06, PD52-11 Fibrosis PD2-05, MP10-05, MP17-17, MP21-15, MP19-18, MP31-01, MP29-04, PD20-12 Fistula V2-07, V2-13, PD11-01, PD14-02, PD14-09, MP29-05, MP29-06, MP29-09, V4-12, MP57-15, V10-03, V10-11, V12-05, MP81-15, PI-01 Flap MP29-03, MP29-05, MP81-16 Fluorescence MP20-15, MP34-07, MP48-02, V8-06, MP61-15, PD42-12 Fusion proteins MP66-15 G Gender MP16-16, MP22-20, MP29-03, MP43-06, PD26-12, FRI-05, FRII-01, MP65-11, PD40-12, MP81-06, MP84-04, PD51-04 Gene therapy PD20-05, MP45-08 Genes MP2-03, MP1-09, PD6-09, MP21-10, MP20-04, PD17-01, MP36-05, MP36-06, MP37-06, MP37-19, MP45-10, MP47-06, MP49-05, MP52-19, MP55-08, MP55-18, MP58-04, MP66-16, MP68-04, MP76-06, MP76-18, MP80-18, PD50-01, MP88-01 Genetics MP1-02, MP7-13, MP6-16, MP17-12, MP31-15, MP36-02, MP36-12, MP35-03, MP35-06, MP37-02, MP37-08, MP37-09, MP37-16, MP37-18, MP34-11, MP34-12, MP45-11, MP47-04, MP47-09, MP47-13, MP47-14, PD33-02, PD33-09, MP61-01, MP61-04, MP61-09, MP60-02, PD36-01, MP64-02, MP66-01, MP66-03, MP66-10, PD38-07, MP68-16, MP68-18, PD44-01, PD45-01, MP76-06, MP76-09, MP76-12, MP76-20, MP86-11, PD52-01, PD52-03, PD52-04 Genitoplasty FRI-04, V7-04 Geriatrics MP16-12, PD16-11, MP60-03, 349 PD39-08, MP71-17, MP84-16 Gleason score MP4-07, MP4-15, MP6-12, MP9-02, MP14-19, MP37-05, MP42-04, MP42-16, MP48-06, MP48-20, MP53-05, MP53-09, MP53-17, MP55-02, MP56-01, MP56-07, MP60-19, PD34-03, PD34-07, MP62-02, PD38-11, PD46-12, PD47-04, MP77-03 Grading PD4-11, MP26-15, MP56-01, MP68-05, MP68-06, MP70-17, MP80-10 Grafts MP10-16, MP29-01, PD48-03, V12-04 Growth factors MP37-12 H Health care MP4-03, MP5-01, MP9-16, PD6-06, MP16-05, MP16-06, MP16-09, MP16-13, MP14-08, MP18-04, PD12-03, MP24-08, MP24-09, MP24-11, MP24-16, MP24-18, MP27-08, PD16-09, MP32-03, MP32-06, MP32-12, MP32-15, MP32-18, MP32-20, PD23-12, PD24-09, PD25-08, MP76-15, PD52-08, PD51-05 Hematuria MP16-05, MP20-19, MP20-20, PD23-11, PD23-12 Hereditary PD30-11, MP83-14 Hernia MP3-10, MP40-13, MP64-11, MP67-06 Histology MP1-20, MP10-04, MP10-13, MP10-15, MP16-17, MP17-13, MP35-04, MP35-07, MP35-11, MP35-13, PD23-03, FRII-06, MP50-06, MP50-17, MP57-20, PD31-07, PD31-08, MP58-10, PD41-01, MP68-08, MP70-18, PD49-09, MP84-06, MP83-03, MP89-14, MP89-19 History FRI-01, FRI-03, FRI-06, FRI-13, FRI-14, FRI-16, FRI-17, FRII-02, FRII-03, FRII-04, FRII-07, FRII-08, FRII-09, FRII-11, FRII-13, FRII-14, MP71-19 Hormonal therapy MP6-11, MP14-07, MP31-08, MP37-01, MP51-05, PD45-01, MP73-01, MP73-03, MP73-04, MP73-05, MP73-09, MP73-11, MP73-15, MP73-18, MP73-19, MP82-15, MP87-01, MP87-03, MP87-04, MP87-14, MP87-17 Hormones MP7-14, MP10-18, MP51-01, MP51-05, MP51-06, MP61-06 Hyaluronic acid MP45-03, MP54-20 Hydronephrosis MP54-05, V11-12 Hyperoxaluria MP33-03, MP33-06, MP33-11 Hypertension PD3-02, MP50-15, MP79-08, PD52-12 Hypogonadism PD2-04, MP9-07, MP21-09, MP24-11, MP27-03, MP25-02, FRI-18, MP52-16, MP51-03, MP51-06, MP51-07, MP51-08, MP51-09, MP51-10, MP51-11, MP51-13, MP51-14, MP51-16, MP56-20, PD37-01, PD37-02,

362 PD37-04, PD37-08, PD37-09, PD39-05, PD45-04, PD45-05, PD45-06, PD45-07, PD45-08, MP71-16, PII-LBA6, PII-LBA7 Hypospadias PD14-09, PD22-09, PD22-10, Hypoxia MP45-09, MP68-09, MP76-01 I ICSI MP27-04, MP74-10, MP74-12 IIEF MP43-14, PD37-05, PD45-10, PD48-12 Ileal neobladder PD9-05, V12-03 Imaging MP2-13, MP7-15, MP5-07, PD3-11, PD4-03, PD4-04, PD4-05, MP9-03, MP11-03, MP11-04, MP11-15, MP11-20, MP10-07, MP12-06, MP12-20, MP17-15, MP17-19, PD8-02, MP22-04, PD13-02, MP28-18, MP23-19, MP33-01, MP30-07, PD20-07, V4-09, MP35-04, MP35-05, MP35-16, MP40-11, MP37-10, PD22-08, PD24-01, PD24-03, PD25-01, MP50-11, MP50-19, MP48-03, MP48-04, MP48-18, MP53-10, MP53-20, MP57-14, MP61-13, MP66-07, MP70-11, PD42-03, MP74-17, MP73-07, MP73-09, PD46-10, MP82-20, MP77-11, MP80-10, PD50-02, MP87-08, MP87-09, MP86-10, MP86-16, MP83-01 Immune system MP4-02, MP26-03, MP31-20, MP39-18, MP47-13, MP47-18, MP55-05, MP55-17, PD31-12, PD33-08, MP59-01, MP87-15 Immunohistochemistry MP7-09, MP7-14, PD7-12, MP31-05, MP31-08, MP36-04, MP39-15, MP45-12, MP49-02, MP49-03, MP49-04, MP52-18, MP55-03, MP55-12, MP55-14, PD31-12, MP61-18, MP68-07, MP83-10, MP89-19 Immunosuppression PD25-07, MP85-08 Immunotherapy MP2-20, MP26-10, MP26-18, PD17-01, PD17-02, PD17-04, PD17-11, MP45-07, MP45-08, MP47-16, MP46-18, PD33-03, PD33-10, MP58-07, MP61-05, MP65-12, MP68-11, MP68-20, MP69-15 Impotence PD2-10, PD26-02, PD26-04, PD26-10, PD45-10 Incontinence MP3-18, PD1-01, PD1-06, MP8-03, MP8-09, MP8-11, MP8-20, V2-02, V2-03, V2-04, V2-05, V2-12, MP11-17, MP11-19, MP12-10, MP17-20, MP14-09, MP15-05, MP15-12, PD10-05, PD10-06, PD10-07, MP21-05, MP19-13, MP19-17, PD11-01, PD11-11, PD15-03, V3-01, V3-02, V3-03, V3-04, MP29-02, MP29-08, V4-03, PD24-05, PD24-06, PD27-03, PD27-04, PD27-05, PD27-08, PD28-01, PD28-02, PD28-03, PD28-04, PD28-05, PD28-06, PD28-07, PD28-10, PD28-11, V7-01, PD40-05, V10-09, PD43-09, MP71-06, V12-13, MP81-04, MP81-08, MP81-09, MP81-10, MP81-11, MP81-20, PD50-03, PD50-08, PD50-09, MP83-05, MP88-03, MP88-04, MP88-05, MP88-06, MP88-08, MP88-10, MP88-13, MP88-14, MP88-16, MP88-18, MP89-01, MP89-02, MP89-03, MP89-10, MP89-13, PI-04 Infection PD2-03, MP8-19, MP9-14, PD8-06, PD8-08, PD8-10, PD8-12, PD9-10, PD10-09, MP20-02, MP20-06, MP20-16, MP25-08, MP25-10, MP25-15, MP25-16, MP25-17, MP25-20, V3-07, V3-08, MP30-03, MP29-14, MP36-06, MP36-09, MP38-05, PD24-07, MP41-16, PD26-02, PD26-04, PD26-08, PD26-09, PD26-11, PD27-09, FRI-03, MP48-11, MP54-08, MP54-18, MP65-13, MP65-14, MP64-13, PD38-09, PD40-07, PD40-11, V10-13, MP68-19, MP67-10, MP75-13, MP78-06, MP80-04, MP86-01, MP85-04, MP85-11, MP88-19 Infertility MP51-11, MP74-03, MP74-04, MP74-05, MP74-08, MP74-09, MP74-10, MP74-18, MP74-19, MP74-20, MP76-05, MP76-17, MP76-18, PD52-03, PD52-05, PD52-07, PD52-08, PD52-09, PD52-10, PD52-11, PD52-12 Instrumentation PD5-03, MP22-15, MP23-16, PD15-11, PD21-01, FRII-06 Insulin-like growth factor MP6-20, MP31-17, MP46-10, MP55-14 Interferon MP69-19 Interleukin MP19-20, MP31-02, MP31-13, MP61-05, PD35-09 International Prostate Symptom Score PD5-03, MP13-20, MP16-11, PD16-08, MP71-13 Intrinsic sphincter deficiency V2-04, PD28-04, PD28-06 Ischemia MP8-08, MP8-12, MP8-14, MP12-17, MP31-02, MP40-10, MP44-09, PD29-11, MP59-12, V9-06, MP63-08, MP63-14, MP79-10 K Kidney MP18-02, MP18-04, MP18-06, MP18-13, MP18-15, MP18-16, MP18-17, MP27-20, MP23-09, MP30-11, MP29-04, MP39-02, V5-02, V6-06, FRI-14, PD29-08, MP57-10, V9-01, V9-04, V9-12, V10-11, MP70-03, V11-02, PD49-09, MP79-02, MP79-04, MP79-10, MP79-15 Kidney calculi PD13-03, PD13-08, PD13-10, PD13-11, PD13-12, MP28-01, MP28-02, MP28-19, MP23-19, MP33-09, MP33-12, MP33-14, MP33-15, MP33-19, MP30-03, MP30-06, MP30-12, MP30-17, MP30-19, MP40-01, MP40-07, MP40-15, MP40-16, MP40-18, MP34-05, MP34-10, MP34-11, MP34-14, MP34-15, MP38-03, MP38-05, MP38-11, MP38-16, MP38-17, MP38-18, MP41-08, MP41-14, V6-01, V6-04, 350 V6-05, V6-07, V6-08, V6-10, V6-11, PD42-02, PD42-12, MP75-02, MP75-03, MP75-04, MP75-15, MP80-05, MP80-07, MP80-09, PD51-01, PD51-03 Kidney cancer MP2-14, MP5-07, MP5-08, MP5-09, PD4-08, MP11-11, MP11-12, MP11-13, MP11-14, MP16-10, MP19-01, MP22-02, MP22-03, MP22-04, PD12-08, MP24-09, MP32-10, PD18-05, PD18-09, MP39-04, MP39-05, MP39-06, MP39-08, MP39-10, MP39-12, MP39-13, MP39-14, MP39-16, MP39-17, MP39-20, MP35-01, MP35-02, MP35-03, MP35-08, MP35-09, MP35-10, MP35-13, MP35-15, MP35-17, MP35-20, V5-04, V5-05, V5-08, V5-10, MP47-01, MP47-02, MP47-03, MP47-04, MP47-07, MP47-08, MP47-09, MP47-10, MP47-12, MP47-13, MP47-14, MP47-16, MP47-18, MP47-20, MP44-03, MP44-05, MP44-07, MP44-09, MP44-10, MP44-11, MP44-12, MP44-13, MP44-15, MP44-18, MP44-20, MP50-03, MP50-05, MP50-06, MP50-08, MP50-09, MP50-10, MP50-11, MP50-12, MP50-13, MP50-14, MP50-16, MP50-17, MP50-20, MP51-07, PD29-02, PD29-04, PD29-06, PD29-09, PD29-10, V7-02, MP57-02, MP57-05, MP57-07, MP57-08, MP57-09, MP57-10, MP57-19, MP57-20, PD33-03, PD33-05, PD33-08, PD33-09, PD33-12, V8-11, MP59-03, MP59-05, MP59-07, MP59-08, MP59-13, MP59-14, MP59-15, PD35-01, PD35-02, PD35-03, PD35-04, PD35-05, PD35-06, PD35-12, V9-02, V9-03, V9-04, V9-06, V9-10, V9-11, MP63-04, MP63-05, MP63-07, MP63-14, MP63-18, MP69-01, MP69-02, MP69-03, MP69-07, MP69-10, MP69-11, MP69-12, MP69-13, MP69-14, MP69-15, MP69-17, MP69-18, MP69-19, MP69-20, MP70-06, MP70-07, MP70-08, MP70-10, MP70-16, MP70-17, MP70-18, MP70-20, PD49-01, PD49-06, PD49-08, PD49-12, MP79-05, MP84-01, MP84-05, MP84-07, MP84-08, MP84-09, MP84-14, MP84-15, MP84-16, MP84-18, MP85-07 Kidney function MP11-13, MP19-02, MP28-16, PD18-07, PD18-10, MP39-07, MP35-07, MP35-08, MP34-15, MP34-19, MP38-16, MP44-02, MP44-05, MP44-09, MP44-19, PD29-09, PD29-11, MP59-04, MP59-14, MP63-02, MP63-03, MP63-17, MP67-08, MP69-07, MP70-19, PD49-10, PD49-11, MP80-09, MP84-01, MP84-13, MP85-03 Kidney transplantation FRI-09, V8-11,

363 MP79-01, MP79-06, MP79-07, MP79-11, MP79-12, MP79-16, MP79-17, MP85-01, MP85-04, MP85-07, MP85-13, MP85-14, MP85-15, MP85-17, MP85-20 Klinefelters syndrome MP74-11, MP76-09, PD52-03 L Laparoscopy PD3-02, PD3-04, PD3-06, V2-13, MP22-06, MP22-07, MP22-11, MP22-14, MP22-17, MP22-19, PD13-06, V3-10, PD18-04, PD18-08, PD18-11, PD19-02, PD19-03, PD19-04, PD19-05, MP40-13, MP38-07, MP38-17, PD21-03, PD21-04, PD21-05, PD21-10, V5-03, V5-05, V5-06, V5-07, V5-08, V5-09, PD29-04, V7-05, V7-10, V7-11, V7-12, MP57-03, MP57-04, MP57-13, MP57-18, V8-12, MP59-11, V9-09, MP63-13, MP62-08, MP62-10, MP67-17, MP70-05, MP70-09, V11-01, V11-05, V11-06, V11-08, V11-10, V11-11, V11-12, MP71-18, PD49-02, V12-06, V12-10, MP79-01, MP81-18 Laser MP3-14, MP3-16, MP3-17, MP3-18, MP3-19, MP3-20, PD5-05, PD5-09, PD5-11, MP13-02, MP13-03, MP13-04, MP13-06, MP13-07, MP13-08, MP13-09, MP13-10, MP13-11, MP13-12, MP13-13, MP13-15, MP13-16, MP13-17, MP13-18, MP13-19, V3-12, MP34-08, V6-13, V6-14, PD28-12, MP57-03, V8-07, V8-08, PD42-05, PD42-06, PD42-07, PD42-08, MP71-05, MP71-06, MP75-05, MP75-10 LH-RH MP73-16 Lithiasis PD4-02, PD12-10, PD13-02, MP28-12, MP30-12, MP40-18, MP34-09, MP38-09, MP41-11, MP41-15, PD42-11, MP75-14, MP80-18, PD51-05, PD51-07 Lithotripsy PD13-08, PD13-10, MP33-12, MP40-01, MP40-09, MP34-08, MP38-02, MP38-03, MP38-06, MP38-09, MP38-10, MP38-11, MP38-14, V6-08, V6-12, V6-14, PD42-02, PD42-03, PD42-04, PD42-05, MP75-14, MP80-11, MP80-12 Lower urinary tract symptoms MP3-01, MP3-02, MP3-12, MP3-16, MP8-05, PD5-01, PD5-08, PD5-10, V2-11, V2-14, MP13-10, MP13-11, MP12-11, PD7-09, MP24-10, V3-14, MP31-06, PD20-11, PD18-01, PD37-07, PD39-01, PD39-02, PD39-03, PD39-05, PD39-06, PD39-07, PD39-08, MP71-03, MP71-04, MP71-07, MP71-12, MP71-13, MP71-16, MP71-17, MP71-18, MP71-19, MP81-04, MP85-12 Lymph node dissection MP2-12, MP2-13, MP2-15, MP2-16, MP4-16, MP5-10, MP10-05, MP10-08, MP10-11, MP10-17, MP14-19, MP24-03, V4-02, MP37-08, MP53-16, PD30-07, MP56-03, MP56-04, PD31-06, PD31-07, V8-09, MP59-20, MP65-02, MP63-04, MP63-20, PD41-09, PD43-05, MP82-03, MP82-06, MP82-20, PI-10 Lymphadenectomy MP2-17, MP7-16, V4-02, MP53-07, MP53-16, MP56-06, PD32-07, PD41-10, PD43-06, MP84-19 M Macrophages MP33-09 MAP kinase MP55-01 Margins MP4-15, PD15-01, MP53-11, MP53-12, MP56-08, MP56-11, PD32-10, MP70-14, PD47-09, MP84-05, MP83-15, MP83-20 Markers MP2-06, MP6-04, MP6-10, MP6-17, MP6-19, MP39-13, MP37-15, PD23-01, MP46-17, MP49-09, MP55-03, MP60-08, MP68-04, MP69-11, PD43-12, MP73-10, MP86-02, MP83-18, MP88-01, PII-LBA3 Medical education MP22-01, MP22-07, MP22-10, MP22-12, MP22-20, MP27-06, MP23-03, MP23-08, MP23-10, MP23-15, MP32-11, PD19-08 Metabolism PD6-09, MP14-15, MP27-03, MP34-03, MP47-17, MP47-19, MP46-02, MP41-19, MP50-04, MP55-16, PD33-01, PD33-04, PD33-11, MP70-02, MP71-08, MP73-18, MP75-09, PD47-10, PD51-08 Metastasis MP2-13, MP2-15, MP4-06, MP4-07, MP4-16, MP1-07, MP1-11, MP1-18, MP7-16, MP5-09, PD3-06, MP14-12, MP14-19, MP36-17, MP35-06, MP37-10, MP37-14, MP45-01, MP45-03, MP47-02, MP47-18, MP44-13, MP46-13, MP46-14, MP46-19, MP49-03, MP49-14, MP53-12, MP53-17, MP56-05, MP56-12, PD31-10, PD33-03, MP58-02, MP58-03, MP59-10, PD35-07, PD35-09, MP65-03, MP66-03, MP66-18, PD38-02, MP69-09, MP69-13, MP69-15, MP69-18, MP69-20, MP70-12, PD43-12, MP73-08, MP73-12, MP73-14, MP82-04, MP82-05, MP82-07, MP82-14, MP82-17, MP84-17, MP87-08, MP87-09, MP87-10, MP87-11, MP87-12, MP87-19 Methylation MP2-01, MP6-14, MP39-12, MP47-08, MP47-11, MP46-12, MP55-10, PD33-06, MP58-03, MP61-01, MP68-06, MP68-12, PD46-07, PD46-09 Microarrays MP6-09, MP37-09, MP34-02, MP45-01, MP45-05, MP46-17, MP49-09, MP52-10, MP55-08, MP66-19 Microscopsy PD15-01, PD15-07, MP33-18, MP74-04, MP74-14 Model MP31-13, MP33-12, V5-04, PD25-08, MP51-02, MP60-07, MP60-18, V9-07, MP68-15, MP67-02 Morbidity MP3-08, MP18-05, MP41-05, 351 PD30-09, PD31-03, MP58-14, MP58-17, MP64-16, MP63-19, MP69-05, MP75-15, PD47-07, MP83-09, MP83-13, MP85-17 Morphogenesis MP19-03 Morphology MP6-14, MP52-20, MP71-15, MP76-13 Mortality MP4-16, MP4-20, MP5-16, MP6-15, MP6-16, MP9-06, MP9-17, MP9-18, PD6-02, PD6-04, MP16-08, MP14-20, PD12-05, MP24-19, MP32-02, MP44-14, MP50-07, MP56-19, MP58-17, MP64-18, MP63-01, MP73-11, PD46-06 Motility PD43-02, MP74-15, PD52-02 MRI PD1-10, PD1-12, PD4-10, PD4-11, MP11-05, MP11-07, MP11-08, MP11-10, MP11-12, MP11-14, MP11-15, MP11-20, MP16-07, MP17-07, MP17-08, MP17-09, MP17-10, MP17-11, MP17-13, MP17-14, MP17-17, MP17-20, MP14-16, PD10-01, PD10-02, MP19-14, MP22-08, PD12-01, PD24-01, MP48-04, MP48-05, MP48-06, MP48-08, MP48-12, MP48-16, MP48-19, MP53-03, MP53-18, MP53-20, PD30-01, PD32-01, PD32-02, PD32-03, PD32-04, MP60-04, MP60-11, PD34-01, PD34-02, PD38-05, PD38-08, PD44-03, PD44-06, PD44-10, PD44-12, PD46-08, PD46-10, PD47-01, MP82-19, MP77-01, MP77-14, MP77-15, MP77-18, PD50-02, MP86-03, MP86-09, MP86-10, MP86-13, MP86-18, MP86-19, MP83-01, MP83-02, MP83-04, MP88-06 Muscle MP21-08, MP29-18, PD24-03 Mutations MP7-12, PD3-05, MP36-12, MP37-06, MP37-16, MP52-19, PD33-02, MP72-20 Myelomeningocele PD10-12 N Nephrectomy MP18-10, PD12-12, MP24-08, PD15-09, MP32-19, PD18-05, PD18-08, MP35-18, MP35-19, MP50-03, MP50-04, MP50-05, PD29-02, PD29-06, PD29-08, V7-02, MP57-04, MP57-15, MP59-01, MP59-03, MP59-06, MP59-09, MP59-13, MP59-16, MP59-18, V9-10, MP63-02, MP63-13, MP63-16, MP63-17, MP63-20, MP69-05, MP70-08, MP70-09, MP70-11, MP70-12, MP70-14, MP70-15, V11-12, PD49-07, PD49-12, MP84-02, MP84-07, MP84-11, MP84-12, MP85-09 Nephrolithiasis PD4-02, PD4-03, MP11-04, MP16-19, MP17-05, MP17-06, PD8-04, PD13-01, PD13-07, PD13-09, MP27-07, MP28-13, MP28-14, MP28-16, MP32-04, MP33-01, MP33-02, MP33-04, MP33-07, MP33-09, MP33-11, MP33-13, MP33-16, MP30-01, MP30-08, MP30-14, MP30-16,

364 MP30-17, MP30-20, MP40-02, MP40-08, MP40-11, MP40-18, MP34-02, MP34-06, MP34-07, MP38-03, MP38-05, MP38-06, MP38-13, MP38-15, MP38-20, MP41-05, MP41-13, V6-02, V6-03, V6-09, V6-12, V7-10, PD42-01, MP75-06, MP75-07, MP75-08, MP75-11, MP75-12, MP75-17, MP75-20, MP80-02, MP80-03, MP80-06, MP80-09, MP80-16, MP80-19, PD51-04, PD51-08, PD51-09, PD51-11 Nephrolithotomy MP17-06, PD13-11, MP28-20, MP30-01, MP30-03, MP30-10, MP30-13, MP30-14, MP30-16, MP30-19, MP30-20, MP40-14, MP38-20, V10-14, PD42-04, MP80-13, PD51-01 Nephron sparing surgery MP16-10, MP22-02, PD15-09, PD18-03, PD18-09, MP35-07, MP35-08, V5-06, V5-07, V5-08, V5-09, V5-11, MP44-05, MP44-12, MP44-15, MP50-02, MP50-15, PD29-01, PD29-03, PD29-04, PD29-09, PD29-10, PD29-12, MP57-09, MP57-12, MP57-17, MP57-18, MP59-05, MP59-13, V9-02, V9-03, V9-05, V9-07, V9-08, MP63-03, MP63-06, MP63-12, MP63-14, MP63-15, MP63-16, MP63-19, MP69-14, MP70-02, MP70-04, MP70-06, MP70-13, MP70-19, PD49-02, PD49-03, PD49-04, PD49-05, PD49-08, PD49-10, PD49-11, MP84-02, MP84-04, MP84-05, MP84-06, MP84-13 Nephrostomy V6-11, MP85-19 Nephroureterectomy MP2-07, MP2-16, MP2-19, MP7-01, MP7-05, MP7-06, MP7-08, MP7-09, MP7-12, MP7-18, PD15-05, V5-14, PD29-12, MP57-15, MP59-02, MP63-11, MP70-01, MP84-20 Nerve damage MP21-06, MP52-05, PD36-04, PD36-05 Nerve growth factor MP3-14, MP12-18, MP25-07, MP88-01 Nerve sparing surgery PD18-12, MP44-04, PD47-09, MP78-18, MP83-05 Nerve stimulation MP52-13, MP89-09, MP89-12 Neural network PD1-05, MP11-20, MP12-06, MP12-20, PD10-02, PD20-07, MP58-16 Neuroanatomy MP8-19, PD7-04, PD7-08, PD20-06 Neurobiology MP12-09, MP21-13, MP31-12 Neurogenic bladder PD1-05, PD1-07, MP8-09, MP12-01, MP12-04, MP12-05, MP12-12, MP12-18, PD8-07, PD8-08, PD10-02, PD10-06, PD10-07, PD10-08, PD10-10, PD10-11, PD10-12, MP20-07, MP20-08, PD11-06, PD11-08, PD11-09, PD11-10, MP27-02, V10-08, V12-10, MP89-02 Neurogenic bowel PD10-07 Neuromodulation PD1-12, MP8-15, MP8-17, MP8-18, MP12-01, MP12-07, V3-06, PD20-06, PD27-04, PD27-07, PD27-10, MP89-01, MP89-02, MP89-03, MP89-10, MP89-12 Neurotransmitter MP8-18, MP12-07, MP21-04, MP89-20 Neurotrophins MP21-12, PD27-12 Neurourology PD1-02, PD1-04, MP8-18, MP8-20, PD7-02, PD10-01, PD10-03, MP31-12, MP89-17 Neurovascular bundle PD18-12, V4-07, V4-08 NF B MP46-04, MP66-13 Nitric oxide MP21-09, MP52-14 Nocturia MP21-03, PD16-10, MP89-05, MP89-06 Nomogram MP2-09, MP7-01, PD6-05, MP42-12, PD30-10, MP60-07, PD35-11, MP62-12, PD38-04, PD38-10, PD44-03, MP71-04, MP78-19, MP86-03, MP89-07, MP89-15 NSAID PD6-01, MP41-11, PD34-06 O Obesity MP5-18, MP8-04, MP8-05, MP8-07, MP14-11, MP14-12, MP14-13, MP21-10, MP31-17, MP33-13, MP36-07, MP39-10, MP39-18, MP35-19, MP50-04, MP50-07, MP53-01, PD28-07, MP54-10, MP56-13, MP60-09, MP60-14, PD39-04, PD39-10, MP67-03, MP67-04, MP67-11, MP73-09, V12-14, MP77-19, MP80-13, MP84-11, MP85-17, MP88-07, PI-02 Obstruction MP15-10, MP21-15, MP28-05, MP31-01, MP29-04, MP54-05, V10-12 Oncogene MP36-05, MP36-08, MP39-16, MP37-05, MP37-07, MP37-17, PD33-05 Oncology MP2-11, MP5-11, MP9-09, MP17-16, MP19-07, MP24-18, V4-04, V5-03, MP44-03, MP50-01, MP57-16, MP57-19, MP61-11, MP61-19, PD35-01, MP65-01, MP65-16, MP64-10, MP64-18, MP63-02, MP63-06, MP63-12, MP63-15, MP67-04, MP70-01, PD43-03, PD43-05, PD43-06, V11-03, MP72-17, PD49-06, MP86-20 Orchiectomy MP10-12, MP10-18, FRI-05 Orchiopexy V7-13 Orthotopic bladder PD9-01, PD9-06, PD11-12 Osteoporosis PD16-04, PD37-09, MP73-07 Outcomes MP3-09, MP3-20, MP2-10, MP2-16, MP4-14, PD2-01, MP5-02, MP5-04, MP5-11, MP5-17, MP5-19, MP5-20, PD5-04, MP13-16, MP9-01, MP9-04, MP9-08, MP9-10, MP9-12, MP9-13, MP9-15, MP9-17, MP9-18, MP9-19, MP10-10, PD6-04, MP16-08, MP16-14, MP14-03, MP14-09, MP15-17, MP15-18, PD8-06, PD8-11, PD9-01, PD9-04, PD9-09, PD10-08, MP18-13, MP18-14, MP18-16, 352 PD12-11, PD11-09, MP26-07, MP27-13, MP27-18, MP28-01, MP28-10, MP23-17, PD15-04, PD15-08, PD14-06, PD14-11, MP32-02, MP32-04, MP32-07, MP32-08, MP32-11, MP30-05, MP29-06, MP29-10, MP29-20, PD19-10, V4-06, MP40-08, MP40-09, MP40-17, PD21-02, PD21-06, PD21-07, PD21-12, PD22-01, MP44-12, MP44-13, MP44-15, MP42-07, MP42-08, MP41-04, MP41-11, PD25-09, PD27-10, MP50-01, MP53-20, MP51-07, PD29-03, PD29-07, PD30-05, PD30-08, PD30-10, PD30-11, PD30-12, PD28-07, PD28-11, MP54-07, MP54-11, MP54-19, MP56-02, MP56-06, MP56-07, MP56-12, PD31-05, PD32-10, MP58-11, MP58-13, MP58-14, MP58-19, MP58-20, MP59-01, MP59-15, MP59-20, PD34-09, PD37-10, MP65-17, MP64-06, MP64-07, MP64-12, MP64-15, MP63-08, MP63-10, MP63-12, MP63-15, MP62-01, MP62-06, MP62-07, MP62-19, MP62-20, PD41-01, PD41-07, PD41-10, MP67-02, MP67-05, MP67-17, MP69-02, MP70-03, MP70-20, PD44-05, PD43-01, PD43-04, PD43-08, MP71-09, MP72-11, MP72-19, MP74-20, MP73-17, MP73-19, PD46-04, PD47-07, PD47-08, PD48-08, MP82-01, MP78-18, MP78-20, MP80-17, MP79-06, MP79-14, PD50-10, PD50-12, MP84-03, MP84-12, MP87-05, MP87-09, MP83-07, MP83-19, MP85-01, MP85-04, MP85-05, MP85-20, MP88-08, MP88-20, MP89-01, MP89-09, MP89-10, PD52-08 Oxalate MP33-13, MP34-01, MP34-04, MP34-09, MP34-14, MP34-17, MP41-18 Oxidative stress MP21-18, MP33-18, MP33-19, MP37-15, MP34-05, MP34-13, MP45-13, MP49-12, MP76-07, MP76-16 P Pain MP5-14, PD7-06, MP21-02, MP21-17, PD12-10, MP27-04, MP27-10, MP25-14, MP28-12, V3-06, PD20-03, PD20-06, PD20-09, MP38-14, PD21-10, PD22-12, MP41-01, MP51-18, PD40-03, PD45-05, MP74-06, MP73-08, MP73-17, MP75-10, PI-03 Pathogenesis MP81-02 Pathology PD2-11, MP7-17, MP14-17, MP26-15, PD17-03, MP35-10, MP35-11, MP34-01, MP42-11, MP49-02, MP53-04, MP53-06, MP53-13, MP53-14, PD30-03, MP55-14, MP56-01, MP56-14, MP56-15, PD32-05, MP58-11, MP59-07, MP60-19, PD34-09,

365 PD41-01, PD41-04, PD41-06, PD38-13, MP68-05, MP72-20, MP81-02, MP84-08, MP86-02, MP83-03, MP83-15 Pediatrics MP17-01, MP18-06, PD13-09, MP40-08, MP40-12, MP40-13, MP40-16, MP40-17, MP38-10, FRII-01, FRII-10, V7-03, V7-08, V7-09, V7-13, V7-14, MP54-08, V10-09, MP80-03, MP79-19, MP79-20, PD51-11 Pelvic pain syndrome PD7-05, PD8-09, MP20-05, MP25-02, MP25-05, MP25-13, MP25-14, PD20-07, PD20-08, PD20-09, PD40-04, PD45-09 Pelvic prolapse MP8-10, V2-01, V2-09, MP22-13, MP32-16, PD20-08, FRII-07, MP81-05, MP81-17, MP81-18, PD50-01, PD50-02, PD50-03, PD50-04, PD50-05, PD50-07, PD50-08, PD50-09, PD50-10, PD50-11 Pelvis MP5-10, MP17-20 Penile cancer MP5-10, MP10-03, MP10-06, MP10-11, MP10-16, MP24-03, PD15-07, V8-09 Penis PD2-01, PD2-06, PD2-10, MP16-17, MP18-03, MP18-19, MP25-11, V3-08, V3-11, MP43-01, MP43-02, MP43-07, PD26-01, PD26-05, FRI-06, FRI-17, MP52-03, MP52-08, MP52-15, MP52-16, MP52-17, MP52-20, PD36-09, PD40-06, PD40-11, PD48-02, PD48-11 Percutaneous access PD4-06, MP22-15, MP22-19, PD13-09, PD13-10, MP28-20, MP23-19, MP30-01, MP30-02, MP30-04, MP30-05, MP30-07, MP30-11, MP30-14, MP30-15, MP30-18, MP40-14, MP34-19, MP38-17, MP38-18, MP38-19, MP38-20, PD21-01, V6-04, V6-05, V6-08, V6-10, V6-11, V7-12, MP57-11, MP57-13, MP75-03 PET PD4-07, PD4-09, MP11-16, MP37-10, MP53-08, PD32-06, PD32-07, PD32-08, PD41-12, PD38-12, PD44-12 Peyronies disease MP19-18, MP29-13, MP43-09, MP43-18, PD36-01, PD40-02, PD48-01, PD48-03, PD48-04, PD48-05, PD48-06, PD48-07, PD48-09, PD48-10 Pharmacology MP5-08, MP12-12, MP14-14, PD7-01, PD7-06, PD7-07, PD7-09, MP21-04, MP31-10, MP41-19, MP52-07, MP52-17, MP65-08, MP64-04, PD48-12 Pheochromocytoma PD3-03, PD3-08, PD3-09, PD3-10, V11-03, V11-04, V11-06, V11-07, V11-08, V11-09 Phosphodiesterase inhibitor MP21-09, MP43-20, MP52-06, MP52-14, PD36-06, MP79-10 Physical therapy PD47-06 Physician reimbursement MP16-15, MP24-16 Physiology PD7-03, PD9-12, MP21-13, MP20-06, MP34-20 Polymorphism MP1-02, MP36-01, MP61-02, PD35-08, MP66-10, MP68-16, MP69-03, MP85-13 Pregnancy MP22-20, MP38-01, MP41-05, MP74-13, PD52-04 Priapism PD2-07, PD2-08, PD2-12, V8-13, PD37-12 Prognosis MP2-02, MP2-04, MP2-06, MP2-09, MP2-12, MP2-17, MP1-01, MP1-02, MP1-05, MP1-08, MP1-15, MP1-16, MP7-06, MP7-13, MP7-18, MP6-05, MP6-09, MP6-12, MP6-15, MP8-11, PD4-08, MP11-11, PD6-05, MP14-18, MP25-08, MP25-12, PD17-03, PD17-07, MP35-10, MP35-14, MP35-15, MP35-18, MP35-19, PD23-06, MP45-12, MP45-16, MP44-01, MP44-07, MP44-08, MP44-11, MP44-14, MP44-16, MP42-02, MP42-04, MP50-14, MP53-17, MP56-10, PD31-09, PD31-10, PD33-06, PD32-11, MP58-01, MP58-13, MP58-15, MP58-20, MP60-03, PD35-07, MP65-04, PD38-03, MP68-08, MP68-09, MP67-01, MP70-14, MP70-15, PD44-08, MP72-03, MP72-15, PD49-12, MP77-20, MP84-06, MP85-09, PD51-01 Proliferation MP31-04, MP39-19, MP45-06, MP49-02, MP55-03, MP66-17 Prostaglandins MP21-07 Prostate MP3-10, MP3-17, MP3-19, MP1-13, PD6-01, MP16-09, MP14-17, MP21-01, MP19-20, MP27-19, MP27-20, MP25-15, MP25-19, PD16-03, V3-07, MP31-17, MP31-18, MP31-19, MP31-20, FRII-11, FRII-12, MP48-14, MP51-15, MP56-03, MP66-16, MP66-20, PD39-03, PD38-05, MP71-14, MP71-15, MP71-18, MP77-02, MP86-12, MP85-18 Prostate cancer MP4-01, MP4-05, MP4-06, MP4-09, MP4-11, MP4-12, MP4-14, MP4-17, MP4-18, MP4-20, MP1-01, MP1-03, MP1-04, MP1-08, MP1-09, MP1-11, MP1-12, MP1-14, MP1-18, MP1-20, MP5-13, MP5-15, MP5-16, MP5-17, MP5-18, MP5-20, MP6-02, MP6-03, MP6-04, MP6-11, MP6-14, MP6-16, MP6-17, MP6-19, PD4-09, PD4-11, PD4-12, MP9-01, MP9-03, MP9-20, MP11-05, MP11-06, MP11-07, MP11-09, MP11-10, PD6-03, PD6-06, PD6-11, PD6-12, MP16-03, MP16-07, MP16-09, MP16-20, MP17-07, MP17-08, MP17-09, MP17-10, MP17-11, MP17-12, MP17-14, MP17-15, MP17-16, MP14-03, MP14-04, MP14-05, MP14-08, MP14-11, MP14-14, MP14-15, MP14-16, MP14-17, MP14-20, MP22-05, PD12-01, PD12-02, PD12-03, PD12-04, PD12-05, PD11-02, MP24-02, MP24-06, MP24-07, MP27-12, MP27-13, MP27-14, MP27-15, MP27-16, MP27-17, MP27-18, MP25-03, MP25-18, MP23-02, MP23-17, 353 PD16-02, PD15-01, PD15-03, PD15-04, PD15-11, V3-03, MP32-06, MP32-14, PD18-02, PD19-06, V4-01, V4-02, V4-03, V4-04, V4-05, V4-07, V4-08, V4-09, MP37-01, MP37-03, MP37-07, MP37-08, MP37-13, MP37-15, MP37-16, MP37-17, MP37-20, MP46-01, MP46-02, MP46-03, MP46-05, MP46-06, MP46-07, MP46-08, MP46-11, MP46-13, MP46-14, MP46-15, MP46-16, MP46-18, MP42-01, MP42-02, MP42-03, MP42-06, MP42-08, MP42-09, MP42-10, MP42-11, MP42-12, MP42-15, MP42-16, MP42-17, MP42-18, MP42-19, MP42-20, MP43-04, MP43-13, FRII-09, MP48-01, MP48-04, MP48-05, MP48-08, MP48-09, MP48-10, MP48-12, MP48-13, MP48-15, MP48-16, MP48-17, MP48-18, MP48-19, MP48-20, MP53-01, MP53-03, MP53-05, MP53-06, MP53-08, MP53-09, MP53-12, MP53-18, MP53-19, PD30-01, PD30-02, PD30-05, PD30-07, PD30-08, MP55-01, MP55-02, MP55-04, MP55-05, MP55-07, MP55-09, MP55-10, MP55-11, MP55-12, MP55-13, MP55-15, MP55-16, MP55-17, MP55-19, MP55-20, MP56-02, MP56-04, MP56-05, MP56-06, MP56-07, MP56-09, MP56-10, MP56-14, MP56-17, MP56-18, MP56-19, MP56-20, PD32-01, PD32-02, PD32-03, PD32-08, PD32-09, PD32-12, MP61-01, MP61-02, MP61-03, MP61-06, MP61-09, MP61-10, MP61-11, MP61-12, MP61-13, MP61-15, MP61-16, MP61-19, MP61-20, MP60-01, MP60-03, MP60-04, MP60-05, MP60-06, MP60-07, MP60-10, MP60-11, MP60-13, MP60-15, MP60-17, MP60-18, MP60-19, MP60-20, PD34-02, PD34-04, PD34-07, PD34-08, PD34-11, PD34-12, PD36-06, PD37-10, MP66-02, MP66-06, MP66-08, MP66-09, MP66-10, MP66-11, MP66-12, MP66-13, MP66-14, MP66-17, MP66-19, MP66-20, MP62-01, MP62-03, MP62-06, MP62-07, MP62-08, MP62-14, MP62-17, MP62-18, PD38-01, PD38-02, PD38-03, PD38-06, PD38-08, PD38-11, PD44-01, PD44-02, PD44-03, PD44-05, PD44-06, PD44-07, PD44-08, PD44-09, PD44-10, PD44-11, PD43-02, PD43-06, PD45-04, V11-14, MP71-10, MP73-01, MP73-04, MP73-05, MP73-06, MP73-08, MP73-11, MP73-12, MP73-13, MP73-15, MP73-17, P73-19, MP73-20, PD46-01, PD46-02, MPD46-03, PD46-05, PD46-06, PD46-08, PD46-11, PD47-01, PD47-03, PD47-05, PD47-06, PD47-09, PD47-10, MP82-01, MP82-02, MP82-05, MP82-06, MP82-08,

366 MP82-11, MP82-13, MP82-16, MP82-17, MP82-18, MP77-01, MP77-04, MP77-06, MP77-07, MP77-09, MP77-10, MP77-13, MP77-14, MP77-15, MP77-16, MP77-18, MP77-20, MP78-02, MP78-04, MP78-11, MP78-15, MP78-16, MP78-19, MP79-03, MP87-01, MP87-02, MP87-07, MP87-10, MP87-11, MP87-12, MP87-14, MP87-16, MP87-18, MP87-19, MP87-20, MP86-02, MP86-03, MP86-05, MP86-06, MP86-08, MP86-09, MP86-11, MP86-13, MP86-14, MP86-15, MP86-19, MP86-20, MP83-01, MP83-02, MP83-03, MP83-05, MP83-07, MP83-10, MP83-13, MP83-16, MP83-17, MP83-20, MP85-05, MP85-08, MP85-10, MP88-03, MP88-10, PI-01, PI-08, PII-LBA2, PII-LBA3, PII-LBA4, PII-LBA10 Prostate enucleation MP3-11, MP3-15, MP3-17, PD5-06, MP13-01, MP13-03, MP13-04, MP13-05, MP13-08, MP13-09, MP13-19, V3-13, V3-14, MP71-10 Prostate specific membrane antigen MP53-08, PD32-06, PD32-07, MP60-14, PD46-05, MP82-09, MP82-10, MP86-06, MP86-14 Prostate stroma MP1-13, MP6-10, MP37-04, MP46-06 Prostate vaporization MP3-20, PD5-02, PD5-08, PD5-10, MP13-02, MP13-13, MP13-14, MP13-18 Prostate volume MP13-14, MP13-18, MP22-18, MP62-13, MP71-01, MP71-08, MP82-19, MP86-14 Prostatectomy MP3-05, MP3-06, MP4-11, MP4-19, MP1-11, MP1-16, MP5-16, MP5-19, MP6-05, MP6-07, MP6-18, PD5-02, PD5-07, MP13-03, MP9-04, PD6-10, MP17-14, MP17-17, MP14-10, MP15-04, MP15-08, MP19-19, PD12-12, MP23-13, PD14-03, V3-13, MP32-19, MP29-02, PD18-01, PD18-02, PD18-11, PD18-12, PD19-01, PD19-06, V4-03, V4-06, V4-13, V4-14, MP42-08, MP42-14, MP42-17, MP43-04, MP43-13, MP53-10, MP53-11, MP53-14, MP51-18, PD30-06, PD30-10, PD30-12, MP56-09, MP56-15, MP56-19, PD32-05, PD32-10, PD36-05, PD37-11, PD37-12, MP62-02, MP62-10, MP62-14, PD44-10, PD43-04, PD43-08, PD43-09, PD43-12, PD46-12, PD47-02, PD47-03, PD47-10, PD47-12, PD48-01, MP82-18, MP82-20, MP78-07, MP78-09, MP78-10, MP78-12, MP78-17, MP78-18, MP78-20, MP83-06, MP83-07, MP83-08, MP83-11, MP83-15, MP83-16, MP83-18, MP88-04, MP88-05, PII-LBA5 Prostatic intraepithelial neoplasia MP6-01, PD38-13, MP77-18 Prostatitis PD6-08, PD8-09, MP27-04, MP25-01, MP25-03, MP25-04, MP25-05, MP25-06, PD20-01, MP42-02, MP71-11 Prosthesis PD2-02, PD2-03, PD2-09, MP29-03, PD26-01, PD26-02, PD26-03, PD26-04, PD26-05, PD26-06, PD26-07, PD26-08, PD26-09, PD26-11, V8-13, PD40-06, PD40-07, PD40-08, PD40-10, PD40-11, PD48-09, PD48-10 Proteins V3-05, MP47-20, MP61-09 Proteome MP35-01, MP40-15, MP68-07, MP76-16, MP80-19 PSA MP4-09, MP4-10, MP1-13, MP5-12, MP6-04, MP6-08, PD6-08, MP16-20, PD16-01, MP32-17, MP43-15, MP48-17, MP53-02, MP56-05, MP60-01, MP60-02, MP60-09, MP60-10, MP60-12, MP60-13, MP60-15, MP60-16, MP60-18, PD34-04, MP62-15, PD38-01, PD38-07, PD38-11, PD44-01, PD44-02, V11-14, MP73-12, MP73-15, PD46-02, PD46-03, PD46-04, MP82-15, MP77-04, MP77-05, MP77-08, MP77-09, MP77-10, MP77-12, MP77-13, MP77-19, MP79-03, MP87-13, MP87-15, MP87-16, MP87-19, MP86-05, MP86-07, MP86-08, MP85-10, PII-LBA2, PII-LBA4 PSA density MP71-10, PD47-02 Psychological stress MP27-12, MP27-15, PD19-11, PD34-12, MP81-04, MP83-14 Psychosocial factors MP27-14, MP32-14, MP42-19, FRII-14, MP83-14, MP89-09 Pyelonephritis MP20-01 Pyeloplasty PD21-04, PD21-09, PD21-12, V6-09, MP54-18, V9-12, V9-13, V10-04, V10-12 Q Quality control MP4-03, MP16-03, MP16-04, MP14-10, MP15-17, MP20-09, MP32-01, MP32-04, MP32-09, MP32-12, MP32-15, MP30-10, PD21-07, MP41-10, MP56-17, PD31-06, MP65-10, MP64-08, MP63-18, MP63-19, PD47-12, PD48-05 Quality of life MP3-01, MP3-12, MP4-05, PD2-09, PD3-12, PD5-01, MP9-10, MP16-14, MP16-15, MP16-16, MP14-01, MP14-02, MP14-04, PD9-02, PD9-03, PD9-04, PD12-03, MP27-08, MP27-09, MP27-12, MP27-14, MP27-15, MP27-16, MP27-17, PD15-12, PD18-01, MP38-08, MP42-01, MP42-13, MP42-19, MP43-05, PD27-07, FRI-04, PD34-08, MP67-20, MP69-08, MP71-11, MP72-18, MP72-19, MP73-02, PD47-11, MP78-11, MP84-12, MP83-11, MP83-19, MP85-15, MP85-18, MP88-04, MP88-09, PD51-06, PII-LBA4, PII-LBA5 Questionnaire MP16-15, MP14-04, PD9-01, MP22-16, MP27-07, MP27-13, MP23-07, MP23-10, MP23-14, 354 MP38-12, MP43-05, MP41-19, MP41-20, MP51-14, MP54-12, PD32-11, MP72-18, MP75-11, PD48-07, MP83-11, MP83-19, PD51-07 R Race MP1-05, MP16-02, MP14-15, PD12-10, MP24-02, MP43-12, PD26-07, FRI-13, MP53-19, PD30-12, MP55-18, MP61-16, MP61-20, MP60-12, MP60-16, MP70-18, PD43-09, PD43-10, MP77-05, MP77-07, MP77-13, MP79-04, MP84-04, PD51-05 Radiation therapy MP4-12, MP9-11, PD6-10, PD6-11, MP20-17, MP20-18, MP20-19, MP18-09, PD12-05, PD12-07, PD11-01, PD11-02, MP26-12, MP24-05, MP24-06, MP24-07, MP29-05, MP29-12, MP39-05, PD22-06, PD22-07, MP46-19, MP42-13, PD30-04, MP56-04, PD31-04, PD31-05, PD33-10, MP62-11, MP62-12, MP62-14, MP62-15, MP62-16, MP62-17, MP62-18, PD43-01, MP72-03, MP72-12, MP82-05, MP82-07, MP78-07, MP78-10, MP78-11, MP83-13, MP88-10, MP88-11, MP89-13 Radio frequency ablation MP50-19, MP57-06, MP57-19, MP70-07, PD49-03, PD49-05, MP84-15 Radiography PD4-03, PD4-04, PD4-09, MP17-05, MP17-06, MP28-18, MP23-14, V6-06, FRI-07, MP58-08, MP63-07 Reactive oxygen species MP40-15 Receptors MP7-14, MP45-04, PD33-04 Reconstructive surgery PD2-01, V2-01, V2-03, V2-06, MP15-05, MP15-20, PD9-09, MP22-06, MP22-13, PD11-04, PD11-11, MP27-05, PD14-02, PD14-03, V3-05, MP29-06, MP29-13, MP29-18, MP29-19, V4-10, V4-12, PD22-02, PD22-10, PD22-12, V7-04, V7-05, MP64-11, V10-07, MP70-19, PD48-02, PD48-03, PD48-11, V12-02, V12-06, V12-14, MP79-02, MP81-15, PD50-04, PD50-06, MP88-13 Reflux MP17-19, MP54-03, MP54-16, MP79-15 Renal failure MP7-15, MP20-16, MP29-10, MP44-02, MP44-04, PD29-08, MP54-01, MP59-05, MP59-14, MP59-17, MP64-15, MP63-03, MP69-14, MP72-09, PD49-05, PD49-07, MP84-02, MP84-03, MP85-09 Renal surgery MP22-03, MP32-10, MP30-12, MP35-09, MP35-12, MP40-14, PD21-01, V5-01, V5-03, V5-06, V5-07, V5-09, V5-10, V5-11, V5-12, V5-13, MP44-19, MP50-03, PD29-01, PD29-10, PD29-11, V7-03, MP57-01, MP57-03, MP57-11, MP57-14, MP57-16, MP59-04, MP59-11, PD35-12, V9-09, V9-11, V9-14, MP63-01, MP63-08, V10-14,

367 MP70-05, MP70-10, PD49-08, PD49-09, MP79-08, MP84-09, MP84-10, MP84-17, MP84-18 Retroperitoneoscopy MP57-05, V11-07 Retroperitoneum MP10-02, MP10-09, MP10-13, MP10-19, MP53-07, V8-01, MP59-20, V11-03, V11-09, V12-06, MP84-18 Robotics MP3-05, MP3-06, MP4-19, PD3-01, PD3-06, V2-05, V2-08, MP9-20, PD6-12, MP15-20, PD9-07, PD9-08, MP22-05, MP22-10, MP22-11, MP22-17, PD13-03, PD13-11, MP27-19, MP23-02, MP23-04, MP23-06, MP23-08, MP23-09, MP23-10, MP23-12, MP23-13, MP23-15, MP23-17, PD15-04, PD15-05, PD15-06, PD15-08, PD15-09, PD15-11, V3-02, V3-11, MP29-01, PD18-02, PD18-03, PD18-08, PD18-09, PD18-11, PD19-01, PD19-06, PD19-07, PD19-08, PD19-10, V4-01, V4-04, V4-05, V4-06, V4-07, V4-08, V4-10, V4-11, V4-12, V4-13, V4-14, PD21-02, PD21-06, PD21-07, V5-04, V5-11, V5-13, V6-01, V6-02, V6-03, MP50-15, PD29-03, PD30-05, PD30-08, V7-02, V7-03, V7-07, V7-11, V7-13, MP57-02, MP57-05, MP57-09, MP57-12, MP57-16, MP54-19, PD31-04, V8-01, V8-02, V8-03, V8-04, V8-05, V8-09, V8-10, V8-11, V8-14, MP59-06, MP59-15, V9-01, V9-02, V9-03, V9-04, V9-05, V9-06, V9-07, V9-08, V9-09, V9-10, V9-11, V9-12, V9-13, V9-14, MP65-03, MP63-05, MP63-10, MP63-13, MP63-16, MP62-01, MP62-02, MP62-04, MP62-05, MP62-06, MP62-08, MP62-15, MP62-20, PD40-03, V10-01, V10-03, V10-04, V10-05, V10-07, V10-12, V10-14, MP67-18, MP67-19, MP70-02, MP70-06, MP70-10, MP70-16, PD43-04, PD43-07, V11-02, V11-04, MP72-17, PD49-02, V12-03, V12-07, V12-08, V12-09, MP82-13, MP82-16, MP82-17, MP78-05, MP78-06, MP78-19, MP79-14, PD50-10, PD50-12, MP83-12, MP88-05 RT-PCR MP49-08 S Sacral stimulation V2-10, MP31-03, PD27-02, PD27-09, MP89-04, MP89-11 Screening MP4-18, PD1-09, MP5-13, PD6-08, PD12-02, MP25-09, MP32-17, MP40-19, MP40-20, PD23-02, MP43-10, MP43-16, MP60-01, MP60-10, MP60-15, MP64-05, PD38-02, PD38-06, PD38-07, MP69-04, PD44-02, PD44-05, PD44-11, PD46-02, PD46-05, PD46-06, PD46-08, MP77-04, MP77-07, MP77-09, MP77-10, MP77-12, MP77-16, MP86-06, MP86-08, MP86-11, MP86-12, PD52-01 Scrotum MP18-12, MP25-08, MP40-17, PD26-08, FRII-04, PI-03 SEER MP4-01, MP5-09, MP5-11, MP5-15, MP9-10, MP10-04, MP10-06, MP10-09, MP14-08, MP26-15, MP24-01, PD23-10, MP50-16, PD29-02, PD30-03, PD31-08, MP78-01 Semen quality score MP40-06, MP76-17, PD52-12 Sensory nerves PD36-10 Serotonin MP31-16 Sex hormones MP51-08, MP51-10 Sexual dysfunction MP12-13, PD14-08, PD20-08, MP43-04, MP43-16, MP43-17, MP43-19, PD26-01, PD26-06, PD26-12, MP52-02, MP52-14, MP52-16, MP51-16, MP51-18, PD36-03, PD36-07, PD37-05, PD40-05, PD40-09, PD48-02, PD48-11, PD50-08 Sexual function MP3-01, PD5-01, PD5-12, MP14-06, MP27-11, PD15-12, MP43-01, MP43-06, MP43-08, FRII-14, MP52-07, MP52-17, MP51-01, PD36-03, PD39-01, PD40-08, PD40-12, PD47-11, MP81-16, PD50-03 Signal transduction MP12-14, MP39-06, MP37-01, MP37-04, MP37-13, MP45-15, MP46-02, MP46-03, MP46-05, MP49-07, MP66-09, MP76-14 Sleep MP21-03, PD37-07, PD39-06, MP80-14 Sling V2-02, V2-04, PD15-03, V3-04, PD28-03, PD28-05, PD28-06, PD28-08, PD28-09, PD28-10, PD28-11, PD28-12, PD40-05, V10-09, MP81-07, MP81-09, MP81-10, MP81-11, PD50-09, MP88-03, MP88-06, MP88-09, PI-05 Smoking MP2-08, MP9-08, MP9-09, MP26-19, PD17-08, MP36-02, MP50-06, MP64-03, MP78-12, PD51-03 Spectroscopy MP47-19, MP48-02 Sperm V3-09, MP74-08, MP74-12, MP74-13, MP74-15, MP74-17, MP74-19, MP76-02, MP76-11, MP76-16, MP76-19, PD52-02, PD52-05 Spermatogenesis MP51-20, PD36-12, MP74-11, MP76-03, MP76-04, MP76-10, MP76-18 Spinal cord injury PD1-03, PD1-06, PD1-09, PD1-10, PD1-11, MP21-16, MP21-20, PD11-08, MP43-17, MP74-15 Staging MP2-11, MP2-12, MP1-10, MP7-05, MP7-13, MP6-06, MP11-10, MP17-03, MP17-09, MP14-18, MP26-04, MP24-09, PD23-05, PD23-08, MP44-11, MP50-14, MP48-15, MP53-02, MP53-03, MP53-07, MP53-19, PD30-07, MP58-12, MP60-13, MP64-20, MP63-20, PD41-02, PD41-04, PD41-05, PD41-08, PD41-12, MP68-18, MP70-17, PD46-10 Statistics MP4-13, MP32-13 Stem cells MP8-03, MP8-10, MP21-08, MP20-05, MP19-07, MP19-08, MP19-09, MP19-11, MP19-12, MP19-16, MP19-17, MP19-18, 355 MP19-19, MP37-19, MP45-18, MP49-05, MP49-17, MP52-01, MP52-02, MP61-03, PD36-12, MP74-16 Stents MP3-13, PD9-10, MP20-13, MP18-17, PD13-04, PD13-05, MP27-01, MP33-08, MP38-15, MP41-16, PD40-01, MP80-12, MP79-17, MP79-18 Stoma PD11-06, MP55-02, V12-14 Stricture MP13-05, MP15-01, MP15-02, MP15-04, MP15-06, MP15-07, MP15-10, MP15-11, MP15-12, MP15-15, MP15-18, MP19-16, PD14-01, PD14-04, PD14-05, PD14-11, MP29-11, MP29-14, MP29-15, MP29-16, MP29-17, PD22-01, PD22-04, PD22-07, PD22-08, PD22-12, V12-02, V12-12, MP79-17, MP81-14, MP85-02 Surgery MP3-09, MP2-15, MP1-04, PD2-11, MP7-07, MP5-06, PD3-01, PD3-04, MP13-06, MP13-20, MP9-08, MP9-14, MP9-20, MP10-01, MP10-02, MP10-06, PD6-11, PD6-12, MP16-01, MP16-13, PD8-10, MP22-05, MP18-01, PD12-11, PD13-03, PD13-06, PD11-03, MP26-14, MP24-04, MP24-06, MP24-17, MP24-20, MP28-07, MP28-19, MP23-02, MP23-04, MP23-06, MP23-12, MP23-13, MP23-18, V3-04, V3-06, V3-09, MP32-05, MP32-08, MP32-18, MP30-10, MP30-19, PD20-10, PD20-11, PD19-08, MP38-16, MP38-18, PD22-06, V5-05, MP44-10, MP42-07, MP42-14, PD26-10, PD26-11, PD27-09, V6-05, V6-10, FRI-01, FRI-14, PD29-05, MP57-04, MP57-08, MP57-12, MP56-16, V8-07, V8-12, MP58-05, MP58-17, MP59-19, PD34-10, MP64-11, MP64-13, MP63-07, MP62-04, MP62-05, MP62-10, MP62-18, MP62-20, PD40-02, MP68-19, MP67-05, MP67-07, MP67-09, MP67-15, MP67-17, MP69-09, MP70-05, PD43-01, PD43-05, PD43-10, PD42-08, V11-11, MP71-03, MP71-08, MP74-18, MP75-03, PD49-06, PD48-08, PD48-09, MP82-04, MP82-07, MP82-10, MP82-16, MP78-01, MP78-04, MP78-05, MP78-06, MP78-17, MP81-06, MP81-15, MP81-16, MP81-17, MP84-01, MP85-05, MP85-20, MP88-15, PD51-02, PD51-11 Surveillance MP4-04, MP4-05, MP4-06, MP1-06, MP1-09, MP1-10, MP1-15, MP9-02, MP11-09, MP10-07, MP10-10, PD6-04, PD6-05, MP14-13, MP14-18, MP15-09, PD12-07, MP26-05, MP26-12, MP27-05, MP25-12, PD14-06, MP35-12, MP44-10, MP42-01, MP42-03, MP42-04, MP42-05, MP42-09, MP42-10, MP42-12, MP42-13, MP42-15, MP42-16, MP42-20, MP50-01, MP50-02, MP50-11, PD29-06,

368 PD30-02, PD30-03, PD30-04, PD31-01, PD32-04, MP59-08, MP59-19, MP60-04, PD34-01, PD34-02, PD34-03, PD34-04, PD34-05, PD34-06, PD34-07, PD34-09, PD34-10, MP66-20, PD44-09, PD44-11, MP82-08, MP77-01, MP78-01, MP84-14, MP86-04, MP83-16 Survival MP4-13, MP4-15, MP7-02, MP7-07, MP7-11, MP5-07, MP13-05, MP9-01, MP9-11, MP10-11, MP10-15, MP10-19, PD6-03, PD6-09, MP14-07, MP18-10, MP18-14, PD12-08, MP39-10, MP35-18, MP47-05, MP44-04, MP44-17, MP44-18, MP44-19, MP44-20, MP53-06, PD29-05, PD30-04, PD30-06, MP56-10, MP56-12, PD31-07, PD31-10, MP58-04, MP58-05, MP58-15, MP58-16, MP59-06, MP59-10, MP59-18, MP61-17, PD35-08, MP65-03, MP65-11, MP64-09, MP64-12, MP64-17, MP64-19, MP64-20, MP63-09, MP63-10, MP62-11, MP62-16, PD41-05, PD41-10, MP67-19, MP69-04, MP69-08, MP69-16, MP69-17, MP73-10, PD49-11, PD46-04, MP82-13, MP82-15, MP78-07, MP78-08, MP78-17, MP87-06, MP87-07, MP87-16 Symptom score MP13-20, MP14-07, PD10-01, MP27-17, PD17-09, MP40-05, PD24-02, MP43-12 Symptoms MP27-07, MP25-10, MP33-08, PD20-10, MP44-14, MP44-17, MP71-09, PD47-08, MP89-08, PD51-02, PD51-06 T T lymphocyte MP31-04, MP55-04, MP55-05, MP85-16 Targeted cancer therapies MP19-01, MP36-10, MP36-11, MP39-03, MP39-04, MP35-01, MP46-07, MP49-06, MP49-10, MP55-06, MP55-17, PD33-07, PD33-12, MP61-12, MP61-19, PD35-03, PD35-08, PD35-09, MP66-07, MP66-15, MP68-17, MP69-04, MP69-06, MP69-07, MP69-08, MP69-13, MP69-17, MP69-19, MP82-10, MP83-02 Technology MP3-11, MP22-01, MP22-11, MP22-14, MP22-15, MP22-16, MP22-19, MP26-04, MP23-06, MP23-08, MP23-11, MP23-20, PD15-06, MP32-18, MP29-19, PD19-01, PD19-02, PD19-03, PD19-04, PD19-05, PD19-11, MP39-14, MP40-03, MP38-13, PD24-06, PD24-08, PD25-02, PD25-04, PD26-03, V6-04, V6-12, FRI-01, MP52-01, MP57-10, PD37-06, V9-14, PD42-04, PD42-10, PD42-11, MP88-02 Telemedicine MP16-05, MP22-08, MP22-16, PD12-09, MP23-11, MP23-15, PD19-12 Testis PD2-11, MP17-02, MP17-18, MP18-12, MP18-18, MP25-14, V3-10, MP40-03, MP40-10, MP40-20, FRI-09, V7-12, PD40-03, PD45-09, MP74-09, MP74-11, MP74-17, MP76-01, MP76-08, MP76-11, MP76-13, MP76-19, MP76-20 Testis cancer MP4-01, PD2-09, MP10-01, MP10-02, MP10-04, MP10-05, MP10-08, MP10-09, MP10-10, MP10-12, MP10-13, MP10-14, MP10-15, MP10-17, MP10-18, MP10-19, PD12-07, MP24-04, PD15-08, MP32-13, V8-01, PD35-06, MP76-04, MP79-05 Testis function MP52-18, MP51-20, MP76-14 Testosterone MP4-09, PD2-06, MP9-07, MP24-11, MP27-03, MP25-01, MP25-02, PD16-04, PD16-11, MP31-18, MP43-15, FRI-18, MP51-01, MP51-02, MP51-03, MP51-04, MP51-05, MP51-06, MP51-08, MP51-09, MP51-10, MP51-11, MP51-12, MP51-13, MP51-14, MP51-17, MP60-05, MP60-14, PD36-08, PD36-11, PD37-01, PD37-02, PD37-03, PD37-04, PD37-05, PD37-06, PD37-07, PD37-08, PD37-09, PD39-02, PD45-01, PD45-02, PD45-03, PD45-04, PD45-05, PD45-07, PD45-08, MP74-18, MP73-16, MP78-04, MP87-03, MP87-06, PII-LBA6, PII-LBA7 Thermotherapy MP55-04 Thrombosis PD2-05, MP9-13, V5-01, MP44-17, MP50-10, PD35-05, PD35-12, PD37-01, MP65-15, MP63-05, MP63-09, MP70-11, MP70-15, MP79-09, MP79-13 Tissue engineering MP19-03, MP19-10, MP29-18, MP52-15 TNM staging MP2-11, MP7-05, MP63-04, PD41-09, MP84-08 Torsion MP16-18, MP40-05, MP40-10, MP40-12 Transitional cell carcinoma MP2-01, MP7-04, PD17-05, V5-14, MP45-07, MP45-20, PD25-02, MP57-11, PD41-04, MP67-10, MP70-01, V11-13 Transplantation PD25-07, V8-10, MP74-16, MP78-20, MP79-02, MP79-04, MP79-09, MP79-14, MP79-16, MP79-19, MP85-02, MP85-03, MP85-08, MP85-10, MP85-11, MP85-16 Transurethral resection of prostate MP3-07, MP3-08, MP3-12, PD5-04, PD5-05, PD5-12, FRII-12, MP62-13, PD43-08, MP89-18 Trauma MP15-14, MP18-02, MP18-03, MP18-04, MP18-05, MP18-06, MP18-08, MP18-10, MP18-12, MP18-13, MP18-14, MP18-15, MP18-16, MP18-17, MP18-18, MP27-05, V3-11, MP29-17, FRI-17, V12-01, V12-08 Tumor MP26-17, MP39-02, PD23-03, PD23-08, V5-02, PD25-11, MP49-01, MP49-19, MP50-13, V8-06, PD35-10, 356 MP63-18, MP68-10, MP70-20, MP84-14 Tumor growth inhibition MP26-01, MP26-08, MP26-09, MP46-01, MP46-20, MP55-15, PD33-11, PD35-10, MP66-13, MP73-04 Tumor markers MP2-04, MP7-10, MP26-06, MP39-19, MP37-05, MP37-20, PD23-05, PD23-06, MP47-12, MP49-03, MP49-04, MP55-12, MP68-06, MP69-11, PD46-01 Tumor suppressor genes MP36-09, MP39-12, MP37-14, MP47-08, MP47-11, MP46-09, MP46-17, MP55-10, MP66-01, MP66-17 Tumor vaccine MP2-20, MP72-10 Tumor volume MP4-07, MP17-13, MP53-01, MP53-13, PD29-01, MP60-12, PD34-03, PD46-01, PD47-04, MP82-11, MP78-13 Tyrosine kinase PD33-08, MP69-02 U Ultrasonography PD4-06, PD4-12, MP11-01, MP11-06, MP11-08, MP11-17, MP11-18, MP17-01, MP17-02, MP17-04, MP17-10, MP17-15, MP15-11, MP22-18, PD15-10, MP39-14, V5-12, MP43-18, PD25-06, FRII-09, MP48-03, MP48-05, MP51-13, MP51-20, PD42-01, PD42-03, MP86-04, MP86-18, PI-03 Ureter MP22-09, MP28-15, MP33-05, MP33-08, MP34-18, MP34-20, PD21-08, FRII-06, V10-11, MP79-20, MP85-02 Ureteral calculi PD4-01, PD13-02, PD13-12, MP28-03, MP28-05, MP28-17, MP30-09, MP38-01, MP38-07, MP38-09, MP38-13, MP38-14, MP38-15, MP41-06, MP41-10, V6-13, FRII-05, PD42-07, MP75-01, MP75-06, MP75-18, MP75-19, MP80-01, MP80-15, MP80-20, PD51-12 Ureteral cancer MP2-07, MP2-14, MP2-17, MP7-02, MP7-08, MP7-18, MP7-20, PD4-07, MP44-03, PD29-12, MP59-02, MP84-19, MP84-20 Ureteral obstruction MP30-09, PD18-07, PD18-10, V4-11, MP38-04, FRII-05, V7-11, MP75-01, MP80-20, MP85-19 Ureteral reconstruction MP15-01, MP29-11, MP29-12, V4-11, V7-09, V10-06, V12-09, V12-11 Ureteral reimplantation V2-07, MP18-07, V4-10, MP54-11 Ureteral surgery MP18-20, MP28-15, MP29-01, MP29-11, MP29-12, MP38-04, V5-14, V10-01, V10-06, V11-10, V12-09, V12-11, MP85-19, MP88-17 Ureteroileal anastomosis PD9-11, MP29-15, MP29-16, V10-10, V12-11 Ureteroneocystostomy MP18-07 Ureteropelvic junction obstruction PD21-04, PD21-12, V6-09, V7-08, V7-09, V9-13, V10-04, V11-10

369 Ureterorenoscopy MP7-04, MP7-19, PD13-01, PD13-05, PD13-07, MP28-06, MP28-07, MP28-14, MP28-16, MP28-18, MP28-20, MP38-07, MP38-10, V6-01, V6-07, PD42-08, MP80-11 Ureteroscopy MP7-07, PD4-07, MP11-03, MP22-09, PD13-01, PD13-07, PD13-12, MP28-01, MP28-02, MP28-03, MP28-04, MP28-05, MP28-06, MP28-08, MP28-09, MP28-10, MP28-11, MP28-12, MP28-13, MP28-15, MP28-17, MP23-01, MP23-05, MP40-09, MP40-11, MP38-01, MP41-01, MP41-07, MP41-16, MP41-17, V6-13, FRII-05, MP59-02, PD42-06, PD42-07, PD42-09, PD42-10, PD42-12, MP75-01, MP75-10, MP75-12, MP75-16, MP80-10 Urethra MP3-13, V2-06, MP15-02, MP15-07, MP15-11, MP15-16, MP15-19, MP17-16, PD7-10, MP21-08, PD14-09, PD14-12, MP31-03, MP29-02, MP29-17, PD22-05, PD22-11, FRI-03, V7-07, MP56-08, MP65-09, PD40-12, V12-05 Urethral obstruction MP15-06, MP15-19, MP19-16, MP27-18, PD22-05, MP89-14, MP89-15 Urethral reconstruction V2-12, MP9-12, MP15-02, MP15-03, MP15-09, MP15-13, MP15-15, MP15-16, MP15-17, MP19-15, MP19-17, MP18-03, PD14-01, PD14-04, PD14-05, PD14-06, PD14-10, PD22-02, PD22-03, PD22-04, PD22-05, PD22-08, PD22-09, V12-01, V12-02, V12-04, V12-05, V12-08, V12-12, V12-13, MP81-13, MP88-07 Urethral sphincter MP8-16, MP19-09, MP19-13, PD14-07, V3-01, MP88-17 Urethrolysis V2-12, V12-13 Urethroplasty MP10-16, MP15-01, MP15-03, MP15-07, MP15-13, MP15-14, MP15-15, MP15-16, MP15-18, PD14-04, PD14-05, PD14-08, PD14-11, PD22-01, PD22-02, PD22-04, PD22-09, PD22-10, V12-01, V12-04, V12-12, MP81-13, MP88-20 Urinary flow MP17-05, PD21-11, PD39-11 Urinary leakage MP8-16, MP15-08, MP24-15, PD15-12, PD24-12, PD27-10, PD27-11, V7-01, MP81-07, MP88-02, MP88-07, MP88-11, MP88-13 Urinary retention MP3-05, PD16-03, PD27-08, FRI-12, MP89-04 Urinary sphincter MP8-03, PD27-11, V10-08, MP88-02, MP88-18 Urinary symptoms MP13-13, PD25-12, PD39-11, MP71-03, MP71-11, MP75-19, MP78-03, MP83-09, MP89-06, MP89-16 Urinary tract cancer MP2-01, MP2-02, MP2-03, MP2-04, MP2-07, MP2-08, MP2-10, MP2-18, MP2-19, MP2-20, MP7-03, MP7-10, MP7-11, MP7-16, MP7-17, MP7-20, MP36-12, PD23-07, PD28-02, V9-01, MP63-11 Urinary tract infection PD1-09, V2-11, MP9-05, PD8-01, PD8-02, PD8-05, PD8-06, PD8-07, PD8-11, MP20-01, MP20-07, MP20-08, MP20-09, MP20-10, MP20-13, MP20-15, PD11-12, MP25-06, MP25-09, PD23-10, PD24-05, FRI-12, MP54-04, MP54-05, MP54-06, MP54-07, MP54-08, MP54-09, MP54-10, MP54-12, MP54-13, MP54-14, MP54-16, MP80-05, MP80-20 Urinary tract obstruction PD1-08, MP11-17, MP30-09, PD28-08, MP80-05, MP79-18 Urinary tract reconstruction MP19-11, PD11-03, PD11-05, PD11-07, MP29-14, PD19-07, PD28-02, V8-03, MP81-13 Urine MP6-01, MP20-09, MP20-13, MP31-13, MP36-14, MP40-02, MP34-04, MP34-10, MP34-16, MP41-08, MP41-12, MP41-14, PD25-03, PD39-04, MP68-14, MP75-04, MP75-07, MP75-08, MP75-09, MP80-02, MP80-16, MP80-17, MP80-19 Urine assay MP33-16, PD23-01, PD23-04, MP45-02, MP45-14, MP47-15, MP44-02, MP44-06, MP49-18, PD46-07 Urodynamics PD1-07, MP11-18, MP12-09, MP12-11, MP15-09, PD7-11, PD9-12, PD10-06, PD21-11, PD24-01, PD24-02, PD24-04, PD24-05, PD24-06, PD24-07, PD24-08, PD24-10, PD24-11, PD24-12, MP71-04, MP71-20, MP89-08, MP89-16 Uroradiology PD4-04, MP17-02, MP17-04, MP35-03, PD25-05, MP48-19, MP81-08, MP81-14 Urothelium MP17-03, PD7-12, MP21-04, MP21-11, MP21-12, MP21-14, MP21-16, MP21-20, MP20-16, MP31-05, PD17-10, MP36-18, MP49-10, MP57-20 V Vaccine PD12-09, MP45-07 Vaginal reconstruction MP81-19, PD50-05, PD50-07 Vaginal surgery V2-05, V2-07, V2-08, MP32-16, MP29-09, MP29-20, FRII-07, PD28-08, MP81-05, MP81-19, PD50-12 Varicocele MP40-06, MP56-20, MP74-14, MP76-01, MP76-02 Varicocelectomy MP40-06, PD36-10, MP74-12, MP74-13, MP74-14 Vascular endothelial growth factor MP39-20, MP40-04 Vasectomy MP23-07, MP23-18, MP43-08, MP74-01, MP74-02, MP74-05, MP74-06, MP74-07 Vasoepididymostomy V3-09, MP74-01, MP74-02, MP74-03, MP74-04 Vena cava V5-01, V5-02, MP44-20, PD35-06, PD35-11, V11-07, PD49-01, MP79-05 Vesicoureteral reflux MP54-01, MP54-02, MP54-04, MP54-10, MP54-11, MP54-15, MP54-17, MP54-20 VHL gene MP39-13, PD33-01 Vitamin MP33-14, MP41-08, MP41-13, MP53-14, MP51-04, MP61-08, MP71-01, MP80-07, PD51-08 Voiding PD1-11, V2-11, MP12-03, MP12-05, MP12-13, MP12-16, MP15-10, PD10-08, PD11-11, PD21-11, PD24-04, PD27-02, PD39-11, MP71-07, MP85-12, MP89-06 W Watchful waiting MP4-04, MP16-11, MP42-06, MP42-10, MP42-18, PD29-07, PD34-11, PD34-12 Xenograft X MP19-13, MP29-13, MP36-17, MP37-12, MP37-14, MP46-20, MP55-20, PD33-11, MP61-14, MP66-15, MP69-01, MP

370 NOTES

371 NOTES

372 VISIT US AT AUA BOOTH 561

373 FOCUSED ON LIFE. DRIVEN BY SCIENCE. MEDIVATION. Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. Visit medivation.com to learn more about our commitment to patients with serious diseases Medivation, Inc. All rights reserved. Printed in USA. PRM-MDV-US /15

374 VISIT US AT AUA BOOTH 561 FOCUSED ON LIFE. DRIVEN BY SCIENCE. MEDIVATION. Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. Visit medivation.com to learn more about our commitment to patients with serious diseases Medivation, Inc. All rights reserved. Printed in USA. PRM-MDV-US /15

375 AUA2015 Meeting Program